Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AACS "ACSF1, FLJ12389, SUR-5" ENSG00000081760 "Acetoacetyl-CoA synthetase" Q86V21 12 125065434-125143333 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 67.1;Excitatory neurons: 59.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058815 Approved Approved Vesicles NA NA "Cluster 44: Non-specific - Transcription" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 29: Early spermatids - Spermatogenesis" Vesicles "HPA058815: AB_2683826" "unprognostic (1.28e-1)" "unprognostic (9.78e-2)" "unprognostic (1.86e-1)" "unprognostic (1.06e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-3)" "unprognostic (6.60e-6)" "unprognostic (3.03e-2)" "unprognostic (3.32e-2)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" "unprognostic (3.04e-1)" "unprognostic (2.69e-2)" "unprognostic (1.69e-1)" "unprognostic (3.73e-2)" "unprognostic (7.71e-2)" "unprognostic (6.80e-2)" 31.7 7.8 6.4 5.6 8.2 3.7 43.4 2.8 11.0 14.6 3.2 12.7 17.9 6.3 8.7 30.9 8.5 7.6 7.4 9.1 3.7 10.3 3.9 6.2 5.8 6.1 3.1 6.0 12.8 9.6 8.5 6.1 6.0 8.6 11.3 6.2 48.2 7.5 5.5 40.4 10.4 5.8 2.4 5.2 16.9 13.5 5.0 10.4 10.0 7.6 10.2 6.1 14.3 6.5 26.8 26.2 11.2 15.3 40.3 26.1 18.7 21.2 20.1 24.6 21.8 34.0 17.4 16.5 21.3 25.7 10.6 28.4 21.0 22.8 13.2 17.8 19.2 13.1 16.9 26.2 33.5 9.4 12.8 29.1 18.2 21.0 21.0 30.8 18.1 9.5 9.4 9.9 15.9 49.1 10.8 12.7 14.2 28.0 30.4 2.1 28.2 23.0 25.0 40.2 29.7 8.6 22.4 35.0 16.6 10.8 26.2 20.7 17.4 11.8 18.7 13.4 16.4 22.0 13.6 18.0 14.8 15.4 13.2 7.7 2.1 5.9 3.3 0.6 4.4 2.4 3.1 2.5 2.4 1.2 4.4 3.0 0.3 5.4 0.7 9.9 2.1 3.4 6.4 8.2 2.8 11.0 9.1 3.7 6.1 3.1 6.0 2.4 5.0 6.5 4.2 6.4 17.3 16.3 4.5 16.6 5.6 14.1 9.1 20.9 23.6 16.9 9.4 17.2 12.0 5.5 27.1 2.1 6.5 14.0 7.9 11.0 67.1 6.3 15.3 6.5 25.2 0.8 59.4 10.7 8.7 11.8 13.3 12.3 2.5 13.1 2.2 4.2 4.8 6.7 28.6 22.0 16.2 4.1 9.0 22.5 9.3 3.9 5.4 5.6 5.4 5.6 5.2 12.1 12.5 9.9 7.4 5.3 12.1 8.2 10.7 6.5 5.7 21.8 0.0 8.6 7.7 22.0 5.3 25.3 28.1 2.5 8.1 20.8 15.8 5.6 AADAC "CES5A1, DAC" ENSG00000114771 "Arylacetamide deacetylase" P22760 3 151814073-151828488 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 224.9;intestine: 241.7;liver: 946.7" "Group enriched" "Detected in some" 8 "Hepatocytes: 687.7;Proximal enterocytes: 460.5" "Cancer enriched" "Detected in many" 22 "liver cancer: 153.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 9.5;ASC diff: 4.2;EFO-21: 4.6;HBEC3-KT: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA002911 Approved NA NA "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" "HPA002911: AB_1078074" "unprognostic (1.26e-1)" "unprognostic (1.82e-2)" "unprognostic (8.11e-2)" "unprognostic (4.41e-2)" "unprognostic (9.23e-2)" "unprognostic (7.82e-2)" "unprognostic (2.15e-1)" "unprognostic (9.89e-2)" "prognostic favorable (5.58e-6)" "prognostic unfavorable (5.02e-4)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.22e-1)" "unprognostic (1.27e-1)" 8.2 224.9 0.0 0.4 0.0 0.0 5.0 0.0 0.1 0.1 0.2 0.3 220.9 0.2 0.0 2.7 0.6 27.4 0.7 0.0 0.0 0.2 946.7 9.1 0.3 0.0 0.1 0.1 36.7 0.0 0.0 1.5 0.0 0.1 0.2 0.0 1.3 0.0 0.0 13.8 241.7 0.0 0.0 0.2 52.3 0.8 0.1 0.4 0.3 0.0 2.5 0.7 0.4 0.0 0.0 9.5 0.0 0.0 4.2 0.1 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.1 4.6 0.0 0.0 0.2 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.5 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.1 1.0 0.4 0.1 0.3 1.7 0.0 1.7 0.1 1.2 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 2.0 0.9 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 6.5 0.0 14.3 0.0 0.7 0.3 0.0 4.4 0.0 0.0 0.0 0.0 1.1 71.4 8.7 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.3 1.8 0.1 0.7 0.0 2.7 0.0 51.9 0.0 39.3 53.5 0.2 0.0 0.0 5.0 687.7 0.2 0.0 0.0 9.6 0.0 14.8 0.3 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 3.9 10.0 0.0 0.1 0.2 460.5 0.0 2.9 0.0 0.0 0.0 3.4 0.0 0.1 1.4 3.4 0.3 0.7 0.3 18.4 0.2 AC008695.1 ENSG00000273217 "Novel protein" 5 131425891-131796983 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 8.2" "Cell line enhanced" "Detected in single" "A549: 2.5" "HPA037982, HPA037983" Uncertain Approved Centrosome,Cytosol NA NA "Cluster 32: T-cells - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" Cytosol Centrosome "HPA037982: AB_10670535, HPA037983: AB_2675769" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.5 0.8 1.9 2.5 0.3 4.4 1.1 2.7 3.0 0.3 1.5 8.2 3.9 0.5 1.9 0.7 0.0 2.3 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 AC010422.5 ENSG00000269590 "Novel protein" 19 12664828-12669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 1.2;lymphoid tissue: 1.4;skeletal muscle: 1.3" "Cell type enhanced" "Detected in single" "Alveolar cells type 2: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "neutrophil: 2.5" "Lineage enhanced" "Detected in single" "granulocytes: 2.5" "Cell line enhanced" "Detected in many" "MCF7: 10.8;RT4: 5.5" HPA065685 Uncertain Approved "Nuclear membrane,Endoplasmic reticulum" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Nuclear membrane, Endoplasmic reticulum" "HPA065685: AB_2685531" 0.1 0.8 0.0 0.4 0.1 0.1 0.0 0.1 0.2 0.0 0.0 0.4 1.2 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.7 1.4 0.1 0.1 0.5 0.0 0.3 0.0 0.3 0.1 0.4 0.0 0.0 0.0 0.1 1.3 0.4 0.3 0.0 0.1 0.2 0.0 0.0 0.1 0.3 0.0 1.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 2.4 0.0 0.3 0.7 0.0 0.0 0.0 0.5 0.0 1.0 0.0 1.6 0.0 0.3 0.7 0.3 0.0 0.0 1.0 0.0 0.0 0.0 0.6 0.0 0.0 1.7 0.0 0.3 0.9 0.1 0.0 0.0 0.1 0.3 2.7 0.0 10.8 2.8 0.3 0.7 0.0 0.0 1.0 0.0 0.0 0.9 5.5 1.6 1.3 0.0 1.3 0.3 0.0 1.7 0.5 0.0 3.7 0.1 1.4 1.7 1.7 2.5 1.3 3.4 0.6 1.5 0.9 0.1 0.7 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 2.5 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC240274.1 ENSG00000271254 "Neuroblastoma breakpoint family member 1" Unmapped 4612-29626 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Spermatocytes: 186.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA038748, HPA038752, HPA042595, HPA043105, HPA043692, HPA044023, HPA046971, HPA058050" Uncertain Approved Microtubules,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol Microtubules "HPA038748: AB_2676188, HPA038752: , HPA042595: , HPA043105: AB_2678318, HPA043692: , HPA044023: AB_2678779, HPA046971: AB_2679883, HPA058050: " 12.0 29.1 16.1 10.4 19.5 9.4 10.9 19.5 17.7 12.7 14.0 21.1 17.0 18.1 13.3 9.6 18.6 12.4 7.9 14.7 18.3 14.9 8.2 12.8 6.6 22.2 19.7 29.6 5.7 18.0 14.6 21.7 11.6 21.8 13.8 11.2 9.2 10.9 11.8 25.0 16.4 18.3 12.9 8.5 40.6 20.5 6.8 12.0 6.8 7.4 8.5 23.5 25.6 33.3 36.9 26.2 12.1 13.2 8.4 37.6 22.7 34.4 28.8 12.2 9.7 20.0 2.9 34.8 11.9 14.0 14.3 7.0 46.2 13.4 29.2 5.4 19.6 16.7 16.4 17.5 11.4 8.7 10.0 19.6 15.6 22.3 9.8 32.6 24.4 6.7 13.5 35.0 21.5 7.5 5.8 3.6 79.2 38.4 23.5 2.9 8.3 14.0 27.3 44.2 37.2 31.0 16.0 10.8 28.1 5.2 13.3 21.2 21.5 53.0 17.1 7.8 28.3 16.1 5.2 26.3 7.6 1.5 0.8 1.1 0.6 0.8 1.1 0.6 0.4 0.4 0.3 0.9 0.6 0.7 0.7 2.3 0.6 0.5 0.0 0.4 16.1 19.5 19.5 17.7 14.7 18.3 22.2 19.7 21.7 18.3 20.5 23.5 2.5 22.4 11.6 0.0 1.4 0.0 1.6 0.0 6.8 2.0 4.3 4.8 0.0 1.5 4.3 0.0 4.2 9.5 0.7 12.9 1.9 2.5 46.1 2.1 3.6 4.4 0.0 5.2 0.0 2.7 12.8 6.4 3.6 1.6 15.2 14.3 2.5 2.7 6.9 0.0 0.0 4.3 0.0 4.2 0.0 11.0 16.8 5.2 0.0 0.0 4.0 2.4 2.1 0.0 0.0 2.8 3.4 18.4 0.6 0.9 5.7 1.6 10.9 1.4 6.6 6.1 2.3 186.6 46.2 5.9 0.0 2.6 1.6 33.3 3.6 0.9 AC244197.3 ENSG00000241489 "Novel protein" X 149477104-149540926 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.2;granulocytes: 5.1;Respiratory ciliated cells: 2.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 15.7" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 60: Granulocytes - Receptor signaling" "unprognostic (1.57e-2)" "unprognostic (2.77e-2)" "unprognostic (5.48e-2)" "unprognostic (4.27e-2)" "unprognostic (4.81e-2)" "unprognostic (9.16e-3)" "unprognostic (4.51e-3)" "unprognostic (1.08e-1)" "unprognostic (2.66e-1)" "unprognostic (1.69e-3)" "unprognostic (4.01e-3)" "unprognostic (4.33e-2)" "unprognostic (1.37e-5)" "unprognostic (1.84e-1)" "unprognostic (2.58e-1)" "unprognostic (3.90e-2)" "unprognostic (3.27e-4)" 8.9 12.7 29.4 7.5 20.4 8.7 10.0 0.0 30.7 12.0 10.3 10.1 9.6 23.6 61.4 9.4 26.4 10.9 17.8 33.0 3.4 10.3 5.1 16.1 9.2 9.7 3.0 24.6 14.9 11.4 45.4 8.3 7.0 17.9 15.0 20.5 17.2 19.4 6.9 20.1 10.2 12.6 0.2 12.6 11.4 8.1 7.6 8.0 15.3 5.7 9.9 11.0 10.7 7.7 5.9 20.1 12.4 4.4 6.3 5.8 2.1 3.8 3.9 3.1 8.9 2.8 9.8 10.2 9.4 8.5 7.8 17.3 1.7 6.4 2.8 11.8 5.9 1.8 15.2 1.5 2.4 2.6 14.3 10.5 5.4 7.7 5.7 18.5 3.5 4.7 1.6 12.6 4.1 15.4 2.3 1.9 1.0 8.4 6.0 2.4 3.1 6.9 8.9 6.2 6.4 6.5 2.7 4.8 1.2 6.4 4.2 2.0 8.9 6.0 7.4 5.5 4.1 11.0 4.6 3.9 8.9 4.7 2.7 0.3 3.1 15.7 5.7 2.9 3.0 1.6 1.8 2.7 1.9 0.9 0.9 0.8 11.5 3.1 5.1 2.0 5.6 5.4 29.4 20.4 0.0 30.7 33.0 3.4 9.7 3.0 7.0 0.2 7.6 7.7 0.0 3.2 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 ACAD9 "MGC14452, NPD002" ENSG00000177646 "Acyl-CoA dehydrogenase family member 9" Q9H845 3 128879596-128924003 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037716, HPA046720" Supported Enhanced Mitochondria No No "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA037716: AB_10673638, HPA046720: AB_2679773" "unprognostic (1.04e-1)" "unprognostic (1.28e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (3.61e-1)" "unprognostic (2.83e-1)" "prognostic unfavorable (3.67e-6)" "unprognostic (1.30e-1)" "unprognostic (3.74e-1)" "unprognostic (3.25e-2)" "unprognostic (1.37e-1)" "unprognostic (6.96e-3)" "prognostic favorable (4.32e-8)" "unprognostic (1.52e-1)" "unprognostic (2.64e-2)" "unprognostic (6.56e-2)" "unprognostic (9.96e-2)" 16.7 20.5 9.0 6.1 8.5 4.7 14.5 9.6 10.2 14.4 9.1 13.6 9.0 14.6 7.7 23.2 12.9 7.3 21.9 8.3 8.7 15.6 20.6 11.0 6.6 8.2 8.7 12.9 14.4 27.7 14.6 8.4 8.4 12.1 9.4 4.1 14.2 12.0 30.4 48.0 11.2 11.1 7.4 12.2 15.9 12.5 8.7 12.1 13.6 28.7 11.2 12.9 14.5 9.0 46.2 22.6 18.0 12.6 28.7 20.7 17.5 22.4 26.2 43.6 36.8 33.3 27.1 33.3 21.1 29.5 29.0 35.5 33.8 45.9 32.8 21.2 23.1 29.3 46.8 24.4 21.6 23.9 10.6 22.5 16.8 23.6 26.7 25.1 35.8 25.2 14.4 11.4 29.5 46.5 36.7 19.0 9.9 49.3 33.8 25.5 17.4 35.1 30.9 25.1 19.0 11.6 37.0 32.9 23.2 17.4 44.5 54.8 18.2 13.2 13.4 14.2 20.3 14.5 5.8 28.3 28.3 21.4 22.7 2.4 15.1 4.9 8.3 18.3 7.8 8.1 7.6 7.3 17.5 5.4 6.2 8.0 0.7 6.8 25.2 9.9 8.3 12.1 9.0 8.5 9.6 10.2 8.3 8.7 8.2 8.7 8.4 7.4 8.7 9.0 10.4 16.0 21.7 13.1 9.3 6.2 11.4 16.7 8.6 14.1 11.9 9.5 30.5 15.7 14.8 14.7 10.4 26.2 10.5 11.7 21.5 20.6 20.2 10.4 11.5 11.2 5.4 14.3 14.3 17.8 18.8 12.9 16.8 12.9 16.5 12.0 15.7 26.7 31.5 10.1 17.7 7.4 16.2 9.5 4.0 17.3 10.2 10.8 16.0 7.5 13.4 15.0 12.3 6.0 12.2 14.1 8.7 14.7 9.5 8.1 9.4 26.3 12.0 11.9 13.1 12.7 14.9 22.6 9.6 13.5 14.2 30.6 8.2 18.1 14.3 8.4 ACTN4 FSGS1 ENSG00000130402 "Actinin alpha 4" O43707 19 38647649-38731589 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Actin-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 626.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 947.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001873, HPA006035" Supported Approved "Nuclear bodies,Actin filaments,Cytosol" NA NA 71000000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies, Actin filaments" Cytosol "HPA001873: AB_1078096, HPA006035: AB_1078095" "unprognostic (1.03e-1)" "unprognostic (6.34e-2)" "unprognostic (2.97e-2)" "unprognostic (2.52e-2)" "unprognostic (2.37e-1)" "unprognostic (3.34e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (1.70e-1)" "unprognostic (5.85e-3)" "prognostic unfavorable (5.65e-4)" "unprognostic (2.99e-1)" "prognostic favorable (5.25e-5)" "unprognostic (6.59e-2)" "unprognostic (1.91e-1)" "unprognostic (6.75e-3)" "unprognostic (6.52e-2)" 176.5 160.8 22.9 63.9 42.0 74.2 151.4 42.9 42.2 165.2 58.5 168.5 128.7 269.4 11.8 232.8 163.2 46.8 89.0 19.5 27.8 166.7 85.0 174.7 37.5 45.9 42.4 102.5 90.6 42.2 80.0 85.7 44.8 115.6 42.2 26.0 148.1 59.0 52.2 183.4 150.3 73.1 30.2 118.1 120.9 23.6 38.1 18.5 105.4 18.8 24.2 150.2 181.3 63.4 364.6 947.0 92.9 48.6 37.7 50.6 237.2 198.7 162.5 178.8 143.9 335.9 265.1 99.0 409.1 260.6 117.4 185.1 57.4 203.8 38.3 238.3 69.5 139.7 356.1 240.4 103.4 101.7 145.2 95.3 63.4 157.5 79.6 146.9 116.4 26.3 165.0 71.8 127.5 221.2 27.2 44.1 78.4 197.8 177.3 89.5 109.4 43.8 174.6 396.3 83.0 49.8 366.3 210.5 94.7 64.0 94.5 78.8 309.7 249.3 138.7 135.3 476.1 44.1 84.5 67.8 231.7 90.6 476.7 7.6 8.1 17.8 13.2 7.7 9.8 3.2 5.7 13.2 7.0 3.0 0.9 4.4 16.9 24.8 6.7 10.8 9.5 10.6 22.9 42.0 42.9 42.2 19.5 27.8 45.9 42.4 44.8 30.2 38.1 63.4 315.2 179.5 120.0 21.5 45.8 234.8 266.4 155.1 153.7 25.6 134.0 148.1 9.2 143.0 119.4 152.6 14.6 123.7 150.7 626.1 19.6 413.5 2.5 272.0 145.7 206.2 162.0 59.3 46.0 419.3 256.7 77.3 219.7 346.4 73.5 75.9 130.6 108.5 72.6 23.5 22.6 365.5 73.2 65.9 103.7 4.5 41.3 75.4 46.2 48.7 162.2 122.4 120.5 35.2 83.6 532.3 425.2 71.5 91.2 322.1 315.5 104.0 122.1 32.3 190.7 97.2 251.0 36.2 23.7 189.3 202.7 168.0 119.4 115.3 280.6 284.7 ADAM32 ENSG00000197140 "ADAM metallopeptidase domain 32" Q8TC27 8 39106990-39284917 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 27.4" "Cell type enhanced" "Detected in many" "Early spermatids: 189.0;Excitatory neurons: 37.3;Late spermatids: 50.5;Spermatocytes: 99.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;MCF7: 1.1;U-2 OS: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA044156, HPA062151" Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 11: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles Nucleoplasm "HPA044156: AB_10796798, HPA062151: AB_2684699" "unprognostic (2.13e-1)" "unprognostic (6.92e-2)" "unprognostic (4.63e-3)" "unprognostic (8.99e-2)" "unprognostic (1.48e-1)" "unprognostic (1.52e-2)" "unprognostic (5.66e-3)" "unprognostic (1.49e-1)" "unprognostic (2.05e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-1)" "unprognostic (3.38e-2)" "unprognostic (1.13e-7)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (8.34e-3)" "unprognostic (7.82e-2)" 1.0 1.0 1.0 0.2 0.9 0.4 1.0 3.2 1.5 0.6 0.0 0.5 0.0 0.4 0.6 0.2 0.5 0.4 0.7 0.9 1.3 0.2 0.0 0.3 0.1 0.1 0.5 0.6 1.8 0.0 0.4 0.1 0.4 0.6 0.4 0.9 0.5 0.3 0.2 0.7 0.2 0.1 0.1 0.7 0.3 27.4 1.0 0.0 0.3 0.1 0.1 0.5 0.4 1.3 0.2 0.4 0.0 0.2 0.6 0.0 0.0 0.4 0.1 0.4 0.2 0.1 0.9 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 1.0 0.1 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.5 0.0 0.1 0.1 0.2 0.5 1.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.0 0.1 0.3 0.0 0.0 0.7 1.3 0.0 0.5 0.0 0.1 0.0 0.2 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 1.0 0.9 3.2 1.5 0.9 1.3 0.1 0.5 0.4 0.1 1.0 1.3 1.0 0.0 0.0 11.8 0.0 0.9 1.1 0.7 0.6 8.2 2.5 2.3 1.7 1.5 0.4 1.8 18.8 0.3 0.1 0.4 0.0 0.4 189.0 5.7 3.6 1.0 4.2 0.0 37.3 1.3 0.2 2.4 0.0 9.8 0.0 3.3 0.7 0.4 0.5 0.0 29.8 1.1 0.0 0.0 1.0 50.5 2.8 0.6 0.0 9.4 0.1 1.0 0.0 18.6 17.6 2.8 0.1 3.0 0.1 1.7 0.0 0.2 1.4 3.8 0.0 3.4 0.9 99.9 2.9 0.5 0.0 0.1 0.2 3.7 1.4 1.5 ADCK5 FLJ35454 ENSG00000173137 "AarF domain containing kinase 5" Q3MIX3 8 144373101-144393242 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 61.7;Theca cells: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025692, HPA028679" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "Plasma membrane, Cytosol" "HPA025692: AB_10599486, HPA028679: AB_10600226" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (8.96e-2)" "unprognostic (1.68e-2)" "unprognostic (1.00e-1)" "unprognostic (2.31e-3)" "unprognostic (6.45e-2)" "unprognostic (2.70e-1)" "unprognostic (4.25e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (1.33e-3)" "unprognostic (1.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-1)" "unprognostic (2.90e-2)" 3.1 9.1 1.3 1.5 1.3 0.9 3.4 1.1 2.6 4.5 0.9 6.7 4.8 3.7 0.2 6.4 3.7 0.5 4.1 1.4 1.1 4.3 6.4 2.8 1.1 1.4 1.1 4.5 5.0 0.8 3.5 0.6 1.3 4.1 0.7 0.5 4.1 0.8 4.0 5.2 8.4 0.4 0.9 5.7 4.4 6.7 1.2 1.1 3.6 0.7 0.5 4.0 4.2 1.2 2.5 3.1 0.7 2.1 0.5 0.5 3.7 2.2 1.2 1.8 0.7 3.6 2.7 1.1 1.5 0.5 0.6 3.2 0.1 2.2 0.1 2.8 1.0 2.9 2.6 3.9 1.6 0.7 2.2 1.0 1.4 0.6 0.7 0.9 1.2 2.1 1.9 1.9 0.9 6.9 2.2 2.9 0.4 2.3 2.3 2.8 1.0 2.0 1.2 2.3 0.4 1.1 3.1 2.4 1.8 0.5 2.1 1.9 0.8 0.8 3.2 2.2 1.5 0.9 0.3 1.0 1.9 2.5 1.3 0.9 2.0 1.2 1.1 2.7 1.3 0.9 1.3 0.8 3.2 2.7 1.3 0.7 0.4 1.0 2.7 2.0 2.1 1.3 1.3 1.3 1.1 2.6 1.4 1.1 1.4 1.1 1.3 0.9 1.2 1.2 5.8 3.2 1.7 4.9 6.5 4.1 3.3 10.2 2.2 10.3 5.0 6.1 2.3 7.2 6.9 5.5 16.7 4.3 6.6 33.5 3.9 9.3 8.2 3.7 4.2 5.0 8.4 3.0 7.6 7.1 11.2 4.5 20.4 4.8 8.9 16.2 2.5 8.2 8.0 3.3 8.3 31.2 12.2 5.5 4.3 11.3 5.9 5.0 3.6 2.8 9.1 6.4 7.2 4.0 2.4 9.5 16.8 7.2 3.7 2.7 61.7 6.9 9.5 16.3 13.1 2.5 4.4 26.5 19.2 4.7 5.1 2.5 4.8 42.3 25.4 3.1 ADCY5 AC5 ENSG00000173175 "Adenylate cyclase 5" O95622 3 123282296-123449090 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "cAMP biosynthesis" Lyase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;heart muscle: 105.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 75.5;Inhibitory neurons: 44.0;Oligodendrocytes: 89.7;Paneth cells: 59.6;Peritubular cells: 73.7;Sertoli cells: 65.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 15.5;RPMI-8226: 2.7;RPTEC TERT1: 5.2" "Region enriched" "Detected in all" 5 "basal ganglia: 388.0" "Region enriched" "Detected in all" 6 "basal ganglia: 155.9" "HPA017730, HPA077682" Uncertain Enhanced "Intermediate filaments" NA NA "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Intermediate filaments" "HPA017730: AB_1844595, HPA077682: AB_2686851" "unprognostic (3.55e-2)" "unprognostic (1.01e-3)" "unprognostic (7.61e-3)" "unprognostic (2.05e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-2)" "unprognostic (1.48e-1)" "unprognostic (7.61e-2)" "unprognostic (2.49e-2)" "unprognostic (2.34e-1)" "unprognostic (7.27e-3)" "unprognostic (2.64e-2)" "prognostic favorable (7.46e-6)" "unprognostic (1.81e-2)" "unprognostic (5.65e-2)" "unprognostic (3.19e-2)" "unprognostic (5.97e-4)" 18.9 3.3 25.5 4.9 97.7 0.0 10.6 13.9 43.9 9.8 0.0 35.1 5.2 14.7 5.7 18.8 12.7 10.0 105.2 25.8 15.9 12.8 3.3 4.1 2.3 20.5 18.3 13.2 7.5 0.8 14.3 6.1 17.4 19.8 5.6 4.5 4.0 21.5 2.7 2.6 13.0 18.2 10.8 6.5 21.2 8.2 34.4 1.3 1.9 5.8 3.0 23.2 7.8 30.1 0.0 0.6 1.3 0.1 0.1 0.1 0.3 0.0 0.0 0.3 0.0 0.1 0.1 0.0 0.3 0.2 2.3 0.5 0.6 0.0 0.0 0.1 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 15.5 0.0 0.0 0.8 0.0 0.1 0.0 0.3 2.7 5.2 0.5 1.8 1.6 0.0 0.5 0.1 1.7 0.0 0.1 0.0 0.1 1.2 0.1 0.2 0.1 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.5 97.7 13.9 43.9 25.8 15.9 20.5 18.3 17.4 10.8 34.4 30.1 0.3 0.0 0.0 8.1 0.1 0.3 0.1 0.2 0.0 21.8 0.4 5.8 75.5 8.6 0.0 7.3 0.0 1.4 0.0 2.6 0.0 15.9 0.9 1.5 7.1 1.8 0.0 0.0 34.0 6.9 4.0 5.2 0.0 4.0 0.0 4.6 3.9 0.1 0.3 0.0 44.0 0.3 0.0 0.0 0.3 3.0 20.5 0.1 0.0 6.5 1.0 1.0 0.0 19.1 89.7 0.4 59.6 73.7 0.0 0.1 0.3 0.8 0.0 2.2 65.7 0.6 21.4 0.8 6.3 0.2 0.9 12.4 0.2 1.0 2.0 0.1 ADGRG6 "FLJ14937, GPR126" ENSG00000112414 "Adhesion G protein-coupled receptor G6" Q86SQ4 6 142301854-142446266 "Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 71.9;placenta: 47.4" "Cell type enhanced" "Detected in many" "Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA017346 Approved NA NA 110000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 15: Hepatocytes - Hemostasis" "HPA017346: AB_1849260" "unprognostic (1.04e-2)" "unprognostic (2.72e-2)" "unprognostic (7.37e-2)" "unprognostic (3.00e-2)" "unprognostic (8.64e-4)" "unprognostic (1.67e-1)" "unprognostic (2.98e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.80e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.78e-5)" "unprognostic (4.46e-1)" "unprognostic (6.49e-2)" "unprognostic (2.15e-1)" "unprognostic (1.36e-2)" "unprognostic (2.97e-2)" "unprognostic (4.59e-2)" 5.8 2.8 2.6 4.1 2.3 0.4 5.2 1.6 1.9 3.0 1.9 6.2 17.5 1.1 1.3 11.6 5.2 8.3 4.0 1.8 1.7 7.2 71.9 15.2 1.7 2.4 2.9 1.4 3.2 1.3 0.3 47.4 2.2 3.2 6.4 0.1 9.0 6.5 0.5 14.5 10.2 2.2 2.5 7.5 12.3 2.1 4.6 4.6 1.6 1.2 4.0 15.1 5.6 1.9 17.0 88.6 1.9 9.4 0.5 0.0 0.2 23.1 4.3 17.2 10.7 71.3 51.0 0.0 20.3 13.4 4.9 41.3 2.6 22.1 28.3 0.0 6.8 3.6 14.5 84.8 16.7 14.6 0.0 0.1 34.9 0.4 81.5 10.0 161.4 0.4 0.6 0.1 6.9 155.6 0.3 0.0 0.7 6.2 20.0 0.0 7.7 17.7 9.0 37.9 0.1 0.1 6.8 30.8 14.5 14.1 16.7 0.3 5.6 0.1 7.6 7.7 11.5 0.0 0.1 0.0 0.1 0.1 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 2.3 1.6 1.9 1.8 1.7 2.4 2.9 2.2 2.5 4.6 1.9 5.1 6.4 5.9 0.0 0.3 0.0 21.9 0.0 18.8 0.0 5.3 2.7 1.9 24.3 8.1 9.2 0.0 5.3 0.0 0.6 0.0 13.2 0.1 0.1 0.5 41.7 0.0 17.0 1.6 5.4 33.5 14.5 32.1 0.5 0.0 0.0 27.1 143.8 2.2 0.0 12.7 3.5 0.0 40.5 0.0 0.6 0.6 8.1 0.0 15.0 0.9 0.0 0.0 0.5 0.3 37.9 8.8 0.4 0.1 18.7 9.5 11.8 2.9 0.0 6.6 0.4 1.3 2.6 5.3 30.2 0.0 13.5 1.6 0.0 1.7 25.0 ADRA2C "ADRA2L2, ADRA2RL2, ADRARL2" ENSG00000184160 "Adrenoceptor alpha 2C" P18825 4 3766348-3768526 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix: 84.9;endometrium 1: 57.6" "Cell type enriched" "Detected in some" 5 "Endometrial stromal cells: 135.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 22.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 13.3;MCF7: 21.9;NTERA-2: 7.4;OE19: 8.6;SCLC-21H: 8.0;SH-SY5Y: 9.7" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "basal ganglia: 34.3" HPA057688 Uncertain NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 36: Stromal cells - Cell proliferation" "HPA057688: AB_2683503" "unprognostic (1.44e-2)" "unprognostic (2.21e-3)" "unprognostic (1.23e-1)" "unprognostic (2.02e-2)" "unprognostic (4.70e-2)" "unprognostic (1.11e-1)" "unprognostic (7.12e-2)" "unprognostic (6.69e-2)" "unprognostic (1.88e-1)" "unprognostic (3.71e-1)" "unprognostic (3.24e-2)" "unprognostic (9.08e-3)" "unprognostic (1.01e-2)" "unprognostic (6.00e-2)" "unprognostic (2.63e-1)" "unprognostic (1.72e-1)" "unprognostic (6.48e-2)" 17.9 3.7 7.6 0.5 22.3 0.0 8.2 3.7 8.8 84.9 3.2 3.1 0.4 57.6 2.2 2.0 22.7 0.4 7.6 6.8 5.5 32.9 0.6 4.1 0.7 5.4 5.7 8.3 3.8 0.2 4.8 3.6 7.1 22.4 0.2 0.8 1.2 18.6 3.5 7.4 3.2 2.1 3.8 22.0 2.4 3.7 8.6 0.4 1.4 1.8 0.1 4.2 14.1 6.4 0.0 4.6 0.1 0.1 0.5 0.0 0.2 0.5 0.0 0.1 0.0 2.4 1.4 0.0 2.3 0.4 0.8 0.0 0.2 0.0 0.0 0.0 6.6 0.0 0.0 13.3 0.6 0.0 0.9 1.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.2 21.9 0.0 0.0 7.4 8.6 0.0 0.0 6.8 0.0 0.0 0.4 8.0 9.7 3.0 0.0 0.1 1.9 7.0 0.1 0.0 0.0 5.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 22.3 3.7 8.8 6.8 5.5 5.4 5.7 7.1 3.8 8.6 6.4 26.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 2.2 1.7 0.8 0.9 1.0 2.8 0.0 12.9 0.0 0.9 0.1 0.1 3.9 0.4 0.0 4.7 135.9 5.4 0.0 0.0 1.2 0.0 0.2 1.4 0.0 2.4 0.0 10.7 1.1 0.0 0.3 3.3 0.6 0.2 0.0 0.0 0.7 0.4 1.5 0.6 0.0 1.0 0.0 5.8 0.0 0.0 0.2 0.1 0.0 3.8 0.0 0.3 0.0 2.4 0.0 0.1 0.0 0.9 5.8 0.1 1.6 0.0 0.0 1.6 0.6 0.0 0.1 0.2 AGO2 "CASC7, EIF2C2, hAGO2, LINC00980, Q10" ENSG00000123908 "Argonaute RISC catalytic component 2" Q9UKV8 8 140520156-140635633 "Enzymes, Plasma proteins, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019309, HPA067849" Approved Supported "Cytosol,Cytoplasmic bodies" NA NA 65000 "Cluster 50: Neutrophils - Cellular senescence" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" "Cytoplasmic bodies" Cytosol "CAB019309: , HPA067849: " "unprognostic (2.75e-2)" "unprognostic (1.79e-3)" "unprognostic (1.27e-1)" "prognostic unfavorable (1.21e-4)" "unprognostic (2.46e-1)" "unprognostic (2.15e-1)" "unprognostic (1.49e-3)" "unprognostic (8.86e-2)" "unprognostic (2.21e-1)" "unprognostic (8.50e-2)" "unprognostic (3.47e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.82e-5)" "unprognostic (1.32e-1)" "unprognostic (2.77e-1)" "unprognostic (1.32e-1)" "unprognostic (3.02e-1)" 7.8 4.1 6.9 6.2 11.5 11.3 5.9 12.4 9.2 6.9 2.4 8.6 3.2 7.7 5.9 6.3 8.3 5.1 7.3 5.7 11.4 5.9 3.8 9.1 6.1 14.0 10.1 9.5 5.0 7.0 8.0 5.8 11.3 5.8 4.0 6.8 4.8 4.6 17.5 8.5 6.2 5.2 5.9 5.2 6.6 3.3 10.8 7.6 6.3 9.1 5.4 6.6 6.7 19.2 18.9 15.2 15.3 17.6 9.9 11.5 12.9 11.6 8.4 5.1 6.3 17.0 5.5 21.5 14.1 11.3 5.5 12.4 26.2 12.5 11.3 12.2 13.7 25.2 28.7 11.0 8.9 10.5 8.2 7.9 11.0 14.1 14.6 7.0 12.0 13.4 26.9 13.2 16.8 28.5 18.2 8.3 11.4 12.9 26.3 18.5 12.9 9.7 6.5 19.3 18.0 13.0 18.1 6.1 12.8 15.7 15.7 15.1 16.9 8.8 24.5 14.0 18.9 11.5 4.0 14.7 6.5 18.7 13.2 0.7 0.8 0.2 0.8 0.7 0.9 0.4 0.8 0.7 0.7 0.7 0.8 0.8 2.2 0.8 0.8 0.5 0.7 0.6 6.9 11.5 12.4 9.2 5.7 11.4 14.0 10.1 11.3 5.9 10.8 19.2 30.8 22.4 25.1 50.3 40.7 21.9 74.8 5.7 17.6 26.5 34.5 24.5 22.2 8.6 22.6 14.7 43.8 46.5 63.1 14.8 7.9 25.6 21.2 73.1 54.3 37.8 24.2 122.9 32.6 18.2 21.5 44.3 28.5 129.4 17.1 31.6 27.5 14.6 14.9 42.1 36.4 19.1 2.0 26.0 48.5 14.9 37.3 53.0 5.4 32.8 36.0 26.1 32.0 51.3 83.2 37.9 18.6 46.3 46.6 115.0 12.7 9.4 15.4 29.7 32.9 65.9 44.5 3.1 4.0 31.8 23.9 79.1 49.1 12.0 19.3 100.1 AHSA1 "Aha1, C14orf3, hAha1, p38" ENSG00000100591 "Activator of HSP90 ATPase activity 1" O95433 14 77457870-77469472 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Stress response" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 345.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000903, CAB006244" Supported Supported Cytosol NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB006244: AB_425858, HPA000903: AB_1078112" "unprognostic (3.91e-1)" "unprognostic (1.92e-1)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (3.48e-1)" "unprognostic (1.49e-3)" "prognostic unfavorable (5.04e-6)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (1.06e-1)" "unprognostic (2.88e-1)" "unprognostic (2.63e-2)" "unprognostic (2.16e-2)" "unprognostic (1.33e-1)" "unprognostic (3.06e-2)" "unprognostic (1.44e-2)" "unprognostic (3.01e-1)" 70.9 99.1 134.7 51.8 136.1 51.0 55.4 142.0 345.7 63.9 135.3 82.4 44.8 80.1 72.3 72.6 120.9 39.4 116.7 134.9 139.1 73.2 71.8 60.8 71.6 141.8 139.3 69.8 50.3 65.5 66.7 76.5 144.0 64.4 71.8 39.1 56.7 70.3 140.2 59.8 54.9 85.0 139.4 55.7 61.9 99.4 142.5 65.2 47.1 118.3 91.4 76.9 61.1 156.2 185.0 356.7 103.1 131.9 159.1 110.3 175.1 131.2 111.6 223.0 165.3 277.0 163.4 361.3 103.0 145.1 258.4 204.7 386.2 186.5 231.8 131.8 207.5 156.1 181.6 343.3 113.7 102.6 230.8 98.3 244.9 150.7 72.2 133.1 209.9 225.3 205.5 115.6 138.5 522.6 278.6 207.8 170.6 347.7 372.9 210.2 110.3 178.1 178.2 187.1 155.0 161.4 119.2 302.9 115.8 154.4 174.4 152.6 100.3 115.3 162.1 126.2 198.7 103.7 241.6 273.8 169.1 211.3 131.1 82.7 51.5 67.9 66.4 74.0 76.9 81.0 59.8 68.0 67.2 63.7 69.0 70.6 39.8 88.7 92.5 66.4 77.2 52.2 134.7 136.1 142.0 345.7 134.9 139.1 141.8 139.3 144.0 139.4 142.5 156.2 46.6 35.3 21.6 10.1 59.4 156.0 208.2 82.8 74.0 36.0 49.9 46.6 92.2 42.9 57.0 27.6 85.5 153.4 66.8 60.0 74.3 74.2 40.6 112.6 60.8 54.9 78.3 55.8 14.6 48.8 113.3 68.3 25.5 59.6 76.2 55.2 28.9 41.0 93.5 18.5 14.7 70.5 65.1 26.7 117.5 34.2 67.7 52.6 90.7 12.2 58.5 46.6 61.8 10.1 23.6 67.8 65.6 66.5 54.1 145.4 56.4 87.0 132.2 54.1 98.6 46.9 135.0 92.0 57.3 67.7 140.1 136.7 92.3 86.0 85.2 120.1 AK7 "CFAP75, FAP75, FLJ32864" ENSG00000140057 "Adenylate kinase 7" Q96M32 14 96392128-96489427 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.3" "Group enriched" "Detected in many" 4 "Endometrial ciliated cells: 97.9;Respiratory ciliated cells: 137.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 23 "basophil: 9.0" "Lineage enriched" "Detected in single" 29 "granulocytes: 9.0" "Cell line enhanced" "Detected in many" "BEWO: 17.0;CAPAN-2: 15.1;MCF7: 49.5;REH: 35.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA003543 Enhanced NA NA "Cluster 38: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA003543: AB_1078117" "unprognostic (4.18e-3)" "unprognostic (1.14e-1)" "unprognostic (9.40e-3)" "prognostic favorable (3.18e-4)" "unprognostic (4.98e-5)" "unprognostic (8.41e-2)" "unprognostic (9.81e-3)" "unprognostic (1.29e-1)" "unprognostic (9.02e-2)" "unprognostic (3.65e-4)" "unprognostic (8.64e-2)" "unprognostic (1.89e-1)" "prognostic favorable (1.14e-4)" "unprognostic (2.00e-2)" "unprognostic (1.23e-2)" "unprognostic (4.01e-2)" "unprognostic (2.25e-3)" 0.7 2.6 2.0 0.6 3.1 1.5 1.4 1.1 1.7 1.7 13.2 2.1 1.9 2.1 3.9 1.5 24.3 2.6 0.7 2.2 5.2 4.5 1.6 4.2 0.6 6.9 9.4 0.4 2.2 6.9 5.1 0.5 5.6 0.9 1.6 3.0 1.0 1.3 0.3 6.1 1.2 1.1 4.4 3.3 2.8 7.6 5.0 0.5 2.7 0.0 0.4 0.5 1.0 4.2 0.2 4.9 2.0 1.5 0.8 2.6 17.0 0.3 0.6 0.3 0.3 0.5 15.1 0.4 0.3 0.0 0.3 1.9 4.7 0.2 0.1 2.2 0.4 0.4 2.4 0.2 0.8 0.1 0.3 0.2 0.6 2.5 0.1 0.8 0.2 1.4 0.2 0.3 0.3 49.5 0.3 0.3 0.8 2.2 1.0 35.2 0.3 0.4 7.6 0.3 3.1 6.7 1.9 0.6 0.1 1.8 4.2 0.2 0.1 0.4 0.2 0.6 0.2 0.6 2.3 0.2 0.2 0.0 0.7 9.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.0 0.2 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.1 2.0 3.1 1.1 1.7 2.2 5.2 6.9 9.4 5.6 4.4 5.0 4.2 1.6 6.4 4.1 0.7 0.8 1.8 0.9 3.6 1.8 0.2 0.9 0.3 0.4 4.3 12.3 7.3 2.1 0.7 0.1 1.4 3.9 3.2 18.7 97.9 1.7 1.9 1.2 6.9 2.0 1.1 1.7 0.8 5.1 11.6 0.0 0.1 0.7 2.4 0.2 0.0 2.4 0.3 4.1 0.3 0.4 4.1 0.0 0.5 1.8 0.0 0.0 0.6 0.0 0.5 3.7 0.5 0.1 0.0 0.0 0.5 1.0 3.4 137.1 1.8 0.0 0.4 1.6 25.4 9.1 0.7 3.0 2.9 0.2 1.5 1.2 0.6 AKAP8 "AKAP95, DKFZp586B1222" ENSG00000105127 "A-kinase anchoring protein 8" O43823 19 15353385-15379815 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004776 Supported Supported Nucleoplasm NA NA 10000 "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA004776: AB_1078122" "unprognostic (9.04e-3)" "unprognostic (3.67e-3)" "unprognostic (1.03e-1)" "unprognostic (4.17e-2)" "unprognostic (8.03e-2)" "unprognostic (1.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.17e-2)" "unprognostic (3.34e-3)" "unprognostic (1.27e-1)" "unprognostic (2.82e-1)" "unprognostic (1.78e-3)" "unprognostic (5.04e-3)" "unprognostic (1.22e-2)" "unprognostic (3.57e-1)" "unprognostic (6.06e-2)" "unprognostic (3.83e-2)" 13.6 10.4 0.1 1.5 0.1 3.1 12.3 0.2 1.0 10.2 0.1 11.7 5.4 12.3 0.0 11.6 11.0 0.0 10.0 0.1 0.1 8.8 12.5 10.3 0.3 0.1 0.1 10.9 10.5 1.5 7.5 0.4 0.1 9.5 0.1 0.3 11.2 1.1 23.0 14.6 12.8 0.4 0.0 13.3 10.7 7.4 0.1 1.8 10.1 2.5 0.2 10.7 10.2 0.1 18.2 12.2 8.4 5.6 2.6 2.3 12.2 10.1 7.1 7.2 7.2 19.4 10.6 19.9 10.2 8.9 6.8 8.5 5.1 12.3 0.4 17.9 12.8 21.1 11.7 18.8 4.3 28.0 8.0 4.5 2.7 7.8 0.0 0.6 7.3 11.5 15.1 6.4 2.3 23.7 15.1 5.7 17.8 9.7 15.8 12.1 12.3 16.8 0.0 22.5 10.5 11.4 13.0 9.9 8.9 1.5 4.3 2.2 18.8 12.4 10.1 7.0 21.0 12.9 12.8 21.0 9.8 10.4 11.5 0.0 4.4 0.9 4.4 4.6 4.7 3.8 4.0 4.8 6.5 4.2 2.9 3.6 0.3 4.1 6.3 4.4 5.6 3.0 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 25.6 12.8 28.1 17.0 24.6 19.2 21.0 14.5 19.9 14.7 16.0 14.7 18.0 10.0 22.3 12.9 27.1 30.0 25.9 26.0 5.9 18.9 3.6 22.8 24.1 20.9 10.8 28.2 14.4 21.6 23.9 17.6 20.9 39.9 30.4 14.3 10.4 13.8 13.1 21.9 14.0 21.9 2.0 13.5 16.1 2.7 19.0 19.8 12.4 10.3 21.3 16.5 12.3 12.1 15.3 18.6 13.1 13.9 25.6 16.7 14.8 9.7 22.1 19.5 6.6 26.3 22.5 19.6 23.2 21.3 16.1 40.2 25.6 15.4 22.6 20.9 AKT1 "AKT, PKB, PRKBA, RAC, RAC-alpha" ENSG00000142208 "AKT serine/threonine kinase 1" P31749 14 104769349-104795751 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 61.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 61.5" "Cell line enhanced" "Detected in all" "MCF7: 558.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002891, CAB003765" Supported Supported Nucleoplasm,Microtubules NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm Microtubules "CAB003765: AB_562035, HPA002891: AB_1078123" "unprognostic (3.30e-2)" "unprognostic (4.27e-2)" "unprognostic (1.98e-1)" "unprognostic (1.84e-1)" "unprognostic (3.70e-1)" "unprognostic (9.17e-3)" "unprognostic (1.55e-3)" "unprognostic (1.21e-1)" "unprognostic (1.47e-1)" "prognostic favorable (4.83e-4)" "unprognostic (3.58e-2)" "unprognostic (1.90e-2)" "prognostic favorable (2.12e-4)" "unprognostic (7.14e-2)" "unprognostic (1.28e-1)" "unprognostic (1.06e-1)" "unprognostic (2.41e-1)" 71.5 102.7 45.9 57.7 45.5 51.2 61.2 43.7 53.2 52.0 50.4 85.0 50.8 59.5 23.2 70.7 53.7 50.0 105.9 45.2 44.3 54.3 97.3 69.2 51.9 50.5 45.7 43.7 94.3 53.0 35.9 55.4 45.0 67.2 39.6 25.1 67.7 73.0 58.1 45.0 53.3 63.4 47.4 63.7 77.8 23.9 48.0 52.4 52.3 64.9 40.3 72.6 48.4 43.3 77.3 150.5 124.6 186.9 95.2 97.7 136.9 142.3 171.5 204.6 163.6 96.8 92.8 91.2 105.5 196.6 102.8 99.4 89.5 131.9 90.1 214.3 36.2 70.6 90.4 103.2 104.6 117.5 178.0 140.0 109.1 102.9 68.1 98.2 154.4 87.5 62.1 102.2 134.1 558.3 145.3 146.8 32.6 153.5 107.2 137.5 111.9 60.5 94.8 189.5 141.2 117.2 117.3 152.2 88.9 56.8 195.7 170.2 123.5 133.2 63.2 192.3 145.1 105.4 52.6 80.7 113.7 96.7 162.0 6.4 9.9 61.5 10.0 10.3 7.2 5.5 8.7 11.4 7.0 7.2 4.6 10.1 22.6 11.0 12.4 10.0 9.0 6.3 45.9 45.5 43.7 53.2 45.2 44.3 50.5 45.7 45.0 47.4 48.0 43.3 45.8 16.0 27.4 16.6 13.7 12.4 20.0 17.3 15.9 26.3 58.0 39.9 16.1 32.9 17.7 22.0 12.5 19.4 54.2 40.9 13.7 23.6 1.9 17.9 28.1 27.5 30.0 11.3 8.2 35.2 31.8 24.0 26.0 24.8 2.5 40.4 23.2 42.9 23.2 42.1 13.0 37.3 22.4 23.3 21.4 3.3 28.6 28.0 10.6 6.5 23.1 51.2 24.7 8.0 9.6 53.3 22.1 30.9 10.3 38.8 23.5 17.9 14.2 26.6 26.3 24.9 29.1 1.8 5.3 16.2 13.9 23.4 23.3 34.0 33.7 33.4 AKT2 PKBβ ENSG00000105221 "AKT serine/threonine kinase 2" P31751 19 40230317-40285536 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Sugar transport, Translation regulation, Transport" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Diabetes mellitus, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004204, HPA064521" Uncertain Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 17: Basophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Vesicles, Cytosol" "CAB004204: AB_626659, HPA064521: AB_2685278" "unprognostic (6.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "prognostic unfavorable (1.05e-6)" "unprognostic (2.85e-1)" "unprognostic (6.40e-3)" "unprognostic (9.59e-2)" "unprognostic (1.22e-2)" "unprognostic (2.98e-2)" "unprognostic (2.49e-2)" "unprognostic (3.02e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (1.30e-2)" "unprognostic (1.89e-1)" "unprognostic (3.28e-1)" "unprognostic (6.16e-2)" "unprognostic (2.00e-1)" 62.8 40.0 31.7 37.3 31.3 48.4 38.6 58.3 40.0 49.8 55.1 42.3 24.5 43.5 49.4 42.5 46.1 25.1 40.8 31.5 24.5 52.2 59.2 30.7 38.1 32.0 26.0 53.9 41.9 58.5 47.8 27.6 26.3 41.2 23.3 41.2 32.5 45.0 101.3 39.4 35.6 34.2 22.1 38.1 33.1 29.7 28.0 53.4 100.1 118.7 37.0 39.8 41.5 35.2 66.2 160.1 63.1 61.5 72.0 88.9 32.5 41.7 63.5 87.6 77.9 71.8 60.8 67.4 36.8 96.3 37.2 28.2 66.8 90.0 56.1 62.5 74.3 43.4 116.5 44.7 45.8 50.7 50.5 82.7 53.6 58.6 56.4 71.9 19.0 73.0 57.3 67.5 49.8 54.6 81.1 24.7 31.7 73.7 41.5 54.2 32.1 48.5 68.3 105.7 82.7 49.8 43.3 75.0 35.0 62.5 59.8 64.9 18.8 52.7 51.5 47.3 67.6 61.5 59.0 56.4 52.6 59.7 44.3 5.7 2.6 2.1 2.2 1.2 2.2 1.9 1.8 1.5 1.7 2.9 1.7 2.6 4.0 1.7 1.6 4.9 1.6 1.7 31.7 31.3 58.3 40.0 31.5 24.5 32.0 26.0 26.3 22.1 28.0 35.2 18.1 16.0 15.9 51.2 33.0 23.8 23.9 20.9 26.2 67.6 25.3 23.9 31.2 30.0 18.1 60.7 41.7 31.3 26.0 23.7 21.5 19.7 5.5 26.2 26.7 17.4 19.2 19.1 30.4 30.4 25.2 27.9 20.9 25.8 14.0 44.2 13.9 87.5 22.3 60.6 25.3 20.1 22.4 23.2 17.5 10.5 42.9 20.0 23.2 23.4 21.7 46.2 50.4 41.7 40.6 24.8 16.9 26.7 30.4 29.7 21.8 24.8 24.9 97.4 19.7 29.3 25.0 14.8 15.6 31.1 27.4 38.7 23.1 56.9 23.3 29.4 ALDH1A1 "ALDH1, PUMB1, RALDH1" ENSG00000165092 "Aldehyde dehydrogenase 1 family member A1" P00352 9 72900671-73080442 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 1500.8" "Cell type enhanced" "Detected in many" "Distal tubular cells: 389.4;Hepatocytes: 624.4;Leydig cells: 406.4;Proximal tubular cells: 375.4;Respiratory ciliated cells: 583.7" "Cancer enhanced" "Detected in all" "liver cancer: 399.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 6 "classical monocyte: 87.3" "Lineage enriched" "Detected in many" 33 "monocytes: 87.3" "Cell line enhanced" "Detected in many" "A549: 4019.8;Hep G2: 1269.3;RPTEC TERT1: 710.6" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 6 "midbrain: 378.3" "HPA002123, CAB020690" Enhanced Approved Enhanced Cytosol NA NA 58000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" Cytosol "CAB020690: , HPA002123: AB_1844722" "unprognostic (8.46e-3)" "prognostic favorable (7.77e-5)" "unprognostic (5.59e-2)" "unprognostic (1.69e-1)" "unprognostic (1.49e-2)" "unprognostic (8.71e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (4.53e-2)" "unprognostic (6.83e-2)" "unprognostic (4.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.24e-3)" "unprognostic (2.20e-1)" "unprognostic (2.36e-1)" "unprognostic (2.96e-2)" "unprognostic (1.90e-3)" 109.4 182.4 51.3 28.4 71.9 31.8 64.3 125.1 72.4 121.8 35.7 218.2 549.7 139.3 583.4 41.3 184.3 175.4 53.7 64.6 62.1 335.4 1500.8 142.6 31.2 93.4 370.7 222.7 498.1 24.3 164.4 32.0 84.7 57.2 88.8 0.4 104.5 245.4 66.7 17.2 304.3 117.0 104.2 77.5 568.5 149.5 74.5 19.8 211.7 83.0 21.6 31.6 90.7 106.1 0.0 4019.8 0.4 0.0 22.4 0.2 1.4 139.6 0.0 0.1 0.1 136.2 0.0 0.1 50.5 0.0 0.3 2.6 0.0 0.2 0.1 0.4 0.1 232.1 0.6 1269.3 13.7 0.6 0.3 6.7 0.1 0.0 0.0 0.3 143.0 0.0 16.9 0.0 153.3 7.2 0.2 1.8 0.7 7.2 0.4 0.5 44.0 1.8 710.6 1.1 0.3 1.4 0.3 0.4 2.9 0.2 0.0 0.5 0.7 0.0 3.5 0.5 0.3 0.4 0.2 1.0 0.0 1.7 0.4 0.0 87.3 1.4 0.0 14.9 0.0 0.0 0.2 0.1 1.4 0.7 0.0 0.0 2.6 0.0 1.1 1.0 0.0 30.3 51.3 71.9 125.1 72.4 64.6 62.1 93.4 370.7 84.7 104.2 74.5 106.1 4.9 96.1 107.6 31.3 6.9 2.7 18.3 168.3 1.2 0.4 12.6 1.7 4.3 187.3 361.1 115.8 0.0 1.7 0.1 20.2 389.4 71.6 12.6 6.3 125.2 26.4 54.9 96.1 3.5 349.7 1.0 102.7 258.4 8.1 158.9 0.2 133.5 624.4 134.4 0.0 0.5 168.9 138.4 109.6 5.1 37.8 406.4 61.7 7.2 17.8 46.0 0.0 2.1 0.0 0.7 128.4 77.4 207.3 1.3 2.0 267.4 375.4 583.7 0.3 26.3 334.2 28.6 8.6 4.6 21.5 3.1 2.5 8.8 129.6 131.7 26.5 ALKBH4 FLJ20013 ENSG00000160993 "AlkB homolog 4, lysine demethylase" Q9NXW9 7 102456238-102464863 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051422 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA051422: AB_2681480" "unprognostic (1.18e-2)" "unprognostic (7.35e-2)" "unprognostic (3.50e-2)" "unprognostic (1.75e-2)" "unprognostic (4.14e-3)" "unprognostic (3.83e-2)" "unprognostic (2.71e-3)" "unprognostic (6.04e-3)" "unprognostic (1.34e-1)" "unprognostic (7.25e-3)" "unprognostic (3.20e-3)" "unprognostic (1.10e-1)" "prognostic favorable (3.09e-4)" "unprognostic (1.44e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.44e-2)" 3.4 5.2 8.3 2.9 9.0 5.0 3.6 10.0 9.4 4.3 7.6 3.9 3.9 4.6 3.5 4.2 3.8 2.3 4.2 8.7 8.8 5.0 4.9 2.7 4.3 8.5 8.5 4.0 5.0 6.9 5.1 2.9 8.8 4.1 2.6 2.3 5.0 3.2 4.3 4.9 5.0 2.9 8.6 7.1 4.3 2.7 8.9 4.4 5.8 4.3 3.3 3.7 3.8 9.2 5.4 7.2 5.9 13.9 4.0 4.5 6.5 4.0 6.9 8.4 7.9 8.2 7.1 6.3 6.6 5.7 7.4 4.3 7.6 5.6 6.2 6.3 15.9 6.3 3.3 6.0 6.2 5.6 5.9 6.8 7.6 6.5 2.9 7.2 5.5 10.1 11.2 7.5 5.2 19.6 15.7 17.5 9.0 10.2 10.9 9.3 6.2 11.2 7.0 5.8 7.3 10.9 5.0 15.1 5.6 7.4 6.3 6.6 1.8 8.9 10.2 13.8 8.8 10.2 8.4 11.7 5.2 7.6 9.4 3.7 5.4 3.0 6.1 4.8 6.4 5.2 4.7 8.0 5.4 4.6 4.7 6.1 1.6 9.2 9.8 6.9 4.9 3.4 8.3 9.0 10.0 9.4 8.7 8.8 8.5 8.5 8.8 8.6 8.9 9.2 10.2 6.4 5.8 2.3 7.0 8.3 4.3 12.9 5.2 16.6 8.1 11.7 2.2 11.5 5.9 9.2 4.2 25.6 9.2 7.3 25.4 16.3 1.3 6.8 12.2 10.5 6.1 19.6 5.2 14.9 15.4 10.8 7.7 10.0 3.8 11.7 10.4 9.1 15.3 28.6 6.2 8.1 10.2 12.0 5.8 1.9 14.0 7.2 3.6 2.8 14.6 13.4 25.7 2.0 4.5 11.8 10.6 21.4 8.3 6.3 12.0 18.8 4.6 10.2 0.0 7.6 9.5 11.9 16.9 9.5 7.4 11.1 8.7 17.7 10.1 1.8 ALKBH6 MGC15677 ENSG00000239382 "AlkB homolog 6" Q3KRA9 19 36009120-36014239 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073835, HPA074340" Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA "Cluster 10: Basophils - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 58: T-cells - T-cell receptor" Nucleoplasm "Focal adhesion sites" "HPA073835: AB_2686637, HPA074340: AB_2686680" "unprognostic (1.90e-3)" "unprognostic (1.82e-1)" "unprognostic (5.16e-3)" "unprognostic (1.12e-2)" "unprognostic (1.24e-1)" "unprognostic (5.86e-5)" "unprognostic (6.21e-2)" "unprognostic (4.53e-2)" "unprognostic (3.95e-1)" "unprognostic (3.56e-2)" "unprognostic (8.78e-4)" "unprognostic (1.77e-2)" "unprognostic (2.31e-5)" "unprognostic (9.34e-2)" "unprognostic (2.15e-1)" "unprognostic (3.82e-1)" "unprognostic (1.05e-3)" 5.4 8.4 9.3 3.1 8.3 3.3 5.3 9.7 12.4 6.6 6.9 9.8 2.9 7.6 2.3 7.6 6.7 2.1 6.8 9.3 12.3 7.2 11.5 5.5 4.3 15.7 10.3 5.6 4.4 4.7 9.9 2.7 15.0 7.6 1.9 2.7 6.1 4.0 6.4 6.3 7.3 3.7 8.3 7.9 7.8 4.5 12.7 4.1 6.6 3.9 3.8 7.9 6.0 10.6 12.5 13.1 4.9 7.2 7.4 4.5 8.2 12.1 8.0 13.9 14.0 5.4 6.4 10.8 18.8 6.7 7.2 4.9 5.1 14.0 7.2 17.2 9.4 6.2 5.1 5.9 8.4 5.4 18.3 6.8 9.9 11.5 3.9 4.8 9.5 16.2 9.9 8.0 7.5 13.1 13.1 7.0 3.8 12.8 8.3 8.4 6.7 7.9 10.3 5.5 5.9 6.0 8.2 9.8 10.8 6.8 7.8 12.1 4.1 7.2 10.5 16.6 12.0 14.9 9.6 7.8 15.5 6.1 7.8 58.5 18.2 47.8 26.2 26.0 20.4 32.9 23.8 25.4 16.0 24.6 20.2 19.3 16.0 28.8 20.7 22.7 34.4 16.0 9.3 8.3 9.7 12.4 9.3 12.3 15.7 10.3 15.0 8.3 12.7 10.6 6.1 3.2 1.7 6.8 16.5 6.8 11.1 4.5 9.1 5.6 8.0 6.5 2.0 10.0 3.3 18.4 0.0 17.7 13.1 9.5 5.9 10.4 7.6 6.8 5.0 5.9 13.1 14.5 8.1 9.2 15.8 8.1 14.3 6.3 0.0 7.1 7.9 12.7 11.0 10.1 7.2 11.9 2.0 5.3 7.7 5.4 11.1 9.1 8.8 3.7 15.2 5.5 23.7 2.0 6.5 13.3 13.6 4.5 12.1 7.1 7.8 11.8 2.3 3.3 6.6 4.1 10.1 3.6 2.4 8.7 5.1 19.0 15.5 6.4 9.5 9.5 ALOX15 15-LOX-1 ENSG00000161905 "Arachidonate 15-lipoxygenase" P16050 17 4630919-4642294 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 37.2;fallopian tube: 12.7" "Group enriched" "Detected in some" 5 "Club cells: 60.3;Langerhans cells: 72.2;Respiratory ciliated cells: 191.8" "Cancer enhanced" "Detected in many" "cervical cancer: 6.6" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in some" 193 "eosinophil: 602.9" "Lineage enriched" "Detected in many" 193 "granulocytes: 602.9" "Group enriched" "Detected in some" 7 "HMC-1: 15.9;MCF7: 14.7;T-47d: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004962, CAB004963, HPA013859" Approved NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "CAB004962: , CAB004963: , HPA013859: AB_1844758" "unprognostic (5.31e-4)" "unprognostic (1.43e-2)" "unprognostic (2.81e-2)" "unprognostic (8.36e-3)" "unprognostic (2.22e-1)" "unprognostic (8.60e-2)" "unprognostic (2.36e-1)" "unprognostic (2.66e-2)" "unprognostic (1.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.51e-2)" "unprognostic (3.77e-1)" "unprognostic (1.31e-3)" "unprognostic (1.88e-2)" "unprognostic (1.30e-1)" "unprognostic (2.78e-1)" "unprognostic (1.59e-1)" 37.2 0.0 0.6 1.6 2.0 0.5 3.2 0.0 1.3 0.5 0.0 1.6 1.9 0.0 0.4 0.8 12.7 0.6 2.9 0.5 0.5 0.0 0.1 6.6 1.9 0.3 0.2 0.1 0.0 0.0 3.0 0.1 0.3 0.2 1.0 0.0 0.2 0.3 0.0 2.2 3.3 0.6 0.1 1.4 1.0 1.8 0.4 0.8 0.0 0.0 0.6 1.1 0.1 0.4 1.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 14.7 0.0 0.3 1.1 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 4.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 602.9 0.0 0.2 0.2 0.1 0.0 0.1 3.1 0.2 0.0 0.1 0.9 0.0 0.1 2.7 0.1 0.4 0.6 2.0 0.0 1.3 0.5 0.5 0.3 0.2 0.3 0.1 0.4 0.4 0.0 0.0 1.1 0.0 0.2 1.5 0.0 13.0 0.0 0.0 1.1 0.1 0.9 11.5 60.3 0.0 0.0 1.8 1.3 0.0 0.0 0.0 19.2 3.0 0.0 0.4 0.0 0.0 0.9 0.0 0.1 3.6 0.0 0.1 1.3 0.0 0.0 0.0 0.6 0.0 0.2 0.0 4.1 0.0 72.2 2.5 0.0 0.6 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 191.8 0.0 0.0 0.1 3.9 1.2 1.2 0.0 0.9 7.4 0.3 0.0 0.0 0.3 AMDHD2 CGI-14 ENSG00000162066 "Amidohydrolase domain containing 2" Q9Y303 16 2520357-2531422 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 64.1;Hofbauer cells: 127.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041184, HPA041321" Enhanced Approved Nucleoli,Cytosol No No 110000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli, Cytosol" "HPA041184: AB_10803998, HPA041321: AB_10795588" "unprognostic (1.20e-1)" "prognostic favorable (5.19e-4)" "unprognostic (7.86e-3)" "unprognostic (2.39e-1)" "unprognostic (1.70e-2)" "unprognostic (1.37e-1)" "unprognostic (1.48e-2)" "unprognostic (2.14e-1)" "unprognostic (3.28e-1)" "unprognostic (1.66e-1)" "unprognostic (1.88e-2)" "unprognostic (8.68e-2)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (4.71e-2)" "unprognostic (1.66e-1)" "unprognostic (1.20e-1)" 14.7 20.2 2.7 5.6 3.4 5.5 13.7 2.4 4.8 12.9 2.8 12.6 9.1 12.2 0.7 10.6 10.8 4.3 7.0 3.3 2.0 18.7 13.8 12.2 7.9 3.4 3.1 9.3 8.2 3.1 8.5 4.5 2.8 10.8 0.8 0.4 13.7 3.2 8.8 15.4 17.3 1.4 2.4 26.1 9.9 37.0 4.2 3.7 12.1 1.3 1.9 10.9 9.8 4.3 9.6 11.7 3.1 6.7 3.5 2.5 15.4 9.0 3.4 7.4 9.0 8.7 16.9 4.4 4.4 1.7 14.0 9.3 1.7 2.5 0.2 6.0 7.8 6.6 13.8 12.7 12.9 4.6 16.8 6.6 2.5 4.9 0.8 1.8 4.0 12.5 14.3 9.3 3.1 19.0 7.8 11.7 6.7 0.8 10.1 29.6 4.4 14.0 2.4 5.4 10.3 9.9 5.7 13.1 21.4 0.5 13.1 1.5 6.9 7.4 11.3 14.3 4.7 15.7 14.1 8.9 8.1 9.5 7.4 9.5 3.3 9.6 4.8 7.5 3.8 6.4 3.5 2.9 1.2 4.1 2.7 2.4 8.4 3.1 9.9 9.9 3.8 2.9 2.7 3.4 2.4 4.8 3.3 2.0 3.4 3.1 2.8 2.4 4.2 4.3 8.0 3.2 11.6 1.3 16.7 8.9 5.2 3.2 4.0 10.3 13.6 11.6 2.5 10.0 5.2 5.5 6.2 16.7 16.4 16.2 5.9 30.3 64.1 6.0 4.1 8.3 12.6 11.0 1.6 17.0 27.1 9.9 7.1 5.2 7.0 13.1 18.2 11.9 127.0 23.5 1.1 12.8 6.1 47.6 12.1 27.4 10.5 28.9 19.6 1.9 26.9 11.0 20.6 0.5 0.8 14.5 26.4 6.4 11.5 4.1 59.4 48.9 9.1 13.0 0.0 7.8 8.4 52.9 16.3 5.1 8.9 27.9 13.2 7.6 10.4 4.2 ANAPC11 "APC11, Apc11p, HSPC214, MGC882" ENSG00000141552 "Anaphase promoting complex subunit 11" Q9NYG5 17 81890790-81900991 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 1161.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021989, HPA027838" Approved Enhanced Nucleoplasm,Nucleoli Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Nucleoli "HPA021989: AB_1844915, HPA027838: AB_10600978" "unprognostic (9.00e-3)" "unprognostic (1.24e-2)" "unprognostic (3.76e-1)" "unprognostic (4.93e-2)" "unprognostic (8.76e-2)" "unprognostic (1.67e-1)" "unprognostic (5.13e-2)" "unprognostic (8.20e-2)" "unprognostic (1.65e-1)" "unprognostic (2.17e-3)" "unprognostic (2.22e-2)" "unprognostic (1.08e-1)" "unprognostic (4.76e-2)" "unprognostic (8.07e-2)" "unprognostic (9.08e-2)" "unprognostic (2.51e-2)" "unprognostic (3.16e-1)" 112.1 120.5 104.8 52.1 108.6 109.3 103.4 110.9 149.5 85.9 100.7 126.0 61.0 86.4 39.0 125.8 80.3 58.0 231.3 106.4 106.8 127.3 185.7 89.3 73.0 110.0 105.1 76.4 108.1 59.0 92.0 54.8 105.0 105.7 27.3 19.3 117.6 42.0 272.8 99.7 83.4 36.5 110.4 86.7 117.9 189.7 113.0 50.1 90.6 126.5 34.0 95.9 94.7 118.1 262.4 605.0 139.0 209.7 118.7 132.8 164.3 123.4 100.6 111.4 127.1 248.6 226.9 82.1 133.3 114.4 121.8 148.9 58.1 166.4 40.5 122.5 437.1 126.8 257.9 379.0 131.3 95.3 103.6 145.6 151.8 120.4 98.2 73.4 184.9 111.9 173.7 233.8 120.8 474.1 225.5 150.6 131.2 259.2 448.7 92.3 136.2 168.0 104.9 229.3 175.8 282.6 133.5 205.7 253.8 96.7 254.1 222.7 108.4 215.0 169.5 229.4 234.1 110.5 52.1 107.0 228.7 144.5 177.7 495.1 419.8 418.8 229.7 359.9 218.7 309.0 232.0 252.9 348.0 296.2 223.0 212.3 212.1 258.5 345.4 581.1 297.9 506.0 104.8 108.6 110.9 149.5 106.4 106.8 110.0 105.1 105.0 110.4 113.0 118.1 137.2 128.2 157.2 11.4 110.5 148.6 215.0 406.1 145.7 59.5 272.5 332.7 360.2 201.6 272.3 198.6 20.9 467.8 119.5 239.6 522.3 260.6 451.9 157.0 151.3 152.9 190.3 201.6 9.8 337.7 524.6 182.9 124.4 169.5 108.3 158.3 159.2 496.4 448.2 33.7 10.2 272.6 319.4 174.6 194.3 1161.0 181.7 170.1 261.5 13.1 251.4 227.7 176.1 7.1 17.0 324.3 274.0 164.7 226.8 334.2 290.7 548.0 199.8 78.9 105.2 115.9 245.0 435.8 252.5 257.4 186.7 508.7 117.3 156.0 271.4 307.0 ANKRD52 "FLJ34236, PP6-ARS-C" ENSG00000139645 "Ankyrin repeat domain 52" Q8NB46 12 56237807-56258384 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043815 Uncertain Approved Nucleoplasm,Mitochondria NA NA "Cluster 34: Basophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Mitochondria" "HPA043815: AB_10961762" "unprognostic (6.25e-3)" "unprognostic (6.45e-2)" "unprognostic (1.19e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (9.84e-2)" "unprognostic (9.46e-2)" "unprognostic (5.43e-2)" "unprognostic (3.97e-3)" "unprognostic (1.24e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (1.27e-1)" "unprognostic (3.70e-2)" "unprognostic (6.31e-2)" 8.4 21.5 10.9 9.8 11.3 9.6 8.7 9.3 12.9 11.9 4.9 12.3 8.4 12.4 5.7 10.5 11.0 6.1 12.9 9.6 13.3 11.6 7.9 9.4 9.2 17.7 16.2 12.9 12.9 19.8 13.2 7.1 21.4 11.2 8.1 9.6 10.9 7.9 25.0 11.2 12.8 11.0 9.2 10.9 10.5 7.4 15.4 8.8 11.2 17.0 9.6 12.0 9.8 10.3 24.7 58.5 25.9 47.4 20.7 16.2 18.2 48.1 20.9 42.1 18.9 39.0 13.4 26.1 29.9 47.3 14.8 31.5 29.0 21.0 24.2 25.3 29.1 46.9 38.6 15.0 14.3 37.3 26.2 16.7 23.2 39.0 19.7 30.9 24.8 21.1 19.6 13.8 40.1 34.2 30.0 12.3 10.9 16.1 27.4 23.4 17.8 10.4 27.7 30.0 19.6 17.8 52.2 33.1 18.9 19.9 26.5 14.3 34.4 43.4 38.1 24.7 30.4 12.7 18.0 12.4 45.0 12.2 29.0 0.4 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.9 11.3 9.3 12.9 9.6 13.3 17.7 16.2 21.4 9.2 15.4 10.3 4.1 6.4 5.3 9.1 7.8 11.2 3.6 8.4 10.2 5.0 9.1 6.9 6.7 4.3 4.3 12.9 27.1 5.8 7.9 12.6 0.0 10.4 0.5 5.8 9.7 5.7 9.6 5.5 12.8 9.5 7.4 5.4 8.2 9.0 1.3 8.6 6.8 6.5 7.0 8.4 12.5 6.6 20.3 7.1 7.5 1.1 6.2 4.8 10.6 7.5 4.6 3.4 7.2 7.5 8.4 15.7 7.0 4.9 8.7 5.7 9.2 6.4 4.2 6.0 0.0 5.6 7.6 6.4 8.8 10.0 10.9 3.7 6.0 5.5 8.9 4.4 ANKS3 "FLJ32345, FLJ32767, KIAA1977" ENSG00000168096 "Ankyrin repeat and sterile alpha motif domain containing 3" Q6ZW76 16 4696510-4734378 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 110.5;Rod photoreceptor cells: 92.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041409, HPA041482" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "HPA041409: AB_10794375, HPA041482: AB_10795594" "unprognostic (3.02e-1)" "unprognostic (2.19e-1)" "unprognostic (3.06e-2)" "unprognostic (2.55e-2)" "unprognostic (5.44e-2)" "unprognostic (1.31e-3)" "unprognostic (1.05e-2)" "unprognostic (8.65e-2)" "unprognostic (3.75e-1)" "unprognostic (4.42e-2)" "unprognostic (7.36e-3)" "unprognostic (1.77e-2)" "unprognostic (1.10e-1)" "unprognostic (2.19e-1)" "unprognostic (2.66e-1)" "unprognostic (9.96e-2)" "unprognostic (1.57e-3)" 5.1 4.9 5.5 2.4 5.6 1.9 4.6 6.1 7.9 7.3 5.3 8.7 2.6 6.3 1.5 3.9 6.8 2.9 4.9 5.3 5.7 7.9 5.0 4.6 3.0 5.4 5.4 8.7 5.5 2.8 7.2 2.4 5.7 6.9 1.2 2.5 6.5 4.0 6.5 4.3 4.1 2.8 5.1 4.3 4.9 5.0 5.5 2.0 6.2 3.3 2.0 6.9 5.7 6.0 2.5 29.4 3.7 8.3 7.1 5.8 8.6 11.0 8.9 10.0 8.9 15.3 6.1 5.5 13.4 7.4 3.9 4.9 8.2 6.0 4.4 7.2 15.6 5.2 14.6 3.8 7.7 2.8 4.3 3.7 6.2 9.6 9.2 6.0 1.9 3.6 12.4 1.7 5.9 9.3 5.5 10.3 10.0 3.7 5.4 8.6 9.3 10.0 7.6 3.1 12.1 11.6 5.7 8.3 4.7 2.1 8.2 3.6 3.4 7.3 9.9 13.7 5.7 8.6 16.4 8.6 4.0 2.8 8.5 0.0 0.4 0.0 0.8 0.5 1.2 1.2 1.0 0.7 0.8 1.3 1.5 0.9 0.0 0.6 0.6 2.2 0.7 0.5 5.5 5.6 6.1 7.9 5.3 5.7 5.4 5.4 5.7 5.1 5.5 6.0 9.0 6.4 14.3 18.3 9.9 7.6 13.2 12.9 8.0 42.9 11.6 11.0 4.9 14.3 11.7 22.0 110.5 12.6 9.9 9.8 19.6 16.5 6.1 10.1 15.1 9.4 9.0 5.5 28.8 8.6 8.5 13.1 13.7 6.8 0.0 21.4 14.6 8.1 8.1 50.5 27.7 13.6 14.2 4.4 4.3 6.4 27.1 4.9 10.6 6.5 12.5 12.5 20.6 17.1 21.2 13.3 13.3 28.2 7.5 16.1 8.8 16.1 15.1 92.2 6.6 13.8 12.3 29.1 25.4 6.0 9.7 6.7 10.6 19.1 12.8 6.2 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737402 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 144.3;intestine: 293.6" "Cell type enhanced" "Detected in some" "Cholangiocytes: 180.1;Enteroendocrine cells: 44.9;Intestinal goblet cells: 161.1;Paneth cells: 58.1;Proximal enterocytes: 125.2;Undifferentiated cells: 38.5" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A549: 27.8;HDLM-2: 14.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 56: Intestine - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.2 0.0 1.1 1.6 2.6 0.0 0.4 2.6 2.2 0.4 1.1 21.6 293.6 1.5 2.2 0.2 58.4 144.3 0.1 1.1 1.5 7.0 20.2 0.2 0.2 4.1 2.9 0.4 0.4 0.0 0.0 0.0 3.3 0.5 36.1 4.3 0.1 24.3 0.0 0.1 219.5 2.9 3.3 0.0 0.8 4.2 2.1 0.1 0.0 0.0 0.0 0.5 0.1 5.3 0.0 27.8 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 14.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.0 0.0 0.0 0.0 1.7 1.6 0.0 0.1 0.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 2.6 2.6 2.2 1.1 1.5 4.1 2.9 3.3 3.3 2.1 5.3 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.2 0.1 1.1 0.4 180.1 0.0 0.0 0.0 0.0 0.0 6.2 3.9 1.4 1.1 4.5 3.6 0.2 44.9 2.7 0.9 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 1.1 0.2 0.0 1.0 161.1 0.0 0.0 0.0 1.4 1.2 0.3 0.0 0.0 0.0 0.3 0.0 0.5 1.2 0.1 58.1 0.0 0.0 0.0 125.2 27.6 2.9 10.9 0.0 0.2 0.1 0.0 0.1 0.0 0.6 0.0 0.4 0.1 38.5 0.1 AP000812.4 ENSG00000284922 "Leucine rich transmembrane and O-methyltransferase domain containing" Q8WZ04 11 72080331-72110782 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Catecholamine metabolism, Hearing, Neurotransmitter degradation" "Methyltransferase, Transferase" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "fallopian tube: 14.1;testis: 9.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 2.9;HBEC3-KT: 2.9;MCF7: 3.0" HPA039949 Approved Uncertain Microtubules NA NA "Cluster 40: Non-specific - Basic cellular processes" Microtubules "HPA039949: AB_10960708" 0.1 0.0 0.4 0.0 0.5 0.0 0.2 0.6 1.8 0.0 0.1 0.0 0.0 0.9 0.0 0.0 14.1 0.0 0.0 0.3 0.6 0.4 0.2 0.6 0.0 0.4 0.4 0.2 0.0 0.5 0.0 0.4 0.0 0.1 0.1 0.0 0.2 0.4 0.0 0.2 0.2 0.3 0.2 0.0 9.5 0.4 0.0 0.1 0.0 0.0 0.1 0.6 0.2 0.1 0.0 0.2 0.7 0.2 0.1 0.4 0.5 0.3 1.2 0.2 0.2 0.0 0.1 2.9 0.5 0.6 0.4 2.9 0.3 1.2 0.5 0.5 0.2 0.2 0.0 0.0 0.0 0.8 0.0 1.3 0.4 0.1 0.1 0.6 0.0 0.0 0.4 3.0 0.0 0.0 0.1 1.0 0.0 0.6 0.5 0.2 0.9 0.5 0.3 0.1 0.4 0.3 0.0 0.0 0.9 0.1 0.0 0.2 0.2 0.4 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.6 1.8 0.3 0.6 0.4 0.4 0.4 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AP1S1 "AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2" ENSG00000106367 "Adaptor related protein complex 1 subunit sigma 1" P61966 7 101154456-101161596 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Deafness, Ichthyosis, Mental retardation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060945 Supported Supported "Golgi apparatus,Vesicles" NA Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Golgi apparatus, Vesicles" "HPA060945: AB_2684393" "unprognostic (1.98e-2)" "unprognostic (5.41e-3)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.98e-3)" "unprognostic (8.70e-3)" "unprognostic (7.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.76e-1)" "unprognostic (7.79e-2)" "unprognostic (1.34e-1)" "unprognostic (3.75e-2)" "unprognostic (2.81e-2)" "unprognostic (2.14e-2)" "unprognostic (1.74e-1)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" 14.4 24.6 72.2 13.9 75.7 5.8 17.2 43.7 82.6 18.3 34.6 28.6 39.0 16.9 17.0 34.2 13.8 12.8 11.8 85.2 59.6 41.2 36.2 14.7 11.9 53.6 51.9 13.5 21.9 22.8 31.0 15.9 53.4 22.2 22.4 14.6 20.3 9.3 6.4 39.2 30.3 12.7 46.1 20.2 22.0 16.4 62.5 19.1 15.2 8.5 13.6 20.1 19.5 62.7 121.0 87.3 63.3 118.4 42.8 70.4 138.2 76.8 51.1 50.8 52.8 47.3 147.5 24.9 127.5 84.6 97.1 59.0 35.3 116.0 45.6 57.0 56.6 16.8 52.0 61.4 54.2 46.8 87.7 79.1 91.0 49.4 20.6 76.7 76.8 54.1 56.7 103.2 129.9 292.1 40.4 107.8 97.8 177.0 188.2 24.9 27.2 54.6 127.8 88.8 47.5 157.7 40.4 121.1 151.4 101.6 50.7 46.8 79.0 74.1 132.3 27.6 55.2 21.4 51.4 48.4 195.2 50.1 152.9 0.5 3.3 0.3 2.3 3.1 2.2 2.6 3.2 2.5 4.6 2.0 1.9 1.8 1.2 1.3 1.8 5.0 3.3 2.4 72.2 75.7 43.7 82.6 85.2 59.6 53.6 51.9 53.4 46.1 62.5 62.7 34.4 6.4 0.0 2.3 17.9 38.7 29.7 173.0 46.7 30.7 54.8 49.0 1.1 45.8 72.9 55.2 8.4 170.7 19.8 88.4 344.4 128.2 2.5 28.8 34.2 36.7 90.3 16.2 21.2 111.7 101.3 27.7 42.8 31.9 5.7 85.3 28.9 43.0 95.2 30.3 10.3 96.5 116.0 24.8 21.6 3.4 35.1 27.3 53.4 7.5 58.0 34.1 17.5 2.5 9.8 183.3 86.1 21.8 17.4 34.9 241.3 304.8 34.9 22.3 19.7 11.4 38.4 13.1 70.9 51.4 45.5 60.5 19.5 157.4 119.9 38.2 AP2M1 "AP50, CLAPM1, mu2" ENSG00000161203 "Adaptor related protein complex 2 subunit mu 1" Q96CW1 3 184174689-184184091 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036849, HPA069870" Uncertain Supported "Plasma membrane" NA NA 7500 "Cluster 31: Non-specific - Inflammatory response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane" "HPA036849: AB_10672101, HPA069870: AB_2686217" "unprognostic (1.16e-1)" "unprognostic (1.35e-2)" "unprognostic (5.28e-3)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (9.12e-4)" "unprognostic (3.80e-3)" "unprognostic (2.09e-1)" "unprognostic (5.53e-2)" "unprognostic (4.11e-2)" "unprognostic (9.18e-2)" "prognostic unfavorable (7.45e-6)" "unprognostic (2.61e-2)" "unprognostic (4.09e-2)" "unprognostic (1.60e-2)" "unprognostic (1.28e-1)" 191.8 364.2 233.5 164.7 250.3 231.3 164.6 211.3 257.3 222.8 196.3 232.4 167.5 216.4 104.2 218.1 178.6 166.5 366.2 261.1 249.0 196.0 140.9 180.0 148.2 234.8 211.1 198.6 106.4 224.8 224.9 243.3 248.9 183.2 141.1 230.4 167.2 231.8 181.2 157.2 156.2 243.7 200.9 162.5 156.3 106.4 235.4 158.4 148.0 194.0 157.6 223.7 192.4 225.6 436.3 327.5 275.7 311.8 432.1 450.8 284.3 714.3 412.5 788.5 550.5 355.1 309.9 198.2 851.3 1076.1 516.1 480.0 376.3 482.9 647.1 409.8 470.4 512.2 365.8 317.9 508.9 254.8 311.5 577.0 269.4 501.1 318.5 711.0 595.3 258.3 250.0 377.1 750.1 993.6 330.1 151.2 674.1 388.1 484.7 302.7 351.5 393.7 489.7 389.3 292.0 212.6 561.3 696.4 335.1 427.5 934.4 305.7 645.0 497.1 400.1 492.4 960.2 336.9 318.7 441.6 937.1 369.9 331.7 194.4 294.8 244.9 137.5 238.8 136.2 114.3 127.6 134.0 268.7 112.7 107.7 111.8 127.7 170.2 206.8 134.1 185.4 441.0 233.5 250.3 211.3 257.3 261.1 249.0 234.8 211.1 248.9 200.9 235.4 225.6 146.8 54.5 50.7 41.4 84.8 124.9 177.2 275.1 97.9 174.2 108.0 98.2 195.9 112.9 133.5 114.0 70.9 400.9 117.3 155.9 375.6 243.7 326.6 69.3 131.2 172.2 140.8 277.8 62.0 161.3 327.1 161.5 71.4 78.5 149.1 173.6 182.4 78.0 576.9 277.6 63.4 119.0 201.4 137.1 162.9 347.8 164.7 185.1 199.3 34.7 369.4 199.4 130.7 26.2 46.1 232.1 153.1 214.8 100.2 138.8 253.8 290.7 58.3 125.9 197.2 106.9 278.0 83.3 101.7 128.5 126.6 513.6 102.6 278.1 154.1 185.1 AP4B1 "BETA-4, SPG47" ENSG00000134262 "Adaptor related protein complex 4 subunit beta 1" Q9Y6B7 1 113894194-113905201 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 65.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028162, HPA028652" Approved Approved Vesicles NA NA "Cluster 46: Basophils - DNA binding" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Vesicles "HPA028162: AB_10610976, HPA028652: AB_10601451" "unprognostic (8.90e-2)" "unprognostic (2.25e-2)" "unprognostic (1.77e-1)" "unprognostic (2.40e-2)" "unprognostic (1.53e-1)" "unprognostic (5.01e-2)" "prognostic unfavorable (8.60e-7)" "unprognostic (3.45e-2)" "unprognostic (1.54e-2)" "unprognostic (8.34e-3)" "unprognostic (1.55e-1)" "unprognostic (2.07e-2)" "prognostic unfavorable (3.73e-6)" "unprognostic (5.08e-3)" "unprognostic (7.88e-2)" "unprognostic (3.12e-1)" "unprognostic (1.55e-2)" 9.7 8.5 12.5 11.1 13.1 20.5 9.3 14.6 14.6 11.9 10.9 11.5 10.6 9.7 14.2 12.1 11.0 7.0 11.2 13.0 13.0 9.7 8.4 9.5 14.3 11.6 11.4 13.7 14.0 4.8 13.7 5.9 11.8 9.6 12.7 20.0 7.6 6.2 11.7 11.5 12.8 9.1 11.5 20.1 10.4 11.1 13.3 16.1 11.0 9.1 13.9 9.2 10.0 13.3 11.0 9.8 10.0 11.8 15.7 14.1 6.4 10.1 9.8 13.0 14.0 6.8 7.7 21.5 15.9 12.4 6.5 9.7 11.3 13.4 16.5 16.6 9.8 17.6 13.6 8.3 9.5 19.6 17.3 16.1 6.7 25.5 15.3 7.8 22.7 20.9 12.3 18.5 17.6 65.2 15.6 21.6 9.4 7.7 19.0 15.0 19.5 13.3 13.2 5.5 10.2 8.5 10.1 19.1 7.8 9.5 5.7 15.4 21.8 15.0 13.9 17.4 20.8 15.2 15.8 21.3 24.6 26.0 25.1 15.9 10.5 8.6 14.7 10.8 15.6 9.5 11.7 12.6 12.9 11.9 12.7 11.1 1.2 12.2 8.5 9.1 10.4 9.5 12.5 13.1 14.6 14.6 13.0 13.0 11.6 11.4 11.8 11.5 13.3 13.3 7.2 3.2 6.7 7.5 12.3 3.6 3.3 5.4 4.6 6.8 3.2 4.3 8.7 5.7 11.9 3.7 31.3 3.8 12.0 7.8 1.9 7.7 3.6 4.6 4.7 7.6 3.0 18.1 11.4 26.8 3.5 7.0 11.2 5.2 2.5 4.5 7.5 4.1 5.2 8.4 11.6 5.3 6.1 7.3 4.9 2.3 2.8 6.9 7.2 7.5 6.1 4.7 3.1 11.6 10.0 10.9 6.9 4.9 7.4 2.8 6.5 3.3 5.2 21.0 13.1 6.1 6.2 16.4 11.5 5.7 3.7 1.6 14.8 6.4 9.0 3.3 APH1A "APH-1A, CGI-78" ENSG00000117362 "Aph-1 homolog A, gamma-secretase subunit" Q96BI3 1 150265399-150269580 "Predicted membrane proteins, Transporters" "Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB037272 Approved NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "CAB037272: AB_476776" "unprognostic (1.00e-1)" "unprognostic (5.55e-2)" "unprognostic (8.84e-2)" "unprognostic (1.20e-3)" "unprognostic (4.92e-2)" "unprognostic (3.55e-2)" "unprognostic (2.75e-3)" "unprognostic (4.42e-2)" "unprognostic (1.20e-1)" "unprognostic (1.68e-2)" "unprognostic (2.42e-3)" "unprognostic (1.53e-1)" "unprognostic (6.99e-2)" "unprognostic (4.48e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (1.87e-1)" 73.5 93.9 59.3 60.5 63.4 78.7 97.8 60.8 60.7 79.6 58.3 100.6 82.2 60.5 84.0 118.6 83.2 69.0 71.0 55.3 59.1 78.6 132.2 83.6 80.7 67.2 62.3 88.6 92.2 110.3 56.5 72.4 62.2 62.0 95.4 24.4 92.7 68.1 58.8 120.6 80.4 54.8 65.7 99.2 95.7 34.8 64.7 72.9 95.7 63.2 90.7 77.8 84.0 63.4 226.4 95.6 113.7 175.8 140.3 115.0 148.3 82.8 171.4 183.7 190.9 78.2 251.5 125.3 116.9 146.2 90.9 180.2 98.8 143.6 127.2 114.0 122.8 93.2 61.3 101.7 173.6 173.1 136.4 145.0 198.7 124.5 147.6 132.7 201.8 128.3 104.1 208.4 119.0 280.7 118.8 101.5 127.5 163.7 158.0 135.9 116.0 203.8 136.1 151.9 93.2 210.7 81.9 133.8 172.0 105.6 174.5 303.8 115.5 104.8 99.4 102.8 147.1 297.0 263.0 113.0 89.4 180.6 116.7 9.7 10.6 8.2 11.1 9.4 11.8 8.6 7.6 7.4 9.9 6.8 7.0 8.4 9.7 12.1 10.5 9.3 3.8 9.9 59.3 63.4 60.8 60.7 55.3 59.1 67.2 62.3 62.2 65.7 64.7 63.4 80.6 22.4 25.5 15.3 91.9 65.8 86.2 107.1 74.6 23.3 92.9 72.6 24.0 70.1 56.1 82.8 8.4 132.8 77.4 110.9 33.2 131.6 7.1 26.3 40.6 77.4 75.6 44.2 6.8 157.2 143.9 60.3 50.0 49.7 35.5 74.9 71.7 68.2 159.8 37.0 7.9 107.4 71.2 125.1 95.0 7.7 60.3 88.7 62.2 12.2 119.2 59.6 113.3 13.0 10.7 140.4 84.7 40.6 84.6 102.8 81.7 49.7 22.1 17.5 26.3 57.1 38.8 17.2 16.4 83.7 81.8 165.4 71.4 62.4 114.0 122.0 APPBP2 "Hs.84084, KIAA0228, PAT1" ENSG00000062725 "Amyloid beta precursor protein binding protein 2" Q92624 17 60443158-60526242 "Cancer-related genes, Predicted intracellular proteins" "Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 391.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 110.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066852, HPA078370" Supported Supported Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 21: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "HPA066852: , HPA078370: " "unprognostic (1.43e-1)" "unprognostic (1.89e-1)" "unprognostic (1.40e-3)" "unprognostic (2.97e-2)" "unprognostic (2.93e-2)" "unprognostic (4.53e-2)" "prognostic unfavorable (3.65e-4)" "unprognostic (7.67e-2)" "unprognostic (9.24e-2)" "unprognostic (2.39e-1)" "unprognostic (2.90e-3)" "unprognostic (6.87e-2)" "unprognostic (5.07e-2)" "unprognostic (1.03e-1)" "unprognostic (3.84e-1)" "unprognostic (1.31e-1)" "unprognostic (9.36e-2)" 14.9 11.2 13.6 10.2 15.3 4.1 11.3 14.9 15.4 11.7 11.9 10.4 7.3 12.8 9.5 10.3 10.0 11.6 7.0 12.0 14.1 13.1 11.0 9.5 8.7 12.6 13.6 19.6 11.5 14.4 8.0 12.2 13.8 13.7 9.1 17.3 8.5 10.1 9.4 8.7 7.2 11.8 14.6 12.0 10.8 23.5 14.4 10.3 12.8 9.8 8.2 10.0 8.8 22.0 16.5 21.9 22.6 19.0 23.7 24.7 12.6 25.4 17.5 13.9 17.6 10.7 14.0 17.0 41.7 21.4 24.0 13.8 16.2 8.8 24.4 15.3 12.4 21.6 20.1 22.5 25.2 18.1 23.1 24.4 11.4 14.6 14.1 21.6 21.9 10.5 16.5 19.3 20.4 110.4 25.5 9.2 5.0 17.9 9.7 16.8 37.8 20.0 21.5 26.7 24.6 21.0 22.0 3.7 18.2 12.5 30.4 12.3 28.4 31.1 37.6 21.7 19.5 20.5 70.8 14.3 20.6 10.5 22.4 13.8 9.5 12.0 7.4 7.1 8.4 7.2 8.7 8.2 9.3 9.7 11.8 8.9 11.9 12.5 12.2 5.6 9.3 7.5 13.6 15.3 14.9 15.4 12.0 14.1 12.6 13.6 13.8 14.6 14.4 22.0 32.8 28.9 24.0 55.5 20.9 18.0 15.6 18.6 21.6 59.4 18.8 15.0 27.3 20.0 20.8 14.7 18.8 27.4 24.0 17.0 19.6 19.7 391.3 21.3 33.6 29.3 33.0 5.9 57.8 16.6 8.9 30.1 13.7 27.3 22.9 40.6 40.0 21.7 19.8 37.0 65.4 22.1 20.3 19.4 14.9 126.2 35.4 17.7 17.8 44.0 22.5 44.4 16.5 55.8 132.0 16.9 13.2 39.1 17.1 24.7 15.9 30.2 19.5 34.9 39.5 32.1 31.6 56.3 33.3 15.3 18.5 63.2 20.8 42.0 20.4 18.1 APRT ENSG00000198931 "Adenine phosphoribosyltransferase" P07741 16 88809339-88811937 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026681 Approved Approved Nucleoplasm,Cytosol NA NA 1600000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Cytosol" "HPA026681: AB_1844964" "unprognostic (5.87e-2)" "unprognostic (5.10e-2)" "unprognostic (1.98e-1)" "unprognostic (3.67e-2)" "unprognostic (1.78e-1)" "unprognostic (2.50e-3)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.71e-1)" "unprognostic (1.82e-1)" "unprognostic (6.78e-2)" "unprognostic (8.74e-2)" "unprognostic (9.58e-3)" "unprognostic (1.14e-1)" "unprognostic (2.51e-1)" "unprognostic (4.75e-2)" "unprognostic (1.48e-2)" 118.5 161.2 30.1 73.6 30.1 103.1 112.3 32.0 39.5 109.6 39.3 121.0 72.2 81.2 25.5 231.1 87.6 31.4 70.2 29.9 32.0 128.7 190.4 85.8 83.8 32.9 31.3 73.3 169.4 66.1 64.9 37.0 32.1 113.6 40.2 5.1 119.8 44.6 62.7 240.1 106.8 29.8 33.7 128.6 131.8 35.2 35.1 77.2 96.9 23.8 64.5 95.7 153.7 35.7 157.9 228.3 44.9 200.4 54.2 106.0 232.2 117.1 105.0 136.0 52.6 237.6 189.0 145.5 221.9 68.4 65.0 165.3 74.8 195.4 27.5 102.9 417.7 124.3 106.5 253.0 168.1 87.4 97.7 113.1 207.6 109.0 139.4 63.7 172.6 244.6 266.6 107.9 71.4 586.0 242.1 254.7 169.4 169.5 288.8 259.2 69.2 351.5 156.3 107.0 218.2 132.4 223.5 130.7 131.2 41.9 427.9 171.1 111.4 122.5 104.9 99.5 118.0 205.9 186.5 408.8 179.9 228.4 110.5 77.7 544.5 202.8 474.5 473.5 631.7 501.1 612.0 510.3 562.4 517.3 557.8 475.3 31.8 501.8 322.1 731.6 551.8 998.0 30.1 30.1 32.0 39.5 29.9 32.0 32.9 31.3 32.1 33.7 35.1 35.7 146.5 115.4 147.4 5.9 247.0 319.0 320.0 375.7 207.7 19.9 346.2 479.7 46.9 230.2 206.8 92.0 6.2 265.0 262.3 273.1 406.9 404.3 11.8 124.6 180.3 163.1 210.8 150.6 5.1 442.6 401.5 170.3 192.7 148.4 131.9 154.9 147.8 309.6 348.0 15.2 4.4 386.4 160.7 253.9 336.1 35.4 239.9 214.6 297.1 3.7 449.4 78.7 355.3 2.5 7.2 392.3 228.3 135.4 171.6 404.3 349.2 647.9 125.5 20.4 39.5 135.6 186.5 18.4 126.9 358.8 494.7 172.7 285.7 339.5 426.7 385.2 ARF5 ENSG00000004059 "ADP ribosylation factor 5" P84085 7 127588386-127591700 "Plasma proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 3900000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" "unprognostic (6.72e-3)" "unprognostic (2.34e-2)" "unprognostic (1.67e-2)" "unprognostic (1.95e-1)" "unprognostic (1.18e-1)" "unprognostic (3.04e-2)" "unprognostic (5.81e-3)" "unprognostic (9.41e-2)" "unprognostic (2.69e-1)" "unprognostic (2.75e-2)" "unprognostic (7.02e-2)" "unprognostic (1.02e-1)" "unprognostic (9.69e-2)" "unprognostic (1.50e-1)" "unprognostic (1.26e-2)" "unprognostic (3.95e-1)" "unprognostic (2.46e-2)" 100.2 93.7 139.3 72.6 147.7 143.0 99.8 128.4 200.6 100.7 124.4 108.3 92.3 104.8 114.1 227.5 97.5 81.7 118.6 152.0 137.2 125.8 139.0 90.8 102.7 133.8 132.0 72.1 168.1 104.0 100.2 69.3 135.1 98.7 61.3 22.9 103.1 71.1 131.9 199.8 98.5 66.3 131.9 105.8 117.8 82.9 135.2 95.8 80.5 101.4 74.6 92.5 122.1 133.4 157.4 148.9 120.1 386.5 101.6 159.1 163.3 43.9 129.6 118.7 135.8 232.0 211.4 114.7 64.4 132.6 135.9 117.5 92.4 198.0 38.4 104.9 222.8 44.9 137.5 160.2 150.1 69.7 100.1 163.1 196.2 77.7 75.8 94.5 173.2 164.1 105.1 124.1 116.9 531.2 249.0 303.7 179.9 157.1 191.7 148.3 73.9 245.6 198.2 158.7 349.1 226.2 142.8 461.8 116.1 77.6 123.9 108.0 103.7 177.3 75.3 128.0 101.9 115.2 77.5 153.9 181.1 142.0 154.6 289.0 321.4 279.7 144.3 270.3 146.7 129.5 151.1 148.4 409.6 117.2 112.0 122.2 447.5 156.5 216.2 259.6 181.8 381.8 139.3 147.7 128.4 200.6 152.0 137.2 133.8 132.0 135.1 131.9 135.2 133.4 110.3 3.2 12.1 28.4 81.3 105.7 72.9 217.1 130.9 14.8 111.8 180.7 2.0 91.5 83.0 112.2 0.0 151.6 89.7 89.4 201.5 107.8 39.3 90.3 95.7 73.9 119.9 102.2 46.5 90.7 125.0 82.2 135.5 88.2 21.0 91.1 75.7 51.6 102.7 20.2 42.5 108.8 140.4 129.6 221.9 40.7 93.2 123.9 149.4 28.1 118.6 27.6 82.4 27.2 36.2 86.4 134.0 94.8 75.1 57.2 147.5 160.0 58.4 11.9 72.3 58.7 85.4 99.2 116.7 248.3 153.4 146.3 100.2 69.1 125.4 93.4 ARHGAP39 "CrGAP, KIAA1688, Vilse" ENSG00000147799 "Rho GTPase activating protein 39" Q9C0H5 8 144529179-144605816 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 21.8" "Cell type enhanced" "Detected in many" "Astrocytes: 34.3;Endometrial ciliated cells: 31.4;Excitatory neurons: 41.7;Inhibitory neurons: 33.1;Oligodendrocytes: 30.8;Respiratory ciliated cells: 27.6;Rod photoreceptor cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044491 Approved "Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol" Yes NA "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "Nucleoplasm, Microtubules, Cytokinetic bridge" "HPA044491: AB_10794775" "unprognostic (3.42e-2)" "unprognostic (2.65e-2)" "unprognostic (9.85e-2)" "unprognostic (4.17e-1)" "unprognostic (1.53e-1)" "unprognostic (2.49e-1)" "unprognostic (1.74e-7)" "unprognostic (1.89e-2)" "unprognostic (3.00e-1)" "unprognostic (2.02e-1)" "unprognostic (6.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.19e-2)" "unprognostic (1.26e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (9.97e-2)" 1.6 3.9 4.3 0.8 5.2 0.0 3.4 2.3 9.4 4.9 1.2 4.5 1.7 2.8 0.8 5.0 8.2 0.7 1.9 8.5 2.3 4.9 1.6 2.7 0.3 8.4 5.9 2.6 5.2 1.3 9.9 0.7 5.5 4.2 0.6 3.1 3.5 1.4 0.7 5.2 2.7 0.5 4.7 1.3 2.0 21.8 3.5 0.7 7.5 0.1 0.1 1.9 3.1 9.5 8.3 8.1 3.8 5.8 0.7 0.6 7.2 2.1 0.7 2.6 1.6 5.2 4.8 0.8 5.4 0.8 2.7 7.0 1.8 2.0 0.5 0.0 7.2 0.1 5.8 3.4 1.3 0.0 0.8 0.5 3.2 3.3 1.4 1.3 0.8 0.4 7.7 0.0 1.1 13.4 4.6 0.0 4.0 3.4 11.4 4.3 3.0 3.2 2.1 4.1 10.9 7.7 6.2 2.1 3.8 1.4 9.0 1.2 2.0 1.9 0.1 6.6 4.5 0.0 0.1 0.3 3.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 5.2 2.3 9.4 8.5 2.3 8.4 5.9 5.5 4.7 3.5 9.5 0.8 3.2 2.3 34.3 0.6 3.7 0.6 1.9 2.2 7.2 5.0 3.3 1.6 0.0 2.8 3.7 20.9 0.6 0.1 7.5 0.0 2.4 3.9 31.4 2.8 1.1 0.0 0.0 41.7 2.5 0.9 1.2 1.1 6.0 0.0 6.0 0.7 1.4 0.5 3.3 33.1 4.2 4.1 0.0 0.4 3.1 2.1 0.2 5.4 1.0 0.0 3.6 0.0 15.6 30.8 1.4 7.9 8.2 0.0 1.0 3.3 1.5 27.6 24.5 6.6 2.5 2.1 8.5 11.2 2.1 3.0 0.5 0.3 3.1 5.2 0.7 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 280450-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 249.4;pancreas: 112.7" "Cell type enhanced" "Detected in some" "Astrocytes: 12.1;Excitatory neurons: 27.8;Inhibitory neurons: 32.1;Proximal enterocytes: 64.0" "Cancer enhanced" "Detected in many" "glioma: 3.5" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.6;HEK 293: 26.6;MCF7: 34.9;SCLC-21H: 10.9;SH-SY5Y: 13.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "Plasma membrane, Cytosol" "HPA078260: AB_2732375" "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 4.5 2.8 116.5 1.1 138.7 0.2 1.3 118.2 249.4 0.5 49.9 5.9 16.7 0.1 0.9 0.5 0.5 0.1 10.2 130.1 121.2 0.3 0.2 0.5 0.0 110.3 106.1 0.3 112.7 0.6 10.1 2.2 109.8 0.9 0.4 4.0 0.4 0.3 1.9 0.2 6.9 0.6 84.9 0.1 26.8 3.6 112.6 0.0 0.3 1.4 0.4 0.4 1.1 134.9 0.0 0.8 0.2 2.9 0.0 0.4 0.0 0.1 0.0 0.4 0.0 0.4 0.1 0.0 0.9 0.1 0.0 0.1 7.6 0.0 0.0 0.0 26.6 0.0 0.4 0.2 0.7 0.0 0.1 0.2 0.0 0.0 0.0 1.3 0.3 0.0 1.8 0.1 0.0 34.9 0.0 0.0 3.1 1.6 0.0 0.0 0.0 0.3 0.0 0.0 10.9 13.9 0.2 0.1 0.0 0.4 2.6 0.0 0.3 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 116.5 138.7 118.2 249.4 130.1 121.2 110.3 106.1 109.8 84.9 112.6 134.9 0.1 0.0 0.0 12.1 0.0 0.4 0.0 0.0 0.0 4.0 0.0 0.3 1.4 0.0 0.0 0.0 2.1 0.1 0.0 0.7 0.0 0.2 0.4 0.0 0.4 0.1 1.2 2.7 27.8 11.7 0.2 2.5 6.1 0.0 0.0 0.2 1.4 0.0 0.4 0.0 32.1 3.7 0.0 0.0 0.0 0.6 0.3 0.0 0.0 8.4 0.0 2.2 0.0 6.6 10.9 3.9 3.9 0.0 0.0 0.1 64.0 0.1 0.0 3.7 0.0 0.0 0.4 0.2 3.9 0.0 0.0 0.4 0.0 0.0 7.0 0.1 ARL2 ARFL2 ENSG00000213465 "ADP ribosylation factor like GTPase 2" P36404 11 65014160-65022184 "FDA approved drug targets, Predicted intracellular proteins" "Cell cycle" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 430.8;Late spermatids: 1125.1;Proximal tubular cells: 505.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044610 Supported Approved "Nucleoplasm,Nucleoli,Golgi apparatus,Focal adhesion sites,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "Nucleoli, Golgi apparatus, Focal adhesion sites, Cytosol" "HPA044610: AB_10964207" "unprognostic (9.23e-2)" "unprognostic (3.66e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (4.58e-4)" "unprognostic (1.61e-1)" "unprognostic (5.08e-2)" "unprognostic (1.07e-3)" "unprognostic (2.34e-1)" "unprognostic (9.85e-3)" "unprognostic (6.43e-2)" "unprognostic (6.87e-3)" "prognostic favorable (7.70e-4)" "unprognostic (2.15e-2)" "unprognostic (1.85e-1)" "unprognostic (1.60e-1)" "unprognostic (4.39e-1)" "unprognostic (1.24e-2)" 124.8 93.7 161.5 40.6 190.2 51.3 112.0 172.4 200.2 106.3 132.3 123.1 52.7 121.2 28.2 67.2 94.6 48.0 169.1 157.0 168.7 138.5 22.5 90.4 37.7 171.5 167.9 95.7 75.3 65.3 68.5 56.1 167.2 84.7 32.9 43.5 67.9 66.6 214.2 95.8 73.4 60.9 171.4 63.4 85.2 116.1 167.4 33.5 85.7 158.1 29.0 112.2 93.5 184.4 162.0 257.0 76.5 115.8 207.4 156.5 70.5 82.5 181.7 111.2 109.1 72.8 110.0 62.1 144.5 112.7 168.1 101.4 82.9 140.0 53.1 65.5 130.6 61.9 109.2 111.9 157.8 77.9 54.9 123.7 114.6 92.6 204.4 160.5 150.4 74.0 152.8 110.1 76.4 194.1 63.1 174.5 120.3 77.7 208.6 33.4 81.6 152.9 120.9 70.6 143.3 79.3 66.4 67.6 225.8 74.4 72.3 94.3 109.2 205.9 68.6 164.7 82.1 37.9 57.6 38.5 97.2 112.5 171.3 46.5 78.2 72.5 120.4 80.2 130.9 163.1 110.0 116.9 101.7 149.0 123.5 137.2 10.2 83.3 48.2 140.1 79.0 136.9 161.5 190.2 172.4 200.2 157.0 168.7 171.5 167.9 167.2 171.4 167.4 184.4 179.1 22.4 43.6 0.0 42.7 81.4 94.4 118.4 63.7 70.2 66.8 83.9 103.2 51.5 66.4 82.8 29.2 179.7 40.0 110.0 268.0 142.0 430.8 42.2 59.0 148.0 83.3 69.4 0.0 76.0 193.5 107.0 29.6 50.7 95.7 71.5 137.4 19.7 98.3 69.0 0.0 68.4 83.4 49.7 73.5 1125.1 71.7 49.5 177.9 0.0 100.6 208.4 55.6 0.0 0.0 68.3 115.7 71.1 16.5 79.9 162.4 505.5 47.0 48.9 65.7 74.2 109.7 126.5 79.4 56.3 82.8 107.3 40.0 65.7 98.0 75.9 ARL6IP4 "SFRS20, SR-25, SRp25, SRrp37" ENSG00000182196 "ADP ribosylation factor like GTPase 6 interacting protein 4" Q66PJ3 12 122980060-122982913 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052098 Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Mitochondria "HPA052098: AB_2681724" "unprognostic (1.10e-1)" "unprognostic (4.01e-2)" "unprognostic (8.42e-3)" "unprognostic (1.86e-1)" "unprognostic (4.23e-2)" "unprognostic (2.04e-3)" "unprognostic (6.48e-4)" "unprognostic (1.06e-2)" "unprognostic (1.38e-1)" "unprognostic (8.62e-2)" "unprognostic (3.03e-5)" "unprognostic (4.01e-2)" "unprognostic (8.41e-8)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (1.43e-2)" "prognostic favorable (1.08e-4)" 134.0 168.4 158.3 88.5 152.0 162.6 130.6 147.5 178.3 135.7 143.1 177.2 108.8 117.1 63.7 118.3 120.5 74.9 190.3 148.9 151.2 159.1 207.4 106.9 117.9 157.2 157.9 142.4 192.6 109.3 120.4 67.3 156.4 131.4 59.2 44.1 151.8 92.6 373.4 118.0 116.0 64.1 149.0 135.5 161.1 91.3 158.1 100.6 114.8 174.0 82.5 145.8 117.5 161.1 233.9 248.5 160.3 108.3 110.3 144.7 125.7 131.0 156.0 192.5 145.4 123.9 96.2 220.5 160.3 166.8 90.1 120.3 129.1 212.6 85.2 197.1 134.8 367.3 227.3 246.5 211.4 202.8 155.6 151.0 168.3 148.4 193.7 210.1 214.8 174.6 166.4 104.3 156.2 274.1 237.5 367.4 126.5 140.1 156.0 178.1 175.9 262.6 168.2 195.1 155.1 185.2 123.7 204.3 314.5 69.6 268.4 259.5 194.5 110.7 202.4 106.6 166.1 221.6 115.0 255.4 159.9 233.8 141.6 182.2 250.1 266.6 194.6 327.5 209.3 241.1 231.4 217.0 315.8 233.8 219.7 198.4 68.5 216.9 385.2 215.0 272.3 298.5 158.3 152.0 147.5 178.3 148.9 151.2 157.2 157.9 156.4 149.0 158.1 161.1 239.4 93.0 127.9 33.6 228.0 204.4 313.8 271.4 156.5 111.1 309.0 379.5 0.0 207.3 146.2 211.5 43.8 282.2 262.0 361.9 516.5 306.3 200.5 141.3 168.6 218.7 223.3 147.5 27.1 635.5 261.0 197.4 171.8 112.1 167.1 273.3 240.2 465.6 386.5 97.6 26.5 332.6 170.9 401.4 412.8 380.8 222.4 270.7 377.1 23.4 477.6 231.0 324.4 18.6 26.4 395.6 332.8 180.9 241.6 337.3 706.6 814.9 135.8 125.5 177.5 215.3 242.7 189.1 164.2 188.8 203.3 240.2 228.5 353.8 331.7 370.1 ARMC6 MGC19595 ENSG00000105676 "Armadillo repeat containing 6" Q6NXE6 19 19033575-19060311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 110.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041420, HPA041681" Supported Enhanced Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" Cytosol "HPA041420: AB_2677469, HPA041681: AB_10793928" "unprognostic (2.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (3.55e-2)" "unprognostic (2.43e-1)" "unprognostic (8.98e-2)" "unprognostic (2.36e-1)" "unprognostic (7.04e-3)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-2)" "unprognostic (1.70e-1)" "unprognostic (3.73e-2)" "unprognostic (1.40e-1)" 11.9 16.6 20.4 11.4 20.4 16.7 11.7 21.6 27.8 13.9 19.8 12.4 10.0 14.7 6.1 18.7 11.7 6.9 17.9 21.2 21.7 16.9 110.5 11.9 15.8 22.9 21.2 12.0 11.2 11.9 17.8 8.8 22.7 15.6 8.9 7.7 13.3 8.0 21.3 12.7 12.3 9.1 19.5 17.8 12.3 24.0 20.3 23.2 19.4 18.2 12.4 14.4 12.6 20.8 64.1 42.8 30.7 38.0 14.5 24.7 39.7 40.3 23.5 64.5 47.7 59.8 56.0 96.3 63.8 34.1 23.8 31.8 73.7 47.8 35.5 20.4 104.0 48.5 39.0 49.0 32.0 87.1 54.3 31.2 44.9 44.0 30.7 14.5 41.6 56.3 86.4 36.0 36.0 78.0 93.2 70.5 71.5 71.9 86.8 76.3 27.7 68.9 31.9 42.6 70.5 30.6 32.4 41.1 33.9 20.7 35.0 54.1 27.2 33.0 28.8 47.3 83.8 27.5 53.2 93.2 27.3 117.1 44.0 10.6 19.0 5.3 22.1 20.3 16.6 13.4 12.0 19.3 28.3 15.1 15.7 18.0 3.8 30.6 16.7 18.2 23.4 18.3 20.4 20.4 21.6 27.8 21.2 21.7 22.9 21.2 22.7 19.5 20.3 20.8 7.1 0.0 5.9 4.6 10.7 6.6 6.8 9.2 9.1 14.1 11.5 11.4 5.9 17.2 8.9 12.9 12.5 20.5 21.3 12.3 7.9 16.0 25.5 6.3 11.8 10.2 15.0 13.7 4.0 10.7 20.3 10.7 12.2 9.6 1.3 11.1 8.2 52.4 20.7 5.0 5.0 10.9 6.1 15.6 6.0 47.9 10.2 9.2 5.4 0.0 14.9 16.4 20.6 5.0 5.5 10.8 10.8 8.2 10.3 12.4 10.4 12.3 4.5 17.9 13.1 7.4 9.1 22.0 31.0 10.0 10.1 13.0 10.3 16.5 17.3 5.5 ARRDC1 MGC40555 ENSG00000197070 "Arrestin domain containing 1" Q8N5I2 9 137605685-137615360 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 204.5;T-47d: 89.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044345 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA044345: AB_10965181" "unprognostic (3.25e-2)" "unprognostic (1.41e-2)" "unprognostic (6.03e-3)" "unprognostic (4.32e-3)" "unprognostic (8.21e-2)" "unprognostic (8.01e-2)" "unprognostic (7.95e-2)" "unprognostic (2.65e-2)" "unprognostic (2.37e-1)" "unprognostic (1.26e-1)" "unprognostic (3.55e-1)" "unprognostic (5.52e-2)" "prognostic favorable (3.59e-4)" "unprognostic (5.01e-3)" "unprognostic (1.51e-1)" "unprognostic (8.70e-2)" "unprognostic (1.11e-3)" 19.8 25.2 8.7 9.1 8.8 23.3 28.3 7.4 15.1 23.7 11.4 39.0 22.7 13.1 3.2 60.4 21.5 4.6 23.9 9.4 8.0 35.7 42.9 35.2 11.0 9.3 8.3 10.3 42.9 9.5 30.8 7.8 9.2 43.4 5.3 3.1 51.9 11.2 13.6 37.2 43.8 2.5 8.2 54.6 53.7 21.0 8.5 8.3 31.7 4.0 4.9 23.6 35.9 8.4 39.4 25.4 2.4 8.3 3.9 4.2 38.7 10.2 8.8 5.5 4.2 21.4 53.1 9.5 25.7 7.2 10.5 79.5 2.8 32.9 0.9 8.9 15.6 6.4 23.1 19.4 9.3 11.2 15.4 1.7 49.2 4.9 20.4 7.4 7.9 14.7 13.8 5.6 2.4 204.5 13.6 72.0 5.1 43.9 31.6 16.3 4.2 43.1 20.4 29.2 10.3 7.8 7.1 83.0 11.4 2.5 89.9 26.5 18.8 3.2 4.7 21.8 8.8 11.1 9.0 8.3 8.5 24.9 3.7 108.7 99.2 214.7 35.7 132.5 26.4 23.3 32.7 32.8 121.8 39.9 28.9 28.4 92.9 28.3 122.3 46.1 49.7 56.1 8.7 8.8 7.4 15.1 9.4 8.0 9.3 8.3 9.2 8.2 8.5 8.4 39.4 19.2 22.3 11.1 29.2 17.0 58.5 78.0 29.0 7.2 52.5 35.3 5.4 45.8 67.1 58.8 62.6 85.4 43.1 71.7 37.2 50.2 12.1 30.9 8.2 22.5 17.4 11.1 10.6 46.0 41.8 10.1 85.6 32.9 18.4 22.1 23.2 23.7 48.1 3.3 6.1 56.1 57.0 54.0 29.8 14.8 10.8 41.3 7.2 16.9 57.0 10.7 46.4 2.5 3.5 69.1 72.8 10.5 20.6 58.6 81.6 27.4 53.9 46.0 0.0 4.1 13.7 21.3 13.7 33.7 21.3 73.3 38.8 6.7 47.1 69.0 ATG101 "C12orf44, FLJ11773" ENSG00000123395 "Autophagy related 101" Q9BSB4 12 52069246-52077494 "Predicted intracellular proteins, Transporters" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "plasmacytoid DC: 261.9" "Lineage enriched" "Detected in all" 5 "dendritic cells: 261.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039904 Approved NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 22: Epithelial cell types - Mixed function" "HPA039904: AB_10673262" "unprognostic (1.77e-2)" "unprognostic (1.51e-1)" "unprognostic (1.53e-2)" "unprognostic (1.29e-1)" "unprognostic (3.19e-1)" "unprognostic (6.33e-3)" "prognostic unfavorable (8.07e-7)" "unprognostic (9.39e-2)" "unprognostic (1.40e-1)" "unprognostic (5.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "unprognostic (3.63e-2)" "unprognostic (1.27e-1)" "unprognostic (1.89e-1)" "unprognostic (3.36e-1)" "unprognostic (1.15e-1)" 32.7 30.1 24.3 21.4 26.5 23.9 26.3 26.0 29.8 22.6 25.7 27.4 19.6 24.4 34.6 32.1 24.4 27.6 29.7 27.0 25.7 38.1 38.0 31.1 24.2 24.4 24.3 24.1 33.9 27.9 29.0 20.2 24.5 30.4 17.5 8.5 37.7 19.2 39.5 44.1 24.2 21.5 24.5 30.5 39.7 36.4 26.0 27.6 27.0 24.6 21.8 34.4 25.2 27.1 63.0 173.0 35.8 49.0 52.3 40.3 52.7 75.6 76.0 69.8 54.7 202.3 71.2 46.7 67.8 91.3 61.3 51.0 44.6 69.4 47.2 53.2 46.8 46.0 135.0 126.1 135.2 39.6 60.0 39.0 77.8 93.8 66.3 53.6 54.7 39.3 44.0 81.8 50.9 237.9 52.0 88.4 69.7 46.6 74.4 36.5 29.8 64.9 49.9 97.4 34.7 46.7 51.6 74.9 103.3 27.3 81.1 47.1 62.0 61.3 55.2 58.1 60.0 51.8 70.8 47.5 63.2 45.7 95.6 8.9 38.2 46.4 28.4 38.0 30.8 40.6 27.9 32.7 49.7 46.3 27.3 30.6 7.1 25.9 47.7 261.9 36.4 38.2 24.3 26.5 26.0 29.8 27.0 25.7 24.4 24.3 24.5 24.5 26.0 27.1 36.0 19.2 22.4 3.9 48.3 0.0 104.6 0.0 56.9 14.8 78.7 54.7 3.1 38.6 9.9 29.5 12.5 52.1 80.9 43.5 70.5 60.8 19.6 52.6 25.2 34.4 30.5 12.8 3.9 65.4 55.7 40.4 38.7 57.8 45.1 26.6 45.3 46.7 45.1 5.0 3.0 54.4 0.0 28.6 0.0 33.1 27.1 40.6 0.0 3.7 57.1 23.0 22.6 2.5 4.4 63.1 49.4 36.5 49.8 108.9 56.5 61.0 9.5 21.3 26.3 65.0 43.9 77.0 75.1 48.1 0.0 65.8 36.2 45.7 41.3 133.5 ATP5MF "ATP5J2, ATP5JL" ENSG00000241468 "ATP synthase membrane subunit f" P56134 7 99448475-99466186 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 777.4;Distal tubular cells: 1430.2;Exocrine glandular cells: 578.8;Extravillous trophoblasts: 636.3;Hofbauer cells: 787.4;Pancreatic endocrine cells: 589.5;Proximal tubular cells: 1616.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067267, HPA070412" Approved Supported "Nuclear membrane,Mitochondria" NA NA 60000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nuclear membrane" "HPA067267: AB_2685815, HPA070412: AB_2686266" "unprognostic (2.43e-2)" "unprognostic (1.42e-1)" "unprognostic (1.23e-2)" "unprognostic (1.90e-1)" "unprognostic (4.55e-3)" "prognostic unfavorable (2.58e-4)" "unprognostic (1.28e-2)" "unprognostic (3.77e-2)" "unprognostic (6.19e-2)" "unprognostic (2.31e-3)" "unprognostic (2.58e-1)" "unprognostic (3.65e-2)" "unprognostic (6.88e-3)" "unprognostic (9.24e-2)" "unprognostic (4.90e-2)" "unprognostic (2.52e-1)" "unprognostic (5.78e-2)" 328.8 423.5 636.9 268.7 655.2 404.4 310.8 658.3 868.4 247.8 671.0 470.9 442.7 188.3 299.1 526.6 191.7 143.8 1184.8 658.1 663.7 559.3 561.2 241.8 293.1 657.5 648.0 179.1 271.6 509.6 332.1 235.7 647.0 315.5 367.9 320.7 317.8 205.9 1337.1 287.0 384.6 192.0 637.6 281.8 354.7 310.5 652.7 439.3 241.4 1439.0 301.2 303.1 303.5 641.3 1251.5 1130.6 905.3 1400.5 752.1 739.2 561.1 799.3 705.9 947.2 994.6 1226.2 1091.7 1161.7 822.7 548.5 1513.9 735.7 1064.0 981.3 1021.4 831.0 1333.6 800.1 1584.6 1555.4 530.7 1324.4 824.4 835.6 944.9 766.6 858.9 760.5 919.8 1009.4 1681.6 1213.0 1057.4 3128.1 1984.5 2396.1 1228.2 2594.9 1410.9 874.9 741.6 1985.9 1936.7 1376.1 845.3 925.9 1073.7 2519.4 773.1 1365.1 644.9 1687.5 703.0 706.0 1142.1 1197.3 1181.5 685.7 1795.6 2432.4 829.7 1325.8 1131.8 1020.3 904.1 1069.1 440.2 912.7 425.6 597.7 508.3 494.8 1122.9 512.2 445.1 468.3 428.0 555.2 731.2 890.5 754.9 1505.3 636.9 655.2 658.3 868.4 658.1 663.7 657.5 648.0 647.0 637.6 652.7 641.3 147.7 22.4 44.9 0.0 57.9 0.0 0.0 0.0 0.0 0.0 252.4 289.6 0.0 0.0 36.5 386.2 0.0 777.4 125.6 0.0 1430.2 460.9 0.0 302.6 225.3 82.0 0.0 0.0 0.0 578.8 636.3 110.5 0.0 278.3 64.3 188.1 0.0 0.0 787.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 190.2 0.0 0.0 339.1 0.0 0.0 0.0 0.0 589.5 0.0 0.0 18.6 0.0 0.0 1616.3 51.0 0.0 0.0 0.0 114.8 0.0 0.0 0.0 0.0 436.3 64.0 206.4 0.0 0.0 ATP5MPL "6.8PL, C14orf2, MLQ, MP68" ENSG00000156411 "ATP synthase membrane subunit 6.8PL" P56378 14 103912288-103928269 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1602.3;Extravillous trophoblasts: 671.4;Hofbauer cells: 920.9;Proximal tubular cells: 1883.7;Syncytiotrophoblasts: 710.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058978, HPA060520" Approved Supported "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "Nucleoli fibrillar center" "HPA058978: AB_2683867, HPA060520: AB_2684302" "unprognostic (1.37e-1)" "unprognostic (1.42e-3)" "unprognostic (1.55e-1)" "unprognostic (2.30e-1)" "unprognostic (2.11e-1)" "unprognostic (1.20e-2)" "unprognostic (1.75e-2)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "prognostic favorable (6.80e-4)" "unprognostic (1.34e-2)" "unprognostic (5.48e-2)" "unprognostic (1.34e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (1.57e-1)" "unprognostic (4.14e-2)" 107.8 166.9 304.6 75.7 318.3 177.4 127.5 305.8 446.6 94.9 306.0 165.2 165.1 80.5 139.6 159.4 87.0 48.8 548.2 321.9 313.4 205.2 181.9 79.9 94.4 301.2 297.7 98.3 113.8 257.3 159.9 77.1 302.4 108.5 167.5 169.9 100.9 87.8 489.6 106.1 128.9 78.9 303.1 108.7 135.6 83.4 305.5 135.0 111.5 471.6 122.5 103.0 101.1 304.1 244.6 278.5 233.6 222.8 275.0 284.2 228.5 185.2 211.7 228.6 199.5 240.6 167.4 254.4 187.9 191.2 183.4 201.1 306.4 225.3 310.0 207.9 306.8 280.4 227.5 380.4 180.4 346.2 188.4 298.6 301.5 155.7 164.2 260.8 264.4 330.6 176.7 264.7 253.7 730.8 333.1 493.9 182.1 560.5 523.7 211.5 202.7 231.2 358.4 345.0 201.2 238.4 155.9 289.0 371.4 256.2 355.3 401.7 142.7 87.9 137.9 242.0 153.2 199.3 372.5 360.2 207.8 195.7 152.3 405.1 512.8 336.0 204.9 409.1 232.9 309.5 261.1 234.1 367.0 261.9 295.5 260.0 517.5 206.2 401.4 355.4 282.2 656.9 304.6 318.3 305.8 446.6 321.9 313.4 301.2 297.7 302.4 303.1 305.5 304.1 88.0 221.2 225.1 0.0 47.9 0.0 0.0 0.0 0.0 0.0 369.7 334.4 0.0 0.0 92.2 413.8 0.0 609.1 63.1 0.0 1602.3 504.6 0.0 341.3 245.9 104.1 0.0 0.0 0.0 572.6 671.4 113.8 0.0 297.7 93.4 207.9 0.0 0.0 920.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 210.3 0.0 0.0 335.5 0.0 0.0 0.0 0.0 570.5 0.0 0.0 0.0 0.0 0.0 1883.7 146.5 0.0 0.0 0.0 104.8 0.0 0.0 0.0 0.0 710.1 70.2 228.6 0.0 0.0 B4GALT7 "beta4Gal-T7, XGALT-1" ENSG00000027847 "Beta-1,4-galactosyltransferase 7" Q9UBV7 5 177600132-177610330 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 132.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042330 Supported NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA042330: AB_10796576" "unprognostic (1.19e-1)" "unprognostic (1.82e-1)" "unprognostic (3.12e-1)" "unprognostic (5.97e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (9.53e-2)" "unprognostic (4.19e-3)" "unprognostic (3.86e-2)" "unprognostic (1.18e-1)" "unprognostic (1.21e-1)" "unprognostic (1.82e-3)" "unprognostic (2.00e-2)" "unprognostic (4.81e-2)" "unprognostic (2.39e-1)" "unprognostic (4.44e-2)" "unprognostic (2.90e-1)" "unprognostic (4.00e-2)" 19.0 43.7 21.1 15.3 20.1 24.8 17.0 20.6 25.5 18.4 21.8 15.1 16.9 20.1 12.5 16.6 16.0 12.5 23.4 20.1 21.8 20.2 30.5 13.4 20.1 24.8 25.1 19.8 37.6 24.3 31.5 14.1 24.8 22.5 11.9 5.9 24.2 18.8 20.2 13.6 14.7 11.8 18.5 21.3 21.8 23.9 22.1 10.6 18.5 10.1 11.8 17.9 13.9 18.7 20.2 34.5 14.2 35.6 28.0 20.7 63.7 30.1 31.9 26.9 30.7 32.6 30.8 25.2 54.7 30.9 47.3 22.9 9.8 64.9 11.7 85.4 25.8 13.3 27.5 23.4 40.0 13.8 22.4 31.8 22.7 29.0 23.5 24.7 30.3 16.9 11.8 23.7 27.4 46.0 11.9 17.1 13.9 17.7 50.0 24.1 10.3 27.8 20.6 29.6 12.5 14.4 15.0 29.8 27.6 11.3 19.4 16.3 23.5 34.0 19.5 22.6 30.6 29.5 14.9 18.4 28.8 33.0 31.8 16.8 16.7 9.7 14.0 19.7 12.6 14.4 12.8 12.2 19.3 18.4 11.4 11.3 1.3 11.1 19.4 15.2 9.2 10.9 21.1 20.1 20.6 25.5 20.1 21.8 24.8 25.1 24.8 18.5 22.1 18.7 16.3 3.2 5.6 5.2 24.5 6.6 15.4 27.8 15.9 12.1 16.5 19.3 6.9 12.8 15.8 16.5 4.2 43.8 16.4 13.8 7.9 34.1 13.9 12.5 17.8 15.6 14.5 8.2 4.3 38.9 132.4 21.2 8.2 13.5 10.2 30.0 10.8 15.9 31.7 11.8 6.0 22.2 8.2 17.8 8.9 9.8 14.0 18.8 21.4 3.7 25.6 13.7 13.4 3.0 3.4 34.0 12.4 18.4 52.8 30.7 17.4 19.6 9.3 16.1 0.0 13.9 16.4 14.3 11.3 13.9 8.8 43.9 12.8 33.4 23.3 16.3 BCAS2 "DAM1, Snt309, SPF27" ENSG00000116752 "BCAS2 pre-mRNA processing factor" O75934 1 114567557-114581629 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 613.4" "Low region specificity" "Detected in all" HPA067881 Supported Supported "Nuclear speckles,Centrosome" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nuclear speckles, Centrosome" "HPA067881: AB_2685915" "unprognostic (6.93e-2)" "unprognostic (1.88e-2)" "unprognostic (8.58e-3)" "unprognostic (4.74e-2)" "unprognostic (2.49e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (8.23e-7)" "unprognostic (1.16e-1)" "unprognostic (8.51e-3)" "prognostic favorable (7.96e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (4.27e-4)" "prognostic favorable (6.49e-4)" "unprognostic (2.25e-3)" "unprognostic (1.03e-1)" "prognostic unfavorable (5.24e-4)" "unprognostic (1.87e-1)" 31.9 40.6 32.8 28.0 35.4 76.2 38.2 36.7 45.3 27.1 34.6 31.6 25.5 35.1 49.7 34.1 24.9 31.8 39.3 35.7 38.8 44.6 51.3 26.9 38.5 34.9 37.6 32.5 28.8 41.3 33.1 27.8 37.8 35.6 32.1 40.4 29.6 27.2 56.4 29.8 26.1 27.8 34.7 26.1 28.7 31.8 34.6 32.2 42.4 25.9 36.2 41.5 23.4 37.7 100.0 35.6 70.8 69.9 37.8 43.8 108.8 71.3 57.0 95.6 97.4 50.8 40.6 88.8 93.9 46.9 64.3 47.8 85.5 72.7 133.3 76.7 75.7 45.0 67.2 74.6 68.8 117.8 48.1 39.2 79.4 97.5 121.3 44.2 63.7 95.0 89.6 64.5 80.5 613.4 103.1 87.5 125.6 60.8 80.8 73.9 127.6 62.2 68.1 85.9 93.5 62.2 90.3 70.3 114.3 59.6 62.3 91.0 52.8 58.2 74.7 116.9 138.2 68.5 76.9 143.4 113.4 94.7 223.9 54.4 36.8 65.3 56.0 45.2 78.9 63.3 71.6 70.6 39.7 58.0 73.8 71.9 34.7 75.0 51.0 51.2 77.6 72.8 32.8 35.4 36.7 45.3 35.7 38.8 34.9 37.6 37.8 34.7 34.6 37.7 51.6 28.9 45.4 11.1 110.1 77.9 114.2 155.9 91.0 62.6 36.7 49.1 76.0 27.1 85.4 49.7 37.5 76.6 99.0 26.4 95.9 66.6 30.3 79.0 51.5 46.9 50.0 30.5 16.4 66.8 89.8 60.0 25.0 139.1 99.1 46.0 28.2 31.3 66.9 38.7 15.1 43.1 103.7 34.9 93.3 17.7 39.7 80.8 67.6 12.2 50.6 98.3 55.6 15.1 18.1 51.2 37.9 43.6 176.7 49.8 29.4 103.9 55.6 67.1 39.5 55.5 71.4 80.8 40.6 95.7 63.4 101.2 117.4 64.2 36.0 114.2 BCAS3 FLJ20128 ENSG00000141376 "BCAS3 microtubule associated cell migration factor" Q9H6U6 17 60677453-61392838 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Transcription, Transcription regulation" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Astrocytes: 241.9;Excitatory neurons: 298.7;Inhibitory neurons: 299.2;Late spermatids: 282.3;Microglial cells: 244.5;Oligodendrocyte precursor cells: 285.0;Oligodendrocytes: 552.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 88.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052409, HPA057289" Approved Approved Nucleoli NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoli "HPA052409: AB_2681821, HPA057289: AB_2683399" "unprognostic (2.84e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.20e-1)" "unprognostic (3.52e-1)" "unprognostic (5.52e-1)" "unprognostic (3.60e-2)" "unprognostic (5.69e-2)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "prognostic favorable (1.23e-5)" "unprognostic (2.55e-1)" "prognostic favorable (1.73e-5)" "unprognostic (1.49e-1)" "unprognostic (2.54e-1)" "unprognostic (1.12e-1)" "unprognostic (2.32e-1)" 9.7 11.6 12.7 4.5 14.2 6.4 9.0 13.8 15.8 9.4 12.0 10.0 4.8 9.3 12.1 9.5 13.9 7.6 9.1 13.6 12.2 11.1 12.4 11.1 6.0 14.3 12.1 7.4 9.3 14.4 6.9 10.0 15.2 11.1 6.1 18.0 9.3 9.2 17.3 14.2 6.8 9.0 10.2 7.4 9.7 14.3 12.1 10.6 8.8 9.8 6.7 10.9 9.6 24.0 5.7 14.5 7.8 28.1 17.2 14.2 9.8 6.6 9.9 7.3 9.3 10.0 13.8 2.5 9.7 12.2 7.6 4.9 4.5 6.1 9.5 6.1 19.4 5.6 7.3 9.5 9.4 2.7 5.6 14.5 6.3 6.2 11.1 14.2 8.3 8.8 5.1 12.9 6.5 88.7 10.0 2.2 7.3 29.1 18.2 11.4 11.2 12.4 6.0 24.4 11.6 10.2 12.1 3.3 10.3 20.9 13.5 5.1 8.1 9.5 7.7 4.2 2.8 29.1 23.6 11.7 11.2 2.3 7.6 27.2 10.1 16.5 15.0 9.3 12.3 11.4 10.2 11.2 8.8 11.2 10.7 9.1 34.5 15.6 10.9 6.8 18.0 9.0 12.7 14.2 13.8 15.8 13.6 12.2 14.3 12.1 15.2 10.2 12.1 24.0 10.1 6.4 12.5 241.9 8.6 5.1 9.9 4.7 12.5 22.6 4.4 4.1 11.4 7.2 9.3 16.5 10.4 6.8 9.3 4.1 9.8 4.7 44.2 20.4 26.1 8.6 7.2 13.2 298.7 3.5 5.5 7.8 5.6 9.1 15.9 11.1 11.7 10.8 4.3 3.3 299.2 4.9 6.1 10.0 2.5 282.3 7.5 5.3 1.8 244.5 8.2 33.3 5.2 285.0 552.6 3.6 5.2 21.1 11.1 2.9 6.0 25.2 35.6 14.2 13.1 7.1 21.2 16.3 6.6 6.8 5.5 7.5 11.4 6.7 3.8 6.0 BCKDK ENSG00000103507 "Branched chain keto acid dehydrogenase kinase" O14874 16 31106107-31112791 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Transferase" "Autism, Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 95.9;granulocytes: 89.7;monocytes: 115.0" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017995, HPA056067" Supported Supported Mitochondria NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" Mitochondria "HPA017995: AB_1845309, HPA056067: AB_2683024" "unprognostic (1.37e-1)" "unprognostic (2.57e-1)" "unprognostic (6.94e-2)" "unprognostic (5.20e-2)" "unprognostic (5.39e-2)" "unprognostic (3.61e-2)" "unprognostic (1.01e-1)" "unprognostic (5.47e-2)" "unprognostic (1.60e-1)" "unprognostic (1.90e-1)" "unprognostic (1.35e-1)" "unprognostic (3.24e-2)" "unprognostic (2.66e-3)" "unprognostic (4.85e-2)" "unprognostic (3.93e-2)" "unprognostic (1.00e-1)" "unprognostic (4.97e-2)" 32.3 56.4 18.4 19.2 18.6 14.5 29.0 17.4 23.8 25.1 18.0 31.4 16.0 27.7 16.7 29.4 24.8 17.9 78.6 18.8 17.8 43.8 76.4 21.7 15.6 20.6 20.7 27.5 70.5 22.9 16.4 15.3 19.3 29.3 12.5 6.3 47.0 21.8 81.3 45.4 24.1 19.5 17.1 30.2 42.0 17.4 18.5 9.8 22.4 69.7 13.6 30.2 24.6 17.5 47.5 49.1 27.1 41.8 32.8 32.5 31.1 40.4 46.3 57.3 55.9 32.1 29.1 41.5 58.9 47.5 28.0 31.4 19.3 65.6 36.5 34.4 60.1 45.2 32.6 59.5 57.5 23.5 41.9 48.3 26.2 49.2 40.6 52.6 62.4 31.1 23.4 39.4 87.7 75.8 22.9 32.4 23.0 20.5 39.1 45.8 39.6 78.8 44.3 30.1 42.1 38.7 31.3 72.4 24.6 22.9 44.5 24.6 41.1 44.2 26.1 45.8 32.2 44.5 15.7 15.1 50.3 33.7 42.6 58.1 115.0 85.2 17.7 97.6 17.2 22.8 16.5 13.9 95.9 19.0 13.6 16.1 89.7 22.8 71.2 19.3 24.5 53.1 18.4 18.6 17.4 23.8 18.8 17.8 20.6 20.7 19.3 17.1 18.5 17.5 27.2 19.2 18.1 5.9 20.0 18.5 24.6 61.0 22.2 11.6 30.9 27.6 39.1 25.8 28.5 20.2 0.0 55.4 9.0 31.5 80.3 68.6 2.5 14.6 24.3 29.2 19.9 16.4 5.1 78.0 71.1 24.9 25.5 20.0 33.0 35.4 25.4 43.8 93.0 11.8 4.4 22.3 42.7 44.5 50.3 7.8 20.8 53.1 12.4 1.9 79.3 22.6 9.2 4.5 4.5 54.8 48.4 25.6 51.7 30.9 66.9 95.2 19.6 9.8 46.0 18.4 33.2 25.8 14.1 25.7 27.4 69.4 12.1 45.5 26.0 27.0 BID ENSG00000015475 "BH3 interacting domain death agonist" P55957 22 17734138-17774770 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 103.5" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 273.2;Langerhans cells: 658.8;monocytes: 491.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 6 "dendritic cells: 345.8;granulocytes: 925.5;monocytes: 985.3" "Cell line enhanced" "Detected in all" "MCF7: 241.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000722, CAB003771" Enhanced Supported Cytosol NA NA 800000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" Cytosol "CAB003771: AB_365478, HPA000722: AB_1078283" "unprognostic (1.59e-1)" "unprognostic (5.51e-2)" "unprognostic (5.02e-2)" "unprognostic (3.04e-2)" "unprognostic (4.27e-3)" "unprognostic (1.11e-2)" "unprognostic (3.84e-2)" "unprognostic (5.21e-3)" "unprognostic (1.44e-2)" "unprognostic (1.53e-1)" "unprognostic (1.12e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (3.50e-13)" "unprognostic (4.66e-3)" "unprognostic (1.59e-1)" "unprognostic (3.55e-3)" "unprognostic (2.18e-2)" 13.6 6.9 19.4 30.5 20.9 103.5 10.7 19.2 22.4 6.0 12.8 14.7 15.1 5.7 7.2 7.5 6.2 14.7 17.4 20.0 19.5 10.0 28.2 12.0 35.6 19.9 19.8 5.7 9.5 3.5 6.4 7.9 20.8 8.1 11.0 36.9 8.1 4.1 23.3 7.6 17.5 6.8 20.1 30.0 12.2 3.6 22.0 26.4 5.8 7.8 16.7 34.4 7.5 20.2 117.5 90.6 14.4 43.7 15.2 27.7 20.4 59.1 45.4 44.8 38.4 55.4 67.2 22.8 41.5 25.7 52.3 97.8 14.5 14.7 24.7 37.0 73.4 101.3 39.7 81.3 19.1 110.4 107.0 26.7 31.4 49.8 11.3 35.6 46.8 64.8 84.0 27.2 23.0 241.6 161.0 148.2 47.2 130.2 62.8 76.6 37.3 32.8 12.0 141.2 91.3 65.9 12.5 38.2 37.1 6.2 80.3 132.9 80.4 26.0 36.0 43.9 46.7 39.8 57.2 75.7 74.6 113.0 33.8 156.9 417.0 691.4 82.1 748.3 81.7 53.0 75.8 92.5 345.8 33.0 61.2 72.2 925.5 124.1 985.3 245.8 108.0 428.1 19.4 20.9 19.2 22.4 20.0 19.5 19.9 19.8 20.8 20.1 22.0 20.2 49.0 16.0 14.5 16.0 34.5 71.9 53.1 273.2 21.1 3.0 30.0 30.5 17.5 17.2 142.6 9.2 2.1 9.3 70.3 25.1 7.9 67.9 0.6 10.5 14.5 47.4 34.1 23.3 17.6 51.4 5.6 24.9 13.7 11.4 25.3 34.3 23.2 44.0 134.1 0.0 15.6 38.7 63.1 69.1 658.8 1.6 5.3 164.2 58.7 13.1 491.3 3.0 65.9 4.5 2.1 78.5 85.1 4.1 45.2 186.4 16.5 28.6 59.7 1.7 0.0 12.0 24.3 1.3 11.9 13.2 64.5 5.1 38.3 13.6 49.8 213.0 BLOC1S1 "BLOS1, BORCS1, GCN5L1" ENSG00000135441 "Biogenesis of lysosomal organelles complex 1 subunit 1" P78537 12 55716037-55720087 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 1180.5;Proximal tubular cells: 719.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021381 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA021381: AB_2228026" "unprognostic (1.27e-1)" "prognostic favorable (2.77e-4)" "unprognostic (1.65e-1)" "unprognostic (4.03e-2)" "unprognostic (1.10e-1)" "unprognostic (2.40e-1)" "unprognostic (1.59e-1)" "unprognostic (6.77e-2)" "unprognostic (2.22e-1)" "prognostic favorable (2.19e-4)" "unprognostic (6.51e-3)" "unprognostic (1.04e-1)" "unprognostic (1.54e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "unprognostic (2.42e-2)" "unprognostic (1.83e-2)" 125.6 168.5 248.4 81.5 256.8 223.7 112.5 261.4 294.0 94.0 248.6 184.6 145.3 118.9 151.1 177.1 133.4 77.0 169.7 249.4 260.6 196.1 219.3 113.0 107.5 259.1 254.9 93.6 110.1 175.6 109.6 71.6 258.7 113.1 167.5 81.7 107.3 77.1 309.8 114.8 155.4 99.7 258.9 174.9 164.8 55.0 250.9 146.8 118.8 201.1 111.7 125.2 106.2 271.6 134.9 258.3 133.7 113.3 170.6 217.1 75.7 93.7 154.4 112.9 111.8 148.5 267.3 148.6 166.5 194.6 95.2 91.7 70.8 132.4 110.9 142.5 160.5 84.6 220.5 224.9 163.6 104.5 177.7 139.8 137.3 108.2 83.1 145.8 152.4 172.0 77.5 221.0 183.3 294.0 164.3 123.8 84.6 219.1 134.2 110.9 129.9 163.3 182.9 164.2 85.1 141.6 85.1 86.0 150.5 93.2 177.5 169.2 114.2 87.2 142.7 96.5 74.0 99.4 126.2 134.6 158.8 97.2 121.8 612.0 471.8 746.5 238.6 543.1 162.2 345.1 224.4 239.8 486.6 326.5 160.9 201.1 631.4 221.7 586.1 409.0 318.2 637.9 248.4 256.8 261.4 294.0 249.4 260.6 259.1 254.9 258.7 258.9 250.9 271.6 155.2 16.0 20.7 0.0 110.4 83.1 120.0 143.2 61.5 51.6 123.8 158.5 37.6 160.2 92.0 160.0 25.0 98.1 159.5 439.5 369.8 207.3 53.7 123.9 60.6 92.1 99.5 191.3 0.0 320.7 182.3 105.1 103.0 88.6 20.2 77.9 122.4 378.7 430.7 30.3 0.0 266.8 179.0 403.1 213.2 213.9 134.2 238.6 176.1 0.0 347.9 192.0 230.7 0.0 0.0 291.0 409.3 98.9 66.9 122.6 1180.5 719.6 114.2 92.9 78.9 133.9 208.5 46.9 55.0 86.6 88.9 73.2 111.5 77.4 256.7 180.7 BOLA1 CGI-143 ENSG00000178096 "BolA family member 1" Q9Y3E2 1 149887890-149900798 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Distal tubular cells: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 49.3;MCF7: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007005 Approved "Intracellular and membrane" NA NA "Cluster 30: Non-specific - Translation" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA007005: AB_1078294" "unprognostic (5.73e-2)" "unprognostic (9.86e-3)" "unprognostic (8.84e-2)" "unprognostic (8.18e-2)" "unprognostic (9.33e-2)" "unprognostic (3.61e-2)" "prognostic unfavorable (5.88e-4)" "unprognostic (1.67e-2)" "unprognostic (2.19e-1)" "prognostic favorable (6.41e-4)" "unprognostic (3.14e-3)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (8.73e-2)" "unprognostic (1.31e-1)" "unprognostic (9.58e-2)" "unprognostic (1.93e-3)" 14.9 21.2 8.6 5.8 9.3 3.9 16.1 9.7 17.9 16.1 7.3 24.0 15.3 17.2 0.9 15.7 15.6 3.7 20.5 8.4 8.2 23.0 26.4 10.0 7.0 9.3 8.0 14.5 19.7 5.5 14.4 2.6 8.4 16.8 1.7 1.1 19.3 7.2 23.2 22.5 15.9 2.0 9.2 16.2 20.3 9.9 9.3 5.3 15.8 5.0 1.4 19.0 13.8 10.8 16.4 21.3 2.0 4.2 1.2 4.1 4.0 6.7 1.7 5.0 4.1 15.2 22.0 2.1 16.6 2.8 2.3 17.9 0.0 3.5 0.2 22.8 8.2 1.1 6.1 2.4 7.7 0.0 16.8 3.8 7.3 1.5 0.5 2.0 6.0 49.3 9.1 5.4 2.7 52.9 21.1 5.3 1.3 14.7 6.1 16.4 1.2 4.4 2.3 2.1 13.5 14.8 8.8 14.5 15.9 1.7 26.9 4.5 2.5 6.4 10.5 14.6 0.2 29.5 23.3 0.2 9.0 5.1 6.8 8.6 9.4 12.4 14.8 8.1 15.3 16.2 13.5 11.5 9.9 14.6 18.8 18.1 4.6 9.1 5.2 19.2 18.8 9.3 8.6 9.3 9.7 17.9 8.4 8.2 9.3 8.0 8.4 9.2 9.3 10.8 11.9 3.2 9.5 5.5 10.0 4.5 16.3 19.0 10.8 7.3 23.9 30.5 21.1 34.3 11.2 23.9 4.2 20.2 6.3 12.8 68.4 24.6 8.8 12.1 13.6 13.7 12.6 27.1 2.4 19.8 25.3 16.4 19.4 10.4 5.1 13.9 20.7 40.9 17.0 10.1 3.3 22.8 18.3 12.5 3.5 3.5 15.8 6.6 5.4 1.0 10.3 23.5 19.6 2.5 7.5 15.7 17.6 20.7 18.0 23.1 41.5 57.4 14.2 12.3 39.5 10.9 15.7 22.6 16.2 18.4 6.7 14.0 10.1 22.8 21.2 10.0 BOLA2 "BOLA2A, My016" ENSG00000183336 "BolA family member 2" Q9H3K6 16 29443056-29454964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 2.7;Erythroid cells: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 24.7;HEK 293: 32.4;Hep G2: 22.1;MCF7: 33.7" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 390000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" 6.6 8.0 0.3 0.8 0.4 2.6 5.8 0.3 0.7 4.6 0.3 9.2 2.4 3.9 0.0 10.2 3.9 0.5 7.0 0.3 0.3 8.6 7.6 6.7 2.0 0.4 0.3 2.2 5.3 0.3 7.9 0.4 0.3 5.1 0.1 0.0 6.6 0.2 6.4 6.6 9.0 0.1 0.3 12.2 8.0 13.2 0.3 0.2 4.9 0.0 0.3 6.6 6.1 0.4 7.0 24.7 0.7 1.3 0.5 0.8 9.2 1.9 0.8 2.3 2.5 12.5 3.2 4.4 9.2 0.2 2.6 4.5 0.4 1.6 0.1 10.2 32.4 8.2 9.4 22.1 1.2 2.8 5.9 0.4 0.7 2.8 0.1 0.2 1.9 11.2 2.6 1.2 0.4 33.7 3.4 6.7 2.9 0.2 18.6 8.0 2.9 8.6 0.5 5.5 3.7 3.3 2.2 4.3 2.0 0.0 1.9 1.3 3.3 5.8 1.6 4.1 3.4 8.4 8.7 7.6 4.2 6.4 3.5 6.0 7.1 7.2 5.0 9.8 6.1 15.3 6.2 6.7 4.4 12.4 5.3 5.3 1.6 4.6 8.2 10.6 8.3 8.8 0.3 0.4 0.3 0.7 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.4 0.4 0.0 2.7 0.3 0.7 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 0.3 1.0 0.7 0.0 0.4 0.5 0.4 0.6 0.2 0.0 2.7 0.9 0.8 0.2 0.4 0.0 0.8 1.3 0.4 0.0 0.4 0.2 0.0 1.0 0.3 0.0 0.6 0.0 0.6 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.5 0.6 0.6 0.4 0.0 0.3 0.4 0.8 0.1 0.7 0.0 0.0 0.5 0.4 0.2 0.4 0.5 0.3 0.3 0.8 0.1 0.3 0.3 BOLA2-SMG1P6 ENSG00000261740 "BOLA2-SMG1P6 readthrough" 16 29443230-29454651 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 21.8;Exocrine glandular cells: 27.3;granulocytes: 18.9;Pancreatic endocrine cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (2.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (4.45e-2)" "unprognostic (3.08e-3)" "unprognostic (7.50e-2)" "unprognostic (9.88e-2)" "unprognostic (2.64e-1)" "unprognostic (8.79e-3)" "unprognostic (2.30e-1)" "unprognostic (3.82e-3)" "unprognostic (9.90e-2)" "unprognostic (5.75e-2)" "unprognostic (1.07e-2)" "unprognostic (9.64e-2)" 11.0 11.7 6.5 8.9 7.0 20.0 8.9 7.5 8.6 7.7 7.2 13.6 8.9 5.1 1.6 13.8 7.1 4.8 15.8 7.1 7.7 15.0 10.2 7.1 14.0 7.1 7.0 5.2 10.9 14.5 6.8 6.0 7.4 6.0 12.8 4.1 9.9 3.0 14.3 9.7 10.2 6.7 7.3 11.5 10.0 8.9 7.0 9.9 5.8 11.0 9.8 8.6 8.8 7.4 17.5 38.1 44.9 18.9 14.7 16.5 25.7 41.3 29.8 31.7 28.5 8.9 37.6 25.8 58.1 25.5 33.5 32.4 12.1 31.6 45.8 28.3 36.4 17.2 21.2 57.9 34.8 44.6 27.4 22.5 26.4 35.3 39.4 17.9 28.0 102.9 51.6 28.5 34.0 57.9 33.5 73.7 78.3 64.0 52.3 35.6 27.8 68.3 37.4 13.4 30.0 57.3 11.1 51.0 57.5 0.5 29.9 68.2 17.8 16.0 16.3 22.2 27.6 34.7 45.6 61.4 31.9 33.7 40.0 1.8 13.9 8.3 13.1 20.7 13.3 14.9 12.1 10.0 21.4 10.8 9.2 13.5 1.8 8.2 28.0 23.8 22.4 11.8 6.5 7.0 7.5 8.6 7.1 7.7 7.1 7.0 7.4 7.3 7.0 7.4 1.9 9.6 9.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.0 2.2 0.0 0.0 8.6 0.0 0.0 3.4 2.7 0.0 3.9 21.8 0.0 1.7 1.8 4.8 0.0 0.0 0.0 27.3 3.0 2.4 0.0 1.9 18.9 0.7 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.4 0.0 0.0 5.5 5.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 2.2 3.7 0.4 0.0 0.0 BOLA2B ENSG00000169627 "BolA family member 2B" Q9H3K6 16 30192932-30194306 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 107.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045380, HPA046696" Supported Uncertain Nucleoplasm NA NA 390000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "HPA045380: AB_2679301, HPA046696: AB_2679757" "unprognostic (2.49e-1)" "unprognostic (4.60e-3)" "unprognostic (8.49e-2)" "unprognostic (3.02e-3)" "unprognostic (9.80e-4)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (1.25e-1)" "unprognostic (3.08e-2)" "unprognostic (2.24e-2)" "unprognostic (1.26e-1)" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (2.94e-1)" "unprognostic (5.29e-1)" "unprognostic (2.21e-2)" "unprognostic (4.91e-3)" 29.1 29.5 84.0 63.6 88.0 98.6 36.8 90.5 115.2 26.3 87.1 84.4 76.2 15.4 30.8 41.3 18.1 26.3 32.4 84.3 88.7 36.4 24.6 27.4 76.7 90.6 87.3 13.7 46.9 69.3 28.6 31.6 88.5 20.6 48.5 8.6 43.4 18.1 44.8 29.5 56.4 21.3 85.2 48.2 54.6 28.2 86.1 58.8 16.9 60.1 59.1 61.1 22.8 91.9 277.0 624.3 120.0 300.3 66.6 93.3 224.4 103.3 111.9 161.0 201.1 317.6 309.1 104.5 304.9 86.7 212.3 174.0 129.9 272.4 63.5 257.0 1029.1 229.0 322.0 937.7 158.6 190.2 270.7 79.6 186.6 307.1 168.3 43.6 204.0 365.9 161.2 359.9 139.3 875.3 292.5 379.3 362.2 275.3 651.2 382.2 143.2 699.6 219.4 272.7 305.0 310.0 59.5 558.5 143.8 42.3 227.1 174.4 112.0 173.6 144.4 259.4 276.8 458.9 353.3 302.1 253.4 303.2 277.1 130.8 178.0 156.5 193.4 226.7 196.8 313.6 191.2 204.6 156.7 245.1 144.6 185.2 31.8 160.2 213.7 254.6 254.0 195.8 84.0 88.0 90.5 115.2 84.3 88.7 90.6 87.3 88.5 85.2 86.1 91.9 4.4 16.0 19.2 0.0 11.7 6.2 3.2 7.5 6.2 0.9 18.3 16.0 107.5 22.8 24.6 23.9 2.1 7.5 11.3 35.7 46.9 14.4 27.8 8.3 4.4 12.6 28.9 5.2 0.0 24.5 5.7 14.1 11.2 8.3 30.3 2.4 16.4 27.1 11.3 1.7 0.0 22.8 8.2 22.0 8.0 31.6 2.5 12.0 7.2 0.0 12.3 7.3 14.4 0.0 0.0 29.6 25.2 1.5 11.0 3.9 51.4 32.7 24.7 2.3 6.6 2.4 11.0 5.7 8.0 5.6 11.2 3.8 14.5 2.7 23.7 4.1 BOP1 KIAA0124 ENSG00000261236 "BOP1 ribosomal biogenesis factor" Q14137 8 144262045-144291438 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 76.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 223.5" "Low region specificity" "Detected in all" "HPA047869, HPA066764" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No "Cluster 26: Non-specific - Mitochondria" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "HPA047869: AB_2680193, HPA066764: AB_2685716" "unprognostic (6.92e-2)" "unprognostic (5.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.06e-3)" "unprognostic (3.32e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (3.35e-5)" "unprognostic (2.25e-2)" "unprognostic (4.14e-1)" "unprognostic (3.31e-1)" "unprognostic (2.26e-2)" "unprognostic (7.00e-2)" "prognostic unfavorable (2.23e-7)" "unprognostic (7.83e-2)" "unprognostic (4.33e-1)" "unprognostic (8.49e-2)" "unprognostic (4.06e-3)" 18.1 17.8 6.8 8.8 6.9 9.7 16.3 7.7 10.9 16.1 3.5 17.3 5.6 18.2 1.0 26.0 13.2 2.8 24.4 7.6 5.5 16.7 21.5 13.3 8.0 7.1 6.0 11.1 32.0 5.6 16.9 3.7 6.5 15.3 1.9 1.1 13.2 3.1 76.6 21.4 14.9 3.1 4.7 20.4 15.4 20.1 6.2 5.4 17.0 8.1 3.6 19.3 16.5 6.1 45.0 87.4 11.8 50.6 6.4 7.7 41.4 30.5 6.5 30.3 19.1 66.3 25.4 54.1 50.1 11.6 11.5 34.9 21.2 36.2 6.9 47.8 82.5 68.4 54.4 49.7 15.1 30.8 35.6 15.5 17.0 25.2 22.1 5.7 18.8 48.3 70.1 18.1 11.9 112.8 82.4 37.6 28.3 45.1 223.5 61.4 17.6 82.2 12.5 30.1 64.7 25.8 32.5 41.9 20.3 5.5 30.6 27.7 36.6 27.8 83.3 37.1 88.5 16.5 11.7 45.6 20.3 48.6 36.7 0.0 2.2 1.3 1.9 2.3 2.1 2.5 2.2 2.5 3.0 1.8 2.0 1.8 0.1 1.8 2.0 2.0 2.0 1.2 6.8 6.9 7.7 10.9 7.6 5.5 7.1 6.0 6.5 4.7 6.2 6.1 12.8 9.6 5.1 3.9 16.7 0.5 18.7 0.0 13.1 9.8 12.7 13.8 7.2 10.0 3.7 11.0 0.0 25.2 20.9 18.7 5.9 25.8 11.2 7.5 10.7 12.0 26.9 22.1 4.4 21.7 45.3 13.2 17.3 8.3 10.2 13.5 4.6 14.8 21.5 15.2 3.5 11.5 0.0 11.1 0.0 24.3 10.5 12.8 0.0 1.0 16.2 16.7 18.6 5.0 2.8 26.4 11.3 9.8 25.4 39.5 11.3 17.2 1.5 4.6 13.1 12.9 15.1 13.9 53.4 25.7 0.1 17.8 11.8 29.6 31.8 14.3 BRF1 "BRF, GTF3B, hBRF, TAF3B2, TAF3C, TFIIIB90" ENSG00000185024 "BRF1 RNA polymerase III transcription initiation factor subunit" Q92994 14 105209286-105315589 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051918, HPA074990" Approved Approved "Nucleoplasm,Nuclear bodies" Yes No "Cluster 40: NK-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "Nuclear bodies" "HPA051918: AB_2681663, HPA074990: " "unprognostic (1.98e-1)" "unprognostic (4.45e-2)" "unprognostic (1.46e-2)" "unprognostic (2.51e-2)" "unprognostic (1.07e-1)" "unprognostic (7.52e-2)" "unprognostic (1.52e-4)" "unprognostic (2.67e-2)" "unprognostic (3.25e-1)" "unprognostic (2.26e-1)" "prognostic favorable (7.25e-6)" "unprognostic (8.83e-2)" "prognostic favorable (1.13e-4)" "unprognostic (1.85e-1)" "unprognostic (2.70e-1)" "unprognostic (5.39e-2)" "unprognostic (2.52e-1)" 10.5 11.4 19.7 5.5 22.2 6.5 10.5 23.1 23.6 12.5 12.9 11.1 7.6 12.1 4.2 10.4 12.8 6.0 12.2 17.1 19.2 11.6 13.1 8.4 8.1 31.8 24.9 13.0 15.1 10.3 20.4 6.0 29.7 12.0 4.2 7.5 10.1 6.3 17.7 11.2 10.3 4.6 18.7 12.6 11.2 14.6 25.4 7.3 10.5 9.6 5.8 11.5 9.9 37.4 12.6 28.0 11.8 25.3 10.3 11.4 11.9 17.4 11.2 15.4 12.2 20.2 18.8 9.4 16.9 12.0 7.5 24.2 14.4 11.7 8.4 25.2 14.2 11.5 15.1 9.9 11.5 13.7 24.3 11.3 10.1 9.3 11.5 7.8 11.3 19.7 13.1 7.5 7.6 40.9 16.2 17.1 8.6 20.7 27.7 28.2 8.1 9.6 7.6 29.9 37.5 27.8 18.4 14.0 16.0 5.4 33.4 18.9 16.8 12.1 9.6 22.7 14.2 13.8 11.5 8.9 14.5 11.3 16.9 0.4 1.2 2.0 1.6 1.0 1.1 1.5 1.1 1.6 1.2 1.4 1.4 1.3 0.5 2.5 4.0 3.1 1.6 1.6 19.7 22.2 23.1 23.6 17.1 19.2 31.8 24.9 29.7 18.7 25.4 37.4 11.5 3.2 5.9 17.6 11.4 7.5 7.1 4.5 8.6 18.8 10.7 9.0 8.5 2.8 6.3 3.7 16.7 11.4 15.5 16.2 3.9 5.8 2.3 26.5 10.9 9.5 9.6 6.3 18.3 7.1 8.9 7.7 14.8 16.5 2.5 16.0 8.9 11.3 7.2 30.3 20.8 11.7 4.1 6.7 10.3 1.4 6.5 7.8 8.8 10.3 5.3 7.1 4.1 15.1 34.2 4.8 6.5 4.5 13.4 7.7 8.9 6.1 12.4 20.0 0.0 9.6 8.2 9.2 12.7 7.7 8.8 9.3 11.6 13.2 12.5 5.1 BRIP1 "BACH1, FANCJ, OF" ENSG00000136492 "BRCA1 interacting protein C-terminal helicase 1" Q9BX63 17 61679139-61863528 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "Helicase, Hydrolase" "Cancer-related genes, Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 7.2;lymphoid tissue: 5.9;testis: 7.0" "Group enriched" "Detected in many" 12 "Early spermatids: 186.2;Late spermatids: 194.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 88.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA005474 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Cluster 26: Non-specific - Mitochondria" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear membrane" "HPA005474: AB_2667333" "unprognostic (1.88e-1)" "unprognostic (1.55e-2)" "prognostic favorable (3.45e-5)" "unprognostic (6.85e-4)" "unprognostic (3.09e-1)" "prognostic favorable (3.62e-4)" "unprognostic (2.60e-3)" "unprognostic (5.60e-2)" "unprognostic (5.66e-3)" "unprognostic (6.71e-2)" "unprognostic (1.50e-3)" "unprognostic (2.75e-2)" "unprognostic (3.41e-12)" "unprognostic (1.19e-2)" "unprognostic (2.25e-1)" "unprognostic (3.96e-2)" "unprognostic (3.62e-3)" 0.3 0.3 0.8 1.7 0.6 7.2 0.9 1.3 0.9 0.4 0.0 1.7 2.0 0.8 0.4 1.5 0.3 0.6 0.1 0.5 0.2 0.3 1.6 0.4 2.8 0.3 0.0 1.1 0.3 0.1 0.0 0.8 0.4 0.4 1.9 0.5 0.4 0.2 0.1 2.0 1.9 0.9 0.0 0.7 0.9 7.0 0.2 5.9 0.3 0.1 3.3 0.7 0.6 0.8 26.6 9.4 25.0 14.1 0.9 2.1 5.5 23.6 13.3 24.6 31.8 9.5 8.0 14.9 5.2 4.9 7.7 9.2 12.8 4.5 33.3 3.8 15.8 15.5 14.4 10.5 0.2 20.3 8.8 0.6 0.4 20.2 5.1 3.4 5.0 14.8 11.6 10.5 14.4 88.9 32.5 6.7 5.3 5.9 7.3 19.7 50.1 7.1 3.0 12.8 10.0 24.2 9.4 3.0 3.3 9.1 8.3 7.3 4.5 36.9 26.5 13.5 26.6 6.3 13.3 16.6 7.3 9.3 8.8 1.0 0.1 0.4 0.1 0.0 0.1 0.5 0.3 0.1 0.1 0.6 0.4 0.2 0.3 0.1 0.1 0.1 1.0 0.1 0.8 0.6 1.3 0.9 0.5 0.2 0.3 0.0 0.4 0.0 0.2 0.8 0.2 0.0 0.5 1.0 1.6 2.3 1.3 0.8 0.6 0.3 1.1 1.8 0.6 0.0 4.0 0.0 0.0 2.0 2.0 1.8 0.0 0.3 186.2 0.7 1.7 0.8 0.0 7.4 4.6 0.2 3.0 2.0 2.0 1.6 0.0 15.5 0.4 3.4 1.7 0.0 3.3 1.8 0.0 0.8 1.1 194.1 1.2 1.0 3.6 2.8 0.6 0.2 1.0 1.5 1.0 0.8 0.1 1.2 4.8 0.4 1.4 0.2 0.8 0.2 0.0 2.5 1.8 12.1 6.0 2.9 0.4 0.3 2.3 2.1 4.7 0.7 BRME1 "C19orf57, MEIOK21, MGC11271" ENSG00000132016 "Break repair meiotic recombinase recruitment factor 1" Q0VDD7 19 13882348-13906452 "Predicted intracellular proteins" Meiosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 18.2" "Cell type enhanced" "Detected in single" "Cardiomyocytes: 1.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA044012, HPA054615" Enhanced Approved Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA044012: AB_10964782, HPA054615: AB_2682543" "unprognostic (1.71e-1)" "unprognostic (3.48e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (3.38e-4)" "unprognostic (2.12e-1)" "prognostic favorable (5.14e-4)" "unprognostic (5.01e-2)" "unprognostic (2.30e-1)" "unprognostic (1.06e-1)" "unprognostic (1.36e-1)" "unprognostic (7.60e-2)" "unprognostic (4.43e-2)" "unprognostic (1.57e-4)" "unprognostic (1.21e-3)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (5.73e-2)" 1.4 0.8 1.9 0.8 2.0 1.9 2.3 3.8 2.8 3.3 1.4 3.7 3.2 1.3 1.4 6.0 2.3 0.4 0.8 1.9 1.5 1.3 1.9 1.1 0.7 2.2 1.7 2.3 6.9 0.6 1.4 0.4 2.0 2.4 1.2 1.7 2.4 0.7 0.9 6.1 5.6 0.5 1.5 1.2 1.7 18.2 1.7 0.4 1.2 0.2 0.8 1.7 4.5 2.7 5.9 0.1 4.3 2.4 1.2 0.2 2.8 1.6 0.6 1.9 1.8 3.7 0.8 6.5 8.9 0.7 1.1 2.9 1.3 0.5 0.6 1.0 2.8 2.8 2.7 0.1 0.3 1.4 5.9 0.2 0.4 1.2 0.2 0.3 0.4 3.5 1.9 2.5 0.6 1.9 5.3 3.0 0.6 2.0 4.4 5.8 1.6 0.3 0.7 1.4 3.8 1.4 6.3 1.1 1.8 0.3 1.2 1.3 0.0 3.5 1.9 8.0 0.4 4.5 1.0 3.5 2.1 4.5 5.5 0.0 0.0 0.0 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.2 1.9 2.0 3.8 2.8 1.9 1.5 2.2 1.7 2.0 1.5 1.7 2.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 BTBD6 BDPL ENSG00000184887 "BTB domain containing 6" Q96KE9 14 105248490-105251093 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031355 Approved Approved Nucleoplasm NA NA "Cluster 35: T-regs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA031355: AB_10611812" "prognostic favorable (1.11e-4)" "unprognostic (2.01e-2)" "unprognostic (2.65e-1)" "unprognostic (1.97e-2)" "unprognostic (2.69e-1)" "unprognostic (2.58e-1)" "unprognostic (2.23e-2)" "unprognostic (4.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-1)" "prognostic favorable (2.25e-4)" "unprognostic (8.48e-3)" "prognostic favorable (6.51e-5)" "unprognostic (6.55e-2)" "unprognostic (3.22e-1)" "unprognostic (6.86e-2)" "unprognostic (9.85e-2)" 69.4 26.3 52.1 20.4 52.6 28.2 56.6 48.3 60.3 32.6 48.1 43.8 28.8 31.4 28.1 50.9 30.8 20.5 52.1 54.2 51.7 34.5 44.2 34.7 22.0 49.7 51.0 36.7 13.2 12.6 39.9 15.6 49.9 43.6 23.1 14.6 42.8 23.5 169.4 48.5 39.5 18.8 48.4 31.4 46.9 79.3 52.1 18.4 30.4 144.6 19.0 38.9 37.7 51.3 50.8 39.8 21.4 56.8 66.8 46.2 0.1 45.6 41.1 69.2 46.9 31.3 45.2 15.9 27.4 67.0 14.5 66.2 41.3 43.9 34.0 41.2 33.5 11.7 58.6 0.0 45.6 35.8 21.7 48.3 59.6 31.9 25.7 26.9 55.9 52.2 0.0 0.3 37.3 71.8 37.8 14.5 9.1 47.6 67.6 40.3 0.1 14.9 26.5 55.0 34.8 14.8 42.9 34.3 35.0 14.7 69.9 45.3 37.9 55.5 1.5 82.1 57.8 10.2 14.7 7.8 57.2 16.4 44.1 0.5 0.6 2.9 2.3 1.0 2.2 1.3 2.4 2.3 0.7 0.7 1.8 1.2 0.3 0.4 0.8 1.5 5.3 0.6 52.1 52.6 48.3 60.3 54.2 51.7 49.7 51.0 49.9 48.4 52.1 51.3 31.5 25.6 24.3 3.9 5.4 11.7 25.7 6.5 6.2 23.1 24.0 23.4 22.0 14.3 15.3 11.0 6.2 2.8 25.3 31.0 21.5 5.7 15.0 25.6 19.5 17.8 20.4 5.2 12.4 0.0 3.8 17.3 10.2 34.9 24.7 22.2 17.9 15.4 7.8 20.2 12.5 31.2 10.2 9.8 10.0 35.2 9.3 10.3 12.4 8.4 3.6 19.1 5.2 5.0 3.7 1.0 11.6 7.5 7.6 16.3 20.5 11.6 15.5 18.8 13.1 15.7 13.0 7.8 8.3 9.6 12.6 2.2 16.4 15.2 21.9 19.5 BUD31 "Cwc14, EDG-2, EDG2, fSAP17, G10, YCR063W" ENSG00000106245 "BUD31 homolog" P41223 7 99408641-99419616 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028943 Approved Approved Nucleoplasm,Microtubules,Centrosome NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Microtubules, Centrosome" "HPA028943: AB_10602396" "unprognostic (1.68e-1)" "unprognostic (2.73e-2)" "unprognostic (2.89e-2)" "unprognostic (2.63e-2)" "unprognostic (5.29e-2)" "unprognostic (2.38e-2)" "unprognostic (2.02e-3)" "unprognostic (2.16e-2)" "unprognostic (4.02e-2)" "unprognostic (1.46e-2)" "unprognostic (8.71e-2)" "unprognostic (2.07e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (1.42e-1)" "unprognostic (4.10e-2)" "unprognostic (1.55e-1)" "unprognostic (1.71e-1)" 48.2 47.1 51.3 32.6 51.0 91.7 45.9 54.5 59.7 37.8 52.3 46.4 32.0 38.1 35.4 49.6 39.9 32.2 39.6 51.9 51.8 65.5 42.9 43.4 45.5 51.4 51.3 39.0 33.9 41.1 54.0 33.9 51.6 42.3 25.7 14.8 37.9 30.8 31.6 40.8 35.2 29.2 51.5 40.9 44.0 68.4 55.0 41.1 41.2 25.1 35.8 40.3 40.7 53.2 111.2 123.9 67.5 153.9 67.3 75.0 67.0 103.7 96.7 113.4 124.1 148.5 104.5 83.7 122.7 98.3 123.8 65.5 76.0 92.9 93.8 102.3 106.9 61.1 83.1 98.2 139.4 106.0 78.2 73.8 112.1 104.1 195.1 66.4 89.8 87.6 151.7 182.3 106.2 283.9 143.3 281.2 152.2 114.6 156.8 73.2 69.5 145.7 100.7 85.6 120.3 145.8 101.8 114.9 216.8 43.8 72.2 129.0 74.8 108.1 138.5 216.8 163.6 115.0 207.2 220.9 94.9 153.6 199.4 390.7 206.8 516.9 175.8 232.0 164.7 226.1 165.5 171.2 175.9 223.9 140.0 145.7 451.2 203.7 252.6 171.2 215.7 360.5 51.3 51.0 54.5 59.7 51.9 51.8 51.4 51.3 51.6 51.5 55.0 53.2 103.2 83.3 81.2 3.6 88.1 192.7 142.3 192.7 103.6 32.8 94.8 134.1 12.8 68.6 110.5 92.0 10.4 169.9 118.5 157.7 238.7 169.9 173.1 137.3 91.7 98.1 146.8 85.2 5.7 187.1 163.0 97.9 65.2 111.9 91.2 79.6 86.0 84.3 151.5 16.8 5.6 187.2 111.9 89.2 125.1 121.3 82.0 90.8 136.9 5.6 148.5 103.5 116.4 5.0 6.8 248.1 153.8 74.1 68.4 153.9 155.4 242.3 171.2 40.1 59.2 77.4 144.3 298.2 135.7 99.1 183.8 182.4 112.0 86.9 132.3 174.8 C11orf98 C11orf48 ENSG00000278615 "Chromosome 11 open reading frame 98" E9PRG8 11 62662817-62665210 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 33.6;Erythroid cells: 25.2;Gastric mucus-secreting cells: 50.0;Plasma cells: 58.3;Squamous epithelial cells: 57.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "unprognostic (3.52e-2)" "unprognostic (2.63e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (7.62e-4)" "unprognostic (3.73e-1)" "unprognostic (4.37e-2)" "prognostic unfavorable (5.85e-5)" "unprognostic (3.30e-1)" "unprognostic (8.35e-2)" "unprognostic (3.02e-3)" "unprognostic (2.52e-1)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.02e-6)" "unprognostic (2.14e-2)" "unprognostic (4.33e-2)" "unprognostic (1.29e-2)" "unprognostic (4.70e-3)" 48.9 63.4 71.5 57.3 73.8 38.0 45.9 75.1 109.4 41.9 70.7 56.9 45.5 37.7 31.6 66.8 41.0 27.2 65.9 70.5 73.8 77.3 74.0 44.3 72.5 74.3 75.6 35.1 47.6 29.8 35.7 29.8 74.9 55.6 50.6 80.2 43.3 29.2 67.6 52.3 57.1 30.2 72.0 68.7 62.1 65.9 74.6 63.7 41.3 35.9 69.3 50.3 41.2 75.3 265.0 162.8 115.3 140.6 66.5 74.8 63.6 129.6 89.1 145.8 100.2 172.8 144.2 164.3 191.8 81.2 100.6 173.8 115.0 130.5 104.5 178.3 69.2 162.7 101.3 174.9 96.0 254.9 143.0 78.6 150.6 151.7 150.5 87.0 117.1 137.3 202.9 76.1 124.0 337.9 185.1 230.6 188.8 194.6 140.8 139.3 106.1 206.2 163.5 135.0 98.4 110.4 102.5 283.2 182.2 89.4 304.4 91.0 99.4 109.3 147.1 278.7 234.1 74.8 123.9 153.7 141.9 101.4 140.1 340.2 187.3 388.7 202.5 206.3 223.2 352.0 224.4 252.2 166.0 313.6 202.5 250.1 201.9 273.2 217.0 279.3 331.4 288.3 71.5 73.8 75.1 109.4 70.5 73.8 74.3 75.6 74.9 72.0 74.6 75.3 3.0 9.6 5.1 0.0 20.0 0.0 0.3 0.0 33.6 0.1 2.9 2.2 0.1 2.8 5.6 1.8 0.0 1.6 3.6 0.8 1.9 4.2 1.6 5.2 4.8 4.0 0.0 25.2 0.0 2.3 2.1 6.5 50.0 4.3 11.4 0.7 2.9 12.0 1.5 0.0 0.0 0.9 0.0 5.0 0.0 1.3 1.2 11.3 0.0 0.0 8.2 0.2 2.1 0.0 0.0 4.7 1.7 0.7 58.3 0.3 3.1 7.1 13.1 0.7 6.6 0.2 3.7 1.2 0.8 57.1 0.0 1.8 19.6 1.0 0.8 0.6 C14orf132 C14orf88 ENSG00000227051 "Chromosome 14 open reading frame 132" Q9NPU4 14 96039362-96093971 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 74.7" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 38.5;Bipolar cells: 57.8;Endometrial ciliated cells: 55.2;Horizontal cells: 63.9;Skeletal myocytes: 44.9" "Cancer enhanced" "Detected in many" "glioma: 12.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 49.9;SCLC-21H: 52.5;SH-SY5Y: 52.0;U-87 MG: 46.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.40e-2)" "unprognostic (1.53e-1)" "unprognostic (2.07e-1)" "unprognostic (5.47e-2)" "unprognostic (2.50e-2)" "unprognostic (1.27e-1)" "unprognostic (1.82e-1)" "unprognostic (4.42e-2)" "prognostic favorable (3.54e-4)" "unprognostic (2.51e-2)" "unprognostic (5.55e-3)" "unprognostic (1.47e-2)" "unprognostic (3.09e-2)" "unprognostic (1.33e-5)" "prognostic unfavorable (4.95e-4)" 5.9 14.0 57.3 3.2 58.1 0.1 6.9 62.8 69.1 23.3 20.5 23.8 2.1 26.2 14.2 7.1 22.5 5.0 4.1 74.7 52.5 9.9 4.1 18.4 0.8 53.6 49.8 5.2 3.2 0.1 38.8 0.8 50.9 9.5 4.4 12.8 3.0 19.8 3.0 13.8 14.2 22.3 51.2 6.2 15.7 1.3 55.8 3.1 2.4 6.6 1.2 8.5 11.9 56.1 0.0 6.4 30.8 9.7 22.0 22.0 0.1 10.6 23.8 13.6 8.3 0.1 0.1 0.0 2.4 23.8 9.0 0.7 3.7 0.8 11.7 0.0 1.4 0.1 1.2 0.1 2.7 0.0 0.2 12.0 1.2 12.7 1.0 0.0 0.2 3.0 0.0 0.1 6.3 49.9 0.8 0.1 15.0 0.0 0.0 28.5 5.0 0.1 11.0 22.4 52.5 52.0 8.3 1.0 1.5 8.3 28.9 1.4 0.0 10.8 6.5 18.0 0.0 0.0 0.0 0.1 46.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.2 0.9 0.1 0.0 0.0 0.0 0.1 0.1 0.2 57.3 58.1 62.8 69.1 74.7 52.5 53.6 49.8 50.9 51.2 55.8 56.1 4.8 38.5 10.6 14.7 0.4 2.7 3.7 5.9 5.2 57.8 0.7 7.1 1.9 1.5 3.9 7.3 20.9 0.3 0.2 0.0 5.9 5.8 3.0 55.2 23.8 8.6 9.0 0.0 20.3 0.2 1.0 16.6 2.0 6.8 1.3 5.4 19.2 4.0 0.3 63.9 11.2 0.1 4.1 0.6 7.1 3.0 15.8 0.5 8.8 7.5 0.1 4.0 0.0 11.1 24.7 1.2 0.1 13.5 0.1 2.1 0.0 0.0 13.6 6.1 0.0 44.9 4.4 0.3 0.6 6.8 7.7 0.3 1.0 0.6 0.1 2.3 C16orf91 "CCSMST1, gs103, URLC5" ENSG00000174109 "Chromosome 16 open reading frame 91" Q4G0I0 16 1419752-1420756 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "unprognostic (1.97e-2)" "unprognostic (4.62e-2)" "unprognostic (4.11e-3)" "unprognostic (6.35e-2)" "unprognostic (2.11e-1)" "unprognostic (2.10e-1)" "unprognostic (5.47e-3)" "unprognostic (5.21e-2)" "unprognostic (1.12e-2)" "unprognostic (1.26e-1)" "unprognostic (4.33e-1)" "unprognostic (7.12e-2)" "prognostic favorable (1.11e-4)" "unprognostic (9.81e-3)" "unprognostic (5.67e-2)" "unprognostic (4.19e-2)" "unprognostic (9.97e-2)" 7.2 14.4 13.3 4.4 13.7 8.0 7.6 13.5 14.5 6.2 14.2 8.7 7.7 7.1 5.8 9.9 7.9 4.6 12.5 13.9 13.6 10.2 12.4 5.2 8.0 13.5 13.2 6.4 8.4 7.7 5.2 7.0 13.8 6.5 6.2 5.8 6.2 7.6 14.0 10.6 7.6 6.3 13.1 8.0 8.2 7.9 13.6 10.1 5.6 16.0 7.7 7.9 6.6 13.6 16.6 31.4 11.3 11.9 18.1 13.6 13.4 12.9 13.8 23.3 19.4 30.3 26.2 15.7 18.8 15.1 17.4 16.6 20.6 21.5 12.9 15.7 29.6 8.9 31.3 24.3 24.7 24.3 12.0 14.9 35.1 22.2 23.5 11.1 19.4 27.1 27.4 25.2 13.8 42.3 20.7 21.3 19.4 26.4 23.0 32.6 11.1 39.1 19.5 8.8 13.9 19.4 16.6 26.1 17.4 7.5 23.8 46.6 12.2 12.1 9.3 9.5 14.6 17.5 20.8 31.2 10.3 15.8 14.6 27.1 23.5 12.5 31.7 23.2 34.0 42.9 28.8 24.5 26.9 32.9 33.6 26.6 12.8 40.2 15.8 37.6 25.2 18.1 13.3 13.7 13.5 14.5 13.9 13.6 13.5 13.2 13.8 13.1 13.6 13.6 20.5 6.4 6.7 3.3 21.8 44.4 26.8 36.7 25.0 13.8 30.8 34.7 13.8 21.5 21.1 7.3 12.5 33.8 27.0 22.3 45.0 23.4 3.9 21.4 20.5 21.0 15.6 21.2 5.8 20.7 26.9 16.6 13.7 19.6 15.2 23.2 13.9 21.6 21.6 13.5 5.4 23.5 26.4 10.9 15.7 2.0 13.1 11.2 16.0 1.0 23.7 26.3 25.7 4.0 5.0 22.6 16.6 11.3 21.3 39.8 21.0 25.0 29.6 25.2 13.1 21.9 18.5 20.7 22.5 35.8 61.1 36.9 22.3 30.8 29.1 30.1 C17orf64 ENSG00000141371 "Chromosome 17 open reading frame 64" Q86WR6 17 60392429-60431426 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 173 "testis: 135.3" "Group enriched" "Detected in some" 25 "Early spermatids: 1057.0;Late spermatids: 524.2;Spermatocytes: 287.9" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 2.5" "Group enriched" "Detected in many" 4 "dendritic cells: 2.5;granulocytes: 1.0" "Cell line enriched" "Detected in some" 4 "MCF7: 5.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA044415 Enhanced Approved Nucleoplasm,Vesicles NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 74: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Vesicles "HPA044415: AB_10797148" "unprognostic (3.00e-1)" "unprognostic (2.60e-2)" "unprognostic (2.36e-1)" "unprognostic (6.50e-2)" "unprognostic (1.77e-1)" "unprognostic (1.51e-2)" "unprognostic (2.30e-2)" "unprognostic (3.24e-1)" "unprognostic (1.43e-1)" "unprognostic (1.80e-1)" "unprognostic (6.85e-2)" "unprognostic (1.68e-6)" "unprognostic (3.30e-1)" "unprognostic (2.77e-1)" "unprognostic (2.80e-2)" "unprognostic (5.46e-2)" 0.3 0.1 0.3 0.0 0.1 0.6 0.2 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.2 0.4 0.3 0.0 0.1 0.1 0.6 0.4 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.5 0.1 135.3 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.3 0.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.3 0.0 5.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 2.5 0.0 0.0 0.3 0.1 0.2 0.7 0.2 0.4 0.6 0.4 0.4 0.2 0.4 0.6 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1057.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 524.2 9.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 287.9 24.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 C19orf53 "HSPC023, LYDG10" ENSG00000104979 "Chromosome 19 open reading frame 53" Q9UNZ5 19 13774456-13778773 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059928, HPA061291" Approved Approved Nucleoplasm,Nucleoli No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA059928: AB_2684165, HPA061291: AB_2684469" "unprognostic (3.94e-2)" "unprognostic (2.70e-3)" "unprognostic (6.53e-2)" "unprognostic (3.12e-1)" "unprognostic (1.99e-2)" "unprognostic (8.93e-2)" "unprognostic (2.93e-3)" "unprognostic (2.77e-2)" "unprognostic (1.32e-1)" "unprognostic (2.96e-2)" "unprognostic (1.67e-1)" "unprognostic (6.31e-2)" "unprognostic (1.60e-3)" "unprognostic (5.21e-2)" "unprognostic (4.06e-2)" "unprognostic (2.69e-3)" "unprognostic (1.85e-2)" 95.6 117.7 154.3 52.1 157.8 80.4 88.9 161.0 209.6 97.0 148.4 94.3 45.4 91.6 85.6 92.3 87.6 49.8 155.6 154.4 163.8 124.4 111.0 80.1 76.9 159.4 159.9 111.7 95.5 92.8 111.6 40.2 157.8 98.8 41.6 35.7 76.9 52.8 167.6 95.2 72.4 63.0 157.5 82.1 91.2 51.6 158.0 101.5 90.4 107.2 70.8 88.6 82.6 157.3 176.4 249.9 123.0 98.9 169.6 191.1 80.1 167.0 145.5 201.0 200.7 235.8 83.5 95.4 198.2 202.4 146.6 90.1 111.6 250.1 102.7 113.5 362.3 90.1 254.6 260.5 174.9 140.7 109.4 237.8 174.7 188.1 105.9 129.0 171.0 136.6 140.9 154.2 157.9 406.2 193.6 145.9 152.6 133.8 441.8 105.7 94.9 160.5 177.1 221.3 108.6 132.4 115.1 130.8 172.5 89.2 120.0 139.0 118.4 221.9 89.2 239.4 227.5 172.3 240.3 144.4 132.3 157.6 121.8 264.1 220.1 275.7 211.0 238.2 240.4 333.2 270.7 248.4 202.2 321.1 318.1 289.7 107.1 184.7 214.3 289.4 337.9 496.3 154.3 157.8 161.0 209.6 154.4 163.8 159.4 159.9 157.8 157.5 158.0 157.3 167.0 115.4 97.8 13.7 205.2 291.1 260.1 349.2 147.4 50.5 258.7 352.9 263.3 213.1 207.8 268.5 22.9 218.6 176.5 230.1 628.0 242.5 176.8 229.3 189.8 194.4 227.3 174.0 10.5 335.2 406.3 184.4 109.6 233.0 128.7 132.4 179.9 367.5 368.2 35.3 10.2 254.3 236.0 247.1 287.1 621.4 218.7 187.5 231.3 5.6 338.9 220.3 260.6 6.6 18.8 269.6 272.8 182.4 164.1 360.5 353.9 820.0 189.3 65.9 92.1 138.5 206.0 102.6 137.0 187.7 348.5 213.0 216.0 169.8 257.5 345.2 C1orf53 ENSG00000203724 "Chromosome 1 open reading frame 53" Q5VUE5 1 197902630-197907367 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 15.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 64.6;Theca cells: 55.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 8.9" "Lineage enriched" "Detected in many" 4 "monocytes: 8.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065352 Approved Vesicles,Aggresome NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles Aggresome "HPA065352: AB_2685477" "prognostic favorable (1.63e-4)" "unprognostic (1.48e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (3.78e-4)" "unprognostic (1.72e-1)" "unprognostic (1.37e-1)" "unprognostic (2.22e-2)" "unprognostic (5.24e-2)" "unprognostic (8.90e-3)" "unprognostic (1.01e-1)" "unprognostic (1.35e-1)" "unprognostic (1.54e-1)" "unprognostic (5.53e-3)" "unprognostic (9.85e-2)" "unprognostic (1.12e-1)" "unprognostic (8.58e-3)" "unprognostic (1.37e-1)" 1.7 9.4 2.6 0.5 2.1 0.8 1.4 1.9 3.6 1.5 5.1 2.8 1.8 1.0 3.1 3.0 0.9 0.8 6.7 2.7 2.2 5.1 15.1 1.9 0.5 2.3 2.6 2.3 2.7 0.4 5.0 0.8 2.1 1.4 1.3 0.5 2.3 0.4 3.7 0.9 1.9 0.8 1.8 1.6 1.8 3.1 3.3 0.3 2.7 1.4 0.3 1.2 1.5 2.5 4.4 6.0 0.4 2.1 3.7 10.5 3.3 7.5 5.4 6.2 3.1 5.4 3.7 8.5 11.8 8.5 1.4 2.0 2.2 1.4 0.6 2.7 15.8 5.0 3.7 8.6 1.0 11.2 6.8 7.1 4.8 1.9 0.8 5.0 2.2 1.8 1.4 2.1 4.7 7.9 0.6 10.1 4.7 6.9 8.7 1.1 3.4 3.1 10.1 6.9 18.4 14.4 9.5 1.6 3.2 2.3 4.5 4.3 5.1 7.2 8.0 10.2 5.2 3.6 2.6 2.2 5.2 3.6 9.0 0.0 2.7 0.0 0.3 8.9 0.0 0.0 0.1 0.6 2.1 0.1 0.3 0.3 0.0 0.0 4.4 0.6 0.1 0.9 2.6 2.1 1.9 3.6 2.7 2.2 2.3 2.6 2.1 1.8 3.3 2.5 0.5 9.6 10.6 0.3 1.6 2.5 4.1 13.1 4.0 2.2 16.3 20.8 11.7 18.6 15.1 22.0 0.0 18.9 0.3 14.8 19.6 9.9 15.7 16.2 6.7 2.0 7.8 4.8 2.0 13.8 10.2 5.5 4.1 12.1 1.3 8.6 2.2 64.6 9.5 3.3 1.5 12.6 14.2 4.1 1.8 2.7 14.0 4.7 8.8 0.0 2.6 11.5 4.1 1.0 0.8 9.3 8.8 10.5 6.0 6.7 10.8 25.8 12.2 3.9 0.0 1.4 6.1 8.6 4.5 12.4 2.8 11.8 1.1 55.8 16.6 5.7 C1orf56 "FLJ20519, MENT" ENSG00000143443 "Chromosome 1 open reading frame 56" Q9BUN1 1 151047751-151051986 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "testis: 76.5" "Cell type enhanced" "Detected in all" "dendritic cells: 213.9;Early spermatids: 440.4;Langerhans cells: 245.2;Spermatocytes: 308.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA037429, HPA037430" Enhanced "Secreted to blood" NA NA 87000000 "Cluster 46: Basophils - DNA binding" "Cluster 83: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "HPA037429: AB_10671755, HPA037430: AB_2675473" "unprognostic (7.60e-2)" "unprognostic (8.26e-2)" "unprognostic (1.09e-2)" "unprognostic (3.83e-1)" "unprognostic (4.31e-2)" "unprognostic (2.83e-2)" "unprognostic (1.11e-2)" "unprognostic (3.81e-3)" "unprognostic (1.59e-2)" "unprognostic (2.70e-3)" "unprognostic (3.28e-3)" "unprognostic (5.29e-2)" "unprognostic (3.61e-2)" "unprognostic (3.61e-2)" "unprognostic (6.16e-2)" "unprognostic (2.26e-1)" "unprognostic (4.79e-2)" 4.6 10.2 2.1 1.5 2.9 0.6 4.4 3.3 2.5 5.7 3.1 4.9 2.1 5.3 3.2 5.4 5.7 2.6 7.9 1.9 2.2 6.5 8.3 2.9 1.6 2.9 2.8 5.9 7.6 3.4 10.0 1.2 2.6 6.4 0.7 1.9 5.5 3.1 6.5 4.2 3.5 1.2 2.9 4.3 5.5 76.5 2.4 0.4 8.2 2.3 0.4 5.1 5.0 3.2 4.1 8.0 2.7 1.2 4.4 4.2 2.4 2.2 3.2 1.4 1.1 3.5 5.6 0.9 3.5 2.4 3.0 5.3 1.5 0.3 0.8 5.2 1.7 1.0 5.9 4.3 3.0 1.1 0.9 3.1 1.7 2.1 0.8 2.7 2.1 1.7 2.2 2.1 1.3 15.9 1.5 2.8 4.5 3.2 4.4 1.3 2.7 2.9 1.2 2.3 3.6 7.0 7.0 3.7 5.5 5.0 7.3 3.0 2.2 1.9 3.3 5.1 2.0 4.7 4.0 12.2 3.5 0.6 2.4 223.6 22.7 50.4 90.8 54.5 70.3 46.7 78.6 80.8 19.7 51.7 64.8 90.8 69.8 59.0 48.2 28.1 48.9 4.1 2.1 2.9 3.3 2.5 1.9 2.2 2.9 2.8 2.6 2.9 2.4 3.2 57.6 6.4 10.1 19.2 56.8 64.6 38.1 20.8 4.6 20.2 80.3 46.2 7.1 40.0 17.1 42.3 20.9 53.8 213.9 15.6 39.2 21.2 440.4 12.3 20.4 34.4 14.8 12.4 27.6 14.5 35.9 34.5 4.1 12.5 38.8 10.7 66.8 38.3 30.9 18.5 25.6 14.4 16.2 95.5 245.2 80.7 28.6 50.4 88.9 24.4 78.0 20.0 119.4 26.7 37.2 32.4 19.5 25.6 50.9 35.7 8.8 36.5 10.8 26.6 26.3 41.4 35.3 308.8 13.7 3.9 83.3 89.5 90.7 11.5 15.0 46.2 C1QTNF6 "CTRP6, ZACRP6" ENSG00000133466 "C1q and TNF related 6" Q9BXI9 22 37180166-37199385 "Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 31.7;placenta: 29.6" "Cell type enriched" "Detected in many" 11 "Extravillous trophoblasts: 398.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 114.2;RT4: 50.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002042 Enhanced Approved Nucleoplasm "Secreted to blood" No No 354000000 "Cluster 48: NK-cells - Unknown function" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "HPA002042: AB_1078342" "unprognostic (9.65e-2)" "unprognostic (1.21e-2)" "unprognostic (2.32e-1)" "unprognostic (2.23e-3)" "unprognostic (1.25e-3)" "unprognostic (3.01e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (9.60e-6)" "unprognostic (6.96e-2)" "unprognostic (5.11e-2)" "unprognostic (2.61e-2)" "unprognostic (1.72e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.61e-2)" "unprognostic (5.36e-2)" "unprognostic (1.08e-3)" "unprognostic (1.52e-2)" 4.9 6.7 4.4 6.6 4.5 1.6 4.0 4.3 5.3 11.1 4.3 5.5 1.6 31.7 1.4 2.7 7.0 8.8 3.7 4.5 4.3 7.4 13.0 5.2 5.1 5.1 4.5 5.5 3.5 2.2 2.5 29.6 4.8 6.8 3.6 0.5 3.2 2.9 1.5 5.0 5.4 8.2 4.4 6.5 3.5 6.2 4.8 2.4 3.8 0.7 2.3 5.6 4.3 6.3 17.7 20.5 10.7 3.6 1.8 21.3 32.6 3.4 6.8 2.8 2.0 3.8 24.7 0.1 14.1 6.0 1.5 34.9 0.4 8.4 1.2 4.9 2.6 2.8 8.3 3.8 7.1 0.1 2.3 29.2 4.9 2.3 0.6 7.3 25.5 0.8 0.1 7.7 1.1 114.2 0.0 0.5 7.1 2.5 0.3 0.2 0.1 2.8 24.5 50.7 1.8 14.6 1.0 19.7 2.8 5.5 7.0 0.5 9.4 1.1 5.6 0.4 0.1 15.5 0.4 0.1 2.1 2.0 3.2 0.4 0.1 0.5 0.2 0.2 0.2 0.2 0.4 0.3 0.1 0.7 0.9 0.7 0.5 1.5 0.1 0.3 1.4 0.3 4.4 4.5 4.3 5.3 4.5 4.3 5.1 4.5 4.8 4.4 4.8 6.3 3.2 0.0 0.0 13.7 2.9 1.5 2.1 1.9 0.6 1.0 8.6 4.2 1.8 1.5 2.2 1.8 0.0 8.1 1.5 7.9 1.9 3.4 2.0 4.8 30.8 6.8 0.0 0.8 3.3 1.1 398.9 7.6 2.0 9.6 1.3 19.8 10.0 7.2 9.3 0.0 4.3 3.1 0.0 1.9 1.4 8.9 0.6 1.2 5.4 3.7 1.1 4.5 1.0 4.0 7.8 2.7 2.8 0.4 3.4 0.8 2.0 1.6 2.7 0.9 0.0 2.2 7.5 7.2 4.5 1.0 0.3 34.5 3.1 7.6 4.4 1.5 C20orf27 FLJ20550 ENSG00000101220 "Chromosome 20 open reading frame 27" Q9GZN8 20 3753508-3767781 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial stromal cells: 178.7;Hofbauer cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "classical monocyte: 144.6;intermediate monocyte: 249.1;myeloid DC: 199.4;non-classical monocyte: 235.3" "Group enriched" "Detected in all" 5 "dendritic cells: 199.4;monocytes: 249.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047483 Approved Approved Nucleoplasm,Cytosol NA NA 140000 "Cluster 7: Monocytes - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "HPA047483: AB_2680064" "unprognostic (1.15e-1)" "unprognostic (1.23e-1)" "unprognostic (8.13e-2)" "unprognostic (3.21e-3)" "unprognostic (2.99e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.69e-5)" "unprognostic (8.36e-2)" "unprognostic (2.07e-1)" "unprognostic (4.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.84e-1)" "prognostic unfavorable (6.18e-6)" "unprognostic (1.80e-1)" "unprognostic (2.16e-1)" "unprognostic (1.49e-1)" "unprognostic (1.27e-1)" 55.8 24.0 48.8 20.4 125.4 103.6 45.2 44.7 70.9 39.5 33.7 117.3 17.0 42.5 8.7 29.6 51.8 25.5 27.9 45.6 63.3 25.7 24.7 20.8 24.5 52.9 59.3 66.3 23.6 9.4 23.3 8.9 67.5 24.2 7.8 4.9 15.7 10.9 22.4 26.9 33.9 14.1 43.8 45.5 86.8 22.7 59.5 11.0 23.4 11.5 9.8 73.9 26.3 40.7 172.9 177.7 24.4 106.1 49.5 28.1 42.7 45.5 25.1 70.4 50.3 120.5 61.6 111.1 41.4 48.2 94.7 140.9 65.7 101.9 24.9 26.1 138.3 63.2 35.9 212.6 36.2 88.2 24.7 41.0 41.8 93.3 46.1 24.2 48.2 72.9 114.6 59.8 37.3 240.2 107.6 186.3 114.9 107.0 248.4 86.6 67.9 123.7 43.9 62.0 121.8 56.6 41.2 155.3 85.1 10.4 36.9 96.8 35.9 104.8 73.8 171.6 129.6 50.5 93.2 80.7 31.5 161.2 53.9 1.3 144.6 2.3 28.7 249.1 42.1 38.7 33.6 38.6 199.4 36.2 37.6 37.5 5.4 32.5 235.3 38.7 34.2 87.4 48.8 125.4 44.7 70.9 45.6 63.3 52.9 59.3 67.5 43.8 59.5 40.7 54.0 0.0 3.3 3.3 26.5 24.2 23.0 26.8 35.3 9.7 28.2 45.7 3.7 8.6 7.4 11.0 2.1 17.5 15.8 10.2 29.4 32.6 21.8 13.8 178.7 28.7 15.7 99.1 6.0 30.0 49.2 27.1 14.3 7.5 22.9 45.0 19.6 17.9 142.9 1.7 9.5 15.9 16.2 119.0 53.1 15.3 32.6 92.2 37.4 5.6 97.4 24.6 15.5 3.5 2.1 34.7 14.6 24.8 20.2 46.6 19.3 32.4 2.7 13.6 65.7 17.1 98.8 27.3 39.1 34.8 32.8 7.3 24.1 69.7 33.0 22.7 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62319015-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 159.7;Spermatocytes: 173.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 28.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 408.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 7.6 15.9 35.4 5.9 37.3 1.3 35.6 32.3 44.5 6.7 23.0 8.3 3.5 7.8 8.1 18.8 4.2 6.5 10.2 37.6 36.7 15.0 3.4 6.9 5.8 32.2 31.4 9.1 12.6 3.8 31.0 5.0 33.0 17.9 4.3 27.2 12.4 5.5 1.3 17.3 4.8 7.1 33.5 4.3 6.2 32.8 33.8 3.7 9.1 1.3 9.2 12.7 9.3 33.0 0.1 22.1 27.2 0.0 18.9 24.8 19.3 33.6 21.2 41.7 41.0 0.3 36.8 0.0 0.1 20.4 84.6 6.7 0.0 21.4 32.1 0.0 14.5 20.5 0.0 0.0 12.0 0.3 45.2 11.3 28.9 47.8 39.6 0.9 21.0 0.0 2.4 0.3 43.0 408.7 0.0 0.0 33.4 31.9 41.9 0.1 0.0 11.8 37.0 64.3 45.9 40.8 21.3 90.0 38.7 20.5 34.0 25.1 0.5 22.2 0.2 105.1 34.8 24.1 0.0 0.0 22.1 0.0 78.4 9.2 4.7 0.7 0.2 17.9 0.0 4.1 3.9 3.3 5.4 1.4 1.1 0.8 0.5 0.9 28.1 7.6 7.9 2.4 35.4 37.3 32.3 44.5 37.6 36.7 32.2 31.4 33.0 33.5 33.8 33.0 8.7 22.4 11.8 11.8 3.3 36.8 23.6 41.5 31.3 34.7 90.2 77.0 7.7 11.5 38.1 22.0 4.2 21.4 8.0 2.6 60.7 35.7 159.7 11.3 14.8 12.1 87.4 2.1 34.8 55.1 19.6 20.9 4.1 12.6 1.3 7.9 5.7 3.1 32.0 37.0 33.4 3.8 44.7 10.0 27.2 62.9 14.0 13.4 46.2 3.7 56.6 35.4 0.0 13.0 15.8 35.8 0.8 10.5 0.5 21.8 2.7 41.5 12.3 28.0 0.0 15.8 21.6 173.2 53.5 30.8 28.7 9.9 5.0 20.6 3.9 23.3 C7orf25 MGC2821 ENSG00000136197 "Chromosome 7 open reading frame 25" Q9BPX7 7 42908726-42912305 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Collecting duct cells: 3.7;Cone photoreceptor cells: 4.2;Excitatory neurons: 4.6;Inhibitory neurons: 4.7;Oligodendrocytes: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 36.6" "Lineage enriched" "Detected in all" 15 "granulocytes: 36.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020120, HPA049635" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm Cytosol "HPA020120: AB_1845755, HPA049635: AB_2680837" "unprognostic (6.29e-2)" "unprognostic (1.55e-1)" "unprognostic (1.56e-2)" "unprognostic (4.83e-2)" "unprognostic (1.13e-3)" "unprognostic (2.23e-2)" "unprognostic (5.23e-2)" "unprognostic (3.29e-1)" "unprognostic (1.66e-2)" "unprognostic (1.73e-1)" "unprognostic (5.25e-2)" "unprognostic (2.34e-1)" "unprognostic (1.26e-2)" "unprognostic (1.26e-1)" "unprognostic (2.66e-1)" "unprognostic (3.87e-2)" "unprognostic (3.05e-3)" 1.5 1.6 2.4 0.6 2.9 0.7 2.0 2.6 4.5 1.6 1.7 1.6 0.5 1.7 3.2 1.6 2.0 1.9 2.1 2.8 3.2 2.7 1.6 1.5 1.6 3.4 3.0 2.2 1.7 3.1 1.4 2.0 3.5 2.6 1.0 1.9 1.6 2.8 1.7 1.4 1.2 1.9 1.9 1.8 1.9 3.7 2.7 1.6 2.7 1.9 1.2 1.2 0.9 4.5 2.7 8.5 2.2 3.7 2.9 2.0 2.5 5.9 2.0 3.4 3.0 4.9 3.9 7.4 3.7 5.2 4.3 4.1 1.7 5.0 4.2 3.3 7.3 4.0 8.2 3.2 6.2 3.2 2.2 2.9 3.4 3.3 3.3 1.4 2.6 4.8 5.0 1.5 3.3 6.1 1.7 2.5 3.0 1.7 9.8 1.7 2.8 3.7 2.1 6.9 2.8 3.9 8.3 2.9 2.7 3.3 3.3 2.1 7.3 3.6 3.8 4.3 3.3 4.0 9.1 2.2 3.7 3.5 8.3 36.6 1.6 15.7 1.5 2.0 2.3 2.2 1.0 1.5 1.0 1.6 1.6 1.7 8.8 2.2 2.3 0.8 0.8 1.1 2.4 2.9 2.6 4.5 2.8 3.2 3.4 3.0 3.5 1.9 2.7 4.5 0.4 0.0 1.1 2.3 0.7 0.3 0.4 0.1 0.6 0.9 0.4 0.5 0.6 0.0 0.1 3.7 4.2 0.7 0.3 0.1 1.9 0.9 0.1 0.4 0.6 0.7 0.0 0.4 4.6 1.1 0.4 0.6 0.0 0.2 0.0 0.6 1.1 0.5 0.2 0.0 4.7 0.2 0.0 0.0 0.4 0.3 0.6 1.2 0.0 2.8 0.3 0.7 2.1 3.0 7.9 0.9 0.3 0.7 0.2 0.3 0.7 1.5 1.0 0.4 0.0 0.3 0.8 1.7 1.3 0.4 0.4 0.8 0.5 1.0 0.2 0.1 C8orf82 MGC70857 ENSG00000213563 "Chromosome 8 open reading frame 82" Q6P1X6 8 144525733-144529132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 138.9;Proximal tubular cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034331 Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "CAB034331: AB_1565393" "unprognostic (3.56e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (8.60e-2)" "unprognostic (6.31e-3)" "unprognostic (1.95e-1)" "unprognostic (4.57e-2)" "unprognostic (3.82e-1)" "unprognostic (1.22e-1)" "unprognostic (3.61e-1)" "unprognostic (4.09e-2)" "prognostic favorable (1.70e-5)" "unprognostic (5.72e-3)" "unprognostic (3.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-3)" 10.6 14.6 9.0 4.5 8.6 2.8 11.4 11.1 10.5 14.7 4.2 14.1 11.1 11.8 2.6 16.7 11.9 3.8 17.0 8.2 7.5 16.2 35.6 8.6 3.8 9.4 8.1 15.1 13.2 6.6 12.2 3.3 8.6 26.3 3.8 4.6 11.6 5.5 12.0 9.1 11.7 2.8 7.2 9.9 12.3 7.4 8.4 4.5 12.6 3.5 2.4 15.0 11.8 11.5 6.8 16.8 9.8 7.9 4.0 3.4 8.2 7.2 3.9 3.9 3.9 8.3 11.2 11.9 11.4 4.5 3.3 8.1 2.2 2.5 1.4 9.0 25.7 23.0 10.4 15.6 4.2 3.5 10.8 5.1 5.5 2.5 2.5 6.4 2.7 6.6 19.1 5.9 2.9 35.7 8.9 14.2 5.3 10.1 46.6 9.9 3.3 5.8 6.1 10.1 33.3 27.3 11.0 7.8 7.1 3.3 14.3 7.1 14.6 7.5 28.7 8.4 5.3 4.2 2.8 9.8 9.9 4.3 7.3 0.1 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.0 9.0 8.6 11.1 10.5 8.2 7.5 9.4 8.1 8.6 7.2 8.4 11.5 12.2 3.2 6.9 0.3 12.9 15.9 49.6 1.9 23.3 30.4 39.6 38.6 17.9 18.6 1.9 16.5 14.6 33.4 13.0 46.3 138.9 5.8 16.8 10.3 22.1 12.3 34.2 14.9 0.1 7.7 35.1 18.5 19.4 26.0 5.7 16.3 9.7 69.8 18.6 28.6 0.1 31.9 2.0 16.1 16.1 21.4 24.2 15.2 33.8 0.0 7.5 28.0 13.4 0.0 0.1 6.7 22.1 20.3 16.3 55.6 35.4 99.1 0.4 35.8 32.9 21.1 23.0 24.4 18.8 36.9 20.9 25.2 13.1 34.5 34.6 43.3 C9orf16 "EST00098, FLJ12823, MGC4639" ENSG00000171159 "Chromosome 9 open reading frame 16" Q9BUW7 9 128160265-128163924 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 325.2" "Cell type enhanced" "Detected in all" "Late spermatids: 869.5;Urothelial cells: 938.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020725 Uncertain Approved Microtubules NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Microtubules "HPA020725: AB_1845816" "unprognostic (8.85e-2)" "prognostic favorable (7.60e-4)" "prognostic unfavorable (9.91e-4)" "unprognostic (6.42e-3)" "unprognostic (3.98e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (3.13e-5)" "unprognostic (8.26e-2)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-3)" "unprognostic (2.13e-1)" "unprognostic (3.09e-3)" "unprognostic (4.67e-2)" "unprognostic (1.45e-1)" "unprognostic (3.00e-3)" "unprognostic (2.48e-2)" 81.3 325.2 174.9 22.8 145.7 66.8 75.7 96.3 295.9 75.5 121.4 62.8 24.4 67.0 9.3 89.0 53.3 27.8 78.3 314.3 114.6 85.4 63.0 59.0 41.2 123.0 114.2 42.4 93.6 18.5 81.6 12.8 136.5 93.4 8.9 5.9 100.1 32.7 41.8 160.6 52.8 13.1 107.4 88.8 64.0 51.7 148.2 41.6 53.5 11.7 22.2 108.2 100.1 154.2 36.4 48.0 26.9 150.2 18.0 39.7 63.1 34.2 27.9 27.7 21.9 23.9 95.4 41.0 67.6 14.9 6.7 103.5 7.5 27.3 1.5 77.0 60.7 29.2 57.3 48.7 31.5 32.6 72.0 30.0 39.8 14.5 7.2 21.9 39.5 111.9 78.5 79.4 15.1 210.4 109.0 139.0 60.4 74.2 89.1 102.0 17.9 170.7 35.7 31.9 67.1 98.9 60.8 54.1 74.0 6.5 60.8 30.1 48.2 28.9 69.4 37.3 30.0 76.5 61.5 63.8 80.1 45.9 29.4 221.4 119.4 205.0 155.7 105.1 169.6 168.8 178.4 153.3 135.4 178.0 139.9 144.2 138.0 165.9 92.5 144.4 254.8 142.0 174.9 145.7 96.3 295.9 314.3 114.6 123.0 114.2 136.5 107.4 148.2 154.2 146.3 6.4 4.8 11.8 149.7 197.2 356.6 519.8 124.1 77.1 265.6 298.3 33.9 108.7 199.9 355.0 14.6 97.1 209.8 291.7 309.1 223.8 162.2 100.5 88.4 151.9 407.8 139.5 26.4 354.5 88.3 103.8 77.5 120.2 162.0 112.7 133.2 106.4 247.4 18.5 19.2 254.0 193.3 247.3 251.6 869.5 76.7 203.1 224.1 9.4 236.7 91.4 311.0 8.0 11.6 223.6 233.9 83.1 129.0 281.5 131.2 224.9 93.7 46.1 72.3 58.1 197.3 30.7 82.9 142.3 233.4 60.3 215.2 155.3 205.9 938.8 CACNA1H Cav3.2 ENSG00000196557 "Calcium voltage-gated channel subunit alpha1 H" O95180 16 1153106-1221771 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 107.7" "Cell type enhanced" "Detected in many" "Bipolar cells: 22.8;Late spermatids: 15.5;Peritubular cells: 25.9;Sertoli cells: 26.3;Smooth muscle cells: 22.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 17.9;AN3-CA: 25.4;MCF7: 48.3;OE19: 16.0;T-47d: 13.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA039125 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Vesicles" "HPA039125: AB_10795578" "unprognostic (1.66e-3)" "unprognostic (2.10e-1)" "unprognostic (4.07e-2)" "unprognostic (1.21e-3)" "unprognostic (1.37e-2)" "unprognostic (2.15e-1)" "unprognostic (4.39e-2)" "unprognostic (2.38e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-2)" "prognostic favorable (3.12e-5)" "unprognostic (1.66e-2)" "prognostic unfavorable (1.78e-5)" "unprognostic (1.93e-2)" "unprognostic (4.65e-2)" "unprognostic (1.70e-2)" "unprognostic (5.55e-2)" 13.6 28.0 13.6 5.2 24.5 0.1 7.6 2.1 12.1 26.3 0.0 107.7 6.4 57.3 2.6 7.1 37.8 10.3 9.3 11.0 8.1 14.1 13.4 11.8 0.7 3.0 3.8 80.1 4.6 3.6 45.9 2.1 2.9 28.0 2.4 1.8 1.9 27.5 6.2 19.4 22.3 15.6 3.7 0.7 27.5 19.4 13.5 0.5 11.0 3.0 0.2 57.0 17.1 0.2 0.0 17.9 3.0 25.4 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 10.4 0.1 0.0 11.0 3.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.0 3.0 4.9 0.0 0.0 48.3 0.0 0.0 9.4 16.0 3.6 0.0 0.0 0.2 4.7 0.0 0.0 0.0 0.0 0.0 0.9 1.0 13.9 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 24.5 2.1 12.1 11.0 8.1 3.0 3.8 2.9 3.7 13.5 0.2 1.3 0.0 0.0 1.0 0.0 1.5 0.1 0.0 0.0 22.8 0.3 0.1 2.7 4.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 3.7 7.2 0.2 5.3 2.2 10.8 0.0 2.6 0.0 0.1 1.3 0.5 0.2 4.5 0.0 0.4 7.8 0.1 0.0 0.7 1.0 2.0 0.0 0.3 15.5 8.4 0.2 0.0 0.0 0.0 0.8 0.0 0.5 0.1 0.4 0.4 25.9 0.0 7.2 0.0 0.7 0.0 1.5 26.3 0.4 22.4 3.4 5.1 0.0 3.4 0.0 0.2 0.3 0.1 1.3 CARM1 PRMT4 ENSG00000142453 "Coactivator associated arginine methyltransferase 1" Q86X55 19 10871553-10923075 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 110.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032961, HPA043561, HPA048073, HPA069313" Supported Enhanced Nucleoplasm "Intracellular and membrane" NA NA 19000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: " "unprognostic (9.46e-2)" "unprognostic (3.61e-1)" "unprognostic (2.94e-2)" "unprognostic (2.23e-1)" "unprognostic (2.69e-2)" "unprognostic (3.13e-2)" "unprognostic (1.66e-3)" "unprognostic (3.76e-2)" "unprognostic (7.81e-2)" "unprognostic (6.18e-2)" "unprognostic (9.31e-2)" "unprognostic (7.25e-2)" "prognostic unfavorable (7.88e-6)" "unprognostic (1.71e-2)" "unprognostic (6.26e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (8.37e-4)" 20.3 17.1 24.7 19.6 26.6 22.7 17.6 18.9 34.1 30.6 17.2 28.4 17.3 31.7 7.8 36.7 23.4 14.7 25.4 27.6 23.7 18.8 20.1 16.4 19.8 22.8 21.8 21.9 22.3 11.5 14.8 20.4 22.6 20.2 14.3 6.4 20.2 17.5 110.5 22.6 20.9 21.3 19.9 18.6 20.3 45.4 22.6 10.9 13.4 72.4 15.4 26.3 28.0 26.0 62.5 46.8 64.9 88.3 52.5 71.1 63.2 42.8 75.6 63.9 61.0 73.4 21.8 85.2 52.4 77.4 32.1 58.0 65.4 66.2 40.1 98.4 52.7 26.5 29.1 89.9 44.8 39.3 33.9 49.0 42.4 43.8 52.4 35.9 82.1 67.9 65.8 79.2 38.2 116.7 70.0 34.3 81.4 40.7 74.8 97.5 32.8 100.7 38.9 29.7 47.0 45.1 30.7 36.2 43.6 31.7 38.4 35.3 48.7 75.4 43.2 72.3 54.0 75.0 64.1 77.2 51.1 63.8 35.3 0.0 0.2 0.0 0.1 0.2 0.1 0.2 0.1 0.5 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.3 0.1 0.1 24.7 26.6 18.9 34.1 27.6 23.7 22.8 21.8 22.6 19.9 22.6 26.0 12.9 9.6 12.2 7.2 11.6 7.8 5.9 4.1 12.0 36.4 14.0 13.7 1.1 14.3 6.5 9.2 52.1 18.5 6.4 42.3 7.9 13.4 32.7 20.1 30.8 12.7 27.6 30.7 12.9 19.7 33.1 13.8 13.7 25.4 1.3 17.8 12.8 27.8 26.7 45.4 10.6 24.9 4.1 20.0 10.9 23.5 28.3 14.8 5.4 5.6 23.9 8.7 4.1 10.6 5.8 24.8 27.2 19.2 11.7 14.1 22.6 9.2 7.4 21.1 6.6 19.6 13.0 23.8 17.5 25.7 7.0 12.0 6.5 6.6 25.7 11.8 CASKIN2 "ANKS5B, FLJ21609, KIAA1139" ENSG00000177303 "CASK interacting protein 2" Q8WXE0 17 75500261-75515537 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 75.5;Endothelial cells: 42.2;Hepatic stellate cells: 56.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071906, HPA075184" Enhanced Supported "Plasma membrane" NA NA "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA071906: AB_2732191, HPA075184: AB_2732281" "unprognostic (1.60e-1)" "unprognostic (4.54e-2)" "unprognostic (9.12e-3)" "unprognostic (5.27e-3)" "unprognostic (9.32e-2)" "unprognostic (5.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.10e-2)" "unprognostic (7.67e-2)" "unprognostic (1.33e-1)" "prognostic favorable (2.47e-5)" "unprognostic (1.82e-2)" "prognostic favorable (4.83e-8)" "unprognostic (1.43e-1)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.95e-2)" 33.8 22.7 19.4 4.9 22.6 0.4 30.0 19.7 18.6 15.1 4.6 16.5 9.0 21.0 2.7 10.8 21.7 11.2 28.2 16.7 17.2 26.9 11.3 42.3 2.9 22.6 21.7 12.0 10.8 9.4 13.6 11.8 18.7 14.9 2.9 4.8 11.5 8.7 15.3 12.7 11.4 10.4 18.1 30.8 15.0 5.6 20.0 2.9 22.6 9.9 1.5 16.0 14.3 23.1 13.3 17.2 10.2 14.4 6.6 4.1 11.2 6.6 8.7 15.8 10.2 19.0 5.6 0.5 7.4 7.7 10.5 12.0 8.2 7.7 3.9 4.7 10.8 9.4 17.2 7.5 7.7 0.5 12.6 3.5 10.4 8.2 5.9 5.3 16.2 13.3 6.9 1.6 5.0 31.1 24.3 0.7 7.5 10.3 17.5 12.8 21.8 2.1 10.2 13.4 10.4 10.2 13.9 18.7 11.0 8.7 13.7 4.0 13.9 16.1 14.6 7.9 8.7 1.2 5.9 1.5 5.6 0.3 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.4 22.6 19.7 18.6 16.7 17.2 22.6 21.7 18.7 18.1 20.0 23.1 75.5 3.2 2.2 11.1 1.3 8.0 2.5 3.5 6.8 6.5 5.8 5.0 11.4 2.8 1.8 9.2 10.4 2.2 0.6 11.7 3.9 5.1 0.5 2.8 4.4 42.2 7.7 8.0 1.3 5.3 1.9 6.0 8.2 5.7 0.0 14.9 56.7 6.8 2.7 3.3 1.7 4.3 8.2 4.1 3.1 2.3 8.1 1.2 1.8 7.5 2.0 28.2 0.0 15.1 8.3 6.0 6.0 11.3 1.6 2.5 8.4 3.1 1.4 6.8 0.0 5.5 6.4 2.7 4.4 4.5 7.0 2.2 0.5 5.7 4.6 2.2 CASTOR2 "GATSL1, GATSL2" ENSG00000274070 "Cytosolic arginine sensor for mTORC1 subunit 2" A6NHX0 7 74964705-75031528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 28.3;skeletal muscle: 48.5;tongue: 26.2" "Cell type enhanced" "Detected in some" "dendritic cells: 1.3;Endometrial ciliated cells: 7.4;Endometrial stromal cells: 2.1;Glandular and luminal cells: 5.1" "Cancer enhanced" "Detected in all" "testis cancer: 11.6" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A549: 18.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057229 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" "HPA057229: AB_2683374" "unprognostic (1.07e-1)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (3.23e-1)" "unprognostic (1.31e-1)" "unprognostic (8.28e-2)" "unprognostic (2.78e-5)" "unprognostic (1.28e-2)" "unprognostic (1.45e-1)" "unprognostic (1.04e-2)" "unprognostic (1.35e-2)" "unprognostic (6.27e-2)" "unprognostic (9.72e-3)" "unprognostic (1.11e-1)" "unprognostic (3.30e-1)" "unprognostic (2.50e-1)" "unprognostic (9.20e-3)" 1.5 1.9 19.9 0.7 16.8 4.7 1.2 11.3 21.4 1.3 0.0 1.4 1.7 2.1 1.6 1.4 1.8 1.6 3.1 21.9 12.8 1.2 0.7 1.2 0.6 24.4 18.2 3.9 3.2 1.7 1.8 2.0 28.3 1.9 0.6 5.3 2.0 2.4 48.5 2.7 1.4 1.8 11.6 0.8 1.0 2.1 18.6 2.1 0.7 26.2 1.1 0.9 1.4 13.0 2.6 18.9 3.5 12.1 6.7 2.1 7.3 2.4 1.5 0.9 1.2 8.8 1.0 0.7 2.0 4.9 2.4 1.2 4.7 1.7 1.2 2.0 3.1 1.5 8.0 15.5 2.6 0.7 2.5 5.8 0.9 2.8 0.3 1.2 3.1 5.8 2.8 1.0 1.1 8.5 3.6 4.1 6.3 7.1 1.7 7.5 3.0 2.5 8.5 4.2 8.8 5.9 3.2 5.4 0.8 4.9 3.9 0.8 3.9 2.0 4.1 5.5 0.9 1.7 3.7 3.3 1.7 2.8 1.1 1.7 0.2 0.8 0.4 0.2 0.3 0.1 0.2 0.3 0.0 0.2 0.2 0.3 1.8 0.3 0.2 0.2 0.7 0.2 19.9 16.8 11.3 21.4 21.9 12.8 24.4 18.2 28.3 11.6 18.6 13.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.2 1.3 0.0 0.0 0.0 0.0 7.4 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.3 0.4 0.0 0.0 CCDC170 "bA282P11.1, C6orf97, FLJ23305" ENSG00000120262 "Coiled-coil domain containing 170" Q8IYT3 6 151494017-151621193 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "fallopian tube: 33.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 236.6;Late spermatids: 82.6;Respiratory ciliated cells: 379.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "eosinophil: 6.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "MCF7: 10.4;T-47d: 5.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA027114, HPA027185" Enhanced Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "Cell Junctions" "HPA027114: AB_2732435, HPA027185: AB_2672151" "unprognostic (7.46e-2)" "unprognostic (3.54e-2)" "unprognostic (6.93e-2)" "prognostic favorable (3.64e-4)" "unprognostic (2.13e-1)" "unprognostic (8.79e-3)" "unprognostic (2.74e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (2.18e-2)" "unprognostic (3.56e-2)" "unprognostic (1.40e-2)" "unprognostic (3.93e-2)" "unprognostic (2.17e-1)" "unprognostic (5.21e-2)" 3.0 4.2 1.5 1.3 1.4 0.1 3.7 0.9 0.7 3.0 8.0 0.7 2.5 3.6 0.4 0.4 33.4 1.3 0.8 1.3 1.8 0.8 1.3 4.1 1.4 3.6 4.9 5.6 0.1 0.1 0.2 1.4 3.1 0.4 0.6 0.2 0.2 0.4 0.3 0.2 1.1 0.9 3.2 2.2 1.7 2.7 1.7 0.3 5.6 0.1 0.6 1.1 0.5 2.8 0.0 0.1 0.3 0.0 0.3 0.3 0.0 0.1 0.4 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.1 0.1 10.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.1 0.0 0.0 0.1 5.9 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 2.1 6.2 0.0 2.8 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 1.8 0.1 2.8 0.1 0.0 0.6 1.5 1.4 0.9 0.7 1.3 1.8 3.6 4.9 3.1 3.2 1.7 2.8 1.2 3.2 1.5 7.5 0.4 0.6 0.3 6.5 1.2 0.3 27.3 8.9 0.7 0.0 39.5 0.0 22.9 0.1 0.4 1.1 0.0 0.3 53.0 236.6 23.6 1.2 0.0 0.0 5.5 1.1 0.4 5.2 3.1 14.1 3.8 3.5 1.1 1.5 11.9 0.0 5.9 0.0 12.2 17.5 11.3 82.6 7.2 16.8 0.0 0.0 11.0 2.5 0.0 3.0 0.8 2.7 5.8 0.0 0.1 0.9 0.5 5.8 379.4 1.0 0.0 0.4 6.5 19.1 1.1 0.2 1.0 0.0 1.2 14.0 0.3 0.5 CCDC22 "CXorf37, JM1" ENSG00000101997 "Coiled-coil domain containing 22" O60826 X 49235470-49250520 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Protein transport, Transport, Ubl conjugation pathway" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000229, HPA000888, HPA075980" Uncertain Approved Approved "Endoplasmic reticulum,Vesicles" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Endoplasmic reticulum, Vesicles" "HPA000229: , HPA000888: AB_1078420, HPA075980: " "unprognostic (1.24e-2)" "unprognostic (1.96e-2)" "unprognostic (1.98e-2)" "unprognostic (3.45e-1)" "unprognostic (1.36e-1)" "unprognostic (2.80e-2)" "prognostic unfavorable (2.17e-4)" "unprognostic (1.68e-2)" "unprognostic (2.62e-2)" "unprognostic (1.70e-1)" "unprognostic (4.57e-3)" "unprognostic (3.61e-2)" "unprognostic (4.99e-2)" "unprognostic (6.99e-2)" "unprognostic (2.57e-1)" "unprognostic (2.10e-2)" "unprognostic (1.40e-3)" 10.3 12.3 9.4 10.1 10.0 18.6 10.3 9.9 10.8 11.7 8.8 12.1 10.4 12.2 5.3 14.2 11.3 6.4 12.8 9.4 9.2 12.3 12.9 10.7 15.0 10.8 9.4 11.2 14.2 8.7 11.2 6.9 10.1 13.5 5.2 4.7 12.3 8.7 17.2 13.8 13.4 6.0 9.6 20.5 12.9 3.8 10.0 13.6 11.0 7.7 8.5 11.9 11.1 10.8 18.8 16.0 9.6 33.5 8.8 8.9 20.4 10.9 7.9 12.0 13.6 16.3 16.0 6.9 15.9 9.7 14.3 15.0 10.6 18.0 4.9 18.1 23.6 7.3 15.6 15.5 14.7 20.8 12.4 8.2 15.2 15.9 8.6 6.1 11.9 13.7 14.7 11.8 8.6 58.3 15.3 24.4 11.2 9.5 23.2 22.0 15.6 30.1 9.4 9.4 11.4 8.8 16.7 19.4 15.0 9.8 30.2 20.2 13.3 15.4 16.5 19.2 11.6 21.2 12.6 12.5 16.8 38.5 12.3 8.6 37.0 23.8 18.3 30.9 20.1 18.9 18.8 21.3 38.2 16.8 16.7 19.6 2.8 10.8 27.1 15.1 21.8 28.0 9.4 10.0 9.9 10.8 9.4 9.2 10.8 9.4 10.1 9.6 10.0 10.8 8.6 0.0 4.4 3.3 15.0 5.6 9.6 13.0 6.2 11.6 7.4 6.1 2.4 15.7 12.0 11.0 6.2 15.2 11.2 12.5 15.6 13.9 0.3 5.8 4.6 7.8 6.7 8.6 3.7 7.3 14.8 7.6 7.1 6.9 11.4 8.6 11.0 7.2 32.0 1.7 2.9 18.2 8.2 14.4 11.9 0.4 8.1 13.8 7.2 1.9 18.0 9.9 9.2 1.0 4.2 8.6 7.6 7.5 10.2 6.2 15.6 12.1 5.6 8.0 6.6 9.1 9.5 0.1 0.9 8.0 6.7 20.2 13.3 11.0 15.7 8.3 CCDC63 "FLJ35843, ODA5" ENSG00000173093 "Coiled-coil domain containing 63" Q8NA47 12 110846769-110907535 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "testis: 17.3" "Group enriched" "Detected in some" 32 "Early spermatids: 305.6;Late spermatids: 241.7" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 19 "MCF7: 4.4" HPA061568 Approved "Nucleoplasm,Nuclear bodies,Vesicles" No NA "Cluster 83: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" Vesicles "HPA061568: AB_2684561" "unprognostic (1.98e-2)" "unprognostic (1.05e-1)" "unprognostic (1.17e-1)" "unprognostic (2.65e-1)" "unprognostic (5.59e-2)" "unprognostic (1.09e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 305.6 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 241.7 1.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 8.4 4.3 0.0 0.0 0.1 0.0 0.9 0.0 0.0 CCDC83 "CT148, FLJ42119, KP-CoT-23, MGC34732" ENSG00000150676 "Coiled-coil domain containing 83" Q8IWF9 11 85855101-85920021 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "testis: 35.5" "Group enriched" "Detected in some" 46 "Early spermatids: 222.2;Late spermatids: 194.2;Spermatocytes: 160.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "MCF7: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039707, HPA039882" Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Plasma membrane, Cytosol" "HPA039707: AB_10795259, HPA039882: AB_10795410" "unprognostic (1.14e-1)" "unprognostic (4.09e-1)" "unprognostic (1.49e-2)" "unprognostic (4.43e-2)" "unprognostic (7.05e-6)" "unprognostic (3.52e-1)" "unprognostic (2.17e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 222.2 0.1 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 194.2 4.1 0.1 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 160.3 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CCNQ "CycM, FAM58A" ENSG00000262919 "Cyclin Q" Q8N1B3 X 153587925-153600045 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 72.4;Extravillous trophoblasts: 98.6;Syncytiotrophoblasts: 120.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050137, HPA059843" Uncertain Approved Nucleoplasm,Cytosol Yes No "Cluster 37: B-cells - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Cytosol" "HPA050137: AB_2681029, HPA059843: AB_2684140" "unprognostic (3.94e-1)" "unprognostic (1.94e-2)" "unprognostic (7.36e-2)" "unprognostic (2.92e-1)" "unprognostic (5.08e-2)" "unprognostic (1.02e-2)" "unprognostic (1.47e-3)" "unprognostic (2.12e-1)" "unprognostic (8.50e-3)" "unprognostic (2.08e-2)" "unprognostic (1.57e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (8.75e-2)" "unprognostic (2.31e-1)" "unprognostic (2.71e-2)" "unprognostic (5.25e-2)" 11.8 12.8 19.9 8.2 21.3 7.3 11.7 19.6 24.9 11.9 15.6 16.2 8.9 12.9 12.7 13.1 11.1 4.0 33.9 20.8 20.5 13.5 13.2 10.6 12.5 23.2 21.6 10.5 15.0 10.3 23.6 9.2 23.4 13.6 8.0 6.4 12.9 8.8 34.3 12.1 13.6 6.1 20.0 17.2 13.3 6.2 21.2 9.0 11.1 13.6 12.2 14.0 11.7 24.9 43.7 31.2 12.1 43.5 20.9 11.2 18.7 25.0 21.8 23.5 23.6 33.3 14.3 34.9 44.6 25.1 35.3 26.7 38.4 22.6 22.2 20.3 39.2 7.8 19.4 23.5 19.0 28.2 18.9 14.1 20.1 15.7 16.1 10.0 19.0 16.1 10.6 15.6 19.1 50.5 19.7 38.0 15.1 44.4 52.4 22.6 20.0 17.8 17.0 17.6 16.0 21.1 12.0 19.3 34.4 11.9 7.3 25.0 14.6 20.5 29.3 46.7 38.5 21.8 23.1 43.4 18.5 45.4 15.7 0.0 1.6 4.9 2.7 1.4 1.0 6.1 2.3 1.9 1.3 4.1 2.5 1.7 0.9 0.7 0.8 1.2 3.4 1.1 19.9 21.3 19.6 24.9 20.8 20.5 23.2 21.6 23.4 20.0 21.2 24.9 21.0 3.2 13.0 0.0 13.5 0.0 0.0 0.0 0.0 0.0 24.1 31.0 0.0 0.0 3.1 7.3 0.0 40.7 20.4 0.0 72.4 23.3 0.0 11.9 17.3 7.8 0.0 0.0 0.0 37.1 98.6 8.4 0.0 8.7 2.5 16.3 0.0 0.0 41.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 22.7 0.0 0.0 0.0 0.0 34.0 0.0 0.0 5.9 0.0 0.0 41.6 2.2 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 120.9 10.0 18.4 0.0 0.0 CCS ENSG00000173992 "Copper chaperone for superoxide dismutase" O14618 11 66593153-66606019 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 204.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008672, HPA040026, HPA044090" Approved NA NA 190000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" "CAB008672: AB_1623300, HPA040026: AB_2676806, HPA044090: AB_2678805" "unprognostic (1.19e-1)" "unprognostic (8.46e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.57e-2)" "unprognostic (3.22e-2)" "unprognostic (3.67e-2)" "unprognostic (1.53e-1)" "unprognostic (3.01e-1)" "unprognostic (3.00e-1)" "unprognostic (8.22e-3)" "unprognostic (1.10e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (3.25e-3)" 21.1 26.6 29.6 18.5 30.5 34.4 14.1 33.4 40.5 18.5 30.7 21.9 27.9 19.8 18.3 16.5 17.7 21.1 21.4 30.7 31.1 21.3 56.2 15.6 23.8 32.4 30.9 23.6 31.1 22.6 17.3 17.9 30.4 22.6 14.7 24.9 36.8 20.0 19.1 21.9 30.1 17.2 30.3 21.8 23.3 16.9 31.3 15.9 17.3 14.2 17.3 17.7 14.7 35.0 24.6 34.1 24.4 26.9 22.0 21.4 29.9 22.4 18.7 15.9 10.7 38.8 26.5 14.4 31.3 19.9 23.8 24.6 7.2 25.8 5.3 26.8 10.9 23.3 30.5 51.1 42.3 6.0 18.3 35.8 18.9 16.9 11.1 33.6 26.0 16.5 12.3 19.2 16.5 55.0 9.5 30.1 22.7 40.2 23.9 17.4 23.3 29.8 25.0 25.6 19.9 12.9 37.2 25.4 49.7 14.4 38.9 17.4 23.6 10.8 17.7 24.4 10.8 32.1 19.2 7.6 29.7 9.2 26.5 23.6 26.4 60.0 19.7 21.0 17.0 32.5 16.9 16.0 31.1 25.3 17.7 17.9 17.8 19.1 13.0 83.7 18.4 17.3 29.6 30.5 33.4 40.5 30.7 31.1 32.4 30.9 30.4 30.3 31.3 35.0 37.8 19.2 33.7 58.8 56.1 24.2 52.9 44.7 31.3 42.4 33.6 37.5 29.9 45.8 30.4 36.8 25.0 55.2 59.3 49.7 82.2 34.1 25.4 16.5 38.0 28.7 73.0 204.4 20.2 59.8 43.8 60.4 44.4 27.2 21.5 63.9 39.3 163.5 64.9 11.8 19.1 41.1 26.4 35.8 32.3 12.6 71.4 43.8 44.4 23.4 38.5 65.4 44.3 15.1 20.6 40.5 44.9 57.2 50.6 31.2 90.4 132.9 19.7 104.2 19.7 31.8 67.1 46.7 31.4 30.1 20.3 51.6 41.0 191.3 46.7 37.2 CD2BP2 "LIN1, PPP1R59, Snu40, U5-52K" ENSG00000169217 "CD2 cytoplasmic tail binding protein 2" O95400 16 30350773-30355308 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041508, HPA061309" Enhanced Enhanced "Nuclear speckles,Cytosol" Yes No "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" "Nuclear speckles" Cytosol "HPA041508: AB_2677523, HPA061309: AB_2684476" "unprognostic (5.66e-2)" "unprognostic (7.50e-3)" "unprognostic (1.47e-1)" "unprognostic (2.82e-2)" "unprognostic (1.65e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.71e-2)" "unprognostic (1.16e-1)" "unprognostic (9.76e-2)" "unprognostic (2.30e-2)" "unprognostic (7.47e-2)" "unprognostic (2.09e-3)" "unprognostic (1.44e-1)" "unprognostic (3.22e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-1)" 31.1 49.3 38.9 34.0 39.7 23.9 32.9 38.0 41.5 39.6 34.0 39.3 29.9 45.0 24.9 35.3 41.0 22.0 35.2 39.9 41.2 42.8 27.3 32.8 38.8 41.4 39.8 36.9 40.7 42.5 42.7 24.4 39.1 38.3 23.7 16.2 30.0 35.5 46.9 33.6 35.2 31.6 39.0 46.4 36.9 24.0 41.6 35.7 42.5 26.6 43.7 37.0 30.1 42.0 55.4 65.7 54.4 49.4 44.3 41.9 46.0 60.0 71.5 66.8 71.3 50.6 64.9 84.6 72.3 65.5 61.4 59.4 57.0 70.3 53.6 50.6 66.6 35.9 67.7 60.3 63.6 51.3 63.4 45.2 58.7 74.2 47.3 45.6 70.3 62.1 41.4 63.2 67.7 132.1 71.6 43.6 73.8 42.9 38.5 104.2 45.3 64.3 54.2 54.7 44.7 85.1 40.2 69.9 42.0 44.7 66.4 41.1 50.6 76.3 53.3 38.9 53.1 105.0 82.3 78.5 52.5 47.2 64.0 107.4 61.7 116.6 71.3 76.3 56.8 87.5 57.3 66.7 55.8 97.3 47.6 58.9 121.9 74.5 102.7 67.1 94.4 79.6 38.9 39.7 38.0 41.5 39.9 41.2 41.4 39.8 39.1 39.0 41.6 42.0 38.1 32.1 29.0 7.2 39.5 28.8 49.6 58.4 31.9 29.8 33.2 29.6 26.5 45.8 41.2 36.8 20.9 61.0 57.0 50.5 60.7 83.6 19.9 41.7 30.7 42.8 33.0 22.3 6.7 97.5 58.1 36.4 28.1 45.2 47.6 33.4 28.2 13.9 69.7 11.8 7.1 32.7 36.7 38.3 23.6 14.2 35.4 34.0 39.2 8.4 84.1 47.6 97.9 3.5 10.7 87.8 64.9 35.7 52.7 40.7 60.3 81.5 46.3 29.0 39.5 30.5 44.6 38.5 40.1 27.4 30.4 88.7 41.9 38.9 31.6 50.7 CDCA4 "FLJ20764, Hepp" ENSG00000170779 "Cell division cycle associated 4" Q9BXL8 14 105009573-105021083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 55.8" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 64.2;Cytotrophoblasts: 84.5;Extravillous trophoblasts: 154.5;Spermatogonia: 69.9;Suprabasal keratinocytes: 67.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA064971 Supported "Nucleoplasm,Plasma membrane,Cytosol" NA Yes "Cluster 16: MAIT-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Plasma membrane, Cytosol" "HPA064971: AB_2685395" "unprognostic (2.22e-3)" "unprognostic (1.84e-1)" "unprognostic (2.69e-1)" "unprognostic (9.93e-3)" "unprognostic (1.42e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (4.19e-4)" "prognostic unfavorable (7.94e-4)" "unprognostic (4.20e-2)" "unprognostic (8.54e-2)" "prognostic unfavorable (6.67e-4)" "unprognostic (6.73e-2)" "prognostic unfavorable (1.47e-6)" "unprognostic (2.15e-1)" "unprognostic (1.55e-1)" "unprognostic (7.50e-2)" "unprognostic (1.24e-2)" 3.9 2.6 1.9 7.4 2.0 55.8 4.2 3.0 2.1 8.7 2.1 4.6 4.7 5.4 1.8 18.6 4.1 2.6 2.7 1.7 1.8 3.4 2.7 3.6 11.6 2.1 1.9 4.1 3.2 1.8 1.7 9.2 2.1 3.8 2.9 1.3 5.5 2.2 1.4 24.7 4.9 3.5 1.9 6.6 3.8 11.6 2.0 14.6 3.3 1.5 8.5 4.2 10.2 2.0 40.6 41.3 46.7 35.6 7.9 13.2 61.1 59.0 18.0 45.2 39.7 50.9 50.2 52.9 31.5 20.9 34.5 63.5 32.9 68.0 27.1 58.2 26.1 33.4 33.9 43.2 9.7 59.8 27.0 9.4 20.8 35.2 32.7 15.1 31.4 45.0 37.5 53.0 32.1 98.8 56.2 40.1 34.8 35.1 94.0 53.6 68.1 19.7 15.9 46.2 27.2 33.5 56.6 22.3 46.8 20.5 44.0 39.8 48.8 39.9 50.5 55.3 79.5 19.5 25.9 54.4 33.5 30.2 67.5 1.1 4.3 10.6 11.9 4.9 14.8 8.4 12.7 16.7 4.7 5.4 7.4 8.9 1.6 12.9 5.6 5.1 11.1 7.0 1.9 2.0 3.0 2.1 1.7 1.8 2.1 1.9 2.1 1.9 2.0 2.0 5.4 0.0 2.2 0.7 7.4 64.2 26.5 36.6 13.1 3.4 8.7 8.3 0.6 0.0 9.0 1.8 0.0 84.5 11.5 4.3 3.9 12.7 8.1 9.0 9.0 10.9 3.0 53.0 1.8 7.0 154.5 10.2 3.1 12.5 28.6 15.1 7.9 2.2 24.3 13.5 1.3 6.6 6.1 5.9 22.6 6.8 8.4 8.4 17.8 2.8 9.3 4.6 9.2 1.0 1.8 12.3 3.3 6.0 11.8 16.1 1.9 1.8 7.7 2.6 6.6 4.6 12.5 43.0 69.9 21.3 67.1 25.9 17.7 3.6 9.5 43.2 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696354 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 30.1 38.5 20.2 10.4 20.4 19.5 26.7 20.3 32.8 49.3 22.0 38.2 22.7 25.9 8.7 35.3 36.3 8.6 27.3 21.0 19.5 52.9 77.0 31.0 14.7 18.6 18.7 43.2 49.2 13.5 55.5 12.5 19.6 39.1 11.3 7.6 24.8 7.5 33.8 32.1 36.1 8.2 17.0 37.5 38.5 17.0 18.4 10.8 54.5 4.1 7.0 32.3 36.5 19.1 27.5 17.8 13.9 5.8 5.7 11.0 14.2 22.3 12.6 15.2 4.9 13.1 21.2 23.9 9.8 19.3 9.1 15.5 5.8 30.8 9.3 5.3 14.1 9.7 21.0 1.7 23.4 15.8 17.1 13.3 10.7 9.3 15.3 10.3 27.0 16.1 25.5 3.2 17.7 36.6 19.5 45.0 28.5 29.7 13.1 26.5 19.0 34.1 27.9 21.2 10.1 29.6 28.0 13.0 6.8 15.2 30.3 25.0 24.1 9.1 26.6 10.1 15.4 11.7 6.4 7.5 16.4 25.0 15.5 5.1 14.0 4.2 14.8 19.7 12.8 7.8 13.2 10.7 18.1 9.0 15.1 12.6 1.5 20.4 15.4 12.4 11.6 11.4 20.2 20.4 20.3 32.8 21.0 19.5 18.6 18.7 19.6 17.0 18.4 19.1 28.2 12.8 26.6 35.3 21.2 15.4 24.2 26.9 23.3 17.2 24.5 25.1 6.5 38.6 20.0 27.6 25.0 28.6 26.7 44.8 43.0 28.6 6.1 20.7 21.9 23.0 67.7 15.4 44.5 12.5 19.8 19.6 85.1 16.9 9.5 40.3 21.8 41.1 18.8 18.5 33.3 49.4 26.4 17.4 16.0 8.8 23.9 17.0 19.6 17.8 15.5 8.5 26.8 24.6 20.0 13.6 41.5 12.4 20.8 30.7 58.3 53.7 28.1 32.3 6.6 11.4 16.3 27.3 28.7 22.4 15.5 27.9 22.0 54.8 58.2 22.9 CDKL5 "CFAP247, EIEE2, STK9" ENSG00000008086 "Cyclin dependent kinase like 5" O76039 X 18425583-18653629 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 216.6;Horizontal cells: 80.8;Inhibitory neurons: 116.1;Oligodendrocytes: 79.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "basophil: 5.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.7" "Cell line enhanced" "Detected in many" "A549: 10.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002847, CAB011577" Approved Supported Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 58: Brain - Synaptic function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Nucleoplasm "CAB011577: AB_727019, HPA002847: AB_1080107" "unprognostic (7.01e-2)" "unprognostic (4.86e-2)" "unprognostic (1.41e-1)" "unprognostic (1.25e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.72e-2)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" "unprognostic (9.63e-3)" "unprognostic (2.05e-3)" "unprognostic (1.66e-1)" "prognostic favorable (5.54e-4)" "unprognostic (7.67e-3)" "unprognostic (1.29e-1)" "unprognostic (2.67e-3)" "unprognostic (1.99e-1)" 2.0 1.6 4.9 1.1 6.7 2.5 2.5 0.0 11.7 3.9 0.0 1.9 0.9 2.6 1.9 3.5 1.7 1.8 3.8 6.8 0.0 3.5 1.2 4.6 0.8 0.0 2.5 3.8 2.4 2.4 1.7 3.2 0.0 3.6 1.2 12.2 2.2 2.3 1.7 2.2 0.9 2.5 0.0 1.2 2.4 7.1 5.7 1.7 3.0 2.0 1.1 2.7 3.4 5.4 1.1 10.0 2.6 2.2 2.4 3.6 1.7 1.7 3.0 2.0 2.5 3.3 1.5 1.5 0.3 1.0 4.5 0.5 3.2 1.8 4.3 0.4 1.7 0.1 5.5 2.1 1.1 0.2 0.7 1.7 1.9 5.4 4.9 1.3 1.0 1.6 0.2 1.5 2.7 1.0 0.6 0.8 5.2 0.9 2.3 0.6 3.0 0.1 1.8 7.1 0.5 3.2 2.7 0.9 1.5 4.4 1.3 0.4 6.2 2.5 1.7 5.5 1.3 0.3 0.1 0.3 1.4 0.4 3.0 5.7 0.5 1.1 0.3 0.3 0.1 0.1 0.2 0.1 0.1 0.3 0.3 0.2 2.0 0.2 0.3 0.5 0.1 0.1 4.9 6.7 0.0 11.7 6.8 0.0 0.0 2.5 0.0 0.0 5.7 5.4 9.4 25.6 24.8 37.5 2.8 0.9 10.7 0.7 4.6 19.0 7.9 6.3 12.9 5.7 5.3 7.3 33.3 27.4 3.8 1.3 7.9 7.7 34.3 6.5 8.4 6.3 2.4 2.7 216.6 9.6 3.1 7.4 7.7 7.9 1.3 3.9 6.1 3.4 4.2 80.8 116.1 1.6 2.0 4.4 0.5 55.3 5.9 4.9 0.0 34.7 4.6 23.5 0.0 41.7 79.7 8.2 0.8 5.3 4.3 16.2 0.6 8.9 4.0 20.4 32.9 7.2 8.4 5.8 10.1 4.2 1.3 47.3 2.3 5.7 1.8 22.9 CELSR2 "ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3" ENSG00000143126 "Cadherin EGF LAG seven-pass G-type receptor 2" Q9HCU4 1 109249539-109275751 "G-protein coupled receptors, Predicted membrane proteins" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.8" "Cell type enhanced" "Detected in many" "Horizontal cells: 97.6;Oligodendrocytes: 48.1" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 8 "amygdala: 13.3;basal ganglia: 21.6;cerebral cortex: 44.6;hippocampal formation: 50.8;white matter: 26.6" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 47.9;HaCaT: 48.4;MCF7: 56.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013952 Uncertain Approved Cytosol NA NA 1300000 "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA013952: AB_1846518" "unprognostic (4.46e-3)" "unprognostic (1.07e-2)" "unprognostic (3.00e-2)" "unprognostic (4.71e-2)" "unprognostic (2.19e-1)" "unprognostic (5.30e-2)" "unprognostic (3.51e-2)" "unprognostic (2.98e-1)" "unprognostic (1.33e-1)" "unprognostic (1.59e-2)" "unprognostic (1.47e-2)" "unprognostic (1.51e-1)" "unprognostic (1.94e-2)" "unprognostic (1.39e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-2)" "unprognostic (5.16e-2)" 0.9 1.4 13.3 0.5 21.6 0.3 4.1 0.1 44.6 5.6 0.0 2.9 0.8 2.2 3.1 13.9 16.1 1.1 5.2 50.8 0.0 4.7 0.6 1.1 0.7 4.1 0.6 0.6 3.8 6.0 2.9 0.9 1.0 3.0 0.7 5.7 5.6 7.9 8.9 24.7 1.1 1.6 0.6 0.4 2.0 9.4 1.5 1.2 9.1 4.0 2.4 1.9 9.4 26.6 14.0 12.8 47.9 8.9 0.1 0.0 13.0 1.6 1.1 2.9 0.8 2.0 0.4 2.5 10.9 1.0 2.2 48.4 12.5 7.8 1.5 0.3 5.3 1.1 11.8 2.8 1.0 0.8 6.2 0.2 18.5 1.2 0.8 10.8 0.5 7.7 8.5 0.6 0.0 56.6 1.4 0.7 15.7 1.6 2.5 12.8 4.4 0.7 10.3 4.7 19.5 9.2 7.6 16.2 10.1 11.3 15.3 3.1 0.0 0.0 8.5 0.8 12.4 3.2 1.0 0.7 2.6 1.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 21.6 0.1 44.6 50.8 0.0 4.1 0.6 1.0 0.6 1.5 26.6 0.9 9.6 5.0 15.0 0.2 15.7 5.1 19.7 9.6 13.2 16.4 16.3 13.5 2.8 11.3 18.4 4.2 2.2 1.9 1.3 1.9 2.6 5.1 12.8 1.4 1.5 1.8 0.0 34.0 0.4 1.3 1.2 2.6 17.7 1.3 5.5 0.4 7.1 1.1 97.6 27.7 0.9 2.0 0.8 3.4 9.3 3.4 0.9 10.6 5.6 1.0 29.9 3.1 24.6 48.1 1.5 0.5 19.2 0.4 4.3 0.2 3.1 8.4 5.2 6.6 5.0 4.9 1.6 6.8 31.0 22.9 0.5 1.5 0.0 2.0 6.9 CENPB ENSG00000125817 "Centromere protein B" P07199 20 3783851-3786740 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011626, HPA053507, HPA054405" Approved Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nuclear bodies" Nucleoplasm "CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477" "unprognostic (2.01e-1)" "unprognostic (8.47e-3)" "unprognostic (2.61e-1)" "unprognostic (1.12e-2)" "unprognostic (1.75e-1)" "unprognostic (1.62e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (2.40e-2)" "unprognostic (3.27e-2)" "unprognostic (3.57e-1)" "unprognostic (1.48e-3)" "unprognostic (7.93e-2)" "unprognostic (2.78e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-1)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" 45.2 39.8 115.4 20.4 120.8 14.9 40.3 97.8 109.8 41.1 68.0 56.9 21.4 45.5 11.0 42.2 36.2 15.3 54.8 89.6 91.8 40.4 42.3 36.0 17.5 121.9 113.7 36.6 40.7 26.1 29.6 15.3 108.2 40.0 12.6 3.9 35.0 24.1 95.0 53.7 34.9 19.4 119.6 35.9 44.3 10.8 111.8 17.7 35.0 43.2 13.7 48.2 33.9 133.5 111.9 140.4 27.1 58.1 56.2 44.4 17.4 78.2 56.4 49.1 39.5 57.5 78.1 38.7 24.0 72.9 77.0 88.3 21.7 88.9 24.6 55.5 37.1 82.3 51.5 51.4 65.2 27.0 26.7 50.5 46.9 70.5 45.0 38.5 42.5 49.2 53.9 23.8 42.4 183.2 81.1 61.8 34.0 62.7 165.4 66.8 3.6 28.3 52.2 67.6 66.2 49.4 64.7 89.7 62.4 12.2 56.7 59.1 73.2 84.9 45.8 74.1 121.3 28.5 44.1 22.5 29.8 95.2 56.9 0.0 1.7 0.6 1.9 1.7 1.3 1.0 1.3 1.2 1.3 1.4 1.1 1.4 0.2 1.7 1.1 1.7 0.4 1.1 115.4 120.8 97.8 109.8 89.6 91.8 121.9 113.7 108.2 119.6 111.8 133.5 30.2 6.4 19.5 2.3 6.8 13.9 5.7 11.2 15.9 18.3 23.8 23.1 16.5 30.0 11.6 14.7 10.4 6.2 17.2 48.0 3.9 18.9 1.2 12.7 21.5 24.7 20.4 12.0 2.6 29.8 7.9 14.6 15.8 18.1 7.6 24.0 17.9 25.6 22.7 21.9 4.5 27.1 6.1 25.7 12.3 7.5 21.8 15.3 17.8 3.7 17.3 31.1 12.3 1.5 3.8 31.0 25.4 25.9 5.7 12.5 28.4 8.7 10.8 13.0 13.1 22.4 21.9 1.1 1.5 17.4 14.1 4.5 11.8 46.5 26.9 7.4 CENPM "C22orf18, CENP-M, MGC861, Pane1" ENSG00000100162 "Centromere protein M" Q9NSP4 22 41938737-41947152 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 29.0;lymphoid tissue: 25.1" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 116.7;Erythroid cells: 60.0;Plasma cells: 70.8;Respiratory ciliated cells: 102.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 50.8" "Group enriched" "Detected in many" 6 "B-cells: 38.6;T-cells: 50.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042404 Enhanced NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" "HPA042404: AB_2677981" "unprognostic (3.78e-2)" "prognostic favorable (3.40e-5)" "unprognostic (7.15e-3)" "unprognostic (2.65e-3)" "unprognostic (2.02e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.50e-5)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.74e-1)" "unprognostic (1.63e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (5.99e-7)" "unprognostic (9.54e-3)" "unprognostic (2.44e-1)" "unprognostic (8.73e-2)" "unprognostic (5.61e-2)" 1.3 1.5 0.6 9.9 0.6 29.0 1.9 1.8 1.1 2.3 0.3 9.9 8.4 1.7 0.1 9.9 10.8 2.0 0.7 0.5 0.7 2.3 1.6 3.8 25.1 0.8 0.8 0.7 0.7 0.3 0.5 3.2 0.8 1.4 5.3 0.1 3.6 0.3 0.9 8.0 8.3 1.8 0.5 10.6 6.1 12.8 1.0 22.6 0.8 0.4 16.3 2.0 4.0 0.5 79.1 79.0 43.5 28.8 3.3 3.3 18.4 37.8 19.4 65.2 66.2 92.3 41.0 101.5 27.8 20.2 42.2 29.5 32.9 38.8 16.2 29.4 137.4 47.8 82.3 64.9 3.2 91.4 51.9 2.7 2.9 42.1 19.3 6.9 24.8 91.5 36.7 95.0 38.8 121.9 91.9 94.8 23.6 47.5 58.1 86.8 43.4 105.6 26.9 46.5 49.3 9.4 58.5 34.5 20.6 7.2 32.8 58.4 12.5 62.8 93.4 42.0 64.1 50.5 38.0 95.2 21.9 75.9 70.0 1.8 0.3 0.0 6.2 0.2 8.8 27.9 18.6 8.4 0.7 38.6 3.5 4.6 1.1 7.4 0.2 0.4 50.8 7.9 0.6 0.6 1.8 1.1 0.5 0.7 0.8 0.8 0.8 0.5 1.0 0.5 0.4 0.0 3.4 0.3 50.7 2.0 4.8 17.8 1.8 1.9 10.9 10.3 0.6 0.0 7.9 0.0 0.0 39.7 5.4 25.3 17.6 2.1 4.5 116.7 4.2 2.6 7.7 60.0 0.5 0.7 38.9 6.4 10.7 18.0 2.5 15.8 3.6 1.3 43.4 3.3 0.8 34.5 28.5 2.9 3.5 6.7 1.2 5.4 7.2 1.0 1.8 0.1 2.1 1.0 0.2 1.5 8.4 0.4 70.8 2.8 4.0 0.3 102.6 0.6 0.0 0.2 7.0 36.4 29.8 13.3 1.0 8.8 18.5 2.9 36.6 9.0 CENPX "CENP-X, FAAP10, MGC14480, MHF2, STRA13" ENSG00000169689 "Centromere protein X" A8MT69 17 82018702-82024107 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 172.6;Breast myoepithelial cells: 190.2;Cytotrophoblasts: 197.7;Extravillous trophoblasts: 455.2;Hofbauer cells: 146.1;Pancreatic endocrine cells: 151.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 45: Intestine - Brush border" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (3.11e-1)" "unprognostic (3.57e-3)" "unprognostic (1.84e-2)" "unprognostic (1.58e-2)" "unprognostic (4.76e-2)" "unprognostic (2.60e-1)" "unprognostic (2.95e-3)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (3.59e-3)" "unprognostic (2.74e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.57e-2)" "unprognostic (3.48e-1)" "unprognostic (2.31e-1)" "unprognostic (1.97e-1)" 39.0 29.1 57.8 27.8 58.7 44.3 41.6 62.4 70.6 34.4 54.4 56.3 38.4 26.2 11.6 63.1 29.0 14.9 33.1 56.8 58.2 45.9 89.5 33.4 25.3 58.7 58.9 29.2 33.0 26.2 18.2 30.2 59.6 65.0 30.6 16.2 50.1 18.3 37.7 44.3 40.8 17.1 57.6 29.6 50.3 22.3 60.2 25.4 34.1 21.1 20.7 42.2 38.4 61.0 131.3 352.7 78.4 116.6 30.0 27.6 62.2 91.9 78.1 116.7 79.3 144.1 101.1 47.8 83.9 50.0 113.0 76.1 71.3 88.6 52.7 51.1 259.0 86.0 157.1 247.8 32.2 103.6 61.5 26.8 43.4 90.4 31.6 34.7 111.8 88.4 153.9 75.0 72.7 376.1 174.3 94.3 51.9 329.6 230.9 78.0 84.4 70.9 69.5 157.5 177.5 113.1 51.3 302.0 49.4 38.0 238.1 80.1 40.7 125.0 154.5 215.1 161.3 50.4 27.5 65.6 86.3 84.7 103.2 47.9 112.3 61.5 82.4 99.4 80.6 106.1 79.4 78.7 85.4 83.8 85.3 72.5 24.5 74.4 90.3 105.4 110.7 99.6 57.8 58.7 62.4 70.6 56.8 58.2 58.7 58.9 59.6 57.6 60.2 61.0 61.2 41.7 59.6 0.0 11.3 0.0 0.0 0.0 0.0 0.0 172.6 190.2 0.0 0.0 29.1 44.1 0.0 197.7 33.7 0.0 129.1 102.4 0.0 41.1 34.6 27.6 0.0 0.0 0.0 128.8 455.2 33.4 0.0 49.3 11.4 60.5 0.0 0.0 146.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.5 0.0 0.0 51.1 0.0 0.0 0.0 0.0 151.5 0.0 0.0 5.5 0.0 0.0 139.3 17.5 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 105.2 21.8 40.1 0.0 0.0 CHCHD5 "C2orf9, MGC11104, MIC14, MIX14" ENSG00000125611 "Coiled-coil-helix-coiled-coil-helix domain containing 5" Q9BSY4 2 112584240-112589275 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038263 Approved Approved Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA038263: AB_10671525" "unprognostic (3.56e-2)" "unprognostic (3.41e-2)" "unprognostic (3.36e-2)" "unprognostic (4.57e-2)" "unprognostic (1.85e-1)" "unprognostic (7.75e-2)" "unprognostic (2.72e-1)" "unprognostic (7.18e-3)" "unprognostic (8.04e-2)" "unprognostic (4.96e-2)" "unprognostic (2.07e-1)" "unprognostic (4.95e-2)" "unprognostic (1.39e-2)" "unprognostic (3.91e-2)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.12e-2)" 19.1 28.9 20.6 12.4 22.0 18.3 22.4 22.6 28.7 18.5 19.8 19.2 18.0 17.8 6.4 28.2 19.6 14.4 24.5 20.0 21.7 35.8 40.2 17.8 14.6 21.4 21.6 15.8 46.1 28.1 31.7 9.8 21.3 22.2 6.3 5.7 16.5 12.6 38.9 23.3 17.2 6.5 21.5 18.5 25.4 22.9 22.6 16.7 27.1 18.7 7.9 19.6 18.8 21.9 32.5 53.1 23.3 0.1 9.3 19.7 22.0 14.0 18.2 28.3 20.0 58.1 39.0 24.7 54.4 19.4 23.9 23.4 8.9 31.2 3.8 26.8 43.2 33.4 15.6 46.4 40.8 28.5 22.5 26.5 26.3 37.4 22.8 13.2 15.8 0.1 35.1 36.5 18.1 80.3 25.8 45.1 26.0 24.1 25.9 0.9 19.3 48.7 37.8 29.1 29.7 33.4 17.7 26.3 31.6 6.2 33.9 24.9 22.0 28.2 39.7 17.2 20.4 65.0 66.3 29.1 39.1 7.7 33.9 22.1 69.0 68.6 49.9 66.6 42.1 49.3 46.8 47.5 64.1 63.2 48.1 49.9 38.3 62.3 62.6 81.3 78.6 61.9 20.6 22.0 22.6 28.7 20.0 21.7 21.4 21.6 21.3 21.5 22.6 21.9 39.3 9.6 13.9 2.0 41.1 43.1 65.1 153.3 51.8 19.2 100.0 109.6 40.4 90.1 73.8 82.8 10.4 131.9 41.2 138.5 219.2 109.7 188.8 138.1 63.5 44.3 91.7 44.6 2.2 176.7 109.5 43.8 67.8 79.6 24.7 50.8 51.4 211.4 123.9 6.7 2.8 107.3 97.6 122.0 63.5 290.9 30.7 63.7 53.4 1.0 101.0 61.5 87.6 1.5 4.4 123.2 140.1 28.2 41.0 76.8 184.7 286.7 99.3 28.3 13.1 33.9 47.8 141.8 39.4 112.2 58.1 92.8 44.6 89.2 97.7 85.7 CHMP1A "CHMP1, KIAA0047, PCOLN3, PRSM1, Vps46A" ENSG00000131165 "Charged multivesicular body protein 1A" Q9HD42 16 89640816-89657738 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Protein transport, Transcription, Transcription regulation, Transport" Repressor Neurodegeneration "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA006776 Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Centrosome, Cytosol" "HPA006776: AB_1078520" "unprognostic (7.12e-2)" "unprognostic (1.64e-2)" "unprognostic (1.08e-1)" "unprognostic (1.41e-2)" "unprognostic (7.29e-2)" "unprognostic (8.03e-3)" "unprognostic (1.28e-3)" "unprognostic (3.92e-3)" "unprognostic (2.42e-1)" "unprognostic (3.53e-1)" "unprognostic (2.21e-1)" "unprognostic (2.56e-1)" "unprognostic (7.98e-3)" "unprognostic (1.59e-2)" "unprognostic (4.19e-2)" "unprognostic (3.24e-1)" "unprognostic (1.73e-1)" 30.3 31.2 46.3 21.1 44.5 31.4 29.4 41.2 53.4 34.3 36.9 42.7 37.8 35.8 17.0 65.4 31.6 24.8 33.1 46.8 42.7 36.6 30.6 28.7 27.5 45.3 44.3 25.0 25.7 30.4 24.8 24.7 44.0 33.5 23.0 5.4 31.8 22.1 50.0 48.7 42.5 22.4 44.3 31.6 34.0 37.3 45.7 30.5 28.3 25.9 24.3 35.6 36.9 44.2 70.5 66.3 29.5 46.2 42.2 38.2 75.3 53.0 54.3 79.3 38.7 97.1 111.5 37.7 53.2 70.1 52.9 88.3 52.6 69.7 36.7 34.2 82.7 31.0 23.4 108.5 57.8 23.0 31.7 54.7 75.6 74.6 33.8 42.7 41.2 46.2 69.9 18.2 45.6 141.4 55.1 88.3 58.1 78.6 63.5 60.1 58.3 39.8 60.4 43.0 52.7 70.8 103.5 34.3 38.1 27.5 117.6 48.5 63.1 52.7 61.6 65.3 45.8 52.1 59.1 51.1 88.1 54.9 62.5 66.7 51.6 108.9 54.4 62.7 42.0 36.3 43.6 50.1 44.2 33.4 27.5 33.4 86.0 49.8 82.3 49.4 58.5 64.1 46.3 44.5 41.2 53.4 46.8 42.7 45.3 44.3 44.0 44.3 45.7 44.2 31.1 32.1 23.6 17.3 27.5 23.8 24.5 28.8 13.1 24.6 33.9 27.6 16.8 28.6 26.6 31.3 8.4 57.7 43.2 147.3 37.2 55.3 56.4 27.2 26.3 28.3 44.3 16.2 8.8 59.5 74.4 26.9 36.2 35.0 27.9 33.0 23.2 31.1 47.6 43.7 7.9 57.7 30.5 30.4 23.8 125.5 20.5 28.3 23.2 11.2 62.8 36.3 43.3 11.1 9.5 84.7 121.6 24.0 14.8 31.7 109.6 40.9 22.4 20.5 26.3 17.1 27.1 45.4 33.3 26.3 32.5 66.2 28.6 28.8 58.2 36.5 CINP MGC849 ENSG00000100865 "Cyclin dependent kinase 2 interacting protein" Q9BW66 14 102341102-102362916 "Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, DNA replication" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (3.47e-1)" "unprognostic (2.84e-1)" "unprognostic (1.50e-2)" "unprognostic (8.07e-2)" "unprognostic (2.19e-1)" "unprognostic (2.17e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (3.91e-2)" "unprognostic (2.61e-2)" "unprognostic (3.41e-2)" "unprognostic (2.55e-1)" "unprognostic (1.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.46e-1)" "unprognostic (2.40e-1)" "unprognostic (2.71e-1)" 20.9 23.9 27.4 13.3 30.5 28.8 19.8 31.1 32.2 14.3 23.1 18.0 13.6 11.5 21.9 25.2 14.3 15.0 27.8 25.7 28.4 22.6 33.5 15.7 20.3 30.0 28.7 13.7 44.1 19.3 12.6 15.0 30.0 15.9 15.9 4.5 29.8 13.7 31.9 16.9 15.1 17.1 30.3 17.1 23.6 29.2 28.7 19.5 18.3 27.0 17.8 18.2 14.4 33.3 32.1 75.1 29.1 33.3 54.5 71.6 33.4 47.0 61.1 63.3 52.3 50.8 49.6 36.3 45.8 59.4 31.6 52.7 52.0 64.7 57.6 41.6 40.2 26.2 48.0 60.4 46.7 67.2 25.7 54.7 47.5 46.1 52.6 41.9 67.7 34.2 38.5 44.0 57.9 161.2 39.8 36.4 31.2 90.2 74.5 26.2 41.3 47.8 61.5 73.2 30.9 30.2 36.6 60.0 33.6 25.7 71.3 31.5 47.3 36.1 22.0 108.7 42.1 84.9 70.9 63.3 60.4 42.5 41.9 46.1 58.3 55.0 37.5 58.4 34.4 44.1 33.4 35.1 54.3 37.6 31.9 31.5 49.8 38.0 50.8 50.7 41.6 46.4 27.4 30.5 31.1 32.2 25.7 28.4 30.0 28.7 30.0 30.3 28.7 33.3 27.5 28.9 16.2 3.3 19.1 14.0 26.0 37.5 14.2 18.2 25.2 28.1 39.7 15.7 29.0 20.2 12.5 48.5 18.4 19.1 56.7 39.6 59.4 15.4 24.9 28.8 19.7 29.5 4.1 45.2 53.7 27.8 16.3 16.7 19.6 25.8 28.5 43.9 59.8 15.2 3.6 27.1 18.3 25.5 22.2 111.2 29.8 28.1 17.8 0.0 65.8 25.2 35.0 4.0 10.0 42.6 21.9 20.3 36.5 25.9 43.9 82.2 19.8 20.1 32.9 18.0 21.4 90.1 16.1 33.6 15.8 37.1 20.5 33.9 32.9 25.4 CLDN3 "C7orf1, CPE-R2, CPETR2, HRVP1, RVP1" ENSG00000165215 "Claudin 3" O15551 7 73768997-73770270 "Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 263.1;thyroid gland: 116.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 529.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4" "Region enhanced" "Detected in single" "basal ganglia: 1.5" "Region enhanced" "Detected in many" "midbrain: 9.7" HPA014361 Enhanced Supported "Cell Junctions" NA NA "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" "Cell Junctions" "HPA014361: AB_2668982" "unprognostic (1.84e-1)" "unprognostic (4.83e-2)" "unprognostic (2.05e-1)" "unprognostic (5.27e-2)" "unprognostic (2.61e-1)" "unprognostic (1.31e-1)" "unprognostic (2.79e-2)" "unprognostic (8.26e-2)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.28e-3)" "unprognostic (1.42e-1)" "prognostic favorable (3.39e-5)" "unprognostic (1.46e-2)" "unprognostic (1.87e-1)" "unprognostic (5.18e-2)" "unprognostic (6.72e-2)" 0.7 0.2 0.2 7.8 0.3 0.2 26.7 4.2 0.3 12.3 37.6 263.1 54.4 7.5 1.4 1.3 29.6 2.2 0.1 1.1 1.2 46.5 40.4 10.7 0.2 1.3 1.9 0.5 96.6 1.5 27.7 1.0 0.6 58.3 17.5 0.4 72.9 8.3 0.1 9.6 169.5 0.8 0.5 0.2 1.4 0.7 0.9 1.0 116.3 0.0 1.2 1.5 0.2 0.2 2.5 3.6 0.0 0.4 0.0 0.0 17.8 0.0 0.0 0.0 0.0 4.2 35.7 0.0 9.9 0.0 0.0 1.0 0.4 0.0 0.0 0.1 4.9 0.0 0.8 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 230.7 0.4 1.2 2.1 9.1 47.6 0.1 0.0 40.5 2.1 0.2 58.0 0.7 0.0 33.6 0.0 0.2 105.4 0.0 0.2 0.2 0.6 0.9 0.1 0.2 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 4.2 0.3 1.1 1.2 1.3 1.9 0.6 0.5 0.9 0.2 1.6 38.5 37.8 0.0 13.2 0.1 60.3 43.7 0.0 0.7 289.9 182.5 0.6 287.4 86.3 126.9 4.2 63.9 5.1 1839.9 9.8 297.5 0.0 1221.7 130.5 10.3 606.1 5.3 0.0 19.1 17.7 4.1 16.8 1555.7 28.0 1.5 0.4 40.5 5.1 0.0 0.0 1471.3 116.0 0.3 0.0 0.3 2.5 9.9 10.6 0.0 2.0 11.8 0.0 0.0 0.0 36.7 2326.0 0.0 4.4 433.2 3162.1 58.6 498.4 10.6 0.0 0.0 20.3 0.1 0.3 2.7 0.0 72.4 17.5 0.0 1266.0 607.3 CLTB Lcb ENSG00000175416 "Clathrin light chain B" P09497 5 176392501-176416539 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Pancreatic endocrine cells: 1839.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HBEC3-KT: 704.2;MCF7: 641.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003692, HPA036458" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Vesicles "Plasma membrane, Cytosol" "CAB003692: AB_425372, HPA036458: AB_2675136" "unprognostic (1.09e-1)" "unprognostic (1.73e-1)" "unprognostic (4.51e-2)" "unprognostic (1.46e-1)" "unprognostic (1.34e-2)" "unprognostic (1.60e-1)" "unprognostic (3.54e-3)" "unprognostic (1.83e-2)" "unprognostic (1.74e-2)" "unprognostic (1.93e-1)" "unprognostic (7.42e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (7.89e-5)" "unprognostic (3.55e-1)" "unprognostic (7.50e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-2)" 102.9 133.6 125.8 50.1 125.1 40.6 82.9 117.8 176.7 180.4 125.3 133.9 92.3 85.9 23.2 473.7 82.4 34.1 320.8 130.8 129.6 90.4 82.5 96.5 32.9 136.9 122.8 107.2 68.2 70.1 112.8 57.5 138.1 88.1 45.5 37.9 128.6 44.4 322.5 453.1 99.7 41.2 114.5 68.7 123.3 38.9 127.9 43.7 69.5 120.8 58.5 106.2 300.8 133.6 229.1 107.6 29.9 128.2 65.7 49.2 244.4 286.3 110.9 178.6 127.0 140.3 103.9 49.6 165.0 130.2 71.8 213.3 51.4 704.2 69.7 341.7 95.3 33.6 163.3 87.7 102.9 53.2 85.6 52.6 241.5 98.1 114.7 36.0 84.7 39.2 65.2 123.4 100.3 641.9 84.5 81.1 24.4 189.5 158.2 91.3 52.9 165.2 95.6 92.0 127.7 43.7 136.6 148.0 103.6 34.7 61.4 101.9 185.2 64.0 96.3 117.5 165.1 96.5 73.3 68.5 51.4 112.7 74.4 6.6 19.7 61.7 13.6 15.8 7.0 5.9 11.9 13.2 20.0 10.1 10.0 10.0 36.6 15.0 20.8 16.1 24.9 8.1 125.8 125.1 117.8 176.7 130.8 129.6 136.9 122.8 138.1 114.5 127.9 133.6 113.7 57.7 19.8 8.5 54.7 634.0 238.7 155.7 180.4 310.5 105.5 124.6 208.5 72.9 93.4 82.8 64.6 141.1 82.3 794.5 135.0 324.7 9.5 58.4 72.7 102.2 151.8 43.6 25.4 453.1 586.9 136.7 193.2 85.2 48.2 40.8 70.3 96.3 111.9 336.5 24.1 348.5 114.0 80.7 226.1 13.7 122.1 88.4 220.5 6.5 85.7 136.1 107.1 8.0 15.2 1839.9 786.9 129.8 76.4 391.4 545.7 269.7 49.6 64.3 78.9 79.6 161.4 15.9 29.1 415.6 803.0 386.5 81.3 151.2 289.7 436.0 CLTC "CLTCL2, Hc" ENSG00000141367 "Clathrin heavy chain" Q00610 17 59619689-59696956 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Cell cycle, Cell division, Mitosis" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010389, CAB011571, CAB017155, HPA059143" Approved Enhanced "Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol" Yes No 14000000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Vesicles, Endosomes, Lysosomes" "Mitotic spindle, Cytosol" "CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924" "unprognostic (1.56e-1)" "prognostic unfavorable (7.35e-4)" "prognostic favorable (7.65e-4)" "unprognostic (1.03e-1)" "unprognostic (2.62e-1)" "unprognostic (5.23e-3)" "prognostic unfavorable (5.54e-4)" "unprognostic (1.11e-1)" "unprognostic (6.43e-2)" "unprognostic (1.09e-1)" "unprognostic (3.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.02e-4)" 105.4 95.2 42.1 89.7 54.9 96.3 81.6 67.3 103.9 92.3 36.7 121.7 74.1 83.1 126.4 82.1 67.8 88.9 90.7 60.7 65.1 125.5 117.7 82.1 75.5 95.5 52.4 73.2 56.8 186.8 51.6 139.6 95.2 97.8 128.3 163.6 68.6 104.2 88.4 81.3 73.3 121.0 43.8 78.8 91.2 71.3 68.2 76.0 114.1 83.9 86.8 101.1 51.6 55.0 293.3 426.1 207.6 207.0 345.8 280.5 240.0 305.7 321.7 268.2 278.9 264.7 175.2 200.6 340.1 436.4 296.9 186.2 313.6 255.1 356.2 214.4 166.8 328.2 248.8 414.0 262.3 228.5 182.3 266.9 154.6 408.0 262.3 211.4 302.0 99.9 334.4 280.4 429.1 511.1 135.6 65.1 179.6 263.3 248.2 118.7 343.6 244.9 297.5 404.1 184.1 216.7 188.3 122.9 180.4 270.5 290.3 142.3 385.6 492.4 287.9 237.0 317.8 213.3 320.3 181.4 357.7 151.6 305.3 16.6 33.1 21.3 17.5 36.3 21.7 13.7 16.1 19.2 36.5 12.9 13.4 15.0 19.9 18.9 32.5 22.8 22.1 23.3 42.1 54.9 67.3 103.9 60.7 65.1 95.5 52.4 95.2 43.8 68.2 55.0 62.6 99.3 107.9 80.3 46.3 63.9 44.4 75.6 28.5 91.9 58.5 34.7 77.9 71.4 103.3 77.3 60.5 109.1 60.7 184.0 27.4 76.2 23.3 95.5 95.6 79.7 120.6 115.9 137.7 97.7 47.7 84.5 99.4 106.1 68.4 75.5 120.7 185.4 182.5 85.8 135.9 120.7 77.3 195.0 93.2 77.2 74.0 128.3 53.4 79.6 102.8 53.9 38.1 73.4 124.2 106.2 76.1 93.6 83.0 86.3 102.7 132.4 128.0 65.2 78.9 66.0 82.8 52.7 38.0 60.5 79.3 107.9 45.9 81.3 127.8 91.6 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329356-99394330 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.7;testis: 9.8" "Cell type enhanced" "Detected in many" "Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.2 1.1 9.9 0.2 9.9 0.0 0.5 5.4 16.7 1.8 0.0 0.7 0.4 0.9 1.7 0.8 1.0 0.3 0.1 7.3 7.3 1.7 0.2 0.1 0.0 3.6 2.9 2.6 1.1 0.6 3.6 0.0 3.5 1.7 0.4 5.2 0.8 0.8 0.0 1.2 0.6 0.4 2.0 0.1 0.6 9.8 4.7 0.1 0.1 0.1 0.1 1.7 1.4 10.1 0.0 19.6 0.0 0.0 0.0 0.0 0.0 2.8 7.4 6.7 11.3 0.0 4.4 0.0 0.0 1.4 0.1 1.7 8.7 0.0 4.8 0.0 0.9 1.9 2.8 3.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 4.3 0.0 0.1 0.0 0.0 0.4 2.7 0.3 0.0 0.9 7.7 0.8 0.0 0.0 0.0 0.9 0.0 2.2 6.1 2.0 0.4 1.0 0.5 0.0 0.0 0.0 0.6 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 9.9 5.4 16.7 7.3 7.3 3.6 2.9 3.5 2.0 4.7 10.1 0.6 0.0 0.0 4.6 0.0 2.3 3.3 0.1 5.2 25.3 0.7 2.8 1.4 0.0 0.2 1.8 14.6 0.0 0.0 0.0 0.0 0.6 103.1 0.5 1.0 0.4 0.0 0.8 69.9 1.5 0.0 1.0 0.0 0.3 0.0 0.2 1.8 0.0 0.0 50.5 89.5 0.1 0.0 0.0 0.8 88.0 2.1 0.3 1.8 4.7 0.1 1.3 0.0 10.6 2.2 2.0 0.3 2.6 0.0 5.9 0.1 0.7 0.6 3.4 0.0 2.0 0.5 1.9 1.6 1.5 1.0 0.0 0.2 1.2 0.1 2.4 CNPPD1 "C2orf24, CGI-57" ENSG00000115649 "Cyclin Pas1/PHO80 domain containing 1" Q9BV87 2 219171897-219178106 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049303 Uncertain NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" "HPA049303: AB_2680703" "unprognostic (9.24e-2)" "unprognostic (4.12e-2)" "unprognostic (1.09e-1)" "unprognostic (9.43e-2)" "unprognostic (3.68e-2)" "unprognostic (5.74e-3)" "prognostic unfavorable (2.04e-4)" "unprognostic (1.77e-1)" "unprognostic (4.15e-3)" "unprognostic (5.54e-3)" "unprognostic (8.53e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.62e-10)" "unprognostic (1.48e-2)" "unprognostic (1.51e-1)" "unprognostic (2.62e-2)" "unprognostic (2.54e-2)" 62.0 90.8 43.0 41.4 50.4 78.6 51.6 51.5 46.9 45.7 36.8 70.3 58.9 46.2 37.2 81.2 39.2 27.9 67.2 41.9 47.0 91.0 49.3 41.3 54.3 52.4 49.3 48.2 53.3 89.3 24.7 30.1 51.4 46.8 43.9 16.5 52.2 41.4 97.2 70.8 69.9 34.4 49.4 71.7 54.0 42.1 47.0 43.6 60.2 57.1 51.7 55.3 47.5 56.7 43.3 32.0 31.5 58.3 63.5 31.7 44.8 54.7 32.0 44.5 35.4 69.3 52.3 24.5 31.5 53.6 35.5 59.1 42.0 44.2 25.9 63.3 24.6 100.1 34.2 69.5 77.7 59.4 66.5 33.8 55.8 44.0 39.2 39.9 37.7 65.4 81.3 89.5 26.1 78.7 65.3 45.2 20.2 49.9 40.4 96.0 23.3 83.6 69.3 59.7 40.8 48.8 31.4 77.8 59.2 34.1 62.3 67.2 35.9 36.2 33.8 71.6 52.7 70.4 29.9 52.8 48.9 70.2 23.7 82.6 63.4 65.5 53.2 95.2 46.3 79.4 51.6 54.2 97.6 87.7 35.5 39.9 76.4 56.9 122.3 53.4 73.2 79.4 43.0 50.4 51.5 46.9 41.9 47.0 52.4 49.3 51.4 49.4 47.0 56.7 23.4 19.2 17.7 6.2 61.4 13.5 14.0 32.9 19.4 11.8 24.0 23.4 24.8 34.3 23.7 42.3 4.2 31.9 46.3 90.8 56.7 36.7 1.9 12.4 16.4 22.1 28.9 46.3 4.2 33.3 21.3 22.8 26.0 27.4 13.3 12.7 26.4 23.7 37.7 11.8 5.6 48.9 38.7 45.2 29.0 4.7 22.4 36.1 21.4 10.3 85.8 28.0 55.6 5.5 13.4 39.9 45.6 21.1 34.3 23.1 73.9 64.2 11.5 12.1 19.7 11.5 21.8 26.5 33.5 28.5 15.9 55.0 38.6 19.1 42.9 16.0 CNTN1 "F3, GP135" ENSG00000018236 "Contactin 1" Q12860 12 40692439-41072415 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Notch signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 158.2" "Group enriched" "Detected in many" 5 "Astrocytes: 763.9;Excitatory neurons: 844.8;Inhibitory neurons: 699.0;Oligodendrocyte precursor cells: 1021.4" "Cancer enhanced" "Detected in many" "glioma: 17.4" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 224.4;HaCaT: 40.3;SCLC-21H: 68.5;SH-SY5Y: 40.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025200, HPA070467" Enhanced Approved "Intracellular and membrane" NA NA 450000000 "Cluster 17: Basophils - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "CAB025200: , HPA070467: AB_2732156" "unprognostic (3.18e-2)" "unprognostic (5.96e-3)" "unprognostic (3.66e-2)" "unprognostic (7.34e-2)" "unprognostic (2.00e-1)" "unprognostic (2.00e-1)" "unprognostic (1.54e-1)" "unprognostic (2.05e-1)" "unprognostic (9.13e-2)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (1.86e-1)" "unprognostic (1.32e-2)" "unprognostic (8.15e-4)" "unprognostic (6.98e-2)" "unprognostic (5.46e-2)" "prognostic unfavorable (3.75e-4)" 3.9 33.2 64.0 2.5 75.3 0.2 8.8 119.4 84.2 14.1 0.0 3.1 1.7 11.5 2.6 9.1 2.2 11.7 0.8 93.6 59.8 12.4 1.2 4.4 4.5 72.6 94.7 49.2 6.0 1.4 10.4 0.3 70.0 27.8 3.8 26.8 5.4 27.7 0.8 12.8 3.0 10.6 129.0 8.2 5.0 9.4 79.2 1.0 1.2 1.6 3.9 21.5 6.6 158.2 0.1 224.4 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.1 0.0 0.3 0.3 0.1 0.1 0.0 0.0 40.3 6.0 11.2 0.0 0.2 2.4 0.0 0.7 0.0 0.0 0.0 0.7 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.4 0.0 0.2 1.5 0.2 0.1 0.0 1.0 0.3 0.0 0.0 68.5 40.3 0.1 2.5 2.7 1.0 0.1 0.6 0.0 0.1 4.3 0.1 10.0 2.8 0.1 0.0 0.3 0.0 0.9 2.6 0.5 0.7 0.3 0.2 0.3 0.4 0.2 0.2 0.1 0.4 0.4 0.2 1.2 0.7 0.4 0.9 0.2 0.0 64.0 75.3 119.4 84.2 93.6 59.8 72.6 94.7 70.0 129.0 79.2 158.2 0.3 0.0 5.9 763.9 0.1 5.2 1.1 1.6 4.0 32.1 0.4 1.8 0.7 0.0 4.5 5.5 29.2 0.0 0.0 0.0 1.9 0.0 34.9 4.3 7.1 0.7 0.0 0.0 844.8 0.0 0.0 13.3 0.0 0.3 0.0 5.0 0.0 0.0 0.1 11.8 699.0 0.0 2.0 0.0 4.0 149.5 62.7 0.1 10.6 54.4 0.0 34.6 0.0 1021.4 23.9 0.7 0.0 60.2 0.0 0.3 0.0 0.0 0.4 5.9 0.0 0.5 3.6 0.6 0.8 2.1 13.5 0.0 0.5 0.3 0.0 0.2 COG7 ENSG00000168434 "Component of oligomeric golgi complex 7" P83436 16 23388493-23453189 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040758, HPA041824, HPA064645" Uncertain Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA040758: AB_2677120, HPA041824: , HPA064645: AB_2685311" "unprognostic (1.72e-1)" "unprognostic (1.02e-2)" "unprognostic (8.21e-2)" "prognostic favorable (6.95e-4)" "unprognostic (3.71e-1)" "unprognostic (2.15e-1)" "unprognostic (5.95e-2)" "unprognostic (2.70e-2)" "unprognostic (3.10e-1)" "unprognostic (4.15e-1)" "unprognostic (6.07e-3)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-4)" "unprognostic (3.77e-1)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 8.7 13.1 9.2 7.2 8.7 9.8 10.3 7.5 10.0 14.9 16.7 13.2 8.3 10.9 11.2 12.1 15.0 8.4 10.0 8.6 8.6 12.7 9.5 10.0 6.8 8.8 9.4 13.4 10.2 16.3 23.8 7.5 9.1 16.2 11.8 13.8 13.4 10.4 9.8 12.2 10.5 8.6 7.4 9.8 12.7 10.0 8.8 8.1 14.6 6.4 7.2 11.4 12.2 10.7 10.2 19.5 11.9 13.5 10.4 16.9 10.8 11.2 14.1 12.9 12.9 8.3 17.6 4.8 11.6 17.8 8.2 15.2 10.8 13.8 9.8 15.7 16.3 5.0 15.3 22.2 11.0 13.9 14.2 11.0 11.0 9.9 10.4 16.0 15.2 15.7 12.2 13.6 10.5 29.9 9.3 10.2 10.7 15.7 9.3 18.7 10.3 17.3 14.0 10.0 7.2 9.2 12.6 14.2 9.7 8.9 21.0 17.8 10.7 14.3 7.5 13.4 8.2 12.4 14.1 6.5 19.1 8.1 14.0 8.4 6.7 7.3 6.0 7.7 7.6 3.9 5.5 5.7 8.0 4.6 5.6 8.5 1.6 5.6 10.0 5.7 7.0 4.9 9.2 8.7 7.5 10.0 8.6 8.6 8.8 9.4 9.1 7.4 8.8 10.7 8.0 25.6 16.9 30.3 6.2 6.6 10.1 13.7 10.2 10.1 12.0 12.2 7.2 8.6 19.9 12.9 31.3 12.5 5.5 19.4 1.9 12.0 5.0 24.4 10.8 7.7 19.2 10.8 39.7 13.8 7.6 9.8 27.5 14.2 8.2 13.1 6.1 6.0 6.4 11.8 39.8 19.3 8.2 4.0 2.3 3.6 9.9 7.7 8.8 19.7 4.4 9.2 5.2 45.8 40.6 12.9 11.3 12.4 7.2 9.3 11.6 8.7 39.1 22.4 13.1 10.1 8.6 16.5 13.3 9.1 5.4 11.8 8.9 7.2 15.9 10.7 COMMD5 "FLJ13008, HCaRG, HT002" ENSG00000170619 "COMM domain containing 5" Q9GZQ3 8 144841042-144853736 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046905 Supported Nucleoplasm,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "Nucleoplasm, Cytosol" "HPA046905: AB_2732535" "unprognostic (2.95e-2)" "unprognostic (7.62e-2)" "unprognostic (2.63e-1)" "unprognostic (1.16e-1)" "unprognostic (1.36e-1)" "unprognostic (9.13e-2)" "unprognostic (5.05e-3)" "unprognostic (6.82e-2)" "unprognostic (3.24e-1)" "unprognostic (9.35e-2)" "unprognostic (2.25e-1)" "unprognostic (7.97e-3)" "unprognostic (1.25e-2)" "unprognostic (8.58e-2)" "unprognostic (3.43e-1)" "unprognostic (2.02e-1)" "unprognostic (7.73e-3)" 17.0 22.9 16.6 11.9 17.0 21.2 15.7 18.1 19.7 14.9 15.6 15.6 12.1 16.1 9.7 20.1 14.2 11.3 18.9 16.2 16.3 18.7 23.2 15.1 16.2 18.1 16.9 12.8 16.7 14.5 17.7 11.0 17.5 16.4 6.8 3.8 15.5 10.7 18.2 16.8 14.9 8.8 17.3 21.9 16.4 11.2 17.2 11.3 16.4 11.4 10.6 15.9 14.3 18.7 32.8 38.3 17.9 24.2 21.8 17.4 16.0 18.5 19.7 30.9 24.2 23.0 25.1 22.3 40.4 22.6 17.9 21.7 22.5 30.6 13.2 29.6 31.7 47.1 35.3 38.8 28.8 16.0 39.6 23.1 27.6 21.2 15.7 15.0 24.2 7.9 34.2 39.8 25.2 59.4 14.6 16.8 27.1 45.6 75.3 18.8 20.4 34.8 30.2 28.3 41.6 36.6 30.9 18.5 27.4 11.9 36.3 29.7 22.4 23.1 45.9 33.3 36.8 16.6 19.2 21.3 32.5 29.7 30.5 66.1 84.3 76.6 55.8 72.4 49.8 60.7 42.4 54.9 74.2 54.1 41.6 46.7 52.3 69.2 47.0 26.8 71.2 70.1 16.6 17.0 18.1 19.7 16.2 16.3 18.1 16.9 17.5 17.3 17.2 18.7 27.8 12.8 15.0 8.5 27.5 27.8 20.4 46.4 11.4 12.3 22.8 23.9 10.9 21.5 25.0 16.5 12.5 35.8 39.0 26.4 39.2 46.4 3.5 19.6 16.4 27.6 19.9 14.1 6.2 40.1 23.8 22.7 13.7 18.6 24.8 15.6 25.7 19.0 70.0 11.8 7.7 16.8 34.6 31.4 27.6 2.5 18.6 34.2 26.6 5.6 37.2 22.3 38.1 6.6 9.5 50.0 18.4 23.3 20.3 42.7 29.8 44.6 28.2 15.2 13.1 16.0 24.6 12.1 17.2 18.4 30.0 33.1 27.0 28.7 18.9 28.5 COMT ENSG00000093010 Catechol-O-methyltransferase P21964 22 19941371-19969975 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Catecholamine metabolism, Neurotransmitter degradation" "Methyltransferase, Transferase" "FDA approved drug targets, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 885.9;Syncytiotrophoblasts: 648.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 818.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001169, CAB011233" Enhanced Enhanced "Endoplasmic reticulum,Vesicles" NA NA 43000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 15: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Endoplasmic reticulum" "CAB011233: , HPA001169: AB_1078402" "unprognostic (5.20e-2)" "unprognostic (2.73e-2)" "unprognostic (3.08e-2)" "prognostic favorable (3.68e-4)" "unprognostic (2.99e-2)" "unprognostic (2.32e-3)" "unprognostic (5.54e-3)" "unprognostic (9.14e-2)" "unprognostic (1.39e-1)" "unprognostic (1.40e-1)" "unprognostic (2.14e-3)" "prognostic favorable (5.67e-4)" "prognostic unfavorable (9.76e-4)" "unprognostic (2.27e-1)" "unprognostic (7.09e-2)" "unprognostic (3.97e-1)" "unprognostic (1.07e-2)" 78.1 180.7 99.3 39.6 108.9 71.8 85.5 114.4 140.4 105.3 119.6 80.1 55.0 76.9 47.7 198.0 65.2 60.3 81.7 96.6 107.4 94.2 292.3 93.3 49.7 117.4 107.9 107.4 74.0 61.5 48.7 116.9 117.3 87.2 20.7 17.2 133.7 70.5 98.6 119.7 64.1 38.3 109.2 63.6 99.8 51.7 102.7 26.9 59.1 49.9 26.0 86.9 124.1 124.3 131.3 131.7 15.0 128.3 141.2 122.5 6.0 143.9 178.8 120.3 133.6 112.1 148.6 51.7 62.7 208.9 48.6 172.9 23.6 152.0 26.2 115.1 163.4 92.5 65.1 267.1 265.1 155.0 35.3 159.2 180.7 104.3 101.3 116.6 113.2 82.0 383.2 109.4 100.6 818.5 63.4 267.9 32.4 361.1 42.9 88.2 127.9 72.8 129.0 404.5 60.4 53.8 47.7 405.7 125.7 7.6 84.0 436.6 137.5 212.7 82.2 71.0 109.6 37.5 18.0 41.2 236.0 211.3 152.5 62.2 312.2 59.6 77.9 218.1 64.0 56.8 52.6 62.6 251.5 57.8 45.5 51.7 12.0 73.5 151.5 291.4 72.6 178.6 99.3 108.9 114.4 140.4 96.6 107.4 117.4 107.9 117.3 109.2 102.7 124.3 99.1 125.0 88.1 22.9 33.1 102.1 231.9 248.1 188.4 73.4 174.9 218.4 41.9 104.4 162.7 152.6 10.4 885.9 80.1 53.0 320.8 201.0 4.6 59.1 72.2 86.7 84.5 70.0 16.8 193.0 113.5 103.1 46.4 46.9 71.7 95.7 77.1 262.0 311.4 25.2 17.2 97.7 191.2 177.0 107.7 13.3 134.2 137.0 240.1 20.6 137.0 158.7 41.2 25.1 45.7 170.2 108.8 179.8 45.5 132.4 179.9 73.8 135.8 43.2 138.1 143.3 113.1 8.4 5.7 236.4 123.5 648.5 41.8 222.0 122.3 206.6 COPS6 "CSN6, MOV34-34KD" ENSG00000168090 "COP9 signalosome subunit 6" Q7L5N1 7 100088969-100092187 "Enzymes, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044315 Approved Supported Nucleoplasm "Intracellular and membrane" NA NA 110000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA044315: AB_10959750" "unprognostic (1.48e-2)" "unprognostic (2.43e-2)" "unprognostic (6.56e-3)" "unprognostic (1.38e-1)" "unprognostic (5.84e-2)" "unprognostic (2.09e-2)" "unprognostic (3.62e-3)" "unprognostic (2.93e-2)" "unprognostic (2.00e-1)" "unprognostic (2.45e-2)" "unprognostic (4.96e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (6.72e-4)" "unprognostic (1.20e-1)" "unprognostic (3.58e-2)" "unprognostic (8.57e-2)" "unprognostic (8.77e-2)" 71.3 85.5 98.5 48.7 103.0 51.8 68.6 102.5 102.0 87.1 99.5 101.3 44.1 86.5 84.0 90.6 78.1 52.9 112.9 101.9 100.7 70.8 71.6 56.5 50.3 99.3 98.4 74.8 60.2 100.8 79.2 64.0 100.4 68.8 57.8 61.4 65.0 74.2 147.3 61.8 58.4 78.5 101.7 63.1 78.4 57.4 98.7 63.1 61.5 152.8 60.6 90.5 74.7 105.0 167.6 233.4 136.2 163.5 116.1 138.4 86.6 147.7 223.5 239.7 174.9 191.9 153.8 114.4 186.1 242.2 267.3 124.1 155.1 247.9 240.4 114.9 242.6 98.2 215.9 149.3 243.3 112.1 97.6 137.5 161.4 259.2 273.9 159.5 333.0 172.7 142.7 160.5 286.4 413.7 251.6 164.8 124.0 241.3 273.2 117.6 226.6 275.4 193.6 153.8 213.4 158.6 152.7 298.5 114.1 176.4 123.7 109.2 177.9 231.3 211.1 280.5 264.8 118.1 140.2 235.3 175.5 150.0 350.6 231.8 187.8 168.2 178.8 206.6 180.7 168.0 176.8 170.9 211.3 170.3 137.4 153.6 73.5 163.5 194.6 157.8 225.8 146.6 98.5 103.0 102.5 102.0 101.9 100.7 99.3 98.4 100.4 101.7 98.7 105.0 87.8 51.3 44.2 24.8 73.4 110.6 118.1 208.1 70.0 108.3 62.8 76.3 166.3 88.6 117.2 86.5 52.1 197.3 84.2 55.1 211.3 138.3 76.5 61.6 103.4 94.9 75.3 69.0 20.9 113.5 133.7 116.0 52.5 48.3 90.7 100.5 90.3 63.2 128.8 95.9 21.0 67.4 158.7 69.6 82.5 197.1 127.7 55.1 156.5 13.1 101.4 147.0 115.4 17.6 24.0 115.1 64.7 125.3 84.3 95.0 84.2 214.2 117.9 127.1 98.6 76.3 261.5 80.5 100.2 81.2 100.3 137.9 82.7 137.9 87.1 96.1 CORO1B coronin-2 ENSG00000172725 "Coronin 1B" Q9BR76 11 67435510-67443821 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 301.4;Paneth cells: 324.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "non-classical monocyte: 221.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017616, HPA040113, HPA070456" Enhanced Supported "Plasma membrane,Cytosol" NA NA 960000 "Cluster 51: Monocytes - Innate immune response" "Cluster 4: Stomach - Digestion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268" "unprognostic (1.94e-1)" "unprognostic (2.40e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.65e-4)" "unprognostic (1.02e-1)" "unprognostic (8.23e-3)" "unprognostic (1.49e-3)" "unprognostic (7.22e-2)" "unprognostic (1.86e-1)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-2)" "unprognostic (8.58e-3)" "unprognostic (1.85e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (6.64e-3)" 54.4 56.4 20.2 29.7 23.8 20.3 53.4 23.4 27.0 55.7 21.1 70.2 62.9 72.8 14.6 80.2 54.2 44.1 26.1 19.4 22.7 48.2 47.2 53.7 41.9 28.0 23.6 42.7 52.5 24.6 35.1 31.2 25.1 71.0 34.5 6.6 73.2 39.6 13.0 42.4 62.3 36.7 24.2 66.0 77.1 13.9 25.1 21.1 55.8 9.9 18.4 58.3 53.5 26.3 80.9 81.4 37.5 76.0 94.1 81.3 56.6 58.5 118.0 94.2 70.8 134.1 116.0 6.4 111.3 80.8 95.8 67.9 41.9 74.9 16.8 19.4 40.7 54.9 47.3 57.9 148.1 2.3 120.8 110.6 66.3 80.1 37.2 59.7 120.7 49.4 42.7 9.2 54.2 238.4 14.4 11.2 47.7 198.2 73.4 11.2 41.0 14.9 62.6 104.3 40.7 50.8 52.4 139.6 181.6 26.0 178.5 63.0 92.2 63.4 47.4 87.4 35.2 1.6 3.3 14.6 103.4 8.2 66.4 57.3 102.8 8.0 10.9 212.9 8.3 20.0 37.6 14.6 79.0 11.0 21.2 11.4 47.8 11.9 221.8 60.8 55.2 57.8 20.2 23.8 23.4 27.0 19.4 22.7 28.0 23.6 25.1 24.2 25.1 26.3 58.7 3.2 2.2 4.6 53.4 27.9 60.1 90.8 40.9 13.0 53.8 39.0 1.6 50.1 66.4 47.8 8.4 87.8 39.2 301.4 60.7 111.4 8.9 43.6 32.9 52.0 99.0 19.8 1.8 105.0 229.8 35.8 111.1 64.8 28.0 46.7 47.8 22.4 251.8 15.2 2.4 188.6 81.4 138.6 66.4 5.0 39.4 96.3 71.2 10.3 195.3 30.0 41.2 4.5 6.8 136.9 324.9 34.6 64.3 55.6 263.5 84.0 41.2 14.6 52.6 22.1 55.1 8.1 6.6 47.6 31.0 150.5 100.3 54.8 128.0 74.5 COX11 COX11P ENSG00000166260 "Cytochrome c oxidase copper chaperone COX11" Q9Y6N1 17 54951902-54968703 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 162.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044020 Approved NA NA "Cluster 24: B-cells - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA044020: AB_2678777" "unprognostic (1.42e-1)" "unprognostic (6.59e-2)" "prognostic favorable (4.30e-4)" "unprognostic (3.13e-1)" "unprognostic (5.37e-2)" "unprognostic (1.63e-2)" "unprognostic (4.69e-2)" "unprognostic (2.85e-2)" "unprognostic (4.11e-2)" "unprognostic (8.12e-3)" "unprognostic (8.18e-2)" "unprognostic (3.65e-2)" "unprognostic (2.02e-3)" "unprognostic (2.69e-2)" "unprognostic (9.25e-2)" "unprognostic (6.29e-2)" "unprognostic (7.85e-2)" 14.3 15.8 6.8 7.3 8.0 1.3 14.6 9.1 9.5 15.7 8.8 18.7 31.3 16.9 8.1 12.1 16.4 5.4 17.0 6.6 6.8 26.2 28.3 14.7 7.5 6.1 7.1 16.4 7.4 7.1 13.5 4.7 6.8 17.0 7.2 20.4 13.6 7.0 33.4 13.4 18.5 5.2 6.8 7.8 12.4 10.1 7.7 4.6 16.5 7.6 5.7 17.3 13.4 8.5 14.6 52.7 12.5 15.8 7.4 9.0 13.1 15.1 2.9 6.8 6.5 34.8 6.7 22.1 27.3 5.9 9.7 12.1 8.4 5.0 8.2 37.8 31.9 21.8 35.9 44.0 2.8 14.6 5.0 7.8 3.2 7.2 3.5 7.3 4.0 15.1 13.2 7.7 10.5 26.9 21.9 7.7 7.6 9.7 30.1 15.8 22.3 13.4 10.6 19.9 16.2 22.0 14.0 9.4 9.7 8.1 20.0 5.0 13.2 18.2 9.6 16.5 24.0 15.1 21.4 16.5 14.9 8.4 10.1 3.7 3.3 4.6 4.3 5.0 5.7 5.6 6.6 5.0 6.6 7.9 5.6 6.9 0.2 3.4 2.4 2.6 7.9 3.7 6.8 8.0 9.1 9.5 6.6 6.8 6.1 7.1 6.8 6.8 7.7 8.5 29.2 25.6 23.4 24.5 29.5 31.5 44.9 47.1 32.5 53.1 17.5 17.8 35.0 32.9 22.2 20.2 70.9 38.5 22.9 25.0 162.4 42.6 63.8 27.9 26.7 28.1 43.3 24.6 33.8 44.2 31.2 31.5 19.4 16.6 20.3 22.8 36.4 33.2 26.7 35.3 30.1 27.6 28.5 23.3 33.7 18.4 54.3 16.7 35.6 11.2 25.4 45.7 35.0 26.7 28.3 29.5 32.1 59.0 26.1 15.6 50.4 118.7 24.4 73.0 72.3 34.0 42.7 81.6 50.5 20.3 27.1 17.5 35.3 35.0 62.8 23.9 COX17 ENSG00000138495 "Cytochrome c oxidase copper chaperone COX17" Q14061 3 119654513-119677454 "Cancer-related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA042226, HPA048158" Supported Supported Mitochondria NA NA 220000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria "HPA042226: AB_2677911, HPA048158: AB_2680292" "unprognostic (1.98e-2)" "unprognostic (3.49e-2)" "unprognostic (1.96e-2)" "unprognostic (8.29e-2)" "unprognostic (2.88e-2)" "unprognostic (6.63e-3)" "unprognostic (3.49e-2)" "unprognostic (2.90e-1)" "unprognostic (1.36e-1)" "unprognostic (7.11e-3)" "unprognostic (2.12e-1)" "unprognostic (4.45e-2)" "unprognostic (1.33e-2)" "unprognostic (2.15e-2)" "unprognostic (1.65e-1)" "unprognostic (9.19e-2)" "unprognostic (2.64e-2)" 81.6 178.5 106.5 77.1 111.2 113.3 68.8 117.5 122.4 50.3 149.2 90.2 90.2 41.2 114.1 55.9 47.3 59.4 279.9 105.5 123.6 94.7 172.7 62.3 110.4 115.8 115.3 31.5 102.0 412.1 119.2 63.9 115.7 78.6 78.7 120.6 80.8 90.7 401.4 43.3 88.5 62.9 112.5 64.9 107.5 44.4 113.0 106.6 94.4 363.9 89.8 75.9 35.7 118.6 219.6 257.0 122.7 33.3 53.4 53.1 45.7 130.5 84.2 127.3 133.4 226.4 157.7 164.6 158.0 72.1 174.8 84.0 138.5 154.9 74.9 205.5 155.9 145.0 195.3 180.1 63.1 205.0 246.7 56.6 142.7 77.9 106.0 82.2 87.9 200.8 122.4 370.7 155.4 410.2 212.8 283.5 133.8 212.2 413.3 88.3 82.3 273.7 203.2 141.0 210.5 86.4 153.1 137.1 189.7 76.9 180.5 313.0 66.6 91.3 144.9 59.8 168.4 257.5 348.9 361.1 129.0 157.8 164.2 591.4 241.1 630.6 218.1 357.5 208.1 378.3 241.7 230.3 252.8 320.4 189.1 187.0 174.4 213.6 487.3 538.7 352.6 260.1 106.5 111.2 117.5 122.4 105.5 123.6 115.8 115.3 115.7 112.5 113.0 118.6 194.5 157.0 167.1 5.2 161.5 94.1 132.8 267.9 46.7 108.9 153.8 147.2 622.8 238.8 202.4 498.4 43.8 137.4 116.7 385.3 716.1 264.0 115.0 282.4 64.3 164.7 214.2 162.9 3.8 413.7 193.9 99.3 150.3 178.8 309.3 70.2 116.0 779.8 216.1 75.7 5.6 327.8 427.2 181.8 281.2 39.9 91.0 190.8 277.5 11.2 345.7 178.8 137.0 8.5 8.8 459.7 512.8 136.9 176.5 198.2 434.6 786.2 280.2 174.4 184.1 112.9 171.6 286.0 159.2 85.4 125.4 211.0 129.0 49.6 151.1 199.0 COX7C ENSG00000127184 "Cytochrome c oxidase subunit 7C" P15954 5 86617928-86620962 "Metabolic proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 2380.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 4586.0;Distal tubular cells: 4724.9;Proximal tubular cells: 5650.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046647 Approved NA NA 39000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA046647: AB_2679736" "unprognostic (1.45e-1)" "unprognostic (1.74e-2)" "unprognostic (9.10e-2)" "unprognostic (2.86e-1)" "unprognostic (2.85e-1)" "unprognostic (8.08e-2)" "unprognostic (1.04e-1)" "unprognostic (3.70e-1)" "unprognostic (4.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.90e-2)" "unprognostic (1.21e-1)" "prognostic favorable (1.23e-5)" "unprognostic (4.56e-2)" "unprognostic (2.06e-1)" "unprognostic (1.46e-1)" "unprognostic (4.46e-2)" 338.6 433.9 600.9 274.3 610.7 314.7 324.9 620.1 771.4 329.2 657.2 563.0 545.8 271.8 402.9 420.1 288.0 194.7 1546.9 609.6 648.8 715.2 621.3 243.3 314.5 619.9 616.5 392.7 382.2 781.1 402.4 196.2 613.5 305.4 398.2 236.6 459.7 253.1 2380.2 274.3 537.4 207.5 614.4 270.0 429.7 174.6 624.6 370.8 328.0 1599.4 319.8 344.4 315.0 614.7 576.6 687.2 595.1 1043.0 551.4 550.5 653.4 432.8 364.4 298.2 416.7 806.4 989.9 794.6 459.2 342.3 799.3 594.8 539.3 876.2 487.2 585.2 829.5 623.6 1006.0 844.4 458.9 732.2 692.1 648.0 745.3 377.5 518.0 841.6 486.3 687.0 392.7 860.9 443.7 1209.9 766.2 954.2 594.7 593.0 1958.6 728.4 654.3 1426.2 909.4 1129.8 700.4 518.2 406.7 946.9 973.0 646.9 963.0 1008.6 449.2 254.2 470.5 448.4 846.6 832.8 1056.8 903.4 652.5 860.4 491.6 344.5 526.0 414.6 399.1 558.3 500.0 682.6 620.5 497.6 668.6 567.2 648.4 579.2 52.3 404.7 538.3 619.0 606.5 996.5 600.9 610.7 620.1 771.4 609.6 648.8 619.9 616.5 613.5 614.4 624.6 614.7 408.8 512.8 732.9 33.0 879.5 723.5 946.8 1663.7 715.4 276.2 1141.9 1079.4 4586.0 1574.2 959.9 1213.8 156.4 1271.2 657.5 1604.6 4724.9 1314.8 1011.8 856.3 538.7 570.2 916.6 651.1 24.6 1506.3 878.3 605.7 677.3 706.8 618.0 814.7 809.2 2748.0 1388.3 230.5 30.2 1829.4 933.8 1457.0 904.7 488.5 985.7 785.3 1115.3 18.7 1443.9 714.6 782.7 15.1 25.9 1114.6 1964.4 720.7 617.5 975.5 3353.2 5650.8 734.8 313.3 598.2 662.7 740.8 927.7 381.9 1319.3 935.4 1320.8 826.7 634.8 2108.4 1356.3 COX8A "COX, COX8, COX8-2, COX8L, VIII, VIII-L" ENSG00000176340 "Cytochrome c oxidase subunit 8A" P10176 11 63974620-63976543 "Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2341.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055942 Supported NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA055942: AB_2682979" "unprognostic (6.93e-2)" "unprognostic (1.01e-3)" "unprognostic (2.96e-2)" "unprognostic (1.02e-2)" "unprognostic (2.24e-1)" "unprognostic (7.70e-3)" "unprognostic (2.01e-2)" "unprognostic (2.12e-1)" "unprognostic (3.46e-1)" "unprognostic (6.49e-3)" "unprognostic (1.00e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.51e-6)" "unprognostic (2.70e-2)" "unprognostic (5.41e-2)" "unprognostic (1.13e-1)" "unprognostic (8.44e-2)" 322.0 443.8 421.6 134.1 435.5 292.0 286.8 470.0 544.7 259.3 524.0 516.1 337.8 236.1 121.2 612.5 246.8 78.4 1287.8 415.9 469.2 771.1 449.9 265.4 119.9 421.5 420.4 248.0 275.7 366.3 373.9 105.7 414.7 316.0 250.2 149.5 362.1 223.8 1523.9 362.0 381.5 132.3 427.7 277.0 467.3 96.7 480.4 206.6 342.9 1005.3 175.8 307.1 331.2 427.9 613.9 803.9 505.6 505.2 213.8 260.8 365.3 317.0 355.2 621.2 480.1 543.1 489.1 290.1 680.8 447.1 581.6 597.7 395.7 550.9 212.5 427.6 687.8 423.2 621.8 650.3 341.4 431.0 527.7 336.7 412.4 497.3 398.6 274.1 391.9 676.2 503.9 613.3 397.7 1600.5 613.8 1461.1 460.7 726.4 1401.4 473.9 406.3 1234.3 512.9 512.7 457.8 645.0 377.1 541.2 816.1 215.0 796.1 459.8 240.7 356.1 481.0 769.2 374.2 760.8 662.4 461.7 462.0 420.9 436.9 764.9 743.9 692.9 407.0 848.8 301.5 398.5 441.6 403.5 867.0 347.3 337.1 369.6 530.6 418.3 794.1 851.2 589.5 723.9 421.6 435.5 470.0 544.7 415.9 469.2 421.5 420.4 414.7 427.7 480.4 427.9 236.7 224.4 259.8 13.7 255.3 294.6 392.2 640.4 385.3 196.8 394.3 458.2 1263.1 424.7 396.1 437.7 73.0 451.2 305.9 1382.7 2341.9 453.1 9.6 271.6 217.2 215.7 721.6 272.9 12.5 483.1 559.6 246.1 395.0 305.1 224.5 209.3 227.4 811.5 927.5 107.7 16.8 1011.7 592.0 535.2 427.0 25.6 239.6 455.4 627.9 11.2 508.9 429.3 416.1 7.5 15.2 562.9 1103.8 221.2 393.2 419.8 1417.0 1658.2 345.2 187.5 157.8 256.0 339.9 74.0 55.5 844.0 370.9 366.9 290.4 203.7 1088.7 593.4 CPSF1 CPSF160 ENSG00000071894 "Cleavage and polyadenylation specific factor 1" Q10570 8 144393229-144409335 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065167, HPA068906" Enhanced Nucleoplasm No No "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA065167: AB_2685426, HPA068906: AB_2686055" "unprognostic (6.37e-2)" "unprognostic (7.72e-2)" "unprognostic (2.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.93e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (1.05e-1)" "unprognostic (2.00e-3)" "unprognostic (6.45e-2)" "unprognostic (7.54e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.54e-5)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (7.90e-2)" "unprognostic (9.66e-3)" 39.1 52.0 16.2 11.0 16.6 20.4 45.5 15.9 23.3 53.5 16.2 54.8 27.4 48.8 3.8 49.2 49.1 9.0 44.9 15.9 14.9 52.2 76.3 43.3 12.3 16.8 14.9 56.6 88.6 6.1 78.0 6.8 17.1 61.7 4.2 5.2 49.6 7.6 41.0 55.3 68.1 5.7 14.6 70.5 68.9 132.0 15.6 15.0 52.9 5.2 6.8 41.2 44.0 16.2 21.4 29.4 26.3 27.7 13.8 11.0 25.7 19.6 12.4 15.8 16.3 29.8 27.0 24.6 18.7 14.8 10.7 19.1 14.9 16.7 4.4 22.2 43.0 48.3 37.4 48.6 11.7 18.6 28.8 12.1 6.9 14.5 8.5 9.5 21.2 40.1 41.1 20.4 8.0 90.7 48.8 38.6 15.9 17.9 41.0 34.7 10.6 19.9 17.0 31.1 21.3 21.1 25.4 15.7 14.8 7.4 27.9 20.5 18.4 10.8 41.3 23.9 22.3 12.1 10.2 23.3 14.6 31.0 13.1 3.8 5.1 3.3 4.8 6.1 5.1 4.0 5.2 5.1 5.7 4.8 4.5 4.3 0.9 4.0 6.2 2.6 6.7 4.2 16.2 16.6 15.9 23.3 15.9 14.9 16.8 14.9 17.1 14.6 15.6 16.2 10.1 16.0 22.5 10.1 9.5 10.1 4.0 6.6 6.2 9.6 15.1 16.9 8.3 20.0 10.7 9.2 12.5 10.1 14.5 26.4 1.9 9.5 19.5 9.6 7.8 11.7 13.1 15.8 9.4 11.5 11.5 10.7 21.9 11.8 14.0 20.7 8.9 8.1 15.1 8.4 6.9 28.6 8.2 12.4 12.4 40.4 14.0 11.7 14.2 3.7 11.9 5.0 10.3 5.5 6.5 10.5 8.8 16.1 17.9 4.1 24.0 6.2 11.7 14.4 6.6 7.7 9.0 36.5 23.1 12.2 12.4 7.3 11.5 7.6 30.3 4.3 CPSF4 "CPSF30, NAR" ENSG00000160917 "Cleavage and polyadenylation specific factor 4" O95639 7 99438922-99457373 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049094, HPA066470" Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Vesicles "HPA049094: AB_2680626, HPA066470: AB_2685672" "unprognostic (4.03e-3)" "unprognostic (1.36e-1)" "unprognostic (1.86e-1)" "unprognostic (1.90e-2)" "unprognostic (2.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.84e-2)" "unprognostic (2.28e-2)" "unprognostic (3.15e-1)" "unprognostic (3.73e-3)" "unprognostic (3.36e-2)" "prognostic unfavorable (1.68e-4)" "unprognostic (2.47e-2)" "unprognostic (1.30e-1)" "unprognostic (1.37e-1)" "unprognostic (4.23e-2)" 20.4 19.0 31.4 13.8 30.8 20.1 19.2 29.9 35.1 18.7 23.6 16.7 14.0 16.8 11.7 20.4 15.7 11.3 17.4 30.1 30.4 17.3 20.2 15.4 23.7 35.5 31.6 18.8 29.9 8.3 18.4 16.7 32.1 19.1 10.7 7.2 19.8 12.3 36.1 20.4 16.1 11.1 30.4 22.0 20.0 32.0 32.3 16.1 13.9 18.0 19.9 16.0 17.4 30.4 40.0 33.9 55.4 44.9 22.4 25.5 66.8 25.8 31.5 38.8 50.5 56.0 52.0 56.4 34.2 25.2 48.2 34.0 39.1 40.5 35.4 41.9 41.6 27.0 41.4 54.4 117.2 49.4 33.3 46.8 34.0 40.7 60.4 28.1 35.8 40.1 70.8 64.8 36.2 95.6 99.6 88.9 51.3 53.0 47.7 40.8 37.0 66.8 24.2 36.1 43.3 50.6 29.4 60.9 61.6 58.2 25.3 51.8 20.0 36.5 50.1 64.3 50.0 59.9 68.6 83.3 28.1 48.1 44.1 1.2 3.4 2.6 3.3 3.0 4.4 8.2 5.0 6.1 4.1 8.4 6.3 5.6 1.3 4.4 2.1 5.4 8.2 3.0 31.4 30.8 29.9 35.1 30.1 30.4 35.5 31.6 32.1 30.4 32.3 30.4 11.6 6.4 8.9 6.2 11.2 8.8 16.4 10.6 9.6 4.6 11.9 10.3 10.4 14.3 8.6 1.8 10.4 55.9 17.7 8.7 15.6 15.6 3.0 4.9 9.3 11.0 7.7 15.6 10.7 17.1 33.1 12.7 5.1 5.3 12.7 27.0 8.2 8.2 21.5 6.7 14.7 10.6 14.2 10.1 13.5 7.8 27.4 8.7 8.8 5.6 18.5 10.7 14.4 6.0 8.1 13.9 6.0 17.3 14.7 28.6 10.1 20.2 4.3 6.9 19.7 23.7 16.4 20.9 19.8 9.3 9.2 45.4 10.7 25.1 12.6 14.9 CRELD2 MGC11256 ENSG00000184164 "Cysteine rich with EGF like domains 2" Q6UXH1 22 49918167-49927540 "Enzymes, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Plasma cells: 349.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000603, CAB025604" Approved "Intracellular and membrane" NA NA 480000 "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" "CAB025604: , HPA000603: AB_1078565" "unprognostic (1.12e-1)" "unprognostic (7.35e-2)" "unprognostic (1.10e-1)" "prognostic favorable (2.42e-7)" "unprognostic (5.04e-2)" "unprognostic (5.43e-2)" "unprognostic (3.21e-3)" "unprognostic (2.71e-1)" "unprognostic (3.60e-1)" "unprognostic (1.24e-1)" "unprognostic (2.57e-2)" "unprognostic (7.97e-2)" "prognostic unfavorable (1.34e-9)" "unprognostic (6.13e-2)" "unprognostic (3.01e-1)" "unprognostic (7.30e-2)" "unprognostic (4.02e-1)" 29.0 28.5 17.7 25.8 20.6 18.1 24.1 19.3 20.1 25.4 19.2 29.6 26.4 31.5 41.8 26.6 28.2 13.6 33.0 18.3 21.4 26.7 97.8 31.5 19.1 22.1 19.9 23.5 123.3 13.0 65.5 14.4 21.5 27.3 16.4 7.7 39.5 17.1 15.8 17.0 26.8 15.8 19.0 40.3 46.0 43.2 24.9 15.4 67.4 7.6 15.2 27.1 21.3 21.9 37.5 25.5 29.3 96.6 30.6 34.6 39.1 76.4 46.0 41.9 35.5 44.7 44.0 20.4 59.6 66.2 42.3 36.4 37.1 38.3 18.0 11.0 60.1 11.2 37.3 55.8 126.1 44.1 41.4 31.8 33.6 36.4 30.6 29.5 42.9 21.8 16.5 79.5 31.8 119.3 17.2 46.2 21.1 73.9 54.7 41.1 51.9 46.4 20.3 33.6 19.0 53.5 64.9 75.2 32.0 19.3 30.8 51.8 32.7 35.5 59.2 33.1 23.9 65.4 16.9 17.9 52.6 32.5 57.3 33.5 12.4 17.2 17.2 14.9 17.7 29.2 14.9 23.2 13.7 28.1 12.4 10.2 6.4 35.4 8.9 52.2 11.3 12.9 17.7 20.6 19.3 20.1 18.3 21.4 22.1 19.9 21.5 19.0 24.9 21.9 42.4 6.4 16.1 12.7 82.6 32.8 34.4 49.0 10.2 34.7 35.3 34.2 17.7 31.5 39.6 9.2 25.0 32.4 65.6 45.6 7.9 41.2 112.5 28.4 41.5 32.2 39.9 12.4 9.7 63.2 120.5 56.8 50.4 37.0 36.2 27.0 47.2 63.9 74.6 25.2 10.9 136.3 26.4 25.7 47.0 25.8 44.1 33.8 96.0 6.5 27.8 41.7 80.3 9.5 16.2 51.2 35.1 41.3 349.6 82.4 28.2 16.6 37.4 32.0 13.1 25.7 39.7 143.5 104.8 21.6 30.7 55.1 53.0 41.0 55.7 43.8 CSDE1 "D1S155E, UNR" ENSG00000009307 "Cold shock domain containing E1" O75534 1 114716913-114758676 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1408.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 2403.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018846, HPA052221" Supported Enhanced "Plasma membrane,Cytosol" NA NA 100000 "Cluster 18: Basophils - Vesicular transport" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Cytosol" "HPA018846: AB_1847266, HPA052221: AB_2681767" "unprognostic (2.84e-1)" "unprognostic (9.18e-3)" "unprognostic (4.86e-3)" "unprognostic (3.30e-3)" "unprognostic (2.83e-2)" "unprognostic (4.51e-2)" "unprognostic (5.32e-3)" "unprognostic (5.16e-2)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.69e-2)" "unprognostic (4.67e-2)" "unprognostic (1.18e-1)" "unprognostic (5.17e-3)" "unprognostic (2.54e-2)" 412.5 166.8 149.0 170.9 168.8 276.4 241.9 160.5 170.8 193.8 163.5 300.1 187.3 226.7 196.2 247.2 162.9 172.0 414.8 137.6 169.8 228.2 233.6 182.8 172.4 166.4 169.5 258.8 216.2 273.8 85.8 182.4 172.6 229.8 199.6 177.6 230.0 245.6 1408.6 201.6 196.1 236.4 172.2 176.5 201.7 257.4 164.7 218.8 262.6 1039.4 208.2 238.4 137.0 187.3 658.8 226.6 395.5 396.1 440.7 561.4 550.1 566.7 420.5 373.0 301.1 334.0 193.7 514.9 465.6 543.1 217.0 272.3 442.4 439.6 539.2 632.1 302.8 506.1 390.3 299.9 388.2 380.7 288.7 414.7 468.2 447.0 583.2 502.2 433.5 426.5 523.3 327.3 458.9 2403.4 513.8 242.0 755.0 274.0 302.5 378.4 1221.9 244.0 295.4 508.4 485.6 320.7 553.9 455.8 433.3 411.9 234.5 599.4 526.9 437.8 597.3 579.6 629.1 495.7 587.9 567.7 564.9 422.2 1365.1 217.2 241.4 230.8 146.4 233.1 199.7 161.6 186.5 180.7 226.8 130.4 219.3 189.1 155.2 191.0 270.8 87.2 222.2 389.4 149.0 168.8 160.5 170.8 137.6 169.8 166.4 169.5 172.6 172.2 164.7 187.3 193.2 198.7 194.2 41.8 198.3 216.2 219.7 149.0 235.6 134.0 218.2 161.5 572.0 160.2 181.1 128.8 58.4 172.4 155.2 160.8 226.9 198.2 405.5 130.4 178.8 191.3 219.9 232.8 70.8 202.9 208.2 181.7 143.2 174.3 219.1 234.7 156.4 189.1 156.8 99.3 73.7 220.3 120.1 277.9 202.0 639.7 161.8 216.8 220.5 55.3 241.8 195.5 117.4 54.3 86.5 213.8 150.6 225.7 283.6 269.0 240.1 235.5 143.2 121.3 164.3 232.4 274.2 263.3 189.8 247.2 234.0 272.9 193.3 208.2 210.5 283.8 CTDSP1 "NLIIF, SCP1" ENSG00000144579 "CTD small phosphatase 1" Q9GZU7 2 218398256-218405941 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cells: 184.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062654 Supported Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA062654: AB_2684819" "unprognostic (1.97e-2)" "unprognostic (4.02e-2)" "unprognostic (1.67e-3)" "unprognostic (2.62e-2)" "unprognostic (1.49e-1)" "unprognostic (1.82e-2)" "unprognostic (3.90e-2)" "unprognostic (8.69e-2)" "unprognostic (2.98e-1)" "unprognostic (6.38e-2)" "unprognostic (3.70e-1)" "unprognostic (1.79e-1)" "unprognostic (2.58e-1)" "unprognostic (6.67e-2)" "unprognostic (2.62e-1)" "unprognostic (7.01e-2)" "unprognostic (1.57e-1)" 84.5 55.4 42.1 43.0 47.8 53.1 76.5 41.6 42.2 82.4 40.6 72.2 56.7 80.2 31.9 71.8 74.3 46.7 79.4 36.8 38.8 83.2 118.6 74.5 49.2 55.6 47.0 82.3 79.1 56.9 28.4 77.7 44.6 104.6 44.7 8.7 65.3 57.2 60.0 71.4 75.9 48.4 45.3 92.7 88.3 16.9 45.5 48.0 78.9 53.7 45.4 82.6 70.4 43.2 29.8 37.8 21.8 71.9 58.1 53.8 80.0 38.9 56.2 37.2 32.0 49.7 72.7 18.0 33.0 69.8 25.3 59.1 32.4 47.2 19.0 63.8 25.5 68.3 48.6 67.0 69.4 42.9 89.3 61.5 56.7 28.3 31.7 58.3 55.5 27.5 56.5 62.6 39.9 84.0 37.5 122.1 15.5 47.6 37.8 51.4 30.8 39.2 47.7 36.6 14.5 36.4 34.4 72.9 38.6 27.4 40.8 101.1 48.5 58.7 35.0 45.4 17.4 40.1 28.1 42.6 52.3 39.7 33.2 54.2 30.4 74.1 24.3 24.7 15.5 7.8 14.7 15.8 15.9 7.2 9.3 12.4 56.4 17.3 26.3 5.4 13.8 21.2 42.1 47.8 41.6 42.2 36.8 38.8 55.6 47.0 44.6 45.3 45.5 43.2 65.0 44.8 40.0 15.0 43.0 27.3 29.1 24.7 37.5 14.6 34.8 34.5 35.1 58.6 23.7 31.3 2.1 42.7 70.5 95.0 33.2 36.6 1.9 15.1 35.1 43.4 21.7 52.6 0.7 42.7 43.3 44.7 45.3 27.7 18.3 23.0 67.5 57.3 39.3 6.7 1.0 53.5 12.2 83.2 28.1 4.6 59.4 59.9 33.8 14.0 56.9 55.6 184.4 13.0 12.9 38.5 43.1 44.0 35.7 39.8 85.1 51.1 10.0 28.0 26.3 36.0 44.8 1.7 8.7 37.8 20.3 54.3 55.1 29.4 41.5 30.2 CYC1 UQCR4 ENSG00000179091 "Cytochrome c1" P08574 8 144095039-144097525 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" Translocase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 730.0;tongue: 724.9" "Cell type enhanced" "Detected in all" "Distal tubular cells: 817.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 1125.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001247 Supported Approved Mitochondria NA NA 45000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA001247: AB_1078602" "unprognostic (3.07e-2)" "unprognostic (1.79e-1)" "unprognostic (1.65e-1)" "unprognostic (3.66e-2)" "unprognostic (1.25e-1)" "unprognostic (6.52e-2)" "unprognostic (1.39e-1)" "unprognostic (3.92e-3)" "unprognostic (6.23e-2)" "unprognostic (1.98e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "prognostic favorable (5.89e-6)" "unprognostic (6.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-1)" "unprognostic (3.13e-2)" 84.7 173.2 92.1 62.4 97.2 104.4 72.7 115.4 103.8 71.4 102.4 162.6 171.2 75.9 35.7 155.5 67.8 39.5 527.7 92.3 105.3 152.6 180.4 56.7 55.8 99.8 96.9 63.6 101.2 163.3 58.2 45.8 103.1 67.8 111.0 42.0 104.4 70.0 730.0 106.5 127.5 59.9 94.9 70.1 139.6 38.9 106.9 63.4 64.8 724.9 61.0 92.0 86.5 99.6 172.0 381.4 98.9 208.4 80.5 88.5 189.6 96.7 116.7 240.2 156.9 269.4 208.2 241.0 210.8 129.8 116.2 247.3 217.9 191.2 89.8 148.2 289.2 259.7 306.5 250.4 143.1 154.7 162.5 129.4 234.9 153.2 301.4 80.6 141.3 163.7 240.4 208.2 127.7 616.8 292.0 143.5 115.1 476.8 1125.5 253.7 132.4 422.1 199.7 273.0 263.3 117.2 267.8 365.7 200.0 54.0 302.5 233.2 108.8 152.1 321.6 169.6 299.7 229.1 179.7 183.8 193.2 261.9 198.4 185.7 340.4 95.7 131.6 360.4 139.8 208.7 108.1 141.5 444.1 180.3 104.9 134.6 32.7 187.8 278.8 251.0 158.2 397.1 92.1 97.2 115.4 103.8 92.3 105.3 99.8 96.9 103.1 94.9 106.9 99.6 77.0 19.2 29.3 23.5 94.0 156.1 191.9 394.8 62.6 113.6 110.7 102.6 402.3 181.6 156.0 79.1 81.3 263.6 61.7 516.1 817.8 239.9 81.2 59.1 68.1 88.0 146.4 130.6 14.4 289.1 257.1 102.8 144.8 60.2 59.7 89.2 62.4 239.4 246.3 87.5 21.6 390.4 272.6 104.8 139.4 88.6 88.9 101.4 179.7 12.2 208.4 115.2 92.7 12.1 17.5 290.6 332.5 90.7 149.9 237.9 570.0 468.6 86.1 100.9 72.3 109.4 250.6 83.1 116.7 212.9 163.7 236.8 63.8 197.5 602.6 258.3 CYHR1 "CHRP, KIAA0496, MGC13010" ENSG00000187954 "Cysteine and histidine rich 1" Q6ZMK1 8 144449582-144465667 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053653, HPA059543" Approved Enhanced Nucleoplasm NA NA "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm "HPA053653: AB_2682219, HPA059543: AB_2684056" "unprognostic (1.04e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (1.05e-4)" "unprognostic (1.58e-2)" "unprognostic (8.28e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (3.90e-4)" "unprognostic (4.02e-2)" "unprognostic (2.63e-1)" "unprognostic (2.13e-1)" "unprognostic (7.08e-3)" "unprognostic (1.46e-1)" "unprognostic (5.33e-2)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" "unprognostic (2.38e-1)" "unprognostic (1.54e-2)" 33.6 57.9 61.2 9.2 60.3 11.1 37.1 58.2 76.1 50.5 57.1 46.8 15.8 41.0 22.8 34.7 43.1 16.0 58.9 61.7 59.5 43.1 48.8 26.6 15.3 63.7 59.9 44.7 60.9 28.9 67.5 10.2 58.6 70.5 8.8 11.2 40.5 27.6 45.9 41.5 30.0 12.0 60.5 35.0 42.1 69.8 59.6 13.7 44.1 22.6 8.5 48.9 40.3 61.2 23.0 27.6 18.3 22.6 30.8 20.7 22.9 15.5 15.9 14.6 18.4 12.8 30.6 10.4 32.5 23.3 18.1 34.0 14.4 22.6 5.6 25.3 23.9 23.6 33.7 22.1 42.9 6.0 12.4 35.6 29.9 18.2 22.7 32.2 16.9 29.0 34.8 27.7 14.0 51.5 28.9 16.6 12.0 34.5 57.5 27.3 7.7 29.6 22.5 19.5 26.7 16.4 33.5 27.9 36.6 13.9 37.5 23.8 20.1 18.4 21.5 20.5 15.6 14.0 9.9 8.4 26.5 20.2 15.2 2.9 11.7 7.0 9.5 8.4 15.5 12.9 11.9 7.8 12.7 14.0 22.2 12.5 5.8 5.3 9.5 27.0 5.0 9.6 61.2 60.3 58.2 76.1 61.7 59.5 63.7 59.9 58.6 60.5 59.6 61.2 32.6 35.3 26.5 52.5 18.5 30.5 46.2 31.8 43.9 75.6 68.7 69.6 19.0 45.8 28.7 58.8 25.0 29.2 33.3 43.2 43.0 28.1 12.5 37.2 37.3 28.9 33.7 23.4 45.9 28.7 20.1 36.4 32.6 32.7 5.1 42.9 37.9 45.6 25.6 90.9 39.4 44.0 36.7 26.7 23.2 44.1 50.7 23.0 26.6 18.7 31.0 120.5 22.6 31.7 37.2 23.2 42.9 39.9 26.2 48.5 47.6 35.0 41.7 59.0 39.5 37.4 35.5 45.8 32.3 36.8 38.8 16.7 24.3 82.2 47.3 35.6 CYP24A1 "CP24, CYP24, P450-CC24" ENSG00000019186 "Cytochrome P450 family 24 subfamily A member 1" Q07973 20 54153446-54173986 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "endometrium 1: 14.9;kidney: 35.3;lymphoid tissue: 10.5;placenta: 10.0;urinary bladder: 28.7" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 48.3;Basal respiratory cells: 142.7;Basal squamous epithelial cells: 74.0;Club cells: 47.0;Proximal tubular cells: 61.3;Urothelial cells: 36.7" "Cancer enhanced" "Detected in many" "lung cancer: 18.3;urothelial cancer: 21.0" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 17 "A549: 411.5;Hep G2: 122.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA022261, HPA063771" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA Yes "Cluster 39: Non-specific - mRNA processing" "Cluster 7: Kidney - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Mitochondria" "Plasma membrane" "HPA022261: AB_1847427, HPA063771: AB_2685120" "unprognostic (1.19e-7)" "unprognostic (1.73e-1)" "unprognostic (2.24e-2)" "unprognostic (7.69e-3)" "unprognostic (3.30e-1)" "unprognostic (2.30e-2)" "unprognostic (1.11e-2)" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (5.37e-3)" "unprognostic (1.23e-1)" "unprognostic (6.05e-2)" "unprognostic (5.98e-2)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.12e-1)" 0.0 0.0 0.2 0.4 0.4 0.0 3.7 0.0 0.3 1.7 0.0 0.0 0.1 14.9 0.2 3.8 0.2 0.0 0.0 0.1 1.8 35.3 0.4 0.7 0.2 0.4 2.0 0.0 0.0 0.0 0.2 10.0 0.3 2.9 0.0 0.0 0.3 2.0 0.0 0.9 0.0 0.2 0.1 0.0 0.0 0.0 0.6 0.2 1.3 0.0 10.5 28.7 1.3 0.2 0.5 411.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 12.6 0.0 3.2 0.0 0.9 15.8 0.0 0.1 0.1 0.0 0.0 0.0 6.5 122.6 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.7 0.0 7.0 1.3 0.0 2.6 0.6 0.0 0.1 0.1 0.0 0.0 0.0 16.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.3 0.1 1.8 0.4 2.0 0.3 0.1 0.6 0.2 0.0 0.0 0.0 0.0 1.3 22.8 48.3 142.7 74.0 0.0 11.0 8.6 0.4 0.0 47.0 0.0 0.0 0.1 0.1 0.1 5.9 0.1 0.0 0.7 0.5 0.3 0.0 0.0 0.2 0.0 0.1 2.0 0.0 4.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 9.8 0.0 61.3 13.1 0.0 0.0 0.0 0.6 0.0 0.0 3.3 19.6 0.1 0.1 0.0 0.2 36.7 CYP4F22 FLJ39501 ENSG00000171954 "Cytochrome P450 family 4 subfamily F member 22" Q6NT55 19 15508525-15552317 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" Ichthyosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 18.8;skin 1: 58.6;vagina: 22.8" "Cell type enhanced" "Detected in some" "Breast glandular cells: 8.8;Breast myoepithelial cells: 5.5;granulocytes: 7.0;Prostatic glandular cells: 4.0;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in many" 7 "breast cancer: 4.5;head and neck cancer: 5.7;liver cancer: 8.5;melanoma: 4.5;urothelial cancer: 13.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "intermediate monocyte: 6.1;MAIT T-cell: 4.3;non-classical monocyte: 14.1" "Group enriched" "Detected in many" 8 "monocytes: 14.1;T-cells: 4.3" "Cell line enhanced" "Detected in some" "MCF7: 1.7;T-47d: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA058960 Uncertain NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 35: Glandular cells - Unknown function" "HPA058960: AB_2683862" "unprognostic (2.32e-3)" "unprognostic (1.17e-2)" "unprognostic (6.81e-2)" "unprognostic (2.47e-2)" "unprognostic (1.03e-1)" "unprognostic (7.02e-2)" "unprognostic (1.30e-1)" "unprognostic (2.43e-1)" "unprognostic (3.33e-1)" "unprognostic (1.89e-2)" "unprognostic (9.33e-2)" "unprognostic (3.00e-2)" "unprognostic (2.21e-5)" "unprognostic (8.10e-2)" "unprognostic (3.16e-1)" "unprognostic (7.25e-3)" "unprognostic (2.03e-2)" 1.3 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.1 10.5 0.0 0.0 0.2 0.3 0.0 18.8 0.1 0.1 0.0 0.0 0.0 0.0 7.0 0.3 0.3 0.1 0.4 0.0 0.0 0.1 0.0 0.0 0.2 8.4 0.0 0.0 3.2 6.4 0.2 58.6 0.1 0.0 0.0 0.3 1.4 1.0 0.0 0.1 0.0 0.0 1.7 6.3 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.7 6.1 4.3 0.0 0.5 1.5 0.2 0.0 0.0 0.4 0.0 1.1 14.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 8.8 5.5 0.4 1.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.0 7.0 0.0 0.0 1.5 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.4 0.0 0.3 0.0 0.0 0.5 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 4.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 1.8 0.0 3.0 0.0 1.8 0.0 0.0 0.3 CYSRT1 "C9orf169, MGC59937" ENSG00000197191 "Cysteine rich tail 1" A8MQ03 9 137224635-137226315 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "esophagus: 239.5" "Group enriched" "Detected in some" 10 "Pancreatic endocrine cells: 58.0;Squamous epithelial cells: 66.0" "Cancer enhanced" "Detected in all" "head and neck cancer: 23.0" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 25.1;CAPAN-2: 28.9;HaCaT: 33.3;HeLa: 30.6;MCF7: 49.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA021883, HPA021886" Approved Approved "Nuclear speckles,Vesicles,Midbody" Yes No "Cluster 7: Monocytes - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" "Nuclear speckles" "Vesicles, Midbody" "HPA021883: AB_1853190, HPA021886: AB_1853192" "unprognostic (1.35e-1)" "unprognostic (2.53e-2)" "unprognostic (8.31e-3)" "unprognostic (6.87e-3)" "unprognostic (2.14e-1)" "unprognostic (2.66e-2)" "unprognostic (8.11e-2)" "unprognostic (5.86e-2)" "unprognostic (3.45e-1)" "unprognostic (2.73e-1)" "unprognostic (1.24e-2)" "unprognostic (1.05e-1)" "unprognostic (6.24e-3)" "unprognostic (7.92e-3)" "unprognostic (1.99e-1)" "unprognostic (1.03e-1)" "unprognostic (2.29e-1)" 0.6 1.1 0.6 0.2 0.4 0.4 1.5 0.3 1.6 43.1 0.0 0.6 0.4 0.5 0.4 239.5 1.8 0.7 0.9 0.8 0.8 3.7 1.7 1.1 0.7 1.4 1.3 0.3 1.5 0.6 7.3 0.3 0.6 2.6 0.1 0.6 29.9 0.5 0.4 34.4 0.8 0.0 1.0 0.7 2.0 4.1 0.9 0.3 2.4 0.0 14.3 1.2 57.7 0.5 25.1 2.4 1.8 3.9 0.0 0.1 5.3 0.4 0.4 0.5 0.2 1.3 28.9 1.3 1.2 0.3 0.7 33.3 0.5 7.0 0.0 2.7 1.8 0.3 30.6 16.8 0.9 0.2 1.4 0.4 3.5 0.9 0.2 1.3 0.3 1.4 0.6 3.1 1.6 49.5 0.7 1.0 0.7 4.8 3.0 2.4 2.8 3.5 0.6 1.6 0.4 1.8 4.5 3.5 0.9 1.5 7.7 0.4 1.0 1.1 0.9 3.2 0.6 1.9 1.7 1.2 1.4 1.3 1.4 0.2 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.9 0.0 0.0 0.0 0.6 0.4 0.3 1.6 0.8 0.8 1.4 1.3 0.6 1.0 0.9 0.5 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.5 0.4 1.5 2.5 5.5 0.0 0.6 0.1 0.4 0.0 4.6 0.5 2.1 0.2 0.3 0.0 0.0 0.3 5.8 0.2 0.1 3.1 1.7 0.0 0.6 0.7 0.8 0.2 0.0 0.3 0.6 0.0 0.3 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 58.0 1.1 0.4 0.1 0.2 1.6 0.9 0.0 0.6 0.0 0.3 0.3 3.0 1.1 66.0 0.0 0.0 0.1 0.9 0.5 1.7 DBNDD1 "FLJ12582, MGC3101" ENSG00000003249 "Dysbindin domain containing 1" Q9H9R9 16 90004871-90019890 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 92.0;skeletal muscle: 48.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 22.8;Ductal cells: 16.0;Exocrine glandular cells: 18.8;Horizontal cells: 30.3;Pancreatic endocrine cells: 15.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 4 "naive B-cell: 12.9" "Lineage enriched" "Detected in many" 4 "B-cells: 12.9" "Cell line enhanced" "Detected in many" "MCF7: 139.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043018 Uncertain Approved "Nuclear speckles,Cytosol" No No "Cluster 21: B-cells - Adaptive immune response" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" "Nuclear speckles" Cytosol "HPA043018: AB_10794921" "unprognostic (1.07e-1)" "unprognostic (8.40e-2)" "unprognostic (8.70e-2)" "unprognostic (1.73e-1)" "unprognostic (1.86e-2)" "unprognostic (4.18e-2)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.07e-2)" "unprognostic (9.52e-2)" "unprognostic (1.54e-1)" "unprognostic (2.86e-2)" "prognostic favorable (2.75e-7)" "unprognostic (1.03e-1)" "unprognostic (5.67e-1)" "unprognostic (2.44e-2)" "unprognostic (2.00e-2)" 1.8 7.4 47.1 2.5 35.3 0.3 4.4 27.5 60.6 4.1 11.6 2.9 1.6 0.9 10.0 28.2 3.6 3.8 4.6 35.2 40.7 13.3 6.5 3.5 4.7 50.6 55.3 3.1 19.5 9.6 7.7 0.1 50.8 3.8 1.4 7.4 15.5 3.1 48.0 6.0 1.7 1.3 30.3 1.2 7.7 1.0 92.0 1.4 5.2 4.8 5.1 1.7 7.3 38.6 22.8 34.7 3.5 44.7 0.9 0.4 24.7 4.9 6.6 10.5 5.3 32.1 19.7 0.0 2.7 1.1 10.2 24.0 41.3 1.2 10.7 0.1 65.4 0.0 4.4 58.6 1.5 0.3 4.7 1.0 3.3 18.8 0.1 25.2 47.3 0.8 6.7 0.4 4.1 139.7 0.1 33.5 59.5 18.6 13.9 14.5 32.3 0.6 64.2 4.5 51.2 53.0 5.6 5.3 44.8 10.2 34.6 4.8 36.2 7.4 15.1 0.4 24.1 0.3 0.3 0.4 3.5 3.9 20.1 0.0 0.0 0.7 0.0 0.0 0.0 1.2 0.6 0.5 0.0 12.9 2.9 0.5 0.0 0.0 0.0 0.1 0.0 1.0 47.1 35.3 27.5 60.6 35.2 40.7 50.6 55.3 50.8 30.3 92.0 38.6 0.3 3.2 2.0 2.9 6.0 0.4 0.6 0.6 0.0 1.8 13.5 7.5 2.5 22.8 2.0 9.2 0.0 0.2 0.1 1.4 9.8 16.0 0.0 5.7 0.7 1.1 6.0 0.0 6.1 18.8 0.3 0.2 2.6 7.8 0.0 3.4 1.4 2.5 0.3 30.3 3.6 1.5 2.0 0.0 0.7 0.0 1.2 0.1 3.6 2.8 0.2 10.4 0.0 1.5 0.7 15.0 2.9 0.4 0.5 4.3 0.2 10.8 2.7 1.8 0.0 1.4 1.2 0.1 2.0 8.1 1.0 0.0 1.4 0.3 0.8 1.3 DCLRE1B "APOLLO, FLJ12810, FLJ13998, SNM1B" ENSG00000118655 "DNA cross-link repair 1B" Q9H816 1 113905213-113914086 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Erythroid cells: 23.6;Sertoli cells: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 57.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064934 Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 15: NK-cells - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Nuclear bodies" "HPA064934: AB_2685387" "unprognostic (1.21e-1)" "unprognostic (3.38e-2)" "unprognostic (4.47e-3)" "unprognostic (4.92e-3)" "unprognostic (1.89e-1)" "unprognostic (1.02e-2)" "prognostic unfavorable (4.50e-5)" "unprognostic (1.31e-2)" "unprognostic (9.67e-3)" "unprognostic (2.73e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.03e-7)" "unprognostic (1.24e-2)" "unprognostic (2.13e-1)" "unprognostic (1.25e-1)" "unprognostic (5.08e-2)" 3.5 1.2 2.5 3.7 2.7 6.0 2.9 4.5 2.8 2.5 2.1 2.8 1.7 2.4 1.6 3.0 2.7 2.2 1.3 2.4 2.7 1.6 1.7 3.2 4.1 2.5 2.7 3.0 0.9 1.1 0.7 3.5 2.5 1.7 3.0 1.2 1.2 1.9 0.8 2.6 1.9 3.3 2.5 4.0 1.6 2.4 2.8 4.8 2.0 1.0 3.9 2.2 1.6 3.3 14.1 5.5 9.9 10.5 7.9 5.4 5.7 11.1 7.4 14.2 15.3 6.0 3.9 14.3 6.8 7.8 6.4 6.4 13.7 11.2 19.6 12.0 10.1 12.4 7.8 5.9 1.5 14.1 12.1 6.2 4.4 18.5 10.6 3.9 7.9 16.5 17.5 11.8 16.7 57.8 21.7 11.5 7.7 5.5 12.6 17.2 30.4 6.5 5.6 6.1 8.7 8.0 12.0 9.2 7.7 7.8 6.1 14.9 4.8 18.6 19.6 31.3 15.8 5.2 5.6 16.0 15.7 13.8 32.9 1.9 4.5 1.3 2.3 3.7 2.5 0.9 2.6 2.2 2.6 1.4 1.7 2.2 0.2 5.8 2.1 1.0 1.8 2.5 2.5 2.7 4.5 2.8 2.4 2.7 2.5 2.7 2.5 2.5 2.8 3.3 3.0 3.2 2.0 0.3 2.8 3.6 1.2 1.7 8.0 3.0 2.6 2.0 1.2 1.5 0.8 0.0 2.1 4.6 4.0 1.0 1.9 4.4 1.3 4.1 2.3 3.4 3.0 23.6 0.8 2.7 9.8 3.4 0.5 2.4 1.3 5.6 2.2 1.6 9.7 1.7 0.9 3.1 2.0 8.5 12.8 0.6 1.8 10.5 0.0 1.0 13.5 0.9 2.1 0.0 1.1 3.7 0.5 2.2 5.0 1.5 0.3 1.7 3.1 1.4 26.3 2.1 5.5 7.9 11.4 6.2 2.7 1.4 4.4 3.0 4.2 1.0 DCTPP1 "CDA03, MGC5627, RS21C6, XTP3TPA" ENSG00000179958 "DCTP pyrophosphatase 1" Q9H773 16 30423615-30430030 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002832 Uncertain Supported Nucleoplasm,Cytosol NA Yes 61000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "HPA002832: AB_1080615" "prognostic unfavorable (1.64e-5)" "unprognostic (1.61e-1)" "unprognostic (1.99e-3)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (4.09e-2)" "prognostic unfavorable (6.28e-4)" "unprognostic (2.23e-1)" "unprognostic (1.07e-1)" "unprognostic (4.35e-2)" "unprognostic (2.43e-2)" "unprognostic (3.65e-2)" "prognostic favorable (9.71e-9)" "unprognostic (1.10e-3)" "unprognostic (8.78e-3)" "unprognostic (1.10e-2)" "unprognostic (2.53e-1)" 21.0 21.4 17.6 27.4 18.4 22.2 30.5 18.7 22.5 18.6 18.9 56.4 32.0 18.6 20.0 28.3 28.1 19.5 31.1 18.4 19.5 39.7 21.8 16.2 35.5 18.1 17.6 14.0 24.9 32.1 10.3 16.0 19.0 21.8 58.4 12.2 25.5 19.3 44.7 25.1 27.7 20.5 18.4 27.8 24.3 9.1 18.1 24.5 20.1 36.9 35.7 27.0 19.1 19.4 124.7 149.8 66.8 85.8 18.4 24.1 61.9 58.4 35.1 87.4 87.9 114.7 103.4 168.1 119.1 36.8 54.9 95.9 141.4 115.1 103.5 89.2 221.0 98.3 61.5 150.3 24.1 177.0 144.2 28.6 64.8 96.4 55.6 25.4 88.7 88.2 125.8 57.4 61.5 217.8 210.0 189.9 88.8 124.2 119.2 293.1 74.8 218.1 98.9 80.2 141.4 80.4 39.0 137.7 55.3 41.5 118.4 73.9 45.9 66.0 59.1 85.8 107.2 36.9 118.4 217.5 43.8 145.7 79.6 70.6 36.7 38.1 54.0 70.0 75.8 146.7 68.4 61.4 86.7 128.7 60.9 59.0 4.6 76.1 79.2 94.6 76.4 81.0 17.6 18.4 18.7 22.5 18.4 19.5 18.1 17.6 19.0 18.4 18.1 19.4 34.0 19.2 15.2 0.7 38.2 90.2 53.3 92.5 33.6 23.3 45.8 48.9 34.8 51.5 37.9 44.1 8.4 103.2 22.7 130.3 127.2 135.6 13.4 32.6 29.9 47.4 38.5 29.6 2.6 124.8 101.0 28.3 27.5 66.5 31.1 40.2 31.1 23.2 76.9 15.2 2.7 142.3 73.2 21.0 49.1 45.1 19.6 26.9 48.0 1.0 73.2 25.0 23.7 2.5 4.4 89.0 115.8 19.9 24.1 86.9 68.8 76.7 27.8 21.4 19.7 23.7 40.0 3.3 44.8 39.4 80.3 27.8 28.3 53.8 168.5 45.7 DCUN1D5 "FLJ32431, MGC2714" ENSG00000137692 "Defective in cullin neddylation 1 domain containing 5" Q9BTE7 11 103050686-103092194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050863 Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 6: Non-specific - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA050863: AB_2681259" "unprognostic (4.47e-2)" "unprognostic (1.96e-1)" "unprognostic (1.29e-1)" "unprognostic (1.47e-2)" "unprognostic (2.99e-1)" "prognostic unfavorable (4.62e-4)" "prognostic unfavorable (2.01e-7)" "unprognostic (1.92e-3)" "unprognostic (1.21e-2)" "prognostic favorable (9.52e-5)" "unprognostic (2.08e-2)" "prognostic unfavorable (4.12e-4)" "unprognostic (2.64e-3)" "unprognostic (1.40e-1)" "unprognostic (1.92e-1)" "unprognostic (6.05e-2)" "unprognostic (1.43e-3)" 15.8 14.6 11.9 4.2 12.7 4.7 13.2 16.6 17.5 11.3 7.9 11.3 1.4 11.1 3.8 21.4 10.3 1.8 23.9 13.3 12.8 14.3 13.7 11.0 5.1 11.8 13.0 9.1 14.2 3.0 13.0 3.3 12.1 11.3 2.2 7.5 12.2 3.0 31.3 11.8 9.4 2.7 13.2 12.3 13.3 18.5 13.5 4.5 9.2 7.7 4.1 11.9 12.1 13.0 18.2 14.5 18.8 16.3 11.6 13.2 10.0 17.9 6.8 9.0 12.7 51.2 24.8 8.0 32.8 13.3 29.0 21.3 24.3 24.0 16.1 9.7 22.4 21.6 16.2 22.3 18.7 33.7 12.4 7.6 23.8 17.7 22.8 18.3 18.1 32.6 26.3 0.1 10.5 21.6 24.4 46.5 24.5 33.6 32.9 9.5 15.1 22.4 15.4 33.9 12.8 11.0 10.0 21.8 21.4 25.1 20.4 22.4 4.0 12.4 14.8 16.6 17.6 7.8 12.5 33.0 7.9 31.4 13.0 12.8 6.6 6.5 8.7 8.5 10.2 11.3 10.8 9.5 9.5 9.3 9.3 10.3 2.5 15.1 7.1 11.1 11.8 9.3 11.9 12.7 16.6 17.5 13.3 12.8 11.8 13.0 12.1 13.2 13.5 13.0 24.9 16.0 11.0 26.8 30.2 79.5 63.2 101.6 38.1 11.7 34.4 36.2 30.7 15.7 42.8 9.2 8.4 57.2 29.3 8.2 49.0 59.5 5.0 26.5 38.2 27.2 14.4 52.1 50.7 55.6 88.6 35.6 21.9 25.3 15.8 37.3 16.1 25.3 44.7 6.7 39.6 17.9 67.1 29.8 32.4 8.4 14.3 22.7 30.2 15.9 26.5 18.9 15.5 25.6 27.5 63.1 12.2 19.5 52.8 92.6 8.6 39.2 28.0 14.1 26.3 31.5 74.6 121.6 119.8 59.0 83.7 43.8 30.9 59.8 23.2 73.0 DCXR "DCR, HCR2, KIDCR, P34H, SDR20C1" ENSG00000169738 "Dicarbonyl and L-xylulose reductase" Q7Z4W1 17 82035136-82037709 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Xylose metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "liver: 1851.6" "Cell type enhanced" "Detected in all" "Distal tubular cells: 812.0;Hepatocytes: 3510.3;Proximal tubular cells: 2919.4" "Group enriched" "Detected in all" 5 "liver cancer: 305.9;prostate cancer: 163.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Hep G2: 365.2;MCF7: 446.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023371, HPA023863" Enhanced Uncertain Nucleoli,Microtubules NA NA 4000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli, Microtubules" "HPA023371: AB_1847530, HPA023863: AB_1847531" "unprognostic (3.33e-2)" "unprognostic (1.67e-3)" "unprognostic (3.75e-1)" "unprognostic (1.16e-2)" "unprognostic (1.19e-1)" "unprognostic (8.43e-2)" "unprognostic (4.54e-3)" "unprognostic (1.86e-2)" "unprognostic (3.05e-1)" "unprognostic (2.56e-2)" "prognostic favorable (4.70e-4)" "unprognostic (1.72e-1)" "prognostic favorable (2.13e-4)" "unprognostic (1.81e-1)" "unprognostic (1.36e-1)" "unprognostic (2.64e-1)" "unprognostic (1.10e-2)" 106.7 43.9 93.1 15.2 95.3 25.3 107.6 102.5 111.1 52.0 84.4 49.6 29.2 39.5 281.3 96.6 59.2 10.8 132.7 87.6 100.7 239.9 1851.6 61.0 16.6 102.4 98.0 70.0 71.6 46.1 63.9 20.2 105.9 138.0 20.9 9.7 103.4 33.6 187.3 87.6 44.4 10.4 91.8 35.8 167.0 44.8 105.9 26.1 60.7 80.6 19.6 48.9 62.1 94.9 50.3 68.2 32.8 56.4 123.2 31.8 80.4 25.0 33.9 68.5 48.4 122.0 21.3 100.3 47.4 35.9 9.4 57.4 59.6 52.6 24.1 21.4 145.9 96.9 48.8 365.2 143.2 75.6 114.5 44.6 62.2 22.7 79.8 16.0 41.1 61.1 112.4 76.3 36.5 446.2 63.7 184.1 35.0 242.9 71.3 57.9 42.0 135.3 53.3 71.9 85.5 51.0 35.5 287.5 46.0 19.7 213.4 74.5 20.5 36.6 45.0 48.9 48.2 73.7 56.2 50.2 31.4 83.0 26.7 49.5 92.6 77.9 66.5 92.0 64.1 86.8 83.0 64.7 151.3 99.2 117.7 85.4 47.2 108.9 88.1 121.6 98.9 110.1 93.1 95.3 102.5 111.1 87.6 100.7 102.4 98.0 105.9 91.8 105.9 94.9 29.0 51.3 198.2 16.6 133.6 58.5 200.3 113.5 109.8 16.0 301.8 269.2 120.7 183.0 123.4 178.4 18.8 372.1 116.6 152.9 812.0 41.4 6.0 67.0 50.9 44.6 54.7 335.7 4.7 42.6 450.6 65.0 151.4 102.3 64.7 62.7 138.5 3510.3 164.7 21.9 9.0 170.4 189.2 165.7 65.6 22.6 70.8 82.3 179.7 1.9 52.8 145.1 78.2 5.5 10.5 30.4 135.7 47.4 98.6 215.2 158.9 2919.4 55.4 26.5 19.7 40.6 79.6 10.3 48.2 219.9 73.2 342.6 135.7 118.6 154.6 178.8 DDAH2 G6A ENSG00000213722 "Dimethylarginine dimethylaminohydrolase 2" O95865 6 31727038-31730617 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 386.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 63.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012389, HPA012509" Uncertain Supported Mitochondria NA NA 1500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA012389: , HPA012509: AB_1847533" "unprognostic (2.29e-2)" "unprognostic (1.38e-1)" "unprognostic (4.49e-2)" "unprognostic (2.39e-1)" "unprognostic (1.44e-1)" "unprognostic (7.67e-2)" "unprognostic (1.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.62e-1)" "unprognostic (8.78e-2)" "unprognostic (1.01e-1)" "unprognostic (1.09e-1)" "unprognostic (1.02e-1)" "unprognostic (9.42e-2)" "unprognostic (2.32e-1)" "unprognostic (2.24e-2)" "unprognostic (2.72e-2)" 96.5 17.2 26.6 12.0 24.7 10.8 81.2 24.2 44.7 131.5 26.1 72.2 4.4 94.4 8.7 39.0 80.5 44.0 63.2 23.9 33.5 67.1 32.1 62.3 20.6 31.8 28.2 67.7 16.5 17.5 26.0 18.3 28.1 65.2 7.7 5.8 58.2 27.0 13.4 67.7 38.9 11.9 32.0 49.4 35.4 13.4 27.4 9.6 65.1 4.5 7.8 61.0 91.0 30.9 2.0 20.1 0.7 28.5 17.0 26.6 3.8 0.0 10.6 10.9 7.3 40.4 6.7 0.4 24.4 26.5 0.9 2.4 0.5 9.7 1.9 0.0 14.2 1.9 7.8 22.4 18.2 0.3 1.5 18.8 1.2 12.2 0.9 3.7 33.3 14.1 0.4 11.1 4.8 63.0 1.5 27.5 4.1 4.3 12.2 0.2 0.9 10.5 21.6 0.5 1.5 5.7 0.0 4.7 27.4 2.9 37.7 7.8 0.1 16.9 24.7 11.2 0.0 4.1 12.8 3.3 11.3 5.9 4.3 141.3 15.4 135.0 14.8 37.4 5.8 49.7 4.0 5.3 26.8 39.6 2.7 3.4 27.8 29.2 44.9 93.9 4.1 11.4 26.6 24.7 24.2 44.7 23.9 33.5 31.8 28.2 28.1 32.0 27.4 30.9 102.3 28.9 14.7 10.4 76.8 66.9 88.7 49.6 56.3 4.5 132.8 96.0 39.5 62.9 36.9 82.8 29.2 15.5 84.4 386.3 178.1 148.2 83.1 62.6 94.2 101.2 150.0 20.4 0.3 32.3 37.3 154.1 33.1 75.0 113.3 121.7 94.9 31.9 223.2 0.0 0.3 71.5 109.9 139.7 301.2 23.6 180.5 95.7 103.2 14.0 64.2 120.9 40.2 4.5 2.7 85.1 299.5 153.1 24.5 95.2 61.5 165.8 50.5 25.7 105.2 122.7 153.0 4.1 12.5 35.8 59.2 18.1 41.1 21.3 104.6 67.0 DDX41 "ABS, MGC8828" ENSG00000183258 "DEAD-box helicase 41" Q9UJV9 5 177511577-177516961 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017911, HPA048803" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA017911: AB_1847558, HPA048803: AB_2680527" "unprognostic (2.52e-1)" "unprognostic (1.51e-1)" "unprognostic (7.57e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.61e-2)" "unprognostic (4.21e-3)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (2.21e-6)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (1.75e-1)" 26.5 29.0 15.1 28.7 16.1 22.3 25.4 13.1 21.9 26.1 13.7 26.5 24.8 25.2 16.8 33.7 30.6 18.3 18.9 17.8 14.2 26.8 27.1 24.5 24.7 15.8 13.7 28.6 23.5 31.2 18.0 22.8 16.0 22.3 19.3 14.6 28.7 19.1 43.4 35.0 28.7 20.1 12.8 26.7 26.7 17.9 16.2 24.3 29.0 20.3 25.0 24.8 27.6 16.4 62.1 71.4 42.4 44.9 43.4 45.2 125.1 58.4 35.1 47.1 36.1 107.7 61.3 67.2 83.3 57.6 67.6 47.8 57.2 128.5 33.2 175.4 68.0 90.5 70.8 66.5 52.5 89.3 82.3 48.7 47.0 45.3 59.0 43.5 53.4 68.1 72.3 50.0 55.6 135.5 80.6 45.9 62.0 59.0 61.3 72.7 48.1 86.2 50.5 78.8 45.0 41.9 64.6 83.2 56.5 27.1 54.6 110.2 51.3 74.4 42.8 43.6 87.6 49.6 75.9 120.1 81.3 100.1 47.0 14.3 31.4 22.3 18.3 28.5 23.5 17.0 18.3 16.8 27.2 14.4 14.6 18.8 9.2 25.8 31.4 11.2 18.8 25.6 15.1 16.1 13.1 21.9 17.8 14.2 15.8 13.7 16.0 12.8 16.2 16.4 17.0 25.6 17.8 7.8 20.6 21.0 22.9 37.9 18.2 16.9 17.5 16.5 9.0 25.8 24.3 9.2 2.1 46.6 22.9 22.9 41.1 42.1 11.2 16.1 16.5 22.3 11.4 25.2 6.0 39.6 63.2 17.6 17.3 19.2 29.8 21.3 16.1 18.0 48.8 8.4 6.4 27.0 18.3 23.5 15.4 22.9 14.9 22.2 12.4 4.7 34.6 23.9 20.6 5.0 3.9 33.5 23.9 21.1 23.2 19.0 29.5 40.1 20.5 10.3 13.1 14.5 29.0 24.5 26.7 26.2 20.3 37.5 19.0 25.6 31.0 22.7 DEF8 FLJ20186 ENSG00000140995 "Differentially expressed in FDCP 8 homolog" Q6ZN54 16 89948697-89968060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041745, HPA049434" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Nucleoplasm, Cytosol" "HPA041745: AB_2677650, HPA049434: " "unprognostic (4.99e-2)" "unprognostic (1.01e-1)" "unprognostic (9.41e-3)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" "unprognostic (8.24e-2)" "unprognostic (1.91e-3)" "unprognostic (9.96e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-2)" "prognostic favorable (1.35e-7)" "unprognostic (1.39e-2)" "prognostic favorable (1.95e-8)" "unprognostic (9.05e-2)" "unprognostic (1.40e-1)" "unprognostic (2.32e-2)" "unprognostic (2.09e-1)" 37.0 40.3 58.3 38.0 59.4 45.4 36.2 60.0 68.5 41.2 38.1 52.4 20.0 45.9 19.4 45.5 42.1 25.4 49.4 57.5 54.7 45.3 35.2 40.8 72.6 71.6 62.1 47.4 51.2 32.3 50.6 17.1 66.9 42.5 13.5 26.9 37.7 27.5 40.8 48.9 33.7 27.7 50.6 45.6 45.9 14.1 62.6 9.8 41.6 24.8 52.0 44.6 36.4 62.4 54.4 107.7 47.0 65.1 46.9 47.4 56.6 82.9 68.1 117.9 53.8 114.9 64.0 66.8 61.2 54.6 47.1 34.6 55.4 94.1 51.4 16.0 164.6 29.5 62.3 167.4 49.6 21.3 44.9 56.0 77.3 84.1 46.3 48.3 87.1 58.2 97.6 21.8 70.7 198.3 41.4 64.2 60.8 24.6 110.2 86.9 35.8 55.3 62.0 50.0 72.1 74.2 131.5 48.3 44.6 24.3 45.4 67.1 89.9 68.9 73.3 36.0 88.3 40.5 31.3 85.1 72.5 54.2 82.1 8.2 39.3 80.7 26.6 33.1 24.0 49.3 21.8 19.6 26.2 61.1 14.5 14.1 52.6 13.1 18.9 69.1 29.6 27.5 58.3 59.4 60.0 68.5 57.5 54.7 71.6 62.1 66.9 50.6 62.6 62.4 27.7 0.0 14.8 31.0 32.6 44.7 22.1 33.0 15.4 24.1 20.1 22.2 33.9 21.5 20.4 14.7 27.1 29.3 30.7 20.0 29.4 42.6 6.5 12.0 25.5 27.8 21.6 9.1 19.2 92.3 48.2 31.5 11.7 15.6 10.1 20.3 20.7 23.9 63.5 30.3 19.3 17.9 42.7 33.5 62.7 23.3 21.1 30.1 46.2 14.0 56.1 17.8 21.6 15.6 22.6 112.4 20.4 33.4 65.1 46.6 16.9 47.7 16.4 26.3 19.7 20.4 40.7 6.2 11.2 19.9 54.7 32.4 17.5 33.3 15.8 30.1 DEFB135 ENSG00000205883 "Defensin beta 135" Q30KP9 8 11982321-11984590 "Predicted secreted proteins" "Antibiotic, Antimicrobial, Defensin" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in single" 50 "epididymis: 34.8" "Group enriched" "Detected in some" 9 "Early spermatids: 2.8;Late spermatids: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.2" "Region enhanced" "Detected in single" "white matter: 1.5" "Secreted in male reproductive system" NA NA "Cluster 30: Epididymis - Antimicrobial activity" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.5 0.6 0.0 0.5 0.0 0.0 0.0 34.8 0.0 0.0 0.1 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 0.6 0.3 0.3 0.3 0.2 0.2 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DGCR6L FLJ10666 ENSG00000128185 "DiGeorge syndrome critical region gene 6 like" Q9BY27 22 20314238-20320080 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 5 "Late spermatids: 2787.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (1.91e-1)" "prognostic favorable (3.82e-5)" "unprognostic (2.74e-2)" "unprognostic (4.61e-3)" "unprognostic (3.97e-2)" "unprognostic (2.46e-1)" "unprognostic (2.61e-1)" "prognostic favorable (5.37e-4)" "unprognostic (1.44e-1)" "unprognostic (4.39e-2)" "unprognostic (3.29e-3)" "unprognostic (9.07e-3)" "unprognostic (6.72e-3)" "unprognostic (4.37e-2)" "unprognostic (2.91e-1)" "unprognostic (1.26e-1)" "unprognostic (2.97e-1)" 34.2 44.8 75.9 15.3 73.2 30.9 36.3 68.7 95.7 38.0 72.4 46.5 19.8 33.6 23.8 41.2 31.7 18.7 67.8 72.9 71.4 57.6 152.6 28.6 24.7 71.2 71.7 36.3 43.1 42.1 43.3 12.5 71.9 51.0 11.4 8.6 45.2 29.0 81.1 54.1 29.8 15.3 71.2 33.8 40.9 132.0 74.1 27.6 45.9 44.1 14.6 39.9 35.3 69.5 34.0 38.0 25.5 64.5 36.6 36.6 26.7 32.4 37.7 58.7 42.6 19.7 16.4 9.1 41.4 35.9 23.7 33.8 19.3 39.0 9.6 43.7 97.6 21.7 26.6 36.8 43.3 46.6 21.0 41.0 35.4 23.0 24.7 22.7 41.4 42.3 99.9 39.4 38.3 79.2 35.1 42.4 18.7 67.2 56.1 61.0 58.5 17.7 31.1 26.3 50.4 36.9 53.3 34.7 60.6 10.3 50.3 37.0 32.5 69.4 80.3 37.1 32.1 34.9 39.5 20.9 56.1 58.5 47.5 115.6 102.0 145.5 104.6 93.3 104.0 81.7 130.7 117.7 93.9 73.5 119.9 113.9 34.0 139.1 92.7 88.2 129.8 120.4 75.9 73.2 68.7 95.7 72.9 71.4 71.2 71.7 71.9 71.2 74.1 69.5 43.6 28.9 30.2 4.9 29.7 43.7 34.2 53.4 33.0 18.6 79.4 106.3 80.3 57.2 41.1 35.0 4.2 67.7 43.1 65.2 133.1 72.2 529.8 28.0 23.2 40.2 52.8 37.2 6.3 63.0 86.4 43.3 26.0 17.5 39.3 38.5 62.4 166.9 80.2 28.6 7.3 64.4 34.6 78.3 52.9 2787.0 70.2 41.7 56.9 1.9 55.5 58.2 95.8 6.0 7.9 51.7 58.5 70.7 44.2 26.2 166.0 164.5 42.5 24.9 46.0 23.6 47.2 117.3 91.0 62.3 60.9 21.9 56.7 36.2 69.0 33.9 DHRS4 "FLJ11008, humNRDR, SCAD-SRL, SDR-SRL, SDR25C2" ENSG00000157326 "Dehydrogenase/reductase 4" Q9BTZ2 14 23953734-23969279 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.21e-2)" "unprognostic (2.59e-1)" "unprognostic (3.46e-2)" "unprognostic (3.79e-3)" "unprognostic (1.97e-1)" "unprognostic (1.66e-1)" "unprognostic (7.35e-3)" "unprognostic (1.61e-3)" "unprognostic (2.66e-1)" "unprognostic (1.19e-2)" "unprognostic (1.06e-2)" "unprognostic (7.65e-2)" "prognostic favorable (4.55e-6)" "unprognostic (2.03e-2)" "unprognostic (1.48e-1)" "unprognostic (2.03e-1)" "unprognostic (5.68e-2)" 34.1 45.8 8.6 10.4 9.2 6.9 34.5 8.8 9.7 30.5 10.1 43.5 34.0 27.1 5.2 45.8 23.6 5.9 49.1 8.3 8.6 92.0 109.7 28.0 10.2 9.2 8.6 33.0 40.3 8.8 19.3 5.3 9.2 31.9 13.5 3.9 31.2 8.4 62.2 44.7 38.6 8.3 8.6 32.2 33.7 37.9 9.0 9.6 25.4 14.0 8.5 30.5 33.1 9.5 15.1 29.6 10.4 17.2 16.6 18.5 0.1 27.4 15.3 11.5 9.1 6.5 16.5 13.3 14.3 14.6 7.6 18.1 8.6 12.3 10.1 34.6 16.5 7.8 23.5 36.6 9.5 11.6 45.2 18.0 14.8 9.2 20.8 12.3 14.4 19.6 11.8 30.4 15.8 52.3 21.1 10.7 9.9 18.9 30.3 33.8 18.0 41.4 12.1 17.1 19.9 16.1 27.7 17.6 13.8 6.8 16.0 14.6 25.5 13.3 13.8 13.9 9.0 22.8 22.8 3.5 11.8 12.6 13.6 5.4 54.4 6.0 18.0 45.8 21.4 21.5 20.3 18.2 47.4 18.5 20.1 19.5 2.3 18.1 25.5 39.4 19.4 36.2 8.6 9.2 8.8 9.7 8.3 8.6 9.2 8.6 9.2 8.6 9.0 9.5 16.6 16.0 30.5 6.2 12.5 12.5 10.4 15.7 55.2 5.1 22.2 31.9 35.4 17.2 21.3 14.7 0.0 9.6 17.8 34.2 78.2 6.4 50.4 13.1 11.6 14.6 19.2 20.8 2.6 9.8 6.0 23.7 34.7 7.8 13.9 10.5 20.0 68.1 30.4 6.7 2.1 50.1 8.2 29.2 13.5 66.1 11.1 35.9 5.4 3.7 33.2 18.1 47.4 4.0 5.0 5.3 22.3 17.3 24.6 11.2 51.8 235.4 23.2 1.8 6.6 13.5 18.1 59.4 1.9 61.6 13.4 3.8 18.1 22.9 71.8 9.0 DHRS4L2 SDR25C3 ENSG00000187630 "Dehydrogenase/reductase 4 like 2" Q6PKH6 14 23969874-24006408 "Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 136.2" "Cell type enhanced" "Detected in all" "Hepatocytes: 204.2;Proximal enterocytes: 326.4;Proximal tubular cells: 581.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA023972 Uncertain Approved "Nuclear membrane,Vesicles" "Secreted - unknown location" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "Nuclear membrane" "HPA023972: AB_1854890" "unprognostic (1.41e-2)" "unprognostic (2.83e-3)" "unprognostic (1.25e-1)" "unprognostic (2.68e-2)" "unprognostic (1.47e-1)" "unprognostic (2.53e-1)" "unprognostic (6.02e-2)" "unprognostic (3.97e-3)" "unprognostic (7.34e-2)" "prognostic favorable (3.21e-4)" "unprognostic (1.57e-2)" "unprognostic (1.46e-2)" "unprognostic (1.36e-3)" "unprognostic (6.00e-2)" "unprognostic (2.38e-1)" "unprognostic (2.00e-1)" "unprognostic (3.65e-2)" 27.2 39.5 28.8 14.6 29.6 11.5 30.5 28.3 38.4 26.9 30.8 34.7 34.4 19.7 12.8 38.4 18.6 10.6 45.9 28.5 27.8 122.5 136.2 22.5 14.6 29.3 28.7 25.2 34.0 24.5 16.7 10.0 28.7 32.5 26.6 6.7 24.7 20.7 50.7 37.1 42.0 18.4 28.6 29.3 27.9 41.4 29.4 16.9 21.5 28.5 16.5 26.0 26.1 29.9 18.7 29.0 4.9 24.4 46.2 47.9 0.6 17.3 34.3 24.8 18.4 8.4 22.5 12.6 11.5 35.3 16.0 20.6 22.3 29.1 20.6 43.3 13.3 3.1 24.8 52.4 34.0 15.3 47.9 50.0 36.4 16.3 23.7 17.0 29.5 40.0 10.1 44.9 26.7 61.5 40.4 16.5 9.7 45.9 31.8 64.9 19.9 38.2 35.6 23.7 26.0 15.7 24.5 21.5 15.0 10.3 25.2 24.5 20.8 12.9 13.4 15.4 8.8 25.5 21.1 3.8 11.1 23.7 18.8 4.8 56.3 6.9 19.4 47.2 20.1 21.9 20.9 22.2 45.4 17.4 21.0 19.1 2.6 17.2 29.3 37.4 21.8 33.6 28.8 29.6 28.3 38.4 28.5 27.8 29.3 28.7 28.7 28.6 29.4 29.9 39.3 16.0 29.6 10.4 17.8 27.8 46.1 56.8 27.9 9.9 45.5 54.4 17.2 47.1 34.3 25.8 2.1 21.2 22.9 37.9 127.2 40.0 20.7 20.6 20.1 32.0 37.3 24.2 7.3 55.7 7.3 36.4 13.3 16.5 17.7 31.8 50.0 204.2 146.1 11.8 6.7 61.7 42.7 55.9 42.8 35.4 43.8 41.9 51.6 10.3 65.0 79.5 35.0 10.1 8.5 30.4 54.9 37.2 10.8 32.5 326.4 581.7 28.6 8.3 32.9 24.2 32.7 17.2 1.7 42.1 40.2 13.0 21.3 37.5 78.1 42.4 DMAC2 "ATP5SL, FLJ10241" ENSG00000105341 "Distal membrane arm assembly complex 2" Q9NW81 19 41431318-41440717 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 47.9;Distal tubular cells: 39.2;Ductal cells: 44.0;Exocrine glandular cells: 40.5;Extravillous trophoblasts: 67.9;Hofbauer cells: 40.4;Proximal tubular cells: 46.3;Syncytiotrophoblasts: 46.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041427 Approved Approved Mitochondria NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 38: Heart - Muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA041427: AB_2677473" "unprognostic (1.42e-3)" "unprognostic (1.12e-1)" "unprognostic (3.17e-2)" "unprognostic (1.20e-1)" "unprognostic (6.88e-3)" "unprognostic (1.55e-1)" "prognostic unfavorable (1.77e-4)" "unprognostic (4.37e-1)" "unprognostic (3.83e-2)" "unprognostic (1.18e-2)" "unprognostic (1.52e-2)" "unprognostic (2.10e-1)" "prognostic favorable (4.07e-5)" "unprognostic (5.20e-2)" "unprognostic (2.48e-1)" "unprognostic (6.60e-2)" "unprognostic (7.29e-3)" 27.3 33.2 29.3 16.1 29.5 18.2 26.2 30.6 34.7 27.6 26.1 41.1 44.9 31.5 10.4 34.5 27.0 14.1 110.1 29.5 30.7 40.8 36.2 32.6 20.5 31.4 31.4 24.4 35.9 33.2 16.2 18.8 31.0 27.5 17.9 18.7 26.4 20.2 68.4 30.8 42.6 22.3 29.8 26.7 38.2 13.9 31.7 25.7 26.9 80.1 17.2 37.1 26.2 30.5 39.1 134.9 48.4 32.4 33.2 32.9 28.8 31.9 36.9 55.7 49.5 96.7 43.5 40.4 47.8 47.3 30.1 28.6 36.9 59.0 28.4 37.3 47.4 38.1 35.2 70.8 49.5 64.6 36.8 52.5 53.3 44.6 31.3 37.9 66.2 54.7 52.3 39.2 38.0 48.4 59.2 26.4 60.5 55.7 40.3 48.7 38.1 35.8 53.8 53.4 34.6 57.1 51.4 41.9 35.0 38.4 39.2 72.3 50.0 47.7 52.0 29.3 55.7 41.0 41.7 36.6 42.5 46.5 35.0 15.0 28.4 24.2 22.0 25.7 22.9 16.8 16.7 22.2 40.3 19.7 17.7 17.2 9.3 22.9 22.8 26.6 21.0 23.2 29.3 29.5 30.6 34.7 29.5 30.7 31.4 31.4 31.0 29.8 31.7 30.5 25.4 28.9 16.9 0.0 3.1 0.0 0.0 0.0 0.0 0.0 25.7 19.7 0.0 0.0 5.6 12.9 0.0 47.9 9.6 0.0 39.2 44.0 0.0 10.3 17.3 11.6 0.0 0.0 0.0 40.5 67.9 9.3 0.0 14.7 7.6 22.4 0.0 0.0 40.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 31.6 0.0 0.0 0.0 0.0 29.2 0.0 0.0 1.4 0.0 0.0 46.3 2.9 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 46.4 6.5 21.0 0.0 0.0 DNLZ "bA413M3.2, C9orf151, HEP, RP11-413M3.2, TIMM15, ZIM17" ENSG00000213221 "DNL-type zinc finger" Q5SXM8 9 136359480-136363744 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 9.1;Suprabasal keratinocytes: 9.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HDLM-2: 13.4;MCF7: 13.2;REH: 13.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062738 Supported Nucleoplasm,Mitochondria NA NA "Cluster 37: B-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Mitochondria Nucleoplasm "HPA062738: AB_2684857" "unprognostic (2.81e-1)" "unprognostic (2.93e-1)" "unprognostic (8.73e-3)" "unprognostic (2.05e-2)" "unprognostic (1.30e-1)" "unprognostic (9.31e-2)" "unprognostic (1.93e-2)" "unprognostic (1.61e-2)" "unprognostic (7.61e-2)" "unprognostic (2.30e-1)" "unprognostic (9.51e-3)" "unprognostic (4.50e-2)" "unprognostic (2.56e-2)" "unprognostic (9.07e-2)" "unprognostic (1.17e-1)" "unprognostic (1.50e-1)" "unprognostic (4.90e-2)" 16.4 12.2 2.1 0.9 2.5 0.9 16.4 2.7 3.4 16.0 1.4 16.9 1.1 16.6 0.4 10.0 14.1 0.5 36.5 2.1 2.0 23.0 14.4 12.6 1.0 2.2 2.3 12.1 27.9 0.9 11.4 0.4 2.4 12.5 0.1 0.3 10.1 0.5 23.1 13.8 11.3 0.3 2.0 15.5 13.5 12.0 2.3 0.8 12.5 3.8 0.4 17.3 12.2 2.6 1.7 2.8 0.9 3.3 0.5 0.9 1.8 1.8 1.3 2.3 1.0 3.5 1.9 4.1 9.7 1.8 1.7 3.4 0.6 1.7 0.2 13.4 3.1 1.1 1.3 1.0 1.9 2.2 1.4 1.4 1.7 1.8 1.1 0.6 1.2 2.0 1.7 2.9 1.5 13.2 4.5 2.7 5.2 2.7 7.6 13.4 1.6 5.1 2.9 1.6 4.1 4.7 2.8 1.9 2.9 0.5 2.6 1.4 2.8 4.0 3.5 2.8 4.6 2.7 3.3 3.5 2.6 0.9 3.7 0.7 0.0 0.0 0.4 0.2 0.7 1.3 0.6 0.7 0.1 0.5 0.6 0.6 0.1 0.1 0.1 0.3 0.8 0.0 2.1 2.5 2.7 3.4 2.1 2.0 2.2 2.3 2.4 2.0 2.3 2.6 5.4 0.0 0.0 3.3 6.0 8.4 1.1 0.0 9.1 0.6 4.7 3.9 0.8 0.0 0.7 5.5 0.0 1.0 4.3 1.2 1.9 0.5 0.1 3.0 6.9 3.4 0.0 1.7 2.0 1.1 0.9 3.7 3.6 2.6 0.0 1.0 1.4 1.1 1.0 0.0 2.1 1.2 0.0 0.3 7.5 0.2 1.2 3.0 1.8 1.9 0.6 0.3 2.1 2.5 3.5 0.6 0.3 1.2 7.1 0.6 0.8 3.0 0.1 0.4 0.0 2.5 3.7 1.5 4.8 5.7 9.1 1.1 6.9 1.1 0.9 0.9 DNM1 DNM ENSG00000106976 "Dynamin 1" Q05193 9 128191655-128255248 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Endocytosis "Hydrolase, Motor protein" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 319.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 112.4;Cone photoreceptor cells: 89.6;Excitatory neurons: 176.1;Inhibitory neurons: 182.2;Rod photoreceptor cells: 78.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 319.5" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 126.9;U-87 MG: 46.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005920, HPA049910" Enhanced NA NA 8800 "Cluster 10: Brain - Neuronal signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB005920: , HPA049910: AB_2680948" "unprognostic (3.25e-2)" "unprognostic (5.49e-2)" "unprognostic (1.34e-3)" "unprognostic (3.95e-2)" "unprognostic (4.57e-2)" "unprognostic (1.16e-1)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (5.53e-2)" "unprognostic (6.53e-2)" "unprognostic (6.62e-3)" "unprognostic (6.30e-1)" "unprognostic (9.58e-2)" "unprognostic (1.10e-1)" "unprognostic (2.02e-1)" "unprognostic (3.07e-3)" "unprognostic (1.10e-3)" 22.2 7.9 99.8 3.7 129.1 2.0 13.2 13.6 319.5 30.8 0.0 8.0 1.9 8.8 2.4 5.5 9.4 13.4 7.8 140.1 15.9 14.1 5.3 4.6 2.4 50.7 4.1 2.5 8.4 4.1 33.6 2.5 36.6 9.0 2.7 68.3 9.0 3.0 3.2 15.0 9.0 5.3 0.0 1.0 5.0 4.9 10.0 0.9 5.2 4.0 1.8 10.6 21.6 123.1 8.7 126.9 11.3 2.8 3.6 36.8 0.6 8.0 18.9 15.7 6.5 1.7 2.6 0.2 10.7 16.7 0.6 15.3 1.8 0.8 8.6 0.1 12.1 8.3 19.5 0.5 2.6 1.1 5.6 9.8 0.2 12.4 0.2 15.2 0.0 7.3 3.1 0.5 0.0 3.6 0.7 2.7 12.2 2.2 23.1 15.6 0.4 3.9 2.4 0.0 16.1 27.1 27.1 0.8 1.2 1.4 0.3 11.2 0.6 0.5 34.8 36.2 16.6 1.0 0.4 0.8 46.8 0.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.8 129.1 13.6 319.5 140.1 15.9 50.7 4.1 36.6 0.0 10.0 123.1 2.2 0.0 0.0 18.9 0.9 7.9 1.7 0.3 8.0 112.4 2.9 3.9 2.0 5.7 0.8 0.0 89.6 0.3 0.2 0.4 1.9 0.8 0.9 1.3 19.0 1.8 0.0 0.0 176.1 0.9 0.4 24.3 2.6 1.4 1.3 2.8 0.7 0.6 10.6 50.5 182.2 0.9 0.0 0.6 10.5 1.0 2.8 9.2 3.6 22.5 1.3 10.7 0.0 33.7 14.3 0.6 5.0 1.5 0.7 0.8 2.5 5.3 1.1 78.4 0.0 2.1 3.8 1.0 1.8 2.5 7.5 0.8 1.6 2.1 1.6 0.8 DOK7 "C4orf25, Dok-7, FLJ33718, FLJ39137" ENSG00000175920 "Docking protein 7" Q18PE1 4 3463306-3501473 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 41.9;skeletal muscle: 29.5" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 17.1;Enteroendocrine cells: 6.0;Late spermatids: 9.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 16 "memory B-cell: 3.4;naive B-cell: 2.3;NK-cell: 1.9" "Group enriched" "Detected in many" 16 "B-cells: 3.4;NK-cells: 1.9" "Cell line enriched" "Detected in some" 4 "MCF7: 36.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA059449, HPA062780" Approved Enhanced Nucleoplasm,Mitochondria NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 38: Heart - Muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Nucleoplasm Mitochondria "HPA059449: AB_2684023, HPA062780: AB_2732688" "prognostic favorable (8.45e-5)" "unprognostic (2.34e-1)" "unprognostic (2.08e-2)" "prognostic favorable (2.19e-4)" "unprognostic (5.96e-2)" "unprognostic (6.80e-3)" "unprognostic (1.05e-2)" "unprognostic (9.54e-2)" "unprognostic (1.12e-2)" "unprognostic (5.75e-2)" "unprognostic (2.54e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-4)" "unprognostic (4.61e-3)" "unprognostic (5.09e-1)" "unprognostic (3.16e-2)" "prognostic favorable (1.28e-4)" 0.1 0.9 1.0 0.2 4.7 0.2 0.4 7.8 2.9 2.1 11.1 0.3 0.1 1.0 1.7 0.3 5.9 0.3 41.9 1.1 0.9 2.7 1.1 1.6 0.7 4.2 1.5 0.3 5.8 0.1 15.7 0.0 4.7 1.8 0.1 0.0 1.9 1.0 29.5 1.6 1.4 0.0 0.2 1.9 2.7 4.8 3.0 0.0 0.7 8.8 0.4 1.2 0.6 0.0 2.7 0.9 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 2.6 0.0 1.2 0.0 0.1 1.3 0.0 4.4 0.0 0.0 0.1 0.0 2.7 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 36.2 0.0 1.4 0.3 1.6 0.1 0.0 6.7 0.3 2.3 3.0 0.6 0.1 3.0 0.0 0.0 0.0 8.3 0.1 0.0 0.1 0.3 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 2.3 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 1.0 4.7 7.8 2.9 1.1 0.9 4.2 1.5 4.7 0.2 3.0 0.0 0.1 0.0 1.5 1.3 5.3 0.0 3.9 3.7 0.0 0.3 0.7 0.9 17.1 0.0 3.0 5.5 0.0 0.0 0.4 0.5 0.0 2.3 5.8 2.6 0.7 0.1 6.0 2.7 0.4 4.4 0.0 1.4 4.1 2.8 0.0 3.0 0.0 0.1 0.1 0.0 0.9 3.0 2.0 0.0 0.0 9.9 0.9 0.1 0.0 0.0 0.1 0.0 3.1 1.0 0.0 1.8 0.0 0.0 0.0 2.0 0.1 0.3 1.8 0.5 0.0 1.0 0.3 0.2 0.4 0.0 0.0 0.0 0.4 0.1 0.4 1.2 DPM3 "MGC125904, MGC125905, MGC34275" ENSG00000179085 "Dolichyl-phosphate mannosyltransferase subunit 3, regulatory" Q9P2X0 1 155139891-155140595 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease variant, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014667 Approved NA NA 290000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA014667: AB_1847848" "unprognostic (6.47e-2)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "prognostic favorable (7.09e-5)" "unprognostic (7.07e-2)" "unprognostic (1.07e-1)" "unprognostic (2.67e-2)" "unprognostic (6.83e-3)" "unprognostic (4.71e-1)" "prognostic favorable (8.97e-5)" "unprognostic (1.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.75e-1)" "unprognostic (1.50e-2)" "unprognostic (1.71e-1)" "unprognostic (1.28e-1)" "prognostic favorable (8.64e-4)" 74.0 135.0 62.4 24.0 63.6 51.2 80.5 67.1 101.5 87.0 78.7 89.2 62.5 89.5 57.3 57.5 81.2 37.4 84.6 62.1 64.1 106.0 145.5 67.5 37.8 61.9 61.2 79.5 127.0 58.8 128.7 18.3 61.7 87.5 18.6 10.4 93.2 55.6 77.1 61.0 72.2 19.7 64.8 82.7 90.7 59.9 67.8 24.9 95.9 34.3 13.4 72.3 67.7 63.9 97.5 106.6 32.6 79.0 59.2 54.9 35.3 31.1 39.9 41.5 44.0 34.1 113.8 31.3 93.3 26.4 14.2 68.6 12.7 37.8 5.4 44.7 219.2 34.4 156.2 120.8 57.0 31.2 44.9 54.8 68.4 30.1 13.3 19.5 50.3 77.7 40.7 165.9 31.8 239.1 71.0 71.3 81.3 110.5 80.5 60.6 36.8 189.2 52.6 67.4 57.2 117.6 71.4 86.0 116.1 11.9 58.9 148.6 39.3 25.8 62.4 37.4 46.2 138.4 75.8 101.6 68.6 68.1 20.0 57.2 101.3 101.0 86.8 69.0 95.8 109.3 91.0 85.3 104.2 99.6 86.6 82.0 57.3 95.6 69.6 118.2 81.1 86.6 62.4 63.6 67.1 101.5 62.1 64.1 61.9 61.2 61.7 64.8 67.8 63.9 99.3 51.3 75.4 4.2 59.4 27.4 63.6 101.6 52.3 31.6 108.0 116.1 120.7 95.8 80.1 176.6 10.4 69.4 46.4 137.8 66.5 60.3 56.7 115.2 116.1 68.3 99.2 56.4 5.5 162.4 70.6 72.5 63.7 111.6 71.0 53.4 84.3 279.1 87.6 13.5 6.1 213.9 77.3 58.6 59.9 18.8 92.6 60.5 97.8 7.5 44.3 115.1 53.5 3.0 9.5 61.0 176.7 97.8 101.2 58.1 178.3 152.2 107.3 31.5 39.5 54.7 75.8 62.2 9.6 56.5 33.8 40.8 53.9 76.7 157.2 63.3 DSCAM "CHD2-42, CHD2-52" ENSG00000171587 "DS cell adhesion molecule" O60469 21 40010999-40847158 "Plasma proteins, Predicted membrane proteins" "Cell adhesion, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.6;pituitary gland: 4.2;retina: 1.9" "Cell type enriched" "Detected in some" 4 "Oligodendrocyte precursor cells: 4376.6" "Cancer enriched" "Detected in single" 14 "glioma: 3.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HBEC3-KT: 3.6;MCF7: 8.3;NTERA-2: 2.2;SCLC-21H: 3.3;T-47d: 2.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019324, HPA057493" Enhanced Approved "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "HPA019324: AB_2670118, HPA057493: " "unprognostic (1.47e-2)" "unprognostic (1.04e-1)" "unprognostic (7.59e-2)" "unprognostic (1.99e-2)" "unprognostic (9.98e-2)" "unprognostic (5.49e-4)" "unprognostic (1.78e-1)" "unprognostic (9.58e-2)" "unprognostic (7.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.85e-3)" "unprognostic (2.12e-2)" "unprognostic (2.00e-3)" "unprognostic (2.17e-2)" "unprognostic (2.29e-1)" "unprognostic (8.75e-2)" "unprognostic (5.46e-3)" 0.0 0.0 5.4 0.0 5.8 0.0 0.1 0.1 6.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 5.6 4.2 0.0 0.1 0.0 0.0 2.3 2.8 0.0 0.1 0.0 4.2 0.7 3.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.8 0.0 0.4 4.1 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 5.8 0.1 6.6 5.6 4.2 2.3 2.8 3.5 2.9 4.1 4.1 0.0 0.0 0.0 19.9 0.0 0.0 0.1 0.0 0.0 19.6 0.0 0.4 1.1 1.5 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.1 2.1 0.0 0.0 0.4 0.0 0.0 1083.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.2 16.8 649.1 0.0 0.0 2.4 0.0 4.2 0.0 0.0 0.0 200.5 0.0 0.7 0.0 4376.6 21.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.0 0.1 1.7 1.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 DUSP8 "C11orf81, FLJ42958, HB5, HVH-5" ENSG00000184545 "Dual specificity phosphatase 8" Q13202 11 1554051-1572271 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 25.5" "Cell type enhanced" "Detected in many" "Bipolar cells: 113.6;Distal enterocytes: 57.8;Glandular and luminal cells: 65.6;Horizontal cells: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "MCF7: 2.5;SCLC-21H: 1.4;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020071 Approved Approved Cytosol NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" Cytosol "HPA020071: AB_1847903" "unprognostic (2.29e-1)" "unprognostic (4.15e-2)" "unprognostic (1.96e-1)" "unprognostic (4.00e-2)" "unprognostic (1.35e-1)" "unprognostic (7.58e-3)" "unprognostic (6.08e-2)" "unprognostic (1.11e-1)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (4.04e-3)" "unprognostic (1.82e-1)" "prognostic favorable (2.75e-6)" "unprognostic (1.51e-1)" "unprognostic (1.57e-1)" "unprognostic (8.65e-2)" "unprognostic (6.30e-2)" 6.6 2.1 3.5 0.2 3.0 1.0 6.0 0.3 8.1 5.1 0.0 11.3 0.0 8.4 0.6 1.4 8.7 0.5 17.0 5.0 0.1 5.4 3.6 9.5 0.3 1.9 0.4 2.4 15.7 0.2 25.5 0.1 0.1 5.1 0.3 1.6 6.1 0.2 13.3 4.3 6.8 1.2 0.3 3.1 8.3 3.1 0.7 0.2 3.7 0.0 0.1 3.6 4.2 2.0 0.6 0.3 0.4 0.0 0.0 0.0 1.1 0.1 0.4 0.1 0.6 0.6 0.0 0.0 0.2 0.1 0.0 0.9 0.0 0.1 0.3 1.1 0.6 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.7 0.0 2.5 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.3 0.0 0.0 1.4 1.7 0.1 0.2 0.3 0.0 0.1 0.0 0.0 0.1 0.8 0.3 0.8 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 3.0 0.3 8.1 5.0 0.1 1.9 0.4 0.1 0.3 0.7 2.0 14.9 3.2 1.1 0.0 6.3 9.8 8.1 2.7 2.8 113.6 32.1 24.3 6.0 14.3 3.2 12.9 47.9 0.3 11.1 57.8 1.9 7.7 0.3 31.5 24.7 6.5 42.3 0.0 11.1 11.3 0.5 4.3 8.6 65.6 0.0 0.4 1.4 0.6 0.5 90.9 11.3 32.6 6.1 0.0 3.4 0.2 0.6 4.7 5.4 2.8 1.0 22.3 1.0 3.0 5.2 11.0 22.4 0.4 4.7 17.4 19.1 1.6 2.8 35.5 6.6 8.0 15.1 0.8 0.6 2.2 4.8 5.9 10.5 0.7 25.0 14.2 DYNC2I2 "bA216B9.3, CFAP133, DIC5, FAP133, MGC20486, WDR34" ENSG00000119333 "Dynein 2 intermediate chain 2" Q96EX3 9 128633653-128656847 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 20.4;Cytotrophoblasts: 89.8;Extravillous trophoblasts: 95.3;Hofbauer cells: 21.9;Syncytiotrophoblasts: 37.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 35.8;naive B-cell: 52.9" "Lineage enriched" "Detected in all" 5 "B-cells: 52.9" "Cell line enhanced" "Detected in all" "MCF7: 432.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040764, HPA041091" Approved Approved Cytosol NA Yes "Cluster 19: B-cells - Humoral immune response" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Cytosol "HPA040764: AB_10795625, HPA041091: AB_10796237" "unprognostic (1.45e-1)" "prognostic favorable (1.63e-4)" "unprognostic (2.55e-1)" "prognostic favorable (7.01e-5)" "unprognostic (2.27e-1)" "unprognostic (7.00e-3)" "prognostic unfavorable (8.79e-4)" "unprognostic (6.04e-2)" "unprognostic (4.39e-1)" "unprognostic (3.65e-1)" "unprognostic (8.55e-2)" "unprognostic (1.04e-1)" "unprognostic (3.57e-3)" "unprognostic (2.06e-2)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (1.28e-1)" 14.4 49.9 15.7 11.4 15.4 33.2 20.1 14.3 20.1 28.2 30.5 26.7 22.2 22.4 8.9 37.9 30.5 11.1 41.4 15.4 18.9 61.8 39.1 25.1 12.0 17.0 19.4 19.1 36.7 21.2 36.1 11.0 16.4 31.0 10.3 4.5 31.9 14.0 11.1 24.0 27.7 6.3 16.5 23.6 26.3 69.8 16.6 23.8 55.6 4.3 9.5 19.2 23.7 14.7 112.7 202.8 49.8 78.8 11.4 16.1 141.4 46.2 32.9 66.5 42.8 96.6 197.3 40.4 32.4 30.8 62.0 169.4 47.5 50.8 16.6 93.5 40.1 24.0 134.8 52.0 13.9 41.5 39.4 8.0 25.0 66.3 18.9 24.0 46.5 112.6 83.5 34.0 36.4 432.4 151.3 106.1 63.7 97.3 121.0 157.2 66.6 136.8 42.1 36.0 125.1 100.1 143.9 135.9 36.8 13.7 230.5 40.7 28.3 75.9 114.8 95.6 90.7 34.6 100.7 39.6 71.4 41.9 74.0 1.7 1.1 0.4 1.4 1.6 2.3 35.8 2.9 3.9 2.8 52.9 1.1 1.7 0.8 4.5 5.7 11.0 5.7 3.8 15.7 15.4 14.3 20.1 15.4 18.9 17.0 19.4 16.4 16.5 16.6 14.7 2.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 89.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 95.3 6.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 37.4 0.2 0.0 0.0 0.0 DYNLRB2 "DNCL2B, DNLC2B, ROBLD2" ENSG00000168589 "Dynein light chain roadblock-type 2" Q8TF09 16 80540734-80550811 "Predicted intracellular proteins" Transport "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "fallopian tube: 60.8;testis: 227.1" "Cell type enhanced" "Detected in many" "Early spermatids: 2380.9;Late spermatids: 965.0;Respiratory ciliated cells: 523.6;Spermatocytes: 706.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 1.6;MCF7: 5.6;RPTEC TERT1: 2.8;SCLC-21H: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "unprognostic (1.41e-2)" "unprognostic (2.31e-1)" "unprognostic (2.32e-1)" "prognostic favorable (3.91e-5)" "unprognostic (2.29e-2)" "unprognostic (2.45e-2)" "unprognostic (1.73e-1)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (1.17e-1)" "unprognostic (1.05e-3)" "unprognostic (1.41e-1)" "unprognostic (8.82e-3)" "unprognostic (1.73e-2)" "unprognostic (1.83e-1)" "unprognostic (3.15e-4)" "unprognostic (1.55e-4)" 0.9 2.5 6.0 0.5 6.3 0.0 3.3 5.8 7.5 2.4 13.5 0.8 0.4 1.3 17.8 0.9 60.8 1.9 0.7 6.3 6.9 5.7 1.0 6.1 0.4 13.2 13.0 1.3 1.2 4.6 4.3 0.9 10.7 2.2 0.2 4.2 1.1 2.7 0.3 1.9 0.5 0.3 9.8 0.3 0.7 227.1 6.0 0.9 3.3 0.4 0.6 0.9 0.6 9.9 0.1 0.0 0.3 0.0 0.7 0.5 0.1 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 1.6 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.0 1.3 0.0 0.1 0.0 0.0 0.4 5.6 0.0 0.0 0.1 0.2 1.1 0.1 0.0 0.0 2.8 0.7 1.7 0.2 0.8 1.6 0.0 0.2 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.5 0.1 0.3 0.2 0.4 0.3 0.0 0.1 0.6 1.3 1.8 0.5 0.0 1.3 1.3 0.2 6.0 6.3 5.8 7.5 6.3 6.9 13.2 13.0 10.7 9.8 6.0 9.9 0.7 3.2 7.4 4.2 0.2 5.1 4.5 25.9 5.2 1.0 9.8 12.6 0.2 2.8 32.0 1.8 0.0 3.0 0.1 0.4 35.2 5.9 2380.9 274.1 2.8 2.0 3.0 0.0 2.5 1.5 0.7 2.7 0.0 5.1 7.6 1.1 1.1 0.8 0.6 0.0 2.3 1.3 30.5 0.8 0.3 965.0 19.6 2.3 0.0 1.0 3.1 23.9 1.0 0.5 1.5 1.2 0.1 15.4 0.5 2.7 0.3 44.7 523.6 2.6 13.1 0.5 7.8 706.2 22.1 0.8 2.8 3.4 0.9 2.9 0.2 3.0 EEF1A2 "EEF1AL, HS1, STN, STNL" ENSG00000101210 "Eukaryotic translation elongation factor 1 alpha 2" Q05639 20 63488013-63499239 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 1638.0" "Cell type enhanced" "Detected in many" "Bipolar cells: 130.8;Cardiomyocytes: 125.5;Horizontal cells: 269.2;Rod photoreceptor cells: 50.9;Skeletal myocytes: 49.9" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebral cortex: 347.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 240.0;MCF7: 405.9;SCLC-21H: 187.0;T-47d: 157.2;U-2 OS: 202.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034019, HPA051759, HPA053862, HPA056990" Approved Approved Nucleoli,Cytosol NA NA 55000000 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 37: Myocytes - Muscle contraction" Cytosol Nucleoli "CAB034019: AB_1562672, HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302" "unprognostic (1.40e-2)" "unprognostic (6.82e-2)" "unprognostic (4.56e-2)" "prognostic unfavorable (2.90e-5)" "unprognostic (5.17e-2)" "prognostic unfavorable (9.11e-4)" "unprognostic (4.85e-1)" "unprognostic (1.68e-1)" "unprognostic (3.02e-2)" "unprognostic (1.74e-2)" "unprognostic (2.20e-2)" "unprognostic (2.30e-1)" "unprognostic (1.86e-1)" "unprognostic (8.29e-3)" "unprognostic (1.82e-1)" "unprognostic (1.36e-2)" "unprognostic (1.07e-1)" 0.9 32.7 59.3 1.4 81.3 0.0 1.7 17.1 347.2 2.8 0.0 5.1 0.7 0.3 1.1 9.7 0.4 2.4 358.0 73.4 97.3 1.3 3.0 0.8 0.6 95.0 2.9 0.5 6.5 16.2 111.5 0.0 76.3 9.6 0.4 37.2 19.5 0.8 1638.0 6.8 1.9 0.8 0.0 0.3 8.5 1.2 30.7 0.2 0.7 320.7 0.1 2.2 1.8 125.0 0.5 71.0 0.8 16.8 0.0 0.6 7.9 10.0 1.3 51.6 16.3 9.8 41.5 0.0 110.4 0.5 13.4 38.8 240.0 0.7 115.9 0.5 13.1 0.0 24.1 4.1 2.9 0.0 13.4 1.4 2.2 0.1 1.0 0.2 0.0 0.0 3.4 0.2 0.5 405.9 1.4 0.5 11.4 95.6 96.5 8.0 0.2 10.2 2.4 3.9 187.0 89.9 90.0 12.6 1.6 2.2 157.2 3.8 0.0 0.3 202.9 0.7 1.8 0.3 0.9 1.4 0.9 0.5 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 59.3 81.3 17.1 347.2 73.4 97.3 95.0 2.9 76.3 0.0 30.7 125.0 0.1 0.0 0.0 9.4 0.7 0.4 0.9 0.0 0.0 130.8 11.8 4.6 125.5 1.5 0.6 0.0 12.5 0.0 1.1 0.4 0.0 1.3 0.2 0.5 0.3 2.2 0.0 0.0 35.5 0.2 0.2 3.6 4.6 1.4 5.7 1.0 1.1 0.1 0.0 269.2 37.2 0.0 0.0 0.3 0.7 0.5 0.0 0.6 0.0 15.0 0.0 11.7 0.0 14.6 12.7 0.3 0.0 0.0 0.3 2.6 0.0 0.5 0.0 50.9 0.0 49.9 3.4 0.0 0.3 0.0 1.8 0.0 1.5 0.0 0.5 1.1 EEF1D "EF-1D, FLJ20897" ENSG00000104529 "Eukaryotic translation elongation factor 1 delta" P29692 8 143579697-143599541 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Transcription, Transcription regulation" "DNA-binding, Elongation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045101, HPA051002" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 1300000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nucleoplasm, Nucleoli fibrillar center" "HPA045101: AB_10963077, HPA051002: AB_2681305" "unprognostic (9.34e-2)" "unprognostic (2.37e-2)" "unprognostic (9.92e-2)" "unprognostic (1.63e-3)" "unprognostic (5.25e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.82e-4)" "unprognostic (8.56e-2)" "unprognostic (3.74e-1)" "unprognostic (2.98e-1)" "unprognostic (1.80e-1)" "unprognostic (1.76e-1)" "prognostic unfavorable (2.58e-5)" "unprognostic (3.99e-2)" "unprognostic (2.06e-1)" "unprognostic (2.67e-2)" "unprognostic (2.14e-1)" 556.9 600.9 278.8 254.4 299.8 474.5 552.1 276.4 339.0 638.4 302.9 716.0 205.3 497.5 228.5 524.8 523.0 179.7 795.4 267.2 277.0 491.3 582.9 435.3 380.0 303.4 283.3 979.4 1349.3 160.2 328.0 147.2 292.4 609.2 148.3 67.1 577.0 201.9 916.1 615.8 505.9 179.9 281.5 609.6 634.3 288.1 281.7 338.7 504.0 433.0 307.3 538.2 554.0 322.1 454.8 644.8 284.2 246.0 251.0 307.0 314.2 344.2 438.4 536.7 424.0 886.7 420.0 345.5 352.2 386.6 160.4 441.8 295.3 556.0 231.7 274.8 487.6 340.6 1211.8 881.5 373.6 214.1 276.9 594.8 796.6 325.1 367.8 309.6 364.5 282.0 325.2 497.6 309.3 1456.4 838.7 539.7 300.3 580.3 852.3 367.2 204.4 681.0 466.3 757.9 280.0 301.6 300.1 726.3 762.5 174.1 544.3 535.7 285.2 309.9 914.8 465.5 757.5 335.2 142.9 380.2 348.4 431.6 275.3 268.2 535.1 259.6 880.1 503.5 1128.3 1400.1 1110.3 922.6 619.1 1461.9 1365.3 1110.3 408.6 864.7 458.9 874.2 1191.8 2020.0 278.8 299.8 276.4 339.0 267.2 277.0 303.4 283.3 292.4 281.5 281.7 322.1 652.3 163.5 415.9 47.7 1397.8 1846.0 1620.8 1277.4 1438.7 75.7 1568.2 2028.8 3.9 732.0 600.3 342.1 20.9 665.5 942.8 718.8 855.0 751.4 413.0 173.0 441.3 705.7 343.3 639.1 11.3 1793.7 822.0 699.2 520.9 263.8 446.1 931.0 871.7 792.9 799.6 79.1 13.0 971.5 526.9 1361.3 1492.3 1087.1 891.3 823.6 1085.1 17.8 1400.9 502.7 1071.1 15.6 30.2 938.4 799.5 633.1 1098.8 1566.2 998.9 1552.3 241.7 88.9 479.9 1005.6 844.4 34.0 142.2 969.5 1648.6 712.5 1297.8 573.3 870.0 1619.4 EFCAB11 C14orf143 ENSG00000140025 "EF-hand calcium binding domain 11" Q9BUY7 14 89794669-89954777 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 36.8" "Group enriched" "Detected in many" 5 "Early spermatids: 557.0;Late spermatids: 363.3;Oligodendrocytes: 139.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 14.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA051209 Approved "Cell Junctions,Cytosol" NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "Cell Junctions, Cytosol" "HPA051209: AB_2681389" "unprognostic (1.03e-1)" "unprognostic (6.10e-3)" "unprognostic (2.36e-2)" "unprognostic (2.00e-3)" "unprognostic (2.39e-1)" "unprognostic (3.74e-3)" "unprognostic (1.38e-1)" "unprognostic (2.77e-1)" "unprognostic (1.00e-2)" "unprognostic (3.37e-2)" "unprognostic (1.77e-1)" "unprognostic (2.24e-1)" "unprognostic (3.84e-7)" "unprognostic (4.16e-2)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (8.45e-2)" 5.0 4.1 8.5 3.2 8.1 6.1 9.1 8.2 10.6 5.3 9.9 5.4 5.1 3.8 6.4 4.8 11.0 3.4 2.6 7.3 7.2 7.6 6.0 3.2 3.7 8.1 8.3 4.8 4.8 8.2 3.3 6.4 7.6 5.2 5.4 6.2 4.7 5.0 2.0 3.3 3.8 3.8 7.6 3.5 4.6 36.8 8.3 4.4 7.8 2.4 4.8 4.7 3.0 8.6 8.4 12.7 11.0 13.5 6.5 7.1 30.5 12.1 10.9 16.1 11.2 15.2 29.1 13.1 22.4 8.1 11.4 17.9 9.3 24.2 23.1 14.9 6.1 9.4 11.0 24.6 1.5 12.1 22.0 4.9 5.9 10.5 11.9 9.2 13.6 13.8 10.0 12.5 19.3 43.4 9.0 16.3 4.7 34.3 22.7 10.3 17.1 9.6 15.2 23.0 4.5 7.7 15.3 27.9 14.5 22.4 22.7 8.6 11.5 8.7 11.9 9.3 12.0 7.6 23.2 23.0 12.7 5.7 16.1 14.9 1.1 3.0 0.4 2.5 0.2 2.2 0.7 0.8 1.8 2.4 1.1 1.1 2.7 2.9 5.0 1.6 1.0 0.6 8.5 8.1 8.2 10.6 7.3 7.2 8.1 8.3 7.6 7.6 8.3 8.6 5.8 0.0 1.1 30.3 6.2 5.1 7.0 14.2 2.2 8.6 8.8 7.9 4.2 11.5 9.7 18.4 2.1 15.7 3.0 3.3 9.8 12.1 557.0 37.7 6.3 7.4 0.0 9.5 16.8 16.9 28.9 6.3 1.5 10.5 5.1 8.0 6.4 6.3 11.7 3.3 19.1 6.1 10.2 4.0 6.6 363.3 5.6 5.7 3.6 18.7 8.0 6.8 2.1 40.2 139.9 6.5 9.7 7.5 6.4 2.6 3.6 20.4 47.7 13.2 0.0 5.3 6.0 62.8 14.7 5.4 3.3 7.7 2.5 10.2 12.2 5.9 EFCAB6 "dJ185D5.1, DJBP, FLJ23588, HSCBCIP1, KIAA1672" ENSG00000186976 "EF-hand calcium binding domain 6" Q5THR3 22 43528744-43812337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 24.3" "Group enriched" "Detected in many" 8 "Early spermatids: 286.6;Late spermatids: 473.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 2.1;RPTEC TERT1: 1.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA003098 Uncertain Nucleoplasm NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA003098: AB_1079087" "unprognostic (1.85e-1)" "unprognostic (8.85e-3)" "unprognostic (4.45e-2)" "unprognostic (1.04e-5)" "unprognostic (1.00e-1)" "unprognostic (4.25e-2)" "unprognostic (4.96e-2)" "unprognostic (8.82e-3)" "unprognostic (2.02e-1)" "unprognostic (1.54e-1)" "unprognostic (1.91e-3)" "unprognostic (3.66e-2)" "unprognostic (1.71e-3)" "unprognostic (4.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.65e-3)" "unprognostic (1.33e-2)" 0.4 0.8 0.9 0.1 0.9 0.0 1.1 0.0 0.7 1.1 6.8 0.5 0.3 1.2 2.1 0.4 7.7 0.5 0.4 0.9 1.4 1.4 0.4 1.2 0.2 2.2 3.2 1.4 1.2 2.4 2.0 0.2 1.5 0.9 0.2 3.1 0.8 1.1 0.2 0.4 0.2 0.5 1.4 0.1 0.9 24.3 1.4 0.2 3.1 0.2 0.1 0.4 0.4 0.4 0.1 0.3 0.4 0.7 0.6 2.1 0.0 0.5 0.4 0.1 0.2 0.0 0.1 0.0 0.3 0.2 0.8 0.6 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.7 0.8 0.5 0.1 0.5 0.1 0.2 0.0 0.0 0.3 1.4 0.0 0.1 0.6 0.4 0.2 0.0 0.0 0.0 1.5 0.3 0.9 0.3 1.4 0.0 0.7 0.3 0.2 0.0 0.1 0.3 0.1 0.5 0.1 0.0 0.1 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.9 0.0 0.7 0.9 1.4 2.2 3.2 1.5 1.4 1.4 0.4 0.2 3.2 1.8 18.9 0.5 0.3 0.9 1.0 2.2 3.0 1.2 1.0 1.7 0.0 2.3 0.0 6.2 0.0 0.0 0.4 0.0 0.9 286.6 21.8 1.5 0.4 0.0 0.0 46.0 0.7 0.1 1.3 1.1 1.9 1.3 1.5 0.4 0.4 0.3 6.7 36.8 0.4 2.0 0.3 0.3 473.7 3.1 0.3 0.0 15.9 0.6 1.7 0.0 15.1 10.2 1.0 0.1 1.5 0.2 0.5 0.1 1.1 20.4 12.5 6.6 1.3 0.8 24.1 4.7 0.8 0.1 0.1 0.1 1.4 0.4 0.3 EGR3 PILOT ENSG00000179388 "Early growth response 3" Q06889 8 22687659-22693480 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2;skin 1: 45.6" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 284.3;Glandular and luminal cells: 116.6;granulocytes: 108.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 47.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 5.5;HMC-1: 9.5;MCF7: 31.9;SK-MEL-30: 22.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 9 "amygdala: 19.3;basal ganglia: 52.5;cerebral cortex: 47.8;hippocampal formation: 41.3;olfactory bulb: 33.7" "HPA006206, CAB009373" Uncertain Uncertain Nucleoplasm,Vesicles NA NA "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB009373: AB_2097202, HPA006206: AB_10602491" "prognostic favorable (1.83e-4)" "unprognostic (1.15e-1)" "unprognostic (2.40e-1)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "unprognostic (4.07e-2)" "unprognostic (1.00e-1)" "unprognostic (6.44e-2)" "prognostic favorable (4.78e-4)" "unprognostic (3.48e-2)" "unprognostic (5.14e-2)" "unprognostic (1.61e-1)" "unprognostic (2.87e-2)" "unprognostic (2.11e-2)" "unprognostic (4.72e-2)" "unprognostic (2.35e-2)" "unprognostic (1.07e-2)" 29.0 24.5 7.7 19.0 9.9 10.1 10.3 0.6 47.2 9.5 0.0 4.6 1.5 5.6 0.4 5.9 17.3 30.0 12.1 16.1 0.0 5.8 2.9 5.8 11.4 5.1 0.0 15.3 4.5 13.8 6.8 1.0 2.0 14.4 3.2 4.5 3.1 0.9 1.9 45.6 3.9 12.5 1.3 3.3 6.5 5.4 0.0 19.5 8.4 3.2 5.9 14.8 3.6 5.8 0.2 0.0 0.2 0.3 1.8 5.5 0.1 0.6 0.6 0.0 0.1 0.1 0.0 0.1 0.1 1.3 0.4 0.5 0.2 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 9.5 0.6 0.2 0.2 0.0 0.8 0.1 0.2 0.3 0.1 0.0 31.9 0.0 0.2 0.1 2.2 0.1 0.1 0.1 0.8 0.0 0.0 0.0 0.1 0.5 0.0 22.5 0.3 1.4 0.1 0.0 0.3 0.1 0.2 0.4 0.4 0.1 0.0 0.9 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 7.7 9.9 0.6 47.2 16.1 0.0 5.1 0.0 2.0 1.3 0.0 5.8 80.2 6.4 11.2 0.3 46.7 23.1 31.9 43.8 39.3 2.3 73.0 68.2 47.1 0.0 12.2 0.0 0.0 1.3 9.3 3.5 0.0 3.3 18.4 47.1 52.7 36.5 284.3 0.0 16.0 4.2 1.3 33.9 35.2 116.6 108.7 21.8 37.5 0.5 4.7 0.0 0.9 19.2 8.2 19.0 20.3 11.6 3.1 27.8 21.4 3.7 0.0 5.1 0.0 1.0 0.7 4.5 2.2 0.4 3.7 16.1 0.2 0.1 5.7 1.3 0.0 41.3 35.9 0.3 0.2 16.5 50.0 9.7 11.5 6.5 7.0 9.8 ELOB "SIII, TCEB2" ENSG00000103363 "Elongin B" Q15370 16 2771414-2777280 "Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 1279.6;Exocrine glandular cells: 911.2;Pancreatic endocrine cells: 1027.1;Proximal tubular cells: 1789.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064006 Approved NA NA 82000 "Cluster 2: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "HPA064006: " "unprognostic (1.77e-1)" "unprognostic (5.27e-3)" "unprognostic (3.93e-1)" "unprognostic (1.50e-3)" "unprognostic (2.02e-1)" "unprognostic (2.28e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-1)" "unprognostic (1.81e-2)" "unprognostic (4.05e-2)" "unprognostic (3.14e-1)" "unprognostic (7.15e-2)" "unprognostic (7.83e-2)" "unprognostic (3.42e-1)" "unprognostic (1.40e-1)" "unprognostic (1.06e-1)" "unprognostic (6.32e-2)" 234.7 293.3 355.3 130.9 359.6 289.7 235.0 363.3 479.4 217.1 339.1 275.5 141.6 214.1 80.8 297.1 217.7 180.2 485.0 365.8 363.9 301.6 340.1 206.6 185.6 356.8 360.3 187.8 207.5 203.4 279.9 109.8 358.2 233.8 83.2 51.4 332.2 112.9 573.1 254.5 203.5 89.5 362.8 208.8 255.6 428.5 366.5 154.6 199.4 266.2 93.4 220.1 228.6 367.5 185.8 559.0 254.5 407.0 263.5 354.6 265.7 233.1 242.6 254.3 210.0 408.8 372.6 288.6 309.4 256.7 275.1 206.6 146.4 403.4 61.9 349.4 593.0 188.5 773.6 578.7 410.1 276.9 286.6 362.8 517.3 242.4 180.6 254.7 225.8 420.1 258.4 465.0 265.5 1212.8 459.7 708.6 331.4 363.2 570.0 487.9 248.3 636.9 311.8 404.2 461.4 335.2 310.0 472.3 320.1 79.0 434.1 506.3 303.5 323.4 308.9 232.4 277.7 382.8 503.1 619.8 152.5 279.6 347.2 3022.8 1566.1 2928.2 711.2 1154.9 687.1 877.6 741.7 760.1 951.3 757.8 638.9 671.0 1519.2 892.1 1236.0 848.6 1046.2 2212.0 355.3 359.6 363.3 479.4 365.8 363.9 356.8 360.3 358.2 362.8 366.5 367.5 401.9 182.7 218.4 0.0 89.7 0.0 0.0 0.0 0.0 0.0 633.1 738.0 0.0 0.0 131.8 505.8 0.0 562.9 243.1 0.0 1279.6 752.8 0.0 641.0 734.0 188.1 0.0 0.0 0.0 911.2 689.1 219.6 0.0 551.8 107.2 339.5 0.0 0.0 719.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 304.4 0.0 0.0 419.2 0.0 0.0 0.0 0.0 1027.1 0.0 0.0 46.1 0.0 0.0 1789.2 241.9 0.0 0.0 0.0 233.3 0.0 0.0 0.0 0.0 496.8 132.1 310.6 0.0 0.0 EMD "LEMD5, STA" ENSG00000102119 Emerin P50402 X 154379273-154381523 "Disease related genes, Human disease related genes, Predicted membrane proteins" Actin-binding "Cardiomyopathy, Disease variant, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000609, CAB001545, CAB002029, CAB058694, CAB062552" Supported Enhanced "Nuclear membrane,Endoplasmic reticulum" NA NA 240000 "Cluster 29: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" "Nuclear membrane" "Endoplasmic reticulum" "CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736" "unprognostic (2.92e-1)" "unprognostic (6.59e-3)" "unprognostic (4.19e-2)" "unprognostic (3.04e-2)" "unprognostic (2.16e-1)" "unprognostic (9.12e-3)" "unprognostic (3.58e-2)" "unprognostic (6.06e-3)" "unprognostic (7.74e-2)" "unprognostic (3.68e-2)" "unprognostic (1.45e-2)" "unprognostic (1.49e-1)" "unprognostic (2.03e-1)" "unprognostic (2.69e-2)" "unprognostic (7.74e-2)" "unprognostic (2.02e-2)" "unprognostic (1.99e-1)" 32.8 32.5 27.4 15.4 27.4 26.5 33.2 27.8 31.8 46.6 26.6 45.7 14.7 58.2 16.0 35.0 56.2 11.2 46.2 26.0 30.1 48.7 30.6 33.3 13.8 28.5 28.6 63.9 50.5 21.3 42.6 15.5 28.2 36.5 11.1 12.9 33.5 21.8 80.3 36.3 27.2 19.9 29.2 26.9 38.5 17.3 29.7 13.0 40.6 29.7 15.4 51.2 36.1 31.4 121.3 42.4 29.0 32.7 26.3 50.6 54.7 58.1 58.2 68.5 72.4 37.9 22.6 99.6 92.2 56.2 143.5 65.5 55.8 67.4 29.5 60.6 116.8 43.7 58.4 22.5 67.9 42.9 46.8 44.1 53.2 60.4 75.0 46.5 48.3 37.5 37.0 39.0 47.9 49.2 74.4 78.1 51.3 66.3 128.9 62.1 45.9 92.4 38.4 21.9 37.9 47.8 29.8 47.6 74.2 27.8 33.6 31.2 43.5 35.7 69.6 80.2 84.2 131.4 100.6 179.3 42.3 70.9 38.1 35.5 29.5 46.4 45.2 37.3 41.8 37.8 43.1 43.6 24.8 37.0 37.7 37.7 31.0 28.7 28.1 54.9 43.3 30.6 27.4 27.4 27.8 31.8 26.0 30.1 28.5 28.6 28.2 29.2 29.7 31.4 30.3 32.1 39.5 8.1 93.1 71.8 74.8 60.9 84.2 35.1 53.4 60.1 22.3 35.8 40.4 27.6 12.5 60.7 87.4 16.6 70.5 43.5 16.3 46.5 51.8 36.2 23.9 46.7 9.6 55.0 66.4 52.9 53.5 64.4 55.1 40.9 27.1 38.8 52.2 30.3 8.8 37.0 28.5 25.2 93.0 15.4 40.7 69.4 67.6 10.3 50.2 46.9 34.0 5.5 10.8 47.7 31.3 44.8 125.8 86.4 30.9 49.5 27.9 32.6 26.3 49.5 60.1 25.4 36.2 99.3 77.0 125.1 92.7 42.3 30.4 68.3 ENOX2 "APK1, COVA1, tNOX" ENSG00000165675 "Ecto-NOX disulfide-thiol exchanger 2" Q16206 X 130622325-130903317 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Growth regulation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 132.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000514, HPA003027" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "Plasma membrane" "HPA000514: AB_1078558, HPA003027: " "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (6.07e-2)" "unprognostic (6.27e-3)" "unprognostic (5.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.09e-5)" "unprognostic (6.42e-2)" "unprognostic (4.60e-2)" "unprognostic (3.02e-1)" "unprognostic (1.38e-1)" 6.4 7.6 6.4 5.6 9.2 3.3 6.4 5.5 6.9 6.9 5.0 4.9 4.1 8.8 5.4 7.2 7.6 6.6 10.8 6.1 8.0 4.3 5.4 5.1 8.2 7.5 6.7 7.9 3.8 7.8 1.7 5.9 6.4 6.1 5.3 2.8 4.6 8.0 6.7 4.4 4.7 8.2 6.2 7.3 5.6 5.9 7.6 8.6 6.3 8.3 9.5 6.9 3.0 9.2 15.7 12.9 16.2 7.4 15.3 13.2 7.3 12.6 15.3 8.5 5.3 6.0 12.9 11.3 30.1 11.6 11.4 10.9 11.4 13.0 10.7 15.3 12.1 24.6 7.4 6.6 10.6 20.2 16.6 10.7 19.3 10.1 11.3 4.0 12.8 9.9 17.1 8.6 7.0 21.4 13.2 3.7 9.0 20.8 16.0 8.7 10.4 12.9 10.0 10.5 5.5 9.6 12.2 7.2 17.0 6.1 4.6 10.1 10.5 8.3 4.9 13.2 26.4 9.2 4.9 7.6 23.6 19.2 13.8 7.0 11.1 12.9 9.4 14.1 9.6 11.7 10.5 9.7 10.8 11.9 11.2 9.7 1.8 10.8 7.7 5.8 12.4 9.3 6.4 9.2 5.5 6.9 6.1 8.0 7.5 6.7 6.4 6.2 7.6 9.2 11.8 3.2 7.4 15.0 11.5 4.2 6.9 5.1 19.4 4.4 8.1 5.3 13.0 5.7 7.5 3.7 0.0 6.2 7.9 4.9 7.9 8.0 1.0 8.3 13.3 8.6 4.8 11.6 18.7 9.3 5.5 9.7 10.7 5.4 6.3 7.4 7.5 12.3 6.9 3.3 31.2 6.7 14.2 21.3 7.7 2.2 5.6 12.6 8.8 23.4 18.4 4.3 19.6 51.3 132.2 10.1 2.6 6.4 11.9 6.4 4.5 8.4 13.1 8.3 6.6 11.6 9.5 11.4 10.6 13.8 4.8 7.3 11.1 7.6 5.7 5.7 ENY2 "DC6, FLJ20480, Sus1" ENSG00000120533 "ENY2 transcription and export complex 2 subunit" Q9NPA8 8 109334324-109345954 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024648 Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Mitochondria" "HPA024648: AB_2100208" "unprognostic (2.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.18e-1)" "unprognostic (7.85e-2)" "unprognostic (7.70e-2)" "unprognostic (7.45e-3)" "unprognostic (1.48e-2)" "unprognostic (6.65e-2)" "unprognostic (2.54e-1)" "unprognostic (1.21e-2)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "prognostic unfavorable (7.17e-6)" "unprognostic (1.74e-1)" "unprognostic (1.51e-1)" "unprognostic (8.84e-2)" "unprognostic (2.66e-1)" 54.4 55.5 28.1 44.7 29.1 87.6 57.0 29.3 45.3 44.2 32.9 59.5 54.5 37.9 53.8 48.2 36.1 29.9 64.2 29.1 32.2 74.4 101.3 40.4 49.6 31.5 30.5 29.5 44.9 47.2 34.4 41.3 30.1 39.0 55.1 24.5 43.7 36.0 71.7 34.7 47.9 44.1 29.8 47.7 47.9 34.8 29.7 60.3 38.0 68.5 53.8 48.4 38.9 30.9 180.3 145.9 213.6 97.1 79.5 101.0 61.4 140.0 89.9 141.2 177.2 109.0 109.1 115.3 127.9 110.9 63.6 89.7 96.8 99.5 171.7 184.1 113.9 223.5 106.7 227.4 85.4 78.3 133.5 77.5 66.7 92.5 87.3 102.2 215.1 111.5 216.5 63.7 162.7 289.9 235.9 175.5 156.1 207.1 140.3 148.4 93.2 144.5 192.5 134.7 128.9 137.5 87.7 109.3 127.2 117.0 138.6 132.3 146.9 94.1 158.9 97.8 144.7 107.9 125.6 222.2 95.2 128.3 112.7 65.6 102.5 93.5 28.9 112.8 36.7 41.4 39.0 35.6 93.8 27.3 31.9 35.8 56.8 42.4 121.8 80.3 42.3 74.5 28.1 29.1 29.3 45.3 29.1 32.2 31.5 30.5 30.1 29.8 29.7 30.9 231.3 70.5 93.8 16.3 135.0 185.6 196.3 305.7 159.9 63.8 149.2 192.7 170.6 138.7 184.6 145.3 123.0 263.3 157.0 171.5 381.5 214.3 173.3 146.4 134.7 226.3 154.2 160.1 22.7 200.0 284.5 161.0 88.7 144.8 91.8 99.3 142.5 371.1 276.8 45.4 23.9 245.1 225.9 230.3 265.7 111.0 148.2 205.0 158.3 17.8 260.9 112.4 126.7 19.6 27.6 251.2 237.1 112.5 147.2 230.3 264.5 546.1 125.0 139.9 78.9 163.9 262.9 208.7 130.4 151.0 174.6 167.3 132.4 143.9 209.1 208.0 EOLA1 "CXorf40, CXorf40A" ENSG00000197620 "Endothelium and lymphocyte associated ASCH domain 1" Q8TE69 X 149540355-149550510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 27.2;Cytotrophoblasts: 26.9;Extravillous trophoblasts: 8.5;Hofbauer cells: 10.9;Syncytiotrophoblasts: 54.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060897 Approved NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA060897: AB_2684381" "unprognostic (1.37e-1)" "unprognostic (1.36e-3)" "unprognostic (1.93e-2)" "unprognostic (7.19e-2)" "unprognostic (5.16e-3)" "unprognostic (5.67e-2)" "unprognostic (3.09e-2)" "unprognostic (3.18e-3)" "unprognostic (2.73e-1)" "unprognostic (6.82e-2)" "unprognostic (1.96e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-3)" "unprognostic (8.98e-3)" "unprognostic (3.02e-1)" "unprognostic (8.73e-2)" "unprognostic (1.06e-2)" 14.7 53.0 17.4 15.7 18.8 29.1 21.2 19.2 22.8 13.1 21.7 19.6 15.9 12.7 31.5 15.5 13.3 10.7 31.7 21.7 19.0 26.0 24.7 13.4 17.6 18.1 19.6 21.2 23.8 38.4 34.3 15.9 18.0 17.8 20.5 23.3 22.5 16.4 32.3 16.6 17.4 13.2 17.9 25.5 22.3 8.0 18.6 17.8 19.0 27.1 19.0 14.1 13.8 20.3 17.4 22.7 10.9 15.8 18.4 19.1 11.4 16.6 16.5 17.1 22.1 7.7 13.6 35.9 48.8 16.6 18.8 19.0 26.5 15.1 15.7 31.0 26.0 8.8 38.9 10.5 21.0 25.6 25.0 19.7 24.3 19.3 19.3 21.9 19.8 18.2 7.7 29.6 15.5 70.2 20.3 31.7 4.5 30.7 35.2 16.3 17.5 36.2 16.6 21.3 22.1 11.8 7.6 22.6 21.7 8.5 10.9 18.4 15.3 10.2 7.1 29.3 32.4 21.7 17.2 52.1 21.0 35.4 12.7 31.5 14.4 10.0 21.6 15.1 17.0 15.5 16.7 17.7 15.1 11.5 20.3 14.5 13.4 34.5 13.8 42.3 22.0 16.7 17.4 18.8 19.2 22.8 21.7 19.0 18.1 19.6 18.0 17.9 18.6 20.3 1.3 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.2 0.0 0.0 0.0 0.0 26.9 2.6 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 8.5 4.5 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 54.2 0.6 0.0 0.0 0.0 EP400 "CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12" ENSG00000183495 "E1A binding protein p400" Q96L91 12 131949942-132080460 "Plasma proteins, Predicted intracellular proteins" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.0;dendritic cells: 4.7;T-cells: 1.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016704, HPA049013" Supported Supported Nucleoplasm NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA016704: AB_1854888, HPA049013: AB_2680598" "unprognostic (2.28e-1)" "unprognostic (4.04e-1)" "unprognostic (4.33e-1)" "unprognostic (8.03e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.11e-4)" "unprognostic (3.10e-1)" "unprognostic (1.37e-2)" "unprognostic (4.90e-2)" "unprognostic (2.05e-2)" "unprognostic (2.35e-1)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (4.36e-1)" "unprognostic (2.46e-2)" "unprognostic (2.24e-1)" 11.9 14.0 18.5 7.6 15.6 12.2 11.9 15.0 18.1 16.8 9.3 15.7 6.0 14.4 13.2 11.4 15.0 5.9 11.6 18.2 14.6 15.4 11.7 11.3 11.4 14.0 12.1 19.5 12.5 9.5 17.4 6.4 13.1 14.3 6.6 18.1 10.3 8.8 19.3 15.4 13.1 7.3 8.7 18.6 11.7 14.6 15.5 11.7 14.3 8.9 8.6 13.1 12.6 16.5 23.5 30.6 28.3 14.2 16.6 16.3 22.3 13.0 9.9 9.8 8.4 18.3 7.1 19.9 11.8 16.2 11.1 17.6 13.7 13.0 13.2 8.3 20.6 28.5 10.8 20.8 13.7 30.9 21.3 14.0 12.1 18.1 16.3 16.7 16.9 12.7 28.3 5.5 14.3 29.6 23.5 42.1 22.6 12.7 26.3 24.6 19.0 8.1 13.3 28.3 22.8 19.2 15.1 10.4 15.0 20.4 17.4 24.1 25.4 15.6 24.3 17.6 18.9 14.1 11.6 19.8 16.2 17.0 16.0 0.7 0.7 0.6 1.1 0.6 1.1 4.0 1.0 0.9 0.6 4.0 1.2 1.7 0.6 0.6 0.6 4.7 0.7 0.6 18.5 15.6 15.0 18.1 18.2 14.6 14.0 12.1 13.1 8.7 15.5 16.5 19.1 3.2 17.9 44.4 27.8 9.9 10.5 11.0 17.1 34.2 14.0 10.5 13.9 7.2 14.3 16.5 39.6 12.6 22.4 13.2 1.9 11.3 12.5 21.3 25.5 18.6 14.4 14.9 59.6 10.4 11.4 17.3 14.8 21.8 6.3 34.1 15.7 12.1 15.0 25.2 56.4 13.8 12.2 14.1 7.6 6.8 16.4 17.9 7.2 24.4 16.7 15.7 29.9 55.8 48.9 15.3 14.0 17.0 24.3 17.8 8.8 4.2 35.9 37.2 19.7 31.2 20.2 62.8 54.3 20.0 13.1 17.8 26.5 26.9 13.5 13.4 EPB41L5 "BE37, FLJ12957, KIAA1548, LULU, LULU1, YMO1, YRT" ENSG00000115109 "Erythrocyte membrane protein band 4.1 like 5" Q9HCM4 2 120013077-120179119 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 218.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 55.5;MCF7: 83.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037563, HPA037564" Uncertain Enhanced "Plasma membrane" NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 1: Thyroid gland - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Plasma membrane" "HPA037563: AB_2675546, HPA037564: AB_2675547" "unprognostic (1.27e-2)" "unprognostic (2.15e-1)" "unprognostic (2.56e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (5.93e-2)" "unprognostic (8.76e-2)" "unprognostic (2.20e-2)" "unprognostic (9.51e-2)" "prognostic favorable (2.28e-6)" "unprognostic (1.99e-1)" "unprognostic (3.88e-1)" "unprognostic (9.59e-2)" "unprognostic (2.61e-1)" 5.7 6.0 9.0 3.0 7.3 1.0 15.7 43.4 10.6 7.2 4.5 9.9 14.0 7.5 5.8 8.8 12.8 7.4 6.3 7.1 11.1 32.7 56.8 29.9 2.5 8.9 11.1 11.6 26.2 25.1 8.2 9.8 9.0 12.4 8.8 27.8 15.3 6.1 10.1 8.3 11.7 6.5 8.7 2.5 9.1 30.5 12.4 3.6 32.9 8.9 6.6 6.1 8.4 8.1 18.0 6.1 23.8 18.5 16.4 11.8 20.8 3.8 3.7 7.8 7.0 55.5 11.7 0.3 12.9 4.8 9.7 12.1 32.4 14.9 11.5 3.6 10.1 5.2 2.8 31.1 19.1 2.3 5.3 10.6 27.6 14.6 10.4 6.7 22.1 10.4 12.4 1.3 15.6 83.4 4.3 7.9 21.5 8.3 5.6 0.0 7.1 5.0 24.2 17.1 12.3 23.5 16.5 29.0 8.2 32.5 14.0 4.3 18.4 0.7 11.2 12.3 3.9 1.9 3.5 9.2 2.0 0.1 4.5 0.1 0.5 0.6 0.4 0.1 0.1 1.7 0.4 0.4 0.1 1.3 1.1 0.8 0.7 0.6 0.3 0.0 0.2 0.4 9.0 7.3 43.4 10.6 7.1 11.1 8.9 11.1 9.0 8.7 12.4 8.1 6.0 218.0 41.9 61.0 11.1 24.5 28.9 9.7 21.6 33.9 28.0 14.1 13.2 24.3 22.5 33.1 25.0 14.9 4.3 20.6 21.5 18.8 38.0 25.8 12.6 6.8 15.5 5.7 68.4 22.3 12.1 13.1 56.1 45.8 0.0 12.0 17.9 54.2 3.2 8.4 79.8 12.7 22.4 2.1 6.8 20.6 9.0 2.8 14.2 26.2 1.1 15.8 0.0 89.5 25.9 23.2 21.7 9.4 5.9 29.1 20.9 29.0 17.5 35.7 19.7 11.7 9.8 43.5 48.6 18.3 21.7 26.4 6.2 5.7 12.9 39.4 ERF "PE-2, PE2" ENSG00000105722 "ETS2 repressor factor" P50548 19 42247569-42255128 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 157.0;Suprabasal keratinocytes: 109.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058532, HPA067952" Approved Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA058532: AB_2683744, HPA067952: AB_2685932" "prognostic favorable (8.07e-4)" "unprognostic (2.86e-1)" "unprognostic (1.47e-2)" "unprognostic (9.07e-2)" "unprognostic (5.21e-2)" "unprognostic (6.66e-2)" "unprognostic (2.21e-1)" "unprognostic (7.27e-3)" "unprognostic (3.61e-2)" "unprognostic (2.20e-1)" "unprognostic (8.63e-3)" "unprognostic (3.24e-1)" "unprognostic (6.41e-2)" "unprognostic (1.63e-1)" "unprognostic (2.85e-1)" "unprognostic (1.91e-2)" "unprognostic (1.54e-2)" 38.2 31.8 21.1 21.9 23.7 15.2 35.1 16.5 24.3 35.8 10.4 37.1 34.4 48.2 17.4 25.6 49.9 50.1 37.8 19.5 23.9 37.5 43.4 41.6 20.0 22.3 22.5 43.0 29.1 21.0 40.3 18.5 19.5 30.9 10.0 14.6 26.4 17.2 11.6 33.5 34.4 19.9 17.5 31.4 29.8 32.8 21.9 24.2 38.7 18.0 15.6 29.7 31.3 37.7 57.6 136.4 57.7 65.8 12.7 32.4 16.4 53.3 37.4 53.5 54.0 63.2 65.1 47.4 32.9 49.3 48.0 61.7 42.1 124.4 39.2 23.5 29.1 28.5 82.9 80.1 34.3 33.2 45.5 37.1 41.3 41.4 45.5 69.6 45.0 37.9 62.0 38.4 29.8 115.8 38.0 25.0 48.5 54.4 29.3 46.6 21.0 20.1 33.5 49.1 26.6 54.2 59.4 43.4 61.8 39.1 43.6 58.7 54.2 78.4 112.9 27.4 100.0 43.2 53.1 39.0 76.9 35.3 108.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.1 0.0 21.1 23.7 16.5 24.3 19.5 23.9 22.3 22.5 19.5 17.5 21.9 37.7 63.3 3.2 1.7 7.8 25.0 157.0 30.2 19.8 77.4 14.1 95.0 57.9 7.3 25.8 6.3 9.2 22.9 7.2 21.7 21.6 7.9 19.1 9.4 35.1 20.5 43.7 26.4 7.8 4.2 15.8 4.9 27.2 13.7 23.4 11.4 10.0 41.4 30.2 11.7 10.1 1.5 22.9 2.0 14.5 58.6 4.1 11.1 22.9 55.2 7.5 7.3 19.0 3.1 3.5 8.5 15.3 27.2 10.1 11.2 18.8 34.6 23.3 11.9 12.3 13.1 61.0 39.8 3.0 16.2 37.9 109.7 14.8 25.5 10.2 21.7 17.6 ERH DROER ENSG00000100632 "ERH mRNA splicing and mitosis factor" P84090 14 69380128-69398299 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002567 Approved Approved Nucleoplasm,Cytosol NA Yes 190000 "Cluster 44: Non-specific - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA002567: AB_1078749" "unprognostic (2.42e-2)" "unprognostic (1.69e-1)" "unprognostic (3.42e-1)" "unprognostic (4.78e-2)" "unprognostic (9.34e-2)" "unprognostic (8.61e-3)" "prognostic unfavorable (7.89e-5)" "unprognostic (1.93e-1)" "unprognostic (1.06e-1)" "unprognostic (8.83e-3)" "unprognostic (2.31e-1)" "unprognostic (9.24e-2)" "unprognostic (2.49e-1)" "unprognostic (1.12e-1)" "unprognostic (9.32e-2)" "unprognostic (4.31e-2)" "unprognostic (2.39e-1)" 107.7 113.7 143.3 119.0 146.2 144.4 119.3 145.1 186.7 97.0 146.9 110.5 110.0 111.9 150.3 75.5 112.8 70.1 100.2 145.4 159.1 118.3 142.5 76.3 147.1 142.8 146.8 107.0 66.7 128.2 58.3 98.1 147.6 87.0 122.9 116.7 110.0 84.3 107.0 58.1 99.1 114.8 153.7 96.5 88.7 91.1 149.6 212.2 97.6 85.8 168.4 117.0 51.2 154.5 972.7 574.9 704.6 409.1 271.8 201.1 356.9 450.7 261.3 401.3 372.0 598.5 403.1 879.9 224.3 305.3 340.3 296.1 563.4 376.9 484.2 437.9 428.3 441.4 366.1 731.8 419.6 389.3 334.6 227.1 203.0 355.9 317.2 239.2 337.8 584.5 454.0 301.6 335.7 1043.2 714.1 750.8 537.2 525.6 686.0 558.9 599.9 320.6 415.4 672.8 449.1 439.8 442.1 464.6 355.6 330.8 539.9 564.4 351.4 425.7 699.7 286.7 480.0 351.7 336.2 1096.1 345.1 417.5 442.4 76.6 101.4 80.9 76.6 98.9 77.5 122.2 100.0 88.0 107.4 94.3 92.7 88.2 45.3 121.5 95.1 122.8 116.5 147.0 143.3 146.2 145.1 186.7 145.4 159.1 142.8 146.8 147.6 153.7 149.6 154.5 231.2 60.9 54.3 22.2 189.1 273.1 225.0 702.7 180.4 126.4 244.2 314.2 118.9 181.6 282.2 253.8 37.5 455.3 179.4 117.5 673.1 363.8 100.4 238.1 198.9 211.9 188.5 252.6 23.9 275.3 560.3 237.0 120.3 158.7 127.6 186.7 169.6 239.9 341.5 74.0 23.1 244.0 510.6 147.5 215.2 51.3 270.9 162.5 307.7 16.9 302.3 350.3 174.0 19.6 34.6 289.8 183.9 259.2 237.9 288.9 203.9 508.5 278.4 119.8 190.7 177.7 273.8 321.5 230.9 251.0 318.8 279.9 165.3 281.4 265.9 230.6 ETNK2 "EKI2, FLJ10761" ENSG00000143845 "Ethanolamine kinase 2" Q9NVF9 1 204131062-204152044 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "kidney: 108.1;liver: 235.5;testis: 125.0" "Group enriched" "Detected in many" 4 "Early spermatids: 417.0;Late spermatids: 1337.3" "Cancer enhanced" "Detected in all" "liver cancer: 32.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 53.8;MCF7: 55.1" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 8 "basal ganglia: 22.6" HPA057167 Enhanced NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "HPA057167: AB_2683358" "unprognostic (1.64e-1)" "unprognostic (4.17e-2)" "unprognostic (2.56e-2)" "unprognostic (7.81e-2)" "prognostic unfavorable (4.11e-4)" "unprognostic (1.95e-1)" "unprognostic (1.99e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-3)" "unprognostic (4.28e-2)" "unprognostic (6.54e-2)" "unprognostic (4.35e-2)" "prognostic favorable (6.50e-4)" "unprognostic (5.50e-3)" "unprognostic (4.69e-2)" "unprognostic (2.00e-2)" "unprognostic (1.20e-1)" 14.4 6.1 12.8 2.1 12.5 2.8 17.4 7.9 12.0 18.8 28.3 5.7 1.9 10.8 29.9 23.9 13.1 5.3 6.3 10.6 14.0 108.1 235.5 3.3 2.1 10.5 13.4 36.1 9.5 18.5 25.6 4.3 11.1 13.7 2.1 5.7 27.7 16.2 2.0 20.3 3.7 6.5 8.5 7.2 4.9 125.0 15.1 3.7 10.6 4.1 9.3 10.0 26.0 7.5 11.3 3.8 11.0 20.9 4.0 1.3 10.9 11.4 25.2 15.6 6.8 19.2 5.4 0.4 18.4 2.8 18.2 9.9 19.7 15.9 10.7 0.4 17.3 0.2 2.5 30.6 16.2 0.5 0.7 5.4 53.8 3.2 0.7 8.0 11.1 11.9 1.6 0.4 2.0 55.1 3.2 0.3 23.0 0.4 8.4 0.8 13.0 0.4 13.4 4.3 2.9 15.4 7.2 33.6 5.4 35.1 32.5 0.7 0.7 4.4 23.8 1.0 8.4 0.5 0.2 0.5 0.3 0.6 6.3 0.0 0.1 0.0 2.2 0.0 2.1 0.0 0.5 1.3 0.0 0.1 1.3 1.6 0.1 0.8 0.0 0.0 0.3 0.6 12.8 12.5 7.9 12.0 10.6 14.0 10.5 13.4 11.1 8.5 15.1 7.5 1.3 0.0 0.0 1.3 1.0 4.1 13.8 8.2 1.8 4.2 12.3 11.6 1.1 4.3 2.5 3.7 4.2 6.1 1.6 0.1 39.2 9.5 417.0 4.5 1.9 2.1 1.2 13.5 1.2 6.3 9.2 6.4 1.1 3.2 8.9 47.4 6.8 196.9 0.8 0.0 2.9 0.1 2.0 6.5 1.1 1337.3 29.2 1.6 10.6 0.0 0.0 3.8 1.0 2.5 0.2 4.5 0.0 42.2 0.0 14.9 0.3 147.2 3.1 0.8 0.0 4.1 4.4 11.0 7.4 16.1 2.4 9.4 2.9 34.1 0.2 13.5 EXOSC5 "hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p" ENSG00000077348 "Exosome component 5" Q9NQT4 19 41386374-41397359 "Predicted intracellular proteins" "rRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 124.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053150, HPA055677" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli Nucleoplasm "HPA053150: AB_2682058, HPA055677: AB_2682882" "unprognostic (1.24e-1)" "unprognostic (5.68e-2)" "unprognostic (2.99e-1)" "unprognostic (2.53e-3)" "unprognostic (7.50e-3)" "unprognostic (5.74e-2)" "unprognostic (3.83e-3)" "unprognostic (9.23e-2)" "unprognostic (2.36e-1)" "unprognostic (1.54e-1)" "unprognostic (9.39e-2)" "unprognostic (2.35e-2)" "prognostic unfavorable (3.45e-7)" "unprognostic (6.84e-2)" "unprognostic (2.27e-1)" "unprognostic (7.79e-2)" "unprognostic (7.82e-2)" 12.9 19.4 18.6 14.1 20.2 17.4 14.0 18.9 26.1 12.5 15.1 13.3 11.4 11.3 4.2 21.4 15.1 6.6 16.8 18.8 17.8 9.9 21.7 7.3 22.0 20.8 18.4 14.3 28.6 5.9 7.2 7.4 19.2 11.0 7.2 2.3 16.4 8.4 41.7 23.0 10.8 7.2 19.0 14.3 13.6 11.4 18.3 14.8 11.6 23.1 11.8 14.7 13.9 22.1 58.2 123.5 15.1 48.8 10.7 13.5 39.4 24.5 13.1 44.6 37.0 72.5 47.5 92.9 64.8 12.9 22.8 25.1 33.1 31.3 12.2 66.7 117.3 42.7 45.5 55.7 32.1 76.7 41.8 16.3 69.0 35.6 33.8 12.1 21.1 57.7 57.5 70.2 14.2 88.1 70.2 58.6 56.6 85.2 59.9 66.9 40.9 94.8 17.6 43.1 64.4 47.8 34.6 62.4 68.2 10.5 31.1 95.6 16.2 45.9 37.4 30.1 76.9 109.6 138.5 106.3 34.9 116.0 39.0 15.2 68.2 1.9 41.3 77.7 47.9 66.0 43.3 40.9 110.1 74.0 63.2 55.4 5.0 62.1 48.6 118.7 37.0 48.6 18.6 20.2 18.9 26.1 18.8 17.8 20.8 18.4 19.2 19.0 18.3 22.1 16.1 3.2 4.8 2.3 21.3 30.5 29.0 29.6 44.9 5.5 30.1 44.2 8.4 22.8 16.9 18.4 4.2 28.4 23.5 12.7 37.2 21.7 9.1 5.5 16.7 11.1 8.5 28.0 5.0 21.4 124.0 13.1 16.3 9.1 5.1 24.7 7.1 20.3 28.8 6.7 4.8 18.4 20.3 11.8 13.3 8.5 16.8 18.9 14.2 2.8 18.9 7.0 18.6 4.0 4.3 17.2 15.3 12.4 21.3 28.0 6.6 34.9 12.7 4.1 6.6 17.8 16.0 17.0 33.1 47.4 33.2 21.2 17.0 31.5 34.2 23.8 F12 ENSG00000131187 "Coagulation factor XII" P00748 5 177402141-177409564 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins" "Blood coagulation, Fibrinolysis, Hemostasis" "Hydrolase, Protease, Serine protease" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 226 "liver: 604.6" "Cell type enriched" "Detected in many" 8 "Hepatocytes: 523.0" "Cancer enriched" "Detected in many" 21 "liver cancer: 171.0" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 1.2;eosinophil: 3.6" "Group enriched" "Detected in many" 5 "granulocytes: 3.6;monocytes: 1.2" "Cell line enhanced" "Detected in some" "HDLM-2: 7.1;MCF7: 9.0;PC-3: 6.4;SH-SY5Y: 4.3;U-937: 4.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA003825 Approved "Secreted to blood" NA NA 1040000 7000000000 "Cluster 52: Eosinophils - Transcription" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" "HPA003825: AB_1078790" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (2.93e-1)" "unprognostic (4.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-1)" "prognostic favorable (4.63e-5)" "unprognostic (6.97e-2)" "unprognostic (1.26e-2)" "unprognostic (3.96e-2)" "unprognostic (4.41e-1)" "unprognostic (6.54e-2)" "prognostic unfavorable (7.09e-4)" "unprognostic (4.11e-2)" "unprognostic (3.69e-1)" "unprognostic (3.40e-6)" "unprognostic (6.48e-2)" 0.4 0.1 1.4 0.1 1.2 2.6 0.3 0.1 1.3 0.4 0.1 0.5 0.5 0.2 0.0 1.9 0.3 0.1 0.4 1.5 0.8 0.8 604.6 0.6 0.0 0.8 0.6 0.0 0.6 0.1 0.6 0.1 0.9 0.3 0.1 0.0 0.4 0.0 0.0 0.9 0.5 0.0 0.4 1.0 0.1 1.2 0.8 0.0 0.2 0.0 0.1 0.2 0.8 0.8 0.7 1.6 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.8 1.0 0.0 0.3 0.0 0.2 1.1 0.5 0.3 0.0 7.1 1.4 1.1 0.3 0.7 0.2 0.6 2.4 0.2 1.0 0.0 0.3 0.1 0.2 1.6 0.3 2.5 0.0 9.0 0.1 2.1 0.0 2.1 6.4 0.5 0.2 1.5 0.9 0.0 2.0 4.3 0.2 0.7 0.6 0.0 0.3 0.0 0.0 0.1 0.8 0.0 0.2 0.4 0.0 0.0 0.0 4.6 0.5 0.0 1.2 3.6 0.1 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.4 0.3 0.5 0.5 0.0 0.5 1.4 1.2 0.1 1.3 1.5 0.8 0.8 0.6 0.9 0.4 0.8 0.8 0.5 0.0 0.0 0.3 5.3 33.1 7.7 15.3 35.9 0.6 12.7 17.5 1.0 17.2 3.9 1.8 4.2 0.0 4.0 27.6 0.0 6.5 23.3 2.2 0.9 2.2 10.3 19.6 2.6 4.2 0.4 1.1 3.6 1.7 0.0 0.2 16.8 523.0 0.5 0.0 0.8 12.3 8.2 16.7 6.1 42.1 0.6 1.0 8.8 0.0 1.2 0.7 2.1 1.5 0.6 11.1 22.0 0.0 8.5 7.2 60.7 16.1 3.6 0.9 0.0 0.5 1.1 12.0 23.6 57.5 54.3 0.1 4.0 0.1 34.8 7.6 F8A1 "DXS522E, F8A" ENSG00000277203 "Coagulation factor VIII associated 1" P23610 X 154886349-154888061 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 49.0;Proximal tubular cells: 57.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (6.72e-2)" "prognostic favorable (1.67e-6)" "unprognostic (2.92e-2)" "unprognostic (2.57e-1)" "unprognostic (6.88e-2)" "unprognostic (6.61e-2)" "unprognostic (4.18e-3)" "unprognostic (3.31e-2)" "unprognostic (7.96e-2)" "unprognostic (9.23e-3)" "unprognostic (1.20e-1)" "unprognostic (1.80e-1)" "unprognostic (3.68e-2)" "unprognostic (6.28e-2)" "unprognostic (6.16e-2)" "unprognostic (5.61e-2)" "unprognostic (2.69e-1)" 23.1 23.7 30.6 12.9 30.1 33.1 21.0 25.4 39.5 13.8 22.4 19.6 15.2 18.8 22.7 17.6 13.3 7.4 25.5 31.7 29.8 22.8 44.6 17.1 19.3 30.8 28.2 8.8 22.2 14.0 13.7 13.0 31.9 16.3 14.9 14.8 21.8 18.1 27.6 16.5 20.1 14.8 26.2 23.1 15.6 5.8 31.3 20.6 19.6 18.1 20.0 19.4 13.3 32.2 106.4 47.2 9.1 14.7 31.3 14.8 0.2 27.5 22.9 27.8 36.0 18.6 40.2 11.4 87.9 16.7 36.3 11.0 13.3 12.7 22.8 63.3 6.3 11.6 13.3 18.8 9.5 21.1 5.6 28.6 11.6 9.2 5.2 20.6 6.0 29.1 1.2 41.8 16.2 53.8 34.0 94.9 16.3 0.0 54.7 64.1 9.0 10.0 31.8 35.9 45.7 19.0 16.7 20.1 36.4 0.0 23.7 41.6 17.1 15.7 36.0 11.6 22.1 41.6 43.9 101.4 8.3 76.7 36.0 0.0 3.0 6.8 2.9 3.1 1.6 1.5 3.2 3.5 3.5 2.5 3.6 4.0 6.0 0.8 1.2 4.2 1.6 1.7 30.6 30.1 25.4 39.5 31.7 29.8 30.8 28.2 31.9 26.2 31.3 32.2 5.5 12.8 2.6 5.5 14.4 6.6 5.2 1.8 2.2 12.1 14.4 12.4 13.6 27.1 1.5 40.5 6.2 4.0 19.5 11.9 49.0 2.7 0.3 9.2 11.9 7.1 6.7 9.5 7.2 2.0 6.2 7.4 6.6 9.7 5.7 7.6 7.5 24.6 11.2 3.3 6.1 10.2 4.1 27.3 16.8 1.5 10.8 16.9 10.6 7.5 16.7 7.3 30.9 6.6 9.6 2.5 5.7 12.4 4.7 3.1 10.4 57.9 2.7 7.0 6.6 4.6 6.1 0.4 1.5 7.6 6.5 1.6 19.0 8.9 9.8 2.8 FABP6 "I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP" ENSG00000170231 "Fatty acid binding protein 6" P51161 5 160187367-160238735 "Metabolic proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 84 "intestine: 4531.3" "Cell type enriched" "Detected in some" 23 "Proximal enterocytes: 52213.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 31.6;EFO-21: 30.5;HDLM-2: 13.6;NB-4: 17.0;RPMI-8226: 17.2;RT4: 15.2;U-2197: 15.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA012601, CAB024713" Enhanced "Intracellular and membrane" NA NA 890000 "Cluster 56: Intestine - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "CAB024713: , HPA012601: AB_1848435" "unprognostic (3.03e-2)" "unprognostic (7.55e-2)" "unprognostic (1.27e-1)" "unprognostic (5.00e-3)" "unprognostic (1.48e-2)" "unprognostic (3.53e-1)" "unprognostic (5.35e-7)" "unprognostic (3.05e-1)" "unprognostic (1.97e-1)" "unprognostic (2.41e-2)" "unprognostic (2.16e-1)" "unprognostic (2.56e-1)" "prognostic unfavorable (4.35e-9)" "unprognostic (2.10e-2)" "unprognostic (1.21e-2)" "unprognostic (2.48e-1)" "unprognostic (1.85e-3)" 0.0 14.4 7.9 2.5 8.1 0.1 0.2 8.3 11.7 3.1 8.7 3.3 4.9 1.9 0.0 1.2 53.9 0.2 2.2 7.4 11.2 0.2 0.1 5.3 4.2 8.9 8.5 0.1 0.1 0.0 0.7 0.1 10.4 0.2 0.0 0.9 0.2 0.2 0.0 0.4 4531.3 3.4 9.4 1.5 0.4 3.1 9.4 5.6 0.1 1.4 3.5 2.7 0.4 7.7 0.3 0.6 0.0 0.2 0.0 0.0 11.4 0.0 0.0 0.0 0.0 8.1 1.3 31.6 30.5 0.0 0.3 0.0 0.0 0.0 0.0 13.6 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 2.3 1.2 0.4 0.0 0.0 0.0 17.0 0.1 0.0 2.9 0.0 1.0 17.2 0.0 15.2 2.8 0.7 0.0 8.8 0.2 0.1 0.2 0.2 0.0 0.0 0.1 15.3 1.7 1.7 6.9 4.0 0.3 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 8.1 8.3 11.7 7.4 11.2 8.9 8.5 10.4 9.4 9.4 7.7 0.0 0.0 1.5 1.3 0.2 0.5 0.3 7.8 0.6 0.2 0.1 0.1 3.4 0.0 21.9 0.0 0.0 0.0 0.0 0.6 0.0 0.9 0.4 110.2 0.6 0.1 0.0 0.0 1.6 0.0 0.3 0.6 0.0 1.4 0.0 0.6 0.0 0.0 0.1 1.7 2.2 2244.4 2.0 0.0 4.2 0.2 0.3 0.4 0.0 0.0 0.6 0.2 0.0 0.0 0.9 0.3 2080.0 0.0 0.0 0.1 52213.9 0.1 134.9 0.7 0.0 0.0 1.2 0.1 2.1 2.0 0.1 0.0 0.1 1.7 1304.0 1.4 FAHD1 "C16orf36, DKFZP566J2046" ENSG00000180185 "Fumarylacetoacetate hydrolase domain containing 1" Q6P587 16 1826941-1840207 "Enzymes, Predicted intracellular proteins" "Hydrolase, Lyase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 64.1" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 112.2;Proximal tubular cells: 210.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025530, HPA043226, HPA043534" Enhanced Enhanced Nucleoplasm,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria Nucleoplasm "CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535" "unprognostic (3.71e-1)" "unprognostic (1.25e-2)" "prognostic favorable (8.27e-4)" "unprognostic (1.99e-1)" "unprognostic (6.74e-2)" "unprognostic (1.01e-3)" "unprognostic (2.89e-2)" "unprognostic (4.32e-1)" "unprognostic (1.13e-1)" "unprognostic (5.36e-2)" "unprognostic (1.65e-1)" "unprognostic (1.38e-1)" "prognostic favorable (2.80e-14)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (1.26e-1)" "unprognostic (3.31e-2)" 12.3 21.4 9.1 8.5 9.4 10.0 9.4 9.3 11.1 8.3 9.2 22.6 36.1 9.7 8.0 19.3 6.9 12.1 19.9 10.9 11.1 64.1 58.5 7.1 7.4 10.7 10.0 8.0 15.8 12.1 9.5 7.5 10.1 9.4 14.2 6.7 11.2 10.7 30.7 17.1 27.1 8.7 8.8 8.4 21.0 10.1 9.4 7.9 7.8 24.7 6.4 11.3 11.1 9.9 20.1 44.6 20.9 36.9 27.0 19.5 12.9 32.4 16.0 21.1 22.9 28.6 20.4 12.8 26.6 20.2 32.7 40.5 16.4 25.8 19.0 19.3 39.0 11.5 38.7 67.0 26.2 20.0 21.2 25.8 33.3 19.3 12.9 17.8 27.8 15.3 12.1 12.8 26.8 92.5 10.9 30.1 12.4 18.4 33.0 24.6 28.3 36.4 76.8 24.9 40.4 33.6 42.3 33.5 52.0 13.8 49.4 13.4 41.1 34.4 24.6 20.5 17.8 18.6 42.3 15.1 22.0 14.5 15.1 15.8 40.8 16.5 25.1 51.5 22.5 37.2 24.7 27.3 42.6 32.7 27.0 24.8 3.5 38.1 38.4 33.1 28.4 24.3 9.1 9.4 9.3 11.1 10.9 11.1 10.7 10.0 10.1 8.8 9.4 9.9 14.6 25.6 16.4 2.9 11.2 14.0 13.3 29.6 13.1 19.8 12.4 15.7 42.9 27.1 17.2 42.3 27.1 22.6 10.9 50.8 50.9 57.2 89.8 16.8 19.8 16.3 29.3 36.4 8.0 39.2 14.2 15.5 17.3 18.2 5.1 13.8 9.7 35.5 30.5 18.5 8.6 25.6 24.4 9.1 14.2 45.0 14.6 13.7 16.0 4.7 18.9 17.4 20.6 3.0 6.4 34.9 36.7 15.4 4.0 11.2 112.2 210.9 14.4 24.2 13.1 12.7 16.5 9.9 9.1 27.2 24.0 15.3 9.8 30.3 52.7 9.6 FAM120AOS C9orf10OS ENSG00000188938 "Family with sequence similarity 120A opposite strand" Q5T036 9 93431441-93453581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 155.5;Syncytiotrophoblasts: 249.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA021475 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA021475: AB_2670718" "unprognostic (1.20e-1)" "unprognostic (2.33e-1)" "unprognostic (1.56e-1)" "unprognostic (1.48e-2)" "unprognostic (1.10e-2)" "unprognostic (8.07e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (3.10e-1)" "unprognostic (3.42e-1)" "unprognostic (3.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.93e-1)" "prognostic favorable (6.04e-4)" "unprognostic (2.33e-1)" "unprognostic (7.91e-2)" "unprognostic (8.45e-3)" "unprognostic (1.42e-1)" 21.5 19.0 27.7 14.7 27.4 12.2 23.5 27.3 34.2 18.0 27.1 25.1 14.5 18.0 35.4 16.7 16.4 16.7 22.7 27.7 27.4 23.4 18.4 17.7 17.2 28.5 27.1 18.8 23.5 27.9 32.3 23.6 27.3 23.5 24.4 23.6 20.1 20.3 20.8 19.9 16.6 16.0 27.4 14.4 24.2 8.6 28.1 18.6 29.1 19.8 18.8 21.2 15.6 28.9 31.3 29.0 20.2 22.5 28.1 12.1 31.6 19.1 19.8 20.7 15.8 21.5 24.1 26.7 23.8 21.8 29.8 39.1 20.2 20.1 18.9 43.5 16.0 27.6 26.5 24.5 28.6 22.3 17.1 15.6 28.1 20.6 33.2 23.2 22.5 23.5 29.1 37.5 20.0 74.4 30.6 12.1 27.3 42.9 31.0 24.5 27.5 27.8 28.3 27.8 42.1 20.3 28.7 30.8 28.9 22.9 33.0 18.0 15.0 13.1 21.0 45.6 27.2 26.1 37.6 11.6 21.2 13.5 27.6 12.9 9.0 6.7 4.1 8.9 5.8 11.8 6.5 5.8 7.3 8.8 7.9 6.0 10.5 8.0 11.3 8.0 6.8 4.4 27.7 27.4 27.3 34.2 27.7 27.4 28.5 27.1 27.3 27.4 28.1 28.9 29.8 35.3 45.4 22.2 30.8 12.6 45.8 21.6 40.5 25.4 47.6 37.6 38.9 14.3 46.1 18.4 14.6 100.9 25.8 60.6 39.2 37.5 0.5 31.0 31.2 28.4 28.3 26.1 22.2 47.8 155.5 37.3 55.0 45.1 22.8 15.1 24.3 22.3 41.2 6.7 17.5 42.8 14.2 31.8 20.0 3.4 23.9 29.7 12.4 12.2 36.6 30.8 19.6 7.5 17.5 37.9 41.0 33.4 37.0 38.9 33.2 33.9 24.7 32.7 26.3 31.6 36.0 13.7 17.1 34.8 25.9 249.0 30.6 21.3 30.6 59.4 FAM83H FLJ46072 ENSG00000180921 "Family with sequence similarity 83 member H" Q6ZRV2 8 143723933-143738234 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Biomineralization "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 70.5;skin 1: 34.9" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 58.7;hTCEpi: 59.8;MCF7: 118.2;OE19: 62.4;RT4: 70.1;T-47d: 58.2" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA024505, HPA024604" Enhanced Approved Cytosol NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" Cytosol "HPA024505: AB_1848417, HPA024604: AB_1848418" "unprognostic (3.80e-2)" "unprognostic (3.75e-3)" "unprognostic (6.87e-2)" "unprognostic (1.63e-2)" "unprognostic (3.10e-2)" "unprognostic (1.17e-1)" "unprognostic (1.88e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (1.93e-1)" "unprognostic (2.40e-1)" "unprognostic (2.24e-3)" "unprognostic (3.95e-2)" "unprognostic (9.69e-3)" "prognostic favorable (4.42e-4)" "unprognostic (5.54e-1)" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" 2.1 4.0 1.9 2.1 1.7 0.5 4.4 1.2 2.2 11.5 2.6 9.8 8.4 0.8 3.3 70.5 4.7 3.3 0.8 2.0 1.1 11.8 13.5 6.3 0.9 1.6 2.4 0.3 13.9 7.9 5.9 3.5 1.5 7.2 4.3 1.1 17.1 3.8 0.1 34.9 9.1 0.3 1.3 1.7 11.0 2.8 1.5 1.5 14.1 0.0 4.0 8.3 23.2 2.2 47.0 28.3 0.3 0.1 0.1 0.0 16.6 4.0 0.0 2.0 0.7 25.8 53.4 0.0 6.1 1.0 0.0 56.1 3.5 51.9 0.9 0.0 0.2 1.5 58.7 18.3 4.3 0.6 1.7 2.9 59.8 0.2 15.0 0.8 0.0 4.2 22.2 0.1 0.0 118.2 0.8 0.4 4.8 62.4 15.3 0.1 0.1 6.0 16.5 70.1 7.1 0.2 38.3 53.8 7.8 7.5 58.2 8.2 0.3 0.1 7.2 3.9 0.2 0.0 0.0 0.2 0.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.7 1.2 2.2 2.0 1.1 1.6 2.4 1.5 1.3 1.5 2.2 0.1 32.1 16.5 0.7 0.6 22.8 17.7 21.9 6.8 2.0 18.2 14.0 4.6 14.3 18.9 29.5 2.1 12.8 0.5 38.5 3.9 22.0 1.2 11.4 2.9 1.0 14.4 0.0 1.3 25.9 17.8 1.6 25.0 25.9 0.0 5.4 0.7 25.5 4.7 10.1 0.5 24.3 16.2 2.8 0.8 0.7 0.0 1.3 1.8 0.0 2.8 6.6 2.1 0.5 0.1 42.7 27.2 0.4 0.4 26.4 23.6 7.0 17.4 2.0 0.0 0.2 1.9 1.7 1.0 38.9 26.9 14.6 0.9 1.2 27.8 33.9 FASTK FAST ENSG00000164896 "Fas activated serine/threonine kinase" Q14296 7 151076593-151080866 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Apoptosis "Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031621, CAB032539" Approved Supported "Nuclear speckles,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nuclear speckles" "CAB032539: AB_2101115, HPA031621: AB_10611966" "unprognostic (7.67e-2)" "unprognostic (6.41e-3)" "prognostic unfavorable (4.73e-4)" "unprognostic (2.60e-1)" "unprognostic (1.75e-3)" "unprognostic (2.03e-3)" "unprognostic (1.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.24e-1)" "unprognostic (4.66e-2)" "prognostic favorable (3.99e-4)" "unprognostic (3.49e-2)" "unprognostic (2.79e-2)" "unprognostic (4.12e-2)" "unprognostic (1.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.17e-2)" 23.4 36.5 35.5 13.4 33.8 8.2 21.7 32.3 50.6 23.5 30.1 31.5 26.2 23.3 11.9 39.5 21.1 14.5 66.9 34.8 32.9 34.9 58.0 18.8 14.4 34.2 33.9 24.6 28.1 31.0 41.2 9.4 34.5 34.1 11.8 7.9 27.8 18.8 122.6 28.2 25.0 11.8 33.1 24.8 29.0 21.8 35.7 14.7 26.9 95.3 10.5 26.7 25.1 34.3 39.3 45.0 13.9 34.9 50.4 22.4 22.8 29.9 40.1 25.3 29.7 31.5 34.9 9.2 41.0 40.9 46.9 24.1 13.5 36.4 6.1 26.9 23.8 11.4 12.7 27.8 62.7 9.0 25.2 29.8 51.8 29.4 21.5 20.9 30.0 22.4 17.0 20.2 29.2 80.4 20.4 23.5 24.6 47.8 50.8 13.2 17.4 30.4 34.2 27.8 16.4 18.2 40.3 62.5 43.0 11.5 34.4 31.2 24.0 32.7 7.5 31.7 28.0 50.5 33.0 6.5 66.2 19.0 39.8 18.0 31.5 30.1 22.3 32.5 23.4 19.5 23.4 23.4 28.4 21.6 25.5 21.9 6.8 20.4 32.5 38.2 28.3 21.9 35.5 33.8 32.3 50.6 34.8 32.9 34.2 33.9 34.5 33.1 35.7 34.3 21.2 0.0 7.0 17.9 34.3 24.6 37.8 68.8 23.3 42.9 31.7 26.9 18.9 30.0 43.6 25.8 25.0 49.2 38.2 59.2 86.1 49.4 10.0 22.5 21.3 22.9 44.9 28.2 12.7 47.6 26.8 33.8 54.6 24.8 38.8 38.6 23.6 37.1 43.3 37.0 13.6 54.9 59.0 26.3 22.5 20.2 36.4 25.8 94.3 7.5 35.3 54.7 44.3 9.5 10.7 38.6 40.0 34.3 46.1 27.7 86.6 66.3 24.9 51.1 13.1 33.7 35.0 58.5 70.7 36.0 25.3 60.5 34.8 50.1 61.2 35.0 FBF1 "ALB, FBF-1, FLJ00103, KIAA1863" ENSG00000188878 "Fas binding factor 1" Q8TES7 17 75909574-75941140 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.3" "Cell type enhanced" "Detected in many" "Late spermatids: 43.1;Spermatocytes: 27.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023677 Supported Centrosome NA NA "Cluster 35: T-regs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Centrosome "HPA023677: AB_1848440" "unprognostic (7.40e-3)" "unprognostic (9.90e-3)" "unprognostic (6.62e-2)" "unprognostic (1.38e-3)" "unprognostic (3.14e-3)" "unprognostic (7.88e-4)" "unprognostic (5.76e-4)" "unprognostic (6.67e-2)" "unprognostic (2.04e-1)" "unprognostic (1.24e-3)" "unprognostic (6.31e-5)" "unprognostic (6.76e-2)" "unprognostic (1.08e-9)" "unprognostic (1.75e-1)" "unprognostic (1.88e-1)" "unprognostic (3.59e-1)" "unprognostic (1.77e-1)" 3.7 6.8 7.8 3.6 9.9 5.2 3.9 7.6 8.3 6.1 6.3 4.9 2.7 4.6 7.9 8.7 6.2 3.1 3.7 7.9 6.9 5.9 2.6 4.2 4.2 8.8 8.9 6.0 4.4 4.2 13.0 2.0 7.9 9.6 1.9 4.2 5.7 4.5 3.3 13.0 4.4 1.7 8.0 5.6 4.0 32.3 9.8 4.4 18.8 1.3 2.7 5.1 8.7 9.5 11.2 14.6 4.3 8.0 3.9 2.7 11.7 6.3 1.2 4.3 3.1 3.7 6.3 5.4 4.0 3.0 6.1 6.9 2.5 4.5 3.1 3.1 4.8 4.9 9.9 2.8 1.9 1.6 7.4 2.7 5.3 7.1 4.7 2.2 3.3 19.2 9.1 6.2 2.9 12.5 14.1 5.5 3.6 3.4 6.2 11.1 7.0 4.8 2.2 1.8 4.9 4.5 9.0 6.7 3.5 3.2 18.7 3.9 2.0 9.3 7.4 4.9 5.8 10.6 2.9 2.3 5.9 3.6 9.2 0.1 0.1 0.1 0.3 0.3 0.1 0.1 0.2 0.4 0.0 0.0 0.3 0.3 0.0 0.2 0.1 0.4 0.5 0.1 7.8 9.9 7.6 8.3 7.9 6.9 8.8 8.9 7.9 8.0 9.8 9.5 2.4 0.0 2.6 9.1 3.7 3.1 4.9 3.1 12.0 5.4 3.9 3.9 1.6 0.0 7.0 3.7 10.4 6.4 4.4 2.8 3.9 1.3 15.7 8.1 4.4 2.3 1.2 3.4 8.0 0.7 2.1 4.1 6.1 3.9 2.5 7.6 0.0 0.0 2.2 5.0 8.9 2.5 0.0 0.0 2.1 43.1 6.5 1.5 3.6 1.9 1.2 2.7 8.2 3.5 5.7 0.7 1.7 6.0 3.2 2.3 6.2 1.4 9.4 8.0 0.0 4.7 3.2 27.1 9.1 5.2 2.6 3.6 5.9 4.3 3.0 2.4 FBP1 FBP ENSG00000165140 "Fructose-bisphosphatase 1" P09467 9 94603133-94640249 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 324.4;kidney: 297.8;liver: 893.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 500.4;Macrophages: 238.6;Proximal enterocytes: 1095.0;Proximal tubular cells: 864.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 404.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HaCaT: 75.2;MCF7: 243.4;OE19: 54.5;RT4: 157.0;U-698: 170.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA005857, HPA012513, CAB033869" Enhanced Approved Mitochondria NA NA 21000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (1.40e-1)" "prognostic favorable (5.16e-4)" "unprognostic (1.13e-2)" "unprognostic (1.37e-1)" "prognostic favorable (1.79e-4)" "unprognostic (6.94e-3)" "unprognostic (4.52e-2)" "unprognostic (7.79e-2)" "unprognostic (7.59e-2)" "unprognostic (1.12e-1)" "prognostic favorable (6.86e-7)" "unprognostic (6.91e-2)" "unprognostic (3.22e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.64e-5)" 13.7 27.4 1.6 12.7 1.8 15.0 41.4 1.8 5.7 19.9 2.6 29.8 324.4 3.6 15.8 2.7 7.1 34.4 2.9 1.5 2.2 297.8 893.2 165.9 6.8 3.6 2.6 1.1 41.4 107.9 8.6 3.0 2.9 25.8 30.5 0.7 53.2 28.9 1.3 8.1 258.1 8.8 2.6 12.2 85.6 2.5 3.2 2.2 16.8 0.9 7.8 70.8 6.7 3.8 0.5 0.1 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.1 0.6 3.8 0.0 0.3 0.8 0.1 75.2 0.1 0.0 0.1 0.0 0.3 0.6 2.9 1.3 0.0 1.5 18.8 0.0 0.1 0.0 0.0 0.0 2.0 0.0 0.2 0.3 0.2 243.4 0.1 4.4 1.1 54.5 9.5 0.0 0.9 1.9 0.0 157.0 0.7 5.6 0.6 44.5 0.0 0.9 26.7 7.7 0.2 0.1 1.0 0.8 0.0 0.3 1.1 170.4 0.0 1.4 0.1 63.3 68.4 404.3 7.9 162.3 11.7 3.0 4.6 4.6 90.1 3.2 16.2 8.3 12.1 15.4 90.7 32.1 2.3 33.1 1.6 1.8 1.8 5.7 1.5 2.2 3.6 2.6 2.9 2.6 3.2 3.8 2.8 76.9 182.8 0.0 10.3 0.8 8.9 0.7 0.0 0.1 62.4 24.3 0.7 102.9 41.0 62.5 0.0 11.1 14.8 26.1 111.6 21.5 0.1 4.0 0.4 4.8 31.9 24.4 0.9 62.7 1.7 5.4 102.4 5.2 47.4 16.0 12.1 500.4 177.6 0.0 0.8 61.4 0.0 79.9 32.1 1.5 1.5 238.6 12.4 1.9 20.1 2.6 8.2 0.5 0.3 24.0 77.6 4.1 18.3 11.9 1095.0 864.1 9.1 0.2 6.6 0.6 2.0 0.6 1.3 0.8 1.0 10.1 12.1 0.5 90.4 68.1 FBXL6 FBL6 ENSG00000182325 "F-box and leucine rich repeat protein 6" Q8N531 8 144355431-144359376 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 43.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008867 Approved Nucleoplasm,Vesicles Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Vesicles "HPA008867: AB_2668161" "unprognostic (2.97e-2)" "unprognostic (3.30e-2)" "unprognostic (1.13e-3)" "unprognostic (3.13e-1)" "unprognostic (9.88e-2)" "unprognostic (1.68e-1)" "unprognostic (6.29e-3)" "unprognostic (2.62e-1)" "unprognostic (1.10e-1)" "unprognostic (1.43e-2)" "unprognostic (9.04e-2)" "unprognostic (9.73e-2)" "prognostic unfavorable (4.49e-10)" "unprognostic (3.93e-2)" "unprognostic (1.44e-1)" "unprognostic (3.53e-1)" "unprognostic (2.00e-1)" 4.6 4.8 2.3 1.4 2.3 2.0 4.9 2.5 3.2 4.3 2.5 8.0 4.6 3.5 0.6 7.2 3.1 1.0 4.1 2.3 2.2 4.6 10.8 3.9 1.8 2.5 2.4 2.1 8.1 1.6 3.8 1.8 2.4 4.2 1.8 0.5 5.1 1.6 4.2 6.6 7.8 0.7 2.4 6.8 5.5 5.2 2.6 1.5 3.3 0.3 1.2 4.6 4.3 2.3 9.0 3.0 2.1 13.3 2.7 0.7 3.8 4.4 5.1 4.5 3.1 3.2 3.9 4.1 5.3 2.2 2.2 5.8 2.4 6.1 1.0 7.6 3.0 8.2 1.6 7.9 4.0 2.1 8.4 1.2 5.5 2.5 6.6 1.2 3.7 6.7 3.8 6.6 1.7 16.7 6.0 1.9 2.6 9.8 8.3 6.7 2.4 14.0 6.0 3.0 3.1 3.0 5.1 8.0 7.7 1.2 13.2 3.7 3.3 2.2 8.1 10.8 5.4 2.5 2.1 3.0 3.4 5.1 2.9 0.0 0.1 0.6 0.4 0.4 0.3 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.3 1.6 0.7 0.0 0.0 2.3 2.3 2.5 3.2 2.3 2.2 2.5 2.4 2.4 2.4 2.6 2.3 17.9 6.4 2.0 4.6 10.1 5.7 6.0 2.1 7.4 9.9 13.2 12.8 1.1 7.2 4.6 0.0 14.6 8.3 17.3 18.2 5.9 5.2 1.9 5.2 6.8 5.9 2.4 3.0 7.4 6.2 11.6 5.2 13.7 7.8 1.3 7.7 6.8 6.7 6.9 1.7 5.6 19.4 2.0 4.7 7.6 1.6 5.3 9.0 5.4 4.7 2.6 7.9 6.2 2.0 2.7 7.5 10.8 1.9 20.1 8.2 43.7 8.1 2.0 9.0 0.0 5.1 13.6 5.0 7.8 14.8 6.7 3.8 10.7 9.9 17.3 6.3 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141991-117190471 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 128.9" "Cell type enhanced" "Detected in all" "Peritubular cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA062411: AB_2684755, HPA071452: AB_2686398" "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favorable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 12.2 40.9 21.7 10.7 23.0 8.5 17.5 22.2 24.7 18.5 25.7 15.6 16.5 25.0 110.8 15.4 128.9 17.0 31.1 27.2 29.7 53.7 27.5 17.5 13.7 17.5 18.7 60.3 30.7 24.8 20.2 19.5 17.2 26.5 14.6 24.3 16.5 29.3 23.8 16.9 14.3 19.5 20.4 15.2 18.7 42.2 30.2 13.7 28.3 28.5 14.1 16.2 13.8 23.5 20.3 47.3 29.2 16.2 23.5 24.4 33.4 26.6 28.6 24.3 19.7 30.8 14.0 26.5 25.7 27.3 18.2 27.0 34.7 26.6 29.1 15.0 31.2 1.3 24.9 25.0 21.3 8.7 9.0 24.1 25.1 19.5 31.0 39.7 34.4 23.0 10.7 8.6 21.2 33.0 25.0 6.3 43.7 30.9 30.6 29.3 42.5 27.8 24.4 47.7 57.6 34.9 66.4 17.3 14.5 23.3 40.6 3.5 26.8 16.1 20.7 19.1 17.4 15.0 16.6 34.4 23.5 13.5 23.1 1.2 7.0 4.5 11.6 12.2 12.1 10.4 12.0 12.1 9.7 14.3 13.6 12.6 0.6 11.4 12.7 6.6 13.6 8.8 21.7 23.0 22.2 24.7 27.2 29.7 17.5 18.7 17.2 20.4 30.2 23.5 28.5 32.1 35.4 44.1 44.0 37.2 49.1 29.5 40.5 44.3 32.3 26.7 65.4 42.9 39.6 51.5 41.7 58.3 26.3 16.4 45.0 62.5 37.2 108.6 38.3 46.2 39.0 12.0 50.7 50.5 38.0 44.3 24.5 113.1 3.8 57.0 60.0 38.9 15.6 74.0 51.4 23.7 54.9 22.3 17.2 60.4 99.7 17.3 23.2 23.4 18.4 54.1 16.5 41.7 67.5 36.9 16.4 222.3 23.4 48.8 19.0 95.4 29.9 34.1 105.2 35.3 40.6 21.6 43.9 33.9 45.3 65.5 34.1 44.2 27.2 38.3 FBXO6 "FBG2, FBS2, FBX6, Fbx6b" ENSG00000116663 "F-box protein 6" Q9NRD1 1 11664200-11674354 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway, Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 60.6;Late spermatids: 117.8;NK-cells: 60.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051175 Approved NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "HPA051175: AB_2681372" "unprognostic (3.23e-3)" "unprognostic (2.58e-2)" "unprognostic (8.27e-2)" "unprognostic (2.69e-3)" "unprognostic (1.11e-1)" "unprognostic (6.64e-2)" "unprognostic (9.46e-3)" "unprognostic (1.22e-1)" "unprognostic (1.18e-1)" "prognostic favorable (7.12e-4)" "unprognostic (1.47e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (7.83e-6)" "unprognostic (2.65e-2)" "unprognostic (2.11e-1)" "unprognostic (5.23e-2)" "prognostic favorable (5.90e-4)" 6.5 10.7 9.9 11.8 10.1 20.3 6.7 10.3 12.4 7.6 8.2 7.6 13.5 5.0 6.0 10.3 14.1 8.7 10.0 9.8 11.5 7.8 18.5 11.4 18.3 9.9 10.5 5.9 13.8 13.5 6.1 2.6 9.7 8.7 6.8 3.6 13.0 8.4 18.7 9.5 8.2 7.4 10.0 13.0 9.8 10.8 12.6 7.1 6.7 14.5 11.1 9.5 7.0 9.8 10.0 7.3 0.8 0.4 2.1 6.8 4.5 4.2 6.6 20.1 9.2 7.6 8.3 0.3 18.7 7.0 5.5 0.2 6.8 7.5 1.5 26.3 1.0 0.2 1.0 7.7 15.4 9.4 0.1 7.9 15.8 2.5 6.3 4.3 2.6 10.3 22.7 18.7 1.8 19.1 3.4 7.8 0.8 10.2 9.7 2.3 0.1 0.7 6.9 1.4 1.6 2.0 9.3 10.9 14.3 1.8 10.5 10.2 2.0 1.0 0.8 2.7 0.3 10.0 7.5 3.9 1.2 21.6 1.8 17.1 49.5 65.0 47.0 75.0 25.4 15.3 12.0 31.3 66.5 15.0 7.1 23.7 41.4 41.4 91.0 27.3 13.1 36.6 9.9 10.1 10.3 12.4 9.8 11.5 9.9 10.5 9.7 10.0 12.6 9.8 6.0 6.4 6.9 3.3 8.4 7.0 6.6 14.6 4.0 4.3 8.3 7.4 6.8 2.8 15.0 9.2 2.1 1.1 19.5 10.7 0.0 14.5 60.6 15.7 4.5 4.0 4.9 1.7 1.8 38.5 9.2 7.8 8.6 5.3 3.8 2.2 8.2 19.9 26.2 5.0 2.6 8.3 8.2 15.4 34.7 117.8 8.1 18.3 7.2 1.0 37.8 9.0 60.8 0.0 1.3 13.0 10.8 11.3 12.2 11.3 14.3 15.6 36.5 7.8 0.0 3.3 4.0 4.0 11.9 7.3 9.8 1.8 16.0 1.8 9.2 11.2 FBXW9 "Fbw9, MEC-15, MGC10870" ENSG00000132004 "F-box and WD repeat domain containing 9" Q5XUX1 19 12688053-12696631 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 65.6;Respiratory ciliated cells: 80.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042087 Approved Approved Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "HPA042087: AB_10794168" "unprognostic (4.46e-1)" "unprognostic (4.31e-2)" "unprognostic (1.20e-2)" "unprognostic (1.65e-1)" "unprognostic (1.03e-1)" "unprognostic (2.82e-3)" "unprognostic (4.69e-3)" "unprognostic (4.91e-2)" "unprognostic (2.97e-2)" "unprognostic (1.07e-1)" "unprognostic (5.83e-2)" "unprognostic (2.71e-2)" "unprognostic (4.02e-2)" "unprognostic (6.08e-3)" "unprognostic (8.04e-2)" "unprognostic (2.61e-1)" "unprognostic (8.42e-3)" 4.2 7.9 4.4 2.1 4.4 4.2 5.6 2.9 5.8 5.2 9.0 5.2 4.4 4.9 2.0 10.3 13.1 2.9 2.9 4.7 4.3 8.6 5.1 4.5 3.0 4.1 6.3 4.0 7.3 4.3 7.4 2.6 4.2 7.2 1.7 2.0 7.6 3.5 2.7 9.4 4.0 1.7 4.0 3.9 5.6 14.9 4.4 2.9 7.5 0.8 1.9 4.6 5.8 3.2 16.6 11.1 7.2 10.6 3.1 5.2 8.7 5.3 5.4 11.1 9.1 6.2 10.0 4.1 13.5 4.8 2.7 14.7 6.9 10.0 1.9 2.9 18.5 4.9 13.2 10.4 7.0 12.3 2.9 7.0 15.8 7.7 3.8 6.6 8.8 9.4 11.9 2.7 2.5 34.5 13.4 16.1 12.2 8.8 10.4 7.0 5.0 23.2 10.0 4.9 16.5 19.6 7.9 16.5 7.6 2.3 16.5 9.3 4.3 6.5 6.0 8.1 8.5 16.4 7.3 4.5 8.1 4.5 4.3 0.0 7.4 0.0 2.7 7.1 4.6 2.8 2.9 2.1 11.1 2.5 2.8 2.0 0.3 4.7 4.9 3.1 5.7 5.0 4.4 4.4 2.9 5.8 4.7 4.3 4.1 6.3 4.2 4.0 4.4 3.2 4.8 3.2 5.4 1.3 1.3 6.0 5.2 18.6 8.0 2.0 12.1 13.0 0.7 8.6 14.3 1.8 6.2 14.4 1.5 5.7 5.9 18.1 6.4 65.6 6.9 4.2 4.8 11.8 3.7 16.0 8.4 4.4 5.6 6.8 0.0 10.7 4.6 3.6 7.0 0.0 3.1 9.2 22.4 4.5 3.7 8.5 2.5 5.9 3.6 0.0 4.2 4.9 1.0 1.0 1.2 11.6 5.6 4.5 1.7 4.2 5.5 17.4 80.3 7.1 6.6 4.4 6.5 30.8 17.3 9.2 8.2 6.4 2.4 20.3 12.5 4.9 FIBP FGFIBP ENSG00000172500 "FGF1 intracellular binding protein" O43427 11 65883740-65888531 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 608.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011729 Approved Supported "Nuclear speckles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear speckles" "HPA011729: AB_1848579" "unprognostic (1.70e-1)" "unprognostic (6.06e-2)" "unprognostic (1.06e-1)" "unprognostic (3.35e-1)" "unprognostic (1.37e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (1.74e-4)" "unprognostic (2.23e-1)" "unprognostic (2.95e-1)" "unprognostic (3.10e-3)" "unprognostic (2.13e-1)" "unprognostic (1.29e-1)" "unprognostic (5.50e-2)" "unprognostic (2.39e-1)" "unprognostic (3.18e-1)" "unprognostic (1.83e-2)" "unprognostic (4.89e-2)" 34.1 48.4 48.0 26.8 49.0 32.2 33.0 48.0 55.1 31.1 41.8 30.8 30.4 35.9 29.4 35.6 37.2 22.3 56.8 51.0 50.5 48.3 37.1 31.6 35.6 53.3 47.6 28.6 39.0 32.8 31.2 25.1 54.3 30.6 27.3 19.8 27.9 24.6 53.6 45.7 35.3 30.9 46.6 43.3 37.7 64.9 49.9 40.3 35.9 56.1 42.9 29.7 28.3 47.8 61.0 86.9 48.3 118.6 72.8 91.2 35.9 54.8 110.9 74.3 62.0 36.1 83.1 79.7 98.2 124.1 35.9 65.2 48.5 121.0 48.1 93.7 62.2 77.3 84.1 54.7 99.8 100.7 64.4 73.8 68.3 54.1 114.4 60.0 93.7 61.5 27.4 139.4 98.9 198.2 78.9 88.0 47.8 61.5 130.7 104.9 45.6 196.3 88.5 79.6 87.8 80.4 60.3 110.6 110.5 32.5 113.0 58.1 86.3 79.7 66.4 130.9 40.3 73.8 87.6 48.4 101.1 73.6 30.7 123.5 121.2 98.9 71.1 136.9 74.4 100.7 67.2 64.9 164.7 83.1 52.7 57.0 20.4 101.1 150.0 84.1 100.6 109.4 48.0 49.0 48.0 55.1 51.0 50.5 53.3 47.6 54.3 46.6 49.9 47.8 55.8 12.8 28.0 4.9 57.0 47.3 51.7 105.7 38.7 47.7 66.9 85.6 44.7 42.9 55.7 44.1 31.3 79.4 41.1 61.6 93.9 114.2 176.7 45.3 59.8 52.6 93.5 39.1 7.1 149.3 125.7 50.3 37.2 39.6 67.2 68.6 45.3 36.5 115.0 42.1 7.3 49.2 57.0 75.3 75.9 608.0 36.1 67.9 51.6 3.7 129.3 47.1 101.0 3.5 5.6 98.9 68.8 39.5 60.1 56.1 185.8 150.1 54.9 52.8 19.7 39.2 77.2 100.5 84.0 51.5 52.1 71.8 54.6 79.6 58.8 61.5 FIS1 "CGI-135, H_NH0132A01.6, TTC11" ENSG00000214253 "Fission, mitochondrial 1" Q9Y3D6 7 101239458-101252316 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 891.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA017430 Approved Supported Mitochondria NA NA 140000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA017430: AB_1848608" "unprognostic (1.45e-2)" "unprognostic (8.20e-2)" "unprognostic (4.31e-2)" "unprognostic (1.78e-1)" "unprognostic (1.48e-2)" "unprognostic (1.63e-1)" "unprognostic (7.73e-2)" "unprognostic (6.54e-2)" "unprognostic (5.33e-2)" "unprognostic (2.93e-1)" "unprognostic (1.36e-3)" "unprognostic (3.47e-2)" "prognostic favorable (1.08e-7)" "unprognostic (1.29e-2)" "unprognostic (1.49e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" 205.8 227.6 202.4 60.0 231.0 110.2 195.2 234.0 230.7 149.5 194.5 211.0 83.0 168.1 100.5 155.9 166.0 70.9 382.2 198.4 213.5 250.5 294.9 140.4 73.2 238.9 222.7 152.3 208.7 201.1 209.3 75.4 237.8 160.3 69.5 34.8 142.4 90.0 475.6 174.3 137.3 83.7 223.9 163.0 194.4 145.5 217.6 84.0 178.9 284.2 63.8 163.2 141.1 256.0 110.1 124.3 94.7 133.6 103.6 136.6 63.5 118.1 139.0 103.2 88.3 81.7 173.2 107.4 145.7 159.4 98.1 64.0 65.8 184.5 56.8 87.9 101.0 49.8 154.7 100.6 124.5 93.1 75.0 131.9 172.5 73.4 111.5 117.2 185.6 60.3 109.0 142.9 155.0 445.1 145.1 160.4 100.8 221.2 123.0 70.7 53.4 235.8 155.1 107.5 120.6 141.9 57.0 261.5 83.0 81.3 88.0 101.5 159.6 120.6 76.6 127.9 125.3 122.2 98.6 61.6 111.7 103.0 159.0 153.9 137.7 135.9 122.3 141.7 126.4 152.7 115.5 115.9 149.6 152.8 115.0 120.5 104.5 126.3 131.6 123.2 155.6 207.9 202.4 231.0 234.0 230.7 198.4 213.5 238.9 222.7 237.8 223.9 217.6 256.0 301.0 102.5 119.1 16.0 127.5 104.9 158.6 158.4 114.4 48.2 220.5 309.2 349.4 207.3 114.8 229.9 16.7 259.8 120.7 334.5 561.5 263.5 208.5 145.4 120.7 205.8 219.4 423.7 13.6 293.4 309.2 166.7 110.1 126.4 136.3 132.4 182.0 384.9 297.0 35.3 13.2 317.9 128.1 170.9 133.5 730.3 193.9 136.0 218.7 15.0 214.1 281.5 171.9 6.6 83.1 232.2 460.4 179.0 184.8 221.0 603.6 891.2 130.9 59.6 98.6 161.1 233.3 188.0 201.2 192.7 135.7 324.1 127.5 247.4 277.5 192.5 FLYWCH2 ENSG00000162076 "FLYWCH family member 2" Q96CP2 16 2883213-2899382 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041354 Uncertain Approved Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA041354: AB_10795007" "unprognostic (3.57e-2)" "prognostic favorable (9.38e-4)" "unprognostic (7.33e-2)" "unprognostic (8.53e-3)" "unprognostic (4.40e-1)" "unprognostic (3.81e-2)" "unprognostic (4.83e-3)" "unprognostic (8.35e-3)" "unprognostic (8.92e-2)" "unprognostic (1.62e-1)" "prognostic favorable (1.87e-5)" "unprognostic (5.50e-2)" "unprognostic (2.54e-2)" "unprognostic (1.06e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" "unprognostic (2.65e-1)" 26.1 44.8 27.0 10.2 25.8 7.6 26.5 31.3 33.2 21.9 21.9 24.9 15.7 27.2 5.7 24.1 21.8 11.0 34.9 28.8 32.9 27.6 11.7 21.5 10.7 37.8 31.4 27.3 14.1 17.6 34.8 7.7 33.2 30.3 5.3 5.8 26.1 14.0 31.5 19.5 17.4 10.1 27.8 35.2 20.2 24.2 30.6 11.6 30.6 17.7 6.9 19.3 21.9 25.8 23.0 44.7 18.9 45.0 17.4 26.2 27.8 18.0 13.7 19.0 13.2 20.9 28.7 23.1 67.0 16.0 17.7 15.0 10.8 25.5 3.4 38.7 28.5 24.9 45.3 17.1 53.3 14.7 23.9 36.5 18.8 15.1 7.4 23.5 15.1 40.5 17.7 24.1 12.9 110.1 37.4 63.8 20.9 22.1 47.3 72.4 20.8 50.7 13.7 6.7 29.2 38.1 50.5 53.2 38.4 7.1 63.2 45.5 20.7 31.7 26.0 50.0 18.6 39.9 38.1 32.6 18.9 21.8 22.9 8.5 19.2 16.2 21.7 28.2 23.1 22.9 24.7 20.7 27.7 22.0 26.7 23.4 7.9 16.2 28.7 38.0 25.3 20.2 27.0 25.8 31.3 33.2 28.8 32.9 37.8 31.4 33.2 27.8 30.6 25.8 62.3 12.8 11.2 7.5 21.9 20.4 40.4 60.0 29.6 19.9 45.5 50.5 15.0 14.3 31.8 44.1 8.4 21.5 25.9 32.8 84.1 45.5 12.6 34.1 46.0 45.0 33.6 11.1 10.5 55.6 46.2 38.3 15.8 31.6 14.5 31.3 18.2 5.5 34.5 15.2 14.0 42.2 61.1 9.2 25.3 12.2 21.1 25.1 42.7 5.6 27.2 54.1 32.0 7.5 7.2 43.8 34.4 25.2 12.8 30.5 29.3 60.2 24.5 19.3 32.9 25.9 46.3 84.8 69.3 34.1 28.4 12.0 22.0 60.5 35.2 34.7 FOXP3 "AIID, DIETER, IPEX, JM2, PIDX, SCURFIN, XPID" ENSG00000049768 "Forkhead box P3" Q9BZS1 X 49250438-49270477 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 7.2;lymphoid tissue: 7.4" "Cell type enhanced" "Detected in some" "granulocytes: 1.3;Hepatocytes: 1.4;Horizontal cells: 3.3;Melanocytes: 1.8;T-cells: 5.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 11 "T-reg: 53.3" "Lineage enriched" "Detected in single" 394 "T-cells: 53.3" "Cell line enhanced" "Detected in some" "HDLM-2: 2.9;MCF7: 5.2;SiHa: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026301, HPA045943" Enhanced Supported Nucleoplasm NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 16: Immune cells - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB026301: , HPA045943: AB_2679508" "unprognostic (2.46e-2)" "prognostic favorable (1.91e-4)" "unprognostic (4.95e-3)" "prognostic favorable (7.02e-4)" "unprognostic (2.55e-4)" "prognostic favorable (4.90e-4)" "unprognostic (2.42e-2)" "unprognostic (3.46e-1)" "unprognostic (1.04e-2)" "unprognostic (1.99e-3)" "unprognostic (8.77e-3)" "unprognostic (1.94e-1)" "unprognostic (2.73e-14)" "unprognostic (5.93e-2)" "unprognostic (4.55e-2)" "unprognostic (1.98e-1)" "unprognostic (1.39e-1)" 0.2 0.2 0.9 7.4 0.7 1.3 0.7 1.5 0.8 0.4 0.0 0.6 0.7 0.2 7.2 1.2 0.2 1.6 0.2 0.8 0.6 0.3 2.4 0.9 6.1 0.7 0.7 0.4 0.2 0.4 0.5 0.1 0.8 0.6 0.7 0.7 1.1 0.8 0.3 2.3 1.9 0.3 0.5 2.4 1.6 1.3 0.8 7.2 0.6 0.1 5.2 2.8 0.3 0.7 0.1 0.3 0.2 0.9 0.1 0.0 1.1 0.2 0.2 0.1 0.4 0.8 0.2 0.6 0.3 0.5 0.6 0.3 0.8 0.0 0.1 2.9 0.5 0.2 0.3 0.2 0.4 0.3 0.4 0.1 0.8 0.9 1.7 0.0 0.0 0.9 0.9 0.7 0.0 5.2 0.1 0.3 0.8 0.1 0.7 0.4 0.3 0.2 0.2 0.2 0.6 0.5 4.7 0.5 2.0 0.5 1.5 0.8 0.8 0.3 1.4 0.5 0.1 0.4 1.1 0.4 0.2 0.8 0.7 0.0 0.0 0.0 0.0 0.1 0.2 0.0 4.7 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 53.3 1.3 0.9 0.7 1.5 0.8 0.8 0.6 0.7 0.7 0.8 0.5 0.8 0.7 0.1 0.0 0.6 0.3 0.4 0.5 0.0 0.0 0.0 0.2 0.3 0.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.1 1.3 0.1 0.0 1.4 0.1 3.3 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.3 1.8 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.8 0.9 0.0 0.4 0.0 5.3 0.2 0.0 0.0 FUNDC2 "DC44, HCBP6" ENSG00000165775 "FUN14 domain containing 2" Q9BWH2 X 155025980-155060304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 18.3;tongue: 19.5" "Cell type enriched" "Detected in all" 4 "Late spermatids: 1375.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059129 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "HPA059129: AB_2683915" "unprognostic (2.23e-1)" "prognostic favorable (9.20e-4)" "unprognostic (2.03e-1)" "prognostic unfavorable (7.26e-4)" "unprognostic (2.07e-2)" "unprognostic (6.20e-2)" "prognostic unfavorable (3.78e-5)" "unprognostic (6.56e-2)" "unprognostic (6.19e-2)" "unprognostic (2.81e-2)" "unprognostic (1.49e-3)" "unprognostic (3.14e-2)" "unprognostic (1.17e-1)" "unprognostic (2.74e-1)" "unprognostic (5.67e-2)" "unprognostic (7.37e-2)" "unprognostic (2.81e-1)" 3.7 3.6 3.3 1.6 3.6 3.3 3.2 4.4 3.5 3.6 3.8 4.0 2.0 3.3 3.5 2.4 3.7 2.8 10.4 3.4 3.6 4.4 2.5 2.5 2.5 3.9 3.6 6.5 7.7 4.3 3.0 2.5 4.0 3.3 2.5 3.1 3.3 2.9 18.3 1.5 2.1 4.0 3.8 1.9 3.2 2.5 3.9 2.8 3.1 19.5 2.2 3.0 2.5 3.4 5.3 2.7 4.9 3.7 6.5 5.0 3.7 3.1 3.6 3.8 7.7 2.8 2.1 7.0 7.7 4.0 2.9 2.2 5.3 4.3 2.6 3.6 6.2 2.2 3.8 1.6 2.9 4.6 2.8 5.6 6.5 3.1 2.7 2.5 2.6 3.0 2.9 4.9 4.0 2.4 3.4 2.6 3.3 4.3 6.4 2.9 3.5 7.0 3.9 2.1 2.6 5.5 2.6 2.7 3.9 2.4 2.8 4.4 2.7 2.8 4.0 5.1 4.9 3.0 5.4 7.3 2.8 5.7 2.3 1.5 2.1 2.1 2.5 2.3 2.3 2.5 2.3 2.4 2.7 2.2 2.4 2.6 0.1 1.7 2.8 2.4 2.6 3.3 3.3 3.6 4.4 3.5 3.4 3.6 3.9 3.6 4.0 3.8 3.9 3.4 92.7 44.8 43.5 8.8 77.4 72.3 109.7 85.1 68.3 39.6 65.1 77.8 141.8 85.8 46.8 64.4 6.2 71.1 67.4 28.7 223.0 116.3 297.0 43.4 49.9 73.8 47.8 84.6 5.5 113.7 95.3 109.2 35.7 45.2 68.9 69.8 48.9 76.1 81.8 45.4 7.1 48.8 61.1 55.4 52.6 1375.2 107.8 66.2 67.6 5.6 60.0 109.3 64.9 7.5 12.8 104.9 35.4 76.3 104.7 142.4 78.2 193.0 39.5 49.2 26.3 141.6 90.9 31.6 46.2 54.6 60.1 79.9 69.4 54.3 51.1 85.8 FUT5 FUC-TV ENSG00000130383 "Fucosyltransferase 5" Q11128 19 5865826-5870540 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.1" HPA046966 Uncertain NA NA "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "HPA046966: AB_2679879" "unprognostic (7.72e-2)" "unprognostic (3.59e-1)" "unprognostic (5.03e-2)" "unprognostic (1.20e-1)" 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 G6PC3 UGRP ENSG00000141349 "Glucose-6-phosphatase catalytic subunit 3" Q9BUM1 17 44070735-44076344 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Gluconeogenesis Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067052 Supported "Endoplasmic reticulum" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" "Endoplasmic reticulum" "HPA067052: AB_2685771" "unprognostic (9.13e-2)" "unprognostic (2.28e-1)" "unprognostic (3.61e-1)" "prognostic favorable (1.11e-4)" "unprognostic (1.88e-3)" "unprognostic (3.16e-1)" "prognostic unfavorable (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (2.43e-1)" "unprognostic (1.15e-2)" "unprognostic (2.59e-2)" "unprognostic (1.85e-3)" "unprognostic (1.87e-3)" "unprognostic (4.53e-2)" "unprognostic (3.06e-2)" "unprognostic (2.35e-1)" "unprognostic (4.49e-2)" 56.7 97.2 64.8 22.5 67.8 16.0 55.6 70.5 79.3 47.6 88.8 42.1 28.7 55.4 63.9 37.1 45.6 23.9 61.9 65.3 77.5 75.2 26.4 42.9 19.3 74.9 86.9 44.3 56.5 66.7 95.1 25.8 96.1 59.5 18.2 17.1 48.7 40.6 54.3 26.8 39.6 23.0 67.9 45.2 51.4 55.1 72.7 15.2 71.1 26.4 12.0 48.7 37.7 72.4 40.0 231.7 73.7 128.5 77.9 58.3 55.3 45.0 86.9 96.2 64.4 97.1 62.3 88.9 62.8 95.1 65.4 67.4 53.5 92.1 44.5 46.4 86.0 49.3 142.5 182.4 84.1 46.1 59.8 77.3 44.3 93.1 62.3 59.6 79.3 35.9 51.5 109.6 72.5 112.1 22.4 71.4 99.3 48.7 133.5 45.6 48.4 207.5 137.6 93.6 92.7 83.0 49.1 57.4 59.3 82.9 158.6 45.1 87.6 98.8 53.1 26.8 63.5 74.0 56.2 26.1 110.3 38.2 128.9 3.0 33.1 7.9 9.9 43.4 12.1 12.1 8.0 9.1 54.2 13.9 9.7 12.9 1.4 17.5 26.3 74.5 8.5 16.9 64.8 67.8 70.5 79.3 65.3 77.5 74.9 86.9 96.1 67.9 72.7 72.4 22.3 3.2 12.9 5.2 10.4 2.5 17.3 31.8 8.0 10.5 20.7 21.5 6.4 21.5 25.2 40.5 12.5 64.3 17.1 12.4 13.7 59.3 5.0 18.9 22.1 26.0 22.9 9.7 2.8 49.4 41.1 25.0 16.8 20.1 18.3 20.2 18.5 7.1 58.7 5.0 4.5 14.1 24.4 21.6 12.2 6.2 20.2 20.9 14.2 0.0 21.8 30.7 10.3 8.0 5.5 33.6 13.6 23.0 27.2 19.5 20.5 36.0 24.6 8.3 13.1 15.3 21.4 31.5 26.7 14.3 2.6 42.5 7.0 43.9 19.7 17.2 G6PD G6PD1 ENSG00000160211 "Glucose-6-phosphate dehydrogenase" P11413 X 154531391-154547572 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" Oxidoreductase "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 105.9" "Cell type enhanced" "Detected in many" "monocytes: 112.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 412.7" "Lineage enriched" "Detected in all" 5 "granulocytes: 412.7" "Cell line enhanced" "Detected in all" "A549: 2333.8;MCF7: 883.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000247, HPA000834" Enhanced Enhanced "Centriolar satellite,Cytosol" No No 2400000 "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" Cytosol "Centriolar satellite" "HPA000247: AB_1078978, HPA000834: AB_1078977" "unprognostic (1.73e-2)" "unprognostic (1.53e-3)" "unprognostic (1.13e-2)" "unprognostic (1.02e-1)" "unprognostic (7.78e-2)" "unprognostic (4.34e-2)" "prognostic unfavorable (9.45e-13)" "unprognostic (2.78e-2)" "unprognostic (1.66e-1)" "unprognostic (1.76e-2)" "unprognostic (1.09e-1)" "unprognostic (3.66e-1)" "unprognostic (2.89e-3)" "unprognostic (2.83e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (7.25e-2)" 40.7 39.1 19.9 30.2 21.8 105.9 31.9 20.5 28.3 20.6 20.0 13.9 13.1 21.6 13.3 54.3 19.3 46.5 14.3 21.3 22.7 12.7 6.5 29.4 28.9 25.4 22.2 24.1 13.0 9.6 27.5 13.7 24.5 12.2 13.1 26.1 21.2 14.4 4.2 21.3 12.4 25.6 19.7 26.9 18.1 54.0 26.1 26.2 45.9 5.1 37.2 33.8 22.4 21.9 168.5 2333.8 49.7 189.7 207.2 281.7 43.5 116.0 341.7 120.0 205.8 111.2 61.9 110.9 174.1 274.3 475.9 146.3 79.3 202.5 60.3 111.4 55.0 116.8 517.2 244.6 401.6 117.8 373.5 136.6 58.5 233.9 49.8 185.6 252.5 79.8 69.6 46.3 218.4 883.9 77.5 93.0 35.3 549.5 172.2 74.9 28.4 120.5 357.1 210.9 49.6 62.0 115.9 444.5 99.9 65.0 67.1 99.4 289.8 73.1 250.0 102.5 181.8 58.2 80.0 189.8 200.6 77.5 150.9 166.1 84.9 412.7 50.3 72.1 32.1 16.0 13.7 36.7 40.1 17.0 16.5 28.2 137.4 69.3 63.5 18.9 18.7 72.8 19.9 21.8 20.5 28.3 21.3 22.7 25.4 22.2 24.5 19.7 26.1 21.9 7.9 0.0 17.0 4.6 21.5 12.5 24.3 46.6 8.6 6.2 14.6 8.6 1.1 14.3 22.9 11.0 18.8 29.6 58.9 25.5 29.4 39.3 10.3 7.7 13.7 13.2 9.5 37.7 2.9 29.3 41.2 19.6 23.4 10.7 37.5 26.1 18.2 1.6 45.6 33.7 2.3 11.5 24.4 58.2 26.0 20.8 26.1 56.6 19.6 5.6 112.3 13.6 83.4 3.5 3.7 31.0 11.4 16.1 21.6 23.9 18.5 18.3 10.9 32.5 6.6 7.5 23.6 10.9 32.8 34.4 13.8 36.3 33.8 11.6 13.5 30.5 GABRD ENSG00000187730 "Gamma-aminobutyric acid type A receptor subunit delta" O14764 1 2019329-2030758 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "brain: 49.6" "Cell type enhanced" "Detected in some" "Bipolar cells: 14.7;Excitatory neurons: 30.0;Horizontal cells: 13.5;Inhibitory neurons: 37.4;Spermatogonia: 11.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HMC-1: 1.2;MCF7: 4.4;NB-4: 2.7;SH-SY5Y: 1.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044371 Enhanced Uncertain "Golgi apparatus,Vesicles" NA NA "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus, Vesicles" "HPA044371: AB_2678916" "unprognostic (4.28e-2)" "unprognostic (1.90e-1)" "unprognostic (5.95e-8)" "unprognostic (6.34e-3)" "unprognostic (2.66e-3)" "unprognostic (1.04e-2)" "unprognostic (3.44e-3)" "unprognostic (2.14e-1)" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.77e-2)" "unprognostic (1.99e-1)" "prognostic unfavorable (4.12e-8)" "unprognostic (1.72e-1)" "unprognostic (1.76e-1)" "unprognostic (2.77e-1)" "unprognostic (5.16e-2)" 0.3 1.5 12.8 0.0 16.9 0.0 0.5 49.6 40.5 0.1 0.1 0.2 0.0 0.3 0.1 0.3 0.2 0.4 0.7 14.7 5.4 0.7 0.2 0.9 0.2 14.3 18.1 0.2 0.1 0.7 2.7 0.1 20.2 0.2 0.0 1.4 0.3 0.0 0.3 0.4 0.2 0.3 1.0 0.3 0.1 3.6 29.7 0.1 0.9 0.4 0.0 0.2 0.2 14.7 0.0 0.3 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 2.7 1.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 12.8 16.9 49.6 40.5 14.7 5.4 14.3 18.1 20.2 1.0 29.7 14.7 1.0 3.2 3.6 4.9 0.1 0.5 0.0 0.0 0.0 14.7 0.3 0.0 0.9 0.0 6.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.2 0.2 3.4 0.0 0.0 30.0 0.0 0.3 0.5 0.0 0.2 2.5 0.3 0.0 0.0 0.1 13.5 37.4 0.0 0.0 0.0 0.3 0.2 0.0 0.9 0.0 8.4 0.0 1.4 0.0 3.0 4.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 4.4 1.6 0.0 0.0 4.8 0.1 11.3 0.1 0.0 0.3 0.4 0.2 0.1 0.1 GALK1 GALK ENSG00000108479 "Galactokinase 1" P51570 17 75751594-75765236 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" "Kinase, Transferase" "Cataract, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 126.4" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 100.1;Hepatocytes: 116.7;Proximal enterocytes: 139.4;Proximal tubular cells: 122.0" "Cancer enhanced" "Detected in all" "liver cancer: 42.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007094, HPA016960" Approved Approved "Golgi apparatus,Cytosol" NA NA 57000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "Golgi apparatus" "HPA007094: AB_1078939, HPA016960: AB_1849430" "unprognostic (1.16e-1)" "unprognostic (1.33e-2)" "unprognostic (1.81e-2)" "unprognostic (2.94e-2)" "unprognostic (1.00e-1)" "unprognostic (2.21e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.04e-2)" "unprognostic (1.06e-1)" "unprognostic (2.35e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (3.04e-1)" "unprognostic (1.71e-1)" "unprognostic (2.77e-1)" "prognostic unfavorable (1.62e-5)" 18.6 12.5 5.9 7.8 6.7 5.6 17.1 6.4 8.4 17.5 5.9 12.5 20.6 16.5 1.0 24.4 14.9 4.3 19.7 6.0 6.6 32.0 126.4 18.7 7.4 7.9 6.3 13.7 31.2 10.6 5.7 5.8 7.5 13.3 2.0 0.7 20.0 5.7 8.6 20.6 18.3 3.9 7.0 24.5 17.6 16.0 6.8 6.1 11.6 3.6 3.4 13.0 17.8 8.2 20.4 65.2 4.9 20.7 6.8 16.6 16.7 16.9 14.3 16.8 15.8 35.4 4.2 31.2 19.5 9.3 12.6 11.9 5.0 4.4 1.9 14.2 39.3 20.1 25.1 62.4 22.1 13.0 41.9 15.3 6.9 8.5 3.5 8.5 39.1 16.9 15.9 21.2 11.7 77.3 38.6 44.7 4.7 9.8 32.3 43.6 50.1 50.9 9.8 7.3 9.9 26.1 14.6 35.8 35.0 3.8 29.8 20.9 33.4 24.3 22.3 21.7 14.6 44.4 12.4 8.2 26.7 30.3 18.3 7.2 77.2 23.0 23.0 67.8 20.8 27.7 18.5 21.2 70.1 18.9 10.0 14.5 53.1 16.2 55.6 93.3 23.6 40.8 5.9 6.7 6.4 8.4 6.0 6.6 7.9 6.3 7.5 7.0 6.8 8.2 42.1 16.0 12.9 3.3 17.7 8.7 10.0 4.4 7.4 7.3 22.4 20.6 22.6 22.8 10.6 12.9 0.0 48.4 16.3 8.4 68.4 28.5 1.3 4.9 24.5 23.5 8.4 9.0 1.5 55.2 100.1 25.3 10.2 8.6 27.9 16.6 29.3 116.7 56.1 3.3 1.7 20.9 22.4 49.0 25.2 5.6 31.1 33.3 39.2 0.0 42.3 19.2 20.6 2.5 1.6 19.3 49.6 24.0 29.1 5.7 139.4 122.0 4.0 6.1 6.6 19.2 20.8 1.7 22.1 16.6 12.5 42.3 14.9 6.1 28.2 9.2 GAPDH GAPD ENSG00000111640 "Glyceraldehyde-3-phosphate dehydrogenase" P04406 12 6534512-6538374 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Glycolysis, Immunity, Innate immunity, Translation regulation" "Oxidoreductase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "skeletal muscle: 27580.7;tongue: 18892.5" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 10357.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "CAB005197, CAB016392, HPA040067, HPA061280, CAB079968" Supported Enhanced "Nuclear membrane,Vesicles,Plasma membrane,Cytosol" No No 1400000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane, Cytosol" "Nuclear membrane, Vesicles" "CAB005197: AB_641107, CAB016392: AB_627678, CAB079968: , HPA040067: AB_10965903, HPA061280: AB_2684463" "unprognostic (3.03e-1)" "unprognostic (2.62e-3)" "unprognostic (3.58e-2)" "unprognostic (4.20e-1)" "unprognostic (9.73e-3)" "unprognostic (1.77e-3)" "prognostic unfavorable (1.79e-6)" "unprognostic (2.89e-3)" "unprognostic (2.86e-1)" "unprognostic (2.06e-2)" "unprognostic (9.50e-3)" "unprognostic (4.52e-1)" "prognostic unfavorable (6.25e-10)" "unprognostic (2.33e-1)" "unprognostic (4.28e-1)" "unprognostic (1.40e-1)" "unprognostic (1.26e-2)" 1219.9 1815.8 2605.9 1191.3 2589.5 4608.5 1042.3 2869.0 3067.8 1163.8 2419.2 1720.0 1480.8 1080.9 769.9 2973.8 1042.8 1161.3 5572.8 2630.1 2880.0 2323.2 2557.9 1137.9 1388.3 2845.2 2861.3 1087.0 652.0 1616.0 1338.7 1190.6 2828.4 1241.0 1586.6 2386.8 1835.8 1238.7 27580.7 1775.5 1457.5 1424.4 2670.8 1208.5 1215.5 693.0 2985.1 1570.9 1022.1 18892.5 1861.0 1889.0 1672.9 2741.6 6063.0 10247.9 3109.5 4709.2 3026.2 5018.7 6516.0 4716.2 7218.1 7172.8 7491.2 7211.3 4091.6 7540.8 878.2 5947.4 4904.2 3359.8 3372.7 10829.1 5432.4 6263.1 3229.5 4224.9 5857.5 6279.2 3890.9 6710.2 3046.1 4089.0 3521.7 6553.0 7609.7 15565.8 7762.7 5052.4 2215.9 1484.1 8670.0 11849.8 7303.1 3247.3 10995.7 7254.7 3950.7 5849.8 5505.7 3512.8 7909.6 7115.9 2088.3 3331.0 4243.1 10206.4 5984.0 8874.7 1657.2 4311.2 4794.3 5049.0 5907.2 2717.1 7931.5 3178.4 2544.6 9374.4 10632.2 4050.5 8040.5 2575.4 4295.8 737.9 1325.8 2011.2 1171.4 1046.9 1364.8 1333.1 3253.6 652.5 757.6 886.9 1981.4 1227.8 1900.6 474.6 2126.1 6812.0 2605.9 2589.5 2869.0 3067.8 2630.1 2880.0 2845.2 2861.3 2828.4 2670.8 2985.1 2741.6 1036.7 237.2 259.5 228.2 1086.9 1818.8 2223.4 7367.5 4070.9 1157.6 1794.6 3689.2 40.4 1263.9 2213.7 1022.5 417.0 4237.7 1032.7 2579.6 3463.0 5198.9 759.8 770.1 702.4 1597.4 1324.3 1180.6 112.1 3794.5 10357.8 1127.1 1068.8 1021.8 562.3 2063.7 1242.9 1742.3 3895.3 2348.7 145.8 2351.2 2543.1 2586.7 2494.4 2257.7 889.4 2134.0 4220.8 86.2 3422.3 6177.9 1045.4 98.5 196.2 5681.8 3001.4 1026.9 2668.2 1714.0 5714.0 7286.7 864.3 1435.2 1150.4 1744.7 2827.8 429.9 476.2 3605.2 1600.7 4694.0 1514.9 1839.0 3140.9 2882.4 GAS8 "DRC4, GAS11" ENSG00000141013 "Growth arrest specific 8" O95995 16 90019629-90044975 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 198.3;Late spermatids: 277.8;Respiratory ciliated cells: 82.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041311, HPA048238" Approved Approved "Plasma membrane,Cytosol" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" Cytosol "Plasma membrane" "HPA041311: AB_2677402, HPA048238: AB_2680324" "unprognostic (2.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.73e-1)" "unprognostic (3.91e-1)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.47e-1)" "prognostic favorable (7.67e-4)" "unprognostic (3.06e-2)" "prognostic favorable (1.09e-7)" "unprognostic (1.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.19e-2)" 5.2 10.3 9.5 2.8 9.7 1.4 6.3 10.0 14.3 7.8 12.3 7.7 2.6 6.5 10.1 8.4 18.9 6.1 15.4 9.5 9.9 13.8 5.5 7.1 2.8 10.3 10.0 8.9 10.5 16.3 14.1 2.1 10.1 7.3 3.0 5.0 11.4 8.6 15.1 4.5 3.9 4.4 10.3 3.4 8.2 16.8 10.9 2.5 12.5 10.0 2.0 6.3 5.8 10.2 17.9 14.5 1.8 8.5 7.8 6.2 14.3 3.6 8.8 13.9 4.1 14.1 13.0 1.0 9.1 7.1 8.4 17.8 5.9 9.9 3.3 0.0 10.7 3.7 9.0 16.2 8.7 2.2 2.8 7.9 6.0 10.4 4.7 6.3 8.3 5.8 14.3 2.1 6.1 41.9 2.5 9.9 11.6 11.3 7.4 0.7 15.7 1.0 17.4 8.5 14.6 10.7 18.4 9.7 21.0 1.6 19.6 8.4 6.2 8.6 10.3 4.7 8.3 3.4 5.4 0.0 21.3 2.7 15.1 1.7 1.2 1.4 0.7 2.0 0.7 0.4 1.0 1.4 1.7 0.8 0.8 0.7 1.5 0.0 1.3 1.9 1.6 0.8 9.5 9.7 10.0 14.3 9.5 9.9 10.3 10.0 10.1 10.3 10.9 10.2 5.9 22.4 11.3 20.5 3.1 1.1 4.7 7.0 5.7 11.9 14.1 10.8 7.9 25.8 13.4 22.0 20.9 3.0 0.7 5.9 13.7 17.1 198.3 45.5 7.1 5.8 6.0 3.0 27.5 10.9 3.6 5.5 12.2 10.0 2.5 16.1 7.1 4.8 4.1 26.9 24.6 6.3 8.2 0.8 1.4 277.8 14.0 2.3 5.4 1.9 1.3 12.4 0.0 13.0 6.0 10.0 4.6 7.5 1.1 5.8 5.3 30.9 82.3 28.0 6.6 6.7 9.5 28.7 11.9 7.2 2.6 1.6 1.6 25.2 5.3 5.8 GCGR GGR ENSG00000215644 "Glucagon receptor" P47871 17 81804132-81814008 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Diabetes mellitus, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 17 "kidney: 50.0;liver: 169.6" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 74.6" "Cancer enriched" "Detected in many" 4 "liver cancer: 10.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA071228 Uncertain "Golgi apparatus" NA NA "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 15: Hepatocytes - Hemostasis" "Golgi apparatus" "HPA071228: AB_2686368" "unprognostic (3.28e-4)" "unprognostic (9.30e-2)" "unprognostic (2.20e-1)" "unprognostic (1.53e-4)" "unprognostic (1.11e-1)" "unprognostic (2.30e-3)" "unprognostic (4.38e-2)" "unprognostic (1.79e-3)" "unprognostic (2.18e-1)" "unprognostic (2.77e-1)" "unprognostic (3.09e-1)" "unprognostic (2.61e-1)" "unprognostic (6.42e-2)" "unprognostic (5.99e-3)" "unprognostic (1.71e-1)" "unprognostic (1.17e-3)" "unprognostic (8.36e-3)" 0.2 2.5 0.0 0.0 0.1 0.0 0.2 0.2 0.1 0.2 0.0 0.8 0.2 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 50.0 169.6 0.0 0.1 0.3 0.1 0.0 1.4 6.3 0.2 0.0 0.2 0.2 0.0 0.7 0.1 0.0 0.0 1.5 0.6 0.0 0.1 0.1 0.1 0.9 0.0 0.0 0.2 0.1 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.4 0.3 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.9 0.0 0.6 0.0 0.5 0.0 0.3 0.6 0.0 0.3 3.7 2.1 0.0 0.0 0.1 3.9 0.2 0.1 0.4 0.0 0.2 0.0 5.3 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.4 74.6 0.1 0.0 0.5 0.0 0.0 1.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.1 0.6 0.4 0.0 0.0 0.0 0.2 0.4 0.5 0.4 0.0 0.2 0.0 0.1 0.0 GCNT3 "C2/4GnT, C2GnT-M, C2GnT2" ENSG00000140297 "Glucosaminyl (N-acetyl) transferase 3, mucin type" O95395 15 59594875-59640239 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 75.5;intestine: 142.9;salivary gland: 55.8" "Cell type enhanced" "Detected in many" "Collecting duct cells: 104.8;Distal enterocytes: 360.1;Ductal cells: 92.6;Glandular and luminal cells: 75.6;Paneth cells: 163.2;Proximal enterocytes: 85.5" "Group enriched" "Detected in many" 4 "colorectal cancer: 16.4;pancreatic cancer: 29.8;stomach cancer: 20.1" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 147.4;EFO-21: 24.6;Hep G2: 30.3;OE19: 75.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA011154 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 9: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" Vesicles "HPA011154: AB_1078961" "unprognostic (5.09e-2)" "unprognostic (2.39e-1)" "unprognostic (5.92e-2)" "prognostic favorable (1.78e-4)" "unprognostic (3.99e-3)" "unprognostic (2.02e-2)" "prognostic unfavorable (6.49e-5)" "unprognostic (1.69e-1)" "unprognostic (1.31e-1)" "unprognostic (2.34e-1)" "unprognostic (1.64e-2)" "unprognostic (1.63e-1)" "unprognostic (4.02e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-2)" "unprognostic (4.65e-2)" "unprognostic (2.43e-1)" 0.2 0.7 0.2 11.9 0.2 0.5 0.4 0.6 0.4 19.2 0.2 142.9 97.5 2.0 0.0 15.8 4.2 75.5 0.1 0.2 0.1 17.9 0.4 0.7 0.9 0.1 0.4 0.1 2.1 0.9 0.1 0.1 0.2 1.2 123.2 0.1 55.8 0.3 0.2 0.3 123.3 4.6 0.0 0.1 25.8 4.3 0.2 1.3 2.1 0.0 10.6 9.1 29.9 0.4 0.1 147.4 0.0 0.2 0.0 1.0 0.2 0.1 7.7 0.0 0.0 6.3 6.0 0.6 24.6 0.0 9.5 0.5 0.0 0.0 0.0 0.5 0.1 0.0 0.5 30.3 0.0 0.2 0.2 0.3 3.5 0.7 0.0 0.1 0.0 0.2 0.0 0.4 1.4 0.6 0.1 0.2 0.2 75.9 0.3 0.4 0.0 0.6 10.2 1.2 0.2 0.2 0.0 0.2 0.4 0.1 0.1 0.0 0.1 0.2 0.4 7.3 0.1 0.2 0.5 0.8 8.9 0.3 0.1 0.9 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.0 0.1 0.7 0.2 0.1 0.3 0.1 0.0 0.2 0.2 0.6 0.4 0.2 0.1 0.1 0.4 0.2 0.0 0.2 0.4 0.0 0.0 2.2 0.0 1.0 0.0 18.3 8.9 0.0 0.0 0.5 0.0 0.7 11.5 40.5 104.8 0.0 0.0 0.1 360.1 0.0 92.6 9.8 23.3 8.6 0.3 7.8 0.0 0.0 14.9 0.0 0.2 27.5 75.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 26.9 8.2 0.6 0.0 19.2 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.0 58.4 163.2 0.0 0.1 8.0 85.5 4.4 9.8 0.0 6.6 0.6 1.5 3.0 0.3 1.4 0.0 0.0 0.8 0.0 48.5 52.4 GET3 "ARSA-I, ASNA1, TRC40" ENSG00000198356 "Guided entry of tail-anchored proteins factor 3, ATPase" O43681 19 12737139-12748323 "Predicted intracellular proteins, Transporters" Transport Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045951, HPA048087" Approved Enhanced Nucleoplasm,Nucleoli NA NA 37000 "Cluster 14: Monocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoli Nucleoplasm "HPA045951: AB_2679511, HPA048087: AB_2680258" "unprognostic (2.87e-1)" "prognostic favorable (9.53e-4)" "unprognostic (1.01e-1)" "unprognostic (2.16e-1)" "unprognostic (2.05e-2)" "unprognostic (5.70e-2)" "unprognostic (2.01e-2)" "unprognostic (1.33e-2)" "unprognostic (3.34e-1)" "unprognostic (3.08e-2)" "unprognostic (1.85e-1)" "unprognostic (4.39e-2)" "prognostic favorable (4.27e-5)" "unprognostic (6.11e-2)" "unprognostic (5.77e-2)" "unprognostic (2.32e-3)" "prognostic unfavorable (8.47e-4)" 47.5 61.6 56.4 39.4 58.2 66.2 46.5 59.0 72.8 48.4 62.4 43.0 39.9 49.8 41.0 58.1 47.0 39.3 62.0 59.6 58.4 61.6 38.4 40.8 48.3 55.4 57.3 41.9 48.2 73.3 48.2 28.0 57.9 34.3 28.7 36.4 47.3 31.4 67.6 59.1 38.7 33.9 55.9 43.4 50.9 60.2 58.9 46.9 56.3 58.6 38.1 46.3 43.3 57.3 143.7 116.5 60.7 132.3 118.6 72.4 74.6 72.4 99.7 137.5 107.6 90.3 69.6 64.8 111.0 95.4 157.5 75.2 84.5 97.6 65.4 100.9 132.7 54.3 82.4 105.3 125.8 83.5 104.9 83.6 84.1 111.3 66.1 89.2 99.4 75.9 71.3 86.8 109.5 320.4 112.9 68.1 154.6 92.0 215.6 82.2 93.6 128.4 130.2 120.7 111.6 95.5 97.3 131.3 119.8 51.5 108.2 80.5 85.5 193.3 65.4 217.1 172.4 153.9 279.4 61.7 136.2 137.0 109.0 33.6 44.3 26.3 24.8 34.3 21.2 20.3 22.0 22.2 44.8 17.0 15.7 19.5 15.6 16.7 42.9 29.4 34.2 35.8 56.4 58.2 59.0 72.8 59.6 58.4 55.4 57.3 57.9 55.9 58.9 57.3 14.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 106.6 13.1 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 80.7 12.5 0.0 0.0 0.0 0.0 0.0 0.0 142.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 110.7 1.7 0.0 0.0 0.0 GFER "ALR, ERV1, HERV1, HPO1, HPO2, HSS" ENSG00000127554 "Growth factor, augmenter of liver regeneration" P55789 16 1984193-1987749 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor, Oxidoreductase" "Cataract, Deafness, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 183.7;Early spermatids: 168.7;Proximal enterocytes: 371.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041227, HPA063553" Approved Enhanced Mitochondria,Cytosol "Secreted to blood" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "Mitochondria, Cytosol" "HPA041227: AB_10795538, HPA063553: AB_2685038" "unprognostic (5.35e-2)" "unprognostic (2.11e-2)" "unprognostic (3.08e-1)" "unprognostic (4.42e-2)" "unprognostic (3.15e-1)" "unprognostic (2.63e-1)" "unprognostic (1.27e-2)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (2.30e-1)" "unprognostic (1.56e-1)" "unprognostic (5.93e-2)" "prognostic favorable (4.06e-4)" "unprognostic (4.93e-2)" "unprognostic (3.64e-1)" "unprognostic (3.56e-1)" "unprognostic (1.09e-2)" 17.7 21.2 19.6 13.8 19.0 18.2 17.8 21.6 23.1 14.2 17.9 32.8 42.7 16.6 6.6 17.5 16.0 13.5 29.8 19.0 19.7 21.9 45.9 15.3 20.9 21.5 21.1 11.3 53.7 29.6 18.1 12.2 20.9 19.6 25.4 7.7 28.8 13.1 40.9 14.5 45.2 10.9 18.8 21.9 24.7 38.5 20.6 10.5 15.9 30.4 16.9 19.4 12.8 20.6 27.2 44.1 35.6 29.2 14.7 28.9 43.5 28.6 31.2 44.2 35.6 63.7 46.1 15.2 39.7 24.2 25.7 39.8 27.3 42.4 27.9 44.7 46.6 20.9 44.3 73.4 26.6 32.1 37.9 18.9 32.5 38.8 34.6 27.8 21.1 32.7 33.0 51.3 32.6 66.1 34.9 33.9 54.9 23.9 39.7 74.5 26.8 50.7 45.5 21.9 30.5 28.9 39.3 91.2 34.5 18.2 43.4 33.6 19.1 42.8 45.0 24.0 54.3 79.1 48.3 45.7 14.2 21.5 36.7 3.8 16.2 13.4 11.2 13.9 11.4 23.5 14.9 18.5 11.6 17.8 13.6 9.5 1.4 10.7 17.4 5.1 24.9 10.6 19.6 19.0 21.6 23.1 19.0 19.7 21.5 21.1 20.9 18.8 20.6 20.6 18.0 3.2 6.7 2.3 32.5 15.9 19.9 21.1 17.6 10.8 32.7 27.6 17.4 27.1 16.6 9.2 0.0 43.4 23.0 183.7 35.2 44.0 168.7 24.0 11.4 17.9 27.2 17.0 3.4 80.8 57.8 17.7 16.8 18.7 12.7 22.8 20.7 59.1 45.9 8.4 3.2 60.3 26.4 39.3 24.8 123.7 17.4 24.7 23.2 1.0 39.6 12.6 39.1 1.5 3.3 57.3 100.3 12.4 39.6 21.7 371.7 84.6 33.3 11.5 13.1 15.8 18.5 41.9 26.7 17.3 14.8 37.5 27.4 26.7 68.7 26.0 GIPC1 "C19orf3, GIPC, GLUT1CBP, Hs.6454, NIP, RGS19IP1, SEMCAP, SYNECTIN, TIP-2" ENSG00000123159 "GIPC PDZ domain containing family member 1" O14908 19 14477760-14496149 "Human disease related genes, Predicted intracellular proteins" "Congenital muscular dystrophy, Dystroglycanopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 345.8" "Cell type enhanced" "Detected in all" "Distal enterocytes: 501.1;Pancreatic endocrine cells: 296.7;Paneth cells: 285.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043958, HPA061786" Approved Approved "Nucleoplasm,Plasma membrane,Cell Junctions" NA NA 11000 "Cluster 35: T-regs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cell Junctions" Nucleoplasm "HPA043958: AB_10963436, HPA061786: AB_2756319" "unprognostic (2.80e-1)" "unprognostic (1.16e-1)" "unprognostic (8.21e-2)" "unprognostic (1.03e-1)" "unprognostic (2.82e-1)" "unprognostic (1.07e-1)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (4.82e-2)" "unprognostic (3.53e-2)" "unprognostic (7.72e-2)" "unprognostic (1.04e-2)" "unprognostic (7.17e-3)" "unprognostic (1.70e-1)" "unprognostic (1.16e-1)" "unprognostic (8.82e-2)" 51.0 54.8 80.0 22.4 91.5 3.3 54.3 88.7 94.4 99.8 64.7 120.2 24.7 53.7 17.6 345.8 48.9 23.4 66.1 74.5 82.1 104.1 58.4 76.3 15.9 89.4 91.4 34.4 43.5 20.8 56.0 28.7 88.1 63.6 41.1 17.9 100.9 31.0 65.1 150.2 45.5 17.5 82.0 37.7 78.7 24.9 91.1 18.6 55.8 23.3 21.0 74.1 140.1 92.3 328.1 148.6 44.7 70.6 40.6 40.7 35.2 119.7 59.8 96.7 87.3 80.3 120.6 4.7 220.3 85.2 64.6 183.8 38.7 100.6 32.6 33.8 69.0 63.9 100.7 79.7 123.7 6.9 75.3 46.7 98.5 58.8 51.3 57.4 66.0 47.2 30.1 54.4 49.9 243.8 21.3 13.3 48.6 182.1 147.8 21.7 37.4 43.7 121.6 281.6 41.8 46.2 67.1 163.2 157.0 23.1 102.5 35.1 115.4 135.7 74.6 191.7 130.1 50.5 70.5 17.3 113.9 51.9 146.2 3.0 0.7 0.1 5.1 1.1 4.7 1.9 5.1 5.1 1.1 0.8 4.2 3.3 0.3 1.5 0.5 3.6 12.0 1.7 80.0 91.5 88.7 94.4 74.5 82.1 89.4 91.4 88.1 82.0 91.1 92.3 30.6 28.9 15.2 22.9 8.3 113.9 77.4 52.1 35.9 69.8 73.6 31.6 14.8 37.1 62.8 82.8 35.5 36.3 19.3 501.1 52.8 167.9 1.1 92.2 30.5 32.4 43.1 1.7 28.8 164.3 77.1 32.6 69.3 76.8 10.2 37.3 23.2 18.0 55.9 75.7 32.2 87.8 42.7 10.8 29.8 2.4 20.5 16.1 58.7 10.3 23.4 73.3 18.6 17.1 71.6 296.7 285.4 25.2 6.8 120.4 36.0 52.7 38.0 46.0 19.7 18.1 44.5 6.4 20.4 107.0 169.8 25.7 22.9 47.7 138.1 199.7 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282980-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 5 "fallopian tube: 7.0;pituitary gland: 5.5;placenta: 2.6" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 10.4;Endometrial ciliated cells: 12.8;Ionocytes: 22.4;Respiratory ciliated cells: 18.4;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.5;HDLM-2: 7.6;MCF7: 4.1;OE19: 4.8;RT4: 3.6;SuSa: 2.4" "Not detected" "Not detected" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.2 0.0 0.1 0.3 0.0 1.0 0.6 0.2 0.0 0.0 0.0 0.1 0.0 0.0 7.0 0.0 0.1 0.1 0.1 0.0 0.0 0.7 0.0 0.4 0.1 0.0 0.0 0.1 5.5 2.6 0.5 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.2 1.5 0.0 0.1 0.1 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 4.1 0.0 0.1 1.2 4.8 0.0 0.1 0.0 0.0 0.0 3.6 0.1 0.0 0.8 0.0 0.0 2.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.0 0.6 0.1 0.1 0.4 0.1 0.5 0.0 0.1 0.2 0.2 0.0 0.0 0.7 0.1 0.0 0.0 1.3 0.0 2.5 0.6 0.3 0.2 0.0 0.5 0.0 0.0 10.4 0.5 0.1 0.0 0.2 1.1 12.8 0.8 0.3 0.0 0.0 0.7 0.2 4.4 0.6 0.0 3.0 0.0 0.1 0.4 0.0 0.5 0.0 1.1 0.0 22.4 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.0 0.0 0.0 18.4 0.6 0.0 1.7 0.3 0.3 0.3 0.0 0.0 7.3 0.5 0.2 0.3 0.2 GLOD5 ENSG00000171433 "Glyoxalase domain containing 5" A6NK44 X 48761747-48773648 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "epididymis: 5.8;intestine: 10.6;kidney: 11.2;liver: 8.2" "Group enriched" "Detected in some" 4 "Proximal enterocytes: 45.2;Proximal tubular cells: 70.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 2.1" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA010667 Enhanced Uncertain Mitochondria NA NA "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA010667: AB_1078975" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (7.78e-2)" "unprognostic (7.04e-2)" "unprognostic (3.14e-1)" "unprognostic (6.11e-2)" "unprognostic (1.80e-2)" "unprognostic (2.64e-1)" "unprognostic (2.76e-1)" "unprognostic (2.21e-1)" "unprognostic (1.05e-8)" "unprognostic (2.08e-2)" "unprognostic (1.73e-1)" "unprognostic (5.07e-2)" "unprognostic (6.79e-4)" 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.1 0.3 0.0 4.7 10.6 0.0 5.8 0.1 1.9 0.8 0.0 0.0 0.0 11.2 8.2 1.3 0.0 0.1 0.0 0.0 0.7 0.1 0.3 0.0 0.1 0.2 6.1 1.9 0.3 0.3 0.0 0.0 10.0 0.1 0.0 0.0 1.4 0.1 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 3.2 2.6 1.3 0.5 0.0 0.3 0.2 0.0 0.6 8.3 1.0 0.0 4.3 0.3 7.3 0.0 0.1 0.0 14.4 13.7 0.6 0.2 3.0 0.1 0.0 1.2 2.7 0.2 0.9 0.1 0.0 0.0 1.1 0.0 0.1 0.0 8.0 0.0 0.0 0.3 7.3 0.0 0.3 0.0 0.2 0.0 0.5 0.0 0.0 0.6 0.5 0.0 0.5 0.5 0.8 13.9 0.0 0.1 0.3 45.2 70.5 2.7 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 8.9 0.7 GLRX5 "C14orf87, GRX5, PR01238" ENSG00000182512 "Glutaredoxin 5" Q86SX6 14 95533503-95544724 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 195.0" "Cell type enhanced" "Detected in all" "Distal tubular cells: 518.5;Erythroid cells: 1134.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042465, HPA063716" Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" Mitochondria "HPA042465: AB_10794048, HPA063716: AB_2685102" "unprognostic (2.57e-1)" "unprognostic (6.76e-2)" "unprognostic (1.60e-2)" "unprognostic (2.69e-2)" "unprognostic (3.72e-2)" "unprognostic (2.43e-3)" "unprognostic (1.29e-1)" "unprognostic (5.41e-2)" "unprognostic (8.28e-2)" "prognostic favorable (1.08e-5)" "unprognostic (1.85e-1)" "unprognostic (1.02e-1)" "prognostic favorable (7.83e-10)" "unprognostic (1.44e-1)" "unprognostic (3.81e-2)" "unprognostic (2.66e-2)" "unprognostic (8.91e-2)" 37.2 52.1 44.1 17.6 44.9 178.8 27.2 43.8 50.2 22.3 46.7 44.8 46.2 19.2 39.0 24.5 23.6 17.5 76.9 46.6 45.8 74.5 105.5 18.3 23.1 43.3 44.5 32.8 31.5 46.3 18.9 37.8 44.3 26.8 37.3 10.1 29.3 29.6 195.0 18.3 33.2 24.4 42.9 20.8 34.2 35.7 46.2 40.3 26.7 168.9 27.0 24.5 15.0 42.9 77.1 92.7 61.4 68.0 74.2 57.5 202.0 54.9 56.1 69.4 69.1 124.8 87.5 111.7 77.4 42.8 39.2 75.5 116.5 79.6 71.5 68.5 94.4 100.3 63.4 202.2 73.5 160.9 96.5 55.4 74.1 49.9 81.1 28.1 76.1 94.4 115.7 88.3 61.2 205.5 133.6 165.9 81.5 89.7 107.8 220.8 184.3 67.8 93.3 89.3 127.9 75.2 54.8 81.3 87.7 59.9 107.7 72.6 55.6 30.5 65.0 77.6 85.7 41.7 57.9 92.0 67.2 99.8 72.2 0.4 2.9 4.8 3.4 4.3 4.9 4.6 4.6 6.0 4.7 5.4 3.7 3.9 1.3 3.9 2.7 9.0 6.2 1.8 44.1 44.9 43.8 50.2 46.6 45.8 43.3 44.5 44.3 42.9 46.2 42.9 78.7 28.9 30.0 7.8 41.1 108.5 58.7 7.5 61.5 38.5 112.8 135.9 150.0 64.3 10.4 95.6 33.3 97.8 66.5 76.3 518.5 15.2 312.0 49.7 61.5 58.9 54.0 1134.9 15.0 15.6 164.9 66.2 46.4 48.3 14.7 110.3 47.2 147.2 58.7 50.5 16.4 72.1 4.1 41.7 58.7 90.2 54.3 50.7 87.2 7.5 21.3 128.1 52.5 12.5 15.2 15.2 39.5 73.7 75.2 108.2 51.8 281.4 9.1 43.0 59.2 61.1 92.7 115.4 79.0 102.2 124.9 53.8 48.8 169.0 88.0 76.6 GNB2 ENSG00000172354 "G protein subunit beta 2" P62879 7 100673567-100679174 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010032, HPA040736" Approved Supported "Plasma membrane" NA NA 940000 "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane" "CAB010032: AB_2263466, HPA040736: AB_2677106" "unprognostic (1.55e-1)" "unprognostic (5.76e-2)" "unprognostic (1.01e-3)" "unprognostic (2.76e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (3.68e-3)" "unprognostic (3.52e-1)" "unprognostic (6.58e-2)" "unprognostic (2.54e-1)" "unprognostic (9.79e-3)" "unprognostic (1.70e-1)" "unprognostic (3.75e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-1)" "unprognostic (5.29e-2)" "unprognostic (2.98e-1)" 198.4 211.0 131.4 128.3 137.3 207.5 188.0 112.3 179.6 209.4 103.8 168.0 103.2 182.4 63.7 328.4 179.8 105.5 175.9 130.2 138.1 186.1 185.8 210.1 107.9 140.3 130.1 175.3 184.8 98.9 203.3 107.4 123.6 183.0 83.6 20.1 190.8 113.6 175.9 295.5 143.5 113.5 126.3 225.9 172.4 92.9 137.6 90.2 144.8 90.2 105.7 165.2 217.7 120.7 358.6 268.6 222.7 272.5 169.8 199.9 194.3 208.4 288.4 294.3 241.7 205.3 333.7 157.7 216.0 311.3 332.2 243.0 177.7 312.6 103.0 216.9 152.1 120.8 198.7 171.3 282.4 157.7 254.5 259.5 291.1 304.2 244.6 237.6 343.6 132.5 228.6 303.3 270.4 980.0 249.5 450.3 173.5 225.1 290.1 234.3 136.3 253.8 235.4 291.3 241.0 380.1 278.0 449.2 201.3 125.3 192.4 192.1 325.8 313.8 346.8 619.2 266.6 88.8 111.9 240.9 237.1 349.7 443.6 27.6 28.6 70.9 17.5 42.7 16.2 13.6 17.9 15.4 28.1 18.1 11.8 12.4 117.2 15.4 35.9 23.8 23.5 12.5 131.4 137.3 112.3 179.6 130.2 138.1 140.3 130.1 123.6 126.3 137.6 120.7 138.1 57.7 97.0 16.0 104.1 151.8 159.3 72.9 148.0 10.4 105.4 106.0 35.0 100.1 55.5 84.6 4.2 172.4 89.4 285.4 162.4 163.7 32.6 133.5 106.8 136.5 180.4 127.7 12.7 218.7 312.1 117.6 135.1 127.2 44.4 97.6 126.0 69.9 264.4 72.3 10.8 211.2 75.3 198.6 198.8 20.1 144.8 193.5 140.5 15.9 160.8 128.2 96.8 5.0 6.9 257.1 285.6 130.1 122.5 226.5 162.3 107.0 68.3 8.5 65.7 62.0 162.2 34.3 69.6 240.7 194.8 293.9 117.8 88.1 192.2 259.5 GNG13 "G(gamma)13, h2-35" ENSG00000127588 "G protein subunit gamma 13" Q9P2W3 16 798041-800734 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 37 "brain: 47.4;retina: 55.8" "Cell type enriched" "Detected in some" 16 "Bipolar cells: 311.6" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 7 "cerebellum: 47.4;thalamus: 23.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 10.4;HEK 293: 9.0;HeLa: 6.5;MCF7: 12.9" "Region enhanced" "Detected in all" "cerebellum: 940.0" "Group enriched" "Detected in many" 6 "cerebellum: 37.7;olfactory bulb: 14.0" HPA046272 Enhanced NA NA "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" "HPA046272: AB_10960062" "unprognostic (1.84e-1)" "unprognostic (2.75e-1)" "unprognostic (3.78e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-2)" "unprognostic (5.41e-2)" "unprognostic (8.47e-2)" "unprognostic (9.16e-3)" "unprognostic (4.04e-2)" "unprognostic (1.78e-1)" "unprognostic (6.77e-2)" "unprognostic (7.12e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" 0.0 0.0 3.8 0.1 1.2 0.2 0.0 47.4 4.6 0.0 0.0 0.9 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.2 0.0 1.9 0.0 0.1 55.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.3 23.2 0.6 0.0 0.0 0.1 0.0 0.0 4.8 0.2 3.6 0.5 1.1 0.0 0.0 0.8 1.0 0.0 0.0 0.0 10.4 0.3 1.1 0.3 0.0 0.1 1.6 0.0 0.0 0.0 1.2 9.0 1.3 6.5 0.0 0.0 2.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.2 1.8 0.8 0.0 12.9 1.3 0.7 1.2 0.1 1.0 2.8 2.8 0.6 0.0 1.5 0.9 0.8 0.9 0.3 0.2 0.3 0.7 0.1 0.0 1.3 1.2 1.7 0.3 0.4 2.5 4.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 1.2 47.4 4.6 0.2 2.4 0.0 4.5 1.9 0.0 23.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 311.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 5.3 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.5 0.1 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 GNL3L "FLJ10613, GNL3B" ENSG00000130119 "G protein nucleolar 3 like" Q9NVN8 X 54530183-54621521 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036314, HPA036315" Supported Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 11: Basophils - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoli "Nucleoplasm, Cytosol" "HPA036314: AB_10669986, HPA036315: AB_2675055" "unprognostic (9.71e-3)" "unprognostic (6.58e-2)" "unprognostic (6.24e-2)" "unprognostic (1.99e-2)" "unprognostic (1.13e-2)" "unprognostic (1.38e-1)" "unprognostic (2.92e-2)" "unprognostic (5.46e-2)" "unprognostic (8.44e-2)" "unprognostic (9.97e-2)" "unprognostic (4.91e-3)" "unprognostic (7.87e-2)" "unprognostic (8.05e-3)" "unprognostic (2.99e-2)" "unprognostic (1.51e-1)" "unprognostic (1.75e-3)" "unprognostic (1.10e-1)" 4.6 3.6 2.0 7.0 3.6 8.9 4.8 2.6 2.7 4.8 3.1 4.7 3.9 4.7 3.7 5.7 4.7 4.7 7.2 2.7 2.6 4.4 3.9 5.0 7.6 3.1 3.6 3.8 5.0 5.7 2.3 5.6 3.2 3.7 6.1 3.8 4.0 4.4 7.1 5.7 4.7 7.3 2.7 6.9 5.3 2.3 3.4 8.3 8.5 7.8 8.5 6.7 3.5 5.4 20.7 49.1 9.5 20.9 10.2 8.3 15.2 9.8 8.7 13.4 9.9 43.4 16.6 26.9 21.3 18.2 15.1 18.7 34.6 14.9 19.0 15.9 16.4 30.0 34.0 17.2 7.9 42.6 26.0 10.0 7.1 31.0 17.4 5.7 13.4 16.4 19.2 27.0 14.0 36.5 25.5 11.8 29.6 13.0 26.7 27.7 23.9 27.8 10.3 28.8 17.1 8.4 39.7 24.3 11.7 20.9 30.9 11.4 20.0 22.6 22.1 21.8 18.4 19.9 25.7 35.9 12.8 34.6 27.8 23.6 14.4 15.0 16.5 12.8 15.0 15.1 14.8 13.8 11.1 16.0 10.6 11.7 19.2 21.5 15.0 10.2 9.3 12.5 2.0 3.6 2.6 2.7 2.7 2.6 3.1 3.6 3.2 2.7 3.4 5.4 9.2 12.8 18.5 14.4 15.3 1.3 3.6 3.9 9.6 10.2 6.1 3.9 8.5 8.6 11.8 3.7 12.5 7.1 14.1 7.4 3.9 9.4 0.4 8.2 17.2 9.4 3.5 12.0 14.8 8.7 6.4 7.4 10.7 9.6 10.8 10.9 7.1 4.6 4.9 8.4 14.8 4.7 8.2 9.4 4.2 0.0 5.6 9.4 0.0 14.0 12.0 3.4 25.7 16.1 23.2 9.8 3.9 3.0 10.0 4.2 6.8 5.3 7.8 9.3 6.6 8.5 7.1 1.1 7.7 6.6 2.0 5.5 11.9 9.5 7.6 3.6 GOLT1A "CGI-141, FLJ42654, GOT1, MGC62027, YMR292W" ENSG00000174567 "Golgi transport 1A" Q6ZVE7 1 204198163-204213988 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 190.7" "Group enriched" "Detected in many" 4 "Hepatocytes: 131.3;Proximal enterocytes: 206.8" "Cancer enriched" "Detected in many" 6 "liver cancer: 80.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 18.0;CAPAN-2: 20.0;Hep G2: 25.9;MCF7: 43.5;OE19: 16.1;RT4: 27.7;SK-BR-3: 27.2" "Region enhanced" "Detected in many" "cerebral cortex: 9.0" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "unprognostic (3.43e-1)" "unprognostic (1.13e-1)" "unprognostic (2.22e-3)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.37e-4)" "unprognostic (6.20e-3)" "unprognostic (2.14e-1)" "unprognostic (8.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.26e-2)" "unprognostic (7.33e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (6.35e-5)" "unprognostic (1.37e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-3)" "prognostic favorable (1.51e-4)" 0.3 0.1 6.1 0.4 9.2 0.0 5.3 7.0 5.3 10.9 3.9 5.6 47.4 0.3 10.7 0.5 3.3 1.6 0.1 4.3 11.2 16.2 190.7 8.3 0.1 4.7 5.3 0.1 22.3 18.3 30.4 3.5 4.7 5.3 5.0 1.5 3.4 2.1 0.3 0.5 45.5 0.3 4.5 0.1 8.2 2.6 11.6 0.8 0.7 0.0 0.2 13.1 0.4 2.8 0.5 8.2 0.0 0.0 0.0 0.0 5.5 0.1 0.1 0.1 0.0 18.0 20.0 0.0 0.7 0.2 0.0 0.6 0.0 0.1 0.1 0.0 0.3 0.1 0.0 25.9 0.1 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 43.5 0.0 0.1 4.0 16.1 0.2 0.0 0.1 0.4 8.5 27.7 1.3 1.8 0.8 27.2 0.1 0.7 8.9 0.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.1 6.1 9.2 7.0 5.3 4.3 11.2 4.7 5.3 4.7 4.5 11.6 2.8 0.1 0.0 19.5 0.3 0.1 0.0 12.7 2.6 2.8 1.7 7.2 4.7 0.2 40.0 5.1 16.5 0.0 13.3 0.1 7.0 13.7 29.2 0.9 0.5 0.1 0.3 10.3 0.0 2.2 19.1 0.5 1.1 8.2 2.0 1.3 1.4 1.8 131.3 1.3 1.7 0.7 7.8 2.0 1.6 0.0 0.4 0.0 0.2 1.8 0.0 0.0 0.0 0.0 4.5 0.1 18.7 5.6 0.0 0.0 15.0 206.8 14.7 0.3 0.2 0.0 0.3 0.3 2.9 0.9 1.4 0.1 26.4 0.5 0.2 12.5 20.5 GPAA1 "GAA1, hGAA1" ENSG00000197858 "Glycosylphosphatidylinositol anchor attachment 1" O43292 8 144082590-144086216 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "PC-3: 275.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077224 Approved Approved "Endoplasmic reticulum,Centrosome,Mitochondria,Cytosol" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum, Cytosol" "Centrosome, Mitochondria" "HPA077224: " "unprognostic (2.53e-3)" "unprognostic (1.39e-1)" "unprognostic (3.06e-2)" "unprognostic (2.57e-2)" "unprognostic (2.49e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-3)" "unprognostic (2.64e-1)" "unprognostic (8.92e-2)" "unprognostic (1.67e-2)" "unprognostic (2.04e-3)" "unprognostic (4.72e-2)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (3.89e-1)" "unprognostic (1.27e-1)" "unprognostic (2.73e-2)" 47.0 75.5 35.7 21.2 37.5 48.2 46.7 39.9 43.6 52.2 62.3 46.1 35.8 56.9 18.8 51.7 45.9 25.0 72.1 35.9 35.6 61.9 69.9 42.6 23.4 41.9 37.4 49.9 66.2 47.5 37.2 20.0 40.7 50.9 13.1 11.4 60.5 40.5 71.7 47.1 46.8 18.8 40.1 48.4 55.8 40.9 38.1 18.6 60.1 28.4 12.9 43.0 42.8 47.6 67.3 117.2 26.9 84.7 60.8 51.5 92.8 68.5 66.5 55.8 57.4 49.0 108.9 36.6 94.1 73.9 26.4 82.5 17.9 67.2 8.1 60.4 59.0 58.0 53.1 36.3 58.6 28.5 83.2 56.8 61.6 56.9 39.4 45.0 46.4 61.5 42.1 125.7 54.1 237.6 55.9 26.5 27.2 79.3 275.8 38.1 34.2 176.9 48.4 46.8 45.7 63.2 88.8 112.4 51.1 14.7 73.2 79.3 31.6 51.8 88.6 29.5 77.2 70.0 57.5 24.9 91.2 34.8 72.0 35.7 64.4 59.0 84.2 78.1 57.2 37.4 41.7 66.7 59.6 40.1 40.6 57.7 14.8 69.1 91.9 107.1 40.1 76.7 35.7 37.5 39.9 43.6 35.9 35.6 41.9 37.4 40.7 40.1 38.1 47.6 41.0 38.5 40.0 13.7 46.7 28.8 54.9 84.6 37.0 60.8 74.9 59.9 42.7 55.8 58.0 44.1 64.6 123.4 72.5 100.2 25.4 125.8 5.7 30.8 30.7 37.3 56.9 48.0 12.8 89.9 152.9 57.1 56.6 37.3 64.8 45.1 42.5 74.9 86.6 55.5 14.6 52.6 79.3 53.6 25.6 10.9 40.4 41.2 72.9 6.5 57.4 98.0 98.9 15.6 20.4 76.0 91.0 37.6 85.5 58.0 155.1 90.3 46.8 73.2 59.2 50.8 50.5 194.8 109.9 55.9 22.3 109.3 38.9 66.5 85.3 48.1 GPKOW "GPATC5, GPATCH5, Mos2, Spp2, T54" ENSG00000068394 "G-patch domain and KOW motifs" Q92917 X 49113407-49123735 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000287, HPA001894" Enhanced Enhanced Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA000287: AB_1079015, HPA001894: AB_1079014" "unprognostic (3.34e-2)" "unprognostic (9.54e-3)" "unprognostic (8.95e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (1.19e-1)" "unprognostic (2.03e-3)" "unprognostic (1.02e-1)" "unprognostic (9.29e-2)" "unprognostic (7.96e-2)" "unprognostic (4.32e-1)" "unprognostic (7.08e-2)" "unprognostic (1.14e-2)" "unprognostic (3.17e-1)" "unprognostic (2.73e-1)" "unprognostic (1.59e-1)" "unprognostic (1.89e-2)" 17.6 15.9 21.5 11.7 22.6 16.1 16.4 22.7 21.8 14.7 14.0 17.0 14.3 16.9 11.8 14.7 15.1 10.3 18.6 19.8 21.2 15.5 14.5 13.8 14.9 24.2 23.6 13.6 12.1 19.0 17.2 13.8 23.9 12.7 12.6 11.9 13.8 16.5 34.8 20.4 14.1 13.8 22.4 15.4 15.5 7.2 25.2 17.7 13.4 25.4 14.4 16.2 14.2 24.4 36.5 38.1 24.9 20.9 21.6 18.6 27.0 23.1 25.9 36.0 38.0 27.9 35.5 15.2 17.4 28.6 36.8 25.2 27.9 27.3 23.4 32.2 29.8 15.8 31.4 19.9 25.8 18.9 32.1 20.4 34.3 28.8 29.2 21.1 27.4 30.0 19.8 23.1 23.8 59.5 26.0 31.5 17.6 19.5 30.0 32.2 27.4 41.5 18.5 45.8 20.8 24.1 26.9 25.2 25.4 26.1 48.5 24.5 30.7 20.7 31.2 30.4 22.1 35.4 26.1 20.7 26.7 31.1 32.7 26.2 22.3 28.9 37.2 31.4 30.3 20.5 28.6 27.8 22.6 34.8 24.3 22.4 17.3 25.0 35.9 20.8 31.1 20.2 21.5 22.6 22.7 21.8 19.8 21.2 24.2 23.6 23.9 22.4 25.2 24.4 10.9 19.2 11.0 7.2 10.5 8.0 14.1 21.8 4.6 14.8 6.4 5.5 13.1 21.5 19.1 7.3 4.2 28.4 16.3 16.2 15.6 26.2 1.1 15.6 10.0 13.4 7.8 22.5 2.8 25.2 20.5 11.7 14.3 10.6 11.4 10.4 11.7 14.5 16.7 5.0 2.8 12.1 18.3 10.9 9.3 1.7 15.5 8.7 5.4 2.8 13.2 20.9 28.8 2.0 3.9 25.6 23.2 15.1 9.4 9.4 19.5 20.5 12.7 13.4 39.5 12.9 13.0 9.9 18.4 6.1 9.9 43.8 16.7 10.6 11.0 12.8 GPS2 ENSG00000132522 "G protein pathway suppressor 2" Q13227 17 7311324-7315564 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 279.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067540 Approved Supported Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA067540: AB_2685860" "unprognostic (1.53e-2)" "unprognostic (3.43e-1)" "unprognostic (3.33e-2)" "unprognostic (1.71e-3)" "unprognostic (1.55e-1)" "unprognostic (1.53e-4)" "unprognostic (1.37e-2)" "unprognostic (1.33e-1)" "unprognostic (3.18e-2)" "unprognostic (2.84e-1)" "prognostic favorable (7.50e-5)" "unprognostic (1.37e-2)" "prognostic unfavorable (3.42e-5)" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (6.87e-2)" "unprognostic (1.28e-3)" 45.4 47.7 30.3 15.5 30.9 26.8 39.7 30.7 37.8 42.1 28.4 47.5 14.6 39.5 14.2 38.0 36.8 13.2 65.8 30.3 30.9 49.8 33.3 34.0 17.2 31.8 30.7 39.5 39.0 24.4 33.8 13.9 31.1 35.3 17.1 12.0 39.4 16.9 154.9 52.0 34.5 15.6 29.5 34.6 40.0 102.7 31.2 21.6 34.6 52.9 20.1 43.9 37.2 31.7 28.1 60.6 24.9 26.4 36.5 20.2 21.2 20.1 26.7 45.2 39.0 39.2 16.1 32.0 15.5 31.1 32.3 42.1 25.4 42.4 31.5 37.9 34.8 30.1 62.2 53.0 26.4 19.1 37.1 19.3 31.2 59.0 17.1 19.5 26.0 29.7 18.8 8.6 43.2 25.8 38.2 21.2 24.6 29.3 22.8 29.5 30.8 34.1 36.4 32.1 23.5 39.5 35.6 23.6 28.9 21.4 23.6 18.6 15.9 23.0 20.5 28.2 48.9 25.0 37.0 21.0 30.3 23.2 38.1 78.3 47.2 82.7 53.5 59.8 49.5 81.6 56.6 58.5 39.5 63.8 51.9 47.8 79.1 41.5 67.7 66.0 81.2 58.1 30.3 30.9 30.7 37.8 30.3 30.9 31.8 30.7 31.1 29.5 31.2 31.7 29.1 12.8 10.8 19.9 36.9 15.8 11.5 11.4 29.0 29.9 19.2 17.8 1.2 17.2 16.6 20.2 66.7 13.5 55.7 52.4 25.4 21.7 100.3 15.0 22.6 18.9 16.8 29.9 15.0 26.8 11.1 14.9 25.5 17.5 19.0 23.4 11.4 10.6 10.3 38.7 12.5 23.2 6.1 14.1 25.0 279.3 21.1 21.1 19.6 13.1 21.6 15.5 41.2 10.6 17.1 19.5 35.9 15.4 42.2 8.4 42.2 25.7 14.6 44.8 19.7 17.4 18.8 37.4 42.9 18.1 16.9 19.6 39.0 17.1 21.8 9.1 GRINA "HNRGW, LFG1, NMDARA1, TMBIM3" ENSG00000178719 "Glutamate ionotropic receptor NMDA type subunit associated protein 1" Q7Z429 8 143990056-143993415 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 432.6;monocytes: 355.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036980, HPA036981" Approved Approved "Nucleoli fibrillar center,Cytosol" NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" "Nucleoli fibrillar center" Cytosol "HPA036980: AB_10696791, HPA036981: AB_10962980" "unprognostic (2.73e-3)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (1.12e-1)" "unprognostic (7.01e-3)" "unprognostic (3.72e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-2)" "unprognostic (2.32e-1)" "unprognostic (6.70e-2)" "unprognostic (8.19e-2)" "unprognostic (3.13e-3)" "unprognostic (1.01e-3)" "unprognostic (1.55e-1)" "unprognostic (9.43e-2)" "unprognostic (6.75e-2)" "unprognostic (5.72e-2)" 273.1 218.3 154.1 109.0 147.4 215.1 236.4 143.9 226.4 178.9 99.4 144.9 72.1 137.8 79.7 134.2 149.0 74.5 154.8 158.9 149.8 200.8 447.1 233.9 77.7 151.6 155.6 152.7 97.2 144.4 127.7 86.2 160.5 176.0 33.2 180.7 116.7 181.7 145.4 167.1 138.1 75.1 152.1 311.3 104.6 269.4 163.1 58.5 187.4 57.4 55.2 162.1 139.3 140.2 79.3 155.9 76.4 129.5 392.6 196.9 114.5 112.5 258.9 184.4 168.7 95.5 64.3 57.9 120.2 249.7 128.6 69.8 136.8 162.3 75.5 83.1 95.9 60.2 85.9 114.5 412.0 12.7 90.7 254.2 441.0 132.7 193.3 194.5 90.1 23.9 56.1 76.8 160.7 489.5 34.7 32.6 53.4 75.8 231.2 45.4 39.9 111.4 93.2 229.1 52.3 84.8 163.5 177.9 225.8 104.1 342.2 77.6 91.8 115.4 127.1 158.0 82.1 124.3 78.3 44.6 147.4 79.0 67.6 1.8 32.0 9.7 2.5 36.4 3.5 8.3 2.5 2.9 13.3 7.1 4.5 4.1 18.6 3.3 36.1 22.9 2.3 16.0 154.1 147.4 143.9 226.4 158.9 149.8 151.6 155.6 160.5 152.1 163.1 140.2 54.5 19.2 52.7 35.3 45.4 37.2 32.5 58.7 121.3 91.1 62.7 79.4 23.2 45.8 27.9 53.3 79.2 137.2 22.6 29.1 23.5 75.0 273.8 36.8 56.1 47.7 42.1 60.0 21.3 69.1 55.8 67.7 16.8 36.1 16.4 76.2 51.4 194.5 178.4 33.7 26.6 24.3 42.7 225.1 86.7 432.6 61.5 184.3 37.4 22.5 355.1 89.9 6.2 12.5 9.3 66.0 54.5 67.7 44.4 46.7 72.9 73.6 29.4 95.8 46.0 32.4 45.6 96.0 16.9 83.2 36.9 264.2 20.8 38.7 31.4 25.5 GSK3A ENSG00000105723 "Glycogen synthase kinase 3 alpha" P49840 19 42226225-42242625 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism, Neurogenesis, Wnt signaling pathway" "Kinase, Serine/threonine-protein kinase, Signal transduction inhibitor, Transferase" "Alzheimer disease, Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004422, HPA028423" Approved Approved Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "CAB004422: AB_627680, HPA028423: AB_10612116" "unprognostic (5.46e-2)" "unprognostic (1.50e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.35e-1)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.13e-4)" "unprognostic (3.80e-3)" "unprognostic (2.27e-1)" "unprognostic (2.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.36e-1)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (4.49e-2)" "unprognostic (7.22e-2)" "unprognostic (8.22e-3)" 30.6 43.3 37.5 22.1 44.0 30.7 29.4 33.6 90.2 34.5 13.7 39.4 40.9 38.1 21.7 40.2 31.8 18.7 45.8 47.0 30.9 39.2 30.4 30.4 23.7 39.1 30.9 34.5 29.6 34.4 32.1 19.9 37.6 33.3 21.1 32.6 31.7 25.9 79.2 42.9 37.1 23.0 20.5 31.2 35.4 30.6 38.2 32.9 29.6 42.0 22.7 37.7 33.0 49.5 57.0 102.1 54.3 53.2 30.3 29.5 25.9 42.7 36.1 49.6 46.0 39.0 39.6 41.0 39.6 33.9 44.8 25.6 49.5 51.3 38.5 33.8 74.5 41.5 41.3 42.7 42.7 51.7 54.0 27.2 45.8 41.9 47.7 44.8 46.5 34.7 73.9 63.0 41.1 80.0 87.7 39.0 42.8 84.5 40.0 58.4 33.8 30.4 43.4 76.1 63.7 67.5 52.8 71.6 36.6 42.8 39.5 69.5 40.6 52.0 40.9 31.0 71.9 65.8 82.8 38.7 66.4 49.8 58.2 0.9 0.5 1.4 0.5 0.8 0.9 0.3 0.3 0.7 0.2 0.2 0.2 0.8 1.7 0.3 0.4 0.6 0.5 0.7 37.5 44.0 33.6 90.2 47.0 30.9 39.1 30.9 37.6 20.5 38.2 49.5 45.6 6.4 16.2 5.2 16.4 24.6 17.7 7.3 14.8 40.8 35.0 39.2 12.9 17.2 7.9 16.5 62.6 23.4 31.4 42.3 3.9 15.2 8.6 19.6 21.5 26.6 23.4 28.6 15.1 17.2 25.3 21.3 16.8 25.0 2.5 27.2 18.2 13.9 20.3 60.6 14.9 29.7 6.1 21.3 15.4 14.6 17.7 25.2 16.0 8.4 14.4 41.8 21.6 11.1 12.2 24.2 24.3 16.6 12.6 29.0 45.0 16.0 5.9 47.0 6.6 50.4 27.4 16.4 19.4 20.2 28.1 44.1 20.6 42.6 28.8 30.1 GSTZ1 "GSTZ1-1, MAAI, MAI" ENSG00000100577 "Glutathione S-transferase zeta 1" O43708 14 77320996-77331597 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Phenylalanine catabolism, Tyrosine catabolism" "Isomerase, Multifunctional enzyme, Transferase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "liver: 263.1" "Cell type enhanced" "Detected in many" "Hepatocytes: 373.2;Late spermatids: 398.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 182.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004701 Approved Approved Nucleoplasm,Cytosol NA NA 340000 "Cluster 18: Basophils - Vesicular transport" "Cluster 62: Liver - Hemostasis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" Cytosol Nucleoplasm "HPA004701: AB_1078990" "prognostic favorable (4.93e-4)" "unprognostic (1.08e-1)" "unprognostic (2.56e-1)" "unprognostic (2.16e-3)" "unprognostic (4.55e-1)" "unprognostic (3.03e-2)" "unprognostic (8.03e-3)" "unprognostic (1.98e-1)" "unprognostic (2.18e-1)" "prognostic favorable (3.73e-4)" "unprognostic (7.90e-2)" "unprognostic (1.73e-1)" "prognostic favorable (1.12e-7)" "unprognostic (1.00e-1)" "unprognostic (1.11e-1)" "unprognostic (4.12e-1)" "unprognostic (4.92e-2)" 13.9 34.7 11.1 9.7 12.5 9.3 23.2 13.2 16.3 12.7 10.5 21.9 22.5 10.8 22.1 26.9 14.9 11.9 14.3 10.5 12.3 24.5 263.1 7.8 13.5 12.6 11.7 6.5 20.1 26.4 13.3 11.2 12.8 21.1 21.7 5.1 24.1 9.6 47.4 22.1 15.6 7.9 12.3 12.1 18.9 57.8 11.9 14.0 19.5 37.3 17.4 11.9 13.8 14.0 18.8 39.0 27.6 19.9 17.1 23.9 45.8 11.4 11.9 21.6 30.9 13.0 45.2 43.5 14.9 13.6 13.4 24.1 18.9 22.5 20.7 23.2 21.0 20.8 13.3 26.9 26.3 7.8 15.8 22.1 24.0 12.4 20.8 12.0 18.6 24.7 17.5 37.0 14.5 182.1 12.2 16.4 8.2 64.1 30.3 20.2 29.5 34.2 32.5 24.0 30.2 26.2 26.0 49.1 35.6 15.5 81.2 11.1 13.8 17.0 52.5 18.9 8.6 28.2 32.7 35.2 41.9 11.3 20.8 13.4 15.5 9.9 2.6 22.2 2.4 8.2 4.6 3.7 20.7 10.4 3.9 3.1 1.6 5.1 20.1 15.0 7.9 7.4 11.1 12.5 13.2 16.3 10.5 12.3 12.6 11.7 12.8 12.3 11.9 14.0 6.1 6.4 9.6 6.5 13.5 13.4 19.8 26.2 15.9 7.3 36.1 34.2 13.0 47.1 19.0 9.2 4.2 91.4 7.5 34.9 46.9 45.0 125.8 19.4 15.6 11.1 28.8 30.3 2.9 68.0 62.5 15.0 33.1 27.0 3.8 25.7 15.4 373.2 44.6 16.8 3.3 45.7 20.3 38.1 10.9 398.1 11.8 19.0 17.8 3.7 30.4 26.4 4.1 2.0 9.2 41.8 37.4 6.0 13.2 19.8 72.9 77.8 15.0 11.9 0.0 12.3 13.2 51.3 29.4 38.0 14.1 76.2 6.7 55.8 50.3 30.3 GTF3C1 TFIIIC220 ENSG00000077235 "General transcription factor IIIC subunit 1" Q12789 16 27459555-27549913 "Predicted intracellular proteins, Predicted membrane proteins" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 93.8;dendritic cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "gdT-cell: 31.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051617, HPA075900" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Nucleoli" "HPA051617: AB_2681553, HPA075900: " "unprognostic (6.46e-2)" "unprognostic (6.86e-3)" "unprognostic (2.16e-1)" "unprognostic (5.59e-2)" "unprognostic (6.65e-2)" "unprognostic (2.90e-2)" "prognostic unfavorable (8.73e-4)" "unprognostic (8.23e-2)" "unprognostic (9.25e-3)" "unprognostic (5.32e-2)" "prognostic favorable (9.56e-4)" "unprognostic (2.10e-1)" "prognostic favorable (1.25e-4)" "unprognostic (2.06e-1)" "unprognostic (5.67e-2)" "unprognostic (5.56e-3)" "unprognostic (8.23e-3)" 18.1 28.8 24.2 9.9 24.4 16.6 16.7 21.5 32.6 31.2 40.5 21.2 8.8 26.7 7.8 65.2 24.6 11.5 38.5 24.6 21.8 25.4 21.7 20.3 12.2 20.4 20.8 24.4 35.3 18.6 47.8 11.0 19.6 40.4 9.7 18.3 24.9 12.6 50.2 51.0 18.5 15.5 17.0 21.3 24.7 26.6 22.2 18.6 34.6 20.8 11.2 19.7 35.1 21.7 27.8 60.1 43.3 50.7 37.8 30.4 24.6 29.5 33.0 40.2 34.0 45.0 25.6 30.5 42.3 36.4 30.6 30.3 55.4 37.6 32.9 13.7 53.1 25.2 49.8 63.8 21.3 29.1 32.2 37.5 28.0 49.5 21.8 26.9 40.2 34.6 31.7 24.2 32.0 67.6 32.5 34.8 58.4 15.1 28.3 59.7 53.4 31.4 25.2 28.7 54.4 36.5 29.8 24.9 18.6 34.4 44.8 21.8 43.2 40.2 24.0 25.6 30.7 25.6 24.8 30.2 16.6 31.7 30.2 2.6 3.4 3.5 31.9 3.2 23.0 3.1 3.6 15.8 4.3 2.2 3.7 10.0 2.5 12.2 3.3 6.6 4.0 6.9 24.2 24.4 21.5 32.6 24.6 21.8 20.4 20.8 19.6 17.0 22.2 21.7 16.9 19.2 23.9 29.7 10.8 18.4 7.3 14.3 23.3 45.5 10.6 11.9 27.4 10.0 17.2 12.9 93.8 7.8 86.2 18.4 5.9 11.8 2.8 40.4 37.3 18.0 30.0 7.2 30.2 11.5 4.3 22.5 19.9 22.3 19.0 26.1 13.9 13.7 10.9 26.9 33.9 17.6 18.3 10.3 7.7 4.5 19.3 12.9 3.6 14.0 10.0 15.0 52.5 17.1 23.4 15.8 9.3 15.8 29.6 13.9 10.2 9.0 30.8 35.1 13.1 16.4 15.1 17.2 18.2 34.8 20.6 4.2 32.7 25.7 12.2 6.7 H2AC14 "H2A/E, H2AFE, HIST1H2AJ" ENSG00000276368 "H2A clustered histone 14" Q99878 6 27814302-27814777 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "bone marrow: 7.2" "Cell type enhanced" "Detected in single" "Extravillous trophoblasts: 1.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enhanced" "Detected in many" "T-reg: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 6.9;Karpas-707: 9.8;MCF7: 11.5" "Low region specificity" "Detected in many" HPA041189 Supported Approved Nucleoplasm NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (8.95e-3)" "unprognostic (4.08e-3)" "unprognostic (3.28e-2)" "unprognostic (5.72e-3)" "unprognostic (2.29e-2)" "unprognostic (2.69e-2)" "unprognostic (6.06e-2)" "unprognostic (1.97e-2)" "unprognostic (1.05e-1)" "unprognostic (2.18e-1)" "unprognostic (9.39e-3)" "unprognostic (3.43e-1)" "unprognostic (9.35e-2)" "unprognostic (1.51e-1)" "unprognostic (1.88e-2)" 0.1 0.0 0.2 0.3 0.4 7.2 0.0 0.5 0.7 0.5 0.4 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.1 0.7 0.7 0.5 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.4 0.6 0.1 0.1 1.0 1.7 0.0 0.0 0.1 0.2 0.1 0.8 3.5 0.0 0.9 0.0 0.0 0.0 0.7 1.0 0.8 0.7 1.8 1.4 0.1 3.1 0.3 0.5 0.1 1.0 0.0 0.8 0.4 1.4 0.3 4.6 0.7 6.9 0.2 0.0 1.7 0.0 0.2 0.5 0.2 0.0 1.0 1.6 0.0 9.8 0.2 11.5 5.0 4.6 1.4 1.5 2.4 4.6 0.0 1.4 0.1 1.9 0.3 0.8 0.8 1.0 0.3 0.2 0.3 3.4 0.0 0.0 1.6 0.3 0.1 4.8 3.1 2.9 0.8 3.2 2.2 0.0 0.0 0.0 0.2 0.2 0.4 0.3 1.3 1.3 1.1 1.3 0.4 0.1 1.1 0.1 0.1 0.1 2.8 1.7 0.2 0.4 0.5 0.7 0.2 0.4 0.7 0.5 1.3 0.4 1.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 H2AC20 "H2A, H2A/q, H2AFQ, HIST2H2AC" ENSG00000184260 "H2A clustered histone 20" Q16777 1 149886918-149887411 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 25.3;brain: 27.2;choroid plexus: 20.0" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 5.7;dendritic cells: 8.1;Extravillous trophoblasts: 18.2;Hofbauer cells: 9.7;Syncytiotrophoblasts: 8.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 60.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA Yes "Cluster 1: Neutrophils - Mixed function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (5.50e-3)" "unprognostic (4.97e-2)" "unprognostic (9.34e-2)" "unprognostic (6.95e-2)" "unprognostic (1.49e-1)" "unprognostic (9.78e-3)" "unprognostic (1.01e-1)" "unprognostic (2.25e-1)" "unprognostic (1.81e-1)" "unprognostic (3.24e-2)" "unprognostic (4.25e-2)" "unprognostic (7.87e-2)" "prognostic unfavorable (1.20e-10)" "unprognostic (1.42e-1)" "unprognostic (1.73e-1)" "unprognostic (4.89e-2)" "prognostic favorable (7.86e-5)" 3.8 3.6 15.5 0.8 20.6 25.3 3.5 24.0 14.0 5.4 20.0 3.1 0.2 2.0 0.0 2.2 2.7 0.4 2.6 10.0 27.2 2.3 2.6 4.7 0.5 19.8 13.1 4.3 2.4 0.1 3.0 0.5 16.7 3.2 0.1 0.5 1.4 0.1 0.7 4.5 3.3 0.4 19.9 5.2 2.5 1.2 18.2 1.6 1.8 0.0 0.1 2.5 4.1 18.2 3.9 4.2 5.0 15.7 0.0 0.7 7.8 1.2 0.9 2.4 3.3 2.5 1.1 8.0 0.2 0.2 0.5 2.0 0.3 1.6 0.0 0.7 5.7 1.9 1.6 12.2 0.0 4.7 4.6 0.9 0.2 0.2 0.5 0.1 1.6 2.0 1.7 10.0 0.5 60.6 5.7 5.4 6.7 4.5 10.0 1.8 2.2 1.4 1.0 2.4 1.8 7.5 3.2 1.2 3.8 0.4 0.6 4.4 1.5 1.1 10.9 1.9 2.9 5.5 4.0 4.2 2.9 6.3 2.3 47.2 33.8 19.0 22.9 22.6 20.2 13.1 20.1 18.5 17.7 33.1 14.0 14.8 98.4 19.1 25.6 24.9 16.3 22.6 15.5 20.6 24.0 14.0 10.0 27.2 19.8 13.1 16.7 19.9 18.2 18.2 2.4 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.7 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 18.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 8.8 1.5 0.0 0.0 0.0 H2AJ "FLJ10903, H2AFJ, MGC921" ENSG00000246705 "H2A.J histone" Q9BTM1 12 14774383-14778002 "Plasma proteins, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 565.0" "Cell type enhanced" "Detected in some" "Adipocytes: 58.1;Cytotrophoblasts: 130.2;dendritic cells: 56.4;Extravillous trophoblasts: 124.3;Fibroblasts: 59.5;Hofbauer cells: 241.2;Syncytiotrophoblasts: 160.3" "Cancer enhanced" "Detected in all" "prostate cancer: 151.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 256.2;MCF7: 338.4;RT4: 239.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041189 Supported Approved Nucleoplasm NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041189: AB_2677357" "unprognostic (9.38e-2)" "unprognostic (8.49e-2)" "unprognostic (9.15e-2)" "unprognostic (7.06e-2)" "unprognostic (2.43e-3)" "unprognostic (4.70e-2)" "unprognostic (3.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.16e-1)" "unprognostic (1.14e-1)" "unprognostic (5.37e-2)" "unprognostic (4.05e-2)" "unprognostic (3.32e-3)" "unprognostic (3.43e-2)" "unprognostic (8.66e-3)" "unprognostic (5.22e-3)" "unprognostic (3.87e-3)" 236.7 186.0 29.1 33.8 34.1 60.4 223.6 33.7 40.9 123.7 37.9 126.6 55.4 105.6 20.9 155.7 106.6 36.0 125.5 27.7 31.3 115.7 82.7 129.6 29.6 37.1 32.5 63.6 182.3 21.1 34.2 57.7 35.7 275.8 29.3 5.3 166.8 35.0 91.4 198.4 85.2 25.1 33.4 94.8 111.1 565.0 33.1 34.2 85.0 24.8 18.2 122.8 124.9 38.7 107.9 256.2 10.0 0.0 112.2 73.8 163.2 78.9 43.4 31.3 30.4 50.9 172.4 0.1 48.7 38.6 0.2 100.7 6.2 60.1 8.5 5.7 4.6 4.3 92.6 43.8 160.5 0.1 39.0 97.0 64.5 43.3 40.0 12.7 63.0 0.0 0.1 0.1 15.9 338.4 0.7 28.7 16.0 77.8 58.0 42.4 0.0 21.0 51.0 239.0 3.0 1.0 99.8 122.3 0.4 34.6 187.0 32.6 63.1 0.3 29.6 46.2 15.6 25.0 39.4 0.4 8.6 0.3 25.4 84.0 127.6 29.3 51.3 76.4 46.3 16.8 49.6 38.0 117.2 21.7 34.9 38.2 46.6 61.2 69.4 58.2 78.1 72.1 29.1 34.1 33.7 40.9 27.7 31.3 37.1 32.5 35.7 33.4 33.1 38.7 58.1 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 130.2 56.4 0.0 0.0 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 124.3 59.5 0.0 0.0 0.0 0.0 0.0 0.0 241.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.9 0.0 0.0 0.0 0.0 160.3 6.5 0.0 0.0 0.0 H2AX H2AFX ENSG00000188486 "H2A.X variant histone" P16104 11 119093854-119095467 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 43.7;Cytotrophoblasts: 83.2;dendritic cells: 34.0;Extravillous trophoblasts: 106.6;Hofbauer cells: 45.8;Syncytiotrophoblasts: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012264, HPA041189, HPA051647" Supported Supported "Nucleoplasm,Nuclear speckles" Yes Yes "Cluster 52: Eosinophils - Transcription" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "Nuclear speckles" "CAB012264: AB_297215, HPA041189: AB_2677357, HPA051647: AB_2681563" "unprognostic (1.44e-1)" "unprognostic (1.96e-1)" "unprognostic (6.46e-2)" "unprognostic (6.41e-2)" "unprognostic (3.07e-1)" "unprognostic (3.25e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (2.32e-3)" "unprognostic (1.93e-1)" "unprognostic (3.07e-3)" "unprognostic (6.78e-2)" "unprognostic (9.31e-2)" "prognostic unfavorable (5.47e-9)" "unprognostic (1.21e-3)" "unprognostic (1.20e-1)" "unprognostic (1.20e-1)" "unprognostic (1.99e-2)" 13.2 20.7 35.2 12.6 37.8 24.9 8.0 39.0 42.2 13.3 20.6 18.6 13.3 14.0 2.1 43.6 13.1 3.1 13.4 33.7 32.3 17.0 13.9 14.3 16.0 43.9 38.9 18.7 11.6 3.4 24.3 11.0 37.8 15.7 4.3 6.6 11.4 4.7 12.4 18.1 18.8 3.5 38.0 24.0 16.1 15.4 37.8 30.5 10.4 3.6 12.0 11.8 15.7 51.8 132.1 77.9 120.3 72.3 10.9 7.9 126.4 146.0 44.0 80.3 70.4 124.0 55.1 89.7 85.9 34.0 60.5 134.0 57.5 41.7 21.5 133.4 161.0 182.2 20.7 129.8 11.4 90.5 108.9 6.7 9.0 34.2 21.0 13.1 40.7 115.4 149.9 143.1 38.9 335.6 207.8 269.9 87.5 60.0 162.6 200.7 141.6 42.7 37.5 56.3 127.6 152.0 116.0 66.6 20.6 20.6 99.8 68.2 50.9 77.7 204.2 63.8 110.2 38.7 40.8 92.3 17.9 145.2 155.0 3.8 1.3 4.2 1.6 0.6 0.8 0.9 1.7 1.7 1.8 0.8 1.1 1.0 0.6 2.2 0.8 0.8 1.6 1.2 35.2 37.8 39.0 42.2 33.7 32.3 43.9 38.9 37.8 38.0 37.8 51.8 43.7 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.2 0.0 0.0 0.0 0.0 83.2 34.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 106.6 9.4 0.0 0.0 0.0 0.0 0.0 0.0 45.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 64.2 7.2 0.0 0.0 0.0 H3-3B "H3.3B, H3F3B" ENSG00000132475 "H3.3 histone B" P84243 17 75776434-75785893 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 4220.9" "Cell type enhanced" "Detected in some" "Adipocytes: 1321.3;Cytotrophoblasts: 1625.3;dendritic cells: 844.9;Extravillous trophoblasts: 1626.9;Hofbauer cells: 1908.9;Syncytiotrophoblasts: 3503.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 21089.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 21089.7" "Low cell line specificity" "Detected in all" "CAB037166, CAB037187, CAB037221, HPA042570" Supported Enhanced Nucleoplasm NA Yes "Cluster 5: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056" "unprognostic (1.66e-1)" "unprognostic (8.42e-3)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "unprognostic (1.81e-1)" "unprognostic (1.95e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-3)" "unprognostic (3.37e-2)" "unprognostic (1.64e-1)" "unprognostic (5.88e-2)" "unprognostic (1.07e-1)" "unprognostic (1.26e-3)" "unprognostic (9.20e-2)" "unprognostic (4.81e-2)" "unprognostic (2.33e-1)" "unprognostic (1.99e-1)" 607.2 369.9 223.8 532.5 262.6 4220.9 628.9 264.4 288.8 741.2 186.6 415.4 329.9 507.4 180.3 798.6 585.7 467.9 312.8 210.7 226.0 438.3 380.2 553.2 509.1 268.7 241.9 1166.0 578.0 341.1 357.5 427.1 242.8 348.2 223.1 299.8 519.2 237.1 332.5 1153.2 407.5 322.9 253.7 449.9 393.0 654.3 246.0 464.0 500.7 155.6 296.2 545.3 675.2 316.1 1386.5 1194.2 490.0 486.1 273.3 424.9 675.1 636.7 557.1 764.8 609.3 1290.7 952.6 683.6 593.1 373.2 539.5 530.0 390.5 881.0 432.0 375.9 883.0 612.8 668.2 1112.0 615.7 1029.2 755.0 467.3 534.2 785.6 1004.7 339.3 582.5 437.8 885.6 1193.0 399.4 2015.3 1492.3 859.5 394.8 442.8 1322.8 1091.7 894.2 746.6 607.3 803.5 988.1 1096.0 645.8 933.7 1402.2 259.3 734.2 1091.3 549.1 1359.7 1205.2 595.2 1721.1 1431.3 932.2 843.5 720.5 967.6 761.1 7991.0 3667.6 10060.5 2613.4 3365.8 2482.2 3199.5 2474.2 2478.9 3218.1 2813.7 2635.4 2173.4 21089.7 3240.7 3199.0 3294.6 2999.0 9615.0 223.8 262.6 264.4 288.8 210.7 226.0 268.7 241.9 242.8 253.7 246.0 316.1 1321.3 0.0 0.0 0.0 294.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 398.6 0.0 0.0 0.0 0.0 1625.3 844.9 0.0 0.0 0.0 0.0 0.0 0.0 172.3 0.0 0.0 0.0 0.0 1626.9 485.1 0.0 0.0 0.0 0.0 0.0 0.0 1908.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 257.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 314.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 377.9 0.0 0.0 0.0 0.0 3503.3 211.7 0.0 0.0 0.0 H3C1 "H3/A, H3FA, HIST1H3A" ENSG00000275714 "H3 clustered histone 1" P68431 6 26020451-26020958 "Disease related genes, Predicted intracellular proteins" DNA-binding "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 7.8;brain: 18.9" "Cell type enhanced" "Detected in some" "dendritic cells: 1.7;Plasma cells: 1.8" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 18.9" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "U-2 OS: 4.0" HPA042570 Approved NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" "HPA042570: AB_2678056" "unprognostic (3.07e-1)" "unprognostic (3.47e-2)" "unprognostic (4.60e-2)" "unprognostic (2.36e-5)" "unprognostic (2.85e-2)" "unprognostic (3.48e-1)" "unprognostic (3.48e-1)" "unprognostic (4.02e-2)" "unprognostic (5.03e-3)" "unprognostic (4.39e-2)" "unprognostic (6.34e-3)" "unprognostic (2.00e-2)" "unprognostic (8.85e-3)" "unprognostic (1.58e-2)" "unprognostic (1.39e-1)" "unprognostic (8.15e-2)" "unprognostic (3.21e-2)" 0.2 0.4 2.5 0.1 0.8 7.8 0.1 18.9 3.9 0.3 0.0 0.2 0.0 0.1 0.9 0.3 0.2 0.1 0.3 1.0 4.2 0.1 0.2 0.3 0.4 2.6 5.8 0.1 0.0 0.0 0.2 0.1 2.7 0.1 0.2 0.1 0.0 0.0 0.0 0.4 0.2 0.1 0.9 0.2 0.2 2.9 1.4 0.6 0.1 0.0 0.1 0.1 0.1 0.5 0.8 0.0 0.7 0.0 0.5 0.2 0.0 1.0 0.0 0.7 1.7 0.0 0.3 0.6 0.4 0.0 0.3 0.0 1.0 0.2 1.4 0.3 1.2 1.0 0.4 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.8 0.2 0.1 0.0 2.2 2.0 1.2 0.9 0.4 0.9 1.1 0.5 0.0 0.7 0.5 0.7 1.0 0.7 1.6 0.2 0.0 0.1 0.9 0.0 0.0 4.0 0.3 0.4 0.3 0.1 0.0 0.4 1.4 1.3 13.6 1.5 4.3 3.5 1.5 3.0 2.2 2.6 2.0 3.1 3.1 1.8 1.7 13.5 8.0 0.9 4.9 3.5 1.3 2.5 0.8 18.9 3.9 1.0 4.2 2.6 5.8 2.7 0.9 1.4 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 H4C12 "dJ160A22.1, H4/d, H4F2iii, H4FD, HIST1H4K" ENSG00000273542 "H4 clustered histone 12" P62805 6 27831174-27831560 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 22.2;brain: 20.7" "Cell type enriched" "Detected in single" 6 "Cardiomyocytes: 2.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in all" "basophil: 160.3" "Lineage enriched" "Detected in all" 4 "granulocytes: 160.3" "Cell line enhanced" "Detected in many" "Hep G2: 63.7;MCF7: 63.3" HPA042201 Supported NA NA 25000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 43: Cardiomyocytes - Nuclear processes" "HPA042201: AB_2677898" "unprognostic (3.19e-1)" "unprognostic (9.09e-3)" "unprognostic (1.16e-1)" "unprognostic (4.84e-3)" "unprognostic (9.63e-2)" "unprognostic (9.13e-2)" "unprognostic (1.48e-1)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.58e-1)" "unprognostic (7.39e-2)" "unprognostic (5.79e-2)" "unprognostic (3.13e-2)" "unprognostic (2.79e-1)" "unprognostic (3.45e-1)" "unprognostic (4.16e-2)" "unprognostic (1.02e-1)" 4.1 5.5 12.2 2.8 14.6 22.2 2.1 4.5 18.9 3.8 0.0 7.6 6.1 3.1 1.0 1.4 3.3 3.7 0.5 17.4 7.1 1.1 8.0 1.2 4.6 0.5 5.5 0.9 1.0 7.1 0.4 1.5 2.0 5.1 3.4 0.4 1.1 2.0 0.4 0.7 5.8 1.2 6.7 5.7 5.9 1.4 4.1 8.8 2.7 2.0 2.2 2.9 0.4 20.7 8.0 9.9 21.0 35.4 13.3 5.0 12.4 8.9 4.4 8.7 5.6 17.2 2.6 12.6 16.4 3.7 2.1 19.4 0.5 13.1 2.7 18.5 3.7 8.4 19.0 63.7 7.5 12.4 10.8 15.9 3.5 5.4 2.9 1.2 7.8 7.1 16.5 26.6 0.3 63.3 22.8 13.0 13.3 13.3 20.3 9.2 1.5 9.1 1.5 3.6 11.7 15.8 16.3 9.0 12.1 2.9 12.4 6.1 7.9 4.4 21.0 2.3 0.1 14.3 16.7 23.0 5.6 9.2 8.7 160.3 9.4 40.4 29.8 21.3 25.8 33.8 29.0 31.6 18.2 37.1 17.4 22.1 22.9 28.0 26.3 20.0 38.9 24.6 12.2 14.6 4.5 18.9 17.4 7.1 0.5 5.5 2.0 6.7 4.1 20.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HAUS7 "UCHL5IP, UIP1" ENSG00000213397 "HAUS augmin like complex subunit 7" Q99871 X 153447666-153495516 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 45.4;Oligodendrocyte precursor cells: 31.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003614 Approved "Plasma membrane,Centrosome" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane, Centrosome" "HPA003614: AB_1080368" "unprognostic (2.06e-1)" "prognostic favorable (6.12e-4)" "unprognostic (3.81e-2)" "unprognostic (3.21e-2)" "unprognostic (5.84e-3)" "unprognostic (5.52e-2)" "unprognostic (1.75e-2)" "unprognostic (7.50e-2)" "unprognostic (1.56e-1)" "unprognostic (3.39e-1)" "unprognostic (4.65e-3)" "unprognostic (6.28e-2)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.98e-1)" "unprognostic (1.15e-1)" "unprognostic (4.25e-2)" "unprognostic (1.09e-2)" 19.0 13.0 29.1 9.2 31.3 11.0 16.2 26.3 54.0 42.3 24.3 15.9 7.1 17.8 15.1 11.4 21.3 13.2 23.5 32.3 26.3 25.2 13.6 19.5 14.4 28.3 27.0 16.0 8.2 5.0 11.9 12.3 28.4 22.5 5.8 3.0 12.5 17.9 12.0 44.7 13.3 11.5 26.4 28.5 11.5 12.6 29.0 10.4 19.2 9.2 9.5 17.4 21.7 32.3 28.2 44.9 24.1 51.2 8.9 14.1 37.2 17.8 12.1 30.1 51.4 36.2 17.3 25.5 59.2 18.5 43.1 32.0 39.6 29.4 15.6 23.6 59.6 19.3 33.5 26.9 9.3 26.9 35.5 21.1 7.4 29.5 16.4 13.1 22.4 32.5 21.7 17.6 15.7 68.9 41.7 60.5 15.7 67.5 65.8 36.5 30.2 47.0 10.2 17.3 25.1 20.5 10.3 27.4 9.6 8.9 10.8 20.8 10.7 27.1 42.9 50.8 36.1 24.0 33.7 97.6 11.7 68.9 34.6 14.8 53.2 22.7 32.6 66.7 34.5 44.0 36.1 33.6 46.7 36.5 35.2 32.2 6.7 39.1 62.0 26.0 33.8 34.3 29.1 31.3 26.3 54.0 32.3 26.3 28.3 27.0 28.4 26.4 29.0 32.3 9.4 6.4 8.1 45.4 5.3 7.1 1.6 3.6 1.2 2.1 2.7 3.0 2.5 4.3 2.6 0.0 4.2 12.6 6.0 9.3 5.9 10.4 0.1 1.0 1.8 5.6 2.4 6.6 11.9 8.0 24.6 6.3 3.6 0.7 19.7 1.6 15.4 4.2 12.2 3.3 4.9 13.8 4.1 10.0 6.8 0.5 5.9 5.0 3.6 4.7 13.4 2.0 12.3 31.7 3.5 7.4 7.7 7.5 2.5 3.3 6.9 14.9 3.5 1.9 6.6 1.9 6.5 2.2 6.7 1.3 4.7 9.3 4.9 1.7 14.9 1.5 HCN2 "BCNG-2, BCNG2, HAC-1" ENSG00000099822 "Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2" Q9UL51 19 589881-617159 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "brain: 146.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 60.4;Horizontal cells: 40.4;Inhibitory neurons: 18.7;Oligodendrocytes: 62.1;Rod photoreceptor cells: 14.9" "Group enriched" "Detected in many" 6 "glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 29.9;HeLa: 15.8;MCF7: 28.4;U-138 MG: 20.2;U-87 MG: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (8.69e-2)" "unprognostic (3.97e-3)" "unprognostic (3.31e-4)" "unprognostic (1.44e-1)" "unprognostic (2.44e-1)" "unprognostic (3.07e-2)" "unprognostic (1.57e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" "unprognostic (5.32e-2)" "unprognostic (1.19e-3)" "unprognostic (8.00e-2)" "prognostic unfavorable (6.99e-5)" "unprognostic (1.07e-1)" "unprognostic (1.41e-1)" "unprognostic (5.53e-4)" "unprognostic (9.72e-3)" 0.1 4.2 34.9 0.2 58.1 0.4 0.1 84.7 111.8 0.1 0.0 0.6 0.1 0.1 0.2 1.6 0.0 0.1 11.6 38.2 56.6 1.3 0.2 0.2 0.3 86.6 76.7 0.1 0.3 3.4 12.8 0.1 84.9 0.3 0.0 7.5 0.3 0.1 0.1 0.9 0.4 0.1 38.2 0.4 0.4 3.1 146.0 0.1 0.1 0.0 0.3 0.1 0.4 66.9 0.1 29.9 0.3 1.0 3.1 2.1 1.0 2.1 2.4 0.8 0.2 4.3 0.3 0.0 6.5 2.9 2.1 0.2 0.6 0.1 0.1 5.1 12.6 0.0 15.8 0.4 2.2 0.3 5.6 5.6 0.5 0.2 0.1 0.9 0.1 0.7 1.8 0.2 2.1 28.4 0.1 0.0 1.4 0.7 0.8 0.2 0.1 0.7 0.5 0.9 11.3 5.8 7.3 0.1 2.3 0.5 5.9 1.0 2.8 20.2 3.0 0.4 8.4 0.5 0.4 0.2 41.7 1.4 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.9 58.1 84.7 111.8 38.2 56.6 86.6 76.7 84.9 38.2 146.0 66.9 0.5 0.0 0.0 2.0 0.6 0.6 0.0 0.0 1.2 60.4 0.7 0.9 4.1 0.0 0.0 0.0 2.1 0.0 1.6 0.3 0.0 0.1 0.1 0.6 0.4 0.9 1.2 2.7 12.8 0.0 0.3 0.2 0.0 1.2 0.0 0.2 0.7 0.1 0.1 40.4 18.7 0.0 0.0 1.3 0.3 0.4 0.0 1.1 0.0 2.8 0.0 2.7 0.0 5.5 62.1 0.1 0.0 0.7 1.4 0.1 0.0 0.3 0.0 14.9 0.0 0.1 0.5 0.1 1.7 4.5 0.6 0.3 1.2 0.1 0.1 0.1 HEATR6 "ABC1, FLJ22087" ENSG00000068097 "HEAT repeat containing 6" Q6AI08 17 60041008-60078922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 64.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030789, HPA062157" Uncertain Approved Mitochondria NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA030789: AB_10601660, HPA062157: AB_2684700" "unprognostic (1.98e-1)" "unprognostic (7.95e-2)" "unprognostic (4.32e-1)" "prognostic unfavorable (2.03e-4)" "unprognostic (4.22e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.02e-6)" "unprognostic (2.24e-1)" "unprognostic (2.86e-1)" "unprognostic (1.97e-1)" "unprognostic (6.81e-3)" "unprognostic (9.84e-2)" "prognostic unfavorable (6.73e-4)" "unprognostic (5.01e-2)" "unprognostic (1.81e-1)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" 4.5 7.2 5.3 2.1 6.0 3.1 4.3 6.8 5.9 6.7 4.4 7.4 1.8 7.1 3.2 4.6 6.6 1.9 5.1 5.1 5.3 4.1 3.6 5.0 3.0 6.2 5.4 7.7 5.1 3.4 7.3 2.7 6.2 5.7 2.3 5.2 5.2 3.5 6.0 5.5 6.1 2.7 5.4 7.2 4.9 4.9 5.8 3.0 4.6 2.4 2.2 6.5 5.2 7.8 4.8 13.0 9.5 7.5 5.1 9.1 6.9 4.5 8.9 8.8 9.7 5.2 3.6 1.8 7.8 8.0 7.1 4.9 5.6 6.0 11.9 4.1 7.2 9.3 8.8 9.7 5.6 7.0 10.1 7.1 8.8 6.4 7.6 9.5 4.7 6.0 5.9 5.1 6.6 64.6 8.9 3.6 5.9 3.9 8.7 3.2 16.9 5.8 5.7 7.1 5.4 13.7 4.6 1.6 6.6 8.2 7.9 5.6 4.5 8.9 15.0 8.2 8.4 6.5 7.1 0.1 7.6 5.1 6.9 2.4 3.4 3.4 3.4 5.4 3.2 8.2 2.5 2.5 6.0 4.3 3.3 2.6 0.5 3.0 5.6 2.9 2.9 2.7 5.3 6.0 6.8 5.9 5.1 5.3 6.2 5.4 6.2 5.4 5.8 7.8 4.6 12.8 6.3 9.4 8.0 0.9 2.8 6.2 6.2 11.1 3.1 5.0 9.2 2.8 8.1 7.3 10.4 5.7 5.0 1.1 3.9 4.8 1.0 4.8 9.1 5.1 6.7 3.0 13.1 3.3 3.4 7.4 6.6 4.3 11.4 8.8 4.2 2.8 4.6 6.7 13.7 1.5 4.1 5.6 2.6 0.7 3.4 8.5 1.8 15.9 15.3 8.8 7.2 16.6 25.3 2.9 1.0 11.3 3.3 1.7 1.5 3.3 10.5 6.6 6.6 6.5 15.4 5.1 7.7 3.6 2.3 2.1 7.6 10.1 3.1 1.2 HEXD "FLJ23825, HEXDC" ENSG00000169660 "Hexosaminidase D" Q8WVB3 17 82418318-82442645 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 7.8;Cardiomyocytes: 6.1;Cytotrophoblasts: 5.9;dendritic cells: 10.1;Extravillous trophoblasts: 6.4;Hofbauer cells: 16.2;Plasma cells: 4.1;Syncytiotrophoblasts: 4.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 62.3" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022834, HPA023379, HPA027844" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" "Nucleoli fibrillar center, Mitochondria" "HPA022834: AB_1850641, HPA023379: AB_1850643, HPA027844: AB_10600711" "unprognostic (8.69e-3)" "prognostic favorable (7.70e-4)" "unprognostic (7.92e-2)" "unprognostic (1.53e-1)" "unprognostic (3.51e-2)" "prognostic favorable (2.71e-4)" "unprognostic (1.31e-1)" "unprognostic (2.11e-2)" "unprognostic (2.71e-1)" "unprognostic (1.14e-2)" "prognostic favorable (5.57e-4)" "unprognostic (9.04e-3)" "unprognostic (1.83e-1)" "unprognostic (3.81e-2)" "unprognostic (2.92e-1)" "unprognostic (1.24e-1)" "prognostic favorable (2.52e-5)" 31.5 20.5 6.9 4.4 7.4 9.0 21.0 10.1 7.8 32.5 9.3 17.0 4.1 22.4 3.9 15.4 25.3 3.1 15.0 6.6 6.3 27.0 29.8 14.8 7.0 7.6 7.0 29.9 55.2 4.1 31.9 1.8 8.0 34.6 2.1 3.6 19.8 4.2 28.4 14.4 24.2 2.1 6.2 36.1 21.3 12.5 7.8 5.0 25.4 7.6 3.4 17.6 21.1 9.6 3.4 8.0 3.5 5.9 11.3 9.9 10.7 4.5 5.4 4.4 4.7 3.1 11.1 9.5 4.8 1.7 3.0 4.9 2.0 2.5 1.7 6.4 15.5 4.1 8.4 3.9 9.9 2.9 10.2 7.3 1.9 1.3 4.6 4.7 5.7 5.9 5.5 3.2 1.3 7.5 10.0 8.6 3.7 6.5 5.1 11.5 3.2 17.9 3.5 4.5 4.9 11.1 9.4 5.5 9.1 1.3 8.4 10.7 5.2 2.8 5.3 2.2 3.1 14.6 2.1 7.0 2.3 6.9 3.2 9.5 3.0 5.6 18.4 24.3 12.4 8.3 3.9 6.5 3.8 11.0 5.8 9.3 5.5 25.4 10.8 62.3 3.2 11.2 6.9 7.4 10.1 7.8 6.6 6.3 7.6 7.0 8.0 6.2 7.8 9.6 7.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 5.9 10.1 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 6.4 3.4 0.0 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 4.0 1.4 0.0 0.0 0.0 HINT2 ENSG00000137133 "Histidine triad nucleotide binding protein 2" Q9BX68 9 35812960-35815354 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 633.9;Hepatocytes: 457.4;Proximal tubular cells: 578.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020961, HPA059109" Supported Enhanced Mitochondria "Intracellular and membrane" NA NA 110000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA020961: AB_1850715, HPA059109: AB_2683906" "unprognostic (9.64e-3)" "unprognostic (1.53e-2)" "unprognostic (3.02e-1)" "unprognostic (3.01e-2)" "unprognostic (5.51e-2)" "unprognostic (3.97e-2)" "unprognostic (1.07e-1)" "unprognostic (2.38e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.66e-4)" "unprognostic (3.71e-3)" "unprognostic (2.87e-2)" "prognostic favorable (2.97e-9)" "unprognostic (4.29e-2)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (1.72e-1)" 50.8 79.5 41.7 15.5 43.9 27.0 48.5 44.9 46.8 23.2 40.3 42.6 34.9 25.9 48.6 27.5 29.9 14.9 87.4 39.8 43.1 91.1 169.2 30.2 21.0 43.8 42.5 19.2 65.9 72.6 41.2 17.6 42.0 33.9 34.2 20.4 39.7 26.1 80.1 33.4 34.2 20.1 43.9 33.8 56.9 29.8 47.3 38.8 38.4 85.5 23.8 30.6 24.2 44.0 30.3 76.1 47.1 45.6 29.0 24.3 33.2 27.8 39.2 42.3 46.1 49.9 31.1 39.9 31.7 25.3 59.8 29.3 21.2 40.9 44.1 87.8 40.7 42.2 64.1 45.8 68.1 25.1 40.0 27.3 36.8 40.2 64.8 16.7 33.2 91.4 25.5 117.4 34.0 60.3 61.3 31.3 21.4 70.0 138.7 60.8 33.1 53.6 61.5 21.5 38.4 46.4 36.0 42.7 49.6 27.5 45.9 44.6 16.5 22.0 37.7 30.4 35.7 107.0 127.3 57.4 49.8 32.2 36.2 41.0 77.5 4.7 68.9 58.5 62.4 98.9 73.7 69.8 113.4 96.7 56.4 58.6 7.6 66.8 56.9 246.1 107.3 81.2 41.7 43.9 44.9 46.8 39.8 43.1 43.8 42.5 42.0 43.9 47.3 44.0 49.3 22.4 17.5 5.2 57.9 45.4 63.4 137.6 49.5 39.8 99.1 105.8 115.1 130.1 68.3 80.9 20.9 154.9 69.3 148.2 633.9 115.5 67.3 83.9 28.6 47.8 96.0 100.8 1.7 172.1 71.7 53.2 52.5 44.6 18.4 43.5 63.1 457.4 113.9 20.2 2.5 127.4 126.1 61.1 51.4 128.0 40.4 47.7 120.9 1.9 74.1 123.7 87.6 1.5 4.5 85.6 157.5 44.8 77.7 40.7 181.4 578.1 105.1 45.5 46.0 54.2 72.6 38.4 77.4 64.7 45.9 56.8 51.0 85.1 126.7 84.8 HIPK1 "KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2" ENSG00000163349 "Homeodomain interacting protein kinase 1" Q86Z02 1 113929324-113977869 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 142.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 176.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016664 Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" Centrosome "HPA016664: AB_1850725" "unprognostic (2.98e-1)" "unprognostic (3.94e-2)" "unprognostic (4.89e-3)" "unprognostic (2.52e-2)" "unprognostic (6.47e-2)" "unprognostic (9.84e-3)" "unprognostic (4.64e-3)" "unprognostic (7.22e-2)" "unprognostic (7.52e-2)" "unprognostic (1.45e-2)" "unprognostic (1.26e-1)" "unprognostic (1.15e-1)" "unprognostic (8.63e-2)" "unprognostic (1.84e-1)" "unprognostic (2.64e-1)" "unprognostic (1.94e-2)" "unprognostic (1.99e-2)" 19.8 20.0 24.7 20.2 23.5 142.0 16.8 44.5 20.9 24.4 42.4 19.0 12.7 18.1 17.2 23.1 35.0 22.2 18.0 20.6 32.5 18.2 17.8 23.4 20.9 37.2 39.4 22.8 21.8 21.3 20.5 17.7 29.8 15.4 18.9 56.5 15.2 17.7 25.7 23.4 16.8 18.2 36.9 20.7 17.8 47.1 27.5 57.4 29.8 27.1 20.6 19.7 18.8 25.6 23.4 18.8 25.4 19.5 29.2 15.2 17.1 15.8 19.0 22.2 20.9 21.8 8.8 31.4 21.2 25.3 8.2 15.5 33.1 18.6 31.7 23.0 16.7 45.8 23.7 23.0 24.3 36.7 54.2 16.5 26.5 28.3 28.7 20.8 33.2 54.2 31.8 32.8 32.1 176.4 48.8 21.0 26.2 17.1 15.8 29.1 74.4 10.9 19.8 19.9 11.2 15.0 28.9 30.6 20.5 27.9 17.7 52.3 32.6 21.5 29.0 35.3 24.3 20.1 17.2 26.7 23.7 29.3 50.3 2.1 2.5 5.0 3.0 2.1 3.0 0.9 2.7 2.8 1.7 1.1 2.6 3.3 5.8 2.7 1.6 3.7 2.0 1.5 24.7 23.5 44.5 20.9 20.6 32.5 37.2 39.4 29.8 36.9 27.5 25.6 30.1 54.5 37.2 14.4 26.0 61.4 16.2 16.7 15.4 57.7 29.8 20.2 34.6 22.8 24.5 27.6 70.9 10.7 125.8 38.9 5.9 14.6 95.2 147.9 33.4 28.9 37.2 64.4 27.4 21.0 10.3 24.3 20.9 47.0 46.9 26.3 21.8 37.4 22.2 74.0 33.9 25.4 12.2 49.5 77.7 101.4 22.1 50.2 21.4 31.9 43.1 30.6 36.0 21.1 26.5 18.8 22.4 37.2 43.5 33.7 17.8 16.4 116.4 64.8 26.3 36.5 44.3 49.7 31.5 25.6 80.6 14.2 69.7 21.9 28.3 32.7 HMCN1 "ARMD1, FBLN6, FIBL-6, FIBL6" ENSG00000143341 "Hemicentin 1" Q96RW7 1 185734391-186190949 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Cell cycle, Cell division, Sensory transduction, Vision" "Age-related macular degeneration, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 20.3" "Cell type enhanced" "Detected in many" "Adipocytes: 33.8;Endothelial cells: 21.4;Fibroblasts: 22.2;Horizontal cells: 26.9;Microglial cells: 45.0" "Cancer enriched" "Detected in many" 6 "melanoma: 14.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 22.3;hTERT-RPE1: 20.1;MCF7: 76.5;SK-MEL-30: 50.2;WM-115: 43.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "olfactory bulb: 9.9" "HPA008220, HPA051677" Uncertain Approved "Golgi apparatus,Cytosol" "Secreted to extracellular matrix" NA NA 9200000 "Cluster 35: T-regs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus, Cytosol" "HPA008220: , HPA051677: AB_2681572" "unprognostic (1.90e-1)" "unprognostic (2.66e-1)" "unprognostic (8.00e-2)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (1.08e-1)" "unprognostic (1.96e-1)" "unprognostic (4.36e-2)" "unprognostic (2.20e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (3.59e-7)" "unprognostic (1.22e-2)" "unprognostic (5.17e-3)" "unprognostic (3.52e-1)" "unprognostic (2.00e-3)" 9.7 1.4 1.3 0.6 1.2 0.0 8.4 0.9 1.1 3.7 1.3 9.0 0.9 1.9 2.5 5.4 1.8 6.5 8.4 0.8 1.1 2.5 7.8 20.3 0.4 1.5 1.9 3.9 0.9 0.9 3.2 4.8 1.5 7.5 2.8 0.6 7.7 1.4 4.8 4.1 3.1 4.3 1.4 8.4 1.7 2.6 1.7 0.8 3.2 7.0 2.4 1.8 3.8 0.9 0.2 0.1 1.6 0.0 4.7 4.7 0.0 0.5 0.9 0.3 0.5 0.0 0.1 1.9 0.2 22.3 1.6 5.0 0.1 0.2 0.1 0.2 0.0 0.5 0.0 0.0 0.3 0.0 0.0 4.7 0.0 5.6 0.4 20.1 2.8 0.0 0.2 0.0 0.0 76.5 0.0 0.0 3.3 0.1 0.1 0.0 0.0 0.0 3.2 0.0 0.2 0.0 0.0 0.0 50.2 4.5 0.1 0.0 0.0 13.7 1.3 0.0 5.1 0.2 0.0 0.3 2.7 0.0 43.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.3 1.2 0.9 1.1 0.8 1.1 1.5 1.9 1.5 1.4 1.7 0.9 33.8 3.2 7.0 0.3 0.0 3.2 0.2 4.9 2.2 1.7 1.2 1.8 2.8 0.0 0.8 0.0 0.0 0.1 0.2 0.3 0.0 0.0 8.3 0.6 1.5 21.4 0.0 0.0 1.1 0.0 0.8 22.2 0.0 0.9 0.0 5.2 7.9 1.9 0.1 26.9 3.8 0.0 0.0 0.3 2.8 2.7 3.7 0.4 5.4 45.0 0.0 0.1 0.0 3.0 1.5 0.0 0.0 2.2 1.2 0.1 0.0 0.2 1.0 0.0 0.0 2.5 7.7 0.5 0.1 0.4 1.7 0.0 0.4 0.1 0.0 0.2 HNRNPAB "ABBP1, FLJ40338, HNRPAB" ENSG00000197451 "Heterogeneous nuclear ribonucleoprotein A/B" Q99729 5 178204533-178211163 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046688 Approved Enhanced Nucleoplasm NA NA 460000 "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA046688: AB_10964924" "unprognostic (2.23e-1)" "unprognostic (6.21e-2)" "unprognostic (2.61e-2)" "unprognostic (1.96e-2)" "unprognostic (8.69e-2)" "unprognostic (1.17e-1)" "unprognostic (1.22e-3)" "unprognostic (4.09e-2)" "unprognostic (6.17e-3)" "prognostic favorable (9.79e-4)" "unprognostic (9.12e-3)" "unprognostic (4.23e-2)" "prognostic unfavorable (1.35e-7)" "unprognostic (3.47e-2)" "unprognostic (1.82e-1)" "unprognostic (3.53e-1)" "unprognostic (2.08e-1)" 86.7 103.2 33.2 92.5 34.9 139.7 63.9 35.6 37.0 66.0 37.3 144.7 98.2 75.5 43.8 122.0 64.4 51.1 83.1 32.4 39.1 91.9 88.3 69.1 95.7 36.9 35.4 56.7 55.4 76.2 46.2 64.0 36.9 59.8 119.0 27.1 68.1 54.0 119.0 115.4 88.9 74.4 35.5 79.9 85.5 38.2 36.9 117.0 52.0 58.7 102.7 122.3 72.7 38.5 347.4 282.5 424.1 414.7 153.8 134.6 613.2 378.5 174.3 296.9 317.2 525.4 251.8 555.2 340.3 204.7 361.1 223.2 373.1 516.7 363.8 865.9 439.5 349.8 223.7 325.1 153.7 446.1 285.6 134.0 239.2 267.3 266.8 122.3 270.3 218.4 290.1 245.7 302.0 934.2 542.6 429.7 389.5 354.0 401.7 436.3 255.6 329.8 254.2 364.8 389.5 302.4 295.2 407.9 278.8 264.0 244.7 270.7 244.0 359.7 305.2 256.2 527.8 285.4 360.2 649.3 145.2 488.2 298.8 3.2 4.4 15.7 5.1 7.0 5.7 5.9 4.1 6.0 4.4 5.2 3.9 4.7 0.8 5.8 7.5 10.9 4.8 2.2 33.2 34.9 35.6 37.0 32.4 39.1 36.9 35.4 36.9 35.5 36.9 38.5 124.7 32.1 41.0 4.6 115.4 281.6 212.1 42.7 243.0 26.5 129.6 141.3 45.9 41.5 42.7 49.7 18.8 106.3 148.5 251.2 50.9 118.9 9.3 112.4 225.6 107.1 119.2 273.2 3.5 151.7 208.9 110.1 167.7 124.7 44.5 102.0 53.6 101.2 101.0 16.8 4.3 219.0 48.8 67.0 129.9 11.1 74.0 109.9 67.6 8.4 56.2 34.7 76.2 3.5 6.1 204.2 138.2 88.0 179.6 275.0 90.5 116.8 25.8 28.3 78.9 149.7 173.6 81.6 122.4 362.5 339.8 114.4 129.7 238.1 247.9 235.5 HPRT1 "HGPRT, HPRT" ENSG00000165704 "Hypoxanthine phosphoribosyltransferase 1" P00492 X 134460165-134520513 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine salvage" "Glycosyltransferase, Transferase" "Disease variant, FDA approved drug targets, Gout" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 226.9;Spermatocytes: 213.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006360, CAB012200" Enhanced Supported Cytosol NA NA 9400000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 58: Brain - Synaptic function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol "CAB012200: AB_297217, HPA006360: AB_1079082" "unprognostic (2.02e-1)" "unprognostic (2.18e-1)" "unprognostic (1.46e-1)" "unprognostic (2.32e-3)" "unprognostic (8.55e-2)" "prognostic unfavorable (1.35e-5)" "unprognostic (1.58e-2)" "unprognostic (4.77e-3)" "unprognostic (4.93e-2)" "unprognostic (2.02e-2)" "unprognostic (7.05e-2)" "unprognostic (1.38e-3)" "unprognostic (6.00e-2)" "unprognostic (2.12e-1)" "unprognostic (2.04e-1)" "unprognostic (2.70e-2)" "unprognostic (1.51e-1)" 15.6 26.2 37.3 24.3 39.4 54.7 20.4 26.0 63.7 13.6 22.9 25.5 20.4 14.0 62.7 20.3 16.9 14.6 24.5 40.3 47.1 45.5 45.8 14.5 32.1 31.2 32.1 16.8 37.1 21.9 31.5 16.3 34.7 15.4 23.5 74.1 13.5 16.0 22.6 14.8 26.5 17.3 24.6 16.9 32.2 76.1 31.4 31.3 22.1 17.8 30.6 25.4 13.9 31.3 138.0 64.9 18.0 37.2 39.4 56.1 54.1 71.6 68.7 89.5 116.8 58.7 85.5 154.4 158.7 46.7 106.8 82.0 117.4 98.2 153.4 129.2 219.3 84.0 85.0 60.2 38.9 182.9 74.0 41.6 36.1 80.1 126.4 49.5 104.9 90.3 65.5 3.8 71.0 141.0 141.9 157.0 37.0 160.7 171.8 83.8 91.1 158.6 109.6 65.7 113.0 61.6 51.7 41.5 50.1 48.8 35.5 75.2 52.4 60.5 45.6 175.0 181.5 56.5 105.1 0.9 74.6 199.5 33.8 5.8 21.9 20.4 20.8 36.5 30.0 24.0 30.4 27.6 37.9 24.8 24.8 26.9 5.6 39.4 35.5 15.7 57.4 25.3 37.3 39.4 26.0 63.7 40.3 47.1 31.2 32.1 34.7 24.6 31.4 31.3 32.1 19.2 8.2 11.1 39.6 39.6 55.7 75.6 18.8 38.3 26.4 22.0 23.8 30.0 29.9 57.0 4.2 17.9 28.1 16.8 226.9 50.1 11.9 30.1 28.3 39.2 27.5 101.8 55.3 32.3 30.5 29.5 30.1 41.8 34.9 29.0 20.7 22.2 71.2 25.2 43.1 30.4 63.1 60.7 81.7 32.2 40.7 56.2 55.2 10.3 122.5 37.2 26.8 22.1 30.7 36.6 28.2 26.7 30.9 78.1 24.1 30.2 28.9 78.0 52.6 31.6 39.4 213.5 172.6 40.4 38.8 6.0 53.8 30.2 51.3 46.8 HS3ST6 HS3ST5 ENSG00000162040 "Heparan sulfate-glucosamine 3-sulfotransferase 6" Q96QI5 16 1911475-1918415 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "skin 1: 75.7" "Cell type enhanced" "Detected in some" "Endometrial ciliated cells: 10.7;Horizontal cells: 21.9;Suprabasal keratinocytes: 9.1;Urothelial cells: 24.9" "Cancer enhanced" "Detected in many" "urothelial cancer: 4.4" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "A549: 1.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (5.72e-2)" "prognostic favorable (3.73e-4)" "unprognostic (1.30e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-2)" "unprognostic (3.10e-1)" "unprognostic (4.99e-3)" "unprognostic (2.10e-2)" "unprognostic (6.55e-3)" "unprognostic (2.42e-1)" "unprognostic (3.61e-1)" "unprognostic (2.26e-1)" 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.5 0.0 0.0 0.0 14.4 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.8 0.0 1.4 0.0 0.0 1.9 0.0 0.3 75.7 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.1 4.1 10.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 3.4 0.9 0.0 0.0 0.1 0.0 0.3 0.0 0.7 1.8 0.0 0.2 0.0 6.3 0.0 0.0 4.5 10.7 0.5 0.1 0.0 0.0 0.1 0.0 0.4 2.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 21.9 0.1 0.9 4.1 0.0 1.5 1.4 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.8 0.0 0.0 2.7 0.2 0.2 5.0 0.2 0.0 0.0 0.3 0.0 0.0 4.5 9.1 0.1 0.1 0.0 1.7 24.9 HSFX1 LW-1 ENSG00000171116 "Heat shock transcription factor family, X-linked 1" Q9UBD0 X 149774068-149776867 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in some" "HPA051700, HPA063040" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" Nucleoplasm "Plasma membrane, Cytosol" "HPA051700: AB_2681578, HPA063040: AB_2732695" "unprognostic (3.50e-2)" "unprognostic (2.86e-1)" "unprognostic (2.30e-2)" "unprognostic (6.32e-2)" "unprognostic (3.38e-2)" "unprognostic (3.78e-1)" "unprognostic (5.03e-2)" "unprognostic (3.70e-1)" "unprognostic (3.56e-1)" "unprognostic (1.47e-1)" "unprognostic (1.68e-2)" "unprognostic (1.92e-1)" "unprognostic (2.46e-1)" "unprognostic (3.10e-1)" 0.8 0.8 1.5 0.3 1.8 0.0 1.1 1.9 2.6 1.7 2.8 1.8 0.5 1.3 3.3 1.2 1.5 0.8 1.9 2.0 1.4 1.0 1.0 0.9 0.4 1.5 1.5 3.1 1.0 0.8 1.2 1.2 2.2 2.0 0.1 0.7 1.3 0.6 1.3 1.2 1.0 0.4 1.0 2.5 1.0 3.4 1.8 0.1 1.5 0.0 0.4 1.4 1.5 1.8 0.0 1.1 0.0 0.4 1.4 0.9 0.2 0.2 0.0 0.2 0.0 0.8 0.7 0.7 1.2 0.1 0.7 0.0 0.6 0.2 0.1 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.0 0.0 0.0 0.6 1.1 0.3 0.0 0.0 0.2 0.1 1.3 0.1 0.5 0.3 0.1 0.6 0.3 0.8 0.0 1.0 0.5 0.5 0.2 0.1 0.0 0.2 0.8 0.1 0.2 0.2 0.0 0.6 0.2 0.4 0.2 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.8 1.9 2.6 2.0 1.4 1.5 1.5 2.2 1.0 1.8 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 HSPB1 "CMT2F, Hs.76067, Hsp25, HSP27, HSP28" ENSG00000106211 "Heat shock protein family B (small) member 1" P04792 7 76302673-76304295 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 5909.6" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 16589.4;Exocrine glandular cells: 6539.7;Squamous epithelial cells: 6300.1;Urothelial cells: 13091.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 2482.8;MCF7: 3979.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000497, CAB004439, CAB047330, CAB047331, CAB047332" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 19000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 22: Epithelial cell types - Mixed function" "Plasma membrane, Cytosol" "CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172" "unprognostic (2.55e-1)" "unprognostic (7.25e-3)" "prognostic unfavorable (9.94e-5)" "unprognostic (7.07e-3)" "unprognostic (3.47e-3)" "unprognostic (6.61e-3)" "unprognostic (4.08e-3)" "unprognostic (4.50e-2)" "unprognostic (1.27e-1)" "unprognostic (9.78e-2)" "unprognostic (8.70e-2)" "unprognostic (2.21e-1)" "unprognostic (5.72e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.56e-1)" "unprognostic (3.63e-1)" 964.4 856.4 810.6 329.6 835.1 52.3 560.5 821.6 1798.8 2123.4 864.3 2043.6 208.7 2824.2 131.7 5909.6 993.8 217.2 2981.9 776.6 944.5 986.4 554.9 790.9 99.0 894.1 838.7 731.6 751.7 221.1 303.3 324.3 870.8 979.0 73.8 10.2 1075.3 522.5 3669.8 2258.3 523.8 1066.9 808.2 224.5 770.3 99.8 840.0 218.7 627.1 628.1 279.3 1579.4 3398.4 869.5 1251.1 902.4 79.5 576.8 487.3 447.5 5.1 514.9 249.8 260.9 325.8 84.8 660.7 8.5 389.1 599.1 514.1 1094.2 359.0 279.6 76.5 690.9 106.4 41.5 611.4 345.5 267.9 69.9 466.5 542.8 2482.8 370.0 50.5 436.6 831.3 169.5 459.4 1079.7 276.5 3979.7 117.1 508.9 407.4 212.7 800.6 417.3 195.8 974.5 342.8 423.2 7.6 529.1 363.8 1323.3 456.0 224.5 1674.9 551.6 504.2 778.8 1200.3 221.7 1310.1 85.7 145.9 10.7 575.9 247.2 579.5 19.7 13.6 10.9 58.8 78.2 28.1 115.0 92.4 62.1 31.5 105.5 102.1 88.2 5.8 79.7 112.8 56.5 64.5 46.7 810.6 835.1 821.6 1798.8 776.6 944.5 894.1 838.7 870.8 808.2 840.0 869.5 708.2 272.4 186.4 78.4 145.4 1849.8 16589.4 3603.0 1728.4 243.4 312.5 174.4 822.3 264.5 1899.4 1144.0 323.2 161.7 62.0 824.2 1500.7 2021.4 11.9 1181.8 1060.9 1038.7 422.0 136.1 4.3 6539.7 399.4 998.5 219.2 1227.1 216.7 136.3 725.7 234.7 1199.8 70.7 2.2 433.0 1245.1 147.7 2828.9 30.8 299.5 1024.8 2056.2 35.6 188.0 171.4 50.4 8.0 2.7 2719.4 1417.1 534.5 296.9 3854.8 95.3 2324.4 1253.9 29.2 611.4 551.2 2129.1 20.3 105.5 6300.1 2241.7 2432.7 758.2 68.2 390.5 13091.2 HSPB8 "CMT2L, E2IG1, H11, HSP22" ENSG00000152137 "Heat shock protein family B (small) member 8" Q9UJY1 12 119171555-119224855 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Stress response" Chaperone "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 897.3" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 599.1;Syncytiotrophoblasts: 1340.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 89.6;HeLa: 66.0;MCF7: 130.5;U-87 MG: 67.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015876 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol Nucleoplasm "HPA015876: AB_1850458" "unprognostic (1.52e-2)" "unprognostic (6.97e-2)" "unprognostic (1.96e-2)" "unprognostic (1.42e-1)" "unprognostic (1.88e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (2.98e-4)" "unprognostic (2.47e-1)" "unprognostic (4.03e-2)" "unprognostic (7.91e-2)" "unprognostic (6.48e-3)" "unprognostic (1.11e-1)" "unprognostic (1.30e-1)" "unprognostic (2.05e-3)" "unprognostic (2.05e-1)" "unprognostic (6.36e-2)" "unprognostic (2.17e-2)" 57.0 13.9 172.2 34.4 172.6 0.0 33.4 179.5 141.8 58.1 147.0 381.0 8.9 114.4 10.1 163.2 58.7 43.1 469.3 147.8 231.0 63.3 4.8 95.7 11.4 188.3 206.1 23.4 30.8 183.1 17.5 92.1 193.0 143.5 35.8 28.2 50.8 289.0 897.3 70.5 50.5 114.1 211.5 56.2 110.4 12.0 193.6 40.3 29.2 448.5 98.7 239.2 100.1 235.5 21.1 16.1 0.3 0.0 14.4 11.5 60.2 32.5 28.7 5.9 0.3 40.0 0.6 0.1 89.6 42.4 48.0 2.4 0.3 0.0 0.6 0.1 1.2 0.0 66.0 3.2 11.2 0.0 0.1 14.1 4.1 22.3 1.3 21.6 12.3 0.0 0.2 0.0 13.0 130.5 0.0 0.2 5.7 0.0 23.0 0.0 22.9 2.9 38.3 6.2 0.4 1.0 13.5 1.6 6.8 50.5 29.0 0.2 20.4 15.8 39.8 21.7 1.7 0.0 0.2 0.2 67.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 172.2 172.6 179.5 141.8 147.8 231.0 188.3 206.1 193.0 211.5 193.6 235.5 2.7 44.8 48.2 42.1 0.7 102.3 108.5 4.5 126.3 0.7 95.2 17.5 599.1 7.2 5.4 5.5 8.4 149.1 1.0 0.0 0.0 59.7 12.2 98.1 20.2 27.4 0.0 0.0 6.2 11.4 17.5 82.2 5.6 142.7 1.3 0.0 25.4 0.0 19.4 1.7 6.6 0.0 2.0 1.0 9.4 11.0 1.5 1.6 12.4 2.8 1.0 51.7 0.0 0.0 0.9 12.9 0.0 0.4 0.3 24.6 0.0 52.0 3.1 2.1 6.6 39.8 76.9 0.9 0.2 38.0 28.7 1340.0 3.5 0.1 0.2 72.7 IDE ENSG00000119912 "Insulin degrading enzyme" P14735 10 92451684-92574096 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063478 Approved "Secreted in other tissues" NA NA 310000 "Cluster 27: Non-specific - Gene expression" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA063478: AB_2685020" "unprognostic (1.70e-1)" "unprognostic (6.40e-2)" "prognostic favorable (3.69e-4)" "prognostic favorable (3.53e-4)" "unprognostic (2.54e-1)" "unprognostic (1.78e-1)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (8.88e-2)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (7.79e-2)" "unprognostic (6.81e-2)" "unprognostic (9.24e-3)" "unprognostic (6.13e-2)" "unprognostic (3.89e-2)" "unprognostic (3.91e-1)" 6.7 10.1 3.4 2.8 3.6 3.5 6.1 3.7 4.2 8.1 5.9 8.6 3.3 7.4 9.7 9.8 6.5 2.9 11.7 3.4 3.7 5.9 11.4 5.9 3.4 3.8 3.7 5.4 12.3 9.5 4.7 2.7 3.9 9.1 3.8 10.3 7.8 4.2 28.8 36.4 6.8 3.7 3.6 6.3 8.2 25.8 3.6 2.4 6.7 9.7 4.1 8.9 7.9 3.8 12.1 22.9 6.2 15.1 10.5 5.8 8.5 10.4 13.3 6.1 5.2 19.4 9.5 12.5 16.4 14.3 7.2 16.3 14.6 10.0 3.9 14.7 8.8 5.1 13.7 25.9 11.5 14.9 6.5 5.4 6.6 9.1 14.0 7.8 8.6 3.3 10.0 8.1 5.4 18.0 6.6 8.8 10.2 10.4 5.2 10.2 10.8 9.0 10.9 19.3 2.2 5.6 14.3 6.4 6.7 6.8 12.6 6.3 15.3 4.4 8.2 5.0 10.4 11.2 12.2 14.5 6.9 10.9 4.4 0.3 3.5 1.4 2.0 4.2 2.2 2.9 2.6 2.9 4.6 2.1 1.9 2.0 0.0 3.7 5.9 1.3 3.9 2.3 3.4 3.6 3.7 4.2 3.4 3.7 3.8 3.7 3.9 3.6 3.6 3.8 12.9 9.6 14.1 20.9 11.1 5.2 6.1 10.5 5.2 15.0 8.7 4.3 45.7 7.2 10.6 7.3 47.9 11.2 10.0 14.0 1.9 14.0 46.4 14.9 19.3 10.8 10.8 19.6 43.3 20.2 5.7 9.1 22.4 16.5 1.3 9.9 11.7 24.1 11.9 6.7 42.6 12.7 18.3 16.6 5.4 12.0 6.5 12.5 8.8 23.4 7.8 7.8 4.1 20.6 24.0 16.5 5.7 10.1 24.2 12.2 9.0 10.7 23.3 26.9 6.6 7.6 13.2 51.5 11.0 19.6 16.3 3.8 8.5 9.8 9.8 9.6 IDH3G ENSG00000067829 "Isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma" P51553 X 153785766-153794523 "Citric acid cycle related proteins, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 284.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000425, HPA002017" Supported Approved Nucleoli,Mitochondria Yes No 19000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitochondria" "HPA000425: AB_1079097, HPA002017: AB_1079096" "unprognostic (4.24e-2)" "unprognostic (1.43e-3)" "unprognostic (5.75e-2)" "unprognostic (1.05e-1)" "unprognostic (6.57e-2)" "unprognostic (2.25e-1)" "unprognostic (4.35e-2)" "unprognostic (1.58e-1)" "unprognostic (2.24e-2)" "unprognostic (1.59e-2)" "unprognostic (2.81e-2)" "unprognostic (1.96e-1)" "prognostic favorable (5.73e-6)" "unprognostic (1.50e-1)" "unprognostic (3.35e-1)" "unprognostic (2.91e-2)" "unprognostic (2.46e-1)" 52.0 67.1 45.5 38.5 50.0 60.3 49.9 47.8 61.3 44.1 46.5 57.2 52.3 50.7 23.5 50.2 44.8 35.0 91.9 54.9 48.8 68.5 49.2 42.0 40.3 50.5 45.7 49.3 48.3 45.5 47.9 28.3 52.3 43.8 34.6 24.4 51.7 39.9 100.5 51.7 54.7 34.5 43.9 51.8 52.2 32.1 49.1 35.2 48.0 82.9 34.9 44.3 43.2 47.2 94.9 90.0 47.3 65.9 74.4 59.4 62.0 47.3 64.1 80.5 84.3 76.0 66.5 121.4 80.2 74.7 68.2 67.2 72.6 69.2 30.0 38.9 101.7 43.0 118.9 59.0 85.5 61.6 87.5 76.1 48.0 64.4 69.4 50.4 65.3 50.3 24.7 60.4 64.7 138.5 72.0 76.0 21.6 84.2 118.0 62.7 43.3 105.8 94.4 61.1 59.5 42.8 30.2 96.3 48.0 20.8 39.6 51.9 56.0 49.9 34.1 76.8 112.5 89.0 22.6 152.1 81.8 75.8 57.6 178.1 159.3 165.8 71.8 163.9 68.0 68.5 73.2 71.2 163.1 78.9 57.9 63.7 57.8 86.5 169.6 101.3 107.5 140.1 45.5 50.0 47.8 61.3 54.9 48.8 50.5 45.7 52.3 43.9 49.1 47.2 44.4 35.3 33.8 5.5 49.2 80.9 67.5 103.9 37.5 34.9 48.4 57.9 55.1 50.1 55.0 51.5 29.2 99.8 48.2 145.0 207.4 93.4 132.0 42.2 39.4 44.6 62.3 41.4 5.6 90.5 98.7 48.2 47.9 39.8 93.8 43.6 43.2 35.4 131.0 18.5 6.4 107.0 79.3 98.0 77.0 284.2 53.4 75.6 67.6 3.7 116.4 50.8 64.9 3.0 5.0 73.5 133.8 58.6 49.7 35.6 222.4 253.1 50.7 49.3 52.6 47.4 68.2 15.9 18.3 50.3 77.4 110.8 55.2 103.0 112.7 64.2 IDNK "bA522I20.2, C9orf103, hGntK" ENSG00000148057 "IDNK gluconokinase" Q5T6J7 9 83623049-83644130 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 70.5" "Cell type enhanced" "Detected in many" "Distal tubular cells: 80.3;Proximal enterocytes: 84.2;Proximal tubular cells: 224.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 26.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020378, HPA058429" Approved Approved Mitochondria,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 7: Kidney - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Mitochondria, Cytosol" "HPA020378: AB_1845794, HPA058429: AB_2683716" "unprognostic (1.49e-3)" "unprognostic (7.94e-2)" "unprognostic (3.30e-1)" "prognostic favorable (1.10e-6)" "unprognostic (1.39e-1)" "unprognostic (1.56e-1)" "unprognostic (5.41e-3)" "unprognostic (1.81e-2)" "unprognostic (6.08e-2)" "unprognostic (1.57e-1)" "unprognostic (2.61e-2)" "unprognostic (3.00e-1)" "unprognostic (5.86e-3)" "unprognostic (7.32e-2)" "unprognostic (1.07e-1)" "unprognostic (2.55e-1)" "unprognostic (3.11e-2)" 8.9 12.0 18.8 6.1 24.5 5.8 8.7 20.6 26.8 4.3 22.7 9.5 26.3 5.3 13.3 8.3 12.9 6.4 5.8 19.1 22.6 50.9 70.5 7.3 11.0 20.3 20.8 5.5 13.8 14.8 9.0 3.0 20.6 8.4 9.2 10.9 8.8 9.5 2.3 7.1 26.9 4.4 20.5 7.9 8.9 3.7 20.8 38.9 13.2 2.6 9.5 5.2 3.9 21.1 4.3 10.4 1.7 1.8 4.6 6.9 7.8 3.4 8.6 3.5 2.8 2.9 5.3 5.8 5.2 5.8 3.5 8.4 1.3 2.0 3.6 11.9 1.6 2.1 4.6 12.7 19.4 1.5 2.8 4.3 3.3 7.2 7.2 6.2 7.9 16.0 1.9 7.1 4.8 26.8 3.7 1.4 1.6 18.1 6.0 4.6 4.2 3.3 9.6 5.5 6.9 8.6 7.5 6.5 7.6 2.5 6.0 8.1 7.4 1.6 1.3 14.3 6.1 9.0 10.4 1.0 7.3 2.4 2.8 100.7 13.0 19.1 30.5 24.1 25.4 39.3 26.0 24.7 18.1 26.7 20.2 27.2 2.8 33.1 47.6 20.9 52.2 24.8 18.8 24.5 20.6 26.8 19.1 22.6 20.3 20.8 20.6 20.5 20.8 21.1 6.2 12.8 8.7 14.7 9.3 6.8 3.2 7.3 4.0 8.9 10.0 8.4 9.9 10.0 8.8 5.5 0.0 8.0 11.3 8.4 80.3 11.3 0.4 34.6 2.0 5.6 7.3 2.5 4.7 16.1 4.6 8.0 4.6 7.0 20.8 10.2 3.3 44.3 11.1 10.1 5.6 12.8 12.2 11.6 7.5 2.0 4.4 8.2 12.4 11.2 19.8 38.0 24.7 8.0 11.4 5.4 21.7 4.1 12.1 4.6 84.2 224.4 28.3 3.5 0.0 8.8 5.9 1.4 1.5 5.4 5.8 3.0 13.7 9.9 11.2 4.2 IER5L bA247A12.2 ENSG00000188483 "Immediate early response 5 like" Q5T953 9 129175552-129178261 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 177.5;Breast myoepithelial cells: 110.2;dendritic cells: 121.9;Endometrial stromal cells: 218.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 24.7;SiHa: 34.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA021327 Approved Nucleoplasm NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA021327: AB_2121674" "unprognostic (2.46e-1)" "unprognostic (3.73e-3)" "unprognostic (3.90e-3)" "unprognostic (8.49e-3)" "unprognostic (1.21e-1)" "unprognostic (5.65e-2)" "unprognostic (3.37e-3)" "prognostic unfavorable (1.48e-6)" "unprognostic (6.91e-3)" "unprognostic (1.45e-2)" "unprognostic (3.73e-1)" "unprognostic (3.99e-2)" "unprognostic (1.08e-3)" "unprognostic (7.23e-3)" "unprognostic (1.03e-1)" "unprognostic (5.50e-2)" "unprognostic (2.29e-1)" 21.4 10.6 3.7 1.2 4.7 0.4 10.7 3.5 7.3 39.4 2.1 9.4 0.8 13.9 2.1 9.4 16.6 1.9 21.6 3.3 4.1 27.2 14.6 13.1 0.7 6.2 4.1 18.9 4.8 0.6 10.7 1.4 4.8 12.3 0.4 0.5 7.5 3.3 3.5 7.5 5.7 1.0 3.7 6.3 9.1 4.7 4.6 0.3 12.4 0.9 0.3 16.2 19.5 4.8 8.6 24.7 6.9 13.3 5.0 7.9 20.9 12.6 1.1 1.9 1.9 1.3 13.8 0.2 4.9 2.9 5.5 18.6 0.3 1.5 0.3 1.2 1.8 0.0 5.7 2.4 3.8 0.3 0.2 8.6 1.9 1.4 0.2 10.8 0.9 0.2 0.7 4.4 0.3 22.1 0.3 1.1 0.6 2.2 12.9 1.2 0.5 3.8 7.6 1.2 3.1 4.1 34.8 11.1 15.7 2.8 3.4 2.2 5.1 11.7 7.0 7.9 18.3 2.4 1.7 0.3 14.9 2.5 5.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.7 4.7 3.5 7.3 3.3 4.1 6.2 4.1 4.8 3.7 4.6 4.8 177.5 16.0 1.7 12.7 25.5 6.8 9.2 11.1 27.9 6.1 52.7 110.2 1.6 25.8 10.7 47.8 0.0 3.9 121.9 34.7 9.8 14.5 0.7 87.1 218.9 42.6 10.7 0.8 13.1 27.1 11.8 41.4 19.9 102.7 0.0 2.2 30.0 11.7 31.0 3.3 4.3 20.6 26.4 17.0 17.2 1.6 10.8 64.7 14.2 15.0 7.4 13.9 0.0 2.0 1.4 20.0 12.5 7.2 11.2 9.8 8.4 17.3 13.4 2.8 26.3 41.8 99.0 0.1 3.6 37.6 4.5 8.1 55.1 3.9 15.4 7.7 IFT22 "DKFZp761N0823, FAP9, FLJ13225, FLJ14117, RABL5" ENSG00000128581 "Intraflagellar transport 22" Q9H7X7 7 101310914-101321823 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 577.5;Late spermatids: 1478.7;Spermatocytes: 357.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 92.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042930 Approved Approved Microtubules,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "Microtubules, Cytosol" "HPA042930: AB_10794537" "unprognostic (1.55e-2)" "unprognostic (7.22e-2)" "unprognostic (1.29e-1)" "unprognostic (2.23e-2)" "unprognostic (6.70e-3)" "unprognostic (1.03e-1)" "unprognostic (1.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.09e-1)" "unprognostic (9.99e-2)" "unprognostic (1.73e-2)" "unprognostic (3.39e-2)" "unprognostic (1.15e-2)" "unprognostic (2.23e-2)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.33e-1)" 12.4 22.1 20.2 3.7 21.4 2.8 14.3 19.1 25.7 18.6 27.2 22.1 2.8 21.1 22.9 8.5 27.8 12.1 24.0 21.4 21.7 35.5 7.8 13.1 4.0 20.0 21.1 19.5 18.4 29.9 31.1 2.8 20.2 18.0 3.4 41.4 14.7 6.4 26.3 10.1 7.5 5.8 20.7 4.7 14.9 76.4 21.2 10.1 24.4 19.6 3.6 17.2 11.5 19.9 26.1 38.6 20.7 47.9 17.1 14.5 4.6 8.6 4.8 10.6 7.9 15.4 19.3 3.1 22.1 17.8 41.1 16.6 12.2 12.7 8.2 6.2 16.4 0.6 16.4 15.8 12.6 8.7 4.9 14.9 10.9 25.2 5.9 36.5 10.4 18.2 11.2 3.4 12.6 92.5 15.6 16.3 21.6 19.5 17.4 14.4 13.1 5.3 20.1 15.8 22.3 37.0 25.3 21.0 13.7 33.5 16.3 6.6 10.6 33.1 24.6 64.0 18.0 3.1 10.3 7.5 21.7 2.5 17.3 1.4 0.8 0.9 4.0 1.7 3.8 7.5 4.8 3.6 1.6 5.9 4.3 4.4 1.1 5.8 3.3 4.7 2.0 2.3 20.2 21.4 19.1 25.7 21.4 21.7 20.0 21.1 20.2 20.7 21.2 19.9 12.0 25.6 14.3 6.5 11.9 0.0 25.1 0.0 22.2 26.6 35.5 54.4 42.9 55.8 19.2 49.7 54.2 19.7 2.3 4.0 138.9 73.9 577.5 176.0 32.1 17.0 18.5 17.4 7.2 36.9 17.3 28.3 12.8 28.0 9.5 37.9 21.8 10.7 17.7 32.0 5.3 13.1 0.0 2.7 0.0 1478.7 37.9 6.9 0.0 2.8 2.9 76.2 3.1 3.0 2.4 29.9 13.5 41.3 4.8 17.1 2.9 170.2 102.7 103.9 13.1 21.8 22.6 357.7 71.5 15.0 0.0 6.6 7.3 36.0 8.0 20.4 IFT46 "C11orf2, C11orf60, CFAP32, FLJ21827" ENSG00000118096 "Intraflagellar transport 46" Q9NQC8 11 118544528-118572970 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 64.9;Respiratory ciliated cells: 84.3;Spermatocytes: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037909, HPA057550" Approved Approved "Actin filaments" NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Actin filaments" "HPA037909: AB_10672731, HPA057550: AB_2683464" "unprognostic (8.77e-2)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (2.35e-3)" "unprognostic (6.76e-2)" "unprognostic (1.55e-2)" "unprognostic (1.07e-1)" "unprognostic (3.29e-2)" "unprognostic (3.75e-3)" "unprognostic (1.47e-1)" "unprognostic (1.37e-1)" "unprognostic (3.61e-1)" "unprognostic (9.02e-3)" "unprognostic (1.42e-1)" "unprognostic (2.48e-1)" "unprognostic (6.53e-2)" "unprognostic (2.41e-1)" 14.7 19.4 29.0 8.8 29.7 5.6 26.8 33.9 35.8 23.1 37.3 18.6 7.7 19.4 24.8 13.7 66.8 16.4 21.3 28.5 32.5 26.9 17.0 15.1 11.0 32.1 37.2 27.2 16.7 18.4 28.9 8.7 31.8 20.9 11.1 35.7 15.9 20.2 17.9 13.5 10.3 20.7 31.5 11.8 15.0 28.1 31.4 16.0 27.5 17.6 12.8 16.0 16.7 32.1 15.6 18.4 26.1 16.9 42.8 35.7 3.2 31.9 46.2 29.3 27.6 22.5 28.8 23.8 46.1 38.6 7.2 22.1 26.7 31.8 34.4 9.1 21.8 49.2 9.0 8.6 32.0 11.8 13.8 32.4 37.0 49.0 46.2 26.6 28.9 32.1 27.4 16.0 37.3 71.7 31.3 15.6 7.7 27.3 38.0 25.6 20.0 19.0 23.5 21.4 16.7 18.3 23.2 29.9 20.1 15.0 46.2 16.7 24.6 31.6 20.2 18.4 12.0 9.9 14.3 26.7 16.0 21.2 23.2 2.8 5.2 5.9 8.6 4.3 9.9 11.1 7.6 7.9 6.9 8.3 9.2 5.5 1.6 11.0 4.2 7.0 9.9 4.8 29.0 29.7 33.9 35.8 28.5 32.5 32.1 37.2 31.8 31.5 31.4 32.1 5.5 9.6 10.3 10.4 4.9 4.0 8.3 14.4 8.0 12.5 11.6 8.4 14.5 10.0 15.4 11.0 18.8 5.3 3.8 1.6 5.9 17.1 20.5 64.9 11.7 9.3 4.2 6.6 8.7 11.6 7.1 9.5 4.1 9.6 12.0 10.2 8.6 5.9 8.8 1.7 8.9 4.3 14.2 2.4 3.5 15.7 10.2 3.1 1.8 5.6 5.5 14.8 2.1 4.0 6.4 10.2 4.2 18.4 6.1 6.1 3.4 14.3 84.3 16.5 0.0 11.3 11.5 44.9 38.4 6.5 7.0 1.9 4.2 9.8 5.3 3.9 IKBKG "FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9" ENSG00000269335 "Inhibitor of nuclear factor kappa B kinase regulatory subunit gamma" Q9Y6K9 X 154541199-154565046 "Disease related genes, Human disease related genes, Predicted intracellular proteins, RAS pathway related proteins" "DNA damage, Host-virus interaction, Transcription, Transcription regulation" "Disease variant, Ectodermal dysplasia, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000426, CAB010373" Uncertain Enhanced Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "CAB010373: AB_2124846, HPA000426: AB_1851572" "unprognostic (7.53e-2)" "unprognostic (2.76e-3)" "unprognostic (1.09e-1)" "unprognostic (3.37e-3)" "unprognostic (9.77e-2)" "unprognostic (3.68e-1)" "unprognostic (9.22e-2)" "unprognostic (1.47e-1)" "unprognostic (9.16e-2)" "unprognostic (1.59e-1)" "unprognostic (4.18e-2)" "unprognostic (9.87e-2)" "unprognostic (3.57e-2)" "unprognostic (4.41e-2)" "unprognostic (2.78e-1)" "unprognostic (7.07e-2)" "unprognostic (1.36e-2)" 24.4 32.1 18.0 27.6 19.2 42.5 21.7 18.1 23.8 18.9 16.6 22.1 21.2 24.3 6.2 25.5 19.4 16.0 21.5 17.9 17.3 20.7 62.5 29.7 29.0 22.7 19.3 18.3 18.7 10.8 20.2 11.9 21.6 19.9 10.7 6.3 19.8 13.3 20.0 28.4 26.6 14.1 17.9 41.8 22.6 18.8 20.6 19.7 22.9 9.8 18.7 24.8 21.1 23.6 45.8 46.6 11.2 37.1 22.2 18.2 29.7 28.2 35.1 29.4 43.9 32.2 26.5 35.6 73.5 32.6 79.6 39.8 15.0 27.3 12.0 39.6 25.2 27.5 65.4 54.9 37.4 29.3 92.7 23.4 25.6 39.9 15.8 19.4 33.2 34.6 16.6 34.3 23.5 43.1 29.7 52.9 10.4 32.5 69.2 35.4 16.7 38.4 27.6 27.4 19.5 19.9 32.7 32.9 23.0 8.7 19.4 33.4 36.4 29.8 33.9 70.6 69.9 67.5 49.0 69.2 41.4 50.6 41.3 24.9 34.2 61.3 35.3 42.2 24.1 21.3 21.4 26.5 29.8 20.9 17.1 21.3 50.4 30.7 51.1 25.4 26.8 31.0 18.0 19.2 18.1 23.8 17.9 17.3 22.7 19.3 21.6 17.9 20.6 23.6 16.0 3.2 14.3 8.5 22.3 12.4 12.1 20.6 6.2 6.1 8.0 9.8 6.9 10.0 13.6 12.9 10.4 23.3 27.3 14.0 1.9 18.7 0.9 8.0 10.8 15.3 4.9 9.9 5.5 16.9 16.8 12.6 12.8 9.5 29.2 12.0 10.8 36.4 28.3 25.2 4.8 7.7 14.2 17.2 15.9 2.0 14.3 29.4 12.4 4.7 44.5 11.1 48.4 3.0 11.4 23.4 12.8 13.9 13.7 12.5 10.9 7.6 8.3 10.2 6.6 9.6 13.7 4.6 12.8 10.6 10.5 38.0 24.6 10.2 8.5 14.2 ILVBL "209L8, AHAS, FLJ39061, HACL1L, ILV2H, MGC1269, MGC19535" ENSG00000105135 "IlvB acetolactate synthase like" A1L0T0 19 15114984-15125786 "Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 148.2;Syncytiotrophoblasts: 253.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067682 Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Golgi apparatus, Vesicles" "HPA067682: AB_2685885" "unprognostic (5.68e-2)" "unprognostic (1.86e-1)" "unprognostic (3.72e-2)" "prognostic unfavorable (1.52e-4)" "unprognostic (8.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.04e-2)" "unprognostic (2.53e-1)" "unprognostic (3.83e-1)" "unprognostic (5.60e-2)" "unprognostic (1.77e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.91e-8)" "unprognostic (4.65e-2)" "unprognostic (1.68e-1)" "unprognostic (1.40e-1)" "unprognostic (2.40e-1)" 29.7 45.5 22.7 13.9 27.5 15.5 27.5 30.9 25.1 29.7 32.8 46.2 50.1 24.3 14.4 40.9 22.6 25.5 73.7 21.4 25.5 41.6 56.8 19.2 15.5 29.2 25.3 28.3 42.5 65.8 34.4 19.2 26.3 24.2 18.6 13.8 27.7 23.2 18.7 43.4 43.7 13.7 24.8 17.6 41.1 25.5 25.2 10.5 48.0 25.0 10.6 28.5 30.6 32.3 68.8 41.0 34.4 40.7 43.8 29.7 39.6 31.6 42.2 37.2 47.5 65.5 162.1 29.7 61.1 34.2 22.3 50.6 20.9 38.5 10.8 27.5 41.1 43.7 41.3 72.4 70.1 37.2 37.0 44.6 43.9 21.7 28.3 30.4 35.0 29.6 17.9 37.6 29.3 159.0 24.9 29.6 31.9 54.9 58.8 36.0 31.1 46.5 32.3 33.6 28.4 38.3 18.8 81.2 62.1 13.2 37.2 31.2 37.7 55.9 30.7 71.0 45.1 26.1 29.2 15.1 35.9 35.8 43.1 22.7 22.2 5.5 21.1 31.8 24.0 11.9 17.7 22.0 26.3 12.9 22.9 23.6 2.5 23.7 30.3 19.1 20.2 23.3 22.7 27.5 30.9 25.1 21.4 25.5 29.2 25.3 26.3 24.8 25.2 32.3 28.0 25.6 11.7 18.3 12.7 12.7 26.8 53.8 22.2 95.3 18.0 14.9 36.1 62.9 43.0 25.8 27.1 84.2 15.8 67.8 19.6 48.4 6.2 9.9 13.4 23.2 44.4 12.6 4.9 50.6 148.2 21.4 40.2 13.0 11.4 29.0 26.7 59.3 43.2 18.5 8.3 60.6 28.5 12.1 9.5 6.5 25.7 15.8 83.6 5.6 6.8 48.0 7.2 9.0 15.7 32.3 68.4 19.9 17.2 18.6 123.0 50.4 26.1 36.8 19.7 14.7 21.2 20.3 20.8 25.0 16.2 253.4 11.8 48.2 73.2 23.4 INSL4 EPIL ENSG00000120211 "Insulin like 4" Q14641 9 5231419-5235304 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "placenta: 15.9" "Cell type enriched" "Detected in some" 10 "Syncytiotrophoblasts: 3575.7" "Cancer enhanced" "Detected in some" "lung cancer: 1.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "A549: 24.6" HPA065145 Approved Vesicles "Secreted to blood" NA NA "Cluster 28: Placenta - Pregnancy" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Vesicles "HPA065145: " "unprognostic (9.77e-2)" "unprognostic (2.02e-1)" "unprognostic (4.66e-1)" "unprognostic (7.74e-2)" 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 24.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.4 0.0 2.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 325.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.0 0.0 0.0 26.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 38.2 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3575.7 0.0 0.0 0.0 0.0 IPO4 "FLJ23338, Imp4" ENSG00000196497 "Importin 4" Q8TEX9 14 24180219-24188869 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.4" "Group enriched" "Detected in many" 4 "Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039043, HPA064572" Uncertain Approved Cytosol NA NA 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA039043: AB_10673233, HPA064572: AB_2685291" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (9.45e-2)" "unprognostic (2.60e-1)" "unprognostic (5.13e-2)" "unprognostic (6.75e-2)" "unprognostic (9.28e-2)" "prognostic unfavorable (3.20e-4)" "unprognostic (8.59e-4)" "unprognostic (5.45e-2)" "unprognostic (2.18e-1)" "unprognostic (2.15e-2)" 8.9 13.2 1.6 4.7 1.4 4.2 8.0 1.5 1.6 6.9 4.4 7.2 3.2 7.7 2.0 14.0 8.0 1.1 7.8 1.3 2.1 14.1 14.7 6.7 2.8 1.6 1.4 6.9 27.7 2.6 9.4 2.5 1.8 6.8 1.4 0.3 8.7 3.6 21.0 10.7 5.9 1.9 1.4 7.3 8.6 40.4 1.6 2.1 7.0 1.0 1.8 8.7 7.0 2.0 21.9 49.2 6.0 36.0 4.1 8.6 28.4 14.8 6.3 23.5 12.5 39.2 22.4 31.3 16.1 10.6 12.2 25.6 20.4 28.8 2.6 12.1 29.8 20.4 18.6 77.0 8.7 45.4 18.1 7.5 12.3 24.3 6.0 5.3 11.8 15.8 37.5 8.5 15.0 76.6 21.8 21.2 29.1 28.5 41.7 24.4 17.3 23.2 12.6 25.7 29.3 21.1 19.7 31.8 13.9 2.9 27.1 14.7 12.4 22.9 30.8 21.0 32.4 19.8 27.1 34.2 10.8 19.3 31.8 0.0 1.1 0.4 3.3 1.9 3.8 1.8 2.8 2.7 2.4 2.6 2.3 2.9 0.0 2.7 2.4 3.2 1.7 1.9 1.6 1.4 1.5 1.6 1.3 2.1 1.6 1.4 1.8 1.4 1.6 2.0 3.5 0.0 7.9 0.7 4.9 5.9 3.8 5.0 4.6 0.8 11.1 9.7 1.6 8.6 8.7 5.5 4.2 12.1 5.5 3.1 0.0 13.3 80.5 8.3 3.9 5.6 4.2 3.4 1.3 11.0 11.1 4.5 1.1 5.0 0.0 3.1 2.9 5.8 7.9 1.7 1.1 5.9 2.0 2.2 2.6 118.0 5.0 1.3 0.0 0.0 1.7 1.6 2.1 1.0 0.8 6.8 2.5 5.7 2.9 6.1 0.7 11.7 15.1 2.7 6.6 7.0 4.7 52.1 18.8 3.9 6.3 5.9 3.1 6.1 10.4 2.7 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 128.3;Cone photoreceptor cells: 114.7;Respiratory ciliated cells: 98.7;Rod photoreceptor cells: 107.4;Spermatocytes: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: AB_2680520" "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 3.8 2.7 5.3 1.3 5.7 0.5 5.9 5.2 6.8 7.5 8.7 2.6 3.8 4.6 15.4 1.6 20.2 5.7 3.5 5.1 8.7 8.7 2.1 4.0 1.5 6.2 7.2 6.5 3.6 19.4 6.3 3.2 5.7 3.4 2.9 11.0 6.4 7.6 3.0 2.1 1.6 3.8 6.8 1.8 3.9 18.2 5.6 1.6 16.8 2.9 1.1 4.1 2.0 8.0 2.6 6.8 8.7 5.7 2.6 8.1 0.5 0.0 4.4 4.0 3.1 0.4 4.8 0.3 4.7 2.4 2.5 3.0 1.9 3.3 2.8 1.1 1.8 0.1 1.9 3.4 8.2 1.6 0.0 4.7 2.7 5.4 1.2 4.5 4.4 4.2 2.8 0.8 2.5 8.5 1.6 0.9 2.6 2.8 6.4 5.3 0.8 0.4 10.0 1.8 8.1 3.4 3.9 1.2 5.3 1.6 3.6 0.9 3.1 1.1 0.9 4.6 0.9 0.1 0.6 0.0 5.4 0.2 1.9 0.0 0.3 0.0 0.5 1.3 0.9 0.5 0.5 0.8 0.1 0.2 1.0 0.5 0.0 0.0 1.3 0.3 0.5 0.3 5.3 5.7 5.2 6.8 5.1 8.7 6.2 7.2 5.7 6.8 5.6 8.0 42.4 16.0 5.1 128.3 1.7 6.1 9.7 16.4 9.6 54.1 18.3 16.5 0.7 24.3 17.8 46.0 114.7 4.9 1.3 8.6 46.9 47.2 57.2 76.9 19.0 22.1 5.4 0.8 31.9 29.6 2.8 11.8 12.8 14.9 0.0 6.2 11.7 2.1 6.0 3.3 45.9 4.3 32.6 2.4 3.9 34.8 18.0 3.7 17.8 15.0 1.5 26.3 0.0 37.2 53.4 29.8 2.2 18.0 2.3 7.3 2.0 32.5 98.7 107.4 6.6 7.5 15.6 101.7 35.8 3.9 5.1 4.1 3.0 18.1 6.7 5.1 IRAK1 "IRAK, pelle" ENSG00000184216 "Interleukin 1 receptor associated kinase 1" P51617 X 154010506-154019902 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction, Immunity, Innate immunity" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 113.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004461, HPA054476" Supported Supported Nucleoplasm,Cytosol No No "Cluster 15: NK-cells - Transcription" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Cytosol Nucleoplasm "CAB004461: AB_2249106, HPA054476: AB_2682501" "unprognostic (4.46e-3)" "unprognostic (9.32e-2)" "unprognostic (1.71e-2)" "unprognostic (5.04e-3)" "unprognostic (7.09e-3)" "unprognostic (4.43e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (7.89e-3)" "unprognostic (3.36e-2)" "unprognostic (3.69e-2)" "unprognostic (1.95e-1)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.06e-4)" "unprognostic (2.76e-3)" "unprognostic (2.36e-1)" "unprognostic (2.21e-3)" "unprognostic (3.04e-1)" 48.6 61.2 24.4 37.6 25.3 82.4 40.7 23.6 34.9 29.0 20.0 41.4 43.3 31.8 7.7 69.1 28.8 20.2 34.4 22.3 26.5 44.2 64.7 48.9 33.7 38.1 30.0 28.9 84.9 12.4 37.5 17.8 30.8 46.1 15.0 4.5 41.6 21.0 92.5 44.3 51.1 16.4 29.6 69.9 41.9 20.8 34.3 19.4 24.5 16.8 24.0 47.7 36.5 29.4 467.2 178.9 24.5 201.2 48.4 38.5 108.3 68.8 64.5 104.0 96.0 142.3 199.4 200.8 371.4 73.6 157.6 124.3 57.6 112.4 39.8 156.7 173.4 73.3 158.6 85.7 110.8 174.2 118.7 53.2 96.1 99.0 107.8 53.2 62.8 39.6 130.9 220.3 73.3 171.4 70.8 152.1 60.9 148.4 353.5 181.6 126.4 334.7 68.5 86.3 137.4 98.7 82.2 88.6 135.2 9.5 34.3 179.2 86.4 123.8 194.6 284.6 424.2 274.8 190.6 358.2 179.6 205.1 130.8 1.3 7.2 6.2 5.3 9.2 4.7 6.5 4.3 4.4 4.8 7.9 2.5 4.7 5.2 5.4 7.5 10.9 2.3 3.3 24.4 25.3 23.6 34.9 22.3 26.5 38.1 30.0 30.8 29.6 34.3 29.4 20.2 0.0 13.3 5.9 29.7 13.4 14.5 10.9 5.2 9.1 23.9 19.0 9.3 18.6 16.0 11.0 6.2 11.4 33.0 41.4 7.9 40.5 0.9 9.8 13.5 18.1 20.4 18.1 9.7 113.6 20.9 15.2 18.3 17.3 12.7 25.5 13.2 35.9 57.2 16.8 8.9 27.2 0.0 51.4 24.7 3.8 18.0 43.0 14.2 11.2 24.2 21.8 13.4 4.5 6.6 75.0 28.6 21.4 33.5 30.0 39.4 19.6 10.0 5.3 0.0 14.5 14.9 1.6 8.1 15.1 13.1 12.3 19.6 18.4 39.4 25.3 JPT1 "ARM2, HN1, HN1A" ENSG00000189159 "Jupiter microtubule associated homolog 1" Q9UK76 17 75135248-75168281 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 406.9" "Cell type enhanced" "Detected in many" "Ductal cells: 371.3;Exocrine glandular cells: 437.2;Extravillous trophoblasts: 1344.2;monocytes: 375.7;Pancreatic endocrine cells: 1434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 767.6" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059729 Approved Supported "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA 40000 "Cluster 5: Granulocytes - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nuclear membrane, Nucleoli" "HPA059729: AB_2684114" "unprognostic (1.13e-2)" "unprognostic (1.81e-1)" "unprognostic (1.31e-3)" "unprognostic (3.57e-3)" "unprognostic (6.71e-2)" "unprognostic (2.51e-3)" "prognostic unfavorable (1.58e-7)" "unprognostic (3.58e-2)" "unprognostic (1.37e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.25e-3)" "unprognostic (8.24e-2)" "prognostic unfavorable (1.77e-7)" "unprognostic (1.83e-1)" "unprognostic (8.99e-2)" "unprognostic (4.84e-2)" "unprognostic (1.51e-1)" 26.1 74.9 44.0 87.5 43.7 83.5 21.3 49.4 54.7 44.1 31.0 140.1 119.2 18.0 7.3 225.1 15.5 63.7 23.3 44.3 54.4 72.2 49.1 49.3 87.6 38.6 42.8 13.4 22.6 6.7 24.3 66.3 49.3 28.3 70.4 17.0 62.1 27.8 96.1 40.7 141.6 23.4 34.3 100.5 134.2 406.9 53.1 88.0 16.1 24.3 91.5 93.9 75.7 36.3 775.3 743.0 371.8 384.7 75.5 75.2 309.5 391.8 111.5 364.6 278.0 614.8 449.1 210.1 247.4 303.0 401.7 446.5 344.3 481.9 278.5 215.7 438.3 336.1 275.2 624.8 177.5 256.3 318.3 117.1 218.4 307.3 308.7 107.1 672.2 388.7 197.3 431.3 335.4 561.4 845.0 248.7 216.9 627.8 979.0 520.8 447.5 326.8 392.7 479.1 465.4 373.8 553.8 293.3 213.4 393.8 786.0 154.9 395.1 214.3 615.7 305.0 469.0 165.9 298.1 332.5 186.9 233.4 254.4 241.7 127.0 372.6 79.6 187.8 57.2 102.3 109.3 96.8 100.7 57.2 51.6 76.1 767.6 74.5 206.7 67.4 202.6 118.4 44.0 43.7 49.4 54.7 44.3 54.4 38.6 42.8 49.3 34.3 53.1 36.3 61.6 25.6 18.1 0.0 36.2 0.0 0.0 0.0 0.0 0.0 81.8 133.2 0.0 0.0 18.0 246.5 0.0 137.6 171.2 0.0 99.7 371.3 0.0 113.2 79.7 32.9 0.0 0.0 0.0 437.2 1344.2 40.4 0.0 194.0 7.6 179.6 0.0 0.0 319.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 102.5 0.0 0.0 375.7 0.0 0.0 0.0 0.0 1434.1 0.0 0.0 13.9 0.0 0.0 203.3 16.8 0.0 0.0 0.0 76.2 0.0 0.0 0.0 0.0 96.9 73.9 95.0 0.0 0.0 KAT5 "cPLA2, ESA1, HTATIP, HTATIP1, PLIP, TIP60, ZC2HC5" ENSG00000172977 "Lysine acetyltransferase 5" Q92993 11 65711996-65719604 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Growth regulation, Host-virus interaction, Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016953, HPA074328" Approved Supported Nucleoplasm,Vesicles,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "Vesicles, Cytosol" "HPA016953: AB_1851277, HPA074328: " "unprognostic (2.20e-1)" "unprognostic (3.58e-1)" "unprognostic (3.59e-2)" "unprognostic (2.74e-1)" "unprognostic (9.61e-2)" "unprognostic (7.16e-2)" "unprognostic (1.29e-3)" "unprognostic (1.20e-1)" "unprognostic (2.01e-1)" "unprognostic (2.74e-1)" "unprognostic (2.13e-1)" "unprognostic (2.54e-1)" "prognostic favorable (1.10e-13)" "unprognostic (1.37e-1)" "unprognostic (2.55e-1)" "unprognostic (1.85e-1)" "unprognostic (8.54e-2)" 31.6 30.0 38.7 23.8 41.0 52.9 32.1 41.7 48.8 39.5 38.6 43.6 21.6 45.1 33.7 34.9 44.9 20.5 32.4 37.9 38.9 32.9 26.3 29.5 28.0 40.0 39.5 39.2 32.7 45.6 33.7 29.9 41.2 33.1 27.0 31.0 29.6 36.3 42.8 47.6 32.2 35.2 40.0 34.3 35.9 45.2 39.9 39.3 38.2 34.6 30.2 39.5 34.8 43.8 37.2 44.1 40.1 29.6 31.3 32.7 41.1 26.7 43.6 44.0 38.0 32.6 42.2 34.3 36.2 47.4 47.5 30.8 50.8 45.1 26.4 44.4 32.5 50.6 36.3 38.9 44.6 55.7 56.4 35.2 49.7 28.9 59.0 33.7 28.1 39.1 52.5 51.1 42.0 68.2 45.7 62.3 33.9 26.8 28.4 38.2 26.5 63.3 40.6 56.2 37.1 38.9 25.4 46.5 51.2 20.8 45.9 34.2 36.3 33.9 30.4 27.6 28.0 38.7 43.7 50.4 29.7 27.0 29.3 42.7 33.6 58.8 33.4 32.0 29.6 28.2 28.8 34.2 34.1 30.4 36.5 29.8 34.8 35.8 34.6 20.9 31.0 36.4 38.7 41.0 41.7 48.8 37.9 38.9 40.0 39.5 41.2 40.0 39.9 43.8 17.6 12.8 17.5 10.7 26.0 21.2 44.2 60.2 17.6 44.9 17.3 15.0 1.0 25.8 33.8 29.5 31.3 51.3 25.6 27.1 35.2 42.2 11.1 20.2 14.2 18.7 30.4 12.4 7.5 51.5 42.6 21.1 20.4 19.8 33.7 27.0 18.2 10.9 36.3 38.7 8.7 25.1 42.7 17.6 15.2 11.1 28.0 20.4 42.7 3.7 38.8 40.3 33.0 7.1 13.8 39.4 30.6 38.7 10.4 24.2 23.3 32.6 30.0 44.8 46.0 27.6 27.0 61.1 27.8 14.6 21.3 102.5 21.6 29.2 26.2 31.0 KAT8 "FLJ14040, hMOF, MOF, MYST1, ZC2HC8" ENSG00000103510 "Lysine acetyltransferase 8" Q9H7Z6 16 31114489-31131393 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 113.9;Late spermatids: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 29.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066324 Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA066324: AB_2685658" "unprognostic (8.58e-2)" "unprognostic (9.53e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "unprognostic (8.59e-2)" "unprognostic (1.06e-1)" "unprognostic (3.22e-1)" "prognostic favorable (6.34e-4)" "unprognostic (3.13e-2)" "unprognostic (3.05e-1)" "unprognostic (5.50e-2)" "unprognostic (9.77e-2)" "unprognostic (7.33e-2)" "unprognostic (2.97e-1)" "unprognostic (1.29e-1)" "unprognostic (5.00e-1)" "unprognostic (1.41e-1)" 28.8 30.9 40.4 17.8 41.6 32.9 31.3 50.6 50.4 40.8 38.2 36.9 16.6 39.2 46.5 21.1 41.7 14.7 42.0 41.5 41.6 28.4 29.0 31.3 24.6 42.0 41.3 60.7 31.8 37.4 31.0 20.4 41.3 32.0 17.3 27.5 34.7 23.7 49.8 33.8 30.2 25.5 40.0 39.7 28.2 32.8 41.6 39.6 35.5 49.8 23.3 30.9 31.0 43.1 18.1 27.4 33.5 10.7 38.5 28.9 34.3 16.0 29.6 24.7 26.8 13.6 38.1 42.3 24.5 19.6 22.8 22.5 53.6 26.4 24.1 35.8 35.0 18.7 21.5 43.3 34.5 30.5 31.9 27.9 51.4 18.5 52.4 33.2 23.6 44.1 49.5 33.7 13.1 51.4 47.4 57.2 38.0 43.1 15.9 75.1 28.1 49.5 20.1 10.7 35.2 35.9 9.4 25.9 14.1 20.7 28.6 49.6 14.7 11.0 22.2 12.1 11.6 32.4 34.8 24.2 16.0 40.7 16.3 8.0 7.4 29.9 3.0 4.1 3.7 3.6 3.6 4.1 6.6 2.9 4.6 3.3 28.4 3.2 8.3 2.7 2.4 3.4 40.4 41.6 50.6 50.4 41.5 41.6 42.0 41.3 41.3 40.0 41.6 43.1 26.2 19.2 18.2 16.0 30.4 20.8 41.9 18.1 34.7 19.0 21.5 26.2 16.8 21.5 21.0 9.2 14.6 30.5 20.9 17.8 21.5 21.9 113.9 17.5 18.2 21.8 24.6 29.5 16.4 26.6 21.7 29.4 17.9 18.0 27.3 33.9 23.2 12.4 29.1 32.0 18.6 21.2 18.3 30.1 25.4 147.5 53.7 28.1 24.9 12.2 32.6 41.0 15.5 11.1 13.2 15.0 25.8 54.2 16.5 35.2 25.1 17.5 11.8 26.9 26.3 32.8 30.6 27.5 26.2 20.6 15.6 45.4 24.6 24.5 22.9 23.2 KCNF1 "IK8, KCNF, kH1, Kv5.1" ENSG00000162975 "Potassium voltage-gated channel modifier subfamily F member 1" Q9H3M0 2 10911934-10914225 "Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 24 "brain: 28.9;choroid plexus: 32.1" "Cell type enhanced" "Detected in some" "Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7" "Cancer enriched" "Detected in many" 7 "glioma: 27.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 14.3;MCF7: 5.1;T-47d: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014738, HPA062278" Enhanced Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA014738: AB_1852114, HPA062278: AB_2732679" "unprognostic (2.54e-1)" "unprognostic (6.06e-3)" "unprognostic (1.37e-1)" "unprognostic (3.07e-2)" "unprognostic (4.39e-2)" "unprognostic (7.41e-4)" "unprognostic (1.54e-3)" "unprognostic (4.83e-5)" "unprognostic (1.57e-1)" "unprognostic (6.95e-2)" "unprognostic (1.60e-2)" "unprognostic (1.40e-1)" "unprognostic (2.96e-1)" "unprognostic (3.10e-4)" "unprognostic (2.37e-1)" "unprognostic (4.28e-2)" "unprognostic (4.08e-2)" 0.1 0.0 20.6 0.1 28.9 0.0 0.2 0.0 21.5 0.0 32.1 1.2 0.2 0.6 0.0 0.2 0.1 0.1 0.7 28.8 14.7 0.4 0.0 0.3 0.1 0.0 5.3 0.0 0.9 0.3 0.8 0.0 0.0 0.7 0.2 0.2 0.1 0.3 0.0 0.0 0.6 0.0 0.6 0.5 0.3 0.5 12.5 0.3 0.0 0.0 0.0 0.6 0.0 15.8 0.1 14.3 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.0 0.0 2.1 0.1 1.5 0.0 0.1 0.0 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.1 6.1 0.7 0.0 0.0 1.6 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.6 28.9 0.0 21.5 28.8 14.7 0.0 5.3 0.0 0.6 12.5 15.8 0.0 0.0 0.0 1.3 0.1 0.0 0.0 0.2 0.0 2.0 0.8 1.4 1.4 0.0 0.0 0.0 2.1 0.0 0.1 1.6 0.0 0.0 2.2 0.8 0.3 0.9 1.2 0.0 9.3 0.0 14.4 0.7 0.0 2.0 0.0 0.2 0.0 0.0 0.2 0.0 8.8 0.2 0.0 0.0 0.0 3.4 0.3 0.1 0.0 1.9 0.0 0.3 0.0 18.1 1.4 0.1 0.2 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.5 0.1 0.0 0.0 7.7 0.0 0.4 0.3 0.1 KCNJ11 "BIR, Kir6.2" ENSG00000187486 "Potassium inwardly rectifying channel subfamily J member 11" Q14654 11 17385248-17389331 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Voltage-gated channel" "Diabetes mellitus, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "skeletal muscle: 134.7;tongue: 40.7" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 14.1;Collecting duct cells: 5.5;Enteroendocrine cells: 4.2;Excitatory neurons: 5.5;Inhibitory neurons: 5.9;Oligodendrocyte precursor cells: 4.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Daudi: 6.6;HEK 293: 12.3;MCF7: 10.0;SCLC-21H: 8.5;U-266/84: 6.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048891 Approved NA NA "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA048891: AB_2680547" "unprognostic (1.95e-2)" "unprognostic (6.18e-3)" "unprognostic (7.79e-2)" "unprognostic (2.26e-1)" "unprognostic (1.77e-1)" "unprognostic (1.25e-1)" "unprognostic (4.81e-5)" "unprognostic (1.83e-3)" "unprognostic (5.45e-2)" "unprognostic (8.09e-3)" "unprognostic (3.72e-3)" "unprognostic (9.23e-3)" "prognostic favorable (1.56e-4)" "unprognostic (4.05e-2)" "unprognostic (2.10e-2)" "unprognostic (1.67e-1)" "unprognostic (4.75e-2)" 2.7 0.6 5.1 0.4 8.3 0.2 3.0 12.4 11.9 0.6 0.0 1.1 1.0 0.9 1.6 1.5 0.7 0.5 13.8 5.3 4.2 4.7 1.5 2.5 0.8 8.0 3.4 0.3 11.3 5.0 7.4 0.1 8.2 2.2 0.4 1.3 2.2 2.4 134.7 1.5 1.3 0.1 2.6 1.6 13.1 0.6 6.4 0.3 5.1 40.7 0.5 0.9 0.4 5.9 1.5 2.1 0.2 4.0 0.0 0.0 1.4 0.0 0.0 0.0 0.1 2.0 0.2 6.6 0.2 0.0 0.3 0.3 4.1 0.1 0.2 1.6 12.3 3.4 0.9 0.5 0.1 0.5 0.3 0.1 0.2 0.0 0.1 0.1 0.0 5.6 3.5 3.6 0.0 10.0 0.7 0.1 1.1 4.0 0.3 1.3 1.6 2.0 0.3 0.9 8.5 0.7 0.0 3.4 0.0 0.0 4.2 0.2 0.0 0.0 1.1 0.0 0.0 0.2 6.5 0.8 0.0 0.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.1 8.3 12.4 11.9 5.3 4.2 8.0 3.4 8.2 2.6 6.4 5.9 1.5 0.0 2.7 3.3 0.1 0.0 0.1 0.0 0.0 2.1 2.6 0.9 14.1 0.0 0.6 5.5 0.0 0.0 0.0 0.2 0.0 0.4 0.1 0.3 0.3 0.3 4.2 0.0 5.5 0.4 0.0 0.9 0.0 0.6 0.0 0.2 0.4 1.3 0.1 0.0 5.9 0.9 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 4.0 0.8 0.1 0.0 0.0 0.0 0.8 0.1 0.2 0.0 0.7 0.0 1.3 0.2 0.2 0.3 1.0 0.0 0.0 0.0 0.1 0.4 0.2 KCNK15 "dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5" ENSG00000124249 "Potassium two pore domain channel subfamily K member 15" Q9H427 20 44745865-44752313 "Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Cholangiocytes: 15.7;Collecting duct cells: 9.2;Exocrine glandular cells: 7.0;Granulosa cells: 6.3;Leydig cells: 6.5;Prostatic glandular cells: 5.6;Urothelial cells: 7.4" "Cancer enriched" "Detected in many" 7 "ovarian cancer: 47.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "MCF7: 48.9" "Region enriched" "Detected in single" 18 "olfactory bulb: 6.8" "Region enriched" "Detected in single" 7 "olfactory bulb: 3.9" HPA064861 Uncertain NA NA "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 50: Fibroblasts - ECM organization" "HPA064861: AB_2685373" "unprognostic (8.70e-2)" "prognostic unfavorable (3.68e-4)" "unprognostic (1.05e-2)" "unprognostic (2.96e-2)" "unprognostic (1.99e-1)" "unprognostic (3.50e-2)" "unprognostic (4.22e-2)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (6.27e-2)" "unprognostic (6.11e-2)" "unprognostic (7.38e-4)" "unprognostic (4.76e-2)" "unprognostic (4.79e-2)" "unprognostic (2.21e-3)" "unprognostic (2.11e-1)" 4.0 2.1 0.3 0.2 0.5 0.0 3.0 0.1 0.4 3.2 0.2 0.5 0.2 2.3 0.2 0.7 5.2 1.0 1.7 0.1 0.9 2.0 0.3 2.0 0.0 0.2 0.3 2.2 1.6 0.1 3.5 0.1 0.1 1.6 0.0 0.2 1.7 1.3 0.4 1.4 0.6 1.1 0.1 0.1 2.8 3.3 0.2 0.0 2.7 0.2 0.0 1.0 1.5 0.0 0.0 0.1 0.0 0.0 1.0 0.3 0.0 0.4 0.3 0.1 0.1 0.3 0.0 0.0 0.8 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.1 4.7 0.0 0.0 0.0 0.4 0.0 1.4 0.6 4.6 0.0 0.5 0.0 2.3 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.4 0.1 0.9 0.2 0.3 0.1 0.1 0.2 0.0 1.0 0.0 0.0 0.0 0.1 0.5 1.9 0.0 0.6 0.1 1.6 1.0 0.7 15.7 0.4 9.2 0.0 0.0 0.0 0.3 0.0 3.9 0.2 1.7 2.3 2.5 1.2 0.0 1.0 7.0 0.0 3.9 1.1 1.6 0.0 6.3 1.4 0.3 0.1 0.0 0.5 0.4 0.0 0.0 0.3 0.3 6.5 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 1.5 0.3 0.4 0.0 5.6 0.0 0.2 0.1 0.1 0.0 0.5 0.6 0.2 0.4 1.4 0.9 0.0 0.1 0.3 1.0 7.4 KCTD13 "FKSG86, PDIP1, POLDIP1" ENSG00000174943 "Potassium channel tetramerization domain containing 13" Q8WZ19 16 29905012-29926236 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Autism, Autism spectrum disorder, Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.5;testis: 36.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043524 Enhanced Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA043524: AB_2678528" "unprognostic (6.97e-2)" "unprognostic (9.06e-3)" "prognostic unfavorable (8.54e-4)" "unprognostic (4.00e-2)" "unprognostic (2.39e-1)" "unprognostic (3.13e-2)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (3.59e-2)" "unprognostic (1.97e-2)" "prognostic favorable (9.05e-4)" "unprognostic (3.92e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "unprognostic (5.49e-3)" 6.0 7.5 27.3 7.8 28.7 8.5 5.4 17.6 37.5 5.0 17.4 6.3 7.3 5.1 9.9 5.9 8.3 7.8 4.4 36.9 24.5 3.9 3.5 4.5 9.8 19.5 21.3 7.5 7.5 7.9 3.6 4.5 19.6 6.7 6.5 9.4 6.5 8.0 2.7 12.2 7.0 5.2 20.5 7.6 5.8 36.3 23.0 9.6 5.7 2.4 7.1 6.0 2.7 28.8 9.7 12.4 6.2 15.5 10.0 8.1 12.5 5.8 7.2 5.7 8.9 3.5 12.6 17.4 11.3 8.5 9.6 14.4 6.8 5.5 4.4 26.5 17.0 3.7 7.1 6.0 13.7 9.2 15.9 10.2 15.3 11.6 8.7 6.1 4.7 19.9 9.1 14.8 7.9 28.1 18.7 14.2 3.6 5.0 6.0 13.9 4.5 9.0 7.8 9.1 15.5 15.4 2.4 7.0 31.7 5.8 10.1 7.2 10.0 5.0 5.1 15.3 10.6 12.4 5.3 3.9 12.0 10.4 14.4 7.2 3.3 8.0 2.9 2.6 3.0 3.0 5.4 5.0 3.5 2.4 5.0 4.7 11.1 3.1 4.4 3.8 4.4 1.9 27.3 28.7 17.6 37.5 36.9 24.5 19.5 21.3 19.6 20.5 23.0 28.8 7.1 0.0 9.7 20.9 10.6 6.0 5.7 10.4 12.5 9.9 8.5 8.0 3.4 5.7 5.8 0.0 8.4 5.3 7.9 5.2 3.9 6.9 17.9 9.1 6.8 4.7 7.7 3.0 15.4 4.2 5.1 6.5 4.6 8.7 2.5 10.9 6.4 2.4 7.6 5.0 20.5 7.2 10.2 4.4 5.6 9.0 6.2 6.3 8.8 12.2 5.7 5.0 11.3 17.6 28.9 11.0 7.4 6.4 3.6 8.7 6.5 2.9 6.3 6.5 0.0 5.0 7.8 20.6 26.5 12.4 9.1 6.7 10.6 5.8 6.1 7.0 KCTD5 FLJ20040 ENSG00000167977 "Potassium channel tetramerization domain containing 5" Q9NXV2 16 2682523-2709030 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 62.6" "Group enriched" "Detected in all" 5 "dendritic cells: 62.6;granulocytes: 16.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "unprognostic (2.48e-2)" "unprognostic (1.87e-1)" "unprognostic (6.72e-2)" "unprognostic (5.15e-3)" "unprognostic (1.60e-1)" "unprognostic (9.95e-3)" "unprognostic (1.47e-3)" "unprognostic (1.45e-3)" "unprognostic (3.74e-1)" "unprognostic (1.52e-1)" "unprognostic (2.43e-3)" "unprognostic (8.21e-2)" "unprognostic (4.06e-3)" "unprognostic (2.15e-2)" "unprognostic (5.52e-3)" "unprognostic (1.42e-1)" "unprognostic (1.96e-1)" 11.8 12.0 14.0 15.4 14.9 14.8 10.4 14.5 15.8 14.5 11.2 23.3 16.8 10.7 6.5 34.4 9.8 11.0 11.3 13.4 13.5 10.3 17.8 12.0 21.1 15.8 14.8 9.8 9.8 8.2 10.8 11.8 15.0 10.6 15.5 6.4 15.1 6.7 16.1 19.0 17.6 8.3 15.6 18.1 16.5 13.0 15.2 15.7 8.8 10.5 16.6 14.9 16.8 16.0 46.9 27.2 23.0 33.6 17.0 20.1 25.9 37.3 21.2 48.1 37.6 32.2 61.9 39.4 26.8 36.3 27.7 40.2 32.5 37.3 24.4 32.0 27.2 41.1 16.0 40.7 33.1 41.1 53.9 21.5 37.6 43.1 38.2 24.6 22.4 40.1 41.2 44.3 29.5 54.6 49.5 41.2 36.2 30.5 48.4 64.7 30.3 73.8 24.2 15.8 38.3 35.2 47.6 48.3 43.8 14.7 40.6 40.1 27.1 60.2 33.0 38.0 44.6 39.9 27.5 58.7 24.3 36.9 47.5 1.1 7.2 16.5 5.1 7.0 4.6 5.4 4.4 6.0 11.5 7.4 4.3 4.8 3.8 6.3 7.0 62.6 4.3 4.3 14.0 14.9 14.5 15.8 13.4 13.5 15.8 14.8 15.0 15.6 15.2 16.0 13.3 9.6 5.9 2.9 19.5 26.9 13.3 7.3 12.5 10.3 14.8 14.4 8.6 5.7 5.6 3.7 2.1 21.5 55.6 46.3 7.9 17.8 1.2 10.0 11.7 10.1 9.0 16.6 5.2 11.8 27.2 9.7 31.6 17.4 4.5 6.4 4.6 8.3 21.1 18.5 4.7 22.3 8.2 27.7 15.4 2.8 7.5 24.0 17.8 8.4 22.1 16.3 12.3 9.0 9.7 30.5 29.6 8.2 13.0 11.3 18.3 7.7 5.6 8.5 13.1 11.0 12.9 5.8 16.6 17.9 31.3 39.4 17.0 9.4 22.7 18.4 KIAA1210 ENSG00000250423 KIAA1210 Q9ULL0 X 119078635-119150579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "epididymis: 39.4;seminal vesicle: 19.8;testis: 30.9" "Cell type enhanced" "Detected in some" "Early spermatids: 4.0;Endometrial stromal cells: 25.2;Granulosa cells: 11.1;Late spermatids: 11.5;Peritubular cells: 6.0" "Cancer enhanced" "Detected in single" "prostate cancer: 1.3" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.0" "Not detected" "Not detected" "HPA000551, HPA048322" Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 36: Stromal cells - Cell proliferation" "Golgi apparatus, Vesicles" "HPA000551: AB_1079165, HPA048322: AB_2680358" "unprognostic (2.48e-1)" "unprognostic (5.63e-2)" "unprognostic (1.77e-1)" "unprognostic (1.43e-1)" "unprognostic (3.90e-1)" "unprognostic (2.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.29e-2)" "unprognostic (2.53e-1)" "unprognostic (1.06e-1)" "unprognostic (2.92e-2)" "unprognostic (5.69e-2)" "unprognostic (1.05e-1)" "unprognostic (8.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.24e-1)" "unprognostic (6.26e-4)" 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 1.6 39.4 0.0 5.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 4.7 0.0 0.0 0.0 19.8 0.3 0.0 0.0 0.2 0.0 0.0 0.0 30.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.2 0.4 1.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 4.0 1.9 25.2 0.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 1.6 0.0 11.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.3 11.5 3.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 2.4 1.1 0.0 0.0 0.3 0.1 0.3 0.0 0.0 KLC2 FLJ12387 ENSG00000174996 "Kinesin light chain 2" Q9H0B6 11 66257294-66267860 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Motor protein" "Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 55.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040416, HPA040434" Approved Supported "Nucleoplasm,Plasma membrane,Mitochondria,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane, Cytosol" "Nucleoplasm, Mitochondria" "HPA040416: AB_10795524, HPA040434: AB_10795367" "unprognostic (1.29e-1)" "unprognostic (4.95e-3)" "unprognostic (2.99e-1)" "unprognostic (3.24e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (3.16e-4)" "unprognostic (2.43e-3)" "unprognostic (2.45e-2)" "unprognostic (6.27e-3)" "unprognostic (1.60e-1)" "unprognostic (3.49e-2)" "unprognostic (1.64e-3)" "unprognostic (4.57e-3)" "unprognostic (1.96e-2)" "unprognostic (1.81e-1)" "unprognostic (1.72e-2)" "unprognostic (8.08e-2)" 15.2 18.0 18.8 9.5 25.4 3.6 15.9 33.0 78.1 27.3 0.0 28.5 9.8 27.1 6.3 18.2 21.6 8.9 32.1 26.6 12.7 22.4 8.2 18.9 9.1 39.8 10.8 24.6 15.5 15.2 48.3 7.2 37.0 28.7 4.7 28.4 15.9 16.0 57.8 18.3 16.3 11.2 5.7 13.7 20.2 32.2 23.1 25.1 17.7 14.2 6.4 27.2 21.7 35.8 49.4 58.2 28.3 16.9 16.9 13.5 21.9 34.1 24.2 34.2 26.1 31.9 14.3 21.3 31.9 25.6 43.9 40.7 29.3 33.2 11.4 35.7 37.2 4.4 48.0 22.4 32.1 9.9 22.7 13.5 42.7 40.1 32.8 22.0 16.1 26.2 24.1 29.0 27.8 69.2 56.8 15.0 27.8 14.2 49.2 21.4 14.6 30.1 27.2 27.4 76.3 37.5 24.6 22.1 41.3 15.7 36.3 6.7 26.8 55.5 49.8 68.2 45.5 30.7 27.4 11.9 39.3 6.7 22.9 0.0 0.2 0.5 2.4 0.1 3.1 1.9 1.1 1.6 0.3 3.2 1.1 1.4 0.3 1.3 0.2 2.1 0.3 1.1 18.8 25.4 33.0 78.1 26.6 12.7 39.8 10.8 37.0 5.7 23.1 35.8 4.0 3.2 1.5 8.8 8.9 8.9 9.2 11.1 7.4 34.4 10.1 7.2 2.4 7.2 5.5 12.9 12.5 9.9 5.1 3.1 13.7 14.8 10.1 7.7 6.2 5.2 37.1 0.8 20.7 8.2 18.2 6.5 13.7 9.7 0.0 8.6 3.9 2.3 3.1 55.5 19.0 7.2 18.3 3.2 4.0 4.6 8.7 2.8 12.4 5.6 6.3 14.6 4.1 4.0 6.2 19.1 4.9 13.9 9.1 18.2 3.9 10.3 7.3 35.2 0.0 9.5 13.3 26.2 29.8 8.9 9.7 12.7 8.2 3.4 4.9 8.5 KMT2B "CXXC10, HRX2, KIAA0304, MLL1B, MLL2, MLL4, TRX2, WBP7" ENSG00000272333 "Lysine methyltransferase 2B" Q9UMN6 19 35717973-35738878 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Methyltransferase, Transferase" "Cancer-related genes, Disease variant, Dystonia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 64.5;Rod photoreceptor cells: 71.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006487 Approved Nucleoplasm,Cytosol NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA006487: AB_1080587" "unprognostic (1.09e-2)" "unprognostic (3.53e-2)" "unprognostic (3.41e-2)" "unprognostic (7.95e-2)" "unprognostic (9.92e-2)" "unprognostic (3.53e-3)" "unprognostic (2.33e-2)" "unprognostic (4.57e-2)" "unprognostic (7.28e-2)" "unprognostic (2.07e-2)" "unprognostic (3.13e-3)" "unprognostic (2.63e-3)" "unprognostic (9.47e-3)" "unprognostic (2.10e-1)" "unprognostic (2.37e-1)" "unprognostic (3.77e-2)" "unprognostic (2.24e-2)" 11.6 10.1 15.4 9.8 15.7 14.3 11.8 17.2 22.9 12.9 12.2 13.6 9.8 14.1 4.4 12.8 13.1 6.8 8.4 14.7 14.8 10.3 10.0 12.1 14.5 15.4 14.4 16.1 16.0 5.1 14.5 5.8 14.7 13.4 3.9 5.8 13.3 5.8 16.1 18.8 14.5 4.5 12.4 15.6 12.7 22.5 15.9 9.3 16.6 5.0 6.8 12.6 12.0 16.0 16.7 36.7 11.1 17.3 6.0 4.3 11.0 6.7 4.7 7.3 5.0 25.3 7.4 15.5 11.8 5.1 8.5 10.8 11.3 5.2 4.2 21.2 13.6 29.7 20.2 24.4 8.6 17.4 26.1 6.9 9.4 8.9 10.7 6.9 5.7 13.5 22.5 15.8 6.4 34.1 15.9 24.4 12.0 18.8 9.2 19.8 8.9 7.6 7.8 21.3 14.0 10.0 13.5 20.6 11.3 7.9 11.8 21.3 12.5 16.3 17.0 10.5 17.4 22.2 15.7 12.4 8.5 18.8 12.2 0.3 0.4 0.4 1.0 0.1 0.5 0.4 0.6 0.7 0.3 0.7 0.6 0.9 1.8 0.5 0.2 2.1 0.8 0.4 15.4 15.7 17.2 22.9 14.7 14.8 15.4 14.4 14.7 12.4 15.9 16.0 24.6 9.6 15.4 13.7 18.6 12.7 10.0 6.2 9.6 64.5 16.1 14.6 9.2 8.6 6.3 9.2 52.1 6.5 27.4 25.2 0.0 6.4 2.8 17.9 31.6 15.6 20.3 7.4 11.7 7.7 6.1 12.4 27.5 26.0 5.1 30.5 11.0 11.2 8.4 35.3 11.8 14.1 6.1 11.8 7.1 4.7 8.1 13.4 5.4 7.5 9.5 25.7 19.6 7.5 10.0 8.4 16.7 12.4 17.9 19.6 13.9 5.0 6.7 71.2 0.0 25.0 17.3 26.5 38.5 11.9 12.9 9.4 20.6 30.7 16.3 14.8 KRT18 ENSG00000111057 "Keratin 18" P05783 12 52948871-52952906 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 3698.8;Ductal cells: 6583.8;Exocrine glandular cells: 4826.1;Extravillous trophoblasts: 5496.7;Pancreatic endocrine cells: 6071.5;Syncytiotrophoblasts: 7643.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 7 "basophil: 76.7" "Lineage enriched" "Detected in many" 7 "granulocytes: 76.7" "Cell line enhanced" "Detected in many" "A549: 5639.4;BEWO: 3818.0;CACO-2: 6249.4;CAPAN-2: 4576.4;MCF7: 8470.0;SK-BR-3: 4583.8" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "spinal cord: 12.1" "CAB000008, CAB000030, HPA001605" Enhanced Supported Cytosol NA NA 140000000 "Cluster 38: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Cytosol "CAB000008: , CAB000030: , HPA001605: AB_2666381" "unprognostic (1.98e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-1)" "unprognostic (1.63e-2)" "unprognostic (1.25e-1)" "unprognostic (7.26e-3)" "unprognostic (4.09e-3)" "prognostic unfavorable (5.06e-4)" "unprognostic (8.81e-2)" "unprognostic (4.17e-1)" "prognostic unfavorable (1.78e-4)" "unprognostic (3.05e-1)" "unprognostic (1.04e-1)" "unprognostic (1.27e-1)" "unprognostic (2.19e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-2)" 170.3 29.0 2.6 77.5 1.4 1.5 209.8 5.3 1.6 243.5 34.8 424.1 324.3 27.8 226.0 118.4 193.5 180.6 38.3 2.2 6.9 247.2 519.5 177.8 8.6 26.1 4.3 16.4 570.2 79.5 251.9 474.5 30.3 183.3 492.3 0.6 323.4 129.5 2.1 44.5 370.7 23.4 2.5 28.5 289.9 8.3 13.9 10.3 244.1 1.4 27.8 199.7 62.2 2.5 2065.1 5639.4 1.1 7.9 0.7 1.1 3818.0 313.3 349.5 368.4 104.6 6249.4 4576.4 1.4 839.8 318.4 196.5 487.2 79.1 2228.5 217.9 2.6 138.2 19.4 865.7 1743.9 942.1 0.6 1.3 13.6 202.9 323.8 437.1 1046.9 399.0 3.4 511.4 0.2 0.3 8470.0 3.8 37.3 471.0 2740.1 457.9 3.0 0.3 236.1 1803.3 1144.9 65.6 3.7 512.7 4583.8 18.8 2696.0 2446.8 6.6 137.9 5.0 441.8 6.9 68.3 1.1 7.3 4.3 0.9 1.2 36.4 76.7 0.3 2.4 0.6 0.2 2.2 4.6 4.5 1.2 2.2 7.4 11.1 4.1 3.2 2.5 0.0 0.1 0.4 2.9 2.6 1.4 5.3 1.6 2.2 6.9 26.1 4.3 30.3 2.5 13.9 2.5 14.4 862.2 286.4 0.3 29.8 14.8 1605.7 912.1 447.3 0.1 814.6 615.6 5.3 1252.5 877.3 623.5 0.0 3698.8 14.2 1942.9 275.9 6583.8 1.0 462.3 60.3 77.8 642.3 15.4 0.0 4826.1 5496.7 203.5 971.5 742.4 48.9 51.2 57.1 610.9 308.3 1.7 0.0 2492.6 1969.3 9.8 13.8 3.8 10.5 28.3 208.1 1.0 41.5 6.2 0.0 0.0 0.0 6071.5 2164.1 0.0 13.7 1205.1 1912.3 718.5 500.8 0.6 0.0 0.6 298.6 2.7 26.0 395.7 6.7 7643.5 38.1 45.0 1635.0 1512.1 KRT8 "CARD2, CK8, CYK8, K2C8, K8, KO" ENSG00000170421 "Keratin 8" P05787 12 52897187-52949954 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 1335.5;stomach 1: 800.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 4302.8;Ductal cells: 6037.3;Exocrine glandular cells: 5457.6;Extravillous trophoblasts: 5323.4;Pancreatic endocrine cells: 5278.1;Paneth cells: 4937.3;Proximal enterocytes: 6802.6;Syncytiotrophoblasts: 5268.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "plasmacytoid DC: 1.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 6130.6;BEWO: 3998.7;CACO-2: 7686.4;CAPAN-2: 4774.8;MCF7: 10521.8;SK-BR-3: 5126.4;T-47d: 4325.7" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 10 "spinal cord: 44.0" "CAB000131, CAB001696, HPA049866" Enhanced Supported "Intermediate filaments" NA NA 1700000000 "Cluster 15: NK-cells - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Intermediate filaments" "CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923" "unprognostic (5.72e-2)" "unprognostic (2.29e-1)" "unprognostic (2.49e-2)" "unprognostic (1.52e-1)" "unprognostic (2.76e-2)" "unprognostic (4.86e-3)" "unprognostic (3.10e-2)" "unprognostic (2.52e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.51e-4)" "unprognostic (8.99e-2)" "unprognostic (2.08e-2)" "unprognostic (2.83e-2)" "unprognostic (3.18e-1)" "unprognostic (3.68e-1)" "unprognostic (1.19e-2)" 135.0 43.6 2.2 158.6 1.3 1.0 113.8 2.0 1.6 183.4 21.3 1079.2 1112.0 34.7 66.4 48.2 134.3 217.5 147.8 1.9 1.9 240.2 463.9 172.5 7.9 8.3 4.5 10.3 654.1 59.9 278.7 368.7 8.8 151.6 564.2 0.4 318.0 73.6 1.5 49.3 1335.5 50.6 0.4 16.3 800.1 7.6 4.9 47.6 237.5 0.3 13.8 209.0 36.7 1.7 2787.7 6130.6 0.2 7.8 0.7 3.2 3998.7 11.1 47.9 6.1 6.3 7686.4 4774.8 1.1 1130.2 14.7 6.9 947.1 17.6 752.6 5.9 4.6 130.8 4.3 1184.4 2234.2 212.8 1.2 2.4 9.5 12.6 14.8 50.8 419.9 17.0 1.0 484.7 1.7 0.1 10521.8 6.5 10.6 418.5 2740.6 132.8 3.8 2.2 15.2 1198.1 1354.5 129.9 5.0 1063.2 5126.4 7.8 1263.8 4325.7 10.5 18.8 5.7 443.4 9.3 10.0 1.6 7.0 7.6 3.3 1.7 13.4 1.3 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.4 0.5 0.1 1.7 0.1 0.2 2.2 1.3 2.0 1.6 1.9 1.9 8.3 4.5 8.8 0.4 4.9 1.7 7.7 400.6 176.5 0.3 26.9 6.0 1948.0 684.7 303.3 2.3 521.6 342.8 30.2 1069.5 734.8 491.1 0.0 2208.2 8.5 4302.8 297.4 6037.3 13.9 419.2 41.0 42.3 942.5 8.6 0.5 5457.6 5323.4 94.7 1740.1 557.1 76.3 88.0 24.3 310.9 252.2 1.7 0.5 2876.3 1625.5 9.9 7.2 69.9 8.1 22.2 131.6 0.0 55.0 3.4 1.0 1.0 0.3 5278.1 4937.3 1.9 6.6 994.7 6802.6 569.1 594.8 4.3 0.0 2.2 167.4 2.0 11.4 258.9 1.7 5268.8 33.4 13.4 2337.3 1542.5 KRT85 "Hb-5, KRTHB5" ENSG00000135443 "Keratin 85" P78386 12 52360006-52367481 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 46 "skin 1: 172.7" "Group enriched" "Detected in some" 12 "Early spermatids: 6.2;Late spermatids: 16.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 5 "A549: 2.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA049778 Supported NA NA 110000000 "Cluster 61: Skin - Cornification" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "HPA049778: AB_2680877" "unprognostic (1.36e-2)" "unprognostic (3.93e-1)" "unprognostic (7.27e-3)" "unprognostic (5.71e-2)" "unprognostic (2.36e-1)" "unprognostic (4.72e-2)" "unprognostic (9.22e-4)" "unprognostic (1.64e-2)" "unprognostic (1.74e-2)" "unprognostic (1.38e-1)" 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 172.7 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 KRT86 "Hb6, KRTHB6, MNX" ENSG00000170442 "Keratin 86" O43790 12 52249300-52309163 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 36 "skin 1: 150.5" "Group enriched" "Detected in many" 4 "dendritic cells: 33.1;Early spermatids: 35.5;Late spermatids: 24.3;NK-cells: 11.3;T-cells: 14.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Immune cell enriched" "Detected in some" 9 "basophil: 87.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 87.5" "Cell line enhanced" "Detected in many" "A-431: 24.9;A549: 25.7;MCF7: 51.6;RPMI-8226: 32.5;U-251 MG: 14.5" "HPA039798, HPA049778" Supported Approved Cytosol NA NA 160000000 "Cluster 38: Basophils - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol "HPA039798: AB_10674986, HPA049778: AB_2680877" "unprognostic (4.52e-2)" "unprognostic (6.83e-2)" "unprognostic (3.16e-2)" "unprognostic (2.20e-1)" "unprognostic (1.78e-2)" "unprognostic (2.61e-2)" "unprognostic (6.49e-2)" "unprognostic (1.06e-2)" "unprognostic (1.98e-1)" "unprognostic (2.59e-2)" "unprognostic (1.37e-1)" "unprognostic (1.74e-1)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (1.24e-1)" "unprognostic (7.22e-2)" 1.2 0.5 0.5 0.2 0.7 2.6 0.5 0.0 0.5 0.2 0.0 0.5 0.4 0.4 0.5 0.1 0.7 0.4 0.1 0.8 0.2 0.2 0.1 0.7 0.0 0.3 0.4 0.1 2.1 0.1 0.1 0.4 0.4 0.3 0.0 0.1 3.8 0.3 0.3 150.5 0.3 0.1 0.2 0.1 0.2 4.0 0.5 0.2 4.1 0.0 0.1 0.8 0.2 1.2 24.9 25.7 0.0 0.0 0.0 0.0 0.3 0.9 0.7 0.3 0.1 0.3 1.3 0.0 1.1 0.0 0.5 1.5 0.0 4.5 0.1 10.9 0.0 0.0 5.4 0.0 0.4 0.0 0.0 0.0 0.3 0.0 0.5 12.7 0.0 0.0 0.0 1.8 0.0 51.6 0.0 3.0 0.1 0.2 6.1 0.0 0.0 32.5 0.4 3.2 2.9 0.0 4.5 2.0 2.0 0.0 1.4 0.0 0.8 0.0 1.3 0.1 14.5 0.0 0.0 0.0 0.0 5.3 0.0 87.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.5 0.5 0.7 0.0 0.5 0.8 0.2 0.3 0.4 0.4 0.2 0.5 1.2 0.1 0.0 0.6 0.0 0.3 0.6 2.9 2.0 0.0 0.4 2.8 3.4 0.4 2.8 3.1 0.0 0.0 0.1 33.1 0.2 0.0 2.1 35.5 3.6 0.8 0.2 0.0 0.0 0.5 5.1 1.6 0.3 1.1 4.9 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 2.0 0.0 1.1 24.3 0.3 0.3 1.8 0.0 0.0 0.2 11.3 0.0 0.5 2.9 0.0 0.0 2.1 2.7 0.0 0.6 1.9 0.3 0.0 1.0 0.4 0.8 0.4 0.0 0.1 1.2 14.2 0.0 0.0 3.5 LAGE3 "CVG5, DXS9879E, DXS9951E, ESO3, ITBA2, Pcc1" ENSG00000196976 "L antigen family member 3" Q14657 X 154477769-154479257 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036122, HPA036123" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Nuclear bodies" "HPA036122: AB_2674951, HPA036123: AB_10601926" "unprognostic (1.70e-1)" "prognostic favorable (5.29e-6)" "unprognostic (1.09e-2)" "prognostic unfavorable (7.60e-4)" "unprognostic (2.28e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (8.63e-5)" "unprognostic (1.99e-2)" "unprognostic (2.08e-1)" "unprognostic (3.04e-2)" "unprognostic (4.88e-3)" "unprognostic (6.73e-2)" "prognostic unfavorable (5.42e-5)" "unprognostic (7.37e-2)" "unprognostic (3.57e-2)" "unprognostic (2.31e-1)" "unprognostic (1.80e-1)" 11.9 29.1 41.2 7.7 43.0 19.4 12.1 41.2 52.4 16.9 36.9 14.2 6.8 12.3 8.4 15.0 11.1 5.9 21.9 44.3 40.6 14.2 20.9 10.8 10.2 38.9 38.3 18.5 25.1 8.9 34.0 5.4 40.4 16.7 4.7 4.6 16.5 6.5 24.4 19.8 12.2 4.0 39.9 16.2 15.2 9.6 41.1 13.4 9.7 10.2 8.9 17.2 13.6 43.4 44.7 41.6 15.1 32.1 16.0 13.3 44.7 13.3 9.4 19.7 22.0 27.0 23.4 94.2 118.6 17.5 34.9 19.1 37.5 13.2 6.8 53.9 59.9 34.4 38.3 15.6 27.2 46.1 49.1 20.5 8.6 29.6 7.7 15.0 14.1 44.9 34.2 44.4 27.3 104.6 61.9 134.3 28.5 59.5 99.7 54.0 26.0 106.4 11.6 12.0 41.8 38.8 31.0 73.8 57.1 10.4 32.0 33.5 15.8 14.1 41.9 59.6 51.3 104.2 117.5 145.0 24.8 81.8 33.3 27.1 25.8 10.9 26.4 25.5 33.9 40.4 36.5 38.6 35.6 33.7 82.0 41.7 2.8 47.0 20.8 66.5 31.7 40.0 41.2 43.0 41.2 52.4 44.3 40.6 38.9 38.3 40.4 39.9 41.1 43.4 41.7 9.6 14.7 8.5 57.1 58.0 50.1 68.4 70.6 54.9 84.5 107.8 30.8 58.6 34.2 35.0 8.4 62.4 58.5 40.0 127.2 50.7 2.0 15.3 22.4 46.5 56.4 79.7 10.9 93.4 119.9 40.0 27.5 14.8 46.9 75.7 33.5 49.6 126.3 23.5 8.3 50.8 67.1 37.4 93.1 6.3 41.7 55.6 92.5 3.7 63.4 87.2 74.2 4.5 9.3 40.9 28.4 36.9 65.0 46.1 38.5 72.6 33.0 18.4 6.6 35.3 31.0 43.5 100.9 61.4 56.0 56.8 51.8 56.8 54.3 45.2 LAMTOR4 C7orf59 ENSG00000188186 "Late endosomal/lysosomal adaptor, MAPK and MTOR activator 4" Q0VGL1 7 100148907-100155944 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 3294.2" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020998 Enhanced Supported Vesicles NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles "HPA020998: AB_1845762" "prognostic favorable (2.48e-4)" "prognostic favorable (6.08e-4)" "unprognostic (1.29e-2)" "unprognostic (1.14e-1)" "unprognostic (8.21e-3)" "unprognostic (6.11e-2)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (6.17e-2)" "unprognostic (1.57e-1)" "unprognostic (2.42e-3)" "unprognostic (8.83e-2)" "unprognostic (1.11e-1)" "unprognostic (1.80e-1)" "unprognostic (2.68e-1)" "unprognostic (2.45e-1)" "unprognostic (1.68e-2)" 145.5 144.7 207.2 92.8 215.4 194.6 143.4 221.1 260.4 148.0 204.4 180.6 89.4 116.7 65.9 117.5 123.1 97.7 167.4 205.7 212.3 188.5 139.1 128.0 159.0 222.1 211.3 142.7 124.2 126.7 162.7 68.1 213.3 160.8 105.8 39.9 116.8 76.2 137.5 478.7 151.0 69.0 217.6 251.9 162.2 86.6 215.8 104.8 133.8 106.0 85.5 145.8 126.7 224.1 105.9 250.9 130.2 165.4 135.2 154.9 105.7 62.1 151.0 113.1 138.9 116.9 165.7 169.1 204.7 94.2 205.7 108.9 124.0 160.0 48.1 172.4 353.2 135.2 245.0 205.4 127.4 106.4 187.1 187.3 155.4 118.5 145.6 125.7 174.9 155.3 129.9 264.4 156.1 501.0 104.0 424.7 138.7 291.1 199.9 107.4 107.1 302.8 129.1 126.9 91.6 169.0 114.3 265.8 211.3 99.0 107.1 207.0 118.3 107.1 158.6 223.7 101.7 159.1 231.2 324.2 171.0 293.5 155.9 1033.3 843.2 3121.0 299.6 795.1 251.1 541.8 377.5 312.8 570.0 475.4 381.8 307.2 3294.2 310.1 756.2 482.6 453.0 893.6 207.2 215.4 221.1 260.4 205.7 212.3 222.1 211.3 213.3 217.6 215.8 224.1 181.8 93.0 150.7 18.9 195.8 274.9 194.0 282.0 167.9 65.3 240.8 277.2 176.6 143.0 172.9 218.8 12.5 258.4 199.9 819.7 534.1 167.3 40.0 152.9 125.8 186.7 299.3 99.3 12.0 326.2 196.5 175.6 146.3 131.4 183.2 120.9 239.1 246.3 531.1 58.9 13.6 423.9 252.3 497.4 351.7 46.6 146.3 365.2 434.0 13.1 411.0 229.9 298.6 11.6 26.2 204.2 867.4 120.4 133.0 169.5 511.6 557.5 194.8 67.0 144.7 142.1 196.9 88.1 101.2 151.3 662.9 201.4 195.9 150.8 511.8 219.0 LCMT1 "CGI-68, PPMT1" ENSG00000205629 "Leucine carboxyl methyltransferase 1" Q9UIC8 16 25111731-25178231 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 197.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041559, HPA043530" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "HPA041559: AB_2677548, HPA043530: AB_2678532" "unprognostic (9.08e-2)" "prognostic favorable (2.78e-4)" "unprognostic (1.18e-1)" "unprognostic (3.71e-1)" "unprognostic (3.15e-1)" "unprognostic (1.73e-1)" "prognostic unfavorable (5.85e-4)" "unprognostic (1.41e-2)" "unprognostic (7.41e-2)" "unprognostic (4.45e-2)" "unprognostic (4.62e-2)" "unprognostic (1.16e-1)" "prognostic favorable (7.53e-6)" "unprognostic (1.23e-1)" "unprognostic (8.99e-2)" "unprognostic (1.84e-3)" "unprognostic (6.71e-2)" 17.5 27.3 41.5 13.3 43.2 19.9 22.5 41.1 44.5 23.9 36.5 22.0 16.8 21.2 31.1 22.8 20.5 13.6 36.1 45.1 42.8 26.9 10.9 14.9 16.7 39.9 39.0 28.1 47.2 32.0 32.9 24.1 42.4 20.8 21.3 21.8 21.2 21.3 52.3 28.2 17.1 18.5 40.2 16.2 22.5 35.4 43.4 21.3 18.6 36.2 20.2 18.1 20.6 43.0 40.3 36.3 33.9 47.2 30.2 42.9 34.9 24.7 40.5 35.7 45.9 46.4 35.7 24.4 34.1 37.6 44.2 20.1 35.9 34.3 47.9 24.9 53.3 13.5 35.4 77.3 67.9 32.0 20.9 48.7 37.7 39.9 41.4 51.3 32.3 54.0 21.5 31.2 39.5 102.3 37.9 60.6 52.1 25.3 37.0 44.3 30.9 47.7 40.7 27.9 55.5 34.1 29.0 45.8 58.2 39.9 46.0 14.9 19.1 34.6 24.3 23.4 25.0 39.8 43.9 25.8 42.3 27.5 26.6 33.4 36.5 46.2 39.4 33.5 43.3 42.0 47.8 42.1 35.0 31.6 42.8 39.2 14.6 33.6 37.6 18.1 82.9 42.2 41.5 43.2 41.1 44.5 45.1 42.8 39.9 39.0 42.4 40.2 43.4 43.0 21.0 16.0 19.8 15.3 23.5 24.1 31.1 55.6 33.6 25.7 39.3 42.0 34.8 15.7 29.6 33.1 2.1 164.5 20.9 60.5 49.0 51.7 76.5 22.7 31.4 22.7 51.4 29.5 29.0 66.7 69.4 29.1 20.9 20.2 9.5 197.7 23.2 9.5 46.8 23.5 30.1 46.9 38.7 33.9 20.0 137.5 26.1 27.0 33.8 17.8 31.3 32.0 32.0 28.1 31.7 46.7 45.1 24.0 28.9 34.6 79.4 90.0 30.0 26.1 26.3 22.9 67.7 67.3 52.9 35.6 31.8 163.8 29.6 78.7 43.7 34.7 LDOC1 "BCUR1, Mar7, Mart7, RTL7, SIRH7" ENSG00000182195 "LDOC1 regulator of NFKB signaling" O95751 X 141111605-141177129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 123.3" "Cell type enhanced" "Detected in many" "Distal tubular cells: 43.0;Proximal tubular cells: 43.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "NK-cell: 6.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 24.7;MCF7: 31.9;PC-3: 34.3;U-251 MG: 21.9" "Region enriched" "Detected in many" 5 "cerebellum: 19.2" "HPA051768, HPA061842" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Nucleoli" "HPA051768: AB_2681599, HPA061842: AB_2684624" "unprognostic (4.09e-1)" "unprognostic (4.72e-2)" "unprognostic (1.88e-1)" "unprognostic (1.73e-3)" "unprognostic (2.47e-1)" "unprognostic (2.42e-1)" "unprognostic (4.51e-2)" "unprognostic (2.08e-2)" "unprognostic (8.92e-2)" "unprognostic (1.21e-1)" "unprognostic (6.40e-3)" "unprognostic (1.21e-1)" "unprognostic (1.27e-2)" "unprognostic (1.98e-2)" "unprognostic (3.06e-2)" "unprognostic (4.38e-3)" "unprognostic (2.76e-2)" 32.3 34.0 4.7 0.9 5.5 0.1 28.0 2.9 8.5 45.8 0.2 18.8 0.9 53.9 1.8 21.4 48.5 1.6 15.1 6.2 5.8 33.2 4.8 19.6 0.8 5.3 5.0 46.8 19.3 10.5 123.3 0.0 5.0 34.3 0.3 3.4 55.1 5.9 5.5 31.5 12.5 2.0 1.2 14.2 18.4 10.8 5.0 0.9 53.7 0.4 0.7 33.1 30.6 6.0 0.0 24.7 3.0 8.4 5.0 6.2 0.0 5.0 5.8 6.3 8.8 0.0 8.0 0.0 4.2 7.7 6.1 10.4 3.4 7.1 4.5 0.0 6.6 0.0 11.7 0.0 2.0 0.0 1.9 10.9 3.6 5.5 2.9 5.1 5.7 0.0 0.1 0.0 5.7 31.9 0.0 0.0 3.3 0.0 34.3 0.0 2.7 0.0 7.7 4.7 0.0 3.2 0.0 4.0 0.0 1.6 5.1 0.0 11.9 0.0 6.8 0.0 21.9 0.0 0.0 0.0 3.5 0.0 0.0 3.1 0.0 0.0 1.2 0.0 0.8 0.9 2.5 0.8 0.2 2.1 2.2 1.4 0.0 6.4 0.0 1.4 2.6 1.0 4.7 5.5 2.9 8.5 6.2 5.8 5.3 5.0 5.0 1.2 5.0 6.0 8.6 0.0 5.3 4.2 4.9 6.0 16.8 4.6 16.5 29.3 23.8 20.2 2.2 30.0 8.2 23.9 8.4 2.8 5.7 0.1 43.0 13.8 0.7 7.8 13.5 12.8 5.4 0.8 9.4 14.0 1.8 16.1 3.6 6.0 2.5 8.8 12.8 0.1 0.9 20.2 9.9 0.4 8.2 0.3 1.8 1.1 22.1 1.0 3.6 7.5 0.3 21.2 5.2 7.1 15.0 13.7 0.2 38.7 0.9 11.9 0.0 43.8 4.6 13.0 13.1 15.3 26.2 0.9 7.6 16.7 6.8 1.5 5.2 13.5 0.3 15.0 LIN37 "F25965, lin-37, ZK418.4" ENSG00000267796 "Lin-37 DREAM MuvB core complex component" Q96GY3 19 35748361-35754519 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043253, HPA047809" Uncertain Supported Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA043253: AB_2678391, HPA047809: AB_2680162" "unprognostic (7.10e-2)" "unprognostic (1.32e-1)" "unprognostic (7.07e-2)" "unprognostic (2.45e-3)" "unprognostic (7.77e-3)" "unprognostic (5.85e-3)" "unprognostic (1.62e-2)" "unprognostic (1.07e-1)" "unprognostic (2.93e-1)" "unprognostic (2.56e-1)" "prognostic favorable (1.67e-4)" "unprognostic (9.88e-3)" "prognostic unfavorable (1.62e-6)" "unprognostic (2.53e-2)" "unprognostic (8.89e-2)" "unprognostic (4.35e-1)" "unprognostic (5.14e-2)" 10.1 9.9 21.5 6.7 22.2 9.7 9.1 22.5 26.9 13.0 18.9 11.1 9.2 11.2 7.7 7.0 10.8 6.9 12.6 21.6 22.4 7.4 7.6 7.5 9.6 21.1 21.4 15.9 8.5 9.2 11.0 11.7 21.6 8.9 5.0 8.6 7.9 8.4 15.7 10.4 7.9 8.2 20.5 8.6 7.9 9.0 22.2 9.7 7.8 12.7 7.5 9.5 8.9 21.7 13.7 29.7 11.4 15.5 18.4 14.4 12.0 14.4 15.7 22.8 24.6 9.8 6.3 7.8 16.3 17.1 15.3 6.9 8.2 12.1 8.8 26.5 11.6 10.0 14.6 15.0 42.2 8.0 22.6 13.4 22.1 20.4 34.9 15.0 16.9 20.8 10.4 15.1 16.5 27.6 13.3 11.0 3.2 22.4 12.9 5.9 7.5 8.4 15.1 6.4 9.8 11.2 13.5 26.7 12.5 9.1 11.1 17.0 16.4 17.2 10.1 16.8 18.3 22.3 19.0 7.3 18.3 12.0 12.9 16.8 7.9 26.4 18.3 8.6 17.2 19.6 19.8 21.4 9.0 18.8 20.6 18.7 32.0 18.4 8.1 18.8 22.2 13.7 21.5 22.2 22.5 26.9 21.6 22.4 21.1 21.4 21.6 20.5 22.2 21.7 2.0 0.0 1.1 2.9 5.0 3.8 0.7 2.5 8.0 1.5 2.2 1.4 0.1 1.5 0.8 3.7 2.1 4.2 1.9 2.8 3.9 1.5 5.5 1.0 1.0 2.0 1.2 4.8 5.9 1.2 3.4 3.3 5.6 0.7 4.5 1.0 1.1 1.0 1.9 1.7 5.6 0.7 2.0 3.1 4.4 5.8 4.1 3.2 5.4 0.0 2.6 1.0 3.1 3.5 4.3 2.8 2.8 3.4 7.3 0.7 9.8 3.2 1.3 2.4 6.6 1.5 3.0 9.2 2.3 6.4 5.4 11.5 5.6 1.0 1.3 0.3 LMAN2 "C5orf8, GP36B, VIP36" ENSG00000169223 "Lectin, mannose binding 2" Q12907 5 177331567-177351668 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 530.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003927 Approved NA NA 88000000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA003927: AB_1079257" "unprognostic (5.85e-2)" "unprognostic (2.16e-1)" "unprognostic (3.87e-2)" "unprognostic (1.85e-3)" "unprognostic (6.25e-2)" "unprognostic (3.90e-3)" "unprognostic (2.88e-3)" "unprognostic (2.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.51e-3)" "unprognostic (4.56e-2)" "unprognostic (6.67e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (4.43e-2)" "unprognostic (6.13e-2)" "unprognostic (1.45e-2)" "unprognostic (2.32e-1)" 72.0 79.5 40.1 63.2 43.5 77.6 65.3 42.4 49.3 76.7 62.6 77.0 91.4 74.0 136.1 147.1 70.3 57.0 74.7 44.5 43.0 85.5 207.8 78.8 66.2 45.2 41.5 69.6 155.9 49.9 60.8 72.6 43.1 64.7 40.1 14.7 117.9 48.7 50.6 64.6 81.2 36.2 41.7 86.9 82.4 93.5 46.4 54.8 97.2 29.2 42.7 67.0 73.1 43.6 108.6 196.4 57.3 317.9 201.5 76.2 298.0 122.1 120.8 105.6 132.9 326.2 254.0 115.9 286.2 162.7 196.3 163.9 69.6 242.9 39.6 556.7 166.6 73.9 136.7 196.5 196.2 155.4 210.7 140.5 94.2 106.0 94.8 118.3 142.3 100.3 90.8 452.0 79.3 318.5 115.8 268.3 82.7 159.7 174.8 132.4 97.6 404.9 99.5 122.6 94.9 105.4 113.3 191.9 205.0 51.9 150.4 349.5 145.5 168.2 108.0 89.2 182.7 252.0 200.8 114.8 234.5 217.8 186.6 569.9 411.8 476.9 408.9 379.2 349.7 252.1 295.6 342.9 358.8 256.6 241.0 280.7 552.6 364.8 346.1 500.9 350.2 828.4 40.1 43.5 42.4 49.3 44.5 43.0 45.2 41.5 43.1 41.7 46.4 43.6 82.7 57.7 74.5 12.1 114.8 57.0 147.9 384.3 47.8 33.2 100.9 74.4 44.6 124.4 229.9 108.5 16.7 312.7 147.4 168.3 52.8 233.2 103.8 87.2 99.5 99.5 58.9 71.8 7.0 237.3 444.4 120.4 70.8 131.2 77.4 97.2 81.8 223.4 240.4 55.5 8.3 190.0 266.5 105.0 85.3 28.2 88.0 107.4 120.9 13.1 116.4 89.0 162.7 13.0 9.7 226.1 130.9 63.9 388.4 146.1 186.1 111.9 151.9 46.5 65.7 70.8 108.9 275.8 192.0 134.1 69.9 530.3 112.5 111.8 160.6 165.6 LRFN4 "FIGLER6, MGC3103, SALM3." ENSG00000173621 "Leucine rich repeat and fibronectin type III domain containing 4" Q6PJG9 11 66856647-66860475 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Late spermatids: 29.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077570 Enhanced NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA077570: " "unprognostic (2.25e-2)" "unprognostic (5.90e-3)" "unprognostic (7.51e-2)" "unprognostic (2.01e-2)" "unprognostic (4.35e-2)" "unprognostic (6.73e-2)" "unprognostic (1.80e-2)" "unprognostic (1.03e-3)" "unprognostic (6.56e-2)" "unprognostic (6.93e-2)" "unprognostic (5.69e-2)" "unprognostic (9.45e-2)" "unprognostic (1.93e-1)" "unprognostic (6.80e-3)" "unprognostic (1.81e-1)" "unprognostic (2.85e-1)" "unprognostic (3.53e-1)" 15.3 13.4 10.8 2.2 9.2 3.9 12.7 10.6 14.1 11.5 0.0 14.8 1.5 13.4 0.1 8.0 11.6 0.7 12.3 10.6 4.5 12.0 2.6 8.4 1.6 3.8 5.2 6.3 3.0 1.2 7.9 0.9 2.3 8.8 1.3 0.5 9.2 2.3 9.6 9.4 5.9 1.0 2.1 7.7 8.3 22.9 6.0 1.2 5.8 2.0 0.6 9.2 10.7 6.3 22.5 18.9 3.0 8.7 2.3 4.5 0.2 14.5 4.7 8.7 4.7 12.0 10.8 10.6 17.1 5.4 9.6 13.2 5.2 5.0 1.0 5.2 16.7 7.8 51.3 4.6 14.6 16.5 19.8 6.6 7.8 4.0 4.0 5.3 6.4 14.4 21.0 0.4 1.3 47.2 30.5 55.0 25.0 10.2 32.4 22.0 11.8 35.0 3.8 0.1 16.6 16.0 21.1 17.5 51.1 0.6 24.0 12.7 15.1 12.1 23.0 35.0 14.0 10.2 10.1 2.3 7.6 18.2 9.1 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.1 10.8 9.2 10.6 14.1 10.6 4.5 3.8 5.2 2.3 2.1 6.0 6.3 4.8 0.0 1.1 10.7 1.1 2.2 2.5 7.1 0.0 18.7 3.6 5.7 0.7 0.0 2.9 3.7 4.2 0.2 1.9 15.9 0.0 1.6 17.1 7.6 18.4 4.0 1.8 1.3 9.1 0.8 1.2 4.9 4.1 10.2 1.3 9.5 2.2 0.2 5.3 13.5 9.5 12.3 6.1 3.1 2.2 29.6 3.7 4.3 5.4 1.9 7.6 2.0 3.1 5.0 6.8 4.3 9.6 1.5 1.9 5.9 0.3 0.5 2.6 8.6 0.0 3.8 6.0 5.5 2.2 2.1 1.7 0.3 2.1 11.8 16.2 1.8 LRRC14 "KIAA0014, LRRC14A" ENSG00000160959 "Leucine rich repeat containing 14" Q15048 8 144517992-144525172 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021047 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Cytosol" "HPA021047: AB_1853298" "unprognostic (7.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.20e-1)" "unprognostic (7.05e-3)" "unprognostic (1.83e-1)" "unprognostic (7.58e-2)" "unprognostic (6.39e-3)" "unprognostic (1.93e-1)" "unprognostic (3.96e-2)" "unprognostic (2.28e-1)" "prognostic favorable (1.78e-4)" "unprognostic (3.31e-1)" "unprognostic (1.52e-1)" "unprognostic (7.25e-2)" "unprognostic (1.77e-1)" "unprognostic (6.93e-2)" "unprognostic (1.04e-3)" 8.6 13.1 10.4 6.4 9.9 7.5 9.7 14.9 11.8 15.6 3.1 15.0 7.5 16.2 5.8 14.1 13.1 5.7 10.9 11.8 7.1 11.8 11.9 9.8 9.3 9.9 9.0 12.9 16.2 8.3 16.0 4.9 9.4 19.4 5.3 3.3 12.0 8.1 11.4 13.1 13.3 5.6 9.1 14.5 14.2 11.7 9.1 7.1 16.8 5.0 6.6 14.6 12.2 10.8 18.2 36.2 9.7 15.8 10.2 8.3 13.8 15.9 6.8 12.6 10.8 15.9 21.6 14.5 16.5 11.9 7.7 19.4 15.3 15.8 5.7 19.7 34.8 21.9 42.7 6.9 9.5 9.3 17.3 10.1 13.3 12.7 6.2 10.4 10.9 16.6 29.2 17.1 12.4 22.3 34.9 12.2 7.9 15.8 51.8 29.6 8.0 20.9 7.6 15.6 26.4 14.7 24.2 19.3 11.2 5.7 29.8 10.3 11.8 21.4 37.6 19.0 23.7 9.5 6.0 18.2 20.1 21.4 13.4 1.6 7.2 1.6 8.3 6.8 8.0 7.8 6.2 7.8 7.2 7.9 6.7 5.6 3.8 11.4 6.0 8.4 6.7 8.0 10.4 9.9 14.9 11.8 11.8 7.1 9.9 9.0 9.4 9.1 9.1 10.8 6.3 6.4 3.1 6.5 10.9 6.4 5.0 3.4 9.1 11.5 9.8 9.5 4.6 14.3 6.0 9.2 2.1 6.9 6.9 10.3 5.9 5.4 2.8 6.3 6.8 7.3 5.4 8.4 3.8 8.2 6.6 5.8 10.2 6.4 7.0 11.2 8.9 9.8 7.7 11.8 2.8 8.1 2.0 6.0 4.0 3.9 7.5 4.4 1.8 8.4 7.4 9.5 9.2 6.6 3.3 7.3 4.9 7.9 11.1 8.3 6.0 7.4 7.5 7.4 6.6 5.0 6.7 29.3 22.0 6.6 5.8 5.5 9.4 16.8 11.9 3.9 LSM10 MGC15749 ENSG00000181817 "LSM10, U7 small nuclear RNA associated" Q969L4 1 36391238-36397908 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048469 Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" Nucleoplasm "Nuclear bodies" "HPA048469: AB_2756307" "unprognostic (2.15e-2)" "unprognostic (4.10e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (6.21e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (1.83e-4)" "unprognostic (1.22e-1)" "unprognostic (1.12e-1)" "unprognostic (1.90e-2)" "prognostic favorable (4.89e-4)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.40e-6)" "unprognostic (1.84e-1)" "unprognostic (2.80e-1)" "unprognostic (3.59e-2)" "unprognostic (8.54e-2)" 39.2 32.7 53.1 32.0 54.2 23.9 32.8 54.5 67.5 31.9 55.0 62.3 20.1 36.3 30.4 26.8 31.6 22.7 72.9 53.4 58.7 42.3 51.7 30.6 52.3 54.4 55.2 31.7 30.5 36.9 41.8 18.0 55.3 40.8 17.7 9.7 29.1 30.5 165.0 30.1 36.7 27.9 55.2 55.3 38.7 28.9 57.8 27.2 31.0 110.3 47.6 42.8 28.2 54.3 54.6 81.2 29.9 80.7 68.9 67.2 31.0 47.9 69.4 75.1 57.1 36.4 50.6 127.4 64.5 65.0 55.6 29.3 51.2 62.1 49.5 87.1 61.2 64.1 47.1 87.1 83.8 49.0 90.3 56.8 54.4 67.6 47.6 40.7 77.8 71.7 60.2 60.5 53.4 96.3 54.8 55.5 77.5 67.0 83.3 40.9 28.8 86.3 73.6 32.6 38.1 28.7 38.7 49.4 120.6 47.9 25.5 41.3 52.2 34.0 47.3 90.0 76.0 79.5 115.7 102.4 68.4 73.9 78.7 240.2 264.1 340.1 125.3 266.4 139.0 386.4 125.1 132.0 189.4 388.0 112.1 120.7 346.4 111.6 256.4 243.9 172.3 301.8 53.1 54.2 54.5 67.5 53.4 58.7 54.4 55.2 55.3 55.2 57.8 54.3 27.8 12.8 14.4 3.9 82.2 32.2 37.2 53.3 13.1 17.4 40.9 44.4 55.9 21.5 30.4 46.0 6.2 56.1 58.5 23.4 140.8 40.7 9.7 18.6 32.7 31.7 28.2 40.2 8.6 47.1 58.8 36.8 19.4 23.3 41.2 25.7 32.2 66.8 105.7 18.5 9.1 23.4 63.1 77.0 89.3 32.9 38.8 67.6 51.6 7.5 72.0 41.0 66.9 3.5 6.7 47.4 35.3 47.0 67.0 40.3 47.7 106.4 12.4 14.3 13.1 28.4 38.8 7.8 23.4 27.7 40.1 40.0 51.0 43.3 28.5 27.3 LSM4 YER112W ENSG00000130520 "LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated" Q9Y4Z0 19 18306236-18323112 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 705.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040932 Uncertain Approved Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" Vesicles "HPA040932: AB_10795529" "unprognostic (2.71e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (7.42e-3)" "unprognostic (1.98e-1)" "unprognostic (4.09e-2)" "unprognostic (1.10e-3)" "unprognostic (9.80e-2)" "unprognostic (1.57e-1)" "prognostic favorable (1.34e-4)" "unprognostic (8.31e-3)" "unprognostic (1.25e-1)" "prognostic favorable (2.22e-4)" "unprognostic (2.51e-2)" "unprognostic (7.23e-2)" "unprognostic (8.08e-2)" "unprognostic (1.34e-1)" 56.5 130.5 97.9 31.8 101.8 62.9 55.1 99.7 111.7 52.7 111.4 86.4 57.6 51.6 36.3 100.5 52.8 17.4 108.2 102.8 104.9 118.8 122.8 60.9 41.4 99.6 102.5 50.6 57.4 48.5 72.5 35.5 105.1 64.2 45.2 33.1 55.2 39.6 149.1 70.4 77.1 27.3 95.9 71.1 78.4 126.8 104.8 78.9 62.2 89.4 38.9 62.1 59.7 97.3 294.3 151.2 252.3 226.2 95.4 91.4 291.8 132.2 113.6 167.9 158.7 137.0 305.5 172.0 274.5 139.0 152.5 192.3 276.4 274.5 127.1 201.1 524.0 156.1 247.0 167.5 94.9 148.9 89.2 83.3 160.5 156.9 182.9 94.2 139.6 248.6 333.0 172.3 177.3 479.7 411.0 321.6 327.1 419.2 475.4 229.4 112.0 320.5 212.9 102.0 283.8 264.9 113.0 141.3 204.2 174.8 140.4 157.8 81.0 98.0 113.2 244.3 250.5 160.2 147.7 204.4 131.4 289.3 170.4 171.5 223.2 163.8 148.3 258.5 182.5 163.5 158.3 154.4 252.8 164.5 169.7 171.4 18.4 220.4 205.6 359.0 166.9 283.9 97.9 101.8 99.7 111.7 102.8 104.9 99.6 102.5 105.1 95.9 104.8 97.3 76.8 28.9 38.8 7.5 85.1 67.4 92.4 183.1 46.7 72.0 141.7 134.9 53.2 74.4 90.5 115.8 14.6 270.4 95.8 179.1 299.3 196.7 280.8 102.8 55.1 75.7 124.4 109.8 11.5 182.1 489.1 67.9 68.8 96.9 117.4 115.7 54.3 89.3 288.4 58.9 11.1 194.5 154.6 85.4 129.0 705.7 62.4 109.1 104.9 7.5 243.2 115.6 130.7 7.1 13.4 159.3 205.5 47.4 98.3 153.1 225.3 347.7 94.6 73.0 46.0 38.5 80.7 203.1 378.6 125.5 71.9 170.5 87.7 174.2 237.1 119.9 LUC7L "hLuc7B1, Luc7, LUC7B1" ENSG00000007392 "LUC7 like" Q9NQ29 16 188969-229463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056424, HPA069321" Supported Approved Nucleoplasm,Mitochondria NA NA 14000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Mitochondria "HPA056424: AB_2683126, HPA069321: AB_2686119" "unprognostic (9.55e-3)" "unprognostic (2.01e-1)" "unprognostic (3.23e-2)" "unprognostic (5.61e-2)" "unprognostic (7.81e-2)" "unprognostic (2.60e-2)" "unprognostic (8.01e-3)" "unprognostic (4.31e-2)" "unprognostic (7.60e-2)" "unprognostic (2.35e-1)" "prognostic favorable (1.30e-4)" "unprognostic (1.57e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (1.33e-1)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (2.02e-3)" 32.9 47.3 46.0 16.5 46.5 24.0 32.2 47.8 62.9 58.9 46.4 42.8 17.1 40.8 28.2 31.8 40.8 19.4 33.5 46.8 47.1 54.6 43.0 31.9 27.6 45.6 44.9 48.3 48.9 14.9 58.8 18.4 45.4 68.6 13.8 19.6 27.4 18.5 23.3 26.0 40.7 16.2 43.8 63.7 39.2 41.8 45.6 20.3 72.9 12.9 16.9 34.7 36.7 48.3 14.6 62.5 65.1 25.0 24.0 18.8 29.2 26.2 19.7 40.6 29.7 65.8 16.7 27.1 33.5 14.8 22.2 18.5 77.5 23.5 41.2 46.7 53.9 31.7 48.2 77.7 27.4 37.8 34.2 17.0 26.8 33.9 13.3 35.3 31.8 22.1 38.7 16.9 33.8 68.6 60.4 63.8 98.1 32.2 30.0 52.3 28.6 27.8 59.1 15.4 38.8 43.1 28.3 19.6 25.9 38.4 25.2 20.3 27.2 30.5 45.6 13.1 32.2 18.2 25.6 28.2 9.3 26.4 28.1 0.3 9.3 3.9 6.3 11.0 5.1 6.4 6.1 6.4 10.2 2.8 3.5 2.7 1.1 4.5 13.3 11.4 7.5 5.9 46.0 46.5 47.8 62.9 46.8 47.1 45.6 44.9 45.4 43.8 45.6 48.3 64.2 51.3 67.9 59.4 46.9 53.2 39.9 36.4 47.8 48.9 33.1 32.8 22.3 12.8 46.7 23.9 37.5 30.1 63.1 27.2 11.7 35.8 56.7 48.9 81.6 48.2 42.3 26.9 56.7 21.1 42.9 44.4 52.5 55.5 41.1 66.9 26.0 12.7 24.3 45.4 54.0 26.0 28.5 16.6 54.9 21.5 32.6 34.0 39.2 30.0 32.2 24.4 17.5 54.8 40.6 25.8 28.0 32.4 47.4 43.5 27.9 15.5 34.6 59.7 26.3 50.0 50.4 82.1 56.7 29.3 54.3 49.9 45.4 42.5 26.2 37.6 MAP2K6 "MAPKK6, MEK6, MKK6, PRKMK6, SAPKK3" ENSG00000108984 "Mitogen-activated protein kinase kinase 6" P52564 17 69414697-69553865 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Stress response, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 40.5" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 53.9;Glandular and luminal cells: 82.7;Oligodendrocytes: 52.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 8.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 7 "classical monocyte: 22.0;neutrophil: 45.9;plasmacytoid DC: 78.3" "Group enriched" "Detected in all" 9 "dendritic cells: 78.3;granulocytes: 45.9;monocytes: 22.0" "Cell line enhanced" "Detected in many" "A549: 40.0;AN3-CA: 21.4;HUVEC TERT2: 28.4;MOLT-4: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007744, HPA031134" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "CAB007744: AB_562318, HPA031134: AB_10603016" "prognostic favorable (2.27e-6)" "unprognostic (2.24e-1)" "unprognostic (8.46e-2)" "unprognostic (4.10e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "unprognostic (7.61e-3)" "unprognostic (9.52e-2)" "unprognostic (3.67e-1)" "unprognostic (4.09e-3)" "prognostic favorable (7.52e-4)" "unprognostic (3.61e-2)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (9.43e-2)" "unprognostic (1.39e-1)" "unprognostic (2.03e-2)" 5.2 1.3 4.2 8.4 4.0 15.9 20.4 11.6 4.0 27.0 7.6 30.7 10.3 6.1 3.2 3.1 4.5 7.2 1.4 2.7 6.2 5.5 12.2 1.8 8.0 5.4 3.8 3.1 8.3 0.3 1.6 1.6 3.9 3.3 31.7 5.8 2.5 3.1 40.5 2.0 10.8 3.3 4.4 4.0 7.4 1.3 5.7 11.5 3.3 21.1 5.9 3.3 1.2 7.7 0.1 40.0 17.6 21.4 7.4 4.0 2.5 0.3 5.8 1.6 2.4 1.2 1.7 1.1 14.2 0.8 1.3 1.9 6.1 0.8 0.5 1.3 3.2 0.1 10.3 11.4 7.4 1.7 1.3 19.0 0.5 0.3 0.0 1.4 28.4 5.3 0.1 2.5 0.0 0.3 21.6 0.7 12.5 0.9 7.3 7.7 1.8 0.5 7.8 5.4 7.8 11.8 1.7 1.3 3.9 9.3 5.4 2.3 5.1 1.9 2.3 1.6 0.5 1.7 2.2 0.5 1.6 2.5 1.5 2.5 22.0 4.0 2.8 2.6 5.0 4.1 3.1 3.5 7.1 5.2 3.6 3.4 45.9 4.7 1.1 78.3 5.0 6.2 4.2 4.0 11.6 4.0 2.7 6.2 5.4 3.8 3.9 4.4 5.7 7.7 11.2 3.2 6.7 27.7 7.7 2.7 4.1 0.8 8.6 5.2 14.3 29.1 1.3 5.7 3.6 0.0 2.1 9.7 29.2 42.3 23.5 1.9 10.2 53.9 11.5 7.9 45.6 5.0 26.0 4.1 6.6 5.0 9.2 82.7 1.3 13.4 4.2 2.5 6.2 3.3 22.4 22.9 0.0 6.8 7.4 2.9 4.4 6.9 3.6 24.4 9.6 31.8 10.3 32.6 52.5 1.1 16.7 3.8 10.7 1.3 14.5 1.5 4.2 4.2 0.0 3.9 5.7 0.1 1.8 4.8 4.3 0.8 13.3 1.4 30.6 2.8 MAP3K6 "ASK2, MAPKKK6, MEKK6" ENSG00000142733 "Mitogen-activated protein kinase kinase kinase 6" O95382 1 27354067-27366961 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA051192 Approved Approved "Nucleoplasm,Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Nucleoplasm "Plasma membrane, Actin filaments, Cytosol" "HPA051192: AB_2681380" "unprognostic (1.19e-2)" "unprognostic (2.77e-3)" "unprognostic (2.62e-2)" "unprognostic (1.97e-2)" "prognostic unfavorable (2.13e-4)" "prognostic favorable (7.26e-4)" "prognostic unfavorable (8.76e-4)" "unprognostic (9.10e-2)" "unprognostic (2.79e-1)" "unprognostic (6.91e-2)" "unprognostic (6.56e-2)" "unprognostic (1.25e-1)" "unprognostic (4.65e-3)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (7.07e-3)" "unprognostic (1.50e-1)" 42.9 17.8 17.2 5.5 17.0 0.6 42.6 17.4 20.7 50.2 16.8 25.4 1.8 30.9 4.1 70.0 38.8 4.7 61.8 16.6 17.4 37.3 10.4 54.2 4.7 18.4 17.5 15.6 15.2 5.2 18.0 5.1 17.6 41.3 4.5 1.4 30.3 7.3 15.2 65.7 17.7 12.1 17.3 22.3 23.6 8.3 18.4 2.8 30.3 11.3 7.9 39.8 53.4 16.6 7.2 7.2 6.9 4.4 9.9 12.5 1.4 9.0 5.3 7.2 4.4 2.0 9.4 0.1 8.4 16.4 3.2 10.1 2.0 6.4 3.6 6.5 7.1 0.3 16.0 4.7 2.7 0.5 0.4 10.2 17.6 7.8 2.3 8.8 4.0 0.7 2.0 2.7 10.2 25.1 0.2 9.0 2.2 8.7 8.1 2.3 3.2 1.7 12.9 9.1 2.0 3.0 8.5 7.1 6.3 3.1 4.4 5.0 11.6 13.2 7.2 16.6 5.2 3.5 4.1 0.0 12.1 5.8 4.3 0.9 0.6 3.3 2.8 2.0 3.7 1.5 2.5 3.1 1.3 2.0 1.8 1.6 1.2 0.7 4.5 0.0 3.0 1.2 17.2 17.0 17.4 20.7 16.6 17.4 18.4 17.5 17.6 17.3 18.4 16.6 45.8 19.2 17.8 6.2 3.9 12.5 11.9 8.8 17.1 1.1 8.1 8.9 12.2 5.7 10.3 3.7 0.0 1.2 4.3 8.4 3.9 2.8 0.4 2.3 6.0 27.7 0.0 0.8 1.5 4.4 2.5 10.3 8.6 5.2 2.5 1.2 28.9 0.9 2.8 5.0 1.7 6.1 4.1 8.5 7.1 1.2 16.1 6.4 5.4 5.6 9.3 5.4 8.2 0.0 0.2 12.8 1.9 15.1 3.1 9.5 1.1 1.7 6.2 0.8 6.6 10.8 11.1 13.5 7.7 14.7 14.8 0.1 8.2 0.3 8.8 14.9 MAP7 E-MAP-115 ENSG00000135525 "Microtubule associated protein 7" Q14244 6 136342281-136550819 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 130.4" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1501.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "neutrophil: 12.2" "Group enriched" "Detected in many" 4 "dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1" "Cell line enhanced" "Detected in many" "CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029712, HPA029713" Enhanced Supported Microtubules,Cytosol NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 45: Intestine - Brush border" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Microtubules "HPA029712: AB_10600303, HPA029713: AB_10601339" "unprognostic (8.68e-3)" "prognostic unfavorable (9.70e-5)" "unprognostic (2.33e-3)" "unprognostic (4.35e-3)" "unprognostic (6.95e-2)" "unprognostic (3.35e-1)" "prognostic favorable (9.22e-4)" "unprognostic (1.24e-1)" "unprognostic (1.71e-1)" "unprognostic (1.72e-1)" "unprognostic (4.61e-2)" "unprognostic (3.33e-1)" "prognostic favorable (5.07e-7)" "unprognostic (1.62e-3)" "unprognostic (7.84e-2)" "unprognostic (3.62e-1)" "unprognostic (6.51e-2)" 2.7 8.4 36.6 4.9 81.2 4.8 13.1 53.0 49.8 6.1 0.6 24.6 29.0 2.4 19.5 15.8 10.0 8.2 1.4 40.2 59.8 32.6 17.2 7.0 1.5 78.0 67.2 1.5 25.1 24.9 12.0 6.8 75.8 20.0 23.2 57.3 20.3 6.4 0.8 17.1 26.6 2.4 43.3 1.8 18.7 27.4 63.0 5.1 16.1 0.2 5.1 12.0 9.6 130.4 25.6 39.2 0.3 0.1 0.2 0.2 40.4 0.7 1.2 0.4 0.7 59.8 26.3 0.1 5.3 0.8 6.7 38.2 11.1 34.6 0.7 0.2 24.6 26.6 69.2 0.5 0.3 26.1 3.0 0.1 31.5 0.2 2.4 1.0 0.2 2.0 18.4 0.6 0.1 88.5 0.2 2.6 5.2 55.3 5.7 0.1 1.0 4.8 23.6 68.4 24.4 5.2 27.4 51.7 0.6 9.1 20.5 2.6 0.5 0.1 1.9 0.4 1.7 4.6 6.4 0.2 0.5 10.1 0.7 2.8 2.3 0.0 0.0 1.6 0.3 1.4 0.5 0.0 5.7 1.6 0.1 0.0 12.2 0.7 3.1 0.0 0.2 0.7 36.6 81.2 53.0 49.8 40.2 59.8 78.0 67.2 75.8 43.3 63.0 130.4 4.0 57.7 51.4 117.2 1.9 28.2 48.7 21.7 33.6 367.0 29.5 18.4 3.0 28.6 42.9 18.4 146.0 33.1 0.7 67.9 31.3 35.8 293.9 30.4 5.9 4.9 117.7 35.1 217.1 49.0 23.1 4.4 42.8 60.8 0.0 1.2 0.7 37.0 16.3 304.5 258.6 81.5 22.4 3.2 8.5 53.1 6.8 6.2 17.8 15.0 3.2 50.9 0.0 26.2 1501.2 37.2 51.9 3.4 4.4 56.6 60.7 81.8 56.0 104.7 19.7 2.0 5.2 37.5 23.4 49.0 30.4 76.2 3.4 2.8 64.2 62.8 MAST3 KIAA0561 ENSG00000099308 "Microtubule associated serine/threonine kinase 3" O60307 19 18097793-18151692 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 62.6;Oligodendrocytes: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035061, HPA035062" Uncertain Approved "Nuclear speckles" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 10: Brain - Neuronal signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles" "HPA035061: AB_10670585, HPA035062: AB_10671508" "unprognostic (5.94e-3)" "unprognostic (4.75e-2)" "unprognostic (1.70e-1)" "unprognostic (1.02e-1)" "unprognostic (3.38e-1)" "prognostic favorable (2.97e-4)" "unprognostic (1.93e-1)" "unprognostic (4.63e-2)" "unprognostic (1.43e-1)" "unprognostic (3.21e-1)" "prognostic favorable (7.01e-4)" "unprognostic (2.58e-1)" "unprognostic (1.64e-3)" "unprognostic (1.02e-2)" "unprognostic (3.61e-1)" "unprognostic (1.58e-3)" "unprognostic (1.26e-3)" 4.9 4.8 49.9 9.2 53.4 14.4 3.7 0.0 62.1 9.4 0.0 7.3 9.6 5.3 4.7 3.3 7.1 3.1 3.7 61.6 0.0 7.6 14.5 9.1 11.2 5.3 1.9 7.1 20.2 5.0 15.5 2.6 4.3 5.6 4.3 1.0 4.8 3.9 3.0 7.3 12.4 3.0 0.0 19.2 4.5 3.6 13.7 4.2 4.5 1.6 10.1 3.7 4.9 47.4 3.5 5.1 2.3 10.2 6.7 5.4 5.5 3.5 2.2 2.4 3.4 5.2 4.7 9.0 5.1 3.5 2.6 1.9 3.4 2.0 1.7 7.7 4.2 4.1 5.7 8.3 5.6 2.2 13.2 6.2 5.7 3.6 1.4 3.2 1.1 6.1 4.3 5.8 2.8 6.3 4.7 7.3 2.4 7.7 6.2 12.6 2.0 6.6 1.9 1.5 3.8 6.2 4.9 2.8 2.1 1.6 3.2 5.1 4.0 3.0 3.2 13.1 1.5 6.2 9.0 8.0 6.7 11.6 2.9 0.3 6.2 14.8 11.7 8.0 8.4 5.9 6.3 4.7 3.2 5.9 4.9 8.4 32.9 8.1 14.7 15.4 7.6 6.1 49.9 53.4 0.0 62.1 61.6 0.0 5.3 1.9 4.3 0.0 13.7 47.4 2.6 6.4 9.4 5.5 13.5 0.5 0.8 2.8 2.8 3.0 2.6 2.8 1.5 7.2 3.6 9.2 2.1 0.5 19.0 30.0 3.9 2.9 9.3 2.8 5.4 3.8 2.4 1.3 62.6 10.5 1.5 3.4 7.7 1.5 2.5 3.0 4.6 16.3 7.7 0.0 6.1 8.5 0.0 21.7 6.3 30.8 4.1 13.3 5.4 19.7 19.6 0.9 32.0 8.0 63.7 7.1 7.9 6.8 5.1 1.2 16.7 8.8 4.2 0.7 0.0 2.1 3.0 0.6 3.9 2.3 2.3 0.4 11.0 5.3 13.0 0.6 MAZ "Pur-1, ZF87, Zif87, ZNF801" ENSG00000103495 "MYC associated zinc finger protein" P56270 16 29806106-29811164 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048315, HPA059495, HPA065930" Approved Enhanced Nucleoplasm "Intracellular and membrane" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579" "unprognostic (1.05e-1)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (1.03e-1)" "unprognostic (1.25e-1)" "unprognostic (3.83e-1)" "unprognostic (3.25e-3)" "unprognostic (6.16e-2)" "unprognostic (1.27e-1)" "unprognostic (5.12e-2)" "unprognostic (2.00e-1)" "unprognostic (6.39e-3)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.20e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (7.08e-2)" 71.0 91.7 156.7 92.1 153.0 270.3 65.5 147.4 179.9 87.4 125.2 139.4 92.7 90.1 51.4 92.6 88.6 73.6 74.4 158.9 134.8 63.6 101.2 73.2 123.9 140.4 144.6 96.7 105.4 113.3 83.0 61.8 136.6 122.9 101.0 50.8 86.2 75.4 126.2 96.3 87.7 75.8 134.8 97.8 85.5 89.9 143.9 256.0 79.5 93.1 111.2 94.4 68.4 145.2 227.2 294.8 298.8 326.9 158.4 149.6 268.4 161.0 130.6 246.0 177.4 378.5 316.5 402.4 205.2 316.9 121.6 201.3 494.2 210.9 87.5 329.9 792.4 267.7 641.3 526.2 222.1 668.7 318.8 160.7 292.1 207.2 232.5 228.7 249.4 556.7 398.5 343.3 118.3 927.1 644.8 566.3 303.7 246.1 227.6 627.9 281.3 468.5 202.3 242.2 456.1 355.1 153.8 330.1 204.6 190.5 284.3 633.7 172.8 269.8 215.4 103.6 256.1 249.3 344.4 448.5 131.9 435.4 227.9 18.1 14.7 23.9 58.8 24.0 63.6 13.5 39.1 56.5 19.4 10.2 31.6 47.3 11.9 40.1 16.4 19.9 45.8 21.3 156.7 153.0 147.4 179.9 158.9 134.8 140.4 144.6 136.6 134.8 143.9 145.2 52.1 6.4 5.4 9.4 35.3 32.9 14.7 26.7 35.3 61.6 77.8 66.9 0.3 31.5 14.5 11.0 12.5 26.8 106.7 111.5 29.4 31.6 2.5 58.5 59.0 41.0 133.3 90.3 12.8 41.9 55.6 46.3 34.7 39.6 33.0 103.1 30.7 37.7 57.5 47.1 13.0 103.6 32.6 47.8 47.8 6.6 28.0 47.6 46.2 8.4 26.4 35.6 50.4 9.5 14.2 36.3 68.5 36.9 41.6 32.8 37.8 21.9 25.6 35.1 32.9 30.1 49.1 22.2 24.5 38.6 35.5 16.7 67.5 70.9 126.8 14.9 MDP1 "FN6Pase, MGC5987" ENSG00000213920 "Magnesium dependent phosphatase 1" Q86V88 14 24213943-24216070 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA003064, HPA070338" Uncertain Approved Nucleoplasm NA NA 29000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA003064: AB_10602350, HPA070338: AB_2686256" "unprognostic (2.70e-1)" "unprognostic (3.68e-1)" "unprognostic (2.51e-1)" "unprognostic (2.11e-1)" "unprognostic (3.09e-1)" "unprognostic (5.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.12e-1)" "unprognostic (6.27e-2)" "unprognostic (8.02e-2)" "unprognostic (2.00e-3)" "unprognostic (1.02e-1)" "prognostic favorable (5.96e-4)" "unprognostic (6.39e-2)" "unprognostic (1.32e-1)" "unprognostic (3.82e-1)" "unprognostic (3.19e-2)" 14.0 18.6 6.8 3.2 6.8 3.9 14.6 7.0 7.5 14.7 6.4 12.6 3.1 11.5 7.9 7.3 12.1 4.0 18.2 7.0 6.9 16.8 10.3 9.2 5.8 6.7 6.8 12.3 15.3 5.8 20.1 4.0 6.9 13.7 3.5 4.1 10.6 4.8 15.0 12.6 9.5 4.5 7.2 11.6 11.9 7.8 6.6 5.3 13.6 4.8 4.7 12.5 11.1 7.8 4.1 9.5 7.2 4.7 6.9 6.3 0.3 4.2 8.9 8.2 8.4 5.0 10.9 15.7 10.4 4.3 2.4 3.7 3.4 8.2 5.0 5.4 3.9 6.0 3.3 12.1 6.7 7.9 4.2 4.5 7.7 4.9 9.4 8.3 5.9 11.1 1.9 11.4 7.4 21.1 11.7 12.6 2.2 7.8 16.9 8.0 5.0 12.6 8.0 5.7 8.7 8.6 6.6 14.3 9.4 3.9 8.3 4.5 3.5 8.8 8.7 3.9 4.4 18.6 8.4 11.7 8.3 3.8 6.9 5.1 13.9 16.5 7.7 15.2 7.3 13.4 9.9 9.0 16.1 12.9 11.7 9.9 4.6 12.4 13.0 29.9 16.3 10.3 6.8 6.8 7.0 7.5 7.0 6.9 6.7 6.8 6.9 7.2 6.6 7.8 6.6 6.4 12.9 0.0 11.0 4.6 3.5 5.6 16.5 3.9 8.2 11.7 0.0 4.3 2.1 5.5 0.0 3.7 7.3 5.9 13.7 13.8 5.7 4.6 5.5 8.2 11.5 7.8 0.0 19.6 5.3 8.1 9.2 4.3 5.1 4.3 8.6 5.8 7.9 3.3 0.0 10.8 12.2 3.3 8.7 3.0 6.2 10.6 17.8 0.0 21.9 5.2 4.1 0.0 0.0 11.7 6.2 7.5 25.8 2.9 23.7 21.7 13.2 2.9 13.1 7.7 8.7 4.4 3.5 11.5 4.5 2.5 9.7 3.4 8.8 2.6 MECP2 "MRX16, MRX79, RTT" ENSG00000169057 "Methyl-CpG binding protein 2" P51608 X 154021573-154137103 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Autism, Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 206.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 47.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 47.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000593, HPA001341, CAB037264" Enhanced Approved Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "CAB037264: AB_477252, HPA000593: AB_1079348, HPA001341: AB_1079347" "unprognostic (1.27e-3)" "unprognostic (2.60e-3)" "unprognostic (2.16e-3)" "prognostic unfavorable (8.35e-5)" "unprognostic (2.35e-1)" "unprognostic (3.66e-1)" "unprognostic (6.12e-2)" "unprognostic (1.18e-2)" "unprognostic (8.81e-2)" "unprognostic (1.53e-1)" "unprognostic (1.84e-3)" "unprognostic (4.22e-1)" "prognostic favorable (7.32e-9)" "unprognostic (7.63e-2)" "unprognostic (1.00e-1)" "unprognostic (9.08e-2)" "unprognostic (6.05e-2)" 21.0 17.7 11.2 13.4 12.8 24.9 18.0 19.4 17.1 24.0 6.6 21.8 9.9 19.0 10.8 14.4 21.7 10.8 23.3 12.0 13.4 17.8 16.5 24.6 13.4 13.7 13.7 24.8 14.8 14.7 22.8 8.6 12.7 23.9 5.3 23.0 14.4 15.6 33.5 14.8 16.1 11.5 9.1 23.6 15.4 8.6 13.6 15.6 18.9 14.4 9.1 20.0 19.3 16.9 34.4 19.2 15.9 18.6 13.1 8.8 12.7 17.0 14.6 14.9 25.2 14.1 13.3 37.4 39.5 13.3 28.9 16.0 19.3 15.9 8.8 32.5 27.8 13.6 17.6 9.4 14.9 18.2 28.2 8.7 10.0 15.6 13.2 15.4 12.9 17.5 17.3 28.9 11.1 17.9 23.1 21.8 11.2 21.9 19.9 20.0 16.2 13.2 9.2 13.3 21.9 13.6 13.0 14.1 31.6 7.7 8.8 24.8 18.0 14.5 28.8 29.2 35.6 41.0 32.6 41.7 19.6 33.2 25.1 47.8 4.7 19.5 9.1 4.7 6.2 7.8 6.1 7.2 3.5 6.8 5.8 5.4 22.7 4.4 8.2 6.0 7.2 2.7 11.2 12.8 19.4 17.1 12.0 13.4 13.7 13.7 12.7 9.1 13.6 16.9 53.9 6.4 34.4 26.4 74.7 30.8 43.4 28.3 21.6 88.0 40.7 24.6 41.2 34.3 34.9 46.0 206.4 17.0 130.8 23.9 66.5 39.4 1.4 28.2 34.4 41.0 36.5 48.4 31.7 30.7 17.7 38.5 16.3 22.7 52.6 32.2 66.4 38.1 25.6 99.3 35.3 21.0 52.9 45.5 68.7 3.5 53.4 54.1 30.2 45.0 58.9 39.8 85.5 30.2 45.0 36.2 30.3 73.7 56.1 34.8 36.7 44.5 28.1 92.7 32.9 53.6 57.1 16.0 39.0 18.1 29.0 18.5 93.6 25.6 17.3 36.4 MED11 "HSPC296, MGC88387" ENSG00000161920 "Mediator complex subunit 11" Q9P086 17 4731428-4733608 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056669 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nuclear bodies" "HPA056669: AB_2683204" "unprognostic (4.01e-2)" "unprognostic (2.34e-2)" "unprognostic (7.91e-2)" "prognostic favorable (1.86e-5)" "unprognostic (8.24e-2)" "unprognostic (5.47e-2)" "unprognostic (1.27e-1)" "unprognostic (1.36e-1)" "unprognostic (3.82e-2)" "unprognostic (3.86e-2)" "unprognostic (2.10e-3)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (4.84e-2)" "unprognostic (1.16e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" 20.5 41.3 28.6 22.5 32.0 11.2 20.3 32.3 33.8 21.1 28.2 25.4 27.2 18.9 25.3 29.2 24.4 19.0 29.5 28.2 30.5 32.7 38.6 22.9 28.5 31.9 31.2 16.8 29.0 35.6 19.1 16.4 31.6 23.3 23.4 17.2 26.6 19.5 39.0 27.2 26.5 16.9 30.4 34.5 30.6 16.2 31.3 25.3 22.4 32.9 26.5 22.3 21.3 35.3 26.2 73.5 26.9 27.8 28.6 34.6 20.7 18.4 30.8 26.4 33.0 25.6 19.7 35.7 18.9 22.3 17.2 38.8 27.1 51.9 20.5 42.5 63.1 17.8 42.6 40.6 17.7 12.9 20.7 30.1 35.6 28.3 17.3 28.2 30.3 36.4 18.1 26.5 23.4 37.6 24.8 16.8 16.0 39.3 23.6 24.5 19.7 23.3 54.3 27.5 10.9 18.1 23.7 31.5 18.5 22.0 28.4 15.1 18.1 14.1 14.1 27.4 29.3 12.5 11.8 14.2 24.4 22.0 18.8 49.1 31.0 79.3 41.6 45.6 45.4 62.8 40.8 41.8 31.0 61.9 48.3 53.1 136.3 40.9 68.0 49.8 33.7 38.5 28.6 32.0 32.3 33.8 28.2 30.5 31.9 31.2 31.6 30.4 31.3 35.3 12.5 6.4 23.5 7.8 31.5 12.2 28.8 42.6 19.4 22.1 20.0 17.8 15.1 32.9 32.3 14.7 10.4 45.4 34.3 32.8 64.6 37.0 1.2 35.1 24.8 15.8 10.8 13.5 5.5 35.3 34.2 17.3 28.5 25.0 29.1 9.3 22.5 29.4 33.8 30.3 7.2 30.9 48.8 31.5 21.1 3.8 17.4 25.5 10.6 5.6 44.6 20.9 50.4 5.0 14.6 22.4 51.1 13.9 18.8 22.9 66.4 99.5 36.9 26.6 19.7 16.5 18.2 56.6 49.9 31.3 18.8 25.0 27.3 33.8 29.7 28.6 MED12 "ARC240, CAGH45, FGS1, HOPA, KIAA0192, Kto, OKS, OPA1, TNRC11, TRAP230" ENSG00000184634 "Mediator complex subunit 12" Q93074 X 71118556-71142454 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003184, HPA003185" Enhanced Approved Nucleoplasm NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA003184: AB_1079349, HPA003185: AB_1079350" "unprognostic (1.39e-1)" "unprognostic (2.23e-1)" "unprognostic (5.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.89e-3)" "unprognostic (7.14e-2)" "unprognostic (1.68e-2)" "unprognostic (1.15e-2)" "unprognostic (2.10e-1)" "unprognostic (1.53e-1)" "unprognostic (2.45e-1)" "unprognostic (2.50e-1)" "unprognostic (1.22e-3)" "unprognostic (1.28e-1)" "unprognostic (1.02e-1)" "unprognostic (3.67e-1)" "unprognostic (5.16e-2)" 18.9 32.3 10.1 13.4 11.6 15.1 19.3 10.8 12.2 20.3 9.3 15.2 8.1 18.1 10.7 13.4 17.8 8.5 13.4 9.7 10.5 13.1 10.3 15.2 13.6 12.3 10.9 28.9 14.9 14.1 16.3 16.8 11.3 17.4 9.2 8.2 14.3 12.6 15.4 14.7 15.9 12.6 10.2 28.4 15.5 13.4 11.2 19.1 18.1 10.6 12.2 15.2 17.1 12.0 14.2 16.4 25.5 15.3 18.3 16.1 37.1 9.9 14.0 15.2 10.8 19.8 13.1 18.5 12.7 17.2 10.5 13.8 29.7 12.3 12.1 19.6 23.0 30.7 37.9 27.5 14.3 28.8 26.2 18.9 13.2 20.0 23.3 19.6 23.8 23.1 29.0 31.6 15.2 24.3 30.5 16.3 14.7 18.2 21.3 28.0 28.5 14.0 11.8 27.5 14.0 16.9 22.7 11.8 12.2 26.2 13.9 14.2 21.1 16.5 19.7 15.4 7.0 15.4 9.5 13.7 9.8 15.8 11.2 6.9 2.1 4.3 3.0 1.9 2.5 2.0 2.1 2.8 2.1 1.9 2.3 2.0 4.1 2.7 1.3 2.8 4.4 2.4 10.1 11.6 10.8 12.2 9.7 10.5 12.3 10.9 11.3 10.2 11.2 12.0 15.4 9.6 4.2 7.2 8.4 6.0 6.3 6.5 4.6 7.2 8.6 11.0 9.3 11.5 7.6 9.2 6.2 20.7 10.9 10.8 1.9 6.9 0.4 7.9 8.9 12.8 7.8 13.7 3.8 6.3 8.0 8.2 8.6 7.1 9.5 21.1 14.6 4.4 9.1 13.5 4.2 5.8 2.0 6.5 9.8 2.3 14.0 8.9 5.4 6.5 7.4 6.3 13.4 4.0 4.2 9.4 10.0 13.5 7.3 7.5 7.5 2.7 7.5 4.9 0.0 10.0 7.6 6.6 7.3 6.1 5.7 27.2 8.8 27.9 6.8 8.6 MED29 "DKFZp434H247, IXL, MED2" ENSG00000063322 "Mediator complex subunit 29" Q9NX70 19 39391303-39400641 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055956 Supported Nucleoplasm NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA055956: AB_2682986" "unprognostic (3.30e-2)" "unprognostic (3.51e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.68e-1)" "unprognostic (1.92e-1)" "unprognostic (2.85e-2)" "unprognostic (1.71e-1)" "unprognostic (5.36e-3)" "unprognostic (1.46e-2)" "unprognostic (1.10e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.15e-5)" "unprognostic (9.51e-2)" "unprognostic (4.84e-2)" "unprognostic (2.17e-1)" "unprognostic (1.87e-2)" 18.8 28.6 38.3 16.0 39.5 18.1 19.0 37.5 39.5 22.6 27.9 23.1 17.2 23.2 21.4 16.3 28.7 17.1 24.1 37.8 37.0 21.8 27.9 17.4 19.1 39.6 39.2 31.9 24.0 42.0 27.9 15.6 37.7 23.1 13.1 18.3 23.1 22.8 38.0 17.7 17.4 18.5 37.2 19.7 20.2 16.5 42.1 18.6 29.9 14.1 16.7 20.7 17.5 38.9 28.3 73.2 21.7 22.3 31.0 23.5 17.3 29.9 31.9 27.1 21.8 36.2 26.6 20.9 38.9 27.7 23.7 14.5 20.3 25.4 16.1 40.8 37.3 26.9 28.8 24.6 25.2 25.8 22.7 25.0 20.3 28.5 31.5 29.3 21.8 39.4 18.1 25.3 27.9 36.7 25.3 7.7 16.6 34.5 25.4 41.3 29.8 29.6 26.3 47.0 33.3 30.1 60.8 39.4 26.6 13.1 30.8 27.9 25.2 22.9 23.8 29.0 30.4 32.5 40.3 35.2 32.3 19.2 37.7 48.2 48.3 41.2 38.3 59.7 38.2 46.5 35.7 35.2 36.9 43.0 42.4 40.6 54.2 40.0 77.5 30.0 46.8 47.0 38.3 39.5 37.5 39.5 37.8 37.0 39.6 39.2 37.7 37.2 42.1 38.9 33.6 28.9 41.1 8.8 36.5 22.2 30.2 31.9 25.6 24.9 45.0 57.9 36.5 25.8 30.1 31.3 12.5 36.6 34.9 53.3 52.8 28.0 49.8 46.6 40.6 30.4 32.8 27.8 8.1 28.4 31.4 36.3 126.9 46.7 43.7 28.0 37.5 43.4 40.7 23.5 10.1 40.2 40.7 40.3 72.5 71.6 38.5 46.9 28.4 8.4 38.1 37.5 26.8 5.5 13.5 25.5 60.2 32.4 47.8 17.6 86.8 62.3 37.1 15.9 52.6 33.3 52.5 34.8 16.4 29.3 20.3 28.9 40.1 27.9 32.7 17.9 MEN1 ENSG00000133895 "Menin 1" O00255 11 64803510-64811294 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030342 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA030342: AB_10610138" "unprognostic (2.06e-1)" "unprognostic (1.76e-1)" "unprognostic (3.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.05e-1)" "unprognostic (8.41e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.66e-1)" "unprognostic (2.59e-1)" "unprognostic (1.42e-2)" "unprognostic (4.96e-2)" "unprognostic (1.36e-1)" "unprognostic (7.39e-2)" "prognostic favorable (6.31e-5)" "unprognostic (1.40e-1)" "unprognostic (3.03e-1)" "unprognostic (3.76e-1)" 15.1 24.2 13.1 8.4 13.7 6.5 15.7 12.7 15.0 19.3 13.0 16.8 7.8 17.4 8.1 23.9 16.3 5.5 12.4 14.3 12.7 19.4 30.3 16.1 10.9 12.5 12.5 20.8 26.2 6.3 21.7 7.8 12.6 20.2 4.7 4.7 21.3 7.7 11.0 24.0 20.9 5.3 11.9 25.5 20.6 16.3 13.5 17.1 24.5 5.8 10.2 16.4 18.7 12.9 30.8 33.7 22.4 37.7 30.4 17.4 24.8 19.2 23.3 35.6 21.2 19.0 25.5 43.6 33.8 16.7 29.8 39.0 36.4 28.3 19.3 30.5 48.1 35.6 17.3 30.9 27.2 23.6 22.8 19.2 18.2 26.8 21.9 16.5 33.7 49.3 51.5 15.7 18.9 54.2 60.3 29.3 36.7 30.3 54.7 45.1 29.8 44.1 23.2 22.8 33.6 28.9 26.0 36.9 27.9 16.5 56.6 27.1 17.4 23.5 28.8 36.5 16.7 21.8 30.4 22.1 25.5 16.2 21.0 0.5 0.5 1.4 1.5 0.6 1.8 1.8 1.1 1.9 0.6 1.8 1.9 0.9 0.1 0.9 0.2 1.3 0.9 0.5 13.1 13.7 12.7 15.0 14.3 12.7 12.5 12.5 12.6 11.9 13.5 12.9 6.9 3.2 5.4 5.9 10.6 5.7 4.6 5.3 7.4 8.5 10.2 11.0 4.5 4.3 2.8 3.7 6.2 19.4 8.0 9.2 3.9 8.9 0.9 7.9 11.0 7.0 4.2 10.8 7.4 7.1 21.7 6.9 13.7 12.1 1.3 14.1 7.9 10.9 9.0 3.3 6.2 9.0 6.1 3.1 2.3 0.9 12.2 4.8 8.8 8.4 6.3 7.7 6.2 4.5 5.0 7.5 10.7 3.8 8.4 6.1 9.3 8.0 4.0 6.5 13.1 5.4 5.6 14.2 13.0 9.4 7.0 16.3 8.9 14.3 10.2 3.3 MEPCE "BCDIN3, FLJ20257" ENSG00000146834 "Methylphosphate capping enzyme" Q7L2J0 7 100428790-100434118 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026384, HPA051587" Supported Approved "Nucleoplasm,Cell Junctions" NA Yes "Cluster 26: Non-specific - Mitochondria" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Cell Junctions" "CAB026384: , HPA051587: AB_2681544" "unprognostic (8.59e-2)" "unprognostic (1.23e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (6.01e-6)" "unprognostic (1.09e-1)" "unprognostic (1.53e-2)" "unprognostic (3.83e-2)" "unprognostic (2.19e-1)" "unprognostic (1.69e-2)" "unprognostic (2.95e-1)" "unprognostic (1.65e-3)" "unprognostic (1.09e-1)" "prognostic favorable (1.01e-10)" "unprognostic (9.66e-2)" "unprognostic (9.31e-2)" "unprognostic (4.57e-1)" "unprognostic (9.50e-3)" 26.4 41.0 27.5 19.4 28.3 28.3 24.2 30.4 31.5 26.1 23.6 25.8 18.5 28.8 27.8 27.5 27.0 19.4 26.8 26.7 27.0 37.0 36.9 21.9 29.0 27.6 27.3 36.0 22.5 35.0 23.6 20.9 27.4 26.5 12.9 9.9 24.9 20.7 38.5 34.5 27.2 18.0 26.8 56.6 24.6 79.8 28.0 28.1 36.5 31.5 24.2 28.3 21.9 28.2 42.6 53.6 38.9 41.9 36.8 36.7 29.1 46.4 66.5 48.7 37.4 43.8 60.1 87.1 75.5 29.1 38.5 38.4 43.0 34.9 32.0 39.4 49.4 45.1 41.5 33.3 30.9 58.0 53.0 38.2 40.9 55.7 70.0 26.5 41.1 27.4 90.6 62.2 47.2 155.6 66.3 129.8 72.1 35.0 58.9 53.0 31.5 79.1 32.7 25.6 58.5 50.6 72.5 139.1 49.1 19.3 35.6 52.1 36.2 81.5 63.5 55.9 62.0 41.0 42.4 96.3 45.8 71.1 72.9 2.6 2.6 3.7 3.8 2.3 4.6 6.2 4.4 4.2 3.3 6.6 6.2 5.5 6.4 5.9 1.9 6.3 4.5 7.5 27.5 28.3 30.4 31.5 26.7 27.0 27.6 27.3 27.4 26.8 28.0 28.2 34.2 9.6 18.9 5.5 33.8 30.2 17.3 7.1 19.9 9.9 30.2 21.6 25.6 20.0 7.8 22.0 8.4 15.8 34.3 32.2 15.6 10.3 29.6 18.3 13.1 21.7 10.7 9.9 2.8 12.0 8.5 17.3 54.6 18.8 18.3 14.5 28.9 22.1 12.7 11.8 2.6 26.1 8.2 26.7 16.9 66.5 17.4 32.9 8.8 7.5 18.1 19.4 15.5 2.5 2.7 10.4 23.6 15.4 14.9 15.6 39.9 14.4 10.4 9.5 6.6 35.0 17.9 44.8 15.1 22.3 25.1 21.2 25.0 19.5 20.3 9.9 METRN "C16orf23, MGC2601" ENSG00000103260 "Meteorin, glial cell differentiation regulator" Q9UJH8 16 715118-719655 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 299.3;choroid plexus: 238.6" "Cell type enriched" "Detected in many" 5 "Muller glia cells: 1153.9" "Cancer enhanced" "Detected in all" "glioma: 69.7" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MCF7: 178.2;PC-3: 133.1;SK-MEL-30: 93.5" "Region enhanced" "Detected in all" "cerebellum: 612.9" HPA051164 Approved Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Secreted in brain" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 5: Muller glia cells - Visual perception" "Nuclear membrane" "Nucleoplasm, Cytosol" "HPA051164: AB_2681369" "unprognostic (1.60e-2)" "unprognostic (3.49e-1)" "unprognostic (4.47e-2)" "unprognostic (2.96e-1)" "unprognostic (1.45e-1)" "unprognostic (7.49e-2)" "unprognostic (1.82e-1)" "unprognostic (2.59e-1)" "unprognostic (8.13e-2)" "unprognostic (2.35e-1)" "unprognostic (2.12e-2)" "unprognostic (3.32e-1)" "unprognostic (5.03e-3)" "unprognostic (3.62e-2)" "unprognostic (1.26e-1)" "unprognostic (3.09e-1)" "unprognostic (2.17e-2)" 16.1 36.3 238.0 4.0 233.8 1.5 14.1 203.7 299.3 15.5 238.6 30.7 4.1 17.3 3.0 10.4 37.0 2.5 56.8 209.7 210.3 29.2 49.9 16.8 2.1 258.1 239.0 5.2 46.1 5.5 88.0 3.7 208.5 25.4 1.2 3.0 25.2 13.1 23.3 11.9 12.0 2.9 244.4 12.3 22.2 15.3 258.3 2.4 30.6 5.1 1.8 20.5 11.3 237.4 8.9 73.4 14.2 72.4 24.6 13.8 22.9 17.5 8.7 6.9 4.4 11.0 21.5 1.5 39.6 12.4 26.3 32.6 2.1 17.0 1.1 4.7 32.0 2.9 13.3 57.1 15.1 6.5 9.2 33.3 18.3 2.1 4.2 21.3 2.3 20.3 5.3 1.7 5.2 178.2 2.4 22.0 5.2 9.8 133.1 24.3 16.4 24.4 18.4 2.6 22.5 28.5 6.9 18.9 93.5 1.6 28.6 12.6 8.0 19.4 36.8 22.7 15.4 11.0 3.3 1.7 30.3 4.8 46.6 0.0 0.1 0.2 0.8 0.3 0.5 1.2 0.4 0.8 0.0 0.1 0.2 0.5 0.0 0.5 0.3 0.2 1.0 0.1 238.0 233.8 203.7 299.3 209.7 210.3 258.1 239.0 208.5 244.4 258.3 237.4 46.7 0.0 2.2 91.4 8.5 3.8 17.1 3.3 0.0 45.5 79.5 75.8 16.3 48.6 1.8 16.5 14.6 0.6 26.7 29.0 50.9 8.4 8.0 230.7 54.8 21.5 27.4 2.7 6.6 5.1 2.1 15.1 5.6 14.4 0.0 2.7 20.0 39.5 6.4 70.7 5.7 10.7 2.0 7.8 6.5 25.8 11.1 6.6 10.6 8.4 1.1 1153.9 23.7 44.2 57.6 5.3 26.7 9.4 7.9 27.7 6.2 55.6 9.5 37.9 26.3 11.8 26.7 4.6 11.7 1.4 3.0 0.4 12.7 5.2 9.2 16.2 MFSD3 ENSG00000167700 "Major facilitator superfamily domain containing 3" Q96ES6 8 144509070-144511213 "Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 63.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056013 Uncertain Approved Vesicles NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA056013: AB_2683009" "unprognostic (7.92e-2)" "prognostic unfavorable (5.08e-4)" "unprognostic (2.00e-1)" "unprognostic (5.18e-2)" "unprognostic (6.50e-2)" "unprognostic (3.74e-2)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (9.41e-2)" "unprognostic (1.06e-1)" "unprognostic (5.49e-2)" "unprognostic (5.29e-2)" "prognostic favorable (5.44e-7)" "unprognostic (4.08e-3)" "unprognostic (2.37e-1)" "unprognostic (1.50e-1)" "unprognostic (9.81e-2)" 8.4 22.6 9.2 3.4 8.0 1.8 10.7 7.2 12.0 8.0 6.4 22.6 13.5 8.3 4.1 16.1 8.4 2.5 21.8 8.8 6.7 27.5 44.6 7.6 2.8 10.8 7.1 6.7 18.8 12.3 17.8 1.5 9.4 19.2 3.3 1.5 19.6 5.4 23.5 17.8 15.4 1.2 5.4 10.8 15.6 6.3 9.5 2.3 23.9 6.1 1.7 9.7 9.2 7.0 16.2 21.7 5.4 4.6 5.9 4.4 17.6 5.1 5.3 2.8 4.2 7.3 11.2 23.3 17.3 4.8 5.6 15.5 2.5 12.1 0.5 11.0 44.0 7.5 19.9 18.3 11.0 3.6 9.9 6.5 22.3 1.8 7.7 12.1 7.3 16.0 14.2 6.2 6.8 53.7 9.0 18.9 14.3 22.9 36.9 9.9 2.8 41.7 13.2 9.5 39.1 19.7 13.0 31.6 11.3 3.4 33.1 5.2 7.9 3.7 9.9 4.2 7.1 6.0 2.6 8.1 8.0 11.3 6.5 1.8 7.4 3.8 3.9 6.7 3.7 4.9 3.9 4.0 11.0 2.5 3.5 3.6 0.4 3.8 3.6 19.2 4.4 4.1 9.2 8.0 7.2 12.0 8.8 6.7 10.8 7.1 9.4 5.4 9.5 7.0 3.0 3.2 3.7 6.5 8.0 6.0 10.3 17.3 8.6 8.2 18.8 14.5 9.3 30.0 11.8 27.6 10.4 16.5 3.7 31.3 37.2 17.6 0.6 5.1 3.9 3.8 19.8 8.2 6.2 21.0 15.0 4.0 16.3 7.4 0.0 9.7 3.3 27.6 15.5 16.8 6.2 19.6 24.4 7.0 3.2 1.8 4.4 6.4 8.8 1.9 7.5 14.8 6.2 2.5 3.8 15.7 19.1 4.9 14.8 12.8 33.1 63.6 3.2 10.0 0.0 7.0 3.4 3.8 11.7 19.0 7.1 9.3 3.5 16.9 27.1 9.8 MFSD5 "HsMOT2, MGC11308" ENSG00000182544 "Major facilitator superfamily domain containing 5" Q6N075 12 53251251-53254406 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039773 Uncertain NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA039773: AB_10793920" "unprognostic (9.42e-3)" "unprognostic (9.03e-3)" "unprognostic (4.25e-2)" "unprognostic (1.10e-1)" "unprognostic (1.37e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (1.43e-6)" "unprognostic (2.20e-2)" "unprognostic (1.69e-1)" "unprognostic (4.25e-1)" "unprognostic (9.79e-2)" "unprognostic (4.52e-2)" "unprognostic (5.63e-2)" "unprognostic (1.65e-2)" "unprognostic (2.12e-1)" "unprognostic (6.51e-3)" "unprognostic (1.19e-2)" 18.5 28.8 15.9 12.2 16.9 22.1 16.5 18.1 17.7 19.7 18.8 19.1 13.5 16.6 12.8 61.3 13.3 11.4 21.8 16.0 17.0 19.3 15.8 15.6 14.7 17.4 17.2 9.9 22.1 19.8 11.7 16.1 17.2 15.7 14.6 26.9 26.1 13.3 19.0 60.1 18.5 13.4 17.4 20.4 19.6 10.6 17.7 9.8 12.9 14.0 20.3 18.2 30.6 18.9 23.8 51.1 15.2 27.9 57.7 32.7 17.6 34.7 43.3 36.4 34.1 27.2 43.8 19.4 29.6 50.1 34.4 43.1 24.9 28.7 24.2 25.0 34.7 14.8 18.6 36.2 40.0 28.6 35.8 40.8 39.5 34.5 17.1 39.4 33.7 18.7 27.8 34.4 35.5 89.2 14.0 35.3 26.4 27.3 44.5 17.1 15.3 26.3 26.8 41.1 12.5 18.8 25.0 34.3 28.0 17.8 59.6 26.4 32.2 30.9 20.0 32.0 22.8 20.8 27.3 15.1 41.1 27.4 30.2 58.3 32.3 103.7 26.6 25.9 32.7 50.1 31.4 30.2 38.1 44.6 23.4 22.4 17.5 27.8 17.7 31.9 27.9 23.4 15.9 16.9 18.1 17.7 16.0 17.0 17.4 17.2 17.2 17.4 17.7 18.9 5.5 9.6 10.6 6.2 12.1 13.0 5.8 15.9 14.2 5.4 9.4 7.4 9.5 10.0 18.1 12.9 31.3 38.4 7.8 20.3 5.9 20.4 0.5 5.2 8.0 10.8 2.4 9.9 2.2 26.5 24.5 12.1 9.2 7.7 5.7 7.6 11.4 10.9 28.6 3.3 2.7 10.9 10.2 18.8 13.4 2.0 6.2 11.7 16.0 0.0 17.2 7.8 14.4 3.5 3.4 21.9 13.3 4.9 10.9 8.7 12.0 10.9 10.3 14.3 6.6 7.7 8.4 4.7 14.2 21.3 17.0 33.2 12.1 6.2 8.5 7.9 MID1 "FXY, OS, RNF59, TRIM18" ENSG00000101871 "Midline 1" O15344 X 10445310-10833654 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 129.3;Basal squamous epithelial cells: 82.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 156.1;AF22: 132.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002878, HPA003715" Approved Uncertain "Golgi apparatus,Centriolar satellite,Cytosol" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Centriolar satellite" "Golgi apparatus, Cytosol" "HPA002878: , HPA003715: AB_1079384" "unprognostic (1.99e-1)" "unprognostic (2.81e-1)" "unprognostic (4.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.78e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.06e-4)" "unprognostic (1.19e-1)" "unprognostic (3.61e-1)" "unprognostic (2.09e-1)" "unprognostic (2.87e-1)" "unprognostic (9.43e-2)" "unprognostic (1.25e-3)" "unprognostic (9.89e-2)" "unprognostic (1.49e-1)" "unprognostic (1.12e-3)" "unprognostic (5.88e-2)" 5.9 2.5 6.9 5.0 7.7 1.7 5.3 17.2 5.0 7.0 6.5 17.3 5.7 8.9 4.9 7.0 6.4 6.8 9.3 7.0 4.9 7.3 4.2 6.5 2.2 3.6 10.4 4.4 3.5 2.8 4.2 6.2 4.9 10.4 10.6 12.3 4.9 12.9 0.7 2.9 5.8 12.3 2.1 1.0 3.8 3.6 8.2 2.3 4.2 2.2 3.1 11.7 6.2 4.4 33.2 156.1 132.5 16.7 8.1 9.2 14.6 16.2 17.8 19.7 20.7 31.0 9.7 10.6 6.5 21.9 58.4 22.5 11.0 15.1 23.0 1.3 11.0 2.7 24.3 1.1 2.8 0.3 1.2 12.1 7.0 16.1 15.8 20.4 23.1 5.1 2.1 3.2 9.6 8.0 5.3 0.5 32.7 5.1 10.0 3.9 28.9 0.4 18.7 36.2 7.1 3.5 7.4 23.5 10.1 42.7 19.2 0.2 13.7 7.2 1.0 34.1 17.0 2.8 1.2 0.4 13.5 0.3 31.3 0.5 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.3 0.0 0.1 0.7 0.0 0.1 0.4 0.0 0.1 6.9 7.7 17.2 5.0 7.0 4.9 3.6 10.4 4.9 2.1 8.2 4.4 16.5 35.3 20.7 129.3 0.7 21.4 31.5 24.7 82.6 10.7 8.5 13.2 4.8 8.6 19.6 23.9 18.8 9.1 1.3 22.6 1.9 13.4 2.2 39.8 8.9 25.4 12.1 2.7 15.5 8.7 26.9 16.2 10.7 38.5 1.3 13.4 69.9 4.0 1.5 69.0 44.3 9.0 2.0 2.5 5.8 7.9 30.1 1.2 3.6 23.4 0.0 37.0 0.0 66.4 59.2 7.3 17.2 41.3 0.2 8.2 11.3 1.5 19.3 2.9 6.6 3.7 3.3 0.3 2.4 36.1 10.1 20.0 0.8 9.7 20.0 49.2 MKS1 "BBS13, FLJ20345, MKS, POC12" ENSG00000011143 "MKS transition zone complex subunit 1" Q9NXB0 17 58205441-58219605 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Respiratory ciliated cells: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021372, HPA021812" Enhanced NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA021372: AB_1848746, HPA021812: AB_2142654" "unprognostic (3.57e-1)" "unprognostic (4.12e-2)" "unprognostic (8.58e-2)" "unprognostic (3.06e-2)" "unprognostic (5.79e-2)" "unprognostic (5.05e-2)" "unprognostic (7.06e-3)" "unprognostic (6.27e-2)" "unprognostic (9.40e-2)" "unprognostic (4.64e-3)" "prognostic favorable (1.25e-4)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.33e-4)" "unprognostic (9.86e-3)" "unprognostic (4.25e-1)" "unprognostic (1.05e-1)" "unprognostic (3.21e-1)" 6.6 9.9 4.2 3.6 4.7 5.8 8.3 6.9 6.1 10.6 3.6 7.8 4.5 9.6 4.3 9.0 13.9 3.9 6.9 4.2 4.3 10.4 8.7 6.2 4.6 5.2 4.9 13.4 11.4 5.7 12.2 3.6 4.8 9.1 3.2 6.1 9.2 3.4 6.7 10.8 7.7 5.0 3.5 8.2 8.5 13.3 4.4 5.8 8.9 3.1 3.9 7.8 8.4 5.7 14.2 12.0 14.5 15.9 5.2 6.4 14.7 7.0 5.9 15.6 9.5 8.4 10.2 7.3 29.5 9.0 9.2 7.7 14.8 10.1 10.8 24.5 16.5 10.2 10.6 14.1 12.5 16.0 6.4 7.0 9.4 8.7 9.3 6.6 8.7 25.5 20.1 5.4 9.2 22.5 27.8 9.7 6.4 12.3 12.0 20.8 18.5 14.6 10.8 7.9 21.4 13.7 10.7 5.9 11.9 6.7 27.8 10.5 6.5 10.6 15.7 8.1 8.8 6.9 7.6 8.6 9.7 9.2 8.3 10.4 6.3 4.2 6.0 6.2 8.7 7.3 9.6 9.3 13.1 4.1 8.9 8.4 1.9 15.7 5.1 8.3 7.8 5.9 4.2 4.7 6.9 6.1 4.2 4.3 5.2 4.9 4.8 3.5 4.4 5.7 4.0 3.2 3.1 10.1 3.3 2.5 5.1 7.9 8.6 6.4 6.6 6.9 3.6 5.7 4.6 9.2 12.5 11.5 1.8 2.9 15.6 7.4 9.5 17.7 6.1 5.1 2.4 14.9 5.8 4.0 9.6 5.6 6.1 4.4 5.7 10.9 5.0 6.3 6.0 0.0 5.3 4.9 8.2 2.5 1.8 8.3 5.3 3.1 1.8 5.6 1.7 5.5 5.2 8.0 9.2 4.8 3.1 6.8 4.3 1.5 5.0 8.2 27.4 10.5 0.0 4.9 4.6 14.0 10.7 5.5 3.3 3.1 3.8 10.2 7.8 2.1 MLPH "exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a" ENSG00000115648 Melanophilin Q9BV36 2 237485428-237555322 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 135.9;salivary gland: 122.0" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 125.0;Alveolar cells type 2: 389.7;Gastric mucus-secreting cells: 251.8;granulocytes: 187.3;Intestinal goblet cells: 189.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "LHCN-M2: 142.9;MCF7: 255.4;SK-BR-3: 234.5;SK-MEL-30: 182.2;U-87 MG: 236.0" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA014685 Enhanced NA NA "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA014685: AB_1853997" "unprognostic (3.32e-3)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "prognostic favorable (5.14e-6)" "unprognostic (2.26e-4)" "unprognostic (1.36e-2)" "unprognostic (5.44e-2)" "unprognostic (2.66e-1)" "unprognostic (3.74e-3)" "unprognostic (8.16e-2)" "unprognostic (5.73e-2)" "unprognostic (3.16e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.34e-1)" "unprognostic (9.37e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-3)" 13.2 1.4 0.6 2.4 0.7 0.1 56.9 0.7 1.6 69.3 1.3 20.4 8.8 18.1 8.9 6.4 18.0 31.0 69.2 1.1 0.7 4.3 39.0 62.7 0.6 1.1 1.0 11.8 16.1 9.0 2.1 1.9 0.8 135.9 21.7 0.3 122.0 13.0 6.6 11.6 15.2 2.8 0.6 0.2 98.1 2.5 0.8 0.9 39.9 2.5 1.2 22.1 21.9 0.9 0.3 133.7 0.3 0.3 58.5 39.5 0.4 26.8 31.5 14.7 18.5 1.1 101.1 0.2 0.1 49.6 51.0 0.3 0.1 0.9 13.0 0.1 0.3 0.1 0.1 0.0 23.3 0.1 0.7 48.1 14.7 43.4 56.2 75.6 0.1 0.0 0.1 0.3 142.9 255.4 0.4 0.6 0.4 105.4 77.1 0.5 0.1 0.2 0.5 3.2 1.5 0.2 0.1 234.5 182.2 0.7 61.5 1.7 26.8 80.1 2.3 0.9 38.0 0.2 0.2 0.2 236.0 0.1 63.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.7 0.7 1.6 1.1 0.7 1.1 1.0 0.8 0.6 0.8 0.9 12.3 125.0 389.7 0.0 0.8 4.1 17.3 6.0 0.0 0.0 95.6 59.7 63.2 52.9 64.2 12.9 0.0 0.4 0.7 34.9 1.9 12.0 0.2 9.5 10.1 10.1 14.4 0.0 0.2 41.3 0.3 4.5 251.8 17.5 187.3 0.2 1.4 28.8 1.2 0.0 0.1 189.0 32.6 0.8 2.9 0.7 8.4 7.4 30.2 5.6 0.6 0.0 0.0 0.0 0.0 58.1 22.4 3.0 0.8 54.4 9.1 0.6 48.5 0.0 0.0 3.1 3.7 0.3 0.6 1.2 2.4 0.7 6.1 0.4 30.5 38.6 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209453 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: AB_2677701" "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 16.7 29.4 31.5 9.8 31.8 13.3 17.1 31.4 51.1 16.0 25.5 17.3 12.5 15.5 5.6 24.8 14.6 9.1 25.0 32.4 29.9 26.0 31.3 13.3 10.5 32.0 31.0 19.4 35.8 13.3 19.8 11.1 32.4 20.5 4.6 5.7 19.7 8.0 39.4 22.2 15.6 4.5 29.4 16.5 22.3 33.6 32.5 9.7 22.4 21.8 5.2 16.7 15.5 34.1 20.5 61.9 23.1 60.5 29.6 20.8 38.2 17.9 20.4 26.7 22.9 83.4 29.5 51.3 40.6 20.1 12.7 25.8 23.1 51.4 3.1 39.4 113.4 36.0 61.0 51.7 44.7 57.3 49.7 29.7 34.8 31.7 41.8 22.6 28.6 74.1 54.9 35.9 14.8 89.4 55.5 74.9 47.3 18.1 57.4 55.6 23.4 93.8 20.7 13.4 73.5 40.1 26.6 62.1 46.3 8.7 38.6 54.2 22.4 33.5 38.9 27.3 23.7 43.0 26.4 57.8 17.6 47.5 29.9 0.0 25.0 4.2 14.1 29.9 11.8 14.4 13.1 15.2 24.6 12.5 15.0 15.1 2.8 14.6 30.1 13.3 13.1 20.7 31.5 31.8 31.4 51.1 32.4 29.9 32.0 31.0 32.4 29.4 32.5 34.1 11.5 6.4 16.0 10.4 24.6 14.7 16.2 29.6 21.6 31.5 24.7 29.8 3.3 15.7 16.2 16.5 20.9 63.2 13.0 44.6 35.2 34.4 48.7 9.6 13.1 16.8 28.8 26.9 8.9 42.6 50.4 19.2 42.8 11.2 8.2 26.8 20.3 16.7 46.9 30.3 8.4 37.9 22.4 19.1 14.6 105.4 14.9 18.4 17.8 1.0 28.0 29.4 19.6 5.5 5.9 28.6 37.9 15.1 34.1 17.9 43.2 36.3 11.1 30.6 19.7 11.6 16.5 34.7 28.2 29.4 15.5 52.7 15.4 26.8 49.3 17.4 MMAB "cblB, CFAP23" ENSG00000139428 "Metabolism of cobalamin associated B" Q96EY8 12 109553715-109573580 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Transferase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 103.6" "Cell type enhanced" "Detected in all" "Hepatocytes: 225.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039017 Supported Approved Mitochondria NA NA "Cluster 44: Non-specific - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 15: Hepatocytes - Hemostasis" Mitochondria "HPA039017: AB_10673603" "unprognostic (1.16e-1)" "unprognostic (1.25e-2)" "unprognostic (1.90e-1)" "unprognostic (1.79e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "unprognostic (1.38e-1)" "unprognostic (4.22e-1)" "unprognostic (2.04e-2)" "unprognostic (5.15e-2)" "unprognostic (1.47e-3)" "unprognostic (2.58e-1)" "prognostic favorable (1.55e-4)" "unprognostic (4.90e-2)" "unprognostic (1.51e-1)" "unprognostic (2.23e-1)" "unprognostic (9.65e-2)" 15.5 51.2 17.8 6.3 18.3 5.8 15.8 18.8 26.9 12.4 18.6 15.8 13.0 10.7 21.2 29.1 13.0 6.0 30.0 17.0 18.8 32.8 103.6 14.9 6.2 22.2 19.0 18.9 23.0 9.8 20.5 4.9 21.3 26.5 7.9 7.3 17.1 6.3 21.1 18.2 14.0 5.6 19.0 12.4 17.7 12.6 18.9 5.5 22.1 16.2 6.5 14.1 14.7 22.9 32.2 22.3 22.2 17.6 8.8 17.7 11.3 7.1 16.2 10.3 10.8 25.8 29.5 21.0 19.9 8.0 19.1 32.9 14.6 54.9 4.6 8.2 60.9 8.6 15.9 42.1 31.3 18.4 7.2 24.0 33.5 22.2 9.7 12.3 9.7 16.4 27.5 15.5 7.3 74.7 16.6 29.2 27.3 3.3 31.6 13.6 8.7 53.9 45.3 30.3 34.1 14.8 15.8 29.2 12.7 6.2 60.5 50.5 5.4 8.6 3.6 6.1 10.4 11.9 9.6 24.0 19.0 22.2 23.9 7.4 7.2 1.0 15.3 10.0 12.2 13.6 11.1 12.1 11.3 17.8 15.2 14.6 1.9 11.2 10.9 9.2 5.8 10.3 17.8 18.3 18.8 26.9 17.0 18.8 22.2 19.0 21.3 19.0 18.9 22.9 25.1 35.3 80.8 9.8 20.4 10.3 33.1 105.6 17.1 32.9 59.6 47.0 52.3 60.1 68.9 42.3 29.2 55.4 15.2 33.6 150.6 49.7 41.3 23.8 10.0 22.1 33.0 34.1 6.4 71.3 37.6 24.7 28.5 16.5 16.5 34.3 28.5 225.3 34.8 104.3 8.5 50.4 71.2 20.4 10.2 82.9 40.4 13.5 26.6 4.7 25.1 30.6 30.9 6.6 21.5 29.7 30.0 30.5 18.1 31.8 61.9 143.6 62.1 29.7 13.1 17.9 26.3 26.0 15.8 44.7 19.7 61.8 16.1 121.1 56.6 30.3 MORC4 "FLJ11565, ZCW4, ZCWCC2" ENSG00000133131 "MORC family CW-type zinc finger 4" Q8TE76 X 106813871-107000212 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 79.9" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 131.4;Alveolar cells type 2: 130.4;Cytotrophoblasts: 329.8;Syncytiotrophoblasts: 257.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 121.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000395, HPA015547, HPA050250" Enhanced Enhanced Nucleoplasm NA NA "Cluster 42: Non-specific - Transcription" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063" "prognostic unfavorable (3.56e-5)" "unprognostic (3.30e-3)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (1.40e-1)" "unprognostic (6.29e-3)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.47e-1)" "unprognostic (2.30e-2)" "unprognostic (5.56e-2)" "unprognostic (8.59e-2)" "unprognostic (1.60e-1)" "unprognostic (1.60e-2)" "unprognostic (6.57e-2)" "unprognostic (4.89e-2)" "unprognostic (8.69e-2)" 13.4 30.9 24.8 7.8 35.5 11.8 12.2 47.8 51.0 12.1 17.8 8.5 10.4 11.5 16.3 9.6 10.4 10.1 7.0 32.4 22.4 10.8 21.1 8.8 5.6 11.1 11.4 17.4 15.1 11.7 6.2 79.9 16.6 12.4 10.8 22.3 10.9 11.5 20.2 18.7 10.0 11.4 3.9 6.0 8.4 20.2 16.6 5.6 10.2 10.3 7.0 7.5 11.1 55.7 29.8 121.0 11.4 26.4 35.0 40.3 60.5 28.7 30.8 14.6 18.3 64.6 13.1 3.7 14.2 30.5 23.9 22.5 39.8 25.5 17.1 4.6 23.0 6.4 40.7 27.1 25.6 4.7 13.9 20.8 24.3 19.6 28.6 85.7 13.1 4.1 3.9 41.4 32.7 26.7 10.7 6.4 8.9 82.0 45.2 4.2 22.9 4.3 47.0 23.3 9.2 11.5 35.4 33.9 23.0 15.9 19.7 5.0 12.6 22.5 21.4 44.7 15.7 11.1 16.2 11.5 24.0 3.8 16.2 8.3 1.5 1.8 1.9 1.3 1.7 1.7 1.9 1.5 0.7 2.7 2.1 1.7 3.7 1.5 1.7 2.5 1.5 0.4 24.8 35.5 47.8 51.0 32.4 22.4 11.1 11.4 16.6 3.9 16.6 55.7 8.6 131.4 130.4 6.2 5.1 17.5 19.1 4.9 21.1 5.4 11.5 9.5 3.0 10.0 61.8 5.5 4.2 329.8 10.4 3.6 21.5 9.9 0.9 6.2 11.5 13.6 1.8 0.4 4.2 7.4 28.2 33.4 10.2 15.5 66.3 10.3 7.5 24.0 23.4 1.7 6.5 10.5 6.1 2.1 5.0 1.8 11.1 8.2 12.4 3.7 0.3 6.7 3.1 15.1 8.7 7.5 6.7 11.7 5.8 16.4 4.4 12.7 62.2 7.2 26.3 16.9 12.0 9.9 26.6 19.7 16.1 257.8 11.9 10.1 10.1 11.8 MPG MDG ENSG00000103152 "N-methylpurine DNA glycosylase" P29372 16 77007-85851 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006531 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA006531: AB_1854075" "unprognostic (1.78e-2)" "unprognostic (8.48e-2)" "unprognostic (9.99e-2)" "prognostic favorable (2.82e-5)" "unprognostic (8.54e-2)" "unprognostic (3.27e-1)" "unprognostic (2.75e-2)" "unprognostic (1.63e-1)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (1.85e-2)" "unprognostic (1.83e-2)" "unprognostic (1.39e-2)" "unprognostic (1.86e-3)" "unprognostic (3.88e-2)" "unprognostic (1.86e-2)" "unprognostic (3.26e-1)" 45.6 63.1 28.6 24.5 28.4 32.8 45.8 28.3 43.8 45.5 25.8 43.0 23.7 46.6 9.4 39.8 40.4 27.5 59.7 28.1 28.7 33.6 66.9 44.6 40.4 27.4 27.5 43.1 59.2 11.9 44.4 21.2 27.4 50.3 7.6 2.0 55.6 21.2 69.2 37.9 37.1 14.7 28.3 53.0 46.8 16.2 29.5 14.2 46.6 21.1 15.1 46.7 38.4 28.5 50.2 70.4 18.1 54.9 34.1 77.2 51.9 78.0 95.1 44.1 49.3 44.2 61.5 40.2 65.0 39.8 20.5 64.7 13.1 30.4 6.7 67.6 59.3 25.3 34.3 67.1 99.3 25.4 141.9 75.4 41.9 50.0 20.4 57.4 80.0 39.9 56.1 58.6 57.8 167.5 43.6 118.1 36.4 27.3 86.1 84.2 25.7 140.5 37.5 17.1 15.5 42.5 41.0 36.2 91.9 8.3 54.1 119.4 80.6 34.1 47.9 49.4 34.4 67.7 23.6 49.6 67.8 71.2 129.9 47.3 75.3 80.9 60.6 56.6 55.0 92.5 57.1 60.3 80.3 85.9 42.5 43.7 38.9 130.2 47.6 110.3 90.8 67.0 28.6 28.4 28.3 43.8 28.1 28.7 27.4 27.5 27.4 28.3 29.5 28.5 72.6 3.2 25.6 14.0 73.9 35.8 82.9 102.9 47.8 13.8 76.8 80.4 1.3 37.1 63.0 40.5 4.2 78.7 74.2 59.1 33.2 76.4 9.9 33.5 63.1 59.3 49.8 39.9 14.2 114.2 89.4 78.7 43.8 36.1 56.3 57.1 62.8 55.6 89.8 10.1 13.9 92.5 83.4 69.4 43.7 5.0 65.9 55.6 56.9 10.3 77.9 39.8 66.9 14.1 12.9 134.8 78.6 57.9 80.1 110.6 83.1 67.7 43.5 11.4 85.5 51.5 73.3 15.1 36.7 53.9 41.1 61.8 59.8 197.2 68.3 114.0 MPV17L2 "FKSG24, MGC12972" ENSG00000254858 "MPV17 mitochondrial inner membrane protein like 2" Q567V2 19 18193218-18196948 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043111 Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" "HPA043111: AB_10794176" "unprognostic (3.71e-1)" "unprognostic (2.75e-3)" "unprognostic (5.52e-2)" "unprognostic (1.28e-1)" "unprognostic (6.74e-2)" "unprognostic (8.23e-2)" "unprognostic (4.41e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (9.93e-3)" "unprognostic (5.21e-2)" "unprognostic (1.99e-1)" "prognostic favorable (2.30e-4)" "unprognostic (1.62e-1)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (5.20e-2)" 9.2 22.3 10.5 6.4 11.1 3.9 9.7 10.6 12.5 7.3 10.5 15.6 5.3 8.9 8.9 9.2 9.1 4.6 19.3 10.4 11.0 14.5 22.1 9.3 7.1 11.2 11.3 8.8 12.6 10.1 11.8 4.8 11.3 10.7 5.0 4.3 9.5 9.9 15.4 9.3 9.7 7.4 11.0 10.4 13.8 6.8 11.2 5.6 10.0 16.5 7.1 10.8 6.9 11.9 13.7 15.3 15.7 23.1 11.1 7.0 31.3 17.7 16.6 31.9 28.7 17.3 12.5 17.3 34.3 10.9 23.3 15.9 29.4 22.1 15.3 12.7 36.2 13.5 11.0 22.9 17.8 17.4 19.7 10.0 18.2 18.4 21.5 5.9 14.4 26.2 28.4 17.1 16.3 48.2 26.3 19.6 19.3 31.2 59.3 22.6 13.8 24.0 20.8 9.2 17.8 13.2 15.6 21.7 14.3 10.9 9.4 16.0 13.3 18.3 9.5 56.8 20.5 13.3 26.6 26.0 12.6 29.0 19.6 13.4 19.4 18.2 16.1 27.1 19.3 25.8 12.7 12.6 25.3 16.2 10.2 12.9 5.5 18.3 19.0 24.2 18.0 11.9 10.5 11.1 10.6 12.5 10.4 11.0 11.2 11.3 11.3 11.0 11.2 11.9 9.5 6.4 3.9 2.9 14.1 10.6 5.8 10.3 15.4 8.1 14.2 11.8 8.2 7.2 7.8 11.0 2.1 22.0 9.4 5.8 23.5 17.9 1.4 3.2 7.4 11.5 6.6 2.5 1.2 26.0 29.4 7.0 5.1 6.1 1.3 6.4 5.7 7.8 18.5 6.7 1.1 9.5 12.2 6.3 24.5 0.2 3.4 13.0 12.4 3.7 32.3 7.8 8.2 3.0 3.3 22.5 6.2 5.3 14.9 10.1 6.2 8.2 2.1 9.8 0.0 3.0 9.7 9.1 8.4 5.4 11.1 22.8 6.6 12.8 9.8 3.9 MREG "DSU, FLJ10116, WDT2" ENSG00000118242 Melanoregulin Q8N565 2 215942584-216034096 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.9" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 60.5;Glandular and luminal cells: 34.1;Rod photoreceptor cells: 40.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 82.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068583 Approved Vesicles NA NA "Cluster 6: Non-specific - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Vesicles "HPA068583: AB_2686009" "unprognostic (4.53e-2)" "unprognostic (1.12e-1)" "unprognostic (3.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.24e-1)" "unprognostic (1.13e-2)" "unprognostic (3.70e-1)" "unprognostic (7.37e-2)" "unprognostic (2.39e-1)" "unprognostic (5.85e-3)" "unprognostic (8.11e-3)" "unprognostic (8.93e-2)" "unprognostic (6.38e-3)" "unprognostic (6.62e-3)" "unprognostic (6.92e-2)" "prognostic favorable (4.20e-4)" "unprognostic (9.99e-2)" 5.9 8.2 3.9 5.4 8.9 5.9 21.4 17.9 5.6 6.7 6.2 5.6 6.4 3.4 5.0 29.8 5.8 2.8 0.7 4.6 4.5 5.4 17.8 10.3 10.8 5.6 4.7 2.5 2.2 7.3 7.6 7.7 5.9 2.4 5.8 46.9 4.9 6.1 2.7 20.2 5.5 1.8 3.3 4.4 6.8 1.1 6.5 9.9 6.6 0.9 15.1 5.5 14.3 5.0 20.9 5.1 5.9 3.5 3.9 2.1 13.1 7.0 5.6 4.6 8.9 24.3 15.5 6.7 6.0 4.3 11.5 13.0 17.9 26.5 10.1 14.1 15.1 10.6 5.6 43.5 2.3 6.0 3.9 3.9 11.2 5.3 7.4 4.6 4.0 15.2 5.3 17.8 2.9 82.8 17.0 5.7 23.3 12.4 4.8 9.8 13.9 10.7 12.3 29.3 16.4 8.6 4.4 36.4 40.3 13.7 20.2 2.8 0.5 9.8 2.5 5.0 10.7 23.0 15.3 17.5 6.0 22.2 7.5 1.6 0.1 0.2 0.7 0.1 1.2 1.1 0.6 1.1 0.1 0.6 0.3 0.5 0.8 0.8 0.2 2.1 1.0 0.1 3.9 8.9 17.9 5.6 4.6 4.5 5.6 4.7 5.9 3.3 6.5 5.0 0.6 3.2 13.4 7.8 4.3 2.7 12.1 0.6 9.6 14.4 24.1 12.1 0.8 2.8 9.2 7.3 60.5 21.7 8.5 3.8 3.9 3.2 0.3 14.0 1.9 1.1 1.8 2.1 21.1 2.5 4.7 1.8 5.6 34.1 1.3 0.6 1.4 8.3 13.4 1.7 21.4 1.8 2.0 0.8 3.0 0.0 2.5 4.0 5.4 6.5 21.3 7.6 2.1 8.5 12.8 7.5 4.6 7.5 7.0 7.0 3.1 1.1 3.0 40.1 6.6 1.2 1.2 1.1 4.6 28.7 1.6 25.9 4.0 1.0 2.9 22.6 MRPL28 "MAAT1, p15" ENSG00000086504 "Mitochondrial ribosomal protein L28" Q13084 16 366969-371289 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030594, CAB033542, HPA055589" Supported Supported Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria "CAB033542: AB_2145899, HPA030594: AB_10601136, HPA055589: AB_2682855" "unprognostic (2.39e-1)" "unprognostic (7.39e-3)" "unprognostic (1.53e-1)" "unprognostic (1.26e-1)" "unprognostic (2.15e-2)" "unprognostic (9.92e-2)" "unprognostic (2.92e-1)" "unprognostic (3.45e-3)" "unprognostic (6.76e-2)" "unprognostic (1.73e-1)" "unprognostic (7.69e-2)" "unprognostic (1.71e-1)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (4.36e-1)" "unprognostic (2.60e-1)" "unprognostic (6.56e-2)" 43.3 63.2 43.2 25.8 46.6 43.7 43.6 41.6 55.9 40.8 39.9 48.9 31.4 47.0 20.6 58.0 39.4 23.3 101.0 46.9 42.7 74.9 79.9 38.7 30.4 41.2 41.7 36.4 32.2 46.6 44.0 21.1 42.5 45.3 18.1 20.4 37.9 23.8 87.6 45.9 43.0 25.8 41.2 52.2 43.8 85.2 42.2 36.8 44.2 59.3 27.1 43.1 42.3 43.9 72.8 135.8 68.3 82.9 37.9 48.6 90.1 82.6 107.3 147.2 143.2 175.4 95.9 105.5 88.6 85.0 75.3 87.6 107.8 172.6 78.2 95.4 211.8 78.7 110.0 149.2 123.9 98.1 96.1 73.8 84.6 136.3 110.5 69.0 109.5 99.5 143.8 75.6 93.0 249.0 152.9 98.2 109.1 72.3 82.5 181.7 85.2 149.1 121.4 41.3 115.2 102.4 102.5 100.3 84.6 66.4 131.1 92.4 85.5 86.0 118.6 70.8 92.4 111.1 100.3 143.0 60.0 68.4 140.8 95.4 105.7 122.1 71.0 107.2 59.1 93.3 62.0 68.9 96.6 105.0 43.0 54.7 120.5 79.3 115.1 119.0 125.8 97.9 43.2 46.6 41.6 55.9 46.9 42.7 41.2 41.7 42.5 41.2 42.2 43.9 44.2 38.5 34.1 8.5 43.6 34.7 50.4 134.5 25.6 34.8 35.6 36.4 55.4 40.0 69.0 69.9 8.4 87.0 46.8 70.2 193.7 112.5 97.7 35.3 30.0 44.9 64.1 51.3 5.8 111.9 108.0 41.2 37.2 31.2 26.6 57.2 47.2 66.6 99.7 28.6 5.0 54.6 77.3 66.5 36.1 232.6 38.2 47.8 71.2 2.8 136.1 56.1 45.3 3.0 5.4 107.0 76.5 38.4 47.2 46.7 106.3 180.0 55.4 42.5 39.5 31.0 61.9 122.2 50.5 38.9 32.4 45.8 37.1 86.6 65.8 52.9 MRPL38 "HSPC262, MGC4810, MRP-L3, RPML3" ENSG00000204316 "Mitochondrial ribosomal protein L38" Q96DV4 17 75898644-75905093 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 34.7;Gastric mucus-secreting cells: 35.2;Plasma cells: 60.1;Squamous epithelial cells: 46.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023054, HPA023135" Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Mitochondria "HPA023054: AB_1854109, HPA023135: AB_1854110" "unprognostic (1.17e-1)" "unprognostic (3.77e-3)" "unprognostic (1.83e-1)" "unprognostic (3.68e-3)" "unprognostic (2.47e-2)" "unprognostic (1.50e-2)" "unprognostic (4.44e-2)" "unprognostic (1.61e-1)" "unprognostic (7.59e-2)" "unprognostic (5.24e-2)" "prognostic favorable (4.23e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (5.58e-4)" "unprognostic (3.06e-2)" "unprognostic (2.40e-1)" "unprognostic (3.72e-1)" "prognostic favorable (9.21e-5)" 23.3 34.7 37.5 16.3 37.4 21.9 22.8 39.7 48.9 20.2 37.8 31.1 26.8 24.0 14.4 30.0 30.6 14.6 51.5 37.7 38.2 31.3 46.8 18.2 23.8 39.4 37.6 22.3 36.8 28.7 19.6 17.3 39.8 22.6 19.2 6.7 36.6 26.2 103.2 26.9 21.9 20.3 38.1 22.5 28.6 25.3 40.4 23.8 20.6 84.7 22.4 25.9 21.0 38.6 82.2 114.2 28.3 39.2 32.5 26.5 86.5 26.4 44.5 96.3 69.5 134.4 49.3 72.7 31.2 45.9 55.1 59.1 79.2 71.1 27.3 24.0 130.5 51.0 39.9 133.7 72.0 69.5 48.6 36.6 77.3 66.8 52.4 29.3 92.6 89.7 64.6 45.6 36.6 163.0 92.9 75.1 33.6 101.8 97.2 69.1 74.7 92.3 76.3 51.0 48.6 51.4 45.3 121.3 104.5 26.1 112.4 74.4 26.3 45.8 67.2 38.6 75.4 51.1 32.1 24.7 50.0 57.1 41.3 24.4 74.1 37.9 84.2 80.8 84.0 101.8 86.0 79.1 106.7 113.7 84.8 81.7 7.0 95.7 69.1 78.1 93.7 83.6 37.5 37.4 39.7 48.9 37.7 38.2 39.4 37.6 39.8 38.1 40.4 38.6 1.7 19.2 7.3 14.7 19.3 1.5 0.8 2.7 34.7 1.0 2.4 1.1 2.3 0.0 5.5 3.7 0.0 5.1 6.6 11.4 3.9 23.8 1.1 2.2 1.8 4.7 10.3 20.2 11.9 21.4 3.7 8.1 35.2 1.8 3.8 1.0 2.5 2.4 3.3 1.7 13.2 13.9 2.0 0.8 1.9 1.9 3.1 6.1 7.2 5.6 14.2 0.9 5.2 7.5 15.7 19.2 17.9 3.0 60.1 1.3 16.3 5.6 9.8 2.9 0.0 0.9 8.3 1.9 1.9 46.2 1.4 3.4 13.6 1.2 20.9 0.8 MRPL41 "BMRP, MRP-L27, MRPL27, PIG3, RPML27" ENSG00000182154 "Mitochondrial ribosomal protein L41" Q8IXM3 9 137551879-137552555 "Predicted intracellular proteins, Ribosomal proteins" "Apoptosis, Cell cycle" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 340.5;skeletal muscle: 407.5" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 909.5;Distal tubular cells: 972.4;Hepatocytes: 856.2;Late spermatids: 839.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 503.2;PC-3: 471.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024550, HPA027160" Supported Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA024550: AB_1854112, HPA027160: AB_1854113" "unprognostic (3.92e-1)" "unprognostic (1.61e-2)" "unprognostic (6.92e-2)" "unprognostic (1.22e-3)" "unprognostic (5.86e-3)" "unprognostic (8.04e-2)" "unprognostic (2.05e-1)" "unprognostic (1.60e-1)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "unprognostic (4.83e-3)" "unprognostic (3.24e-2)" "unprognostic (2.06e-3)" "unprognostic (3.28e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" 83.7 74.7 222.0 22.9 206.1 26.1 57.4 203.8 340.5 53.9 169.2 66.4 45.4 45.9 8.4 42.4 46.6 14.8 325.4 210.3 190.6 79.8 157.8 42.1 24.6 209.0 190.7 61.1 44.8 42.2 55.1 12.2 187.9 113.0 17.4 9.9 69.6 26.2 407.5 58.6 56.8 12.2 183.4 54.2 79.1 40.3 227.1 16.1 44.9 129.4 13.1 59.4 45.4 188.9 93.7 165.9 25.5 61.9 40.7 35.5 122.1 112.8 33.1 59.1 47.4 122.6 49.6 71.0 148.4 31.5 78.0 186.5 37.4 60.0 6.4 97.9 208.6 62.0 91.9 193.6 92.8 101.1 211.4 67.3 85.4 51.5 18.2 23.4 55.4 58.7 147.8 26.8 32.6 503.2 33.7 337.6 94.6 118.0 471.6 40.1 44.0 95.9 50.5 67.7 85.7 88.6 78.0 138.6 194.5 15.2 124.0 91.5 95.4 93.1 121.3 162.9 153.4 78.4 146.2 133.7 101.8 104.4 70.9 425.2 305.5 251.8 225.6 272.9 211.5 313.8 235.0 257.0 260.3 249.7 221.0 206.2 38.3 180.8 254.2 422.6 332.2 350.3 222.0 206.1 203.8 340.5 210.3 190.6 209.0 190.7 187.9 183.4 227.1 188.9 99.0 28.9 33.6 59.7 90.7 140.1 138.3 239.3 121.3 52.4 193.9 221.5 909.5 178.7 121.1 263.0 10.4 115.9 89.7 670.5 972.4 157.8 299.6 165.2 136.0 103.1 268.5 66.0 30.6 192.1 147.7 127.1 192.7 136.7 54.0 85.4 102.1 856.2 244.8 28.6 47.7 332.9 229.9 122.7 115.4 839.0 121.8 106.0 224.1 15.9 162.1 102.7 95.8 8.0 31.1 222.8 446.5 104.6 146.9 223.1 458.4 657.6 134.9 47.5 111.7 66.8 143.8 112.6 79.7 175.6 166.1 82.2 112.8 249.9 348.8 176.8 MRPL53 ENSG00000204822 "Mitochondrial ribosomal protein L53" Q96EL3 2 74471982-74472687 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034612, HPA056185" Uncertain Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA034612: , HPA056185: AB_2683060" "unprognostic (2.22e-2)" "unprognostic (1.94e-2)" "unprognostic (2.81e-2)" "unprognostic (1.81e-1)" "unprognostic (2.04e-1)" "unprognostic (2.88e-2)" "prognostic unfavorable (7.36e-5)" "unprognostic (3.60e-2)" "unprognostic (1.24e-1)" "unprognostic (4.06e-2)" "prognostic favorable (1.37e-4)" "unprognostic (1.26e-1)" "prognostic unfavorable (1.16e-8)" "unprognostic (8.76e-2)" "unprognostic (2.79e-1)" "unprognostic (4.13e-1)" "unprognostic (2.45e-2)" 60.9 82.9 68.8 46.8 72.2 61.8 38.9 77.0 98.9 31.3 79.2 41.5 48.0 28.7 39.1 41.0 50.2 34.0 114.4 67.1 72.3 54.5 65.1 34.2 78.4 72.3 69.3 61.5 118.0 72.1 35.1 34.8 72.7 46.0 20.3 27.1 107.1 36.2 169.7 27.3 45.9 24.4 74.2 54.7 55.0 23.1 70.2 50.3 47.1 89.0 42.3 44.7 27.0 76.5 101.5 271.0 60.0 58.5 77.9 69.7 103.4 79.8 73.7 70.5 60.9 224.7 130.1 87.6 78.8 61.4 97.3 76.3 32.5 105.7 24.5 174.6 188.3 77.7 115.6 133.7 70.7 88.4 85.6 96.7 75.1 90.4 59.0 82.3 75.3 109.0 93.0 156.6 63.8 316.5 118.6 163.3 57.5 166.0 204.5 89.1 196.0 212.9 88.9 115.6 103.5 128.0 74.1 195.6 137.3 40.8 102.3 111.1 83.6 115.9 119.6 101.7 135.2 292.3 260.6 141.1 116.4 94.8 125.8 244.9 293.8 133.8 168.2 277.6 188.5 350.0 215.9 173.1 250.3 367.5 282.0 211.4 185.5 167.6 271.8 360.3 275.3 345.5 68.8 72.2 77.0 98.9 67.1 72.3 72.3 69.3 72.7 74.2 70.2 76.5 5.2 9.6 23.2 4.6 18.0 17.2 6.0 9.7 12.0 2.0 24.0 16.4 1.6 4.3 12.1 11.0 0.0 14.7 10.5 29.5 21.5 32.8 8.9 7.2 4.3 11.2 39.7 18.9 3.4 56.9 17.5 10.9 15.3 4.7 33.6 3.0 16.1 23.8 18.0 1.7 3.5 27.2 6.1 25.9 23.9 2.3 8.7 15.6 26.6 2.8 35.8 4.6 15.5 2.0 7.1 35.8 43.5 4.5 34.8 4.9 41.8 45.3 46.1 4.0 6.6 7.7 11.2 11.2 6.8 16.6 25.1 15.7 14.6 3.3 21.7 6.9 MRPL57 MRP63 ENSG00000173141 "Mitochondrial ribosomal protein L57" Q9BQC6 13 21176658-21179084 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 719.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039779, HPA059370" Supported Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA039779: AB_10673362, HPA059370: AB_2683993" "unprognostic (1.00e-1)" "unprognostic (1.92e-1)" "unprognostic (4.32e-2)" "unprognostic (9.57e-3)" "unprognostic (1.51e-1)" "unprognostic (5.54e-2)" "unprognostic (1.47e-1)" "unprognostic (1.68e-1)" "unprognostic (2.64e-1)" "unprognostic (1.68e-2)" "prognostic favorable (8.35e-4)" "unprognostic (7.65e-2)" "unprognostic (2.01e-1)" "unprognostic (5.72e-2)" "unprognostic (1.32e-1)" "unprognostic (1.10e-1)" "unprognostic (6.78e-2)" 13.6 27.0 16.0 8.4 16.1 11.0 13.9 16.8 18.3 12.1 15.3 17.2 10.8 12.9 11.7 17.6 13.4 5.2 28.1 16.7 20.5 24.7 29.1 11.7 8.8 16.8 17.0 16.1 16.9 15.3 27.9 7.1 16.9 17.9 6.8 15.5 14.9 8.4 38.8 14.9 13.7 5.6 16.3 14.8 16.2 11.8 17.3 17.0 16.4 18.3 6.6 14.8 12.4 16.5 16.9 30.3 20.8 19.0 15.6 12.8 21.9 20.0 12.4 18.5 13.9 39.6 30.6 9.7 22.7 12.5 14.5 28.7 18.3 19.0 13.9 25.8 30.8 44.2 21.3 45.3 23.2 24.6 21.3 13.2 20.8 14.8 13.9 11.2 17.9 39.0 19.5 12.4 13.2 59.3 53.7 64.8 15.1 54.8 35.0 32.1 31.4 17.2 23.1 20.3 41.4 19.4 16.2 20.1 31.2 14.0 20.2 22.8 12.6 9.6 17.9 20.5 17.9 17.2 14.9 17.7 8.6 28.5 24.6 51.1 70.4 56.3 49.8 59.0 56.4 63.1 62.4 53.2 64.0 60.5 69.6 55.6 10.4 54.5 50.4 102.2 70.2 72.4 16.0 16.1 16.8 18.3 16.7 20.5 16.8 17.0 16.9 16.3 17.3 16.5 93.3 80.1 124.4 12.1 95.4 0.0 107.2 0.0 84.2 88.3 172.1 195.7 495.7 140.2 56.3 176.6 45.9 233.6 118.8 171.7 508.7 159.8 256.0 188.6 98.8 91.6 149.5 165.6 16.8 245.1 205.0 94.2 116.2 107.6 72.2 104.5 117.8 478.4 231.4 77.4 21.3 218.9 0.0 126.6 0.0 341.6 115.2 104.1 0.0 8.4 166.2 181.4 109.2 6.6 17.9 171.6 190.7 98.9 141.9 160.4 266.5 719.5 80.9 100.7 52.6 69.0 74.0 83.6 48.9 175.7 0.0 223.1 99.0 179.5 204.1 112.2 MRPL9 ENSG00000143436 "Mitochondrial ribosomal protein L9" Q9BYD2 1 151759647-151763496 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008579 Approved Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA008579: AB_1079412" "unprognostic (2.55e-1)" "unprognostic (1.75e-1)" "unprognostic (2.34e-1)" "unprognostic (7.43e-3)" "unprognostic (7.66e-2)" "unprognostic (2.73e-1)" "prognostic unfavorable (1.04e-7)" "unprognostic (1.47e-1)" "unprognostic (5.22e-2)" "unprognostic (9.51e-3)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (1.44e-5)" "unprognostic (1.79e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (6.30e-2)" 33.2 27.6 26.2 28.6 27.3 41.1 33.5 29.5 29.3 28.7 24.9 35.1 27.0 33.0 30.9 32.2 28.8 21.2 31.0 26.9 29.4 35.6 29.8 25.4 39.9 28.4 27.7 32.6 30.4 49.0 22.6 29.1 28.2 30.8 28.0 18.1 40.4 28.6 71.3 35.1 29.4 28.9 28.2 32.2 30.7 24.5 27.4 46.5 30.8 55.3 38.8 32.2 28.4 28.8 120.3 98.6 63.8 74.6 44.9 50.5 103.9 66.4 62.7 102.3 80.5 151.9 113.3 79.5 126.7 67.8 65.7 106.3 111.8 84.8 81.6 107.3 107.2 64.0 81.7 99.5 71.4 177.1 56.7 56.3 77.7 89.7 113.6 68.3 100.2 119.7 133.3 104.4 80.5 284.6 112.9 134.8 134.6 139.4 141.1 93.6 74.0 155.7 63.0 96.5 103.2 108.2 79.5 113.1 98.7 88.6 169.4 210.1 69.4 79.2 79.5 66.6 149.5 113.2 168.1 252.5 96.2 116.8 91.7 58.1 42.7 29.5 82.0 54.4 94.7 96.2 94.4 96.3 98.7 89.0 89.1 84.8 5.2 85.4 49.0 83.0 122.0 73.5 26.2 27.3 29.5 29.3 26.9 29.4 28.4 27.7 28.2 28.2 27.4 28.8 31.5 28.9 21.8 8.1 41.0 31.4 48.0 52.9 30.7 19.9 46.2 51.3 4.3 28.6 38.1 33.1 6.2 98.4 43.4 17.2 64.6 69.6 100.0 21.9 27.6 43.8 28.7 39.5 7.5 64.4 124.4 29.2 19.4 22.1 41.1 44.8 43.9 28.4 65.6 18.5 7.7 31.6 42.7 32.4 38.2 36.0 39.1 26.6 35.6 3.7 64.0 32.1 54.6 7.1 7.8 67.1 24.6 47.0 26.9 44.6 29.5 86.8 33.4 19.8 72.3 37.6 35.5 56.3 36.4 33.0 31.7 74.6 43.9 42.5 46.8 40.2 MRPS11 "FLJ22512, FLJ23406, HCC-2" ENSG00000181991 "Mitochondrial ribosomal protein S11" P82912 15 88467453-88480776 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043752, HPA050345" Enhanced Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA043752: AB_2678653, HPA050345: AB_2681100" "unprognostic (2.66e-1)" "prognostic favorable (3.60e-4)" "unprognostic (6.51e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (3.21e-1)" "unprognostic (3.45e-1)" "unprognostic (1.44e-1)" "unprognostic (6.45e-2)" "prognostic favorable (4.75e-4)" "unprognostic (8.31e-2)" "unprognostic (3.37e-1)" "unprognostic (1.83e-1)" "unprognostic (9.44e-2)" "unprognostic (7.26e-2)" "unprognostic (7.85e-2)" "unprognostic (1.74e-1)" 9.4 16.9 12.0 4.0 12.1 2.8 8.6 12.8 18.3 5.3 11.4 9.3 7.9 5.3 3.8 10.9 4.8 4.5 26.1 12.5 12.1 14.0 20.5 5.2 5.6 12.7 12.3 3.5 10.5 3.8 7.6 2.3 12.9 7.4 3.5 2.5 6.0 3.4 24.7 7.2 7.4 4.3 11.7 8.0 9.6 9.0 12.7 5.1 9.6 15.0 4.4 8.4 5.6 12.1 10.5 41.1 6.1 10.4 13.8 6.6 16.1 8.3 14.6 10.7 11.5 28.9 16.0 9.7 17.0 7.1 11.3 14.8 17.9 11.5 5.5 12.8 43.8 13.2 23.1 32.0 16.5 4.5 8.3 13.4 11.1 9.2 9.2 5.8 14.3 12.3 9.6 4.3 18.1 45.1 9.3 19.0 16.3 13.4 43.8 19.0 11.6 23.0 15.5 28.4 19.3 9.6 8.6 21.6 33.6 5.3 19.8 24.7 6.8 15.2 16.8 9.9 12.5 8.5 16.5 11.7 18.3 11.2 16.3 31.1 25.1 19.3 15.1 27.6 17.6 27.5 17.2 17.8 29.5 18.2 18.1 17.6 9.5 30.1 17.8 31.9 35.1 26.0 12.0 12.1 12.8 18.3 12.5 12.1 12.7 12.3 12.9 11.7 12.7 12.1 42.1 6.4 20.4 10.4 30.4 22.8 27.5 69.2 31.9 36.9 38.1 47.2 6.3 35.8 39.6 46.0 47.9 91.0 34.6 85.5 135.0 63.9 30.2 27.1 37.8 34.2 24.7 40.6 14.0 66.8 89.7 32.7 25.0 32.5 33.6 40.4 44.6 92.6 90.5 26.9 15.0 60.3 50.8 33.1 24.5 34.2 33.2 31.0 32.0 8.4 65.0 44.4 72.1 16.6 16.8 67.0 70.7 42.5 36.5 32.2 90.8 145.3 29.7 45.1 19.7 29.7 51.8 90.3 42.0 49.1 28.3 89.6 32.3 96.0 64.6 34.5 MRPS12 "RPMS12, RPS12, RPSM12" ENSG00000128626 "Mitochondrial ribosomal protein S12" O15235 19 38930944-38933168 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 287.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 226.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046775, HPA050633" Uncertain NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA046775: AB_2679800, HPA050633: AB_2681195" "unprognostic (3.78e-1)" "unprognostic (8.43e-2)" "unprognostic (1.32e-1)" "unprognostic (2.15e-2)" "unprognostic (2.17e-2)" "unprognostic (5.98e-2)" "unprognostic (9.10e-3)" "unprognostic (6.95e-3)" "unprognostic (2.77e-2)" "unprognostic (5.25e-3)" "unprognostic (4.48e-2)" "unprognostic (7.94e-2)" "unprognostic (2.42e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (1.24e-1)" "unprognostic (4.55e-2)" 26.6 43.4 16.2 11.4 16.0 14.5 23.8 18.1 20.2 18.4 16.4 33.0 18.2 20.7 4.0 45.2 19.4 4.6 71.6 16.2 17.1 51.3 71.8 20.4 10.9 16.6 16.7 17.3 32.2 13.9 15.0 6.0 17.1 24.4 6.5 2.4 26.2 7.9 53.6 32.9 27.3 5.3 17.0 32.7 41.1 19.5 18.3 8.2 19.1 17.4 7.5 24.8 23.3 18.0 56.5 226.3 9.9 27.5 12.9 14.1 34.8 33.4 21.0 34.7 30.2 93.4 43.8 60.1 62.4 17.2 26.8 30.4 28.3 53.8 9.2 53.2 64.4 45.0 37.8 62.1 41.4 48.4 39.2 29.1 35.3 30.2 15.3 12.8 32.4 39.4 48.9 32.5 20.7 104.5 54.2 39.4 23.1 81.4 94.4 50.8 33.1 60.5 32.2 73.6 28.9 32.3 32.3 86.1 35.4 8.9 43.0 41.2 29.5 30.7 35.7 45.8 65.7 39.7 40.4 54.4 48.0 52.1 36.4 42.6 76.1 33.1 72.5 91.9 71.9 91.8 66.3 62.0 96.5 92.2 57.1 63.6 9.6 69.1 72.9 110.7 76.8 91.6 16.2 16.0 18.1 20.2 16.2 17.1 16.6 16.7 17.1 17.0 18.3 18.0 32.1 22.4 26.7 3.6 54.5 91.9 72.6 126.2 64.3 17.7 67.2 73.8 59.8 82.9 56.5 66.2 22.9 120.1 61.5 99.6 287.6 111.6 34.2 30.1 44.5 43.2 51.8 61.0 3.9 114.0 161.4 41.8 65.2 42.0 27.8 56.9 27.5 143.2 101.5 23.5 4.8 116.6 71.2 55.5 52.8 72.5 37.3 47.4 53.4 1.9 103.7 23.6 97.9 4.5 5.0 129.4 59.0 32.7 72.5 127.4 151.2 220.9 31.3 25.9 32.9 27.5 48.6 21.0 32.1 91.8 107.3 103.0 43.9 121.8 163.7 101.6 MRPS18C "CGI-134, FLJ11146, FLJ22967, MRPS18-1" ENSG00000163319 "Mitochondrial ribosomal protein S18C" Q9Y3D5 4 83455932-83469735 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050404 Approved NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA050404: AB_2681115" "unprognostic (4.53e-3)" "unprognostic (7.58e-3)" "unprognostic (5.70e-3)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (7.81e-3)" "unprognostic (1.43e-1)" "unprognostic (3.86e-2)" "unprognostic (8.19e-2)" "unprognostic (1.53e-2)" "unprognostic (5.25e-2)" "unprognostic (8.26e-3)" "prognostic favorable (2.90e-5)" "unprognostic (1.52e-2)" "unprognostic (9.86e-2)" "unprognostic (2.24e-2)" "unprognostic (8.31e-3)" 26.5 33.6 27.1 24.0 28.1 26.7 25.1 29.6 42.7 23.2 27.1 26.2 24.8 24.5 17.7 33.6 25.2 14.4 46.7 27.6 29.6 36.4 44.3 21.6 24.6 28.2 27.7 22.3 22.0 20.0 20.1 20.7 28.5 16.8 25.9 19.6 21.1 14.8 85.2 24.2 25.4 21.0 28.2 25.0 24.7 19.5 27.6 25.1 19.4 53.4 32.5 22.7 23.3 29.5 74.4 76.2 58.9 45.3 36.3 24.1 56.9 78.1 39.6 60.5 51.6 136.2 66.8 69.8 86.8 38.5 68.9 39.4 61.0 47.3 71.2 62.7 48.8 59.6 105.6 136.5 49.3 143.2 74.5 25.3 41.0 49.4 58.4 34.9 39.8 86.1 86.5 55.7 39.8 142.9 95.3 87.6 35.4 109.7 53.3 53.6 51.0 55.8 46.4 66.8 61.7 33.2 41.9 82.9 68.0 57.4 36.1 85.7 47.8 53.5 82.5 53.3 104.7 50.7 70.3 158.5 51.1 73.2 67.4 126.2 122.9 196.1 105.9 139.5 108.6 174.7 126.3 117.2 142.5 164.4 130.8 116.5 56.0 117.2 117.3 164.7 195.5 113.5 27.1 28.1 29.6 42.7 27.6 29.6 28.2 27.7 28.5 28.2 27.6 29.5 102.2 51.3 61.3 4.6 67.8 68.1 73.7 169.1 47.8 33.3 54.3 87.2 81.3 90.1 93.3 77.3 37.5 132.4 62.7 57.1 229.0 139.1 117.0 75.9 59.6 77.3 33.6 117.0 8.7 187.8 119.7 57.2 33.1 54.5 109.5 57.1 77.1 180.6 112.6 32.0 8.0 59.3 91.6 65.4 46.8 25.2 82.0 58.1 62.2 6.5 72.9 80.7 96.8 8.0 9.7 134.6 84.1 77.5 63.6 62.7 101.8 211.0 124.7 47.7 59.2 71.2 93.7 109.0 71.6 70.4 64.1 96.2 55.7 70.3 79.9 61.9 MRPS21 ENSG00000266472 "Mitochondrial ribosomal protein S21" P82921 1 150293861-150308979 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 863.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078289 Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA078289: AB_2686881" "unprognostic (3.48e-2)" "unprognostic (1.94e-2)" "unprognostic (5.46e-2)" "unprognostic (2.33e-1)" "unprognostic (2.88e-1)" "unprognostic (8.45e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (1.15e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (9.71e-2)" "unprognostic (7.59e-2)" "unprognostic (2.12e-2)" "unprognostic (4.02e-2)" "unprognostic (3.97e-2)" "unprognostic (1.46e-1)" 46.8 76.7 91.7 35.7 93.8 39.0 51.7 92.9 121.4 48.7 97.4 51.8 38.4 46.7 53.7 54.5 46.3 27.6 72.7 93.2 95.0 67.1 59.9 39.2 42.8 93.8 92.7 56.6 51.1 65.4 70.1 32.5 94.5 51.5 28.9 42.3 43.7 39.1 55.6 45.0 45.2 38.7 89.0 53.3 52.1 52.2 95.2 49.0 53.1 66.5 46.6 47.9 45.8 92.3 112.7 88.4 112.9 57.5 108.3 108.2 93.9 80.5 69.1 77.0 74.5 18.0 101.6 111.9 54.2 89.3 22.8 102.9 96.8 86.4 67.8 77.7 125.9 64.3 133.4 137.0 84.7 98.4 53.8 119.2 87.0 93.4 105.8 47.0 100.3 96.8 106.7 144.3 107.1 255.8 84.3 89.1 196.0 216.3 159.3 75.9 59.0 195.8 93.7 79.9 83.7 182.1 68.4 131.9 136.4 126.3 73.4 143.0 71.7 28.1 56.7 81.6 90.9 120.4 136.4 112.7 39.5 53.1 58.3 41.1 78.4 50.7 70.1 79.7 86.6 116.8 92.7 82.5 89.1 102.1 103.8 89.6 17.8 71.5 73.6 136.2 97.2 104.9 91.7 93.8 92.9 121.4 93.2 95.0 93.8 92.7 94.5 89.0 95.2 92.3 124.7 112.2 115.8 24.8 152.7 120.3 199.9 466.6 191.8 72.6 189.3 246.4 295.6 201.6 227.8 263.0 33.3 283.8 110.4 114.4 526.3 226.2 863.2 217.2 216.0 150.2 138.5 151.7 31.8 311.4 245.5 172.3 152.4 155.7 132.9 157.8 189.2 366.9 288.2 48.8 34.7 141.6 266.5 196.2 162.3 605.4 230.2 143.7 181.5 18.7 234.1 140.3 118.4 23.1 27.1 300.8 133.1 233.2 156.5 197.6 230.1 703.7 291.7 59.5 98.6 115.4 211.1 276.4 112.1 262.6 147.2 235.2 144.4 183.8 168.5 200.9 MRTFB "FLJ31823, MKL2, MRTF-B" ENSG00000186260 "Myocardin related transcription factor B" Q9ULH7 16 14071319-14266773 "Disease related genes, Predicted intracellular proteins" "Differentiation, Myogenesis, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Adipocytes: 43.9;Cardiomyocytes: 26.9;Cytotrophoblasts: 9.9;Endothelial cells: 9.6;Extravillous trophoblasts: 10.0;Smooth muscle cells: 14.9;Syncytiotrophoblasts: 10.4" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 170 "amygdala: 9.4;basal ganglia: 15.1;cerebral cortex: 21.4;hippocampal formation: 21.7" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011286 Enhanced Supported "Nuclear speckles" NA NA "Cluster 30: Non-specific - Translation" "Cluster 46: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear speckles" "HPA011286: AB_1853973" "unprognostic (2.00e-1)" "unprognostic (5.28e-1)" "unprognostic (1.30e-2)" "unprognostic (3.62e-1)" "unprognostic (7.16e-2)" "unprognostic (7.14e-3)" "unprognostic (1.21e-1)" "unprognostic (1.37e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-1)" "unprognostic (3.19e-1)" "unprognostic (2.32e-1)" "prognostic favorable (6.20e-4)" "unprognostic (5.22e-2)" "unprognostic (3.55e-1)" "unprognostic (2.47e-2)" "unprognostic (5.96e-2)" 21.4 7.3 9.4 8.6 15.1 3.8 18.3 0.0 21.4 19.0 0.0 9.9 9.7 14.9 9.1 14.5 14.0 13.3 11.8 21.7 0.0 8.4 5.9 13.2 7.6 0.0 0.0 7.1 12.1 22.2 4.9 21.7 0.0 15.5 10.8 8.6 11.6 15.2 11.9 16.6 7.9 15.6 0.0 5.1 10.1 17.5 0.0 10.3 16.9 14.5 8.1 11.3 12.2 0.0 17.6 17.8 17.8 13.2 5.9 11.0 8.0 4.9 13.3 7.4 10.6 7.7 16.4 9.4 12.4 8.4 9.3 13.8 12.9 14.4 13.5 23.1 7.0 6.0 13.6 13.3 8.2 4.2 5.4 8.4 14.6 12.8 8.3 7.8 14.7 12.2 7.9 9.7 5.6 15.1 13.4 2.8 6.0 4.7 4.8 20.5 13.7 8.1 7.3 17.3 6.2 10.8 23.9 10.2 4.9 8.2 18.0 3.5 9.4 15.3 14.9 4.4 6.4 6.6 8.8 8.4 16.6 7.1 11.7 0.2 0.5 0.0 1.1 0.7 1.7 3.7 1.9 0.9 0.7 1.5 2.4 1.3 0.3 1.1 0.8 1.7 0.9 0.6 9.4 15.1 0.0 21.4 21.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.9 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.9 0.0 0.0 0.0 0.0 9.9 1.5 0.0 0.0 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 10.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.0 0.0 0.0 0.0 10.4 0.4 0.0 0.0 0.0 MSRB1 "SelR, SelX, SepR, SEPX1" ENSG00000198736 "Methionine sulfoxide reductase B1" Q9NZV6 16 1938229-1943293 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 234.2" "Cell type enhanced" "Detected in many" "Hepatocytes: 275.6;monocytes: 178.7;Proximal tubular cells: 496.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "eosinophil: 1414.9;neutrophil: 3051.8" "Lineage enriched" "Detected in all" 7 "granulocytes: 3051.8" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008650, HPA043463, HPA069557" Enhanced Enhanced Nucleoplasm NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153" "unprognostic (3.93e-2)" "unprognostic (3.68e-1)" "unprognostic (1.32e-1)" "unprognostic (9.61e-2)" "unprognostic (1.76e-2)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" "unprognostic (1.49e-1)" "unprognostic (2.88e-2)" "unprognostic (4.90e-2)" "unprognostic (5.29e-2)" "unprognostic (3.60e-1)" "unprognostic (4.27e-2)" "unprognostic (8.46e-2)" "unprognostic (4.92e-2)" "unprognostic (7.31e-2)" "unprognostic (4.59e-3)" 28.1 15.1 26.2 31.8 27.3 96.3 21.3 27.8 28.4 17.5 25.8 36.7 29.4 29.5 11.2 45.3 33.5 23.2 47.3 25.6 26.8 80.3 234.2 30.4 17.7 29.3 28.0 16.4 149.6 14.8 14.5 13.2 27.1 32.0 17.4 2.7 16.5 29.2 76.0 31.1 27.5 36.8 27.5 67.0 33.3 17.7 28.5 13.7 12.5 93.6 12.2 40.8 20.1 27.1 23.6 59.1 21.3 50.4 39.9 17.0 36.4 27.8 36.0 41.2 35.6 96.2 25.5 22.7 90.6 33.5 36.0 37.9 36.3 25.2 12.8 127.7 41.1 17.5 20.5 154.9 36.1 49.3 40.3 32.0 21.9 29.6 6.0 12.9 41.9 28.8 28.2 12.3 22.3 131.2 28.2 82.7 29.2 42.7 33.5 40.3 29.3 106.0 66.0 37.2 20.5 26.9 32.3 35.6 17.3 13.9 38.7 87.9 24.8 12.3 33.7 24.3 16.7 32.0 53.4 42.4 12.5 47.4 22.0 493.5 412.0 1414.9 31.9 194.8 32.2 28.0 26.5 26.7 171.2 28.3 20.5 22.7 3051.8 42.2 182.9 73.2 45.9 226.7 26.2 27.3 27.8 28.4 25.6 26.8 29.3 28.0 27.1 27.5 28.5 27.1 24.9 9.6 13.4 3.9 10.0 6.5 9.1 21.5 8.0 6.5 27.9 21.3 36.1 32.9 14.9 33.1 4.2 33.3 12.3 69.1 93.9 65.9 5.9 23.9 13.4 15.4 60.3 21.5 0.8 111.2 121.4 13.7 11.7 17.0 4.5 12.2 20.7 275.6 63.5 8.4 1.2 38.6 34.6 59.2 21.2 13.9 9.3 37.9 16.0 2.8 178.7 22.5 25.7 1.5 2.9 66.0 62.8 23.0 13.0 16.3 97.3 496.8 37.9 4.2 0.0 8.1 22.8 28.9 8.7 11.1 9.5 38.6 10.6 14.8 33.5 21.9 MTHFD1 "MTHFC, MTHFD" ENSG00000100714 "Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1" 14 64388031-64463457 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "liver: 356.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 142.9;Proximal tubular cells: 75.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000704, HPA001290, HPA015006, HPA050052" Approved Enhanced Cytosol NA Yes "Cluster 43: B-cells - Humoral immune response" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998" "unprognostic (3.58e-2)" "unprognostic (5.50e-3)" "unprognostic (1.24e-1)" "unprognostic (2.46e-2)" "unprognostic (1.37e-1)" "unprognostic (7.01e-2)" "unprognostic (8.85e-3)" "unprognostic (7.62e-3)" "unprognostic (1.28e-1)" "unprognostic (2.29e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.84e-1)" "prognostic favorable (5.93e-5)" "unprognostic (2.45e-2)" "unprognostic (1.75e-1)" "unprognostic (7.30e-2)" "unprognostic (2.29e-2)" 56.4 18.0 8.6 20.0 17.4 27.0 29.8 8.3 12.3 16.9 15.0 23.3 19.7 16.1 9.9 25.1 16.0 13.1 28.1 12.9 8.1 55.3 356.9 15.4 23.6 7.5 7.8 24.9 23.8 27.5 9.2 13.3 7.0 12.9 27.5 3.6 15.6 13.8 64.1 17.1 18.9 20.0 7.2 14.5 17.9 4.7 8.9 30.2 20.5 61.9 27.7 18.6 16.6 8.3 294.1 164.9 58.5 143.6 70.5 53.4 95.7 106.4 83.3 148.1 147.4 161.2 144.2 103.3 49.6 67.1 68.3 146.0 177.6 111.2 160.4 107.3 117.9 122.2 143.5 131.8 50.6 104.5 81.2 43.0 37.3 124.3 66.4 57.5 93.1 98.1 108.5 98.7 114.7 270.1 179.9 62.3 118.0 186.5 160.4 138.3 201.2 114.4 110.5 160.9 128.7 49.0 183.7 111.4 58.3 54.0 164.4 58.6 51.5 115.1 184.1 102.2 134.2 58.8 65.6 177.9 107.4 125.2 134.8 0.4 11.7 0.1 9.7 19.5 13.0 27.0 10.1 12.3 17.7 15.3 7.8 10.7 0.9 17.8 16.7 4.0 19.5 12.2 8.6 17.4 8.3 12.3 12.9 8.1 7.5 7.8 7.0 7.2 8.9 8.3 8.1 19.2 23.5 15.0 16.2 13.8 14.2 14.7 13.6 0.0 9.8 8.1 43.9 15.7 19.5 16.5 0.0 30.6 10.8 7.9 41.1 16.9 1.4 6.8 11.7 12.3 3.0 42.3 19.5 10.3 30.9 14.9 15.3 8.7 50.7 27.2 12.8 142.9 25.3 0.0 15.6 14.3 2.0 13.0 11.0 1.5 13.1 12.3 14.2 8.4 13.3 0.0 8.2 14.1 10.9 11.7 6.3 13.2 24.1 10.2 8.2 75.3 11.5 0.0 19.7 13.1 19.3 0.9 8.9 19.5 10.7 9.9 16.6 21.4 24.6 12.7 MTLN "LEMP, LINC00116, MOXI, MPM, NCRNA00116, SMIM37" ENSG00000175701 Mitoregulin Q8NCU8 2 110211529-110245420 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 229.3;skeletal muscle: 784.7;tongue: 280.3" "Cell type enhanced" "Detected in some" "Adipocytes: 27.4;Cytotrophoblasts: 43.7;Extravillous trophoblasts: 32.8;Hofbauer cells: 78.4;Syncytiotrophoblasts: 20.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" "unprognostic (3.74e-2)" "unprognostic (1.86e-1)" "unprognostic (7.68e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-1)" "unprognostic (2.64e-1)" "unprognostic (3.49e-3)" "unprognostic (8.20e-2)" "unprognostic (9.10e-2)" "unprognostic (6.08e-2)" "unprognostic (5.08e-3)" "unprognostic (8.27e-2)" "unprognostic (1.97e-1)" "unprognostic (2.93e-2)" "unprognostic (1.04e-1)" "unprognostic (8.80e-2)" "unprognostic (1.95e-2)" 66.5 68.9 67.3 22.2 71.2 10.1 51.1 80.5 103.8 42.0 63.5 73.9 41.6 58.0 52.1 63.5 41.6 9.2 229.3 68.8 77.2 69.8 78.0 40.2 15.9 75.8 71.4 33.6 46.2 37.0 41.3 12.9 75.6 48.6 12.4 11.0 43.9 34.0 784.7 44.6 46.8 16.7 70.4 44.4 57.3 25.7 78.1 18.5 48.0 280.3 12.0 55.7 46.1 75.6 0.4 125.0 13.3 15.3 14.7 17.5 81.1 49.9 38.6 58.7 39.2 86.0 39.7 16.9 95.0 13.8 81.4 52.9 13.2 57.5 9.6 72.0 51.4 10.1 30.5 73.3 61.2 35.6 50.3 45.6 67.8 48.8 0.0 31.8 52.9 50.2 28.6 40.6 28.1 130.0 49.8 121.6 34.1 39.9 36.9 5.5 28.0 51.9 37.2 77.9 29.5 19.4 27.7 95.2 57.1 8.9 26.4 59.2 41.0 57.7 81.3 56.9 75.9 67.8 48.0 5.3 60.0 56.1 42.1 9.6 101.9 13.8 109.6 112.1 125.1 104.0 123.5 118.7 110.6 115.0 129.1 129.1 5.6 85.9 67.6 150.2 119.0 77.4 67.3 71.2 80.5 103.8 68.8 77.2 75.8 71.4 75.6 70.4 78.1 75.6 27.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.7 8.7 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 32.8 11.8 0.0 0.0 0.0 0.0 0.0 0.0 78.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 20.2 1.5 0.0 0.0 0.0 MTX1 "MTX, MTXN" ENSG00000173171 "Metaxin 1" Q13505 1 155208695-155213824 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 601.3;Late spermatids: 1473.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011543 Uncertain Approved Mitochondria NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Mitochondria "HPA011543: AB_1853824" "unprognostic (2.57e-1)" "unprognostic (9.51e-3)" "unprognostic (3.27e-1)" "unprognostic (5.98e-3)" "unprognostic (1.60e-1)" "unprognostic (2.62e-2)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (8.38e-2)" "unprognostic (1.28e-2)" "unprognostic (1.71e-1)" "unprognostic (6.78e-2)" "prognostic unfavorable (3.39e-4)" "unprognostic (1.30e-2)" "unprognostic (1.70e-1)" "unprognostic (1.37e-1)" "unprognostic (1.96e-2)" 29.3 33.2 23.9 16.1 24.5 39.1 28.2 25.2 29.2 22.3 29.2 25.9 18.9 25.3 17.8 33.0 31.0 13.1 22.1 23.2 24.2 34.1 44.8 22.9 19.6 24.8 24.7 17.6 27.7 37.7 20.3 20.8 24.5 22.1 18.8 3.7 31.6 21.7 17.5 25.5 23.0 18.6 24.7 29.3 28.1 90.3 24.8 20.9 24.4 16.7 21.2 20.7 21.2 25.3 54.3 87.6 27.3 39.3 49.9 44.8 86.4 27.4 55.0 79.4 55.1 109.5 88.2 44.3 88.2 63.4 25.2 52.8 40.6 77.4 28.8 32.9 95.4 28.3 64.0 107.1 78.8 52.5 38.0 57.5 71.2 82.2 54.9 30.4 71.2 64.4 58.1 21.5 47.9 131.7 59.6 65.9 54.7 76.5 100.2 48.3 17.2 105.4 73.1 46.2 44.5 55.3 34.0 106.3 31.0 41.6 86.2 84.1 30.0 37.8 42.6 25.4 46.9 41.1 37.3 46.2 50.1 26.8 41.3 32.8 69.0 17.4 24.2 38.3 23.2 41.6 29.6 25.7 60.8 37.7 29.3 26.5 114.2 34.6 22.2 32.9 39.0 40.6 23.9 24.5 25.2 29.2 23.2 24.2 24.8 24.7 24.5 24.7 24.8 25.3 26.0 9.6 17.0 4.9 28.9 20.3 42.0 91.3 26.7 0.0 41.8 42.4 1.1 27.1 45.1 35.0 0.0 107.5 17.1 36.5 97.8 80.1 601.3 56.6 35.1 24.7 19.8 14.7 2.8 84.7 130.7 33.6 40.8 30.1 26.6 42.2 23.9 54.4 97.3 0.0 3.6 42.3 54.9 37.1 23.3 1473.9 43.2 38.9 49.8 1.0 65.1 0.0 37.0 3.0 4.8 72.7 48.4 39.5 39.3 41.6 44.3 144.6 61.2 0.0 46.0 29.2 58.4 105.2 52.9 34.9 21.0 88.7 22.5 43.9 54.6 42.6 MYBL2 "B-MYB, BMYB" ENSG00000101057 "MYB proto-oncogene like 2" P10244 20 43667019-43716495 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "bone marrow: 91.8;lymphoid tissue: 55.5" "Cell type enhanced" "Detected in many" "B-cells: 33.0;dendritic cells: 32.6;Erythroid cells: 82.3;Extravillous trophoblasts: 32.3;Plasma cells: 139.6;Spermatogonia: 33.6" "Cancer enriched" "Detected in all" 5 "testis cancer: 295.8" "Not detected" "Not detected" "Immune cell enriched" "Detected in some" 34 "plasmacytoid DC: 91.5" "Lineage enriched" "Detected in many" 34 "dendritic cells: 91.5" "Cell line enhanced" "Detected in many" "MCF7: 763.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017114, HPA030530, HPA055416" Uncertain Supported Nucleoplasm,Cytosol Yes Yes "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm Cytosol "CAB017114: , HPA030530: AB_2673515, HPA055416: AB_2682811" "unprognostic (9.75e-3)" "unprognostic (1.29e-2)" "unprognostic (3.20e-1)" "prognostic unfavorable (9.73e-4)" "unprognostic (2.35e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (2.11e-7)" "unprognostic (2.66e-3)" "unprognostic (9.23e-3)" "unprognostic (1.78e-1)" "unprognostic (2.38e-3)" "unprognostic (1.32e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (1.42e-1)" "unprognostic (2.27e-1)" "unprognostic (1.19e-1)" "unprognostic (1.84e-1)" 1.6 0.6 0.1 24.2 0.1 91.8 1.6 0.1 0.2 1.1 0.2 8.6 7.0 1.4 0.1 10.1 0.4 1.0 0.4 0.1 0.1 0.6 1.1 1.8 55.5 0.1 0.1 0.3 11.2 0.1 0.2 5.7 0.1 0.5 6.9 0.0 1.6 0.2 0.1 4.2 7.8 2.1 0.1 27.8 6.1 15.6 0.4 33.3 0.5 0.0 53.5 3.5 2.5 0.1 195.8 121.8 105.4 109.6 1.0 3.5 136.2 87.0 29.0 265.6 194.6 600.2 118.8 393.6 49.2 37.8 55.8 116.1 192.1 59.6 98.8 74.2 124.1 183.2 118.7 164.2 0.2 168.6 121.7 2.4 5.1 101.6 22.9 5.9 72.2 189.6 188.1 470.3 23.8 763.7 346.0 236.3 121.8 155.4 105.4 237.3 216.3 222.1 49.6 39.7 96.7 140.6 255.6 253.3 26.1 110.4 167.2 183.1 34.0 16.3 264.3 118.3 151.5 162.1 363.8 606.5 34.2 142.3 103.9 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.3 0.0 1.4 0.0 0.0 0.1 0.2 0.0 91.5 1.3 0.8 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.1 0.2 0.0 0.0 0.0 33.0 4.2 0.8 0.8 0.0 0.0 2.5 3.4 2.0 1.5 0.1 0.0 0.0 14.4 32.6 3.4 0.0 0.4 5.9 0.9 1.3 1.8 0.0 82.3 0.4 0.9 32.3 4.8 10.2 2.9 0.0 18.9 0.7 1.4 13.5 0.0 0.3 5.1 0.0 2.4 2.6 14.1 0.0 3.2 1.8 0.0 0.0 0.0 1.0 0.0 0.5 0.7 1.1 0.0 139.6 0.3 0.5 0.0 0.0 0.0 0.0 0.1 3.9 7.0 33.6 8.2 2.4 3.7 3.0 1.2 8.6 2.4 MYG1 "C12orf10, Gamm1, MYG" ENSG00000139637 "MYG1 exonuclease" Q9HB07 12 53299695-53307177 "Disease related genes, Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 16.4;Cytotrophoblasts: 38.4;Extravillous trophoblasts: 60.7;Hofbauer cells: 70.1;Syncytiotrophoblasts: 25.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038626, HPA038627" Approved Supported Supported Nucleoplasm "Intracellular and membrane" NA NA 20000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA038626: AB_10674692, HPA038627: AB_2676123" "unprognostic (5.33e-2)" "unprognostic (4.41e-2)" "unprognostic (6.77e-2)" "unprognostic (2.44e-2)" "unprognostic (3.59e-1)" "unprognostic (7.56e-2)" "unprognostic (1.61e-3)" "unprognostic (2.73e-1)" "unprognostic (1.97e-1)" "unprognostic (3.58e-2)" "unprognostic (2.71e-2)" "unprognostic (1.39e-1)" "unprognostic (2.81e-1)" "unprognostic (6.41e-2)" "unprognostic (2.18e-1)" "unprognostic (2.16e-1)" "unprognostic (1.61e-1)" 33.8 35.8 40.0 18.0 41.4 20.8 31.8 45.5 66.7 35.0 40.4 33.2 18.6 32.8 21.2 24.9 35.7 20.7 32.0 39.7 44.0 36.9 28.0 20.8 22.5 45.4 45.6 40.6 45.4 31.4 29.0 15.4 46.8 25.3 14.9 17.3 26.1 20.8 48.0 31.3 21.1 19.8 41.9 20.5 33.2 104.8 43.5 22.7 30.6 26.3 19.9 34.4 27.5 42.2 42.3 78.0 33.8 53.5 35.1 52.4 3.9 27.3 43.6 62.0 44.1 74.5 44.9 40.6 63.2 38.3 35.1 46.6 46.8 60.8 32.8 34.0 78.9 41.7 60.4 91.5 81.0 43.8 27.1 49.7 40.1 57.4 58.1 61.7 53.8 46.8 2.4 81.0 41.5 164.8 58.9 71.0 55.0 42.7 73.9 54.9 31.9 93.6 53.7 41.0 66.7 63.9 30.9 60.3 68.3 19.3 94.8 42.0 37.3 60.3 55.8 43.7 43.9 73.3 81.8 43.8 75.7 37.2 47.6 24.2 55.0 26.1 35.8 44.4 52.6 49.9 46.3 35.5 63.5 41.5 47.8 44.3 14.6 42.4 32.9 39.8 69.5 50.1 40.0 41.4 45.5 66.7 39.7 44.0 45.4 45.6 46.8 41.9 43.5 42.2 13.8 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 38.4 6.8 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 60.7 9.7 0.0 0.0 0.0 0.0 0.0 0.0 70.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 25.9 1.5 0.0 0.0 0.0 MYO5C MGC74969 ENSG00000128833 "Myosin VC" Q9NQX4 15 52192322-52295804 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 68.5;Alveolar cells type 1: 131.4;Alveolar cells type 2: 84.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 25.4;MCF7: 46.3;OE19: 41.2;RT4: 26.4;SK-BR-3: 34.0;T-47d: 40.9" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020790, HPA032115, HPA032116" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" Cytosol Nucleoplasm "CAB020790: , HPA032115: AB_2674158, HPA032116: AB_2674159" "unprognostic (1.85e-1)" "unprognostic (1.29e-1)" "unprognostic (3.49e-2)" "prognostic favorable (5.18e-5)" "unprognostic (2.94e-1)" "unprognostic (4.01e-2)" "unprognostic (2.07e-1)" "unprognostic (1.53e-1)" "unprognostic (4.53e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-3)" "unprognostic (4.82e-2)" "prognostic favorable (2.47e-5)" "prognostic favorable (5.82e-4)" "unprognostic (9.15e-2)" "unprognostic (2.34e-1)" "unprognostic (2.32e-1)" 11.1 1.5 3.0 2.8 3.3 0.8 13.2 7.9 3.1 14.1 17.0 14.0 5.3 4.2 12.8 7.0 11.5 6.9 1.6 2.6 2.9 5.6 3.4 13.8 1.9 5.1 2.8 1.6 27.3 13.7 7.3 2.5 6.3 10.3 17.7 1.6 21.1 4.4 2.1 4.8 5.1 4.0 7.3 3.5 19.4 4.7 3.3 1.9 17.9 2.6 2.4 4.4 4.4 5.9 21.4 25.4 3.5 0.0 0.0 0.1 3.0 0.0 0.3 0.1 0.0 3.9 8.8 1.2 5.3 0.1 0.2 3.4 5.3 7.4 0.0 1.1 8.4 0.1 17.3 15.7 0.0 0.0 0.2 0.0 7.2 0.0 6.8 3.6 5.6 0.9 0.0 0.3 0.1 46.3 1.3 0.2 1.4 41.2 12.0 17.6 2.1 10.6 19.5 26.4 3.5 3.9 1.6 34.0 0.0 5.4 40.9 0.0 0.0 0.0 0.2 0.0 3.3 0.7 0.7 2.1 0.1 0.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.7 0.0 3.0 3.3 7.9 3.1 2.6 2.9 5.1 2.8 6.3 7.3 3.3 5.9 68.5 131.4 84.5 3.9 1.5 0.6 20.5 10.2 2.2 0.4 22.4 10.9 4.9 18.6 47.1 22.0 0.0 2.3 0.3 26.5 3.9 21.1 2.8 34.1 4.8 26.1 5.4 2.1 29.3 29.6 1.5 3.7 41.3 50.4 3.8 5.1 2.5 5.1 0.9 0.0 3.9 47.1 22.4 0.8 3.1 3.2 1.8 1.4 7.2 14.0 0.1 5.6 1.0 8.0 2.8 39.0 21.5 0.4 2.7 28.1 2.1 1.3 49.8 0.5 0.0 1.3 1.5 9.0 5.9 14.1 1.4 0.7 1.6 2.0 25.8 38.7 NAA60 "FLJ14154, NAT15" ENSG00000122390 "N-alpha-acetyltransferase 60, NatF catalytic subunit" Q9H7X0 16 3443649-3486953 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Chromosome partition" "Acyltransferase, Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040916 Approved Uncertain "Actin filaments,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "Actin filaments, Cytosol" "HPA040916: AB_10794428" "unprognostic (8.59e-2)" "unprognostic (2.16e-3)" "unprognostic (3.39e-1)" "prognostic favorable (3.14e-4)" "unprognostic (1.81e-1)" "unprognostic (5.90e-2)" "unprognostic (2.88e-2)" "unprognostic (1.53e-2)" "unprognostic (5.23e-2)" "unprognostic (5.12e-2)" "prognostic favorable (4.30e-4)" "unprognostic (9.54e-2)" "unprognostic (1.64e-1)" "unprognostic (1.60e-2)" "unprognostic (8.96e-2)" "unprognostic (3.59e-1)" "unprognostic (6.74e-3)" 25.5 45.4 31.5 16.9 30.0 20.1 25.1 37.5 35.9 28.4 22.7 40.4 40.5 31.6 18.7 31.0 28.2 20.3 48.9 31.9 27.5 52.4 67.5 32.0 20.2 30.8 30.5 26.8 47.9 49.1 41.6 19.5 29.3 35.2 22.6 16.3 26.0 23.9 42.9 24.2 39.3 19.1 28.8 42.9 58.9 32.7 31.2 19.5 32.0 21.2 16.7 28.4 23.2 30.3 16.8 61.9 40.1 44.1 26.5 19.4 39.1 26.9 25.0 29.3 26.6 43.9 30.5 31.7 30.0 29.6 21.0 37.4 40.1 31.2 29.4 49.7 27.8 35.4 25.7 53.0 32.9 53.1 45.6 24.4 27.9 20.4 38.9 29.2 45.1 29.4 44.8 41.4 19.4 73.6 33.4 36.3 50.1 35.8 18.1 42.3 30.8 47.5 27.7 29.7 21.6 42.5 45.8 48.3 24.6 38.5 40.2 34.7 30.8 36.0 27.7 12.8 26.7 35.2 33.6 30.5 12.1 29.0 29.2 33.3 18.6 53.8 17.7 20.6 19.2 11.6 15.8 17.7 18.1 11.0 12.3 16.4 20.0 18.4 23.6 11.6 20.1 19.5 31.5 30.0 37.5 35.9 31.9 27.5 30.8 30.5 29.3 28.8 31.2 30.3 26.3 9.6 16.0 24.8 17.7 0.1 13.4 0.1 17.6 21.2 24.5 16.4 15.5 38.6 5.6 12.9 6.2 28.3 22.7 66.7 43.0 30.1 55.7 33.3 25.7 21.0 27.0 18.7 22.2 41.7 40.0 18.0 37.2 30.9 30.4 18.4 26.7 53.5 32.1 11.8 26.5 43.1 0.0 34.8 0.3 54.4 11.5 23.6 0.0 25.3 27.0 29.3 26.8 22.1 34.8 37.0 54.3 15.8 15.4 20.2 84.2 49.0 3.7 15.3 26.3 16.8 17.7 19.6 24.5 16.5 0.3 33.0 22.9 21.1 35.3 23.5 NACC1 "BEND8, BTBD14B, BTBD30, NAC-1, NAC1" ENSG00000160877 "Nucleus accumbens associated 1" Q96RE7 19 13116862-13141147 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021238, HPA062245, CAB069927" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Vesicles "CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724" "unprognostic (2.19e-1)" "unprognostic (9.20e-3)" "unprognostic (2.67e-2)" "unprognostic (2.84e-2)" "unprognostic (2.62e-1)" "unprognostic (7.75e-2)" "unprognostic (8.46e-3)" "unprognostic (1.10e-1)" "unprognostic (1.93e-1)" "unprognostic (8.46e-2)" "unprognostic (2.40e-2)" "unprognostic (3.04e-2)" "unprognostic (7.35e-2)" "unprognostic (2.80e-2)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (9.74e-2)" 12.6 19.5 31.0 14.6 19.2 8.8 10.3 7.1 26.6 9.7 0.0 17.3 13.3 18.4 7.9 27.6 11.9 6.4 20.9 25.7 7.4 14.8 20.5 16.7 12.1 13.4 15.9 7.7 12.2 10.7 14.8 12.4 15.1 14.6 6.6 3.7 15.8 11.2 24.2 17.4 16.0 7.7 8.9 15.9 16.0 17.0 20.6 11.3 14.0 7.9 8.8 15.0 12.6 16.4 98.8 110.0 28.0 59.6 15.0 17.7 74.9 47.4 34.2 42.4 32.4 114.8 40.4 50.9 104.1 39.8 37.3 49.0 34.8 80.7 16.2 89.1 52.5 32.4 87.9 84.7 35.5 52.0 82.3 28.8 28.0 46.1 24.7 36.5 50.2 46.4 72.5 19.8 22.9 206.1 82.9 39.6 123.6 28.9 101.7 47.8 32.9 49.5 28.2 101.1 58.2 37.7 49.6 64.9 39.1 29.8 59.3 46.4 76.7 94.6 58.8 67.2 87.0 53.4 88.1 42.4 99.7 52.8 58.9 0.0 0.2 0.0 0.2 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 31.0 19.2 7.1 26.6 25.7 7.4 13.4 15.9 15.1 8.9 20.6 16.4 4.9 0.0 1.7 6.2 5.6 12.1 7.5 11.8 2.8 16.6 11.5 7.5 2.1 12.8 8.5 16.5 2.1 19.0 12.9 22.7 7.9 12.3 2.3 10.9 8.9 8.1 4.9 12.2 7.2 8.8 20.0 5.2 10.7 17.6 10.2 13.3 8.6 18.0 21.1 26.9 5.9 16.2 14.2 9.6 9.6 2.0 4.4 8.8 5.4 3.7 10.5 12.0 10.3 5.5 5.4 21.7 11.1 9.4 5.6 16.5 14.0 15.0 5.9 7.7 6.6 7.5 7.0 11.1 15.6 8.4 13.9 27.1 7.9 15.2 15.4 17.2 NAXE "AIBP, APOA1BP, MGC119143, MGC119144, MGC119145, YJEFN1" ENSG00000163382 "NAD(P)HX epimerase" Q8NCW5 1 156591756-156609507 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted secreted proteins" "Lipid transport, Transport" Isomerase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 136.7;Distal tubular cells: 201.5;Ductal cells: 112.8;Exocrine glandular cells: 100.1;Proximal tubular cells: 219.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043766, HPA048164" Enhanced Approved Nucleoplasm,Vesicles,Cytosol "Secreted to blood" NA NA 3300000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Vesicles, Cytosol" "HPA043766: AB_2678660, HPA048164: AB_2680294" "unprognostic (1.27e-1)" "unprognostic (2.34e-2)" "unprognostic (2.49e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (7.38e-2)" "unprognostic (5.32e-2)" "unprognostic (2.46e-3)" "unprognostic (2.60e-1)" "unprognostic (1.72e-1)" "unprognostic (3.08e-3)" "unprognostic (3.23e-2)" "unprognostic (3.14e-2)" "unprognostic (2.15e-2)" "unprognostic (8.05e-2)" "unprognostic (7.43e-2)" "unprognostic (2.09e-1)" "unprognostic (3.81e-1)" 47.1 74.8 61.0 20.9 63.7 22.2 47.9 66.1 69.6 56.8 71.1 62.9 45.5 68.8 88.7 58.0 59.5 26.5 111.1 60.9 64.3 83.8 86.5 43.6 27.0 62.7 64.8 46.5 69.7 104.7 70.0 23.7 61.8 62.5 41.6 17.4 53.9 48.3 71.8 55.8 48.3 39.7 64.7 43.2 67.5 40.8 63.5 30.6 59.8 68.2 34.3 55.0 47.8 70.5 114.2 155.4 43.9 84.4 64.0 43.8 55.5 29.5 62.3 69.5 72.6 130.6 76.8 62.4 113.4 52.5 55.9 111.1 49.4 99.0 47.5 81.2 98.5 58.1 76.2 86.1 75.1 60.0 60.9 44.2 123.7 87.9 81.9 53.4 95.4 104.7 54.7 70.1 71.6 209.6 83.3 98.0 43.1 158.1 118.2 87.7 40.2 212.6 93.0 93.6 114.7 102.9 90.4 172.4 141.6 66.4 178.3 117.5 51.1 45.1 64.8 64.6 70.6 180.1 110.3 53.0 63.1 37.0 70.4 25.4 96.3 52.9 121.2 111.3 121.3 236.2 109.4 124.3 89.1 186.5 122.8 114.9 11.4 141.3 89.1 225.7 110.1 186.6 61.0 63.7 66.1 69.6 60.9 64.3 62.7 64.8 61.8 64.7 63.5 70.5 29.5 41.7 32.9 0.0 14.8 0.0 0.0 0.0 0.0 0.0 87.5 96.0 0.0 0.0 23.5 68.0 0.0 136.7 28.7 0.0 201.5 112.8 0.0 27.3 29.9 18.4 0.0 0.0 0.0 100.1 43.1 27.2 0.0 32.0 5.1 53.5 0.0 0.0 92.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.5 0.0 0.0 40.8 0.0 0.0 0.0 0.0 91.0 0.0 0.0 6.2 0.0 0.0 219.6 11.7 0.0 0.0 0.0 24.5 0.0 0.0 0.0 0.0 81.3 13.4 48.1 0.0 0.0 NBPF4 FLJ32833 ENSG00000196427 "NBPF member 4" Q96M43 1 108223341-108244081 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.1;intestine: 1.2;testis: 3.7" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "breast cancer: 0.9" "Region enhanced" "Detected in single" "basal ganglia: 1.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;K-562: 10.2;Karpas-707: 3.1;MCF7: 12.6;THP-1: 3.8" "HPA045044, HPA046411, HPA047447, HPA058050" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: " "unprognostic (6.33e-2)" "unprognostic (2.08e-1)" "unprognostic (2.18e-2)" "unprognostic (8.29e-2)" "unprognostic (2.90e-1)" "unprognostic (8.73e-2)" 0.0 0.0 0.0 0.0 1.1 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.7 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.2 3.1 0.0 12.6 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.2 0.0 0.0 0.1 1.4 0.0 0.1 3.8 0.0 0.0 0.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NCOA3 "ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1" ENSG00000124151 "Nuclear receptor coactivator 3" Q9Y6Q9 20 47501887-47656877 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Acyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "B-cells: 155.8;Plasma cells: 168.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 187.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009800, HPA024210" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 16: Immune cells - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" Nucleoplasm Cytosol "CAB009800: AB_2251314, HPA024210: AB_10602011" "unprognostic (7.26e-3)" "unprognostic (1.00e-1)" "unprognostic (2.69e-1)" "unprognostic (3.23e-2)" "unprognostic (5.78e-2)" "unprognostic (4.33e-2)" "prognostic unfavorable (8.09e-4)" "unprognostic (2.83e-2)" "unprognostic (1.47e-1)" "unprognostic (5.22e-3)" "unprognostic (2.09e-2)" "unprognostic (2.10e-1)" "unprognostic (2.05e-1)" "unprognostic (1.95e-1)" "unprognostic (2.04e-2)" "unprognostic (4.18e-1)" "unprognostic (1.63e-1)" 14.7 8.2 4.7 22.9 4.7 13.4 11.5 5.7 9.0 11.1 3.8 9.9 8.8 11.8 7.1 14.3 10.7 10.3 13.3 4.0 5.5 9.4 10.5 14.8 35.0 6.5 5.3 14.1 11.1 11.2 6.0 28.1 6.9 9.6 11.2 11.6 11.3 8.8 25.2 14.0 14.8 11.5 5.3 27.5 14.8 7.5 5.9 17.9 12.9 16.5 39.2 15.3 12.5 6.4 17.6 50.1 16.1 21.5 37.5 41.9 105.2 16.4 24.2 27.3 14.1 25.2 19.0 61.8 11.0 28.5 36.1 43.2 12.2 20.7 20.9 31.3 6.4 8.1 15.3 39.3 22.6 6.8 43.3 19.9 61.2 24.4 30.3 23.5 20.0 10.0 18.7 14.0 16.2 187.0 9.9 12.8 5.8 14.2 20.6 17.8 11.0 27.4 16.8 38.2 3.1 5.7 41.0 53.7 18.8 18.0 24.3 17.8 35.8 16.4 12.9 20.5 7.4 38.5 35.9 60.6 19.4 7.0 10.8 2.8 3.9 3.0 2.5 5.2 2.2 9.3 2.3 2.2 5.0 6.8 2.6 2.9 4.5 2.1 5.0 4.2 3.1 2.6 4.7 4.7 5.7 9.0 4.0 5.5 6.5 5.3 6.9 5.3 5.9 6.4 86.7 12.8 23.7 27.7 155.8 34.5 15.7 25.0 52.9 18.1 23.8 13.8 26.1 20.0 29.0 14.7 8.4 69.5 39.9 12.5 5.9 12.9 12.1 36.4 29.1 49.8 14.9 14.9 48.5 19.6 26.2 26.4 26.5 78.8 8.8 15.3 68.2 20.0 22.8 13.5 64.3 10.7 36.7 46.8 62.2 6.0 24.8 58.2 33.8 109.6 46.1 9.3 28.8 49.3 54.1 21.0 16.9 27.4 168.8 28.1 9.0 6.5 39.8 23.8 19.7 19.7 30.3 43.2 30.0 63.3 51.7 89.2 47.6 14.2 11.7 59.2 NDUFB1 "CI-MNLL, MNLL" ENSG00000183648 "NADH:ubiquinone oxidoreductase subunit B1" O75438 14 92116122-92121917 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 2435.4;Hepatocytes: 1690.0;Proximal tubular cells: 1614.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063737 Supported Supported "Nuclear speckles,Mitochondria" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "Nuclear speckles" "HPA063737: AB_2685109" "unprognostic (1.12e-2)" "unprognostic (1.31e-3)" "unprognostic (6.70e-2)" "unprognostic (2.67e-2)" "unprognostic (1.28e-1)" "unprognostic (2.54e-2)" "unprognostic (6.91e-2)" "unprognostic (3.74e-3)" "unprognostic (5.35e-3)" "unprognostic (4.55e-3)" "unprognostic (1.18e-2)" "unprognostic (4.15e-2)" "prognostic favorable (1.31e-5)" "unprognostic (7.35e-2)" "unprognostic (1.19e-1)" "unprognostic (2.16e-1)" "unprognostic (5.05e-3)" 260.8 396.4 370.4 109.0 381.4 167.4 231.8 388.5 588.6 178.3 409.2 313.4 165.7 164.9 178.3 281.5 177.1 61.2 1221.5 381.0 401.1 512.7 503.2 182.3 118.4 379.8 374.6 162.7 206.3 373.5 314.7 61.1 383.2 221.5 122.4 260.9 233.5 59.5 862.6 153.6 225.9 69.4 381.2 214.0 292.4 112.3 376.4 230.6 250.4 1053.8 106.1 192.1 202.4 391.0 198.3 388.3 332.5 208.4 219.1 160.7 143.0 243.2 143.7 147.5 135.4 236.9 341.0 187.0 215.7 151.3 205.8 249.6 198.4 212.3 133.9 280.8 425.1 361.3 665.8 308.5 178.2 290.4 196.4 202.5 132.0 159.5 140.7 334.8 136.7 353.7 199.0 370.1 211.8 759.0 286.6 250.0 166.4 779.6 492.1 253.3 309.7 274.2 397.7 491.3 210.8 152.8 486.6 289.7 338.3 277.7 432.0 435.0 291.8 89.3 173.0 181.3 161.7 288.4 477.2 422.0 278.4 208.5 187.9 456.1 566.8 447.5 247.4 409.6 288.5 373.7 361.5 286.0 508.6 306.8 355.4 343.9 721.3 296.6 386.6 604.6 438.9 653.6 370.4 381.4 388.5 588.6 381.0 401.1 379.8 374.6 383.2 381.2 376.4 391.0 158.5 166.7 227.4 11.4 187.4 128.7 102.1 334.5 96.8 84.6 328.2 353.6 2435.4 467.5 237.0 389.9 39.6 260.3 170.4 627.2 1166.1 245.4 175.8 326.0 208.6 188.2 317.4 256.1 18.4 427.7 118.8 203.6 189.6 225.8 215.8 96.2 397.3 1690.0 422.3 55.5 21.7 515.9 268.5 619.8 179.3 57.3 262.5 281.7 332.6 10.3 478.1 223.3 241.0 11.1 15.0 294.4 628.7 241.1 201.6 97.9 845.2 1614.3 337.6 183.3 223.5 172.4 188.2 138.8 151.5 204.5 176.2 205.8 163.7 97.4 540.6 116.3 NDUFB2 "AGGG, CI-AGGG" ENSG00000090266 "NADH:ubiquinone oxidoreductase subunit B2" O95178 7 140690777-140722790 "Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3191.4;Distal tubular cells: 1997.6;Proximal tubular cells: 2437.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051377 Approved Uncertain Nucleoplasm,Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Mitochondria "HPA051377: AB_2681460" "unprognostic (1.17e-2)" "unprognostic (4.63e-2)" "unprognostic (2.25e-1)" "unprognostic (4.83e-2)" "unprognostic (2.29e-2)" "unprognostic (2.07e-1)" "unprognostic (3.20e-2)" "unprognostic (3.30e-2)" "unprognostic (8.30e-2)" "unprognostic (1.95e-3)" "unprognostic (4.35e-3)" "unprognostic (1.23e-1)" "prognostic favorable (7.60e-7)" "unprognostic (2.05e-1)" "unprognostic (1.07e-1)" "unprognostic (8.28e-2)" "unprognostic (1.55e-1)" 187.2 225.3 347.4 123.4 363.9 143.1 159.9 377.3 441.6 142.0 374.0 239.9 166.0 153.4 171.5 196.9 129.6 141.8 847.4 343.6 369.1 420.0 281.2 140.1 164.8 359.0 355.8 108.0 159.4 362.6 182.3 105.9 361.1 152.0 183.0 175.9 197.6 152.3 834.7 152.0 161.1 154.8 369.8 155.1 216.4 125.5 378.3 162.3 350.5 913.1 134.0 186.6 145.5 377.6 322.5 497.0 182.1 400.9 291.9 297.5 259.9 227.0 207.6 241.4 229.1 389.7 317.3 243.1 331.7 289.9 441.7 155.4 167.0 333.4 194.1 399.5 556.9 179.1 442.3 461.3 230.0 279.2 231.0 331.6 287.5 227.0 138.2 201.3 368.1 338.8 311.2 289.9 343.2 945.8 448.2 719.4 424.0 670.0 585.0 251.1 174.6 569.4 492.0 634.2 369.0 359.3 310.4 513.8 281.0 205.7 222.9 315.7 295.2 307.0 179.2 365.6 401.5 267.6 567.2 457.2 469.0 447.7 395.8 713.9 1045.5 503.4 779.4 1117.0 673.3 1009.8 755.0 768.2 1161.9 787.8 800.5 793.7 85.6 823.9 1037.9 926.9 772.0 1795.1 347.4 363.9 377.3 441.6 343.6 369.1 359.0 355.8 361.1 369.8 378.3 377.6 262.7 189.1 238.4 25.5 191.1 226.5 289.3 693.4 128.1 181.9 458.3 514.8 3191.4 351.8 398.1 673.1 98.0 555.4 275.3 776.2 1997.6 373.9 901.2 294.2 298.4 283.6 428.7 143.7 19.9 314.4 466.6 327.2 307.3 366.3 280.6 212.8 205.6 1079.3 710.8 139.7 22.7 576.3 687.7 280.3 337.3 246.9 222.7 336.5 434.0 13.1 356.7 367.2 465.5 19.6 42.3 279.4 647.9 243.8 210.7 440.1 867.3 2437.9 370.2 284.1 197.2 199.2 372.0 77.0 208.6 321.9 280.6 515.0 241.7 288.6 669.6 435.8 NHP2 "FLJ20479, NOLA2" ENSG00000145912 "NHP2 ribonucleoprotein" Q9NX24 5 178149463-178153894 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 1398.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044171, HPA050400" Enhanced NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA044171: AB_2678844, HPA050400: AB_2681113" "unprognostic (1.19e-1)" "unprognostic (1.59e-1)" "unprognostic (3.71e-2)" "prognostic unfavorable (4.97e-4)" "unprognostic (4.05e-1)" "unprognostic (3.97e-2)" "prognostic unfavorable (5.24e-4)" "unprognostic (8.87e-2)" "unprognostic (9.12e-2)" "unprognostic (1.78e-2)" "unprognostic (4.20e-2)" "unprognostic (6.72e-2)" "unprognostic (1.67e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-1)" "unprognostic (4.04e-2)" "unprognostic (8.63e-2)" 101.1 106.0 100.4 76.2 108.4 111.6 102.0 106.0 129.1 102.7 86.8 91.8 56.9 99.8 40.8 185.4 89.0 41.6 110.2 105.7 105.4 109.4 107.4 70.4 96.8 101.3 101.5 107.6 114.6 52.7 79.0 51.1 101.7 89.9 45.1 31.0 90.0 51.1 133.2 129.8 68.3 49.5 105.4 77.1 89.6 64.2 104.1 64.8 78.3 58.1 68.3 104.9 111.0 109.1 288.3 474.1 148.2 417.3 99.9 133.1 499.8 216.1 119.0 260.4 222.5 290.8 252.4 413.6 396.3 133.4 233.8 185.3 225.7 514.8 131.8 778.2 789.2 216.4 343.0 319.3 168.1 371.8 229.6 162.3 240.5 199.6 176.9 96.7 243.6 294.0 226.5 273.5 143.6 1398.1 529.0 280.1 215.9 271.9 739.0 362.6 190.9 641.5 192.3 195.5 375.2 407.7 167.9 470.0 426.5 89.7 227.1 274.6 222.4 253.3 274.0 207.6 513.3 316.8 679.2 494.1 250.1 519.9 284.6 58.3 218.3 32.8 188.4 254.5 265.5 335.5 232.7 218.7 310.1 347.2 238.9 245.3 16.8 260.1 188.2 507.4 245.0 363.7 100.4 108.4 106.0 129.1 105.7 105.4 101.3 101.5 101.7 105.4 104.1 109.1 94.4 60.9 67.3 9.4 123.7 193.2 226.4 222.9 155.4 46.8 228.2 309.9 11.6 131.5 139.5 126.9 18.8 233.7 85.4 88.0 358.1 230.6 59.2 75.2 165.5 116.6 126.6 100.7 9.2 302.4 359.6 113.8 76.5 83.2 79.3 133.0 84.3 172.3 172.6 30.3 9.1 151.8 97.6 78.4 131.8 114.0 134.8 81.3 145.9 5.6 117.2 78.3 93.7 9.0 14.0 231.0 71.2 97.4 128.7 389.5 54.5 320.7 73.1 36.7 59.2 100.0 139.4 107.5 129.2 343.9 242.9 166.9 87.0 183.3 207.7 289.4 NINJ1 NIN1 ENSG00000131669 "Ninjurin 1" Q92982 9 93121496-93134251 "Predicted membrane proteins" "Angiogenesis, Cell adhesion, Cytolysis, Inflammatory response" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 286.9" "Cell type enhanced" "Detected in many" "Hofbauer cells: 539.9;Langerhans cells: 741.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 1668.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 1668.9" "Cell line enhanced" "Detected in many" "Hep G2: 197.5;MCF7: 191.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045063 Uncertain "Intracellular and membrane" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "HPA045063: AB_10964133" "unprognostic (1.23e-2)" "unprognostic (8.25e-3)" "unprognostic (3.64e-3)" "unprognostic (1.40e-2)" "unprognostic (8.18e-2)" "unprognostic (1.28e-2)" "unprognostic (4.29e-2)" "unprognostic (5.88e-2)" "unprognostic (6.82e-2)" "unprognostic (9.06e-2)" "unprognostic (1.93e-1)" "unprognostic (1.74e-2)" "unprognostic (9.45e-3)" "unprognostic (2.51e-1)" "unprognostic (2.69e-2)" "unprognostic (1.40e-3)" "unprognostic (7.46e-3)" 60.9 129.8 51.0 39.9 48.9 286.9 53.0 47.9 58.7 47.6 50.2 60.1 27.0 36.5 20.2 25.7 47.6 39.2 64.0 44.2 51.9 100.4 118.0 65.0 41.5 54.5 53.2 35.9 35.0 137.7 59.2 66.6 53.3 58.9 16.5 6.1 77.3 56.2 38.0 80.4 37.6 36.0 57.6 89.9 42.5 37.6 57.2 30.5 71.4 30.0 19.6 100.5 37.9 59.2 45.0 68.2 13.2 30.0 47.4 19.1 51.6 30.2 85.9 43.5 26.7 29.5 15.5 0.6 15.0 29.7 47.6 44.8 14.7 84.6 9.4 103.3 28.7 6.8 17.2 197.5 163.7 4.8 13.8 62.5 80.9 41.1 22.5 132.4 41.3 16.3 5.0 49.6 9.9 191.1 13.9 13.8 18.7 51.9 53.0 24.6 10.3 79.0 35.0 18.6 4.3 18.4 67.3 105.4 41.9 22.0 81.9 31.3 31.1 15.8 44.6 33.2 22.9 26.2 11.4 1.0 48.2 14.8 12.1 152.9 313.3 824.9 69.8 315.4 94.5 7.8 65.0 59.3 75.9 2.4 76.5 55.1 1668.9 44.7 355.8 10.7 73.8 219.1 51.0 48.9 47.9 58.7 44.2 51.9 54.5 53.2 53.3 57.6 57.2 59.2 15.7 28.9 41.6 6.5 24.3 114.6 75.8 273.0 130.3 1.8 117.8 96.6 31.6 62.9 80.7 40.5 0.0 128.3 45.8 19.4 129.1 95.2 3.9 22.9 20.9 46.9 18.0 3.0 3.4 101.7 78.3 64.9 20.9 24.5 47.0 13.8 23.6 48.5 539.9 1.7 3.9 21.3 111.9 176.9 741.7 21.1 42.0 278.1 147.7 18.7 214.9 76.1 33.0 3.0 1.7 68.7 23.7 72.6 32.5 60.3 75.5 240.6 18.8 3.8 13.1 45.7 53.3 0.9 11.4 36.3 135.7 73.3 54.7 4.5 19.7 76.9 NKRF "ITBA4, NRF" ENSG00000186416 "NFKB repressing factor" O15226 X 119588337-119606443 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001476 Supported Nucleoplasm,Nucleoli NA NA "Cluster 46: Basophils - DNA binding" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" Nucleoli Nucleoplasm "HPA001476: AB_1079488" "unprognostic (6.12e-3)" "unprognostic (7.58e-2)" "unprognostic (8.10e-2)" "unprognostic (2.39e-1)" "unprognostic (9.92e-2)" "unprognostic (4.74e-3)" "prognostic unfavorable (4.92e-5)" "unprognostic (2.47e-1)" "unprognostic (1.20e-1)" "unprognostic (2.65e-1)" "unprognostic (1.33e-2)" "unprognostic (9.56e-3)" "unprognostic (2.62e-2)" "unprognostic (5.06e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-3)" "unprognostic (3.08e-3)" 4.4 6.5 11.3 5.7 11.8 6.9 5.4 9.6 16.9 4.2 7.3 3.7 4.1 3.9 4.0 5.6 4.4 3.5 4.1 11.5 13.1 6.1 6.0 4.1 8.7 11.2 10.1 6.1 3.8 5.2 5.5 6.5 11.5 4.1 3.5 5.3 4.0 3.5 5.5 6.2 4.3 4.0 9.4 5.9 4.1 1.9 11.4 9.5 4.6 4.6 8.4 6.3 4.3 10.6 17.9 18.3 10.4 11.3 8.7 8.5 15.5 10.7 8.5 14.1 15.0 19.8 15.3 31.8 18.4 9.2 12.1 20.4 43.8 16.4 17.2 16.4 28.9 16.8 20.3 12.9 8.3 33.5 11.8 9.5 13.2 16.3 19.2 9.6 14.1 15.3 18.5 12.6 12.5 27.6 20.8 25.2 23.1 26.2 19.9 16.5 15.2 32.7 18.8 12.7 16.7 14.2 15.2 23.1 16.5 10.6 9.7 20.0 12.2 8.7 9.5 19.3 27.1 10.5 14.1 32.9 9.3 36.3 10.1 1.1 0.5 0.7 1.0 0.8 1.1 1.3 1.2 1.3 0.6 1.2 1.9 1.6 0.1 0.5 0.3 0.9 1.8 0.8 11.3 11.8 9.6 16.9 11.5 13.1 11.2 10.1 11.5 9.4 11.4 10.6 5.4 6.4 8.9 5.9 11.1 19.4 10.4 4.1 6.8 13.3 6.1 6.9 4.5 8.6 3.1 5.5 27.1 14.4 8.5 3.0 1.9 4.2 0.1 6.1 7.4 7.0 10.7 2.5 20.6 3.6 14.3 6.1 3.1 8.1 14.7 6.6 3.3 3.9 6.4 8.4 20.6 4.4 10.2 7.5 33.1 0.6 7.8 11.6 5.4 7.5 5.6 4.4 1.0 9.0 9.2 4.1 1.9 6.8 5.2 10.7 3.6 4.4 3.9 7.9 0.0 10.1 7.2 1.7 1.9 6.9 25.7 14.9 15.7 6.9 7.4 9.5 NMB "MGC17211, MGC2277, MGC3936" ENSG00000197696 "Neuromedin B" P08949 15 84655129-84658563 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 68.3;brain: 58.9" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 319.5;Club cells: 164.2;Ductal cells: 123.9" "Cancer enhanced" "Detected in all" "glioma: 93.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 90.1" "Region enriched" "Detected in all" 16 "olfactory bulb: 168.0" "Group enriched" "Detected in all" 5 "olfactory bulb: 43.3;pons: 14.1" CAB019302 Approved Approved "Nucleoplasm,Vesicles,Plasma membrane" "Secreted to blood" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Vesicles" "Plasma membrane" "CAB019302: " "unprognostic (2.44e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-3)" "unprognostic (3.79e-1)" "prognostic favorable (3.43e-4)" "unprognostic (3.81e-1)" "unprognostic (6.45e-2)" "unprognostic (1.45e-2)" "unprognostic (2.17e-1)" "unprognostic (4.36e-1)" "unprognostic (7.24e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.25e-4)" "unprognostic (7.92e-3)" "unprognostic (1.45e-1)" "unprognostic (1.71e-2)" "unprognostic (1.00e-1)" 68.3 24.0 19.9 4.1 17.9 6.0 30.7 18.2 23.5 8.3 16.3 5.3 3.1 7.5 4.9 6.9 8.6 4.8 5.4 21.4 58.9 10.7 3.1 6.2 5.7 29.3 22.7 7.1 8.4 4.5 9.8 1.9 26.2 5.0 2.9 3.0 7.4 2.5 2.5 4.9 4.1 4.7 22.4 4.8 5.5 11.9 21.4 4.5 17.7 3.1 3.0 8.5 6.5 44.7 90.1 35.3 6.1 1.3 17.1 7.7 0.8 4.7 10.5 12.5 16.6 12.9 23.5 3.4 12.9 14.7 0.1 15.0 34.0 7.0 7.4 30.3 36.7 12.4 13.2 59.7 4.4 8.2 13.6 7.6 2.8 18.2 7.2 7.6 17.9 23.3 0.2 1.4 6.9 55.2 8.8 30.0 22.9 18.0 8.9 25.7 0.1 38.7 11.5 7.3 3.1 34.6 8.2 5.1 40.5 6.0 5.9 33.8 4.0 2.4 10.3 10.3 7.9 0.7 9.9 8.2 26.3 52.9 14.1 0.0 1.0 7.8 7.9 0.7 2.9 5.9 5.9 7.7 4.5 11.3 5.8 4.1 1.6 1.8 0.5 13.4 7.6 3.4 19.9 17.9 18.2 23.5 21.4 58.9 29.3 22.7 26.2 22.4 21.4 44.7 39.0 3.2 2.7 5.5 13.6 15.6 29.5 319.5 21.6 1.9 30.7 37.6 3.5 20.0 164.2 31.3 0.0 2.4 25.3 5.3 13.7 123.9 33.7 21.3 7.3 19.6 18.6 7.4 0.6 58.2 14.1 19.7 11.2 15.6 5.7 12.0 7.5 3.7 32.3 5.0 1.2 6.5 18.3 8.8 86.4 29.0 4.4 26.0 33.8 1.9 18.5 6.5 25.7 2.0 1.0 45.2 5.1 3.8 32.5 39.3 0.8 32.0 57.8 4.1 13.1 22.5 28.6 24.0 21.6 29.5 12.8 3.1 19.7 8.2 9.1 60.6 NOTCH3 "CADASIL, CASIL" ENSG00000074181 "Notch receptor 3" Q9UM47 19 15159038-15200995 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Sertoli cells: 414.2;Skeletal myocytes: 131.6;Smooth muscle cells: 317.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 66.3;MCF7: 66.9;RT4: 41.2;U-87 MG: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005393, HPA044392" Approved Supported "Nucleoplasm,Actin filaments,Cytosol" NA NA 46000000 "Cluster 41: Basophils - Cellular respiration" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "Actin filaments" "CAB005393: AB_2151246, HPA044392: AB_2678926" "unprognostic (4.97e-2)" "unprognostic (3.89e-2)" "unprognostic (7.06e-3)" "prognostic unfavorable (5.92e-4)" "unprognostic (9.20e-2)" "unprognostic (1.73e-2)" "unprognostic (2.72e-1)" "unprognostic (9.04e-2)" "unprognostic (3.90e-3)" "unprognostic (1.23e-1)" "unprognostic (1.19e-1)" "unprognostic (3.13e-1)" "prognostic unfavorable (2.53e-7)" "unprognostic (3.35e-2)" "unprognostic (8.34e-3)" "unprognostic (4.40e-2)" "unprognostic (2.00e-3)" 85.7 5.3 14.8 10.4 12.4 0.2 50.5 11.0 21.3 49.4 7.1 14.8 5.5 39.9 16.9 74.3 35.8 23.5 43.6 9.5 11.3 26.0 3.2 38.3 9.2 12.0 15.2 18.9 10.7 12.6 10.3 59.8 14.3 22.0 4.2 0.5 24.4 16.5 29.7 82.1 14.3 16.9 8.2 15.0 11.6 3.8 15.8 34.1 32.3 25.1 10.4 26.3 55.1 10.0 13.0 8.1 66.3 30.3 9.2 7.3 29.8 10.2 0.4 0.4 0.3 15.6 13.4 0.4 7.7 18.9 0.1 15.1 12.1 0.2 0.6 0.1 3.1 0.4 12.4 3.5 4.5 0.0 1.2 8.4 7.3 15.5 1.6 0.6 0.8 4.6 0.5 0.6 1.2 66.9 15.9 0.1 38.8 11.2 0.0 0.1 3.7 0.3 0.0 41.2 1.9 21.4 0.1 37.8 0.0 19.6 40.3 0.1 0.0 1.9 21.0 0.3 0.1 0.1 0.7 0.0 45.7 0.4 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 14.8 12.4 11.0 21.3 9.5 11.3 12.0 15.2 14.3 8.2 15.8 10.0 39.6 9.6 1.5 5.9 0.4 24.1 7.8 17.8 4.6 0.4 41.5 30.7 60.7 0.0 28.5 16.5 0.0 20.2 1.0 0.0 5.9 14.8 0.5 4.8 13.5 32.0 0.0 0.0 0.6 0.0 3.9 24.2 2.0 11.8 0.0 5.9 4.2 0.0 2.8 0.0 0.3 0.3 6.1 10.4 12.3 0.1 9.0 4.1 17.8 13.1 0.7 0.8 0.0 0.0 0.2 0.9 0.1 11.7 0.0 13.0 0.1 0.0 4.2 0.8 414.2 131.6 317.0 0.9 1.2 72.1 72.2 31.5 2.0 1.2 0.2 36.0 NOX3 GP91-3 ENSG00000074771 "NADPH oxidase 3" Q9HBY0 6 155395368-155455839 "Predicted membrane proteins, Transporters" Oxidoreductase "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 10 "MCF7: 4.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA073837 Uncertain Vesicles NA NA "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA073837: " "unprognostic (3.42e-1)" 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPEPL1 "bA261P9.2, FLJ11583" ENSG00000215440 "Aminopeptidase like 1" Q8NDH3 20 58689131-58719238 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 23.9;classical monocyte: 18.5;eosinophil: 7.2;intermediate monocyte: 13.0;myeloid DC: 11.4;neutrophil: 13.7;non-classical monocyte: 18.8" "Group enriched" "Detected in all" 5 "dendritic cells: 11.4;granulocytes: 23.9;monocytes: 18.8" "Cell line enhanced" "Detected in many" "MCF7: 106.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004986, CAB017025, HPA036356" Approved Approved Nucleoplasm,Cytosol NA NA 14000 "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "CAB004986: AB_426073, CAB017025: , HPA036356: AB_2675082" "unprognostic (1.68e-1)" "unprognostic (5.87e-3)" "unprognostic (8.28e-2)" "unprognostic (2.78e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (2.86e-3)" "unprognostic (3.11e-2)" "unprognostic (4.14e-1)" "unprognostic (1.08e-2)" "unprognostic (1.62e-3)" "unprognostic (3.78e-2)" "prognostic unfavorable (1.87e-9)" "unprognostic (7.97e-2)" "unprognostic (1.64e-1)" "unprognostic (2.21e-1)" "prognostic favorable (5.73e-4)" 31.9 24.8 20.6 9.4 21.5 19.9 28.1 20.2 28.9 20.4 22.5 40.8 15.9 24.8 3.9 26.9 23.2 15.8 30.7 20.7 19.0 40.6 20.6 26.6 13.6 22.6 20.3 23.6 24.1 16.7 27.0 10.0 20.9 29.3 4.4 2.5 29.7 15.2 66.3 23.7 25.4 8.6 19.7 40.1 27.1 23.1 22.1 7.7 39.2 28.8 6.1 39.2 22.1 21.0 22.5 31.2 5.5 4.5 11.8 21.7 1.7 8.5 0.7 26.6 14.9 18.0 16.6 1.0 44.6 15.7 0.3 24.0 7.5 10.4 2.6 20.0 7.5 8.0 26.0 8.3 29.6 8.1 13.0 21.3 31.7 9.3 0.0 9.8 22.6 6.1 1.1 3.5 10.6 106.6 3.3 21.2 8.3 13.1 33.8 6.6 2.6 12.6 11.1 14.8 10.1 3.2 22.4 6.1 41.8 3.0 23.4 15.3 25.3 6.7 5.4 14.0 4.4 11.7 4.3 0.7 9.8 15.2 2.7 23.9 18.5 7.2 2.5 13.0 3.1 1.4 1.5 1.7 11.4 0.9 0.9 1.8 13.7 3.2 18.8 0.5 3.7 6.3 20.6 21.5 20.2 28.9 20.7 19.0 22.6 20.3 20.9 19.7 22.1 21.0 23.6 9.6 15.6 0.0 3.5 9.2 8.2 17.1 10.8 19.0 17.2 16.0 16.7 10.0 16.4 27.6 25.0 15.0 11.8 7.6 13.7 14.8 2.3 11.9 8.1 13.6 12.0 3.0 0.0 9.2 7.8 16.1 18.8 6.4 2.5 32.3 15.0 9.1 11.2 8.4 0.0 10.2 20.3 16.7 12.0 8.5 22.1 15.1 7.2 0.0 16.3 20.1 6.2 0.0 0.0 10.8 14.3 14.7 8.4 4.4 17.6 19.9 19.0 8.5 19.7 14.9 15.2 6.7 3.0 16.9 11.2 8.9 9.0 9.7 13.1 7.7 NPY4R "PP1, PPYR1, Y4" ENSG00000204174 "Neuropeptide Y receptor Y4" P50391 10 46461099-46465958 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 2.3;intestine: 6.0;skin 1: 3.0" "Not detected" "Not detected" "Cancer enhanced" "Detected in single" "prostate cancer: 0.8" "Region enhanced" "Detected in single" "thalamus: 2.3" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "A549: 28.6" HPA027863 Approved NA NA "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "HPA027863: AB_10602819" "unprognostic (2.26e-6)" "unprognostic (2.94e-1)" "unprognostic (8.17e-2)" "unprognostic (1.20e-1)" "unprognostic (1.30e-1)" "unprognostic (1.77e-3)" "unprognostic (1.98e-1)" "unprognostic (2.64e-3)" "unprognostic (6.58e-2)" "unprognostic (9.79e-2)" 0.5 0.0 0.3 0.7 0.1 0.0 0.2 0.6 0.2 0.1 0.0 4.9 1.5 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.4 0.0 0.0 0.7 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.6 1.3 6.0 0.0 0.0 0.0 0.0 3.0 1.2 1.0 0.3 0.0 1.9 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.5 28.6 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.3 0.1 0.0 0.8 0.0 0.0 5.9 0.0 0.4 0.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.2 1.5 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.2 0.2 0.4 0.5 0.5 0.6 0.3 2.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NPY4R2 CH17-360D5.1 ENSG00000264717 "Neuropeptide Y receptor Y4-2" P0DQD5 10 47918739-47923524 "Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "intestine: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 12 "A549: 10.2" HPA027863 Uncertain NA NA "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "HPA027863: AB_10602819" "unprognostic (1.74e-2)" "unprognostic (1.24e-2)" "unprognostic (1.59e-1)" "unprognostic (7.78e-2)" "unprognostic (6.72e-3)" "unprognostic (1.23e-1)" "unprognostic (1.46e-2)" "unprognostic (3.25e-1)" 0.3 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.0 1.7 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.1 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.1 0.0 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 10.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.1 0.2 0.1 0.2 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NR0B1 "AHC, AHCH, DAX1, DSS" ENSG00000169297 "Nuclear receptor subfamily 0 group B member 1" P51843 X 30304206-30309390 "Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Receptor, Repressor" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "adrenal gland: 32.7;testis: 19.3" "Cell type enhanced" "Detected in some" "Enteroendocrine cells: 5.4;Ionocytes: 8.2;monocytes: 2.6;Oligodendrocyte precursor cells: 10.6;Theca cells: 4.9" "Cancer enhanced" "Detected in many" "lung cancer: 4.1" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "A549: 62.5;RT4: 19.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA061948, HPA067207" Supported "Nuclear speckles,Vesicles,Centriolar satellite" NA NA "Cluster 17: Adrenal gland - Steroid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 68: Oligodendrocytes - Mixed function" "Nuclear speckles" "Vesicles, Centriolar satellite" "HPA061948: AB_2732673, HPA067207: AB_2732761" "unprognostic (1.50e-2)" "unprognostic (9.68e-2)" "unprognostic (9.47e-3)" "unprognostic (1.23e-1)" "unprognostic (2.81e-1)" "unprognostic (7.45e-3)" "unprognostic (4.83e-2)" "unprognostic (9.00e-2)" "unprognostic (1.33e-3)" 0.2 32.7 1.4 0.0 1.3 0.0 0.2 1.0 1.5 2.4 0.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 1.4 1.3 3.6 2.1 0.0 2.5 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 1.2 0.1 0.7 19.3 5.9 0.0 0.0 0.0 0.0 0.0 2.0 1.4 0.0 62.5 0.0 0.0 2.3 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 2.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 19.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 8.8 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 1.3 1.0 1.5 1.3 1.8 1.4 1.3 1.3 1.2 5.9 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.1 5.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.3 8.2 0.0 0.0 1.9 1.2 0.1 1.8 0.0 2.6 0.0 0.0 10.6 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.6 0.8 0.0 0.1 0.0 0.0 4.9 0.0 0.1 NR2C2AP TRA16 ENSG00000184162 "Nuclear receptor 2C2 associated protein" Q86WQ0 19 19201409-19203414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Prostatic glandular cells: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042054, HPA055653" Approved Supported Nucleoplasm NA NA "Cluster 30: Non-specific - Translation" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" Nucleoplasm "HPA042054: AB_10965022, HPA055653: AB_2682877" "unprognostic (9.54e-2)" "unprognostic (2.93e-3)" "prognostic unfavorable (8.53e-4)" "unprognostic (2.36e-2)" "unprognostic (6.81e-2)" "unprognostic (6.26e-3)" "prognostic unfavorable (5.63e-5)" "unprognostic (1.60e-2)" "unprognostic (1.53e-1)" "unprognostic (8.77e-2)" "unprognostic (3.65e-3)" "unprognostic (5.89e-2)" "unprognostic (7.62e-3)" "unprognostic (1.17e-2)" "unprognostic (5.99e-2)" "prognostic favorable (1.65e-4)" "unprognostic (2.10e-2)" 14.5 10.0 13.8 12.5 14.2 7.6 15.6 14.3 14.2 14.6 12.6 15.0 8.2 14.8 13.7 17.0 14.9 6.7 10.7 14.2 13.8 16.2 10.6 9.5 13.6 14.4 14.1 16.4 15.3 7.8 8.2 7.6 14.4 14.8 11.0 3.5 13.3 10.6 12.6 21.0 12.4 11.4 14.5 13.4 13.4 5.5 14.1 10.2 11.1 7.8 13.6 17.8 14.6 15.6 50.7 29.2 13.6 28.9 11.1 11.1 52.7 28.3 16.0 37.9 35.8 19.7 60.4 27.3 77.2 15.0 26.5 44.2 36.0 37.3 23.1 24.3 39.0 15.6 18.0 21.9 12.9 30.5 23.2 11.3 45.1 26.3 35.4 10.7 15.2 31.0 28.4 35.0 22.8 130.0 51.2 27.6 24.4 72.9 58.8 36.3 22.0 53.3 23.5 26.4 45.2 20.7 24.3 47.1 37.0 16.5 25.6 18.9 12.2 24.5 23.3 61.7 54.7 20.7 32.4 36.3 28.5 51.3 33.2 2.6 14.9 1.5 31.4 21.5 41.2 43.6 40.7 30.4 12.6 42.8 42.3 39.7 2.7 27.4 17.4 24.7 37.7 26.3 13.8 14.2 14.3 14.2 14.2 13.8 14.4 14.1 14.4 14.5 14.1 15.6 14.7 0.0 9.4 2.3 19.2 31.7 41.3 19.8 38.1 3.8 26.8 31.8 2.5 5.7 12.3 7.3 0.0 24.8 17.2 10.3 7.9 20.8 0.7 8.9 7.8 13.5 4.8 8.8 2.9 16.2 34.3 12.1 6.6 11.4 14.0 14.0 5.3 4.5 18.5 8.4 1.7 12.8 10.2 5.0 11.0 1.2 16.4 9.3 10.6 1.0 15.2 5.5 11.3 2.0 2.4 19.0 5.4 13.5 8.0 67.8 7.6 10.9 9.2 3.9 0.0 11.7 10.9 4.6 16.7 26.3 25.1 12.6 16.3 8.7 17.9 36.0 NR5A2 "B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1" ENSG00000116833 "Nuclear receptor subfamily 5 group A member 2" O00482 1 200027614-200177420 "Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters" "Transcription, Transcription regulation" "Activator, DNA-binding, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 17.8;liver: 38.6;pancreas: 61.1" "Cell type enriched" "Detected in many" 5 "Granulosa cells: 276.2" "Cancer enhanced" "Detected in many" "liver cancer: 6.6" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 4 "basophil: 3.2;neutrophil: 1.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 3.2" "Cell line enhanced" "Detected in some" "A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4" "Region enhanced" "Detected in single" "hypothalamus: 1.2" "Not detected" "Not detected" "HPA005455, HPA017067" Approved Uncertain "Nuclear speckles" NA NA "Cluster 17: Basophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "HPA005455: AB_1078140, HPA017067: AB_1844767" "unprognostic (7.47e-2)" "unprognostic (1.43e-1)" "unprognostic (5.84e-2)" "unprognostic (1.56e-2)" "unprognostic (1.19e-2)" "unprognostic (6.63e-3)" "unprognostic (4.46e-2)" "unprognostic (3.78e-2)" "unprognostic (3.34e-1)" "unprognostic (8.50e-2)" "unprognostic (4.64e-2)" "unprognostic (1.44e-1)" "unprognostic (1.00e-7)" "unprognostic (5.48e-2)" "unprognostic (5.07e-2)" "unprognostic (9.23e-2)" "unprognostic (1.37e-1)" 5.4 0.4 0.5 2.6 0.2 0.9 3.7 0.5 0.3 3.4 0.2 11.9 17.4 3.3 1.4 0.9 2.2 8.0 1.0 0.3 2.8 0.7 38.6 2.7 2.1 0.7 0.6 1.0 61.1 0.4 0.1 0.4 0.8 1.6 13.1 0.2 0.5 0.8 1.1 1.1 17.8 4.3 0.4 0.2 1.3 0.8 0.8 0.5 0.9 0.7 1.4 1.8 1.2 0.7 0.0 25.0 0.0 0.1 0.0 0.2 0.6 0.0 0.4 0.0 0.0 6.2 0.1 0.0 0.0 0.0 0.7 0.7 14.9 0.0 0.0 3.3 1.1 0.0 0.3 2.7 0.5 0.1 6.4 0.1 0.0 0.0 0.1 0.0 20.4 0.1 0.0 0.3 0.0 0.6 0.0 0.4 0.9 0.0 0.3 0.4 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 0.1 1.7 4.7 0.3 0.1 1.0 0.2 0.1 0.2 3.4 2.3 2.6 0.3 0.2 0.1 3.2 0.4 0.4 0.2 0.2 0.2 0.3 0.3 0.3 0.1 0.4 0.4 0.3 1.5 0.5 0.2 0.5 0.4 0.1 0.5 0.2 0.5 0.3 0.3 2.8 0.7 0.6 0.8 0.4 0.8 0.7 23.7 0.0 1.7 0.3 0.2 1.9 0.1 0.0 0.0 0.2 0.2 0.0 9.9 32.9 0.0 0.0 0.0 0.0 0.3 37.5 0.0 38.2 0.4 0.3 0.3 32.4 4.9 2.7 0.4 54.5 0.0 0.8 0.0 0.2 13.3 276.2 38.6 38.5 0.1 0.0 0.6 13.8 0.0 4.9 1.5 0.3 0.6 0.6 0.0 0.0 3.1 0.0 0.0 1.0 0.3 22.0 21.8 0.0 1.2 0.3 49.9 0.0 0.8 0.3 0.0 0.5 6.1 0.1 0.1 0.0 1.4 0.0 0.3 0.1 32.3 0.2 NRAS N-ras ENSG00000213281 "NRAS proto-oncogene, GTPase" P01111 1 114704469-114716771 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010157, HPA049830, CAB079912" Uncertain Supported "Plasma membrane" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "Plasma membrane" "CAB010157: AB_632073, CAB079912: AB_2784586, HPA049830: AB_2680903" "unprognostic (4.75e-2)" "unprognostic (2.81e-1)" "unprognostic (1.09e-3)" "unprognostic (2.11e-2)" "unprognostic (8.59e-3)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.03e-7)" "unprognostic (7.76e-3)" "unprognostic (1.57e-2)" "unprognostic (1.01e-3)" "prognostic unfavorable (1.36e-4)" "unprognostic (6.60e-3)" "prognostic unfavorable (7.87e-4)" "unprognostic (2.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.16e-1)" "unprognostic (3.33e-2)" 19.0 9.1 10.3 25.7 11.2 58.5 18.0 11.5 12.3 12.5 8.6 27.8 21.5 12.4 7.8 20.7 10.3 17.2 8.3 10.2 12.2 20.9 24.9 18.5 30.4 12.3 12.1 9.6 11.4 9.0 4.3 28.3 12.3 11.4 26.6 6.6 10.9 7.1 7.7 19.8 22.5 14.1 11.7 18.6 21.8 9.6 11.4 39.0 16.1 7.8 29.7 22.2 8.6 13.4 93.7 24.9 65.2 24.9 26.4 56.3 46.5 43.5 48.4 79.5 89.0 50.4 33.9 70.4 56.3 58.9 55.4 26.0 88.2 70.6 113.4 96.5 34.2 47.8 34.5 60.2 52.3 120.0 71.0 51.1 56.1 91.5 66.2 25.0 102.8 54.6 77.3 78.5 71.0 248.9 83.5 46.4 111.0 30.2 17.9 62.9 116.0 44.1 70.6 49.5 39.4 59.0 44.7 36.4 107.1 75.4 31.9 96.2 79.2 43.3 82.2 81.5 90.3 137.7 101.6 81.6 86.4 64.6 159.0 38.7 12.8 12.6 11.7 19.2 10.5 12.8 9.3 11.6 12.6 10.5 9.9 12.9 3.4 15.5 17.6 9.6 13.4 13.1 10.3 11.2 11.5 12.3 10.2 12.2 12.3 12.1 12.3 11.7 11.4 13.4 22.7 16.0 16.5 8.1 25.9 30.7 31.2 23.1 15.4 5.2 18.5 13.6 5.6 18.6 19.3 22.0 8.4 22.4 27.7 49.2 13.7 34.1 3.9 22.9 24.7 29.2 24.6 31.6 5.8 31.5 50.4 16.1 29.0 38.0 31.1 22.2 33.2 29.7 49.2 5.0 5.2 28.1 30.5 44.9 30.7 5.9 8.1 30.4 23.2 9.4 41.6 7.8 22.6 5.0 8.1 51.4 32.9 6.4 39.6 30.6 28.1 39.4 23.1 3.3 6.6 12.8 15.3 7.3 15.4 24.6 36.2 31.2 21.9 13.8 28.8 40.2 NT5C "cdN, DNT-1, DNT1, PN-I, UMPH2" ENSG00000125458 "5', 3'-nucleotidase, cytosolic" Q8TCD5 17 75130225-75131757 "Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA021581, HPA023632" Approved Supported Cytosol NA NA 760000 "Cluster 10: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA021581: AB_1854663, HPA023632: AB_1854662" "unprognostic (3.83e-2)" "unprognostic (4.45e-2)" "unprognostic (2.39e-1)" "unprognostic (3.61e-2)" "unprognostic (1.26e-1)" "unprognostic (9.21e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.26e-1)" "unprognostic (7.25e-2)" "unprognostic (8.26e-3)" "unprognostic (7.15e-2)" "unprognostic (2.22e-1)" "unprognostic (6.57e-2)" "unprognostic (1.58e-1)" "unprognostic (1.10e-1)" "unprognostic (2.13e-1)" "prognostic favorable (7.66e-4)" 31.6 31.4 14.5 17.9 15.9 16.3 31.8 16.5 17.4 37.0 14.8 43.0 24.5 34.7 5.2 45.9 32.1 8.4 32.6 14.1 16.7 47.8 29.1 29.2 18.3 17.1 15.5 37.5 33.7 11.7 18.9 10.2 15.6 35.7 13.1 8.7 25.8 15.3 41.1 33.8 43.7 7.6 16.6 40.7 36.8 15.2 15.5 16.0 37.7 16.1 15.2 37.9 35.9 18.4 52.5 77.7 25.3 26.5 7.5 15.4 33.7 29.5 26.2 29.7 18.8 29.5 58.3 35.5 21.5 21.0 5.2 33.7 18.1 37.7 16.5 16.1 51.3 40.5 68.7 50.0 38.0 38.8 17.2 23.1 17.4 21.3 57.0 11.9 33.0 27.6 38.4 16.8 30.2 51.2 28.0 39.0 26.5 43.6 50.6 24.9 32.9 50.9 39.3 26.7 30.0 60.1 28.3 34.8 43.9 14.0 49.8 27.2 20.4 25.0 62.1 9.8 40.3 33.3 5.6 41.1 23.8 23.3 40.4 183.7 29.7 48.9 39.2 49.6 27.7 94.9 25.5 33.6 37.9 87.4 21.6 33.5 14.4 72.6 50.7 50.4 45.2 30.2 14.5 15.9 16.5 17.4 14.1 16.7 17.1 15.5 15.6 16.6 15.5 18.4 23.0 32.1 19.5 22.2 132.9 47.4 86.1 108.8 90.5 66.0 58.8 101.9 16.4 77.2 35.2 58.8 20.9 64.9 85.8 272.8 78.2 102.2 2.1 53.2 53.5 26.6 64.1 59.5 7.7 121.4 100.4 59.8 181.5 43.2 46.3 59.0 11.7 41.9 74.5 42.1 8.0 133.4 52.9 55.7 64.4 6.8 59.4 56.2 58.7 18.7 108.4 55.9 98.9 19.6 19.2 127.5 221.6 47.4 51.2 115.8 231.6 144.2 31.1 65.5 32.9 39.0 107.6 19.0 49.6 89.4 44.3 31.2 67.4 98.4 152.8 85.9 NT5C3B "cN-IIIB, MGC20781, NT5C3L" ENSG00000141698 "5'-nucleotidase, cytosolic IIIB" Q969T7 17 41825057-41836260 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 131.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 39.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030786, HPA057095" Approved NA NA "Cluster 30: Non-specific - Translation" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA030786: AB_10602716, HPA057095: AB_2683333" "unprognostic (3.90e-2)" "unprognostic (5.75e-2)" "unprognostic (8.87e-2)" "unprognostic (1.46e-1)" "unprognostic (2.25e-1)" "unprognostic (1.21e-1)" "prognostic unfavorable (8.11e-5)" "unprognostic (3.40e-2)" "unprognostic (6.05e-2)" "unprognostic (2.31e-1)" "prognostic favorable (2.67e-4)" "unprognostic (3.07e-1)" "unprognostic (7.17e-3)" "unprognostic (2.36e-2)" "unprognostic (4.80e-3)" "unprognostic (7.14e-3)" "unprognostic (1.42e-2)" 7.9 7.6 12.4 1.5 12.8 1.2 7.6 15.5 13.4 7.6 10.8 12.9 1.9 7.0 3.3 6.3 7.0 3.2 7.1 13.0 12.3 11.1 8.7 6.5 2.8 10.9 11.3 7.4 11.5 2.8 9.9 3.0 10.6 9.0 1.1 3.6 7.8 4.2 6.0 4.7 6.5 4.8 10.0 5.7 8.9 9.5 11.8 0.9 13.0 5.6 1.9 8.9 6.8 12.7 8.1 39.5 7.8 12.7 8.6 6.0 3.2 9.5 8.5 12.9 14.3 34.0 2.1 9.3 5.6 6.3 8.6 8.3 8.2 9.9 4.6 5.9 19.7 4.1 21.8 17.8 10.1 0.1 4.7 5.3 5.4 17.4 6.5 4.7 7.5 13.8 3.6 2.4 8.6 18.0 8.2 5.1 5.0 7.9 4.2 6.2 13.2 7.8 3.7 10.0 6.0 3.5 13.4 13.8 4.9 6.7 6.7 6.3 7.1 5.3 5.4 9.3 9.5 2.7 5.6 4.2 4.2 0.1 8.1 1.1 2.3 0.3 1.8 0.5 2.5 1.8 2.4 1.8 2.4 2.5 1.9 2.1 1.3 0.7 0.4 1.3 0.4 2.0 12.4 12.8 15.5 13.4 13.0 12.3 10.9 11.3 10.6 10.0 11.8 12.7 24.8 9.6 17.2 15.0 16.9 18.1 58.7 47.3 33.6 33.8 45.1 61.1 13.6 22.8 16.6 29.5 18.8 39.0 8.7 5.1 101.8 51.6 99.8 10.9 26.8 29.1 39.4 2.5 14.2 41.6 56.2 35.2 14.3 12.1 11.4 40.1 26.7 24.0 13.4 116.1 15.5 13.2 32.6 13.2 18.5 121.6 32.3 11.7 35.6 6.5 5.8 42.4 6.2 13.0 7.2 39.1 9.8 30.5 15.5 78.7 1.4 65.1 12.7 36.5 39.5 31.1 49.3 131.8 30.0 19.8 17.2 31.2 13.8 23.7 15.2 44.6 NUBP1 "CIAO5, NBP1, NBP35" ENSG00000103274 "Nucleotide binding protein 1" P53384 16 10743786-10769351 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041656, HPA041799" Enhanced Supported Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" Cytosol "HPA041656: AB_10960278, HPA041799: AB_10960692" "unprognostic (2.51e-2)" "prognostic favorable (2.81e-5)" "unprognostic (4.01e-3)" "unprognostic (1.66e-3)" "unprognostic (2.81e-1)" "unprognostic (7.04e-2)" "unprognostic (1.33e-1)" "unprognostic (7.30e-3)" "unprognostic (8.28e-2)" "unprognostic (5.08e-2)" "unprognostic (1.61e-1)" "unprognostic (2.50e-1)" "prognostic favorable (7.61e-8)" "unprognostic (2.12e-1)" "unprognostic (1.04e-1)" "unprognostic (8.23e-2)" "unprognostic (1.69e-2)" 22.7 39.3 12.6 25.9 12.7 31.0 22.0 13.6 16.5 19.9 15.2 27.4 21.6 21.3 24.8 19.7 25.6 19.6 46.7 12.5 13.1 27.8 31.1 21.2 31.1 13.2 12.7 22.9 31.9 30.3 17.0 19.6 13.1 21.1 20.0 12.0 21.7 21.0 37.7 15.7 22.1 22.7 13.5 28.5 28.7 17.3 12.9 21.4 23.5 34.7 36.9 24.4 16.8 13.8 31.3 55.9 37.2 23.1 16.8 31.0 35.5 29.9 27.9 51.4 42.6 49.0 33.2 53.7 60.5 36.7 40.0 33.5 34.9 30.7 38.2 84.8 43.9 30.3 39.3 80.4 33.7 27.7 34.3 29.2 23.0 35.2 19.2 28.6 34.2 20.6 43.3 31.7 38.3 72.0 18.2 40.2 46.1 25.5 29.9 72.5 48.2 58.6 37.0 37.7 22.9 33.5 51.8 38.6 29.2 23.7 39.3 30.2 30.5 40.0 40.8 49.9 38.2 56.0 52.0 42.4 36.7 55.3 48.0 3.8 82.7 41.3 39.2 88.2 35.9 75.6 34.7 39.1 89.7 69.3 29.9 31.1 9.7 35.2 66.7 44.0 46.5 52.9 12.6 12.7 13.6 16.5 12.5 13.1 13.2 12.7 13.1 13.5 12.9 13.8 20.3 6.4 23.1 3.9 33.7 14.3 26.6 39.8 10.8 17.0 14.9 17.3 6.0 34.3 32.2 23.9 6.2 49.6 19.0 12.3 66.5 54.2 2.4 17.3 12.2 21.3 16.8 12.0 8.4 79.1 29.2 16.7 15.8 17.2 24.1 17.3 14.6 29.6 56.4 6.7 8.1 19.2 40.7 38.4 91.2 3.6 25.7 38.0 16.0 3.7 72.7 30.1 20.6 3.0 5.2 48.7 18.4 19.5 17.6 17.9 27.2 65.0 31.6 18.5 6.6 20.0 15.9 33.1 29.4 12.3 11.9 60.7 17.8 25.3 18.0 29.2 NUBP2 "CFD1, CIAO6" ENSG00000095906 "Nucleotide binding protein 2" Q9Y5Y2 16 1782932-1789186 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041704 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "HPA041704: AB_10804006" "unprognostic (1.94e-1)" "unprognostic (5.73e-3)" "unprognostic (2.83e-1)" "unprognostic (1.17e-1)" "unprognostic (2.16e-1)" "unprognostic (6.02e-2)" "unprognostic (8.44e-2)" "unprognostic (1.21e-1)" "unprognostic (3.42e-1)" "unprognostic (1.53e-1)" "unprognostic (8.64e-2)" "unprognostic (1.20e-1)" "prognostic favorable (9.63e-5)" "unprognostic (2.92e-2)" "unprognostic (1.82e-1)" "unprognostic (2.21e-1)" "unprognostic (5.83e-2)" 19.4 34.3 18.2 10.6 19.7 16.6 17.6 19.5 25.5 21.6 26.5 21.9 14.5 18.7 3.8 30.8 17.1 5.9 20.8 17.6 17.1 26.4 53.2 18.0 16.0 21.3 18.4 17.7 34.2 8.3 18.7 10.9 18.9 25.6 4.2 3.4 22.4 10.4 27.9 25.8 20.5 6.7 18.9 26.8 27.2 10.1 19.7 14.0 18.9 8.2 6.4 20.8 20.1 19.8 28.6 91.4 16.2 49.6 12.1 9.2 50.9 32.2 14.8 20.7 23.3 56.1 41.5 45.0 38.1 7.4 15.2 32.6 10.8 31.6 3.8 39.6 85.7 19.6 67.2 83.0 23.6 30.2 38.2 13.1 26.6 16.9 12.1 13.0 26.2 54.9 49.4 29.6 8.7 109.1 58.8 53.7 44.2 26.4 52.6 80.0 33.4 106.1 16.7 21.1 58.4 70.4 31.9 50.4 38.1 4.2 75.5 35.9 29.8 33.8 42.6 31.9 34.1 65.1 44.9 54.4 20.4 36.0 44.2 72.3 58.1 59.8 64.9 61.6 59.2 48.5 56.5 57.7 62.3 47.6 47.1 45.0 29.7 57.9 60.7 87.5 84.2 67.9 18.2 19.7 19.5 25.5 17.6 17.1 21.3 18.4 18.9 18.9 19.7 19.8 41.0 16.0 30.9 9.4 38.4 35.8 39.4 75.8 24.5 36.0 52.2 65.9 24.9 42.9 43.7 31.3 20.9 103.9 55.5 40.2 66.5 64.7 33.1 23.1 32.7 35.1 38.2 36.4 6.2 74.3 83.0 38.0 32.6 24.5 20.3 48.6 31.8 65.0 62.2 23.5 7.4 51.7 54.9 39.3 28.8 90.9 36.7 27.9 58.7 7.5 55.1 54.4 68.0 6.0 11.0 63.7 30.4 30.9 38.0 45.0 65.4 67.1 22.2 42.5 46.0 28.2 43.3 34.0 30.6 44.7 41.5 41.3 42.0 49.6 58.2 32.2 NUDT16L1 "SDOS, TIRR" ENSG00000168101 "Nudix hydrolase 16 like 1" Q9BRJ7 16 4693694-4695859 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044186, HPA063605" Approved Approved "Plasma membrane,Cytosol" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Plasma membrane, Cytosol" "HPA044186: AB_10968571, HPA063605: AB_2685058" "unprognostic (1.35e-2)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.17e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-2)" "unprognostic (3.14e-1)" "prognostic favorable (2.79e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (6.12e-3)" "unprognostic (6.81e-2)" "prognostic favorable (1.02e-6)" "unprognostic (2.78e-1)" "unprognostic (1.47e-1)" "unprognostic (4.08e-2)" "unprognostic (6.81e-3)" 19.7 46.4 43.1 12.0 44.8 22.2 21.5 43.6 52.5 23.1 45.6 28.5 21.7 21.4 15.3 28.9 23.4 8.4 58.2 44.1 42.0 43.4 64.1 17.2 17.9 45.3 43.2 22.7 24.6 20.4 39.9 8.0 41.9 34.8 11.9 14.5 26.6 14.7 25.0 25.2 29.2 8.5 43.3 33.7 30.1 22.8 44.3 18.2 30.8 16.9 13.1 22.7 21.8 45.7 14.7 23.8 21.2 28.7 15.7 12.1 19.4 17.2 12.9 20.4 12.8 26.9 11.6 15.2 24.4 20.7 10.3 16.8 23.1 23.4 9.5 22.6 38.9 16.8 21.1 32.8 17.0 24.4 19.2 18.7 21.3 17.2 10.7 13.9 15.1 22.6 31.2 18.5 20.1 57.3 36.8 36.0 33.6 24.4 27.0 50.9 22.4 24.2 24.8 18.0 41.8 31.5 25.1 25.9 11.7 16.5 38.4 56.4 20.0 16.7 25.3 39.8 15.9 32.1 20.5 26.1 10.4 32.3 34.8 56.6 54.3 96.2 52.6 48.2 63.1 60.7 63.4 62.8 50.2 65.3 74.0 63.5 68.2 63.9 53.5 83.6 78.3 98.1 43.1 44.8 43.6 52.5 44.1 42.0 45.3 43.2 41.9 43.3 44.3 45.7 23.3 16.0 22.4 14.4 32.6 14.0 19.7 37.4 27.9 52.1 36.0 36.2 52.6 24.3 28.0 42.3 10.4 53.8 43.6 47.7 109.5 28.7 5.2 28.7 33.6 21.4 43.1 23.1 10.2 30.9 31.8 24.0 30.5 29.0 27.9 31.7 17.9 41.8 40.9 47.1 11.8 51.7 89.5 18.3 18.7 8.7 31.4 20.8 30.2 3.7 43.3 83.5 34.0 9.5 15.0 30.0 48.5 50.0 33.0 17.9 77.8 98.2 20.1 58.3 46.0 14.2 22.8 14.8 34.7 24.9 16.6 49.1 43.6 58.0 51.4 17.6 NUP210L ENSG00000143552 "Nucleoporin 210 like" Q5VU65 1 153992685-154155116 "Cancer-related genes, Metabolic proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 26.6" "Cell type enhanced" "Detected in some" "Early spermatids: 20.3;Inhibitory neurons: 8.4;Late spermatids: 8.5;Oligodendrocytes: 19.2;Spermatocytes: 28.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 47 "MCF7: 15.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA047195, HPA064245, HPA066707" Enhanced Approved "Nuclear bodies" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies" "HPA047195: AB_2679980, HPA064245: AB_2685224, HPA066707: AB_2685706" "unprognostic (2.11e-1)" "unprognostic (1.78e-1)" "unprognostic (3.01e-1)" "unprognostic (1.80e-2)" "unprognostic (1.63e-2)" "unprognostic (1.72e-3)" "unprognostic (6.90e-2)" "unprognostic (1.79e-3)" "unprognostic (3.45e-2)" "unprognostic (5.57e-2)" "unprognostic (4.51e-4)" "unprognostic (1.15e-1)" "unprognostic (9.35e-10)" "unprognostic (4.20e-2)" "unprognostic (3.78e-2)" "unprognostic (7.45e-2)" "unprognostic (4.09e-2)" 0.1 0.0 0.2 0.0 0.7 0.1 0.0 2.4 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.3 0.1 0.0 0.1 0.0 0.7 0.6 0.1 0.1 0.0 0.3 0.0 0.8 0.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.2 0.3 0.0 0.0 26.6 0.5 0.0 0.2 0.0 0.0 0.3 0.0 2.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 15.8 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.1 0.0 0.2 0.7 2.4 0.9 0.4 0.3 0.7 0.6 0.8 0.3 0.5 2.3 0.6 0.0 0.0 6.2 0.5 0.3 0.1 0.1 0.0 0.0 0.3 0.3 1.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 20.3 0.7 0.6 0.9 0.0 0.4 7.0 0.2 0.1 0.5 0.0 1.5 0.0 0.1 0.0 0.0 0.2 0.0 8.4 0.1 0.0 0.0 0.6 8.5 0.9 0.8 0.0 2.8 0.0 0.0 0.0 4.5 19.2 0.0 0.0 1.2 1.7 0.1 0.0 0.1 0.1 0.0 6.6 1.8 0.3 28.2 5.1 0.3 0.6 0.0 0.4 0.1 0.1 0.3 OSGEP "GCPL1, KAE1, OSGEP1, PRSMG1, TCS3" ENSG00000092094 "O-sialoglycoprotein endopeptidase" Q9NPF4 14 20446401-20455089 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039751 Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 23: Antigen presenting cells - Antigen presentation" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" Nucleoplasm "Plasma membrane" "HPA039751: AB_10794754" "prognostic favorable (1.48e-4)" "unprognostic (4.15e-3)" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (1.54e-2)" "unprognostic (3.95e-2)" "unprognostic (5.54e-3)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.35e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.64e-6)" "unprognostic (4.83e-2)" "unprognostic (1.86e-2)" "unprognostic (2.53e-2)" "unprognostic (9.91e-2)" 5.7 6.3 6.1 3.8 6.2 6.1 7.0 6.4 7.3 6.8 6.8 7.6 3.8 6.4 8.5 6.0 6.1 6.6 8.1 6.0 6.3 5.8 11.1 6.2 9.3 6.4 6.1 5.3 5.6 7.4 5.2 6.7 6.4 4.9 7.0 4.1 5.3 8.3 10.5 4.7 6.2 5.6 6.5 8.4 6.4 2.4 6.3 9.9 7.6 9.9 10.1 8.2 4.9 6.9 10.3 17.2 5.6 16.2 9.9 6.6 17.6 8.0 11.3 21.1 20.1 21.5 12.3 21.1 10.3 11.0 9.0 8.6 17.9 17.6 14.1 16.8 19.1 14.8 12.2 32.1 7.4 24.3 19.7 5.3 5.2 26.1 14.0 4.6 14.3 18.8 14.0 12.1 17.6 21.0 25.0 11.8 9.1 31.5 31.8 35.3 10.3 12.4 12.8 11.7 21.3 4.2 15.4 16.0 11.9 3.3 9.7 23.7 6.1 8.7 21.2 11.3 10.7 3.4 18.0 31.7 5.0 36.1 11.0 9.3 29.2 38.5 18.8 27.9 17.4 28.7 19.7 17.2 44.5 38.1 15.9 17.4 13.8 20.9 23.3 16.9 19.2 24.6 6.1 6.2 6.4 7.3 6.0 6.3 6.4 6.1 6.4 6.5 6.3 6.9 27.1 35.3 34.9 16.3 46.0 11.5 20.9 26.2 14.2 37.8 24.0 25.1 17.2 15.7 29.1 23.9 37.5 66.3 31.8 22.5 35.2 24.7 3.1 19.2 18.3 24.1 26.9 19.6 23.0 29.8 47.0 23.4 28.1 16.3 25.9 24.6 25.7 19.3 65.8 10.1 24.1 24.2 22.4 30.7 32.8 3.0 19.3 34.2 21.4 7.5 28.4 31.0 32.0 16.6 17.0 20.0 30.6 21.4 26.2 10.9 42.2 39.7 25.5 51.5 13.1 24.6 23.9 7.8 16.9 22.0 11.5 46.1 26.8 37.3 31.6 17.4 OTUB1 "FLJ20113, FLJ40710" ENSG00000167770 "OTU deubiquitinase, ubiquitin aldehyde binding 1" Q96FW1 11 63985853-64001811 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039176, CAB072836" Approved Supported Approved Nucleoplasm,Cytosol NA NA 500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "CAB072836: , HPA039176: AB_10674980" "unprognostic (2.50e-1)" "unprognostic (5.70e-3)" "unprognostic (3.93e-2)" "unprognostic (1.63e-1)" "unprognostic (2.78e-1)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.85e-3)" "unprognostic (1.34e-2)" "unprognostic (2.45e-1)" "unprognostic (1.27e-2)" "unprognostic (3.04e-1)" "unprognostic (1.34e-1)" "unprognostic (1.33e-3)" "unprognostic (6.76e-2)" "unprognostic (1.42e-1)" "unprognostic (4.84e-2)" "unprognostic (1.82e-1)" 44.8 57.0 69.9 43.0 78.0 63.5 47.3 53.0 93.4 54.1 39.7 51.9 42.0 49.0 37.4 85.4 55.8 35.9 62.4 79.3 62.5 61.3 47.0 47.1 59.8 65.0 58.0 44.5 43.9 47.1 48.6 49.3 66.1 53.5 39.3 25.6 54.3 42.6 70.2 78.1 51.9 38.0 51.2 58.6 54.0 57.1 65.0 56.0 51.9 48.4 57.1 52.5 56.7 67.7 113.4 198.9 107.2 95.7 70.7 77.8 83.0 66.0 97.1 143.6 105.1 138.1 104.5 59.3 122.0 106.6 124.4 138.1 140.4 165.4 88.1 69.9 111.7 99.3 114.1 172.9 98.8 99.2 104.3 83.4 106.4 110.2 69.8 74.4 137.2 54.6 71.2 65.3 97.9 237.2 109.2 133.0 126.5 95.4 94.1 88.3 41.8 102.5 151.1 162.1 81.5 117.5 74.6 114.1 123.3 72.9 178.2 86.3 100.1 75.8 74.2 103.3 88.4 76.2 51.7 86.4 98.4 64.0 74.5 228.8 186.8 189.9 165.5 244.2 131.2 149.6 152.1 153.6 203.1 139.3 117.1 130.4 184.6 161.8 218.9 140.7 224.7 313.4 69.9 78.0 53.0 93.4 79.3 62.5 65.0 58.0 66.1 51.2 65.0 67.7 37.0 19.2 56.5 15.0 67.2 48.3 70.9 137.8 83.6 44.4 42.5 48.8 31.9 37.1 82.5 46.0 39.6 146.2 56.5 104.7 74.3 80.7 72.6 55.4 36.2 43.4 87.8 35.5 17.8 85.5 109.2 50.0 71.9 44.3 48.7 54.6 35.7 33.2 90.4 30.3 16.9 70.8 101.7 57.4 65.9 87.1 34.2 61.0 51.6 8.4 98.0 43.2 78.2 12.5 18.8 90.1 92.0 25.6 80.8 51.8 90.8 85.2 89.2 55.7 26.3 28.1 62.0 48.0 71.4 77.7 52.6 194.8 73.7 51.7 62.7 71.6 OXLD1 "C17orf90, MGC104712" ENSG00000204237 "Oxidoreductase like domain containing 1" Q5BKU9 17 81665036-81666635 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056878, HPA057019" Uncertain Approved Vesicles,Cytosol NA NA 12000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Vesicles, Cytosol" "HPA056878: AB_2683265, HPA057019: AB_2683310" "unprognostic (1.08e-1)" "prognostic favorable (2.91e-4)" "unprognostic (1.37e-1)" "unprognostic (1.38e-1)" "unprognostic (9.03e-2)" "unprognostic (3.79e-2)" "unprognostic (1.07e-2)" "unprognostic (1.92e-2)" "unprognostic (2.14e-1)" "unprognostic (7.60e-3)" "unprognostic (1.22e-2)" "unprognostic (2.38e-1)" "unprognostic (3.06e-2)" "unprognostic (3.64e-1)" "unprognostic (8.71e-2)" "unprognostic (2.01e-1)" "unprognostic (2.30e-2)" 11.4 16.7 8.4 3.2 8.3 6.3 12.6 8.5 15.2 7.7 7.9 10.0 4.5 7.9 0.0 11.0 8.4 1.2 15.4 8.1 8.9 14.2 18.0 7.4 3.9 8.9 8.7 5.5 14.8 1.5 6.6 1.7 8.6 11.1 0.2 0.1 10.6 1.9 16.4 14.3 9.8 1.3 9.0 11.7 15.4 29.7 8.9 0.6 8.9 0.0 0.7 10.0 7.5 9.3 15.2 56.0 0.5 12.6 3.2 0.3 9.5 7.3 0.2 0.1 1.4 14.9 14.1 4.7 12.6 0.0 7.8 13.1 0.0 10.0 0.0 7.7 29.4 4.2 26.1 37.2 22.9 3.0 11.1 4.8 6.8 2.9 3.1 0.7 5.3 22.3 7.3 7.2 1.1 38.3 10.7 12.4 6.9 7.9 24.9 9.7 0.4 20.5 2.9 8.2 2.4 11.2 3.1 19.0 27.6 0.2 27.4 17.1 4.5 10.8 7.2 12.2 8.4 19.8 7.9 6.5 14.6 11.3 11.0 18.6 23.6 18.4 23.5 20.8 25.1 26.4 31.9 27.0 22.9 28.6 33.5 26.0 17.1 35.5 22.6 31.2 30.6 23.8 8.4 8.3 8.5 15.2 8.1 8.9 8.9 8.7 8.6 9.0 8.9 9.3 17.9 32.1 17.1 7.5 26.1 8.5 21.5 48.6 21.6 19.9 40.3 40.0 16.2 30.0 26.1 23.9 6.2 37.1 24.8 43.4 72.4 38.1 85.7 29.9 25.6 19.2 21.7 38.1 8.3 47.9 28.8 20.6 28.1 26.9 14.0 26.1 23.6 55.0 44.2 23.5 7.7 35.5 50.8 34.2 11.1 34.6 33.2 21.0 16.0 5.6 41.2 41.3 47.4 7.5 12.6 43.9 41.5 23.7 19.7 40.4 63.4 89.3 36.0 30.9 26.3 11.9 18.5 95.7 20.4 35.8 8.5 27.9 29.5 56.5 31.6 26.6 PAF1 "F23149_1, FLJ11123, PD2" ENSG00000006712 "PAF1 homolog, Paf1/RNA polymerase II complex component" Q8N7H5 19 39385629-39391154 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041875, HPA043637" Approved Supported Nucleoplasm NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm "HPA041875: AB_2677720, HPA043637: AB_2678592" "unprognostic (5.33e-3)" "unprognostic (3.57e-1)" "unprognostic (1.70e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-1)" "unprognostic (2.99e-1)" "prognostic unfavorable (8.68e-4)" "unprognostic (6.65e-2)" "unprognostic (4.21e-1)" "unprognostic (8.37e-2)" "prognostic favorable (8.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.35e-1)" "unprognostic (1.05e-1)" "unprognostic (2.32e-1)" "unprognostic (4.60e-1)" "unprognostic (2.73e-1)" 36.9 45.4 32.3 26.1 36.4 36.9 37.5 35.1 36.3 40.7 32.4 41.4 22.9 36.9 28.0 44.8 38.9 23.6 45.2 32.8 38.8 35.4 49.5 33.5 29.3 36.4 34.9 50.1 31.9 38.3 48.5 21.0 35.6 40.6 20.2 26.5 38.2 27.7 62.3 34.3 37.3 23.2 33.0 46.9 39.4 68.5 35.7 31.0 41.4 30.9 31.5 37.9 37.4 40.0 92.1 114.9 74.9 40.3 46.7 39.5 30.5 75.0 69.4 86.1 82.7 95.3 48.3 72.6 51.0 61.6 51.3 31.4 81.3 62.1 70.2 82.4 95.2 71.6 77.0 62.6 50.4 61.5 65.6 39.9 42.0 72.0 46.4 54.3 63.8 63.0 56.7 59.0 71.5 103.3 70.7 40.5 26.5 76.2 38.7 70.8 73.4 51.7 64.7 102.3 63.2 42.6 80.5 52.8 41.6 37.1 50.4 52.5 60.8 51.6 68.1 54.5 84.0 63.2 61.2 61.9 51.6 53.0 49.0 32.3 20.0 33.7 29.4 28.0 30.9 40.1 24.4 29.4 21.8 36.6 27.3 25.3 31.3 30.5 26.6 20.4 26.0 21.6 32.3 36.4 35.1 36.3 32.8 38.8 36.4 34.9 35.6 33.0 35.7 40.0 26.6 22.4 46.2 9.4 49.9 53.5 63.0 29.9 63.2 14.1 28.9 27.1 37.5 21.5 35.9 22.0 8.4 38.4 33.2 26.0 13.7 27.3 40.4 48.4 25.3 24.4 26.4 16.4 3.8 27.3 30.0 33.0 43.3 62.8 50.7 19.0 18.2 24.1 24.8 8.4 4.8 22.4 26.4 12.9 62.4 30.6 35.1 28.1 23.2 1.9 20.4 23.4 12.3 6.6 8.8 23.3 22.1 27.8 54.2 24.5 22.9 25.9 64.0 16.8 13.1 22.5 29.8 96.0 26.8 41.0 49.2 64.0 48.7 24.6 21.9 34.8 PAFAH1B3 ENSG00000079462 "Platelet activating factor acetylhydrolase 1b catalytic subunit 3" Q15102 19 42297033-42303546 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 188.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035639 Uncertain Approved "Intermediate filaments" NA NA 290000 "Cluster 26: Non-specific - Mitochondria" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Intermediate filaments" "HPA035639: AB_10670163" "unprognostic (3.19e-1)" "unprognostic (5.38e-3)" "unprognostic (1.13e-1)" "unprognostic (5.99e-2)" "unprognostic (1.83e-1)" "unprognostic (2.09e-2)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.73e-1)" "unprognostic (2.67e-1)" "unprognostic (6.36e-2)" "unprognostic (2.37e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (2.07e-4)" "unprognostic (2.68e-1)" "unprognostic (3.21e-2)" "unprognostic (4.56e-2)" "unprognostic (6.80e-3)" 8.3 23.5 34.7 12.4 35.4 27.9 13.7 36.5 44.1 18.9 31.3 16.8 12.4 13.8 12.9 28.1 14.8 10.8 4.6 35.1 39.9 21.8 7.9 9.2 17.0 32.2 33.1 18.3 18.1 13.8 21.2 5.9 34.4 15.2 12.1 13.0 17.0 6.3 13.5 13.6 14.7 7.5 32.0 16.0 15.9 23.7 42.9 37.6 9.3 5.2 18.3 14.1 16.6 32.5 111.9 200.2 127.5 135.8 2.6 6.7 38.1 27.9 39.2 91.9 94.4 67.7 94.7 70.0 34.8 35.0 63.7 37.1 58.9 75.2 38.3 105.7 77.0 85.8 52.7 91.8 19.3 54.4 90.3 19.9 33.9 56.5 26.3 50.7 41.3 152.5 58.5 81.9 67.9 162.5 124.2 42.4 70.3 138.3 0.2 90.0 47.9 62.0 76.4 117.7 144.8 109.9 44.6 89.4 47.0 40.4 111.4 62.1 22.3 74.8 98.5 6.7 77.3 38.0 84.9 60.6 41.3 87.4 65.8 23.2 27.5 15.7 23.4 22.3 31.2 38.3 32.8 26.7 51.1 48.2 43.3 30.6 3.4 18.2 12.0 27.8 58.1 21.0 34.7 35.4 36.5 44.1 35.1 39.9 32.2 33.1 34.4 32.0 42.9 32.5 18.8 16.0 11.2 3.6 26.1 28.2 45.7 82.7 46.1 26.5 67.9 83.2 2.3 30.0 41.6 33.1 14.6 38.6 13.2 39.1 80.3 112.9 16.7 30.4 12.4 24.4 58.9 53.0 3.0 55.3 44.9 21.7 38.7 33.1 27.9 71.4 17.9 10.3 62.7 11.8 5.4 54.0 87.5 28.2 33.5 27.0 13.7 21.8 46.2 1.0 18.2 33.7 11.3 3.0 3.6 81.5 36.1 9.1 37.3 31.0 30.9 63.7 35.0 19.8 0.0 3.6 52.6 5.6 188.8 59.0 17.8 13.5 24.6 46.2 74.3 58.9 PAGR1 "C16orf53, GAS, MGC4606, PA1" ENSG00000280789 "PAXIP1 associated glutamate rich protein 1" Q9BTK6 16 29816152-29822489 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 166.5" "Cell type enhanced" "Detected in many" "Astrocytes: 66.6;Plasma cells: 34.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041440, HPA043608" Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "HPA041440: AB_10795541, HPA043608: AB_10797144" "unprognostic (2.35e-1)" "unprognostic (2.19e-1)" "unprognostic (3.20e-2)" "unprognostic (1.44e-2)" "unprognostic (4.20e-1)" "unprognostic (1.14e-3)" "unprognostic (7.09e-3)" "unprognostic (5.12e-2)" "unprognostic (1.25e-1)" "unprognostic (2.55e-1)" "unprognostic (1.84e-3)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (8.99e-3)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "unprognostic (5.39e-2)" 23.5 27.8 10.2 5.5 10.8 6.5 23.2 18.4 12.3 120.8 8.9 48.9 8.7 55.3 7.1 25.7 68.4 6.1 32.0 10.1 9.9 30.4 28.1 23.0 8.7 10.9 10.7 166.5 26.3 7.4 128.9 3.7 10.8 69.3 5.7 6.8 21.4 8.8 24.6 18.0 30.8 4.7 10.5 23.6 26.4 31.2 10.6 9.3 30.2 9.0 6.8 50.7 73.8 12.5 16.7 24.1 13.9 8.7 7.0 6.7 11.8 12.7 11.5 14.5 12.7 17.1 16.9 33.4 12.7 9.1 7.2 15.4 15.2 19.1 9.2 14.8 31.1 14.8 16.4 16.1 7.3 23.6 26.9 7.5 15.1 10.2 10.0 13.4 12.1 31.0 20.1 10.4 9.9 45.2 18.6 27.6 19.3 14.2 20.4 35.4 24.5 24.9 10.8 7.8 34.9 13.2 9.6 22.4 9.7 10.5 20.9 15.0 9.2 12.0 10.9 15.2 12.9 19.4 21.3 13.1 15.8 24.2 15.0 22.5 16.9 33.0 19.7 17.0 22.1 19.7 16.8 20.0 21.3 19.5 21.7 20.1 11.0 13.9 19.6 21.5 12.7 15.2 10.2 10.8 18.4 12.3 10.1 9.9 10.9 10.7 10.8 10.5 10.6 12.5 1.3 0.0 9.8 66.6 15.2 0.0 0.3 0.1 18.2 3.5 4.7 2.9 0.6 14.3 6.9 1.8 0.0 5.6 5.3 5.9 0.0 27.9 0.5 1.0 1.3 3.8 14.6 10.7 16.2 21.7 8.2 4.4 13.3 0.8 7.6 0.3 6.1 2.0 7.5 5.0 16.5 11.1 0.0 5.6 0.0 0.6 0.9 7.7 0.0 9.4 22.5 1.9 4.1 11.6 8.6 13.5 15.8 3.4 34.5 0.7 20.7 2.1 3.0 3.3 0.0 0.9 5.0 3.1 1.6 16.7 0.4 6.7 10.9 0.2 13.2 0.2 PAK4 ENSG00000130669 "P21 (RAC1) activated kinase 4" O96013 19 39125770-39182816 "Enzymes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "A549: 154.7;MCF7: 172.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025747, CAB044670, HPA070175, HPA072220" Uncertain Supported "Plasma membrane,Cell Junctions" NA Yes "Cluster 26: Non-specific - Mitochondria" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 17: Intestinal endocrine cells - Hormone signaling" "Plasma membrane, Cell Junctions" "CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (5.86e-2)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (8.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.13e-3)" "unprognostic (3.90e-2)" "unprognostic (4.04e-2)" "unprognostic (7.29e-2)" "prognostic unfavorable (9.85e-4)" "prognostic favorable (5.29e-5)" "unprognostic (2.39e-1)" "unprognostic (7.05e-2)" "unprognostic (2.02e-1)" "unprognostic (4.85e-2)" 11.6 20.0 16.7 8.1 18.2 5.3 22.1 14.2 18.4 27.2 14.0 30.2 27.4 20.6 9.4 43.9 23.4 7.5 15.5 13.9 13.4 37.2 26.2 39.6 4.5 17.1 17.2 24.2 31.8 16.2 30.5 16.3 15.8 40.7 8.0 5.8 42.4 11.0 14.0 40.4 25.1 5.7 12.0 13.8 25.3 35.0 15.7 5.4 29.3 4.3 5.4 20.2 30.4 17.0 62.8 154.7 22.7 34.8 7.1 7.5 68.1 29.3 11.7 19.3 19.4 102.1 51.9 14.3 43.3 18.7 25.2 22.7 12.6 23.2 7.2 38.0 35.4 16.9 27.5 50.4 11.3 17.5 23.6 9.0 10.2 18.1 12.9 12.6 25.5 21.4 34.3 11.0 11.8 172.7 18.6 18.9 41.4 55.2 36.7 18.5 17.9 10.9 19.0 67.9 72.2 49.9 29.8 130.6 33.6 11.7 58.1 28.4 42.8 32.6 55.6 37.8 53.0 12.3 12.9 11.9 39.9 10.3 39.9 0.3 0.7 1.2 0.6 0.3 0.8 0.5 0.7 1.1 0.9 0.6 0.5 0.5 0.5 0.9 0.6 0.8 0.9 0.7 16.7 18.2 14.2 18.4 13.9 13.4 17.1 17.2 15.8 12.0 15.7 17.0 5.1 0.0 1.5 9.4 3.9 14.4 15.9 13.8 9.6 18.8 34.2 21.7 2.0 20.0 9.1 18.4 25.0 42.6 4.4 47.5 31.3 20.5 4.1 19.5 8.5 15.0 44.9 5.0 3.9 19.7 67.4 8.8 23.9 23.3 5.7 21.6 10.0 13.3 9.6 21.9 4.2 33.8 28.5 5.3 4.1 6.4 11.8 3.6 7.2 8.4 11.2 13.6 8.2 9.5 13.5 21.8 44.2 10.5 5.8 21.7 39.5 14.4 13.7 13.4 0.0 8.5 7.5 10.4 24.0 20.1 18.8 65.4 6.0 22.3 33.9 24.3 PATZ1 "dJ400N23, MAZR, PATZ, RIAZ, ZBTB19, ZNF278, ZSG" ENSG00000100105 "POZ/BTB and AT hook containing zinc finger 1" Q9HBE1 22 31325804-31346346 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047893, HPA048315" Approved Supported Nucleoplasm No No "Cluster 13: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA047893: AB_2680201, HPA048315: AB_2680353" "unprognostic (3.25e-1)" "unprognostic (8.72e-2)" "unprognostic (1.77e-1)" "unprognostic (2.88e-3)" "prognostic favorable (1.06e-4)" "unprognostic (1.77e-1)" "unprognostic (8.34e-3)" "prognostic favorable (8.71e-5)" "unprognostic (1.14e-1)" "unprognostic (1.41e-2)" "unprognostic (1.99e-3)" "unprognostic (1.76e-1)" "prognostic favorable (8.54e-8)" "unprognostic (9.22e-2)" "unprognostic (2.15e-1)" "unprognostic (1.51e-1)" "prognostic favorable (7.79e-6)" 10.2 10.5 16.0 11.4 18.1 15.8 12.1 16.4 16.1 14.5 11.1 14.8 9.9 18.7 14.2 6.1 22.2 9.3 10.8 14.7 16.0 11.6 11.8 11.2 20.3 18.4 16.7 27.3 13.5 21.0 10.5 9.3 17.6 13.1 6.9 14.9 18.7 17.0 10.5 7.9 12.7 12.2 17.1 15.7 11.1 8.1 16.4 24.0 19.3 8.5 14.8 15.7 9.7 20.4 19.0 23.3 46.7 27.7 12.1 11.1 24.5 5.7 14.2 22.6 20.6 16.5 17.7 40.1 20.1 10.6 7.9 14.5 32.0 17.3 11.5 23.7 29.5 16.9 16.7 33.8 19.7 57.4 21.9 17.4 20.5 14.4 16.0 17.8 18.0 19.4 7.3 15.7 14.6 57.7 37.1 39.3 31.4 34.4 27.1 61.9 19.9 13.3 15.3 39.4 60.8 48.7 14.2 17.1 31.4 15.4 33.8 36.2 12.8 15.1 28.3 9.5 19.5 20.3 14.4 36.5 6.3 7.5 26.3 0.0 1.0 2.8 1.8 0.6 1.8 2.5 1.3 2.3 1.4 1.8 2.9 2.2 0.4 2.1 0.3 4.0 2.2 1.2 16.0 18.1 16.4 16.1 14.7 16.0 18.4 16.7 17.6 17.1 16.4 20.4 6.6 3.2 14.9 11.4 12.8 1.7 7.1 7.6 8.0 16.8 22.0 16.0 13.7 17.2 11.7 20.2 8.4 5.2 17.0 3.3 19.6 14.3 0.6 14.9 8.8 7.6 20.4 8.0 2.4 6.2 2.0 6.4 5.6 16.7 6.3 19.3 7.1 16.2 9.4 21.9 5.0 9.7 20.3 8.1 2.6 1.7 9.6 6.6 3.6 7.5 7.7 14.4 12.3 11.1 8.8 6.4 6.0 8.6 5.5 7.4 5.0 7.1 10.5 14.3 6.6 7.1 8.5 0.7 8.1 2.3 1.6 0.8 10.4 8.4 11.8 7.3 PCNX3 "FLJ22427, PCNXL3" ENSG00000197136 "Pecanex 3" Q9H6A9 11 65615773-65637439 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Collecting duct cells: 12.9;Endometrial ciliated cells: 13.5;Glandular and luminal cells: 20.4;Granulosa cells: 17.7;Pancreatic endocrine cells: 13.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018084 Uncertain Approved Cytosol NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 64: Macrophages - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA018084: AB_1855083" "unprognostic (9.93e-2)" "unprognostic (1.33e-1)" "unprognostic (5.46e-2)" "unprognostic (1.09e-2)" "unprognostic (2.54e-1)" "unprognostic (1.70e-2)" "unprognostic (3.13e-3)" "unprognostic (1.42e-1)" "unprognostic (1.16e-1)" "unprognostic (7.69e-3)" "unprognostic (7.06e-2)" "unprognostic (2.44e-2)" "unprognostic (8.52e-3)" "unprognostic (6.51e-3)" "unprognostic (1.93e-1)" "unprognostic (2.32e-2)" "unprognostic (4.82e-1)" 5.2 6.5 3.9 8.0 3.3 10.4 5.5 2.5 4.7 5.9 2.0 7.3 8.2 7.8 1.6 7.7 6.4 4.5 4.5 3.2 1.1 5.4 5.1 6.7 7.3 4.4 3.2 6.0 8.1 4.6 6.6 5.0 2.9 6.2 3.2 2.6 7.9 4.9 4.2 7.7 9.0 4.0 1.8 8.6 7.1 8.9 4.2 7.2 7.4 2.1 4.3 6.3 5.6 4.7 19.5 28.6 10.3 25.6 7.9 6.1 23.3 13.5 11.5 12.9 9.4 13.8 21.5 14.2 25.4 12.0 17.5 31.2 11.0 15.6 3.8 12.1 19.4 18.6 28.6 11.4 8.8 18.3 21.9 11.6 7.7 12.7 10.0 5.8 12.7 14.7 21.7 11.7 7.6 28.8 15.6 14.1 20.9 8.4 18.2 21.6 9.2 18.6 5.6 30.9 12.7 19.0 14.3 18.6 15.7 4.5 32.8 12.4 18.3 22.3 20.7 18.6 13.6 19.1 12.2 12.7 17.8 8.8 19.9 3.5 0.9 0.6 1.2 0.4 1.0 0.5 0.7 0.7 0.5 0.8 0.5 0.7 1.3 0.6 0.7 1.2 0.2 0.6 3.9 3.3 2.5 4.7 3.2 1.1 4.4 3.2 2.9 1.8 4.2 4.7 10.8 6.4 6.4 0.0 1.5 0.0 0.0 0.0 0.0 0.0 11.3 8.4 0.0 0.0 0.6 12.9 0.0 6.8 10.7 0.0 0.0 9.1 0.0 13.5 9.1 5.1 0.0 0.0 0.0 8.9 5.6 3.2 0.0 20.4 5.1 17.7 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 2.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 5.9 0.0 0.0 4.3 0.7 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 8.3 3.0 10.2 0.0 0.0 PDAP1 "HASPP28, PAP, PAP1" ENSG00000106244 "PDGFA associated protein 1" Q13442 7 99392048-99408597 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021103, HPA050294, HPA060836" Approved Enhanced "Plasma membrane,Cytosol" NA NA 410000 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Cytosol "Plasma membrane" "CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374" "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.67e-4)" "unprognostic (5.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.65e-2)" "unprognostic (2.63e-1)" "unprognostic (3.35e-2)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (1.79e-1)" "unprognostic (3.49e-1)" "unprognostic (2.97e-2)" 25.7 29.6 35.8 22.6 36.2 23.2 24.4 36.5 39.3 26.2 34.1 32.4 17.9 26.9 17.5 37.2 22.6 11.9 40.2 34.4 36.1 28.5 31.3 24.0 18.9 37.3 37.9 25.7 26.6 22.5 21.9 19.2 37.4 26.0 18.0 22.9 26.2 20.9 105.0 27.9 23.3 21.1 37.6 23.8 26.3 19.7 37.0 25.5 24.3 59.7 22.4 29.3 26.4 36.6 96.9 82.4 54.6 71.0 41.5 43.2 34.7 76.7 44.9 61.6 51.8 83.9 47.4 41.3 67.2 74.7 78.4 50.2 66.3 78.4 60.5 59.8 74.4 43.6 80.8 74.1 60.8 80.1 40.5 45.6 58.5 68.1 110.3 56.3 62.7 67.5 103.0 75.6 61.4 200.3 110.4 111.2 68.7 98.1 88.3 50.5 54.3 73.6 63.6 73.0 54.8 110.6 58.0 92.4 43.4 61.3 41.1 42.5 57.6 83.6 91.4 100.8 123.6 71.4 87.5 91.0 67.7 72.2 89.1 13.4 12.1 12.5 15.4 16.6 13.9 15.7 14.2 11.2 10.2 14.9 9.8 13.2 31.6 28.0 15.6 21.1 20.9 6.6 35.8 36.2 36.5 39.3 34.4 36.1 37.3 37.9 37.4 37.6 37.0 36.6 82.9 86.6 94.7 6.2 73.6 62.2 110.6 104.6 57.5 97.4 84.3 76.6 63.6 72.9 86.7 42.3 33.3 213.1 84.7 101.6 168.3 176.1 60.3 91.3 118.6 99.1 117.9 151.7 10.1 171.0 223.0 87.4 59.7 88.3 72.2 83.4 61.8 80.8 114.9 77.4 11.6 116.5 75.3 38.3 63.3 78.3 83.6 66.1 103.2 5.6 102.1 166.4 119.4 8.0 17.4 177.4 92.2 92.2 102.5 184.3 100.0 134.5 96.8 101.0 52.6 85.6 127.2 132.5 123.0 131.9 65.6 184.4 79.5 115.2 114.0 122.5 PDCD5 "MGC9294, TFAR19" ENSG00000105185 "Programmed cell death 5" O14737 19 32581190-32587453 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018471 Enhanced Approved Nucleoplasm,Cytosol NA NA 47000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Cytosol Nucleoplasm "HPA018471: AB_1855108" "unprognostic (1.04e-1)" "unprognostic (2.08e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (2.02e-1)" "unprognostic (8.64e-2)" "unprognostic (3.64e-3)" "unprognostic (2.43e-2)" "unprognostic (6.22e-2)" "unprognostic (8.49e-2)" "unprognostic (3.87e-2)" "unprognostic (1.93e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.00e-2)" "unprognostic (3.35e-2)" "unprognostic (1.10e-1)" "unprognostic (9.54e-2)" 95.7 96.1 86.2 73.8 87.0 46.8 82.0 85.4 110.2 73.2 80.8 100.1 65.8 68.8 50.8 109.3 70.9 34.8 170.9 86.7 91.1 97.8 101.2 68.0 58.6 87.1 87.7 71.8 102.4 52.6 95.1 61.2 88.4 64.3 55.7 39.2 70.1 41.9 224.2 60.5 62.0 65.8 85.8 56.8 78.9 144.4 94.6 41.8 60.6 132.2 59.5 91.1 80.3 89.9 499.0 630.0 168.8 163.7 223.8 334.0 190.0 353.2 225.6 295.2 252.2 525.0 188.3 272.6 498.7 177.1 286.3 133.2 213.6 281.7 254.4 493.1 333.6 412.4 303.9 382.8 284.0 587.0 157.3 219.7 253.8 195.9 315.0 145.1 198.8 214.9 381.0 298.8 247.2 332.0 243.6 298.6 164.9 410.5 211.6 238.9 248.8 323.6 231.9 167.6 326.0 178.4 338.1 351.8 283.4 125.2 152.6 294.6 299.4 272.6 291.7 274.2 602.7 270.6 413.0 504.4 302.3 459.8 244.2 40.7 93.4 50.9 106.4 149.0 134.3 147.3 167.4 132.1 120.6 116.3 115.3 114.3 13.7 116.9 197.6 123.6 217.8 122.7 86.2 87.0 85.4 110.2 86.7 91.1 87.1 87.7 88.4 85.8 94.6 89.9 115.4 73.7 62.7 16.6 70.4 121.6 174.0 292.0 97.3 43.2 129.1 216.4 336.1 94.4 119.4 75.4 27.1 194.7 69.0 94.6 189.8 245.3 469.7 94.0 166.4 121.3 71.3 44.8 24.0 247.3 216.5 150.4 64.2 115.0 46.9 84.9 83.6 151.1 146.7 50.5 29.3 113.6 140.4 48.3 93.1 481.2 142.6 67.4 124.5 11.2 113.8 104.0 66.9 17.6 16.8 292.2 100.4 123.0 124.4 392.4 125.1 216.8 107.9 45.3 72.3 126.8 218.4 487.0 413.1 170.9 119.9 143.0 78.4 164.9 157.8 140.4 PGD ENSG00000142657 "Phosphogluconate dehydrogenase" P52209 1 10398592-10420511 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Gluconate utilization, Pentose shunt" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 400.2;esophagus: 572.4" "Cell type enhanced" "Detected in all" "monocytes: 214.9;Squamous epithelial cells: 496.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "basophil: 1060.2;classical monocyte: 321.0;eosinophil: 1074.7;neutrophil: 332.6" "Group enriched" "Detected in all" 5 "granulocytes: 1074.7;monocytes: 321.0" "Cell line enhanced" "Detected in all" "A549: 1445.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031314, HPA031315" Enhanced Supported Approved "Intermediate filaments,Cytosol" No No 41000000 "Cluster 2: Granulocytes - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" "Intermediate filaments, Cytosol" "HPA031314: AB_10610278, HPA031315: AB_2673825" "unprognostic (4.65e-2)" "unprognostic (2.58e-1)" "unprognostic (8.65e-2)" "unprognostic (9.80e-2)" "unprognostic (1.31e-2)" "unprognostic (2.28e-1)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.90e-2)" "unprognostic (2.83e-1)" "unprognostic (1.40e-2)" "unprognostic (4.92e-1)" "unprognostic (1.36e-1)" "unprognostic (1.37e-3)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" 115.8 51.0 49.5 59.8 49.2 400.2 89.0 52.9 49.3 75.9 52.5 52.9 91.6 23.1 41.9 572.4 30.0 94.2 34.3 47.4 54.3 53.2 81.3 88.5 38.1 57.0 54.6 35.7 32.0 52.7 43.8 47.4 55.4 30.4 46.3 49.1 133.7 22.9 34.7 50.0 70.7 35.0 49.7 110.4 61.4 68.3 59.2 53.6 71.8 28.2 73.8 61.8 126.9 52.0 191.5 1445.2 319.3 340.6 445.4 274.0 71.8 124.8 185.9 144.4 195.3 219.2 190.4 163.5 151.0 109.2 202.4 148.0 225.6 192.1 96.4 127.5 199.9 227.8 264.3 452.1 136.3 390.9 249.7 196.5 92.2 229.4 55.5 186.9 344.0 223.0 305.3 145.7 183.5 202.5 321.4 179.4 194.7 221.0 109.1 252.7 298.1 312.2 199.6 105.5 178.0 154.1 99.1 153.5 137.5 196.7 173.3 308.5 369.3 81.1 149.6 98.3 134.5 111.6 256.0 323.5 175.1 393.9 73.6 1060.2 321.0 1074.7 23.2 137.7 26.5 33.1 21.4 20.8 144.6 23.3 21.1 22.3 332.6 19.7 105.6 98.7 23.1 225.0 49.5 49.2 52.9 49.3 47.4 54.3 57.0 54.6 55.4 49.7 59.2 52.0 7.4 19.2 35.0 11.8 24.9 13.0 30.8 78.0 70.6 7.8 30.4 18.5 11.0 50.1 73.2 20.2 18.8 134.6 29.8 24.3 52.8 52.1 10.9 17.8 18.6 22.6 23.4 55.7 8.6 40.3 40.7 37.5 41.8 24.5 25.9 53.9 16.1 66.2 134.6 1.7 12.6 30.2 59.0 163.8 30.9 13.4 17.1 150.9 17.8 4.7 214.9 16.5 10.3 13.6 9.0 38.7 26.7 10.5 41.9 43.5 66.6 55.1 46.2 20.2 19.7 23.4 21.5 41.5 38.4 496.0 16.6 81.3 19.4 27.3 51.7 76.1 PHKG2 ENSG00000156873 "Phosphorylase kinase catalytic subunit gamma 2" P15735 16 30748293-30761176 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Carbohydrate metabolism, Glycogen metabolism" "Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Disease variant, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 130.1" "Group enriched" "Detected in many" 5 "Early spermatids: 397.0;Late spermatids: 1576.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065618, HPA068751" Supported Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA065618: AB_2685520, HPA068751: AB_2686025" "unprognostic (7.63e-3)" "prognostic favorable (7.90e-4)" "prognostic unfavorable (9.92e-4)" "unprognostic (1.08e-1)" "unprognostic (1.25e-1)" "unprognostic (5.81e-2)" "unprognostic (3.72e-2)" "prognostic favorable (1.90e-4)" "unprognostic (6.45e-2)" "unprognostic (1.25e-2)" "prognostic favorable (8.02e-4)" "unprognostic (6.15e-2)" "unprognostic (5.27e-2)" "unprognostic (1.36e-2)" "unprognostic (2.41e-1)" "unprognostic (2.18e-2)" "unprognostic (3.03e-2)" 9.0 15.8 17.5 11.5 16.9 30.0 9.9 17.1 18.7 10.0 15.9 12.9 11.0 10.1 9.5 10.2 11.7 8.2 12.1 18.9 16.4 14.7 19.1 10.0 12.5 17.7 17.2 8.3 9.7 18.9 15.9 7.8 18.8 14.7 12.0 8.9 11.5 12.0 13.2 14.6 12.0 9.9 16.0 12.9 13.8 130.1 17.5 11.6 13.6 8.8 12.7 10.1 9.2 16.2 24.7 16.3 13.1 16.2 11.8 9.4 29.8 17.2 24.6 22.1 25.1 13.5 12.6 21.0 19.3 17.1 11.5 24.0 13.5 21.5 17.6 11.4 38.2 11.9 28.8 38.7 18.1 18.1 16.9 12.9 11.2 21.4 9.9 10.7 22.8 15.3 16.1 11.7 16.3 55.5 22.3 27.1 18.0 17.6 18.0 29.4 20.0 28.2 25.7 27.2 17.5 11.9 13.5 38.1 16.6 11.8 30.1 15.5 13.6 14.4 15.1 17.2 16.0 24.1 14.4 14.8 27.3 35.2 11.4 44.0 55.8 114.9 37.8 56.5 30.9 21.1 27.1 38.8 52.0 21.5 24.2 27.7 44.7 63.8 42.3 46.1 43.3 49.0 17.5 16.9 17.1 18.7 18.9 16.4 17.7 17.2 18.8 16.0 17.5 16.2 10.4 12.8 21.7 13.7 18.5 21.0 15.2 28.7 22.8 8.8 21.8 17.1 15.9 10.0 32.0 18.4 10.4 29.6 32.2 32.1 27.4 11.9 397.0 35.8 13.0 10.0 16.3 20.2 14.7 24.4 41.5 11.8 44.4 38.8 13.3 16.1 10.4 24.1 28.2 20.2 14.5 21.4 26.4 19.1 27.2 1576.6 17.4 26.4 12.4 11.2 40.3 13.7 39.1 9.0 8.1 19.6 18.5 23.3 20.5 31.5 27.8 47.3 33.0 9.9 0.0 8.9 14.8 180.5 22.9 20.5 23.0 75.5 25.9 20.8 27.0 16.9 PI4KB "PI4K-BETA, pi4K92, PIK4CB" ENSG00000143393 "Phosphatidylinositol 4-kinase beta" Q9UBF8 1 151291797-151327715 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Host-virus interaction" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006280, HPA006281, CAB022071" Approved Supported "Golgi apparatus" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" "Golgi apparatus" "CAB022071: , HPA006280: AB_1079613, HPA006281: AB_1079614" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (5.42e-3)" "unprognostic (5.23e-3)" "unprognostic (7.32e-2)" "unprognostic (1.36e-2)" "prognostic unfavorable (2.97e-4)" "unprognostic (1.87e-1)" "unprognostic (3.94e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.25e-5)" "unprognostic (8.51e-2)" "prognostic unfavorable (3.23e-4)" "unprognostic (2.53e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.78e-4)" "unprognostic (7.08e-2)" 45.6 45.0 57.3 33.1 61.4 78.0 47.6 64.4 63.2 62.6 53.2 50.9 35.8 58.8 54.8 48.0 58.6 40.2 45.8 59.2 62.3 50.4 40.5 47.2 46.8 57.9 60.7 60.2 46.1 56.0 56.5 39.6 60.4 57.6 44.0 46.4 45.8 42.6 68.5 60.5 47.0 62.2 54.4 59.8 48.0 46.0 61.0 45.7 67.8 58.6 47.5 48.9 51.3 68.2 49.2 40.1 34.2 53.9 92.8 68.1 28.9 50.9 88.3 65.3 53.8 51.7 43.4 46.1 57.1 78.5 41.1 44.9 57.3 52.5 50.1 63.0 50.9 33.0 48.8 26.6 64.8 38.5 60.9 71.7 62.4 72.3 51.3 56.3 63.7 46.3 57.5 67.9 56.0 91.2 41.0 30.9 27.6 69.5 60.3 36.2 28.8 54.4 45.2 61.2 41.3 35.4 35.5 71.1 46.7 53.9 60.1 71.9 50.3 46.5 36.3 37.3 55.1 71.6 50.4 89.8 52.9 39.7 82.3 41.3 22.7 36.0 17.8 24.7 19.9 20.4 18.5 23.6 24.3 16.7 15.1 14.3 21.0 19.3 26.3 13.9 20.0 23.9 57.3 61.4 64.4 63.2 59.2 62.3 57.9 60.7 60.4 54.4 61.0 68.2 16.8 16.0 24.3 19.2 26.4 22.3 18.2 17.7 28.5 33.5 24.3 24.6 7.0 21.5 17.7 12.9 20.9 30.1 16.0 28.7 19.6 20.9 12.2 21.5 19.9 19.3 18.5 26.9 17.8 24.9 20.5 25.9 23.0 24.6 19.0 30.0 15.4 12.4 29.2 35.3 19.0 16.4 10.2 20.1 20.5 15.5 23.3 21.3 14.2 15.9 29.3 23.1 21.6 18.1 25.8 23.5 17.3 24.8 24.4 17.7 25.7 15.2 17.1 28.4 13.1 24.2 23.2 28.9 25.1 24.8 31.1 48.7 23.8 44.7 20.2 28.1 PIEZO1 "FAM38A, KIAA0233" ENSG00000103335 "Piezo type mechanosensitive ion channel component 1" Q92508 16 88715338-88785220 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 73.7;Pancreatic endocrine cells: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 270.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA047185 Uncertain NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "HPA047185: AB_2679973" "unprognostic (1.76e-1)" "prognostic unfavorable (2.37e-4)" "unprognostic (1.77e-1)" "unprognostic (1.12e-2)" "unprognostic (4.08e-2)" "unprognostic (2.34e-2)" "unprognostic (2.64e-2)" "prognostic unfavorable (2.36e-5)" "unprognostic (4.39e-2)" "prognostic unfavorable (3.78e-4)" "unprognostic (3.51e-2)" "unprognostic (3.05e-2)" "prognostic unfavorable (8.89e-7)" "unprognostic (2.04e-1)" "unprognostic (3.59e-2)" "unprognostic (2.86e-2)" "unprognostic (3.74e-1)" 79.0 26.4 15.2 20.5 16.0 29.8 65.1 16.5 19.0 30.7 10.4 86.7 7.7 40.4 0.5 48.4 38.1 9.0 29.4 12.9 13.8 57.2 48.2 67.2 14.8 25.0 17.6 15.8 21.9 5.2 6.8 18.6 22.5 49.4 4.8 1.7 33.3 11.2 6.8 48.8 41.1 14.3 17.6 55.2 38.0 5.2 17.4 7.2 32.4 4.3 5.9 65.3 40.4 21.2 42.0 42.1 6.5 31.3 27.6 30.0 155.2 99.9 43.9 36.1 14.0 61.3 68.5 34.2 68.2 48.4 18.0 88.4 13.9 36.0 7.3 33.8 56.0 58.3 77.9 49.4 41.6 26.4 9.3 24.6 19.4 28.3 23.3 21.3 43.9 56.1 80.4 42.8 21.2 270.1 32.7 91.2 14.7 19.7 25.7 77.7 9.3 86.9 16.4 61.1 12.8 3.4 130.5 68.0 17.8 6.5 93.0 76.5 120.1 86.0 49.6 58.4 51.6 8.7 21.1 21.2 67.9 46.5 52.2 1.8 5.0 3.3 8.1 9.7 7.8 2.3 6.0 5.5 9.7 3.1 1.0 2.5 0.1 1.0 13.1 1.7 5.0 3.9 15.2 16.0 16.5 19.0 12.9 13.8 25.0 17.6 22.5 17.6 17.4 21.2 69.1 73.7 19.8 27.1 14.3 19.1 12.9 27.6 5.2 2.2 23.5 16.3 5.0 10.0 17.1 58.8 16.7 6.7 16.8 19.3 0.0 37.3 1.6 6.2 15.4 45.0 21.0 12.6 0.4 21.7 30.5 13.7 25.0 9.9 8.8 0.7 55.3 22.0 23.6 3.3 0.5 29.5 10.2 16.8 19.0 1.0 5.6 21.8 16.0 21.5 15.6 1.5 3.1 16.6 5.0 85.9 18.0 2.6 30.8 48.3 8.1 5.5 9.7 4.1 0.0 30.3 9.0 0.3 2.0 18.9 15.9 5.1 21.6 5.6 12.0 21.8 PISD "dJ858B16.2, PSDC" ENSG00000241878 "Phosphatidylserine decarboxylase" Q9UG56 22 31618491-31662432 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Decarboxylase, Lyase" "Cataract, Deafness, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 223.5;Syncytiotrophoblasts: 245.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 80.7" "Low region specificity" "Detected in all" "HPA031090, HPA031091" Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" "Golgi apparatus, Cytosol" "HPA031090: AB_10600114, HPA031091: AB_10600893" "unprognostic (7.96e-2)" "unprognostic (5.41e-3)" "unprognostic (2.60e-1)" "unprognostic (8.31e-2)" "unprognostic (5.61e-2)" "unprognostic (4.55e-3)" "unprognostic (2.44e-3)" "unprognostic (8.13e-3)" "unprognostic (6.37e-3)" "unprognostic (1.23e-1)" "unprognostic (1.11e-3)" "unprognostic (1.70e-2)" "unprognostic (4.18e-3)" "unprognostic (1.91e-2)" "unprognostic (4.85e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.27e-5)" 34.1 13.7 6.7 12.2 6.3 18.7 16.0 14.3 9.8 7.4 7.5 8.9 8.8 10.1 4.8 7.3 10.8 7.1 7.3 6.1 7.5 18.9 6.3 14.7 8.4 7.0 6.0 7.6 9.2 5.0 12.6 19.9 6.8 9.0 2.0 3.5 7.5 5.3 5.3 7.8 7.8 3.2 3.8 18.0 8.2 20.3 7.2 3.8 11.5 3.2 4.3 7.3 7.1 5.1 21.7 19.7 5.8 5.8 17.3 6.6 13.2 17.4 13.6 11.9 12.9 28.6 6.6 12.9 18.0 8.8 15.8 24.0 7.9 15.5 1.9 14.4 16.9 13.5 12.8 23.7 35.9 28.7 34.2 12.4 8.5 21.2 9.1 4.9 10.6 9.0 40.3 7.6 6.9 80.7 12.5 12.4 5.7 14.2 8.1 17.4 6.5 13.0 7.6 18.9 14.2 8.4 10.1 31.8 11.0 4.7 26.5 15.5 21.0 14.9 17.7 9.6 16.3 8.9 13.3 16.2 14.2 19.0 12.1 24.1 21.7 16.1 10.6 15.8 10.3 11.9 7.7 9.0 18.3 11.9 10.3 8.6 47.0 10.4 8.7 8.9 8.2 13.8 6.7 6.3 14.3 9.8 6.1 7.5 7.0 6.0 6.8 3.8 7.2 5.1 11.1 16.0 15.6 17.3 12.4 25.6 34.7 31.5 38.7 26.0 18.6 12.6 55.5 12.8 31.1 42.3 20.9 223.5 12.9 12.0 11.7 33.2 60.0 36.2 17.9 19.6 20.9 32.4 40.3 16.8 25.9 13.6 17.3 87.3 18.3 13.2 8.9 7.5 36.4 18.5 35.5 12.9 22.4 36.4 12.7 81.9 9.6 19.8 3.6 9.4 27.1 11.8 24.7 16.1 19.9 15.9 8.4 7.2 11.4 52.1 12.3 13.9 10.9 25.8 19.7 4.9 11.1 25.0 17.9 27.7 21.3 245.0 11.8 8.3 14.2 43.5 PKMYT1 "MYT1, PPP1R126" ENSG00000127564 "Protein kinase, membrane associated tyrosine/threonine 1" Q99640 16 2968024-2980479 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 27.6;testis: 56.9" "Cell type enhanced" "Detected in many" "Erythroid cells: 29.0;Extravillous trophoblasts: 52.0;Plasma cells: 22.9;Spermatocytes: 114.7;Spermatogonia: 46.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Immune cell enriched" "Detected in single" 6 "T-reg: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068860 Supported "Nucleoplasm,Nucleoli,Golgi apparatus" NA Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" "Golgi apparatus" "Nucleoplasm, Nucleoli" "HPA068860: AB_2686050" "unprognostic (7.82e-2)" "unprognostic (8.70e-2)" "unprognostic (5.93e-2)" "unprognostic (2.04e-2)" "unprognostic (4.54e-2)" "unprognostic (1.44e-1)" "prognostic unfavorable (8.33e-4)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.52e-2)" "unprognostic (2.15e-1)" "unprognostic (1.61e-2)" "unprognostic (7.95e-3)" "unprognostic (0.00e+0)" "unprognostic (1.09e-3)" "unprognostic (9.13e-2)" "unprognostic (1.96e-1)" "unprognostic (5.91e-2)" 1.1 1.0 0.4 6.8 0.5 27.6 0.6 1.6 1.4 2.2 0.2 3.9 2.8 0.6 0.3 11.5 0.4 0.6 0.9 0.5 0.2 0.9 1.6 2.0 8.0 0.7 0.6 0.3 1.8 0.1 1.0 3.1 0.8 1.0 1.3 17.4 1.9 0.1 2.4 4.4 4.0 1.0 0.5 5.6 3.3 56.9 0.7 9.6 0.5 0.0 4.5 0.7 3.3 0.8 84.2 57.0 22.0 31.2 0.3 0.9 64.0 65.5 15.1 40.0 38.4 45.0 49.3 54.2 29.2 7.9 24.2 106.7 15.7 20.7 7.2 71.7 56.7 27.9 52.7 40.0 0.0 31.2 73.6 0.7 1.8 24.0 6.5 5.0 8.4 57.6 80.6 87.0 13.5 127.5 83.6 88.0 37.9 39.3 34.4 93.7 51.2 100.7 7.8 17.7 42.6 46.7 31.9 77.7 23.9 12.1 44.7 56.9 7.7 53.2 69.7 77.3 68.0 67.6 54.2 94.0 19.4 40.0 61.2 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.3 0.4 0.5 1.6 1.4 0.5 0.2 0.7 0.6 0.8 0.5 0.7 0.8 0.0 0.0 1.1 0.0 1.9 2.5 1.3 2.1 0.6 0.4 1.5 1.3 0.6 1.5 1.6 1.8 6.2 16.0 1.3 5.0 0.0 0.8 20.0 0.6 0.8 0.8 1.8 29.0 0.4 0.6 52.0 2.5 3.1 1.9 0.0 4.5 0.0 0.4 11.8 0.0 0.2 3.6 6.1 2.1 1.8 8.6 0.3 1.9 0.0 0.0 0.7 0.2 0.0 0.0 0.3 0.6 0.3 0.4 22.9 0.7 0.3 0.1 0.2 7.1 0.0 0.1 2.6 114.7 46.1 11.2 0.6 7.4 4.2 0.5 8.6 2.0 PLCG1 "NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1" ENSG00000124181 "Phospholipase C gamma 1" P19174 20 41136960-41196801 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Host-virus interaction, Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 69.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 8 "gdT-cell: 4.7;MAIT T-cell: 6.4;memory CD4 T-cell: 4.1;memory CD8 T-cell: 3.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 4.3;NK-cell: 3.4;T-reg: 3.8" "Group enriched" "Detected in many" 9 "NK-cells: 3.4;T-cells: 6.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004277, HPA036681, HPA036682" Approved Enhanced Cytosol NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 58: T-cells - T-cell receptor" Cytosol "CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246" "unprognostic (2.77e-1)" "unprognostic (1.35e-1)" "unprognostic (1.65e-1)" "unprognostic (4.31e-2)" "unprognostic (5.82e-2)" "unprognostic (2.09e-2)" "unprognostic (4.45e-3)" "unprognostic (1.25e-2)" "unprognostic (2.29e-2)" "unprognostic (1.16e-1)" "prognostic favorable (4.72e-4)" "unprognostic (3.32e-1)" "unprognostic (2.73e-3)" "unprognostic (1.82e-1)" "unprognostic (2.65e-1)" "unprognostic (9.27e-2)" "unprognostic (2.79e-2)" 33.3 22.4 36.2 21.7 37.3 10.0 31.8 43.8 41.3 42.5 27.8 25.2 17.8 36.1 13.7 18.9 31.9 19.9 31.9 35.6 32.9 23.2 9.7 32.4 36.4 34.8 36.2 42.6 11.4 13.3 21.6 23.8 34.2 30.2 13.7 10.9 20.2 20.5 18.5 31.5 28.8 22.9 32.0 30.0 19.4 26.3 39.5 60.5 45.0 20.3 24.0 30.4 32.0 38.6 16.6 20.8 97.2 71.6 38.0 26.5 30.9 26.7 34.1 52.4 44.3 50.1 5.4 37.0 31.9 29.1 55.0 30.2 42.7 47.8 30.4 10.5 22.7 2.6 36.4 59.6 28.9 14.7 9.7 34.1 26.3 38.8 30.0 47.2 59.4 77.3 28.0 23.6 48.0 123.8 90.7 11.5 36.2 21.3 37.6 71.1 70.8 18.2 28.7 30.1 34.4 65.7 47.8 22.1 48.4 54.1 25.8 17.0 64.6 124.4 40.3 40.2 32.9 26.1 12.4 30.3 29.7 15.6 52.9 0.0 0.0 0.0 4.7 0.0 6.4 0.2 4.1 3.9 0.0 0.5 4.3 4.3 0.0 3.4 0.0 0.0 3.8 3.0 36.2 37.3 43.8 41.3 35.6 32.9 34.8 36.2 34.2 32.0 39.5 38.6 33.4 16.0 7.0 69.2 5.1 5.6 1.8 5.3 14.8 4.3 4.7 5.8 9.6 1.5 3.8 3.7 10.4 1.9 7.4 9.4 0.0 3.3 7.0 5.4 16.9 24.2 1.8 2.1 9.7 1.6 2.0 11.5 10.2 10.3 1.3 19.8 11.7 3.1 4.0 3.3 9.1 9.5 4.1 2.9 4.3 7.2 15.2 1.7 3.6 16.9 1.2 6.7 2.1 13.0 16.4 3.3 4.8 18.4 6.3 2.3 7.8 3.0 1.8 5.1 13.1 8.5 10.2 15.9 13.0 6.1 7.0 0.8 17.0 5.7 6.4 0.9 PLEC "EBS1, PCN, PLEC1, PLTN" ENSG00000178209 Plectin Q15149 8 143915153-143976734 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes, Disease variant, Epidermolysis bullosa, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 256.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 257.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "PC-3: 384.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003847, HPA025967, HPA029906" Enhanced Supported "Intermediate filaments,Focal adhesion sites,Cytosol" NA NA 7400000 "Cluster 39: Non-specific - mRNA processing" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Intermediate filaments, Cytosol" "Focal adhesion sites" "CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279" "unprognostic (1.02e-1)" "unprognostic (1.37e-3)" "prognostic unfavorable (4.29e-4)" "unprognostic (2.09e-2)" "unprognostic (1.04e-1)" "unprognostic (1.05e-2)" "unprognostic (1.76e-3)" "prognostic unfavorable (5.33e-4)" "unprognostic (1.72e-3)" "unprognostic (1.13e-2)" "unprognostic (2.85e-3)" "unprognostic (5.48e-2)" "prognostic unfavorable (7.98e-6)" "unprognostic (2.30e-1)" "unprognostic (4.04e-2)" "unprognostic (6.58e-2)" "unprognostic (5.58e-3)" 41.8 30.9 44.2 22.6 25.4 43.2 37.9 20.4 39.7 57.4 6.7 58.0 21.1 55.2 8.5 59.7 47.9 22.8 78.9 42.2 31.0 30.0 31.3 49.2 22.1 48.5 28.6 47.1 27.6 8.1 33.0 18.3 30.8 49.5 13.0 3.9 42.9 19.8 256.5 83.1 53.8 27.7 28.8 46.1 49.1 15.3 43.2 14.4 25.7 74.7 15.8 56.5 55.7 25.9 92.6 247.3 15.1 20.3 31.6 66.9 62.8 125.9 49.3 32.3 18.7 39.2 88.5 8.9 82.9 179.7 54.6 98.9 10.3 162.6 13.3 58.7 10.0 24.9 268.0 34.0 54.0 9.6 26.1 71.8 40.7 84.6 164.2 28.3 43.0 7.6 16.2 25.9 39.7 175.3 5.1 19.8 12.2 29.4 384.8 1.8 46.2 24.6 67.7 147.7 16.6 16.8 217.4 50.0 21.1 21.7 55.7 12.4 125.7 117.8 217.3 110.6 155.1 4.7 3.7 6.3 106.9 15.2 176.2 0.0 2.0 0.1 0.6 1.7 1.3 0.6 1.2 0.9 1.6 0.6 0.8 0.5 0.4 0.3 1.2 1.3 1.4 2.0 44.2 25.4 20.4 39.7 42.2 31.0 48.5 28.6 30.8 28.8 43.2 25.9 83.8 28.9 15.6 78.0 27.0 108.0 53.1 62.9 50.7 15.8 29.4 27.9 39.3 31.5 42.9 40.5 25.0 34.4 27.1 257.8 0.0 39.3 1.4 39.4 52.6 68.2 32.2 11.8 47.3 20.2 32.1 45.7 170.2 57.3 8.2 14.4 63.1 69.0 35.2 30.3 36.5 79.9 10.2 67.5 100.4 5.0 44.4 61.2 33.8 27.2 54.9 11.2 15.5 14.6 3.4 157.8 194.1 74.9 39.3 144.9 124.9 4.6 50.3 10.8 6.6 42.1 61.5 1.2 7.1 72.2 76.7 69.0 35.0 18.8 61.6 121.0 PMF1 ENSG00000160783 "Polyamine modulated factor 1" Q6P1K2 1 156212993-156240042 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034583, HPA071854" Approved Nucleoplasm,Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Vesicles "HPA034583: AB_2674234, HPA071854: AB_2686459" "unprognostic (1.17e-2)" "unprognostic (3.76e-3)" "unprognostic (2.58e-2)" "unprognostic (5.67e-2)" "unprognostic (3.86e-2)" "unprognostic (2.22e-2)" "unprognostic (6.44e-2)" "unprognostic (1.32e-1)" "unprognostic (3.13e-1)" "unprognostic (1.26e-2)" "unprognostic (1.41e-2)" "unprognostic (9.29e-2)" "unprognostic (5.22e-2)" "unprognostic (2.51e-2)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "unprognostic (1.62e-2)" 39.3 39.6 33.5 29.6 35.9 73.7 42.8 35.1 39.5 47.2 33.0 38.3 30.6 42.6 24.4 50.0 34.8 26.0 69.7 33.3 34.7 56.6 62.3 38.8 46.8 37.1 34.9 42.9 39.4 56.3 34.9 29.9 36.5 47.2 26.8 16.8 42.9 27.1 113.3 54.2 36.7 28.6 35.0 52.5 43.6 15.1 34.9 45.6 50.7 89.7 39.7 39.4 41.7 38.6 68.2 82.5 86.8 66.1 16.1 33.5 67.3 34.6 48.7 91.4 75.4 101.6 95.3 62.2 73.3 44.5 31.6 44.4 88.1 57.7 47.0 44.6 104.6 46.3 59.3 91.8 33.3 65.8 61.3 30.2 57.2 41.2 43.0 36.3 69.9 44.7 69.9 70.1 45.0 138.2 69.2 84.7 151.5 99.6 72.2 75.2 46.3 123.6 97.2 50.5 79.0 99.5 57.4 65.4 45.6 63.2 106.1 79.7 40.7 39.4 50.5 44.4 69.4 52.0 58.1 123.7 31.9 63.1 55.7 18.4 85.7 40.5 43.9 60.6 39.6 54.0 43.0 41.4 70.0 45.6 41.5 42.0 59.9 49.5 55.2 95.9 75.5 77.7 33.5 35.9 35.1 39.5 33.3 34.7 37.1 34.9 36.5 35.0 34.9 38.6 25.5 19.2 25.1 0.0 38.2 49.8 87.2 108.6 3.4 12.3 39.5 33.4 11.9 51.5 57.4 75.4 12.5 136.3 63.4 21.5 176.1 98.0 5.3 22.1 26.3 41.5 49.1 13.2 0.0 99.0 115.7 34.7 8.6 36.5 45.0 50.3 47.2 56.7 80.5 8.4 0.0 46.6 61.1 40.3 43.9 6.0 39.1 34.2 85.4 0.0 59.6 71.2 43.3 0.0 0.0 81.6 52.1 28.2 11.7 51.5 44.7 120.1 15.6 28.8 26.3 36.6 35.7 14.7 33.4 7.6 51.0 157.5 47.3 66.1 52.5 83.8 PNKD "BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, MR-1S, PDC, PKND1, TAHCCP2" ENSG00000127838 "PNKD metallo-beta-lactamase domain containing" Q8N490 2 218270392-218346793 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 508.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010134, HPA017068" Approved Enhanced Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA010134: AB_1079645, HPA017068: AB_1855495" "unprognostic (3.15e-3)" "unprognostic (1.80e-2)" "unprognostic (5.86e-3)" "unprognostic (1.89e-2)" "unprognostic (1.90e-1)" "unprognostic (1.60e-1)" "unprognostic (3.81e-2)" "unprognostic (1.54e-1)" "unprognostic (1.37e-1)" "unprognostic (7.51e-2)" "unprognostic (3.29e-1)" "unprognostic (7.67e-2)" "prognostic unfavorable (5.13e-5)" "unprognostic (7.98e-2)" "unprognostic (2.17e-1)" "unprognostic (9.61e-2)" "unprognostic (1.44e-3)" 50.9 88.9 127.6 33.3 134.7 35.4 49.7 131.2 168.4 62.8 129.3 74.7 40.6 45.6 77.3 40.5 60.6 41.6 98.4 127.8 137.5 106.5 191.5 55.5 40.9 133.9 130.9 47.1 46.1 93.4 49.5 46.9 134.1 87.4 54.7 26.7 60.6 55.3 85.1 44.9 51.1 36.4 128.7 58.7 81.6 45.6 137.8 45.8 90.0 93.6 37.6 64.2 45.4 134.7 53.2 68.3 49.1 77.0 72.2 60.6 90.0 32.7 70.3 76.1 85.0 112.9 51.2 61.7 63.7 55.0 83.5 53.6 95.4 61.4 52.9 128.0 119.4 90.0 119.5 169.4 78.7 58.9 38.6 83.0 59.8 51.9 15.0 51.0 83.2 48.0 67.8 78.3 68.4 152.2 77.6 139.5 49.0 121.3 69.3 75.1 49.5 51.8 88.3 79.2 47.4 39.9 23.6 156.9 94.6 52.0 52.4 56.4 51.5 31.4 53.7 37.5 45.5 32.4 35.7 69.0 79.9 95.8 38.8 142.4 111.4 151.9 97.7 114.3 94.2 223.1 105.7 117.7 106.4 187.2 116.4 111.2 31.3 136.2 109.4 99.0 150.0 132.2 127.6 134.7 131.2 168.4 127.8 137.5 133.9 130.9 134.1 128.7 137.8 134.7 84.5 70.5 91.2 30.0 58.2 55.2 91.5 179.2 82.6 54.5 130.1 162.4 154.5 128.7 127.8 196.8 6.2 172.9 48.2 292.0 508.7 70.6 13.5 125.9 116.5 66.9 121.3 56.3 44.9 49.8 105.3 88.5 99.9 114.1 57.1 97.0 83.2 250.4 136.7 35.3 47.4 186.3 187.2 85.3 59.6 16.5 103.2 66.2 136.9 20.6 79.6 168.8 51.5 19.6 32.8 37.7 143.6 124.1 74.6 93.4 162.7 326.7 148.5 41.6 92.1 60.0 128.6 42.5 50.6 113.9 62.4 77.3 52.5 97.2 228.1 117.5 PNMA1 MA1 ENSG00000176903 "PNMA family member 1" Q8ND90 14 73711783-73714384 "Predicted intracellular proteins" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 84.2;Peritubular cells: 84.7;Spermatocytes: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA003817, HPA015007" Enhanced Supported "Nucleoplasm,Focal adhesion sites,Cytosol" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Nucleoplasm, Focal adhesion sites" "HPA003817: AB_1079646, HPA015007: AB_1855502" "unprognostic (2.82e-2)" "unprognostic (3.26e-1)" "unprognostic (9.50e-2)" "unprognostic (1.10e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (7.49e-5)" "prognostic unfavorable (3.00e-5)" "unprognostic (2.90e-1)" "unprognostic (5.35e-2)" "unprognostic (3.63e-1)" "unprognostic (5.58e-2)" "unprognostic (4.58e-2)" "unprognostic (1.67e-3)" "unprognostic (2.04e-3)" "unprognostic (4.17e-2)" "unprognostic (2.23e-3)" "prognostic unfavorable (4.51e-5)" 35.5 30.2 75.0 20.3 80.5 8.8 20.6 55.5 85.6 37.6 34.7 56.7 13.9 46.3 54.6 23.4 38.1 24.6 23.3 77.3 90.0 27.8 4.9 15.5 16.4 62.1 62.5 53.4 9.2 8.0 53.1 21.4 62.9 48.8 16.5 59.9 10.9 89.3 12.0 9.8 24.9 52.3 66.9 19.2 26.0 71.0 78.4 19.0 18.5 10.4 12.5 41.7 26.6 70.3 48.2 42.8 72.3 54.1 53.1 56.0 29.9 49.8 27.8 44.5 32.5 40.6 29.2 1.1 33.8 60.7 42.4 31.6 56.0 29.4 45.7 45.7 34.7 27.2 35.8 30.7 56.8 15.3 41.6 49.8 35.1 53.4 33.5 87.4 68.1 28.7 23.9 29.3 61.2 117.6 30.5 37.1 21.8 24.6 149.0 47.5 45.0 1.1 58.8 1.5 85.4 65.5 87.5 19.9 40.4 43.6 97.0 25.6 66.5 89.3 71.7 54.9 41.1 25.7 42.9 14.2 88.3 21.4 30.3 2.9 1.8 4.7 8.5 3.5 5.8 2.8 10.9 8.7 3.9 3.1 10.4 10.0 1.6 5.6 5.3 0.6 14.2 7.3 75.0 80.5 55.5 85.6 77.3 90.0 62.1 62.5 62.9 66.9 78.4 70.3 13.1 6.4 3.0 21.9 8.8 3.8 6.8 5.0 6.2 48.6 7.0 7.5 19.9 2.8 4.1 14.7 12.5 7.5 10.4 6.7 15.6 10.1 84.2 32.2 30.6 13.5 18.7 3.0 31.4 6.7 11.3 20.5 14.3 10.2 16.5 16.6 20.0 1.6 15.6 58.9 28.9 5.4 14.2 6.8 25.9 57.6 32.6 18.8 19.6 12.2 14.1 65.2 10.3 17.1 21.7 30.2 1.4 84.7 10.9 7.4 1.6 26.6 23.1 49.1 72.3 31.2 44.1 87.2 44.4 4.7 3.8 6.0 20.0 43.8 2.5 3.7 POLR2G "hRPB19, hsRPB7, RPB7" ENSG00000168002 "RNA polymerase II subunit G" P62487 11 62761565-62766710 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053000 Approved Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA053000: AB_2682010" "unprognostic (7.58e-3)" "unprognostic (2.75e-1)" "unprognostic (2.37e-2)" "prognostic favorable (8.23e-4)" "unprognostic (1.39e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (6.02e-5)" "unprognostic (8.50e-2)" "unprognostic (6.01e-2)" "unprognostic (6.26e-3)" "unprognostic (9.41e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (1.11e-4)" "unprognostic (1.53e-1)" "unprognostic (1.64e-1)" "unprognostic (2.46e-1)" "unprognostic (2.21e-1)" 63.1 69.5 75.5 48.3 79.7 70.6 75.3 82.0 101.1 54.8 72.3 53.9 37.3 52.5 85.8 59.2 64.3 41.5 53.5 75.1 80.7 67.7 67.9 49.1 89.1 85.0 76.6 54.6 41.1 57.9 41.1 60.7 84.5 55.2 66.1 76.0 41.9 51.8 45.4 60.9 44.1 66.2 83.8 62.7 49.9 32.6 79.2 112.2 53.6 47.3 106.2 53.1 50.1 90.1 124.4 212.7 225.1 142.9 114.0 111.7 56.7 85.7 107.8 199.8 159.9 129.3 141.4 173.9 192.5 129.8 86.2 118.9 103.6 159.8 176.4 342.3 129.7 116.6 157.2 156.5 159.6 159.7 103.2 108.8 161.2 93.0 185.9 105.6 157.9 160.5 148.5 115.4 143.4 389.4 230.6 209.4 142.3 130.7 218.2 185.6 207.0 234.8 150.8 103.8 95.7 162.1 143.8 112.8 226.2 84.6 318.6 132.6 62.7 101.7 109.0 199.1 101.0 89.0 177.6 192.8 103.7 99.8 139.1 169.9 147.5 164.1 127.2 160.7 124.2 150.4 109.0 126.0 174.9 146.7 103.5 129.6 64.0 154.6 175.3 184.5 151.0 230.5 75.5 79.7 82.0 101.1 75.1 80.7 85.0 76.6 84.5 83.8 79.2 90.1 50.9 38.5 60.7 3.3 69.1 44.9 46.6 209.0 43.3 43.5 47.0 56.3 46.4 55.8 102.3 77.3 8.4 222.1 79.3 27.5 140.8 120.3 7.4 51.3 66.4 73.3 58.6 59.3 1.9 111.3 138.4 69.5 30.5 61.2 90.0 69.6 73.5 73.8 191.6 38.7 2.2 55.1 148.5 74.5 80.7 14.9 70.8 86.4 88.9 2.8 149.2 147.2 118.4 2.5 8.5 93.1 48.3 62.1 39.3 35.1 44.1 150.4 58.0 55.9 78.9 51.8 65.7 36.4 38.9 62.9 60.4 139.0 79.7 91.7 77.6 41.4 POLR2I "hRPB14.5, RPB9" ENSG00000105258 "RNA polymerase II subunit I" P36954 19 36113709-36115213 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 1145.8;Late spermatids: 2796.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035632, HPA045156" Uncertain Enhanced Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA035632: AB_2674711, HPA045156: AB_10964748" "unprognostic (1.95e-2)" "unprognostic (7.88e-3)" "unprognostic (3.54e-1)" "unprognostic (7.41e-3)" "unprognostic (2.05e-1)" "unprognostic (3.01e-1)" "unprognostic (1.24e-2)" "unprognostic (4.12e-2)" "unprognostic (7.39e-2)" "unprognostic (4.69e-3)" "unprognostic (2.86e-2)" "unprognostic (8.16e-2)" "unprognostic (1.83e-1)" "unprognostic (3.36e-2)" "unprognostic (3.84e-3)" "unprognostic (1.08e-1)" "unprognostic (1.16e-1)" 32.6 41.0 97.6 23.3 104.3 44.4 34.8 104.2 118.6 30.6 85.8 35.0 28.9 28.4 39.7 40.2 55.7 27.2 78.9 94.6 100.8 32.9 40.2 25.5 31.5 98.5 98.6 50.0 83.9 61.3 26.1 21.8 101.0 30.2 20.2 25.9 66.9 35.9 195.2 41.5 29.9 21.7 98.5 29.7 31.5 66.8 97.4 30.4 37.2 119.7 24.2 28.3 15.7 120.6 96.7 364.7 61.9 103.8 38.5 44.6 67.7 35.5 47.5 80.5 67.5 179.0 62.0 61.6 80.4 38.2 46.8 49.6 60.4 82.5 42.1 107.8 115.5 59.1 88.8 180.9 70.0 88.7 53.1 47.5 71.4 51.7 75.1 51.1 52.8 112.2 66.6 117.1 48.5 292.1 124.6 111.0 74.5 201.6 151.7 130.4 51.6 114.0 94.0 121.3 145.0 74.0 60.1 172.5 59.5 53.7 81.3 92.7 35.7 88.6 91.6 60.3 128.2 83.2 88.4 99.6 102.3 88.0 94.7 130.7 109.5 128.4 113.9 115.2 130.6 168.7 148.3 134.1 90.2 134.8 150.4 117.2 72.5 111.0 113.0 223.8 176.5 114.0 97.6 104.3 104.2 118.6 94.6 100.8 98.5 98.6 101.0 98.5 97.4 120.6 108.2 83.3 66.3 2.9 62.9 79.0 94.9 156.4 75.1 63.1 203.5 279.4 253.5 133.0 124.7 163.7 25.0 144.5 76.3 141.5 352.1 178.2 1145.8 380.4 114.9 101.6 106.2 199.9 2.9 240.5 166.2 96.9 71.4 126.0 82.4 150.0 111.0 282.5 124.3 33.7 3.2 163.3 126.1 72.9 63.8 2796.6 139.1 68.7 168.9 0.0 122.5 183.2 77.2 1.5 7.9 196.8 196.8 154.2 88.5 127.9 221.4 528.2 386.6 73.6 111.7 111.1 125.1 378.2 183.1 155.9 109.0 103.8 68.1 133.7 167.7 90.1 POLR2J "hRPB14, POLR2J1, RPB11, RPB11A, RPB11m" ENSG00000005075 "RNA polymerase II subunit J" P52435 7 102473118-102478907 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA046970 Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA046970: AB_2679882" "unprognostic (1.11e-1)" "unprognostic (1.24e-2)" "unprognostic (1.46e-2)" "unprognostic (1.62e-1)" "unprognostic (1.90e-2)" "unprognostic (4.80e-2)" "unprognostic (6.47e-2)" "unprognostic (4.26e-2)" "unprognostic (3.46e-1)" "unprognostic (1.53e-3)" "unprognostic (4.46e-2)" "unprognostic (7.32e-2)" "unprognostic (7.13e-2)" "unprognostic (2.45e-1)" "unprognostic (4.23e-2)" "unprognostic (1.37e-1)" "unprognostic (2.19e-2)" 54.8 87.0 85.3 36.5 87.4 90.0 51.7 88.2 108.0 48.3 83.2 59.1 46.4 48.1 54.7 60.0 46.5 32.7 125.8 85.3 89.6 71.2 99.4 43.3 46.1 89.2 87.2 59.3 58.6 62.9 66.4 32.5 87.4 59.7 33.9 17.8 58.6 38.2 195.7 56.5 51.1 28.3 88.3 59.1 63.6 43.6 90.2 53.2 56.0 127.7 40.1 51.1 48.1 88.4 143.4 143.0 96.2 127.5 89.2 68.5 70.4 77.4 82.3 111.2 94.2 131.1 108.4 65.7 145.9 108.7 160.2 74.8 89.8 95.6 67.8 123.3 160.4 65.9 101.2 129.1 108.9 128.5 94.6 89.6 117.4 100.1 55.8 72.5 100.8 138.3 156.8 190.0 92.5 439.6 212.9 228.5 89.5 141.4 182.2 100.1 94.4 194.0 91.2 93.6 81.4 135.6 93.5 176.1 113.9 97.3 79.1 155.3 82.3 125.0 160.0 198.4 154.5 116.5 183.6 171.0 111.3 157.8 149.1 180.3 116.5 199.5 90.5 122.5 86.2 137.6 96.0 101.0 93.8 122.9 81.4 81.8 174.6 84.7 115.5 127.5 140.8 128.9 85.3 87.4 88.2 108.0 85.3 89.6 89.2 87.2 87.4 88.3 90.2 88.4 87.9 35.3 46.7 17.9 91.1 95.0 113.5 190.7 79.1 37.0 149.6 195.2 193.2 81.5 107.4 125.0 12.5 197.7 93.0 241.7 273.9 139.0 53.1 84.1 64.4 86.8 103.0 128.2 5.6 199.6 195.5 94.4 78.0 73.2 43.7 90.7 86.0 203.5 202.5 35.3 6.2 164.0 146.5 111.0 107.6 43.2 127.1 99.5 142.3 4.7 154.0 171.3 127.7 8.5 10.8 191.8 281.6 110.6 111.4 128.9 236.3 242.0 107.0 46.7 52.6 76.9 113.2 117.1 229.3 114.3 116.1 182.1 91.4 114.5 131.2 153.9 POLR2L "hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6" ENSG00000177700 "RNA polymerase II, I and III subunit L" P62875 11 837356-842529 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 1813.6;Proximal tubular cells: 1989.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 569.0;PC-3: 706.8" "Low region specificity" "Detected in all" HPA073614 Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA073614: " "unprognostic (2.65e-2)" "unprognostic (6.56e-3)" "unprognostic (1.40e-1)" "unprognostic (5.71e-2)" "unprognostic (3.49e-2)" "unprognostic (3.46e-2)" "prognostic unfavorable (2.37e-4)" "unprognostic (6.17e-3)" "unprognostic (1.34e-1)" "unprognostic (7.51e-3)" "unprognostic (2.37e-2)" "unprognostic (6.77e-2)" "prognostic favorable (5.56e-4)" "unprognostic (3.60e-2)" "unprognostic (1.32e-1)" "unprognostic (4.03e-3)" "unprognostic (1.73e-1)" 112.1 101.2 68.2 21.5 69.9 27.2 91.0 69.0 98.3 48.0 90.5 63.5 26.1 48.9 16.5 87.1 43.3 16.4 161.8 72.9 75.3 112.7 107.6 68.3 20.4 68.3 71.0 37.3 111.5 30.4 71.7 21.1 70.1 67.9 15.4 11.9 62.6 31.3 101.0 65.3 46.2 24.9 67.9 68.4 63.3 34.3 70.1 21.0 72.5 43.1 17.6 63.3 54.1 69.7 106.4 569.0 52.9 66.5 150.1 107.8 45.6 134.5 94.1 129.6 86.5 166.2 97.6 64.4 35.6 166.6 110.4 69.5 79.7 160.8 39.9 59.9 381.6 63.4 160.7 216.6 88.3 62.3 49.3 178.9 71.6 74.2 36.6 79.2 101.7 63.9 67.0 71.3 156.1 268.4 59.7 63.1 82.6 124.7 706.8 58.8 41.9 99.3 160.7 81.1 104.1 32.1 133.3 135.2 107.3 28.2 81.2 36.7 117.9 87.5 69.1 48.3 83.8 40.0 50.0 62.3 130.8 58.3 78.2 93.3 119.5 121.7 92.9 109.0 100.1 75.5 86.0 92.0 114.0 73.6 71.8 89.3 32.1 123.7 76.6 141.1 92.5 134.7 68.2 69.9 69.0 98.3 72.9 75.3 68.3 71.0 70.1 67.9 70.1 69.7 364.4 410.3 390.2 9.8 265.9 611.8 245.0 767.6 279.4 68.1 491.1 412.0 500.6 584.8 415.4 526.0 25.0 625.4 305.0 669.3 1287.4 444.0 84.2 388.4 377.2 400.3 501.7 363.4 5.0 684.1 467.7 392.3 283.4 301.7 266.2 194.4 649.6 1813.6 700.2 50.5 5.3 641.6 323.5 434.5 582.0 235.7 305.7 307.3 658.1 11.2 493.6 368.5 389.3 3.5 9.0 751.1 589.2 255.1 382.8 300.0 813.6 1989.1 329.9 82.5 157.8 195.2 340.8 182.6 268.6 459.8 696.6 449.6 286.1 284.9 553.1 289.7 POP5 ENSG00000167272 "POP5 homolog, ribonuclease P/MRP subunit" Q969H6 12 120578764-120581402 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047598, HPA069204" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA047598: AB_2680096, HPA069204: " "unprognostic (1.50e-2)" "prognostic favorable (2.68e-5)" "unprognostic (1.55e-1)" "unprognostic (3.61e-3)" "unprognostic (3.81e-1)" "unprognostic (1.50e-1)" "unprognostic (4.80e-3)" "unprognostic (1.28e-1)" "unprognostic (7.34e-2)" "unprognostic (5.75e-2)" "unprognostic (4.13e-2)" "unprognostic (1.33e-1)" "prognostic unfavorable (4.85e-4)" "unprognostic (3.07e-1)" "unprognostic (6.21e-2)" "unprognostic (2.68e-1)" "unprognostic (5.68e-2)" 27.0 51.3 5.2 5.6 6.1 9.5 25.6 6.0 8.9 20.7 6.1 24.6 6.0 21.8 2.4 25.9 20.1 5.1 42.5 5.5 5.9 38.3 40.5 19.0 10.8 6.1 5.7 17.2 25.2 7.3 26.2 2.1 6.4 24.3 2.8 1.2 25.2 4.8 22.9 22.4 24.6 3.5 6.2 31.8 25.4 10.2 5.8 7.9 27.4 3.6 4.3 24.3 21.0 6.4 22.2 43.4 3.8 8.7 10.1 4.5 14.7 14.2 5.7 13.6 11.2 36.6 6.6 13.4 26.9 7.8 6.1 15.7 8.0 30.1 1.1 41.4 42.1 13.5 20.3 26.5 12.1 11.7 11.3 14.1 11.2 13.5 2.4 3.4 8.9 30.2 18.2 5.6 7.5 45.0 18.9 11.2 8.0 14.6 36.5 20.5 9.8 28.5 11.5 18.5 7.4 8.7 27.7 6.5 15.7 2.8 27.5 20.7 11.8 8.1 13.2 13.6 19.8 16.1 35.8 16.7 20.5 21.6 13.3 4.5 12.7 3.1 17.7 14.9 16.4 25.2 14.2 16.2 16.8 18.0 17.6 16.3 0.9 16.0 14.1 26.6 15.8 20.8 5.2 6.1 6.0 8.9 5.5 5.9 6.1 5.7 6.4 6.2 5.8 6.4 24.2 12.8 27.6 10.1 47.8 19.6 38.6 83.7 34.1 22.0 37.5 50.4 60.5 37.1 59.3 77.3 14.6 51.7 49.3 21.6 154.6 44.9 1.7 39.9 30.5 25.4 22.1 30.1 6.4 44.9 42.9 33.8 32.6 24.8 54.6 24.0 24.3 58.3 53.2 18.5 6.9 30.5 54.9 19.8 21.7 5.0 36.1 35.7 49.8 7.5 33.4 79.3 52.5 10.6 8.2 40.0 21.9 37.6 56.8 23.6 31.2 136.2 45.2 34.4 19.7 27.5 39.4 22.7 43.8 53.3 24.7 17.6 46.1 106.3 44.2 33.5 POP7 "RPP2, RPP20" ENSG00000172336 "POP7 homolog, ribonuclease P/MRP subunit" O75817 7 100706121-100707486 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021007 Uncertain Supported Nucleoli,Vesicles NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" "Nucleoli, Vesicles" "HPA021007: AB_10963575" "unprognostic (3.19e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-2)" "unprognostic (1.80e-3)" "unprognostic (6.47e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (2.98e-2)" "unprognostic (2.28e-1)" "unprognostic (3.12e-2)" "unprognostic (9.50e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (6.02e-4)" "unprognostic (1.05e-2)" "unprognostic (1.44e-1)" "unprognostic (6.21e-2)" "unprognostic (6.73e-2)" 25.6 31.7 30.1 18.1 31.6 33.9 26.6 33.4 38.6 24.2 23.8 27.9 19.3 27.7 11.0 34.0 21.3 9.8 37.6 32.3 30.8 25.8 67.1 18.2 17.3 30.1 27.8 18.1 31.3 16.6 22.8 16.6 30.8 22.6 9.2 9.6 29.0 13.5 69.0 50.2 22.3 12.1 29.4 22.7 26.4 12.5 29.1 15.6 16.8 31.9 12.0 25.4 24.9 33.9 115.7 115.3 47.2 78.4 25.1 23.9 92.0 65.6 32.4 73.7 73.1 159.8 71.0 97.5 105.1 30.0 81.4 70.4 70.1 79.5 36.8 82.7 212.4 44.9 75.0 166.5 42.1 69.2 49.8 27.6 30.2 76.2 74.8 20.9 41.6 68.9 157.4 77.8 39.8 330.4 158.0 232.9 135.2 77.8 164.4 123.6 50.0 159.4 45.3 65.2 90.4 92.3 54.5 156.2 78.7 42.0 50.0 66.2 41.3 92.0 117.7 191.0 127.6 34.0 99.4 175.8 61.0 115.1 104.6 106.3 63.2 72.4 54.7 64.7 50.7 60.3 54.6 54.3 55.3 47.7 49.5 52.0 39.0 78.9 70.3 51.2 69.8 62.5 30.1 31.6 33.4 38.6 32.3 30.8 30.1 27.8 30.8 29.4 29.1 33.9 30.5 19.2 17.0 2.9 29.7 105.0 32.0 57.2 56.3 26.1 61.6 64.1 27.9 37.1 31.5 35.0 6.2 148.2 25.8 51.8 93.9 75.4 2.1 31.2 32.3 37.2 40.2 50.1 5.2 87.4 181.3 37.3 25.0 35.1 17.7 32.4 33.5 99.0 66.1 32.0 6.0 61.7 67.1 27.3 40.7 7.9 42.0 22.4 56.9 2.8 38.7 41.8 41.2 4.0 5.8 92.2 47.6 37.2 55.1 75.6 69.8 86.1 27.8 21.3 46.0 29.8 52.2 9.2 45.5 74.7 119.2 139.3 27.2 39.9 55.8 43.5 PPM1D "PP2C-DELTA, Wip1" ENSG00000170836 "Protein phosphatase, Mg2+/Mn2+ dependent 1D" O15297 17 60600183-60666280 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Hydrolase, Protein phosphatase" "Autism spectrum disorder, Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022277, HPA061848" Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Nucleoli "HPA022277: AB_1858839, HPA061848: " "unprognostic (1.48e-1)" "unprognostic (1.36e-2)" "prognostic favorable (3.52e-4)" "unprognostic (1.76e-1)" "unprognostic (1.02e-1)" "unprognostic (5.12e-2)" "prognostic unfavorable (4.27e-4)" "unprognostic (5.50e-2)" "unprognostic (1.70e-2)" "unprognostic (6.07e-2)" "unprognostic (2.52e-3)" "unprognostic (3.46e-2)" "unprognostic (1.95e-3)" "unprognostic (7.33e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-2)" "unprognostic (1.98e-1)" 4.4 2.4 2.7 2.2 5.2 5.9 3.9 14.8 4.6 4.5 5.0 3.1 2.9 4.3 2.9 3.5 3.7 3.1 2.9 3.3 3.4 2.8 2.8 3.6 2.7 4.0 3.5 6.3 3.3 2.3 2.4 5.9 4.7 3.1 3.5 6.4 3.1 2.2 4.0 2.9 2.7 3.0 3.4 3.8 2.7 5.5 3.7 4.4 2.9 3.1 2.3 2.8 4.0 9.1 3.8 6.9 7.5 6.4 5.0 3.1 10.7 5.8 3.6 3.4 4.9 7.1 2.0 9.9 4.5 3.7 1.3 3.4 4.9 2.2 4.6 1.9 11.1 7.4 6.7 8.1 4.2 2.9 5.3 2.7 3.6 5.1 3.0 2.8 7.9 4.1 5.4 4.0 3.7 34.4 8.1 4.4 3.5 3.4 5.2 9.5 9.6 6.6 3.1 4.2 10.5 7.4 7.1 2.4 1.6 8.0 2.8 3.9 5.7 4.7 12.5 3.5 3.3 6.7 7.7 7.3 1.7 2.9 3.8 9.9 16.1 18.0 7.6 12.5 6.8 8.9 6.3 7.0 16.0 6.2 6.8 7.0 24.7 8.6 8.1 7.0 10.6 9.8 2.7 5.2 14.8 4.6 3.3 3.4 4.0 3.5 4.7 3.4 3.7 9.1 40.9 32.1 7.7 15.0 23.1 21.0 6.2 3.3 52.3 13.1 14.2 9.8 6.3 8.6 4.6 5.5 4.2 17.6 19.4 15.0 3.9 6.6 68.9 14.0 15.5 25.2 14.4 14.1 19.6 6.6 6.4 14.7 10.2 15.6 1.3 7.2 23.6 4.2 8.8 3.3 20.8 11.4 6.1 21.4 19.2 12.8 13.7 16.1 3.6 28.1 12.3 7.0 6.2 20.6 38.6 5.4 10.2 7.5 24.5 7.8 8.7 5.1 3.6 10.4 0.0 12.1 14.0 43.8 15.0 34.4 18.0 38.6 18.1 6.0 11.5 7.7 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 208.9;Proximal enterocytes: 440.8;Proximal tubular cells: 404.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MCF7: 49.9" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 6.1 15.0 10.2 4.7 8.6 3.8 8.2 4.3 15.0 10.5 16.7 25.1 27.1 10.5 1.6 9.8 18.9 3.1 9.6 12.9 8.9 26.7 23.5 10.8 2.9 10.2 10.4 7.9 17.7 7.4 36.9 1.7 7.1 15.5 2.4 2.9 11.6 5.6 6.3 9.0 24.6 1.6 8.1 8.0 14.1 33.3 10.3 2.4 27.0 1.0 1.0 9.1 6.7 5.1 30.4 24.3 3.9 15.1 1.6 2.7 19.3 8.2 5.1 6.3 5.1 6.4 21.2 5.0 21.1 3.0 5.6 19.8 2.0 6.7 1.0 10.3 11.9 6.0 26.4 6.8 4.7 4.3 7.9 2.7 8.9 7.3 2.1 4.1 4.5 8.2 24.0 6.1 2.3 49.9 15.3 19.9 7.4 15.6 30.3 15.9 1.9 10.1 5.7 10.0 12.5 23.9 14.9 13.7 13.0 1.0 32.3 9.1 7.7 7.1 33.2 19.8 15.8 4.0 4.3 1.8 22.8 8.3 6.5 0.0 0.8 0.0 1.0 1.2 0.9 0.8 0.8 1.0 1.2 0.1 0.5 1.1 0.2 0.2 1.7 0.7 0.6 0.8 10.2 8.6 4.3 15.0 12.9 8.9 10.2 10.4 7.1 8.1 10.3 5.1 7.9 3.2 15.4 28.1 6.2 43.2 36.2 47.6 54.1 25.0 78.3 82.0 85.8 157.3 24.6 40.5 14.6 7.2 6.0 135.9 121.3 33.7 12.6 43.8 15.6 13.3 51.6 6.1 7.8 41.6 24.3 13.3 70.3 24.2 3.8 16.4 12.8 208.9 6.1 30.3 7.6 98.1 26.4 7.0 27.1 14.4 22.7 9.8 8.8 5.6 3.8 102.8 5.2 6.6 2.8 29.3 109.8 15.4 5.9 40.0 440.8 404.2 59.8 50.9 6.6 17.2 17.3 52.9 28.7 77.8 61.8 6.7 7.1 69.2 116.0 28.3 PPP4C "PP4, PPX" ENSG00000149923 "Protein phosphatase 4 catalytic subunit" P60510 16 30075978-30085376 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043837 Supported Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Plasma membrane, Cytosol" "HPA043837: AB_2678695" "unprognostic (1.20e-1)" "unprognostic (1.33e-2)" "unprognostic (2.68e-1)" "unprognostic (4.74e-2)" "unprognostic (2.16e-1)" "unprognostic (5.79e-3)" "unprognostic (3.28e-3)" "unprognostic (2.60e-3)" "unprognostic (3.82e-1)" "unprognostic (1.29e-1)" "unprognostic (2.52e-1)" "unprognostic (3.17e-2)" "unprognostic (1.98e-2)" "unprognostic (3.78e-2)" "unprognostic (9.36e-2)" "unprognostic (9.96e-2)" "unprognostic (1.88e-1)" 44.3 57.9 34.8 43.2 34.7 63.2 42.5 35.9 38.7 42.8 41.0 49.8 47.0 39.6 47.1 88.3 35.9 32.5 45.6 34.0 35.7 49.9 83.2 46.2 58.6 35.5 34.9 29.4 41.0 46.4 33.5 49.6 35.3 37.8 35.2 18.1 44.0 28.5 60.8 60.8 49.0 32.8 35.6 62.5 49.2 65.4 38.4 61.2 35.4 30.2 63.7 56.3 48.9 36.4 132.7 145.9 95.5 134.0 88.4 73.8 148.5 115.8 127.7 148.7 163.8 129.5 167.9 102.7 145.2 137.0 95.5 105.9 119.3 143.2 87.0 130.1 213.0 70.5 86.0 290.4 133.5 100.1 126.8 107.9 124.7 135.9 85.5 88.4 174.9 130.5 139.6 91.0 115.1 382.2 174.4 180.7 182.2 104.7 77.1 190.9 99.4 180.4 142.5 134.5 91.9 136.8 57.1 169.1 101.8 79.4 156.0 166.0 113.3 86.4 90.4 70.6 90.8 155.4 183.8 122.4 123.1 126.9 107.0 100.6 103.5 236.1 66.5 113.2 47.7 68.5 69.6 74.2 115.8 88.3 62.0 54.1 215.2 51.7 100.1 90.6 95.1 48.3 34.8 34.7 35.9 38.7 34.0 35.7 35.5 34.9 35.3 35.6 38.4 36.4 87.8 51.3 33.4 10.7 85.8 147.2 121.7 206.9 71.2 23.3 94.2 82.8 11.1 82.9 133.5 77.3 29.2 313.7 106.0 217.0 158.5 226.9 156.9 80.5 55.5 91.7 125.6 89.2 8.0 193.3 335.3 66.7 106.0 85.2 69.2 66.7 74.6 94.2 239.3 35.3 8.6 159.3 193.3 105.4 138.4 143.8 62.7 124.4 80.0 9.4 221.1 61.1 118.4 8.0 12.9 345.5 220.8 52.3 97.6 161.3 191.0 198.6 119.7 29.5 72.3 43.4 85.9 228.5 157.8 113.2 172.5 421.0 93.0 61.7 175.9 227.2 PPP6R2 "dJ579N16.1, KIAA0685, SAP190, SAPS2" ENSG00000100239 "Protein phosphatase 6 regulatory subunit 2" O75170 22 50343304-50445090 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030656, CAB034919" Uncertain Supported Vesicles,Cytosol NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Vesicles, Cytosol" "CAB034919: AB_2183817, HPA030656: AB_10602926" "unprognostic (1.24e-1)" "unprognostic (1.82e-3)" "unprognostic (1.03e-1)" "prognostic favorable (1.70e-5)" "unprognostic (2.17e-1)" "unprognostic (3.79e-3)" "unprognostic (2.32e-1)" "unprognostic (1.30e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-2)" "prognostic favorable (7.51e-4)" "unprognostic (6.89e-2)" "unprognostic (1.42e-2)" "unprognostic (1.20e-2)" "unprognostic (2.13e-1)" "unprognostic (1.02e-1)" "unprognostic (7.77e-3)" 21.9 35.6 23.5 20.9 27.3 21.4 23.2 24.3 32.2 23.7 19.2 28.5 24.5 25.4 11.5 28.3 23.8 18.0 36.7 25.4 19.7 29.6 72.4 25.2 27.3 26.9 22.2 24.8 29.0 21.4 41.0 14.8 21.8 31.4 11.8 12.6 27.9 17.1 65.8 27.6 28.7 14.0 18.2 32.4 30.1 62.7 26.0 25.8 30.8 31.7 16.5 23.9 22.3 25.8 30.9 17.8 27.3 34.8 19.7 21.0 24.4 30.1 31.9 31.5 31.7 15.0 18.7 36.9 14.5 30.0 17.4 24.6 16.9 22.4 11.8 19.3 30.9 19.8 37.7 37.7 25.6 46.9 52.1 31.2 23.8 19.0 10.1 24.8 27.8 30.8 20.5 31.5 23.2 50.0 32.3 33.9 11.3 19.5 21.9 44.8 20.9 24.3 23.1 36.1 17.0 23.1 31.0 47.6 25.0 10.1 17.2 35.2 32.5 29.3 26.4 24.6 20.3 33.6 8.7 32.7 30.6 22.6 41.2 4.0 8.6 5.8 9.0 9.4 10.4 7.9 6.2 9.6 8.8 8.4 5.9 7.9 13.7 5.9 6.8 11.0 13.3 8.5 23.5 27.3 24.3 32.2 25.4 19.7 26.9 22.2 21.8 18.2 26.0 25.8 28.5 22.4 20.6 79.0 32.0 8.8 14.4 12.9 22.8 43.7 25.5 21.8 19.2 37.1 17.1 27.6 56.3 17.3 39.9 39.8 31.3 19.3 84.0 30.8 39.0 18.1 26.9 19.8 83.0 32.5 11.8 15.3 35.2 34.8 31.8 23.9 18.9 65.1 16.0 65.6 80.8 23.0 16.2 25.3 8.8 48.6 19.6 23.4 10.6 61.8 32.1 25.0 50.4 52.8 59.9 33.3 29.0 19.9 42.0 19.4 27.0 23.6 17.9 43.2 26.3 16.9 18.7 78.5 47.1 17.9 8.5 28.5 28.4 17.8 25.2 17.5 PRDX2 "MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA" ENSG00000167815 "Peroxiredoxin 2" P32119 19 12796820-12801800 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Antioxidant, Oxidoreductase, Peroxidase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 1316.7;Erythroid cells: 3153.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB008713 Approved NA NA 800000000 "Cluster 20: T-cells - T-cell receptor" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" "CAB008713: AB_1620974" "unprognostic (1.12e-1)" "unprognostic (1.98e-3)" "unprognostic (8.58e-2)" "unprognostic (4.40e-2)" "unprognostic (4.56e-2)" "unprognostic (1.92e-2)" "unprognostic (2.44e-1)" "unprognostic (2.59e-2)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.26e-2)" "unprognostic (9.18e-2)" "prognostic favorable (5.66e-11)" "unprognostic (7.01e-3)" "unprognostic (2.15e-1)" "unprognostic (3.51e-2)" "unprognostic (1.41e-1)" 199.0 622.0 350.8 88.3 366.6 686.7 159.7 408.2 461.5 167.8 365.6 208.1 251.7 178.8 144.5 271.8 153.5 133.9 704.0 369.6 400.0 287.7 310.2 109.1 118.3 407.5 380.4 218.2 201.7 454.5 314.6 87.8 408.2 175.3 141.5 207.1 200.1 124.4 722.9 260.7 201.1 127.0 357.0 118.1 226.6 32.8 399.1 181.3 156.3 847.9 129.2 163.6 171.6 355.5 420.4 1.1 553.9 721.3 79.5 54.2 408.4 189.0 188.0 253.9 143.4 438.1 102.8 122.7 430.9 185.0 30.2 389.5 354.7 309.7 72.9 528.5 561.4 222.6 537.4 665.1 212.4 0.7 1.4 233.6 140.5 191.1 93.0 327.6 238.8 255.3 485.7 187.0 98.7 763.3 500.1 190.2 409.1 289.6 789.4 485.8 0.7 593.0 343.1 450.0 683.8 538.5 449.5 454.9 153.7 100.7 408.0 318.0 105.7 188.2 156.9 526.7 417.7 226.3 242.1 573.5 178.9 75.5 43.8 35.4 170.0 85.6 436.1 129.4 460.6 375.2 589.8 446.2 211.6 288.5 594.7 460.9 22.4 213.2 148.0 124.5 697.4 686.6 350.8 366.6 408.2 461.5 369.6 400.0 407.5 380.4 408.2 357.0 399.1 355.5 192.2 22.4 36.7 39.5 117.5 221.3 255.6 877.7 187.2 317.9 271.2 322.2 37.1 265.9 347.7 279.6 100.1 692.8 83.5 367.4 1316.7 329.5 3.1 138.6 218.5 130.3 333.7 3153.4 31.8 167.2 558.8 204.3 214.6 197.7 47.0 466.0 137.8 489.7 234.0 215.4 50.8 360.7 754.8 63.8 128.8 13.0 293.9 58.7 281.1 23.4 61.4 531.2 56.7 41.7 29.1 179.6 250.6 321.2 263.4 169.3 765.6 1097.9 152.7 373.2 157.8 142.4 273.2 4.8 7.7 368.5 229.4 508.4 144.4 816.6 475.7 243.1 PRELID1 "CGI-106, PRELI, PX19" ENSG00000169230 "PRELI domain containing 1" Q9Y255 5 177303799-177306949 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005701 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" Mitochondria Nucleoplasm "HPA005701: AB_1079721" "unprognostic (1.27e-1)" "unprognostic (8.99e-2)" "unprognostic (3.18e-2)" "unprognostic (2.09e-3)" "unprognostic (2.19e-1)" "unprognostic (8.07e-2)" "prognostic unfavorable (5.46e-5)" "unprognostic (7.63e-3)" "unprognostic (1.49e-1)" "unprognostic (8.90e-3)" "unprognostic (1.71e-1)" "unprognostic (6.97e-2)" "prognostic unfavorable (2.89e-7)" "unprognostic (3.59e-2)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "unprognostic (2.21e-1)" 89.1 106.5 63.6 89.2 63.5 90.7 78.9 64.0 70.5 69.9 64.6 121.8 109.3 69.3 37.5 146.9 61.4 37.1 70.6 63.8 65.2 140.1 182.3 76.0 79.0 64.3 65.8 64.0 262.3 48.1 67.4 58.6 66.2 74.9 85.8 24.4 95.7 29.8 32.2 108.3 121.8 47.2 66.6 117.4 103.2 43.0 69.0 30.9 65.9 13.7 87.4 81.5 78.7 62.8 221.4 193.8 116.1 307.1 103.3 111.0 400.6 154.5 106.6 214.6 206.1 443.2 232.5 181.4 181.6 143.7 236.0 118.1 212.5 400.0 145.8 826.0 291.9 154.9 195.7 291.1 109.6 243.6 215.1 102.7 142.2 170.6 144.9 89.1 269.0 129.2 181.4 247.7 210.5 556.7 160.5 362.5 242.1 251.6 319.7 52.7 232.1 324.5 140.0 171.5 186.3 237.7 136.8 266.9 267.5 144.4 172.5 293.4 148.5 189.3 174.9 157.4 365.5 155.4 270.9 267.4 162.2 328.0 200.4 411.1 764.6 1198.6 248.0 988.0 238.5 276.0 202.6 245.4 775.1 238.7 175.7 195.7 553.7 327.4 989.8 281.9 246.6 614.3 63.6 63.5 64.0 70.5 63.8 65.2 64.3 65.8 66.2 66.6 69.0 62.8 174.4 22.4 23.4 8.1 198.3 348.3 297.0 331.8 152.5 60.8 339.3 415.4 0.4 168.7 159.0 104.8 22.9 756.9 231.4 572.7 303.3 382.9 6.6 114.1 111.2 171.5 157.5 128.9 9.7 563.3 552.7 134.0 110.6 129.9 108.1 145.9 120.3 247.5 352.2 60.6 10.0 311.3 219.7 271.0 337.1 24.6 114.0 293.8 256.1 7.5 410.1 117.1 325.4 4.0 12.2 752.9 664.0 109.1 393.9 612.4 853.7 567.0 60.5 68.9 46.0 126.6 177.3 81.5 218.6 246.7 420.8 883.6 169.7 221.0 433.6 480.2 PREX1 "KIAA1415, P-REX1" ENSG00000124126 "Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1" Q8TCU6 20 48624252-48827999 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 52.5;brain: 78.1" "Cell type enhanced" "Detected in many" "Astrocytes: 87.1;dendritic cells: 84.0;Kupffer cells: 104.7;Macrophages: 76.5;Microglial cells: 95.5;NK-cells: 90.6;Oligodendrocytes: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 157.9;SK-BR-3: 162.2;T-47d: 145.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001927 Supported Supported Vesicles,Cytosol NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "Vesicles, Cytosol" "HPA001927: AB_1079674" "unprognostic (8.07e-2)" "unprognostic (3.16e-2)" "unprognostic (2.15e-2)" "unprognostic (2.55e-1)" "unprognostic (7.47e-2)" "prognostic favorable (8.56e-4)" "unprognostic (2.16e-1)" "unprognostic (1.85e-1)" "unprognostic (1.31e-1)" "unprognostic (5.21e-2)" "unprognostic (1.13e-2)" "unprognostic (2.70e-2)" "unprognostic (5.86e-3)" "unprognostic (6.84e-2)" "unprognostic (2.31e-1)" "unprognostic (1.50e-1)" "unprognostic (1.01e-2)" 14.8 10.6 32.8 37.4 56.4 52.5 15.0 43.2 47.2 12.3 1.2 7.0 6.3 4.0 1.4 6.4 4.7 13.0 6.7 32.1 42.0 4.8 5.2 26.8 36.6 52.1 52.0 2.5 5.3 6.9 7.6 11.7 53.8 4.8 6.0 3.9 5.3 3.4 6.6 3.5 12.7 7.7 43.5 42.9 8.8 6.0 45.3 9.8 9.4 8.6 21.8 12.3 3.2 78.1 2.3 6.1 78.4 0.0 1.3 5.7 27.2 2.7 3.5 11.2 2.8 0.4 0.3 16.4 49.5 7.2 21.4 1.0 4.1 0.2 7.5 3.7 2.0 2.4 8.8 0.0 4.6 9.0 51.1 6.3 0.0 25.7 0.0 7.6 68.4 7.2 0.2 0.6 14.8 157.9 0.2 24.7 3.1 8.1 6.4 24.1 22.8 9.8 0.5 0.0 16.5 2.4 14.7 162.2 17.8 4.4 145.0 67.4 77.2 4.5 15.6 0.2 4.6 0.9 3.5 20.1 72.4 17.8 24.3 4.5 1.9 2.2 3.7 2.2 2.2 1.5 2.0 3.2 1.6 1.4 0.3 1.1 9.2 1.8 2.0 1.3 7.3 2.0 32.8 56.4 43.2 47.2 32.1 42.0 52.1 52.0 53.8 43.5 45.3 78.1 43.2 3.2 6.6 87.1 35.4 2.5 0.3 0.4 1.2 0.3 40.0 21.5 3.7 2.8 2.6 1.8 8.4 0.7 84.0 0.9 0.0 0.2 3.5 3.5 4.7 24.5 1.2 14.1 13.3 1.2 4.4 10.3 4.1 6.2 1.3 0.7 20.7 1.9 32.1 0.0 4.6 1.8 0.0 104.7 28.2 2.9 0.9 76.5 8.8 95.5 47.1 19.4 90.6 49.3 190.2 0.1 1.0 0.4 23.3 0.7 0.3 0.2 4.5 0.7 0.0 18.1 3.3 2.2 11.6 0.4 2.4 9.3 63.9 41.2 4.5 0.7 PRICKLE3 LMO6 ENSG00000012211 "Prickle planar cell polarity protein 3" O43900 X 49174802-49186528 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Early spermatids: 60.8;Late spermatids: 100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA000998 Uncertain NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "HPA000998: AB_1079258" "unprognostic (9.83e-3)" "unprognostic (7.02e-2)" "unprognostic (6.97e-3)" "unprognostic (2.54e-1)" "unprognostic (1.12e-2)" "unprognostic (5.61e-2)" "unprognostic (2.53e-2)" "unprognostic (2.55e-1)" "unprognostic (1.89e-1)" "unprognostic (2.41e-2)" "unprognostic (3.78e-2)" "unprognostic (1.14e-3)" "prognostic unfavorable (5.73e-6)" "unprognostic (2.28e-3)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "prognostic favorable (4.84e-5)" 4.3 3.8 2.3 3.5 2.5 2.1 4.0 2.5 2.9 4.8 4.2 3.7 3.0 4.0 1.7 10.2 4.7 2.9 5.7 2.1 2.4 2.5 3.1 4.0 3.3 2.7 2.7 2.6 5.1 4.0 2.1 3.8 2.7 4.6 3.0 0.6 4.5 5.8 11.6 12.0 3.5 3.3 2.9 3.8 4.0 1.1 2.7 3.4 3.9 10.5 4.5 5.1 6.6 3.0 17.7 20.3 0.5 1.7 8.4 9.1 19.0 6.8 10.2 5.1 7.9 6.2 10.9 0.0 6.1 8.4 1.6 24.8 15.6 25.1 2.3 21.9 8.4 7.4 12.2 4.7 12.2 5.0 24.3 8.3 19.3 6.4 15.7 3.3 5.3 4.5 12.4 6.6 8.6 27.8 6.0 7.4 3.0 10.6 21.7 8.3 5.3 9.8 6.7 24.7 3.4 0.0 9.4 8.6 6.7 6.0 17.4 5.6 6.2 0.1 8.0 7.2 2.6 11.6 8.3 4.1 8.0 6.6 0.1 2.4 8.3 9.2 2.3 9.1 3.2 7.0 3.1 3.8 7.5 4.1 2.5 2.6 4.7 3.0 12.1 3.5 4.2 5.1 2.3 2.5 2.5 2.9 2.1 2.4 2.7 2.7 2.7 2.9 2.7 3.0 2.7 0.0 1.5 1.0 4.2 15.2 5.5 13.7 10.8 0.3 1.4 2.2 1.5 0.0 6.6 1.8 2.1 3.2 1.0 1.9 1.9 3.4 60.8 2.7 2.0 3.2 1.2 2.5 0.2 2.7 6.8 2.8 6.6 2.4 0.0 1.7 1.4 1.4 2.5 0.0 0.1 3.3 8.2 1.3 8.1 100.8 1.5 2.8 8.8 0.0 2.9 0.9 1.0 2.0 1.0 2.2 2.7 0.7 3.2 4.8 1.7 2.0 3.3 0.2 0.0 1.5 2.6 0.4 0.5 15.9 19.0 3.3 2.2 2.2 2.5 4.6 PRKRIP1 "C114, FLJ13902, KRBOX3" ENSG00000128563 "PRKR interacting protein 1" Q9H875 7 102363872-102426676 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051146 Uncertain Supported "Actin filaments,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Actin filaments" Cytosol "HPA051146: AB_2681361" "unprognostic (4.78e-3)" "unprognostic (7.23e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (8.25e-2)" "unprognostic (2.99e-3)" "unprognostic (3.15e-2)" "unprognostic (1.99e-2)" "unprognostic (4.38e-3)" "unprognostic (1.57e-3)" "unprognostic (1.50e-2)" "unprognostic (2.61e-3)" "unprognostic (9.79e-3)" "prognostic unfavorable (4.39e-4)" "unprognostic (1.82e-1)" "unprognostic (1.01e-1)" "unprognostic (4.88e-1)" "prognostic favorable (1.94e-4)" 12.6 16.2 15.1 7.2 15.2 16.5 12.8 18.4 17.9 15.4 14.3 14.1 8.6 13.7 3.5 11.7 14.2 5.7 10.1 15.1 17.0 16.1 12.1 9.7 12.5 16.0 15.4 14.7 11.6 11.6 15.4 7.0 15.5 15.5 3.7 4.2 12.1 6.8 12.2 18.6 12.4 5.0 14.8 18.3 13.5 19.0 15.4 12.1 14.5 7.4 7.7 13.6 13.1 16.0 17.0 12.4 11.8 17.3 5.4 7.7 17.6 13.1 9.0 21.1 17.8 20.3 14.7 17.6 20.3 11.2 15.0 19.2 9.0 12.9 10.7 20.1 19.1 7.3 12.3 11.9 13.3 10.3 10.3 5.5 12.4 16.2 10.9 11.3 10.7 19.9 21.1 26.3 13.1 33.7 34.4 46.7 18.3 15.1 14.7 24.8 11.5 27.5 11.3 7.2 13.5 25.9 19.5 29.2 20.1 11.8 15.1 20.0 12.7 21.6 26.0 23.3 20.5 36.0 26.7 31.6 18.3 18.4 29.4 3.8 10.1 18.3 11.5 10.0 10.7 14.0 11.5 12.9 7.8 13.0 14.2 12.4 20.7 12.9 13.6 14.1 9.6 10.0 15.1 15.2 18.4 17.9 15.1 17.0 16.0 15.4 15.5 14.8 15.4 16.0 23.4 32.1 21.8 0.0 31.4 13.4 19.0 14.8 20.5 23.1 21.1 19.3 23.8 14.3 23.0 16.5 31.3 27.5 31.7 13.7 31.3 24.8 77.8 29.6 26.0 21.4 16.3 21.8 0.0 25.1 26.7 21.3 16.3 32.0 22.8 27.1 15.0 14.1 27.6 23.5 0.0 13.8 8.2 13.8 16.9 92.5 17.1 19.2 12.4 0.0 22.1 25.3 20.6 0.0 0.0 29.5 9.8 16.6 28.6 22.4 14.6 26.6 27.1 21.5 32.9 29.2 27.0 88.4 47.6 20.8 17.6 41.9 30.4 24.2 12.0 19.4 PRLH PRH ENSG00000071677 "Prolactin releasing hormone" P81277 2 237566574-237567175 "Predicted secreted proteins" Hormone "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 22.8" "Cell type enhanced" "Detected in single" "Endometrial ciliated cells: 1.0" "Cancer enhanced" "Detected in single" "endometrial cancer: 0.7" "Region enhanced" "Detected in many" "medulla oblongata: 22.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.3;MCF7: 1.8;RPMI-8226: 1.4" "Group enriched" "Detected in some" 58 "hypothalamus: 11.3;pons and medulla: 21.5" "Region enriched" "Detected in single" 14 "medulla oblongata: 5.5" HPA014976 Uncertain "Secreted in brain" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA014976: AB_2732413" "unprognostic (8.28e-4)" "unprognostic (3.22e-2)" "unprognostic (5.42e-2)" 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 0.0 1.2 0.0 0.0 0.1 0.0 22.8 0.1 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.2 0.9 0.4 0.0 0.0 0.0 0.0 0.0 8.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.2 22.8 0.1 0.5 5.0 0.9 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056674-107067636 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 308.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 4.9 10.0 5.7 7.2 5.6 4.2 8.0 5.6 5.7 6.1 13.8 7.9 6.1 7.0 8.0 6.8 8.8 6.0 3.9 5.2 6.9 12.0 7.1 4.6 9.6 6.1 6.5 8.6 10.9 9.6 8.4 7.3 5.3 8.5 7.2 6.4 6.5 7.8 1.8 5.6 7.2 5.9 5.5 8.3 7.4 6.6 8.2 10.3 7.0 3.1 8.7 7.9 5.0 6.0 13.6 0.2 25.7 11.3 16.6 18.4 7.0 17.8 13.2 16.9 17.2 17.2 9.2 33.1 24.1 16.5 9.2 18.9 23.9 26.2 13.3 0.0 25.4 20.0 35.6 25.0 16.5 41.6 11.9 17.4 14.2 15.2 15.5 11.4 14.8 18.5 27.1 5.0 15.4 308.1 24.5 14.6 11.1 10.6 24.6 30.8 56.0 12.6 41.3 27.1 47.8 58.3 24.2 34.5 12.1 15.5 24.0 30.7 17.2 12.5 25.5 26.3 26.8 5.4 4.0 5.7 18.4 19.3 10.2 2.1 10.4 1.9 7.9 11.9 9.5 7.4 8.3 7.6 14.1 10.3 11.5 11.9 0.6 17.4 12.0 17.2 9.2 9.3 5.7 5.6 5.6 5.7 5.2 6.9 6.1 6.5 5.3 5.5 8.2 6.0 3.0 0.0 4.4 1.3 6.2 4.5 6.9 9.7 8.6 14.2 8.9 5.0 2.6 5.7 5.8 14.7 0.0 18.3 8.5 3.3 27.4 10.3 1.2 5.2 6.2 4.7 17.5 15.8 1.5 7.4 14.6 6.7 4.6 4.9 1.3 9.4 7.5 2.4 10.0 15.2 2.2 7.4 8.2 7.0 1.6 3.0 8.7 3.8 1.8 3.7 3.9 6.9 3.1 2.0 2.2 4.7 8.5 9.1 2.0 5.1 4.1 18.4 7.4 5.1 13.1 5.9 6.3 9.1 8.1 8.9 6.1 7.1 5.0 13.7 10.3 5.4 PRPF19 "hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4" ENSG00000110107 "Pre-mRNA processing factor 19" Q9UMS4 11 60890547-60906585 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012448, HPA038051, HPA059070" Supported Enhanced "Nuclear speckles" NA NA 71000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear speckles" "CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896" "unprognostic (5.73e-2)" "unprognostic (2.11e-1)" "unprognostic (2.49e-1)" "unprognostic (2.68e-1)" "unprognostic (4.51e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (4.11e-8)" "unprognostic (1.03e-1)" "unprognostic (2.13e-1)" "unprognostic (9.37e-3)" "unprognostic (9.53e-2)" "unprognostic (1.54e-1)" "unprognostic (6.70e-2)" "unprognostic (9.62e-2)" "unprognostic (7.12e-2)" "unprognostic (9.04e-2)" "unprognostic (3.41e-3)" 46.1 70.6 89.8 49.8 87.9 67.0 48.8 73.7 100.2 57.4 60.2 54.5 42.9 55.4 34.2 81.7 57.3 29.4 47.9 91.3 94.1 50.4 77.2 34.6 64.1 92.0 80.7 66.6 69.4 79.8 79.3 42.9 92.9 62.1 51.8 46.1 56.5 48.2 75.2 80.3 49.5 47.9 75.6 54.3 54.3 30.5 81.1 78.5 43.4 38.9 73.7 58.7 55.9 84.5 197.5 147.0 161.8 116.2 92.7 80.8 155.6 102.4 137.5 200.2 149.0 162.7 141.1 280.5 145.2 98.2 120.2 179.0 229.2 184.6 153.4 207.0 153.4 232.4 111.3 184.9 134.2 308.6 161.1 86.3 137.0 154.4 171.9 58.7 158.7 167.4 248.2 155.3 99.5 270.6 328.9 249.5 292.6 150.5 197.7 285.8 165.5 227.5 101.7 127.5 142.3 172.9 126.6 208.3 178.0 73.1 225.8 170.2 101.9 89.6 147.2 161.8 171.2 147.2 223.3 287.9 111.6 208.6 138.6 4.2 7.8 2.0 2.4 3.8 1.7 0.9 1.8 1.7 3.6 2.4 2.2 2.0 0.5 1.8 2.3 3.9 1.7 1.0 89.8 87.9 73.7 100.2 91.3 94.1 92.0 80.7 92.9 75.6 81.1 84.5 15.8 19.2 23.7 10.1 26.7 42.1 35.2 40.2 33.0 32.0 24.6 19.4 17.6 20.0 28.6 27.6 10.4 94.7 16.2 20.4 27.4 48.5 21.6 21.4 19.7 27.3 39.0 45.2 19.8 51.6 90.2 24.9 23.4 28.4 22.8 25.4 20.0 46.1 46.3 62.2 22.2 40.0 32.6 23.0 21.6 3.6 37.0 19.3 26.6 11.2 41.2 25.4 21.6 10.1 11.8 33.4 27.7 38.7 31.9 40.4 27.8 27.9 17.8 25.3 46.0 22.4 22.6 25.2 38.0 37.4 41.6 40.6 24.8 24.8 55.1 26.3 PRPS2 ENSG00000101911 "Phosphoribosyl pyrophosphate synthetase 2" P11908 X 12791355-12824222 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide biosynthesis" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ovary: 147.8;parathyroid gland: 182.0" "Group enriched" "Detected in many" 7 "Leydig cells: 1431.5;Peritubular cells: 1995.0;Sertoli cells: 624.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051269, HPA067599, CAB070417" Enhanced Approved "Nuclear speckles,Vesicles" NA NA "Cluster 44: Non-specific - Transcription" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Vesicles "Nuclear speckles" "CAB070417: AB_11152035, HPA051269: , HPA067599: AB_2685869" "unprognostic (7.50e-2)" "prognostic favorable (1.90e-4)" "unprognostic (2.09e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-2)" "unprognostic (1.10e-1)" "unprognostic (7.63e-2)" "unprognostic (4.75e-2)" "unprognostic (6.98e-2)" "unprognostic (2.64e-3)" "unprognostic (4.44e-3)" "unprognostic (1.81e-1)" "unprognostic (7.83e-2)" "unprognostic (2.20e-1)" "unprognostic (1.50e-1)" "unprognostic (1.35e-1)" "unprognostic (2.04e-1)" 11.0 46.0 6.3 24.5 7.3 24.2 19.7 1.9 12.0 54.5 2.5 30.3 14.0 32.8 26.5 16.1 29.7 28.1 5.4 6.9 2.9 28.0 26.1 13.1 36.8 3.0 6.5 147.8 62.8 182.0 3.4 6.1 2.2 21.9 31.3 1.3 27.9 84.0 2.1 21.9 15.8 24.3 4.4 15.6 32.5 131.1 8.8 44.6 18.1 4.2 31.5 22.5 21.2 6.4 114.2 63.7 22.1 40.3 26.7 31.8 14.6 54.4 26.8 53.1 51.1 46.3 78.7 34.9 24.2 23.5 45.3 79.9 43.1 53.7 61.5 89.7 108.0 41.7 49.6 43.3 24.7 77.3 38.9 30.5 35.0 39.1 51.7 26.9 22.1 86.8 30.4 39.8 45.2 68.5 117.6 34.7 49.9 81.0 107.3 61.5 102.7 79.5 33.0 81.7 46.1 33.6 64.9 2.1 38.9 30.2 58.8 32.4 24.9 41.8 32.0 162.5 55.5 103.6 41.3 76.8 44.4 39.4 67.4 25.9 20.1 9.4 17.2 19.4 19.9 27.8 25.0 16.4 28.2 30.6 31.7 23.0 8.0 24.3 12.3 19.9 22.6 28.2 6.3 7.3 1.9 12.0 6.9 2.9 3.0 6.5 2.2 4.4 8.8 6.4 12.2 3.2 8.7 0.7 25.4 64.0 48.5 16.2 41.5 0.6 53.1 15.9 2.0 11.5 12.4 55.2 0.0 1.1 18.5 21.1 72.4 19.3 12.1 24.7 62.5 14.5 21.8 28.4 14.8 39.2 7.3 25.8 31.1 26.4 27.9 16.2 10.4 13.7 24.4 0.0 6.3 27.9 8.2 21.4 44.3 65.8 1431.5 20.7 40.9 3.7 18.2 1.2 18.6 3.5 5.1 24.6 17.4 1995.0 30.7 52.2 6.0 10.4 20.3 0.2 624.5 9.4 19.2 10.3 8.1 29.2 43.8 0.4 27.2 179.2 50.2 36.9 PRR14 MGC3121 ENSG00000156858 "Proline rich 14" Q9BWN1 16 30650717-30656413 "Predicted intracellular proteins" Myogenesis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052022, HPA060265, HPA075914" Uncertain Enhanced Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: " "unprognostic (1.57e-1)" "prognostic favorable (8.19e-5)" "unprognostic (3.74e-3)" "unprognostic (1.42e-2)" "unprognostic (5.18e-2)" "unprognostic (5.44e-2)" "unprognostic (5.28e-3)" "unprognostic (1.42e-2)" "unprognostic (5.75e-2)" "unprognostic (1.82e-2)" "unprognostic (1.61e-2)" "unprognostic (5.69e-2)" "unprognostic (1.83e-2)" "unprognostic (3.81e-2)" "unprognostic (4.54e-1)" "unprognostic (9.10e-2)" "unprognostic (2.31e-3)" 20.5 20.2 17.1 13.9 16.8 23.6 20.3 19.0 21.7 26.6 12.8 30.8 13.8 29.8 7.1 22.4 26.1 6.6 16.4 16.0 15.3 22.1 21.3 24.1 14.1 18.5 16.6 25.1 24.9 13.0 21.2 8.3 16.1 26.2 7.8 9.4 19.1 13.7 15.1 26.2 25.6 10.9 15.0 32.5 26.0 12.6 18.3 18.7 23.4 9.6 10.6 24.5 22.7 17.9 18.2 20.3 17.1 18.2 15.2 11.7 11.9 17.6 11.8 18.1 17.2 9.3 17.3 30.5 15.3 12.9 8.4 17.7 14.4 20.4 9.8 41.5 36.0 17.9 19.6 21.4 23.6 16.1 43.3 9.8 23.1 13.0 13.7 18.9 23.1 8.2 22.8 24.3 10.0 42.2 36.7 28.4 6.2 12.4 10.3 29.4 8.4 44.2 13.7 7.3 14.5 32.4 7.1 26.8 18.2 5.3 29.9 13.1 18.1 16.3 17.7 17.0 18.4 44.1 29.4 21.3 11.0 33.0 14.7 11.4 6.0 23.7 9.6 6.5 7.4 7.0 8.0 9.7 5.7 10.5 7.3 7.2 22.5 8.6 10.9 7.6 10.3 5.5 17.1 16.8 19.0 21.7 16.0 15.3 18.5 16.6 16.1 15.0 18.3 17.9 18.1 9.6 10.4 13.7 23.2 22.8 26.1 28.8 33.6 13.9 19.1 18.7 6.6 25.8 13.2 12.9 14.6 15.8 31.9 24.1 15.6 22.3 6.7 8.8 13.0 20.9 12.6 15.4 7.5 22.2 15.3 15.3 27.5 15.1 12.0 15.4 18.9 10.1 18.2 1.7 7.7 18.3 20.3 16.0 34.1 2.5 19.3 20.2 8.8 8.4 30.2 13.1 33.0 5.5 8.7 20.4 14.6 21.1 17.3 23.6 23.6 15.1 10.0 14.2 19.7 12.8 19.9 17.2 27.2 28.5 23.0 14.1 26.5 11.7 19.8 17.3 PSMA3 HC8 ENSG00000100567 "Proteasome 20S subunit alpha 3" P25788 14 58244843-58272012 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000905 Approved NA NA 9700000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "HPA000905: AB_1079702" "unprognostic (3.60e-1)" "unprognostic (4.81e-3)" "unprognostic (1.17e-1)" "unprognostic (2.19e-2)" "unprognostic (4.91e-1)" "unprognostic (5.79e-2)" "unprognostic (1.97e-3)" "unprognostic (1.27e-1)" "unprognostic (7.92e-2)" "unprognostic (7.36e-3)" "unprognostic (1.65e-2)" "unprognostic (7.57e-2)" "unprognostic (1.83e-3)" "unprognostic (2.33e-2)" "unprognostic (6.47e-2)" "prognostic favorable (2.91e-4)" "unprognostic (2.16e-1)" 74.1 88.6 50.0 84.8 52.6 82.8 82.1 54.9 61.8 59.6 54.2 76.7 81.3 55.4 127.6 75.8 57.9 60.7 99.9 51.2 55.2 94.3 162.2 69.0 104.1 53.2 52.3 40.4 55.4 72.9 46.6 90.8 53.3 60.9 82.9 48.3 54.7 76.3 170.6 53.1 74.3 78.6 55.8 66.6 61.0 41.3 51.9 108.6 74.9 130.4 96.9 102.5 48.6 56.6 359.2 214.3 215.1 179.2 166.4 154.3 277.8 187.2 209.3 257.4 256.8 317.8 294.2 304.1 330.9 171.3 202.4 243.9 249.2 200.9 299.7 262.3 148.9 208.5 150.9 360.8 314.2 340.4 170.0 132.8 142.2 179.2 169.1 151.7 307.2 242.0 201.3 174.6 209.3 400.4 299.7 314.4 144.9 286.8 328.3 249.3 279.6 222.7 377.5 339.7 202.9 100.3 167.5 261.8 189.5 201.6 273.3 244.9 198.3 148.4 287.1 167.6 249.4 68.4 137.3 314.1 215.7 260.2 184.1 95.3 78.9 52.0 71.2 98.9 92.2 85.8 87.1 86.0 91.8 61.9 69.5 80.8 48.2 94.1 85.6 122.4 112.6 95.5 50.0 52.6 54.9 61.8 51.2 55.2 53.2 52.3 53.3 55.8 51.9 56.6 132.9 118.6 119.2 21.9 93.7 118.7 169.6 418.7 71.2 43.5 69.2 77.6 117.0 71.4 195.7 88.3 35.5 387.5 104.5 83.3 166.3 241.3 24.7 127.6 95.6 137.7 64.4 60.6 27.6 231.1 269.2 108.5 59.1 109.1 95.7 412.6 66.4 145.4 184.0 42.1 29.1 103.8 250.3 59.2 77.5 27.4 109.3 89.4 108.5 26.2 206.0 87.3 84.5 32.6 33.6 192.9 89.0 106.1 118.4 167.5 108.9 297.5 157.4 68.6 98.6 83.7 279.6 109.3 66.9 89.8 106.0 403.5 99.3 104.9 108.4 171.6 PSMB4 "HN3, PROS26" ENSG00000159377 "Proteasome 20S subunit beta 4" P28070 1 151399560-151401937 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006700, HPA073499" Approved Uncertain Nucleoplasm,Mitochondria NA NA 12000000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Mitochondria "HPA006700: AB_1079704, HPA073499: " "unprognostic (1.11e-1)" "unprognostic (1.44e-1)" "unprognostic (2.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.63e-1)" "unprognostic (5.74e-2)" "prognostic unfavorable (7.45e-4)" "unprognostic (2.27e-1)" "unprognostic (1.69e-1)" "unprognostic (4.37e-3)" "unprognostic (3.73e-1)" "unprognostic (3.77e-1)" "prognostic unfavorable (2.90e-10)" "unprognostic (5.33e-2)" "unprognostic (2.46e-2)" "unprognostic (3.82e-2)" "unprognostic (5.85e-2)" 189.5 242.7 200.2 156.7 202.1 172.9 174.2 210.6 212.4 167.0 201.9 194.3 150.0 195.5 225.6 170.4 178.3 139.1 241.8 201.7 212.9 196.6 269.5 143.2 214.0 206.8 203.9 179.5 164.0 218.6 168.0 187.1 211.7 162.4 166.4 94.3 169.6 190.6 299.1 186.6 152.8 191.7 210.5 173.8 171.8 69.0 205.8 233.5 156.1 237.5 235.4 196.7 151.3 218.4 428.3 451.9 373.0 447.8 412.9 392.3 507.8 247.6 549.2 719.3 503.1 608.6 569.5 384.1 730.7 424.3 379.1 419.7 383.2 472.7 407.6 535.6 391.1 268.6 320.8 463.3 444.4 377.0 355.7 431.7 444.8 672.5 276.2 364.8 506.1 419.1 434.3 740.0 512.7 1174.2 463.5 452.0 952.8 638.6 576.2 433.8 266.9 688.2 594.4 354.2 408.6 488.0 283.6 626.5 879.8 459.1 564.1 594.6 320.7 310.4 326.1 333.8 557.0 726.9 902.5 769.1 459.5 337.8 667.8 291.8 343.4 227.0 265.0 342.2 314.8 293.6 303.7 301.0 421.7 257.5 260.4 272.8 251.5 347.3 270.5 468.1 405.1 395.2 200.2 202.1 210.6 212.4 201.7 212.9 206.8 203.9 211.7 210.5 205.8 218.4 72.2 153.8 127.4 10.1 82.2 76.6 81.9 131.5 82.0 56.3 62.0 71.6 128.0 68.6 123.2 71.7 16.7 209.8 79.7 87.8 103.7 127.9 16.0 118.1 107.5 97.7 66.4 87.1 10.4 195.8 146.7 91.9 47.4 110.0 111.1 81.1 92.8 151.7 125.0 48.8 11.5 80.5 89.5 108.1 88.8 15.6 104.4 89.4 96.0 12.2 186.2 89.5 64.9 6.6 14.7 131.7 75.0 105.3 89.1 75.5 117.5 148.9 141.5 62.8 65.7 86.0 127.5 54.5 49.7 80.0 75.9 267.3 80.2 124.5 96.0 89.1 PSMC3 "TBP-1, TBP1" ENSG00000165916 "Proteasome 26S subunit, ATPase 3" P17980 11 47418769-47426473 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006065 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA 290000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "Nuclear bodies" "HPA006065: AB_1079706" "unprognostic (2.01e-2)" "unprognostic (5.08e-3)" "unprognostic (9.43e-2)" "unprognostic (8.12e-3)" "unprognostic (6.32e-2)" "unprognostic (5.71e-2)" "unprognostic (8.99e-3)" "unprognostic (1.63e-1)" "unprognostic (9.95e-2)" "unprognostic (1.27e-2)" "unprognostic (3.88e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.24e-4)" "unprognostic (1.49e-1)" "unprognostic (2.25e-1)" "unprognostic (2.55e-2)" "unprognostic (1.84e-1)" 85.3 86.1 106.8 64.7 117.3 96.1 77.9 105.3 131.0 73.7 105.8 110.2 52.2 89.9 62.5 88.7 69.0 44.0 172.1 107.8 106.3 73.8 117.7 76.2 65.3 108.6 114.7 58.2 81.4 74.1 55.4 78.8 111.0 74.2 59.1 30.9 73.0 69.8 292.0 103.4 64.0 77.5 104.6 67.8 87.7 74.7 115.2 90.6 69.4 162.9 76.5 80.8 71.7 107.0 223.7 248.2 233.5 173.3 109.6 117.3 226.5 181.5 267.4 445.7 313.8 223.3 126.8 179.5 110.1 230.1 195.7 218.3 206.7 237.7 199.0 269.4 268.1 173.1 301.1 218.5 141.4 203.7 177.0 131.4 126.1 181.6 202.5 98.4 253.8 182.7 249.2 164.7 276.0 497.0 259.5 258.4 229.5 280.7 296.1 269.3 458.8 157.3 209.5 165.2 170.0 147.1 148.7 206.9 116.2 98.2 255.7 209.8 181.3 253.7 321.1 363.8 474.7 176.5 220.0 209.2 262.4 201.7 325.1 111.5 154.3 121.8 160.8 194.6 146.7 146.8 132.9 147.8 160.6 122.4 116.5 118.6 33.9 173.3 211.6 160.0 191.0 254.7 106.8 117.3 105.3 131.0 107.8 106.3 108.6 114.7 111.0 104.6 115.2 107.0 81.5 57.7 42.0 3.9 59.5 86.3 112.8 198.5 50.7 41.2 61.4 64.1 217.6 81.5 103.7 68.0 16.7 265.9 60.0 143.9 152.6 199.2 152.5 72.0 75.7 96.0 64.5 136.6 6.4 202.6 257.9 100.4 54.0 70.1 75.3 79.2 77.1 144.2 158.2 37.0 5.3 111.5 75.3 62.4 80.0 217.6 88.6 62.5 99.6 1.9 132.0 120.2 74.2 3.0 5.2 214.2 110.8 100.1 96.3 102.8 127.7 191.3 76.9 47.4 118.3 75.1 193.3 147.0 63.6 51.3 77.3 352.9 61.8 74.1 117.6 101.6 PSMC4 "MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7" ENSG00000013275 "Proteasome 26S subunit, ATPase 4" P43686 19 39971165-39981764 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002044, HPA005471" Approved Supported Nucleoplasm,Cytosol NA NA 200000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA002044: AB_1079707, HPA005471: AB_1855838" "unprognostic (1.66e-1)" "unprognostic (9.08e-2)" "unprognostic (1.69e-1)" "unprognostic (1.83e-2)" "unprognostic (7.46e-2)" "unprognostic (2.27e-2)" "unprognostic (1.29e-3)" "unprognostic (1.53e-2)" "unprognostic (4.45e-1)" "unprognostic (4.42e-2)" "unprognostic (9.90e-2)" "unprognostic (8.45e-2)" "unprognostic (1.10e-1)" "unprognostic (2.34e-1)" "unprognostic (2.02e-1)" "unprognostic (2.81e-1)" "unprognostic (2.32e-1)" 41.3 54.8 21.8 21.0 22.5 14.5 38.2 24.1 24.8 38.0 21.3 41.6 20.4 50.9 26.9 54.8 38.2 16.7 58.9 22.9 25.4 48.4 69.1 35.9 18.2 24.1 23.5 32.0 32.5 30.9 37.1 19.3 25.8 35.2 19.0 13.8 36.5 20.3 112.7 48.1 39.0 20.8 24.6 40.3 43.6 43.2 22.7 22.3 41.1 30.2 23.1 41.6 38.0 26.1 68.7 221.3 43.8 53.5 38.0 31.3 47.0 38.6 50.4 87.0 66.4 129.0 46.8 33.0 72.7 49.2 50.5 35.6 61.6 52.7 72.1 60.6 63.0 46.9 39.2 110.4 52.5 52.2 54.7 31.3 46.0 69.1 48.6 25.8 60.5 42.3 63.0 48.5 57.2 108.3 62.4 32.1 80.5 88.3 66.8 54.6 49.7 48.2 64.3 105.7 56.9 74.8 42.3 69.3 38.9 41.9 47.8 45.5 36.2 53.2 54.9 52.2 97.1 62.2 114.6 51.9 69.7 54.0 62.8 38.0 41.5 33.5 44.8 64.8 39.0 35.8 39.8 46.6 66.9 34.7 32.6 32.8 22.3 43.8 89.8 34.8 59.8 61.9 21.8 22.5 24.1 24.8 22.9 25.4 24.1 23.5 25.8 24.6 22.7 26.1 52.5 32.1 19.8 8.1 53.6 64.0 84.8 191.9 40.9 50.1 31.2 31.9 38.1 52.9 96.2 44.1 14.6 174.7 53.7 119.7 92.0 143.3 203.9 70.3 46.3 63.2 59.2 48.8 8.5 110.9 118.9 55.8 53.5 57.1 41.2 41.9 29.6 50.9 163.7 42.1 8.5 41.7 126.1 42.7 66.3 120.0 55.0 57.4 44.4 12.2 91.6 59.5 63.8 6.6 10.7 127.0 103.1 70.0 58.3 65.4 95.2 179.2 88.0 49.9 92.1 49.0 152.1 114.6 45.7 44.7 58.2 399.5 57.5 69.5 69.1 79.8 PSMC5 "p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1" ENSG00000087191 "Proteasome 26S subunit, ATPase 5" P62195 17 63827152-63832026 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 596.6;Late spermatids: 1350.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017871, HPA064293" Enhanced Supported "Plasma membrane,Cytosol" NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Cytosol" "HPA017871: AB_1857638, HPA064293: AB_2685234" "unprognostic (9.65e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-1)" "unprognostic (2.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.35e-1)" "unprognostic (8.29e-3)" "unprognostic (1.24e-2)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" "unprognostic (2.17e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (9.54e-2)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" 90.4 99.0 134.8 80.9 137.5 82.4 80.6 141.3 159.0 79.6 130.2 106.1 68.0 80.1 112.3 104.9 83.2 59.4 107.5 136.2 139.3 120.9 112.7 68.1 93.0 140.5 140.2 63.3 71.0 161.1 82.5 75.5 141.2 81.4 84.4 85.3 73.4 86.7 236.2 121.5 70.6 90.3 137.7 82.4 84.5 73.3 139.6 93.3 86.4 168.7 108.0 93.4 79.6 138.9 240.1 369.1 233.9 172.9 171.4 174.7 202.8 225.3 197.0 327.1 243.8 390.3 154.7 158.7 154.7 241.6 246.0 182.8 239.1 228.5 383.5 136.8 289.7 330.3 288.9 362.4 180.1 336.0 230.4 177.5 171.4 291.9 266.6 139.1 263.7 180.9 258.4 210.2 284.9 450.7 279.4 237.4 215.6 266.3 330.0 248.9 445.5 244.3 249.0 270.9 203.2 274.1 158.6 313.9 152.3 254.4 306.8 197.8 238.8 360.3 329.9 161.5 482.6 220.5 335.2 250.4 225.8 255.7 241.5 105.1 120.4 149.4 164.1 176.3 222.8 142.7 191.6 179.3 140.0 122.0 161.3 183.1 37.7 167.4 206.3 108.6 272.1 216.1 134.8 137.5 141.3 159.0 136.2 139.3 140.5 140.2 141.2 137.7 139.6 138.9 97.9 51.3 78.6 8.5 82.7 94.6 145.0 206.3 71.7 84.9 71.1 79.1 156.0 110.1 139.6 68.0 18.8 250.4 85.1 98.8 246.5 195.2 596.6 75.4 69.4 104.7 90.9 107.7 7.9 214.5 187.2 101.4 69.3 68.1 90.2 53.3 86.4 130.9 162.9 72.3 7.9 92.7 197.4 89.8 85.0 1350.2 133.0 93.4 99.6 5.6 148.0 221.4 109.2 7.5 10.5 167.5 96.3 153.4 88.0 125.6 163.7 330.3 95.1 108.4 111.7 113.0 228.7 151.6 150.2 95.0 102.9 369.0 102.9 124.7 97.9 137.9 PSMD4 "AF, AF-1, Rpn10, S5A" ENSG00000159352 "Proteasome 26S subunit, non-ATPase 4" P55036 1 151254709-151267479 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038807, HPA039252, CAB047300" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 69000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418" "unprognostic (3.83e-2)" "unprognostic (7.89e-2)" "unprognostic (6.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.63e-1)" "unprognostic (2.89e-2)" "unprognostic (1.79e-3)" "unprognostic (2.16e-1)" "unprognostic (2.81e-1)" "unprognostic (2.61e-2)" "unprognostic (7.57e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (6.66e-10)" "unprognostic (9.80e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (3.91e-1)" 108.8 118.0 198.8 77.8 203.8 89.4 97.9 203.0 288.1 88.7 195.2 136.9 68.9 99.5 114.3 115.5 91.0 58.2 191.2 202.8 205.8 110.2 170.5 81.7 95.7 208.5 215.3 85.8 114.0 91.6 79.4 91.1 209.3 91.3 82.1 64.5 83.9 86.4 404.1 103.3 91.3 91.0 204.2 109.6 115.4 152.0 203.7 114.3 76.7 188.0 114.0 118.6 88.2 203.4 251.4 294.8 213.4 175.2 227.4 167.0 231.9 166.0 202.1 258.6 205.1 388.3 278.2 202.2 396.2 235.4 178.7 255.4 277.1 250.6 219.6 331.9 236.6 197.8 256.2 396.6 250.8 234.7 220.5 182.5 204.2 296.3 271.4 193.3 229.5 222.4 313.6 247.9 220.2 723.5 217.4 276.7 406.0 384.3 293.4 181.6 207.7 364.7 252.7 210.6 166.7 283.8 184.5 266.3 222.7 313.0 278.9 452.3 203.4 128.1 201.2 159.2 288.2 295.1 397.7 430.3 212.6 218.1 238.7 439.4 439.0 713.9 247.3 478.1 281.2 399.0 287.4 274.4 398.4 426.1 261.0 258.1 580.2 351.2 502.3 240.3 476.6 651.0 198.8 203.8 203.0 288.1 202.8 205.8 208.5 215.3 209.3 204.2 203.7 203.4 90.1 57.7 62.9 15.7 78.5 88.6 111.9 249.0 58.1 50.9 60.9 69.3 245.2 82.9 125.0 60.7 27.1 328.6 74.0 104.1 168.3 177.3 279.1 91.5 63.0 95.8 84.2 107.3 25.3 186.9 234.1 88.5 46.9 59.1 83.6 88.8 83.2 116.0 184.5 33.7 24.2 94.1 156.6 104.0 98.0 243.2 105.3 90.3 104.9 11.2 256.6 91.9 115.4 16.1 23.2 172.2 129.1 98.6 67.0 121.4 168.6 206.6 148.3 54.6 118.3 79.0 221.1 234.8 83.5 66.7 86.5 414.6 77.7 105.6 114.5 107.2 PSMD6 "KIAA0107, p44S10, Rpn7, S10" ENSG00000163636 "Proteasome 26S subunit, non-ATPase 6" Q15008 3 64010550-64024010 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 285.7" "Cell type enhanced" "Detected in all" "Early spermatids: 513.3;Late spermatids: 717.7;Spermatocytes: 336.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 7 "MCF7: 1458.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036921, HPA036922" Uncertain NA NA 120000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "HPA036921: AB_2675383, HPA036922: AB_10670850" "unprognostic (3.44e-2)" "unprognostic (2.03e-1)" "unprognostic (4.76e-3)" "unprognostic (1.95e-1)" "unprognostic (2.43e-1)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (8.65e-2)" "unprognostic (1.38e-1)" "unprognostic (1.95e-3)" "unprognostic (6.69e-2)" "unprognostic (4.73e-2)" "unprognostic (4.06e-3)" "unprognostic (4.20e-2)" "unprognostic (1.89e-1)" "unprognostic (9.55e-2)" "unprognostic (8.22e-3)" 47.2 67.9 43.9 43.3 45.2 115.0 49.5 47.5 63.2 37.1 44.7 46.2 34.0 43.1 60.1 61.4 35.2 28.2 74.9 46.2 47.5 62.9 74.9 37.9 50.2 47.5 47.5 32.8 285.7 72.9 30.8 54.2 49.2 42.1 43.4 48.4 43.7 45.6 160.8 54.6 34.8 49.5 49.2 38.8 46.1 120.2 45.2 54.8 40.3 90.9 63.9 52.3 40.4 49.0 98.4 102.5 141.1 99.5 97.6 87.0 125.9 136.3 128.8 221.5 162.4 193.0 79.8 136.9 57.6 132.4 154.7 66.1 166.4 144.7 207.3 141.1 104.6 183.6 76.3 128.2 142.9 204.9 112.2 93.7 100.8 184.2 80.3 107.4 141.5 117.7 187.3 86.1 157.8 1458.7 141.0 125.3 180.7 157.3 71.9 117.2 101.1 132.4 177.1 140.7 52.1 85.0 101.6 85.4 136.2 123.4 74.3 125.0 125.7 98.1 106.5 145.2 217.1 108.2 171.0 204.1 144.3 190.8 116.1 99.2 113.9 140.3 103.4 133.0 107.3 124.7 114.0 112.9 120.1 120.3 113.6 110.5 139.4 111.5 139.8 84.0 137.1 167.2 43.9 45.2 47.5 63.2 46.2 47.5 47.5 47.5 49.2 49.2 45.2 49.0 46.4 32.1 43.2 7.5 48.7 62.1 71.7 152.5 27.9 37.0 33.9 34.9 100.0 22.8 86.4 44.1 22.9 197.8 47.3 27.6 86.1 104.0 513.3 49.0 42.3 55.3 25.8 99.9 11.7 133.7 102.3 47.6 27.0 48.9 45.6 46.7 28.9 47.4 92.2 33.7 10.9 27.3 73.2 38.1 40.5 717.7 51.9 51.7 48.0 4.7 71.0 81.8 39.1 10.1 15.4 87.1 30.4 51.1 58.1 44.7 29.7 95.9 73.0 41.2 59.2 41.3 145.8 336.9 131.3 53.4 69.9 290.6 50.4 68.7 35.8 66.1 PSMD8 "HIP6, HYPF, Nin1p, p31, Rpn12, S14" ENSG00000099341 "Proteasome 26S subunit, non-ATPase 8" P48556 19 38374550-38383824 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 708.9" "Cell type enhanced" "Detected in all" "Late spermatids: 1164.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006702, CAB021101" Supported Approved "Nuclear speckles,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "Nuclear speckles" "CAB021101: AB_10061018, HPA006702: AB_1079710" "unprognostic (9.50e-2)" "unprognostic (7.02e-2)" "unprognostic (1.70e-2)" "prognostic unfavorable (3.84e-4)" "unprognostic (1.59e-1)" "unprognostic (5.54e-3)" "unprognostic (1.94e-3)" "unprognostic (5.03e-2)" "unprognostic (2.85e-2)" "unprognostic (1.73e-2)" "unprognostic (4.61e-1)" "unprognostic (8.79e-2)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.28e-1)" "unprognostic (2.08e-2)" "unprognostic (2.58e-3)" "unprognostic (4.84e-2)" 224.8 130.8 102.3 78.0 109.6 118.8 184.9 104.1 114.8 109.6 97.6 111.8 98.1 115.8 119.4 156.6 104.0 69.2 361.8 114.4 117.5 122.4 143.0 114.9 90.8 109.2 104.3 82.1 117.3 150.2 111.1 101.1 121.9 107.1 98.9 60.6 118.8 84.5 708.9 178.4 106.4 105.2 105.4 99.4 117.6 145.8 112.6 120.3 91.2 361.1 109.9 106.3 111.0 112.6 337.3 522.7 202.2 231.9 322.0 256.9 105.9 238.7 322.9 358.9 372.3 362.0 196.3 234.7 242.8 320.0 220.1 114.1 341.7 296.8 321.6 389.8 225.6 256.1 159.6 226.4 415.1 260.8 217.9 261.2 290.8 309.7 408.8 197.3 286.5 279.9 324.9 255.7 400.6 332.8 247.6 146.1 157.8 492.8 282.7 254.7 324.6 187.4 255.7 275.1 210.8 214.3 247.3 315.7 233.8 187.1 165.3 242.0 212.7 272.1 251.5 289.0 355.8 257.2 322.4 318.0 410.1 264.8 310.1 169.0 239.5 132.6 188.2 265.1 160.0 172.8 162.0 181.0 263.1 173.6 133.0 129.5 89.0 182.7 319.8 183.2 295.2 352.3 102.3 109.6 104.1 114.8 114.4 117.5 109.2 104.3 121.9 105.4 112.6 112.6 137.4 67.3 67.9 8.1 122.9 206.0 224.5 293.5 80.2 102.6 116.3 141.0 263.8 81.5 158.8 80.9 54.2 367.2 128.2 194.6 348.3 276.0 422.3 137.2 158.2 127.0 146.0 129.2 14.7 267.4 327.5 146.8 71.4 122.5 93.8 146.9 81.4 123.1 296.9 77.4 15.4 183.9 219.7 93.1 169.5 1164.7 118.4 126.9 199.3 10.3 224.0 179.8 143.2 8.0 19.8 296.8 181.2 117.8 178.9 255.0 305.7 332.4 128.5 120.4 151.2 106.6 221.1 305.1 135.4 120.3 212.3 570.3 133.0 201.0 182.5 218.7 PSMD9 "p27, Rpn4" ENSG00000110801 "Proteasome 26S subunit, non-ATPase 9" O00233 12 121888732-121918297 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040512, HPA044220" Enhanced Supported "Plasma membrane,Cytosol" NA NA 500000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Cytosol "Plasma membrane" "HPA040512: AB_2677014, HPA044220: AB_2678860" "unprognostic (2.24e-1)" "unprognostic (2.48e-3)" "unprognostic (2.12e-1)" "unprognostic (3.36e-1)" "unprognostic (1.20e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (9.64e-3)" "unprognostic (3.17e-2)" "unprognostic (5.73e-2)" "unprognostic (6.19e-2)" "unprognostic (8.63e-2)" 16.5 4.6 7.5 2.3 8.1 19.2 4.8 8.0 10.0 5.8 11.8 13.8 11.5 7.1 2.2 6.2 6.4 3.8 5.5 7.9 8.1 10.8 4.6 6.0 5.7 9.0 8.9 5.9 10.6 4.8 3.5 3.9 8.3 4.6 2.2 3.6 8.8 6.7 18.5 5.9 6.2 3.3 8.3 8.9 14.9 5.1 8.7 6.6 5.1 6.0 3.2 4.1 5.5 9.4 54.8 81.8 6.7 12.2 11.2 11.6 13.9 54.5 17.8 27.3 15.5 60.0 6.3 40.5 45.0 28.6 9.2 22.1 20.0 29.1 16.3 78.5 41.6 33.3 40.9 30.5 27.5 23.3 22.7 20.4 14.0 30.4 11.7 9.9 16.6 24.7 30.1 5.3 17.6 63.2 47.1 17.8 14.0 7.1 63.4 35.6 18.3 24.9 13.4 53.9 14.1 19.3 54.4 7.7 29.3 5.8 23.3 11.3 43.3 25.4 29.0 50.1 38.4 30.4 73.0 62.1 45.5 30.1 23.8 41.8 43.6 53.0 33.9 46.2 27.3 47.6 32.6 31.0 38.5 38.5 25.0 21.2 41.3 29.3 41.7 63.7 48.1 51.6 7.5 8.1 8.0 10.0 7.9 8.1 9.0 8.9 8.3 8.3 8.7 9.4 22.8 48.1 33.7 10.1 32.6 60.5 11.4 64.1 67.2 7.3 40.9 34.8 8.0 34.3 40.0 35.0 18.8 30.3 45.8 66.6 52.8 116.9 34.9 32.6 28.7 29.7 46.6 121.4 12.9 121.4 30.7 30.5 42.8 27.4 44.4 11.0 33.9 26.8 39.8 15.2 10.7 66.5 54.9 37.9 55.3 11.4 37.9 43.6 55.2 7.5 93.9 17.2 35.0 7.1 18.7 138.2 64.2 38.7 73.2 9.5 146.8 100.7 36.6 14.8 39.5 19.5 46.8 33.9 37.5 69.4 71.6 37.8 44.9 12.9 67.7 12.8 PTPA "PPP2R4, PR53" ENSG00000119383 "Protein phosphatase 2 phosphatase activator" Q15257 9 129110950-129148946 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 51.9;Collecting duct cells: 53.3;Cytotrophoblasts: 49.5;Distal tubular cells: 54.8;Ductal cells: 70.3;Exocrine glandular cells: 62.3;Hofbauer cells: 53.9;Pancreatic endocrine cells: 61.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005695, CAB022068, CAB035999" Approved Enhanced Nucleoplasm,Cytosol NA NA 4300000 "Cluster 39: Non-specific - mRNA processing" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB022068: , CAB035999: , HPA005695: AB_1855658" "unprognostic (4.97e-2)" "unprognostic (1.70e-2)" "unprognostic (1.13e-2)" "prognostic favorable (6.50e-5)" "unprognostic (1.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.65e-2)" "unprognostic (6.44e-3)" "unprognostic (2.22e-1)" "unprognostic (1.15e-2)" "unprognostic (3.20e-2)" "unprognostic (1.37e-1)" "unprognostic (1.01e-2)" "unprognostic (1.92e-2)" "unprognostic (1.18e-1)" "unprognostic (1.48e-1)" "unprognostic (1.69e-1)" 47.2 118.0 157.8 56.2 154.0 52.9 60.9 136.2 185.0 73.5 124.6 105.2 49.6 87.4 55.8 116.8 77.3 49.3 176.7 158.5 141.6 125.5 154.2 72.6 49.9 151.3 148.8 63.8 70.4 146.7 73.1 49.8 147.6 119.0 51.3 43.4 97.1 86.8 340.8 73.7 57.1 92.1 143.2 82.8 83.5 124.5 162.7 59.1 75.3 206.2 54.9 71.1 62.2 148.5 108.9 183.9 111.0 219.9 74.4 94.5 118.3 115.5 120.2 144.8 100.1 103.4 135.4 113.9 83.3 187.3 173.1 184.1 110.9 138.2 100.6 198.6 68.1 64.6 193.6 101.7 229.1 113.1 147.2 114.6 133.1 109.8 101.8 230.9 146.5 120.3 102.0 124.7 117.1 293.8 103.0 76.6 186.8 301.0 193.0 108.3 93.7 216.2 159.0 119.8 120.6 86.9 220.4 237.3 147.3 99.4 253.4 55.0 101.7 127.6 113.8 129.9 165.2 114.9 284.1 96.8 153.2 79.1 180.7 7.6 19.2 9.8 20.8 18.4 19.9 10.8 15.8 18.5 23.0 13.4 13.8 13.9 6.1 20.4 18.3 16.4 16.9 20.4 157.8 154.0 136.2 185.0 158.5 141.6 151.3 148.8 147.6 143.2 162.7 148.5 19.8 3.2 8.3 0.0 3.1 0.0 0.0 0.0 0.0 0.0 51.9 38.6 0.0 0.0 3.1 53.3 0.0 49.5 9.2 0.0 54.8 70.3 0.0 33.7 21.8 19.0 0.0 0.0 0.0 62.3 44.2 12.2 0.0 32.9 8.8 24.8 0.0 0.0 53.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 21.7 0.0 0.0 0.0 0.0 61.8 0.0 0.0 0.9 0.0 0.0 41.9 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 37.9 4.0 31.8 0.0 0.0 PUF60 "FIR, RoBPI, SIAHBP1" ENSG00000179950 "Poly(U) binding splicing factor 60" Q9UHX1 8 143816344-143829352 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 332.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045733, HPA052096, HPA059714" Enhanced Enhanced Nucleoplasm NA NA 70000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110" "unprognostic (3.49e-2)" "unprognostic (8.78e-2)" "unprognostic (2.66e-1)" "unprognostic (4.05e-2)" "unprognostic (1.81e-2)" "unprognostic (3.47e-2)" "unprognostic (1.51e-2)" "unprognostic (4.34e-3)" "unprognostic (2.64e-2)" "unprognostic (1.07e-2)" "unprognostic (1.75e-1)" "unprognostic (5.45e-2)" "unprognostic (2.36e-2)" "unprognostic (2.64e-2)" "unprognostic (7.00e-2)" "unprognostic (2.28e-2)" "unprognostic (3.42e-2)" 71.6 73.5 7.9 11.0 7.6 39.6 75.5 8.1 22.9 71.4 5.3 84.8 22.3 84.9 5.9 84.9 76.3 7.3 88.5 7.8 15.4 82.8 124.3 64.0 17.7 12.2 11.6 57.2 62.9 11.7 71.0 19.2 14.1 67.2 5.8 1.3 63.3 17.8 125.5 108.7 69.5 10.5 7.3 72.3 73.2 70.8 14.5 15.9 59.8 9.0 9.7 74.5 68.6 12.4 95.7 211.5 36.7 31.3 16.6 15.6 62.7 74.4 27.4 70.3 75.1 95.4 103.9 89.4 71.2 58.9 52.8 83.0 86.5 91.4 3.6 91.4 147.7 110.2 117.0 106.3 60.4 38.5 70.0 45.4 61.8 89.8 26.9 21.1 69.0 92.1 88.7 37.4 20.5 332.5 156.1 26.4 77.8 63.3 191.6 84.2 42.9 91.8 19.5 91.8 71.5 80.3 101.6 40.4 77.7 9.1 116.7 21.4 79.0 72.9 176.2 85.7 98.6 66.7 103.9 109.7 70.7 73.3 71.9 90.8 112.6 99.8 129.0 133.7 139.3 116.8 103.1 128.6 127.1 135.9 98.6 113.1 58.8 132.6 137.6 76.8 139.0 193.9 7.9 7.6 8.1 22.9 7.8 15.4 12.2 11.6 14.1 7.3 14.5 12.4 70.2 38.5 46.4 21.5 64.7 107.7 102.1 197.4 65.4 62.8 51.3 67.9 63.7 51.5 103.0 29.5 29.2 146.6 56.4 98.0 92.0 110.7 20.5 65.6 55.3 67.3 66.9 65.0 8.2 89.8 134.3 68.4 74.9 60.3 55.8 75.0 41.7 76.8 101.1 43.7 8.3 75.9 118.0 44.0 62.3 47.8 64.0 52.3 90.7 6.5 105.2 182.6 81.4 9.5 23.7 98.2 91.4 59.0 52.7 83.0 91.9 118.1 85.4 64.8 65.7 57.1 122.9 104.2 128.5 63.1 107.1 173.3 74.2 99.3 97.7 81.2 PYCR1 P5C ENSG00000183010 "Pyrroline-5-carboxylate reductase 1" P32322 17 81932384-81942412 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis, Stress response" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 111.8;salivary gland: 121.1" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 63.8;Extravillous trophoblasts: 63.8;Intestinal goblet cells: 83.4;Prostatic glandular cells: 59.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "memory B-cell: 4.2" "Group enriched" "Detected in many" 8 "B-cells: 4.2;dendritic cells: 1.9;T-cells: 1.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047660 Approved NA NA "Cluster 43: B-cells - Humoral immune response" "Cluster 25: Pancreas - Digestion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 30: Mammary glandular cells - Lactation" "HPA047660: AB_2680115" "unprognostic (1.12e-2)" "unprognostic (2.13e-2)" "unprognostic (7.04e-2)" "unprognostic (7.27e-2)" "unprognostic (9.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (2.33e-4)" "unprognostic (2.80e-1)" "unprognostic (9.36e-3)" "unprognostic (6.65e-2)" "unprognostic (3.02e-3)" "unprognostic (7.12e-2)" "prognostic unfavorable (7.33e-12)" "unprognostic (7.98e-2)" "unprognostic (1.56e-1)" "unprognostic (1.12e-2)" "unprognostic (5.92e-2)" 7.5 4.1 13.8 13.8 14.1 12.5 17.4 13.2 15.2 24.2 9.6 23.8 14.3 10.6 2.5 18.7 9.7 8.9 10.0 12.5 14.4 6.3 8.7 13.6 6.9 16.1 13.9 7.5 111.8 1.9 21.6 11.7 14.8 25.5 14.4 0.9 121.1 7.8 11.5 6.3 12.5 12.2 12.7 8.0 42.4 15.1 15.8 2.6 8.5 2.0 6.7 12.0 10.3 14.2 107.4 111.9 62.7 228.3 36.7 69.0 117.2 176.0 85.4 54.7 73.7 129.3 116.9 163.2 38.0 188.9 33.3 45.8 148.2 67.1 32.7 42.4 18.6 96.5 56.5 350.8 213.8 64.8 70.6 58.5 129.8 68.2 178.7 64.8 95.5 129.4 314.0 147.2 35.1 376.4 68.1 49.5 52.8 291.9 170.1 0.9 105.6 205.5 49.9 38.7 237.7 167.2 36.9 203.6 219.5 46.3 210.0 117.1 70.1 53.7 201.8 91.4 66.3 183.4 141.3 156.2 57.2 0.8 178.1 0.0 0.1 0.0 0.2 0.2 0.4 4.2 0.7 0.2 1.3 1.8 1.6 1.2 0.0 0.3 0.0 1.9 0.3 1.1 13.8 14.1 13.2 15.2 12.5 14.4 16.1 13.9 14.8 12.7 15.8 14.2 2.3 0.0 3.9 2.3 9.1 7.0 11.4 12.2 4.6 0.3 50.6 29.5 0.6 1.5 7.2 3.7 0.0 2.0 2.3 17.2 0.0 13.3 13.8 3.4 14.6 4.7 10.8 27.8 0.9 63.8 63.8 24.9 35.7 13.8 4.5 13.9 2.5 1.8 5.0 3.3 1.4 83.4 8.2 0.0 5.4 32.4 7.5 0.8 8.8 0.0 0.7 0.5 0.0 3.5 0.7 48.0 19.5 3.8 34.1 59.6 1.2 1.9 1.3 0.2 0.0 3.3 17.8 28.2 16.9 8.0 6.0 3.8 1.9 15.5 43.1 8.6 PYCR3 "FLJ13852, PYCRL" ENSG00000104524 "Pyrroline-5-carboxylate reductase 3" Q53H96 8 143603210-143609773 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Proline biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 14.7;Ductal cells: 10.2;Exocrine glandular cells: 9.1;Extravillous trophoblasts: 11.8;Proximal tubular cells: 12.4;Theca cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "naive B-cell: 4.7" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053776, HPA063416, HPA069706" Uncertain Supported "Cytokinetic bridge,Mitotic spindle,Cytosol" Yes NA "Cluster 24: B-cells - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "Cytokinetic bridge, Mitotic spindle" "HPA053776: , HPA063416: AB_2685010, HPA069706: AB_2686178" "unprognostic (2.12e-2)" "unprognostic (3.16e-2)" "unprognostic (2.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.06e-2)" "unprognostic (2.30e-1)" "unprognostic (7.68e-3)" "unprognostic (1.79e-1)" "unprognostic (1.96e-1)" "unprognostic (2.26e-2)" "unprognostic (5.85e-2)" "unprognostic (5.44e-2)" "unprognostic (1.82e-2)" "unprognostic (3.64e-2)" "unprognostic (2.96e-1)" "unprognostic (3.54e-2)" "unprognostic (2.54e-1)" 5.0 9.7 2.8 0.4 2.9 0.6 5.2 2.7 3.3 5.1 1.0 4.2 0.5 5.2 1.1 7.1 6.0 0.8 3.9 2.9 1.6 9.7 17.2 3.8 0.9 2.3 2.2 5.1 9.2 0.6 10.0 0.4 2.7 8.7 0.6 0.7 5.8 0.5 3.0 4.0 4.1 0.4 1.5 5.9 5.5 7.0 2.7 0.4 8.4 0.3 0.7 4.4 3.8 2.1 3.2 4.0 1.6 2.5 1.8 0.6 2.0 3.0 1.4 2.9 1.9 2.9 2.6 6.2 2.1 2.0 1.1 2.6 2.0 4.0 1.1 3.0 5.3 3.7 2.2 2.0 0.6 1.9 1.0 0.8 1.9 3.1 1.9 1.2 0.7 3.7 4.3 3.1 1.9 7.2 3.0 1.7 2.1 4.5 10.4 2.8 1.8 4.3 3.4 2.2 5.3 1.4 3.6 4.9 1.6 0.8 6.4 2.0 0.9 2.9 4.0 3.4 3.1 2.5 0.8 4.2 2.6 2.0 1.9 0.2 0.9 0.0 1.1 0.6 1.2 1.3 0.8 0.8 0.6 4.7 1.1 1.0 0.1 1.3 0.7 3.0 0.9 0.6 2.8 2.9 2.7 3.3 2.9 1.6 2.3 2.2 2.7 1.5 2.7 2.1 2.9 3.2 3.6 0.0 1.8 0.0 0.0 0.0 0.0 0.0 8.8 7.7 0.0 0.0 0.6 14.7 0.0 5.1 1.6 0.0 3.9 10.2 0.0 6.8 6.6 1.9 0.0 0.0 0.0 9.1 11.8 2.9 0.0 5.2 0.0 5.5 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.6 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.8 0.0 0.0 12.4 4.4 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 2.5 1.2 14.7 0.0 0.0 PYDC2 POP2 ENSG00000253548 "Pyrin domain containing 2" Q56P42 3 191461163-191461456 "Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 24 "brain: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebral cortex: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 11 "A549: 1.1" "Not detected" "Not detected" HPA055895 Uncertain NA NA "Cluster 10: Brain - Neuronal signaling" "Cluster 40: Non-specific - Basic cellular processes" "HPA055895: AB_2682962" 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.4 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 R3HDM4 "C19orf22, MGC16353" ENSG00000198858 "R3H domain containing 4" Q96D70 19 896503-913245 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 5 "neutrophil: 586.7" "Lineage enriched" "Detected in all" 12 "granulocytes: 586.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043025, HPA048638" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm Cytosol "HPA043025: AB_2678275, HPA048638: AB_2680472" "unprognostic (9.22e-2)" "unprognostic (2.32e-2)" "unprognostic (1.28e-2)" "prognostic favorable (7.33e-6)" "unprognostic (4.30e-2)" "unprognostic (2.02e-2)" "unprognostic (3.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.67e-1)" "unprognostic (1.17e-1)" "unprognostic (2.02e-1)" "unprognostic (4.28e-1)" "unprognostic (1.46e-3)" "unprognostic (7.44e-2)" "unprognostic (4.52e-1)" "unprognostic (2.08e-1)" "unprognostic (6.74e-2)" 37.7 26.3 34.5 50.1 31.2 98.0 37.0 33.7 38.5 42.0 29.3 39.4 23.9 34.1 13.4 81.8 36.9 28.4 32.4 32.1 28.0 58.8 47.8 55.7 54.3 31.3 29.4 23.7 50.8 19.2 33.1 25.1 28.9 42.2 17.5 22.0 48.1 15.8 55.8 58.8 45.5 18.7 25.6 93.9 39.1 9.1 29.7 39.6 32.4 23.8 36.5 43.2 49.4 37.0 44.2 25.4 26.1 36.5 16.6 28.9 43.7 29.3 23.2 28.8 25.4 27.6 36.7 31.5 23.9 33.4 6.1 39.6 15.4 34.7 12.9 49.2 33.0 43.7 19.7 48.3 49.3 24.6 73.0 38.7 65.9 18.7 39.1 26.3 33.4 35.7 82.2 62.8 27.1 79.0 34.7 46.5 34.5 53.3 41.2 33.9 12.5 60.8 48.2 45.7 46.6 45.4 25.8 56.2 48.9 20.0 49.1 57.8 34.3 52.3 29.1 62.0 30.0 69.1 39.1 47.6 33.5 34.9 45.9 117.4 13.1 111.0 14.9 10.1 23.1 38.5 30.3 20.5 14.3 21.5 28.1 20.1 586.7 8.6 14.0 6.0 49.3 26.5 34.5 31.2 33.7 38.5 32.1 28.0 31.3 29.4 28.9 25.6 29.7 37.0 23.2 19.2 21.5 0.7 59.6 35.1 49.0 24.9 25.0 17.5 30.7 20.6 6.8 20.0 26.3 18.4 8.4 38.1 29.0 34.7 7.9 57.7 1.3 20.1 20.1 22.8 32.8 106.5 4.0 55.4 46.7 20.0 30.5 33.5 23.5 10.3 12.1 13.3 26.2 28.6 3.0 31.3 34.6 27.5 37.0 2.6 11.1 59.0 24.9 1.9 51.4 8.0 29.9 1.5 3.1 68.4 31.9 11.7 37.3 48.9 13.1 16.0 19.9 12.4 26.3 13.6 20.6 0.8 4.0 34.3 31.7 69.0 48.1 15.2 22.6 70.9 RAB1B ENSG00000174903 "RAB1B, member RAS oncogene family" Q9H0U4 11 66268590-66277492 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010225, HPA056141" Approved Supported "Endoplasmic reticulum,Golgi apparatus" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "Endoplasmic reticulum" "CAB010225: AB_2284660, HPA056141: AB_2683051" "unprognostic (6.07e-2)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (2.90e-1)" "unprognostic (9.91e-2)" "unprognostic (2.61e-2)" "unprognostic (2.04e-3)" "unprognostic (2.10e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-2)" "unprognostic (2.00e-1)" "prognostic favorable (1.09e-5)" "unprognostic (2.41e-2)" "unprognostic (9.45e-2)" "unprognostic (9.42e-2)" "unprognostic (5.85e-2)" 127.1 129.7 121.7 84.0 117.4 91.1 120.9 117.7 137.7 113.7 106.2 129.3 112.5 111.2 82.3 180.9 105.7 83.0 146.7 117.5 116.8 127.2 126.4 116.5 90.3 122.7 121.0 103.5 96.1 132.9 112.6 88.4 119.3 140.6 90.3 46.5 128.0 105.1 233.2 147.6 112.9 86.9 119.3 125.3 125.5 79.9 124.2 105.5 111.5 152.8 86.1 113.6 119.2 118.9 226.5 248.0 126.2 166.1 205.6 150.9 113.8 182.7 212.8 232.2 163.4 141.4 223.7 91.7 235.7 263.1 172.1 209.0 140.7 253.9 125.9 190.3 128.0 144.7 156.0 124.2 135.0 124.3 258.2 158.7 212.4 199.6 102.4 163.2 221.1 144.9 153.1 158.8 223.6 434.5 219.1 197.1 131.5 196.1 230.8 133.0 101.8 237.2 234.7 204.5 122.9 137.1 132.7 319.2 133.7 91.4 487.5 141.6 228.1 221.4 152.9 267.9 164.9 89.9 77.9 121.5 251.2 104.3 207.8 173.1 199.8 329.3 227.5 211.9 171.7 109.8 135.5 188.1 163.0 130.2 115.3 140.6 420.5 203.5 243.9 188.3 165.5 375.6 121.7 117.4 117.7 137.7 117.5 116.8 122.7 121.0 119.3 119.3 124.2 118.9 56.3 38.5 59.6 7.8 41.7 33.6 31.4 42.4 53.5 22.0 55.0 53.1 1.1 40.0 47.9 36.8 29.2 56.2 50.8 137.1 50.9 49.3 13.4 41.3 38.6 50.6 54.0 27.1 7.2 71.3 84.2 36.5 58.1 44.9 53.8 24.6 48.9 47.8 54.2 16.8 8.0 85.0 36.7 55.2 26.4 27.2 35.8 51.4 24.9 5.6 47.7 37.8 43.3 5.5 13.1 71.6 80.6 42.2 61.0 41.4 79.6 49.5 36.0 18.2 39.5 36.2 39.7 23.8 17.4 64.5 42.1 80.2 57.4 28.1 64.9 43.5 RABEP2 "FLJ23282, FRA" ENSG00000177548 "Rabaptin, RAB GTPase binding effector protein 2" Q9H5N1 16 28904421-28936526 "Predicted intracellular proteins" "Cilium biogenesis/degradation, Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047641 Approved Supported Vesicles,Cytosol NA NA "Cluster 19: B-cells - Humoral immune response" "Cluster 64: Macrophages - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 57: B-cells - Immune response" "Vesicles, Cytosol" "HPA047641: AB_2680111" "unprognostic (4.93e-2)" "unprognostic (1.21e-2)" "unprognostic (2.13e-2)" "unprognostic (7.06e-2)" "unprognostic (1.44e-1)" "prognostic favorable (5.84e-4)" "unprognostic (2.46e-1)" "unprognostic (1.42e-1)" "unprognostic (8.41e-2)" "unprognostic (6.13e-2)" "unprognostic (1.26e-3)" "unprognostic (5.86e-2)" "prognostic favorable (1.24e-6)" "unprognostic (7.50e-2)" "unprognostic (8.20e-2)" "unprognostic (1.08e-1)" "unprognostic (5.92e-3)" 7.3 21.5 7.3 25.1 8.8 11.5 9.3 8.2 9.2 11.0 10.7 15.0 16.8 8.4 2.7 18.7 7.0 6.6 16.8 6.5 7.9 19.2 10.6 10.1 46.7 10.7 8.5 6.3 17.9 11.5 16.4 5.3 8.4 28.6 4.6 3.5 17.5 7.0 6.5 23.6 28.3 3.4 7.9 47.9 14.4 6.2 8.2 5.3 13.9 3.2 9.4 12.5 12.3 8.5 13.5 21.1 5.6 10.5 3.3 4.7 10.1 15.5 9.2 10.9 10.7 15.9 12.0 27.7 23.7 6.5 4.4 17.8 2.2 9.9 2.1 9.5 9.9 10.5 17.0 21.7 6.5 7.7 32.1 7.9 8.0 13.5 2.4 6.3 15.5 7.4 4.9 9.7 8.5 31.9 9.5 17.8 7.3 5.4 11.4 33.6 5.1 17.4 7.5 17.5 8.6 11.1 7.6 34.8 7.0 1.2 27.6 15.9 27.5 16.4 8.4 12.1 15.6 15.3 5.0 20.7 17.3 18.2 12.6 0.9 2.8 2.4 3.5 2.9 2.4 12.1 2.5 3.2 3.7 15.0 2.2 2.1 0.7 5.5 3.3 2.2 2.2 2.8 7.3 8.8 8.2 9.2 6.5 7.9 10.7 8.5 8.4 7.9 8.2 8.5 11.5 3.2 10.0 4.9 42.4 5.1 14.7 14.6 17.6 11.1 13.3 11.0 1.9 11.5 12.9 20.2 35.5 26.1 21.0 35.0 17.6 16.0 0.7 9.2 8.2 14.2 17.3 6.5 4.8 20.9 7.1 9.0 23.0 10.0 18.4 12.1 7.9 4.2 12.4 15.2 6.5 33.7 18.3 8.4 11.3 1.3 4.1 10.5 10.6 9.4 11.6 8.6 22.6 5.0 8.4 20.0 44.1 6.4 21.4 15.4 32.3 11.6 8.0 43.4 13.1 7.9 9.6 4.3 6.0 16.6 8.4 22.0 14.5 22.6 26.7 19.0 RABIF "mss4, RASGRF3" ENSG00000183155 "RAB interacting factor" P47224 1 202878282-202889149 "Predicted intracellular proteins" "Protein transport, Transport" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Late spermatids: 3764.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027715 Approved NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "HPA027715: AB_10602151" "unprognostic (4.87e-2)" "unprognostic (3.70e-2)" "unprognostic (2.09e-1)" "unprognostic (1.37e-1)" "unprognostic (3.51e-1)" "unprognostic (1.36e-2)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.70e-1)" "unprognostic (5.62e-3)" "prognostic favorable (5.64e-5)" "unprognostic (4.40e-2)" "unprognostic (2.94e-1)" "prognostic unfavorable (2.61e-5)" "unprognostic (1.23e-1)" "unprognostic (5.21e-2)" "unprognostic (8.54e-2)" "unprognostic (2.47e-1)" 4.0 3.9 6.3 5.7 6.6 8.4 3.9 5.8 8.4 4.1 4.2 5.5 5.6 3.4 3.9 8.9 3.0 4.1 4.5 7.0 6.5 5.6 5.3 4.7 6.7 6.2 6.3 2.0 3.3 3.2 3.9 4.9 6.3 4.2 6.0 6.8 4.8 3.2 4.8 5.5 5.3 4.7 5.9 6.2 3.8 18.0 6.3 5.7 3.1 4.3 8.6 5.1 4.8 6.6 11.7 12.2 8.8 10.6 13.4 9.9 9.5 12.9 7.1 12.8 11.8 8.9 9.9 9.6 6.0 10.0 8.8 10.9 6.9 8.0 9.7 11.8 12.7 7.9 9.8 9.1 10.8 11.1 13.4 8.5 11.2 16.0 4.1 6.3 16.9 12.4 12.7 10.3 12.5 19.5 12.5 12.0 7.2 9.1 15.1 8.7 12.3 13.2 13.2 12.2 12.3 11.0 11.0 19.1 10.4 10.6 12.6 8.1 13.3 8.9 8.2 4.3 11.2 5.4 13.0 10.1 8.8 10.3 8.5 32.4 21.1 31.6 18.4 23.2 13.5 17.8 17.3 17.4 19.0 17.8 15.6 16.5 33.3 17.9 22.0 18.1 21.1 18.3 6.3 6.6 5.8 8.4 7.0 6.5 6.2 6.3 6.3 5.9 6.3 6.6 11.8 0.0 15.9 4.6 26.2 54.3 37.8 53.3 17.6 5.4 18.9 12.3 11.2 17.2 33.8 12.9 2.1 52.5 39.1 42.4 15.6 37.3 696.1 17.9 8.5 20.6 23.4 21.2 9.0 53.4 50.5 16.6 13.7 14.5 12.7 8.0 20.3 34.9 42.1 1.7 7.0 14.7 40.7 37.4 36.0 3764.0 28.3 29.1 53.4 5.6 48.4 18.2 62.8 5.5 7.3 77.5 40.9 30.1 27.1 28.2 34.3 59.1 32.0 6.0 13.1 9.5 21.7 98.0 62.7 23.4 51.9 78.9 35.0 10.8 14.6 49.2 RAD51C "FANCO, RAD51L2" ENSG00000108384 "RAD51 paralog C" O43502 17 58692573-58735611 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 117.7;Spermatocytes: 140.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 319.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA045198 Supported "Nucleoplasm,Vesicles,Cell Junctions,Mitochondria,Cytosol" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Mitochondria, Cytosol" "Vesicles, Cell Junctions" "HPA045198: AB_2679250" "unprognostic (5.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.23e-2)" "unprognostic (6.20e-2)" "unprognostic (1.83e-1)" "unprognostic (4.59e-2)" "prognostic unfavorable (8.68e-5)" "unprognostic (3.65e-2)" "unprognostic (2.91e-2)" "unprognostic (1.03e-2)" "prognostic favorable (5.33e-4)" "unprognostic (2.55e-1)" "unprognostic (2.62e-2)" "unprognostic (7.62e-2)" "unprognostic (2.41e-1)" "unprognostic (9.52e-2)" "unprognostic (2.42e-2)" 10.8 20.2 15.5 10.0 15.7 23.1 15.3 19.0 18.4 10.8 13.4 12.4 7.5 12.6 22.0 13.0 11.2 11.0 25.7 16.4 15.0 12.8 13.3 8.8 22.0 14.9 13.8 12.5 10.6 20.1 10.5 15.1 16.0 17.4 14.5 13.5 10.7 12.0 18.3 10.6 8.7 13.8 13.2 12.2 11.6 20.2 14.6 21.2 12.3 17.3 19.1 10.9 8.6 18.2 63.7 72.1 43.3 48.5 22.9 19.6 100.1 34.2 14.5 43.5 55.3 31.0 39.3 37.4 48.9 23.5 58.8 23.3 59.5 46.6 81.7 91.6 123.0 53.0 84.6 119.4 23.3 69.1 45.0 12.1 42.2 47.8 38.6 24.0 50.0 60.9 83.6 48.5 37.0 319.1 96.8 95.3 12.1 42.5 66.5 62.1 69.5 69.8 26.9 39.6 54.3 49.6 27.3 12.0 53.5 11.1 39.2 71.6 16.5 37.6 100.1 34.3 42.4 44.1 187.2 111.5 38.3 67.1 42.0 27.6 9.2 12.5 15.6 14.3 15.2 18.0 16.9 17.2 15.9 17.3 18.2 17.4 5.1 15.0 12.5 14.3 27.1 11.0 15.5 15.7 19.0 18.4 16.4 15.0 14.9 13.8 16.0 13.2 14.6 18.2 20.5 19.2 13.9 10.1 20.5 11.9 18.7 42.9 15.9 15.0 25.1 34.0 63.7 7.2 20.9 16.5 6.2 67.8 15.0 7.1 58.7 25.7 117.7 17.3 13.0 19.3 6.7 43.8 21.5 18.6 94.1 19.8 7.1 13.0 22.9 23.3 15.7 15.7 33.4 16.8 17.7 11.7 32.6 16.1 47.7 65.4 17.4 21.8 24.9 13.1 18.7 31.3 21.6 23.1 22.8 13.0 10.4 15.4 28.5 17.2 5.7 24.6 14.1 26.9 32.9 14.7 23.9 140.7 98.3 15.9 10.7 36.3 20.5 28.2 15.3 13.9 RAD9A RAD9 ENSG00000172613 "RAD9 checkpoint clamp component A" Q99638 11 67317871-67398410 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006725, HPA048155, CAB079979" Enhanced Enhanced "Nucleoplasm,Nuclear bodies" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Nuclear bodies" "CAB079979: , HPA006725: AB_1856041, HPA048155: AB_2680290" "unprognostic (7.64e-2)" "prognostic favorable (6.95e-4)" "unprognostic (8.83e-3)" "unprognostic (1.13e-1)" "unprognostic (2.68e-1)" "unprognostic (2.12e-3)" "unprognostic (9.64e-3)" "unprognostic (1.05e-2)" "unprognostic (1.23e-1)" "unprognostic (1.97e-1)" "unprognostic (9.19e-2)" "unprognostic (2.50e-2)" "prognostic unfavorable (2.82e-5)" "unprognostic (6.16e-2)" "unprognostic (3.72e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.52e-6)" 5.8 5.0 3.3 6.9 3.6 10.2 6.9 2.1 6.0 9.2 2.9 7.3 10.9 7.4 2.1 9.0 10.9 5.7 4.2 3.8 2.4 7.1 6.6 6.7 8.3 2.9 3.6 8.0 8.0 3.4 10.1 4.4 2.2 10.8 3.0 1.8 9.8 6.1 5.2 11.4 11.1 2.4 2.2 9.4 8.4 8.6 2.5 6.1 9.7 2.1 3.7 6.5 8.5 2.2 10.8 15.8 9.5 13.8 2.8 1.1 12.0 5.7 4.9 8.0 7.1 23.2 20.9 11.1 12.4 1.8 13.0 18.7 6.0 5.5 0.9 13.0 16.3 16.8 8.5 10.4 3.8 12.3 20.3 3.2 5.3 7.2 3.5 6.1 5.5 23.2 14.7 15.6 2.3 33.2 21.9 21.8 13.2 15.9 12.1 18.8 12.5 13.6 2.2 9.0 9.8 10.6 9.9 27.2 21.1 2.4 19.1 10.9 4.2 11.7 14.3 23.3 8.7 14.6 14.2 11.5 7.5 11.6 9.6 5.3 1.8 6.0 5.2 2.3 3.8 4.3 4.1 4.3 1.2 3.1 2.9 3.2 2.8 3.1 2.5 3.4 2.4 1.5 3.3 3.6 2.1 6.0 3.8 2.4 2.9 3.6 2.2 2.2 2.5 2.2 16.0 22.4 17.1 10.1 31.0 17.1 17.7 17.9 23.3 19.6 19.7 18.4 1.1 12.8 22.2 20.2 70.9 27.9 31.3 54.2 13.7 11.3 27.3 32.1 13.4 16.3 14.3 17.7 8.5 13.1 22.4 13.8 27.0 14.9 20.3 26.0 11.0 6.6 15.1 21.9 6.0 48.9 10.2 10.3 31.4 13.2 10.5 14.0 19.6 11.2 8.9 15.0 56.7 2.5 5.3 11.6 31.6 12.4 38.5 16.6 61.8 10.9 44.0 32.1 13.1 10.5 14.5 32.0 17.6 18.3 17.3 40.6 30.3 15.3 38.7 18.0 RARA "NR1B1, RAR" ENSG00000131759 "Retinoic acid receptor alpha" P10276 17 40309180-40357643 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "neutrophil: 52.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 221.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058282, HPA071548" Supported "Nucleoplasm,Nucleoli,Actin filaments,Cytosol" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" Nucleoplasm "Nucleoli, Actin filaments, Cytosol" "HPA058282: AB_2683666, HPA071548: " "unprognostic (8.05e-3)" "unprognostic (1.89e-1)" "unprognostic (9.48e-3)" "prognostic favorable (2.60e-4)" "unprognostic (8.67e-3)" "unprognostic (4.87e-3)" "unprognostic (2.77e-1)" "unprognostic (5.73e-2)" "unprognostic (1.45e-1)" "unprognostic (3.54e-2)" "unprognostic (1.19e-1)" "unprognostic (1.79e-1)" "unprognostic (2.29e-3)" "unprognostic (1.59e-2)" "unprognostic (5.60e-2)" "unprognostic (1.60e-1)" "unprognostic (1.09e-2)" 47.6 21.1 3.2 28.3 4.4 59.6 37.2 7.2 16.5 43.7 5.1 31.0 28.4 32.2 10.7 14.9 40.7 41.3 40.8 7.0 5.7 24.1 42.3 58.4 16.4 5.3 2.7 40.8 14.7 11.3 30.6 25.7 2.8 29.8 13.2 18.3 20.6 21.3 62.6 24.8 32.2 28.6 1.8 41.7 22.9 28.8 4.9 10.0 26.9 17.4 11.8 30.3 30.2 4.3 18.0 41.9 11.8 20.5 23.4 35.9 12.5 14.9 21.8 21.5 13.6 28.6 15.1 9.6 22.7 33.2 18.9 51.1 14.2 33.9 12.0 77.5 21.4 26.6 21.2 29.8 37.0 9.4 81.3 48.2 10.0 22.7 29.2 75.8 30.9 8.4 17.6 20.2 23.7 221.5 6.4 34.2 10.7 16.2 13.3 12.9 71.3 37.0 12.2 14.4 5.4 40.5 31.0 124.8 42.1 11.7 119.1 36.6 35.8 25.3 45.3 44.2 15.4 48.7 16.9 8.3 38.4 18.7 77.1 26.3 8.9 34.6 3.2 14.6 5.1 2.0 3.6 3.8 12.4 1.7 1.5 2.8 52.6 5.9 19.5 3.8 3.1 5.0 3.2 4.4 7.2 16.5 7.0 5.7 5.3 2.7 2.8 1.8 4.9 4.3 35.6 3.2 7.0 2.3 43.4 19.5 25.6 8.4 18.8 23.2 35.4 17.5 3.8 10.0 5.5 7.3 6.2 2.2 36.9 41.2 13.7 16.7 60.5 20.7 22.0 28.4 9.6 5.7 5.4 19.2 5.8 28.5 10.7 18.4 35.5 13.9 26.0 28.8 12.3 3.3 2.6 13.1 6.1 45.4 65.5 66.2 41.7 56.9 28.4 2.8 26.1 11.8 6.2 4.0 0.3 22.0 33.1 23.0 21.0 13.4 70.9 17.7 4.9 10.2 32.9 42.1 26.7 3.6 7.6 7.1 18.9 5.2 31.7 6.5 16.5 19.3 RARG "NR1B3, RARC" ENSG00000172819 "Retinoic acid receptor gamma" P13631 12 53210567-53232980 "Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 141.6;skin 1: 121.4" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 42.7;Squamous epithelial cells: 69.9;Suprabasal keratinocytes: 55.8;Urothelial cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "MAIT T-cell: 18.8" "Group enriched" "Detected in all" 4 "dendritic cells: 6.7;T-cells: 18.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 101.0;MCF7: 110.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053883 Supported Supported Nucleoplasm NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "HPA053883: AB_2682292" "unprognostic (7.29e-2)" "unprognostic (1.95e-2)" "unprognostic (6.11e-2)" "prognostic unfavorable (3.68e-6)" "unprognostic (2.53e-1)" "unprognostic (5.43e-2)" "unprognostic (2.28e-1)" "unprognostic (1.08e-2)" "unprognostic (3.54e-3)" "unprognostic (7.21e-3)" "unprognostic (3.78e-3)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.08e-6)" "unprognostic (5.41e-3)" "unprognostic (1.98e-2)" "unprognostic (5.94e-3)" "unprognostic (7.41e-2)" 17.4 16.2 10.2 5.7 9.7 3.7 19.4 13.0 10.9 55.0 10.8 22.7 2.5 23.3 6.0 141.6 27.2 15.7 17.3 9.7 9.5 12.5 3.2 15.2 5.9 10.3 10.0 20.5 8.5 7.2 8.7 9.5 9.3 26.9 7.8 3.9 30.6 16.2 6.9 121.4 10.4 13.0 10.0 10.2 14.5 4.8 9.5 5.1 22.6 10.6 22.5 26.2 69.3 10.0 22.8 24.7 5.5 50.9 55.0 46.8 1.7 23.2 50.0 29.7 23.3 8.3 101.0 0.5 12.5 93.6 16.2 74.3 18.4 44.6 7.4 5.7 9.4 3.3 18.6 7.4 23.2 0.0 9.1 34.8 63.9 28.5 6.4 74.7 12.7 4.6 0.8 9.8 11.9 110.3 1.3 1.1 16.3 30.4 42.7 7.3 1.9 18.1 8.9 37.1 4.4 22.9 47.0 50.6 32.1 6.8 43.9 1.4 13.8 35.4 16.5 23.6 1.5 4.2 2.6 1.8 43.4 3.8 51.3 1.8 3.1 0.9 7.4 0.9 18.8 2.0 6.5 5.4 6.7 0.6 5.2 4.7 0.0 2.3 0.0 0.6 1.8 4.0 10.2 9.7 13.0 10.9 9.7 9.5 10.3 10.0 9.3 10.0 9.5 10.0 10.7 3.2 7.0 21.2 2.5 34.2 24.1 21.6 42.7 0.5 18.0 15.6 3.7 11.5 11.1 3.7 2.1 7.5 6.2 3.2 0.0 10.5 0.1 3.6 14.4 11.0 1.8 0.8 2.5 5.1 1.2 19.6 13.7 3.4 1.3 0.3 20.3 0.1 2.7 0.0 3.0 2.1 12.2 4.1 13.3 0.5 5.3 4.9 8.8 6.5 1.8 3.6 5.2 7.1 0.7 14.3 4.4 5.3 3.0 19.2 0.2 0.5 3.9 5.2 6.6 9.5 22.0 0.8 5.6 69.9 55.8 1.8 7.2 0.4 5.5 45.7 RBM42 MGC10433 ENSG00000126254 "RNA binding motif protein 42" Q9BTD8 19 35629030-35637686 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 384.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043671 Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm Cytosol "HPA043671: AB_10794890" "unprognostic (4.77e-3)" "unprognostic (3.37e-2)" "unprognostic (6.33e-2)" "unprognostic (7.03e-2)" "unprognostic (3.05e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-2)" "unprognostic (3.34e-1)" "unprognostic (1.53e-1)" "unprognostic (8.81e-2)" "unprognostic (4.95e-3)" "unprognostic (3.26e-2)" "unprognostic (5.78e-3)" "unprognostic (3.37e-2)" "unprognostic (1.66e-2)" "unprognostic (1.40e-1)" "unprognostic (7.33e-2)" 57.6 48.0 34.9 24.5 39.8 38.2 54.3 41.3 41.5 56.1 30.9 60.6 27.5 65.2 12.0 58.5 53.8 11.8 60.8 35.1 36.3 57.5 54.0 46.5 24.1 43.8 38.0 54.8 39.6 23.1 41.4 23.2 38.7 55.2 10.7 9.1 44.2 24.9 76.0 67.3 46.3 14.5 37.6 51.7 49.7 41.5 38.0 25.9 49.9 21.6 15.5 58.0 50.8 42.9 115.6 176.5 38.8 52.9 34.6 27.0 104.8 77.2 41.8 88.3 69.0 105.0 72.8 63.7 137.8 49.4 48.2 46.6 44.8 54.0 26.0 165.6 80.0 87.8 57.7 87.5 88.8 78.5 81.1 38.6 42.3 65.4 36.0 28.4 48.8 65.3 92.9 50.8 40.5 130.5 99.9 103.1 44.4 103.1 71.9 107.7 52.9 63.8 43.0 52.6 50.5 73.3 87.8 71.5 62.4 21.1 57.0 122.0 76.2 63.1 86.4 84.4 136.6 123.0 140.7 99.1 60.9 73.8 90.2 98.8 79.6 124.5 82.8 95.6 70.9 76.2 67.8 83.1 94.3 81.3 59.4 67.1 73.9 79.3 94.5 87.6 82.6 73.3 34.9 39.8 41.3 41.5 35.1 36.3 43.8 38.0 38.7 37.6 38.0 42.9 56.5 38.5 24.6 4.6 38.4 51.9 52.6 94.3 43.9 23.3 31.2 37.5 14.7 40.0 57.4 53.3 12.5 197.9 47.0 67.2 74.3 78.0 38.4 41.0 35.4 50.9 52.1 43.8 2.3 90.4 101.5 47.0 38.7 41.6 51.4 46.0 46.8 31.6 91.2 10.1 2.6 56.4 54.9 31.1 60.9 16.3 58.1 40.9 53.4 2.8 63.0 46.5 27.8 3.5 5.8 80.6 48.9 63.2 43.7 31.8 72.3 78.0 44.5 19.8 52.6 34.5 92.4 71.9 52.9 36.2 43.5 384.3 44.9 44.3 64.7 45.4 RBM8A "BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP" ENSG00000265241 "RNA binding motif protein 8A" Q9Y5S9 1 145917714-145927678 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 735.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018403 Supported Supported "Nuclear speckles" NA NA 100000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles" "HPA018403: AB_1858908" "unprognostic (3.81e-1)" "unprognostic (3.99e-3)" "unprognostic (1.59e-1)" "unprognostic (6.83e-2)" "unprognostic (1.12e-1)" "unprognostic (3.16e-1)" "unprognostic (4.62e-3)" "unprognostic (1.91e-1)" "unprognostic (1.38e-1)" "unprognostic (8.79e-3)" "unprognostic (7.27e-3)" "prognostic unfavorable (1.55e-4)" "unprognostic (3.30e-3)" "unprognostic (2.18e-1)" "unprognostic (3.77e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-3)" 86.1 74.9 37.2 105.4 39.1 214.7 82.3 38.7 43.0 69.6 35.6 70.5 70.1 67.7 49.3 163.6 62.2 58.0 73.0 36.8 41.7 81.6 77.5 72.8 126.4 39.7 39.8 72.0 59.9 78.4 65.8 85.3 40.8 66.4 56.4 45.0 79.2 48.2 214.9 92.0 69.2 57.7 42.1 81.6 67.5 71.3 40.0 120.7 68.8 100.1 123.7 112.8 80.4 43.9 377.0 300.7 268.8 215.7 94.6 92.2 330.0 224.3 150.7 315.0 230.1 400.0 277.4 342.0 344.9 155.3 166.5 252.5 289.3 245.3 257.0 305.6 275.7 264.2 229.2 299.8 133.6 446.6 222.6 102.2 180.8 283.0 300.3 137.4 238.1 291.9 405.2 314.7 246.2 1033.8 452.3 352.2 463.7 323.9 518.4 394.4 234.6 341.2 203.2 355.6 274.6 335.7 334.5 169.7 316.5 231.0 318.0 534.3 247.3 252.3 324.0 250.9 626.0 352.2 603.4 502.6 226.4 264.9 223.2 464.6 316.5 513.6 337.2 363.9 322.1 444.3 317.6 346.4 318.0 389.6 296.1 328.3 363.7 389.8 361.3 498.4 386.3 582.7 37.2 39.1 38.7 43.0 36.8 41.7 39.7 39.8 40.8 42.1 40.0 43.9 289.1 70.5 132.4 8.1 251.0 332.9 396.7 475.4 244.2 66.3 168.5 184.7 78.0 98.7 262.8 88.3 54.2 376.2 276.0 125.3 187.9 224.1 243.7 148.0 134.3 206.0 158.9 149.2 10.8 223.2 506.3 174.1 80.5 152.8 244.0 136.8 120.3 124.4 204.3 35.3 9.1 127.6 313.3 100.3 265.2 54.4 102.2 170.7 208.1 9.4 197.7 120.3 165.8 6.0 16.1 245.4 159.8 85.4 174.9 259.6 119.5 204.1 195.1 86.3 98.6 213.7 208.1 212.0 168.9 208.1 318.0 735.5 282.1 139.7 141.7 393.0 RBMX2 "CGI-79, Snu17" ENSG00000134597 "RNA binding motif protein X-linked 2" Q9Y388 X 130401987-130413656 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026609 Approved Approved "Nuclear membrane,Nucleoli" NA NA "Cluster 37: B-cells - Transcription" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nuclear membrane" Nucleoli "HPA026609: AB_1846601" "unprognostic (2.54e-1)" "unprognostic (1.17e-2)" "unprognostic (1.80e-3)" "unprognostic (3.32e-2)" "unprognostic (1.16e-1)" "unprognostic (3.50e-2)" "prognostic unfavorable (7.04e-4)" "prognostic favorable (9.15e-4)" "unprognostic (1.34e-3)" "unprognostic (1.86e-2)" "unprognostic (6.21e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (8.44e-9)" "unprognostic (1.06e-1)" "unprognostic (4.78e-2)" "unprognostic (3.08e-2)" "unprognostic (5.63e-3)" 15.6 12.2 26.3 10.1 26.1 11.8 14.6 26.1 48.8 21.7 23.6 17.3 10.4 16.8 16.4 13.8 16.3 9.9 13.9 26.3 27.4 14.4 13.0 11.6 14.1 25.8 26.3 18.0 16.5 10.5 11.9 10.5 26.1 15.0 11.6 11.2 11.9 12.3 12.4 17.4 12.8 13.2 25.3 15.1 14.5 7.0 26.2 17.2 12.6 10.0 16.6 16.6 15.6 27.9 22.7 23.3 23.4 24.3 23.1 41.3 23.2 21.0 21.1 23.2 25.4 17.5 27.6 21.8 48.9 16.1 31.1 24.4 37.2 19.2 33.4 20.2 32.5 19.8 22.6 18.6 20.2 30.6 22.8 30.2 27.1 25.9 36.1 33.8 26.1 27.2 17.2 18.8 26.4 39.2 36.4 37.9 17.4 40.0 37.2 27.4 22.7 29.5 23.7 18.0 26.8 32.0 13.2 28.0 39.1 18.8 18.2 22.2 17.5 19.0 15.5 44.8 43.6 24.6 27.9 30.5 22.9 49.5 23.9 9.3 6.8 8.6 7.7 7.7 8.2 10.9 10.0 10.7 5.9 9.0 10.6 9.7 6.0 7.3 7.2 7.7 16.5 4.1 26.3 26.1 26.1 48.8 26.3 27.4 25.8 26.3 26.1 25.3 26.2 27.9 30.5 19.2 19.0 5.5 32.9 32.1 29.0 42.8 22.8 22.0 27.5 33.0 22.6 22.8 40.1 11.0 10.4 33.1 28.4 14.1 15.6 34.2 3.8 21.0 43.5 31.9 40.7 19.4 7.4 35.6 40.8 27.3 13.7 18.3 35.5 27.8 45.0 24.5 34.5 16.8 8.2 23.6 36.7 47.6 24.4 5.8 32.3 27.6 28.4 2.8 41.5 23.3 41.2 7.1 9.4 29.8 18.1 44.0 17.9 26.4 17.9 39.5 27.9 12.5 32.9 30.8 29.8 30.2 53.3 22.4 29.7 25.9 32.0 31.9 29.2 22.9 RECQL4 RecQ4 ENSG00000160957 "RecQ like helicase 4" O94761 8 144511288-144517845 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Helicase, Hydrolase" "Cancer-related genes, Cataract, Craniosynostosis, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 25.4;testis: 22.4" "Cell type enhanced" "Detected in many" "Spermatocytes: 23.5;Spermatogonia: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB017800, HPA025821" Supported Enhanced Nucleoplasm NA Yes "Cluster 32: T-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB017800: , HPA025821: AB_1856168" "unprognostic (5.92e-2)" "unprognostic (1.86e-1)" "unprognostic (2.05e-1)" "unprognostic (1.18e-1)" "unprognostic (9.17e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (1.12e-2)" "unprognostic (4.12e-2)" "unprognostic (7.53e-2)" "unprognostic (2.65e-2)" "unprognostic (4.26e-2)" "unprognostic (1.12e-3)" "unprognostic (8.82e-3)" "unprognostic (1.74e-1)" "unprognostic (2.24e-1)" "unprognostic (1.34e-1)" 1.7 1.8 3.0 5.8 3.7 25.4 2.0 7.7 7.0 2.9 0.1 4.7 6.0 2.5 0.4 13.3 2.1 2.1 1.8 2.6 1.6 2.5 2.7 2.3 6.8 6.9 2.3 2.7 3.1 0.7 3.1 2.5 7.4 8.6 1.6 1.5 5.8 0.8 2.5 10.1 5.2 1.0 1.7 6.5 3.2 22.4 4.1 7.4 3.4 0.5 2.5 2.5 3.1 3.6 33.7 58.8 27.0 57.1 1.6 2.6 47.1 33.2 5.9 24.2 20.2 58.4 48.4 22.8 21.5 5.6 14.2 40.1 18.0 14.2 6.6 40.3 68.6 82.4 118.5 44.3 0.5 21.2 65.7 3.3 2.1 27.1 5.5 3.4 6.8 45.4 83.3 28.9 8.5 104.1 77.3 56.9 18.8 27.8 69.5 80.0 21.2 37.9 6.7 35.8 52.9 32.0 45.2 37.3 12.1 7.4 45.5 45.7 9.2 38.9 117.4 47.3 62.6 16.0 18.1 39.3 22.4 64.6 39.9 0.0 0.0 0.0 0.2 0.2 0.0 0.3 0.1 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 3.0 3.7 7.7 7.0 2.6 1.6 6.9 2.3 7.4 1.7 4.1 3.6 0.7 0.0 0.0 2.0 2.2 1.5 0.7 0.9 1.2 2.7 3.7 2.7 1.8 1.5 0.5 0.0 4.2 3.9 1.0 5.9 0.0 0.5 3.9 2.1 0.9 0.7 0.0 6.1 2.0 0.4 8.1 1.8 4.6 2.0 0.0 8.8 0.0 0.7 3.6 0.0 1.6 4.1 0.0 0.6 1.1 7.4 1.2 1.0 0.0 0.0 0.3 0.3 1.0 0.0 0.8 0.3 0.2 1.5 9.1 0.7 0.7 0.5 0.7 1.7 0.0 1.4 1.2 23.5 20.6 6.6 1.0 1.5 1.2 0.5 7.0 0.7 RFXANK "ANKRA1, BLS, F14150_1, MGC138628, RFX-B" ENSG00000064490 "Regulatory factor X associated ankyrin containing protein" O14593 19 19192229-19201869 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049157, HPA053330" Approved Enhanced Nucleoplasm NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA049157: AB_2680658, HPA053330: AB_2682114" "unprognostic (3.16e-2)" "unprognostic (6.39e-3)" "unprognostic (1.47e-2)" "unprognostic (1.22e-1)" "unprognostic (5.23e-2)" "unprognostic (4.46e-2)" "unprognostic (1.25e-3)" "unprognostic (3.40e-2)" "unprognostic (3.89e-1)" "unprognostic (1.57e-1)" "unprognostic (2.71e-1)" "unprognostic (1.97e-1)" "unprognostic (1.31e-2)" "unprognostic (3.62e-2)" "unprognostic (3.52e-1)" "unprognostic (2.73e-2)" "unprognostic (2.04e-3)" 30.2 20.2 27.3 21.4 30.2 41.1 29.6 29.4 34.8 28.6 25.8 30.5 21.4 28.4 14.1 40.2 34.8 13.6 27.4 27.1 29.3 36.6 20.6 25.8 31.1 31.1 28.1 27.1 29.6 23.1 24.3 18.2 29.0 32.3 11.1 8.7 34.1 14.2 31.6 34.9 27.6 13.0 28.6 38.9 31.8 12.7 28.7 28.4 38.0 15.0 22.1 26.1 27.1 29.9 60.0 36.6 25.6 50.2 8.7 24.2 64.5 29.0 30.3 48.8 47.7 30.7 121.4 58.2 72.9 30.2 20.8 43.6 21.9 56.2 21.5 40.4 33.7 46.7 36.7 45.1 89.4 66.8 94.6 44.7 32.4 42.8 31.0 29.8 49.1 56.8 94.4 64.2 27.1 119.3 88.0 88.3 30.7 62.6 82.0 73.5 26.1 101.9 41.5 39.8 21.0 43.6 30.3 38.2 70.4 17.1 54.1 134.8 49.1 25.4 27.9 63.3 47.6 73.5 86.9 87.7 37.6 82.3 52.2 48.5 29.4 52.2 23.9 32.7 20.4 41.7 27.2 26.5 34.2 41.4 27.1 26.6 13.4 33.3 24.6 54.2 40.5 29.0 27.3 30.2 29.4 34.8 27.1 29.3 31.1 28.1 29.0 28.6 28.7 29.9 33.4 32.1 36.9 6.5 28.9 22.0 33.8 77.9 28.5 10.0 30.5 33.5 3.4 31.5 39.5 31.3 2.1 63.5 24.9 46.2 76.3 44.0 6.4 48.4 29.7 35.7 37.2 45.8 1.2 57.4 61.3 26.8 35.2 37.7 31.8 31.4 33.2 16.7 63.1 15.2 1.4 40.0 40.7 44.5 27.8 11.1 30.4 34.1 21.4 8.4 57.8 27.6 36.0 3.5 3.3 59.3 44.4 19.2 27.9 27.0 56.5 70.7 57.6 12.3 39.5 14.6 37.5 6.3 20.1 35.4 24.6 45.6 29.4 28.5 46.9 27.1 RHBDD2 "NPD007, RHBDL7" ENSG00000005486 "Rhomboid domain containing 2" Q6NTF9 7 75842602-75888926 "Enzymes, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 380.1" "Cell type enhanced" "Detected in all" "Late spermatids: 300.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 398.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 165.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045074, HPA051960" Uncertain Enhanced "Golgi apparatus" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA045074: AB_10965705, HPA051960: AB_2681673" "unprognostic (2.75e-1)" "unprognostic (3.89e-2)" "prognostic unfavorable (3.31e-5)" "unprognostic (9.79e-2)" "prognostic unfavorable (1.81e-4)" "unprognostic (2.05e-2)" "unprognostic (1.18e-2)" "unprognostic (2.37e-3)" "unprognostic (1.55e-1)" "unprognostic (2.75e-1)" "unprognostic (5.11e-2)" "unprognostic (1.87e-2)" "prognostic favorable (8.68e-6)" "unprognostic (3.73e-1)" "unprognostic (6.53e-2)" "unprognostic (1.89e-1)" "unprognostic (1.03e-1)" 43.9 232.5 247.5 20.0 248.6 26.9 47.7 169.0 313.0 46.7 224.2 39.4 35.7 36.4 59.3 48.5 47.0 23.2 54.7 255.0 380.1 97.7 99.8 72.0 16.2 216.3 252.8 61.2 56.8 182.8 299.6 16.5 274.5 79.0 16.0 39.1 53.3 94.8 35.0 49.4 44.9 11.8 187.5 50.2 57.6 87.2 321.2 19.9 91.1 11.6 12.5 45.3 43.6 208.3 24.0 80.2 34.5 57.9 16.3 11.5 12.8 12.8 50.6 26.6 27.2 43.6 59.7 7.5 13.0 26.3 59.4 33.7 22.4 17.6 10.3 25.9 46.3 9.0 48.0 41.4 45.0 13.8 61.5 25.0 35.7 31.1 12.3 43.9 20.4 51.2 19.0 51.6 26.9 165.3 26.1 74.9 31.7 41.0 45.1 19.4 22.7 66.8 47.2 42.9 43.3 88.7 59.3 107.8 47.9 23.2 66.3 23.2 20.4 43.5 39.6 29.2 27.9 48.4 18.5 12.9 50.4 20.4 59.9 398.8 62.8 79.0 80.0 66.1 68.9 51.7 89.1 71.7 63.0 50.8 72.5 65.3 104.7 63.6 35.1 49.7 126.8 61.2 247.5 248.6 169.0 313.0 255.0 380.1 216.3 252.8 274.5 187.5 321.2 208.3 20.5 41.7 31.9 16.6 23.7 23.2 46.5 127.6 18.2 34.9 42.3 22.4 8.8 55.8 76.8 86.5 33.3 54.8 20.7 48.3 19.6 94.1 171.2 30.2 12.8 26.9 89.8 10.3 27.0 102.1 41.3 34.7 39.8 16.2 192.7 72.4 57.8 43.1 45.5 18.5 31.9 35.1 128.1 35.9 32.7 300.8 42.6 47.8 60.5 5.6 21.4 68.8 29.9 13.0 11.0 78.1 37.6 52.6 27.9 47.8 52.8 52.5 89.3 35.7 6.6 19.0 26.4 57.3 29.7 27.9 23.7 52.0 61.2 198.1 30.2 50.1 RHBDF1 "C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1" ENSG00000007384 "Rhomboid 5 homolog 1" Q96CC6 16 58059-76355 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Growth factor binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077399 Uncertain Vesicles NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA077399: " "unprognostic (2.62e-1)" "unprognostic (2.86e-2)" "unprognostic (4.76e-2)" "unprognostic (4.04e-2)" "unprognostic (1.51e-2)" "unprognostic (3.69e-2)" "unprognostic (5.60e-3)" "unprognostic (4.54e-3)" "unprognostic (4.51e-2)" "unprognostic (1.02e-1)" "unprognostic (7.81e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (2.49e-5)" "unprognostic (4.81e-2)" "unprognostic (1.87e-1)" "unprognostic (8.36e-2)" "unprognostic (4.22e-2)" 41.9 11.5 14.5 6.0 14.4 0.5 44.3 13.5 19.5 65.1 13.3 38.2 7.5 38.1 13.0 47.0 36.4 22.1 51.7 14.3 13.5 24.7 13.2 58.5 5.5 14.5 14.4 55.6 23.4 8.9 13.3 27.5 13.9 61.2 7.1 2.5 38.3 16.5 34.1 46.1 24.8 10.5 14.0 19.3 28.5 8.0 14.7 1.2 33.4 16.9 5.5 44.6 61.4 13.5 10.8 17.3 9.7 22.5 37.2 45.7 31.8 29.1 53.8 20.1 19.1 23.5 36.9 0.6 11.8 31.1 10.2 33.6 4.8 19.6 3.4 0.5 5.3 0.4 18.8 6.6 41.4 0.3 18.3 38.3 20.3 51.9 8.6 35.5 31.4 0.1 4.1 0.4 32.2 60.6 0.1 3.5 8.8 22.7 14.5 0.3 11.5 0.9 22.7 11.0 0.3 2.4 8.4 31.8 18.7 11.9 49.1 3.8 32.6 31.5 21.9 24.8 8.1 0.2 0.7 0.3 22.0 0.6 50.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 14.4 13.5 19.5 14.3 13.5 14.5 14.4 13.9 14.0 14.7 13.5 10.5 19.2 6.2 9.1 0.3 6.8 9.9 15.2 5.2 0.8 17.8 13.5 9.9 22.8 15.8 9.2 66.7 19.0 0.3 21.9 0.0 21.4 1.1 3.8 9.9 9.2 0.0 0.0 1.7 8.0 16.3 20.6 15.8 11.2 0.0 8.7 8.2 3.0 2.2 0.0 0.6 9.8 18.3 0.6 5.1 1.1 19.6 0.4 16.0 5.6 0.0 6.9 0.0 16.6 0.7 28.4 13.6 13.9 0.2 25.8 2.1 2.3 5.3 4.9 13.1 10.8 22.3 0.3 1.9 6.6 5.5 30.6 0.8 16.4 3.8 17.9 RHOT2 "ARHT2, C16orf39, MIRO-2" ENSG00000140983 "Ras homolog family member T2" Q8IXI1 16 668105-674174 "Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 264.8;Rod photoreceptor cells: 284.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012624, HPA012895" Approved Supported Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" Mitochondria "HPA012624: AB_1856272, HPA012895: AB_1856271" "unprognostic (1.59e-1)" "unprognostic (8.24e-2)" "unprognostic (1.03e-1)" "unprognostic (4.50e-2)" "unprognostic (1.09e-1)" "prognostic favorable (5.01e-4)" "unprognostic (4.68e-3)" "unprognostic (4.66e-2)" "unprognostic (3.41e-2)" "unprognostic (7.55e-2)" "unprognostic (7.87e-3)" "unprognostic (3.25e-1)" "prognostic favorable (5.43e-4)" "unprognostic (1.51e-2)" "unprognostic (2.38e-1)" "unprognostic (1.24e-1)" "unprognostic (2.17e-2)" 32.3 48.6 28.9 20.4 28.4 28.1 34.9 27.9 36.4 38.7 32.8 42.8 29.1 32.8 7.8 37.7 38.2 12.8 53.6 29.2 27.4 46.6 44.9 34.4 26.0 29.1 28.1 34.5 34.2 20.4 51.5 14.7 28.0 50.3 8.1 36.4 35.9 17.3 33.5 38.7 45.1 9.2 27.0 57.1 41.4 36.7 28.8 20.3 45.7 15.5 11.6 37.5 35.6 28.1 25.0 52.4 25.6 39.7 13.1 13.7 44.7 41.7 19.2 33.9 26.2 70.3 37.1 29.5 28.8 16.6 11.8 47.3 17.7 39.6 8.7 41.9 77.2 32.5 65.5 52.2 24.7 29.9 44.2 21.3 29.5 25.0 14.2 17.9 24.5 35.9 62.6 22.1 17.3 108.2 33.1 32.5 67.3 21.5 33.5 72.6 30.5 59.1 20.6 48.8 57.7 70.1 39.2 50.6 22.8 11.0 49.6 46.4 38.9 25.4 41.7 23.5 30.8 56.0 40.0 38.6 17.9 28.3 39.6 5.5 19.5 21.8 22.9 23.0 13.9 11.6 18.3 18.4 19.4 12.1 13.7 11.7 16.8 12.0 18.4 20.3 23.0 17.6 28.9 28.4 27.9 36.4 29.2 27.4 29.1 28.1 28.0 27.0 28.8 28.1 30.1 32.1 27.5 53.2 37.1 33.8 26.8 80.0 25.6 98.6 29.6 25.8 25.7 30.0 38.3 29.5 264.8 63.2 46.7 63.3 21.5 40.2 6.3 16.5 21.7 26.6 43.0 17.1 46.5 35.8 52.1 26.5 51.0 21.9 51.4 40.6 20.0 34.7 35.8 85.8 36.2 52.2 61.1 30.3 29.8 7.5 27.1 26.0 28.4 20.6 45.2 40.1 46.4 17.1 27.3 43.8 46.8 25.6 23.7 25.0 47.3 24.3 27.9 284.9 52.6 19.9 31.5 44.5 51.4 19.3 31.7 67.0 42.1 45.5 54.2 23.3 RMND5B "FLJ22318, GID2, GID2B" ENSG00000145916 "Required for meiotic nuclear division 5 homolog B" Q96G75 5 178130996-178150568 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 186.6;Late spermatids: 415.4;Spermatocytes: 133.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 130.3;MCF7: 185.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047778 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "HPA047778: AB_2680153" "unprognostic (2.08e-1)" "unprognostic (6.83e-2)" "unprognostic (2.58e-1)" "unprognostic (1.35e-2)" "unprognostic (4.38e-2)" "unprognostic (9.81e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (2.48e-1)" "prognostic favorable (7.66e-4)" "unprognostic (1.60e-1)" "prognostic favorable (7.22e-8)" "unprognostic (1.77e-2)" "unprognostic (1.41e-1)" "unprognostic (6.43e-2)" "unprognostic (5.78e-2)" 18.9 23.4 19.8 11.2 19.7 13.2 18.8 19.2 20.3 24.0 19.4 24.5 13.2 22.7 12.2 69.8 19.2 9.6 28.1 19.7 18.7 22.4 27.2 17.4 18.0 22.3 19.4 17.1 25.4 23.5 20.7 16.4 19.1 19.0 11.4 10.5 24.2 15.9 45.6 29.6 17.3 15.9 19.6 19.2 23.2 81.6 21.2 23.7 20.5 32.4 23.0 22.1 28.2 20.9 21.3 37.5 21.4 53.5 27.4 2.8 71.3 16.9 18.2 25.1 29.2 42.1 30.2 44.6 32.9 11.9 27.6 27.6 21.5 36.7 8.8 130.3 28.7 46.8 39.1 22.8 29.0 21.9 16.3 5.9 27.1 17.3 27.3 14.0 25.5 14.7 40.1 28.8 8.1 185.2 15.5 12.5 29.5 25.9 20.4 19.7 15.8 31.6 21.1 32.4 22.5 32.2 22.8 73.0 40.3 17.3 56.9 29.5 17.7 13.9 21.9 12.8 21.3 42.4 43.4 37.0 18.2 21.2 19.6 21.8 16.5 42.5 6.5 20.1 2.8 18.3 13.0 7.3 8.8 24.9 20.4 11.3 11.4 4.2 27.2 13.7 22.4 12.4 19.8 19.7 19.2 20.3 19.7 18.7 22.3 19.4 19.1 19.6 21.2 20.9 13.5 12.8 6.9 7.8 20.5 9.6 20.6 15.3 14.2 48.6 19.3 16.1 22.2 27.1 12.2 31.3 52.1 31.7 8.0 17.6 23.5 21.0 186.6 7.8 10.2 13.3 9.0 28.0 15.4 19.1 29.8 16.7 23.0 10.5 5.1 16.4 15.0 14.0 21.7 48.8 16.6 15.0 28.5 15.0 9.6 415.4 28.9 10.5 7.2 10.3 22.7 30.9 14.4 8.5 14.1 19.1 13.3 25.2 14.8 20.6 26.1 21.6 7.3 61.4 13.1 17.5 16.3 133.0 35.7 28.9 13.4 44.5 10.9 18.5 17.9 20.0 RNASEH2A "AGS4, RNASEHI, RNHIA, RNHL" ENSG00000104889 "Ribonuclease H2 subunit A" O75792 19 12806584-12813640 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Endonuclease, Hydrolase, Nuclease" "Aicardi-Goutieres syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 62.3;Extravillous trophoblasts: 117.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042692 Enhanced Nucleoplasm,Cytosol No No "Cluster 12: Non-specific - Basic cellular processes" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA042692: AB_10793981" "unprognostic (6.74e-2)" "prognostic favorable (1.18e-4)" "prognostic favorable (6.18e-4)" "unprognostic (2.24e-1)" "unprognostic (2.62e-1)" "unprognostic (5.13e-2)" "prognostic unfavorable (8.72e-5)" "unprognostic (8.48e-2)" "unprognostic (9.33e-2)" "prognostic favorable (1.22e-4)" "unprognostic (3.80e-3)" "unprognostic (8.71e-2)" "prognostic unfavorable (6.29e-6)" "unprognostic (3.40e-3)" "unprognostic (4.35e-2)" "unprognostic (5.35e-2)" "unprognostic (8.60e-2)" 8.9 6.8 7.0 11.8 7.2 28.0 9.0 10.4 9.1 10.8 6.2 10.5 10.3 8.5 4.9 18.3 10.6 4.9 7.6 7.2 6.1 7.4 6.9 7.3 17.1 7.3 6.5 8.9 9.2 5.3 5.4 10.4 7.4 6.0 10.7 8.4 8.6 5.0 8.9 13.9 10.0 8.2 6.0 14.5 9.4 19.8 6.8 24.4 7.5 6.6 18.7 8.2 10.8 9.5 130.0 103.8 94.8 75.7 12.3 23.4 76.2 68.4 40.0 126.3 136.0 76.2 58.7 126.9 106.2 36.6 59.6 79.4 82.6 89.2 83.5 82.7 118.1 67.7 112.9 89.9 7.1 70.6 60.5 10.4 19.7 110.7 43.9 21.4 47.3 114.8 91.2 46.8 82.0 251.4 132.8 83.0 56.4 79.1 167.4 146.1 102.0 113.7 39.6 63.8 119.8 76.7 67.0 39.8 46.7 39.8 76.1 78.4 29.3 129.2 55.7 197.0 126.1 97.6 130.3 108.5 77.4 129.4 105.5 9.4 19.1 17.2 23.9 27.6 23.3 36.8 19.6 22.5 19.0 36.3 15.9 19.6 4.4 44.8 27.7 21.0 25.8 19.1 7.0 7.2 10.4 9.1 7.2 6.1 7.3 6.5 7.4 6.0 6.8 9.5 5.3 0.0 2.6 1.3 15.3 14.0 15.7 22.9 6.8 16.2 2.8 11.7 2.7 12.8 7.6 0.0 4.2 62.3 9.1 11.3 0.0 5.4 16.1 0.8 1.6 9.0 8.4 38.7 2.2 6.0 117.4 10.3 10.7 1.1 3.8 2.5 11.7 4.4 48.9 8.4 3.0 13.9 22.4 9.1 13.2 18.8 8.4 9.3 12.4 1.9 8.5 10.4 14.4 1.0 2.4 2.1 6.8 4.9 33.0 5.3 6.2 1.0 9.5 13.9 6.6 15.6 9.8 51.2 44.9 23.8 13.2 22.7 10.2 0.8 24.8 16.1 RNF113A "Cwc24, RNF113, ZNF183" ENSG00000125352 "Ring finger protein 113A" O15541 X 119870475-119871733 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000160, HPA076658" Approved Supported Nucleoplasm NA NA "Cluster 44: Non-specific - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA000160: AB_1079821, HPA076658: AB_2732319" "unprognostic (2.85e-1)" "unprognostic (4.38e-3)" "unprognostic (5.55e-3)" "unprognostic (2.38e-2)" "unprognostic (1.02e-1)" "unprognostic (1.28e-2)" "unprognostic (3.65e-3)" "unprognostic (2.02e-3)" "unprognostic (6.29e-2)" "unprognostic (2.57e-1)" "unprognostic (6.49e-3)" "unprognostic (1.83e-1)" "prognostic unfavorable (7.93e-4)" "unprognostic (7.99e-2)" "unprognostic (3.19e-1)" "unprognostic (3.91e-2)" "prognostic favorable (6.23e-4)" 11.0 9.6 11.5 13.0 12.1 35.3 10.2 13.0 14.4 10.5 11.3 11.4 13.2 9.8 9.6 11.3 10.2 8.2 12.7 11.7 13.9 9.2 17.7 11.0 24.7 12.7 13.0 13.4 19.1 9.2 10.0 9.0 13.1 8.9 9.5 15.6 14.4 8.8 12.3 17.1 17.5 7.5 11.9 24.3 12.1 3.4 13.1 24.7 9.9 10.6 19.0 10.8 10.3 12.6 16.9 22.9 11.0 17.7 20.7 14.9 22.3 14.8 25.0 17.6 21.0 19.7 14.1 28.0 28.1 13.8 25.1 20.4 24.4 19.1 13.1 21.9 18.0 17.0 25.8 23.5 28.3 33.7 28.3 18.4 20.6 17.7 26.0 20.7 17.1 19.4 12.2 38.4 17.3 47.5 23.5 39.9 16.1 29.5 32.8 21.7 23.2 45.3 18.5 20.6 14.7 12.9 23.1 35.5 33.1 12.9 8.7 32.9 13.1 18.6 6.6 26.7 29.7 43.2 36.0 27.9 16.8 44.1 12.3 96.4 59.5 109.5 73.9 60.3 74.4 83.6 78.3 79.0 63.4 88.6 81.3 73.1 27.5 65.9 72.6 53.3 96.6 73.6 11.5 12.1 13.0 14.4 11.7 13.9 12.7 13.0 13.1 11.9 13.1 12.6 14.8 9.6 14.8 2.6 42.8 24.3 17.2 26.6 30.7 11.5 13.6 21.1 8.9 18.6 21.4 14.7 14.6 18.5 51.6 10.8 9.8 18.3 0.5 13.1 18.8 17.4 4.2 10.3 3.0 16.8 37.6 15.2 16.3 16.5 26.5 14.4 18.2 13.1 24.4 13.5 4.1 16.8 14.2 17.6 23.1 1.4 12.2 17.0 26.6 5.6 17.2 16.5 39.1 2.0 6.2 15.5 17.8 9.8 59.6 12.3 34.9 25.1 19.6 17.7 6.6 8.3 19.3 2.9 5.8 20.9 24.4 26.4 50.2 15.9 15.5 14.3 RNF208 DKFZP761H1710 ENSG00000212864 "Ring finger protein 208" Q9H0X6 9 137220247-137221581 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.0" "Cell type enhanced" "Detected in many" "Distal tubular cells: 25.4;Horizontal cells: 16.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "Hep G2: 23.5;MCF7: 55.7;REH: 44.9;RPMI-8226: 25.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021256, HPA021429" Uncertain Enhanced Nucleoplasm NA NA "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA021256: AB_1844331, HPA021429: AB_2180654" "unprognostic (2.97e-1)" "unprognostic (7.37e-2)" "unprognostic (1.46e-2)" "unprognostic (6.33e-3)" "unprognostic (9.99e-2)" "unprognostic (2.10e-3)" "unprognostic (3.52e-3)" "unprognostic (1.50e-1)" "unprognostic (9.51e-2)" "unprognostic (2.95e-2)" "unprognostic (8.42e-3)" "unprognostic (1.60e-1)" "prognostic favorable (1.12e-8)" "unprognostic (3.41e-1)" "unprognostic (1.69e-1)" "unprognostic (7.66e-2)" "unprognostic (3.40e-2)" 6.1 23.1 29.0 0.8 27.1 0.6 6.8 5.0 83.0 8.9 0.0 9.4 1.6 4.9 0.6 32.5 8.1 0.8 42.3 36.9 7.5 15.6 22.6 5.0 0.8 21.1 8.4 5.0 9.0 5.6 19.8 0.5 20.0 14.2 0.4 2.6 13.1 4.1 15.4 15.3 5.1 0.6 2.2 5.2 10.0 5.8 19.8 0.4 14.4 3.7 0.9 7.8 13.4 36.9 1.5 2.8 1.9 3.3 1.3 0.3 5.8 0.8 1.1 1.4 1.2 8.3 5.2 0.7 4.1 0.9 0.3 4.4 4.6 0.2 0.3 2.1 1.7 5.9 10.1 23.5 4.2 1.2 2.0 1.0 1.5 1.3 0.6 5.1 1.4 8.4 8.3 0.4 0.5 55.7 3.0 2.8 2.4 5.5 6.1 44.9 0.4 25.1 1.4 0.2 5.4 19.0 0.6 1.7 1.2 1.0 19.5 4.3 0.6 0.9 1.2 2.0 0.1 0.7 0.8 0.3 2.6 0.4 1.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 29.0 27.1 5.0 83.0 36.9 7.5 21.1 8.4 20.0 2.2 19.8 36.9 1.9 6.4 2.2 2.9 1.2 0.4 1.0 2.0 0.6 9.3 7.7 5.8 9.3 4.3 1.7 7.3 12.5 0.3 0.4 5.5 25.4 5.3 0.6 4.4 1.2 1.4 7.8 0.4 13.1 2.2 0.2 1.4 1.5 5.9 0.0 13.0 1.4 9.1 1.3 16.8 13.4 4.4 0.0 0.6 0.8 1.1 1.2 1.8 1.8 5.6 1.6 8.7 0.0 1.5 2.9 3.6 5.1 3.4 0.3 1.9 4.4 9.4 3.9 5.6 0.0 2.5 1.8 1.5 2.4 2.7 1.8 0.3 0.5 2.7 3.8 1.6 RNF223 ENSG00000237330 "Ring finger protein 223" E7ERA6 1 1070967-1074306 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix: 10.6;esophagus: 26.2;vagina: 13.0" "Cell type enhanced" "Detected in many" "Breast glandular cells: 29.1;Endometrial ciliated cells: 30.9;Extravillous trophoblasts: 19.3;Gastric mucus-secreting cells: 38.2;Glandular and luminal cells: 32.1;Urothelial cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 15.4;CAPAN-2: 11.1;HaCaT: 7.0;MCF7: 24.4;OE19: 7.0;SK-BR-3: 16.0;T-47d: 10.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 84: Esophagus - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 35: Glandular cells - Unknown function" "unprognostic (4.71e-1)" "unprognostic (2.79e-1)" "unprognostic (1.06e-1)" "prognostic favorable (8.08e-5)" "unprognostic (3.50e-1)" "unprognostic (6.50e-2)" "unprognostic (1.43e-3)" "unprognostic (3.91e-1)" "unprognostic (5.09e-2)" "prognostic unfavorable (6.53e-4)" "unprognostic (1.16e-1)" "unprognostic (4.06e-3)" "unprognostic (1.50e-1)" "unprognostic (1.16e-1)" "unprognostic (4.58e-1)" "unprognostic (9.52e-3)" 0.0 0.0 0.3 0.0 0.4 0.2 0.4 1.2 0.5 10.6 0.0 1.1 0.1 0.3 0.0 26.2 0.0 0.0 0.0 0.1 0.3 0.9 0.0 0.4 0.0 0.8 0.3 0.0 0.1 0.0 0.0 0.6 1.0 0.4 0.3 0.2 4.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 3.8 0.1 0.3 0.0 0.0 0.0 0.9 3.4 13.0 0.6 15.4 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.5 11.1 0.0 0.1 0.0 0.1 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 24.4 0.0 0.1 0.0 7.0 0.3 0.0 0.0 0.4 0.0 1.4 0.0 0.0 0.2 16.0 0.3 0.1 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 1.2 0.5 0.1 0.3 0.8 0.3 1.0 0.0 0.3 0.6 0.1 9.6 0.0 0.0 0.1 0.5 8.8 1.3 0.0 0.0 29.1 10.8 0.6 0.0 2.3 1.8 0.0 0.8 0.4 15.6 0.0 7.3 0.0 30.9 3.0 0.5 0.0 0.0 0.0 3.1 19.3 0.3 38.2 32.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 9.7 2.0 0.0 0.0 0.0 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 15.6 8.1 0.0 0.0 7.0 0.9 0.1 3.8 0.0 0.0 0.2 0.5 0.0 0.0 11.7 1.4 5.1 0.3 0.0 5.2 32.8 RNF224 ENSG00000233198 "Ring finger protein 224" P0DH78 9 137227502-137229640 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "esophagus: 3.4;pituitary gland: 5.8" "Cell type enhanced" "Detected in single" "Proximal tubular cells: 2.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 5.5;HeLa: 4.3;MCF7: 9.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA079078 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Golgi apparatus" "HPA079078: " "unprognostic (2.45e-1)" "unprognostic (2.34e-3)" "unprognostic (7.01e-4)" "unprognostic (6.04e-2)" "unprognostic (5.26e-2)" "unprognostic (1.70e-3)" "unprognostic (3.87e-2)" "unprognostic (1.78e-1)" "unprognostic (5.82e-3)" "unprognostic (4.57e-2)" "unprognostic (5.24e-2)" "unprognostic (9.56e-2)" "unprognostic (3.50e-1)" "unprognostic (4.95e-2)" "unprognostic (1.27e-1)" "unprognostic (2.41e-1)" "unprognostic (1.21e-1)" 0.2 0.2 0.0 0.0 0.1 0.2 0.3 0.0 0.2 0.5 0.0 0.3 0.3 0.2 0.0 3.4 1.4 0.3 0.5 0.1 0.1 2.1 0.0 0.8 0.1 0.8 1.2 0.1 0.8 0.0 5.8 0.0 0.3 1.0 0.0 0.2 1.4 0.0 0.1 0.6 0.5 0.0 0.5 0.2 0.6 1.2 0.5 0.0 0.9 0.0 0.1 0.4 0.9 0.2 0.6 1.0 0.4 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.4 5.5 0.1 0.2 0.0 0.3 2.7 0.0 0.1 0.0 1.8 0.2 0.0 4.3 0.6 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.4 0.0 0.1 0.2 0.4 0.0 9.8 0.1 0.0 0.4 0.7 1.3 0.6 0.2 0.1 0.1 0.6 0.0 1.1 0.5 2.0 0.0 0.7 1.9 0.2 0.2 0.2 0.1 1.1 0.0 0.6 0.2 0.1 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.1 0.8 1.2 0.3 0.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.3 0.9 2.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 RNH1 "RAI, RNH" ENSG00000023191 "Ribonuclease/angiogenin inhibitor 1" P13489 11 494512-507300 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 262.3;monocytes: 299.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039223, HPA040781" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 22000000 "Cluster 7: Monocytes - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Nucleoplasm, Cytosol" "HPA039223: AB_10795581, HPA040781: AB_10796227" "unprognostic (1.87e-1)" "unprognostic (2.44e-1)" "unprognostic (1.38e-1)" "unprognostic (1.59e-3)" "unprognostic (2.48e-3)" "unprognostic (6.09e-2)" "unprognostic (4.82e-3)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (2.20e-1)" "unprognostic (1.55e-1)" "unprognostic (2.44e-1)" "prognostic favorable (2.14e-5)" "unprognostic (3.35e-1)" "unprognostic (1.66e-1)" "unprognostic (4.78e-2)" "unprognostic (4.35e-2)" 163.5 137.2 27.3 29.0 41.8 46.3 133.7 42.4 33.9 156.4 28.9 123.0 27.1 140.8 10.0 215.0 119.5 29.7 198.0 26.3 32.5 118.6 111.9 146.7 30.8 48.6 39.7 119.1 89.5 25.6 80.6 27.3 38.2 100.9 8.8 5.6 112.5 31.0 145.9 257.4 91.1 25.3 35.3 113.3 101.1 90.1 38.3 15.6 106.6 21.8 13.9 144.5 160.3 49.4 86.5 123.9 13.2 39.8 66.3 93.8 43.9 70.6 51.3 68.9 58.3 61.9 92.9 41.8 54.3 175.1 41.9 72.7 20.6 76.5 10.4 51.3 104.9 28.2 28.5 65.7 243.3 39.8 90.0 77.1 108.2 40.2 46.7 29.2 47.9 27.7 36.2 71.3 37.7 86.6 30.5 78.4 19.8 45.3 112.6 37.7 22.3 55.8 40.7 34.6 35.7 23.2 41.8 59.1 73.7 7.4 44.6 122.2 77.3 109.3 32.8 39.8 49.5 44.9 53.0 32.2 117.5 81.9 74.3 37.6 246.2 57.3 51.1 298.9 59.9 63.0 55.3 51.1 262.3 48.4 49.8 45.1 17.1 54.2 299.1 71.7 58.4 236.5 27.3 41.8 42.4 33.9 26.3 32.5 48.6 39.7 38.2 35.3 38.3 49.4 156.0 112.2 83.5 18.9 92.3 202.1 239.0 265.0 89.4 102.4 82.0 105.5 83.3 88.6 138.6 79.1 110.5 222.2 85.3 126.6 225.0 188.8 105.1 72.8 132.4 136.1 57.4 59.7 10.9 164.4 217.4 194.9 64.2 82.8 140.2 93.8 101.7 68.6 374.0 168.2 14.5 115.6 148.5 191.8 323.0 42.7 211.6 230.3 193.9 12.2 334.2 144.6 79.3 10.1 70.8 171.6 120.5 179.8 101.7 161.0 139.4 242.3 97.9 146.4 177.5 99.1 178.0 153.4 157.8 140.0 260.0 305.5 96.5 199.7 114.4 217.4 RNLS "C10orf59, FLJ11218, renalase" ENSG00000184719 "Renalase, FAD dependent amine oxidase" Q5VYX0 10 88273864-88584530 "Enzymes, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 103.0;Inhibitory neurons: 101.1;Oligodendrocyte precursor cells: 51.8;Oligodendrocytes: 61.8;Proximal tubular cells: 43.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 18.3;fHDF/TERT166: 17.1;HSkMC: 19.5" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 10500000000 "Cluster 7: Monocytes - Unknown function" "Cluster 1: Thyroid gland - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "unprognostic (3.27e-2)" "unprognostic (9.16e-2)" "unprognostic (1.27e-1)" "unprognostic (2.58e-1)" "unprognostic (1.46e-3)" "unprognostic (1.99e-1)" "unprognostic (2.01e-1)" "unprognostic (2.29e-1)" "unprognostic (1.32e-1)" "unprognostic (1.59e-1)" "unprognostic (3.98e-1)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "unprognostic (7.74e-3)" "unprognostic (1.37e-2)" "unprognostic (9.80e-2)" "unprognostic (1.71e-1)" 7.1 13.4 2.0 2.8 2.4 2.2 6.7 6.1 3.5 7.4 7.2 7.6 5.5 5.0 5.3 4.9 6.1 5.5 11.8 2.0 2.9 16.6 8.7 3.0 3.8 5.0 6.6 5.8 8.2 9.0 5.3 2.0 5.2 7.0 8.3 4.8 6.0 3.9 11.8 4.3 5.6 3.5 3.4 2.8 6.7 5.3 2.7 2.5 9.1 9.8 4.0 4.7 4.4 3.2 18.3 8.2 0.3 0.1 2.4 2.8 0.0 5.1 0.5 2.7 2.3 1.0 5.2 0.0 8.0 17.1 0.0 2.4 0.0 0.9 2.2 3.8 0.1 2.9 5.1 0.2 11.2 0.0 0.5 19.5 1.4 10.2 0.1 0.3 5.7 0.1 1.4 9.2 0.1 6.3 0.0 3.5 0.0 0.0 0.0 2.1 0.0 0.0 0.0 1.1 4.3 0.1 0.1 4.0 12.4 4.9 2.2 8.9 1.3 2.5 4.1 6.3 3.9 5.3 8.4 0.2 0.0 9.8 0.0 0.0 2.1 1.2 2.3 3.6 1.7 2.4 1.7 1.6 3.1 2.2 1.8 1.4 0.1 2.7 2.3 2.7 0.9 1.8 2.0 2.4 6.1 3.5 2.0 2.9 5.0 6.6 5.2 3.4 2.7 3.2 1.2 3.2 1.5 32.0 5.5 3.2 6.8 5.7 4.0 6.5 5.5 3.9 16.7 4.3 5.8 1.8 2.1 2.0 3.2 6.2 23.5 6.4 8.9 3.8 3.1 1.3 5.4 4.6 103.0 9.6 0.5 6.2 7.1 3.2 1.3 2.2 2.5 10.1 6.5 5.0 101.1 5.5 2.0 4.7 3.8 4.3 1.5 3.8 3.6 40.3 3.7 6.8 3.1 51.8 61.8 4.2 8.9 6.4 3.9 4.4 8.5 43.1 1.6 5.7 0.0 4.6 4.6 4.7 8.2 10.4 5.5 1.6 3.0 2.9 7.2 6.9 RPH3AL Noc2 ENSG00000181031 "Rabphilin 3A like (without C2 domains)" Q9UNE2 17 212389-386254 "Predicted intracellular proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 52.5;pituitary gland: 44.4" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 35.2;Hepatocytes: 43.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 22.1;PC-3: 7.2;TIME: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA024311 Approved NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 15: Hepatocytes - Hemostasis" "HPA024311: AB_1856429" "unprognostic (4.55e-2)" "unprognostic (1.66e-1)" "unprognostic (3.85e-2)" "unprognostic (9.43e-3)" "unprognostic (8.40e-2)" "unprognostic (1.39e-1)" "unprognostic (2.54e-1)" "unprognostic (1.14e-1)" "unprognostic (6.71e-2)" "unprognostic (1.02e-1)" "unprognostic (2.24e-3)" "unprognostic (1.33e-2)" "prognostic favorable (1.03e-8)" "unprognostic (9.10e-2)" "unprognostic (1.63e-2)" "unprognostic (4.14e-1)" "unprognostic (3.59e-3)" 10.0 18.5 1.3 1.0 1.4 0.3 9.5 3.6 1.7 4.8 1.5 6.9 5.2 3.0 4.6 8.1 3.9 2.8 6.2 1.2 2.3 13.5 24.2 9.5 1.2 4.5 2.2 10.8 52.5 1.6 44.4 2.5 4.5 5.5 2.6 2.0 3.4 2.2 8.3 5.0 6.5 1.0 1.4 17.7 9.1 2.8 2.1 1.4 12.0 1.5 1.5 5.3 6.0 1.9 0.3 22.1 0.3 0.1 0.2 0.1 1.8 0.0 0.0 0.0 0.1 3.0 3.8 0.4 3.1 2.2 1.4 0.3 0.8 0.2 0.0 0.9 1.4 0.0 1.8 5.2 0.6 0.2 2.2 0.0 0.1 0.0 0.0 0.7 0.9 2.3 1.5 4.5 1.3 5.4 0.3 0.1 1.2 2.6 7.2 0.4 0.2 4.0 4.0 4.9 0.3 0.7 0.3 0.1 0.3 1.3 2.0 2.1 7.2 0.3 2.9 0.5 0.6 0.7 0.2 0.2 0.3 3.0 0.0 0.3 0.7 1.5 0.8 2.2 0.3 0.6 0.4 0.6 1.1 0.6 0.7 0.4 1.6 0.3 1.8 2.8 0.3 0.3 1.3 1.4 3.6 1.7 1.2 2.3 4.5 2.2 4.5 1.4 2.1 1.9 21.8 22.4 17.0 1.3 2.0 2.4 13.4 9.7 5.2 1.5 8.8 6.5 2.3 17.2 5.2 22.0 0.0 0.2 7.8 13.2 5.9 10.3 3.6 7.7 7.8 15.9 35.2 2.7 4.6 8.7 0.3 3.4 23.4 4.9 7.0 14.3 28.2 43.3 11.6 11.8 6.2 14.2 12.2 7.0 2.9 4.0 5.3 2.9 3.6 12.2 2.0 26.4 3.1 6.0 1.3 7.7 12.9 1.9 0.9 3.9 9.3 5.9 2.1 1.9 6.6 6.1 3.4 3.4 1.8 6.9 3.1 0.4 1.7 7.6 10.8 9.4 RPL13 "BBC1, D16S444E, L13" ENSG00000167526 "Ribosomal protein L13" P26373 16 89560677-89564542 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051702 Approved Enhanced "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 190000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA051702: AB_2681579" "unprognostic (5.41e-3)" "unprognostic (1.69e-1)" "unprognostic (1.14e-2)" "prognostic favorable (6.26e-4)" "unprognostic (1.57e-2)" "unprognostic (3.68e-2)" "unprognostic (7.38e-2)" "unprognostic (2.37e-1)" "unprognostic (2.70e-1)" "unprognostic (1.44e-2)" "unprognostic (2.14e-1)" "unprognostic (7.57e-2)" "prognostic unfavorable (6.64e-4)" "unprognostic (4.34e-2)" "unprognostic (7.10e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" 2508.9 1855.2 1068.8 1015.2 1070.1 2207.4 2514.6 1007.8 1300.0 2885.7 1027.9 2382.3 1082.7 1830.7 799.8 2804.1 2342.7 756.7 1661.7 984.6 1007.1 1722.4 2142.4 1560.6 2106.2 1129.1 1023.0 5001.9 4316.1 896.0 1581.0 636.9 1076.3 2852.9 719.0 215.3 2413.8 826.7 2404.7 4466.0 2067.4 689.9 1159.2 2545.7 2148.6 856.8 1078.9 1718.3 1609.7 1175.1 1635.1 2301.1 2682.5 1123.0 1402.1 1524.2 1063.0 1733.2 1869.8 3083.4 2218.9 863.7 1857.6 1768.8 712.9 2316.0 2113.8 1954.1 1729.3 1484.1 700.0 1903.0 1279.4 2281.5 873.2 551.7 3534.0 666.7 817.4 3149.0 3985.0 818.9 781.2 3770.4 4759.6 1136.6 2847.0 2870.3 1870.2 2424.6 2074.1 1084.5 1380.2 4385.7 2272.4 6404.2 2180.5 2755.6 1601.9 3323.5 1128.8 2786.0 2205.4 1162.1 1491.3 2176.3 1195.0 1544.6 2735.2 665.7 3044.3 4780.1 1101.8 1132.3 1218.4 1008.8 1211.3 1626.1 1668.7 2104.6 1479.4 2863.7 1220.5 1017.1 3191.4 507.1 3779.3 2446.7 7007.7 7792.3 6813.4 5173.6 3626.5 8215.0 8509.1 6722.0 323.4 4085.8 1910.1 5071.9 5277.8 13749.1 1068.8 1070.1 1007.8 1300.0 984.6 1007.1 1129.1 1023.0 1076.3 1159.2 1078.9 1123.0 3260.3 1804.5 3489.0 39.8 9318.5 12528.7 15921.0 7329.9 8523.7 675.1 10709.1 13191.6 465.3 3808.9 4064.9 1616.6 189.7 6201.2 5935.5 1800.0 4652.6 4068.5 4125.7 2011.7 5627.8 4627.9 2937.8 3784.5 39.1 10909.9 11178.8 4536.6 2934.8 2679.4 2651.1 6392.0 5119.5 4261.1 5228.5 249.0 52.5 6292.1 2089.4 7058.1 8832.3 12884.5 8244.9 5051.4 5457.0 66.5 7569.8 1941.5 5395.5 158.3 86.4 7077.2 4715.7 3652.3 4667.7 14016.4 5245.4 7448.2 1834.7 786.9 2084.0 5936.3 5693.8 1721.1 1052.9 9022.1 16171.5 6165.5 7831.2 7839.7 7465.8 15137.1 RPL26L1 RPL26P1 ENSG00000037241 "Ribosomal protein L26 like 1" Q9UNX3 5 172958729-172969771 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 408.0;Spermatocytes: 316.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030449 Approved Approved "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Endoplasmic reticulum, Cytosol" Nucleoli "HPA030449: AB_10602125" "unprognostic (3.02e-1)" "unprognostic (1.41e-1)" "unprognostic (3.39e-2)" "unprognostic (4.12e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (2.04e-3)" "unprognostic (2.45e-1)" "unprognostic (7.51e-2)" "unprognostic (5.86e-3)" "unprognostic (3.18e-1)" "unprognostic (1.06e-1)" "unprognostic (7.17e-2)" "unprognostic (2.55e-1)" "unprognostic (1.90e-1)" "unprognostic (1.14e-1)" "unprognostic (2.14e-3)" 27.4 45.8 28.0 28.9 29.2 39.1 27.3 29.7 39.1 23.5 26.4 24.5 25.2 28.5 37.7 37.5 26.6 22.1 37.8 31.0 29.8 43.7 47.9 22.1 34.4 29.3 28.9 25.7 24.9 34.5 30.3 23.8 30.6 25.5 26.2 17.9 24.6 28.9 37.8 21.3 21.9 26.0 28.1 26.8 26.2 91.2 29.3 34.0 29.5 28.1 29.0 30.4 25.4 29.1 129.8 114.7 101.9 140.8 68.9 72.3 131.7 120.6 70.6 170.5 151.1 141.1 135.3 96.6 301.5 166.6 181.6 82.1 170.1 239.8 156.4 124.1 220.9 71.6 122.8 174.5 135.1 105.7 60.8 91.0 99.2 176.1 122.3 69.1 99.2 93.6 100.3 79.0 123.1 286.6 129.5 165.6 65.2 59.7 180.5 93.3 157.5 128.4 101.0 80.1 102.0 62.7 110.6 100.2 167.6 64.7 122.8 111.5 105.4 193.2 109.0 114.3 92.5 70.3 119.0 182.3 152.6 130.2 117.6 25.4 86.6 39.9 33.1 80.5 42.7 50.4 40.4 46.1 99.5 38.1 32.9 42.0 42.9 39.5 72.2 68.1 55.8 55.7 28.0 29.2 29.7 39.1 31.0 29.8 29.3 28.9 30.6 28.1 29.3 29.1 41.5 41.7 32.8 4.6 29.8 48.8 56.9 191.3 32.5 18.8 50.2 61.8 45.5 41.5 82.7 58.8 18.8 111.6 28.7 36.2 181.9 119.0 408.0 98.4 70.0 47.7 40.2 49.2 4.5 113.0 124.5 45.3 29.6 70.6 26.6 60.2 41.4 132.1 115.0 15.2 5.2 48.6 93.6 48.6 51.9 79.9 37.9 45.6 51.6 2.8 93.5 61.7 49.4 2.0 5.0 138.0 38.6 41.0 59.2 67.9 48.2 216.2 92.4 20.2 19.7 35.6 56.1 316.7 178.6 70.5 52.8 78.9 28.9 81.1 59.1 57.7 RPL35 L35 ENSG00000136942 "Ribosomal protein L35" P42766 9 124857880-124861981 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Diamond-Blackfan anemia, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006047 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA006047: AB_1856443" "unprognostic (1.16e-2)" "unprognostic (5.42e-3)" "unprognostic (3.04e-2)" "unprognostic (3.69e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" "unprognostic (2.67e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" "unprognostic (1.79e-1)" "unprognostic (1.45e-1)" "unprognostic (1.37e-3)" "unprognostic (6.58e-2)" "unprognostic (2.74e-2)" "unprognostic (1.47e-1)" "unprognostic (2.31e-2)" 1898.8 1508.6 1462.7 973.8 1489.9 2729.0 1959.9 1434.2 1780.8 2116.4 1400.9 1768.2 809.5 1343.7 793.9 2540.7 1694.2 839.0 1467.3 1421.2 1502.6 1380.8 1746.4 1271.3 1990.2 1480.9 1456.2 3011.1 3413.2 853.0 1225.5 743.7 1484.9 1709.2 708.6 273.8 1811.1 736.6 2552.7 3033.7 1383.2 717.4 1498.9 1708.9 1567.2 669.4 1507.0 1569.3 1349.1 1589.5 1380.7 1655.0 2080.7 1516.5 2104.6 3225.4 1780.5 2469.8 1923.1 4033.9 2443.2 1626.3 2589.3 3295.8 2235.0 5370.0 2030.1 3127.8 1631.9 1836.1 1970.9 3986.3 2097.6 3578.7 1209.0 1929.9 3742.5 1266.5 4071.9 3541.9 3433.2 2856.0 1626.0 3759.1 5481.9 1973.9 3480.3 1809.7 2473.6 2927.1 2775.1 3857.2 2523.6 6848.9 3384.5 6510.7 3362.5 6272.1 4016.6 2849.6 2744.6 7026.2 2896.8 2469.0 2412.8 1946.7 1466.3 3452.9 3423.3 876.8 3508.4 4592.6 1269.5 1472.5 1558.9 2578.9 3357.6 2151.5 5523.9 4935.8 2059.7 2982.8 2523.1 753.7 1769.0 695.2 2322.2 1602.3 3101.1 4455.5 3086.5 2676.2 2564.2 4099.1 3218.0 2834.7 221.1 2414.5 1352.2 3650.6 2715.7 7293.7 1462.7 1489.9 1434.2 1780.8 1421.2 1502.6 1480.9 1456.2 1484.9 1498.9 1507.0 1516.5 1202.7 637.8 1152.6 15.3 3024.6 5507.5 4326.2 3639.5 1752.9 221.3 4389.9 4459.0 750.7 1732.9 1653.3 1134.8 85.5 2799.3 2227.9 1319.7 2701.9 2347.8 1562.9 826.5 1969.5 1751.1 1298.1 2073.6 9.0 6137.7 4495.9 1544.5 976.6 1135.5 1308.1 2164.6 2362.3 3182.4 2826.7 109.4 9.7 3044.7 1249.2 3375.2 4877.3 6025.8 2777.4 1833.7 2821.1 11.2 3348.5 925.7 2482.0 9.5 16.2 3542.4 2346.8 1285.2 1756.4 4196.5 2319.0 3772.0 618.9 410.0 992.7 2309.7 3771.2 790.9 905.5 3017.8 7263.3 2464.8 2473.5 1760.1 3346.1 3998.4 RPL36A "L36A, RPL44" ENSG00000241343 "Ribosomal protein L36a" P83881 X 101390824-101396155 "Metabolic proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 3019.1;Undifferentiated cells: 3021.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 2852.7" "Low region specificity" "Detected in all" "HPA063979, HPA077586" Uncertain Supported "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "Plasma membrane" "HPA063979: AB_2685164, HPA077586: AB_2686846" "unprognostic (3.38e-2)" "unprognostic (2.11e-2)" "unprognostic (7.04e-2)" "unprognostic (2.06e-1)" "unprognostic (1.02e-2)" "unprognostic (4.19e-3)" "unprognostic (4.15e-3)" "unprognostic (1.28e-1)" "unprognostic (2.86e-2)" "unprognostic (2.77e-1)" "unprognostic (2.19e-2)" "unprognostic (8.17e-2)" "prognostic unfavorable (8.81e-11)" "unprognostic (1.87e-2)" "unprognostic (4.50e-3)" "unprognostic (3.57e-3)" "unprognostic (4.06e-2)" 1674.1 1002.0 390.2 179.6 390.9 502.0 1779.0 387.0 608.7 1862.0 390.9 1384.5 163.9 1291.5 278.5 1823.7 1542.2 94.6 878.4 384.9 392.9 1127.4 829.5 1066.3 304.6 398.8 389.8 3553.5 2580.0 160.2 799.7 230.4 393.6 1347.0 290.4 94.6 1304.2 219.6 1546.0 2491.5 1369.6 209.8 398.2 1575.2 1319.0 266.3 391.9 430.4 981.5 224.1 502.0 1430.5 1751.0 405.9 508.3 1045.1 465.5 237.5 640.1 1232.0 273.6 198.9 532.7 642.1 1017.6 1196.0 360.1 571.6 367.5 318.1 399.5 350.5 727.8 641.2 651.0 309.1 1445.2 205.8 1919.5 1159.3 803.0 413.1 364.3 985.5 1395.8 436.6 895.6 931.0 576.9 563.1 486.8 660.7 546.2 2852.7 288.5 1285.4 583.8 1637.7 1118.7 367.7 384.8 863.5 633.5 811.3 314.8 508.8 116.8 506.3 608.3 459.4 238.4 806.3 187.0 206.4 369.8 477.2 350.9 330.0 475.0 470.0 223.6 749.5 240.3 130.7 562.7 109.4 608.3 591.8 1102.4 1242.0 1212.6 866.9 814.7 957.9 1322.5 1179.8 51.0 760.6 615.8 919.8 678.7 1804.2 390.2 390.9 387.0 608.7 384.9 392.9 398.8 389.8 393.6 398.2 391.9 405.9 309.5 439.1 987.0 0.0 1100.1 917.4 432.3 574.6 595.8 28.9 1600.3 970.8 16.1 885.0 946.8 174.7 14.6 762.3 615.9 641.2 434.3 1235.1 9.4 124.9 331.6 566.0 1100.8 1215.5 0.0 3019.1 1125.2 523.5 315.0 164.3 1272.4 137.9 1387.8 738.4 609.1 15.2 0.0 2744.0 183.1 2089.7 1144.3 49.3 1055.9 565.6 524.7 0.0 1620.0 187.9 710.6 0.0 0.0 2338.4 1805.5 418.6 559.4 350.6 1349.6 611.7 329.9 41.2 236.7 512.1 467.7 28.7 99.3 758.7 1122.1 751.4 875.8 153.1 3021.8 351.4 RPL8 L8 ENSG00000161016 "Ribosomal protein L8" P62917 8 144789765-144792587 "Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 6599.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045095, HPA050165" Enhanced Supported "Nucleoli,Endoplasmic reticulum,Cytosol" NA NA 170000000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Nucleoli, Endoplasmic reticulum, Cytosol" "HPA045095: AB_2679213, HPA050165: AB_2681038" "unprognostic (2.52e-2)" "unprognostic (2.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.04e-2)" "unprognostic (1.67e-1)" "unprognostic (9.84e-2)" "prognostic unfavorable (7.22e-4)" "unprognostic (4.48e-2)" "unprognostic (1.41e-1)" "unprognostic (1.54e-1)" "unprognostic (9.28e-2)" "unprognostic (1.92e-1)" "unprognostic (1.19e-3)" "unprognostic (1.79e-2)" "unprognostic (1.77e-1)" "unprognostic (2.31e-1)" "unprognostic (4.13e-2)" 1100.4 864.4 197.2 397.5 201.1 1020.7 1162.7 197.3 361.6 1387.5 199.5 1138.7 688.7 1042.4 63.7 1406.6 1118.6 146.4 962.6 174.2 193.7 889.8 709.6 796.1 424.5 214.1 195.2 2192.7 2021.1 150.3 784.2 264.4 199.9 974.9 110.0 22.9 1320.1 201.8 1651.4 1800.7 885.7 115.6 222.7 918.6 1003.5 304.7 218.2 150.0 739.9 194.0 196.4 1099.7 1240.2 218.1 2486.1 2860.3 200.1 874.6 220.0 496.0 1913.2 1747.7 325.3 522.4 369.7 2518.8 1299.5 3296.6 2461.9 208.4 174.3 1470.7 263.8 609.1 95.7 1446.1 3218.7 1962.1 2166.5 1805.2 546.9 1299.9 1027.5 537.1 680.7 235.9 400.8 246.5 387.8 703.1 2695.3 742.2 226.0 6599.2 1862.9 1754.6 1865.3 674.7 3196.8 1806.5 1154.4 3160.7 280.1 1842.0 1215.9 2028.4 1677.7 899.2 2541.5 81.0 2093.2 1233.3 1573.7 689.8 2622.6 1454.9 2127.3 1344.2 1235.8 2856.3 1372.4 2117.5 968.7 534.8 1464.1 574.8 1160.0 1504.9 1934.6 2970.9 1937.9 1430.4 2051.1 2991.2 2181.6 1718.2 166.1 1469.4 1479.6 1129.7 2070.5 5473.9 197.2 201.1 197.3 361.6 174.2 193.7 214.1 195.2 199.9 222.7 218.2 218.1 2510.5 852.5 1309.5 28.7 4225.5 6439.6 7085.5 5724.6 4563.8 424.0 6122.9 9469.1 1049.0 1988.8 2513.8 1028.1 268.9 4313.8 1790.8 1780.8 4433.5 2429.1 891.2 1083.4 2465.0 2455.7 1698.3 2407.7 24.0 5851.2 6733.6 2161.3 1804.3 1452.8 1044.4 2390.5 2116.1 1309.7 3031.0 166.5 28.5 3563.5 1698.8 2811.4 5097.7 2782.3 3122.7 2281.9 3520.0 30.9 2951.5 1300.3 1607.7 16.1 32.8 3402.4 3311.1 1432.3 3168.7 6500.7 3930.7 4195.9 961.7 689.1 1078.1 2701.0 3865.8 591.8 583.4 5817.5 8224.4 4365.8 2704.6 3472.7 4291.2 7522.7 RPP25L "bA296L22.5, C9orf23, MGC29635" ENSG00000164967 "Ribonuclease P/MRP subunit p25 like" Q8N5L8 9 34610486-34612104 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 118.4" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 132.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052187, HPA059698" Uncertain Supported Nucleoplasm NA NA "Cluster 24: B-cells - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "HPA052187: AB_2681755, HPA059698: AB_2684106" "unprognostic (1.56e-1)" "unprognostic (1.43e-2)" "unprognostic (7.44e-2)" "unprognostic (1.38e-1)" "unprognostic (1.98e-1)" "unprognostic (1.78e-1)" "unprognostic (4.78e-2)" "unprognostic (2.56e-1)" "unprognostic (1.66e-1)" "unprognostic (2.53e-2)" "unprognostic (3.39e-2)" "unprognostic (2.44e-1)" "prognostic favorable (3.01e-9)" "unprognostic (4.63e-3)" "unprognostic (6.20e-2)" "unprognostic (3.40e-1)" "prognostic favorable (8.21e-4)" 17.2 23.2 30.5 13.8 31.7 9.7 18.3 32.7 36.2 20.6 28.4 26.4 27.5 19.9 12.5 28.2 20.1 14.5 46.8 30.5 31.5 30.6 51.4 11.8 20.7 31.9 30.6 19.5 23.0 24.0 17.4 12.2 32.3 24.5 14.4 4.8 23.1 15.1 118.4 17.5 26.4 10.5 30.8 26.5 21.9 16.0 33.0 22.5 18.5 103.1 13.9 20.5 18.5 30.2 42.6 54.0 21.9 21.4 21.4 20.2 21.5 18.1 18.5 28.9 33.1 24.3 28.2 32.8 27.1 11.0 13.5 28.1 33.2 44.2 10.4 66.1 44.5 19.5 37.9 36.2 46.1 20.5 28.3 35.2 42.4 24.3 55.3 25.1 30.8 44.5 31.6 34.1 22.7 45.8 42.9 76.4 20.1 43.4 48.7 37.2 23.0 33.2 31.9 22.1 14.6 8.5 32.9 36.6 21.6 10.8 33.6 35.7 14.5 9.1 26.3 22.3 15.1 16.4 30.8 38.6 27.6 41.3 44.7 71.2 55.6 56.4 38.2 48.5 47.3 57.1 44.5 40.3 47.8 67.3 51.8 49.8 51.9 56.6 57.5 39.3 68.4 39.6 30.5 31.7 32.7 36.2 30.5 31.5 31.9 30.6 32.3 30.8 33.0 30.2 12.9 0.0 15.1 6.5 20.7 11.1 50.4 61.9 24.5 7.8 30.9 39.9 34.4 22.8 30.5 20.2 2.1 61.8 14.4 55.7 99.7 31.0 3.3 10.3 21.5 17.5 33.6 12.6 3.0 19.8 38.1 18.4 17.9 13.7 10.2 16.4 27.1 77.5 32.0 0.0 3.9 44.7 38.7 33.6 10.4 6.0 22.4 18.4 12.4 3.7 33.1 25.6 51.5 2.0 3.4 18.9 61.6 15.4 14.7 40.8 132.7 82.2 21.0 12.3 6.6 18.2 18.8 50.3 24.0 30.6 14.8 41.9 17.4 47.7 50.1 44.4 RPRM "FLJ90327, REPRIMO" ENSG00000177519 "Reprimo, TP53 dependent G2 arrest mediator homolog" Q9NS64 2 153477338-153478762 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 13.7;Endometrial stromal cells: 63.3;Fibroblasts: 16.3;Sertoli cells: 13.1;Theca cells: 50.4" "Cancer enriched" "Detected in many" 4 "testis cancer: 28.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HEK 293: 25.9;MCF7: 29.8;NTERA-2: 20.5;SCLC-21H: 7.5;SH-SY5Y: 8.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 36: Stromal cells - Cell proliferation" "unprognostic (6.66e-2)" "unprognostic (2.69e-1)" "unprognostic (1.08e-1)" "unprognostic (1.72e-2)" "unprognostic (2.48e-2)" "unprognostic (1.11e-1)" "unprognostic (1.62e-2)" "unprognostic (5.19e-1)" "unprognostic (5.51e-2)" "unprognostic (3.09e-3)" "unprognostic (2.58e-1)" "unprognostic (6.19e-2)" "unprognostic (6.38e-4)" "unprognostic (5.21e-2)" "unprognostic (1.25e-2)" "unprognostic (8.61e-2)" 5.6 16.2 12.2 0.1 8.1 0.0 0.4 2.4 8.0 25.9 11.6 18.0 0.1 22.9 2.0 0.5 3.9 0.0 0.3 6.1 22.9 2.7 0.0 0.7 0.0 9.9 7.5 17.9 0.0 1.0 19.6 0.1 6.7 12.7 0.4 1.3 11.2 6.4 0.2 1.1 0.6 12.2 5.6 2.0 9.3 1.1 9.5 0.1 1.2 0.2 0.0 3.1 3.2 6.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.0 25.9 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 29.8 0.0 0.0 20.5 0.0 1.1 0.0 0.0 0.1 0.0 0.2 7.5 8.5 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 12.2 8.1 2.4 8.0 6.1 22.9 9.9 7.5 6.7 5.6 9.5 6.4 0.9 3.2 0.0 0.0 0.0 0.1 0.8 1.3 1.2 7.8 0.8 2.2 0.5 2.8 1.6 1.8 0.0 0.3 0.0 0.0 13.7 0.0 0.5 2.2 63.3 0.9 1.8 0.0 3.2 1.7 0.4 16.3 1.1 1.0 0.0 2.9 0.0 0.0 0.6 0.0 3.1 0.0 10.2 0.0 0.3 0.8 0.9 0.5 0.0 1.0 0.0 0.8 0.0 3.0 0.3 0.4 0.0 0.7 0.0 1.6 0.0 0.5 1.1 1.8 13.1 0.7 4.0 0.6 5.2 2.2 0.3 0.8 0.3 50.4 0.0 1.4 RPS2 "LLREP3, S2" ENSG00000140988 "Ribosomal protein S2" P15880 16 1962058-1964841 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055133 Approved Approved "Endoplasmic reticulum,Cytosol" NA NA 320000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "HPA055133: AB_2682708" "unprognostic (2.98e-2)" "unprognostic (2.44e-1)" "unprognostic (8.43e-2)" "unprognostic (3.49e-2)" "unprognostic (4.15e-2)" "unprognostic (4.39e-2)" "prognostic unfavorable (7.70e-4)" "unprognostic (7.43e-2)" "unprognostic (3.17e-1)" "unprognostic (7.23e-2)" "unprognostic (2.00e-2)" "unprognostic (3.33e-1)" "prognostic unfavorable (3.04e-7)" "unprognostic (1.61e-1)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (1.47e-1)" 1690.3 1371.4 724.2 1077.5 741.5 2753.6 1803.0 715.7 944.0 1873.9 730.0 1509.2 957.5 1382.0 615.7 2558.8 1584.3 696.4 1237.7 712.7 742.4 1051.6 1423.2 1204.2 1914.1 797.8 741.9 3256.7 4556.8 388.1 972.5 832.6 777.7 1473.5 762.9 148.1 1477.9 636.9 2367.2 2781.5 1482.9 616.5 775.9 1849.7 1599.6 419.7 767.4 1570.4 1025.2 1558.8 1602.3 1750.8 1810.5 777.2 2258.0 3020.8 1716.3 5571.2 2433.0 5946.5 3093.8 1506.8 3381.7 3653.7 2581.3 5415.0 1451.8 4124.7 2329.8 2599.8 1226.5 2625.3 2553.6 4786.8 1372.0 2720.7 4959.5 1437.5 3382.8 4939.7 6019.8 3263.4 2174.4 8105.2 6715.4 3155.0 5057.6 3734.5 3606.2 3601.3 3014.4 2244.9 2591.9 9854.0 4110.2 5683.0 5591.7 2742.4 2706.1 4981.3 2846.5 4915.9 3411.9 1993.3 3154.5 2856.4 1465.0 4355.3 3538.6 1481.8 2933.7 5612.6 1757.9 1961.2 2605.3 499.3 3123.2 908.6 1554.7 5464.5 1056.9 2809.3 2532.6 74.1 438.2 239.9 562.4 545.5 932.7 1765.0 1096.6 864.3 805.8 1525.5 1366.1 1034.5 88.0 667.8 449.4 803.5 844.5 749.9 724.2 741.5 715.7 944.0 712.7 742.4 797.8 741.9 777.7 775.9 767.4 777.2 1261.2 519.2 1240.7 8.8 5674.4 11938.0 10835.5 3903.6 3510.9 362.3 12291.0 12660.6 252.4 2427.7 2182.1 910.4 187.7 8328.8 4158.8 1406.9 3212.6 4491.8 298.5 1154.3 4108.9 4082.2 2111.6 4032.5 13.2 11401.9 14898.5 2987.2 1703.4 1777.4 1021.9 4053.7 3477.4 2195.6 6029.4 277.6 15.7 4569.6 1627.6 5640.5 9869.6 489.7 4210.7 3709.4 5115.6 15.9 6772.9 965.3 3821.9 13.0 25.5 5585.7 2941.4 1575.6 3202.3 9790.4 2044.2 2439.2 906.1 477.8 1255.6 4193.6 3603.8 388.8 1997.9 5900.2 15069.3 8184.0 4718.2 6863.0 6345.9 11758.5 RPS6KB1 "p70(S6K)-alpha, PS6K, S6K, S6K1, STK14A" ENSG00000108443 "Ribosomal protein S6 kinase B1" P23443 17 59893046-59950574 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Translation regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "MCF7: 243.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003838, CAB018346, HPA039442" Approved Supported Nucleoplasm NA NA "Cluster 18: Basophils - Vesicular transport" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: AB_2676510" "unprognostic (2.25e-1)" "unprognostic (4.52e-2)" "unprognostic (1.91e-3)" "unprognostic (1.35e-2)" "unprognostic (9.81e-2)" "unprognostic (1.13e-1)" "unprognostic (3.72e-3)" "unprognostic (1.70e-1)" "unprognostic (5.86e-2)" "unprognostic (1.66e-1)" "unprognostic (3.67e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (5.09e-7)" "unprognostic (3.45e-1)" "unprognostic (2.09e-1)" "unprognostic (3.98e-2)" "unprognostic (1.52e-3)" 14.0 11.3 7.1 11.9 7.8 18.0 13.3 11.8 9.8 11.8 9.4 10.7 10.0 13.8 10.1 16.3 10.2 9.4 10.6 7.2 6.6 9.8 15.2 9.9 14.2 7.3 7.0 14.9 16.9 14.9 7.4 15.4 7.5 10.6 11.0 10.9 9.4 10.2 22.7 10.6 9.3 14.3 6.2 12.4 11.1 6.9 7.5 15.2 11.9 18.3 17.3 14.9 11.0 9.6 34.5 33.5 27.5 26.2 18.1 26.2 20.8 31.2 28.3 26.3 29.3 27.6 16.8 41.7 37.9 25.4 32.1 17.3 36.0 27.3 42.7 23.3 41.5 28.7 21.2 31.2 26.9 44.5 27.1 26.7 20.7 31.0 22.8 21.9 35.0 26.0 38.5 25.9 19.7 243.6 53.2 18.4 18.6 29.8 24.9 30.8 46.7 38.8 21.9 25.1 20.1 23.8 26.2 15.2 16.6 31.7 29.7 24.2 31.1 25.8 42.9 21.2 42.0 46.2 42.0 46.3 19.4 26.7 21.2 43.8 12.1 11.4 12.7 12.2 15.5 10.4 11.6 14.7 15.3 9.4 13.5 14.3 11.5 11.9 14.4 9.5 11.9 10.3 7.1 7.8 11.8 9.8 7.2 6.6 7.3 7.0 7.5 6.2 7.5 9.6 22.8 22.4 34.2 29.0 32.6 33.0 21.4 13.0 30.7 18.0 23.1 17.8 16.8 12.8 30.4 3.7 18.8 24.3 33.5 12.4 3.9 12.9 5.1 24.0 31.7 25.5 13.2 11.8 47.3 16.4 18.2 24.8 26.0 37.7 23.4 20.0 13.6 15.1 12.1 18.5 45.2 14.1 4.1 15.2 20.4 3.8 15.8 19.0 10.6 28.1 20.0 12.8 18.6 25.6 54.8 15.1 10.9 18.0 34.6 27.9 9.3 9.2 21.1 18.9 26.3 33.4 32.6 13.0 13.7 34.5 32.0 30.5 29.9 26.0 13.9 25.4 RPUSD1 "C16orf40, MGC19600, RLUCL" ENSG00000007376 "RNA pseudouridine synthase domain containing 1" Q9UJJ7 16 784974-788397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041144, HPA041938" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions,Cytosol" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "Nucleoplasm, Cell Junctions, Cytosol" "HPA041144: AB_10794265, HPA041938: AB_10795601" "unprognostic (1.51e-2)" "unprognostic (1.26e-3)" "unprognostic (2.03e-1)" "unprognostic (4.01e-1)" "unprognostic (2.99e-1)" "unprognostic (9.05e-3)" "unprognostic (1.07e-3)" "unprognostic (3.45e-2)" "unprognostic (1.08e-1)" "unprognostic (3.31e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" "unprognostic (6.25e-2)" "unprognostic (8.07e-3)" "unprognostic (5.44e-2)" "unprognostic (2.95e-1)" "unprognostic (1.41e-1)" 11.8 12.9 12.3 9.7 11.9 13.5 12.0 11.2 21.1 11.0 6.8 14.9 9.8 13.1 3.1 18.7 10.6 4.7 12.0 12.5 10.0 13.0 15.3 9.5 11.3 12.9 10.7 9.2 16.1 4.5 11.2 4.2 10.9 14.6 2.5 2.2 15.2 5.1 11.2 18.1 15.6 3.6 9.7 21.9 17.0 7.2 12.4 8.3 11.0 3.1 5.3 13.1 11.8 11.6 28.2 32.5 7.8 35.7 6.8 7.9 36.2 22.9 13.0 29.4 21.3 76.4 25.8 38.9 24.3 11.1 20.6 47.2 18.1 23.1 5.3 35.7 74.0 19.2 52.1 28.0 10.9 35.8 31.1 11.7 21.9 25.4 6.7 8.7 20.4 22.6 45.7 17.1 10.2 89.2 44.8 37.4 40.0 13.0 55.4 79.0 21.0 80.5 10.9 17.0 40.8 29.4 26.4 42.7 26.1 4.6 22.0 43.9 23.3 29.1 37.9 30.9 33.6 27.2 29.6 45.7 14.1 27.8 24.5 16.5 14.8 13.7 12.7 13.7 12.6 10.2 10.7 14.1 17.0 12.0 10.7 11.1 9.2 13.4 13.6 15.8 14.8 13.1 12.3 11.9 11.2 21.1 12.5 10.0 12.9 10.7 10.9 9.7 12.4 11.6 9.4 3.2 3.3 3.6 12.9 15.9 3.5 13.2 10.8 42.0 12.8 13.3 4.4 5.7 5.2 9.2 2.1 20.5 13.7 23.0 7.9 19.5 0.4 4.7 7.1 8.1 13.2 6.3 6.0 26.9 25.7 6.8 17.9 8.2 0.0 10.9 9.3 5.1 19.6 1.7 4.2 11.5 10.2 5.7 7.0 1.8 6.8 9.0 14.2 1.9 19.2 11.1 23.7 1.5 3.5 29.9 16.6 6.4 19.5 6.3 21.1 10.2 3.4 3.8 13.1 3.6 9.4 3.6 11.4 11.5 16.8 14.6 11.9 13.3 20.7 5.0 RSPO3 "FLJ14440, THSD2" ENSG00000146374 "R-spondin 3" Q9BXY4 6 127118671-127199481 "Cancer-related genes, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 51.4" "Cell type enhanced" "Detected in some" "Endometrial stromal cells: 18.5;Endothelial cells: 42.4;Fibroblasts: 73.0;Hepatic stellate cells: 26.4;Inhibitory neurons: 17.8;Leydig cells: 27.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 21.9;BJ hTERT+: 3.6;hTERT-RPE1: 6.3;U-138 MG: 4.6;U-87 MG: 4.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in many" "hippocampal formation: 21.2" HPA029957 Uncertain "Secreted to blood" NA NA "Cluster 46: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 33: Fibroblasts - ECM organization" "HPA029957: AB_10602087" "unprognostic (4.77e-2)" "unprognostic (3.95e-2)" "unprognostic (1.27e-2)" "unprognostic (2.27e-2)" "unprognostic (1.10e-1)" "unprognostic (2.99e-1)" "unprognostic (9.71e-2)" "unprognostic (1.49e-2)" "unprognostic (3.77e-2)" "unprognostic (3.21e-1)" "unprognostic (1.37e-1)" "unprognostic (3.37e-1)" "unprognostic (1.07e-3)" "unprognostic (7.94e-2)" "unprognostic (2.76e-1)" "unprognostic (1.64e-2)" "unprognostic (7.89e-3)" 30.9 15.1 2.1 16.1 2.4 0.0 12.4 3.3 4.9 13.8 0.0 7.4 2.2 51.4 28.4 5.4 25.3 11.1 0.9 8.5 1.5 4.0 6.5 5.1 3.7 1.6 1.4 3.6 1.6 0.1 3.1 35.4 0.3 6.3 6.6 0.1 5.4 20.0 39.8 2.8 10.3 48.1 0.0 1.8 13.3 1.0 1.0 2.4 3.6 5.0 1.4 8.6 7.1 0.9 0.0 21.9 0.0 0.0 1.0 0.0 0.0 0.0 3.6 0.3 0.4 0.0 0.0 0.0 0.4 0.0 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 6.3 2.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.0 4.6 1.8 0.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 2.4 3.3 4.9 8.5 1.5 1.6 1.4 0.3 0.0 1.0 0.9 3.6 0.0 0.0 0.7 0.1 0.9 0.1 0.0 0.6 1.5 0.2 0.9 0.5 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.4 12.3 0.3 18.5 42.4 0.0 0.0 5.9 0.0 1.1 73.0 5.1 0.3 0.0 0.0 26.4 0.4 1.6 0.0 17.8 0.0 0.0 1.0 0.8 2.2 27.4 0.4 1.8 1.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.3 0.9 0.0 0.0 0.0 0.2 6.6 2.1 3.5 0.1 0.4 0.4 0.1 1.6 0.1 0.1 0.0 0.2 RTL8A "CXX1b, DKFZP564B147, FAM127B, MAR8A, SIRH6" ENSG00000203950 "Retrotransposon Gag like 8A" Q9BWD3 X 135050932-135052196 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 109.5;Ductal cells: 71.3;Pancreatic endocrine cells: 78.2;Proximal tubular cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 174.7" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "unprognostic (2.10e-2)" "prognostic favorable (5.35e-4)" "unprognostic (2.07e-3)" "prognostic unfavorable (2.83e-4)" "unprognostic (9.91e-2)" "unprognostic (1.63e-2)" "prognostic unfavorable (1.10e-5)" "unprognostic (2.16e-2)" "unprognostic (4.48e-1)" "prognostic favorable (2.71e-4)" "unprognostic (2.05e-2)" "unprognostic (1.37e-1)" "unprognostic (1.76e-1)" "unprognostic (2.10e-1)" "unprognostic (2.51e-1)" "unprognostic (3.35e-2)" "unprognostic (1.57e-2)" 38.5 30.3 22.4 6.9 25.6 4.7 36.3 25.1 38.0 46.1 12.3 44.3 10.2 45.0 4.9 57.4 41.0 9.2 43.0 21.6 27.1 37.7 19.2 32.2 6.6 25.0 24.4 47.5 20.2 10.1 51.0 10.7 23.7 41.9 5.8 7.7 31.6 17.3 19.9 39.0 28.8 10.3 21.8 26.5 30.5 12.1 24.7 6.0 38.1 8.6 4.1 44.7 43.4 27.8 47.9 57.1 28.4 62.8 29.5 25.3 40.9 18.8 17.8 45.3 49.4 59.1 20.1 0.0 50.4 29.4 50.3 29.9 14.8 32.8 14.5 16.4 52.1 9.4 59.7 0.0 71.6 3.0 13.6 48.0 55.7 46.6 20.9 17.6 33.9 9.4 15.0 0.0 21.4 174.7 3.3 30.4 14.7 12.5 57.0 10.4 29.4 0.1 9.0 26.5 52.3 67.2 21.7 15.9 50.6 10.7 17.5 8.5 35.0 34.4 29.3 66.4 46.8 7.1 12.6 0.2 20.0 13.4 27.9 31.7 19.5 21.0 6.9 27.8 6.0 4.4 7.3 8.7 14.0 5.5 8.1 9.2 4.6 4.6 34.1 10.8 5.0 8.6 22.4 25.6 25.1 38.0 21.6 27.1 25.0 24.4 23.7 21.8 24.7 27.8 43.9 60.9 19.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 52.6 63.5 0.0 0.0 26.0 62.5 0.0 60.1 7.4 0.0 109.5 71.3 0.0 39.3 49.6 21.7 0.0 0.0 0.0 63.5 60.7 22.6 0.0 38.1 11.4 34.8 0.0 0.0 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 14.5 0.0 0.0 0.0 0.0 78.2 0.0 0.0 1.8 0.0 0.0 110.5 14.6 0.0 0.0 0.0 28.1 0.0 0.0 0.0 0.0 28.2 5.0 54.1 0.0 0.0 SAMD15 "C14orf174, FAM15A, FLJ35963" ENSG00000100583 "Sterile alpha motif domain containing 15" Q9P1V8 14 77376689-77391497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 15.3;testis: 17.7" "Group enriched" "Detected in many" 6 "Cone photoreceptor cells: 62.6;Early spermatids: 81.8;Endometrial ciliated cells: 38.8;Late spermatids: 111.7;Respiratory ciliated cells: 41.5;Rod photoreceptor cells: 75.7;Spermatocytes: 59.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030673, HPA030677" Enhanced Approved "Nucleoplasm,Nuclear membrane,Nucleoli" NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nucleoplasm, Nuclear membrane, Nucleoli" "HPA030673: AB_10600655, HPA030677: AB_10599938" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (1.15e-1)" "unprognostic (1.02e-2)" "unprognostic (1.38e-2)" "unprognostic (3.70e-3)" "unprognostic (5.20e-2)" "unprognostic (5.76e-2)" "unprognostic (1.11e-1)" "unprognostic (3.83e-3)" "unprognostic (6.19e-2)" "unprognostic (2.53e-3)" "unprognostic (6.87e-3)" "unprognostic (9.90e-2)" "unprognostic (3.73e-3)" "unprognostic (1.76e-2)" 0.5 0.8 1.7 0.3 2.8 0.6 1.0 0.7 1.5 0.7 7.7 0.2 0.3 1.0 5.3 0.2 4.5 1.1 0.1 1.7 3.4 1.9 0.1 0.8 1.4 2.8 3.5 0.7 2.0 2.4 2.4 0.3 2.0 0.7 0.3 15.3 0.3 0.7 0.2 0.5 0.2 0.3 1.4 0.2 0.4 17.7 2.7 0.4 3.9 0.0 1.4 0.8 0.2 0.8 2.5 3.4 1.3 2.7 0.3 1.4 1.2 1.0 0.9 2.6 2.3 2.5 2.2 2.8 1.1 1.0 2.3 2.4 0.9 1.4 3.7 0.2 0.5 0.4 1.0 0.6 0.1 0.5 2.9 1.3 0.9 2.3 0.2 1.1 1.8 1.4 0.3 0.7 1.1 7.6 0.6 0.2 0.5 0.6 1.0 1.2 1.2 0.1 4.6 1.4 2.8 1.8 3.5 0.5 0.5 0.5 4.3 0.8 0.7 2.5 1.4 2.6 1.3 0.4 2.4 1.8 3.1 0.1 1.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.7 2.8 0.7 1.5 1.7 3.4 2.8 3.5 2.0 1.4 2.7 0.8 0.7 0.0 0.0 1.0 0.3 0.3 0.5 0.6 0.0 11.2 0.9 0.9 1.9 2.8 1.8 0.0 62.6 0.3 0.8 0.7 1.9 2.8 81.8 38.8 4.6 0.5 3.6 0.0 1.3 0.6 0.2 1.0 0.0 1.4 0.0 1.3 0.4 0.0 0.1 3.3 0.6 0.5 0.0 0.0 0.0 111.7 1.5 0.3 0.0 0.0 0.1 5.5 0.0 0.5 0.4 0.9 0.1 0.0 0.0 0.2 0.0 3.5 41.5 75.7 0.0 1.0 1.0 59.3 7.3 0.0 0.0 0.3 0.3 6.0 0.1 0.3 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930763 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.1;Late spermatids: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 7.3 17.3 4.2 7.2 4.7 9.3 8.2 4.4 6.8 9.7 3.6 10.1 9.3 9.3 2.8 14.3 8.5 5.9 12.4 4.7 4.4 14.6 18.7 6.6 9.8 5.0 4.4 9.8 15.9 7.8 11.9 7.6 5.3 12.2 5.3 2.3 11.3 6.2 16.4 12.3 10.2 5.1 4.2 12.0 11.9 10.7 4.4 7.5 14.4 11.5 6.6 9.4 9.6 5.4 17.6 47.3 15.5 10.7 5.8 13.3 23.7 10.7 12.6 23.1 17.7 36.0 18.4 17.2 16.3 12.5 9.7 13.9 14.7 29.2 5.3 12.7 24.4 33.7 17.7 32.0 15.4 29.1 31.9 20.7 13.5 14.5 7.6 9.5 14.2 26.3 29.9 14.2 10.6 28.4 21.4 20.7 18.5 21.6 8.5 31.2 16.4 18.6 20.5 36.2 29.1 18.1 14.2 32.7 8.9 4.6 21.8 19.1 11.4 13.7 17.7 11.7 15.1 11.0 7.1 13.2 10.9 18.5 13.8 0.0 8.0 1.0 14.2 14.4 11.5 12.0 10.7 14.7 25.2 10.7 7.5 8.6 0.5 14.0 13.7 9.9 13.4 8.9 4.2 4.7 4.4 6.8 4.7 4.4 5.0 4.4 5.3 4.2 4.4 5.4 2.7 6.4 7.9 6.2 8.4 4.2 3.8 8.3 3.4 8.0 7.0 5.3 8.1 7.2 6.8 5.5 8.4 40.1 5.6 8.9 15.6 15.5 15.7 3.6 3.6 3.8 11.4 13.2 6.8 12.7 23.0 4.8 9.7 3.9 5.7 7.4 6.1 10.1 12.9 5.0 6.7 9.2 10.2 6.7 4.2 56.9 4.7 4.8 3.6 1.9 7.7 3.1 5.2 1.5 3.1 8.4 5.6 4.9 10.1 2.6 7.4 10.3 5.1 13.4 0.0 2.7 4.2 1.9 8.2 12.8 4.1 29.1 7.4 10.6 17.8 3.2 SART1 "Ara1, HAF, SNRNP110, Snu66" ENSG00000175467 "Spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP" O43290 11 65961728-65980137 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Allergen, Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031188, HPA031189, HPA031190" Supported Enhanced "Nuclear speckles,Golgi apparatus" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "Golgi apparatus" "HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289" "unprognostic (2.93e-2)" "unprognostic (1.13e-2)" "unprognostic (1.09e-2)" "unprognostic (1.76e-1)" "unprognostic (1.45e-1)" "unprognostic (6.99e-2)" "unprognostic (2.52e-3)" "unprognostic (8.15e-2)" "unprognostic (8.97e-2)" "unprognostic (2.10e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (1.39e-1)" "unprognostic (1.04e-1)" "unprognostic (1.58e-1)" "unprognostic (1.62e-1)" "unprognostic (4.24e-2)" 24.6 18.3 15.5 18.3 16.8 41.6 23.1 15.4 17.4 29.2 14.7 26.0 15.6 29.1 8.0 22.7 25.6 8.6 23.2 14.9 16.1 20.4 21.8 22.9 20.3 16.6 16.2 29.2 25.8 11.7 21.4 14.0 15.9 21.7 7.7 8.0 22.2 14.4 38.1 32.0 24.3 10.9 14.6 32.7 24.8 23.5 15.7 20.9 23.5 13.0 13.3 26.2 24.6 17.9 50.4 60.8 27.2 36.8 26.1 20.7 40.8 37.5 27.2 43.8 28.6 44.2 34.3 56.9 42.4 33.8 52.9 48.7 34.6 35.6 22.0 45.8 33.5 65.6 43.6 41.4 39.0 57.4 52.7 26.2 26.4 40.8 36.3 17.4 27.6 42.3 42.2 39.8 25.6 92.6 74.0 83.5 45.7 27.3 55.9 80.8 39.0 60.7 18.4 33.7 30.5 43.0 35.6 37.2 45.5 12.6 41.7 47.0 40.6 54.5 53.0 53.9 54.1 59.6 49.4 48.3 45.0 28.8 47.0 1.4 2.8 8.1 4.3 3.5 3.6 3.9 4.8 4.4 3.6 3.5 3.5 3.9 4.1 2.8 2.0 3.2 5.4 1.8 15.5 16.8 15.4 17.4 14.9 16.1 16.6 16.2 15.9 14.6 15.7 17.9 17.5 6.4 9.1 7.8 27.8 22.7 24.0 12.2 17.6 19.2 12.2 9.1 9.4 21.5 11.3 16.5 10.4 34.1 27.2 30.5 5.9 23.7 9.0 14.2 16.3 19.8 12.5 32.8 5.1 29.3 31.9 17.6 21.9 16.8 32.4 21.8 21.0 15.6 29.4 16.8 4.8 26.5 16.2 22.5 23.6 8.7 37.0 22.9 17.8 6.5 35.7 23.8 34.0 7.1 7.8 26.3 20.1 33.1 31.2 20.5 28.3 18.5 17.5 26.0 32.9 27.6 34.9 26.7 29.7 18.3 21.7 45.3 28.4 15.5 27.5 18.2 SBK3 SgK110 ENSG00000231274 "SH3 domain binding kinase family member 3" P0C264 19 55540656-55545543 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "heart muscle: 32.5;tongue: 15.1" "Cell type enriched" "Detected in single" 5 "Cardiomyocytes: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 5.0;CACO-2: 1.8;CAPAN-2: 2.9;K-562: 1.2;NTERA-2: 1.3;RH-30: 2.2" "Not detected" "Not detected" HPA078322 Approved Mitochondria NA NA "Cluster 38: Heart - Muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 43: Cardiomyocytes - Nuclear processes" Mitochondria "HPA078322: AB_2732379" "unprognostic (2.15e-1)" "unprognostic (1.99e-3)" "unprognostic (2.71e-1)" "unprognostic (1.39e-3)" "unprognostic (7.52e-2)" "unprognostic (2.83e-1)" "unprognostic (5.47e-5)" "unprognostic (4.64e-3)" "unprognostic (7.24e-2)" "unprognostic (1.65e-1)" "unprognostic (3.38e-1)" "unprognostic (3.08e-3)" "unprognostic (1.21e-2)" "unprognostic (4.92e-2)" "unprognostic (2.41e-1)" "unprognostic (1.79e-1)" 2.5 0.0 0.0 0.1 0.0 0.0 1.0 0.4 0.0 0.3 0.0 0.1 0.4 0.2 0.0 2.0 0.2 0.3 32.5 0.0 0.0 0.4 0.1 0.5 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.3 0.2 0.0 0.0 0.5 0.0 6.5 0.2 0.2 0.2 0.1 0.0 0.4 0.2 0.1 0.0 0.5 15.1 0.0 0.3 0.1 0.1 0.0 5.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 1.8 2.9 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.3 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SCAMP4 FLJ33847 ENSG00000227500 "Secretory carrier membrane protein 4" Q969E2 19 1905372-1926013 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043284 Approved Approved "Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus, Vesicles" "Lipid droplets, Plasma membrane" "HPA043284: AB_10806501" "unprognostic (1.60e-1)" "unprognostic (3.62e-1)" "unprognostic (5.04e-2)" "prognostic favorable (4.40e-6)" "unprognostic (2.58e-1)" "unprognostic (4.58e-1)" "prognostic unfavorable (1.92e-5)" "unprognostic (2.04e-1)" "unprognostic (1.58e-1)" "unprognostic (2.55e-1)" "unprognostic (3.01e-3)" "unprognostic (5.66e-2)" "prognostic favorable (3.56e-4)" "unprognostic (6.16e-2)" "unprognostic (1.58e-1)" "unprognostic (3.93e-2)" "unprognostic (1.03e-1)" 23.2 27.4 31.1 15.5 39.9 11.4 25.4 41.3 33.3 28.1 33.6 23.3 19.8 26.0 17.5 39.9 38.3 19.5 15.5 28.9 33.1 34.4 28.3 25.5 15.6 51.5 42.9 27.1 36.5 15.8 31.8 18.8 47.7 31.7 9.8 7.4 43.9 20.4 13.9 36.3 20.3 12.3 39.7 25.1 26.4 22.0 40.6 8.3 32.7 5.8 9.4 22.0 25.0 53.5 53.6 53.9 25.7 56.8 50.7 31.7 29.6 35.5 33.1 39.3 46.7 44.9 51.1 22.5 32.1 30.7 23.1 63.7 24.7 38.2 14.5 34.8 21.7 15.8 19.0 44.3 65.6 16.9 23.2 48.8 24.2 34.8 21.2 32.9 27.2 25.2 35.7 25.3 23.3 67.8 21.5 31.6 38.8 31.1 18.6 25.9 18.1 34.6 49.8 47.5 33.8 45.0 23.9 49.9 31.4 18.1 50.6 41.5 29.6 44.8 30.5 81.1 35.7 57.8 62.6 21.0 59.1 26.9 30.1 1.7 4.4 1.9 3.9 4.9 2.0 5.1 2.7 2.6 4.8 3.4 1.5 2.9 2.1 5.8 4.5 12.0 2.3 3.7 31.1 39.9 41.3 33.3 28.9 33.1 51.5 42.9 47.7 39.7 40.6 53.5 16.9 9.6 7.3 12.1 22.9 17.1 25.0 20.8 33.0 19.7 40.0 23.5 3.0 21.5 14.1 49.7 75.0 40.0 59.6 53.0 7.9 20.8 0.8 63.2 23.2 17.8 18.7 11.6 8.3 12.5 38.1 18.2 43.3 42.1 17.2 27.8 15.7 13.4 38.0 21.9 8.0 36.1 20.3 20.1 24.9 1.9 21.8 24.2 21.4 5.6 21.0 29.6 33.0 16.6 18.9 16.1 25.3 17.3 16.0 30.0 47.6 10.1 33.2 52.2 0.0 15.8 15.7 19.0 26.1 30.8 20.2 59.0 20.4 26.9 31.1 28.1 SCRIB "KIAA0147, SCRB1, Vartul" ENSG00000180900 "Scribble planar cell polarity protein" Q14160 8 143790920-143815773 "Disease related genes, Predicted intracellular proteins" "Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 100.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015463, CAB022081, HPA023557, HPA064312" Supported Enhanced "Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cell Junctions" "Nucleoplasm, Rods & Rings" "CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242" "unprognostic (1.24e-1)" "unprognostic (1.94e-2)" "unprognostic (7.78e-2)" "unprognostic (8.95e-2)" "unprognostic (3.77e-1)" "unprognostic (3.96e-2)" "unprognostic (1.14e-3)" "unprognostic (1.86e-2)" "unprognostic (2.46e-1)" "unprognostic (2.56e-1)" "unprognostic (8.22e-2)" "unprognostic (1.87e-1)" "unprognostic (2.16e-3)" "unprognostic (3.46e-3)" "unprognostic (1.99e-1)" "unprognostic (1.10e-1)" "unprognostic (1.83e-1)" 18.7 17.1 11.5 7.2 10.8 5.6 23.6 6.0 10.4 45.6 0.0 32.3 9.1 24.7 0.9 100.5 26.0 3.4 24.6 8.7 2.7 27.7 25.4 21.3 4.0 10.7 8.1 23.0 38.8 5.2 24.8 5.0 5.9 28.4 3.4 1.0 40.2 5.2 54.3 68.3 26.5 2.0 4.9 22.9 30.0 26.4 9.0 3.0 24.6 1.7 3.9 27.8 52.6 15.3 55.7 33.1 12.7 20.5 5.1 6.9 33.0 30.9 5.3 11.2 9.1 15.3 29.8 24.2 39.7 7.2 4.6 52.4 7.9 32.9 1.7 30.8 58.5 24.6 30.5 26.1 10.8 13.0 14.8 5.1 29.9 9.4 5.5 5.1 11.5 19.8 42.2 6.4 7.5 93.0 38.1 26.9 15.7 25.0 55.1 44.5 10.6 25.0 5.6 45.5 29.6 27.1 31.4 30.5 33.6 4.5 41.5 28.2 25.7 10.1 64.1 25.2 44.7 31.6 31.0 23.8 13.1 9.5 19.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.5 10.8 6.0 10.4 8.7 2.7 10.7 8.1 5.9 4.9 9.0 15.3 12.3 0.0 9.9 33.0 4.4 8.5 5.0 10.2 13.6 11.3 16.8 17.0 11.1 11.5 8.3 14.7 14.6 11.0 9.7 28.7 3.9 8.6 1.5 14.0 7.7 7.8 13.8 13.7 5.0 9.4 6.3 7.3 29.6 27.3 0.0 17.9 3.6 8.8 6.5 5.0 6.2 17.8 18.3 6.0 4.1 0.7 9.0 6.6 8.8 6.5 5.0 10.0 5.2 12.1 15.2 11.5 22.8 9.8 5.6 9.3 16.9 4.5 9.9 16.0 13.1 12.0 8.7 9.4 10.0 19.9 10.7 5.1 7.3 8.0 23.2 7.1 SCYL1 "GKLP, HT019, MGC78454, NKTL, NTKL, P105, TAPK, TEIF, TRAP" ENSG00000142186 "SCY1 like pseudokinase 1" Q96KG9 11 65525077-65538704 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "ER-Golgi transport, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Mental retardation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 138.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015015 Uncertain Supported Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA015015: AB_1856643" "unprognostic (5.56e-2)" "unprognostic (1.16e-1)" "unprognostic (1.03e-1)" "unprognostic (3.99e-1)" "unprognostic (1.23e-2)" "unprognostic (7.87e-2)" "unprognostic (1.23e-2)" "unprognostic (5.06e-2)" "unprognostic (1.14e-1)" "unprognostic (7.23e-2)" "unprognostic (4.41e-1)" "unprognostic (4.29e-1)" "unprognostic (7.86e-3)" "unprognostic (6.49e-3)" "unprognostic (4.27e-1)" "unprognostic (8.29e-2)" "unprognostic (2.29e-3)" 43.4 69.3 36.6 26.4 37.4 32.8 41.1 33.1 53.9 46.8 37.1 46.7 28.0 49.4 32.5 40.0 44.0 26.3 59.7 39.2 34.1 45.7 83.2 42.4 30.7 36.0 35.2 52.4 61.6 35.5 44.7 34.6 35.5 47.3 17.2 12.4 48.5 33.7 104.5 44.5 39.6 27.5 30.9 46.4 50.0 50.6 37.7 23.4 48.8 51.6 21.8 47.8 39.5 39.0 55.0 45.9 36.6 50.9 65.4 56.6 50.0 66.6 89.4 77.7 60.4 66.9 32.2 39.2 65.7 86.9 66.2 49.1 38.7 50.1 27.0 46.6 49.7 46.4 50.8 78.3 92.8 30.8 64.0 79.1 48.6 66.9 49.4 54.2 51.6 39.7 49.2 53.8 49.0 118.9 41.4 70.4 35.3 36.9 63.4 41.4 28.5 72.5 48.1 48.4 33.7 35.7 41.2 89.6 74.5 22.4 88.8 38.4 51.4 61.3 41.0 100.7 40.1 73.8 55.8 41.4 71.0 25.3 43.7 2.9 21.1 28.4 20.7 20.0 16.6 14.0 19.6 20.9 23.5 14.3 15.2 15.0 41.9 18.2 13.6 17.0 14.4 19.8 36.6 37.4 33.1 53.9 39.2 34.1 36.0 35.2 35.5 30.9 37.7 39.0 22.7 19.2 16.7 11.4 25.7 21.9 29.8 30.9 25.0 25.4 29.9 20.1 5.8 21.5 26.0 20.2 12.5 64.6 18.5 47.4 37.2 37.5 25.7 17.3 22.7 23.7 30.5 22.3 14.6 43.4 70.0 34.1 38.2 25.4 25.4 34.0 22.1 35.0 38.1 16.8 12.8 39.9 28.5 19.2 24.3 25.2 45.7 24.5 30.2 11.2 34.3 26.6 21.6 6.6 10.5 36.4 31.4 45.5 53.4 44.8 50.8 37.2 15.3 22.0 13.1 24.4 33.8 39.5 21.8 27.5 23.2 138.6 23.2 44.3 36.2 38.5 SDHAF2 "C11orf79, FLJ20487, PGL2, SDH5" ENSG00000167985 "Succinate dehydrogenase complex assembly factor 2" Q9NX18 11 61430042-61446733 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" Chaperone "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039464, HPA039732" Supported Approved Nucleoli,Mitochondria,Cytosol NA NA "Cluster 35: T-regs - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Mitochondria, Cytosol" Nucleoli "HPA039464: AB_10962146, HPA039732: AB_10962868" "unprognostic (5.31e-2)" "unprognostic (1.12e-2)" "unprognostic (3.13e-1)" "unprognostic (1.30e-2)" "unprognostic (1.40e-1)" "unprognostic (6.71e-2)" "unprognostic (1.98e-3)" "unprognostic (9.06e-2)" "unprognostic (2.17e-1)" "unprognostic (2.09e-3)" "unprognostic (4.21e-3)" "unprognostic (1.50e-1)" "unprognostic (1.81e-2)" "unprognostic (3.61e-1)" "unprognostic (1.78e-1)" "unprognostic (1.45e-1)" "unprognostic (4.48e-2)" 27.5 37.1 36.2 26.4 37.4 45.6 28.9 37.9 38.2 23.8 37.4 27.2 24.7 23.8 34.8 28.8 28.7 25.5 40.4 35.9 40.2 36.5 46.4 23.8 39.9 37.9 37.6 26.9 24.0 32.9 41.0 24.9 37.9 29.0 29.1 23.4 26.3 20.9 38.9 26.3 27.0 26.9 37.7 34.7 27.6 22.1 38.0 38.0 28.6 44.7 41.6 32.8 21.7 39.2 45.0 58.4 36.5 25.1 57.2 52.2 27.0 33.3 58.0 48.9 41.8 52.8 46.8 42.3 58.4 55.6 62.8 45.4 45.4 51.4 56.6 60.4 39.7 33.2 35.5 71.9 52.8 41.4 48.1 55.6 58.7 50.2 45.8 35.3 80.8 43.5 42.2 50.9 63.5 86.0 49.2 89.3 56.1 47.0 78.6 45.9 45.9 76.6 63.7 57.9 36.9 40.6 46.9 53.5 99.0 38.5 83.0 40.2 53.3 45.0 32.7 54.3 37.5 31.2 51.2 54.7 43.4 37.3 46.0 125.3 68.8 126.6 82.5 64.5 103.1 89.7 93.0 91.7 55.9 84.8 101.5 97.5 97.9 97.9 53.3 63.3 126.7 78.6 36.2 37.4 37.9 38.2 35.9 40.2 37.9 37.6 37.9 37.7 38.0 39.2 32.8 35.3 33.2 11.1 28.9 20.6 34.6 53.7 10.2 14.0 27.9 35.1 22.3 14.3 33.5 29.5 6.2 77.0 41.9 29.5 54.8 55.3 15.8 19.3 21.7 36.5 34.2 30.3 13.2 60.3 51.4 28.4 16.8 19.0 32.3 22.2 42.5 42.3 52.7 15.2 13.3 31.4 59.0 36.5 22.8 17.8 31.4 29.7 44.4 8.4 66.4 49.4 69.0 16.6 18.1 62.9 34.9 30.9 16.3 30.8 34.0 51.9 31.5 19.7 32.9 17.3 27.2 23.1 25.8 10.9 22.4 99.6 41.5 45.1 27.6 38.8 SDSL "cSDH, SDS-RS1" ENSG00000139410 "Serine dehydratase like" Q96GA7 12 113422380-113438276 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 104.6" "Cell type enhanced" "Detected in many" "Distal tubular cells: 78.2;Hepatocytes: 116.7;Hofbauer cells: 95.7;monocytes: 103.1;Proximal tubular cells: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 8.7;intermediate monocyte: 10.0;myeloid DC: 18.5;plasmacytoid DC: 17.8" "Group enriched" "Detected in many" 6 "dendritic cells: 18.5;monocytes: 10.0" "Cell line enhanced" "Detected in many" "HMC-1: 51.4;MCF7: 90.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA005740 Approved Approved Cytosol NA NA 48000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 15: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 3: Monocytes - Immune response regulation" Cytosol "HPA005740: AB_10601486" "unprognostic (1.34e-1)" "unprognostic (8.33e-2)" "unprognostic (3.62e-2)" "unprognostic (3.54e-2)" "unprognostic (2.24e-2)" "unprognostic (6.17e-3)" "unprognostic (1.57e-1)" "unprognostic (6.46e-2)" "unprognostic (8.22e-2)" "unprognostic (2.00e-2)" "prognostic favorable (8.58e-4)" "unprognostic (2.93e-1)" "prognostic favorable (3.09e-5)" "unprognostic (2.22e-2)" "unprognostic (1.43e-1)" "unprognostic (2.54e-1)" "unprognostic (7.33e-2)" 4.5 33.1 12.7 7.1 14.2 3.2 4.9 16.4 15.2 4.6 10.8 12.2 16.8 4.8 9.9 2.5 7.9 7.7 12.8 11.8 16.1 34.9 104.6 5.7 3.4 18.7 16.2 4.6 18.7 12.4 15.5 4.4 16.0 8.5 8.5 2.4 4.8 6.6 3.0 1.3 12.2 5.2 15.8 5.8 9.1 10.6 16.4 1.5 23.9 1.3 1.7 6.2 1.4 17.4 8.5 33.3 4.7 14.1 0.9 1.9 3.2 4.8 1.2 5.2 4.4 14.1 8.7 0.4 24.2 8.1 14.4 8.6 2.2 11.4 1.7 20.5 8.4 22.1 8.5 6.3 27.5 2.8 51.4 4.4 16.0 12.8 18.8 5.9 8.0 0.0 17.3 6.6 6.5 90.2 0.1 10.2 4.6 9.6 14.6 0.0 7.0 16.5 13.6 10.6 1.5 0.5 20.6 23.6 18.4 4.2 28.6 24.8 7.2 6.2 11.9 26.9 4.2 1.4 1.4 0.3 26.3 8.4 7.8 0.2 8.7 0.0 0.0 10.0 0.0 2.2 0.0 0.0 18.5 0.1 0.0 0.0 0.4 1.8 1.3 17.8 0.3 2.5 12.7 14.2 16.4 15.2 11.8 16.1 18.7 16.2 16.0 15.8 16.4 17.4 1.2 0.0 5.1 2.0 3.1 0.9 2.2 7.0 0.0 0.5 15.3 10.2 18.2 27.1 6.3 29.5 2.1 16.3 4.9 43.7 78.2 36.1 0.5 14.8 7.7 4.0 31.8 10.1 1.3 20.1 3.0 4.5 12.8 10.1 43.8 15.3 6.4 116.7 95.7 3.3 0.6 36.4 4.1 18.1 8.4 1.5 2.8 36.9 3.6 1.9 103.1 33.5 0.0 1.5 2.0 16.2 63.2 5.7 0.0 6.1 63.2 115.7 3.8 2.6 0.0 0.2 7.3 0.2 0.4 1.1 0.6 7.3 1.9 29.5 31.0 5.9 SEC16A "KIAA0310, p250, Sec16L" ENSG00000148396 "SEC16 homolog A, endoplasmic reticulum export factor" O15027 9 136440096-136483759 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005684 Supported Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 48000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Endoplasmic reticulum" "HPA005684: AB_1079189" "unprognostic (1.24e-3)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.84e-2)" "unprognostic (3.48e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-3)" "unprognostic (4.75e-1)" "prognostic favorable (4.47e-4)" "unprognostic (5.57e-3)" "unprognostic (2.64e-1)" "unprognostic (2.47e-2)" "unprognostic (1.41e-1)" 16.8 18.2 6.4 16.6 6.7 35.3 17.1 8.0 9.4 16.6 19.3 17.3 14.9 17.9 9.0 17.9 16.4 12.4 14.5 7.0 5.2 14.3 37.9 19.4 16.9 4.4 4.9 16.2 29.2 14.0 24.3 10.8 3.5 18.7 10.5 9.2 25.8 13.1 23.5 19.7 19.1 10.7 2.4 20.7 27.2 17.6 5.2 17.4 15.3 11.9 12.3 15.9 14.5 5.0 26.5 57.7 28.5 47.2 29.6 30.3 33.6 32.1 27.9 23.4 17.8 41.9 22.1 26.4 22.1 39.2 28.8 71.3 31.8 46.2 12.7 56.2 20.7 26.9 55.1 33.7 28.6 46.2 45.8 32.8 32.5 32.7 38.1 18.9 32.2 34.5 34.1 35.6 25.0 114.3 31.2 24.9 25.1 79.0 40.4 44.3 35.2 45.0 23.8 35.0 40.0 26.6 41.6 62.2 19.8 13.8 63.6 35.9 47.0 37.6 28.1 30.8 25.2 16.9 27.7 33.4 29.2 20.6 38.3 1.7 2.8 1.2 2.5 3.1 2.7 2.3 2.6 3.0 1.6 1.4 1.6 2.8 2.0 1.5 3.4 2.6 1.9 2.4 6.4 6.7 8.0 9.4 7.0 5.2 4.4 4.9 3.5 2.4 5.2 5.0 20.0 25.6 41.7 16.6 16.4 24.9 15.3 18.4 10.8 20.2 38.7 30.6 11.5 12.8 23.6 12.9 25.0 8.1 17.5 30.1 7.9 14.2 5.1 26.9 19.5 18.2 40.7 12.0 27.4 16.4 11.8 16.0 46.9 38.2 23.5 25.4 17.9 62.2 16.5 33.7 19.2 65.5 20.3 23.4 19.5 6.0 13.1 22.3 14.2 17.8 19.5 13.0 11.3 9.5 14.7 22.8 14.7 16.6 25.1 26.3 22.3 10.1 34.7 17.1 13.1 20.5 16.6 24.4 16.1 17.2 26.9 15.1 17.8 15.8 22.8 22.1 SERTAD1 "SEI1, TRIP-Br1" ENSG00000197019 "SERTA domain containing 1" Q9UHV2 19 40421589-40425992 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 480.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063323 Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 82: Adipose tissue - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" Nucleoplasm "HPA063323: AB_2684984" "unprognostic (2.23e-2)" "unprognostic (4.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.73e-1)" "unprognostic (1.29e-1)" "unprognostic (1.34e-1)" "unprognostic (1.55e-1)" "unprognostic (3.44e-3)" "unprognostic (1.01e-2)" "unprognostic (3.82e-2)" "unprognostic (1.62e-1)" "unprognostic (5.21e-2)" "unprognostic (1.28e-1)" "unprognostic (9.46e-2)" "unprognostic (9.43e-2)" "unprognostic (1.74e-1)" "unprognostic (3.08e-3)" 27.1 9.3 8.1 7.3 7.8 28.7 10.7 9.4 12.1 9.1 8.5 12.0 6.7 11.3 2.1 18.8 15.2 12.7 21.2 9.0 7.5 21.9 14.1 22.3 5.8 8.7 7.9 6.9 15.1 4.4 8.9 6.6 8.7 11.1 3.0 0.9 8.4 4.2 15.1 15.5 10.8 7.1 8.4 10.0 18.8 3.8 9.7 5.5 11.6 13.2 3.5 11.0 11.9 8.7 18.5 21.4 3.0 7.4 8.3 5.9 8.0 29.0 8.7 15.4 15.1 9.5 14.6 3.6 13.4 9.8 4.4 7.4 2.4 26.2 4.7 10.1 5.1 3.2 5.0 8.3 9.4 1.1 11.0 9.6 15.8 16.8 3.1 7.4 8.7 3.1 6.8 5.6 14.1 27.7 1.7 5.6 2.3 13.2 14.2 2.2 4.8 9.3 8.2 12.8 0.9 1.4 15.3 14.0 14.5 3.4 14.0 3.1 16.2 15.2 17.2 12.3 19.8 8.1 3.6 4.8 21.3 4.8 7.2 22.5 21.9 15.0 9.7 19.8 5.8 13.3 9.5 9.3 26.1 12.7 10.9 7.8 17.5 15.9 19.4 23.8 14.2 13.6 8.1 7.8 9.4 12.1 9.0 7.5 8.7 7.9 8.7 8.4 9.7 8.7 480.2 73.7 52.3 2.3 138.2 126.2 196.5 83.4 243.6 5.0 221.4 299.7 83.2 32.9 51.5 31.3 0.0 46.0 203.8 246.0 23.5 62.6 1.4 100.0 72.1 156.1 106.1 6.1 1.1 61.7 72.8 159.7 169.7 126.7 132.9 27.9 86.7 12.8 53.9 3.3 0.6 152.3 46.8 28.9 98.3 4.2 16.4 102.6 94.3 4.7 30.0 17.9 6.2 1.5 0.8 91.6 300.8 10.9 69.7 130.9 158.9 18.5 31.7 2.4 39.5 292.5 201.5 1.7 5.4 174.7 130.4 130.2 150.4 24.2 102.0 111.9 SERTAD3 RBT1 ENSG00000167565 "SERTA domain containing 3" Q9UJW9 19 40440844-40444335 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 187.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068262 Approved Nucleoli NA Yes "Cluster 28: Myeloid DCs - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoli "HPA068262: AB_2685965" "unprognostic (1.56e-2)" "unprognostic (3.57e-2)" "unprognostic (1.10e-1)" "unprognostic (6.55e-3)" "unprognostic (6.50e-2)" "unprognostic (6.74e-2)" "unprognostic (2.24e-2)" "unprognostic (3.51e-3)" "unprognostic (7.18e-2)" "unprognostic (1.25e-1)" "unprognostic (1.28e-3)" "unprognostic (2.80e-2)" "unprognostic (8.74e-3)" "unprognostic (2.34e-1)" "unprognostic (2.88e-1)" "unprognostic (1.18e-1)" "unprognostic (4.66e-3)" 31.9 21.5 10.9 18.7 12.5 22.7 23.3 12.1 11.8 19.9 12.3 29.8 21.5 22.5 26.6 25.9 24.8 25.5 27.9 10.7 12.3 21.2 17.3 24.0 21.8 14.1 12.6 25.8 14.9 22.4 17.7 31.4 13.0 29.1 22.9 2.5 18.0 27.0 27.5 19.4 19.8 27.4 12.4 24.8 24.4 16.1 12.3 16.0 24.8 37.1 16.2 26.1 24.5 14.2 36.6 65.3 22.4 30.4 25.7 38.4 32.6 28.3 38.8 39.7 34.3 24.9 27.2 16.6 12.6 37.9 23.9 12.6 23.0 28.3 21.7 19.2 10.7 11.4 21.5 21.3 31.4 3.2 34.7 35.7 37.3 24.6 17.9 31.7 33.3 8.0 34.6 11.9 32.0 55.4 7.1 14.2 12.7 30.8 17.5 10.1 15.1 14.6 31.4 27.6 3.6 15.1 25.6 42.1 22.9 33.7 37.3 30.6 28.7 34.2 27.7 27.4 23.2 19.0 10.5 14.7 27.5 12.7 15.6 44.8 59.0 66.1 18.5 59.2 19.0 39.9 20.4 20.5 64.7 36.6 14.8 17.7 80.3 22.5 51.7 69.8 17.6 40.0 10.9 12.5 12.1 11.8 10.7 12.3 14.1 12.6 13.0 12.4 12.3 14.2 78.4 9.6 12.0 2.9 42.0 46.1 55.8 139.9 91.6 4.6 81.5 50.9 10.5 11.5 45.4 23.9 4.2 89.8 44.2 40.7 31.3 32.1 11.4 26.0 24.8 42.1 49.1 3.0 0.3 30.5 105.4 38.9 27.5 30.7 21.0 13.2 33.9 6.6 35.0 3.3 0.5 50.8 42.7 27.0 55.3 6.9 28.6 32.1 33.8 8.4 29.1 19.3 4.1 1.5 3.7 37.1 48.5 30.5 16.3 50.5 47.8 22.7 28.0 0.8 59.2 20.2 50.4 15.7 20.0 64.2 43.0 187.4 33.6 17.6 30.6 49.8 SF3B4 "Hsh49, SAP49, SF3b49" ENSG00000143368 "Splicing factor 3b subunit 4" Q15427 1 149923317-149927803 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028578, HPA064660" Approved Approved "Nuclear speckles" NA NA 36000 "Cluster 8: Neutrophils - Inflammatory response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "HPA028578: AB_10601601, HPA064660: AB_2685314" "unprognostic (2.43e-1)" "unprognostic (6.58e-2)" "unprognostic (2.49e-2)" "unprognostic (9.26e-3)" "unprognostic (2.74e-1)" "unprognostic (2.30e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.11e-1)" "unprognostic (2.04e-1)" "unprognostic (6.60e-2)" "unprognostic (2.12e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (1.74e-7)" "unprognostic (9.63e-2)" "unprognostic (6.54e-2)" "unprognostic (3.15e-2)" "unprognostic (1.91e-1)" 35.6 36.8 27.9 42.3 28.4 74.3 31.6 30.1 35.8 36.0 29.3 55.8 39.6 48.5 37.5 45.1 51.8 33.8 28.9 28.6 30.4 29.9 27.1 36.8 48.5 31.1 28.3 47.5 34.6 53.4 26.0 40.1 28.7 32.3 44.2 20.8 40.1 47.9 22.5 62.4 40.1 46.7 28.0 39.4 32.4 46.4 29.1 58.0 39.1 26.9 57.6 50.3 33.4 29.8 153.0 144.1 119.4 110.9 75.5 58.4 172.0 119.0 118.2 188.0 143.0 152.0 125.6 144.2 87.1 139.7 103.0 154.3 150.9 158.2 161.8 95.3 110.7 130.0 77.3 112.8 121.7 156.6 163.5 74.7 122.6 184.0 84.5 59.0 94.6 126.7 116.6 119.6 172.9 456.6 203.9 148.9 199.4 175.9 146.1 157.9 106.4 157.6 137.4 128.2 79.6 147.6 109.8 151.1 92.5 141.4 229.9 205.1 78.3 154.9 170.0 122.9 222.8 169.0 259.4 161.2 124.2 133.8 147.5 70.5 81.1 130.5 84.0 109.8 87.4 80.2 79.6 90.4 71.3 73.1 74.3 71.9 111.2 104.7 120.0 84.6 100.1 67.5 27.9 28.4 30.1 35.8 28.6 30.4 31.1 28.3 28.7 28.0 29.1 29.8 30.4 16.0 13.4 4.2 39.9 54.2 47.5 83.2 65.4 20.0 34.3 41.4 3.9 21.5 41.2 23.9 4.2 80.8 54.2 42.2 60.7 64.3 80.3 38.9 30.4 30.6 26.0 34.3 4.1 51.6 77.5 31.8 27.0 44.5 39.3 32.9 16.8 14.7 53.0 8.4 4.8 40.0 59.0 24.7 42.5 13.3 45.1 34.9 24.9 3.7 61.8 27.5 44.3 4.5 7.0 62.3 35.9 29.3 38.6 32.2 28.5 43.0 49.8 15.9 46.0 30.8 64.6 64.0 51.5 47.0 51.3 94.7 44.9 27.9 36.7 43.8 SFXN1 "FLJ12876, SLC56A1" ENSG00000164466 "Sideroflexin 1" Q9H9B4 5 175477062-175529742 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, One-carbon metabolism, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 99.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 99.8" "Group enriched" "Detected in all" 5 "granulocytes: 99.8;T-cells: 36.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019543, HPA063745" Approved Enhanced Mitochondria NA NA 23000 "Cluster 46: Basophils - DNA binding" "Cluster 85: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 58: T-cells - T-cell receptor" Mitochondria "HPA019543: AB_1856789, HPA063745: AB_2685111" "unprognostic (4.77e-3)" "unprognostic (5.26e-2)" "unprognostic (1.54e-2)" "unprognostic (3.62e-3)" "unprognostic (2.35e-1)" "unprognostic (1.30e-2)" "unprognostic (3.59e-2)" "unprognostic (8.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.17e-2)" "unprognostic (2.48e-2)" "unprognostic (1.51e-1)" "unprognostic (1.31e-1)" "unprognostic (7.30e-2)" "unprognostic (4.98e-1)" "unprognostic (1.08e-3)" "unprognostic (4.23e-2)" 7.6 15.4 14.0 18.2 14.8 21.9 8.1 15.0 17.4 9.3 15.0 28.1 19.3 8.5 8.0 14.7 8.7 9.8 12.3 13.3 15.3 41.6 99.7 5.9 27.0 12.1 12.6 18.7 13.1 15.8 12.9 15.3 13.2 9.6 17.7 20.7 9.6 10.4 10.9 8.8 20.1 11.3 13.0 10.5 14.6 6.6 13.8 24.0 10.5 15.7 27.0 13.8 11.2 14.8 39.9 123.1 61.7 67.0 21.0 44.4 99.2 99.1 41.5 81.3 78.3 156.5 77.6 82.3 74.9 51.9 100.4 49.7 119.0 171.9 87.8 202.1 102.4 60.6 103.4 69.0 30.3 119.6 73.3 36.5 33.1 90.3 39.2 48.3 63.3 74.9 89.1 63.4 60.2 138.3 140.3 9.7 48.7 66.5 41.1 116.3 63.1 87.8 31.3 154.2 104.6 66.7 95.6 88.9 47.8 50.5 43.1 38.3 62.3 63.9 100.3 47.5 130.2 80.2 101.8 184.6 105.1 104.9 68.1 99.8 5.1 26.3 26.2 6.7 21.4 10.7 36.4 29.2 7.3 9.3 28.4 29.3 1.6 12.7 4.3 3.5 32.3 14.2 14.0 14.8 15.0 17.4 13.3 15.3 12.1 12.6 13.2 13.0 13.8 14.8 6.0 3.2 13.5 55.2 29.1 19.5 33.5 30.6 48.9 59.3 13.7 9.9 18.1 17.2 18.8 18.4 47.9 41.4 19.0 68.9 25.4 27.7 1.2 10.9 23.3 14.2 31.2 45.4 77.3 18.7 74.2 24.8 26.0 11.3 9.5 38.1 12.8 98.7 17.2 77.4 62.9 23.9 26.4 8.1 11.4 4.0 47.2 9.5 10.6 30.9 9.0 19.8 37.0 55.3 60.1 31.8 20.1 35.0 63.4 31.6 89.8 51.1 15.5 49.9 26.3 21.7 23.1 2.8 7.4 43.6 21.6 30.9 61.9 67.2 21.7 27.0 SFXN5 "BBG-TCC, SLC56A5" ENSG00000144040 "Sideroflexin 5" Q8TD22 2 72942036-73075619 "Predicted intracellular proteins, Predicted membrane proteins" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.6" "Cell type enhanced" "Detected in many" "Astrocytes: 405.2;Early spermatids: 96.4;Late spermatids: 168.4" "Cancer enhanced" "Detected in all" "glioma: 13.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015473, HPA056866" Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 11: Basophils - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 64: Astrocytes - Nervous system maintenance" "Nucleoplasm, Mitochondria" "HPA015473: AB_1856794, HPA056866: AB_2683261" "unprognostic (7.75e-2)" "unprognostic (1.64e-2)" "unprognostic (1.40e-1)" "unprognostic (2.71e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-3)" "unprognostic (1.21e-1)" "unprognostic (1.49e-1)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "prognostic favorable (2.26e-6)" "unprognostic (1.57e-1)" "unprognostic (8.51e-2)" "unprognostic (3.50e-1)" "unprognostic (3.23e-1)" "unprognostic (3.97e-1)" "unprognostic (1.43e-2)" 3.2 11.7 52.1 4.6 45.5 13.7 2.5 40.0 63.6 3.2 21.9 6.1 6.9 3.1 16.6 3.1 4.2 4.0 3.5 48.0 45.2 11.4 29.4 3.6 3.9 51.5 49.2 2.6 2.4 2.0 3.5 3.7 41.4 4.2 5.7 6.2 2.2 4.5 7.7 4.5 6.5 3.9 42.6 5.6 4.6 2.4 57.0 4.9 3.7 4.6 3.0 3.8 2.3 37.4 4.2 9.1 13.7 11.5 3.0 5.0 5.4 8.4 5.4 13.3 6.9 13.7 10.7 2.3 8.8 8.9 9.2 3.7 10.8 11.1 6.0 10.2 6.7 10.7 11.0 18.7 4.4 5.9 11.1 5.8 3.5 9.0 1.1 4.9 7.4 3.2 9.5 2.9 4.3 8.7 1.5 9.5 17.1 8.1 6.6 10.6 12.2 3.1 8.1 10.5 9.0 2.7 8.6 4.3 3.5 7.7 2.2 5.3 6.8 4.1 13.5 6.1 10.2 4.0 4.1 3.1 15.0 10.3 5.3 4.7 6.0 3.5 0.6 2.6 0.9 1.6 0.3 0.7 2.7 2.4 0.4 0.5 4.6 4.3 3.2 1.9 0.7 1.7 52.1 45.5 40.0 63.6 48.0 45.2 51.5 49.2 41.4 42.6 57.0 37.4 7.1 0.0 4.4 405.2 4.8 4.7 4.3 7.6 4.6 26.8 6.9 5.5 5.8 7.2 4.8 36.8 33.3 12.4 6.8 18.4 3.9 5.1 96.4 5.1 13.1 7.6 13.8 13.7 84.4 9.1 2.4 8.9 9.2 11.2 0.0 42.8 9.3 61.3 12.4 20.2 57.4 8.6 2.0 8.7 9.6 168.4 10.5 9.6 8.8 43.1 19.7 65.8 10.3 40.2 29.9 8.0 6.5 11.3 7.1 3.6 17.5 22.2 3.2 42.3 13.1 12.2 8.8 11.2 15.7 7.3 9.2 4.2 6.3 15.9 8.8 2.3 SGF29 "CCDC101, FLJ32446, TDRD29" ENSG00000176476 "SAGA complex associated factor 29" Q96ES7 16 28553915-28591790 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Early spermatids: 222.2;Late spermatids: 384.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052590, HPA053608" Enhanced Approved Nucleoplasm,Nucleoli Yes No "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" Nucleoli Nucleoplasm "HPA052590: AB_2681875, HPA053608: AB_2682205" "unprognostic (1.38e-2)" "prognostic favorable (4.77e-4)" "unprognostic (1.73e-1)" "unprognostic (2.46e-3)" "unprognostic (2.80e-2)" "unprognostic (7.27e-3)" "unprognostic (1.48e-1)" "prognostic favorable (3.37e-4)" "unprognostic (1.98e-1)" "unprognostic (1.41e-1)" "prognostic favorable (2.99e-4)" "unprognostic (2.96e-1)" "unprognostic (1.35e-2)" "unprognostic (1.66e-1)" "unprognostic (2.19e-1)" "unprognostic (1.76e-1)" "unprognostic (5.42e-3)" 16.8 16.1 13.6 11.2 15.6 12.4 16.5 16.7 14.6 26.8 13.8 28.0 12.8 29.1 9.5 12.0 27.6 9.1 15.3 13.4 14.9 11.1 19.9 14.0 16.9 15.2 14.4 33.3 25.6 10.7 10.3 7.1 15.4 16.4 7.2 7.8 16.6 16.7 51.1 16.0 18.8 12.0 14.9 16.2 19.8 43.0 14.6 14.1 17.6 19.8 10.2 23.5 16.4 16.8 13.1 21.3 16.3 10.5 10.6 10.9 29.5 8.5 9.6 21.7 20.2 24.6 11.5 39.1 21.1 6.7 13.2 15.0 12.4 15.4 6.1 12.8 24.0 24.3 12.9 33.7 27.1 22.1 26.1 11.5 20.0 13.1 13.2 11.7 8.3 24.5 20.8 19.4 7.9 43.4 25.5 43.2 22.7 9.6 20.5 38.9 10.6 34.2 11.3 19.5 26.3 12.2 13.3 25.3 15.0 5.8 20.7 18.4 5.9 15.4 12.9 9.2 15.3 22.4 35.7 22.7 10.9 36.9 12.5 20.6 47.0 50.0 53.6 41.8 65.2 57.9 74.2 65.8 47.6 65.9 84.1 66.3 13.4 55.1 33.7 71.4 78.3 58.7 13.6 15.6 16.7 14.6 13.4 14.9 15.2 14.4 15.4 14.9 14.6 16.8 11.2 16.0 16.7 0.0 20.0 0.0 18.1 0.0 32.5 5.5 12.5 21.1 0.0 12.8 7.4 18.4 14.6 17.3 27.1 7.9 9.8 12.6 222.2 8.5 10.1 8.7 3.6 17.1 0.0 12.9 11.8 12.7 10.2 7.7 6.3 16.9 11.0 17.3 14.2 0.0 0.0 8.8 0.0 12.9 0.0 384.4 30.7 13.5 0.0 0.0 17.1 11.8 22.6 0.0 0.0 10.1 15.7 21.8 16.7 9.5 40.1 23.7 6.6 14.1 19.7 18.3 13.0 10.5 30.9 17.0 0.0 21.1 21.0 14.8 11.9 12.0 SIVA1 "CD27BP, SIVA, Siva-1, Siva-2" ENSG00000184990 "SIVA1 apoptosis inducing factor" O15304 14 104753147-104768494 "Predicted intracellular proteins" "Apoptosis, Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 506.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065398, HPA066693" Supported Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA065398: AB_2685484, HPA066693: AB_2685703" "unprognostic (1.86e-1)" "prognostic favorable (5.95e-4)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (6.89e-2)" "unprognostic (2.27e-1)" "unprognostic (4.77e-3)" "unprognostic (2.89e-1)" "unprognostic (2.17e-2)" "unprognostic (7.19e-3)" "unprognostic (5.85e-3)" "unprognostic (3.21e-2)" "unprognostic (4.94e-2)" "unprognostic (3.06e-2)" "unprognostic (4.08e-1)" "unprognostic (3.51e-1)" "unprognostic (7.43e-2)" 79.8 64.3 36.0 28.4 37.7 102.2 80.8 36.1 60.4 95.9 43.3 108.3 39.8 78.5 9.0 76.1 86.2 24.2 104.6 35.0 36.8 79.6 155.7 65.1 39.6 39.0 36.5 94.4 103.9 16.0 94.2 27.5 36.5 87.8 7.1 3.1 63.2 37.0 168.8 65.5 73.8 10.5 38.3 83.3 91.1 102.7 40.8 69.7 82.9 35.5 12.7 85.4 78.0 38.9 143.3 233.6 58.9 94.8 19.4 24.7 157.8 76.5 41.5 92.2 80.3 179.8 124.1 135.9 109.6 27.5 60.3 138.4 23.2 77.2 7.9 106.6 230.9 56.5 129.5 214.6 48.4 98.8 95.3 29.9 34.5 42.1 13.5 13.6 53.8 382.9 57.7 76.1 22.2 506.6 319.6 225.9 85.9 94.1 317.9 186.6 117.8 107.8 20.7 133.3 151.6 76.2 107.3 63.1 106.4 9.4 123.5 103.0 58.6 74.4 92.8 176.4 124.8 61.0 71.0 161.9 85.6 112.3 84.7 210.7 139.5 255.0 140.4 171.6 159.5 205.1 167.3 154.6 107.5 195.3 182.3 156.1 134.0 102.7 188.2 502.3 195.3 193.9 36.0 37.7 36.1 60.4 35.0 36.8 39.0 36.5 36.5 38.3 40.8 38.9 127.0 60.9 126.7 8.1 109.3 116.5 213.0 188.9 92.8 38.7 178.1 261.1 54.6 107.2 130.2 103.0 12.5 297.4 147.9 145.0 138.9 91.2 241.3 103.3 88.9 109.6 91.1 148.5 6.3 170.9 345.1 139.8 63.7 74.3 145.1 127.9 163.1 221.0 180.6 38.7 6.3 194.0 103.7 89.7 106.5 54.1 140.8 98.0 108.5 5.6 119.6 143.9 84.5 4.5 9.9 113.2 131.8 124.1 131.3 162.4 201.4 180.2 176.5 45.3 111.7 126.2 143.1 368.9 325.2 112.8 116.9 278.4 115.2 136.3 198.7 218.8 SLC10A3 "DXS253E, P3" ENSG00000126903 "Solute carrier family 10 member 3" P09131 X 154487306-154490690 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 63.6;Syncytiotrophoblasts: 103.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in all" 10 "basophil: 218.6" "Lineage enriched" "Detected in all" 17 "granulocytes: 218.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021656 Approved Approved "Intermediate filaments" NA NA "Cluster 38: Basophils - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" "Intermediate filaments" "HPA021656: AB_1856955" "unprognostic (1.60e-1)" "prognostic favorable (4.53e-4)" "prognostic unfavorable (4.15e-5)" "unprognostic (8.00e-3)" "prognostic unfavorable (9.97e-4)" "unprognostic (5.47e-2)" "unprognostic (2.28e-3)" "unprognostic (9.76e-2)" "unprognostic (1.63e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.22e-4)" "unprognostic (3.42e-1)" "unprognostic (2.52e-3)" "unprognostic (6.23e-2)" "unprognostic (2.99e-1)" "unprognostic (7.29e-2)" "unprognostic (2.99e-2)" 23.3 22.9 6.1 13.1 6.2 34.0 21.0 6.8 7.9 27.1 5.8 22.5 13.9 29.6 18.4 31.2 22.8 21.3 23.2 5.9 6.1 20.6 10.3 22.7 15.1 7.4 6.8 40.8 22.8 9.6 18.8 21.1 7.4 22.9 8.3 2.0 17.4 15.7 18.3 42.9 18.7 13.5 6.9 19.3 18.9 8.9 8.1 9.8 20.6 9.4 11.2 31.8 26.0 7.7 66.4 27.0 7.3 38.3 25.2 27.6 48.9 49.2 29.2 32.5 32.3 25.0 31.8 51.0 91.1 46.8 41.3 55.9 24.4 24.7 8.6 32.7 11.8 15.9 36.0 20.3 47.0 19.0 24.9 34.8 28.1 29.9 15.8 28.5 22.6 8.7 17.6 48.6 21.6 90.0 10.2 17.0 5.9 32.4 54.9 16.8 19.9 38.8 24.7 24.2 6.8 12.0 29.8 55.4 13.0 8.5 17.9 15.0 29.5 38.0 23.9 89.6 63.2 34.3 35.6 52.8 40.9 39.6 20.2 218.6 4.5 21.1 12.9 6.5 9.6 5.3 8.5 9.2 3.9 5.2 6.0 5.9 6.1 8.8 5.6 9.5 6.4 6.3 6.1 6.2 6.8 7.9 5.9 6.1 7.4 6.8 7.4 6.9 8.1 7.7 13.3 3.2 7.0 2.3 21.1 22.6 27.1 15.2 50.7 2.8 13.7 11.8 4.0 15.7 7.3 18.4 6.2 49.5 17.4 22.1 7.9 17.8 3.6 13.0 14.8 15.8 10.2 11.1 1.6 19.4 63.6 21.2 13.7 21.0 12.7 15.8 16.8 2.3 19.4 3.3 1.4 15.5 4.1 8.4 19.6 1.2 27.1 22.7 3.6 1.0 13.2 3.0 23.7 1.5 1.6 20.9 16.0 13.2 19.8 14.1 17.2 10.4 6.9 1.9 6.6 12.1 14.3 1.9 2.9 45.5 27.8 103.0 24.5 5.4 11.7 23.5 SLC12A5 "KCC2, KIAA1176" ENSG00000124140 "Solute carrier family 12 member 5" Q9H2X9 20 46021690-46060150 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Symport, Transport" "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 145.8;retina: 117.4" "Cell type enhanced" "Detected in many" "Bipolar cells: 244.0;Cone photoreceptor cells: 383.7;Excitatory neurons: 92.7;Inhibitory neurons: 91.3;Rod photoreceptor cells: 170.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "naive CD4 T-cell: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "Hep G2: 24.9;NB-4: 50.8;SK-BR-3: 24.8;U-2 OS: 28.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072058 Enhanced NA NA "Cluster 35: T-regs - Unknown function" "Cluster 58: Brain - Synaptic function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "HPA072058: AB_2686485" "unprognostic (2.01e-1)" "unprognostic (3.58e-1)" "unprognostic (7.55e-2)" "unprognostic (9.44e-4)" "prognostic unfavorable (5.60e-4)" "unprognostic (2.48e-1)" "unprognostic (5.16e-3)" "unprognostic (3.61e-1)" "unprognostic (2.49e-1)" "unprognostic (6.63e-2)" "unprognostic (3.72e-3)" "unprognostic (5.61e-4)" "unprognostic (8.78e-4)" "unprognostic (3.25e-2)" "unprognostic (9.22e-2)" "unprognostic (1.99e-1)" "unprognostic (2.34e-2)" 1.5 26.7 101.3 0.9 103.5 0.4 1.0 97.6 145.8 0.9 14.9 1.4 1.0 0.7 0.9 0.4 0.5 0.7 5.1 107.0 96.6 1.1 1.2 2.5 2.2 76.3 80.5 2.3 2.2 1.8 41.5 2.0 69.9 1.0 0.9 117.4 0.7 0.5 0.4 0.6 1.6 0.4 69.3 3.0 1.9 7.8 86.7 2.9 0.7 0.2 1.4 0.6 0.7 88.4 0.0 15.2 6.6 4.9 0.6 0.0 1.5 0.6 0.0 0.0 0.5 2.0 0.0 5.8 22.5 0.4 5.9 1.4 4.3 2.3 0.4 3.7 5.7 4.9 3.0 24.9 2.5 0.0 6.5 0.8 0.0 0.0 0.3 10.0 1.4 5.4 9.3 0.0 0.0 23.1 3.5 50.8 2.4 2.1 7.7 5.8 4.2 1.3 2.3 0.0 8.1 11.5 2.9 24.8 7.9 6.0 9.0 14.4 2.3 2.7 28.0 0.2 1.1 0.0 4.2 8.2 5.9 5.9 0.2 0.0 0.6 0.0 1.1 0.4 0.5 0.4 0.1 0.1 0.1 0.5 2.4 1.3 0.0 0.4 0.1 0.0 1.9 0.3 101.3 103.5 97.6 145.8 107.0 96.6 76.3 80.5 69.9 69.3 86.7 88.4 2.2 0.0 0.0 10.4 0.4 0.5 0.0 0.0 0.0 244.0 0.8 2.2 1.2 0.0 0.0 0.0 383.7 1.6 0.9 0.0 1.9 0.1 1.9 0.4 0.1 2.9 19.9 4.4 92.7 0.2 2.5 0.4 1.5 0.6 0.0 14.4 4.6 1.3 19.8 13.5 91.3 0.7 0.0 2.6 5.3 6.1 0.0 3.4 5.4 10.3 0.6 28.2 0.0 3.5 6.3 0.4 0.0 0.0 0.8 0.2 0.0 0.3 0.0 170.9 0.0 0.0 2.2 4.2 7.7 0.1 0.6 1.6 1.0 8.5 0.3 0.1 SLC25A1 "CTP, SLC20A3" ENSG00000100075 "Solute carrier family 25 member 1" P53007 22 19175581-19178739 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Transport "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 197.7" "Cell type enhanced" "Detected in all" "Hepatocytes: 221.1;Proximal enterocytes: 304.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "eosinophil: 101.9" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" "unprognostic (2.12e-1)" "unprognostic (3.98e-1)" "unprognostic (8.17e-2)" "unprognostic (1.13e-1)" "unprognostic (9.39e-2)" "unprognostic (2.61e-2)" "unprognostic (3.11e-2)" "unprognostic (7.12e-2)" "unprognostic (1.06e-1)" "unprognostic (5.74e-2)" "unprognostic (3.90e-2)" "unprognostic (5.72e-2)" "unprognostic (4.52e-2)" "unprognostic (1.84e-1)" "unprognostic (3.46e-2)" "unprognostic (6.14e-2)" "unprognostic (9.03e-2)" 113.3 76.3 45.8 22.3 46.9 14.2 90.3 49.5 58.6 43.5 47.6 63.9 114.1 40.0 16.2 59.2 34.7 21.5 27.3 41.5 65.8 86.8 197.7 33.6 21.4 61.0 58.3 43.6 54.8 33.1 39.3 27.4 73.0 53.9 33.9 5.6 39.5 30.0 17.3 49.1 92.4 21.0 49.4 31.4 52.9 36.3 51.8 16.3 46.1 7.7 25.5 43.9 40.8 55.2 111.9 114.3 85.9 73.6 209.1 102.5 91.2 77.5 96.9 65.7 90.4 136.4 77.2 66.9 38.8 110.5 70.5 95.4 82.9 138.1 37.2 59.6 164.1 35.5 97.7 278.4 148.2 67.3 107.5 145.1 81.7 75.7 58.4 73.3 62.8 53.4 184.6 61.9 74.7 288.1 37.0 80.8 57.5 173.5 70.0 70.4 44.6 29.9 196.2 135.8 55.5 71.2 83.1 163.0 48.6 52.6 122.6 171.7 63.6 80.3 69.3 62.0 53.2 78.2 39.9 35.4 82.5 31.5 41.4 11.6 15.7 101.9 16.6 17.9 10.6 33.3 18.7 18.2 13.7 43.5 16.7 14.3 8.1 13.7 23.8 10.5 19.6 10.6 45.8 46.9 49.5 58.6 41.5 65.8 61.0 58.3 73.0 49.4 51.8 55.2 18.5 9.6 18.9 10.7 35.0 22.0 27.2 21.6 31.9 7.8 44.2 41.9 7.2 38.6 17.0 33.1 2.1 135.6 18.4 178.6 50.9 33.5 30.5 41.4 37.0 16.8 41.0 21.7 5.2 45.6 139.5 27.1 50.4 83.7 2.5 67.5 21.4 221.1 47.5 13.5 6.1 107.3 28.5 30.5 18.2 98.8 28.9 32.6 28.4 2.8 29.6 27.7 16.5 3.0 10.1 39.7 128.1 29.3 38.7 28.7 304.3 127.3 11.1 4.2 13.1 14.5 37.8 15.3 29.5 60.5 30.4 127.7 24.6 55.7 108.3 30.4 SLC25A39 "CGI-69, FLJ22407" ENSG00000013306 "Solute carrier family 25 member 39" Q9BZJ4 17 44319625-44324870 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Heme biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 491.0;Erythroid cells: 1310.3;Late spermatids: 756.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026785 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" "HPA026785: AB_10601715" "unprognostic (8.10e-2)" "unprognostic (2.46e-1)" "unprognostic (1.41e-2)" "unprognostic (1.29e-1)" "unprognostic (6.04e-2)" "unprognostic (2.35e-3)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "prognostic favorable (3.58e-5)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (3.21e-2)" 52.4 123.2 71.4 49.3 72.6 305.6 49.6 72.1 84.4 53.3 84.4 77.5 73.9 47.3 39.8 143.4 44.6 41.7 68.4 67.8 72.4 178.0 142.8 56.1 48.7 75.3 72.7 44.9 120.8 98.9 73.4 46.3 74.9 75.3 47.3 9.4 77.7 43.9 44.7 87.1 62.7 30.4 72.4 89.2 81.8 89.4 76.2 35.6 87.1 47.9 40.2 55.9 62.2 71.4 247.0 152.9 47.0 198.0 89.3 68.8 163.0 79.9 71.8 101.8 78.3 151.9 116.0 131.0 137.7 114.0 180.6 124.0 147.2 242.6 35.9 154.9 236.2 68.9 131.2 281.2 97.1 120.9 145.0 104.8 211.9 95.5 122.2 92.2 105.2 195.3 205.7 204.0 87.4 463.5 153.3 118.0 92.5 187.3 417.4 182.6 129.1 375.6 177.9 128.8 316.1 118.2 92.5 146.5 166.8 85.9 281.3 102.4 76.2 132.9 185.9 229.6 160.3 126.9 165.1 122.6 119.7 93.8 82.4 36.5 56.2 29.2 73.7 83.5 83.0 96.1 79.1 79.0 89.5 78.0 80.3 74.1 8.2 139.6 87.7 103.5 80.3 93.2 71.4 72.6 72.1 84.4 67.8 72.4 75.3 72.7 74.9 72.4 76.2 71.4 36.1 9.6 25.4 17.6 52.2 53.3 71.2 117.2 42.1 18.8 93.2 77.0 27.0 52.9 79.9 69.9 10.4 93.1 42.3 123.7 491.0 188.1 223.6 28.6 24.7 44.5 65.3 1310.3 20.7 310.6 166.3 35.2 71.9 54.1 32.9 44.4 30.0 75.7 134.7 13.5 19.5 120.9 132.2 62.5 44.7 756.5 39.7 61.6 92.5 10.3 99.9 45.3 62.8 8.0 16.0 176.7 88.9 38.7 80.0 162.4 130.9 322.8 41.3 15.3 19.7 27.9 52.3 134.4 105.5 110.7 64.6 117.5 51.8 75.4 157.7 108.2 SLC25A43 ENSG00000077713 "Solute carrier family 25 member 43" Q8WUT9 X 119399336-119454478 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035188, HPA078530" Uncertain Approved Cytosol NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA035188: AB_10602400, HPA078530: " "unprognostic (6.05e-3)" "unprognostic (1.48e-1)" "unprognostic (9.92e-2)" "prognostic unfavorable (3.76e-5)" "unprognostic (4.99e-3)" "unprognostic (1.59e-2)" "unprognostic (3.26e-2)" "unprognostic (2.74e-2)" "unprognostic (7.19e-2)" "unprognostic (2.14e-1)" "unprognostic (2.80e-3)" "unprognostic (1.26e-1)" "prognostic unfavorable (5.06e-8)" "unprognostic (2.63e-1)" "unprognostic (2.62e-1)" "unprognostic (1.96e-2)" "unprognostic (4.92e-2)" 10.6 2.6 3.1 7.3 3.4 1.8 9.3 3.3 4.1 8.2 5.4 14.0 14.2 5.0 3.4 21.4 5.3 4.3 5.0 3.2 3.6 7.7 10.6 10.2 5.5 4.3 3.5 6.0 5.9 6.9 1.9 8.3 3.9 4.6 15.5 0.5 10.8 4.6 1.6 16.3 12.8 8.8 3.5 4.9 8.9 2.1 3.6 3.6 4.2 4.5 11.3 7.9 11.3 3.8 32.4 23.3 1.9 9.2 30.0 44.5 12.2 17.9 21.7 13.8 13.2 12.4 16.0 4.0 10.2 47.4 41.1 23.2 18.2 16.0 12.4 28.5 5.4 11.3 7.4 16.4 19.3 10.6 11.7 18.8 28.3 22.5 19.8 18.9 16.6 6.1 2.3 17.1 15.7 58.9 0.1 15.9 10.3 16.6 35.1 3.2 0.0 4.6 22.3 10.9 1.5 0.0 23.0 47.8 29.1 7.3 8.5 11.0 24.2 22.2 7.1 25.0 28.0 0.4 14.2 8.3 22.3 17.8 19.7 0.0 3.5 0.2 0.9 4.9 1.7 4.4 1.8 2.9 6.0 3.7 0.9 1.8 0.1 6.4 11.2 1.6 1.5 1.6 3.1 3.4 3.3 4.1 3.2 3.6 4.3 3.5 3.9 3.5 3.6 3.8 8.3 6.4 9.7 30.7 8.0 7.8 7.3 8.9 9.6 0.2 6.1 6.6 1.6 2.8 5.6 3.7 0.0 11.9 9.1 21.8 9.8 4.5 0.0 0.9 7.6 6.9 7.3 3.4 10.3 8.9 7.1 11.8 9.7 1.8 8.2 2.1 6.4 5.8 10.3 0.0 6.2 9.6 4.1 7.1 13.6 0.4 8.1 7.5 10.6 1.0 11.9 0.2 9.2 36.7 1.4 13.9 11.4 5.7 2.8 5.4 19.8 9.6 2.0 0.4 0.0 7.8 9.2 0.5 2.3 19.8 13.9 6.8 6.8 1.0 12.2 5.8 SLC25A5 "2F1, ANT2, T2, T3" ENSG00000005022 "Solute carrier family 25 member 5" P05141 X 119468422-119471396 "FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" "Antiport, Chromosome partition, Host-virus interaction, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 2533.6;Proximal enterocytes: 2785.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046835, HPA071684" Approved Supported Mitochondria NA NA 640000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" Mitochondria "HPA046835: AB_2679831, HPA071684: AB_2686431" "unprognostic (1.25e-2)" "prognostic favorable (7.35e-4)" "prognostic favorable (7.47e-4)" "unprognostic (1.48e-1)" "unprognostic (4.58e-2)" "unprognostic (1.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (6.52e-2)" "unprognostic (2.47e-1)" "unprognostic (1.60e-1)" "unprognostic (2.17e-1)" "prognostic favorable (8.06e-6)" "unprognostic (1.41e-1)" "unprognostic (2.65e-1)" "unprognostic (4.36e-2)" "unprognostic (3.03e-1)" 178.1 178.3 116.9 176.0 116.1 260.9 161.3 141.6 126.0 155.0 114.3 458.7 740.2 134.5 63.9 411.0 118.6 100.4 196.1 109.0 141.5 491.8 336.1 216.5 255.4 120.6 118.0 108.2 629.1 295.3 89.0 138.1 126.4 111.9 503.0 127.7 250.2 103.8 61.6 294.9 562.8 150.5 119.3 182.6 492.1 54.2 126.4 351.9 128.8 65.1 297.7 200.8 235.3 121.5 845.1 789.6 303.3 525.4 189.5 277.3 561.0 306.8 331.3 631.7 560.8 662.4 518.4 1059.3 400.9 296.1 456.1 576.9 752.1 640.5 572.5 281.1 711.2 357.5 418.7 477.0 239.8 984.0 566.1 303.7 705.2 652.2 412.6 240.1 660.4 535.0 292.5 425.9 350.1 1868.4 878.6 995.1 640.4 1147.6 1244.3 474.5 383.4 825.7 486.9 663.6 365.0 344.5 526.7 793.3 646.7 306.7 327.7 491.0 279.5 297.3 428.9 670.8 1122.2 494.6 656.3 847.4 329.5 987.7 492.2 113.4 603.4 170.2 170.7 1045.7 198.1 459.2 248.3 224.6 872.6 376.0 243.3 232.1 99.2 318.1 824.2 476.1 443.1 931.8 116.9 116.1 141.6 126.0 109.0 141.5 120.6 118.0 126.4 119.3 126.4 121.5 260.4 163.5 308.6 28.7 339.6 815.7 567.0 1615.3 398.9 109.8 406.2 413.5 131.2 301.7 609.2 187.6 60.5 1038.8 336.2 1379.0 2533.6 578.2 4.0 137.3 134.2 257.5 401.0 349.1 16.8 1056.4 463.1 214.4 543.3 157.6 192.9 306.0 146.7 333.6 881.7 26.9 25.5 856.4 1129.1 610.6 650.9 18.1 145.4 473.2 547.8 15.0 441.2 140.8 218.3 24.1 19.2 554.1 1061.8 110.6 419.9 522.3 2785.2 1622.3 239.5 199.0 131.5 163.9 506.7 11.5 119.2 1046.8 960.2 1589.1 291.2 626.6 1053.7 809.7 SLC34A3 "FLJ38680, NPTIIc" ENSG00000198569 "Solute carrier family 34 member 3" Q8N130 9 137230757-137236555 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 9.7;kidney: 13.6" "Group enriched" "Detected in some" 9 "Proximal enterocytes: 83.7;Proximal tubular cells: 40.3" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 4.0;HDLM-2: 2.8;HeLa: 3.3;MCF7: 7.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA023776 Enhanced NA NA "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA023776: AB_1857102" "unprognostic (2.69e-1)" "unprognostic (4.16e-1)" "unprognostic (9.08e-3)" "unprognostic (1.83e-2)" "unprognostic (2.41e-1)" "unprognostic (1.29e-3)" "unprognostic (4.02e-3)" "unprognostic (1.75e-2)" "unprognostic (1.05e-2)" "unprognostic (9.84e-3)" "unprognostic (2.05e-2)" "unprognostic (2.20e-2)" "unprognostic (5.94e-2)" "unprognostic (1.94e-2)" "unprognostic (9.12e-2)" "unprognostic (5.80e-2)" "unprognostic (2.20e-1)" 0.0 0.1 0.1 0.1 0.3 0.3 0.0 0.0 0.5 0.2 0.0 0.1 0.5 0.2 0.0 2.9 0.4 0.5 0.2 0.2 0.2 13.6 0.0 0.3 0.2 1.8 2.0 0.0 0.6 0.0 1.2 0.0 0.5 0.3 0.0 0.2 1.6 0.0 0.1 0.4 9.7 0.0 0.5 0.2 0.4 0.4 0.8 0.0 0.3 0.0 0.0 0.1 0.5 1.1 0.6 1.2 0.7 1.5 0.0 0.0 0.3 0.4 0.0 0.1 0.0 0.5 4.0 0.5 0.1 0.0 0.1 1.8 0.0 0.0 0.1 2.8 0.3 0.1 3.3 1.5 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.3 0.6 0.0 7.6 0.0 0.1 0.3 0.7 0.8 0.9 0.5 0.0 0.0 0.6 0.0 1.3 0.4 0.9 0.2 0.6 2.2 0.0 0.3 0.3 0.3 1.5 0.1 0.7 0.3 0.3 0.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.5 0.2 0.2 1.8 2.0 0.5 0.5 0.8 1.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.3 0.0 0.0 0.0 83.7 40.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "L0R6Q1, Q96G79" 5 140564446-140569100 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA062210: AB_2684712" "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favorable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 45.6 62.1 34.0 39.8 37.3 23.2 42.2 38.9 35.6 36.7 29.9 51.6 45.6 38.0 31.3 69.1 39.4 33.9 72.2 31.5 36.7 58.6 53.8 46.3 42.0 39.6 38.7 32.7 44.3 59.4 24.1 33.1 38.2 41.1 47.5 19.5 66.0 33.6 138.5 64.3 44.0 36.1 36.9 47.5 46.4 45.1 38.0 44.3 44.6 94.1 44.4 42.2 41.6 34.9 43.9 134.2 57.5 124.6 77.5 43.0 92.4 60.8 45.5 84.3 91.3 186.2 57.0 115.7 80.0 65.7 105.2 55.2 0.0 107.7 59.3 155.0 96.7 91.3 109.1 1.3 74.7 91.7 83.7 65.5 92.6 83.3 71.0 38.2 74.2 73.0 83.6 136.4 80.5 98.3 110.5 62.7 43.5 74.2 92.1 82.5 93.5 129.2 69.1 79.5 66.6 91.1 79.8 157.1 84.0 50.4 131.4 52.7 69.3 78.2 52.9 70.0 78.7 57.8 127.8 53.9 54.0 127.6 91.9 16.6 65.0 37.0 56.5 83.1 54.4 29.9 45.5 52.1 75.5 32.7 53.5 49.3 24.5 63.4 79.4 28.3 33.7 83.4 34.0 37.3 38.9 35.6 31.5 36.7 39.6 38.7 38.2 36.9 38.0 34.9 13.0 12.8 22.4 4.9 17.0 10.5 23.2 20.3 15.4 13.7 21.1 15.4 30.0 32.9 21.8 16.5 4.2 32.1 13.2 56.4 45.0 33.3 71.3 9.4 11.8 18.1 25.2 19.0 3.3 35.1 50.2 16.2 24.5 15.5 21.0 14.3 25.4 25.0 32.9 13.5 3.5 27.9 20.3 24.2 13.3 127.2 12.5 18.9 17.8 5.6 27.6 28.6 44.3 3.5 5.7 39.5 26.4 12.4 15.7 22.1 33.5 39.9 10.5 10.3 32.9 11.8 15.0 9.7 17.5 20.4 11.6 30.5 17.6 18.1 38.5 28.8 SLC52A2 "D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2" ENSG00000185803 "Solute carrier family 52 member 2" Q9HAB3 8 144333957-144361286 "Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Host cell receptor for virus entry, Receptor" "Deafness, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 149.0;PC-3: 167.6" "Low region specificity" "Detected in all" HPA063036 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA063036: AB_2684928" "unprognostic (7.80e-3)" "prognostic unfavorable (7.55e-4)" "unprognostic (2.15e-1)" "unprognostic (2.94e-1)" "unprognostic (3.09e-2)" "unprognostic (3.94e-2)" "prognostic unfavorable (2.04e-6)" "unprognostic (7.74e-3)" "unprognostic (9.20e-2)" "unprognostic (2.24e-2)" "unprognostic (4.85e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (3.12e-2)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" 29.7 31.6 13.7 5.4 13.4 5.6 27.8 15.3 18.5 21.7 14.5 35.7 9.4 23.0 8.0 33.3 17.3 3.2 26.4 13.5 14.5 29.2 16.9 24.6 5.6 15.0 14.9 15.6 41.6 5.3 24.5 7.7 14.6 22.2 5.7 1.3 29.8 6.3 13.5 30.4 29.6 4.3 14.0 34.8 31.4 31.5 15.1 4.0 21.7 2.7 4.1 24.9 21.2 14.1 38.7 65.0 7.5 17.9 19.3 12.3 37.3 28.1 18.9 26.5 24.6 57.9 42.3 16.3 42.3 27.5 20.7 42.6 18.4 25.3 9.8 18.3 34.5 26.3 31.3 50.1 51.7 9.4 29.4 14.8 34.7 27.4 24.4 19.2 15.8 16.2 40.9 23.7 18.7 149.0 15.6 38.0 17.9 51.5 167.6 29.8 8.9 44.9 30.6 34.4 25.9 29.4 31.1 44.1 35.7 9.9 27.8 18.7 20.2 20.9 46.9 48.2 37.9 9.4 13.8 12.4 37.8 26.6 25.7 0.5 4.2 9.2 5.6 5.9 3.8 3.3 3.9 5.6 4.5 9.8 3.6 2.6 1.1 5.2 7.5 7.6 5.7 1.5 13.7 13.4 15.3 18.5 13.5 14.5 15.0 14.9 14.6 14.0 15.1 14.1 31.9 6.4 8.7 5.5 24.3 31.2 27.0 41.5 12.0 11.1 30.6 17.0 3.1 12.8 34.4 12.9 2.1 85.0 36.3 81.8 0.0 62.3 3.3 11.6 16.6 24.3 17.4 7.8 3.2 66.9 92.1 22.2 42.3 21.5 10.2 16.6 18.9 5.5 52.4 11.8 3.7 56.3 36.7 13.5 27.8 5.8 12.8 21.4 30.2 2.8 40.7 14.3 19.6 7.1 2.4 85.1 46.7 19.9 43.3 54.7 52.4 14.5 11.7 10.8 19.7 12.1 31.1 34.0 40.2 20.2 36.1 52.5 24.8 23.4 65.6 36.7 SLC9A3R2 "E3KARP, NHERF-2, SIP-1, TKA-1" ENSG00000065054 "SLC9A3 regulator 2" Q15599 16 2025356-2039026 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 568.2" "Cell type enhanced" "Detected in many" "Adipocytes: 1013.8;Endothelial cells: 398.9;Hepatic stellate cells: 374.4;Hepatocytes: 227.4;Pancreatic endocrine cells: 326.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 2.2;intermediate monocyte: 1.6;myeloid DC: 3.9;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 5 "dendritic cells: 3.9;monocytes: 2.2" "Cell line enhanced" "Detected in many" "A549: 188.6;MCF7: 306.8;PC-3: 281.2;SK-BR-3: 188.3;U-251 MG: 193.6;WM-115: 202.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001672, HPA066520" Enhanced Supported "Plasma membrane" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Plasma membrane" "HPA001672: AB_1080017, HPA066520: AB_2732748" "unprognostic (6.99e-2)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "prognostic favorable (1.03e-4)" "unprognostic (1.41e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-3)" "unprognostic (9.17e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.70e-2)" "unprognostic (2.20e-2)" "unprognostic (6.20e-3)" "unprognostic (9.10e-2)" "unprognostic (2.40e-1)" "unprognostic (2.80e-2)" 234.7 81.7 107.0 20.7 98.6 0.7 181.7 83.4 119.7 92.6 60.6 77.4 27.2 92.7 10.7 47.3 77.7 34.8 568.2 82.4 88.5 207.5 408.3 289.1 22.0 96.4 95.5 57.9 47.7 24.0 95.6 51.3 99.3 129.1 11.9 3.0 149.1 42.4 144.6 45.3 81.2 18.8 87.0 143.8 109.5 36.3 116.2 7.9 188.4 109.0 7.4 77.4 72.6 94.7 32.5 188.6 5.0 38.6 6.2 8.6 5.7 138.1 81.9 67.9 22.5 25.4 41.9 0.1 63.4 59.2 9.1 30.9 15.0 13.7 7.1 0.4 45.0 3.1 80.8 61.6 44.3 0.5 13.9 9.2 13.7 20.2 5.9 32.1 68.2 15.0 24.0 2.9 4.8 306.8 0.6 35.7 7.5 76.8 281.2 27.6 8.1 50.5 16.0 2.9 35.3 33.1 9.7 188.3 12.8 5.0 152.6 16.8 176.4 21.5 30.7 1.9 193.6 5.1 4.6 0.7 2.5 3.6 202.4 0.0 2.2 0.0 0.5 1.6 0.2 0.0 0.1 0.1 3.9 0.0 0.4 0.5 0.0 0.0 0.5 2.9 0.1 0.7 107.0 98.6 83.4 119.7 82.4 88.5 96.4 95.5 99.3 87.0 116.2 94.7 1013.8 3.2 10.5 4.2 7.3 15.2 19.6 17.1 7.4 2.6 79.5 65.0 25.5 88.6 47.3 12.9 0.0 1.0 11.4 13.3 5.9 36.1 16.1 37.2 36.8 398.9 21.5 17.3 3.4 8.8 0.8 53.5 33.6 67.8 0.0 5.1 374.4 227.4 2.6 3.3 5.5 77.0 22.4 30.9 35.1 35.8 82.0 7.0 33.8 31.9 2.2 17.2 7.2 4.0 3.6 326.8 9.3 44.4 4.9 51.8 1.2 14.7 27.3 5.0 26.3 22.3 69.1 7.0 15.4 3.4 11.4 1.0 8.8 9.5 18.0 66.6 SLIRP "C14orf156, DC50" ENSG00000119705 "SRA stem-loop interacting RNA binding protein" Q9GZT3 14 77708071-77761104 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 1099.6;Proximal tubular cells: 1027.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020291 Approved Supported Mitochondria No Yes 32000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA020291: AB_1845563" "unprognostic (9.28e-2)" "unprognostic (4.88e-2)" "unprognostic (1.87e-1)" "unprognostic (3.62e-1)" "unprognostic (1.34e-1)" "prognostic unfavorable (4.88e-4)" "unprognostic (1.18e-1)" "unprognostic (8.23e-2)" "unprognostic (2.19e-1)" "unprognostic (1.14e-2)" "unprognostic (1.92e-2)" "unprognostic (1.35e-1)" "unprognostic (9.95e-3)" "unprognostic (1.52e-1)" "unprognostic (2.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.37e-1)" 121.9 131.0 241.0 80.4 251.7 122.7 155.0 250.5 391.0 92.8 228.9 161.3 112.5 91.5 196.3 163.7 89.6 68.3 336.8 249.8 251.6 203.0 211.2 81.1 82.8 251.4 247.5 82.0 110.5 145.2 120.2 91.9 248.6 95.7 141.3 109.9 105.0 90.3 364.5 92.1 107.6 97.0 248.2 92.9 140.2 122.9 245.9 97.4 94.6 442.3 113.5 123.8 101.8 261.2 422.5 867.3 340.9 330.8 226.0 227.7 441.2 240.0 234.8 484.1 419.6 1187.1 387.1 314.2 238.9 284.7 295.6 415.7 645.4 508.0 647.3 166.5 717.2 316.3 816.1 1199.5 343.4 211.8 216.6 242.5 332.3 387.3 428.2 232.4 408.7 403.2 321.2 172.8 430.0 1442.6 325.3 562.2 525.1 938.0 1211.5 294.8 282.9 345.6 508.8 840.3 425.5 274.1 253.3 533.0 360.3 373.7 555.7 360.9 227.0 237.1 422.5 254.0 416.9 184.8 374.7 605.0 325.7 407.2 309.6 88.9 276.1 103.9 105.2 275.3 112.0 169.4 139.0 104.6 239.8 143.1 143.4 120.3 87.8 93.3 288.8 247.4 154.9 216.2 241.0 251.7 250.5 391.0 249.8 251.6 251.4 247.5 248.6 248.2 245.9 261.2 130.4 109.0 140.0 8.5 112.3 178.8 164.5 542.9 92.8 68.8 168.8 154.3 1099.6 270.2 303.9 264.8 47.9 393.0 82.7 330.9 770.9 405.1 548.5 163.7 141.9 169.0 246.8 203.2 10.8 530.1 382.3 166.0 119.3 123.7 171.5 73.1 179.2 793.4 313.6 43.7 9.6 373.1 388.6 202.8 119.5 123.0 168.0 135.2 250.8 2.8 211.4 206.4 93.7 8.5 16.7 440.6 334.4 170.0 136.9 190.5 563.3 1027.1 254.5 126.8 170.9 178.6 202.7 382.6 210.3 178.5 214.4 240.5 80.6 84.7 404.0 163.8 SMARCD2 "BAF60B, CRACD2, PRO2451, Rsc6p" ENSG00000108604 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2" Q92925 17 63832081-63843065 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 101.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059934, HPA061348" Enhanced Nucleoplasm NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA059934: AB_2684170, HPA061348: AB_2684486" "unprognostic (1.70e-1)" "unprognostic (2.17e-2)" "unprognostic (8.04e-2)" "unprognostic (3.84e-2)" "unprognostic (1.59e-1)" "unprognostic (2.00e-2)" "unprognostic (7.84e-2)" "unprognostic (4.79e-1)" "prognostic unfavorable (3.51e-4)" "unprognostic (4.75e-1)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (1.81e-2)" "unprognostic (1.26e-1)" "unprognostic (1.79e-3)" "unprognostic (6.80e-2)" 53.8 55.2 23.3 44.6 28.1 71.6 65.9 35.5 28.5 48.0 29.1 49.9 51.1 37.4 58.5 71.3 52.9 33.1 31.2 22.9 23.2 26.4 54.9 46.7 66.0 27.7 26.7 38.3 89.5 42.8 36.7 47.8 27.0 52.7 46.6 17.6 78.0 49.0 25.3 97.0 49.8 32.4 25.5 60.6 68.2 42.7 25.6 70.2 33.8 34.2 70.1 52.3 55.9 31.7 142.9 87.9 21.3 93.0 133.6 196.1 139.7 52.5 64.1 97.5 61.7 101.7 76.8 163.0 32.5 79.0 43.9 99.4 65.7 99.1 57.3 61.1 169.5 109.3 40.3 141.7 102.3 159.5 128.9 154.3 122.0 55.3 42.1 56.4 78.3 110.8 89.5 101.7 57.2 279.1 203.8 132.3 51.3 202.0 96.9 195.0 77.8 185.0 66.9 96.0 80.2 145.9 79.2 228.4 97.1 69.3 212.2 121.7 58.4 67.7 52.5 61.4 90.7 119.8 113.2 113.5 54.1 129.6 50.4 4.2 9.1 8.8 9.4 8.4 5.6 7.2 9.9 9.8 12.1 9.5 6.3 8.5 10.8 8.0 10.0 10.1 11.5 6.0 23.3 28.1 35.5 28.5 22.9 23.2 27.7 26.7 27.0 25.5 25.6 31.7 14.8 28.9 42.4 19.9 18.2 22.9 23.6 14.3 26.2 9.7 47.1 41.0 5.9 30.0 25.2 16.5 6.2 54.9 21.1 36.0 3.9 16.9 1.0 17.6 25.3 17.4 33.0 12.6 7.2 19.6 38.2 25.8 18.8 20.7 14.0 88.1 25.7 83.3 22.0 11.8 5.8 42.0 12.2 36.9 19.6 5.4 49.4 23.1 14.2 8.4 31.9 16.9 15.5 6.6 10.7 21.0 26.2 30.9 12.6 19.0 30.0 11.6 23.8 12.4 32.9 21.9 14.6 12.3 22.4 29.7 31.1 52.9 16.7 101.7 40.8 24.1 SMDT1 "C22orf32, DDDD, dJ186O1.1, EMRE" ENSG00000183172 "Single-pass membrane protein with aspartate rich tail 1" Q9H4I9 22 42079691-42084284 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032117, HPA060340" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 22: NK-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "HPA032117: AB_10601093, HPA060340: AB_2684257" "unprognostic (1.11e-2)" "unprognostic (1.46e-3)" "unprognostic (5.77e-2)" "prognostic favorable (5.32e-8)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (1.03e-1)" "unprognostic (2.07e-2)" "unprognostic (2.55e-1)" "unprognostic (4.84e-2)" "prognostic favorable (5.87e-4)" "unprognostic (2.96e-1)" "prognostic favorable (2.36e-9)" "unprognostic (1.91e-1)" "unprognostic (2.65e-1)" "unprognostic (1.45e-1)" "unprognostic (9.72e-3)" 12.2 13.9 21.6 6.1 22.2 17.6 19.5 25.7 27.7 14.6 21.2 14.7 10.3 12.3 19.5 12.6 15.2 7.4 20.0 22.1 22.0 18.2 15.1 9.7 16.1 21.6 21.4 22.5 21.5 18.0 14.9 7.3 22.2 16.1 11.2 16.0 22.7 13.4 35.6 14.8 13.5 8.4 21.3 12.6 17.7 6.9 21.3 12.4 18.6 37.9 12.2 12.4 11.9 22.4 5.7 3.7 7.4 8.9 13.1 9.5 5.8 2.0 10.0 12.1 10.5 7.1 5.3 7.8 2.4 10.3 3.4 6.1 9.8 10.4 7.7 3.8 15.7 4.7 8.1 10.3 16.5 8.6 5.9 7.4 17.3 4.8 9.9 6.9 12.2 5.1 7.9 12.3 8.4 11.2 12.1 13.0 2.8 14.1 2.7 10.8 6.5 20.8 15.5 6.4 9.2 6.0 5.0 11.1 12.8 3.7 9.3 9.3 4.8 5.1 5.3 4.5 3.9 8.2 9.8 16.9 7.9 8.5 4.1 4.0 5.8 2.9 3.1 3.1 5.9 5.9 8.6 4.5 8.4 7.2 9.3 6.0 0.5 5.5 4.5 6.4 5.4 5.4 21.6 22.2 25.7 27.7 22.1 22.0 21.6 21.4 22.2 21.3 21.3 22.4 161.1 83.3 109.3 11.8 295.0 166.7 202.2 157.3 191.2 71.6 400.9 477.3 350.9 237.4 160.3 204.1 20.9 308.7 127.8 285.6 573.2 160.0 114.0 156.8 81.1 138.2 345.2 135.7 10.5 199.6 190.6 127.8 150.3 127.2 91.4 55.4 161.3 380.1 256.1 55.5 12.8 356.5 262.4 164.5 200.6 131.9 189.2 187.7 211.7 5.6 125.8 196.4 124.6 7.5 13.8 193.7 314.0 149.0 275.8 238.2 486.7 623.4 223.7 109.5 124.9 133.6 202.7 256.0 55.5 271.5 274.1 308.8 186.3 151.7 308.8 272.2 SMIM5 C17orf109 ENSG00000204323 "Small integral membrane protein 5" Q71RC9 17 75633434-75641404 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 28.4" "Cell type enhanced" "Detected in many" "Collecting duct cells: 125.0;Distal tubular cells: 92.0;Endometrial ciliated cells: 69.4;Erythroid cells: 142.5;Glandular and luminal cells: 67.6;Urothelial cells: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 56 "plasmacytoid DC: 207.6" "Lineage enriched" "Detected in many" 56 "dendritic cells: 207.6" "Cell line enhanced" "Detected in some" "HEL: 2.3;MCF7: 10.5;OE19: 2.8;SK-BR-3: 4.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA065332, HPA071268" Approved Approved "Golgi apparatus,Vesicles" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" Vesicles "Golgi apparatus" "HPA065332: AB_2685471, HPA071268: AB_2686377" "unprognostic (6.97e-2)" "prognostic favorable (5.52e-4)" "unprognostic (2.13e-2)" "unprognostic (1.24e-1)" "unprognostic (9.31e-2)" "unprognostic (1.05e-4)" "unprognostic (3.29e-2)" "unprognostic (2.16e-2)" "unprognostic (1.82e-1)" "unprognostic (2.66e-2)" "unprognostic (3.52e-3)" "unprognostic (1.10e-1)" "prognostic favorable (1.12e-4)" "unprognostic (2.64e-1)" "unprognostic (4.94e-2)" "unprognostic (8.26e-2)" "unprognostic (2.58e-1)" 1.3 0.6 4.5 1.9 8.5 11.4 1.5 8.5 6.4 8.4 10.7 10.5 9.6 1.2 0.8 27.4 7.4 4.4 12.2 5.0 5.6 28.4 1.4 3.1 1.1 11.2 8.8 2.7 2.5 3.4 2.4 1.9 9.6 4.2 2.6 0.7 7.8 1.9 0.5 14.3 15.2 0.5 7.2 4.8 10.1 2.2 7.8 0.6 15.9 0.3 3.6 6.1 14.6 16.4 1.8 1.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 2.3 0.4 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 10.5 0.1 0.0 0.0 2.8 0.1 0.3 0.3 0.0 0.0 2.0 0.8 0.0 0.0 4.5 0.0 0.3 0.6 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.5 0.5 1.1 0.3 0.6 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 3.7 0.1 0.0 207.6 0.0 13.7 4.5 8.5 8.5 6.4 5.0 5.6 11.2 8.8 9.6 7.2 7.8 16.4 0.7 9.6 7.0 0.7 1.6 1.1 7.3 4.8 0.6 1.5 1.2 0.9 25.1 10.0 13.9 125.0 2.1 3.1 51.9 48.4 92.0 2.9 0.1 69.4 10.1 1.8 14.4 142.5 0.0 0.5 5.8 2.3 26.0 67.6 0.0 0.3 1.8 0.2 0.7 0.0 0.0 16.1 44.7 0.6 0.9 0.3 0.6 17.0 7.2 0.0 1.2 3.3 1.0 0.0 17.9 10.7 54.2 1.5 0.9 7.4 15.5 0.9 48.0 2.1 0.0 1.4 3.1 0.4 0.5 10.0 8.4 32.8 0.8 0.3 2.3 90.6 SNRNP35 U1SNRNPBP ENSG00000184209 "Small nuclear ribonucleoprotein U11/U12 subunit 35" Q16560 12 123458088-123473154 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059145, HPA067031" Supported Supported Nucleoli NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoli "HPA059145: AB_2683926, HPA067031: AB_2685766" "unprognostic (3.80e-2)" "unprognostic (1.17e-2)" "unprognostic (6.16e-2)" "unprognostic (1.35e-3)" "unprognostic (6.78e-2)" "unprognostic (1.96e-1)" "unprognostic (7.43e-2)" "unprognostic (2.30e-1)" "unprognostic (1.75e-1)" "unprognostic (6.24e-2)" "unprognostic (2.56e-3)" "unprognostic (7.24e-2)" "unprognostic (3.36e-2)" "unprognostic (1.21e-1)" "unprognostic (7.10e-2)" "unprognostic (2.30e-2)" "unprognostic (1.31e-3)" 19.0 20.0 33.1 16.0 34.8 17.6 18.7 36.2 46.3 24.2 33.4 20.8 15.4 22.2 15.1 26.2 19.0 10.3 41.2 32.7 35.3 29.2 26.4 19.1 20.1 34.6 34.0 17.1 19.2 20.5 24.5 16.8 34.1 24.9 17.8 18.3 23.7 12.7 79.5 26.5 23.3 16.2 32.0 30.8 22.9 16.4 34.8 18.7 23.3 43.3 19.3 18.4 21.4 37.2 22.8 23.7 28.1 14.4 20.0 18.6 24.6 19.5 28.4 20.1 14.6 14.9 15.3 45.0 14.0 28.4 14.5 23.0 24.3 34.9 17.2 33.0 19.7 21.1 22.0 34.6 14.0 21.8 32.5 22.7 24.0 18.0 17.1 36.3 27.8 14.0 27.5 8.9 28.4 48.0 23.6 49.1 19.6 30.5 22.4 18.0 12.3 24.0 46.8 45.2 23.9 35.3 17.3 36.1 28.2 27.8 43.6 29.1 32.4 13.3 24.3 16.9 17.7 22.0 23.8 26.6 21.7 21.1 18.6 81.0 45.6 74.3 43.3 48.5 43.0 71.5 54.3 49.2 47.0 66.2 41.9 45.2 70.2 47.9 47.0 47.8 79.3 36.8 33.1 34.8 36.2 46.3 32.7 35.3 34.6 34.0 34.1 32.0 34.8 37.2 21.4 51.3 20.1 14.0 25.0 14.0 19.1 57.3 13.1 30.9 16.3 19.3 29.5 18.6 36.7 33.1 12.5 51.6 31.3 26.9 50.9 35.2 38.3 26.1 21.2 22.5 14.9 29.2 8.4 33.6 34.8 19.3 27.0 22.9 13.3 19.9 23.9 27.1 33.1 15.2 12.1 22.4 44.7 17.0 10.2 10.9 24.2 19.3 16.0 11.2 35.9 37.1 39.1 12.1 27.1 35.0 33.4 25.9 15.9 20.6 37.4 48.9 32.5 28.6 32.9 19.0 24.1 25.3 24.2 18.9 14.5 42.0 24.4 18.3 18.1 25.4 SNX12 ENSG00000147164 "Sorting nexin 12" Q9UMY4 X 71056332-71073426 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB070423 Approved NA NA 89000 "Cluster 10: Basophils - Unknown function" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" "CAB070423: AB_11153407" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.39e-1)" "prognostic unfavorable (1.17e-4)" "unprognostic (4.83e-3)" "unprognostic (9.88e-3)" "unprognostic (1.61e-2)" "unprognostic (1.34e-1)" "unprognostic (2.46e-1)" "unprognostic (9.55e-2)" "unprognostic (1.29e-3)" "unprognostic (6.15e-2)" "prognostic favorable (1.51e-7)" "unprognostic (3.52e-2)" "unprognostic (8.81e-2)" "unprognostic (1.54e-1)" "unprognostic (9.59e-2)" 26.6 37.6 36.4 27.4 38.3 28.1 29.6 34.4 39.9 31.9 26.0 35.9 37.4 36.1 34.2 49.7 33.2 30.0 40.7 33.7 40.2 42.1 25.0 26.9 23.4 36.8 38.7 39.2 24.8 59.6 18.8 35.6 37.2 33.7 34.3 28.5 27.9 43.9 44.3 43.3 42.8 41.0 37.4 24.1 32.6 16.1 40.6 25.2 42.0 51.3 29.3 40.4 31.2 34.4 67.9 97.6 53.6 46.8 79.9 73.2 58.7 75.8 75.7 74.1 65.7 73.2 110.7 36.4 62.9 89.7 120.3 57.4 104.8 89.4 64.3 29.0 55.4 39.3 108.8 40.7 65.4 38.4 46.0 57.9 94.3 94.5 67.5 61.3 87.1 37.6 60.8 61.3 108.6 69.7 46.5 28.9 71.6 109.7 84.6 45.2 81.6 57.2 60.5 58.3 36.9 28.4 101.4 55.9 65.1 65.2 35.5 30.1 101.5 66.8 64.8 92.6 46.0 35.0 54.8 42.7 64.8 83.9 47.8 6.9 2.9 4.9 2.6 4.2 3.0 4.2 2.9 2.3 3.3 3.1 2.2 3.5 2.5 3.5 2.5 2.7 4.7 1.6 36.4 38.3 34.4 39.9 33.7 40.2 36.8 38.7 37.2 37.4 40.6 34.4 12.2 0.0 6.7 2.9 11.8 15.3 22.5 17.2 22.2 10.1 15.4 13.5 21.4 21.5 12.8 11.0 2.1 40.2 5.6 21.8 11.7 27.3 0.5 3.6 11.8 16.8 10.8 10.1 6.4 24.4 22.5 13.5 10.7 8.2 14.5 6.6 16.8 13.8 24.3 15.2 6.0 16.8 16.2 17.6 11.2 1.2 10.8 12.8 17.8 1.9 24.1 12.5 15.5 7.1 4.8 31.5 9.0 19.9 5.9 12.3 48.1 29.7 3.4 10.2 26.3 8.7 14.8 5.9 14.7 22.2 16.3 33.1 10.1 25.8 16.5 18.0 SPATA20 "FLJ21347, SSP411, Tisp78" ENSG00000006282 "Spermatogenesis associated 20" Q8TB22 17 50543058-50555852 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 117.5" "Group enriched" "Detected in all" 15 "Early spermatids: 594.1;Late spermatids: 1543.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 60.1;MCF7: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022023, HPA027144, HPA031442" Enhanced Approved Nucleoplasm "Secreted in male reproductive system" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557" "unprognostic (9.27e-3)" "unprognostic (1.90e-1)" "unprognostic (9.60e-2)" "unprognostic (9.74e-3)" "unprognostic (2.63e-3)" "unprognostic (7.23e-2)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (7.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.12e-3)" "unprognostic (4.93e-2)" "unprognostic (6.74e-2)" "unprognostic (1.75e-1)" "unprognostic (2.29e-1)" "unprognostic (2.66e-1)" "prognostic favorable (9.69e-5)" 10.3 36.8 25.7 7.2 24.6 4.4 10.5 25.5 33.2 16.9 30.0 14.8 10.0 18.0 9.7 10.1 13.7 12.9 33.3 24.2 27.6 18.6 17.6 8.9 6.4 26.9 28.0 21.1 22.0 17.0 11.7 6.4 27.5 17.1 6.4 3.2 17.7 11.2 18.5 8.6 10.8 8.3 26.0 14.1 22.0 117.5 33.1 2.3 22.5 18.4 3.8 14.6 10.3 24.8 8.8 39.4 4.8 25.7 7.9 22.7 6.0 14.9 24.2 9.2 7.3 29.1 12.9 9.2 38.4 13.9 8.9 7.0 1.4 6.3 4.2 14.4 5.3 7.4 9.5 60.1 27.8 2.4 17.1 33.3 8.8 4.7 13.0 17.9 11.6 2.4 0.7 16.8 5.5 59.3 0.0 2.1 3.1 19.0 18.0 4.4 6.9 2.9 35.4 39.5 4.5 11.3 13.0 12.1 17.0 5.6 21.0 1.1 19.7 9.8 22.2 5.6 3.7 31.8 14.0 0.2 14.9 1.4 6.9 0.0 5.0 1.0 1.6 4.5 1.9 2.8 1.2 1.1 8.3 1.7 1.5 1.7 0.2 7.3 3.4 1.6 0.8 3.7 25.7 24.6 25.5 33.2 24.2 27.6 26.9 28.0 27.5 26.0 33.1 24.8 12.6 6.4 5.0 17.3 14.0 10.7 15.1 13.4 25.6 5.3 13.3 17.4 32.5 20.0 13.1 23.9 4.2 17.3 9.8 32.6 27.4 35.6 594.1 13.0 13.2 11.7 37.9 6.1 10.3 39.0 10.3 23.5 66.8 23.2 17.7 38.5 10.8 26.7 34.6 11.8 9.5 28.4 16.2 23.6 14.8 1543.1 38.2 20.0 21.4 6.5 19.3 26.9 12.3 8.5 2.3 23.7 31.1 38.0 17.9 12.2 18.4 38.8 5.9 2.4 6.6 18.1 19.1 10.0 13.8 11.9 8.8 9.9 11.2 39.9 23.8 17.1 SPATA2L "C16orf76, MGC26885, tamo" ENSG00000158792 "Spermatogenesis associated 2 like" Q8IUW3 16 89696357-89701705 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 34.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041182, HPA042453" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 9: Neutrophils - Innate immune response" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Mitochondria" Cytosol "HPA041182: AB_2677352, HPA042453: AB_2678005" "unprognostic (1.22e-1)" "unprognostic (9.04e-2)" "unprognostic (5.23e-2)" "unprognostic (9.13e-3)" "unprognostic (2.21e-1)" "unprognostic (6.62e-2)" "unprognostic (2.72e-2)" "unprognostic (2.13e-1)" "unprognostic (4.86e-2)" "unprognostic (9.25e-2)" "unprognostic (1.40e-3)" "unprognostic (5.32e-2)" "unprognostic (2.36e-3)" "unprognostic (8.86e-2)" "unprognostic (4.19e-2)" "unprognostic (5.84e-2)" "unprognostic (2.55e-1)" 6.7 5.1 5.7 2.3 6.6 5.0 4.9 4.8 8.7 3.9 5.2 6.2 5.9 6.1 0.7 5.8 6.2 2.2 4.9 8.0 4.9 10.3 13.6 7.1 1.5 4.9 3.8 5.4 14.2 2.2 16.7 1.8 3.1 5.9 0.8 0.6 5.7 1.3 1.3 7.7 7.1 1.4 2.6 6.0 6.9 4.9 4.2 1.7 7.0 0.3 0.8 3.8 3.5 6.3 7.4 5.8 2.0 9.6 1.5 1.6 10.7 4.9 2.3 2.3 1.5 11.1 6.2 2.5 6.6 1.6 3.1 12.5 1.8 2.8 0.5 2.5 19.9 1.7 2.2 15.3 5.1 1.3 5.0 1.6 3.5 3.6 1.1 2.6 2.6 2.9 7.7 1.7 1.6 34.0 4.3 8.0 5.4 7.6 7.5 9.4 1.0 7.4 3.4 2.6 11.0 7.0 5.3 5.4 6.5 0.9 14.0 5.7 6.7 2.3 8.5 0.4 2.3 4.2 2.8 2.3 6.9 4.1 4.4 2.8 4.0 5.3 5.5 6.5 3.9 3.7 3.9 4.2 4.4 4.1 3.5 3.9 13.7 2.1 4.9 4.6 3.7 4.1 5.7 6.6 4.8 8.7 8.0 4.9 4.9 3.8 3.1 2.6 4.2 6.3 5.9 3.2 0.5 2.3 10.8 15.7 18.7 7.7 5.2 9.5 11.0 6.6 0.4 7.2 3.1 11.0 0.0 8.7 18.4 27.8 1.9 13.7 7.4 7.6 3.2 6.3 23.8 0.0 13.6 13.8 5.7 6.4 9.2 9.3 4.5 2.1 6.1 5.7 7.4 3.3 7.1 7.6 14.2 6.1 13.2 1.5 2.8 9.1 8.8 2.8 4.3 6.6 8.2 2.5 1.3 12.7 21.8 2.2 8.6 12.7 32.3 10.3 1.5 8.0 0.0 9.3 7.0 2.7 2.5 2.6 19.9 24.9 10.5 4.7 9.3 11.7 SPDEF "bA375E1.3, PDEF" ENSG00000124664 "SAM pointed domain containing ETS transcription factor" O95238 6 34537802-34556333 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 140.7;salivary gland: 114.8" "Cell type enhanced" "Detected in many" "Breast glandular cells: 94.2;Breast myoepithelial cells: 61.1;Intestinal goblet cells: 315.1;Prostatic glandular cells: 72.7" "Cancer enhanced" "Detected in many" "prostate cancer: 388.1" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "MCF7: 288.4;OE19: 118.0;SK-BR-3: 192.2;T-47d: 154.0" "Not detected" "Not detected" "Region enriched" "Detected in single" 7 "midbrain: 2.9" HPA055707 Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 24: Salivary gland - Salivary secretion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Nucleoli" Cytosol "HPA055707: AB_2682894" "unprognostic (2.98e-1)" "unprognostic (9.68e-2)" "unprognostic (2.84e-1)" "prognostic favorable (9.26e-9)" "unprognostic (1.57e-1)" "unprognostic (7.10e-3)" "unprognostic (2.56e-2)" "unprognostic (1.15e-1)" "unprognostic (1.63e-1)" "unprognostic (7.39e-3)" "unprognostic (3.48e-3)" "unprognostic (2.92e-1)" "unprognostic (6.16e-11)" "unprognostic (8.04e-2)" "unprognostic (1.85e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-2)" 0.4 0.1 0.5 1.4 0.5 0.1 36.6 0.8 1.1 28.0 0.0 18.4 11.6 9.0 0.5 2.2 6.3 2.4 0.4 0.5 0.2 0.1 0.1 1.1 0.0 0.3 0.4 0.1 0.6 0.0 0.2 0.0 0.2 140.7 10.2 0.0 114.8 0.1 0.3 9.3 14.3 0.6 0.1 0.1 35.4 0.3 0.5 0.0 0.1 0.0 0.0 1.0 0.3 0.5 0.0 30.9 0.1 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.3 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 288.4 0.3 0.4 0.0 118.0 38.6 0.1 0.0 0.3 0.3 0.3 2.1 0.2 0.0 192.2 0.0 0.0 154.0 0.0 0.0 0.0 0.5 0.4 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.8 1.1 0.5 0.2 0.3 0.4 0.2 0.1 0.5 0.5 0.8 0.0 2.2 0.7 0.3 0.1 13.3 20.7 0.0 0.0 94.2 61.1 0.3 5.7 31.7 0.0 0.0 0.0 1.4 27.1 0.0 2.6 1.1 6.2 0.7 0.6 5.4 0.0 0.8 1.2 0.0 0.4 28.1 18.7 0.0 0.2 0.4 0.0 0.0 0.0 0.6 315.1 12.2 0.0 0.2 5.5 0.0 0.9 3.6 0.0 0.0 0.0 0.0 0.0 0.2 20.2 12.3 0.0 0.1 72.7 5.7 0.0 2.9 0.0 0.0 0.0 1.2 0.1 0.2 0.0 0.0 0.3 0.8 0.0 30.0 11.5 SPEF1 "C20orf28, CLAMP, DKFZP434I114, SPEF1A" ENSG00000101222 "Sperm flagellar 1" Q9Y4P9 20 3777504-3781448 "Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 9.6;choroid plexus: 15.9;fallopian tube: 11.5;testis: 12.4" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 104.7;Respiratory ciliated cells: 66.5;Rod photoreceptor cells: 22.4;Spermatocytes: 24.9" "Cancer enhanced" "Detected in many" "endometrial cancer: 6.4" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 2.2;hTEC/SVTERT24-B: 1.1;MCF7: 1.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050786 Enhanced NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "HPA050786: AB_2681238" "unprognostic (2.41e-2)" "unprognostic (1.18e-2)" "unprognostic (1.28e-1)" "unprognostic (4.91e-3)" "unprognostic (1.09e-1)" "unprognostic (1.40e-2)" "unprognostic (9.08e-3)" "unprognostic (8.12e-3)" "unprognostic (5.95e-2)" "unprognostic (8.41e-2)" "unprognostic (8.88e-3)" "unprognostic (1.69e-1)" "unprognostic (3.81e-3)" "unprognostic (1.83e-1)" "unprognostic (6.60e-2)" "prognostic unfavorable (9.87e-4)" "unprognostic (7.49e-2)" 0.1 0.2 3.6 0.0 9.6 0.0 0.1 2.4 4.5 1.7 15.9 0.2 0.0 0.3 0.5 0.0 11.5 0.0 0.2 5.5 4.0 2.1 0.1 2.8 0.0 7.6 9.1 0.3 0.6 0.3 2.9 0.0 5.8 0.2 0.0 2.1 0.1 0.1 0.0 0.1 0.0 0.0 6.9 0.0 0.1 12.4 4.2 0.0 1.7 0.0 0.0 0.1 0.0 3.9 0.9 2.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.1 0.1 0.2 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.2 1.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.6 0.4 0.2 0.2 0.1 0.2 0.0 0.1 0.1 0.6 0.0 0.4 0.3 0.0 0.4 0.6 0.0 0.5 0.0 0.0 0.3 0.1 0.4 0.1 0.1 0.0 0.1 0.7 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 9.6 2.4 4.5 5.5 4.0 7.6 9.1 5.8 6.9 4.2 3.9 0.3 0.0 0.0 2.3 0.1 0.4 0.1 3.5 0.0 1.5 1.5 1.1 0.4 0.0 9.9 3.7 16.7 0.1 0.1 0.1 5.9 1.2 5.5 104.7 1.0 0.4 0.0 0.0 16.7 0.2 0.2 0.3 0.0 1.7 0.0 0.2 0.7 0.2 0.2 0.0 6.6 0.0 4.1 0.0 0.0 4.1 0.3 0.3 0.0 1.9 0.0 2.6 0.0 1.0 1.0 0.0 0.0 0.0 0.0 0.5 0.0 7.3 66.5 22.4 0.0 0.3 1.5 24.9 2.8 0.0 0.1 0.1 0.3 0.2 0.3 0.1 SPR SDR38C1 ENSG00000116096 "Sepiapterin reductase" P35270 2 72887382-72892158 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal enterocytes: 85.3;Exocrine glandular cells: 81.1;Proximal tubular cells: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 8.3;intermediate monocyte: 2.4;myeloid DC: 8.9" "Group enriched" "Detected in many" 11 "dendritic cells: 8.9;monocytes: 8.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039505 Uncertain Supported Nucleoplasm,Cytosol NA NA 180000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" "Nucleoplasm, Cytosol" "HPA039505: AB_10795466" "unprognostic (4.09e-1)" "unprognostic (1.22e-1)" "unprognostic (7.72e-3)" "unprognostic (1.97e-1)" "unprognostic (2.46e-2)" "unprognostic (1.06e-2)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.12e-1)" "unprognostic (9.79e-2)" "unprognostic (1.62e-1)" "unprognostic (1.37e-1)" "unprognostic (1.80e-1)" "unprognostic (7.50e-3)" "unprognostic (2.87e-1)" "unprognostic (1.43e-3)" "unprognostic (1.95e-1)" 25.9 50.8 26.0 7.6 27.2 0.6 20.0 27.2 61.4 14.5 39.6 36.4 23.4 13.4 36.9 19.7 26.3 11.9 44.4 26.8 30.0 44.2 99.8 15.9 3.2 27.9 31.5 12.2 63.5 38.4 10.9 6.8 29.8 26.2 32.5 3.1 31.2 16.7 43.9 9.1 22.0 11.5 27.9 9.6 42.1 7.3 28.5 2.4 20.5 25.4 5.1 25.2 13.7 28.0 47.5 130.9 0.6 20.0 51.2 18.5 31.8 21.4 31.8 16.0 15.0 84.0 48.0 34.5 25.4 26.1 80.6 43.9 58.1 35.1 13.3 10.0 43.7 51.7 30.8 87.4 19.1 8.2 13.6 16.7 38.7 17.6 19.7 32.7 42.6 25.4 54.0 6.8 21.4 100.5 3.3 31.1 10.9 139.9 118.7 0.0 82.8 20.3 85.8 73.4 8.0 14.6 39.6 89.7 31.0 16.9 40.4 9.9 52.8 17.4 42.2 30.5 38.7 7.2 16.9 2.3 25.0 17.6 31.0 0.0 8.3 0.7 0.3 2.4 0.3 0.0 0.1 0.1 8.9 0.0 0.1 0.3 0.0 0.0 0.9 0.9 0.0 2.4 26.0 27.2 27.2 61.4 26.8 30.0 27.9 31.5 29.8 27.9 28.5 28.0 13.8 12.8 7.3 0.3 1.1 8.4 23.0 14.8 20.5 0.7 22.2 16.5 46.2 38.6 10.8 42.3 0.0 18.1 0.4 85.3 21.5 56.9 0.3 12.5 4.2 16.7 11.4 6.6 0.7 81.1 10.6 13.9 26.0 6.7 4.5 8.4 17.2 62.9 42.1 1.7 0.4 39.6 12.2 6.0 7.4 1.5 9.3 9.7 14.2 1.9 20.8 13.8 0.0 0.0 0.3 43.3 50.4 5.7 1.4 33.9 71.0 91.6 11.2 0.7 6.6 8.3 8.6 0.4 10.2 17.8 6.5 4.4 1.9 8.7 57.8 15.6 SPRYD3 FLJ14800 ENSG00000167778 "SPRY domain containing 3" Q8NCJ5 12 53064316-53079404 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039426, HPA039685" Enhanced Approved "Nucleoplasm,Vesicles,Plasma membrane,Actin filaments,Cytosol" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 50: Fibroblasts - ECM organization" "Nucleoplasm, Cytosol" "Vesicles, Plasma membrane, Actin filaments" "HPA039426: AB_10673358, HPA039685: AB_2676623" "unprognostic (7.73e-3)" "unprognostic (6.55e-2)" "unprognostic (1.37e-2)" "unprognostic (5.05e-3)" "unprognostic (1.52e-2)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.27e-3)" "unprognostic (2.58e-1)" "unprognostic (1.83e-2)" "unprognostic (1.43e-2)" "unprognostic (2.64e-2)" "unprognostic (3.14e-2)" "prognostic favorable (1.78e-15)" "unprognostic (9.82e-2)" "unprognostic (5.27e-2)" "unprognostic (7.44e-3)" "unprognostic (1.41e-1)" 32.2 29.2 70.6 18.4 77.9 6.4 30.2 35.6 84.2 33.6 38.1 32.8 18.9 38.1 36.2 31.7 45.1 20.4 42.4 79.9 60.4 29.5 22.1 23.6 17.4 61.7 55.1 43.5 50.0 43.3 60.7 14.0 61.5 34.5 17.0 39.3 43.9 40.6 21.2 27.0 23.4 31.6 43.8 24.3 35.8 11.5 58.0 13.7 34.6 23.1 20.6 36.5 30.7 67.9 28.4 43.0 5.6 11.5 45.4 22.4 7.3 42.6 22.2 16.1 10.1 7.4 23.8 18.6 34.2 53.5 19.2 26.0 7.6 32.9 10.5 19.4 11.3 11.5 25.5 16.9 34.0 22.3 20.1 20.2 51.6 23.1 34.9 31.6 33.5 9.3 10.4 45.3 28.5 62.3 16.3 11.7 3.2 23.1 30.8 7.1 9.5 38.4 20.6 22.3 9.4 8.9 37.3 34.6 18.1 3.0 31.8 16.7 46.4 18.1 17.9 40.9 29.0 24.7 24.1 5.4 53.8 19.5 22.4 29.9 16.7 47.5 32.7 28.9 30.9 14.6 22.4 26.9 15.5 11.3 18.8 22.7 25.8 17.0 32.8 7.4 13.5 28.9 70.6 77.9 35.6 84.2 79.9 60.4 61.7 55.1 61.5 43.8 58.0 67.9 13.4 3.2 10.1 4.9 13.3 5.7 19.5 12.0 13.1 46.4 11.3 8.8 20.4 17.2 10.4 18.4 8.4 6.2 8.8 9.1 11.7 30.4 0.9 21.2 10.9 17.1 11.5 2.1 14.4 36.5 14.6 22.9 15.8 16.1 10.1 5.1 18.9 9.1 11.8 43.7 13.5 13.8 10.2 11.7 5.7 2.7 16.1 10.3 10.6 3.7 15.0 38.5 16.5 4.5 5.6 28.6 9.3 33.1 19.1 20.8 10.7 15.6 18.2 23.8 19.7 11.1 20.0 4.5 3.9 12.0 9.5 4.2 14.9 5.1 7.9 16.4 SPSB2 "GRCC9, SSB-2" ENSG00000111671 "SplA/ryanodine receptor domain and SOCS box containing 2" Q99619 12 6870935-6889358 "Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 40.2" "Cancer enriched" "Detected in all" 5 "testis cancer: 38.5" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 43.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055225 Approved NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA055225: AB_2682746" "unprognostic (1.13e-1)" "unprognostic (3.66e-1)" "unprognostic (1.72e-2)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (8.14e-2)" "prognostic unfavorable (2.62e-4)" "unprognostic (3.05e-1)" "unprognostic (1.81e-1)" "unprognostic (6.19e-2)" "unprognostic (1.42e-1)" "unprognostic (2.13e-2)" "unprognostic (4.83e-2)" "unprognostic (1.35e-2)" "unprognostic (2.77e-1)" "unprognostic (9.05e-2)" "unprognostic (2.39e-2)" 5.5 11.2 7.0 5.9 7.6 6.2 5.9 10.0 9.8 8.2 7.0 7.7 5.0 7.9 3.3 7.2 7.7 6.3 4.8 6.7 6.9 13.5 6.7 12.4 7.3 7.9 7.4 5.1 8.6 4.6 7.5 2.4 7.7 7.2 2.2 4.3 7.7 6.1 5.1 8.2 7.5 3.0 7.5 9.3 7.6 9.7 7.6 8.4 12.1 1.7 3.5 7.4 6.5 7.7 9.4 43.6 4.2 6.5 9.7 4.6 8.3 9.7 11.0 8.4 4.0 19.9 35.8 3.2 4.5 8.4 6.1 8.8 10.3 5.5 1.2 21.4 3.5 11.0 13.7 7.8 14.7 5.0 10.5 4.9 7.8 11.1 9.8 6.9 5.7 12.6 7.1 4.3 8.7 13.7 10.0 5.8 17.1 12.6 13.2 9.3 5.5 6.4 16.7 6.4 1.8 5.3 6.7 13.0 10.4 12.3 3.9 8.5 4.8 8.4 13.2 8.8 10.3 5.7 9.2 4.1 9.3 9.6 12.0 0.1 8.4 24.0 12.1 9.9 14.2 11.8 11.9 9.9 9.3 13.2 13.5 12.1 6.8 7.0 12.1 17.3 13.6 8.3 7.0 7.6 10.0 9.8 6.7 6.9 7.9 7.4 7.7 7.5 7.6 7.7 4.2 28.9 19.9 2.0 7.1 2.5 3.7 7.5 2.2 5.3 8.5 4.4 3.3 7.2 9.4 20.2 2.1 5.8 4.4 11.1 33.2 13.3 16.8 18.6 5.3 5.5 9.5 6.6 0.5 10.7 4.5 5.8 3.6 8.9 8.2 2.5 7.5 4.7 11.5 6.7 0.9 10.8 0.0 7.6 3.9 8.9 9.6 8.1 0.0 1.9 13.4 9.4 17.5 1.0 1.8 9.0 6.6 9.1 2.2 7.6 15.6 40.2 19.5 14.3 6.6 6.5 6.3 29.0 9.2 4.1 4.8 7.7 8.5 10.2 7.8 3.4 SPTSSB "ADMP, C3orf57, ssSPTb" ENSG00000196542 "Serine palmitoyltransferase small subunit B" Q8NFR3 3 161344792-161372880 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Sphingolipid metabolism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 45.5;stomach 1: 61.4;urinary bladder: 49.5" "Cell type enhanced" "Detected in many" "Excitatory neurons: 28.5;Exocrine glandular cells: 46.0;Gastric mucus-secreting cells: 37.2;Melanocytes: 46.2;Prostatic glandular cells: 74.6;Suprabasal keratinocytes: 36.4;Urothelial cells: 65.6" "Cancer enhanced" "Detected in many" "urothelial cancer: 24.0" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in some" 13 "NK-cell: 353.6" "Lineage enriched" "Detected in many" 13 "NK-cells: 353.6" "Group enriched" "Detected in some" 10 "MCF7: 1167.1;RT4: 304.2" HPA047712 Uncertain "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 35: Glandular cells - Unknown function" "Nuclear speckles" "HPA047712: AB_2680127" "unprognostic (2.09e-1)" "unprognostic (4.19e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-1)" "unprognostic (1.34e-2)" "unprognostic (4.15e-2)" "unprognostic (3.18e-2)" "unprognostic (1.98e-1)" "unprognostic (5.10e-2)" "unprognostic (6.37e-3)" "unprognostic (2.72e-1)" "unprognostic (4.08e-2)" "unprognostic (5.37e-4)" "unprognostic (8.21e-2)" "unprognostic (1.99e-1)" "unprognostic (1.22e-2)" "unprognostic (9.51e-3)" 1.9 0.1 3.7 0.6 1.9 0.3 8.3 5.2 7.9 4.8 3.0 0.8 0.3 1.0 0.1 8.7 0.4 1.3 0.4 2.2 1.3 1.2 0.5 0.1 1.2 2.8 5.6 0.2 0.8 0.1 0.4 0.0 4.8 14.7 0.7 2.5 11.4 0.1 0.1 45.5 0.3 0.2 0.2 1.3 61.4 0.0 6.7 0.4 0.3 1.5 2.0 49.5 11.1 3.7 0.0 2.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 2.9 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.4 0.0 0.0 0.1 0.1 2.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1167.1 0.0 0.0 4.3 71.5 13.4 0.0 0.0 0.5 0.0 304.2 1.9 11.9 0.0 40.6 0.0 0.1 64.7 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 7.1 0.2 26.2 0.1 0.9 2.5 0.0 0.1 0.3 0.4 0.9 353.6 0.0 0.2 0.0 2.5 3.7 1.9 5.2 7.9 2.2 1.3 2.8 5.6 4.8 0.2 6.7 3.7 0.2 0.0 0.0 4.2 0.1 3.8 16.6 19.6 1.8 1.4 16.6 8.4 0.4 1.5 22.5 3.7 0.0 0.0 3.6 0.1 0.0 1.3 0.0 0.5 0.2 0.8 0.0 0.0 28.5 46.0 0.0 0.7 37.2 1.2 0.0 4.3 0.0 0.0 0.2 0.0 14.2 2.5 6.1 0.0 0.8 0.0 0.0 0.4 46.2 1.0 0.1 0.6 7.2 5.0 1.5 27.6 0.0 0.0 0.4 74.6 0.0 0.0 4.1 1.4 0.0 0.1 2.2 0.0 0.0 6.8 36.4 0.1 3.2 0.0 0.0 65.6 STUB1 "CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1" ENSG00000103266 "STIP1 homology and U-box containing protein 1" Q9UNE7 16 680224-682870 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037202, CAB037209, HPA041222, HPA043531" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533" "unprognostic (5.70e-2)" "unprognostic (2.53e-1)" "unprognostic (1.90e-1)" "unprognostic (3.89e-1)" "unprognostic (9.00e-2)" "unprognostic (3.06e-1)" "unprognostic (4.09e-3)" "unprognostic (2.21e-1)" "unprognostic (2.23e-1)" "unprognostic (8.31e-2)" "unprognostic (5.78e-2)" "unprognostic (6.77e-2)" "prognostic favorable (6.49e-9)" "unprognostic (9.67e-2)" "unprognostic (3.57e-1)" "unprognostic (1.55e-1)" "unprognostic (1.30e-1)" 80.2 126.3 185.5 35.6 186.9 48.9 76.0 183.8 242.7 74.8 173.1 100.3 50.7 67.0 60.3 86.8 65.3 42.1 151.1 187.3 185.3 91.4 100.7 65.0 52.5 188.2 184.2 65.7 93.7 90.6 93.7 23.9 187.9 80.2 32.6 33.2 86.6 53.5 201.8 111.7 63.1 40.1 180.6 70.0 86.2 45.1 193.5 42.3 72.9 125.2 38.2 80.7 69.1 188.0 81.6 107.6 59.4 108.0 123.4 102.5 43.8 112.8 95.1 100.9 90.5 131.0 97.1 83.0 78.2 147.5 69.1 69.7 73.0 137.3 42.9 93.6 318.8 53.4 154.1 104.7 183.7 85.9 96.4 141.1 134.3 118.2 71.4 76.3 106.2 72.3 87.1 119.2 149.3 318.4 90.1 85.4 76.4 107.1 127.5 143.5 46.8 200.6 132.5 72.6 121.1 103.4 89.4 165.8 137.1 35.9 114.1 147.8 108.7 104.3 99.8 94.3 125.9 137.6 150.2 132.3 83.8 73.9 122.0 17.7 13.6 21.7 15.7 12.9 14.5 19.6 13.5 13.8 12.1 21.0 12.8 11.6 13.4 11.2 13.9 20.7 13.2 7.2 185.5 186.9 183.8 242.7 187.3 185.3 188.2 184.2 187.9 180.6 193.5 188.0 96.2 38.5 27.9 24.5 88.9 114.7 107.2 63.9 83.1 93.3 137.1 158.7 1.0 104.4 52.4 130.6 52.1 80.1 101.4 142.7 285.7 139.6 8.6 82.8 69.6 71.6 76.0 68.5 23.2 169.7 93.8 85.7 68.3 65.0 21.0 97.9 80.3 122.1 113.1 84.1 21.1 101.4 85.5 69.4 94.9 16.7 109.0 79.0 117.4 15.0 154.4 184.3 110.2 14.1 24.8 190.2 110.8 112.1 108.6 160.8 165.5 324.1 61.2 83.9 72.3 82.3 129.7 50.4 62.4 107.0 120.5 100.7 96.2 132.5 109.3 118.8 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Langerhans cells: 149.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 41: Macrophages - Immune response" "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favorable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 38.3 44.0 33.1 34.2 36.2 22.3 33.9 37.4 36.4 36.3 32.3 37.5 38.3 31.4 24.4 35.8 29.8 27.7 39.8 33.2 37.8 33.5 35.8 36.2 31.1 38.0 36.6 30.4 27.7 38.4 23.2 32.3 37.7 29.9 28.6 8.5 29.9 26.5 45.8 44.3 35.9 31.6 36.1 43.7 32.4 14.9 36.2 28.4 29.5 33.8 37.1 38.1 32.6 39.0 51.9 70.6 16.0 36.1 51.1 52.1 33.8 47.7 79.2 47.5 48.7 22.1 53.2 35.4 58.9 80.8 54.4 36.6 15.2 52.6 45.6 60.3 43.8 25.3 48.7 59.7 58.3 29.2 80.1 50.2 36.1 82.1 61.1 58.5 64.3 22.3 29.9 38.6 84.9 80.3 28.0 44.8 33.1 36.9 36.7 24.0 47.1 46.1 45.9 38.7 13.1 24.6 40.6 41.1 17.4 20.7 33.7 38.7 74.4 48.3 21.8 55.8 26.6 41.2 37.0 14.6 73.3 46.4 29.7 21.3 21.7 27.3 17.6 23.8 15.4 12.7 14.7 17.9 18.8 17.5 11.0 14.2 23.0 24.6 21.9 11.1 9.0 11.2 33.1 36.2 37.4 36.4 33.2 37.8 38.0 36.6 37.7 36.1 36.2 39.0 34.9 44.8 22.7 7.8 32.6 65.1 34.6 56.3 31.9 7.4 22.3 20.6 23.6 48.6 35.2 22.0 12.5 31.1 35.9 69.7 29.4 60.6 12.9 22.1 26.6 46.0 25.7 11.1 4.8 67.7 35.7 51.7 43.3 29.0 60.3 42.1 33.9 20.0 89.5 5.0 3.6 39.5 38.7 49.6 149.9 15.7 38.5 83.2 30.2 2.8 51.7 24.1 42.2 3.0 16.0 73.4 58.5 35.3 23.0 61.6 77.7 50.8 31.3 6.9 39.5 40.6 36.4 9.4 6.7 27.0 65.1 33.1 35.4 39.0 47.9 36.2 SURF2 ENSG00000148291 "Surfeit 2" Q15527 9 133356550-133361158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 105.8" "Group enriched" "Detected in many" 4 "Early spermatids: 448.9;Late spermatids: 992.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 104.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044340, HPA052213, HPA059710" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Cluster 35: T-regs - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: " "unprognostic (1.53e-1)" "unprognostic (6.10e-3)" "unprognostic (1.24e-3)" "unprognostic (2.25e-2)" "unprognostic (2.50e-1)" "unprognostic (6.27e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (1.05e-1)" "unprognostic (1.85e-1)" "unprognostic (5.46e-3)" "unprognostic (8.28e-2)" "unprognostic (1.07e-3)" "unprognostic (1.09e-2)" "unprognostic (3.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" 15.3 16.4 13.2 5.4 13.0 5.4 15.3 13.5 15.6 13.8 12.5 16.9 7.6 13.1 6.0 25.8 13.4 3.5 18.9 12.9 12.6 27.7 22.6 12.1 7.1 14.3 13.5 13.2 28.9 5.8 24.2 3.1 13.2 17.7 2.9 4.7 17.0 4.4 21.6 28.3 14.2 2.3 12.6 15.6 20.1 105.8 13.5 6.1 15.5 3.9 4.9 16.5 15.6 13.3 17.4 29.4 12.1 15.1 8.7 6.7 25.4 8.6 7.5 13.5 7.0 40.5 14.0 17.1 12.2 5.8 11.6 46.5 19.2 21.1 6.1 16.7 26.8 13.5 34.7 15.3 17.3 22.6 9.9 8.1 24.5 19.3 28.1 4.8 6.3 20.6 21.9 11.5 9.3 104.3 23.4 15.0 38.1 41.3 56.0 25.7 18.1 40.4 11.8 19.6 44.8 22.7 19.3 31.7 27.0 7.3 33.8 10.6 12.1 20.3 20.7 21.2 31.2 14.3 30.6 18.7 13.0 13.3 20.8 23.7 23.0 18.6 24.3 24.8 32.1 22.3 29.7 28.0 20.3 27.5 27.9 26.6 10.3 21.1 18.6 22.7 42.1 20.8 13.2 13.0 13.5 15.6 12.9 12.6 14.3 13.5 13.2 12.6 13.5 13.3 26.7 12.8 11.5 3.3 23.2 84.1 27.6 53.7 50.7 18.3 31.1 55.1 13.3 35.8 27.3 22.0 2.1 37.8 25.0 30.6 105.7 73.0 448.9 44.4 16.8 20.9 36.5 28.2 3.5 81.6 28.4 19.3 19.9 16.5 9.5 12.9 22.5 23.6 29.7 13.5 2.9 21.5 36.7 25.5 31.7 992.3 26.1 18.7 42.7 0.0 33.1 28.2 34.0 1.0 3.5 63.8 37.4 24.5 19.6 28.8 81.4 78.0 60.2 23.6 65.7 24.4 26.8 169.9 107.3 43.0 88.2 25.6 38.2 52.2 30.1 23.2 SWI5 "bA395P17.9, C9orf119, SAE3" ENSG00000175854 "SWI5 homologous recombination repair protein" 9 128275379-128316123 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 142.5" "Group enriched" "Detected in all" 9 "Early spermatids: 1180.8;Late spermatids: 1131.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052032 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "Nucleoplasm, Cytosol" "HPA052032: AB_2681702" "unprognostic (1.27e-2)" "unprognostic (1.74e-2)" "unprognostic (3.56e-3)" "unprognostic (3.21e-2)" "unprognostic (1.42e-3)" "unprognostic (3.28e-2)" "prognostic unfavorable (6.78e-4)" "unprognostic (2.11e-1)" "unprognostic (1.19e-1)" "unprognostic (1.81e-1)" "unprognostic (4.58e-3)" "unprognostic (1.15e-1)" "prognostic favorable (9.39e-4)" "unprognostic (1.43e-1)" "unprognostic (6.73e-2)" "unprognostic (2.40e-1)" "unprognostic (7.38e-2)" 27.5 26.5 29.0 11.2 31.3 11.0 28.2 31.3 40.8 39.2 32.7 23.5 15.9 27.5 68.8 33.3 31.7 17.8 34.9 28.7 31.9 36.4 42.3 20.6 12.5 30.4 30.8 40.8 21.2 71.4 54.5 17.6 30.4 32.8 12.7 21.1 25.6 37.1 25.2 26.0 18.6 20.3 29.7 18.0 23.0 142.5 30.4 17.1 44.0 25.6 17.7 26.4 31.5 31.6 29.2 51.4 29.7 34.8 79.2 71.8 33.7 50.6 66.7 64.2 42.6 66.6 33.5 27.7 65.7 82.6 39.5 47.8 48.1 67.5 42.6 41.4 35.7 21.0 97.5 52.9 101.9 13.6 18.6 60.8 31.7 107.4 57.8 55.9 62.5 96.8 50.5 42.8 66.5 119.9 29.6 19.6 20.3 67.8 105.3 27.1 41.0 44.4 43.6 15.2 34.0 18.9 63.0 39.8 63.0 32.9 66.2 14.5 39.0 46.4 38.0 90.9 43.3 45.6 75.0 37.0 61.8 20.9 50.7 54.3 14.2 25.8 14.5 8.7 17.0 17.6 14.1 14.4 14.7 20.2 16.7 21.6 9.0 22.2 9.1 21.4 15.6 15.3 29.0 31.3 31.3 40.8 28.7 31.9 30.4 30.8 30.4 29.7 30.4 31.6 33.8 6.4 17.4 5.2 18.0 24.5 35.1 54.0 31.3 13.7 33.6 38.9 36.2 31.5 33.5 36.8 12.5 65.7 13.7 15.7 66.5 25.5 1180.8 30.7 29.1 31.3 25.6 17.2 2.9 38.5 41.1 40.7 19.9 30.7 9.5 27.9 35.7 82.4 33.2 1.7 3.3 27.5 28.5 20.8 13.0 1131.1 43.2 31.5 37.4 2.8 23.8 50.7 20.6 4.5 7.8 29.8 27.1 31.6 17.9 34.9 68.4 84.1 29.5 21.1 32.9 25.7 31.3 93.7 44.3 33.5 21.9 117.0 18.6 32.8 23.4 36.6 SWSAP1 "C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1" ENSG00000173928 "SWIM-type zinc finger 7 associated protein 1" Q6NVH7 19 11374666-11376951 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052712 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 64: Macrophages - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA052712: AB_2681925" "unprognostic (6.45e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.75e-1)" "unprognostic (1.92e-1)" "unprognostic (1.79e-2)" "unprognostic (5.03e-1)" "unprognostic (1.34e-2)" "unprognostic (4.65e-2)" "unprognostic (8.62e-3)" "unprognostic (1.40e-3)" "unprognostic (2.53e-1)" "unprognostic (1.34e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.18e-3)" 2.4 3.6 1.6 3.9 1.5 5.1 4.0 3.9 2.0 3.7 2.5 4.4 4.5 2.9 3.6 3.6 4.8 3.9 3.1 1.6 1.2 3.7 5.3 3.6 7.1 1.6 1.4 5.3 4.5 2.6 2.0 4.1 1.8 4.0 3.2 0.7 5.1 4.4 3.6 5.0 3.7 2.2 1.3 6.5 4.6 3.6 1.5 4.2 5.0 3.0 4.2 3.4 1.6 2.4 8.1 6.8 3.6 2.2 3.6 3.0 5.3 2.0 2.2 4.6 4.2 7.1 5.5 14.9 10.0 1.9 3.2 5.7 3.4 8.6 0.5 4.8 8.5 6.9 3.0 10.3 3.3 11.3 12.0 4.7 7.4 2.6 1.7 2.7 5.5 6.9 8.4 6.4 2.5 17.6 6.6 15.0 9.0 6.0 9.0 5.5 1.7 16.2 8.6 5.5 7.4 5.5 2.6 8.7 5.5 1.9 11.9 12.9 5.7 3.8 2.7 5.4 4.0 9.5 14.8 10.6 2.1 13.2 3.0 3.2 31.4 7.9 12.5 30.5 12.1 20.9 13.1 13.6 24.3 19.4 16.1 13.9 20.2 16.7 29.5 15.3 13.8 12.3 1.6 1.5 3.9 2.0 1.6 1.2 1.6 1.4 1.8 1.3 1.5 2.4 4.9 3.2 2.0 2.3 10.3 2.7 8.5 16.7 4.0 7.2 9.8 9.3 3.2 2.8 10.6 16.5 8.4 17.8 11.3 10.5 41.1 7.1 10.8 4.5 3.7 6.7 2.4 7.0 1.1 10.7 10.5 4.0 3.1 4.1 1.3 3.7 6.8 13.5 12.1 10.1 1.0 14.2 22.4 9.8 5.4 1.9 11.8 6.5 7.2 0.0 9.6 8.8 19.6 0.0 2.7 6.1 12.2 7.9 3.4 5.6 11.2 17.2 14.6 10.2 6.6 3.2 6.3 10.7 15.0 4.1 3.1 31.7 8.8 13.7 8.9 5.5 SYT10 ENSG00000110975 "Synaptotagmin 10" Q6XYQ8 12 33374238-33439819 "Predicted membrane proteins" Exocytosis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 6.3;fallopian tube: 2.2" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.9;Distal tubular cells: 7.9;Excitatory neurons: 4.4;Inhibitory neurons: 15.4;Late spermatids: 16.2" "Cancer enriched" "Detected in single" 5 "renal cancer: 0.6" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.7;K-562: 1.0;MCF7: 3.5;RT4: 1.3;SCLC-21H: 1.7" "Region enhanced" "Detected in all" "olfactory bulb: 49.5" "Low region specificity" "Detected in all" HPA055426 Approved Nucleoplasm,Vesicles NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA055426: AB_2682812" "unprognostic (3.60e-1)" "unprognostic (4.93e-2)" "unprognostic (9.34e-4)" "unprognostic (5.53e-2)" "unprognostic (3.67e-1)" "unprognostic (4.74e-3)" "unprognostic (3.19e-1)" "unprognostic (1.97e-6)" "unprognostic (4.00e-1)" "unprognostic (2.39e-1)" "unprognostic (2.41e-1)" "unprognostic (1.91e-1)" 0.0 0.3 0.9 0.1 1.9 0.0 0.0 0.0 0.9 0.5 0.4 0.8 0.2 0.0 0.1 0.0 2.2 0.0 0.0 0.6 5.1 0.8 0.3 0.0 0.0 4.1 1.7 0.0 0.0 0.0 0.5 0.0 4.3 0.4 0.4 0.1 0.0 0.7 0.0 0.0 0.3 0.1 2.4 0.0 0.4 0.1 6.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 3.5 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.8 1.3 1.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.9 0.6 5.1 4.1 1.7 4.3 2.4 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.5 0.0 2.5 0.0 0.0 0.1 0.0 0.0 7.9 0.0 1.5 1.8 0.3 0.1 0.0 0.0 4.4 0.0 0.0 0.3 0.0 1.0 0.0 0.8 1.4 0.0 0.0 0.0 15.4 0.2 0.0 0.0 0.0 16.2 0.3 0.0 0.0 1.0 0.0 0.6 0.0 0.5 0.1 0.0 1.2 0.0 0.0 0.1 0.0 0.1 0.7 0.2 0.0 0.0 0.3 0.2 3.7 0.0 0.0 0.1 0.0 3.2 0.1 0.1 TAF6 "MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85" ENSG00000106290 "TATA-box binding protein associated factor 6" P49848 7 100107070-100119841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006566 Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA006566: AB_1080194" "unprognostic (5.60e-2)" "unprognostic (3.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (2.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-3)" "unprognostic (1.68e-1)" "unprognostic (4.55e-2)" "unprognostic (1.95e-1)" "unprognostic (3.38e-1)" "unprognostic (4.78e-1)" "unprognostic (1.37e-1)" 24.2 37.0 28.9 23.4 29.2 23.4 24.4 24.1 42.7 39.5 23.8 38.9 17.2 42.9 21.9 27.3 34.9 20.5 32.2 31.3 25.2 30.9 20.6 24.8 22.6 25.2 23.2 41.2 23.0 30.5 41.1 24.9 24.4 30.7 19.5 19.2 25.5 31.1 45.0 26.5 28.0 33.9 19.0 28.3 28.0 38.5 25.4 29.3 32.9 35.8 25.7 37.3 29.9 25.6 55.1 101.8 64.4 105.7 84.1 44.5 89.3 60.0 66.4 77.2 70.6 76.1 65.6 50.4 65.5 92.7 130.4 45.7 90.6 73.2 81.3 82.0 57.0 49.4 99.3 50.8 86.6 46.2 43.5 46.4 44.5 111.0 121.7 61.0 63.0 87.7 84.6 89.0 69.2 194.4 101.1 76.9 94.7 50.1 82.4 73.2 78.7 75.0 54.5 44.8 57.9 84.4 73.7 115.3 49.3 93.2 42.1 47.2 60.4 113.2 114.6 146.2 77.6 55.0 104.0 85.1 74.9 65.7 99.2 17.2 13.5 17.5 18.0 14.4 21.5 11.9 17.3 18.3 17.6 17.9 17.0 16.3 7.1 18.8 35.3 10.3 18.3 17.5 28.9 29.2 24.1 42.7 31.3 25.2 25.2 23.2 24.4 19.0 25.4 25.6 13.0 9.6 11.8 10.1 15.4 11.3 21.0 25.1 12.5 12.7 13.2 15.9 0.9 18.6 15.7 25.8 0.0 72.1 13.0 12.9 17.6 25.7 28.3 20.7 18.5 14.8 15.6 12.8 12.6 16.6 34.5 16.3 18.3 14.6 0.0 25.6 13.6 6.1 20.9 13.5 10.7 11.9 26.4 8.8 6.9 50.7 21.8 12.3 12.4 3.7 18.7 18.7 18.6 6.0 7.3 14.9 18.7 31.2 12.8 13.0 14.2 25.8 21.8 14.0 26.3 14.6 23.8 25.5 52.3 15.4 11.8 34.5 18.3 16.2 17.4 14.4 TAOK2 "KIAA0881, MAP3K17, PSK, PSK1, TAO1, TAO2" ENSG00000149930 "TAO kinase 2" Q9UL54 16 29973868-29992261 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Adipocytes: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010650 Approved Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" Nucleoli "HPA010650: AB_1080204" "unprognostic (7.30e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.51e-4)" "prognostic favorable (3.87e-5)" "unprognostic (8.46e-2)" "unprognostic (2.14e-3)" "unprognostic (6.08e-2)" "unprognostic (1.12e-3)" "unprognostic (1.01e-2)" "unprognostic (1.60e-1)" "prognostic favorable (4.78e-4)" "unprognostic (3.85e-3)" "prognostic favorable (3.66e-4)" "unprognostic (7.42e-3)" "unprognostic (3.17e-1)" "unprognostic (7.47e-2)" "unprognostic (1.37e-1)" 31.4 36.0 23.4 14.7 21.2 12.7 30.8 18.0 26.1 24.8 11.9 21.8 17.3 25.9 11.1 20.8 22.6 12.0 32.6 23.0 18.9 22.7 17.6 34.0 14.4 21.0 20.0 24.1 19.5 17.4 29.4 19.4 18.9 22.5 8.5 14.3 20.5 13.3 23.4 22.4 24.4 13.3 15.3 33.8 21.8 34.8 20.8 13.2 25.4 12.7 10.5 22.4 21.6 19.0 22.2 41.8 22.4 35.1 25.8 17.1 34.2 40.0 21.1 26.4 24.4 33.6 28.7 23.8 32.8 28.8 18.0 33.9 20.4 20.0 14.1 37.5 43.3 25.8 46.2 34.8 18.7 25.5 47.5 20.0 17.1 28.1 11.2 18.5 44.7 22.4 23.5 23.6 25.8 41.0 29.8 36.0 21.5 16.4 27.6 54.2 32.5 22.2 16.6 20.5 26.1 20.8 22.8 30.2 12.1 14.4 37.5 28.5 62.9 45.0 20.7 32.4 23.6 34.2 23.7 22.1 27.6 28.8 33.7 0.3 0.7 0.4 0.7 0.7 0.8 0.5 0.7 0.6 0.4 0.6 0.4 0.3 1.2 0.5 0.4 0.8 0.9 0.6 23.4 21.2 18.0 26.1 23.0 18.9 21.0 20.0 18.9 15.3 20.8 19.0 52.0 9.6 11.5 21.9 6.3 10.7 4.6 7.5 7.4 14.6 10.5 5.7 9.8 7.2 9.1 9.2 39.6 7.8 7.6 27.0 1.9 8.5 3.9 8.7 9.5 35.3 13.1 3.4 7.9 12.0 6.2 9.7 14.3 8.9 3.8 16.0 47.2 11.8 9.8 10.1 10.7 16.8 12.2 11.2 11.1 4.4 12.5 8.2 7.2 7.5 9.0 8.4 11.3 9.0 12.7 16.1 14.8 12.8 5.9 7.4 27.2 8.0 10.0 21.4 6.6 8.7 8.7 19.7 21.6 9.1 9.7 12.0 9.2 16.0 14.7 7.4 TARBP2 Trbp ENSG00000139546 "TARBP2 subunit of RISC loading complex" Q15633 12 53500921-53506431 "Predicted intracellular proteins" "RNA-mediated gene silencing, Translation regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 48.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051181, HPA061454, CAB069406" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nuclear bodies" "CAB069406: AB_1622301, HPA051181: AB_2681376, HPA061454: AB_2684526" "unprognostic (1.71e-1)" "unprognostic (1.24e-1)" "unprognostic (1.85e-1)" "unprognostic (1.06e-1)" "unprognostic (1.53e-1)" "unprognostic (6.61e-3)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.04e-1)" "unprognostic (4.72e-3)" "unprognostic (1.44e-1)" "unprognostic (1.31e-2)" "unprognostic (5.58e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (8.06e-2)" "unprognostic (1.32e-1)" "unprognostic (8.02e-2)" "unprognostic (4.31e-1)" 9.2 13.1 9.8 9.2 10.0 6.8 8.9 13.4 11.3 8.9 9.5 9.5 9.0 8.5 7.9 13.1 11.7 6.7 9.7 9.6 10.1 18.6 20.6 10.1 10.5 10.0 10.0 8.0 18.7 8.5 8.5 13.8 9.9 11.3 5.5 6.7 11.0 5.1 9.8 9.8 9.5 6.1 9.9 15.2 12.4 13.1 10.8 10.3 12.0 7.1 9.0 10.4 8.9 10.5 25.5 69.1 26.8 29.6 15.3 20.8 35.0 22.6 19.2 34.1 20.3 61.2 33.5 24.5 44.6 24.9 22.2 20.0 32.8 34.1 19.9 30.5 54.1 28.6 26.6 43.9 33.3 48.0 31.9 24.3 21.0 35.2 16.5 23.2 41.2 36.6 37.1 38.3 24.9 102.9 32.5 62.9 53.0 19.7 37.1 23.9 14.4 31.6 22.6 26.4 34.8 24.8 11.8 28.7 58.9 19.1 40.4 63.7 22.1 31.2 29.8 11.9 27.4 19.7 39.6 26.1 34.8 24.2 35.6 2.1 11.5 5.7 13.9 11.9 13.3 10.9 13.3 12.8 14.9 15.3 13.7 13.6 0.7 13.1 7.7 13.3 11.7 12.5 9.8 10.0 13.4 11.3 9.6 10.1 10.0 10.0 9.9 9.9 10.8 10.5 5.2 0.0 8.2 4.6 10.7 6.4 10.5 15.3 17.1 9.3 12.0 10.0 6.0 15.7 11.2 9.2 10.4 46.5 7.2 9.8 21.5 20.7 10.7 7.9 8.8 11.6 5.4 9.4 2.3 26.2 48.9 9.3 13.7 7.2 10.8 10.5 12.1 18.4 25.6 1.7 3.1 10.8 18.3 9.3 4.7 23.8 5.6 7.9 14.2 1.0 12.2 10.2 10.3 4.5 6.2 16.8 9.9 4.1 15.6 11.2 11.3 28.6 7.1 14.2 0.0 4.0 10.0 11.6 13.0 14.4 4.7 32.2 9.0 9.9 14.8 10.1 TATDN1 CDA11 ENSG00000147687 "TatD DNase domain containing 1" Q6P1N9 8 124488485-124539458 "Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023634, HPA053045" Uncertain Supported Nucleoplasm NA NA 660000 "Cluster 41: Basophils - Cellular respiration" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 32: Non-specific - Translation" Nucleoplasm "HPA023634: AB_1857779, HPA053045: AB_2682024" "unprognostic (2.19e-3)" "unprognostic (3.78e-2)" "unprognostic (1.74e-1)" "unprognostic (1.87e-2)" "unprognostic (1.65e-1)" "unprognostic (1.23e-2)" "unprognostic (1.54e-3)" "unprognostic (2.28e-2)" "unprognostic (1.56e-1)" "unprognostic (1.45e-2)" "prognostic unfavorable (2.53e-4)" "unprognostic (2.50e-1)" "unprognostic (6.33e-3)" "unprognostic (3.44e-2)" "unprognostic (4.30e-2)" "unprognostic (2.24e-1)" "unprognostic (5.12e-2)" 23.4 18.7 16.0 15.8 16.8 16.9 39.1 16.8 21.9 20.1 13.0 21.2 18.1 23.5 21.0 16.4 23.5 14.6 23.1 16.1 17.1 28.1 25.2 14.8 19.8 17.0 16.9 39.5 44.8 24.4 8.9 13.6 18.5 17.2 22.4 13.7 27.7 15.0 52.2 20.4 18.1 19.7 17.1 12.2 22.7 12.3 16.4 27.1 36.9 43.9 20.0 21.0 17.3 19.4 65.5 45.1 42.5 30.2 36.8 69.9 31.9 35.5 38.1 43.3 40.0 44.7 69.1 49.7 77.4 38.6 33.6 53.7 52.0 51.9 71.6 64.0 34.3 45.6 36.5 39.1 70.2 35.5 17.0 52.5 80.5 63.5 132.4 48.3 35.3 48.4 38.1 31.4 59.1 198.4 52.8 21.6 42.7 132.8 58.8 35.4 31.7 55.7 61.3 45.5 35.7 49.2 39.2 80.3 87.2 39.3 52.7 38.1 28.4 30.8 82.7 57.3 96.7 40.0 65.3 62.1 57.9 61.4 27.1 29.3 11.0 4.3 12.8 9.1 19.1 17.2 19.5 16.2 15.6 16.6 27.7 24.8 2.1 17.7 6.6 14.0 22.5 14.8 16.0 16.8 16.8 21.9 16.1 17.1 17.0 16.9 18.5 17.1 16.4 19.4 39.8 16.0 27.1 25.5 37.0 64.7 100.9 129.4 75.7 19.3 79.5 131.4 23.9 21.5 55.6 27.6 14.6 66.6 26.7 17.8 107.6 55.2 7.0 40.1 43.0 31.9 16.2 23.8 36.6 62.0 62.5 42.7 29.6 44.4 20.8 76.5 26.7 40.2 54.6 16.8 35.2 41.6 65.1 36.7 43.6 6.7 49.7 36.3 48.0 30.0 51.6 24.8 37.0 20.1 48.6 40.8 34.3 34.6 34.1 94.2 57.8 128.9 33.8 19.2 19.7 64.7 57.5 34.6 45.1 54.0 58.2 59.7 38.9 68.6 60.7 82.6 TAZ "BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2" ENSG00000102125 Tafazzin Q16635 X 154411524-154421726 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Cardiomyopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039557 Approved Approved "Plasma membrane" NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "Plasma membrane" "HPA039557: AB_10672899" "unprognostic (1.14e-1)" "prognostic favorable (5.70e-4)" "unprognostic (4.94e-3)" "unprognostic (1.43e-1)" "unprognostic (8.29e-2)" "unprognostic (7.84e-2)" "unprognostic (1.56e-2)" "unprognostic (8.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "unprognostic (4.68e-2)" "unprognostic (8.39e-2)" "prognostic unfavorable (1.22e-7)" "unprognostic (4.00e-3)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" 19.0 13.8 37.2 8.5 38.1 41.4 17.2 38.1 44.4 18.1 37.0 18.3 9.7 15.1 7.6 21.7 16.6 8.7 43.5 37.0 37.0 22.3 21.9 21.4 17.9 39.3 37.6 18.5 21.3 12.1 14.5 6.6 38.5 17.9 11.7 8.4 13.6 10.2 47.0 18.7 22.9 12.3 37.7 39.2 17.4 4.5 37.9 14.1 18.5 65.6 16.0 18.4 18.4 39.4 24.5 28.6 9.3 11.7 18.3 13.4 18.4 6.9 21.0 15.3 17.1 8.5 29.6 28.2 43.6 16.4 36.6 28.4 17.2 16.6 12.3 25.5 19.6 5.5 20.0 16.4 25.8 12.3 11.8 15.4 35.6 11.7 31.7 12.9 25.6 30.9 12.1 34.9 18.1 17.6 29.0 33.2 2.4 24.9 27.9 21.4 16.2 40.1 24.2 9.0 11.8 17.9 5.3 17.9 26.6 11.1 10.5 16.0 15.5 10.4 11.9 25.5 15.2 55.9 30.6 66.2 13.7 36.6 13.3 5.8 11.1 17.5 12.4 10.4 11.5 12.5 16.6 15.5 14.5 18.7 14.1 12.0 9.9 12.7 7.8 7.9 15.4 9.4 37.2 38.1 38.1 44.4 37.0 37.0 39.3 37.6 38.5 37.7 37.9 39.4 36.2 6.4 11.8 37.2 29.3 10.8 7.9 10.5 14.8 21.6 11.1 15.6 21.1 14.3 13.0 9.2 18.8 5.0 29.7 13.6 5.9 14.7 1.1 6.5 9.6 18.5 6.1 9.7 22.4 16.5 10.1 12.4 23.4 9.6 18.4 19.2 15.0 7.9 24.4 10.1 28.4 15.9 12.2 19.9 16.5 2.0 11.5 20.4 14.2 14.0 21.7 14.2 15.5 23.1 39.7 13.4 12.2 9.1 17.2 8.3 19.6 5.9 8.0 25.6 13.1 12.4 11.3 10.4 3.8 16.8 11.2 2.9 25.6 9.2 15.8 6.7 TBC1D10B "DKFZP434P1750, EPI64B, FLJ13130, Rab27A-GAPbeta" ENSG00000169221 "TBC1 domain family member 10B" Q4KMP7 16 30357102-30370494 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048894 Uncertain NA NA 250000 "Cluster 49: Eosinophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "HPA048894: AB_2680549" "unprognostic (2.55e-1)" "unprognostic (1.33e-3)" "prognostic unfavorable (1.35e-4)" "unprognostic (4.08e-3)" "unprognostic (2.85e-1)" "unprognostic (7.45e-2)" "prognostic unfavorable (8.94e-5)" "unprognostic (1.39e-2)" "unprognostic (3.58e-2)" "unprognostic (1.52e-1)" "unprognostic (4.17e-2)" "unprognostic (1.23e-3)" "unprognostic (2.03e-1)" "unprognostic (2.62e-2)" "unprognostic (7.42e-2)" "unprognostic (7.11e-2)" "unprognostic (2.59e-2)" 17.4 18.1 13.3 11.7 14.1 12.6 15.6 13.1 14.7 17.9 2.9 16.3 12.0 19.1 3.6 18.1 15.5 8.4 15.7 14.3 11.0 12.6 8.0 15.1 11.1 17.2 13.4 16.0 12.8 10.6 11.6 9.4 13.5 13.4 5.3 4.6 14.0 11.0 36.0 21.5 15.1 8.9 13.7 17.1 13.7 42.8 13.9 14.3 12.7 17.8 9.5 15.7 16.1 19.4 30.6 40.2 16.6 32.7 21.4 20.1 37.5 31.8 25.1 34.8 32.2 29.0 23.0 37.0 32.7 23.7 22.9 25.9 22.2 23.7 12.7 37.2 56.8 19.6 28.1 31.1 30.9 27.2 38.9 26.5 23.3 41.8 23.9 15.4 32.7 33.5 38.9 38.7 23.3 47.6 39.5 19.8 9.4 22.7 29.1 50.4 26.5 36.7 18.7 23.0 34.8 24.8 18.0 29.7 13.0 11.1 31.8 32.9 34.3 39.4 19.4 25.9 30.0 27.0 30.6 29.7 35.0 37.8 25.8 0.3 0.9 1.7 1.2 0.4 0.6 0.9 0.6 1.2 0.9 0.5 0.2 0.2 1.3 0.9 0.8 0.8 0.6 1.0 13.3 14.1 13.1 14.7 14.3 11.0 17.2 13.4 13.5 13.7 13.9 19.4 13.8 0.0 10.2 10.4 9.3 18.1 6.4 8.3 7.4 18.8 14.5 13.5 6.8 7.2 7.7 11.0 0.0 12.4 12.2 20.4 3.9 8.6 14.8 10.6 11.2 12.2 15.0 8.2 9.6 10.9 12.5 9.8 9.2 12.5 5.1 17.6 10.8 6.6 17.3 11.8 8.8 11.9 10.2 16.4 16.1 34.2 10.2 18.3 7.2 7.5 14.4 13.8 14.4 4.0 19.8 14.1 9.5 12.0 10.5 8.5 19.0 7.1 5.6 13.6 0.0 9.7 10.6 17.1 14.0 10.5 17.5 11.2 10.6 18.4 13.6 9.8 TBC1D9B "GRAMD9B, KIAA0676" ENSG00000197226 "TBC1 domain family member 9B" Q66K14 5 179862066-179907897 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038350 Approved Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 15: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "Plasma membrane" "Nucleoplasm, Nucleoli fibrillar center" "HPA038350: AB_10673170" "unprognostic (5.06e-2)" "unprognostic (1.37e-1)" "unprognostic (1.60e-2)" "unprognostic (9.53e-2)" "unprognostic (9.45e-3)" "unprognostic (4.25e-1)" "unprognostic (1.06e-1)" "unprognostic (2.84e-1)" "unprognostic (1.10e-1)" "unprognostic (5.08e-2)" "unprognostic (2.01e-1)" "unprognostic (2.28e-2)" "unprognostic (3.95e-2)" "unprognostic (1.86e-1)" "unprognostic (4.01e-2)" "prognostic unfavorable (3.99e-4)" "unprognostic (8.22e-2)" 54.9 61.8 53.9 20.8 62.2 22.8 46.3 58.1 51.1 39.3 38.6 34.1 22.8 38.9 12.0 43.9 34.2 23.8 30.9 51.4 50.1 44.8 55.0 31.7 23.9 60.5 59.8 39.0 46.4 27.0 29.2 17.2 61.6 33.6 12.1 9.1 37.0 25.0 45.9 44.4 34.4 21.1 63.4 39.5 35.5 20.5 57.2 13.1 36.3 18.7 15.3 35.1 35.7 65.9 42.7 64.0 27.4 62.4 69.9 49.0 66.8 51.0 47.2 50.1 48.4 43.8 41.9 29.3 60.2 57.8 56.6 39.6 28.3 115.9 9.8 98.0 39.1 26.0 47.3 27.9 41.5 35.1 85.0 50.6 42.6 39.2 18.9 22.6 48.4 55.3 17.7 28.1 39.5 104.2 22.7 24.5 20.3 17.4 36.5 38.7 22.1 27.8 35.1 66.8 40.1 30.4 48.2 54.5 54.9 11.0 45.0 48.8 57.2 71.2 31.9 34.8 45.2 16.8 23.3 22.7 68.0 41.7 51.7 5.0 7.8 5.5 6.1 9.2 4.8 6.3 4.2 4.9 9.3 5.1 3.9 3.5 0.9 4.2 9.2 9.5 4.0 7.1 53.9 62.2 58.1 51.1 51.4 50.1 60.5 59.8 61.6 63.4 57.2 65.9 24.9 22.4 19.2 20.2 19.7 16.6 10.2 14.6 15.4 27.8 23.9 21.6 9.5 12.8 14.0 27.6 8.4 19.8 20.4 28.4 13.7 21.1 2.4 18.2 20.2 21.0 18.0 17.5 32.1 18.0 23.6 21.1 21.9 27.0 11.4 30.0 24.3 35.2 30.7 62.2 23.6 23.9 10.2 33.5 15.7 8.2 32.3 28.6 16.0 15.9 21.4 17.8 24.7 14.6 27.0 25.2 24.3 28.6 16.4 15.3 24.4 22.6 13.3 18.0 26.3 26.7 16.4 11.1 18.5 25.0 15.6 14.1 17.9 57.1 20.5 13.7 TBCB "CG22, CKAP1, CKAPI" ENSG00000105254 "Tubulin folding cofactor B" Q99426 19 36114289-36125947 "Metabolic proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 448.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041428, HPA041722" Approved Supported Cytosol NA NA 120000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA041428: AB_10794517, HPA041722: AB_10804007" "unprognostic (3.88e-3)" "unprognostic (3.05e-1)" "unprognostic (8.52e-2)" "unprognostic (1.38e-2)" "unprognostic (7.94e-2)" "unprognostic (1.25e-2)" "prognostic unfavorable (2.09e-4)" "unprognostic (1.15e-2)" "unprognostic (5.19e-2)" "unprognostic (1.32e-1)" "prognostic favorable (3.11e-4)" "unprognostic (4.54e-2)" "unprognostic (6.34e-3)" "unprognostic (9.20e-2)" "unprognostic (6.11e-2)" "unprognostic (5.39e-2)" "unprognostic (1.02e-1)" 83.7 83.8 332.0 49.9 365.5 52.8 77.9 365.7 448.6 95.6 289.2 102.5 34.9 117.6 33.0 83.3 88.7 31.0 109.5 332.5 357.6 92.0 57.5 73.3 52.1 368.9 354.4 89.6 44.8 47.5 116.3 36.6 370.0 67.4 29.8 62.3 51.6 46.8 87.8 58.7 66.6 48.0 356.8 76.1 69.7 89.4 359.9 53.3 58.8 49.5 42.3 99.7 82.0 412.4 119.8 361.0 122.7 89.0 84.2 83.4 54.8 95.6 72.6 158.0 111.5 161.0 62.0 99.4 167.4 144.9 114.3 59.0 99.8 102.6 84.0 231.4 127.9 85.5 89.4 224.9 104.7 96.6 166.8 97.6 74.7 123.9 76.4 105.7 102.5 139.7 39.7 141.1 125.3 189.2 152.6 117.5 83.0 137.8 139.8 135.2 69.5 93.2 137.9 108.3 139.6 153.0 89.3 112.2 102.9 109.2 58.7 120.2 106.5 156.9 166.9 91.3 181.4 70.9 182.3 113.1 140.7 99.2 87.5 310.8 240.3 318.5 286.0 335.8 190.5 258.8 260.4 249.5 265.2 246.6 155.9 195.5 103.8 246.1 409.3 280.2 386.5 358.2 332.0 365.5 365.7 448.6 332.5 357.6 368.9 354.4 370.0 356.8 359.9 412.4 110.6 60.9 29.7 13.1 76.9 66.9 89.8 170.1 56.9 61.3 73.5 98.9 53.5 58.6 90.9 138.0 12.5 136.7 111.5 64.8 180.0 147.2 143.5 88.7 85.6 100.9 107.2 52.4 14.0 111.8 212.5 93.0 53.0 80.5 83.7 99.4 80.7 33.7 160.5 72.3 14.9 58.4 160.7 70.9 154.0 274.0 90.1 95.8 129.9 13.1 239.2 127.8 142.2 11.6 68.3 129.8 95.3 101.2 53.3 61.7 63.1 188.4 115.8 85.6 65.7 75.6 195.8 108.3 156.9 71.7 67.6 82.6 114.3 88.2 56.7 78.5 TCEAL4 "FLJ21174, WEX7" ENSG00000133142 "Transcription elongation factor A like 4" Q96EI5 X 103576231-103587729 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Leydig cells: 1524.1;Peritubular cells: 1785.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "unprognostic (2.21e-1)" "unprognostic (2.21e-1)" "unprognostic (6.17e-3)" "unprognostic (1.47e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.11e-5)" "unprognostic (1.08e-1)" "prognostic favorable (2.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.63e-2)" "unprognostic (5.36e-2)" "unprognostic (4.16e-1)" "unprognostic (2.02e-2)" "unprognostic (7.49e-2)" "unprognostic (3.35e-2)" "unprognostic (5.46e-2)" "unprognostic (7.63e-2)" 167.6 213.2 157.9 44.3 159.0 28.1 156.1 154.5 204.9 517.9 206.4 204.4 32.4 712.6 251.4 113.8 428.0 86.9 179.3 154.9 166.8 144.3 111.4 167.2 30.5 164.6 160.6 855.8 98.1 134.6 180.4 112.1 163.8 318.4 49.5 77.5 88.9 262.6 95.9 146.6 111.8 277.5 157.1 125.7 159.3 118.9 158.0 30.7 134.9 81.5 30.3 423.5 278.9 170.0 153.8 115.2 96.1 85.7 330.5 196.1 96.4 165.0 165.3 101.5 118.2 49.6 112.0 37.9 178.5 181.5 242.6 96.8 107.3 120.2 122.9 0.6 72.4 51.7 179.9 65.0 291.9 0.4 41.2 262.6 182.4 84.5 193.7 253.3 149.2 52.7 0.7 39.9 303.9 376.5 56.5 2.8 87.6 3.6 136.8 55.5 162.8 7.5 155.3 186.4 97.3 95.6 265.4 64.1 224.0 112.0 102.3 25.1 185.3 100.6 39.8 257.3 68.9 11.7 71.7 1.7 138.7 0.7 104.6 12.3 28.5 1.0 12.8 15.3 18.4 36.4 17.5 13.7 37.7 22.8 15.9 16.8 1.1 24.7 11.9 11.8 57.0 13.6 157.9 159.0 154.5 204.9 154.9 166.8 164.6 160.6 163.8 157.1 158.0 170.0 131.6 112.2 159.1 20.9 28.8 130.0 305.9 170.2 117.3 88.5 169.2 191.4 278.7 114.4 130.8 198.6 14.6 222.8 11.7 19.6 385.4 156.6 11.7 117.0 459.5 143.2 104.2 28.6 19.5 95.2 331.5 202.4 46.4 178.9 116.9 167.0 231.0 218.6 148.4 90.9 21.1 44.9 91.6 61.7 80.5 65.2 1524.1 69.9 104.9 11.2 82.3 201.9 4.1 26.2 31.9 68.7 33.7 1785.5 23.3 195.5 7.6 297.2 81.0 60.5 361.6 120.3 192.8 34.8 58.5 91.1 104.3 94.3 29.7 144.7 39.4 135.8 TCF25 "KIAA1049, Nulp1" ENSG00000141002 "Transcription factor 25" Q9BQ70 16 89873570-89913627 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041699, HPA041786" Enhanced NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" "HPA041699: AB_10960254, HPA041786: AB_10960526" "unprognostic (1.33e-1)" "unprognostic (2.30e-2)" "unprognostic (1.37e-1)" "prognostic favorable (6.95e-4)" "unprognostic (6.67e-2)" "unprognostic (4.96e-2)" "unprognostic (2.72e-1)" "unprognostic (6.02e-2)" "unprognostic (2.50e-1)" "unprognostic (3.49e-1)" "unprognostic (1.05e-2)" "unprognostic (1.27e-1)" "unprognostic (7.64e-3)" "unprognostic (1.44e-1)" "unprognostic (1.36e-1)" "unprognostic (6.10e-3)" "unprognostic (1.08e-1)" 71.9 91.2 48.2 51.1 53.7 98.7 71.0 45.6 58.4 72.2 34.6 77.4 61.4 77.4 42.3 69.3 69.0 55.0 73.4 50.7 52.1 65.8 78.4 68.3 63.8 48.2 44.8 85.3 85.9 65.4 85.7 53.3 52.4 70.6 37.2 22.9 72.8 53.7 83.8 71.8 70.9 46.1 35.2 78.0 84.9 76.9 48.8 45.0 77.7 41.4 44.4 73.3 65.4 48.1 51.1 72.9 80.6 107.8 65.4 70.1 89.7 122.4 91.9 91.9 42.9 46.9 75.4 120.2 95.0 88.2 30.7 50.3 45.7 53.8 36.5 50.6 96.7 61.2 71.0 94.4 109.7 72.1 78.7 84.8 55.3 56.6 61.1 90.4 83.1 46.7 113.6 72.4 95.4 166.8 78.4 138.9 52.1 77.3 40.4 122.4 77.2 68.2 78.1 69.0 71.7 42.7 184.5 70.5 67.9 33.6 66.0 75.1 126.6 75.0 81.6 42.7 51.8 91.0 34.7 68.7 72.0 83.0 98.8 124.5 131.5 107.5 97.8 107.4 72.3 74.9 71.2 76.3 91.5 93.2 60.1 63.0 222.6 78.2 102.9 145.3 67.2 81.0 48.2 53.7 45.6 58.4 50.7 52.1 48.2 44.8 52.4 35.2 48.8 48.1 160.7 160.3 154.7 64.3 170.9 102.3 155.7 145.6 124.7 360.0 135.7 142.0 90.7 107.2 148.7 165.5 277.3 249.1 277.8 194.9 148.7 110.8 271.7 165.3 209.1 143.3 148.2 85.0 65.2 152.3 329.5 149.4 181.5 203.1 172.8 153.1 126.7 157.7 156.4 464.4 69.7 233.2 120.1 154.6 161.0 383.9 173.4 160.2 186.7 45.0 195.6 150.8 307.9 38.7 54.7 117.2 179.7 184.3 236.4 175.1 192.8 179.1 162.7 279.4 157.8 119.1 152.1 192.7 74.6 114.9 104.0 538.8 193.8 185.4 185.6 199.4 TEDC1 C14orf80 ENSG00000185347 "Tubulin epsilon and delta complex 1" Q86SX3 14 105489855-105499575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Ductal cells: 11.6;Endometrial ciliated cells: 12.0;Exocrine glandular cells: 12.7;Extravillous trophoblasts: 26.6;Hofbauer cells: 14.6;monocytes: 11.9;Pancreatic endocrine cells: 14.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 66.7" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA039049, HPA039050" Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" "Intracellular and membrane" No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 6: Brain - Smell perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA039049: AB_2676320, HPA039050: AB_10670918" "unprognostic (8.06e-2)" "unprognostic (1.06e-2)" "unprognostic (9.17e-2)" "unprognostic (1.65e-1)" "unprognostic (3.06e-1)" "unprognostic (1.57e-2)" "prognostic unfavorable (3.54e-4)" "unprognostic (5.19e-2)" "unprognostic (1.49e-1)" "unprognostic (3.12e-1)" "unprognostic (3.81e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-3)" "unprognostic (8.73e-3)" "unprognostic (2.88e-1)" "unprognostic (1.17e-1)" "unprognostic (6.18e-3)" 5.1 1.6 5.2 4.9 5.5 6.8 4.7 4.1 7.8 4.3 0.5 5.5 5.1 3.8 1.0 6.8 4.6 1.8 4.3 5.8 3.0 4.0 5.4 4.9 5.4 7.0 3.5 2.5 3.0 1.0 5.3 1.6 4.2 4.2 1.6 0.5 4.3 2.3 2.3 8.2 5.4 1.0 3.1 6.8 5.9 4.9 3.6 4.5 5.7 0.5 3.1 3.9 4.5 5.3 17.2 38.9 9.2 13.5 0.8 1.5 24.5 13.4 5.0 15.9 14.7 14.0 31.2 25.6 27.2 2.2 6.2 43.5 3.2 14.0 3.0 29.0 16.0 6.5 22.8 13.3 0.6 12.9 17.9 0.3 4.6 10.6 3.5 2.0 6.4 23.2 10.5 31.2 2.5 66.7 26.9 29.6 11.9 14.6 41.8 21.9 13.8 17.9 4.5 14.3 25.7 15.5 13.7 15.8 9.8 2.0 26.0 12.6 7.8 10.9 18.4 33.4 22.4 17.8 8.2 15.7 13.9 14.8 18.0 0.0 0.5 0.6 0.5 0.9 0.4 0.1 0.8 1.4 0.7 0.3 0.6 0.1 0.1 0.0 0.8 2.4 0.6 0.2 5.2 5.5 4.1 7.8 5.8 3.0 7.0 3.5 4.2 3.1 3.6 5.3 4.8 3.2 2.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 5.9 5.3 0.0 0.0 0.6 1.8 0.0 8.0 10.1 0.0 3.9 11.6 0.0 12.0 3.0 4.0 0.0 0.0 0.0 12.7 26.6 3.4 0.0 7.2 0.0 8.1 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 11.9 0.0 0.0 0.0 0.0 14.7 0.0 0.0 4.7 0.0 0.0 2.0 3.6 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 4.0 4.2 2.5 0.0 0.0 TFF1 "BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2" ENSG00000160182 "Trefoil factor 1" P04155 21 42362282-42366535 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 48 "stomach 1: 7973.0" "Group enriched" "Detected in many" 9 "Gastric mucus-secreting cells: 12908.9;Pancreatic endocrine cells: 14603.3" "Group enriched" "Detected in many" 10 "breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 42 "MCF7: 13512.4;OE19: 5337.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB002170, HPA003425" Enhanced "Secreted to digestive system" NA NA 950000 "Cluster 4: Stomach - Digestion" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "CAB002170: AB_563985, HPA003425: AB_1848260" "prognostic favorable (5.00e-4)" "unprognostic (8.81e-3)" "unprognostic (9.82e-2)" "prognostic favorable (5.67e-4)" "unprognostic (2.42e-1)" "unprognostic (1.72e-3)" "unprognostic (8.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.52e-1)" "unprognostic (6.62e-2)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (7.72e-3)" "unprognostic (1.07e-1)" 2.3 0.3 0.0 20.3 0.0 0.0 26.7 0.0 0.0 9.7 0.0 114.7 34.8 0.2 0.0 18.3 0.9 167.2 0.6 0.0 0.0 0.9 0.8 1.3 0.2 0.0 0.0 0.2 10.7 0.0 0.2 1.1 0.0 25.0 108.4 0.0 32.4 0.7 0.2 0.1 68.4 4.8 0.0 3.1 7973.0 0.1 0.0 0.2 5.3 0.0 0.2 30.6 2.2 0.0 0.0 42.7 0.0 0.2 0.0 0.0 3.4 0.0 0.0 0.0 0.0 16.2 5.7 0.0 1.1 0.0 1.7 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 13512.4 4.6 0.5 5.5 5337.9 223.4 1.7 0.0 0.2 0.0 1.4 0.3 0.2 0.0 5.0 0.0 1.3 5.0 0.1 0.0 0.0 3.5 0.1 0.0 3.6 0.6 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 18.7 0.0 6.1 5.9 0.0 0.0 432.7 197.2 0.0 564.7 12.1 35.0 0.0 0.1 3.1 601.9 0.0 245.7 0.0 1.8 0.2 3.5 430.2 0.0 0.0 821.8 3.1 5.1 12908.9 2.9 13.4 0.0 0.0 1.6 0.2 0.0 0.0 1395.6 111.9 0.0 0.0 0.0 0.0 9.2 0.0 0.0 10.3 0.0 0.0 0.0 0.0 14603.3 500.9 0.0 40.6 432.4 78.0 0.0 2.8 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.3 8.9 0.0 80.0 232.6 THOC7 "FLJ23445, fSAP24, NIF3L1BP1" ENSG00000163634 "THO complex 7" Q6I9Y2 3 63833870-63863868 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 1032.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044143 Approved Supported "Nuclear speckles,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nuclear speckles, Cytosol" "HPA044143: AB_10794892" "unprognostic (4.33e-2)" "unprognostic (9.68e-2)" "unprognostic (1.75e-2)" "unprognostic (1.30e-1)" "unprognostic (2.26e-2)" "unprognostic (2.86e-1)" "unprognostic (1.20e-3)" "unprognostic (3.53e-2)" "unprognostic (1.85e-2)" "unprognostic (1.52e-2)" "unprognostic (2.86e-2)" "unprognostic (9.90e-2)" "unprognostic (3.26e-2)" "unprognostic (1.51e-2)" "unprognostic (5.18e-2)" "unprognostic (4.25e-2)" "unprognostic (2.31e-1)" 54.7 63.5 57.1 43.2 60.0 80.1 75.1 58.1 85.1 54.4 52.0 69.9 64.2 50.5 53.2 73.1 43.0 48.6 88.0 61.5 59.1 67.8 73.5 40.9 68.1 58.4 59.1 44.4 62.3 52.1 33.5 53.5 57.1 43.8 69.1 64.5 50.5 49.5 103.5 64.2 53.7 59.6 57.3 38.2 49.1 47.6 57.8 72.3 44.4 104.0 68.0 60.8 50.3 61.1 141.2 83.5 95.6 23.9 125.1 172.5 89.6 120.2 126.9 139.2 140.1 101.6 151.5 168.3 49.1 155.1 139.2 79.3 107.5 190.4 194.1 169.6 75.5 150.2 102.8 117.2 130.1 212.6 69.6 123.9 157.2 118.4 213.1 137.6 155.1 110.0 116.8 158.6 170.2 1032.4 186.4 186.9 120.4 304.8 65.5 132.3 89.7 227.4 245.4 128.0 47.3 107.8 105.0 147.6 171.6 93.9 93.6 289.6 113.6 100.8 105.9 125.1 216.3 101.3 162.3 204.1 125.3 268.3 133.5 73.1 40.4 33.1 38.7 47.7 54.0 46.7 47.9 53.2 59.0 31.5 40.5 43.4 23.4 55.6 41.9 54.0 61.7 35.6 57.1 60.0 58.1 85.1 61.5 59.1 58.4 59.1 57.1 57.3 57.8 61.1 82.6 89.8 45.0 14.4 59.2 61.6 91.2 179.9 70.6 53.5 70.9 121.3 143.8 81.5 102.9 84.6 18.8 180.3 66.0 62.1 207.4 145.2 84.7 100.7 75.6 57.8 55.2 159.7 26.8 126.9 166.1 65.4 47.4 73.8 54.4 74.3 44.6 78.1 111.6 48.8 26.4 106.3 101.7 75.6 58.9 89.7 88.9 70.2 67.6 14.0 173.1 82.5 93.7 12.5 18.9 127.6 86.7 71.5 53.3 96.6 108.8 241.2 102.1 73.1 52.6 66.9 83.4 244.9 54.5 116.6 71.6 213.4 68.0 80.7 133.2 95.7 TIMM10 "TIM10, TIM10A, TIMM10A" ENSG00000134809 "Translocase of inner mitochondrial membrane 10" P62072 11 57528464-57530803 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 284.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039946 Supported Enhanced Mitochondria NA NA 16000 "Cluster 26: Non-specific - Mitochondria" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA039946: AB_10673023" "unprognostic (9.34e-3)" "unprognostic (1.16e-2)" "unprognostic (2.21e-1)" "unprognostic (2.01e-1)" "unprognostic (4.42e-2)" "unprognostic (1.25e-2)" "unprognostic (2.74e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (3.40e-3)" "unprognostic (7.62e-2)" "unprognostic (1.18e-1)" "unprognostic (5.96e-2)" "unprognostic (9.87e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-2)" "unprognostic (2.15e-2)" 40.5 41.6 55.1 28.5 56.9 34.8 42.5 56.3 68.3 24.8 53.2 35.5 27.0 27.2 43.8 44.1 25.1 20.3 60.9 56.7 57.4 50.7 77.6 27.9 45.8 55.8 55.6 25.5 33.6 45.1 29.2 21.7 56.1 31.0 35.9 15.1 28.0 30.2 77.8 33.7 27.8 27.5 58.5 37.9 35.3 35.6 56.1 38.5 29.7 67.7 50.1 33.7 27.2 58.0 115.6 171.9 79.1 76.0 67.6 57.2 99.7 96.6 77.0 151.1 85.9 127.6 97.9 218.1 108.0 86.5 131.4 86.3 114.0 112.6 136.4 74.8 84.9 139.4 67.0 167.5 71.3 183.3 148.0 54.2 89.6 146.1 101.4 40.0 95.2 142.8 157.1 96.7 112.7 241.1 99.4 243.5 83.4 99.9 184.4 163.5 167.0 190.3 77.6 78.2 64.0 82.2 101.5 198.6 128.6 77.7 150.1 69.3 60.2 86.0 160.5 150.6 188.1 133.2 192.6 176.1 79.2 91.3 146.2 30.9 88.3 20.9 71.5 84.2 81.6 187.6 86.4 79.0 146.4 179.0 118.0 103.6 4.9 67.3 81.3 146.6 84.0 145.1 55.1 56.9 56.3 68.3 56.7 57.4 55.8 55.6 56.1 58.5 56.1 58.0 53.2 12.8 11.0 3.9 66.4 122.9 42.9 94.5 54.1 16.9 103.1 142.2 124.1 78.6 45.6 44.1 4.2 68.0 52.5 78.2 211.3 84.1 134.7 36.7 28.1 55.8 27.0 56.8 3.2 125.6 88.2 42.0 24.5 39.1 52.6 30.1 40.4 212.3 125.9 8.4 3.9 61.0 48.8 71.7 100.3 284.7 46.3 52.9 81.8 3.7 103.2 55.0 56.7 3.0 5.6 85.3 63.5 51.1 51.5 102.4 120.3 227.3 23.2 15.5 13.1 50.5 71.3 85.9 52.8 78.1 129.7 39.5 42.2 37.7 92.6 52.4 TIMM17B "DXS9822, JM3" ENSG00000126768 "Translocase of inner mitochondrial membrane 17B" O60830 X 48893447-48898143 "Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029093 Approved Approved Microtubules,Mitochondria NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Mitochondria "HPA029093: AB_10600913" "unprognostic (7.87e-2)" "prognostic favorable (6.63e-4)" "unprognostic (8.44e-2)" "unprognostic (3.52e-2)" "unprognostic (1.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.89e-3)" "unprognostic (1.44e-1)" "unprognostic (2.01e-1)" "unprognostic (1.14e-2)" "unprognostic (2.04e-1)" "unprognostic (2.16e-1)" "unprognostic (2.67e-2)" "unprognostic (9.40e-2)" "unprognostic (5.24e-3)" "unprognostic (8.67e-2)" "prognostic favorable (7.88e-4)" 24.0 42.0 49.8 18.8 51.1 28.2 25.9 50.6 60.6 29.2 47.0 40.3 25.5 27.7 21.0 38.2 29.1 17.6 75.3 50.1 49.6 47.5 48.7 28.1 27.8 49.5 48.9 27.3 33.4 47.6 45.1 23.0 48.9 36.4 19.4 26.2 25.3 27.7 99.1 35.4 32.2 18.0 50.5 37.9 40.5 18.7 50.6 40.7 30.4 83.2 26.8 35.5 28.7 53.1 71.0 127.8 78.7 78.1 24.2 19.3 65.4 31.3 47.7 81.1 52.9 113.3 93.4 51.8 47.4 27.2 131.1 52.5 125.1 68.3 30.4 111.2 140.1 37.6 69.2 101.4 68.3 56.5 35.0 24.9 67.3 60.9 80.8 40.3 37.6 90.1 56.5 118.2 37.8 183.5 89.4 136.7 102.8 93.2 118.3 62.1 51.0 187.8 80.9 41.1 77.6 69.7 48.6 77.0 47.0 98.5 168.7 97.4 26.2 37.1 72.4 89.8 54.9 107.8 137.1 64.3 51.4 100.3 44.6 178.2 123.4 179.9 67.2 123.9 77.4 113.4 67.1 76.3 121.1 113.4 64.8 59.7 139.6 75.7 104.8 127.6 74.4 124.3 49.8 51.1 50.6 60.6 50.1 49.6 49.5 48.9 48.9 50.5 50.6 53.1 23.8 25.6 34.9 4.9 56.5 30.2 52.4 99.0 21.1 40.4 52.9 62.2 40.0 41.5 59.4 73.5 16.7 94.4 45.0 40.2 185.9 94.5 5.6 42.4 25.5 24.6 81.5 48.8 4.3 73.1 94.3 31.0 34.1 37.8 52.0 50.3 24.7 56.0 99.6 35.3 5.6 68.3 91.6 37.6 49.8 7.4 23.9 48.9 44.4 3.7 85.9 48.7 55.6 2.5 9.1 89.9 92.7 23.0 103.7 63.3 102.4 160.0 56.6 43.8 32.9 21.2 45.0 29.0 39.9 52.0 34.4 79.6 48.2 52.7 59.8 61.2 TMED9 "HSGP25L2G, p24a2, p24alpha2" ENSG00000184840 "Transmembrane p24 trafficking protein 9" Q9BVK6 5 177592203-177597242 "Predicted membrane proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 915.2;Syncytiotrophoblasts: 773.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014650 Approved NA NA 36000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 55: Plasma cells - Humoral immune response" "HPA014650: AB_1858066" "unprognostic (5.75e-3)" "unprognostic (4.35e-2)" "unprognostic (1.37e-1)" "unprognostic (3.82e-2)" "unprognostic (9.37e-3)" "unprognostic (5.14e-3)" "unprognostic (2.55e-2)" "unprognostic (1.90e-2)" "unprognostic (1.37e-1)" "unprognostic (7.00e-2)" "unprognostic (4.01e-1)" "unprognostic (2.58e-1)" "prognostic unfavorable (5.88e-5)" "unprognostic (2.88e-1)" "unprognostic (4.71e-2)" "unprognostic (9.07e-2)" "unprognostic (3.65e-2)" 86.5 106.7 29.8 38.3 30.0 37.7 74.4 29.8 34.0 74.9 42.0 87.5 31.8 76.6 65.6 135.7 60.7 25.7 99.1 29.9 30.7 97.3 229.5 100.6 29.7 32.4 31.2 62.4 253.7 40.8 82.1 59.1 30.8 87.0 45.5 15.7 139.2 34.4 55.7 83.8 75.6 39.4 31.0 102.1 114.0 54.0 32.3 24.4 87.8 16.8 36.4 84.8 82.5 30.6 100.4 115.9 51.0 163.3 131.5 93.0 224.1 181.5 139.1 91.0 125.3 178.5 142.5 57.5 214.3 171.2 179.5 79.9 49.6 244.8 91.1 275.7 73.6 47.8 93.2 151.2 132.7 130.9 170.4 88.1 125.6 95.8 106.7 122.9 137.4 51.7 55.9 100.0 99.3 243.9 31.3 96.4 57.0 89.9 112.7 53.3 66.9 147.8 109.3 86.0 26.6 38.4 89.7 104.1 99.9 80.4 104.7 131.0 121.0 112.2 83.2 93.0 140.5 171.4 109.9 56.7 149.1 165.9 146.5 78.9 98.3 77.2 85.5 94.5 85.3 65.9 68.3 67.0 91.9 63.5 58.0 53.8 39.1 76.8 89.0 201.4 74.8 131.9 29.8 30.0 29.8 34.0 29.9 30.7 32.4 31.2 30.8 31.0 32.3 30.6 115.6 67.3 69.5 10.1 127.3 145.0 193.4 601.4 48.9 67.4 118.6 94.0 48.0 147.3 235.8 128.8 31.3 525.6 167.8 172.8 29.4 428.6 7.1 51.0 108.4 145.1 112.3 78.9 9.3 354.1 915.2 175.9 79.0 89.8 113.4 141.8 115.6 118.4 384.5 60.6 9.6 323.1 238.0 79.5 139.2 13.5 135.2 121.2 256.1 15.9 189.2 105.4 147.2 17.6 10.3 320.0 155.7 98.2 370.3 229.6 84.2 71.7 94.5 73.7 65.7 83.4 160.3 89.1 175.7 59.9 138.5 773.2 104.7 157.7 182.7 203.6 TMEM121 "hole, MGC4659, TMEM121A" ENSG00000184986 "Transmembrane protein 121" Q9BTD3 14 105526583-105530202 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Granulosa cells: 31.2;Muller glia cells: 14.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "memory B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 8.1;MCF7: 8.1;PC-3: 10.2;REH: 6.7;SCLC-21H: 5.3;WM-115: 5.4" "Low region specificity" "Detected in all" HPA049857 Uncertain Approved Cytosol NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA049857: AB_2680917" "unprognostic (4.25e-2)" "unprognostic (3.34e-1)" "unprognostic (2.05e-3)" "unprognostic (2.20e-2)" "unprognostic (1.31e-1)" "unprognostic (9.50e-2)" "unprognostic (1.88e-3)" "unprognostic (9.54e-2)" "unprognostic (3.47e-2)" "unprognostic (1.20e-1)" "unprognostic (1.03e-3)" "unprognostic (5.31e-2)" "unprognostic (5.48e-4)" "unprognostic (2.83e-2)" "unprognostic (1.71e-1)" "prognostic unfavorable (5.87e-4)" "unprognostic (5.90e-2)" 2.0 1.0 4.8 0.5 5.0 0.2 2.4 2.9 6.4 4.6 0.4 2.4 0.2 4.3 0.1 1.0 4.6 0.1 2.3 5.7 3.1 2.6 2.6 1.7 0.3 5.8 4.8 2.4 2.4 0.6 5.1 0.2 3.8 3.7 0.0 0.0 1.4 0.4 0.3 1.5 1.8 0.2 2.6 3.4 1.8 1.2 3.3 0.1 2.6 0.0 0.0 2.1 2.1 3.9 0.0 4.0 0.4 3.6 0.0 0.2 0.7 2.4 0.5 0.4 0.0 0.0 1.3 1.2 8.1 0.0 0.7 0.4 0.4 0.1 0.0 0.5 1.9 0.0 0.4 1.4 0.6 0.0 1.4 0.2 0.0 0.1 0.0 0.2 0.4 0.5 0.1 0.0 0.2 8.1 0.2 0.0 1.2 0.1 10.2 6.7 0.0 0.1 0.1 0.0 5.3 2.0 0.4 0.0 2.0 0.0 2.4 0.3 1.4 1.1 2.1 0.2 0.4 0.6 0.0 0.0 0.1 0.5 5.4 0.0 0.0 0.0 0.6 0.0 1.0 2.1 1.2 0.6 0.2 0.6 0.7 0.4 0.0 0.8 0.0 0.0 0.0 0.2 4.8 5.0 2.9 6.4 5.7 3.1 5.8 4.8 3.8 2.6 3.3 3.9 10.6 0.0 0.5 2.3 2.8 4.6 2.6 0.1 2.2 5.1 8.9 10.8 1.5 1.5 0.7 5.5 0.0 0.2 0.7 0.0 0.0 1.0 1.7 5.4 5.5 9.5 0.0 3.4 5.7 0.2 2.2 4.6 1.1 1.4 0.0 31.2 10.8 2.3 0.4 10.1 4.8 0.0 0.0 0.6 4.8 2.2 4.4 0.4 7.2 2.8 0.0 14.4 1.0 12.1 11.5 0.0 0.0 6.4 0.5 1.8 0.0 0.1 1.6 1.6 0.0 4.0 3.2 0.7 3.1 0.4 2.6 0.3 3.2 1.8 0.2 0.6 TMEM150C "FLJ12993, TTN3" ENSG00000249242 "Transmembrane protein 150C" B9EJG8 4 82483170-82562357 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 134.9" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3" "Cancer enhanced" "Detected in all" "breast cancer: 23.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "basophil: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052921 Enhanced NA NA "Cluster 17: Basophils - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "HPA052921: AB_2681988" "unprognostic (2.99e-1)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (1.89e-3)" "unprognostic (1.71e-3)" "prognostic favorable (7.87e-4)" "unprognostic (2.94e-2)" "unprognostic (5.55e-2)" "unprognostic (1.06e-1)" "unprognostic (3.94e-2)" "prognostic favorable (5.68e-4)" "unprognostic (4.57e-2)" "prognostic favorable (4.59e-6)" "unprognostic (4.18e-1)" "unprognostic (2.64e-2)" "unprognostic (1.19e-1)" "unprognostic (3.51e-3)" 13.1 43.1 12.9 4.6 15.3 1.9 22.0 9.7 16.8 15.1 6.3 7.7 7.4 4.9 134.9 3.6 7.4 6.5 12.7 15.7 12.7 17.3 13.9 6.2 14.7 12.9 15.9 31.5 3.4 5.4 8.4 9.8 14.7 12.6 4.3 4.5 17.0 7.6 6.9 4.3 6.9 6.9 12.0 14.3 5.0 3.2 12.2 9.1 11.4 9.7 12.8 5.0 5.2 12.5 0.1 1.0 8.8 10.9 0.1 0.1 0.4 1.9 4.7 1.3 1.2 0.0 0.6 0.3 0.9 0.3 3.6 0.2 5.0 0.0 1.4 0.4 2.3 0.7 1.2 0.1 0.0 0.0 1.0 4.5 0.6 0.0 0.0 0.8 2.7 5.3 0.0 0.0 0.2 32.2 0.6 0.8 3.9 0.0 0.5 1.0 0.2 1.2 0.2 4.8 20.1 3.5 0.5 0.4 2.8 4.1 0.5 0.2 0.8 0.5 0.3 0.1 1.1 0.1 0.5 0.4 0.6 0.1 2.2 2.6 0.3 0.5 0.2 0.2 0.1 1.0 0.3 0.2 0.1 1.1 0.2 0.2 1.4 0.5 0.3 0.6 0.1 0.1 12.9 15.3 9.7 16.8 15.7 12.7 12.9 15.9 14.7 12.0 12.2 12.5 30.7 0.0 1.1 36.6 0.2 2.4 3.5 1.9 0.6 1.1 19.3 13.6 10.1 5.7 6.1 14.7 2.1 88.6 1.4 0.2 0.0 7.2 5.5 2.6 11.2 24.8 1.2 3.0 35.6 2.5 1.3 13.1 0.5 10.5 6.3 104.7 25.4 20.4 5.7 1.7 24.2 1.1 0.0 1.0 3.6 2.9 14.3 1.8 1.8 7.5 7.8 14.8 0.0 17.6 13.1 1.4 0.2 9.8 1.2 4.9 0.4 2.6 7.1 2.2 0.0 3.9 7.8 1.1 4.1 1.6 1.1 117.3 0.6 1.8 4.3 0.9 TMEM18 "DKFZp434C1714, lncND" ENSG00000151353 "Transmembrane protein 18" Q96B42 2 663877-677406 "Predicted membrane proteins, Transporters" Transcription DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040233 Approved Approved "Endoplasmic reticulum,Mitochondria" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Mitochondria "Endoplasmic reticulum" "HPA040233: AB_10794737" "unprognostic (9.01e-3)" "unprognostic (2.45e-1)" "unprognostic (7.48e-2)" "unprognostic (1.77e-3)" "unprognostic (2.68e-2)" "unprognostic (1.61e-1)" "unprognostic (1.27e-2)" "unprognostic (4.11e-2)" "prognostic unfavorable (3.21e-4)" "unprognostic (6.05e-2)" "unprognostic (1.86e-1)" "unprognostic (9.45e-2)" "unprognostic (8.20e-2)" "unprognostic (2.49e-1)" "unprognostic (3.65e-1)" "unprognostic (4.98e-3)" "unprognostic (8.08e-2)" 18.5 19.9 9.3 6.3 9.1 8.8 18.5 8.8 11.7 14.8 7.6 12.3 8.9 17.7 9.7 14.8 15.8 8.5 11.6 9.6 10.0 13.2 10.1 11.0 8.4 9.8 9.4 28.3 25.2 12.4 9.7 9.9 9.8 9.5 6.2 12.0 14.3 7.0 27.3 15.4 10.1 9.5 9.4 9.2 13.3 12.2 10.2 7.0 12.8 12.2 6.4 13.6 13.1 10.4 17.4 14.1 20.3 21.7 23.9 35.4 19.0 23.8 19.0 20.2 19.5 1.9 27.6 25.1 44.5 31.1 10.7 24.0 7.2 26.3 17.8 37.1 16.6 14.4 7.6 28.7 25.9 13.5 11.9 24.6 26.4 35.1 26.7 18.2 5.9 39.1 14.7 14.7 30.5 48.1 32.7 32.1 13.8 15.1 21.4 17.8 9.9 17.8 21.0 16.3 14.4 24.9 13.1 22.7 25.4 9.5 16.2 25.6 19.5 19.0 25.5 12.6 36.7 19.3 34.4 21.8 20.7 14.4 13.1 3.8 16.1 6.9 11.8 15.7 11.3 18.4 13.5 9.5 16.6 14.8 14.8 14.4 1.0 18.5 18.4 22.3 17.1 13.1 9.3 9.1 8.8 11.7 9.6 10.0 9.8 9.4 9.8 9.4 10.2 10.4 49.2 22.4 32.8 4.6 39.4 35.9 29.7 46.0 61.5 19.8 68.3 108.2 28.3 31.5 39.2 27.6 8.4 72.5 28.1 26.0 31.3 34.1 14.2 37.5 53.7 41.0 19.8 37.9 4.1 46.3 62.1 47.1 27.0 53.1 29.8 77.6 38.2 37.4 49.1 20.2 3.9 39.4 36.7 37.4 31.5 13.1 63.3 31.2 40.9 2.8 36.4 49.8 20.6 4.5 10.2 36.6 50.7 51.1 43.1 40.1 51.0 45.8 32.1 33.7 19.7 31.8 48.8 93.3 68.1 72.6 43.2 81.1 30.0 63.5 41.7 40.4 TMEM251 "C14orf109, DKFZP564F1123" ENSG00000153485 "Transmembrane protein 251" Q8N6I4 14 93184951-93188463 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 113.5;Hofbauer cells: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048559 Uncertain Approved "Golgi apparatus,Cell Junctions" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 4: Macrophages - Innate immune response" "Cell Junctions" "Golgi apparatus" "HPA048559: AB_2680441" "unprognostic (1.21e-2)" "unprognostic (4.56e-2)" "unprognostic (4.61e-3)" "unprognostic (3.37e-2)" "unprognostic (2.14e-1)" "unprognostic (4.03e-2)" "prognostic unfavorable (6.14e-7)" "unprognostic (1.67e-2)" "unprognostic (1.88e-1)" "unprognostic (9.99e-3)" "unprognostic (5.80e-3)" "unprognostic (1.58e-1)" "prognostic favorable (1.10e-4)" "unprognostic (5.17e-2)" "unprognostic (1.61e-1)" "unprognostic (7.47e-2)" "unprognostic (6.17e-2)" 16.6 22.9 7.3 6.4 7.8 2.7 16.9 7.9 10.0 15.5 8.2 22.9 10.3 14.2 16.5 13.1 14.7 6.7 25.6 7.6 7.6 33.2 17.2 17.1 8.0 7.7 7.8 14.2 21.2 10.3 19.8 6.9 7.8 25.7 12.5 20.7 19.6 9.2 30.6 13.7 18.1 6.8 7.4 15.9 21.8 8.4 8.1 8.6 17.6 12.4 6.9 17.2 12.8 9.0 11.0 12.1 15.3 16.1 17.2 7.3 9.4 7.9 8.2 12.7 16.2 7.8 11.1 12.1 12.9 7.9 15.9 15.9 17.8 12.6 17.7 9.3 13.4 10.9 8.8 18.3 15.2 16.0 14.7 9.3 14.6 10.0 16.2 6.8 12.2 13.5 9.3 12.0 11.6 52.5 10.2 12.8 8.3 28.0 11.6 4.7 16.0 11.3 16.6 23.6 12.9 13.4 11.7 6.0 36.9 12.4 17.7 11.4 5.0 6.1 10.8 14.6 9.4 9.3 16.0 11.8 11.4 6.1 9.1 6.8 9.7 13.6 3.9 9.4 2.9 4.7 4.6 4.4 8.0 5.5 5.2 5.9 10.5 5.3 13.0 7.3 4.1 4.2 7.3 7.8 7.9 10.0 7.6 7.6 7.7 7.8 7.8 7.4 8.1 9.0 13.4 3.2 14.4 5.2 22.4 23.2 37.9 33.6 13.1 14.8 41.1 39.1 22.5 32.9 22.0 31.3 27.1 36.6 16.5 44.8 113.5 30.3 1.8 33.1 16.3 11.9 15.0 11.3 5.9 26.6 21.1 16.6 20.9 35.7 17.2 15.2 8.9 19.2 110.1 13.5 7.8 36.1 26.4 28.4 20.0 2.3 11.8 39.6 32.0 2.8 16.2 34.8 12.3 5.0 13.8 17.7 23.8 10.9 13.1 43.3 31.7 69.6 17.2 30.6 39.5 13.9 23.2 4.5 17.8 18.1 31.1 27.4 16.1 17.6 30.9 36.4 TMEM270 "MGC26719, WBSCR28" ENSG00000175877 "Transmembrane protein 270" Q6UE05 7 73861159-73865890 "Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 215 "testis: 77.6" "Cell type enriched" "Detected in single" 7 "Endometrial ciliated cells: 2.1" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA077196 Approved Vesicles NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA077196: AB_2732334" "unprognostic (3.84e-2)" "unprognostic (6.91e-2)" "unprognostic (6.87e-5)" "unprognostic (1.38e-2)" "unprognostic (1.11e-2)" "unprognostic (2.81e-3)" "unprognostic (1.34e-1)" "unprognostic (8.31e-3)" "unprognostic (2.07e-1)" "unprognostic (1.66e-1)" "unprognostic (4.69e-1)" "unprognostic (2.56e-2)" "unprognostic (3.35e-2)" "unprognostic (1.26e-1)" "unprognostic (1.44e-1)" "unprognostic (7.23e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 77.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TMEM31 MGC39655 ENSG00000179363 "Transmembrane protein 31" Q5JXX7 X 103710909-103714032 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "testis: 110.1" "Cell type enriched" "Detected in some" 5 "Late spermatids: 3288.8" "Cancer enhanced" "Detected in some" "testis cancer: 1.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 1.8;BEWO: 4.3;MCF7: 6.4;NTERA-2: 1.8;U-937: 2.4" "Low region specificity" "Detected in all" HPA052760 Approved "Nucleoli fibrillar center" NA NA "Cluster 28: Myeloid DCs - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli fibrillar center" "HPA052760: " "unprognostic (9.42e-5)" "unprognostic (1.46e-2)" "unprognostic (1.18e-1)" "unprognostic (7.51e-2)" "unprognostic (7.75e-3)" "unprognostic (1.22e-2)" "unprognostic (2.43e-1)" "unprognostic (4.50e-2)" "unprognostic (1.06e-2)" "unprognostic (1.59e-1)" "unprognostic (1.39e-2)" "unprognostic (3.77e-1)" "unprognostic (5.91e-5)" "unprognostic (1.75e-2)" "unprognostic (1.12e-1)" "unprognostic (2.72e-1)" "unprognostic (4.68e-2)" 0.4 0.2 2.1 0.1 2.4 0.0 0.6 2.1 3.3 1.4 1.6 0.3 0.0 0.6 0.5 0.1 1.0 0.2 0.3 2.1 2.3 0.7 0.3 0.3 0.2 2.3 2.2 1.7 0.2 1.3 0.9 0.9 2.4 0.6 0.0 0.2 0.2 0.3 0.9 0.4 0.2 0.1 2.2 0.4 0.2 110.1 2.4 0.3 0.3 0.0 0.0 0.4 0.5 2.7 0.0 0.0 1.8 0.1 0.1 0.0 4.3 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.1 0.0 0.3 0.0 0.7 0.0 0.2 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.2 6.4 0.1 1.2 1.8 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.5 0.3 0.4 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 2.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.3 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 2.1 2.4 2.1 3.3 2.1 2.3 2.3 2.2 2.4 2.2 2.4 2.7 0.3 0.0 0.0 0.0 0.0 0.8 0.7 0.2 0.0 0.0 0.4 1.5 0.2 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 641.3 10.1 0.4 1.1 0.0 0.0 0.2 0.7 8.6 0.6 0.0 0.2 0.0 1.1 0.7 0.2 0.4 0.0 0.1 0.1 0.0 0.3 0.3 3288.8 13.4 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.1 0.0 7.5 0.0 0.3 0.0 0.2 0.0 0.0 13.1 0.3 0.3 19.6 12.1 0.0 0.3 2.9 0.0 0.2 0.0 0.2 TMUB1 "C7orf21, HOPS, SB144" ENSG00000164897 "Transmembrane and ubiquitin like domain containing 1" Q9BVT8 7 151081085-151083493 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 191.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029429 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm Cytosol "HPA029429: AB_10601825" "unprognostic (8.14e-2)" "unprognostic (2.19e-2)" "unprognostic (2.76e-3)" "unprognostic (1.30e-1)" "unprognostic (7.23e-3)" "unprognostic (7.04e-2)" "unprognostic (2.12e-3)" "unprognostic (7.73e-2)" "unprognostic (1.25e-1)" "unprognostic (2.93e-2)" "unprognostic (1.74e-2)" "unprognostic (2.24e-1)" "unprognostic (1.97e-2)" "unprognostic (2.49e-3)" "unprognostic (2.74e-1)" "unprognostic (1.03e-1)" "unprognostic (3.31e-2)" 33.1 53.3 26.8 25.6 24.7 23.0 34.3 25.6 38.6 34.0 19.4 52.7 47.2 33.6 8.6 54.2 32.8 14.9 50.4 24.9 24.6 56.3 131.3 41.6 26.3 29.6 25.9 37.0 93.5 20.3 68.8 20.4 27.0 51.2 8.3 5.2 44.1 14.9 84.5 47.0 56.7 9.0 24.2 53.6 66.8 25.9 29.4 17.9 51.3 20.0 12.1 40.8 38.9 23.7 88.3 77.5 18.0 93.2 11.6 14.2 67.2 35.3 29.3 30.8 34.3 67.5 104.6 58.6 73.9 17.4 39.9 58.6 20.0 31.2 6.8 108.0 74.4 24.8 74.8 104.7 29.5 31.3 84.8 22.0 25.4 25.8 6.9 23.4 22.9 59.3 159.4 77.4 14.0 141.2 104.5 134.5 77.2 51.7 48.3 64.8 22.7 108.5 32.2 67.4 65.6 73.2 28.6 43.6 47.9 10.6 34.0 42.9 28.3 39.0 28.5 49.3 59.1 121.2 72.5 41.4 89.8 58.2 50.4 4.2 3.1 23.8 5.7 4.3 5.0 5.3 8.7 6.4 3.2 11.2 8.7 4.8 5.3 3.7 2.6 4.8 12.1 2.4 26.8 24.7 25.6 38.6 24.9 24.6 29.6 25.9 27.0 24.2 29.4 23.7 24.0 6.4 3.2 7.5 51.2 26.4 25.9 26.0 31.9 15.2 45.7 34.8 9.9 28.6 15.9 22.0 14.6 93.1 50.2 136.7 35.2 73.1 11.9 15.8 11.7 21.5 41.3 23.2 4.5 109.6 60.2 18.3 52.0 29.3 15.9 23.3 25.4 51.4 44.2 20.2 5.3 85.9 46.8 30.4 61.2 5.1 12.5 32.4 32.0 6.5 44.8 28.9 70.0 2.5 7.2 96.3 109.7 16.6 67.8 39.3 191.0 37.9 6.4 16.0 39.5 9.3 21.8 22.3 15.6 39.5 36.9 94.5 52.8 25.4 84.0 37.9 TNRC18 "CAGL79, KIAA1856, TNRC18A" ENSG00000182095 "Trinucleotide repeat containing 18" O15417 7 5306790-5425414 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "neutrophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020730, HPA024251" Uncertain Supported "Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol" NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Nuclear membrane, Mitochondria" Cytosol "HPA020730: AB_2670506, HPA024251: AB_2671498" "unprognostic (1.66e-1)" "unprognostic (3.17e-3)" "unprognostic (2.67e-3)" "unprognostic (4.44e-1)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "unprognostic (1.13e-2)" "unprognostic (1.79e-1)" "unprognostic (3.01e-1)" "unprognostic (2.11e-2)" "unprognostic (6.08e-2)" "unprognostic (1.36e-1)" "unprognostic (9.29e-3)" "unprognostic (2.14e-1)" "unprognostic (2.94e-1)" "unprognostic (1.02e-1)" "unprognostic (4.34e-2)" 30.4 18.3 10.8 29.0 8.9 51.8 30.1 16.2 14.2 40.8 2.2 56.3 25.3 57.6 16.4 26.0 43.5 22.4 22.1 10.3 0.5 22.9 19.8 32.0 16.1 6.2 1.7 46.0 29.5 35.0 22.2 30.6 1.6 36.1 22.6 12.2 28.8 34.3 24.0 33.2 29.0 36.4 1.3 25.2 33.8 22.6 5.1 17.2 32.6 11.1 14.6 40.8 31.9 3.2 72.8 63.4 51.5 43.4 42.9 50.6 133.8 50.4 47.3 27.4 29.0 26.3 62.4 49.3 48.3 74.7 60.8 79.7 30.2 60.5 23.0 21.6 19.2 31.4 56.6 43.1 37.1 104.3 111.2 51.2 70.0 54.8 63.2 39.5 31.3 43.6 45.4 27.2 35.3 120.0 24.6 127.2 4.5 47.5 48.0 27.0 25.7 37.3 22.3 91.3 22.3 53.4 38.8 102.5 37.0 23.1 106.9 106.1 78.7 78.3 109.6 47.0 36.7 38.6 44.1 46.2 44.1 72.6 94.1 14.2 3.8 3.6 1.7 1.5 1.2 2.2 1.2 1.0 1.4 2.3 0.9 1.7 20.8 3.2 2.1 5.4 1.9 0.2 10.8 8.9 16.2 14.2 10.3 0.5 6.2 1.7 1.6 1.3 5.1 3.2 25.6 9.6 29.0 59.7 7.4 9.3 3.7 9.8 13.6 51.7 15.8 25.9 7.5 14.3 12.4 14.7 2.1 14.5 20.4 33.6 1.9 5.0 14.4 22.2 29.7 17.3 31.3 9.7 40.9 6.6 3.8 17.8 19.4 36.2 14.0 48.3 29.6 25.4 11.2 50.5 45.6 30.4 8.2 41.8 12.4 18.8 18.3 22.8 5.4 71.2 25.9 31.0 11.3 32.6 20.3 9.0 10.6 19.9 12.1 6.5 7.4 5.4 11.1 4.0 19.7 18.4 21.2 0.4 2.1 12.5 8.8 10.0 12.3 18.6 25.1 3.8 TNS3 "FLJ13732, H_NH0549I23.2, TEM6, TENS1" ENSG00000136205 "Tensin 3" Q68CZ2 7 47275154-47582558 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 90.8;Oligodendrocyte precursor cells: 150.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "classical monocyte: 4.0;intermediate monocyte: 3.2;memory B-cell: 2.3;myeloid DC: 2.6;naive B-cell: 1.9;non-classical monocyte: 3.2;plasmacytoid DC: 3.7" "Group enriched" "Detected in many" 7 "B-cells: 2.3;dendritic cells: 3.7;monocytes: 4.0" "Cell line enhanced" "Detected in many" "A549: 266.7;LHCN-M2: 170.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055338, HPA056015" Approved Enhanced "Focal adhesion sites" NA NA 8100 "Cluster 14: Monocytes - Unknown function" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 68: Oligodendrocytes - Mixed function" "Focal adhesion sites" "HPA055338: AB_2682789, HPA056015: AB_2683010" "unprognostic (1.46e-1)" "unprognostic (2.97e-2)" "unprognostic (1.34e-1)" "unprognostic (7.02e-2)" "unprognostic (9.04e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (2.05e-1)" "unprognostic (8.00e-2)" "unprognostic (3.77e-2)" "unprognostic (3.70e-1)" "unprognostic (6.60e-2)" "prognostic favorable (5.21e-4)" "unprognostic (3.13e-2)" "unprognostic (4.41e-2)" "unprognostic (3.20e-2)" "unprognostic (9.09e-3)" 30.4 35.3 57.3 23.8 59.0 6.3 20.9 57.3 51.6 26.2 59.2 19.3 18.7 24.6 6.5 6.4 21.9 21.3 23.8 55.2 64.7 59.7 51.6 40.7 36.7 81.4 63.3 38.3 57.0 30.8 10.5 56.7 73.2 16.3 16.9 9.1 48.5 16.0 22.0 14.4 23.9 16.6 63.2 42.0 30.3 9.4 73.9 8.3 29.8 15.0 19.4 16.2 16.6 63.6 26.5 266.7 15.9 27.7 35.6 28.8 50.6 23.6 133.8 22.7 34.7 60.5 34.7 13.4 40.9 86.4 84.8 49.4 25.9 38.6 20.6 0.2 1.6 37.4 37.3 32.3 36.8 0.1 0.4 28.7 16.3 13.0 20.7 147.3 18.1 0.0 0.1 80.6 170.0 16.4 0.1 0.8 15.4 38.1 31.5 12.1 38.7 44.5 77.5 53.0 1.5 32.3 46.5 9.3 26.9 79.6 35.2 27.6 72.6 35.0 27.1 0.4 36.5 51.7 72.4 30.6 8.7 26.0 129.6 0.2 4.0 0.0 0.0 3.2 0.1 2.3 0.0 0.0 2.6 1.9 0.0 0.0 0.5 0.0 3.2 3.7 0.0 1.4 57.3 59.0 57.3 51.6 55.2 64.7 81.4 63.3 73.2 63.2 73.9 63.6 8.5 67.3 15.8 90.8 10.9 4.8 6.5 26.3 14.2 1.6 8.5 10.3 23.9 35.8 18.8 31.3 0.0 27.7 7.1 41.3 1.9 15.5 11.8 19.8 11.0 12.4 15.0 6.3 2.4 18.4 59.2 14.9 18.3 23.2 0.0 11.4 31.4 40.3 77.4 0.0 6.4 14.0 10.2 41.3 8.4 18.5 6.2 28.9 16.0 76.8 23.1 35.2 1.0 150.8 3.7 23.8 9.9 15.4 5.3 10.5 33.6 14.1 11.1 1.4 26.3 45.5 21.8 2.2 3.0 1.5 3.3 30.0 3.5 20.1 17.0 3.2 TONSL "IKBR, NFKBIL2" ENSG00000160949 "Tonsoku like, DNA repair protein" Q96HA7 8 144428775-144444440 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 8.5" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 76.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024679, HPA046494" Uncertain Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 48: NK-cells - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 45: Enterocytes - Digestion" Nucleoplasm "Nuclear bodies" "HPA024679: AB_1854441, HPA046494: AB_2679673" "unprognostic (6.68e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (2.88e-2)" "unprognostic (7.35e-2)" "unprognostic (2.10e-3)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.04e-3)" "unprognostic (7.81e-2)" "unprognostic (4.39e-2)" "unprognostic (3.38e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (2.62e-7)" "unprognostic (3.24e-2)" "unprognostic (1.78e-1)" "unprognostic (9.11e-3)" "unprognostic (7.96e-2)" 1.0 2.1 0.4 2.5 0.4 8.5 1.3 0.4 1.3 1.7 0.0 3.4 3.5 1.6 0.2 3.9 1.4 0.6 1.4 0.3 0.3 1.4 1.7 1.3 2.3 1.3 0.6 1.7 1.5 0.4 0.9 1.5 1.1 1.6 0.8 0.1 1.5 0.8 0.5 3.3 4.4 0.6 0.1 3.9 2.2 3.8 0.8 2.3 2.4 0.1 1.4 2.3 2.1 0.3 21.2 18.6 13.7 21.7 1.0 1.7 33.0 17.6 3.4 10.4 8.1 15.0 17.9 19.6 17.5 2.7 4.9 14.2 13.4 10.7 2.3 20.2 26.6 46.5 26.1 15.9 0.6 14.3 28.1 1.7 1.5 10.9 2.1 2.6 5.0 26.5 53.0 14.3 4.2 43.4 35.5 24.5 19.4 20.4 26.7 42.6 8.9 20.3 5.9 22.6 22.9 13.0 18.4 12.3 7.8 5.2 17.6 13.2 5.9 12.7 52.3 14.5 21.7 5.0 9.9 12.0 12.3 30.2 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.4 0.4 1.3 0.3 0.3 1.3 0.6 1.1 0.1 0.8 0.3 2.5 6.4 22.4 1.6 2.9 8.9 5.2 1.0 1.2 3.1 3.5 2.9 2.3 8.6 3.7 1.8 2.1 4.1 1.3 20.2 0.0 0.9 0.4 4.3 2.7 4.3 2.4 7.2 2.4 1.0 5.3 3.8 11.7 6.1 2.5 8.5 2.9 11.4 4.5 1.7 1.0 14.6 0.0 0.9 16.7 0.7 0.3 3.0 14.2 1.9 1.2 1.1 1.0 0.5 0.8 1.2 7.1 1.2 4.0 3.9 76.5 7.7 4.1 3.0 6.6 6.4 2.8 4.6 7.8 3.4 11.2 1.2 3.1 3.3 15.9 3.9 TPD52L1 "D53, hD53, TPD53" ENSG00000111907 "TPD52 like 1" Q16890 6 125119049-125264407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 258.3;salivary gland: 298.3" "Cell type enhanced" "Detected in many" "Astrocytes: 390.1;Squamous epithelial cells: 272.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027915, HPA027916" Enhanced Approved "Plasma membrane,Cell Junctions,Cytosol" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cell Junctions, Cytosol" "HPA027915: AB_10602074, HPA027916: AB_10601860" "unprognostic (1.44e-1)" "unprognostic (2.01e-2)" "unprognostic (2.76e-2)" "unprognostic (1.26e-1)" "unprognostic (1.39e-1)" "unprognostic (2.87e-2)" "unprognostic (1.38e-2)" "unprognostic (2.14e-1)" "unprognostic (7.85e-2)" "unprognostic (7.80e-2)" "unprognostic (9.42e-3)" "unprognostic (1.76e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.06e-1)" "unprognostic (6.83e-2)" "prognostic favorable (3.97e-4)" "prognostic unfavorable (5.34e-4)" 44.7 258.3 83.9 10.1 96.2 0.8 67.0 72.6 97.4 35.8 103.4 36.2 9.7 15.2 68.8 152.4 34.6 27.3 71.4 78.4 81.3 40.6 58.4 10.9 6.6 81.4 76.8 20.7 47.1 67.3 24.8 8.9 78.8 41.0 13.0 1.9 298.3 79.1 111.9 47.9 10.6 12.3 68.5 2.0 43.1 5.1 81.5 3.4 60.7 126.2 12.3 59.6 60.8 76.6 37.7 42.0 0.5 269.1 2.4 0.6 63.3 6.2 5.9 0.0 0.7 67.3 46.9 0.1 136.2 31.2 9.1 83.8 8.4 58.2 0.2 0.8 58.0 0.8 58.0 0.5 5.7 0.2 0.1 7.4 234.3 0.1 30.7 82.5 0.0 0.0 30.5 0.6 4.7 365.5 0.0 0.7 4.4 36.8 22.7 0.4 0.1 0.0 271.4 9.8 9.1 0.2 70.5 189.4 4.6 9.6 162.3 0.8 0.2 1.8 5.9 0.5 2.0 0.1 0.1 0.2 1.0 0.3 0.7 1.8 0.5 0.3 0.3 0.2 0.3 0.3 0.6 0.2 0.2 0.4 0.7 0.5 2.7 2.6 0.1 0.4 0.2 0.4 83.9 96.2 72.6 97.4 78.4 81.3 81.4 76.8 78.8 68.5 81.5 76.6 141.6 0.0 28.3 390.1 2.2 19.6 44.6 70.2 128.1 3.8 164.4 154.9 45.8 25.8 51.7 125.0 4.2 32.7 3.2 3.9 176.1 30.7 6.9 71.7 21.1 87.2 16.2 0.0 16.4 110.8 140.2 18.8 13.7 184.5 2.5 29.5 15.4 59.9 10.9 0.0 48.2 11.3 83.4 2.1 5.2 4.9 17.4 3.4 131.6 28.1 0.6 3.9 1.0 11.6 2.9 35.3 2.3 36.5 2.6 37.1 10.9 45.4 15.7 1.3 0.0 177.1 10.1 5.7 9.2 272.2 37.2 14.4 3.5 53.8 17.8 19.2 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" NA NA "Cluster 7: Monocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 29.1 29.4 16.5 24.4 15.1 35.0 28.2 18.2 23.0 32.1 17.0 38.0 40.0 31.2 11.6 54.6 30.4 22.2 21.3 17.9 14.6 28.1 51.5 33.2 22.9 17.8 15.3 23.5 37.4 14.6 32.1 20.6 14.8 27.0 17.4 8.5 34.7 16.5 30.4 47.7 35.2 18.8 14.2 34.5 35.6 14.8 17.7 19.1 25.6 9.9 18.6 34.5 34.8 14.3 57.7 72.2 40.3 72.5 40.8 76.5 47.4 43.4 53.9 49.9 44.6 88.2 72.1 36.6 50.2 55.4 31.8 65.9 38.1 76.8 18.8 58.3 48.8 52.4 98.5 68.3 53.8 56.3 72.7 76.2 62.8 48.1 62.6 41.0 97.4 70.6 57.1 47.9 48.2 131.1 58.3 65.2 79.7 78.7 34.8 107.4 66.7 74.2 40.2 30.4 80.9 67.2 36.3 68.5 48.6 20.9 78.1 68.2 74.3 60.2 83.9 56.7 48.2 69.2 55.0 48.4 34.4 35.9 47.8 4.0 9.1 7.3 4.5 12.4 4.3 5.5 4.4 4.7 11.2 3.9 3.1 3.8 6.2 2.9 8.9 5.3 6.5 5.3 16.5 15.1 18.2 23.0 17.9 14.6 17.8 15.3 14.8 14.2 17.7 14.3 18.9 0.0 9.2 12.4 18.2 28.8 21.1 34.2 22.8 15.9 31.6 27.9 4.9 21.5 20.8 14.7 6.2 23.5 17.4 56.4 17.6 39.0 5.0 23.6 34.6 26.5 34.0 33.6 8.9 59.0 36.3 19.0 38.7 27.9 9.5 22.1 26.0 32.3 42.2 37.0 8.2 38.7 34.6 41.8 21.3 13.1 24.8 26.8 10.6 8.4 33.9 12.6 6.2 6.6 4.9 53.0 43.6 22.2 24.0 33.8 80.0 29.2 19.7 10.9 6.6 11.9 18.3 8.5 25.3 50.7 32.5 26.7 16.0 29.0 42.5 38.5 TRAV39 "TCRAV27S1, TCRAV39S1" ENSG00000211818 "T cell receptor alpha variable 39" A0A0B4J263 14 22304054-22304553 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 16 "lymphoid tissue: 65.2" "Cell type enhanced" "Detected in single" "T-cells: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in many" 6 "memory CD4 T-cell: 33.2;memory CD8 T-cell: 27.1;naive CD4 T-cell: 35.8;naive CD8 T-cell: 23.6;T-reg: 36.7" "Lineage enriched" "Detected in many" 7 "T-cells: 36.7" "Cell line enhanced" "Detected in single" "MCF7: 1.1" "Not detected" "Not detected" NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 63: T-cells - Adaptive immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 58: T-cells - T-cell receptor" "unprognostic (9.69e-3)" "unprognostic (4.53e-3)" "unprognostic (8.90e-2)" "unprognostic (6.16e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-2)" "unprognostic (5.71e-2)" "unprognostic (8.03e-3)" "unprognostic (3.17e-1)" "unprognostic (8.97e-2)" "unprognostic (8.96e-2)" "unprognostic (2.29e-1)" "unprognostic (6.55e-8)" "unprognostic (7.91e-2)" "unprognostic (5.25e-2)" "unprognostic (4.51e-2)" "unprognostic (3.56e-1)" 0.6 0.3 0.3 2.8 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.5 1.0 0.7 0.0 0.1 0.2 0.5 0.6 0.6 0.2 1.8 0.0 3.9 7.7 0.2 0.2 0.3 0.0 0.0 0.0 0.2 0.2 0.8 1.2 0.0 0.1 0.6 0.0 0.2 0.4 0.3 0.2 1.9 0.7 1.3 0.3 65.2 0.0 0.6 6.0 1.0 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.2 33.2 27.1 0.0 0.0 35.8 23.6 0.0 0.0 0.0 5.3 36.7 8.6 0.3 0.2 0.2 0.2 0.6 0.2 0.2 0.2 0.2 0.2 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 TRDN TRISK ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2" "Group enriched" "Detected in some" 11 "Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6" "Group enriched" "Detected in some" 5 "head and neck cancer: 2.2;prostate cancer: 0.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.9" "Region enriched" "Detected in some" 10 "olfactory bulb: 11.0" "Region enriched" "Detected in some" 23 "olfactory bulb: 28.9" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 41: Basophils - Cellular respiration" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 54: Cardiomyocytes - Muscle contraction" "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: AB_2683643" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 16.3 2.6 4.2 0.0 3.7 0.0 2.0 4.0 5.8 0.7 3.1 0.4 0.0 1.7 10.4 18.5 12.5 0.2 421.6 3.0 12.5 0.4 0.1 0.4 0.1 6.7 7.0 1.3 0.1 0.0 15.3 0.2 7.9 17.0 0.3 83.5 13.1 0.9 1944.1 0.6 0.2 1.0 9.2 0.1 0.1 5.1 10.2 0.3 0.3 1018.2 0.1 0.0 0.6 6.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 3.7 4.0 5.8 3.0 12.5 6.7 7.0 7.9 9.2 10.2 6.3 0.3 0.0 0.0 4.2 0.0 0.0 0.5 0.0 0.0 7.9 0.0 0.3 1145.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 68.0 0.0 0.0 6.0 0.0 0.0 1.1 0.0 0.0 38.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.6 0.0 0.0 0.0 0.4 35.5 13.1 0.5 1.8 0.0 0.0 765.7 0.0 3.0 3.2 0.0 0.0 11.3 0.0 0.0 0.0 0.2 0.0 21.8 0.0 398.6 7.1 1.3 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 TREX2 ENSG00000183479 "Three prime repair exonuclease 2" Q9BQ50 X 153444720-153470587 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 24.5" "Cell type enhanced" "Detected in single" "Suprabasal keratinocytes: 1.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 11 "basophil: 1.7;eosinophil: 2.7" "Lineage enriched" "Detected in single" 14 "granulocytes: 2.7" "Cell line enhanced" "Detected in many" "HEK 293: 5.4;U-698: 7.3;U-937: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA054060 Uncertain NA NA "Cluster 10: Basophils - Unknown function" "Cluster 61: Skin - Cornification" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA054060: AB_2682362" "unprognostic (2.32e-2)" "unprognostic (2.05e-3)" "unprognostic (1.13e-3)" "unprognostic (7.18e-4)" "unprognostic (6.05e-2)" "unprognostic (1.81e-2)" "unprognostic (8.40e-2)" "unprognostic (2.19e-1)" "unprognostic (2.09e-1)" "unprognostic (1.61e-1)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (1.42e-1)" "unprognostic (1.52e-1)" "unprognostic (9.34e-2)" "unprognostic (2.15e-1)" "unprognostic (1.23e-2)" 0.9 0.5 0.4 0.6 0.4 0.7 0.8 0.5 1.1 3.2 5.0 0.6 0.2 1.2 0.6 2.9 1.2 0.7 1.0 0.7 0.2 1.4 0.6 1.1 1.4 0.5 0.3 0.9 0.8 0.2 0.7 0.9 0.5 1.3 0.2 0.0 1.9 2.4 0.3 24.5 1.1 0.5 0.3 2.4 0.7 1.0 0.4 0.5 1.3 0.1 1.1 0.6 3.2 0.4 2.1 2.6 0.2 0.9 0.3 0.5 0.2 0.6 0.5 0.5 1.4 0.7 0.5 0.2 1.3 0.5 0.1 2.2 0.9 1.4 0.0 2.3 5.4 0.2 0.5 0.3 0.2 0.6 1.4 0.6 1.3 0.6 0.5 0.3 0.2 0.4 0.3 2.5 0.1 2.5 1.5 1.6 0.8 0.4 1.7 3.5 0.7 1.7 0.2 0.7 0.6 0.3 0.2 0.2 0.8 0.0 0.4 0.7 0.0 0.9 1.6 2.0 0.8 2.8 2.1 7.3 0.2 7.0 1.1 1.7 0.0 2.7 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.5 1.1 0.7 0.2 0.5 0.3 0.5 0.3 0.4 0.4 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 1.1 0.7 0.1 0.1 0.0 0.1 TRGC1 "C1, TCRGC1" ENSG00000211689 "T cell receptor gamma constant 1" 7 38257879-38265678 "Predicted membrane proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 8 "bone marrow: 31.7;prostate: 76.6" "Group enriched" "Detected in some" 5 "dendritic cells: 95.8;NK-cells: 230.7;Prostatic glandular cells: 61.9;T-cells: 65.6" "Cancer enriched" "Detected in some" 141 "prostate cancer: 107.1" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 4 "gdT-cell: 384.7" "Lineage enriched" "Detected in many" 4 "T-cells: 384.7" "Cell line enhanced" "Detected in some" "HL-60: 21.0;MCF7: 89.8;SK-BR-3: 49.6;U-937: 45.5" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" "unprognostic (2.37e-2)" "unprognostic (2.38e-4)" "unprognostic (3.43e-3)" "unprognostic (6.04e-4)" "unprognostic (1.04e-2)" "unprognostic (3.77e-3)" "unprognostic (1.33e-3)" "unprognostic (3.80e-2)" "unprognostic (3.55e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.08e-1)" "unprognostic (2.14e-1)" "unprognostic (2.15e-1)" "unprognostic (2.98e-1)" "unprognostic (8.36e-2)" "unprognostic (2.56e-2)" 0.6 0.2 1.6 1.1 1.6 31.7 2.1 1.4 2.0 0.1 1.1 0.5 1.0 0.2 0.5 0.1 0.3 1.0 0.2 1.4 1.4 0.8 0.8 1.9 2.0 1.7 1.5 0.1 0.0 0.0 0.2 0.5 1.6 76.6 0.6 0.0 0.4 0.2 0.1 0.1 1.4 0.2 1.6 6.0 0.6 0.4 2.1 7.0 0.3 0.0 1.3 0.6 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 21.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 89.8 0.2 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 49.6 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 45.5 0.0 3.8 0.3 0.5 384.7 0.4 56.7 0.2 6.8 33.5 0.3 0.0 2.3 21.7 1.8 87.5 0.3 0.5 0.1 43.7 1.6 1.6 1.4 2.0 1.4 1.4 1.7 1.5 1.6 1.6 2.1 1.5 0.5 0.0 1.1 0.0 2.1 0.0 1.3 0.0 0.0 0.0 1.8 0.6 0.2 0.0 0.6 0.0 0.0 0.0 95.8 0.1 0.0 0.0 2.3 0.0 0.1 0.5 1.2 2.7 0.0 0.0 0.0 0.5 0.5 0.1 0.0 0.0 2.2 0.9 0.1 0.0 0.0 0.2 0.0 1.9 0.0 0.9 0.0 2.1 0.0 0.0 19.5 0.0 230.7 0.0 0.0 0.0 0.0 0.0 14.3 61.9 0.0 0.3 0.7 0.0 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 65.6 0.0 0.3 1.2 TRGJ1 "J1, TCRGJ1" ENSG00000211690 "T cell receptor gamma joining 1" A0A075B6S0 7 38269491-38269540 "Predicted intracellular proteins, T-cell receptor genes" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 17.2;lymphoid tissue: 13.0;prostate: 57.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 293.4;MAIT T-cell: 274.9;memory CD8 T-cell: 299.2;naive CD8 T-cell: 194.4" "Lineage enriched" "Detected in many" 14 "T-cells: 299.2" "Group enriched" "Detected in some" 6 "HL-60: 11.7;MCF7: 15.9;SK-BR-3: 14.8;U-937: 13.5" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" 0.0 0.0 3.0 3.1 1.0 17.2 2.3 0.3 1.7 0.0 0.4 1.1 4.7 0.2 1.9 0.0 1.2 0.7 0.3 0.4 0.5 1.0 0.5 1.2 5.1 2.7 1.7 0.6 3.0 0.0 0.0 0.0 1.9 57.9 2.4 0.0 0.7 0.0 0.0 0.0 4.9 0.7 1.6 13.0 0.7 1.1 2.4 2.0 0.1 0.0 1.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 15.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.1 0.3 0.3 293.4 0.6 274.9 0.2 55.8 299.2 0.3 0.2 15.0 194.4 2.2 21.7 0.7 0.6 1.1 52.8 3.0 1.0 0.3 1.7 0.4 0.5 2.7 1.7 1.9 1.6 2.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRGJ2 "J2, TCRGJ2" ENSG00000211687 "T cell receptor gamma joining 2" 7 38253380-38253429 "Predicted intracellular proteins, T-cell receptor genes" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "bone marrow: 17.2;lymphoid tissue: 13.0;prostate: 57.9" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "gdT-cell: 293.4;MAIT T-cell: 274.9;memory CD8 T-cell: 299.2;naive CD8 T-cell: 194.4" "Lineage enriched" "Detected in many" 14 "T-cells: 299.2" "Group enriched" "Detected in some" 6 "HL-60: 11.7;MCF7: 15.9;SK-BR-3: 14.8;U-937: 13.5" NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" 0.0 0.0 3.0 3.1 1.0 17.2 2.3 0.3 1.7 0.0 0.4 1.1 4.7 0.2 1.9 0.0 1.2 0.7 0.3 0.4 0.5 1.0 0.5 1.2 5.1 2.7 1.7 0.6 3.0 0.0 0.0 0.0 1.9 57.9 2.4 0.0 0.7 0.0 0.0 0.0 4.9 0.7 1.6 13.0 0.7 1.1 2.4 2.0 0.1 0.0 1.8 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 15.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.5 0.0 1.1 0.3 0.3 293.4 0.6 274.9 0.2 55.8 299.2 0.3 0.2 15.0 194.4 2.2 21.7 0.7 0.6 1.1 52.8 3.0 1.0 0.3 1.7 0.4 0.5 2.7 1.7 1.9 1.6 2.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TRIM33 "FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA" ENSG00000197323 "Tripartite motif containing 33" Q9UPN9 1 114392790-114511203 "Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "DNA-binding, Repressor, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 237.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 13.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 115.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004345 Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 38: Basophils - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Vesicles Nucleoplasm "HPA004345: AB_1858287" "unprognostic (8.90e-2)" "unprognostic (5.86e-2)" "prognostic favorable (6.20e-4)" "unprognostic (1.09e-2)" "unprognostic (8.42e-3)" "prognostic favorable (8.93e-4)" "unprognostic (1.34e-2)" "unprognostic (1.83e-1)" "unprognostic (6.75e-2)" "unprognostic (4.58e-2)" "unprognostic (2.14e-1)" "unprognostic (1.08e-1)" "unprognostic (2.27e-2)" "unprognostic (4.84e-2)" "unprognostic (1.99e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" 9.3 8.1 10.1 10.7 11.3 25.4 13.5 18.3 16.9 12.5 8.2 9.5 8.8 15.2 29.8 11.7 9.1 10.9 8.9 11.5 9.9 13.5 12.2 10.9 13.3 8.0 9.1 14.4 12.2 15.3 7.3 16.0 8.2 12.6 10.1 18.8 10.7 11.0 8.8 14.8 8.9 11.8 8.1 12.7 11.2 25.3 9.5 17.8 14.2 10.7 12.8 11.5 9.8 11.3 30.9 16.3 30.1 22.6 12.5 13.1 51.0 15.4 16.3 20.9 22.1 18.5 12.8 32.8 15.5 18.1 13.6 17.4 27.6 18.0 28.6 24.9 16.4 31.6 21.7 21.6 13.8 40.3 25.3 12.5 12.9 24.9 25.2 16.0 17.8 27.3 40.1 22.5 20.2 115.4 40.9 17.0 40.7 11.7 16.3 34.8 45.9 10.8 14.9 47.7 20.8 21.9 29.2 34.7 27.4 19.3 15.8 21.7 20.1 14.5 23.4 33.8 21.7 15.7 15.6 33.4 20.4 23.0 42.0 13.2 1.2 6.1 2.5 1.5 2.2 3.0 2.6 2.7 1.5 1.4 2.0 3.1 3.6 4.1 2.4 3.0 1.6 0.8 10.1 11.3 18.3 16.9 11.5 9.9 8.0 9.1 8.2 8.1 9.5 11.3 31.0 19.2 33.3 70.5 35.4 52.8 28.9 28.6 25.6 75.6 35.9 23.9 29.2 30.0 32.3 55.2 98.0 64.9 53.9 33.3 1.9 21.0 237.3 50.4 37.5 33.2 52.1 37.9 120.7 23.6 34.0 28.7 30.1 90.0 37.4 55.6 40.7 44.3 29.6 26.9 108.5 30.4 30.5 50.3 47.9 97.9 49.0 37.2 19.6 79.6 42.9 31.5 54.6 116.6 101.8 31.4 34.9 36.9 31.6 47.3 26.6 17.3 31.4 58.3 32.9 38.3 32.5 60.0 31.9 31.2 55.4 87.7 42.8 48.1 31.2 55.3 TRIM37 "KIAA0898, MUL, POB1, TEF3" ENSG00000108395 "Tripartite motif containing 37" O94972 17 58982638-59106921 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Transcription, Ubl conjugation pathway" "Repressor, Transferase" "Dwarfism, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 62.3" "Cell type enhanced" "Detected in all" "Early spermatids: 129.2;Excitatory neurons: 96.7;Inhibitory neurons: 105.2;Late spermatids: 88.8;Spermatocytes: 133.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "basophil: 30.4" "Group enriched" "Detected in all" 5 "granulocytes: 30.4;T-cells: 8.3" "Cell line enriched" "Detected in all" 4 "MCF7: 242.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021911 Uncertain NA NA "Cluster 38: Basophils - Unknown function" "Cluster 21: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA021911: AB_10964487" "unprognostic (4.07e-2)" "unprognostic (1.71e-1)" "unprognostic (2.99e-3)" "unprognostic (1.23e-1)" "unprognostic (2.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (4.99e-6)" "unprognostic (7.83e-2)" "unprognostic (1.44e-1)" "unprognostic (2.21e-1)" "unprognostic (1.10e-3)" "unprognostic (4.79e-2)" "unprognostic (2.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.46e-1)" "unprognostic (4.27e-2)" "unprognostic (3.04e-2)" 8.8 12.3 16.2 9.5 19.3 6.8 8.2 24.8 31.4 7.9 5.2 9.0 6.7 8.8 10.7 8.4 9.7 8.9 11.5 19.5 13.8 7.6 8.2 8.9 9.0 21.4 15.2 6.1 7.7 8.6 10.3 9.4 23.0 9.4 7.0 32.9 5.8 9.2 11.1 7.4 6.2 10.8 9.4 8.6 6.5 62.3 18.2 12.1 13.3 12.7 8.4 9.0 6.5 18.7 21.4 33.3 21.9 27.5 20.5 19.0 35.3 24.0 36.9 25.3 41.4 19.6 14.4 21.1 36.1 25.3 43.3 19.0 31.5 17.7 40.5 41.8 30.4 32.6 28.9 27.1 36.1 16.8 15.8 15.4 16.1 32.5 40.8 25.8 33.0 19.1 25.4 29.7 24.9 242.4 34.0 9.5 31.5 28.9 22.0 15.0 57.1 13.7 24.0 29.7 51.7 29.9 24.8 10.2 23.2 26.4 30.4 7.8 25.9 39.5 47.6 36.5 27.6 30.5 48.5 18.5 26.8 17.5 18.7 30.4 3.7 4.5 7.2 2.7 6.7 3.6 4.7 4.6 4.0 3.9 4.0 5.4 5.3 3.4 2.8 3.0 8.3 3.1 16.2 19.3 24.8 31.4 19.5 13.8 21.4 15.2 23.0 9.4 18.2 18.7 10.3 9.6 11.0 44.4 13.2 7.9 6.0 6.5 15.4 19.7 13.2 12.2 24.1 7.2 15.6 9.2 33.3 15.1 7.8 12.0 3.9 10.3 129.2 30.8 13.8 13.7 12.0 12.8 96.7 5.6 10.6 14.0 11.7 13.5 10.8 18.0 12.1 18.9 8.7 45.4 105.2 7.2 16.2 9.1 6.9 88.8 9.9 9.3 12.4 18.7 7.2 19.9 5.2 36.2 43.5 10.2 11.3 17.7 15.1 9.9 3.3 9.7 29.1 38.8 13.1 10.9 17.3 133.1 45.0 14.0 6.3 17.8 14.7 19.7 9.1 6.8 TRIM6-TRIM34 ENSG00000258588 "TRIM6-TRIM34 readthrough" 11 5596725-5644398 "Predicted intracellular proteins" "No human protein/transcript evidence" "No human protein/transcript evidence" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "A549: 4.8" HPA077996 Uncertain Nucleoli,Centrosome NA NA "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Nucleoli "HPA077996: AB_2686873" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.1 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.2 0.2 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.7 0.1 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 TRIP6 "MGC10556, MGC10558, MGC29959, MGC3837, MGC4423, OIP1, ZRP-1" ENSG00000087077 "Thyroid hormone receptor interactor 6" Q15654 7 100867387-100873454 "Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB046454, CAB046460, HPA052813" Approved Supported "Plasma membrane,Focal adhesion sites,Cytosol" NA NA 21000 "Cluster 26: Non-specific - Mitochondria" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Plasma membrane, Focal adhesion sites, Cytosol" "CAB046454: AB_10604048, CAB046460: AB_2303907, HPA052813: AB_2681961" "unprognostic (7.94e-3)" "unprognostic (1.06e-1)" "unprognostic (3.22e-3)" "unprognostic (2.84e-3)" "unprognostic (3.52e-2)" "unprognostic (2.92e-2)" "unprognostic (3.18e-2)" "unprognostic (4.61e-3)" "unprognostic (8.48e-2)" "unprognostic (4.18e-2)" "unprognostic (5.08e-2)" "unprognostic (1.42e-1)" "unprognostic (1.25e-2)" "unprognostic (5.07e-2)" "unprognostic (9.71e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" 42.2 43.0 34.3 15.7 39.5 15.7 42.6 36.2 41.6 59.4 40.4 45.2 9.7 74.6 16.2 63.7 49.5 37.0 39.1 32.6 36.2 55.8 41.1 33.8 14.6 40.6 36.9 50.6 39.8 46.4 16.8 27.4 35.9 42.9 8.4 5.4 46.8 56.7 10.2 55.1 21.5 27.5 36.9 20.0 27.6 18.4 38.4 16.6 50.5 5.8 12.1 47.2 52.5 37.0 128.1 63.4 26.8 126.1 37.8 44.9 131.2 82.3 79.8 101.2 94.8 55.8 143.9 5.5 81.3 87.7 128.3 94.2 38.0 149.2 27.3 19.1 58.5 0.5 117.9 0.8 99.3 66.5 7.1 81.1 94.0 67.8 108.2 64.2 52.8 19.1 83.3 1.0 90.5 286.9 1.3 99.5 92.4 52.3 50.4 47.9 27.0 12.7 65.5 42.8 9.7 1.7 67.5 192.3 78.1 43.8 20.3 77.5 86.5 149.5 145.8 167.5 186.7 1.0 2.1 0.8 92.9 7.8 230.5 0.0 1.2 0.2 0.1 2.1 0.4 2.5 0.9 0.7 1.9 2.4 1.1 0.6 0.0 0.0 3.8 5.2 0.9 0.4 34.3 39.5 36.2 41.6 32.6 36.2 40.6 36.9 35.9 36.9 38.4 37.0 24.5 48.1 38.8 14.4 8.0 131.9 151.5 144.1 78.0 0.9 48.3 55.8 13.9 38.6 87.0 60.7 0.0 113.0 12.0 9.5 80.3 106.9 1.1 22.7 46.1 26.3 4.9 6.7 0.3 84.3 90.4 54.6 40.8 44.8 8.2 55.3 23.9 28.8 44.0 1.7 0.4 12.8 34.6 8.0 59.3 2.8 65.9 17.5 37.4 5.6 20.3 94.8 0.0 4.0 6.5 95.0 13.1 72.6 16.0 72.9 3.6 130.0 34.3 4.6 72.3 50.9 104.0 4.7 4.5 68.2 98.3 132.8 7.1 58.3 18.8 155.6 TRIR "C19orf43, fSAP18, MGC2803, TERCIR" ENSG00000123144 "Telomerase RNA component interacting RNase" Q9BQ61 19 12730640-12734684 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 390.7;Exocrine glandular cells: 381.0;Extravillous trophoblasts: 514.9;Proximal tubular cells: 510.1;Syncytiotrophoblasts: 579.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059965 Approved Approved Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA059965: AB_2684182" "unprognostic (5.57e-2)" "unprognostic (2.73e-3)" "unprognostic (3.69e-2)" "unprognostic (1.12e-1)" "unprognostic (1.48e-2)" "unprognostic (1.99e-1)" "unprognostic (3.17e-3)" "unprognostic (1.93e-2)" "unprognostic (1.74e-1)" "unprognostic (9.33e-3)" "unprognostic (2.43e-3)" "unprognostic (9.43e-2)" "unprognostic (1.60e-2)" "unprognostic (4.84e-2)" "unprognostic (1.30e-1)" "unprognostic (2.63e-3)" "unprognostic (1.02e-2)" 171.6 146.4 162.7 76.7 168.5 133.5 161.3 163.0 211.3 168.9 153.2 191.4 78.2 164.6 108.6 170.1 141.8 45.6 169.1 156.0 169.9 164.8 261.8 132.8 98.7 167.8 158.5 166.4 152.3 76.3 131.9 71.9 160.5 144.9 68.6 53.5 137.9 61.4 167.0 162.4 155.4 66.2 165.4 178.7 163.3 99.6 170.5 104.7 124.6 73.5 107.6 163.1 152.4 163.7 276.7 148.0 185.0 135.2 146.5 156.5 174.3 230.8 144.4 175.7 171.6 195.9 94.1 221.0 294.2 142.8 143.0 188.6 185.5 150.3 143.1 250.9 353.8 147.8 177.6 327.5 140.0 214.8 265.8 158.9 182.6 134.4 108.6 151.1 171.0 156.5 208.3 88.4 168.0 612.7 350.0 504.5 200.8 161.7 416.8 302.3 141.1 222.1 209.2 192.7 203.9 268.2 158.0 159.4 277.4 122.8 138.6 311.5 175.5 212.9 164.4 323.0 296.0 292.2 341.3 248.1 173.7 257.0 147.3 22.5 22.9 85.3 25.0 22.0 28.2 66.5 31.4 31.1 21.5 48.6 29.5 26.1 45.3 23.7 20.2 29.1 37.7 13.8 162.7 168.5 163.0 211.3 156.0 169.9 167.8 158.5 160.5 165.4 170.5 163.7 264.0 70.5 76.0 0.0 93.5 0.0 0.0 0.0 0.0 0.0 262.4 287.0 0.0 0.0 34.0 183.9 0.0 390.7 254.9 0.0 272.0 313.9 0.0 162.2 165.6 95.0 0.0 0.0 0.0 381.0 514.9 92.1 0.0 153.6 25.2 177.4 0.0 0.0 359.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 128.5 0.0 0.0 247.6 0.0 0.0 0.0 0.0 351.9 0.0 0.0 29.7 0.0 0.0 510.1 30.6 0.0 0.0 0.0 113.7 0.0 0.0 0.0 0.0 579.3 113.6 162.0 0.0 0.0 TRMO "C9orf156, HSPC219" ENSG00000136932 "TRNA methyltransferase O" Q9BU70 9 97904489-97922516 "Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 30.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021281, HPA052197" Approved Approved Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA021281: AB_2670649, HPA052197: AB_2681758" "unprognostic (2.53e-1)" "unprognostic (5.66e-2)" "unprognostic (2.13e-1)" "unprognostic (1.63e-3)" "unprognostic (1.12e-1)" "unprognostic (6.28e-2)" "unprognostic (1.08e-2)" "unprognostic (7.27e-3)" "unprognostic (1.64e-1)" "unprognostic (8.67e-2)" "unprognostic (3.12e-2)" "unprognostic (2.99e-2)" "prognostic favorable (4.81e-10)" "unprognostic (1.97e-1)" "unprognostic (1.78e-1)" "unprognostic (1.74e-2)" "unprognostic (4.39e-2)" 7.5 9.4 7.4 11.3 8.5 16.4 13.6 8.1 7.8 9.0 9.3 7.2 7.0 9.1 11.8 7.8 10.4 7.5 6.6 6.8 8.2 9.9 11.3 9.2 14.6 7.8 7.7 9.0 9.7 11.6 7.8 7.5 8.2 9.5 8.1 5.5 9.6 7.7 7.3 10.3 9.3 6.4 8.0 11.9 9.3 12.0 7.5 13.8 18.4 7.8 14.0 7.1 6.5 10.2 19.4 12.1 6.5 8.0 8.1 6.7 11.2 9.7 11.0 15.3 11.6 16.9 14.0 12.1 6.4 9.7 17.1 18.0 10.6 7.6 11.8 14.6 8.4 10.0 14.8 15.3 16.7 19.4 15.8 11.7 17.0 8.5 6.9 9.2 6.9 9.5 16.0 15.3 10.7 28.1 8.3 13.3 9.1 20.7 13.4 9.8 14.5 8.7 14.5 15.5 11.5 10.1 7.1 15.4 16.6 5.5 6.8 10.5 10.6 8.4 8.5 17.7 15.0 16.3 12.6 6.1 9.0 9.8 7.7 44.4 21.1 49.4 20.4 23.4 25.4 19.4 30.8 24.6 22.6 28.8 39.7 27.9 32.4 22.9 16.1 13.1 35.1 20.1 7.4 8.5 8.1 7.8 6.8 8.2 7.8 7.7 8.2 8.0 7.5 10.2 7.5 12.8 5.3 0.0 16.7 0.0 14.6 0.0 10.2 9.1 7.3 7.6 0.0 4.3 6.8 5.5 0.0 8.9 17.5 3.5 7.9 9.1 30.6 9.3 5.4 4.9 2.4 6.9 0.0 9.6 6.9 6.0 9.2 7.1 0.0 4.1 5.3 7.3 10.8 6.7 0.0 5.6 0.0 10.7 0.0 18.3 5.0 9.7 0.0 0.0 10.7 12.1 8.2 0.0 0.0 10.3 5.7 7.2 12.0 6.1 4.9 9.9 5.8 4.9 6.6 8.6 5.2 16.7 13.3 7.8 0.0 18.3 14.6 6.6 3.9 8.1 TRMT112 "HSPC152, HSPC170, hTrm112, TRM112, TRMT11-2" ENSG00000173113 "TRNA methyltransferase subunit 11-2" Q9UI30 11 64316460-64317559 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039901, HPA040006" Uncertain Approved Nucleoplasm,Microtubules NA NA 17000 "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Microtubules Nucleoplasm "HPA039901: AB_10796334, HPA040006: AB_10793859" "unprognostic (1.48e-1)" "unprognostic (2.08e-1)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" "unprognostic (2.44e-1)" "prognostic unfavorable (1.62e-4)" "unprognostic (6.08e-3)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (1.44e-3)" "unprognostic (6.28e-3)" "unprognostic (2.56e-1)" "prognostic unfavorable (2.78e-4)" "unprognostic (2.53e-1)" "unprognostic (1.73e-1)" "unprognostic (3.15e-3)" "unprognostic (1.32e-2)" 159.1 273.6 158.4 109.5 159.8 149.7 152.5 161.3 182.3 182.2 172.7 143.8 68.5 173.0 140.7 167.7 167.5 90.9 138.0 157.3 175.5 176.0 164.7 129.6 170.8 165.9 169.2 238.2 145.5 109.9 182.0 112.2 170.3 137.7 65.4 64.3 116.5 96.4 159.4 146.6 110.0 105.6 163.0 146.8 129.4 130.7 169.0 152.3 142.0 81.8 153.4 145.8 150.3 177.6 411.4 590.3 203.2 298.9 238.0 195.8 199.9 195.3 245.2 231.2 188.3 308.0 401.7 320.5 575.6 204.5 353.1 338.8 367.8 430.1 157.7 373.0 340.1 359.7 503.6 708.9 264.3 282.2 225.2 227.1 401.0 205.5 409.7 241.4 239.7 218.3 298.2 394.5 220.0 1070.4 414.0 527.9 543.0 279.2 511.0 249.6 233.0 451.3 270.6 416.8 133.3 599.3 278.1 322.8 571.4 178.1 503.8 249.7 197.0 241.7 297.2 408.7 365.7 338.7 591.5 512.8 330.2 276.3 255.4 780.9 377.7 573.3 428.7 331.8 444.1 956.3 559.0 481.0 404.8 808.8 617.8 534.8 459.0 392.8 303.5 671.5 551.1 883.6 158.4 159.8 161.3 182.3 157.3 175.5 165.9 169.2 170.3 163.0 169.0 177.6 234.8 160.3 164.3 8.1 269.6 349.9 421.7 465.9 299.9 89.4 219.5 323.8 137.4 135.8 255.8 274.0 22.9 561.1 239.3 96.1 491.0 232.1 71.3 270.9 200.4 236.0 154.4 251.8 10.0 224.4 469.8 249.8 96.8 257.8 217.4 251.8 189.5 196.0 395.2 52.2 10.9 160.6 205.4 174.6 312.3 63.1 299.5 179.1 336.2 12.2 321.2 177.2 247.2 9.0 24.5 221.2 126.4 218.6 296.7 304.4 111.0 610.2 305.0 88.1 216.9 196.2 246.6 230.6 531.2 276.6 396.4 412.1 261.6 258.2 155.3 386.8 TRMT12 "FLJ20772, Trm12, TYW2" ENSG00000183665 "TRNA methyltransferase 12 homolog" Q53H54 8 124450820-124462150 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 73.1" "Low region specificity" "Detected in all" HPA023939 Approved Approved Nucleoplasm,Mitochondria No No "Cluster 22: NK-cells - Unknown function" "Cluster 52: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Mitochondria "HPA023939: AB_1848793" "unprognostic (2.54e-2)" "unprognostic (2.20e-1)" "unprognostic (7.81e-2)" "unprognostic (1.02e-2)" "unprognostic (8.75e-2)" "prognostic unfavorable (2.99e-5)" "prognostic unfavorable (5.10e-4)" "unprognostic (6.89e-2)" "unprognostic (1.99e-1)" "unprognostic (1.28e-1)" "unprognostic (1.51e-1)" "unprognostic (6.56e-2)" "unprognostic (4.72e-3)" "unprognostic (3.39e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (9.25e-4)" "unprognostic (1.04e-2)" 6.0 5.8 5.0 5.4 5.1 3.1 8.7 4.3 6.7 6.5 5.5 5.7 4.6 6.5 6.1 5.6 7.6 4.4 5.9 6.5 4.8 7.6 6.0 5.9 6.5 3.6 3.9 5.0 5.1 8.6 4.7 5.4 4.1 6.9 6.5 8.1 7.7 6.1 9.7 5.3 5.0 8.2 3.4 5.5 5.7 6.4 5.5 8.3 8.8 10.0 6.7 6.7 4.3 4.9 14.8 12.6 10.3 8.1 19.0 9.7 2.5 9.1 10.6 13.1 11.2 7.7 10.0 14.9 12.3 9.4 8.5 10.1 14.7 14.9 15.4 14.8 11.2 14.4 12.8 2.6 14.8 0.0 11.2 12.1 19.6 12.9 16.2 3.8 11.1 15.4 20.4 10.1 8.2 73.1 17.2 6.1 0.0 33.9 11.5 5.4 6.9 9.9 12.1 15.7 17.3 13.8 13.4 49.5 19.5 8.7 14.1 6.1 8.9 9.1 23.8 6.8 10.4 10.4 15.6 5.8 8.2 5.0 7.5 0.4 3.5 3.8 2.3 2.9 3.0 2.1 3.2 2.5 2.8 2.8 3.9 3.9 1.3 3.1 3.3 0.8 2.1 2.4 5.0 5.1 4.3 6.7 6.5 4.8 3.6 3.9 4.1 3.4 5.5 4.9 4.9 9.6 7.5 2.0 11.2 5.2 6.1 3.5 7.4 5.6 5.5 4.7 3.9 7.2 2.2 3.7 16.7 7.3 8.4 4.2 5.9 5.6 18.6 6.3 4.9 5.7 3.0 1.7 1.5 6.2 5.4 4.5 6.6 3.6 9.5 7.7 4.2 5.4 5.1 8.4 1.8 4.4 4.1 4.1 2.5 21.0 4.1 5.2 5.4 1.0 8.1 4.0 9.2 1.0 1.2 4.3 3.9 6.0 8.4 4.8 3.9 8.2 7.6 8.2 0.0 8.2 6.5 14.2 5.8 4.7 4.3 4.9 6.3 7.9 4.9 4.6 TRMT61A "C14orf172, FLJ40452, GCD14, Gcd14p, hTRM61" ENSG00000166166 "TRNA methyltransferase 61A" Q96FX7 14 103529196-103537073 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 62.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 10.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024269 Approved Mitochondria NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 43: Cardiomyocytes - Nuclear processes" Mitochondria "HPA024269: " "unprognostic (5.12e-2)" "unprognostic (2.73e-2)" "unprognostic (1.36e-1)" "unprognostic (5.59e-3)" "unprognostic (1.49e-1)" "unprognostic (3.70e-2)" "prognostic unfavorable (1.60e-4)" "unprognostic (1.94e-1)" "unprognostic (3.29e-1)" "unprognostic (2.20e-1)" "unprognostic (3.70e-2)" "unprognostic (9.86e-3)" "unprognostic (2.88e-3)" "unprognostic (4.16e-1)" "unprognostic (2.79e-1)" "unprognostic (1.42e-1)" "unprognostic (1.28e-1)" 10.5 10.0 11.2 4.5 13.6 4.5 9.6 11.2 14.4 15.2 8.1 24.3 4.4 18.7 2.3 9.7 18.9 2.4 7.5 10.9 10.0 13.9 11.6 8.1 3.7 11.9 11.6 10.8 11.0 3.0 7.5 2.7 11.0 17.1 1.7 1.5 7.4 7.0 9.9 10.8 9.6 4.3 10.7 7.6 12.4 8.3 11.7 2.3 15.3 2.6 1.8 21.3 11.2 12.8 10.0 24.4 3.7 7.6 3.8 3.9 15.1 10.8 4.8 13.3 7.2 33.4 16.8 16.1 13.3 5.7 7.8 25.2 8.0 8.3 3.7 11.0 15.0 12.3 9.6 18.0 6.7 15.9 9.2 4.4 10.4 11.6 4.7 3.1 2.3 11.4 18.5 7.6 4.5 28.9 19.6 12.2 12.9 20.7 48.8 24.0 11.6 13.9 5.4 14.5 19.4 12.2 12.4 11.5 14.7 1.4 21.5 9.3 4.6 12.0 12.8 31.9 22.4 10.2 7.0 20.2 12.8 12.7 23.3 0.0 2.1 0.3 2.6 5.4 1.9 2.5 2.1 2.8 3.3 2.6 2.3 2.3 0.0 2.7 10.8 2.2 1.6 2.2 11.2 13.6 11.2 14.4 10.9 10.0 11.9 11.6 11.0 10.7 11.7 12.8 9.8 0.0 6.0 4.9 11.0 26.1 19.9 7.7 6.8 13.7 11.5 13.5 62.7 7.2 4.7 7.3 4.2 13.0 7.2 19.2 17.6 19.4 4.0 6.0 15.7 10.6 10.7 2.5 4.1 12.2 15.5 13.6 8.2 7.2 2.5 12.6 3.9 9.9 12.3 30.3 3.2 10.4 4.1 7.8 7.8 18.9 11.1 6.6 10.6 2.8 12.8 9.4 4.1 0.5 4.8 19.7 9.3 18.4 6.3 22.8 6.3 15.7 5.0 11.2 0.0 12.5 15.4 6.9 12.5 8.5 30.0 12.0 7.0 10.7 19.4 13.6 TSEN54 "SEN54, SEN54L" ENSG00000182173 "TRNA splicing endonuclease subunit 54" Q7Z6J9 17 75515944-75524735 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, tRNA processing" "Disease variant, Neurodegeneration, Pontocerebellar hypoplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "dendritic cells: 78.4;granulocytes: 81.7;NK-cells: 87.6;T-cells: 70.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024543, HPA053097" Uncertain Approved Nucleoplasm NA NA "Cluster 36: GdT-cells - Adaptive immune response" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA024543: , HPA053097: AB_2682043" "unprognostic (3.52e-2)" "unprognostic (2.52e-3)" "unprognostic (9.60e-3)" "unprognostic (2.55e-3)" "unprognostic (1.81e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (8.06e-6)" "unprognostic (2.33e-2)" "unprognostic (8.37e-2)" "unprognostic (9.04e-2)" "prognostic favorable (2.62e-5)" "unprognostic (7.26e-3)" "unprognostic (5.01e-2)" "prognostic favorable (7.78e-5)" "unprognostic (8.69e-2)" "unprognostic (2.03e-2)" "prognostic favorable (8.54e-4)" 11.1 14.9 2.8 1.3 4.2 2.1 12.7 5.2 3.2 14.1 2.3 19.2 2.9 11.8 0.2 23.2 15.5 3.1 8.3 2.6 3.2 27.2 18.2 17.8 2.9 5.0 4.1 12.4 29.9 4.1 18.3 1.7 3.5 20.0 2.1 0.4 17.4 3.4 9.5 24.3 22.5 2.3 4.1 25.4 20.4 14.2 3.5 5.1 18.1 1.8 2.5 15.1 17.0 4.6 21.8 25.3 2.6 7.2 2.7 2.7 14.7 6.1 6.6 14.4 13.0 35.4 3.9 32.5 9.1 3.6 12.3 11.9 14.3 11.1 7.5 7.7 33.9 26.2 4.7 23.9 11.8 7.5 36.0 2.7 13.7 6.2 5.8 2.0 14.0 20.7 31.5 6.0 2.8 36.6 46.7 19.1 9.0 31.7 30.5 26.4 23.6 25.1 8.4 9.5 19.0 17.0 13.2 30.8 14.3 8.5 11.9 17.3 3.0 6.2 20.7 13.7 12.5 22.6 14.1 19.0 6.1 32.7 6.4 20.0 4.1 14.4 82.1 9.7 56.1 11.5 34.1 62.4 10.8 7.2 26.5 50.0 0.2 47.7 9.8 26.2 21.2 27.1 2.8 4.2 5.2 3.2 2.6 3.2 5.0 4.1 3.5 4.1 3.5 4.6 9.8 9.6 9.6 15.7 13.3 26.4 10.7 19.0 17.6 15.4 11.3 11.9 2.6 20.0 11.6 9.2 4.2 13.6 78.4 25.4 11.7 17.8 6.1 7.7 6.9 10.8 18.7 14.9 14.7 17.2 18.2 8.1 29.0 7.0 81.7 10.2 8.6 8.6 13.2 32.0 15.0 16.9 24.4 4.7 11.1 4.6 4.7 9.2 16.0 5.6 12.5 15.4 87.6 14.1 23.9 14.5 13.8 7.5 29.2 22.3 23.1 13.1 5.0 7.7 13.1 5.9 7.4 15.0 33.8 21.3 24.3 7.5 70.4 14.6 22.6 8.7 TUBB4B "Beta2, TUBB2C" ENSG00000188229 "Tubulin beta 4B class IVb" P68371 9 137241287-137243707 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Deafness, Disease variant, FDA approved drug targets, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 2190.0;Late spermatids: 2907.1;Spermatocytes: 1717.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010880, HPA043640, HPA046280" Enhanced Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes Yes "Cluster 38: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Microtubules "Cytokinetic bridge, Mitotic spindle" "CAB010880: AB_609915, HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (2.24e-1)" "unprognostic (1.77e-3)" "unprognostic (1.50e-1)" "prognostic favorable (4.91e-4)" "unprognostic (1.29e-2)" "unprognostic (8.93e-2)" "prognostic unfavorable (9.98e-4)" "unprognostic (9.92e-3)" "unprognostic (2.90e-1)" "unprognostic (3.63e-1)" "unprognostic (2.34e-1)" "unprognostic (4.09e-2)" "unprognostic (2.47e-3)" "unprognostic (6.37e-2)" "unprognostic (1.36e-2)" "prognostic favorable (6.36e-6)" "unprognostic (1.69e-1)" 134.5 112.6 162.0 97.2 163.4 423.9 94.4 149.4 182.7 88.1 482.7 198.3 142.0 107.7 209.1 343.3 507.2 106.0 435.8 174.0 185.2 122.5 140.1 130.5 95.5 184.1 233.6 72.9 123.8 87.8 118.0 86.3 213.9 120.2 111.9 261.8 177.9 121.5 202.5 240.0 166.4 119.8 162.9 85.6 161.4 765.7 192.6 162.9 115.7 96.6 119.7 188.3 139.4 133.9 706.2 1032.5 431.7 314.2 213.2 223.6 600.5 643.7 536.0 872.4 598.6 1101.0 840.2 429.0 480.2 631.2 848.2 1305.1 539.5 1039.2 330.2 307.9 458.5 311.2 789.6 877.8 134.5 370.0 331.5 145.0 291.5 667.5 183.1 215.7 631.7 300.6 443.0 239.7 731.2 1936.4 337.4 504.2 457.8 1234.8 1778.1 423.5 822.2 394.2 666.8 647.8 301.5 323.6 853.9 485.8 173.2 244.2 699.0 397.6 495.6 618.1 685.0 710.0 863.6 92.4 274.9 475.1 503.6 286.9 549.8 95.7 30.0 43.2 40.5 30.1 38.2 32.6 31.3 34.4 34.9 30.8 19.7 26.7 56.4 24.4 30.5 36.3 44.7 32.6 162.0 163.4 149.4 182.7 174.0 185.2 184.1 233.6 213.9 162.9 192.6 133.9 478.5 221.2 146.3 21.5 315.8 326.2 945.7 458.7 327.2 508.1 286.9 389.5 91.9 143.0 284.1 143.5 300.3 346.6 640.9 744.1 221.1 348.6 2190.0 1191.6 224.8 203.9 391.5 419.9 30.1 446.8 545.5 247.8 274.7 415.0 189.2 200.9 142.5 139.2 265.9 244.0 24.3 503.6 323.5 59.9 214.9 2907.1 254.2 299.3 138.7 22.5 224.0 299.3 49.4 15.6 19.7 477.4 697.2 153.1 264.0 475.1 540.7 345.5 1558.7 763.3 111.7 261.8 416.0 1717.5 740.9 419.1 297.6 321.1 362.9 89.8 487.3 592.7 TUBB8 bA631M21.2 ENSG00000261456 "Tubulin beta 8 class VIII" Q3ZCM7 10 46888-74163 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in single" "testis: 2.4" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 3.4;Early spermatids: 11.7;Late spermatids: 3.4;Spermatocytes: 13.0;Spermatogonia: 15.9" "Cancer enriched" "Detected in single" 5 "testis cancer: 1.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.3" "HPA043640, HPA046280" Uncertain Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" Yes NA "Cluster 49: Eosinophils - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Microtubules "Cytokinetic bridge, Mitotic spindle" "HPA043640: AB_2678594, HPA046280: AB_2679612" "unprognostic (4.75e-2)" "unprognostic (6.02e-2)" "unprognostic (1.50e-1)" "unprognostic (2.82e-1)" "unprognostic (2.78e-1)" "unprognostic (1.80e-1)" "unprognostic (7.74e-2)" "unprognostic (8.33e-3)" "unprognostic (1.50e-1)" "unprognostic (4.15e-3)" "unprognostic (7.17e-2)" "unprognostic (3.30e-2)" "unprognostic (1.33e-3)" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.19e-2)" "unprognostic (6.86e-3)" 0.1 0.1 0.4 0.1 0.4 0.0 0.2 0.3 0.6 0.2 0.2 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.3 0.3 0.7 0.0 0.1 0.1 0.3 0.3 0.4 0.3 0.3 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.3 0.1 2.4 0.3 0.0 0.7 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.0 0.0 0.2 0.1 3.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 11.7 0.4 0.1 0.1 0.0 0.0 0.7 0.0 0.2 0.2 0.0 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 3.4 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.7 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.5 13.0 15.9 0.0 0.0 0.0 0.0 0.4 0.0 0.6 TUBD1 "FLJ12709, TUBD" ENSG00000108423 "Tubulin delta 1" Q9UJT1 17 59859479-59892945 "FDA approved drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 83.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004609, HPA023980, HPA027090" Approved Approved Nucleoplasm,Cytosol NA Yes "Cluster 13: T-cells - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Cytosol" "CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457" "unprognostic (1.92e-1)" "unprognostic (5.95e-2)" "prognostic favorable (2.04e-4)" "unprognostic (1.39e-1)" "unprognostic (1.32e-2)" "unprognostic (5.64e-2)" "prognostic unfavorable (1.00e-5)" "unprognostic (2.86e-2)" "unprognostic (8.87e-3)" "unprognostic (1.02e-1)" "unprognostic (1.77e-3)" "unprognostic (2.59e-1)" "prognostic unfavorable (6.06e-4)" "unprognostic (4.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.36e-1)" "unprognostic (8.83e-2)" 4.4 4.4 5.8 4.9 6.9 3.9 7.0 9.2 7.4 7.5 5.0 7.5 3.8 5.5 9.1 10.6 6.5 4.6 6.0 5.9 6.3 6.2 5.9 5.1 6.7 6.7 6.9 9.0 7.8 5.9 6.9 4.2 7.0 7.8 4.7 5.6 7.0 6.2 6.5 6.8 4.8 4.3 6.3 5.8 6.4 5.5 6.2 8.2 7.3 7.7 8.3 6.4 8.3 8.9 11.7 15.8 12.2 12.8 6.8 4.9 9.7 9.1 5.3 11.7 9.5 17.0 7.5 10.5 15.0 2.1 7.9 9.7 17.4 5.4 11.1 6.1 21.2 12.6 12.4 20.4 3.6 7.6 6.4 2.7 8.3 10.1 3.5 4.0 9.4 10.3 27.5 7.1 4.0 83.1 15.6 8.5 10.8 13.0 6.9 16.1 17.9 16.2 5.0 4.8 11.3 6.8 6.4 4.9 6.5 14.5 11.8 7.2 3.0 8.4 18.3 5.9 9.8 8.3 13.7 16.2 4.0 8.3 7.5 6.5 8.4 16.3 11.4 5.8 13.2 11.7 14.0 12.1 5.9 8.9 18.1 14.8 8.8 10.1 6.5 9.9 16.7 7.1 5.8 6.9 9.2 7.4 5.9 6.3 6.7 6.9 7.0 6.3 6.2 8.9 8.3 12.8 36.1 10.7 16.9 15.7 14.4 9.1 10.8 7.6 10.9 11.3 5.3 5.7 17.6 3.7 6.2 6.3 9.4 3.2 11.7 5.7 1.7 9.2 8.5 9.4 10.3 13.9 9.2 4.8 7.4 9.6 4.1 16.3 11.4 9.9 8.9 3.8 4.0 3.3 9.5 5.5 8.2 4.7 7.1 0.8 5.6 6.9 7.2 9.4 6.0 10.3 13.4 8.5 18.4 3.7 7.5 8.2 10.9 12.5 3.6 3.6 9.4 8.6 6.6 13.3 9.6 14.7 24.2 10.6 16.9 4.0 16.2 2.6 4.9 6.8 TUBG1 "TUBG, TUBGCP1" ENSG00000131462 "Tubulin gamma 1" P23258 17 42609641-42615238 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, FDA approved drug targets, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 173.8" "Cell type enhanced" "Detected in all" "Early spermatids: 670.6;Erythroid cells: 286.9;Late spermatids: 560.5;Spermatocytes: 347.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB004608 Enhanced NA Yes "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "CAB004608: AB_628417" "unprognostic (1.00e-1)" "unprognostic (5.57e-2)" "unprognostic (1.79e-2)" "prognostic favorable (8.99e-4)" "unprognostic (2.86e-2)" "unprognostic (2.01e-1)" "prognostic unfavorable (1.08e-8)" "unprognostic (2.62e-3)" "unprognostic (5.67e-2)" "unprognostic (1.83e-1)" "unprognostic (3.79e-1)" "unprognostic (2.16e-1)" "prognostic unfavorable (6.48e-5)" "unprognostic (2.64e-1)" "unprognostic (3.52e-1)" "unprognostic (2.61e-3)" "unprognostic (1.97e-2)" 23.0 30.4 17.7 20.4 18.4 51.7 19.0 17.8 25.4 17.6 21.1 24.0 16.6 20.7 13.4 35.6 16.3 10.1 43.6 18.5 19.8 24.8 27.1 19.1 18.0 20.3 18.0 12.5 48.7 29.9 20.2 21.0 20.0 19.7 14.9 10.5 19.1 18.3 60.7 29.0 18.1 27.2 15.9 19.3 29.8 173.8 21.4 27.6 14.8 36.3 20.6 21.7 19.9 19.7 117.8 288.8 112.1 124.0 70.5 47.8 97.7 133.4 87.2 205.6 158.8 177.4 76.9 80.2 92.8 105.9 178.5 171.9 124.2 178.0 149.7 225.9 142.6 64.1 168.5 299.3 34.6 73.8 87.6 38.1 54.0 251.1 75.8 50.6 131.9 119.0 119.7 77.2 155.9 326.7 176.3 66.2 59.3 176.7 139.1 81.8 164.2 130.5 91.7 136.6 158.9 74.5 78.0 76.9 63.6 113.9 233.6 70.2 88.5 197.9 131.0 169.2 207.0 111.2 169.0 126.2 108.6 70.6 144.2 1.7 13.1 3.1 10.6 25.1 11.6 14.9 9.8 11.4 15.7 15.0 10.4 10.5 0.4 12.7 27.4 44.1 13.5 10.4 17.7 18.4 17.8 25.4 18.5 19.8 20.3 18.0 20.0 15.9 21.4 19.7 14.9 16.0 4.2 3.9 12.8 17.6 16.3 49.4 12.0 14.1 14.6 16.5 18.8 14.3 24.1 7.3 4.2 45.8 7.0 10.2 39.2 35.2 670.6 15.1 13.7 20.1 9.6 286.9 7.2 54.4 78.6 15.7 15.8 10.7 2.5 16.9 15.7 15.9 40.2 20.2 6.4 13.7 38.7 6.3 10.8 560.5 22.7 9.7 17.8 8.4 26.4 17.7 10.3 4.0 3.8 42.3 6.2 21.8 41.5 15.2 15.1 76.6 18.1 10.9 59.2 7.1 43.5 347.8 128.0 27.3 28.6 20.1 8.5 15.0 14.0 15.6 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278635-133312337 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.0 22.2 14.4 20.9 15.4 35.0 13.4 13.5 19.3 15.7 18.2 18.2 22.1 16.0 10.5 17.3 30.3 14.9 20.4 14.8 14.1 19.3 16.4 17.3 20.9 17.1 15.2 26.8 28.3 26.0 3.5 15.8 17.5 17.8 13.3 11.8 28.2 17.1 33.2 22.5 22.1 14.9 13.0 21.9 20.4 21.7 15.0 20.7 19.0 24.4 14.4 15.9 5.8 14.5 64.2 84.2 30.7 35.6 28.3 29.8 42.9 47.5 66.5 50.0 49.5 97.0 45.9 42.1 27.7 48.6 21.6 47.2 35.8 32.3 22.8 50.5 75.7 24.6 46.7 52.3 35.5 63.4 57.0 31.3 29.9 46.5 58.0 55.3 33.3 29.9 36.4 45.6 41.2 79.9 41.4 56.3 30.4 37.2 64.6 32.7 32.9 19.5 32.7 40.8 20.6 43.0 33.0 40.1 36.1 17.9 23.6 38.3 45.6 30.9 27.6 38.0 47.9 43.7 25.9 53.8 102.3 27.3 19.8 6.4 22.5 15.9 15.3 23.2 14.8 11.4 13.3 14.6 27.6 12.3 14.0 15.4 13.8 27.7 25.8 11.7 18.3 19.0 14.4 15.4 13.5 19.3 14.8 14.1 17.1 15.2 17.5 13.0 15.0 14.5 29.1 48.1 38.5 18.9 36.7 13.9 27.4 30.2 23.3 45.7 25.9 25.3 33.9 22.8 38.8 40.5 31.3 41.4 40.1 34.8 23.5 34.5 25.9 78.0 41.6 26.4 29.3 28.0 17.5 37.1 32.9 35.9 38.7 37.1 39.9 49.5 28.9 27.5 44.4 38.7 15.9 36.2 8.2 42.7 25.5 28.6 33.8 51.6 14.2 15.9 75.0 39.3 62.8 9.5 20.1 37.3 33.5 35.3 37.2 28.6 37.3 53.4 112.2 74.8 32.9 39.9 32.1 74.3 65.3 29.0 13.8 42.5 35.7 50.4 36.0 30.3 U2AF1L4 "MGC33901, U2AF1L3, U2af26" ENSG00000161265 "U2 small nuclear RNA auxiliary factor 1 like 4" Q8WU68 19 35742464-35745445 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052083, HPA061644" Supported Approved Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA052083: AB_2681720, HPA061644: AB_2684574" "prognostic favorable (2.44e-4)" "unprognostic (1.31e-1)" "unprognostic (2.39e-3)" "unprognostic (1.31e-2)" "unprognostic (2.35e-1)" "prognostic favorable (2.58e-5)" "unprognostic (3.95e-2)" "unprognostic (1.29e-1)" "unprognostic (1.95e-1)" "unprognostic (3.67e-2)" "prognostic favorable (8.58e-5)" "unprognostic (8.44e-2)" "prognostic unfavorable (9.73e-5)" "unprognostic (1.06e-1)" "unprognostic (7.21e-2)" "unprognostic (1.92e-1)" "prognostic favorable (7.05e-4)" 2.6 3.7 8.9 1.5 9.9 1.7 2.2 8.6 12.6 3.5 7.1 5.5 1.6 3.5 0.0 2.3 3.9 0.5 11.4 9.5 9.9 4.3 2.4 2.4 0.4 9.8 9.3 4.4 2.2 5.4 5.4 1.8 9.6 3.7 0.6 4.6 1.8 3.0 9.1 1.5 2.6 2.1 8.8 2.5 3.5 8.5 9.2 2.6 2.8 6.9 0.9 4.1 2.5 9.9 4.1 13.7 2.2 3.3 0.4 1.6 3.0 3.3 3.4 8.3 8.2 5.1 3.3 1.7 6.6 7.7 7.7 1.9 6.7 5.4 5.1 10.7 1.5 2.3 3.4 5.9 10.2 2.6 5.5 2.0 2.1 3.4 2.0 3.0 1.6 5.2 4.4 4.6 5.5 8.5 8.0 2.5 3.1 8.9 2.7 2.2 3.0 0.0 1.9 0.6 4.5 4.1 5.0 3.7 1.2 4.4 3.7 4.9 2.9 5.3 2.2 1.4 5.5 5.4 7.0 3.5 4.1 5.9 6.6 0.0 2.0 1.7 2.9 4.0 2.9 8.4 5.7 5.5 2.4 6.8 8.1 7.8 2.3 0.9 2.7 9.0 10.2 3.3 8.9 9.9 8.6 12.6 9.5 9.9 9.8 9.3 9.6 8.8 9.2 9.9 12.0 19.2 25.4 7.8 40.9 10.3 14.3 34.7 10.2 26.9 19.8 18.9 4.7 8.6 16.5 9.2 14.6 14.9 35.2 20.1 27.4 11.1 13.9 6.5 8.9 11.9 12.6 7.8 6.5 12.6 9.4 13.6 12.2 7.8 36.6 10.3 10.4 18.3 19.2 20.2 7.1 13.4 48.8 18.5 36.3 15.6 15.5 18.4 30.2 1.9 27.9 12.3 30.9 4.5 7.7 9.5 22.5 12.4 38.4 12.0 23.6 26.6 12.7 29.3 13.1 15.2 16.7 36.7 16.0 9.3 8.8 29.6 39.1 12.6 10.7 12.7 UBL4A "DXS254E, GDX, GET5, MDY2, TMA24, UBL4" ENSG00000102178 "Ubiquitin like 4A" P11441 X 154483717-154486615 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003617 Approved Supported Nucleoplasm,Cytosol NA NA 11000 "Cluster 44: Non-specific - Transcription" "Cluster 80: Striated muscle - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 51: Myeloid cells - Hemostasis" "Nucleoplasm, Cytosol" "HPA003617: AB_1080450" "unprognostic (2.75e-2)" "unprognostic (3.39e-3)" "unprognostic (5.52e-2)" "unprognostic (2.88e-2)" "unprognostic (2.62e-1)" "unprognostic (2.13e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (4.83e-2)" "unprognostic (3.56e-2)" "unprognostic (2.24e-2)" "unprognostic (8.26e-3)" "unprognostic (4.50e-1)" "unprognostic (4.41e-2)" "unprognostic (2.74e-2)" "unprognostic (6.01e-2)" "unprognostic (2.10e-1)" "unprognostic (3.49e-2)" 18.3 29.6 31.2 11.3 32.5 11.2 17.1 28.8 38.3 21.2 25.8 27.1 17.7 19.0 18.0 29.1 17.9 11.4 47.8 32.4 30.0 20.0 28.1 17.7 16.1 31.0 29.7 15.8 36.9 20.9 16.0 13.5 31.7 20.9 12.4 6.4 27.8 20.2 97.9 24.8 19.5 11.9 30.4 18.9 23.1 4.5 32.0 17.3 15.8 72.1 17.0 25.8 21.5 34.0 84.8 50.9 15.3 42.1 31.3 31.3 51.0 35.0 26.3 37.2 39.5 50.3 32.6 64.1 107.8 33.7 31.5 31.5 76.9 40.4 20.2 42.6 46.5 46.3 46.6 29.6 38.9 55.8 48.1 24.0 45.9 24.8 42.8 36.1 27.0 46.5 51.9 31.4 30.1 66.2 49.9 52.3 17.8 74.4 82.0 44.5 44.5 68.4 31.0 34.2 29.3 44.2 19.4 66.7 59.0 18.2 30.8 40.3 27.3 37.6 42.5 61.1 77.9 60.8 67.8 115.8 39.6 92.4 44.5 94.7 22.0 22.1 33.2 18.9 46.4 20.4 31.2 35.5 21.7 16.3 26.5 30.0 7.1 34.1 16.7 12.7 34.0 41.9 31.2 32.5 28.8 38.3 32.4 30.0 31.0 29.7 31.7 30.4 32.0 34.0 17.6 3.2 6.7 3.9 12.3 9.6 11.7 13.2 4.0 19.4 16.7 24.5 32.5 15.7 9.2 16.5 4.2 32.5 25.2 21.8 43.0 25.3 0.3 5.7 11.9 14.2 8.5 29.0 8.7 32.2 47.4 14.5 9.2 7.7 9.5 16.8 13.2 18.9 24.2 18.5 6.3 17.2 14.2 13.8 10.2 1.0 12.5 31.7 28.4 1.9 20.3 17.2 38.1 5.5 4.9 30.2 11.4 18.8 19.5 16.7 24.6 25.1 4.7 11.4 0.0 13.2 24.9 0.1 5.7 21.9 12.1 13.0 16.2 7.2 17.4 7.8 UCK1 "FLJ12255, URK1" ENSG00000130717 "Uridine-cytidine kinase 1" Q9HA47 9 131523801-131531264 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050969, HPA070526" Approved Approved Nucleoplasm,Nucleoli NA NA "Cluster 35: T-regs - Unknown function" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Nucleoli "HPA050969: AB_2681294, HPA070526: " "unprognostic (2.20e-1)" "prognostic favorable (3.19e-4)" "unprognostic (1.16e-2)" "unprognostic (1.74e-3)" "unprognostic (7.29e-2)" "unprognostic (1.43e-1)" "unprognostic (8.71e-2)" "unprognostic (1.78e-1)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (1.36e-3)" "unprognostic (1.54e-1)" "prognostic favorable (2.21e-7)" "unprognostic (5.11e-2)" "unprognostic (3.29e-2)" "unprognostic (1.74e-1)" "unprognostic (1.07e-1)" 21.5 25.3 40.3 10.2 41.2 16.4 20.4 40.5 45.2 21.2 37.0 26.0 11.8 20.2 18.7 21.2 19.9 12.2 28.1 38.1 39.2 29.3 52.7 17.2 15.1 41.6 41.4 22.2 29.8 22.6 24.2 14.3 40.0 26.9 9.3 13.5 25.6 17.3 43.9 19.1 18.0 11.2 40.7 20.9 24.9 20.4 42.1 17.5 23.4 26.8 11.5 20.9 17.2 40.9 13.9 30.0 33.9 43.8 23.6 16.7 28.9 22.0 32.1 37.0 28.0 30.1 12.4 15.0 12.9 26.4 28.9 26.3 31.9 28.0 15.8 27.7 29.8 14.0 46.3 19.2 33.6 23.2 19.9 18.8 25.8 29.9 21.6 22.4 23.0 36.3 17.9 11.2 27.6 55.2 31.9 11.8 40.4 27.0 29.6 30.1 52.5 25.1 24.1 13.0 45.7 28.9 31.8 23.9 34.3 15.4 46.6 13.5 17.1 40.9 20.7 25.7 21.7 22.7 31.3 19.4 20.3 16.0 29.1 2.1 5.5 9.0 7.3 7.2 9.8 7.4 8.5 6.4 5.2 8.0 11.3 5.6 3.6 7.0 2.6 5.9 12.0 5.6 40.3 41.2 40.5 45.2 38.1 39.2 41.6 41.4 40.0 40.7 42.1 40.9 13.6 16.0 5.0 7.8 12.4 14.3 10.3 9.9 12.5 18.0 16.2 20.1 14.0 4.3 6.2 14.7 8.4 33.8 12.0 20.4 29.4 22.7 21.9 9.0 10.2 14.3 12.1 3.0 4.7 26.2 17.5 15.7 6.6 9.2 2.5 16.2 13.2 20.5 26.4 26.9 6.1 11.6 16.2 10.0 13.4 33.3 17.7 14.0 16.0 4.7 20.4 22.0 9.2 2.0 6.0 18.6 12.3 19.9 8.0 14.3 21.1 31.6 3.1 13.1 19.7 12.4 17.2 32.8 33.4 11.8 12.5 25.7 10.0 14.9 14.8 8.5 UQCC3 "C11orf83, UNQ655" ENSG00000204922 "Ubiquinol-cytochrome c reductase complex assembly factor 3" Q6UW78 11 62670273-62673686 "Disease related genes, Human disease related genes, Predicted membrane proteins" "ATP synthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal enterocytes: 209.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 82.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046851 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Mitochondria" Cytosol "HPA046851: AB_2679839" "unprognostic (5.89e-2)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "unprognostic (3.42e-2)" "unprognostic (3.91e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (2.55e-4)" "unprognostic (2.18e-1)" "unprognostic (1.67e-1)" "unprognostic (8.70e-3)" "unprognostic (7.84e-2)" "unprognostic (8.96e-2)" "unprognostic (7.07e-2)" "unprognostic (7.21e-3)" "unprognostic (1.48e-1)" "unprognostic (3.20e-1)" "unprognostic (1.36e-1)" 7.5 12.2 7.4 3.7 7.5 5.7 7.5 8.2 9.7 7.6 9.3 9.9 8.1 6.5 1.7 12.3 6.1 1.2 10.2 7.1 7.1 10.7 11.9 4.7 4.2 7.6 7.3 6.5 9.0 3.5 6.7 2.2 7.7 9.4 1.9 3.9 11.5 3.3 15.7 9.0 8.3 1.5 7.0 7.4 9.6 3.4 7.4 2.4 6.3 5.0 1.6 6.3 8.1 8.1 26.9 52.9 7.7 12.0 4.7 4.6 6.5 10.4 3.5 7.7 7.6 31.4 22.8 17.4 21.1 3.6 10.4 26.1 7.4 12.3 2.4 8.8 27.4 9.8 28.7 20.3 6.3 16.0 7.6 4.4 10.3 6.8 7.6 4.8 6.0 8.1 21.3 12.2 4.3 82.4 15.7 39.2 8.6 10.6 29.8 17.9 11.7 31.1 6.1 13.2 15.5 15.7 11.5 41.7 16.2 2.4 39.7 14.9 7.9 16.8 19.7 17.6 23.6 18.7 11.0 18.3 13.8 13.7 12.3 14.6 25.0 20.1 21.3 19.1 20.4 30.8 21.1 19.0 20.0 29.9 19.2 15.3 11.0 19.6 17.2 26.7 25.8 20.0 7.4 7.5 8.2 9.7 7.1 7.1 7.6 7.3 7.7 7.0 7.4 8.1 49.0 44.8 25.0 3.6 32.3 0.0 42.2 0.0 47.3 21.8 77.5 86.4 35.8 70.1 16.1 64.4 16.7 53.1 22.9 65.2 140.8 56.6 1.7 50.3 40.6 32.9 35.2 32.2 2.4 78.4 53.1 32.4 54.6 41.1 5.1 28.0 44.6 125.4 54.8 18.5 4.2 75.2 0.0 39.7 0.0 3.7 48.4 29.2 0.0 7.5 47.2 59.7 66.9 5.0 5.2 67.4 66.9 36.1 38.4 85.1 209.3 170.6 12.4 37.0 39.5 28.3 31.8 4.2 32.0 91.0 0.0 29.0 25.3 35.1 79.0 57.0 UQCRQ "QCR8, QP-C, UQCR7" ENSG00000164405 "Ubiquinol-cytochrome c reductase complex III subunit VII" O14949 5 132866630-132868847 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 1301.6" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 3312.4;Hepatocytes: 5039.2;Proximal tubular cells: 3336.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046693, HPA053323" Approved Enhanced Mitochondria NA NA 18000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA046693: AB_10968453, HPA053323: AB_2682112" "unprognostic (3.22e-1)" "unprognostic (1.06e-1)" "unprognostic (4.92e-2)" "prognostic favorable (4.23e-4)" "unprognostic (1.09e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.45e-2)" "unprognostic (1.37e-1)" "unprognostic (3.72e-2)" "unprognostic (7.31e-2)" "unprognostic (3.49e-1)" "unprognostic (1.81e-3)" "unprognostic (1.06e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (3.37e-2)" 226.5 378.7 277.6 91.8 283.7 132.6 189.2 309.6 391.9 151.7 293.2 313.0 220.8 147.9 211.2 332.4 138.6 78.3 1301.6 283.6 315.5 460.7 1036.6 149.0 69.1 291.2 285.6 120.0 269.4 318.5 222.8 89.0 294.9 272.9 232.2 187.4 253.8 122.2 1024.7 182.3 244.5 98.5 286.6 151.8 372.3 128.9 294.7 130.3 167.3 873.5 92.3 219.9 193.3 302.3 300.9 391.1 246.7 599.9 364.2 292.2 209.3 216.3 310.6 341.7 424.9 556.4 353.8 126.5 433.4 291.5 424.5 302.7 229.5 536.6 300.7 222.9 466.0 169.4 606.3 459.9 312.7 188.8 276.2 314.0 366.5 247.4 341.6 229.6 274.1 258.3 219.2 398.6 369.7 547.5 450.5 442.1 175.3 568.1 367.0 288.4 271.7 541.7 460.9 573.4 410.7 335.8 269.1 302.7 493.9 170.4 451.9 422.5 168.3 316.0 392.1 257.2 438.7 423.1 616.3 236.6 417.9 350.0 320.6 474.1 528.3 355.5 245.6 431.0 251.8 317.2 280.3 280.2 472.0 260.6 273.5 263.6 258.8 322.9 410.0 516.7 326.1 658.2 277.6 283.7 309.6 391.9 283.6 315.5 291.2 285.6 294.9 286.6 294.7 302.3 252.0 250.0 349.3 17.6 258.1 348.3 334.0 1046.6 235.6 97.8 575.5 657.7 3312.4 993.7 556.9 787.2 120.9 720.4 200.6 1678.3 1813.7 685.6 470.0 424.1 308.5 288.4 549.3 319.4 13.9 947.7 484.1 330.2 438.3 467.5 294.5 277.0 333.8 5039.2 771.4 72.3 17.0 1047.6 807.7 421.1 448.6 1116.6 282.4 301.6 715.1 11.2 394.7 459.2 260.6 13.6 23.5 705.7 1460.8 288.9 416.2 537.1 2476.1 3336.0 512.5 271.5 184.1 217.8 388.7 308.1 174.7 570.1 514.0 562.7 205.0 235.9 1205.6 500.2 USB1 "C16orf57, FLJ13154, HVSL1, Mpn1" ENSG00000103005 "U6 snRNA biogenesis phosphodiesterase 1" Q9BQ65 16 57999546-58021618 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041791, HPA059854" Approved Supported Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA041791: AB_10793933, HPA059854: AB_2684143" "unprognostic (2.79e-1)" "unprognostic (3.84e-2)" "unprognostic (1.21e-2)" "unprognostic (9.65e-2)" "unprognostic (2.03e-1)" "unprognostic (2.23e-3)" "prognostic unfavorable (6.69e-7)" "unprognostic (4.30e-3)" "unprognostic (2.92e-1)" "unprognostic (4.98e-2)" "unprognostic (1.95e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (2.02e-4)" "unprognostic (2.18e-1)" "unprognostic (1.56e-1)" "unprognostic (1.06e-3)" "unprognostic (5.04e-2)" 21.5 27.5 24.0 27.6 23.4 30.9 14.8 22.4 26.2 15.6 20.9 22.8 14.3 19.0 16.3 17.4 15.7 14.7 27.7 23.6 25.8 19.0 29.9 20.5 20.2 26.5 24.9 11.8 17.6 14.7 13.4 16.6 26.3 17.2 18.6 6.7 14.1 18.4 15.6 15.2 18.1 24.8 23.8 25.7 19.4 20.2 25.7 18.4 19.1 13.0 20.8 28.1 15.4 23.5 53.2 109.2 36.5 69.7 46.4 32.5 57.6 43.9 58.2 68.6 48.3 70.9 31.0 32.5 56.6 65.3 61.0 38.6 58.2 93.6 97.6 31.9 32.9 40.5 43.0 103.8 52.7 54.2 114.1 46.6 54.7 87.2 50.8 45.4 76.1 69.7 55.4 15.4 58.2 56.0 50.1 62.3 60.6 47.7 88.5 49.3 32.9 53.8 49.1 63.4 17.6 41.6 114.8 29.8 27.6 57.6 14.8 54.5 82.6 40.2 59.0 43.3 60.5 23.4 37.3 58.9 48.3 51.1 50.0 112.3 58.4 86.8 57.1 67.8 37.4 19.5 33.2 43.7 54.8 13.4 20.3 36.7 162.2 45.5 95.5 23.8 45.1 32.4 24.0 23.4 22.4 26.2 23.6 25.8 26.5 24.9 26.3 23.8 25.7 23.5 12.9 0.0 9.2 6.2 12.2 18.1 17.7 22.8 13.1 3.2 15.2 13.0 13.0 14.3 12.4 9.2 4.2 29.3 33.2 30.2 11.7 39.5 1.3 9.5 10.7 13.5 12.6 9.0 10.4 46.2 55.3 13.3 14.3 9.7 16.5 6.3 17.5 13.0 42.0 6.7 6.2 15.9 28.5 19.8 16.4 1.4 8.1 26.5 14.2 5.6 37.2 11.5 48.4 2.5 5.2 49.7 20.0 11.7 16.4 14.7 18.3 16.2 9.7 3.6 6.6 7.7 15.3 12.6 22.5 10.9 13.1 20.5 24.3 13.0 10.2 15.2 USP32 "NY-REN-60, USP10" ENSG00000170832 "Ubiquitin specific peptidase 32" Q8NFA0 17 60177327-60422470 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 102.1" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 241.8;Inhibitory neurons: 113.1;Oligodendrocytes: 268.9;Rod photoreceptor cells: 136.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in all" "plasmacytoid DC: 59.2" "Group enriched" "Detected in all" 10 "dendritic cells: 59.2;granulocytes: 29.4" "Cell line enhanced" "Detected in all" "MCF7: 171.4" "Low region specificity" "Detected in all" HPA044365 Approved Approved "Golgi apparatus,Cytosol" NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus" Cytosol "HPA044365: AB_2678914" "unprognostic (4.10e-2)" "unprognostic (3.38e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (2.15e-1)" "unprognostic (4.33e-2)" "unprognostic (1.90e-3)" "unprognostic (2.33e-2)" "unprognostic (2.24e-1)" "unprognostic (3.93e-1)" "unprognostic (6.49e-2)" "unprognostic (2.78e-1)" "unprognostic (2.82e-1)" "unprognostic (1.97e-1)" "unprognostic (7.23e-2)" "unprognostic (8.35e-2)" "unprognostic (4.16e-2)" 16.1 21.8 13.6 15.0 27.8 32.1 14.1 23.2 23.6 12.4 25.2 13.0 9.5 10.3 6.8 21.7 10.7 11.8 17.4 14.3 22.8 20.2 26.6 20.7 10.5 22.2 25.0 10.0 12.5 19.2 11.9 13.2 24.8 10.8 11.4 58.8 12.9 11.2 40.8 21.0 10.5 13.7 18.1 18.5 12.2 102.1 22.3 14.4 20.6 29.2 11.6 13.1 14.7 44.4 32.6 38.2 19.0 30.8 44.8 45.3 17.2 26.4 41.9 34.5 45.8 18.6 20.0 19.4 21.5 50.0 56.1 16.3 33.1 36.9 61.5 16.8 13.9 39.7 31.8 19.5 44.1 31.7 33.6 39.6 24.6 49.9 45.2 33.5 38.6 24.4 42.9 17.1 41.1 171.4 32.3 21.3 21.7 29.6 18.8 15.8 51.6 11.5 33.1 24.5 13.1 19.1 22.9 6.0 33.8 32.1 27.4 41.3 32.6 49.7 54.9 33.1 23.5 16.2 37.4 19.6 24.6 23.6 33.4 14.5 4.3 16.5 2.0 3.7 1.4 3.0 1.4 1.7 8.5 2.2 1.0 1.9 29.4 1.3 4.6 59.2 2.6 2.1 13.6 27.8 23.2 23.6 14.3 22.8 22.2 25.0 24.8 18.1 22.3 44.4 8.0 6.4 16.4 58.8 12.5 26.9 13.3 5.8 11.4 17.3 9.2 7.6 8.2 10.0 10.1 5.5 241.8 5.1 12.6 8.5 3.9 11.3 95.0 9.0 9.9 9.8 8.3 44.2 92.3 7.5 8.4 12.6 15.8 11.6 11.4 18.5 12.5 12.0 18.5 13.5 113.1 5.6 6.1 29.7 41.3 33.3 13.1 25.1 5.4 101.2 28.0 10.4 24.7 70.4 268.9 9.6 11.4 5.7 8.3 10.3 7.4 4.6 7.0 136.4 26.3 11.9 9.1 92.7 14.9 11.2 21.9 4.9 10.9 8.5 5.5 8.2 VANGL1 STB2 ENSG00000173218 "VANGL planar cell polarity protein 1" Q8TAA9 1 115641970-115698224 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "NK-cell: 6.2" "Group enriched" "Detected in many" 7 "dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025235, CAB076375" Approved Approved "Plasma membrane" NA Yes "Cluster 48: NK-cells - Unknown function" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Plasma membrane" "CAB076375: AB_2665604, HPA025235: AB_1858718" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "prognostic favorable (7.53e-4)" "unprognostic (9.94e-2)" "unprognostic (1.71e-2)" "unprognostic (5.18e-2)" "unprognostic (2.18e-3)" "unprognostic (5.11e-3)" "unprognostic (2.11e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (7.89e-4)" "unprognostic (1.88e-2)" "unprognostic (1.74e-2)" "unprognostic (7.71e-3)" "unprognostic (1.21e-1)" "unprognostic (4.50e-3)" "unprognostic (9.06e-3)" 4.9 3.9 2.1 3.8 1.2 2.5 3.2 0.8 1.1 9.1 3.0 6.8 3.8 5.5 4.9 10.4 12.0 3.8 5.4 1.3 1.3 5.3 3.0 4.1 2.1 1.2 3.0 4.4 5.0 5.2 0.5 3.6 1.7 4.4 6.4 1.6 6.4 4.5 0.9 6.8 3.9 7.3 1.2 2.2 5.5 5.0 6.5 7.3 7.6 2.4 2.5 6.4 4.4 1.0 49.6 20.7 6.6 8.9 24.1 21.5 13.1 18.8 13.5 24.1 19.1 12.0 24.1 0.0 31.5 21.9 22.7 60.9 11.2 33.3 15.8 57.9 13.7 27.4 18.4 9.8 8.8 8.2 11.4 11.4 23.1 17.2 18.2 12.8 24.1 45.9 16.8 14.8 24.5 65.7 41.0 3.4 16.7 28.8 19.5 0.1 19.1 14.3 11.0 32.8 5.9 8.0 33.9 22.2 15.4 12.4 11.3 8.8 26.2 16.5 25.7 36.3 34.6 2.1 2.3 0.2 22.3 14.3 41.1 0.0 0.5 0.0 1.9 0.3 0.5 0.2 1.2 1.9 2.3 0.0 0.4 2.0 0.0 6.2 0.5 2.0 3.0 1.0 2.1 1.2 0.8 1.1 1.3 1.3 1.2 3.0 1.7 1.2 6.5 1.0 9.2 3.2 3.2 5.5 0.5 7.4 7.4 16.8 11.4 5.2 4.6 4.6 7.9 2.8 9.6 9.2 39.6 5.0 3.4 11.2 0.0 15.7 6.1 25.1 7.7 10.5 6.7 13.2 0.9 13.8 7.3 10.1 8.2 17.0 0.0 5.1 28.9 2.5 4.3 0.0 0.7 8.6 10.2 1.9 1.4 3.0 5.9 2.9 0.0 4.7 11.1 4.7 9.2 2.0 0.1 20.8 6.1 8.2 1.8 8.3 2.6 5.6 12.8 0.9 6.6 4.3 8.5 5.5 7.0 20.0 6.5 0.4 3.1 3.2 10.3 6.5 VAX2 DRES93 ENSG00000116035 "Ventral anterior homeobox 2" Q9UIW0 2 70900576-70965373 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 5.4;retina: 11.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 9.5;Cone photoreceptor cells: 16.7;Horizontal cells: 11.8;Muller glia cells: 7.6;Rod photoreceptor cells: 19.5" "Cancer enhanced" "Detected in many" "endometrial cancer: 7.8" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 4.7;MCF7: 5.6;RH-30: 4.6;SCLC-21H: 4.6;SH-SY5Y: 5.6" "Not detected" "Not detected" "Region enhanced" "Detected in some" "hypothalamus: 3.2" HPA009708 Approved "Nuclear speckles" NA NA "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 46: Photoreceptor cells - Phototransduction" "Nuclear speckles" "HPA009708: AB_2668261" "unprognostic (1.56e-1)" "unprognostic (1.45e-1)" "unprognostic (1.96e-2)" "unprognostic (3.16e-2)" "unprognostic (1.63e-2)" "unprognostic (2.17e-1)" "unprognostic (3.52e-2)" "unprognostic (7.23e-3)" "unprognostic (2.42e-1)" "unprognostic (1.98e-1)" "unprognostic (3.81e-1)" "unprognostic (2.16e-1)" "unprognostic (7.74e-3)" "unprognostic (6.63e-3)" "unprognostic (4.65e-1)" "unprognostic (6.67e-3)" "unprognostic (2.18e-2)" 1.5 0.4 1.8 0.1 1.0 0.0 1.1 5.4 1.6 0.9 0.6 0.6 0.0 1.0 0.0 0.4 0.7 0.0 0.6 1.9 2.6 0.4 0.0 0.5 0.0 0.9 1.0 0.7 1.2 0.2 0.9 0.2 1.0 0.7 0.0 11.1 0.8 0.0 0.5 1.2 0.3 0.3 0.7 0.0 0.2 0.2 1.6 0.0 0.2 0.1 0.0 0.5 0.4 1.0 1.5 3.6 0.8 4.7 1.2 0.7 2.6 0.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.2 1.8 0.0 0.1 0.0 3.0 0.0 0.0 2.1 0.6 0.0 0.0 1.2 0.0 0.2 0.0 1.3 0.4 0.2 0.0 0.0 1.8 5.6 0.0 0.0 2.0 0.0 0.0 0.0 4.6 0.0 1.5 1.2 4.6 5.6 3.7 0.0 2.1 0.1 2.1 0.2 0.9 2.2 0.5 1.1 0.9 0.0 0.0 0.0 1.1 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.0 5.4 1.6 1.9 2.6 0.9 1.0 1.0 0.7 1.6 1.0 3.2 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 9.5 1.4 1.4 0.1 0.0 0.1 0.0 16.7 0.1 0.1 0.2 1.9 1.2 0.1 0.0 0.1 1.5 0.0 0.0 0.6 0.6 0.4 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 11.8 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.8 0.0 4.2 7.6 0.0 2.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 19.5 0.0 0.8 0.8 0.0 0.2 0.0 0.0 0.1 0.1 0.8 0.1 0.0 VMO1 ENSG00000182853 "Vitelline membrane outer layer 1 homolog" Q7Z5L0 17 4785285-4786433 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.8;pituitary gland: 27.7" "Group enriched" "Detected in many" 4 "Club cells: 923.5;monocytes: 857.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 9 "non-classical monocyte: 111.9" "Lineage enriched" "Detected in many" 9 "monocytes: 111.9" "Cell line enhanced" "Detected in some" "A549: 3.0;MCF7: 3.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA023038 Uncertain "Secreted to blood" NA NA 2900000 "Cluster 7: Monocytes - Unknown function" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA023038: AB_10964632" "unprognostic (1.30e-1)" "unprognostic (5.71e-2)" "unprognostic (1.65e-3)" "unprognostic (9.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.10e-1)" "unprognostic (7.77e-2)" "unprognostic (5.58e-3)" "unprognostic (1.20e-1)" "unprognostic (1.65e-1)" "unprognostic (7.41e-2)" "unprognostic (4.23e-1)" "prognostic unfavorable (1.34e-6)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (2.60e-1)" "unprognostic (2.69e-1)" 5.1 2.5 4.5 7.0 4.5 2.4 2.3 4.7 6.5 3.1 6.7 2.1 4.9 1.6 0.1 1.7 1.6 3.4 2.3 4.5 5.2 5.5 10.4 8.9 2.0 6.1 4.7 1.0 2.3 13.3 27.7 2.3 5.1 3.0 0.8 0.5 5.2 1.6 10.1 2.0 5.6 0.9 5.3 21.8 1.6 0.7 5.1 2.1 1.4 1.5 0.5 4.7 2.5 6.1 0.2 3.0 0.3 1.8 0.3 0.7 0.3 0.6 1.1 0.1 0.3 0.9 1.1 0.1 0.0 0.1 0.2 0.5 0.0 0.4 0.2 2.2 0.4 0.1 0.6 0.8 0.6 0.0 1.3 0.5 0.4 0.1 0.4 0.6 0.0 0.4 0.3 0.4 0.6 3.9 0.0 0.9 0.7 0.7 1.3 0.7 1.5 0.3 0.0 0.7 0.2 0.4 0.2 0.2 0.3 0.2 1.2 0.1 0.3 1.2 0.1 0.3 0.2 0.0 0.3 0.0 0.5 0.6 0.9 0.1 0.2 0.0 0.0 9.7 0.0 0.0 0.0 0.0 12.3 0.1 0.0 0.1 0.0 0.4 111.9 0.0 0.0 3.7 4.5 4.5 4.7 6.5 4.5 5.2 6.1 4.7 5.1 5.3 5.1 6.1 2.8 3.2 7.7 1.0 2.8 8.5 13.4 217.2 0.6 6.7 2.8 3.7 0.9 1.5 923.5 0.0 0.0 0.4 0.8 1.1 1.9 0.9 8.2 0.4 0.8 5.2 1.2 3.2 0.5 1.5 0.3 2.5 0.0 0.4 14.0 0.3 79.6 3.3 16.2 0.0 0.9 1.0 101.7 59.8 210.9 40.3 0.3 70.8 5.4 1.0 857.9 1.0 0.0 0.0 0.6 1.5 0.3 1.2 0.7 11.2 4.3 2.4 158.4 2.9 13.1 1.3 45.5 0.6 1.5 0.8 7.2 0.3 2.0 0.5 1.3 14.2 VPS53 "FLJ10979, HCCS1" ENSG00000141252 "VPS53 subunit of GARP complex" Q5VIR6 17 508503-721717 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Epilepsy, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 270.0;Late spermatids: 203.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022988, HPA024446" Approved Supported "Golgi apparatus,Vesicles,Cytosol" NA NA "Cluster 6: Non-specific - Transcription" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" Cytosol "HPA022988: AB_1848679, HPA024446: AB_1848680" "unprognostic (8.62e-3)" "unprognostic (7.98e-2)" "unprognostic (2.09e-1)" "prognostic favorable (1.08e-5)" "unprognostic (1.39e-2)" "unprognostic (9.08e-3)" "unprognostic (3.12e-1)" "unprognostic (9.67e-2)" "unprognostic (1.43e-1)" "unprognostic (2.72e-1)" "prognostic favorable (1.56e-5)" "unprognostic (1.53e-2)" "unprognostic (1.82e-2)" "unprognostic (1.89e-2)" "unprognostic (2.81e-1)" "unprognostic (4.82e-2)" "unprognostic (1.31e-1)" 4.3 4.7 7.0 3.0 5.9 20.5 4.6 21.4 10.3 5.2 2.8 4.5 3.7 4.4 3.4 9.0 4.0 3.6 4.3 8.2 3.3 4.0 4.5 5.1 4.9 3.0 3.9 5.3 4.5 6.4 6.0 4.6 4.2 4.6 5.9 8.1 4.7 5.0 7.0 7.1 4.0 6.1 0.9 4.5 5.0 14.6 4.0 4.9 7.6 5.1 5.2 4.1 4.8 9.4 12.9 26.5 7.6 8.3 12.4 9.5 5.5 6.4 9.4 15.8 15.4 12.6 5.8 7.8 5.9 19.9 10.0 10.9 16.5 13.9 23.1 6.7 11.4 5.0 17.2 8.1 6.1 6.6 9.2 11.1 7.8 14.7 9.8 6.4 11.7 9.7 9.1 9.1 14.9 8.9 4.3 5.1 6.2 5.6 6.9 10.5 3.9 5.2 8.0 10.4 7.6 6.1 12.4 4.3 5.4 7.5 6.5 3.5 7.9 6.8 5.4 12.5 7.0 4.3 3.3 4.8 11.5 5.2 8.6 8.1 1.9 4.4 2.4 2.3 1.8 2.1 2.2 1.7 1.1 3.0 2.3 1.9 6.1 1.9 5.6 3.0 1.9 0.9 7.0 5.9 21.4 10.3 8.2 3.3 3.0 3.9 4.2 0.9 4.0 9.4 16.0 12.8 25.9 54.5 19.3 25.5 16.5 11.6 19.9 53.3 19.6 9.3 17.4 14.3 21.5 40.5 70.9 10.5 19.9 24.9 1.9 16.7 270.0 23.9 22.2 18.7 24.6 5.0 109.3 18.3 7.9 18.5 26.5 28.1 24.1 18.2 15.7 17.7 21.4 63.9 103.6 27.4 4.1 20.6 19.4 203.9 18.6 21.0 10.6 39.4 27.5 18.3 37.0 48.2 62.5 25.3 15.5 23.0 20.6 18.7 21.0 10.6 24.3 52.2 6.6 31.1 20.7 46.0 35.3 24.6 38.8 8.9 26.8 17.2 22.0 19.6 VTI1B VTI2 ENSG00000100568 "Vesicle transport through interaction with t-SNAREs 1B" Q9UEU0 14 67647085-67674820 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 493.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044121, HPA048150, HPA060118" Approved Enhanced "Golgi apparatus,Vesicles" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 27: Brain & Skin - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus, Vesicles" "HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206" "unprognostic (2.26e-1)" "unprognostic (4.83e-2)" "unprognostic (8.09e-2)" "unprognostic (2.24e-1)" "unprognostic (3.00e-2)" "unprognostic (2.36e-3)" "unprognostic (3.25e-3)" "unprognostic (9.12e-2)" "unprognostic (1.90e-2)" "unprognostic (3.86e-1)" "unprognostic (2.60e-1)" "unprognostic (2.11e-2)" "prognostic favorable (3.53e-12)" "unprognostic (8.35e-3)" "unprognostic (1.53e-1)" "unprognostic (1.43e-1)" "unprognostic (8.02e-3)" 53.8 26.9 55.5 20.4 56.8 22.3 39.8 54.4 102.1 22.7 49.8 42.9 28.3 18.4 53.5 44.3 18.5 28.7 60.1 56.6 58.1 53.0 41.6 26.8 23.8 55.1 56.6 21.0 44.0 23.9 17.1 21.3 56.8 22.3 35.2 23.0 30.1 13.6 46.5 31.0 24.1 22.4 56.0 26.5 40.0 30.8 56.3 12.1 34.0 28.2 27.0 33.3 23.4 56.9 111.7 54.8 31.4 18.1 61.9 37.2 45.4 48.1 30.5 23.8 23.7 27.3 38.5 32.9 40.2 54.5 27.5 30.6 36.8 36.6 37.7 34.3 22.6 33.4 32.5 34.8 26.6 20.9 22.9 36.3 39.6 25.6 26.1 60.5 27.2 23.1 22.2 25.4 34.5 131.1 26.6 77.7 20.3 76.6 88.0 31.8 35.6 12.2 35.1 65.0 17.4 35.5 33.8 45.5 71.4 23.7 41.9 58.0 38.5 62.6 93.8 51.4 45.6 23.8 27.8 53.2 52.9 38.9 29.0 88.8 61.5 143.8 49.4 80.4 42.4 49.0 43.1 51.1 59.6 43.0 40.5 50.3 27.2 56.4 70.2 38.6 60.2 58.3 55.5 56.8 54.4 102.1 56.6 58.1 55.1 56.6 56.8 56.0 56.3 56.9 47.6 25.6 35.0 13.1 48.7 42.3 61.4 91.7 33.0 23.2 82.2 65.4 30.5 67.2 64.4 66.2 22.9 107.4 47.5 138.2 217.2 109.1 141.7 58.5 43.2 51.5 46.6 102.7 15.8 131.4 167.9 51.6 40.8 49.5 64.0 43.6 73.9 95.3 131.4 15.2 18.2 96.0 50.8 99.8 49.2 493.5 41.7 80.9 71.2 11.2 121.6 65.4 78.2 13.6 17.1 130.7 119.4 39.9 51.0 120.5 165.4 268.6 55.3 44.8 19.7 36.5 58.2 104.5 57.2 58.2 52.8 125.9 46.8 35.5 91.9 124.6 WBP1 WBP-1 ENSG00000239779 "WW domain binding protein 1" Q96G27 2 74458400-74460891 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 29.0;Gastric mucus-secreting cells: 33.1;Plasma cells: 57.2;Squamous epithelial cells: 28.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057067 Approved Approved Cytosol No No "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Cytosol "HPA057067: AB_2683326" "unprognostic (5.94e-2)" "unprognostic (2.48e-1)" "prognostic unfavorable (1.04e-4)" "unprognostic (6.05e-2)" "unprognostic (2.98e-1)" "unprognostic (1.11e-1)" "unprognostic (5.80e-2)" "unprognostic (1.32e-2)" "unprognostic (1.03e-1)" "unprognostic (1.91e-1)" "prognostic favorable (6.83e-4)" "unprognostic (1.17e-2)" "unprognostic (1.87e-2)" "unprognostic (1.78e-1)" "unprognostic (1.57e-1)" "unprognostic (5.09e-2)" "prognostic favorable (6.36e-4)" 36.9 70.7 141.7 19.6 145.8 31.9 37.7 139.4 171.9 48.2 133.1 46.6 29.1 39.1 44.8 35.7 56.1 36.5 49.9 137.7 136.6 71.2 80.3 33.7 32.2 144.2 141.3 55.6 62.3 73.7 60.8 24.9 138.2 69.9 17.7 24.4 56.4 37.3 31.4 34.9 33.2 19.8 138.1 42.5 58.0 31.8 145.0 44.7 66.9 53.9 20.6 45.7 37.5 139.0 20.6 91.3 56.2 66.7 69.9 54.0 45.7 20.6 40.3 22.4 17.5 47.3 41.9 19.4 39.3 48.9 33.2 28.3 24.8 55.8 19.0 74.3 49.1 27.4 41.4 68.9 47.6 10.3 27.4 76.2 58.9 30.4 42.2 93.8 44.7 51.6 11.5 72.0 54.8 133.8 40.1 25.5 43.3 53.6 46.3 36.4 63.5 33.6 55.9 83.1 35.0 81.3 28.2 49.9 62.5 49.4 65.5 26.9 26.5 53.0 41.9 20.0 23.5 106.7 38.8 22.2 56.2 27.0 48.5 24.1 28.5 19.2 26.5 23.5 22.5 28.4 23.0 25.5 30.2 27.8 31.3 28.0 18.6 34.6 20.1 47.0 39.2 27.1 141.7 145.8 139.4 171.9 137.7 136.6 144.2 141.3 138.2 138.1 145.0 139.0 1.5 3.2 4.2 0.0 14.3 0.9 0.6 2.0 29.0 1.6 3.2 2.2 0.5 0.0 4.2 1.8 2.1 1.4 1.7 3.3 1.9 5.5 2.4 3.1 2.4 3.6 1.8 9.7 0.0 3.9 1.4 7.2 33.1 1.8 1.3 1.1 0.4 0.8 1.7 0.0 0.0 4.7 2.0 2.4 1.0 1.8 2.1 7.1 0.0 0.0 6.0 1.7 2.1 0.0 0.0 5.2 3.1 1.2 57.2 1.2 5.6 3.3 13.1 1.7 0.0 0.5 5.8 0.6 0.2 28.1 1.3 1.8 10.4 0.9 3.7 0.3 WDR20 "DMR, FLJ33659, MGC33177" ENSG00000140153 "WD repeat domain 20" Q8TBZ3 14 102139503-102224847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 241.9;Late spermatids: 250.6;Oligodendrocytes: 201.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 77: Retina - Visual perception" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 34: Spermatids - Unknown function" "unprognostic (5.59e-2)" "unprognostic (1.00e-1)" "unprognostic (8.45e-2)" "unprognostic (7.70e-2)" "unprognostic (5.48e-2)" "unprognostic (5.14e-2)" "unprognostic (2.43e-2)" "unprognostic (3.96e-2)" "unprognostic (1.78e-1)" "unprognostic (5.04e-2)" "unprognostic (1.19e-2)" "unprognostic (3.26e-2)" "prognostic favorable (3.26e-9)" "unprognostic (6.62e-2)" "unprognostic (2.01e-1)" "unprognostic (2.68e-2)" "unprognostic (1.41e-2)" 12.2 17.0 11.2 9.4 16.3 10.7 11.7 18.7 15.6 11.5 13.3 10.8 16.0 10.3 12.0 13.5 10.7 8.9 10.0 12.3 15.0 12.5 10.9 8.8 11.5 16.5 14.0 12.3 12.3 11.9 10.5 9.9 16.1 10.2 10.5 29.9 11.4 7.4 11.8 16.0 13.1 9.1 11.6 10.4 10.6 23.9 14.3 12.3 14.1 13.0 10.8 10.4 12.1 28.7 16.2 20.6 14.6 13.0 16.4 14.3 19.2 19.8 16.4 21.9 17.7 17.6 15.2 17.7 12.9 18.6 11.9 19.3 21.6 17.8 27.7 25.0 9.8 9.3 14.8 19.4 12.6 14.4 16.1 11.2 16.7 15.8 15.5 22.0 15.4 14.2 12.3 18.6 23.9 37.2 13.3 21.8 13.0 22.3 22.7 13.3 14.5 11.9 31.8 25.4 18.4 20.8 17.3 22.2 13.9 16.2 24.1 13.8 17.0 20.3 9.3 32.2 18.7 14.6 21.9 18.8 18.5 11.7 22.2 28.5 20.7 37.7 25.8 21.2 27.0 27.6 28.4 24.2 21.0 19.9 28.9 27.4 40.2 30.4 21.4 12.4 33.6 21.0 11.2 16.3 18.7 15.6 12.3 15.0 16.5 14.0 16.1 11.6 14.3 28.7 17.5 9.6 14.5 48.6 21.0 25.1 15.4 19.6 16.5 20.5 16.3 12.7 10.4 10.0 16.7 11.0 16.7 25.6 22.8 19.6 21.5 17.9 241.9 20.1 14.5 12.9 11.4 25.0 43.3 17.3 19.4 15.6 14.3 21.1 22.9 15.0 15.0 12.7 13.4 33.7 42.9 12.8 18.3 10.4 13.8 250.6 13.1 12.9 21.4 48.7 15.6 23.8 22.6 68.9 201.5 18.9 17.6 15.1 17.4 19.0 27.5 25.1 15.6 54.6 13.1 18.6 17.4 43.0 25.3 16.4 27.4 34.9 22.3 8.7 12.1 21.7 WDR24 "C16orf21, DKFZp434F054, JFP7" ENSG00000127580 "WD repeat domain 24" Q96S15 16 684622-690444 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039506 Approved Supported Vesicles,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Cytosol "HPA039506: AB_10795148" "unprognostic (9.07e-2)" "unprognostic (2.67e-3)" "unprognostic (6.67e-2)" "unprognostic (1.48e-1)" "unprognostic (1.67e-1)" "unprognostic (8.15e-2)" "unprognostic (7.05e-2)" "unprognostic (4.35e-2)" "unprognostic (1.75e-1)" "unprognostic (5.09e-3)" "unprognostic (2.29e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.75e-6)" "unprognostic (5.38e-2)" "unprognostic (3.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" 6.1 9.1 3.9 4.0 3.6 3.9 6.2 5.0 6.9 7.5 4.1 7.1 4.8 7.9 1.0 7.1 7.5 2.8 7.9 3.8 3.0 7.5 11.2 6.0 4.8 4.2 4.0 9.2 7.2 5.8 9.4 3.2 3.5 8.5 1.1 1.8 6.9 3.0 11.7 8.5 7.1 2.0 3.2 9.2 7.8 14.2 3.9 4.3 8.7 4.1 2.4 7.5 6.6 3.7 6.1 14.0 6.2 8.6 5.9 4.2 10.9 7.5 6.7 9.2 8.0 15.3 8.8 9.4 12.8 3.4 2.3 9.4 6.1 7.4 2.0 15.9 19.0 6.4 19.8 5.8 9.4 7.9 9.6 7.4 4.9 6.6 5.5 4.8 5.0 9.0 12.7 10.3 3.4 22.2 14.0 5.8 9.7 3.1 10.6 20.4 5.1 17.6 3.0 4.2 15.1 6.9 8.5 14.3 8.7 2.8 13.2 7.8 7.3 6.6 6.8 7.4 7.3 21.9 21.5 15.3 4.3 7.8 9.4 4.3 5.1 2.8 6.6 3.0 5.4 4.3 4.2 4.9 5.1 3.7 4.9 4.8 1.2 3.0 7.8 4.1 6.1 5.0 3.9 3.6 5.0 6.9 3.8 3.0 4.2 4.0 3.5 3.2 3.9 3.7 2.9 6.4 6.2 2.3 4.2 1.1 2.6 4.7 4.0 5.1 5.2 4.4 5.0 1.5 5.0 7.3 2.1 7.4 2.9 6.0 7.9 4.9 17.1 12.2 2.9 3.1 10.1 5.2 2.0 5.6 4.4 3.1 6.6 2.9 4.5 6.9 2.5 9.6 5.1 21.9 2.0 7.3 4.1 6.3 1.6 48.0 5.6 3.9 0.0 1.9 4.4 7.3 1.0 2.0 2.4 4.5 2.1 3.0 6.8 3.8 8.0 6.4 19.4 2.6 19.7 2.6 4.2 18.8 8.7 2.1 1.6 7.4 3.4 7.6 5.5 2.0 WDR25 "C14orf67, MGC4645" ENSG00000176473 "WD repeat domain 25" Q64LD2 14 100376418-100530303 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Exocrine glandular cells: 33.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003113 Uncertain Approved Nucleoplasm "Secreted to blood" NA NA "Cluster 34: Basophils - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 1: Pancreatic cells - Digestion" Nucleoplasm "HPA003113: AB_2215263" "unprognostic (5.31e-2)" "unprognostic (5.76e-3)" "unprognostic (2.28e-2)" "unprognostic (1.24e-1)" "unprognostic (1.11e-1)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.36e-4)" "unprognostic (1.79e-2)" "unprognostic (6.62e-2)" "unprognostic (3.94e-3)" "unprognostic (2.44e-2)" "unprognostic (1.37e-2)" "prognostic favorable (3.89e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (7.30e-2)" "unprognostic (7.51e-2)" 6.4 10.0 7.6 2.5 7.8 4.1 6.5 8.0 9.5 8.1 8.1 6.7 3.2 7.9 4.2 4.5 6.8 3.0 6.6 7.4 7.5 7.0 8.6 5.8 3.6 7.6 7.6 6.6 12.9 3.5 11.3 3.3 8.5 7.9 2.5 4.5 5.7 3.6 10.7 5.7 4.8 2.7 7.0 5.7 6.5 7.4 7.3 5.6 9.1 4.5 2.3 7.9 5.4 7.8 3.5 6.1 4.2 15.6 6.7 6.2 3.5 6.4 10.2 7.3 7.4 2.9 6.5 5.1 7.9 5.0 2.0 6.2 4.0 7.8 3.8 5.0 2.9 3.4 6.9 4.9 12.2 4.0 3.8 9.3 9.2 5.3 7.9 6.4 5.3 5.9 4.2 7.3 4.8 13.5 6.0 4.4 3.2 4.2 10.7 4.3 5.9 3.6 5.6 2.8 9.8 10.3 5.2 1.9 9.0 4.0 7.2 1.4 9.2 2.8 3.2 10.8 3.7 4.9 2.6 2.5 9.7 3.0 5.4 34.0 16.4 24.6 8.6 14.6 8.7 13.0 11.1 9.1 14.3 8.5 11.7 8.6 8.7 5.6 16.3 11.0 12.0 12.2 7.6 7.8 8.0 9.5 7.4 7.5 7.6 7.6 8.5 7.0 7.3 7.8 7.1 0.0 6.4 12.1 5.1 3.2 4.3 8.6 0.6 8.8 5.5 6.1 2.6 0.0 6.9 3.7 10.4 8.4 6.7 6.3 9.8 12.7 9.2 13.8 6.7 8.8 5.4 11.0 17.8 33.6 4.7 6.2 8.2 8.5 3.8 3.9 5.0 8.7 6.9 5.0 16.9 9.0 14.2 5.6 4.0 6.3 6.8 3.7 5.4 16.9 5.4 14.0 5.2 14.6 19.1 13.3 3.8 11.3 6.3 3.3 7.5 17.9 11.8 16.2 13.1 4.5 7.2 15.6 17.0 2.8 3.0 7.0 5.0 9.2 7.1 3.0 WDR54 FLJ12953 ENSG00000005448 "WD repeat domain 54" Q9H977 2 74421678-74425755 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 70.2" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 207.0;Late spermatids: 124.6;Respiratory ciliated cells: 395.9;Spermatocytes: 147.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043257, HPA053558" Enhanced Approved Vesicles,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Vesicles, Cytosol" "HPA043257: AB_10795981, HPA053558: AB_2682189" "unprognostic (1.12e-1)" "unprognostic (3.68e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-2)" "unprognostic (2.62e-1)" "unprognostic (3.06e-3)" "unprognostic (4.10e-3)" "unprognostic (1.96e-1)" "unprognostic (2.68e-2)" "unprognostic (1.51e-1)" "unprognostic (7.25e-3)" "unprognostic (3.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.19e-1)" "unprognostic (1.61e-1)" "unprognostic (8.96e-2)" "unprognostic (4.85e-2)" 8.2 8.5 11.0 6.5 11.7 6.7 7.7 8.5 11.2 11.8 17.6 6.7 3.2 10.4 5.6 3.4 70.2 8.4 4.3 11.8 14.2 12.1 1.9 10.7 11.6 10.3 12.5 10.8 6.3 30.0 24.4 6.3 11.2 7.4 4.0 28.0 5.2 9.9 1.3 4.9 7.0 7.7 10.8 12.2 7.0 38.0 11.7 18.5 7.8 1.7 11.2 8.6 6.3 9.9 44.9 78.3 37.9 32.5 14.0 25.7 11.8 22.5 45.8 56.8 52.8 6.9 34.4 39.3 22.5 25.1 34.5 37.6 27.8 100.6 49.8 30.3 16.8 19.4 42.4 4.7 14.3 30.6 15.3 11.6 27.6 58.1 30.3 67.5 30.6 61.6 7.7 45.8 32.4 69.8 48.6 32.3 30.3 10.9 29.8 41.2 44.1 84.4 51.3 22.4 66.4 52.1 17.6 15.9 27.0 11.2 25.6 14.7 15.3 29.2 50.9 32.1 50.7 49.2 26.7 10.1 86.5 18.8 21.6 6.6 8.5 0.6 31.1 11.5 31.4 24.2 35.5 33.7 28.6 22.0 25.1 23.8 0.7 29.1 10.1 46.7 36.8 21.6 11.0 11.7 8.5 11.2 11.8 14.2 10.3 12.5 11.2 10.8 11.7 9.9 20.0 3.2 12.8 1.3 23.1 7.0 20.1 64.1 10.2 48.3 9.4 10.9 1.7 20.0 39.4 23.9 83.4 9.8 30.1 1.5 19.6 28.5 77.8 207.0 18.5 25.1 28.9 5.5 5.6 6.0 14.6 14.3 7.1 9.2 12.7 23.8 30.0 1.9 8.6 32.0 4.1 6.0 38.7 6.9 17.4 124.6 17.1 7.4 12.4 0.0 29.8 51.9 26.8 3.0 2.4 13.6 4.4 22.2 17.5 9.4 0.8 28.4 395.9 112.5 0.0 8.4 30.6 147.9 19.3 1.7 4.8 2.9 30.5 37.2 3.8 13.3 WDR83 MORG1 ENSG00000123154 "WD repeat domain 83" Q9BRX9 19 12666802-12675832 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 61.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042629, HPA042838" Uncertain Approved "Nucleoplasm,Vesicles,Centriolar satellite" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Vesicles "Nucleoplasm, Centriolar satellite" "HPA042629: AB_10794763, HPA042838: AB_10794173" "unprognostic (1.12e-2)" "unprognostic (3.15e-3)" "unprognostic (1.43e-3)" "unprognostic (1.34e-2)" "unprognostic (1.36e-1)" "unprognostic (1.35e-2)" "unprognostic (2.64e-1)" "unprognostic (3.60e-3)" "unprognostic (2.52e-1)" "unprognostic (1.56e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.30e-2)" "unprognostic (4.07e-2)" "unprognostic (2.85e-2)" "unprognostic (1.18e-1)" "unprognostic (2.37e-1)" "prognostic favorable (3.12e-4)" 5.2 6.7 7.5 3.4 8.1 5.3 5.2 8.0 9.3 6.0 7.1 7.1 2.6 6.2 2.0 4.2 6.8 2.9 7.2 7.5 7.9 6.9 4.8 4.6 5.0 7.8 7.8 6.5 6.3 5.6 5.7 2.7 7.7 5.9 1.4 2.5 8.1 3.3 4.2 6.5 4.6 1.9 7.5 5.3 6.9 10.0 7.8 6.8 5.8 2.9 3.1 5.7 4.5 8.2 6.8 11.0 6.2 8.1 11.0 4.4 4.9 6.1 5.8 7.3 7.5 13.4 5.7 10.0 8.7 5.6 4.2 7.0 7.3 9.6 1.3 10.2 16.0 8.0 7.6 8.0 9.3 11.3 8.4 8.0 7.6 6.0 4.9 5.1 7.2 21.6 7.2 0.8 3.4 25.6 16.4 9.2 4.8 8.0 18.8 10.9 7.7 9.3 7.1 8.0 12.6 8.6 6.4 9.0 5.3 3.5 5.1 11.2 4.0 8.0 2.4 6.2 6.1 24.7 17.7 4.9 12.7 8.7 4.6 5.6 13.4 5.7 10.2 12.4 12.2 9.7 10.2 10.2 14.0 10.8 9.8 12.8 6.7 21.9 6.4 23.5 12.2 10.8 7.5 8.1 8.0 9.3 7.5 7.9 7.8 7.8 7.7 7.5 7.8 8.2 10.8 0.0 14.4 4.2 13.5 15.4 12.1 15.9 11.4 21.1 10.1 9.8 4.4 17.2 12.0 18.4 12.5 12.4 22.3 9.0 17.6 15.6 17.8 12.2 7.3 12.0 9.6 16.2 7.2 17.5 13.9 9.9 9.2 6.1 14.0 12.4 8.6 9.2 13.2 20.2 7.1 7.8 16.2 11.6 19.2 61.9 15.8 9.6 16.0 1.9 17.8 18.2 24.7 4.5 4.4 13.5 5.8 18.0 11.6 15.4 13.6 33.7 18.4 22.7 19.7 8.1 11.3 25.8 17.6 8.3 16.1 9.0 12.4 10.1 9.6 14.6 WDR83OS "Asterix, C19orf56, PTD008" ENSG00000105583 "WD repeat domain 83 opposite strand" Q9Y284 19 12668073-12669415 "Predicted membrane proteins, Transporters" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065685 Approved Approved "Endoplasmic reticulum" NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Endoplasmic reticulum" "HPA065685: AB_2685531" "unprognostic (1.73e-1)" "unprognostic (5.37e-3)" "unprognostic (1.03e-1)" "unprognostic (4.86e-2)" "unprognostic (1.27e-1)" "unprognostic (3.29e-2)" "unprognostic (7.47e-2)" "prognostic favorable (2.09e-4)" "unprognostic (1.71e-1)" "prognostic favorable (8.84e-4)" "unprognostic (4.17e-3)" "unprognostic (1.09e-1)" "unprognostic (7.87e-3)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (1.02e-1)" "unprognostic (8.34e-2)" 152.2 219.2 204.0 80.1 213.4 203.3 156.9 213.2 226.5 164.0 199.2 138.5 103.9 146.9 276.1 174.0 223.2 138.0 206.8 198.6 212.5 194.9 189.2 133.3 128.7 209.9 205.9 226.2 210.0 204.7 164.8 119.7 211.1 160.6 151.4 50.2 180.9 135.9 226.7 175.1 128.5 169.6 216.9 146.5 164.7 80.4 210.8 129.8 190.1 234.1 174.2 164.4 144.8 223.7 190.9 204.4 223.1 252.8 338.2 267.0 96.4 135.3 230.3 211.6 181.7 170.0 161.1 86.2 310.0 390.4 143.5 150.9 242.7 255.9 175.2 180.9 333.0 107.4 170.3 259.6 262.1 183.5 148.5 287.1 343.2 208.0 243.7 309.9 265.2 161.2 196.2 196.3 253.5 661.5 136.8 399.3 187.7 254.4 584.9 110.0 117.7 310.1 241.7 217.2 182.3 278.6 155.2 162.4 193.5 148.2 197.6 295.1 156.7 289.8 78.2 317.2 205.8 342.4 428.4 126.5 245.4 313.2 189.0 612.8 502.8 492.3 329.2 469.3 312.0 445.2 308.6 336.5 466.7 394.4 280.0 305.8 485.8 451.4 503.7 319.2 396.0 635.4 204.0 213.4 213.2 226.5 198.6 212.5 209.9 205.9 211.1 216.9 210.8 223.7 198.5 80.1 54.6 11.8 156.8 171.7 193.7 391.7 272.0 42.3 310.7 424.2 129.4 168.7 204.5 342.1 27.1 435.7 153.8 233.0 401.1 255.5 7.9 128.6 184.0 185.7 195.3 126.4 10.5 255.8 333.8 205.2 162.6 162.7 147.9 239.7 183.1 314.3 287.5 50.5 10.6 282.6 301.1 212.5 230.2 22.7 170.6 209.3 297.1 13.1 254.5 264.8 179.2 13.0 39.4 243.4 295.7 144.8 256.0 230.9 398.1 586.3 103.6 55.7 98.6 140.9 187.6 87.3 98.4 353.6 221.3 405.1 172.2 279.8 262.4 241.1 WIZ ZNF803 ENSG00000011451 "WIZ zinc finger" O95785 19 15419978-15449956 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022923, HPA023774" Supported Enhanced Nucleoplasm,Midbody Yes No "Cluster 14: Monocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm Midbody "HPA022923: AB_1858845, HPA023774: AB_2671308" "unprognostic (3.50e-2)" "unprognostic (3.91e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.12e-5)" "unprognostic (1.05e-1)" "unprognostic (4.96e-3)" "unprognostic (9.73e-3)" "unprognostic (3.00e-1)" "unprognostic (2.24e-2)" "unprognostic (4.69e-2)" "unprognostic (7.46e-2)" "unprognostic (5.47e-2)" "unprognostic (2.65e-1)" "unprognostic (4.27e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.11e-1)" 13.9 13.7 22.2 10.2 18.0 7.5 13.2 11.1 28.2 13.5 8.3 15.8 9.6 18.7 3.6 12.2 13.4 6.6 18.7 21.4 12.2 13.3 12.3 9.9 6.6 14.0 15.4 14.0 19.7 9.3 7.9 6.7 13.7 12.0 3.5 3.6 10.4 10.3 14.4 13.7 10.2 8.3 12.2 9.5 15.8 21.3 17.7 6.6 9.1 7.3 4.0 16.0 11.6 15.7 23.0 13.1 22.6 28.0 32.2 13.4 17.0 23.2 10.8 19.8 13.4 14.1 43.0 18.8 36.7 22.9 12.1 20.3 12.5 17.3 5.0 13.8 21.3 14.6 13.5 11.3 21.2 15.2 19.9 23.8 22.9 14.7 16.4 12.3 18.3 14.4 22.5 16.8 13.8 48.4 30.2 15.9 28.7 23.8 38.2 27.7 10.4 19.9 13.2 18.5 31.0 36.4 20.2 19.5 15.7 8.3 21.4 16.0 29.2 45.4 16.7 36.0 32.0 22.8 15.6 21.2 18.0 19.1 31.5 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.2 0.1 0.5 1.0 0.3 0.2 0.1 22.2 18.0 11.1 28.2 21.4 12.2 14.0 15.4 13.7 12.2 17.7 15.7 11.3 12.8 6.9 6.5 4.1 15.8 7.2 7.8 5.7 9.4 16.2 17.8 10.9 8.6 5.6 12.9 0.0 7.1 8.4 8.4 3.9 14.9 9.0 6.3 15.3 14.9 6.7 3.0 3.2 20.0 9.9 10.3 9.2 12.1 1.3 17.3 14.3 14.7 7.8 6.7 3.2 9.0 4.1 11.3 7.2 10.0 15.8 8.7 7.2 3.7 6.7 8.5 2.1 2.0 2.8 19.1 3.9 19.2 3.1 14.1 6.2 5.3 2.5 7.4 13.1 9.5 12.7 34.8 21.9 9.3 20.3 7.4 5.4 16.8 10.0 12.8 WWOX "FOR, SDR41C1, WOX1" ENSG00000186153 "WW domain containing oxidoreductase" Q9NZC7 16 78099430-79212667 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Wnt signaling pathway" Oxidoreductase "Disease variant, Epilepsy, Neurodegeneration, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 14 "Astrocytes: 927.8;Excitatory neurons: 270.5;Inhibitory neurons: 540.9;Microglial cells: 471.2;Oligodendrocyte precursor cells: 914.9;Oligodendrocytes: 793.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050992 Approved Supported "Golgi apparatus,Cytosol" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA050992: AB_2681299" "prognostic unfavorable (9.07e-5)" "unprognostic (1.14e-2)" "unprognostic (1.92e-1)" "unprognostic (9.27e-2)" "unprognostic (2.32e-1)" "unprognostic (1.81e-1)" "unprognostic (6.24e-2)" "unprognostic (1.69e-1)" "unprognostic (1.65e-1)" "unprognostic (3.61e-3)" "unprognostic (4.33e-2)" "unprognostic (3.50e-2)" "prognostic favorable (4.49e-5)" "unprognostic (3.75e-1)" "unprognostic (1.78e-1)" "unprognostic (2.36e-2)" "unprognostic (1.77e-1)" 8.6 6.3 18.6 4.0 23.9 4.2 7.4 24.0 20.3 8.6 21.2 5.2 5.3 8.2 10.1 7.7 9.0 7.4 5.2 18.8 22.5 12.7 12.0 5.3 4.6 24.0 22.4 7.6 8.3 12.1 9.8 5.3 25.3 7.7 3.2 6.9 8.5 6.4 3.3 7.1 4.5 5.1 22.0 4.7 6.0 9.3 21.0 9.0 21.8 2.1 6.0 6.7 7.1 30.0 11.1 9.5 9.2 7.7 11.0 5.3 11.1 1.6 3.2 3.7 3.2 7.0 9.6 19.5 8.6 1.5 5.2 10.0 5.1 1.3 2.6 11.0 26.8 6.0 1.9 15.7 7.5 16.7 3.4 5.9 3.8 2.3 2.4 0.9 4.4 25.9 9.2 4.2 2.6 85.7 27.7 21.9 8.6 5.9 5.7 32.2 3.9 19.1 5.3 3.9 17.6 10.0 7.1 11.9 4.0 9.3 12.8 12.0 1.6 2.7 10.4 2.2 6.4 0.0 18.3 41.2 10.4 8.4 4.6 7.0 9.1 2.1 11.4 7.9 13.4 9.3 8.2 9.1 7.7 6.6 8.4 8.3 0.7 9.1 5.8 14.5 13.5 6.0 18.6 23.9 24.0 20.3 18.8 22.5 24.0 22.4 25.3 22.0 21.0 30.0 12.0 6.4 6.9 927.8 9.0 9.2 21.2 8.0 19.4 7.4 12.1 16.1 8.8 17.2 13.3 14.7 4.2 25.7 10.9 4.5 33.2 12.4 43.1 18.2 13.9 9.5 9.6 13.3 270.5 10.3 11.9 12.0 9.2 7.6 12.7 18.7 13.2 18.9 9.2 5.0 540.9 5.1 0.0 5.6 5.7 38.2 14.0 7.7 5.4 471.2 5.9 46.3 9.2 914.9 793.5 4.5 5.9 17.7 18.4 11.5 8.7 28.3 18.7 12.2 6.6 10.3 11.8 19.7 17.9 13.3 6.8 17.4 9.9 12.1 6.8 13.0 XRCC3 ENSG00000126215 "X-ray repair cross complementing 3" O43542 14 103697609-103715504 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 10.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA062422, HPA068953" Enhanced Nucleoplasm NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA062422: AB_2684757, HPA068953: AB_2686062" "unprognostic (2.52e-2)" "unprognostic (1.81e-3)" "unprognostic (6.75e-2)" "unprognostic (4.01e-2)" "unprognostic (4.29e-1)" "unprognostic (1.83e-1)" "unprognostic (2.53e-4)" "unprognostic (2.93e-2)" "unprognostic (4.67e-2)" "unprognostic (1.58e-2)" "unprognostic (4.46e-2)" "unprognostic (2.53e-2)" "unprognostic (3.52e-7)" "unprognostic (1.27e-1)" "unprognostic (1.57e-1)" "unprognostic (8.84e-2)" "unprognostic (3.72e-2)" 9.8 6.0 8.7 8.7 12.5 31.9 9.3 7.2 10.3 13.7 11.9 11.1 6.9 10.4 1.7 13.9 10.9 6.6 8.3 6.6 5.8 7.9 7.7 12.1 15.4 13.6 9.7 12.7 9.8 1.7 8.6 5.2 9.7 13.4 7.5 4.5 12.7 3.3 12.4 39.0 12.6 2.8 7.7 21.3 9.1 13.8 9.7 10.0 10.5 2.5 11.0 9.6 12.4 14.3 32.4 58.4 31.5 38.5 2.8 7.9 57.0 35.5 11.6 48.9 52.3 32.4 50.3 51.8 29.5 7.5 38.4 50.3 34.6 52.4 29.9 31.3 36.1 50.6 31.6 30.4 4.9 45.3 30.8 6.0 5.2 43.2 26.7 10.4 20.2 51.3 31.8 30.4 25.2 70.7 79.6 35.8 26.4 47.1 42.0 63.7 45.7 19.8 10.5 44.2 31.1 25.7 41.3 21.7 14.3 17.4 34.6 35.0 17.5 25.1 28.9 80.0 38.8 26.2 25.8 63.7 15.6 36.9 38.4 0.7 0.5 0.9 1.0 0.9 1.0 1.1 0.8 0.8 0.5 0.9 0.8 0.5 0.3 0.7 0.7 0.4 0.6 1.3 8.7 12.5 7.2 10.3 6.6 5.8 13.6 9.7 9.7 7.7 9.7 14.3 2.2 0.0 0.0 2.6 2.5 1.5 1.9 2.1 1.8 1.7 3.2 3.6 0.2 2.8 2.5 0.0 2.1 10.2 1.8 6.9 1.9 1.5 0.7 1.9 2.2 2.0 1.2 7.4 2.6 1.8 6.1 1.2 0.5 2.0 0.0 4.7 0.4 0.3 4.4 3.3 1.0 7.4 0.0 0.0 2.0 1.8 0.3 1.5 0.0 1.0 1.5 1.7 2.1 1.5 1.4 1.7 2.6 1.2 4.4 1.6 0.7 0.2 1.7 2.3 0.0 2.6 1.2 3.1 5.8 2.8 1.3 3.1 2.0 4.2 8.3 1.2 YIPF2 "FinGER2, MGC3262" ENSG00000130733 "Yip1 domain family member 2" Q9BWQ6 19 10922185-10928681 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019902 Approved Approved "Golgi apparatus,Mitochondria" No No "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus, Mitochondria" "HPA019902: AB_1858925" "unprognostic (1.27e-1)" "unprognostic (8.56e-2)" "unprognostic (2.90e-3)" "unprognostic (8.38e-2)" "unprognostic (3.66e-1)" "unprognostic (3.96e-1)" "unprognostic (1.93e-1)" "unprognostic (7.65e-2)" "unprognostic (4.30e-2)" "unprognostic (5.62e-3)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (3.28e-2)" "unprognostic (3.92e-2)" "unprognostic (5.99e-2)" "unprognostic (2.00e-2)" 29.5 43.5 18.1 15.9 18.7 29.6 34.1 20.5 26.6 41.7 30.7 34.7 31.8 38.1 26.8 51.0 35.2 30.3 31.6 19.4 20.3 45.1 56.1 32.8 16.8 22.4 19.6 39.6 114.3 33.4 108.2 38.9 21.0 40.3 15.8 6.5 105.7 23.6 24.8 33.8 29.9 14.2 18.2 27.7 39.2 76.8 19.4 14.3 47.5 10.3 11.2 32.6 39.6 20.4 64.9 22.3 17.5 25.4 40.0 38.9 30.1 48.9 71.6 36.6 52.9 68.1 51.6 12.8 80.2 56.2 16.7 49.8 11.9 47.6 9.5 41.7 43.2 24.2 27.3 39.1 62.1 42.5 49.3 35.7 33.6 24.7 35.4 47.7 26.2 31.1 31.6 69.2 22.9 109.4 27.4 42.7 29.4 44.3 55.2 22.8 14.1 65.3 33.0 30.2 45.4 22.2 35.2 56.4 48.8 15.3 51.7 60.1 39.1 41.6 15.3 60.2 36.7 96.7 42.5 24.2 65.1 72.9 43.9 39.2 18.8 9.3 13.3 21.3 10.4 16.3 10.4 12.3 22.3 9.5 9.3 13.3 3.1 12.1 19.4 34.1 12.6 10.4 18.1 18.7 20.5 26.6 19.4 20.3 22.4 19.6 21.0 18.2 19.4 20.4 20.5 16.0 21.2 2.6 16.0 6.8 41.6 22.4 17.1 19.4 46.9 37.8 0.5 27.1 27.3 35.0 16.7 109.5 20.6 31.9 27.4 69.3 131.1 23.0 20.1 19.2 43.3 17.2 6.4 80.7 114.1 36.0 33.6 29.3 21.6 22.5 22.5 23.0 38.7 18.5 6.7 69.4 14.2 15.3 5.2 34.6 35.1 20.5 5.4 5.6 21.1 23.8 16.5 3.5 3.3 50.3 47.7 25.6 55.4 51.6 52.5 27.0 26.1 16.4 6.6 20.0 21.9 159.1 16.6 22.6 7.0 174.3 13.9 27.9 50.6 50.0 ZC3H3 "KIAA0150, ZC3HDC3" ENSG00000014164 "Zinc finger CCCH-type containing 3" Q8IXZ2 8 143437659-143541447 "Predicted intracellular proteins" "mRNA transport, Transport" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023658, HPA050577" Uncertain Approved Nucleoplasm NA NA "Cluster 10: Basophils - Unknown function" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm "HPA023658: AB_1858973, HPA050577: " "unprognostic (1.15e-1)" "unprognostic (7.74e-2)" "unprognostic (1.87e-2)" "unprognostic (6.77e-2)" "unprognostic (1.33e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.06e-4)" "unprognostic (2.18e-3)" "unprognostic (2.12e-1)" "unprognostic (1.30e-2)" "unprognostic (3.69e-1)" "unprognostic (3.32e-1)" "prognostic unfavorable (4.38e-7)" "unprognostic (3.59e-2)" "unprognostic (1.33e-1)" "unprognostic (5.67e-2)" "unprognostic (2.18e-1)" 16.4 12.7 6.0 5.6 6.1 17.2 14.4 6.3 9.4 11.8 2.7 13.4 11.7 12.3 1.0 14.6 11.3 2.2 11.4 6.6 3.6 25.0 45.9 14.5 5.0 6.3 4.7 12.0 10.5 2.9 8.2 3.6 6.4 12.1 1.5 1.9 11.0 3.5 21.1 16.9 21.5 2.6 3.7 19.1 11.8 19.4 6.2 5.3 14.0 2.9 2.5 12.2 12.0 6.8 11.3 16.1 5.1 12.4 3.1 3.6 13.7 6.4 4.5 8.0 6.5 8.8 10.3 8.0 11.2 5.3 4.3 12.9 4.1 6.6 1.7 16.7 14.2 10.0 10.6 14.2 7.6 5.0 8.9 8.0 6.1 6.6 4.7 3.7 5.9 7.6 17.1 14.5 3.3 29.3 24.1 9.7 9.4 9.2 26.0 13.9 4.1 25.6 5.9 6.8 13.1 8.7 12.4 10.9 7.1 2.6 17.5 9.4 8.2 7.0 21.1 15.4 11.3 13.2 9.4 6.8 9.1 11.6 7.8 6.5 4.6 6.3 3.9 5.5 4.5 3.2 4.6 4.8 3.7 2.7 5.8 4.8 9.1 2.2 3.6 3.2 3.4 5.4 6.0 6.1 6.3 9.4 6.6 3.6 6.3 4.7 6.4 3.7 6.2 6.8 6.9 0.0 2.3 10.7 8.4 7.0 3.4 4.5 5.7 7.3 5.1 3.4 1.4 4.3 3.4 5.5 8.4 7.9 4.0 14.2 1.9 6.5 8.8 5.6 6.1 5.5 10.7 12.8 9.8 7.3 9.4 5.4 20.4 7.2 5.7 28.1 5.0 13.2 8.5 5.0 9.9 11.2 6.1 9.8 6.0 7.9 5.3 10.9 3.6 6.5 6.4 6.1 7.2 4.0 10.5 7.6 2.3 5.7 8.4 4.4 16.7 11.2 3.5 7.5 13.1 4.0 5.8 22.8 14.8 6.3 8.7 12.3 7.2 3.8 9.0 5.5 ZER1 "C9orf60, Hzyg, ZYG, ZYG11BL" ENSG00000160445 "Zyg-11 related cell cycle regulator" Q7Z7L7 9 128729786-128772414 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 67.7;Inhibitory neurons: 61.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048464 Approved Cytosol NA NA "Cluster 5: Granulocytes - Unknown function" "Cluster 47: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA048464: AB_2756306" "unprognostic (1.37e-1)" "prognostic favorable (1.18e-6)" "unprognostic (9.11e-3)" "unprognostic (2.36e-2)" "unprognostic (7.46e-2)" "unprognostic (9.35e-2)" "unprognostic (2.18e-1)" "unprognostic (4.81e-3)" "unprognostic (3.65e-1)" "unprognostic (4.90e-3)" "unprognostic (6.65e-3)" "unprognostic (1.69e-1)" "prognostic favorable (5.15e-11)" "unprognostic (5.77e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.14e-1)" 24.3 31.0 57.4 12.4 56.4 17.1 23.8 28.3 72.8 26.7 23.2 38.9 33.3 29.8 13.1 28.6 25.9 17.4 44.1 59.7 48.2 26.5 22.9 19.9 13.9 44.6 40.1 28.1 26.6 31.9 33.5 15.9 44.8 31.7 13.0 17.3 27.4 24.7 72.0 33.8 31.5 16.4 28.5 19.6 26.9 36.6 43.8 19.2 26.5 43.6 11.3 31.0 24.7 46.1 17.3 19.1 12.4 17.0 36.4 24.9 34.3 16.7 28.4 22.6 18.1 17.3 19.6 10.6 18.1 29.3 16.9 37.1 13.8 24.8 9.5 21.2 17.7 7.0 34.2 12.4 28.3 11.1 20.1 31.1 36.6 22.9 16.1 30.6 19.5 21.2 13.7 22.9 15.5 65.9 20.9 12.5 12.3 24.6 24.4 18.6 15.6 41.4 16.8 23.4 23.7 17.9 26.7 35.4 18.9 14.4 52.0 12.7 22.2 18.4 7.8 23.5 10.2 28.7 29.3 8.6 27.2 6.6 13.5 11.5 3.2 8.8 4.4 4.7 6.0 3.0 4.7 5.7 3.3 3.8 4.9 4.7 13.6 5.1 5.2 4.9 4.7 5.0 57.4 56.4 28.3 72.8 59.7 48.2 44.6 40.1 44.8 28.5 43.8 46.1 10.7 12.8 16.8 33.0 8.0 2.8 2.9 5.2 6.2 20.2 13.0 12.6 22.6 4.3 4.7 5.5 14.6 4.8 4.8 41.7 1.9 5.8 7.1 15.2 8.6 9.0 7.2 17.9 67.7 9.6 2.5 8.6 13.7 11.8 10.2 12.0 7.1 13.0 6.2 21.9 61.2 15.0 2.0 4.4 1.0 2.4 11.1 5.7 8.8 16.9 9.5 9.8 6.2 23.1 48.9 7.1 23.2 10.5 8.7 6.4 25.4 13.8 13.5 13.4 13.1 9.2 9.1 10.6 3.5 8.0 5.8 8.5 7.1 16.0 9.6 3.4 ZFPL1 "D11S750, MCG4" ENSG00000162300 "Zinc finger protein like 1" O95159 11 65084210-65088398 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014909, HPA017347" Enhanced Enhanced "Golgi apparatus" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Golgi apparatus" "HPA014909: AB_1859055, HPA017347: AB_1859056" "unprognostic (2.03e-1)" "unprognostic (5.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (2.50e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.12e-6)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (2.16e-1)" "unprognostic (3.63e-1)" "unprognostic (7.34e-2)" "prognostic favorable (2.73e-5)" "unprognostic (1.88e-1)" "unprognostic (1.44e-1)" "unprognostic (4.34e-2)" "unprognostic (6.94e-2)" 30.8 32.5 23.0 11.5 25.7 29.3 29.3 24.9 29.8 29.5 22.6 30.4 17.9 31.4 18.7 30.0 27.8 10.0 30.7 22.4 23.9 27.9 32.6 21.4 11.9 25.1 24.5 29.3 32.0 15.6 40.5 12.8 24.0 31.5 9.1 7.6 30.8 16.8 37.8 35.2 28.1 12.7 23.8 25.4 30.4 27.5 25.2 11.0 27.1 20.4 8.3 31.1 26.5 26.3 60.3 41.1 25.4 26.5 22.3 31.5 40.5 26.0 33.8 31.8 25.2 27.5 40.9 19.5 51.2 39.5 31.0 30.8 15.0 34.4 11.1 27.7 25.0 20.0 29.3 54.3 48.0 14.8 27.0 29.7 45.2 24.0 40.6 20.2 31.2 30.4 24.3 29.4 23.9 83.1 25.6 35.8 17.2 19.9 35.7 23.3 14.5 53.7 25.0 27.9 27.6 22.3 21.5 41.8 63.5 12.1 61.7 25.4 30.1 21.2 35.0 47.2 21.4 19.4 21.0 24.0 33.2 14.6 41.2 77.1 19.7 42.2 15.1 21.4 16.3 18.0 14.0 15.9 20.0 20.1 15.3 13.8 27.3 23.8 21.2 19.6 26.1 12.0 23.0 25.7 24.9 29.8 22.4 23.9 25.1 24.5 24.0 23.8 25.2 26.3 22.6 12.8 18.4 6.8 16.1 11.0 29.6 45.0 19.4 20.4 27.4 27.1 4.4 21.5 35.3 12.9 4.2 49.9 19.0 49.6 58.7 39.4 18.6 24.1 17.9 17.9 22.8 14.5 6.4 47.9 47.1 19.4 25.0 29.6 9.5 30.0 16.4 20.7 32.1 23.5 6.1 40.1 32.6 15.7 11.9 47.0 20.5 12.8 17.8 3.7 25.0 39.2 18.6 5.0 23.7 44.0 44.4 20.3 29.5 29.8 55.0 32.6 25.8 19.5 19.7 17.5 27.5 35.7 18.3 24.4 12.5 68.3 13.6 17.0 37.5 36.1 ZFYVE21 "MGC2550, ZF21" ENSG00000100711 "Zinc finger FYVE-type containing 21" Q9BQ24 14 103715730-103733668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 165.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055721 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA055721: AB_2682896" "unprognostic (1.10e-2)" "unprognostic (3.35e-1)" "unprognostic (8.89e-2)" "unprognostic (7.54e-3)" "unprognostic (1.96e-1)" "unprognostic (8.32e-2)" "unprognostic (4.74e-2)" "unprognostic (1.16e-1)" "unprognostic (1.04e-2)" "unprognostic (5.11e-3)" "unprognostic (5.02e-2)" "unprognostic (9.13e-2)" "prognostic favorable (2.58e-6)" "unprognostic (2.30e-3)" "unprognostic (1.71e-1)" "unprognostic (7.18e-2)" "unprognostic (2.06e-1)" 57.4 28.9 117.0 14.2 121.0 11.9 54.0 115.6 143.1 69.3 113.2 52.3 18.2 70.8 50.3 68.4 71.8 28.4 51.6 112.8 116.0 37.0 34.7 31.6 16.5 121.3 114.4 56.1 26.7 34.1 32.0 30.1 118.0 41.0 25.7 15.2 61.5 53.3 22.0 73.2 31.0 45.6 123.6 28.1 44.9 35.5 120.0 19.3 50.3 29.9 17.5 65.1 67.8 127.4 27.1 34.1 29.1 26.7 76.9 61.6 48.2 49.8 35.2 41.5 36.2 40.2 34.3 6.0 31.5 53.2 29.9 45.4 25.3 59.4 37.3 11.5 30.9 33.5 23.0 55.3 60.8 8.6 21.4 42.1 61.6 18.4 29.8 37.4 51.0 19.6 13.0 11.4 29.9 165.5 23.3 26.8 13.4 41.3 47.9 12.6 21.6 9.2 81.5 95.5 16.6 11.5 35.2 44.3 26.2 32.2 56.6 22.3 44.7 20.1 16.3 68.4 25.6 12.8 13.8 9.2 22.7 18.7 19.5 28.3 36.2 42.1 20.0 57.6 19.8 18.1 18.7 20.1 23.9 24.7 19.4 18.5 29.6 16.3 47.8 19.4 21.7 24.6 117.0 121.0 115.6 143.1 112.8 116.0 121.3 114.4 118.0 123.6 120.0 127.4 68.0 19.2 23.9 61.7 9.5 45.5 83.5 161.9 59.2 27.8 58.8 68.6 36.0 41.5 83.1 80.9 33.3 115.7 20.9 33.6 121.3 56.4 14.2 25.3 54.7 71.0 19.3 76.2 30.9 54.5 40.0 65.3 12.2 30.3 19.7 22.0 66.4 26.9 55.4 20.2 11.8 34.2 81.4 22.6 29.5 23.0 109.6 28.4 103.2 19.7 32.3 91.6 24.7 11.6 21.8 79.3 51.9 197.1 7.4 87.7 31.5 98.9 47.1 29.6 65.7 57.2 60.7 46.3 78.4 50.9 60.2 101.5 13.4 36.3 32.4 81.9 ZMYND11 BS69 ENSG00000015171 "Zinc finger MYND-type containing 11" Q15326 10 134465-254637 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015816 Supported Nucleoplasm NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA015816: AB_1845427" "unprognostic (1.96e-1)" "unprognostic (1.66e-1)" "unprognostic (3.00e-1)" "unprognostic (1.12e-1)" "unprognostic (9.12e-2)" "unprognostic (2.33e-2)" "unprognostic (5.49e-2)" "unprognostic (1.52e-2)" "unprognostic (1.80e-2)" "unprognostic (3.73e-2)" "unprognostic (4.47e-3)" "unprognostic (6.35e-2)" "prognostic favorable (4.76e-7)" "unprognostic (1.25e-1)" "unprognostic (2.40e-1)" "unprognostic (9.04e-2)" "unprognostic (1.42e-1)" 41.7 37.1 50.7 26.3 58.8 11.3 45.8 60.0 64.6 47.4 38.5 54.8 29.9 55.0 46.6 42.8 39.8 35.6 58.0 50.7 54.8 51.1 34.9 39.0 26.3 54.1 52.8 55.3 46.4 99.7 27.7 34.8 54.8 52.8 33.8 43.2 46.1 56.0 58.1 33.1 30.9 50.9 52.4 32.7 39.2 33.1 54.1 23.8 88.0 64.7 24.8 46.7 31.1 59.1 64.0 64.6 53.8 42.9 57.3 55.0 33.3 63.0 35.8 43.7 40.5 39.2 62.3 0.1 19.8 78.4 13.8 38.3 28.9 44.2 55.8 25.1 25.1 71.8 33.4 42.3 64.6 19.5 38.8 38.4 60.6 42.3 38.3 56.8 55.6 32.8 19.5 44.7 76.0 75.4 29.3 27.3 17.4 69.3 10.7 28.4 34.4 34.5 58.0 72.7 24.3 44.3 72.3 83.3 34.1 29.4 74.9 37.8 72.2 43.4 15.8 89.2 48.8 37.0 48.4 4.6 44.2 36.1 30.3 15.6 2.3 19.5 11.9 3.5 10.4 5.2 8.3 11.9 3.8 3.1 9.2 9.1 1.0 14.7 1.7 4.5 8.9 5.0 50.7 58.8 60.0 64.6 50.7 54.8 54.1 52.8 54.8 52.4 54.1 59.1 51.2 60.9 51.4 90.8 25.3 25.9 27.0 17.5 34.1 37.5 46.3 33.8 103.0 31.5 31.9 33.1 12.5 15.2 39.4 14.6 50.9 29.3 28.6 27.0 50.3 45.7 25.9 25.0 110.8 31.8 4.6 45.7 27.5 37.1 46.2 42.1 35.3 28.1 14.4 20.2 118.0 26.2 16.2 25.1 14.9 27.1 39.1 21.7 24.9 94.6 13.9 62.5 34.0 128.2 131.5 28.1 14.5 56.1 31.1 44.1 19.1 41.9 23.7 22.0 13.1 56.9 49.8 26.8 25.6 32.2 27.8 12.4 32.6 28.5 22.1 29.8 ZNF394 "FLJ12298, ZKSCAN14, ZSCAN46" ENSG00000160908 "Zinc finger protein 394" Q53GI3 7 99473877-99504857 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "bone marrow: 97.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051421, HPA054639" Approved Enhanced Nucleoplasm,Cytosol Yes No "Cluster 38: Basophils - Unknown function" "Cluster 67: Neutrophils - Humoral immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA051421: AB_2681479, HPA054639: AB_2682553" "prognostic favorable (3.56e-4)" "unprognostic (1.62e-1)" "unprognostic (2.83e-3)" "unprognostic (2.60e-1)" "unprognostic (2.09e-2)" "unprognostic (1.53e-1)" "unprognostic (2.54e-1)" "prognostic favorable (2.11e-4)" "unprognostic (3.62e-2)" "unprognostic (4.14e-1)" "unprognostic (6.28e-2)" "unprognostic (2.45e-1)" "unprognostic (1.59e-1)" "unprognostic (4.70e-2)" "unprognostic (7.47e-2)" "unprognostic (3.42e-1)" "prognostic favorable (1.09e-4)" 13.3 9.6 8.6 10.3 9.5 97.0 12.5 16.4 8.3 11.9 8.8 12.5 10.3 10.4 6.9 12.6 12.5 7.3 12.2 7.7 9.0 10.4 10.1 13.3 13.6 9.8 9.1 13.9 9.7 7.7 9.4 8.1 9.0 13.5 8.6 5.4 10.2 7.7 12.2 15.4 14.3 7.8 8.5 19.2 11.5 10.6 9.4 12.8 10.2 9.6 11.3 11.9 12.2 10.6 10.3 10.2 6.6 14.0 10.4 7.1 13.1 8.5 11.6 9.9 9.7 11.0 11.0 12.4 12.2 9.2 13.5 9.6 9.2 11.2 9.8 9.1 12.0 12.2 12.0 12.1 8.3 17.4 20.0 9.4 9.6 9.6 10.2 7.3 11.6 10.5 17.6 24.0 9.3 19.6 18.3 28.8 15.0 12.9 12.0 10.2 7.3 22.1 11.0 14.7 7.8 16.5 10.2 24.6 16.9 16.5 6.4 21.8 11.9 11.7 12.0 17.4 10.9 19.7 22.1 20.0 8.5 17.4 12.9 56.8 20.6 36.6 31.7 25.5 33.2 24.5 31.8 34.3 22.6 23.6 38.5 30.8 37.8 36.8 26.8 32.8 37.7 24.6 8.6 9.5 16.4 8.3 7.7 9.0 9.8 9.1 9.0 8.5 9.4 10.6 29.3 16.0 19.7 5.2 37.1 35.6 36.1 16.4 16.5 9.7 20.6 14.6 11.4 8.6 16.6 11.0 12.5 15.8 56.7 26.3 17.6 15.7 10.4 17.3 12.9 22.2 20.8 31.5 4.6 14.1 18.2 17.5 25.0 24.4 58.9 17.1 17.5 12.3 18.9 15.2 5.0 16.9 8.2 25.5 29.6 2.9 15.5 29.3 28.4 1.9 19.3 13.6 45.3 7.1 5.6 16.4 20.8 13.5 31.8 29.2 29.7 11.7 19.4 11.7 13.1 22.6 19.7 41.9 30.6 21.5 35.5 29.7 54.3 24.6 18.6 65.6 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220312-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 33.3;granulocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: AB_2671057, HPA056609: AB_2683189" "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 3.4 2.5 2.1 2.8 2.3 3.8 3.1 4.3 2.6 3.9 2.0 3.3 3.3 3.6 2.3 3.1 3.5 1.9 2.8 2.0 2.1 2.3 2.8 2.6 4.0 2.4 2.2 4.5 3.5 3.9 3.0 3.0 2.3 3.3 2.1 2.0 4.6 3.3 5.1 5.2 3.1 2.4 1.6 3.6 3.1 3.5 2.4 4.2 2.8 4.0 3.6 3.5 3.4 3.4 7.8 24.8 7.1 6.4 8.0 7.7 6.2 8.9 8.2 9.2 10.1 13.0 5.5 12.6 6.3 9.5 4.2 5.7 7.7 9.7 5.7 7.5 9.2 12.6 12.0 12.5 7.5 8.1 7.8 7.6 7.7 9.2 9.6 5.7 5.8 6.7 12.3 7.8 5.9 10.8 8.2 5.2 4.7 6.8 8.7 9.4 8.7 5.7 4.2 14.0 7.3 6.4 10.2 10.1 7.2 5.4 4.1 14.4 7.8 11.3 7.7 4.8 11.2 9.3 5.9 8.5 7.5 7.8 9.5 1.8 3.6 1.4 4.5 3.6 6.9 4.7 3.5 4.1 2.8 4.4 4.2 5.3 0.7 3.4 5.3 4.2 3.9 3.3 2.1 2.3 4.3 2.6 2.0 2.1 2.4 2.2 2.3 1.6 2.4 3.4 3.0 22.4 33.3 2.0 6.9 5.5 4.4 2.8 4.0 7.4 3.1 2.4 3.2 0.0 17.1 3.7 14.6 8.0 3.2 5.7 3.9 4.1 5.8 1.7 4.0 7.1 13.8 9.5 1.4 3.0 8.3 7.4 4.6 2.3 25.2 4.9 3.6 2.6 4.6 6.7 1.5 4.2 2.0 6.8 1.8 6.3 7.2 7.0 0.0 1.9 5.8 4.1 11.3 1.0 1.4 2.9 2.8 3.0 6.1 4.6 7.8 2.8 9.2 9.6 0.0 5.7 3.6 9.9 10.1 1.9 5.1 10.3 6.7 3.7 5.7 2.6 ZNF572 FLJ38002 ENSG00000180938 "Zinc finger protein 572" Q7Z3I7 8 124973295-124979389 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" "Astrocytes: 3.9;Inhibitory neurons: 2.5;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 2.7;Spermatogonia: 2.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 4.1" "Low region specificity" "Detected in all" HPA066838 Approved Approved "Nuclear speckles" NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 89: Fibroblasts - ECM organization" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nuclear speckles" "HPA066838: AB_2685734" "unprognostic (8.65e-2)" "unprognostic (3.11e-1)" "unprognostic (5.59e-2)" "unprognostic (2.33e-2)" "unprognostic (1.49e-3)" "unprognostic (8.37e-2)" "unprognostic (4.11e-2)" "unprognostic (1.81e-2)" "unprognostic (3.36e-1)" "unprognostic (8.88e-2)" "unprognostic (8.67e-2)" "unprognostic (2.42e-2)" "unprognostic (1.43e-1)" "unprognostic (8.95e-3)" "unprognostic (2.89e-1)" "unprognostic (2.82e-1)" "unprognostic (6.17e-2)" 0.6 0.3 0.9 1.0 1.3 0.1 1.8 1.0 1.2 1.1 0.7 1.0 0.9 1.4 2.2 0.5 1.5 0.7 0.9 0.8 1.0 1.7 0.9 0.7 1.9 1.4 1.1 2.3 1.0 0.6 0.4 1.5 1.1 1.4 1.3 1.9 1.3 1.5 0.2 0.8 0.9 0.8 1.1 1.5 1.4 3.6 1.1 1.9 1.8 0.2 1.9 1.1 0.8 1.6 1.0 0.5 1.1 0.0 1.5 1.7 0.0 0.3 0.1 1.3 0.7 1.4 0.7 2.5 1.6 0.4 0.2 1.9 0.6 0.0 1.1 0.0 0.5 0.0 0.7 1.7 1.2 0.0 1.2 1.3 1.6 1.3 0.0 0.3 0.8 0.0 1.5 0.0 1.7 4.1 0.0 0.0 0.0 2.4 0.0 1.6 2.8 0.3 0.7 0.7 2.5 2.4 1.5 2.4 2.6 2.1 1.0 1.6 0.5 1.5 1.7 0.4 0.0 0.0 1.4 1.1 0.3 0.0 0.1 0.0 0.1 0.3 0.2 0.3 0.4 0.6 0.2 0.1 0.1 0.6 0.8 0.5 0.0 0.7 0.2 0.0 0.0 0.1 0.9 1.3 1.0 1.2 0.8 1.0 1.4 1.1 1.1 1.1 1.1 1.6 0.2 0.0 0.0 3.9 0.8 0.1 0.2 0.0 0.0 1.0 0.3 0.4 0.6 0.0 0.6 0.0 0.0 0.9 0.2 0.2 1.9 0.3 0.5 0.9 0.5 0.4 0.0 0.4 1.3 0.2 0.3 0.4 0.0 0.3 0.0 1.6 0.4 0.3 0.4 0.0 2.5 0.1 0.0 0.3 0.0 0.4 0.0 0.2 0.0 2.8 0.6 2.3 1.0 2.5 2.7 0.0 0.1 1.2 0.0 0.1 0.1 1.0 0.9 0.6 0.0 0.1 0.2 2.4 2.8 0.3 0.0 0.3 0.3 0.5 0.6 0.1 ZNF574 FLJ22059 ENSG00000105732 "Zinc finger protein 574" Q6ZN55 19 42068477-42081552 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023196, HPA057274" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Vesicles "HPA023196: AB_2671105, HPA057274: AB_2683392" "unprognostic (3.90e-1)" "unprognostic (3.68e-2)" "unprognostic (3.39e-2)" "unprognostic (7.84e-2)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (9.49e-2)" "unprognostic (2.84e-2)" "unprognostic (5.24e-2)" "unprognostic (1.55e-3)" "unprognostic (6.36e-3)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (6.48e-2)" "unprognostic (3.51e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" 8.1 5.4 6.8 4.6 6.1 11.1 7.9 9.5 7.7 8.4 4.3 9.5 6.7 10.3 2.7 9.6 8.8 5.1 6.8 6.2 6.2 5.5 5.4 5.6 6.5 6.9 5.8 9.6 7.9 6.1 6.5 5.0 5.8 7.5 2.8 4.1 8.1 6.7 9.3 12.8 7.5 3.7 5.6 8.4 7.2 27.1 6.3 6.3 6.0 6.4 4.2 8.2 7.5 6.3 15.0 41.1 9.0 11.4 8.1 8.0 9.7 11.0 9.6 14.2 13.6 16.2 10.1 21.4 9.7 9.1 7.5 8.9 10.4 14.1 5.6 11.4 17.6 20.5 10.1 14.0 8.6 12.6 13.5 9.5 13.9 13.2 11.1 8.7 7.9 11.8 17.1 13.3 10.1 31.2 15.2 10.9 16.1 13.5 16.2 20.7 8.6 9.3 7.4 19.7 14.9 12.8 11.3 24.0 7.3 6.2 11.0 20.5 9.5 19.2 14.9 5.8 16.4 14.3 9.3 15.7 10.6 11.9 11.0 12.3 10.5 16.7 16.2 7.8 17.6 17.3 12.1 17.8 12.5 12.8 12.6 11.9 13.3 10.9 11.2 11.1 10.3 12.9 6.8 6.1 9.5 7.7 6.2 6.2 6.9 5.8 5.8 5.6 6.3 6.3 6.0 0.0 3.3 1.3 11.3 29.3 15.1 6.1 40.9 7.5 11.0 7.6 4.3 4.3 6.0 1.8 2.1 7.9 6.3 5.8 1.9 6.9 25.3 6.1 5.7 7.6 3.5 8.6 1.4 5.1 6.7 6.6 7.7 5.7 12.7 5.4 6.8 3.1 5.1 3.3 1.7 7.6 6.1 2.5 11.0 15.7 5.6 3.0 8.8 1.0 7.5 3.9 4.1 1.5 0.9 4.3 8.5 8.6 8.1 10.6 6.4 4.3 5.2 9.8 6.6 8.8 8.0 35.5 20.5 22.1 22.7 4.8 10.6 3.8 7.9 9.6 ZNF576 MGC2508 ENSG00000124444 "Zinc finger protein 576" Q9H609 19 43596392-43601157 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 96.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050064 Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 37: B-cells - Transcription" "Cluster 35: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Golgi apparatus" "HPA050064: AB_2681003" "unprognostic (1.28e-2)" "unprognostic (8.69e-3)" "unprognostic (1.12e-1)" "unprognostic (1.84e-3)" "unprognostic (2.82e-2)" "unprognostic (1.05e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (1.60e-1)" "unprognostic (7.42e-3)" "unprognostic (2.42e-2)" "unprognostic (6.65e-3)" "unprognostic (8.66e-2)" "unprognostic (1.76e-3)" "unprognostic (2.58e-2)" "unprognostic (1.40e-1)" "unprognostic (3.02e-1)" "unprognostic (1.34e-3)" 10.3 13.9 10.3 7.1 11.2 3.4 10.5 12.5 12.5 10.7 6.0 12.4 9.4 11.4 4.8 11.1 9.8 7.9 11.7 10.1 9.8 12.0 18.7 6.8 8.4 11.3 11.5 11.8 9.4 8.7 15.0 5.1 11.3 15.1 4.8 5.3 10.7 6.8 14.0 9.0 9.7 5.5 9.9 9.3 10.2 13.6 12.1 7.6 9.1 10.7 5.2 11.9 10.1 11.2 21.9 24.9 9.1 11.6 11.7 10.5 8.1 17.8 11.6 17.5 19.4 12.2 16.2 14.3 19.7 13.4 10.2 8.6 13.0 12.6 4.7 15.6 22.3 10.5 16.7 15.4 9.9 14.2 18.8 9.1 15.4 15.3 6.0 8.7 12.6 12.3 13.3 18.0 13.2 21.4 20.0 6.3 6.4 18.0 21.0 16.7 8.0 14.1 10.5 19.2 16.7 10.5 11.7 23.3 9.3 6.5 11.0 16.2 13.2 23.3 13.1 10.5 26.5 9.4 11.4 10.0 20.1 16.4 20.6 10.5 15.2 16.2 17.2 15.4 15.5 28.2 17.2 14.6 15.9 18.6 18.5 14.6 8.5 19.3 15.6 25.4 18.9 11.5 10.3 11.2 12.5 12.5 10.1 9.8 11.3 11.5 11.3 9.9 12.1 11.2 12.7 6.4 7.3 1.3 11.3 10.6 8.7 17.1 11.4 23.2 15.1 20.1 13.1 10.0 12.7 14.7 31.3 13.7 11.0 16.8 21.5 18.9 34.2 8.6 12.5 13.5 11.4 8.6 3.4 18.9 20.3 13.4 6.6 7.9 9.5 42.0 14.6 20.3 15.4 23.5 3.1 11.9 6.1 6.3 9.2 96.2 13.4 6.6 19.6 0.0 11.1 24.8 12.3 4.0 3.7 19.3 13.0 15.4 9.6 18.0 30.6 32.4 10.7 33.4 6.6 11.3 11.3 28.4 19.4 11.8 12.4 5.7 8.7 14.7 16.0 10.9 ZNF623 KIAA0628 ENSG00000183309 "Zinc finger protein 623" O75123 8 143636019-143656418 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in all" "PC-3: 18.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044372 Uncertain Approved Nucleoplasm NA NA "Cluster 34: Basophils - Unknown function" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA044372: AB_10966790" "unprognostic (1.06e-3)" "unprognostic (1.38e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.44e-1)" "unprognostic (8.67e-2)" "unprognostic (4.00e-3)" "unprognostic (6.95e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-1)" "unprognostic (1.66e-1)" "unprognostic (2.25e-1)" "unprognostic (1.36e-1)" "unprognostic (2.08e-1)" "unprognostic (1.82e-1)" "unprognostic (5.21e-2)" "unprognostic (8.03e-2)" 5.8 5.0 2.5 1.8 2.3 0.6 5.5 1.8 3.0 7.4 1.2 7.4 2.3 7.0 1.7 6.2 6.6 1.5 6.0 2.6 2.7 5.2 5.7 5.2 2.3 2.2 2.1 8.5 5.4 2.8 5.9 1.8 2.5 5.9 2.0 1.7 6.0 1.3 7.2 7.8 6.4 2.1 1.5 6.8 5.4 7.2 2.7 2.1 5.2 1.8 1.9 7.6 6.5 2.3 3.0 6.9 2.6 2.5 4.1 8.0 2.5 2.9 3.8 4.7 3.3 2.4 2.5 1.8 3.6 6.5 3.2 1.9 3.0 1.9 3.7 5.1 2.3 7.5 7.3 2.2 3.2 1.7 2.1 3.3 3.8 2.0 8.7 5.1 3.3 4.9 6.1 3.3 3.4 6.6 5.8 2.4 3.4 3.7 18.3 4.0 2.3 2.8 2.6 4.0 6.4 6.2 11.9 2.4 4.0 2.6 5.4 5.2 1.5 4.4 1.5 1.8 2.4 1.9 2.3 2.8 3.2 2.8 3.6 1.1 0.2 0.4 0.4 0.4 0.3 0.4 0.3 0.3 0.3 0.5 0.4 0.4 0.4 0.2 0.5 0.5 0.4 0.2 2.5 2.3 1.8 3.0 2.6 2.7 2.2 2.1 2.5 1.5 2.7 2.3 4.6 6.4 3.9 3.9 5.8 1.7 3.1 1.6 7.4 5.9 4.4 4.2 10.3 7.2 1.5 7.3 6.2 5.9 4.7 5.8 3.9 5.9 5.4 3.0 8.1 5.8 5.4 9.9 7.5 3.8 6.0 5.6 4.6 5.0 1.3 9.2 7.1 6.6 5.8 15.2 5.3 5.3 2.0 6.6 2.4 4.5 8.4 4.6 3.6 4.7 8.3 7.2 7.2 5.5 5.4 4.4 2.3 13.9 2.8 4.5 5.4 3.9 1.3 7.0 19.7 8.2 5.1 10.8 13.9 6.2 2.6 4.8 5.8 5.8 5.2 1.7 ZNF629 "KIAA0326, ZNF65" ENSG00000102870 "Zinc finger protein 629" Q9UEG4 16 30778456-30787205 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019550, HPA056051" Uncertain Supported "Nucleoplasm,Golgi apparatus" NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 8: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "Golgi apparatus" "HPA019550: AB_1859386, HPA056051: AB_2683020" "unprognostic (1.03e-2)" "unprognostic (2.15e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (3.17e-1)" "unprognostic (6.38e-2)" "unprognostic (6.14e-2)" "unprognostic (2.98e-2)" "unprognostic (3.15e-1)" "unprognostic (6.24e-2)" "unprognostic (4.87e-3)" "unprognostic (2.66e-2)" "prognostic favorable (4.57e-10)" "unprognostic (8.41e-2)" "unprognostic (1.96e-1)" "unprognostic (5.71e-2)" "unprognostic (9.70e-2)" 5.6 9.0 5.6 3.0 6.0 4.1 5.7 7.1 5.9 6.5 4.3 6.8 5.5 8.0 4.3 5.1 6.6 3.6 12.6 5.9 6.1 7.8 4.3 5.3 1.9 6.2 6.7 6.8 5.9 15.0 6.6 3.6 5.6 6.3 4.5 7.8 6.5 6.0 9.7 8.6 5.3 6.8 5.0 4.0 7.3 4.1 7.0 3.9 5.9 9.6 2.3 6.5 5.1 5.5 9.8 15.8 23.9 18.5 11.5 10.6 3.6 10.8 15.6 16.6 14.0 9.7 8.8 1.8 10.2 17.6 5.2 11.4 11.7 14.3 11.0 0.4 17.6 13.6 14.0 10.2 12.3 4.8 8.0 17.7 10.5 10.3 8.6 13.0 8.9 0.8 20.2 0.4 14.6 20.8 7.2 6.3 12.6 4.7 6.4 24.3 18.4 0.8 13.9 15.9 22.6 25.3 10.5 19.4 2.6 7.8 14.6 17.4 10.8 15.5 10.1 10.6 8.3 0.3 0.1 0.5 10.2 11.9 5.3 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 0.3 0.1 0.6 0.0 0.1 5.6 6.0 7.1 5.9 5.9 6.1 6.2 6.7 5.6 5.0 7.0 5.5 4.9 19.2 9.4 5.9 2.6 1.9 3.4 4.3 5.7 16.7 4.2 3.4 28.3 4.3 6.5 9.2 4.2 1.3 1.6 5.4 1.9 8.7 1.7 5.1 9.5 8.0 11.5 4.6 2.4 8.0 0.6 5.3 7.1 5.3 2.5 10.7 8.2 4.7 4.4 16.8 3.7 7.9 6.1 5.2 3.0 4.7 9.3 2.6 1.8 1.0 7.7 13.4 1.0 4.5 3.4 10.9 5.0 4.5 3.0 4.8 5.1 4.3 5.9 12.4 0.0 6.7 5.6 4.6 1.5 3.8 1.8 0.5 1.4 8.3 9.0 3.8 ZNF687 KIAA1441 ENSG00000143373 "Zinc finger protein 687" Q8N1G0 1 151281618-151292176 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "eosinophil: 13.5" "Group enriched" "Detected in many" 8 "granulocytes: 13.5;monocytes: 4.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021193, HPA023948" Approved Enhanced Nucleoplasm NA NA "Cluster 49: Eosinophils - Unknown function" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA021193: AB_1859415, HPA023948: AB_2671380" "unprognostic (2.23e-1)" "unprognostic (3.25e-1)" "unprognostic (2.93e-2)" "unprognostic (9.64e-3)" "unprognostic (2.44e-2)" "unprognostic (7.82e-2)" "unprognostic (2.62e-2)" "unprognostic (1.56e-1)" "unprognostic (1.39e-1)" "unprognostic (9.91e-2)" "unprognostic (8.69e-3)" "unprognostic (2.10e-1)" "unprognostic (5.82e-3)" "unprognostic (1.36e-1)" "unprognostic (1.41e-1)" "unprognostic (8.54e-2)" "unprognostic (7.99e-2)" 8.5 10.9 9.0 8.2 9.9 31.2 8.7 12.6 10.2 9.9 6.9 10.7 8.6 10.5 5.5 11.0 9.7 7.0 8.9 8.5 8.4 10.2 9.7 8.6 10.1 10.5 9.6 11.7 16.0 14.1 13.0 7.1 9.5 11.3 5.7 9.4 12.0 8.6 10.9 12.3 11.3 6.1 8.9 14.4 10.8 14.5 9.7 9.3 10.8 6.9 7.5 10.4 8.7 10.5 14.8 21.5 20.4 12.6 11.3 9.5 26.3 7.6 12.9 13.8 13.1 18.1 19.6 12.6 18.7 12.3 14.7 22.3 18.1 15.2 6.1 17.3 18.3 11.9 18.8 20.1 12.1 14.3 16.7 14.7 15.3 11.6 12.1 12.3 9.4 13.4 19.5 22.6 7.8 44.8 19.2 16.8 27.6 19.8 16.5 16.9 16.1 22.8 11.6 22.1 18.5 27.7 20.8 24.6 19.7 19.2 32.2 30.1 9.2 11.0 12.1 13.9 11.6 26.2 24.1 31.3 14.0 9.4 14.2 0.5 1.8 13.5 0.5 2.3 0.5 1.0 0.5 0.4 0.9 1.1 0.7 0.8 8.8 0.4 4.5 0.8 0.4 1.2 9.0 9.9 12.6 10.2 8.5 8.4 10.5 9.6 9.5 8.9 9.7 10.5 4.3 3.2 4.6 3.6 5.8 4.7 2.8 4.9 5.7 6.7 6.0 5.5 1.4 10.0 3.5 1.8 10.4 6.7 3.8 9.3 3.9 5.5 3.1 4.3 3.7 4.4 2.4 3.0 1.6 6.0 5.3 4.2 7.7 5.3 0.0 8.5 2.9 4.5 5.3 8.4 1.9 5.6 8.2 5.2 4.1 2.8 6.2 5.8 0.0 2.8 6.0 5.2 5.2 3.0 1.7 7.3 3.5 7.2 5.8 4.7 10.2 4.1 3.4 10.8 13.1 4.4 3.9 6.9 6.8 4.3 3.4 9.4 4.3 6.5 7.3 5.1 ZNF789 ENSG00000198556 "Zinc finger protein 789" Q5FWF6 7 99472890-99503650 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 33.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029500, HPA050793" Uncertain Enhanced Nucleoplasm NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA029500: AB_10603009, HPA050793: AB_2681240" "unprognostic (6.84e-3)" "unprognostic (5.75e-2)" "unprognostic (5.71e-2)" "unprognostic (2.49e-2)" "unprognostic (3.08e-1)" "unprognostic (2.90e-2)" "unprognostic (1.25e-3)" "unprognostic (4.38e-3)" "unprognostic (5.16e-2)" "unprognostic (1.56e-1)" "prognostic favorable (7.14e-4)" "unprognostic (1.58e-2)" "prognostic unfavorable (3.56e-4)" "unprognostic (6.63e-2)" "unprognostic (2.03e-1)" "unprognostic (8.33e-2)" "prognostic favorable (5.31e-6)" 5.2 5.7 8.2 4.7 8.3 7.6 5.5 11.0 9.9 7.7 8.1 8.7 8.5 6.1 7.2 5.0 7.1 2.6 4.6 8.3 8.7 9.8 8.8 4.9 6.2 8.4 8.7 7.9 7.6 3.3 11.8 2.6 8.8 16.4 7.3 11.7 6.1 4.3 5.7 7.3 9.8 3.7 8.0 10.7 6.1 13.4 8.5 4.5 8.4 2.9 5.8 5.1 5.2 9.2 12.0 3.8 6.1 11.0 1.9 1.8 8.4 5.8 2.2 3.7 7.9 6.0 7.7 8.6 4.8 2.7 3.7 5.0 3.2 3.3 5.0 4.0 6.0 6.6 10.3 11.8 3.1 4.3 14.5 2.1 2.8 7.2 3.5 2.2 3.9 11.1 10.2 7.7 3.3 11.6 5.7 12.0 6.1 5.7 5.6 7.0 6.2 9.4 4.9 3.4 5.9 6.6 4.2 11.8 7.3 3.4 3.0 7.5 6.1 6.4 8.0 9.9 5.9 5.0 7.6 11.9 10.8 8.2 6.9 2.0 1.5 1.5 2.3 1.0 2.7 2.3 3.0 2.6 5.2 3.6 6.0 3.7 0.3 4.2 1.3 13.5 5.1 1.8 8.2 8.3 11.0 9.9 8.3 8.7 8.4 8.7 8.8 8.0 8.5 9.2 8.2 0.0 6.3 11.8 9.5 5.5 4.2 4.0 4.6 18.3 6.3 6.7 2.4 1.5 4.6 1.8 14.6 4.4 14.0 6.3 1.9 3.8 33.9 5.2 4.8 7.2 5.4 8.6 10.4 5.4 3.2 4.7 9.2 5.6 3.8 11.8 1.8 3.5 6.9 6.7 12.7 6.3 4.1 3.1 6.5 8.4 3.4 4.6 7.2 10.3 3.8 12.0 5.2 12.5 10.6 4.3 5.4 4.5 6.1 2.7 5.2 4.6 4.9 14.7 0.0 6.5 4.8 20.8 4.8 6.7 5.3 2.2 6.9 8.5 6.6 3.4 ZNHIT1 "CG1I, H_DJ0747G18.14, ZNFN4A1" ENSG00000106400 "Zinc finger HIT-type containing 1" O43257 7 101218165-101224190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 905.3;Proximal tubular cells: 889.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019043 Uncertain Approved Nucleoplasm NA NA "Cluster 31: Non-specific - Inflammatory response" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA019043: AB_1859481" "unprognostic (1.16e-1)" "unprognostic (3.55e-1)" "unprognostic (3.52e-3)" "unprognostic (1.24e-1)" "unprognostic (4.26e-2)" "unprognostic (6.61e-2)" "unprognostic (3.49e-2)" "unprognostic (3.72e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-2)" "unprognostic (1.05e-2)" "unprognostic (2.02e-2)" "unprognostic (2.10e-3)" "unprognostic (1.98e-1)" "unprognostic (2.01e-1)" "unprognostic (3.36e-1)" "unprognostic (7.24e-3)" 67.1 58.3 142.9 34.3 149.3 59.5 53.7 153.0 173.5 51.9 149.9 65.4 66.8 38.4 54.1 45.4 60.8 46.5 67.6 141.2 146.9 82.3 199.3 38.1 48.5 152.3 148.5 32.5 62.3 77.8 45.0 44.1 149.5 49.1 43.2 21.0 73.6 52.8 90.8 46.3 58.0 39.8 148.5 48.7 62.8 20.7 148.6 55.8 49.2 70.0 38.8 44.8 39.1 158.1 100.1 92.5 61.8 128.6 114.4 147.4 63.0 113.8 112.8 111.2 111.2 97.6 120.9 70.1 154.6 132.7 87.8 80.2 56.5 159.8 49.1 76.7 221.5 37.8 83.0 116.6 142.7 75.4 82.9 137.8 190.5 97.6 49.8 94.0 166.4 102.4 121.4 126.8 99.9 280.8 145.0 411.2 121.8 151.5 239.7 73.5 47.7 222.1 154.4 46.6 79.6 176.0 79.8 166.2 197.7 70.5 44.6 99.8 121.8 109.0 94.0 190.6 91.0 95.8 136.8 95.3 101.7 142.5 138.7 231.5 214.5 220.2 121.3 202.7 126.5 130.9 133.6 124.4 186.6 142.4 107.9 114.7 181.3 121.4 205.5 202.3 195.2 234.5 142.9 149.3 153.0 173.5 141.2 146.9 152.3 148.5 149.5 148.5 148.6 158.1 203.1 93.0 81.8 6.8 85.3 100.7 121.1 214.6 76.2 30.8 146.0 163.3 77.6 183.0 139.4 191.3 16.7 204.4 115.8 358.1 361.9 200.5 30.5 177.2 153.2 158.5 241.4 195.5 4.6 254.5 199.9 124.7 121.3 169.9 78.6 110.4 174.9 905.3 205.9 11.8 5.0 315.6 166.8 205.4 133.7 59.9 135.2 126.3 129.9 5.6 222.1 89.9 176.1 5.0 17.3 271.4 389.9 124.8 119.4 89.4 432.8 889.4 139.4 37.4 151.2 71.7 150.1 70.6 42.0 109.1 116.5 163.5 104.5 153.8 287.1 138.8 ZP3 "ZP3-372, ZP3-424, ZP3A, ZP3B, ZPC" ENSG00000188372 "Zona pellucida glycoprotein 3" P21754 7 76397518-76442071 "Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins" Fertilization Receptor "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Basal respiratory cells: 78.4;Early spermatids: 45.6;Late spermatids: 89.7;Spermatocytes: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 35.2;hTCEpi: 37.8;Karpas-707: 52.0;MCF7: 71.6;OE19: 30.2" "Not detected" "Not detected" "HPA054061, HPA071198" Supported "Secreted in female reproductive system" NA NA "Cluster 14: Monocytes - Unknown function" "Cluster 50: Non-specific - Ribosome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "HPA054061: AB_2682363, HPA071198: " "unprognostic (6.48e-2)" "unprognostic (3.08e-1)" "unprognostic (7.74e-2)" "unprognostic (1.59e-1)" "unprognostic (9.04e-2)" "unprognostic (2.68e-2)" "unprognostic (1.99e-3)" "unprognostic (1.29e-1)" "unprognostic (9.20e-2)" "unprognostic (1.94e-1)" "unprognostic (3.10e-3)" "unprognostic (1.15e-2)" "prognostic unfavorable (1.02e-6)" "unprognostic (1.33e-1)" "unprognostic (1.42e-2)" "unprognostic (6.72e-2)" "unprognostic (2.13e-1)" 1.0 2.9 1.1 0.7 1.9 2.2 3.1 1.3 1.7 1.1 1.9 2.4 1.9 0.8 2.2 4.2 4.0 0.6 0.3 1.0 1.1 1.0 0.8 0.5 0.8 1.2 1.0 2.8 4.1 0.6 1.2 0.6 1.3 1.4 2.6 0.5 1.5 0.7 1.4 4.1 1.1 1.1 1.0 1.8 1.1 1.3 1.2 0.5 0.8 0.4 0.9 0.7 2.4 1.3 17.6 35.2 0.2 18.4 0.9 1.0 0.9 1.2 2.8 0.3 3.3 1.3 15.2 0.1 0.6 4.6 0.5 4.3 3.8 1.2 0.3 9.5 8.5 2.8 10.5 0.1 8.0 0.7 5.2 1.5 37.8 3.9 1.1 0.1 0.7 9.1 4.0 52.0 0.0 71.6 1.6 9.1 3.8 30.2 10.0 0.1 1.5 3.9 1.6 0.2 7.6 0.0 4.6 23.9 0.6 0.4 15.6 3.0 2.2 0.1 1.8 0.1 0.1 15.4 13.4 0.1 1.5 20.2 3.2 0.6 9.4 0.1 0.1 4.0 0.4 2.4 1.1 0.5 9.6 1.1 4.5 3.2 0.8 0.2 4.5 2.0 0.1 3.1 1.1 1.9 1.3 1.7 1.0 1.1 1.2 1.0 1.3 1.0 1.2 1.3 2.6 3.2 3.6 1.3 2.9 8.5 5.8 78.4 9.6 1.5 9.3 12.6 0.8 4.3 21.1 1.8 0.0 5.8 2.7 5.3 0.0 2.9 45.6 1.6 1.4 2.8 4.2 3.0 3.3 4.3 3.6 1.9 1.1 3.0 0.0 5.0 2.9 0.8 7.0 1.7 2.7 4.7 6.1 7.2 4.6 89.7 4.4 5.7 3.6 2.8 5.4 4.4 0.0 1.5 1.7 3.3 8.6 5.7 4.2 5.5 0.6 3.7 20.4 2.0 6.6 3.1 2.5 34.9 12.4 9.0 9.9 9.3 2.2 2.7 7.6 17.1 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857614-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 7.6;Inhibitory neurons: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: AB_2682887, HPA060508: AB_2684297" "prognostic unfavorable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 1.3 2.9 2.3 2.0 2.2 0.7 1.8 2.8 2.5 1.8 1.4 2.3 2.4 1.9 2.8 1.8 2.1 1.5 2.0 2.1 2.3 1.8 2.3 1.9 3.4 2.0 2.1 2.7 1.5 2.2 1.9 1.7 2.1 1.9 2.3 3.3 1.8 1.6 1.4 2.2 2.4 1.7 2.0 3.2 1.8 3.2 2.2 3.5 1.9 2.4 3.9 1.6 1.4 2.1 1.7 1.4 4.1 2.4 4.9 3.5 2.4 2.6 3.1 4.7 4.6 5.9 2.6 5.3 8.8 2.2 2.3 2.8 5.9 2.8 3.5 3.3 2.5 5.1 2.6 3.8 5.9 2.9 6.7 3.2 3.1 3.6 2.2 5.0 4.1 4.6 4.8 2.5 3.6 8.5 4.0 5.8 1.6 3.9 5.6 3.9 3.8 4.0 1.3 1.0 5.4 2.7 4.2 4.8 3.3 3.1 2.3 7.6 4.1 4.7 1.5 1.8 1.6 5.4 3.0 3.4 4.0 3.4 1.5 1.0 1.1 1.6 1.3 1.5 2.8 2.1 1.5 2.0 1.9 1.8 1.4 1.9 0.8 1.7 4.8 1.1 2.4 1.1 2.3 2.2 2.8 2.5 2.1 2.3 2.0 2.1 2.1 2.0 2.2 2.1 1.6 3.2 1.1 4.6 4.1 0.4 0.3 0.7 0.6 4.4 1.1 1.0 1.3 0.0 0.5 1.8 0.0 1.3 1.4 2.8 0.0 1.2 0.5 0.6 1.2 1.8 2.4 0.8 7.6 1.4 0.6 1.4 1.5 1.0 0.0 5.2 2.2 0.8 1.0 0.0 9.2 1.1 0.0 1.3 1.4 0.7 0.3 1.1 0.0 6.5 0.6 2.8 0.0 7.1 7.0 0.6 0.3 1.2 2.6 0.2 2.0 1.2 0.5 4.3 0.0 1.3 1.2 2.4 4.3 1.3 0.3 0.8 3.1 4.7 0.9 0.4 ZSWIM7 SWS1 ENSG00000214941 "Zinc finger SWIM-type containing 7" Q19AV6 17 15976560-15999717 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054681 Uncertain Uncertain Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA054681: AB_2682572" "unprognostic (3.07e-2)" "unprognostic (5.51e-2)" "unprognostic (1.58e-1)" "prognostic favorable (3.54e-5)" "unprognostic (1.58e-1)" "unprognostic (1.15e-1)" "unprognostic (1.75e-2)" "unprognostic (8.28e-2)" "unprognostic (4.61e-2)" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (4.23e-2)" "unprognostic (1.84e-2)" "unprognostic (8.56e-2)" "unprognostic (2.45e-3)" "unprognostic (8.80e-3)" "unprognostic (1.70e-1)" 12.5 18.0 6.9 6.0 7.2 4.3 12.6 6.8 10.4 11.8 6.2 12.9 7.3 11.7 4.8 8.5 10.9 4.4 18.2 7.3 7.8 14.5 13.8 10.1 7.2 7.4 7.1 15.7 12.6 6.6 16.2 5.4 7.5 10.8 4.6 5.6 9.3 4.7 32.7 10.9 10.1 5.4 6.8 13.9 10.2 5.8 7.7 4.6 11.7 10.2 3.7 10.4 10.4 7.5 17.2 24.5 12.4 30.1 5.1 4.8 15.1 11.3 4.4 11.7 8.6 4.6 4.9 8.1 9.8 12.2 3.5 5.5 4.1 8.9 5.5 8.7 14.1 9.3 11.5 9.7 12.1 7.5 15.1 11.7 15.4 6.4 11.0 1.7 15.1 21.2 5.9 4.5 6.1 23.2 26.2 17.4 8.1 25.0 14.4 16.2 31.7 13.1 10.6 9.0 4.4 18.9 17.5 17.4 12.4 33.2 12.5 1.8 21.5 18.9 6.4 4.9 9.9 2.3 6.3 9.8 16.2 9.3 16.3 28.0 27.2 12.0 13.6 27.5 14.6 26.8 15.9 13.1 42.0 24.6 18.8 18.0 1.6 18.0 19.8 25.9 12.6 19.7 6.9 7.2 6.8 10.4 7.3 7.8 7.4 7.1 7.5 6.8 7.7 7.5 42.4 35.3 54.5 16.6 35.7 25.6 33.7 50.0 37.0 38.4 56.0 65.0 65.0 67.2 32.7 40.5 62.6 99.9 39.2 35.0 86.1 56.5 13.6 32.9 40.0 33.9 50.8 24.0 16.1 52.0 58.9 29.5 21.9 27.6 55.2 52.3 37.5 55.2 49.7 18.5 13.4 37.1 59.0 55.4 37.8 14.4 45.4 53.0 55.2 15.0 46.9 60.1 53.5 14.6 21.9 50.6 35.7 39.9 24.5 37.0 50.0 134.5 35.8 56.9 26.3 33.9 30.6 87.1 74.1 28.8 27.6 72.8 29.1 71.2 36.3 28.8